qid,sentid,question,sentence text,label
2346,0,What are the 4 cardinal signs of inflammation according to Celsus?,"Tumor, calor, rubor, and dolor describe four cardinal signs of inflammation.",1
2346,1,What are the 4 cardinal signs of inflammation according to Celsus?,"Reference was paid to the cardinal signs of inflammation (pain, heat, redness, and swelling)",0
2346,2,What are the 4 cardinal signs of inflammation according to Celsus?,Inflammation is the body's response to injury or infection.,0
2346,3,What are the 4 cardinal signs of inflammation according to Celsus?,"As early as 2000 years ago, the Roman encyclopaedist Aulus Cornelius Celsus recognised four cardinal signs of this response-redness, heat, swelling and pain;",0
2346,4,What are the 4 cardinal signs of inflammation according to Celsus?," inflammation gives rise to clinical cardinal signs: rubor, calor, dolor, tumor",0
2346,5,What are the 4 cardinal signs of inflammation according to Celsus?,"The cardinal signs of inflammation dolor, calor, tumor and rubor",1
2346,6,What are the 4 cardinal signs of inflammation according to Celsus?,"The concept of the four cardinal signs of acute inflammation comes from antiquity as rubor et tumor cum calore et dolore, (redness and swelling with heat and pain)",0
2346,7,What are the 4 cardinal signs of inflammation according to Celsus?,"Inflammation is considered a nonspecific response to injury, characterized by exudation of serum into damaged tissue, and identified by the cardinal signs of rubor, calor, dolor, and tumor.",0
2346,8,What are the 4 cardinal signs of inflammation according to Celsus?,"four well-known cardinal signs of Celsus (rubor, calor, tumor, dolor)",1
2346,9,What are the 4 cardinal signs of inflammation according to Celsus?,"four cardinal signs of Celsus (redness, heat, swelling and pain).",1
2346,10,What are the 4 cardinal signs of inflammation according to Celsus?,Inflammation,0
2346,11,What are the 4 cardinal signs of inflammation according to Celsus?,"(the famous four cardinal signs of Celsus: pain, redness, swelling, heat)",0
2346,12,What are the 4 cardinal signs of inflammation according to Celsus?,"As early as 2000 years ago, the Roman encyclopaedist Aulus Cornelius Celsus recognised four cardinal signs of this response-redness, heat, swelling and pain; a fifth sign is loss of function.",0
2346,13,What are the 4 cardinal signs of inflammation according to Celsus?,[...,0
2346,14,What are the 4 cardinal signs of inflammation according to Celsus?,"It was Galen who added the disturbance of function (functio laesa) as the fifth cardinal sign of inflammation to the four well-known cardinal signs of Celsus (rubor, calor, tumor, dolor).",0
2346,15,What are the 4 cardinal signs of inflammation according to Celsus?,"The concept of the four cardinal signs of acute inflammation comes from antiquity as rubor et tumor cum calore et dolore, (redness and swelling with heat and pain) extended later by functio laesa (loss of function).",0
2346,16,What are the 4 cardinal signs of inflammation according to Celsus?,"The cardinal signs of inflammation dolor, calor, tumor and rubor are intrinsically associated with events including vasodilatation, edema and leukocyte trafficking into the site of inflammation.",0
2346,17,What are the 4 cardinal signs of inflammation according to Celsus?,"Tumor, calor, rubor, and dolor describe four cardinal signs of inflammation.",1
2346,18,What are the 4 cardinal signs of inflammation according to Celsus?,"The four cardinal signs of inflammation are redness, swelling, heat, and pain, phenomena explained at the cellular level.",0
2346,19,What are the 4 cardinal signs of inflammation according to Celsus?,inflammation is the body s response to injury or infection as early as 2000 years ago the roman encyclopaedist aulus cornelius celsus recognised four cardinal signs of this response redness heat swelling and pain a fifth sign is loss of function.,0
457,0,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab, a humanized monoclonal antibody that binds to and inactivates interleukin-5, has been shown to reduce asthma exacerbations in patients with severe eosinophilic asthma.",1
457,1,Which molecule is targeted by a monoclonal antibody Mepolizumab?," Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks.",0
457,2,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Among developing therapies, biologics designed to block certain pro-inflammatory cytokines, such as IL-5 (mepolizumab) and IL-13 (lebrikizumab), have a greater chance of being used in the clinic.",0
457,3,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Imatinib and mepolizumab, a humanized anti-interleukin 5 monoclonal antibody, may be useful in patients with eosinophilic myositis as part of a hypereosinophilic syndrome.",1
457,4,Which molecule is targeted by a monoclonal antibody Mepolizumab?, Recent results of the treatment of idiopathic hypereosinophilic syndrome (HES) with the anti-interleukin 5 monoclonal antibody mepolizumab showed its efficacy and manageable safety profile.,0
457,5,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Individuals also received a segmental bronchoprovocation with allergen (SBP-Ag) 1 month before and after administering a single dose of mepolizumab (anti-IL-5 monoclonal antibody) to reduce airway EOS.,0
457,6,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"For example, patients with the hypereosinophilic syndrome have received mepolizumab, an anti-IL-5 monoclonal antibody, for as long as 6 years and have not developed any characteristic set of adverse events.",0
457,7,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials.,0
457,8,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Previous clinical trials have evaluated the efficacy and safety of mepolizumab, a monoclonal antibody against IL-5, in patients with asthma.",0
457,9,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"In this large (616 patients), double-blind, placebo-controlled, dose-ranging study of mepolizumab (a monoclonal antibody that blocks IL-5 binding to its receptor), patients were given placebo, 75-, 250- or 750-mg mepolizumab by intravenous infusion every 4 weeks for 1 year.",0
457,10,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"BACKGROUND: We examined levels of hyaluronan, a matrix glycosaminoglycan and versican, a matrix proteoglycan, in the sputum of asthmatics treated with mepolizumab (anti-IL-5 monoclonal antibody) versus placebo to evaluate the utility of these measurements as possible biomarkers of asthma control and airway remodeling.",0
457,11,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab is a humanized monoclonal antibody that blocks binding of the key cytokine implicated specifically in eosinophil maturation and survival, interleukin-5, to its receptor.",1
457,12,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Early studies suggest that inhibition of eosinophilic airway inflammation with mepolizumab-a monoclonal antibody against interleukin 5-is associated with a reduced risk of exacerbations.,0
457,13,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"IL-5 antagonist therapies in current development include two monoclonal anti-IL-5 antibodies (mepolizumab, reslizumab), a monoclonal antibody directed at the IL-5 receptor (benralizumab), and anti-sense oligonucleotide therapy (TPI ASM8).",0
457,14,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Two monoclonal antibodies have been designed to neutralize IL-5 (mepolizumab and reslizumab).,0
457,15,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"To date, two humanized monoclonal antibodies, mepolizumab and reslizumab, have been developed that bind to human IL-5.",0
457,16,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab (Bosatria(®), GlaxoSmithKline) is a biologic agent developed to treat asthma.",0
457,17,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"It represents a humanized monoclonal antibody of IgG1 κ type, which targets human IL-5 and thus prevents its interaction with the α-chain of the IL-5 receptor.",0
457,18,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"There has been a variable effect with the leukotriene receptor antagonist montelukast and promising early results with mepolizumab, a monoclonal antibody against interleukin-5.",0
457,19,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody.",0
457,20,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab is a fully humanized monoclonal antibody (IgG1/κ) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function.",0
457,21,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex on the eosinophil cell surface, thereby inhibiting IL-5 signalling.",0
457,22,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Recently, encouraging results of treatment with monoclonal antibody neutralizing IL-5, mepolizumab, have been published.",0
457,23,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"This manuscript reviews the available treatments for HES and the range of side-effects associated with long-term corticosteroid use, and then focuses on the anti-IL-5 monoclonal antibodies, mepolizumab and reslizumab.",0
457,24,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"The therapeutic progress is primarily due to an explosion of biological therapies, particularly four of them very useful for internists (in an off label use) : Interleukin 1 inhibitors (anakinra, Canakinumab) to treat some auto inflammatory diseases (cryopirin associated periodic syndromes and deficency of interleukin 1 receptor antagonist), monoclonal antibody against interleukin 5 (mepolizumab) to treat some hypereosinophilic syndromes and Churg and Strauss angiitis, interleukin 6 inhibitiors to treat multifocal Castleman's disease and adult Still disease, a monoclonal antibody against vascular endothelial growth factor (Bevacizumab) to treat hereditary hemorrhagic telangiectasia.",0
457,25,Which molecule is targeted by a monoclonal antibody Mepolizumab?," Besides steroid therapy, the anti-IL-5 monoclonal antibody mepolizumab is considered as a target therapy for L-HES.",0
457,26,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Mepolizumab is a humanized monoclonal antibody (mAb) with potent IL-5 neutralizing effects that represents a potential treatment for eosinophilic diseases.,1
457,27,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.",0
457,28,Which molecule is targeted by a monoclonal antibody Mepolizumab?,The pharmacodynamic effect of mepolizumab (a humanised anti-interleukin-5 monoclonal antibody) in EoO was evaluated.,0
457,29,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"We studied the prednisone-sparing effect of mepolizumab, a monoclonal antibody against interleukin-5, in a rare subgroup of patients who have sputum eosinophilia and airway symptoms despite continued treatment with prednisone.",0
457,30,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Subjects received infusions of either mepolizumab, an anti-interleukin-5 monoclonal antibody (29 subjects), or placebo (32) at monthly intervals for 1 year.",0
457,31,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"A recent study showed that a monoclonal antibody to IL-5, mepolizumab, reduced glucocorticoid therapy in HES patients who did not possess the FIP1L1-PDGFRA mutation while controlling eosinophilia and preventing recurrence or progression of tissue damage.",0
457,32,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"METHODS: We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome.",0
457,33,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.",0
457,34,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab is an anti-interleukin-5 monoclonal antibody that is in clinical trials with GlaxoSmithKline (GSK) for the treatment of severe asthma, nasal polyposis and hypereosinophilic syndrome and eosinophilic oesophagitis (the latter two indications are classed as eosinophilia in the phase table).",0
457,35,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"A previous small dose-finding study found that mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, had no effect on allergen challenge in humans.",0
457,36,Which molecule is targeted by a monoclonal antibody Mepolizumab?,No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.,0
457,37,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab is a monoclonal antibody to interleukin-5, which reduces peripheral blood eosinophils.",1
457,38,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Previously, we reported that mepolizumab treatment did not result in clinical improvement in AD.",0
457,39,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab, an anti-IL-5 monoclonal antibody, currently being evaluated, seems promising.",0
457,40,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"These include imatinib mesylate, a tyrosine kinase inhibitor, and more recently, mepolizumab, an anti-IL-5 monoclonal antibody.",0
457,41,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.,0
457,42,Which molecule is targeted by a monoclonal antibody Mepolizumab?,A monoclonal antibody to human interleukin-5 (mepolizumab) was developed for atopic diseases.,0
457,43,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Anti-IL-5 monoclonal antibody (mepolizumab) reduces baseline bronchial mucosal eosinophils and deposition of extracellular matrix proteins in the reticular basement membrane in mild asthma.,0
457,44,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Skin biopsies were performed in 24 atopic subjects at allergen- and diluent-injected sites before 6 and 48 h after, three infusions of a humanized, monoclonal antibody against IL-5 (mepolizumab) using a randomized double-blind, placebo-controlled design.",0
457,45,Which molecule is targeted by a monoclonal antibody Mepolizumab?,OBJECTIVE: We aimed to assess the safety and efficacy of a humanized blocking monoclonal antibody against IL-5 (mepolizumab) in patients with several forms of hyper-eosinophilic syndromes.,0
457,46,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.,0
457,47,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Bronchial biopsies were obtained before and after three infusions of a humanized, anti-IL-5 monoclonal antibody (mepolizumab) in 24 atopic asthmatics in a randomized, double-blind, placebo-controlled study.",0
457,48,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"GlaxoSmithKline (formerly SmithKline Beecham) is developing mepolizumab (SB-240563), a monoclonal antibody directed against IL-5, as a potential treatment for asthma and atopic dermatitis.",0
457,49,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"METHODS: Blood, bone marrow, and airway mucosal biopsy specimens were examined before and after anti-IL-5 (mepolizumab) treatment of asthmatic individuals in a double-blind, placebo-controlled trial.",0
457,50,Which molecule is targeted by a monoclonal antibody Mepolizumab?,Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics.,0
457,51,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"The role of eosinophils as effector cells in asthma pathogenesis has been questioned since an anti-interleukin (IL)-5 monoclonal antibody (mepolizumab), which depleted blood and sputum eosinophils, failed to inhibit allergen-induced bronchoconstriction and airway hyperresponsiveness.",0
457,52,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab (SB-240563), a humanized monoclonal antibody (mAb) specific for human IL-5, is currently in clinical trials for treatment of asthma.",0
457,53,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"CONCLUSION: These studies demonstrate that chronic antagonism of IL-5 by mepolizumab in monkeys is safe and has the potential, through long-term reductions in circulating and tissue-resident eosinophils, to be beneficial therapy for chronic inflammatory respiratory diseases.",0
457,54,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.",0
457,55,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab is a fully humanized monoclonal antibody (IgG1/�) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function.",0
457,56,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"BACKGROUND: Mepolizumab, a monoclonal anti-IL-5 antibody, is an effective corticosteroid-sparing agent for patients with Fip1-like 1/platelet-derived growth factor receptor � fusion (F/P)-negative hypereosinophilic syndrome (HES).",0
457,57,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab is a fully humanized monoclonal antibody (IgG1/κ) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function",0
457,58,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex on the eosinophil cell surface, thereby inhibiting IL-5 signalling",0
457,59,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"Besides steroid therapy, the anti-IL-5 monoclonal antibody mepolizumab is considered as a target therapy for L-HES",0
457,60,Which molecule is targeted by a monoclonal antibody Mepolizumab?,"IL-5 antagonist therapies in current development include two monoclonal anti-IL-5 antibodies (mepolizumab, reslizumab), a monoclonal antibody directed at the IL-5 receptor (benralizumab), and anti-sense oligonucleotide therapy (TPI ASM8)",0
3891,0,What is a bacteriocin?,"One such strategy involves using narrow-spectrum protein antibiotics (so-called bacteriocins), which diverse bacteria use to compete against closely related species.",1
3891,1,What is a bacteriocin?,"Many enterococcal strains produce bacteriocins, which could be useful as natural food preservatives through inhibition of pathogenic and spoilage microorganisms.",1
3891,2,What is a bacteriocin?,"Bacteriocins, the ribosomally produced antimicrobial peptides of bacteria, represent an untapped source of promising antibiotic alternatives",1
3271,0,Salzburg EEG criteria are used to diagnose which disorder?,Reevaluation of the Critically Ill Patients With Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria.,0
3271,1,Salzburg EEG criteria are used to diagnose which disorder?,OBJECTIVE: We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus (NCSE).,0
3271,2,Salzburg EEG criteria are used to diagnose which disorder?,CONCLUSION AND SIGNIFICANCE: Our findings suggest that SCC is highly compatible with clinical practice in the decision for treatment of patients with NCSE.,0
3271,3,Salzburg EEG criteria are used to diagnose which disorder?,Clinical presentations and the Salzburg EEG criteria for NCSE were used to identify patients with NCSE after CSE.,1
3271,4,Salzburg EEG criteria are used to diagnose which disorder?,EEGs recorded in the ICU were classified using the Salzburg criteria for NCSE.,0
3271,5,Salzburg EEG criteria are used to diagnose which disorder?,Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study.,0
3271,6,Salzburg EEG criteria are used to diagnose which disorder?,"BACKGROUND: Several EEG criteria have been proposed for diagnosis of non-convulsive status epilepticus (NCSE), but none have been clinically validated.",0
3271,7,Salzburg EEG criteria are used to diagnose which disorder?,"We aimed to assess the diagnostic accuracy of the EEG criteria proposed by a panel of experts at the fourth London-Innsbruck Colloquium on Status Epilepticus in Salzburg, 2013 (henceforth called the Salzburg criteria).",0
3271,8,Salzburg EEG criteria are used to diagnose which disorder?,"Two raters blinded to all other patient data retrospectively analysed the EEG recordings and, using the Salzburg criteria, categorised patients as in NCSE or not in NCSE.",0
3271,9,Salzburg EEG criteria are used to diagnose which disorder?,"INTERPRETATION: The Salzburg criteria for diagnosis of NCSE have high diagnostic accuracy and excellent inter-rater agreement, making them suitable for implementation in clinical practice.",0
3271,10,Salzburg EEG criteria are used to diagnose which disorder?,Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus--approach to clinical application.,0
3271,11,Salzburg EEG criteria are used to diagnose which disorder?,BACKGROUND: Salzburg Consensus Criteria for diagnosis of Non-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus in Salzburg (2013).,0
3271,12,Salzburg EEG criteria are used to diagnose which disorder?,"The Salzburg Consensus Criteria for NCSE [1] have been modified according to the Standardized Terminology of the American Clinical Neurophysiology Society [2] and validated in three different cohorts, with a sensitivity of 97.2%, a specificity of 95.9%, and a diagnostic accuracy of 96.3% in patients with clinical signs of NCSE.",0
3271,13,Salzburg EEG criteria are used to diagnose which disorder?,"Two raters blinded to all other patient data retrospectively analysed the EEG recordings and, using the Salzburg criteria, categorised patients as in NCSE or not in NCSE.",0
3271,14,Salzburg EEG criteria are used to diagnose which disorder?,Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner.,1
3271,15,Salzburg EEG criteria are used to diagnose which disorder?,"INTERPRETATION

The Salzburg criteria for diagnosis of NCSE have high diagnostic accuracy and excellent inter-rater agreement, making them suitable for implementation in clinical practice.",0
3271,16,Salzburg EEG criteria are used to diagnose which disorder?,Clinical presentations and the Salzburg EEG criteria for NCSE were used to identify patients with NCSE after CSE.,1
3271,17,Salzburg EEG criteria are used to diagnose which disorder?,The difficulty of diagnosing NCSE in clinical practice; external validation of the Salzburg criteria.,0
3271,18,Salzburg EEG criteria are used to diagnose which disorder?,"To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount.",1
3271,19,Salzburg EEG criteria are used to diagnose which disorder?,Clinical presentations and the Salzburg EEG criteria for NCSE were used to identify patients with NCSE after CSE.,1
3271,20,Salzburg EEG criteria are used to diagnose which disorder?,We divided the patients into those who were finally with diagnosed NCSE (NCSE-p) and those who were not (non-NCSE) according to the Salzburg Diagnostic EEG criteria.,0
3271,21,Salzburg EEG criteria are used to diagnose which disorder?,"We performed an external, retrospective, diagnostic accuracy study of the Salzburg criteria, using EEG recordings from patients with and without a clinical suspicion of having NCSE.",0
3271,22,Salzburg EEG criteria are used to diagnose which disorder?,BACKGROUND Salzburg Consensus Criteria for diagnosis of Non-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus in Salzburg (2013).,0
3271,23,Salzburg EEG criteria are used to diagnose which disorder?,"To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount.",0
3271,24,Salzburg EEG criteria are used to diagnose which disorder?,"We performed an external, retrospective, diagnostic accuracy study of the Salzburg criteria, using EEG recordings from patients with and without a clinical suspicion of having NCSE.",0
3271,25,Salzburg EEG criteria are used to diagnose which disorder?,"INTERPRETATION: The Salzburg criteria for diagnosis of NCSE have high diagnostic accuracy and excellent inter-rater agreement, making them suitable for implementation in clinical practice.",0
3271,26,Salzburg EEG criteria are used to diagnose which disorder?,We divided the patients into those who were finally with diagnosed NCSE (NCSE-p) and those who were not (non-NCSE) according to the Salzburg Diagnostic EEG criteria.,0
3271,27,Salzburg EEG criteria are used to diagnose which disorder?,"Two raters blinded to all other patient data retrospectively analysed the EEG recordings and, using the Salzburg criteria, categorised patients as in NCSE or not in NCSE.",0
1188,0,Which protein is affected by dusp8 activation?,"Thus, rosiglitazone's neuroprotective effect after ischemia is mediated by blocking JNK phosphorylation induced by ischemia via DUSP8 upregulation.",0
1188,1,Which protein is affected by dusp8 activation?,Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.,1
1188,2,Which protein is affected by dusp8 activation?,These results suggest that JNK activation by H(2)O(2) plus PDTC resulted from the down-regulation of JNK phosphatases.,0
1188,3,Which protein is affected by dusp8 activation?,M3/6 is a dual-specificity phosphatase selective for JNK,1
1188,4,Which protein is affected by dusp8 activation?,Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite.,1
1188,5,Which protein is affected by dusp8 activation?,Dual-specificity phosphatases (DUSPs) play a very important role in these events by modulating the extent of JNK phosphorylation and activation and thus regulating cellular responses to stress.,0
1188,6,Which protein is affected by dusp8 activation?,M3/6 (DUSP8) is one of the dual-specificity protein phosphatases with distinct specificity towards JNK,1
1188,7,Which protein is affected by dusp8 activation?,"Both anisomycin and arsenite activate the JNK pathway and, in addition, inactivate the M3/6 phosphatase.",0
1188,8,Which protein is affected by dusp8 activation?,"M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK and, to a lesser extent, p38 MAPKs and is found in a complex with these kinases, along with other pathway components, held together by scaffold proteins.",1
1188,9,Which protein is affected by dusp8 activation?, We suggest that reduction of HSP70 by expanded polyglutamine is implicated in aggregation and inhibition of M3/6 and in activation of JNK and AP-1.,0
1817,0,Is SUMOylation a post-translational modification in eukaryotes?,"SUMOylation, the conjugation of target proteins with SUMO (small ubiquitin-related modifier), is a type of post-translational modification in eukaryotes and involves the sequential action of activation (E1), conjugation (E2) and ligation (E3) enzymes.",1
1817,1,Is SUMOylation a post-translational modification in eukaryotes?,Plants have evolved to cope with changing environmental conditions.,0
1817,2,Is SUMOylation a post-translational modification in eukaryotes?,One way plants achieve this is through post-translational modification of target proteins by ubiquitination and SUMOylation.,0
1817,3,Is SUMOylation a post-translational modification in eukaryotes?,"Sumoylation is a post-translational modification essential in most eukaryotes that regulates stability, localization, activity, or interaction of a multitude of proteins.",0
1817,4,Is SUMOylation a post-translational modification in eukaryotes?,"SUMOylation, the covalent attachment of a member of the small ubiquitin-like modifier (SUMO) family of proteins to lysines in target substrates, is an essential post-translational modification in eukaryotes.",0
1817,5,Is SUMOylation a post-translational modification in eukaryotes?,Post-translational modification by SUMO is a highly conserved pathway in eukaryotes that plays very important regulatory roles in many cellular processes.,0
1817,6,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is an essential post-translational modification that regulates a variety of cellular processes including cell cycle progression.,0
1817,7,Is SUMOylation a post-translational modification in eukaryotes?,"Although the SUMOylation pathway has been identified and investigated in many eukaryotes, the mechanisms of SUMOylation in regulating the functions of various substrates are still poorly understood.",0
1817,8,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is a relevant protein post-translational modification in eukaryotes.,1
1817,9,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is a reversible post-translational modification essential for genome stability.,0
1817,10,Is SUMOylation a post-translational modification in eukaryotes?,"Many SUMOylated lysines have previously been reported to be ubiquitinated, acetylated or methylated, thus indicating cross-talk between SUMO and other post-translational modifications.",0
1817,11,Is SUMOylation a post-translational modification in eukaryotes?,Sumoylation is a post-translational modification shown to play a role in diverse biological processes.,0
1817,12,Is SUMOylation a post-translational modification in eukaryotes?,"Besides phosphorylation or ubiquitylation, for which many examples of modulation by pathogens exist, a post-translational modification called SUMOylation was recently shown to be targeted by pathogenic bacteria.",0
1817,13,Is SUMOylation a post-translational modification in eukaryotes?,"cruzi SUMOylated proteins are similarly modified, indicating conserved functions for protein SUMOylation in this early divergent eukaryote.",0
1817,14,Is SUMOylation a post-translational modification in eukaryotes?,"PML is a potent tumor suppressor and proapoptotic factor and is functionally regulated by post-translational modifications such as phosphorylation, sumoylation, and ubiquitination.",0
1817,15,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is an essential post-translational modification that regulates a variety of cellular processes including cell cycle progression.,0
1817,16,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation in Giardia lamblia: A Conserved Post-Translational Modification in One of the Earliest Divergent Eukaryotes,0
1817,17,Is SUMOylation a post-translational modification in eukaryotes?,"SUMOylation, the covalent attachment of a member of the small ubiquitin-like modifier (SUMO) family of proteins to lysines in target substrates, is an essential post-translational modification in eukaryotes",0
1817,18,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is a relevant protein post-translational modification in eukaryotes,1
1817,19,Is SUMOylation a post-translational modification in eukaryotes?,"Post-translational modifications (PTMs) are one facet of this proteasomal regulation, with over 400 known phosphorylation sites, over 500 ubiquitination sites and 83 internal lysine acetylation sites, as well as multiple sites for caspase cleavage, glycosylation (such as O-GlcNAc modification), methylation, nitrosylation, oxidation, and SUMOylation",0
1817,20,Is SUMOylation a post-translational modification in eukaryotes?,"SUMOylation is an important post-translational modification, and Akt SUMOylation was found to regulate cell proliferation, tumorigenesis and cell cycle, but the molecular mechanism of Akt SUMOylation is less well known",0
1817,21,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is a form of post-translational modification where small ubiquitin-like modifiers (SUMO) are covalently attached to target proteins to regulate their properties,0
1817,22,Is SUMOylation a post-translational modification in eukaryotes?,"One distinctive feature in acute proteotoxic stresses, such as heat shock (HS), is rapid post-translational modification of proteins by SUMOs (small ubiquitin-like modifier proteins; SUMOylation)",0
1817,23,Is SUMOylation a post-translational modification in eukaryotes?,"Post-translational modification by the Small Ubiquitin-like Modifier (SUMO) proteins, a process termed SUMOylation, is involved in many fundamental cellular processes",0
1817,24,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is an important post-translational modification that is involved in many key biological processes,0
1817,25,Is SUMOylation a post-translational modification in eukaryotes?,Group III metabotropic glutamate receptors (mGluRs) undergo post-translational modification by SUMO in in vitro assays but the SUMOylation of full-length mGluRs in mammalian cells has not been reported,0
1817,26,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is a relevant protein post-translational modification in eukaryotes.,1
1817,27,Is SUMOylation a post-translational modification in eukaryotes?,"However, the effects of pathogenic bacteria on SUMOylation, an essential post-translational modification in eukaryotic cells, remain largely unknown.",0
1817,28,Is SUMOylation a post-translational modification in eukaryotes?,"A novel post-translational modification of nucleolin, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating gadd45� mRNA stability.",0
1817,29,Is SUMOylation a post-translational modification in eukaryotes?,Drosophila Bicoid is a substrate of sumoylation and its activator function is subject to inhibition by this post-translational modification.,0
1817,30,Is SUMOylation a post-translational modification in eukaryotes?,"Here, we demonstrate that SUMOylation of RelB might be one of these post-translational modifications rendering the function of the NF-�B transcription factor RelB.",0
1817,31,Is SUMOylation a post-translational modification in eukaryotes?,"In the last decade, SUMOylation has emerged as an essential post-translational modification in eukaryotes.",0
1817,32,Is SUMOylation a post-translational modification in eukaryotes?,"SUMOylation, the conjugation of target proteins with SUMO (small ubiquitin-related modifier), is a type of post-translational modification in eukaryotes and involves the sequential action of activation (E1), conjugation (E2) and ligation (E3) enzymes.",1
1817,33,Is SUMOylation a post-translational modification in eukaryotes?,"SUMOylation, the covalent attachment of a member of the small ubiquitin-like modifier (SUMO) family of proteins to lysines in target substrates, is an essential post-translational modification in eukaryotes.",0
1817,34,Is SUMOylation a post-translational modification in eukaryotes?,One way plants achieve this is through post-translational modification of target proteins by ubiquitination and SUMOylation.,0
1817,35,Is SUMOylation a post-translational modification in eukaryotes?,"The small ubiquitin-like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",0
1817,36,Is SUMOylation a post-translational modification in eukaryotes?,Post-translational modification by SUMO is a highly conserved pathway in eukaryotes that plays very important regulatory roles in many cellular processes.,0
1817,37,Is SUMOylation a post-translational modification in eukaryotes?,"Many SUMOylated lysines have previously been reported to be ubiquitinated, acetylated or methylated, thus indicating cross-talk between SUMO and other post-translational modifications.",0
1817,38,Is SUMOylation a post-translational modification in eukaryotes?,"We identified 70 phosphorylation and four acetylation events in proximity to SUMOylation sites, and we provide evidence for acetylation-dependent SUMOylation of endogenous histone H3.",0
1817,39,Is SUMOylation a post-translational modification in eukaryotes?,"SUMOylation regulates target proteins involved in all nuclear processes including transcription, DNA repair, chromatin remodeling, precursor-mRNA splicing and ribosome assembly.",0
1817,40,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation is a reversible post-translational modification essential for genome stability.,0
1817,41,Is SUMOylation a post-translational modification in eukaryotes?,"Using high-resolution MS, we have studied global SUMOylation in human cells in a site-specific manner, identifying a total of>4,300 SUMOylation sites in>1,600 proteins.",0
1817,42,Is SUMOylation a post-translational modification in eukaryotes?,"We quantitatively studied SUMOylation dynamics in response to SUMO protease inhibition, proteasome inhibition and heat shock.",0
1817,43,Is SUMOylation a post-translational modification in eukaryotes?,"Many SUMOylated lysines have previously been reported to be ubiquitinated, acetylated or methylated, thus indicating cross-talk between SUMO and other post-translational modifications.",0
1817,44,Is SUMOylation a post-translational modification in eukaryotes?,"We identified 70 phosphorylation and four acetylation events in proximity to SUMOylation sites, and we provide evidence for acetylation-dependent SUMOylation of endogenous histone H3.",0
1817,45,Is SUMOylation a post-translational modification in eukaryotes?,Sumoylation is a post-translational modification shown to play a role in diverse biological processes.,0
1817,46,Is SUMOylation a post-translational modification in eukaryotes?,"Here, we demonstrate that sumoylation is essential for proper heterochromatin function in Drosophila through modification of SU(VAR)3-7.",0
1817,47,Is SUMOylation a post-translational modification in eukaryotes?,"Indeed, SU(VAR)3-7 is sumoylated at lysine K839; this modification is required for localization of SU(VAR)3-7 at pericentric heterochromatin, chromosome 4, and telomeres.",0
1817,48,Is SUMOylation a post-translational modification in eukaryotes?,Sumoylation is a post-translational modification shown to play a role in diverse biological processes.,0
1817,49,Is SUMOylation a post-translational modification in eukaryotes?,"Here, we demonstrate that sumoylation is essential for proper heterochromatin function in Drosophila through modification of SU(VAR)3-7.",0
1817,50,Is SUMOylation a post-translational modification in eukaryotes?,Our results suggest a new level of regulation of Sall activity in vivo during animal development through post-translational modification by sumoylation.,0
1817,51,Is SUMOylation a post-translational modification in eukaryotes?,"BACKGROUND: Small Ubiquitin-like MOdifier protein (SUMO) is a key regulator of nuclear functions but little is known regarding the role of the post-translational modification sumoylation outside of the nucleus, particularly in the Central Nervous System (CNS).METHODOLOGY/PRINCIPAL FINDINGS: Here, we report that the expression levels of SUMO-modified substrates as well as the components of the sumoylation machinery are temporally and spatially regulated in the developing rat brain.",0
1817,52,Is SUMOylation a post-translational modification in eukaryotes?,SUMOylation in Giardia lamblia: A Conserved Post-Translational Modification in One of the Earliest Divergent Eukaryotes.,0
1817,53,Is SUMOylation a post-translational modification in eukaryotes?,Identification of a novel post-translational modification in Plasmodium falciparum: protein sumoylation in different cellular compartments.,0
1817,54,Is SUMOylation a post-translational modification in eukaryotes?,"More recently, Akt has been identified as a substrate for many different post-translational modifications, including not only phosphorylation of other residues, but also acetylation, glycosylation, oxidation, ubiquitination and SUMOylation.",0
1049,0,Approximately how many recombination hotspots have been found in the yeast genome?,In the fission yeast genome DSBs are located within 194 prominent peaks separated on average by 65-kbp intervals of DNA that are largely free of DSBs,1
1049,1,Approximately how many recombination hotspots have been found in the yeast genome?,"Most meiotic recombination is positioned at hotspots, but knowledge of the mechanisms is nebulous",1
1049,2,Approximately how many recombination hotspots have been found in the yeast genome?,meiotic recombination is initiated by double-strand DNA breaks (DSBs) which occur at relatively high frequencies in some genomic regions (hotspots) and relatively low frequencies in others (coldspots),1
230,0,What are the functions of sorting nexin 27?,"Knockdown of SNX27 by siRNA in HEK293 cells raised MRP4 expression on the plasma membrane, increased the extrusion of 6-[(14)C]mercaptopurine, an MRP4 substrate, and conferred resistance against 6-[(14)C]mercaptopurine.",0
230,1,What are the functions of sorting nexin 27?,Sorting nexin 27 (SNX27) is a 62-kDa protein localized to early endosomes and known to regulate the intracellular trafficking of ion channels and receptors.,1
230,2,What are the functions of sorting nexin 27?,"Finally, migration assays revealed that depletion of SNX27 from HeLa and mouse principal kidney cortical collecting duct cells significantly decreases cell motility.",0
230,3,What are the functions of sorting nexin 27?,We propose a model by which SNX27 regulates trafficking of β-Pix to focal adhesions and thereby influences cell motility.,1
230,4,What are the functions of sorting nexin 27?,We found that SNX27a redirected part of 5-HT4(a)R to early endosomes.,0
230,5,What are the functions of sorting nexin 27?,"sorting nexin 27 (SNX27), a recently described member of a protein family involved in intracellular trafficking,",1
230,6,What are the functions of sorting nexin 27?,"SNX27 co-localized with transferrin receptor-positive vesicles, pointing to its participation in T cell endocytic recycling.",0
230,7,What are the functions of sorting nexin 27?,"This protein is a unique member of the sorting nexin family of proteins, a group generally involved in the endocytic and intracellular sorting machinery",1
230,8,What are the functions of sorting nexin 27?,"These previously unreported results indicate that SNX27 is a participant in NK cell polarization, as a mediator or target of the mechanism.",0
230,9,What are the functions of sorting nexin 27?,"Like most sorting nexins, SNX27 possesses a functional PX domain that selectively binds the membrane phospholipid phosphatidylinositol-3-phosphate (PI3P) and is important for trafficking to the early endosome.",0
230,10,What are the functions of sorting nexin 27?,"This is consistent with a role of SNX27 as a general regulator for sorting of membrane proteins containing a PDZ-binding motif, and its absence may alter the trafficking of these proteins, leading to growth and survival defects.",0
230,11,What are the functions of sorting nexin 27?,"Sorting nexin 27 (SNX27) belongs to the sorting nexin family of proteins, which participate in vesicular and protein trafficking.",1
230,12,What are the functions of sorting nexin 27?,"Similarly to all sorting nexin proteins, SNX27 has a functional PX domain that is important for endosome binding, but it is the only sorting nexin with a PDZ domain.",0
230,13,What are the functions of sorting nexin 27?,"These results identify SNX27 as a PDZ-containing component of the T cell immunological synapse, and demonstrate a role for this protein in the regulation of the Ras-ERK pathway, suggesting a functional relationship between SNX27 and DGKζ.",0
230,14,What are the functions of sorting nexin 27?,Sorting nexins have been implicated in trafficking of proteins through endosomal compartments.,0
1112,0,Which are the major transcription factors regulating glycolysis in mammals?,myc regulates hepatic glycolysis,0
1112,1,Which are the major transcription factors regulating glycolysis in mammals?,"increase in c-Myc protein was able to induce liver glucose utilization and accumulation, and suggested that c-Myc transcription factor is involved in the control in vivo of liver carbohydrate metabolism",0
1112,2,Which are the major transcription factors regulating glycolysis in mammals?,STAT3 is a negative regulator of aerobic glycolysis.,0
1112,3,Which are the major transcription factors regulating glycolysis in mammals?,HIF1 alpha-mediated switches in the energy production of tumor cells from OXPHOS to glycolysis,0
1112,4,Which are the major transcription factors regulating glycolysis in mammals?,NF-κB organizes energy metabolism networks by controlling the balance between the utilization of glycolysis and mitochondrial respiration.,0
1112,5,Which are the major transcription factors regulating glycolysis in mammals?,NF-κB inhibition causes cellular reprogramming to aerobic glycolysis under basal conditions and induces necrosis on glucose starvation,0
1112,6,Which are the major transcription factors regulating glycolysis in mammals?,"Hypoxia-inducible factor-1α (HIF-1α), which is a transcription factor that enhances glycolysis in cells in response to hypoxia",1
1112,7,Which are the major transcription factors regulating glycolysis in mammals?,"SIRT6 appears to function as a corepressor of the transcription factor Hif1alpha, a critical regulator of nutrient stress responses",1
1112,8,Which are the major transcription factors regulating glycolysis in mammals?,SIRT6-deficient cells exhibit increased Hif1alpha activity and show increased glucose uptake with upregulation of glycolysis and diminished mitochondrial respiration,0
1112,9,Which are the major transcription factors regulating glycolysis in mammals?,"c-Myc regulates genes involved in the biogenesis of ribosomes and mitochondria, and regulation of glucose and glutamine metabolism",0
1112,10,Which are the major transcription factors regulating glycolysis in mammals?,"Myc regulates gene expression either directly, such as glycolytic genes including lactate dehydrogenase A (LDHA)",0
1112,11,Which are the major transcription factors regulating glycolysis in mammals?,"loss of the widely expressed transcription factor Oct1 induces a coordinated metabolic shift: mitochondrial activity and amino acid oxidation are increased, while glucose metabolism is reduced.",1
1112,12,Which are the major transcription factors regulating glycolysis in mammals?,PVHL is a regulator of glucose metabolism,0
1112,13,Which are the major transcription factors regulating glycolysis in mammals?,Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays a critical role in the glucose-mediated induction of gene products involved in hepatic glycolysis and lipogenesis,0
1112,14,Which are the major transcription factors regulating glycolysis in mammals?,"Activation of NF-kappaB, by loss of p53, caused an increase in the rate of aerobic glycolysis and upregulation of Glut3",0
1112,15,Which are the major transcription factors regulating glycolysis in mammals?,p53 restricts activation of the IKK-NF-kappaB pathway through suppression of glycolysis,0
1112,16,Which are the major transcription factors regulating glycolysis in mammals?,"cells express hypoxia-inducible factor (HIF)-1alpha, a transcription factor that responds to oxygen tension and regulates glycolysis",0
1112,17,Which are the major transcription factors regulating glycolysis in mammals?,"The HIF-1 dependent genic products are involved in tumoral angiogenesis, in the metabolic switch to anaerobic glycolysis and in prosurvival, proliferative and apoptotic mechanisms",0
1112,18,Which are the major transcription factors regulating glycolysis in mammals?,"he hypoxia-inducible transcription factor (HIF) regulates the expression of genes involved in angiogenesis, erythropoiesis and glycolysis",0
1112,19,Which are the major transcription factors regulating glycolysis in mammals?,"hypoxia-inducible factor-1, which activates a gene program associated with angiogenesis, glycolysis, and adaptation to pH",0
1112,20,Which are the major transcription factors regulating glycolysis in mammals?,ChREBP (carbohydrate response element-binding protein) was recently identified as a candidate transcription factor in the glucose-signaling pathway,0
1112,21,Which are the major transcription factors regulating glycolysis in mammals?,"Hypoxia-inducible factor (HIF)-1 is a master transcription factor, which up-regulates glycolysis",0
1112,22,Which are the major transcription factors regulating glycolysis in mammals?,"(Src) express HIF-1alpha protein under normoxia, which results in the expression of multiple HIF-1alpha target genes.",0
1112,23,Which are the major transcription factors regulating glycolysis in mammals?,"HIF-1 alpha can then translocate to the nucleus and facilitate transcription of numerous target genes, the majority of which are involved in glycolysis and angiogenesis via heterodimerisation with the beta subunit (HIF-1 beta/ARNT)",0
1112,24,Which are the major transcription factors regulating glycolysis in mammals?,We previously observed that the c-Myc oncogenic transcription factor regulates lactate dehydrogenase A and induces lactate overproduction.,0
1112,25,Which are the major transcription factors regulating glycolysis in mammals?,"We, therefore, sought to determine whether c-Myc controls other genes regulating glucose metabolism",0
1112,26,Which are the major transcription factors regulating glycolysis in mammals?,overexpression of the c-Myc oncoprotein deregulates glycolysis through the activation of several components of the glucose metabolic pathway,1
1112,27,Which are the major transcription factors regulating glycolysis in mammals?,HNF4alpha is critical for regulating glucose transport and glycolysis and in doing so is crucial for maintaining glucose homeostasis,1
3073,0,Is the NLM medical text indexer (MTI) still useful and relevant?,12 years on - Is the NLM medical text indexer still useful and relevant?,0
3073,1,Is the NLM medical text indexer (MTI) still useful and relevant?,"Facing a growing workload and dwindling resources, the US National Library of Medicine (NLM) created the Indexing Initiative project in 1996.",0
3073,2,Is the NLM medical text indexer (MTI) still useful and relevant?,This cross-library team's mission is to explore indexing methodologies for ensuring quality and currency of NLM document collections.,0
3073,3,Is the NLM medical text indexer (MTI) still useful and relevant?,The NLM Medical Text Indexer (MTI) is the main product of this project and has been providing automated indexing recommendations since 2002.,0
3073,4,Is the NLM medical text indexer (MTI) still useful and relevant?,"After all of this time, the questions arise whether MTI is still useful and relevant.METHODS: To answer the question about MTI usefulness, we track a wide variety of statistics related to how frequently MEDLINE indexers refer to MTI recommendations, how well MTI performs against human indexing, and how often MTI is used.",0
3073,5,Is the NLM medical text indexer (MTI) still useful and relevant?,"To answer the question of MTI relevancy compared to other available tools, we have participated in the 2013 and 2014 BioASQ Challenges.",0
3073,6,Is the NLM medical text indexer (MTI) still useful and relevant?,The BioASQ Challenges have provided us with an unbiased comparison between the MTI system and other systems performing the same task.RESULTS: Indexers have continually increased their use of MTI recommendations over the years from 15.75% of the articles they index in 2002 to 62.44% in 2014 showing that the indexers find MTI to be increasingly useful.,0
3073,7,Is the NLM medical text indexer (MTI) still useful and relevant?,The MTI performance statistics show significant improvement in Precision (+0.2992) and F1 (+0.1997) with modest gains in Recall (+0.0454) over the years.,0
3073,8,Is the NLM medical text indexer (MTI) still useful and relevant?,MTI consistency is comparable to the available indexer consistency studies.,0
3073,9,Is the NLM medical text indexer (MTI) still useful and relevant?,"MTI performed well in both of the BioASQ Challenges ranking within the top tier teams.CONCLUSIONS: Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded.",1
3073,10,Is the NLM medical text indexer (MTI) still useful and relevant?,The BioASQ Challenge results have shown that we need to incorporate more machine learning into MTI while still retaining the indexing rules that have earned MTI the indexers' trust over the years.,1
3073,11,Is the NLM medical text indexer (MTI) still useful and relevant?,"We also need to expand MTI through the use of full text, when and where it is available, to provide coverage of indexing terms that are typically only found in the full text.",1
3073,12,Is the NLM medical text indexer (MTI) still useful and relevant?,"The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant.",0
3073,13,Is the NLM medical text indexer (MTI) still useful and relevant?,"The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant.",0
3073,14,Is the NLM medical text indexer (MTI) still useful and relevant?,"CONCLUSIONS
Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded.",0
3073,15,Is the NLM medical text indexer (MTI) still useful and relevant?,"12 years on - Is the NLM medical text indexer still useful and relevant?Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded.",1
3073,16,Is the NLM medical text indexer (MTI) still useful and relevant?,"The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant.",0
3073,17,Is the NLM medical text indexer (MTI) still useful and relevant?,"After all of this time, the questions arise whether MTI is still useful and relevant.<br><b>METHODS</b>: To answer the question about MTI usefulness, we track a wide variety of statistics related to how frequently MEDLINE indexers refer to MTI recommendations, how well MTI performs against human indexing, and how often MTI is used.",0
3073,18,Is the NLM medical text indexer (MTI) still useful and relevant?,"The MTI performance statistics show significant improvement in Precision (+0.2992) and F<br><b>CONCLUSIONS</b>: Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded.",0
3073,19,Is the NLM medical text indexer (MTI) still useful and relevant?,"The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant.<br>",0
3073,20,Is the NLM medical text indexer (MTI) still useful and relevant?,"After all of this time, the questions arise whether MTI is still useful and relevant.",0
3073,21,Is the NLM medical text indexer (MTI) still useful and relevant?,"The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant.",0
3073,22,Is the NLM medical text indexer (MTI) still useful and relevant?,"Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded.",1
147,0,Has the protein TIEG1 been associated with apoptosis?,"TGF-beta) inducible early gene 1 (TIEG1) is known to induce apoptosis in TGF-beta sensitive pancreatic cancer cells, yet its effect on TGF-beta resistant cancer cells remains unclear",0
147,1,Has the protein TIEG1 been associated with apoptosis?,"overexpression of TIEG1, protected ALL cells against chemotherapy-induced cell death",0
147,2,Has the protein TIEG1 been associated with apoptosis?, TIEG1 might be involved in mediating this effect from the microenvironment onto the leukemia cells,0
147,3,Has the protein TIEG1 been associated with apoptosis?,We also demonstrate that TIEG-1 ectopic expression in CGNPs induces cell cycle arrest that can lead to apoptosis but fails to promote differentiation,0
147,4,Has the protein TIEG1 been associated with apoptosis?,"TIEG1 acts as an inducer or repressor of gene transcription to enhance the TGFbeta/Smad pathway, as well at other signaling pathways, to regulate cell proliferation, differentiation, and apoptosis.",0
147,5,Has the protein TIEG1 been associated with apoptosis?,TGFbeta inducible early gene (TIEG1) mimics TGFbeta action and induces apoptosis,0
147,6,Has the protein TIEG1 been associated with apoptosis?,"the transforming growth factor-beta- (TGF-beta-) inducible early response 1 gene (TIEG1), which plays a pivotal role in TGF-beta-regulated cell growth control and apoptosis",1
147,7,Has the protein TIEG1 been associated with apoptosis?,Induction of mRNA for Smad4 and the TGF-beta1-regulated apoptosis-inducing transcription factor TGF-beta1-inducible early gene (TIEG1) was detected within the first 6 h of doxazosin treatmen,0
147,8,Has the protein TIEG1 been associated with apoptosis?,TIEG1 (TGF-beta inducible early gene) is a recently characterized transcription factor regulated by TGF-beta that induces apoptosis when overexpressed in pancreatic adenocarcinoma cell lines,0
147,9,Has the protein TIEG1 been associated with apoptosis?,Influence of TIEG1 on apoptosis,0
147,10,Has the protein TIEG1 been associated with apoptosis?,the influence of TIEG1 on apoptosis of HL-60 cells and the expression of Bcl-2/Bax,0
147,11,Has the protein TIEG1 been associated with apoptosis?,"The expression of genes involved in insulin resistance (PDK4, AHSG) is increased, together with expression of TIEG1, a transcription factor that can induce apoptosis via the mitochondrial pathway",0
147,12,Has the protein TIEG1 been associated with apoptosis?,"the overexpression of TIEG1 mediated growth inhibition and apoptosis in TGF-β1-resistant HCC cell lines,",0
147,13,Has the protein TIEG1 been associated with apoptosis?,"On the other hand, KLF10 deficient keratinocytes showed increased proliferation and apoptosis",0
147,14,Has the protein TIEG1 been associated with apoptosis?,"LF10, transforming growth factor-β-inducible early gene 1",0
147,15,Has the protein TIEG1 been associated with apoptosis?,IEG1 can induce apoptosis of cancer cells,0
147,16,Has the protein TIEG1 been associated with apoptosis?,TGF-β inducible early gene 1) plays a significant role in regulating cell proliferation and apoptosis,1
147,17,Has the protein TIEG1 been associated with apoptosis?,TIEG1) is a Krüppel-like transcription factor (KLF10) that was originally cloned from human osteoblasts as an early response gene to TGF-β treatment,1
147,18,Has the protein TIEG1 been associated with apoptosis?,Adenoviral delivery of TIEG1 (AdTIEG1) to TIEG1(-/-) cells reversed the RANKL-induced NFATc1 signaling defect in TIEG1(-/-) precursors and eliminated the differentiation and apoptosis defects,0
147,19,Has the protein TIEG1 been associated with apoptosis?,"(TGF)-β inducible early gene (TIEG)-1 is implicated in the control of cell proliferation, differentiation, and apoptosis in some cell types",0
147,20,Has the protein TIEG1 been associated with apoptosis?,TIEG1 has been shown to mimic the effects of TGF-beta in various carcinoma cells and plays a critical role in the apoptotic cascade,1
147,21,Has the protein TIEG1 been associated with apoptosis?,"(TIEG) is a family of primary response genes induced by TGF-beta, which are well recognized in regulating cellular proliferation and apoptosis",1
147,22,Has the protein TIEG1 been associated with apoptosis?,In human and murine tissues it has been shown that TIEG1 and TIEG2 induce apoptosis and inhibit cell growth,0
147,23,Has the protein TIEG1 been associated with apoptosis?,overexpression of TIEG1 in OLI-neu cells induced apoptosis,0
147,24,Has the protein TIEG1 been associated with apoptosis?,"(TGF-beta(1))-inducible transcription factors have recently elicited interest because of their critical role in the regulation of cell proliferation, differentiation, and apoptosis",0
147,25,Has the protein TIEG1 been associated with apoptosis?,ectopic overexpression of TIEG is sufficient to trigger the apoptotic cell program in these cells,0
2881,0,Is collagen the most abundant human protein?,"As the most abundant protein in the body, collagen is essential to maintain the normal structure and strength of connective tissue, such as bones, skin, cartilage, and blood vessels.",1
2881,1,Is collagen the most abundant human protein?,Collagen is the most abundant protein family in mammals.,1
2881,2,Is collagen the most abundant human protein?,"Collagen is a fibrillar protein that conforms the conjunctive and connective tissues in the human body, essentially skin, joints, and bones.",1
2881,3,Is collagen the most abundant human protein?,This molecule is one of the most abundant in many of the living organisms due to its connective role in biological structures.,1
1107,0,Which are the subunits of the IkB protein kinase (IKK)?,NEMO (NF-κB essential modulator) associates with catalytic subunits IKKα and IKKβ to form the IκB kinase (IKK) complex and is a key regulator of NF-κB pathway signaling.,0
1107,1,Which are the subunits of the IkB protein kinase (IKK)?,All known NF-κB activators converge on the IkappaB kinase (IKK) complex to activate the canonical and non-canonical NF-κB pathways.,0
1107,2,Which are the subunits of the IkB protein kinase (IKK)?,"The IKK complex contains two catalytic subunits (IKKα and IKKβ) and a regulatory subunit NEMO/IKKγ that regulates the canonical NF-κB pathway, whereas IKKα regulates the non-canonical pathway.",0
1107,3,Which are the subunits of the IkB protein kinase (IKK)?," The IKK protein complex is comprised of IKKα, IKKβ and NEMO subunits, with IKKβ thought to play the dominant role in modulating NF-κB activity.",1
1107,4,Which are the subunits of the IkB protein kinase (IKK)?,The IκB kinase (IKK) complex plays a crucial role in the activation of the transcription factor NF-κB by phosphorylating an inhibitory molecule IκBα.,0
1107,5,Which are the subunits of the IkB protein kinase (IKK)?,"Recently, we showed that IKK2 (also called IKKβ), a catalytic subunit of the IKK complex, induces immunoglobulin E-mediated degranulation in mast cells by phosphorylating SNAP-23, the target-membrane soluble N-ethylmaleimide-sensitive fusion factor attachment protein receptor (SNARE).",0
1107,6,Which are the subunits of the IkB protein kinase (IKK)?,"The depletion of any of the three subunits of the inhibitor of NFκB (IκB) kinase (IKKα, IKKβ, IKKγ/NEMO), each of which is essential for the canonical NFκB activation pathway, limits autophagy induction by physiological or pharmacological triggers, while constitutive active IKK subunits suffice to stimulate autophagy.",0
1107,7,Which are the subunits of the IkB protein kinase (IKK)?,"NF-κB activation is tightly regulated by the IκB kinase (IKK) complex, which is composed of two catalytic subunits IKKα and IKKβ, and a regulatory subunit IKKγ/NEMO.",0
1107,8,Which are the subunits of the IkB protein kinase (IKK)?,"Activation of the classical NF-κB pathway is mediated through the activity of the IKK kinase complex, which consists of a heterotrimer of IKKα, IKKβ, and IKKγ subunits.",0
1107,9,Which are the subunits of the IkB protein kinase (IKK)?,NF-kB is a key regulator of inflammation and immunity in cancer development.,0
1107,10,Which are the subunits of the IkB protein kinase (IKK)?,"The IkB kinase (IKK) is a multisubunit complex containing catalytic subunits termed IKK-α, -β and -γ.",0
1107,11,Which are the subunits of the IkB protein kinase (IKK)?,"Activation of NF-κB involves the IκB kinase (IKK)-complex composed of two catalytic subunits, IKKα and IKKβ, and a regulatory scaffold protein, IKKγ.",0
1107,12,Which are the subunits of the IkB protein kinase (IKK)?,The IKK kinase complex is the core element of the NF-kappaB cascade.,0
1107,13,Which are the subunits of the IkB protein kinase (IKK)?,"It is essentially made of two kinases (IKKalpha and IKKbeta) and a regulatory subunit, NEMO/IKKgamma.",1
1107,14,Which are the subunits of the IkB protein kinase (IKK)?,"Additional components may exist, transiently or permanently, but their characterization is still unsure.",0
1107,15,Which are the subunits of the IkB protein kinase (IKK)?,"Activation of NF-kappaB subunits is regulated by the upstream IkappaB kinase (IKK) complex which contains IKKalpha, IKKbeta, and IKKgamma; the latter also known as NF-kappaB essential modulator (NEMO).",0
1107,16,Which are the subunits of the IkB protein kinase (IKK)?,Proinflammatory NF-kappaB activation requires the IkappaB (inhibitor of NF-kappaB) kinase (IKK) complex that contains two catalytic subunits named IKKalpha and IKKbeta and a regulatory subunit named NF-kappaB essential modulator (NEMO).,1
1107,17,Which are the subunits of the IkB protein kinase (IKK)?,"Inhibition of NF-kappaB by suppressing the canonical NF-kappaB activation pathway, for instance by knockdown of the three subunits of the inhibitor of NF-kappaB (I kappaB) kinase (IKK) complex (IKK1, IKK2 and NEMO) triggers apoptosis in such cells.",0
1107,18,Which are the subunits of the IkB protein kinase (IKK)?,The IkappaB-Kinase (IKK) complex is a multisubunit protein complex crucial for signal-induced phosphorylation of the IkappaB proteins and thus controls the activity of the transcription factor NF-kappaB.,1
1107,19,Which are the subunits of the IkB protein kinase (IKK)?,"Besides the two kinases IKKalpha and IKKbeta, the IKK complex contains NEMO/IKKgamma, an additional subunit with regulatory and adaptor functions.",1
1107,20,Which are the subunits of the IkB protein kinase (IKK)?,"Activation of a large multisubunit protein kinase, called the inhibitor kappaB kinase (IKK) complex, is central to the induction of the family of transcription factors nuclear factor kappaB.",0
1107,21,Which are the subunits of the IkB protein kinase (IKK)?,"IKK is comprised of two catalytic subunits, IKKalpha and IKKbeta, and a regulatory IKKgamma subunit.",0
1107,22,Which are the subunits of the IkB protein kinase (IKK)?,"The IkB kinase (IKK) is a multisubunit complex containing catalytic subunits termed IKK-α, -β and -γ",0
3178,0,What is the cause of Krabbe disease?,Krabbe disease (KD) is a rare disease caused by the deficiency of β-galactocerebrosidase.,1
3178,1,What is the cause of Krabbe disease?,"Globoid cell leukodystrophy (GLD), or Krabbe disease, is an inherited, neurologic disorder that results from deficiency of a lysosomal enzyme, galactosylceramidase.",1
3178,2,What is the cause of Krabbe disease?,Krabbe disease is a rare neurodegenerative genetic disorder caused by deficiency of galactocerebrosidase.,1
1940,0,What is the doRiNA database?,doRiNA: a database of RNA interactions in post-transcriptional regulation.,1
1940,1,What is the doRiNA database?, We provide a database that supports the quest for deciphering this regulatory code.,0
1940,2,What is the doRiNA database?,"Within doRiNA, we are systematically curating, storing and integrating binding site data for RBPs and miRNAs.",0
1940,3,What is the doRiNA database?,Users are free to take a target (mRNA) or regulator (RBP and/or miRNA) centric view on the data.,0
1940,4,What is the doRiNA database?,We have implemented a database framework with short query response times for complex searches (e.g.,0
1940,5,What is the doRiNA database?,asking for all targets of a particular combination of regulators).,0
1940,6,What is the doRiNA database?,"All search results can be browsed, inspected and analyzed in conjunction with a huge selection of other genome-wide data, because our database is directly linked to a local copy of the UCSC genome browser.",0
1940,7,What is the doRiNA database?,"At the time of writing, doRiNA encompasses RBP data for the human, mouse and worm genomes.",0
1940,8,What is the doRiNA database?,"For computational miRNA target site predictions, we provide an update of PicTar predictions.",0
1940,9,What is the doRiNA database?,DoRiNA 2.0--upgrading the doRiNA database of RNA interactions in post-transcriptional regulation.,1
1940,10,What is the doRiNA database?,"At the time of writing, doRiNA encompasses RBP data for the human, mouse and worm genomes.",0
1940,11,What is the doRiNA database?,"Within doRiNA, we are systematically curating, storing and integrating binding site data for RBPs and miRNAs.",0
1940,12,What is the doRiNA database?,doRiNA: a database of RNA interactions in post-transcriptional regulation,1
1940,13,What is the doRiNA database?,"Within doRiNA, we are systematically curating, storing and integrating binding site data for RBPs and miRNAs",0
1940,14,What is the doRiNA database?,"At the time of writing, doRiNA encompasses RBP data for the human, mouse and worm genomes",0
1940,15,What is the doRiNA database?,"Within doRiNA, we are systematically curating, storing and integrating binding site data for RBPs and miRNAs.",0
1940,16,What is the doRiNA database?,"At the time of writing, doRiNA encompasses RBP data for the human, mouse and worm genomes.",0
1940,17,What is the doRiNA database?,"Within doRiNA, we are systematically curating, storing and integrating binding site data for RBPs and miRNAs.",0
1940,18,What is the doRiNA database?,"At the time of writing, doRiNA encompasses RBP data for the human, mouse and worm genomes.",0
1940,19,What is the doRiNA database?,DoRiNA 2.0--upgrading the doRiNA database of RNA interactions in post-transcriptional regulation.,1
1940,20,What is the doRiNA database?,doRiNA: a database of RNA interactions in post-transcriptional regulation.,1
1233,0,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"In this work, we propose a method based on radial basis networks for predicting the number of beta-strands in OMPs and identifying their membrane spanning segments.",0
1233,1,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"We have developed a web server, TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http://rbf.bioinfo.tw/~sachen/tmrbf.html.",0
1233,2,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"We have developed a prediction server, TMBETADISC-RBF, which is available at http://rbf.bioinfo.tw/~sachen/OMP.html.",0
1233,3,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,TMB finding pipeline: novel approach for detecting beta-barrel membrane proteins in genomic sequences.,0
1233,4,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"Interestingly, the present approach identified TMBs from all 15 families in TCDB.",0
1233,5,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,A new method is presented for identification of beta-barrel membrane proteins.,0
1233,6,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,It is based on a hidden Markov model (HMM) with an architecture obeying these proteins' construction principles.,0
1233,7,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"Once the HMM is trained, log-odds score relative to a null model is used to discriminate beta-barrel membrane proteins from other proteins.",0
1233,8,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane proteins.,0
1233,9,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"We present here a web server (PRED-TMBB, http://bioinformatics.biol.uoa.gr/PRED-TMBB) which is capable of predicting the transmembrane strands and the topology of beta-barrel outer membrane proteins of Gram-negative bacteria.",1
1233,10,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"The method is based on a Hidden Markov Model, trained according to the Conditional Maximum Likelihood criterion.",0
1233,11,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,Predicting transmembrane beta-barrels in proteomes.,0
1233,12,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"Here we introduced the design, statistics and results of a novel profile-based hidden Markov model for the prediction and discrimination of TMBs.",0
1233,13,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,A sequence-profile-based HMM for predicting and discriminating beta barrel membrane proteins.,0
1233,14,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"RESULTS: We develop a HMM model, which can predict the topology of beta barrel membrane proteins using, as input, evolutionary information.",0
1233,15,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative bacteria.,0
1233,16,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,This work describes the development of a program that predicts whether or not a polypeptide sequence from a Gram-negative bacterium is an integral beta-barrel outer membrane protein.,0
1233,17,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"The program, called the beta-barrel Outer Membrane protein Predictor (BOMP), is based on two separate components to recognize integral beta-barrel proteins.",0
1233,18,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"On the basis of existing knowledge of beta-barrel outer-membrane proteins, several state of the art prediction methods, as well as a new in-house program (PROB) were employed for the systematic exploration of Mycobacterium tuberculosis predicted proteomes for potential beta-barrel structures.",1
1233,19,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,Computational identification of beta-barrel outer-membrane proteins in Mycobacterium tuberculosis predicted proteomes as putative vaccine candidates.,0
1233,20,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins in prokaryotes.,0
1233,21,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"Recently, we developed two top-performing methods based on machine-learning approaches to tackle both the detection of TMBBs in sets of proteins and the prediction of their topology.",0
1233,22,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,Supersecondary structure prediction of transmembrane beta-barrel proteins.,0
1233,23,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,We introduce a graph-theoretic model for predicting the supersecondary structure of transmembrane β-barrel proteins--a particular class of proteins that performs diverse important functions but it is difficult to determine their structure with experimental methods.,0
1233,24,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,BOCTOPUS: improved topology prediction of transmembrane β barrel proteins.,0
1233,25,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"Here, we present BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs) and Hidden Markov Models (HMMs).",1
1233,26,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and the exposure status of transmembrane residues.,1
1233,27,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"We present here TMBHMM, a computational method based on a hidden Markov model for predicting the structural topology of putative TMBs from sequence.",0
1233,28,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"In addition to predicting transmembrane strands, TMBHMM also predicts the exposure status (i.e., exposed to the membrane or hidden in the protein structure) of the residues in the transmembrane region, which is a novel feature of the TMBHMM method.",0
1233,29,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"Furthermore, TMBHMM can also predict the membrane residues that are not part of beta barrel forming strands.",0
1233,30,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"We present BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e.",0
1233,31,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,exposed to the bilayer or hidden in the protein structure) of transmembrane residues in transmembrane beta barrel proteins (TMBs).,1
1233,32,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"BTMX predicts the exposure status of known TM residues with an accuracy of 84.2% over 2,225 residues and provides a confidence score for all predictions.",0
1233,33,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,A method for discovering transmembrane beta-barrel proteins in Gram-negative bacterial proteomes.,0
1233,34,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,A web server based on the proposed method is available at http://yanbioinformatics.cs.usu.edu:8080/TMBKNNsubmit.,0
1233,35,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,This paper presents a k-nearest neighbor (K-NN) method for discriminating TMB and non-TMB proteins.,0
1233,36,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"TMBpro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-barrel proteins.",0
1233,37,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"We develop a suite (TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts (TMBpro-CON) and tertiary structure (TMBpro-3D) of transmembrane beta-barrel proteins.",0
1233,38,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"We compare our results to the recent state-of-the-art predictors transFold and PRED-TMBB using their respective benchmark datasets, and leave-one-out cross-validation.",0
1233,39,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,A consensus algorithm to screen genomes for novel families of transmembrane beta barrel proteins.,0
1233,40,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,"Here we describe a new algorithm combining composition and hidden Markov model topology based classifiers (called TMB-Hunt2), which achieves a crossvalidation accuracy of >95%, with 96.7% precision and 94.2% recall.",0
1233,41,What are the computational tools for the prediction of beta-barrel transmembrane proteins?,Tools and datasets are made available through a website called TMB-Web (http://www.bioinformatics.leeds.ac.uk/TMB-Web/TMB-Hunt2).,0
1516,0,Which peptide plays a pivotal role in human cystatin C fibrillization?,Human cystatin C (HCC) is a low molecular weight member of the cystatin family (type2).,1
1516,1,Which peptide plays a pivotal role in human cystatin C fibrillization?,HCC consists of 120 amino acids.,0
1516,2,Which peptide plays a pivotal role in human cystatin C fibrillization?,"Normally it is an inhibitor of cysteine proteases, but in pathological conditions it forms amyloid fibrils in brain arteries of young adults.",1
1516,3,Which peptide plays a pivotal role in human cystatin C fibrillization?,"An 'aggregation-prone' pentapeptide ((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide prediction algorithm developed in our lab.",1
1516,4,Which peptide plays a pivotal role in human cystatin C fibrillization?,"This peptide was synthesized and self-assembled into amyloid-like fibrils in vitro, as electron microscopy, X-ray fiber diffraction, Attenuated Total Reflectance Fourier-Transform Spectroscopy and Congo red staining studies reveal.",1
1516,5,Which peptide plays a pivotal role in human cystatin C fibrillization?,"Thus, the (47)LQVVR(51) peptide seems to have an important role in HCC fibrillization.",1
1516,6,Which peptide plays a pivotal role in human cystatin C fibrillization?,The pentapeptide LQVVR plays a pivotal role in human cystatin C fibrillization.,0
1516,7,Which peptide plays a pivotal role in human cystatin C fibrillization?,the (47)LQVVR(51) peptide seems to have an important role in HCC fibrillization.,0
1516,8,Which peptide plays a pivotal role in human cystatin C fibrillization?,"Thus, the (47)LQVVR(51) peptide seems to have an important role in HCC fibrillization.",0
298,0,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,"Mutations beneficial in one environment may cause costs in different environments, resulting in antagonistic pleiotropy.",0
298,1,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,"Here, we describe a novel form of antagonistic pleiotropy that operates even within the same environment, where benefits and deleterious effects exhibit themselves at different growth rates.",1
298,2,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,"The hfq mutations were beneficial, deleterious or neutral at an intermediate growth rate (0.5 h(-1)) and one changed from beneficial to deleterious within a 36 min difference in doubling time.",1
298,3,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,Two genetic models exist to explain the evolution of ageing - mutation accumulation (MA) and antagonistic pleiotropy (AP).,0
298,4,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,"Under AP, late-acting deleterious mutations accumulate because they confer beneficial effects early in life.",0
298,5,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,"Many marker loci responded in opposite directions to selection for late- and early-life fitness, indicating negative genetic correlations or trade-offs between those traits.",0
298,6,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,Indirect evidence suggested that some negative genetic correlations were due to antagonistic pleiotropy.,0
298,7,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,"Here, we describe a novel form of antagonistic pleiotropy that operates even within the same environment, where benefits and deleterious effects exhibit themselves at different growth rates.",1
298,8,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,The basis of antagonistic pleiotropy in hfq mutations that have opposite effects on fitness at slow and fast growth rates.,1
298,9,Can a given genotype exhibit opposite fitness effects (beneficial and detrimental) within the same environment?,"Here, we describe a novel form of antagonistic pleiotropy that operates even within the same environment, where benefits and deleterious effects exhibit themselves at different growth rates",1
3439,0,How long in bp is the human pseudoautosomal region 2 (PAR2)?,"The human sex chromosomes differ in sequence, except for the pseudoautosomal regions (PAR) at the terminus of the short and the long arms, denoted as PAR1 and PAR2.",1
3439,1,How long in bp is the human pseudoautosomal region 2 (PAR2)?,The boundary between PAR1 and the unique X and Y sequences was established during the divergence of the great apes.,1
3439,2,How long in bp is the human pseudoautosomal region 2 (PAR2)?,The insertion is generated by non-allelic homologous recombination between a 548 bp LTR6B repeat within the Y chromosome PAR1 and a second LTR6B repeat located 105 kb from the PAR boundary on the X chromosome.,0
3439,3,How long in bp is the human pseudoautosomal region 2 (PAR2)?,The pseudoautosomal regions (PAR1 and PAR2) of the human X and Y chromosomes pair and recombine during meiosis.,1
3439,4,How long in bp is the human pseudoautosomal region 2 (PAR2)?,Thus genes in this region are not inherited in a strictly sex-linked fashion.,0
3439,5,How long in bp is the human pseudoautosomal region 2 (PAR2)?,PAR1 is located at the terminal region of the short arms and PAR2 at the tips of the long arms of these chromosomes.,1
3439,6,How long in bp is the human pseudoautosomal region 2 (PAR2)?,"To date, 24 genes have been assigned to the PAR1 region.",0
3439,7,How long in bp is the human pseudoautosomal region 2 (PAR2)?,"In contrast, so far only 4 genes have been discovered in the PAR2 region.",0
3439,8,How long in bp is the human pseudoautosomal region 2 (PAR2)?,The 320-kb human pseudoautosomal region 2 (PAR2) at the tips of the long arms of the X and Y chromosomes is thought to have been duplicated onto the Y chromosome recently in primate evolution,1
3439,9,How long in bp is the human pseudoautosomal region 2 (PAR2)?," The four genes within PAR2 have been proposed to constitute two zones with different base ratios and transcription, one of which was added recently to the X chromosome.",0
3439,10,How long in bp is the human pseudoautosomal region 2 (PAR2)?," This map extends 2.3 Mbp from the telomere to sex-chromosome-specific DNA, includes at least seven CpG islands and locates four genetically mapped loci.",0
83,0,Which gene is required for the efficient function of clopidogrel?,The CYP2C19 G681A single polymorphism has been proven to affect clopidogrel responsiveness.,0
83,1,Which gene is required for the efficient function of clopidogrel?,This study investigated the effect of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and adverse clinical events in Chinese patient,0
83,2,Which gene is required for the efficient function of clopidogrel?,"ssociation of a functional polymorphism in the clopidogrel target receptor gene, P2Y12",0
83,3,Which gene is required for the efficient function of clopidogrel?,We tested for an association of gene sequence variations in P2Y12 and occurrence of neurological adverse events in patients with symptomatic peripheral artery disease (PAD) during clopidogrel treatment,0
83,4,Which gene is required for the efficient function of clopidogrel?,"Variability in clopidogrel response might be influenced by polymorphisms in genes coding for drug metabolism enzymes (cytochrome P450 [CYP] family), transport proteins (P-glycoprotein) and/or target proteins for the drug (adenosine diphosphate-receptor P2Y12)",1
83,5,Which gene is required for the efficient function of clopidogrel?,"Polymerase chain reaction-based genotyping evaluated polymorphisms in the CYP2C19, CYP2C9, CYP3A4, CYP3A5, ABCB1, P2Y12, and CES genes.",0
83,6,Which gene is required for the efficient function of clopidogrel?,The prodrug clopidogrel requires activation by cytochrome P-450 (CYP) enzymes for its antiplatelet effect,1
83,7,Which gene is required for the efficient function of clopidogrel?,Carriers of the CYP2C19*2 and *4 alleles showed reduced platelet inhibition after a clopidogrel 600-mg loading dose but responded to higher loading and maintenance dose regimens,0
83,8,Which gene is required for the efficient function of clopidogrel?,"Carriers of the CYP2C19*17 T-allele, with increased clopidogrel activation, had a 37% relative reduction in the TLR incidence, the primary end point",0
83,9,Which gene is required for the efficient function of clopidogrel?,The cytochrome P450 (CYP) 2C19*2 polymorphism is associated with reduced responsiveness to clopidogrel and poor clinical outcome after stent implantation,0
83,10,Which gene is required for the efficient function of clopidogrel?,From these results it is suggested that CYP2C19*2 polymorphism is associated with subclinical thrombus formation among Japanese patients receiving clopidogrel.,0
83,11,Which gene is required for the efficient function of clopidogrel?,To determine the effect of various SNPs on post-clopidogrel platelet reactivity and clinical outcome.,0
83,12,Which gene is required for the efficient function of clopidogrel?,"MATERIALS & METHODS: Cytochrome 2C19 (CYP2C19) loss-of-function (LOF; *2, *3) and gain-of-function (GOF; *17) allelic variants, together with ABCB1 (3435 C→T and 2677 G→T/A) and paraoxonase-1 (PON-1; 192 Q→R) SNPs were analyzed in 189 patients after elective stent implantation who participated in a randomized, placebo-controlled trial (NCT00638326)",0
83,13,Which gene is required for the efficient function of clopidogrel?,Chinese people are more frequent carriers of cytochrome P450 2C19 (CYP2C19) loss-of-function alleles than Caucasians.,0
83,14,Which gene is required for the efficient function of clopidogrel?,"The aim of this study was to investigate the effect of the CYP2C19, ABCB1, and PON1 variants on clopidogrel pharmacodynamics and clinical outcomes in these patients",1
83,15,Which gene is required for the efficient function of clopidogrel?,The risk of a low response to clopidogrel and composite ischemic events increased with the number of CYP2C19 loss-of-function alleles.,0
83,16,Which gene is required for the efficient function of clopidogrel?,"However, there were not significant differences in clopidogrel pharmacodynamics and clinical outcomes across the ABCB1 and PON1 genotype groups; bleeding was not significantly different across the CYP2C19, ABCB1, and PON1 genotype groups",0
83,17,Which gene is required for the efficient function of clopidogrel?,The CYP2C19 loss-of-function alleles had a gene dose effect on the pharmacodynamics and composite ischemic events of clopidogrel in our study population.,1
83,18,Which gene is required for the efficient function of clopidogrel?,Neither the ABCB1 nor the PON1 genotype significantly influenced the antiplatelet effect and clinical outcomes of clopidogrel in these patients,1
627,0,What is the mode of inheritance of Marchesani syndrome?,Autosomal recessive and autosomal dominant WMS cannot be distinguished by clinical findings alone.,0
627,1,What is the mode of inheritance of Marchesani syndrome?,Weill-Marchesani syndrome (WMS) is a well-characterized disorder in which patients develop eye and skeletal abnormalities.,0
627,2,What is the mode of inheritance of Marchesani syndrome?,"Autosomal-recessive and autosomal-dominant forms of WMS are caused by mutations in ADAMTS10 and FBN1 genes, respectively.",1
627,3,What is the mode of inheritance of Marchesani syndrome?,"Finally, WMS is transmitted either by an autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance.",1
627,4,What is the mode of inheritance of Marchesani syndrome?,"Weill-Marchesani syndrome (WMS) is a rare condition characterized by short stature, brachydactyly, joint stiffness, and characteristic eye abnormalities including microspherophakia, ectopia of lens, severe myopia, and glaucoma.",0
627,5,What is the mode of inheritance of Marchesani syndrome?,Both autosomal recessive (AR) and autosomal dominant (AD) modes of inheritance have been described for WMS.,0
627,6,What is the mode of inheritance of Marchesani syndrome?,"Weill-Marchesani syndrome (WMS) is a connective tissue disorder characterised by short stature, brachydactyly, joint stiffness, and characteristic eye anomalies including microspherophakia, ectopia of the lenses, severe myopia, and glaucoma.",0
627,7,What is the mode of inheritance of Marchesani syndrome?,Both autosomal recessive (AR) and autosomal dominant (AD) modes of inheritance have been described and a gene for AR WMS has recently been mapped to chromosome 19p13.3-p13.2.,0
627,8,What is the mode of inheritance of Marchesani syndrome?,Both autosomal recessive and autosomal dominant modes of inheritance have been described in association with WMS.,1
627,9,What is the mode of inheritance of Marchesani syndrome?,"We report 6 patients with Weill-Marchesani syndrome (with or without ocular involvement) in three generations, identified by screening 26 members of two families.",0
627,10,What is the mode of inheritance of Marchesani syndrome?,This is the largest family in the literature showing an autosomal dominant pattern of inheritance.,1
627,11,What is the mode of inheritance of Marchesani syndrome?,"Weill-Marchesani syndrome comprises short stature, brachydactyly, microspherophakia, glaucoma, and ectopia lentis is regarded as an autosomal recessive trait",1
627,12,What is the mode of inheritance of Marchesani syndrome?,We present two families each with affected individuals in 3 generations demonstrating autosomal dominant inheritance of Weill-Marchesani syndrome.,0
627,13,What is the mode of inheritance of Marchesani syndrome?,"Weill-Marchesani syndrome is a rare, generalized disorder of connective tissue manifested by short stature, brachymorphia, and spherophakia.",0
627,14,What is the mode of inheritance of Marchesani syndrome?,Inheritance is autosomal recessive.,0
1073,0,How does TNF affect thyroid hormone receptors?,"treatment of the cells with T(3) for 2 d induced the expression of thyroid hormone receptor-beta and caspase-3, and this thyroid hormone receptor-beta induction was drastically repressed by xTNF-alpha.",1
2941,0,Which disease is PGT121 used for?,We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice.,1
2941,1,Which disease is PGT121 used for?,"In HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral loads than did AAV1.PGT121.",1
2941,2,Which disease is PGT121 used for?,Ad5.PGT121 also led to more-sustained virologic control than purified PGT121 IgG.,0
2941,3,Which disease is PGT121 used for?,"Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected humanized mice.",1
2941,4,Which disease is PGT121 used for?,We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121.,1
2941,5,Which disease is PGT121 used for?,"Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected humanized mice.",1
861,0,Which are the cellular targets of imatinib mesylate?,"Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases.",1
861,1,Which are the cellular targets of imatinib mesylate?,Imatinib mesylate is a novel anti-tumor agent useful in the clinical management of chronic myelogenous leukemia and gastrointestinal stromal tumors with minimal toxicity relative to other forms of cancer therapy.,1
861,2,Which are the cellular targets of imatinib mesylate?,"Its clinical activity and minimal toxicity are related to specific inhibition of cellular targets including BCR-ABL, platelet-derived growth factor receptor and c-kit kinases, resulting in the collapse of downstream signaling cascades important for transformation.",1
4077,0,Which molecule is targeted by Camrelizumab?,Camrelizumab (SHR-1210) is a humanised anti-programmed death-1 (anti PD-1) antibody.,1
4077,1,Which molecule is targeted by Camrelizumab?,The PD-1 antibody camrelizumab was well tolerated in patients with nasopharyngeal carcinoma.,0
4077,2,Which molecule is targeted by Camrelizumab?,"As decitabine is known to boost T-cell function, we assessed the safety and efficacy of anti-PD-1 camrelizumab alone versus decitabine-primed camrelizumab in patients with relapsed/refractory cHL.",0
4077,3,Which molecule is targeted by Camrelizumab?,Camrelizumab (SHR-1210) is a humanised anti-programmed death-1 (anti PD-1) antibody.,1
4077,4,Which molecule is targeted by Camrelizumab?,Decitabine plus camrelizumab may reverse resistance to PD-1 inhibitors in patients with relapsed/refractory cHL.,0
4077,5,Which molecule is targeted by Camrelizumab?,Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma.,0
4077,6,Which molecule is targeted by Camrelizumab?,CONCLUSION CR rate in patients with relapsed/refractory cHL who were clinically naïve to PD-1 blockade was significantly higher with decitabine plus camrelizumab than with camrelizumab alone.,0
4077,7,Which molecule is targeted by Camrelizumab?,"As decitabine is known to boost T-cell function, we assessed the safety and efficacy of anti-PD-1 camrelizumab alone versus decitabine-primed camrelizumab in patients with relapsed/refractory cHL.",0
4077,8,Which molecule is targeted by Camrelizumab?,"Recent phase 1-2 trials reported manageable safety profiles and promising antitumor activities of anti-PD-1 drugs (pembrolizumab, nivolumab, camrelizumab and JS001) with/without chemotherapy in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC), however head-to-head comparison among these regimens is lacking.",0
4077,9,Which molecule is targeted by Camrelizumab?,Camrelizumab (SHR-1210) is a humanised anti-programmed death-1 (anti PD-1) antibody.,1
4077,10,Which molecule is targeted by Camrelizumab?,"As decitabine is known to boost T-cell function, we assessed the safety and efficacy of anti-PD-1 camrelizumab alone versus decitabine-primed camrelizumab in patients with relapsed/refractory cHL.",0
4077,11,Which molecule is targeted by Camrelizumab?,"Recent phase 1-2 trials reported manageable safety profiles and promising antitumor activities of anti-PD-1 drugs (pembrolizumab, nivolumab, camrelizumab and JS001) with/without chemotherapy in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC), however head-to-head comparison among these regimens is lacking.",0
4077,12,Which molecule is targeted by Camrelizumab?,"Here, we represent preliminary evidence for the comparative safety and efficacy of existing anti-PD-1 agents with/without chemotherapy in RM-NPC, which indicated that camrelizumab has the least toxicity profile and merits future investigation.",0
4077,13,Which molecule is targeted by Camrelizumab?,"Camrelizumab (AiRuiKa™), a programmed cell death 1 (PD-1) inhibitor being developed by Jiangsu Hengrui Medicine Co.",1
4077,14,Which molecule is targeted by Camrelizumab?,"Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody.",0
4077,15,Which molecule is targeted by Camrelizumab?,"All patients were administered intravenous camrelizumab (SHR-1210), a novel anti-PD-1 antibody, at doses of 60 mg, 200 mg, or 400 mg (4-week interval after first dose followed by a 2-week schedule) until disease progression or intolerable toxicity.",0
4077,16,Which molecule is targeted by Camrelizumab?,"Here we describe a case of a novel pattern of RRP induced by anti-PD-1 blockade Camrelizumab 2 years after radiotherapy, with some focus on further understanding of this phenomenon.",0
4077,17,Which molecule is targeted by Camrelizumab?,"After 15 months, due to tumor progression and brain metastasis, he started with administration of anti-PD-1 blockade Camrelizumab (200 mg q2w) and stereotactic radiosurgery (SRS).",0
4077,18,Which molecule is targeted by Camrelizumab?,We aimed to assess efficacy and safety of the anti-PD-1 antibody camrelizumab versus investigator's choice of chemotherapy in previously treated patients.,0
4077,19,Which molecule is targeted by Camrelizumab?,This study aimed to assess the antitumour activity and safety of the anti-PD-1 inhibitor camrelizumab in pretreated patients with advanced hepatocellular carcinoma.,0
4077,20,Which molecule is targeted by Camrelizumab?,"In our present report, we described a newly diagnosed non-small-cell lung cancer patient who suffered from focal vitiligo for approximately ten years and was treated with the anti-programmed cell death-1 receptor antibody camrelizumab (SHR-1210), which accelerated the aggravation of depigmentation of the skin over the whole body in just half a year.",0
4077,21,Which molecule is targeted by Camrelizumab?,"PATIENTS AND METHODS: In this open-label, single-arm, phase II study, the safety and efficacy of combined regimen of chemotherapy consisting of gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD) plus anti-PD-1 antibody camrelizumab was assessed in rrPMBCL.",0
4077,22,Which molecule is targeted by Camrelizumab?,"Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial.",0
4077,23,Which molecule is targeted by Camrelizumab?,"We further benchmarked the dissociation kinetics for three clinically approved PD-1 blockade mAbs (Nivolumab, Pembrolizumab, and Camrelizumab), intriguingly correlating well with the objective response rates in the hepatocellular carcinoma second-line treatment.",0
4077,24,Which molecule is targeted by Camrelizumab?,Purpose: Camrelizumab inhibits PD-1 in non-clinical models and showed typical non-clinical pharmacokinetic (PK) and safety profiles for an IgG4 monoclonal antibody.,0
4077,25,Which molecule is targeted by Camrelizumab?,Camrelizumab is a programmed cell death protein 1 inhibitor.,1
4077,26,Which molecule is targeted by Camrelizumab?,"sions: Our findings suggest that (I) PD-1 targeted immunotherapy with toripalimab, camrelizumab, or sintilimab yielded a promising outcome in Chinese HBV patients with HCC and that (II) immunotherapy was well tolerated generally and had manageable side effects.",0
4077,27,Which molecule is targeted by Camrelizumab?,This,0
4077,28,Which molecule is targeted by Camrelizumab?,"ately, the tumors dramatically shrank after one cycle of camrelizumab, an anti-programmed cell death-1 (PD-1) antibody developed by Chinese Hengrui Medicine.",0
4077,29,Which molecule is targeted by Camrelizumab?,In concl,0
4077,30,Which molecule is targeted by Camrelizumab?,We report a case of a 68-year-old man diagnosed with pulmonary pleomorphic carcinoma who showed partial response after a single treatment with camrelizumab (PD1 monoclonal antibody),0
4077,31,Which molecule is targeted by Camrelizumab?,"JECTIVE: To evaluate the immune-related adverse events (irAEs) induced by Camrelizumab, an anti-PD-1 antibody in a patient with gastric cancer.C",0
4077,32,Which molecule is targeted by Camrelizumab?,"RT OPINION: Camrelizumab is a selective, humanized, high-affinity IgG4 kappa mAb against PD-1.",0
4077,33,Which molecule is targeted by Camrelizumab?,Ca,0
4077,34,Which molecule is targeted by Camrelizumab?,"INTRODUCTION: Camrelizumab (also known as SHR-1210), a humanized monoclonal antibody against PD-1, has been shown to block the binding of PD-1 to PD-L1 and consequently inhibit the immune escape of tumor cells",0
4077,35,Which molecule is targeted by Camrelizumab?,"The structure of the camrelizumab/PD-1 complex reveals that camrelizumab mainly utilizes its heavy chain to bind to PD-1, while the light chain sterically inhibits the binding of PD-L1 to PD-1.",0
4077,36,Which molecule is targeted by Camrelizumab?,"Here, we demonstrate varied N-glycan composition in PD-1, and show that the binding affinity of camrelizumab, a recently approved PD-1-specific MAb, to non-glycosylated PD-1 proteins from E. coli is substantially decreased compared with glycosylated PD-1.",0
4077,37,Which molecule is targeted by Camrelizumab?,This study aimed to assess the antitumour activity and safety of the anti-PD-1 inhibitor camrelizumab in pretreated patients with advanced hepatocellular carcinoma.M,0
4077,38,Which molecule is targeted by Camrelizumab?,"INTRODUCTION: Camrelizumab (also known as SHR-1210), a humanized monoclonal antibody against PD-1, has been shown to block the binding of PD-1 to PD-L1 and consequently inhibit the immune escape o",0
4077,39,Which molecule is targeted by Camrelizumab?,Purpose: Camrelizumab inhibits PD-1 in non-clinical models and showed typical non-clinical pharmacokinetic (PK) and safety profiles for an IgG4 monoclonal,0
4077,40,Which molecule is targeted by Camrelizumab?,"Camrelizumab (AiRuiKa™), a programmed cell death 1 (PD-1) inhibitor being developed by Jiangsu Hengrui Medicine Co. Ltd, recently received conditional approval in China for the treatment of relapsed or refractory classical Hodgkin lymphoma.",0
4077,41,Which molecule is targeted by Camrelizumab?,The PD-1 antibody camrelizumab plus the VEGFR2 inhibitor apatinib had efficacy in a phase II trial.,0
4077,42,Which molecule is targeted by Camrelizumab?,PURPOSE: We assessed the efficacy and safety of camrelizumab (an anti-PD-1 monoclonal antibody) plus apatinib (a vascular endothelial growth factor [VEGFR]-2 tyrosine kinase inhibitor) in patients with advanced hepatocellular carcinoma (HCC).,0
4077,43,Which molecule is targeted by Camrelizumab?,"However, all three patients responded to low-dose decitabine, an epigenetic drug, in combination with camrelizumab (anti-PD-1 antibody), with only controllable adverse events, indicating that low-dose decitabine can sensitize PD-1/PD-L1 inhibitors.",0
4077,44,Which molecule is targeted by Camrelizumab?,Background: Camrelizumab is a promising anti-programmed cell death-1 agent for non-small cell lung cancer (NSCLC) and induces reactive capillary hemangiomas (RCHs).,0
4077,45,Which molecule is targeted by Camrelizumab?,"Camrelizumab is a programmed cell death protein 1 inhibitor; however, current evidence of its efficacy in PSC is lacking.",0
4077,46,Which molecule is targeted by Camrelizumab?,Camrelizumab is a programmed death receptor-1 inhibitor originally developed in China for the treatment of refractory lymphoma.,0
4077,47,Which molecule is targeted by Camrelizumab?,"Recent phase 1-2 trials reported manageable safety profiles and promising antitumor activities of anti-PD-1 drugs (pembrolizumab, nivolumab, camrelizumab and JS001) with/without chemotherapy in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC), however head-to-head comparison among these regimens is lacking.",0
4077,48,Which molecule is targeted by Camrelizumab?,"Camrelizumab, a programmed cell death 1 (PD-1) inhibitor, has been approved for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma, nasopharyngeal cancer and non-small cell lung cancer.",0
4077,49,Which molecule is targeted by Camrelizumab?,PURPOSE: Camrelizumab is an antibody against programmed death protein 1.,0
4077,50,Which molecule is targeted by Camrelizumab?,"All patients were administered intravenous camrelizumab (SHR-1210), a novel anti-PD-1 antibody, at doses of 60 mg, 200 mg, or 400 mg (4-week interval after first dose followed by a 2-week schedule) until disease progression or intolerable toxicity.",0
4077,51,Which molecule is targeted by Camrelizumab?,"Therefore, we explored the efficacy and safety of a PD-1 checkpoint inhibitor camrelizumab in advanced or metastatic solid tumour with dMMR/MSI-H.",0
4077,52,Which molecule is targeted by Camrelizumab?,Aim: The present study evaluated the safety and efficacy of camrelizumab (a programmed death-1 antibody) in combination with microwave ablation (MWA) in advanced non-small cell lung cancer (NSCLC).,0
3702,0,Describe the Open Targets platform,Open Targets: a platform for therapeutic target identification and validation.,0
3702,1,Describe the Open Targets platform,We have designed and developed a data integration and visualization platform that provides evidence about the association of known and potential drug targets with diseases.,1
3702,2,Describe the Open Targets platform,The platform is designed to support identification and prioritization of biological targets for follow-up.,1
3702,3,Describe the Open Targets platform,Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources.,1
3702,4,Describe the Open Targets platform,"The platform provides either a target-centric workflow to identify diseases that may be associated with a specific target, or a disease-centric workflow to identify targets that may be associated with a specific disease.",1
3702,5,Describe the Open Targets platform,Users can easily transition between these target- and disease-centric workflows.,0
3702,6,Describe the Open Targets platform,The Open Targets Validation Platform is accessible at https://www.targetvalidation.org.,1
3702,7,Describe the Open Targets platform,Here we describe a systematic approach utilizing the Open Targets Platform data to uncover and prioritize potential new disease indications for the G-protein coupled receptors and their ligands.,0
3702,8,Describe the Open Targets platform,The recently developed Open Targets platform consolidates a wide range of comprehensive evidence associating known and potential drug targets with human diseases.,0
3702,9,Describe the Open Targets platform,BACKGROUND The Open Targets Platform integrates different data sources in order to facilitate identification of potential therapeutic drug targets to treat human diseases.,0
3702,10,Describe the Open Targets platform,Here we describe a systematic approach utilizing the Open Targets Platform data to uncover and prioritize potential new disease indications for the G-protein coupled receptors and their ligands,0
3702,11,Describe the Open Targets platform,The recently developed Open Targets platform consolidates a wide range of comprehensive evidence associating known and potential drug targets with human diseases,0
3702,12,Describe the Open Targets platform,"The Open Targets Platform integrates evidence from genetics , genomics , transcriptomics , drugs , animal models and scientific literature to score and rank target-disease associations for drug target identification",0
3702,13,Describe the Open Targets platform,"Here, we present the latest developments of the Open Targets Platform, expanding the evidence and target-disease associations with new and improved data sources, refining data quality, enhancing website usability, and increasing our user base with our training workshops, user support, social media and bioinformatics forum engagement.",0
3702,14,Describe the Open Targets platform,"The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease associations for drug target identification.",0
3702,15,Describe the Open Targets platform,Here we describe a systematic approach utilizing the Open Targets Platform data to uncover and prioritize potential new disease indications for the G-protein coupled receptors and their ligands.,0
3702,16,Describe the Open Targets platform,"CONCLUSIONS
The Open Targets gene-disease score can be used to prioritize potential G-protein coupled receptors-indication hypotheses.",0
3702,17,Describe the Open Targets platform,BACKGROUND: The Open Targets Platform integrates different data sources in order to facilitate identification of potential therapeutic drug targets to treat human diseases.,0
3702,18,Describe the Open Targets platform,"Here, we present the latest developments of the Open Targets Platform, expanding the evidence and target-disease associations with new and improved data sources, refining data quality, enhancing website usability, and increasing our user base with our training workshops, user support, social media and bioinformatics forum engagement.",0
3702,19,Describe the Open Targets platform,"The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease associations for drug target identification.",0
3702,20,Describe the Open Targets platform,The Open Targets Platform integrates different data sources in order to facilitate identification of potential therapeutic drug targets to treat human diseases.,0
3702,21,Describe the Open Targets platform,Here we describe a systematic approach utilizing the Open Targets Platform data to uncover and prioritize potential new disease indications for the G-protein coupled receptors and their ligands.,0
3702,22,Describe the Open Targets platform,We present the Europe PMC literature component of Open Targets - a target validation platform that integrates various evidence to aid drug target identification and validation.,0
3249,0,Which receptor is inhibited by bimagrumab?,Bimagrumab is a human anti-ActRII antibody which was found to increase muscle mass and function by blocking ActRII signaling,0
3249,1,Which receptor is inhibited by bimagrumab?,"BACKGROUND: Bimagrumab is a human monoclonal antibody inhibitor of activin type II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking binding of myostatin and other negative regulators of muscle growth.",1
3249,2,Which receptor is inhibited by bimagrumab?,"CONCLUSION: Bimagrumab alters the function of pituitary gonadotroph cells, consistent with blockade of activin on local ActRII.",0
3249,3,Which receptor is inhibited by bimagrumab?,"RATIONALE: Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.",1
3249,4,Which receptor is inhibited by bimagrumab?,CONCLUSIONS: Blocking the action of negative muscle regulators through the activin type II receptors with bimagrumab treatment safely increased skeletal muscle mass but did not improve functional capacity in patients with COPD and low muscle mass.,0
3249,5,Which receptor is inhibited by bimagrumab?,"This study aimed to explore the clinical potential of bimagrumab, a human monoclonal antibody targeting the activin type II receptor, for the recovery of skeletal muscle volume from disuse atrophy using an experimental model of lower extremity immobilization.",0
3249,6,Which receptor is inhibited by bimagrumab?,"Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes.",0
3249,7,Which receptor is inhibited by bimagrumab?,Bimagrumab (BYM338) is a novel fully human monoclonal antibody that exerts strong promyogenic effects on skeletal muscle by blocking activin type II receptors (ActRII).,0
3249,8,Which receptor is inhibited by bimagrumab?,"BACKGROUND

Bimagrumab is a human monoclonal antibody inhibitor of activin type II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking binding of myostatin and other negative regulators of muscle growth.",0
3249,9,Which receptor is inhibited by bimagrumab?,"RATIONALE

Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.",0
3249,10,Which receptor is inhibited by bimagrumab?,"CDD866 (murinized version of bimagrumab) is a neutralizing antibody against the activin receptor type II (ActRII) preventing binding of ligands such as myostatin and activin A, which are involved in cancer cachexia.",0
3249,11,Which receptor is inhibited by bimagrumab?,"We have developed a novel , human anti-ActRII antibody ( bimagrumab , or BYM338 ) to prevent binding of ligands to the receptors and thus inhibit downstream signaling",0
3249,12,Which receptor is inhibited by bimagrumab?,"This study aimed to explore the clinical potential of bimagrumab , a human monoclonal antibody targeting the activin type II receptor , for the recovery of skeletal muscle volume from disuse atrophy using an experimental model of lower extremity immobilization",0
3249,13,Which receptor is inhibited by bimagrumab?,"Bimagrumab is a human monoclonal antibody inhibitor of activin type II receptors ( ActRII) , with anabolic action on skeletal muscle mass by blocking binding of myostatin and other negative regulators of muscle growth",1
3249,14,Which receptor is inhibited by bimagrumab?,"Novel antiresorptive and anabolic therapies are emerging for osteoporosis as well as drugs for sarcopenia , cancer cachexia or muscle wasting disorders , including antibodies against myostatin or activin receptor type IIA and IIB ( e.g.",0
3249,15,Which receptor is inhibited by bimagrumab?,bimagrumab,0
3249,16,Which receptor is inhibited by bimagrumab?,"A global , randomized , double-blind placebo-controlled study was conducted to confirm that BYM338 ( bimagrumab) , an anti-activin type II receptor antibody , improves motor function in patients with sporadic inclusion body myositis after 52 weeks' treatment consisting of intravenous administration every 4 weeks at doses of 10 , 3 , and 1 mg/kg",0
3249,17,Which receptor is inhibited by bimagrumab?,Bimagrumab ( BYM338 ) is a novel fully human monoclonal antibody that exerts strong promyogenic effects on skeletal muscle by blocking activin type II receptors ( ActRII,0
3249,18,Which receptor is inhibited by bimagrumab?,Bimagrumab (BYM338) is a novel fully human monoclonal antibody that exerts strong promyogenic effects on skeletal muscle by blocking activin type II receptors (ActRII).,0
3249,19,Which receptor is inhibited by bimagrumab?,"BACKGROUND
Bimagrumab is a human monoclonal antibody inhibitor of activin type II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking binding of myostatin and other negative regulators of muscle growth.",0
3249,20,Which receptor is inhibited by bimagrumab?,"Bimagrumab also blocks other endogenous ActRII ligands, such as activins, which act on the neurohormonal axes, pituitary, gonads and adrenal glands.",0
3249,21,Which receptor is inhibited by bimagrumab?,"RATIONALE
Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.",0
3249,22,Which receptor is inhibited by bimagrumab?,"Bimagrumab also blocks other endogenous ActRII ligands, such as activins, which act on the neurohormonal axes, pituitary, gonads and adrenal glands.",0
3249,23,Which receptor is inhibited by bimagrumab?,"We have developed a novel, human anti-ActRII antibody (bimagrumab, or BYM338) to prevent binding of ligands to the receptors and thus inhibit downstream signaling.",0
3249,24,Which receptor is inhibited by bimagrumab?,"Bimagrumab is a human monoclonal antibody inhibitor of activin type II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking binding of myostatin and other negative regulators of muscle growth.",1
3249,25,Which receptor is inhibited by bimagrumab?,"Bimagrumab is a fully human monoclonal antibody that blocks the activin type II receptors, preventing the activity of myostatin and other negative skeletal muscle regulators.",1
3249,26,Which receptor is inhibited by bimagrumab?,Blocking the action of negative muscle regulators through the activin type II receptors with bimagrumab treatment safely increased skeletal muscle mass but did not improve functional capacity in patients with COPD and low muscle mass.,0
3249,27,Which receptor is inhibited by bimagrumab?,"This study aimed to explore the clinical potential of bimagrumab, a human monoclonal antibody targeting the activin type II receptor, for the recovery of skeletal muscle volume from disuse atrophy using an experimental model of lower extremity immobilization.",0
3249,28,Which receptor is inhibited by bimagrumab?,"CDD866 (murinized version of bimagrumab) is a neutralizing antibody against the activin receptor type II (ActRII) preventing binding of ligands such as myostatin and activin A, which are involved in cancer cachexia.",0
3249,29,Which receptor is inhibited by bimagrumab?,We tested inhibition of activin receptors IIA and IIB (ActRII) in 14 patients with sIBM using one dose of bimagrumab (n = 11) or placebo (n = 3).,0
2057,0,What is DECKO?,"DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs",1
2057,1,What is DECKO?,"We present a dual CRISPR tool, DECKO, which is cloned using a single starting oligonucleotide, thereby affording simplicity and scalability to CRISPR knockout studies of non-coding genomic elements, including long non-coding RNAs.",1
2057,2,What is DECKO?," We present a vector system adapted for this purpose called DECKO (Double Excision CRISPR Knockout), which applies a simple two-step cloning to generate lentiviral vectors expressing two guide RNAs (gRNAs) simultaneously.",0
2057,3,What is DECKO?,"The key feature of DECKO is its use of a single 165 bp starting oligonucleotide carrying the variable sequences of both gRNAs, making it fully scalable from single-locus studies to complex library cloning.",0
2057,4,What is DECKO?,"DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs.",0
2057,5,What is DECKO?,"We present a vector system adapted for this purpose called DECKO (Double Excision CRISPR Knockout), which applies a simple two-step cloning to generate lentiviral vectors expressing two guide RNAs (gRNAs) simultaneously.",0
2057,6,What is DECKO?,"The key feature of DECKO is its use of a single 165 bp starting oligonucleotide carrying the variable sequences of both gRNAs, making it fully scalable from single-locus studies to complex library cloning.",0
2057,7,What is DECKO?,"We present a vector system adapted for this purpose called DECKO (Double Excision CRISPR Knockout), which applies a simple two-step cloning to generate lentiviral vectors expressing two guide RNAs (gRNAs) simultaneously",0
2057,8,What is DECKO?,"The key feature of DECKO is its use of a single 165 bp starting oligonucleotide carrying the variable sequences of both gRNAs, making it fully scalable from single-locus studies to complex library cloning.We apply DECKO to deleting the promoters of one protein-coding gene and two oncogenic lncRNAs, UCA1 and the highly-expressed MALAT1, focus of many previous studies employing RNA interference approaches",0
2057,9,What is DECKO?,"These clones have reductions in steady-state MALAT1 RNA levels of up to 98 % and display reduced proliferation rates.We present a dual CRISPR tool, DECKO, which is cloned using a single starting oligonucleotide, thereby affording simplicity and scalability to CRISPR knockout studies of non-coding genomic elements, including long non-coding RNAs",1
2057,10,What is DECKO?,"We present a vector system adapted for this purpose called DECKO (Double Excision CRISPR Knockout), which applies a simple two-step cloning to generate lentiviral vectors expressing two guide RNAs (gRNAs) simultaneously.",0
2057,11,What is DECKO?,"The key feature of DECKO is its use of a single 165 bp starting oligonucleotide carrying the variable sequences of both gRNAs, making it fully scalable from single-locus studies to complex library cloning.We apply DECKO to deleting the promoters of one protein-coding gene and two oncogenic lncRNAs, UCA1 and the highly-expressed MALAT1, focus of many previous studies employing RNA interference approaches.",0
2057,12,What is DECKO?,"These clones have reductions in steady-state MALAT1 RNA levels of up to 98 % and display reduced proliferation rates.We present a dual CRISPR tool, DECKO, which is cloned using a single starting oligonucleotide, thereby affording simplicity and scalability to CRISPR knockout studies of non-coding genomic elements, including long non-coding RNAs.",1
2057,13,What is DECKO?,"DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs.",0
2057,14,What is DECKO?,"We present a dual CRISPR tool, DECKO, which is cloned using a single starting oligonucleotide, thereby affording simplicity and scalability to CRISPR knockout studies of non-coding genomic elements, including long non-coding RNAs..",1
1125,0,Does smoking increase risk for glioblastoma?,Glioma risk has consistently been inversely associated with allergy history but not with smoking history despite putative biologic plausibility.,1
1125,1,Does smoking increase risk for glioblastoma?,"No relation was observed between glioma risk and smoking (odds ratio = 0.92, 95% confidence interval: 0.77, 1.10; P = 0.37), and there were no interactions for glioma risk of smoking history with any of the risk alleles.",1
1125,2,Does smoking increase risk for glioblastoma?,"Non-smokers with G/A and A/A genotype showed increased glioma risk compared with G/G genotype (adjusted OR = 1.72, 95%CI: 1.29-2.30, p = 0.0002 and adjusted OR = 1.81, 95%CI: 1.10-2.99, p = 0.020, respectively).",0
1125,3,Does smoking increase risk for glioblastoma?,This association was not found in ever- or current-smokers.,0
1125,4,Does smoking increase risk for glioblastoma?,"There was no significant association between glioma and alcohol consumption, smoking and mobile phone use.",0
1125,5,Does smoking increase risk for glioblastoma?,"RESULTS: We found no associations between the GSTM3, GSTP1, NQO1, CYP1A1, GSTM1, or GSTT1 polymorphisms and adult brain tumor risk with the possible exception of a weak association between the G-C (Val-Ala) GSTP1 105/114 haplotype and glioma [odds ratio (OR), 0.73; 95% confidence interval (95% CI), 0.54, 0.99], nor was there an interaction between the effects of the GSTM3 or GSTP1 polymorphisms and cigarette smoking.",0
1125,6,Does smoking increase risk for glioblastoma?,"We did not find any evidence for an association with life-style characteristics such as cigarette smoking, alcohol consumption, use of drugs of any kind, or dietary intake of cured or smoked meat or fish.",0
1125,7,Does smoking increase risk for glioblastoma?,No relation was observed between glioma risk and smoking (odds ratio = 0,1
1125,8,Does smoking increase risk for glioblastoma?,Glioma risk has consistently been inversely associated with allergy history but not with smoking history despite putative biologic plausibility,1
1125,9,Does smoking increase risk for glioblastoma?,"Compared with nonsmokers, duration of cigarette smoking, number of cigarettes smoked per day and pack-years of smoking were associated with increased glioma risk, although the increases in risk were relatively modest",0
1125,10,Does smoking increase risk for glioblastoma?,"Among ever smokers, women who reported having quit smoking had a 51% increase in risk of glioma compared with never smokers (HR = 1.51, 95% CI = 0.97-2.34), while current smokers did not appear to have an increase in risk",1
3236,0,List 3 indications for rituximab.,"o assess clinical outcomes including imaging findings on computed tomography (CT), pulmonary function testing (PFT), and glucocorticoid (GC) use in patients with the antisynthetase syndrome (AS) and interstitial lung disease (ILD) treated with rituximab (RTX).",0
3236,1,List 3 indications for rituximab., RIX is the preferred off-label biologic drug for poly- and dermatomyositis in Germany.,1
3236,2,List 3 indications for rituximab.,"Rituximab (RTX) may be a treatment option for children and young people with JIA, although it is not licensed for this indication",0
3236,3,List 3 indications for rituximab., rituximab in children and young people with juvenile idiopathic arthritis,1
3236,4,List 3 indications for rituximab.,"chronic lymphocytic leukemia (CLL) patients, including the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, phosphatidylinositol-3-kinase (PI3K) delta isoform inhibitor idelalisib combined with rituximab",1
3236,5,List 3 indications for rituximab.,rituximab's efficacy has been well-documented in adults with refractory PF,0
3236,6,List 3 indications for rituximab.,Rituximab in the management of juvenile pemphigus foliaceus,1
3236,7,List 3 indications for rituximab.,"BACKGROUND
Rituximab is a chimeric, anti-CD20 monoclonal antibody registered for the treatment of B-cell malignancies and refractory rheumatoid arthritis in Australia.",0
3236,8,List 3 indications for rituximab.,"Currently, rituximab is only FDA-approved for treatment of follicular and diffuse large B-cell non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis (formerly Wegener's granulomatosis) and microscopic polyangiitis.",1
3236,9,List 3 indications for rituximab.,"<AbstractText Label=""CONCLUSIONS"" NlmCategory=""CONCLUSIONS"">In our study, off-label rituximab was mainly used for the treatment of hematological, kidney, and systemic connective tissue disorders, and the response among our patient cohort was variable depending on the specific disease.",0
2675,0,What disease is tinea ?,Onychomycosis is a common infection of the nail unit that is usually caused by a dermatophyte (tinea unguium) and most frequently affects toenails in adults,1
2675,1,What disease is tinea ?,"skin infections with dermatophytes such as tinea pedis and tinea corporis,",0
2675,2,What disease is tinea ?,Tinea capitis is the most common dermatophyte infection in children.,1
2675,3,What disease is tinea ?,"The term ""tinea incognita"" refers to diverse clinical presentation of mycotic infections modified by inappropriate use of topical or systemic corticosteroids",0
2675,4,What disease is tinea ?,"Dermatophyte infections are common at all ages, in both sexes, and they have a worldwide distribution.",0
2675,5,What disease is tinea ?,"These infections include tinea capitis, tinea cruris, tinea pedis, tinea corporis, tinea manuum and tinea barbae.",0
2675,6,What disease is tinea ?,"Tinea versicolor, caused by Malassezia furfur,",0
2675,7,What disease is tinea ?,Tinea capitis is a fungal infection of the skin and the hair with involvement of the hair shaft and the pilosebaceous unit.,1
2675,8,What disease is tinea ?,"The genus Trichophyton gives rise to most of the tinea dermatophytoses, including tinea capitis, tinea pedis, and tinea unguium (onychomycosis).",0
2675,9,What disease is tinea ?," For the men, onychomycosis (nail fungus, 31.5%), tinea pedis (foot fungus, 27.8%), and acne (24.1 %) were the most commonly diagnosed skin diseases, with contact dermatitis diagnosed in 5.6% of the sample",0
2675,10,What disease is tinea ?,"A statistical 30-year study of dermatomycosis in Sendai National Hospital (1968-1997) revealed many changes in the prevalent diseases: Tinea pedis and tinea unguium constantly increased during this period, and the ratio of the former associated with nail infection finally reached 30% of all tinea pedis patients",0
2675,11,What disease is tinea ?,Eighty percent of the examined boys were with unless one skin disease.,0
2675,12,What disease is tinea ?,"Tinea capitis (42.66%), scabiosis (13.33%), pyoderma (15.33%), plantar keratodermia (100%) were the skin diseases.",0
2675,13,What disease is tinea ?,Tinea capitis is a dermatophyte infection that occurs mainly in childhood;,1
2675,14,What disease is tinea ?,"Tinea pedis is a chronic fungal infection of the feet, very often observed in patients who are immuno-suppressed or have diabetes mellitus.",1
2675,15,What disease is tinea ?,Tinea infections are caused by dermatophytes and are classified by the involved site.,0
2675,16,What disease is tinea ?,"The most common infections in prepubertal children are tinea corporis and tinea capitis, whereas adolescents and adults are more likely to develop tinea cruris, tinea pedis, and tinea unguium (onychomycosis).",0
2675,17,What disease is tinea ?,The most frequent diseases observed at arrival were dermatological conditions.,0
2675,18,What disease is tinea ?,"Of the adoptees, 70% presented at least one skin disease, of which 57.5% were infectious; Tinea capitis being the most frequent (n = 42).",0
2675,19,What disease is tinea ?,The recovery rate of Tinea capitis was 89% (n = 32/36).,0
2602,0,Is Rucaparib effective for ovarian cancer?,"INTERPRETATION: In patients with BRCA mutant or BRCA wild-type and LOH high platinum-sensitive ovarian carcinomas treated with rucaparib, progression-free survival was longer than in patients with BRCA wild-type LOH low carcinomas.",0
2602,1,Is Rucaparib effective for ovarian cancer?,High LOH is associated with response to the PARP inhibitor rucaparib in BRCA wild-type ovarian cancer.,0
2602,2,Is Rucaparib effective for ovarian cancer?,Rucaparib Approved for Ovarian Cancer.,0
2602,3,Is Rucaparib effective for ovarian cancer?,The FDA approved the PARP inhibitor rucaparib to treat women with advanced ovarian cancer who have already been treated with at least two chemotherapies and have a BRCA1 or BRCA2 gene mutation identified by an approved companion diagnostic test.,1
2602,4,Is Rucaparib effective for ovarian cancer?,"Rucaparib (Rubraca™) is an oral, small molecule, poly (ADP-ribose) polymerase inhibitor being developed by Clovis Oncology, Inc. (Boulder, CO, USA) for the treatment of solid tumours.",1
2602,5,Is Rucaparib effective for ovarian cancer?,It has been approved in the USA as monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies.,1
2602,6,Is Rucaparib effective for ovarian cancer?,"In 2016, the US Food and Drug Administration approved three novel drugs for the treatment of solid malignancies-olaratumab in selected patients with soft-tissue sarcoma, atezolizumab for the treatment of bladder cancer, and rucaparib for the treatment of ovarian cancer; also in 2016, the use of previously approved anticancer agents (including atezolizumab) was expanded into 11 new patient populations.",0
2602,7,Is Rucaparib effective for ovarian cancer?,Conclusions:Rucaparib was tolerable and had activity in patients with platinum-sensitive germlineBRCA1/2-mutated HGOC.,0
2602,8,Is Rucaparib effective for ovarian cancer?,"<b>OBJECTIVE</b>: To review the pharmacology, safety, efficacy, and the role of rucaparib in the treatment of relapsed, advanced ovarian cancer.<br><b>SUMMARY</b>: A total of 2 phase I/II trials and 1 phase II trial have evaluated the safety and efficacy of oral rucaparib in ovarian cancer.",0
2602,9,Is Rucaparib effective for ovarian cancer?,"Rucaparib was found to be relatively well tolerated in clinical trials, with the most common adverse events being anemia, fatigue, and nausea.<br><b>CONCLUSION</b>: Rucaparib appears to be a safe and effective new option in the treatment of relapsed, advanced BRCA1/2 mutant ovarian cancer.",0
2602,10,Is Rucaparib effective for ovarian cancer?,"In patients with deleterious BRCA1/2 mutation, an overall response rate of 80% was achieved in the phase II trial Assessment of Rucaparib in Ovarian CancEr Trial 2 (ARIEL2).",0
2602,11,Is Rucaparib effective for ovarian cancer?,This article summarizes the milestones in the development of rucaparib leading to this first approval for ovarian cancer.<br>,0
2602,12,Is Rucaparib effective for ovarian cancer?,These results support further clinical evaluation of rucaparib either as a single agent or as an adjunct to chemotherapy for the treatment of sporadic ovarian cancer.<br>,0
2602,13,Is Rucaparib effective for ovarian cancer?,Rucaparib: a Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Ovarian Cancer.,0
2602,14,Is Rucaparib effective for ovarian cancer?,"CONCLUSION Rucaparib appears to be a safe and effective new option in the treatment of relapsed, advanced BRCA1/2 mutant ovarian cancer.",0
2602,15,Is Rucaparib effective for ovarian cancer?,These results support further clinical evaluation of rucaparib either as a single agent or as an adjunct to chemotherapy for the treatment of sporadic ovarian cancer.,0
2602,16,Is Rucaparib effective for ovarian cancer?,Rucaparib received US FDA Breakthrough Therapy designation for treatment of platinum-sensitive BRCA-mutated advanced ovarian cancer patients who received greater than two lines of platinum-based therapy.,0
2602,17,Is Rucaparib effective for ovarian cancer?,"BACKGROUND Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-wide loss of heterozygosity.",1
2602,18,Is Rucaparib effective for ovarian cancer?,"Rucaparib appears to be a safe and effective new option in the treatment of relapsed, advanced BRCA1/2 mutant ovarian cancer.",0
2602,19,Is Rucaparib effective for ovarian cancer?,Rucaparib: A Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Ovarian Cancer.,0
2602,20,Is Rucaparib effective for ovarian cancer?,"Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer.",0
2602,21,Is Rucaparib effective for ovarian cancer?,FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer.,1
2602,22,Is Rucaparib effective for ovarian cancer?,Olaparib and rucaparib have been approved by the US FDA as monotherapy for advanced recurrent ovarian cancer.,0
3673,0,What cellular process is the protein clathrin involved in?,ligand-receptor complexes are internalized via clathrin coated pits by a process called receptor-mediated endocytosis.,1
3673,1,What cellular process is the protein clathrin involved in?,Receptor-mediated endocytosis proceeds by transfer of receptor-ligand complexes from clathrin-coated pits at the cell surface to uncoated endocytic vesicles termed receptosomes (or endosomes).,1
3673,2,What cellular process is the protein clathrin involved in?,while clathrin mediated endocytosis w,0
3673,3,What cellular process is the protein clathrin involved in?,Clathrin-mediated endocytosis (CME) is a cellular trafficking process in which cargoes and lipids are internalized from the plasma membrane into vesicles coated with clathrin and adaptor proteins.,0
3673,4,What cellular process is the protein clathrin involved in?,Clathrin is involved in the endocytosis and exocytosis of cellular proteins and the process of virus infection.,1
3673,5,What cellular process is the protein clathrin involved in?,"Endocytosis is a crucial cellular process in eukaryotic cells which involves clathrin and/or adaptor proteins , lipid kinases , phosphatases and the actin cytoskeleton",0
3673,6,What cellular process is the protein clathrin involved in?,"Clathrin-independent endocytosis ( CIE ) is the process of cellular uptake of various particles , including pathogens , without the coat protein clathrin",0
3673,7,What cellular process is the protein clathrin involved in?,"Endocytosis is an essential cellular process in eukaryotic cells that involves concordant functions of clathrin and adaptor proteins , various protein and lipid kinases , phosphatases and the actin cytoskeleton",0
3673,8,What cellular process is the protein clathrin involved in?,"Endocytosis mediated by clathrin , a cellular process by which cells internalize membrane receptors and their extracellular ligands , is an important component of cell signaling regulation",0
3673,9,What cellular process is the protein clathrin involved in?,Clathrin-mediated endocytosis ( CME ) is a cellular trafficking process in which cargoes and lipids are internalized from the plasma membrane into vesicles coated with clathrin and adaptor proteins,0
3673,10,What cellular process is the protein clathrin involved in?,"Clathrin plays an important role in many cellular processes, including endocytosis, secretion, and sorting of membranous organelles.",1
3673,11,What cellular process is the protein clathrin involved in?,Clathrin-mediated endocytosis is a major regulator of cell-surface protein internalization.,1
1203,0,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,"Purified iMSCs displayed fibroblast-like morphology, formed three-dimensional spheroid structures, and expressed characteristic mesenchymal stem cell surface markers such as CD29, CD33, CD73, CD90, and CD105.",1
1203,1,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,"Moreover, iMSCs were capable of differentiating into adipogenic, osteogenic, and chondrogenic lineages.",1
1203,2,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,"Transplanting iMSC cells to tibialis anterior skeletal muscle tissue in mdx mice lowered oxidative damage as evidenced by a reduction in nitrotyrosine levels, and normal dystrophin expression levels were restored",1
1203,3,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,This study demonstrates the therapeutic potential of purified iMSCs in skeletal muscle regeneration in mdx mice,0
1203,4,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice,0
1203,5,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,"Within mdx mice, an animal model of DMD, adipose tissue-derived Flk-1(+) MSCs (AD-MSCs) homed to and differentiated into cells that repaired injured muscle tissue.",0
1203,6,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,This repair correlated with reconstitution of dystrophin expression on the damaged fibers,0
1203,7,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,Flk-1(+) AD-MSC transplants may repair muscular dystrophy,0
1203,8,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,"This study demonstrates the therapeutic potential of purified iMSCs in skeletal muscle regeneration in mdx mice, and suggests that iPSCs are a viable alternate source for deriving MSCs as needed.",1
1203,9,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,"Transplanting iMSC cells to tibialis anterior skeletal muscle tissue in mdx mice lowered oxidative damage as evidenced by a reduction in nitrotyrosine levels, and normal dystrophin expression levels were restored",1
1203,10,Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?,"This study demonstrates the therapeutic potential of purified iMSCs in skeletal muscle regeneration in mdx mice, and suggests that iPSCs are a viable alternate source for deriving MSCs as needed",0
4083,0,Which mutation is targeted by Sotorasib?,"In a phase I trial, the KRASG12C inhibitor sotorasib elicited responses in about a third of patients with the disease and was generally well tolerated.",1
4083,1,Which mutation is targeted by Sotorasib?,Sotorasib is a small molecule that selectively and irreversibly targets KRASG12C.METHODS: We conducted a phase 1 trial of sotorasib in patients with advanced solid tumors harboring the KRAS p.G12C mutation.,1
4083,2,Which mutation is targeted by Sotorasib?,CONCLUSIONS: Sotorasib showed encouraging anticancer activity in patients with heavily pretreated advanced solid tumors harboring the KRAS p.G12C mutation.,0
4083,3,Which mutation is targeted by Sotorasib?,"In a phase I trial, the KRASG12C inhibitor sotorasib elicited responses in about a third of patients with the disease and was generally well tolerated.",0
4083,4,Which mutation is targeted by Sotorasib?,SIONS: Sotorasib showed encouraging anticancer activity in patients with heavily pretreated advanced solid tumors harboring the KRAS p.G12C mutation.,0
4083,5,Which mutation is targeted by Sotorasib?,Grad,0
4083,6,Which mutation is targeted by Sotorasib?,THODS: We conducted a phase 1 trial of sotorasib in patients with advanced solid tumors harboring the KRAS p.G12C mutation.,0
4083,7,Which mutation is targeted by Sotorasib?, Sotorasib is a small molecule that selectively and irreversibly targets KRASG12C,1
4083,8,Which mutation is targeted by Sotorasib?,Sotorasib is a small molecule that selectively and irreversibly targets KRASG12C.METHODS: We conducted a phase 1 trial of sotorasib in patients with advanced solid tumors harboring the KRAS p.G,1
4083,9,Which mutation is targeted by Sotorasib?,er cancers.,0
4083,10,Which mutation is targeted by Sotorasib?,Sotorasib is a small molecule that selectively and irreversibly targets KRASG12C.METHODS: We conducted a phase 1 trial of sotorasib in patients with advanced solid tumors harboring the,1
113,0,Which are the genes thought to be regulated by EWS/FLI?,BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma,0
113,1,Which are the genes thought to be regulated by EWS/FLI?,EWS/FLI dysregulates gene expression during tumorigenesis by abnormally activating or repressing genes.,1
113,2,Which are the genes thought to be regulated by EWS/FLI?,"The expression levels of thousands of genes are affected in Ewing sarcoma, however, it is unknown which of these genes contribute to the transformed phenotype.",1
113,3,Which are the genes thought to be regulated by EWS/FLI?,Here we characterize BCL11B as an up-regulated EWS/FLI target that is necessary for the maintenance of transformation in patient derived Ewing sarcoma cells lines,1
113,4,Which are the genes thought to be regulated by EWS/FLI?,"BCL11B, a zinc finger transcription factor, acts as a transcriptional repressor in Ewing's sarcoma and contributes to the EWS/FLI repressed gene signature",0
113,5,Which are the genes thought to be regulated by EWS/FLI?,EWS/FLI functions as an aberrant transcription factor to regulate genes that mediate the oncogenic phenotype of Ewing's sarcoma.,1
113,6,Which are the genes thought to be regulated by EWS/FLI?,"One of these regulated genes, NR0B1, encodes a corepressor protein, and likely plays a transcriptional role in tumorigenesis",0
113,7,Which are the genes thought to be regulated by EWS/FLI?,GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance,0
113,8,Which are the genes thought to be regulated by EWS/FLI?,"We recently showed that EWS/FLI regulates one of its key targets, NR0B1, through a GGAA-microsatellite in its promoter",0
113,9,Which are the genes thought to be regulated by EWS/FLI?,"We found that EWS/FLI directly binds the GSTM4 promoter, and regulates GSTM4 expression through a GGAA-microsatellite in its promoter",0
113,10,Which are the genes thought to be regulated by EWS/FLI?,The gene that was most reproducibly up-regulated by EWS/FLI was NR0B1,0
113,11,Which are the genes thought to be regulated by EWS/FLI?,We validated NR0B1 as an EWS/FLI-dysregulated gene and confirmed its expression in primary human tumor samples,0
113,12,Which are the genes thought to be regulated by EWS/FLI?,Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma,0
113,13,Which are the genes thought to be regulated by EWS/FLI?,Functional analysis revealed that NKX2.2 is an EWS/FLI-regulated gene that is necessary for oncogenic transformation in this tumor,0
113,14,Which are the genes thought to be regulated by EWS/FLI?,Neuroblastoma-Ews/Fli-1 infectant cell lines showed marked increases in p53 protein expression without transcriptional up-regulation,0
113,15,Which are the genes thought to be regulated by EWS/FLI?,"We then tested the p53 response pathway and observed that the neuroblastoma parent cells responded to genotoxic stress, whereas the neuroblastoma-Ews/Fli-1 infectants did not.",0
113,16,Which are the genes thought to be regulated by EWS/FLI?,These results suggest that Ews/Fli-1 can directly abrogate the p53 pathway to promote tumorigenesis,0
113,17,Which are the genes thought to be regulated by EWS/FLI?,"We recently showed that EWS/FLI interacts with GGAA-microsatellites to regulate some of its target genes, including NR0B1, an EWS/FLI-regulated gene that is required for the oncogenic phenotype of Ewings sarcoma.",0
113,18,Which are the genes thought to be regulated by EWS/FLI?,BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.,0
113,19,Which are the genes thought to be regulated by EWS/FLI?,The gene that was most reproducibly up-regulated by EWS/FLI was NR0B1.,0
113,20,Which are the genes thought to be regulated by EWS/FLI?,Here we characterize BCL11B as an up-regulated EWS/FLI target that is necessary for the maintenance of transformation in patient derived Ewing sarcoma cells lines,1
2899,0,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,Computer-aided diagnosis systems powered by convolutional neural networks (CNNs) can improve diagnostic accuracy and save lives.,1
2899,1,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,CNNs have been successfully used in both skin lesion segmentation and classification.,0
2899,2,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,Machine learning-based diagnosis of melanoma using macro images,0
2899,3,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,"We tested the use of a deep learning algorithm to classify the clinical images of 12 skin diseases-basal cell carcinoma, squamous cell carcinoma, intraepithelial carcinoma, actinic keratosis, seborrheic keratosis, malignant melanoma, melanocytic nevus, lentigo, pyogenic granuloma, hemangioma, dermatofibroma, and wart",1
2899,4,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,Skin Lesion Analysis towards Melanoma Detection Using Deep Learning Network.,0
2899,5,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,Deep learning computer vision systems classified melanoma dermoscopy images with accuracy that exceeded some but not all dermatologists.,0
2899,6,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists.,1
2899,7,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,"Deep learning convolutional neural networks (CNN) may facilitate melanoma detection,",1
2899,8,Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,"In order to meet these challenges, we propose a novel method for melanoma recognition by leveraging very deep convolutional neural networks (CNNs).",1
1143,0,By which methods can we evaluate the reliability of a phylogenetic tree?,"For robustness evaluation, we apply bootstrap and jackknife techniques to input data.",0
1143,1,By which methods can we evaluate the reliability of a phylogenetic tree?,An alignment confidence score capturing robustness to guide tree uncertainty.,0
1143,2,By which methods can we evaluate the reliability of a phylogenetic tree?,We build on the widely used bootstrap method for perturbing the phylogenetic tree.,1
1143,3,By which methods can we evaluate the reliability of a phylogenetic tree?,SuperTRI: A new approach based on branch support analyses of multiple independent data sets for assessing reliability of phylogenetic inferences.,0
1143,4,By which methods can we evaluate the reliability of a phylogenetic tree?,"To overcome these limitations, we propose a new approach, called SuperTRI, which is based on the branch support analyses of the independent data sets, and where the reliability of the nodes is assessed using three measures: the supertree Bootstrap percentage and two other values calculated from the separate analyses: the mean branch support (mean Bootstrap percentage or mean posterior probability) and the reproducibility index.",0
1143,5,By which methods can we evaluate the reliability of a phylogenetic tree?,"In contrast to other similar software, the program FreeTree (available at http://www.natur.cuni.cz/~flegr/programs/freetree or http://ijs.sgmjournals.org/content/vol51/issue3/) can also assess the robustness of the tree topology by bootstrap, jackknife or operational taxonomic unit-jackknife analysis.",1
1143,6,By which methods can we evaluate the reliability of a phylogenetic tree?,"Unlike any previous tool for inferring phylogenies from rearrangement data, TIBA uses novel methods of robustness estimation to provide support values for the edges in the inferred tree.",0
1143,7,By which methods can we evaluate the reliability of a phylogenetic tree?,Fast and accurate phylogenetic reconstruction from high-resolution whole-genome data and a novel robustness estimator.,0
1143,8,By which methods can we evaluate the reliability of a phylogenetic tree?,"Moreover, whereas phylogenetic analyses from sequence data are deemed incomplete unless bootstrapping scores (a measure of confidence) are given for each tree edge, no equivalent to bootstrapping exists for rearrangement-based phylogenetic analysis.",0
1143,9,By which methods can we evaluate the reliability of a phylogenetic tree?,We also describe a novel approach to estimate the robustness of results-an equivalent to the bootstrapping analysis used in sequence-based phylogenetic reconstruction.,1
1143,10,By which methods can we evaluate the reliability of a phylogenetic tree?,The standard deviation also suggests the reliability level of the branch order.,1
1143,11,By which methods can we evaluate the reliability of a phylogenetic tree?,Assessment of the reliability of a given phylogenetic hypothesis is an important step in phylogenetic analysis.,0
1143,12,By which methods can we evaluate the reliability of a phylogenetic tree?,The reliability of the phylogenetic trees was probed with the bootstrapping of 100 replicates of the original sequence alignments.,1
2725,0,List proteins with HEAT repeats,mTOR N-terminal heat repeat domain,1
2725,1,List proteins with HEAT repeats,TOG5-specific N-terminal HEAT repeat,1
2725,2,List proteins with HEAT repeats,DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is central to the regulation of the DNA damage response and repair through nonhomologous end joining.,1
2725,3,List proteins with HEAT repeats,The structure has proved challenging due to its large size and multiple HEAT repeats.,1
2725,4,List proteins with HEAT repeats,HEAT repeat-containing protein 1 (HEATR1),1
2725,5,List proteins with HEAT repeats,"The first 1,300 residues of Tor form a HEAT repeat-containing α-solenoid with four distinct segments: a highly curved 800-residue N-terminal 'spiral', followed by a 400-residue low-curvature 'bridge' and an extended 'railing' running along the bridge leading to the 'cap' that links to FAT region.",0
2725,6,List proteins with HEAT repeats,"Rif1 proteins are large and characterized by N-terminal HEAT repeats, predicted to form an elongated alpha-helical structure",0
2725,7,List proteins with HEAT repeats,B56γ contains 18 α-helices that are organized into eight HEAT (Huntington-elongation-A subunit-TOR) repeat motifs.,0
2725,8,List proteins with HEAT repeats,"Here, we reveal a remarkable complexity in the unfolding of giant HEAT-repeat protein PR65/A,",0
2725,9,List proteins with HEAT repeats,A HEAT-repeat superhelix within SF3b155 plays a key role in branch site recognition.,0
2725,10,List proteins with HEAT repeats,The HEAT-repeat protein Pds5B,0
1805,0,What is BioCreative?," two biomedical named entity recognition (NER) comparative evaluations that have been held to date, namely BioCreative and Coling",0
1805,1,What is BioCreative?,"The BioCreative II.5 community challenge addressed these tasks in a competition-style assessment to evaluate and compare different methodologies, to make aware of the increasing accuracy of automated methods, and to guide future implementations.",1
1805,2,What is BioCreative?,"In this paper, we present our approaches for protein-named entity recognition,",0
1805,3,What is BioCreative?,"In task 1A of the BioCreAtIvE evaluation, systems had to be devised that recognize words and phrases forming gene or protein names in natural language sentences",0
1805,4,What is BioCreative?,"BioCreAtIvE, a competition for automated gene/protein name recognition.",0
1805,5,What is BioCreative?,An overview of the BioCreative 2012 Workshop Track III: interactive text mining task.,0
1805,6,What is BioCreative?,Biocuration workflows and text mining: overview of the BioCreative 2012 Workshop Track II.,1
1805,7,What is BioCreative?,Evaluation of text-mining systems for biology: overview of the Second BioCreative community challenge.,0
1805,8,What is BioCreative?,How to link ontologies and protein-protein interactions to literature: text-mining approaches and the BioCreative experience.,1
1805,9,What is BioCreative?,The 2006 BioCreative competition was aimed at evaluating text-mining procedures in comparison with manual annotation of protein-protein interactions.,0
1805,10,What is BioCreative?,"RESULTS: The Biocreative 2010 competition addressed three tasks: gene normalization, article classification and interaction method identification.",0
1805,11,What is BioCreative?,BioCreAtIvE task 2 was an experiment to test if automatically derived classification using information retrieval and extraction could assist expert biologists in the annotation of the GO vocabulary to the proteins in the UniProt Knowledgebase.,0
1805,12,What is BioCreative?,"To this end BioCreative I was held in 2004, BioCreative II in 2007, and BioCreative II.5 in 2009.",0
1805,13,What is BioCreative?,Each of these workshops involved humanly annotated test data for several basic tasks in text mining applied to the biomedical literature.,1
1805,14,What is BioCreative?,BACKGROUND: The overall goal of the BioCreative Workshops is to promote the development of text mining and text processing tools which are useful to the communities of researchers and database curators in the biological sciences.,0
1805,15,What is BioCreative?,"To this end BioCreative I was held in 2004, BioCreative II in 2007, and BioCreative II.5 in 2009.",0
1805,16,What is BioCreative?,BACKGROUND: The overall goal of the BioCreative Workshops is to promote the development of text mining and text processing tools which are useful to the communities of researchers and database curators in the biological sciences.,0
1805,17,What is BioCreative?,"To this end BioCreative I was held in 2004, BioCreative II in 2007, and BioCreative II.5 in 2009.",0
1805,18,What is BioCreative?,Each of these workshops involved humanly annotated test data for several basic tasks in text mining applied to the biomedical literature.,1
1805,19,What is BioCreative?,"To this end BioCreative I was held in 2004, BioCreative II in 2007, and BioCreative II.5 in 2009.",0
1805,20,What is BioCreative?,Each of these workshops involved humanly annotated test data for several basic tasks in text mining applied to the biomedical literature.,0
1805,21,What is BioCreative?,Participants in the workshops were invited to compete in the tasks by constructing software systems to perform the tasks automatically and were given scores based on their performance.,0
1805,22,What is BioCreative?,Overview of BioCreAtIvE: critical assessment of information extraction for biology.,0
2366,0,Which virus can be diagnosed with the monospot test?,"Epstein-Barr virus (EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents.",1
2366,1,Which virus can be diagnosed with the monospot test?,"Heterophile antibody tests, including the Monospot test, are red cell or latex agglutination assays, which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV infection.",0
2366,2,Which virus can be diagnosed with the monospot test?,"Laboratory investigations revealed that monospot test was positive, EBV serology tests; Anti-EA-D Ig G: 3+, Anti-VCA gp125 Ig G: 3+, Anti-VCA p19 Ig M: 2+, Anti EBNA-1 Ig M: negative, Anti EBNA-1 Ig M: negative, Anti EBNA-1 Ig G: negative.",0
2366,3,Which virus can be diagnosed with the monospot test?,"A 75-year-old woman presented with altered mental status, septic picture, and influenza-like symptoms.",0
2366,4,Which virus can be diagnosed with the monospot test?,"Initial investigations revealed atypical lymphocytosis, thrombocytopenia, elevated liver enzymes, and a positive monospot test result.",0
2366,5,Which virus can be diagnosed with the monospot test?,"Further investigation showed the Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection.",0
2366,6,Which virus can be diagnosed with the monospot test?,Monospot test was positive.,0
2366,7,Which virus can be diagnosed with the monospot test?,He subsequently had both a CT pulmonary angiogram and a CT angiogram of the aorta to exclude pulmonary embolism and aortic dissection.,0
2366,8,Which virus can be diagnosed with the monospot test?,The CT revealed splenomegaly with a large subdiaphragmatic haematoma secondary to splenic rupture.,0
2366,9,Which virus can be diagnosed with the monospot test?,This had likely caused referred pain through diaphragmatic irritation.,0
2366,10,Which virus can be diagnosed with the monospot test?,He was taken to theatre for urgent splenectomy.,0
2366,11,Which virus can be diagnosed with the monospot test?,The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection.,0
2366,12,Which virus can be diagnosed with the monospot test?,"BACKGROUND: Infection with Epstein-Barr virus (EBV) is almost ubiquitous in humans and generally occurs at two ages: infantile, which is usually asymptomatic and associated with poorer socioeconomic conditions, and adolescent, which causes infectious mononucleosis (IM) in ~25% cases.",1
2366,13,Which virus can be diagnosed with the monospot test?,The determinants of whether the infection causes IM remain uncertain.,0
2366,14,Which virus can be diagnosed with the monospot test?,"We aimed to evaluate seasonality and temporal trends in IM.METHODS: Data from all Monospot tests, used as a marker for IM, were collected from the Grampian population over 16 years.RESULTS: Positive Monospot test results peaked at 17 years in females and 19 in males.",0
2366,15,Which virus can be diagnosed with the monospot test?,"The evaluated diagnostic methods were real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus viral load (EBV-VL) in peripheral blood, neutrophil/lymphocyte/monocyte counts, C-reactive protein values, and monospot test].",0
2366,16,Which virus can be diagnosed with the monospot test?,Serological tests for EBV infection were consistent with acute infection (EBV virus capsid antigen was reactive with IgM and IgG antibodies).,0
2366,17,Which virus can be diagnosed with the monospot test?,The Monospot test was also positive.,0
2366,18,Which virus can be diagnosed with the monospot test?,"Investigations revealed lymphocytosis and activated atypical lymphocytes in the peripheral smear, and positive monospot test.",0
2366,19,Which virus can be diagnosed with the monospot test?,The boy subsequently recovered in one week with total disappearance of his rash.,0
2366,20,Which virus can be diagnosed with the monospot test?,Epstein-Barr virus-related infectious mononucleosis was considered the most likely diagnosis for our patient.,1
2366,21,Which virus can be diagnosed with the monospot test?,Sera negative for the markers of both viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and tested for anti-CMV (IgM) by ELISA technique for the diagnosis of acute Cytomegalovirus (CMV) infection.,1
2366,22,Which virus can be diagnosed with the monospot test?,A serologic test for early antigen (EA) is more specific for diagnosing active EBV disease than the monospot or heterophile test.,1
2366,23,Which virus can be diagnosed with the monospot test?,"His septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus.",0
2366,24,Which virus can be diagnosed with the monospot test?,"Heterophile antibody tests, including the Monospot test, are red cell or latex agglutination assays, which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV infection.",0
2317,0,Which proteins are controlling sterol metabolism in S. cerevisiae?,We have taken advantage of this property to study the regulation of the Delta8-Delta7-sterol isomerase-encoding ERG2 gene in an ergosterol auxotrophic mutant devoid of squalene-synthase activity.,1
2317,1,Which proteins are controlling sterol metabolism in S. cerevisiae?,Ergosterol starvation leads to an 8-16-fold increase in ERG2 gene expression.,0
2317,2,Which proteins are controlling sterol metabolism in S. cerevisiae?,"The yeast genome encodes seven oxysterol binding protein homologs, Osh1p-Osh7p, which have been implicated in regulating intracellular lipid and vesicular transport",1
2317,3,Which proteins are controlling sterol metabolism in S. cerevisiae?,Sterol metabolism and ERG2 gene regulation in the yeast Saccharomyces cerevisiae.,0
2317,4,Which proteins are controlling sterol metabolism in S. cerevisiae?,"Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance.",0
2317,5,Which proteins are controlling sterol metabolism in S. cerevisiae?,"To better understand Upc2p function in C. albicans, we used genomewide location profiling to identify the transcriptional targets of Upc2p in vivo.",1
2317,6,Which proteins are controlling sterol metabolism in S. cerevisiae?,"Upc2p, a transcription factor of the zinc cluster family, is an important regulator of sterol biosynthesis and azole drug resistance in Candida albicans",1
2317,7,Which proteins are controlling sterol metabolism in S. cerevisiae?," Taken together, our results indicate that Upc2p is a key regulator of ergosterol metabolism.",0
2317,8,Which proteins are controlling sterol metabolism in S. cerevisiae?,They also suggest that Upc2p may contribute to azole resistance by regulating the expression of drug efflux pump-encoding genes in addition to ergosterol biosynthesis genes.,0
2317,9,Which proteins are controlling sterol metabolism in S. cerevisiae?,"Northern blot analysis showed that increased binding correlates with increased expression for the analyzed Upc2p targets (ERG11, MDR1, CDR1, YOR1, SUT1, SMF12, and CBP1).",1
2317,10,Which proteins are controlling sterol metabolism in S. cerevisiae?," Overrepresented functional groups of genes whose promoters were bound by Upc2p included 12 genes involved in ergosterol biosynthesis (NCP1, ERG11, ERG2, and others)",0
2317,11,Which proteins are controlling sterol metabolism in S. cerevisiae?,"Cell wall maintenance genes TIR4 and CCW12, sterol metabolism gene UPC2, small molecule transport genes AUS1 and YHK8, and stress response gene CUP1-1 were expressed at a level at least 2.5-fold higher than the expression level found in 9763S.",0
1263,0,What is  the clinical value of naltrexone in Parkinson's disease patients?,Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.,1
1263,1,What is  the clinical value of naltrexone in Parkinson's disease patients?,"These patients responded poorly to serotonin reuptake inhibitors, whereas treatment with opioid antagonist naltrexone resulted in the remission of PG.",0
1263,2,What is  the clinical value of naltrexone in Parkinson's disease patients?,CONCLUSIONS: The opioid antagonist naltrexone could be an effective option for the treatment of PG in PD.,1
1263,3,What is  the clinical value of naltrexone in Parkinson's disease patients?,No improvement in the clinical features of either disorder was noted,0
1263,4,What is  the clinical value of naltrexone in Parkinson's disease patients?,"Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.",1
1263,5,What is  the clinical value of naltrexone in Parkinson's disease patients?,Naltrexone as compared with placebo did not demonstrate any significant change in motor function in either group.,1
1263,6,What is  the clinical value of naltrexone in Parkinson's disease patients?,"Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinsons disease.",1
2712,0,Where is the EpCam protein mainly located?,"The following cell-surface markers were immunohistochemically analyzed: E-cadherin, epithelial membrane antigen (EMA), human epidermal growth receptor type 2 (Her2/neu), carcinoembryonic antigen (CEA), αvβ6 integrin and epithelial cell adhesion molecule (EpCAM).",1
2712,1,Where is the EpCam protein mainly located?,Tumor cells display increased EpCAM expression that often correlates with the loss of strict basolateral localization.,0
2712,2,Where is the EpCam protein mainly located?,Papillary thyroid carcinoma shows loss of EpCAM membranous expression and increased cytoplasmic/nuclear accumulation.,1
2712,3,Where is the EpCam protein mainly located?,Epithelial cell adhesion molecule (EpCAM) (CD326) is a surface glycoprotein expressed by invasive carcinomas and some epithelia.,1
2712,4,Where is the EpCam protein mainly located?,"Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein, which is frequently and highly expressed on carcinomas, tumor-initiating cells, selected tissue progenitors, and embryonic and adult stem cells",1
2712,5,Where is the EpCam protein mainly located?,Epithelial cell adhesion molecule (EpCAM) is a type I transmembrane glycoprotein overexpressed in human epithelioma but with relatively low expression in normal epithelial tissues.,1
1832,0,Which pipelines are used for analyzing data from ChIP-nexus experiments?,PeakXus: comprehensive transcription factor binding site discovery from ChIP-Nexus and ChIP-Exo experiments.,1
1832,1,Which pipelines are used for analyzing data from ChIP-nexus experiments?,We describe a peak caller PeakXus that is specifically designed to leverage the increased resolution of ChIP-exo/Nexus and developed with the aim of making as few assumptions of the data as possible to allow discoveries of novel binding patterns.,0
1832,2,Which pipelines are used for analyzing data from ChIP-nexus experiments?,We apply PeakXus to ChIP-Nexus and ChIP-exo experiments performed both in Homo sapiens and in Drosophila melanogaster cell lines.,0
1832,3,Which pipelines are used for analyzing data from ChIP-nexus experiments?,Q-nexus: a comprehensive and efficient analysis pipeline designed for ChIP-nexus.,1
1832,4,Which pipelines are used for analyzing data from ChIP-nexus experiments?,"Here, we present a comprehensive software package for ChIP-nexus data that exploits the random barcodes for selective removal of PCR duplicates and for quality control.",0
1832,5,Which pipelines are used for analyzing data from ChIP-nexus experiments?,"Furthermore, we developed bespoke methods to estimate the width of the protected region resulting from protein-DNA binding and to infer binding positions from ChIP-nexus data.",1
1832,6,Which pipelines are used for analyzing data from ChIP-nexus experiments?,"Finally, we applied our peak calling method as well as the two other methods MACE and MACS2 to the available ChIP-nexus data.",0
1832,7,Which pipelines are used for analyzing data from ChIP-nexus experiments?,Q-nexus: a comprehensive and efficient analysis pipeline designed for ChIP-nexus.,1
1832,8,Which pipelines are used for analyzing data from ChIP-nexus experiments?,PeakXus: comprehensive transcription factor binding site discovery from ChIP-Nexus and ChIP-Exo experiments.,1
2343,0,List main clinical features of the POEMS syndrome.,POEMS syndrome is a rare paraneoplastic syndrome secondary to a plasma cell dyscrasia.,0
2343,1,List main clinical features of the POEMS syndrome.,"Recognition of a combination of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, and Castleman disease is the first step in managing the disease.",1
2343,2,List main clinical features of the POEMS syndrome.,"Treatment of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome should be directed at the underlying plasma cell clone with risk-adapted therapy based on the extent of the plasma cell disorder.",0
2343,3,List main clinical features of the POEMS syndrome.,"Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (POEMS) syndrome is a rare paraneoplastic disorder.",0
2343,4,List main clinical features of the POEMS syndrome.,"POEMS is an acronym for the main clinical features of the syndrome, namely, Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities.",1
2343,5,List main clinical features of the POEMS syndrome.,"POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) is a multisystem disorder with a good long-term prognosis.",1
2343,6,List main clinical features of the POEMS syndrome.,"The association of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms a characteristic multisystem syndrome, Crow-Fukase syndrome, or acronym POEMS syndrome.",0
2343,7,List main clinical features of the POEMS syndrome.,"Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome is a multisystem disorder arising from underlying plasma cell dyscrasia.",0
2343,8,List main clinical features of the POEMS syndrome.,"Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is an uncommon condition related to a paraneoplastic syndrome secondary to an underlying plasma cell disorder.",0
2343,9,List main clinical features of the POEMS syndrome.,"Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome, occurring in approximately 25-30% of the affected individuals.",0
2343,10,List main clinical features of the POEMS syndrome.,"Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare disorder.",0
2343,11,List main clinical features of the POEMS syndrome.,"Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome, a plasma cell dyscrasia associated with pulmonary hypertension, has been treated in the past with anticytokine strategies with a poor outcome.",0
2343,12,List main clinical features of the POEMS syndrome.,"A 48-year-old man with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema (ODE), bilateral cystoid macular edema (CME), anasarca, and elevated serum vascular endothelial growth factor (VEGF).",0
2343,13,List main clinical features of the POEMS syndrome.,"A 39-year-old woman presented with polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes, several of the many clinical features of the recently described POEMS syndrome.",0
2343,14,List main clinical features of the POEMS syndrome.,"The acronym POEMS is derived from main features of the syndrome namely 'polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions'.",1
2343,15,List main clinical features of the POEMS syndrome.,"POEMS syndrome, also known as Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes.",0
2343,16,List main clinical features of the POEMS syndrome.,"Polyneuropathy is often an initial manifestation of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome and therefore this disorder is frequently misdiagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP).",0
2343,17,List main clinical features of the POEMS syndrome.,"POEMS syndrome is a rare paraneoplastic condition, commonly associated with Castleman disease, that manifests with progressive distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites, erythrocytosis, and thrombocytosis.",0
2343,18,List main clinical features of the POEMS syndrome.,"POEMS syndrome, a rare multisystem disease, is a variant of osteosclerotic myeloma and is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes.",0
2343,19,List main clinical features of the POEMS syndrome.,"We report a case of a 64-year-old man with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously misdiagnosed as systemic sclerosis.",0
2343,20,List main clinical features of the POEMS syndrome.,"POEMS syndrome is a rare plasma cell dyscrasia characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes.",0
2343,21,List main clinical features of the POEMS syndrome.,"The POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes) syndrome is a rare variant of plasma cell dyscrasia with multisystemic manifestations.",0
2343,22,List main clinical features of the POEMS syndrome.,a 39 year old woman presented with polyneuropathy hepatomegaly splenomegaly endocrinopathy monoclonal protein and skin changes several of the many clinical features of the recently described poems syndrome in addition she had a castleman s disease angiofollicular lymph node hyperplasia in this case ascites was a main presenting feature thus the poems syndrome must be added to the list of rare causes of ascites electron microscopy of the liver showed perisinusoidal fibrosis.,0
2343,23,List main clinical features of the POEMS syndrome.,the poems syndrome is a rare multisystemic disorder with polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes we describe a 46 year old man who developed ascites one year after the onset of peripheral neuropathy with accompanying muscle atrophies and increasing weakness extensive evaluation revealed that the patient had no underlying liver disease malignancy infection or cardiac or renal disease the ascites initially responded to high dose corticosteroid therapy the patient had many clinical features of the described poems syndrome including sclerotic bone lesions a persistent lambda paraprotein and refractory ascites in this case ascites was a main presenting feature thus the poems syndrome must be added to the list of rare causes of refractory ascites.,0
2343,24,List main clinical features of the POEMS syndrome.,poems syndrome is a paraneoplastic manifestation associated with hematopoietic disorders such as multiple myeloma and castleman disease poems is an acronym for the main clinical features of the syndrome namely polyneuropathy organomegaly endocrinopathy m protein and skin abnormalities glomeruloid hemangiomas are considered to be a specific clinical marker of poems syndrome however while they are not pathognomonic their presence should raise suspicion of this syndrome or alert clinicians to its possible future development as these lesions can appear years before the onset of the syndrome we report the cases of 2 women with plasma cell dyscrasias and sudden onset of lesions with a vascular appearance and histologic findings consistent with glomeruloid hemangioma recognition of this vascular tumor is important for the early diagnosis of poems syndrome.,1
2343,25,List main clinical features of the POEMS syndrome.,poems syndrome is a rare conglomeration of disorders associated with plasma cell dyscrasia the acronym poems is derived from main features of the syndrome namely polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions other clinical features include presence of sclerotic bone lesions castleman s disease papilledema pleural effusion edema ascites erythrocytosis and thrombocytosis myeloma is the most common plasma cell dyscrasia associated with poems syndrome renal involvement is rare and renal biopsy is characterized by glomerular involvement with membranoproliferative glomerulonephritis and endothelial injury we report a case of a 67 year old male who presented with clinical features satisfying the diagnostic criteria of poems syndrome and had rapidly progressive renal failure renal biopsy showed extensive interstitial infiltration by plasma cells and concomitant presence of classic polyarteritis nodosa although association with small vessel vasculitis has been reported in patients with poems syndrome to the best of our knowledge this is the first report of poems syndrome associated with medium sized vessel vasculitis.,0
2343,26,List main clinical features of the POEMS syndrome.,poems syndrome also known as crow fukase syndrome represents a rare multisystem syndrome characterized by polyneuropathy organomegaly endocrinopathy m protein and skin changes hypothyroidism is one of the common endocrine abnormalities which are central features of poems syndrome the clinical data associated with the measurement of thyroid function and its clinical significance in poems syndrome is still rare herein we report 24 cases with poems syndrome which were studied thyroid function and clinical manifestations and performed an associated analysis between hypothyroidism and edema effusions of the 24 patients with poems syndrome 17 70 8 had a recognized hypothyroidism including 11 clinical hypothyroidism and 6 subclinical hypothyroidism fourteen patients 58 3 had some form of extravascular volume overload in 14 patients with edema effusions 12 were diagnosed as having hypothyroidism hypothyroidism may be one of causes of edema effusions after thyroid hormone treatment and chemotherapy symptoms of hypothyroidism and edema effusions were improved greatly.,0
2343,27,List main clinical features of the POEMS syndrome.,we present a case of a woman with unique multisystem disorder poems syndrome and endocrine abnormalities coexisting with it the poems acronym comprises the dominant features polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy was described in 1956 year by crow the main features were coined in the acronym poems by bardwick in 1980 year the polysymptomatic clinical picture progressive course and no concurrent manifestations of main features impede the diagnosis in this case the first symptoms were the sensomotor polyneuropathy peripheral oedema osteosclerotic bone lesions skin changes organomegaly they preceded diagnosis by 3 years the first endocrinopathy was hypothyroidism definite diagnosis was delayed because we couldn t detect the presence of m protein immunoelectrophoresis didn t detect it but analysis by immunofixation detected m protein in serum and urine within 3 years of the first symptoms she developed hypogonadism hypergonadotropic at first the monotherapy with corticosteroids was used then melfalan with prednisone due to the progression of the disease a thalidomide was used in therapy it is anti vegf agent one of the side effects of the treatment of thalidomide is the progression of polyneuropathy which was observed in this patient after finishing this therapy she received chemotherapy this case report imposes the necessity of constants observation of patients with poems syndrome because there is a possibility of their developing other disorders in the event of coexistence polyneuropathy and plasma cell dyscrasia this disease should be taken into consideration.,0
1528,0,What is the treatment of choice  for gastric lymphoma?,The treatment of choice should be comprehensive therapy based on surgery.,0
1528,1,What is the treatment of choice  for gastric lymphoma?,The treatment of choice for localized primary GI lymphoma is controversial.,1
1528,2,What is the treatment of choice  for gastric lymphoma?,"Complete surgical resection may increase the chance of complete remission, but mortality and relapse rates might be higher than those observed with combination chemotherapy alone.",1
1528,3,What is the treatment of choice  for gastric lymphoma?,The most common gastric lymphoma are low-grade marginal zone B-cell lymphoma (MZBCL) of MALT type.,0
1528,4,What is the treatment of choice  for gastric lymphoma?,"In early stages of disease, H. pylori eradication alone may lead to complete lymphoma remission in up to 75% of cases.",0
1528,5,What is the treatment of choice  for gastric lymphoma?,Nonresponder or locally advanced lymphoma should be treated with radiation therapy.,0
1528,6,What is the treatment of choice  for gastric lymphoma?,Advanced lymphoma may be treated with the nucleoside analogon cladribine within clinical trials,0
1528,7,What is the treatment of choice  for gastric lymphoma?,"In patients with primary gastric diffuse large cell lymphoma and aggressive histology, diffuse large cell lymphoma in early stage SCT achieved good results, but surgery was associated with some cases of lethal complications.",0
1528,8,What is the treatment of choice  for gastric lymphoma?,Thus it appears that CT should be considered the treatment of choice in this patient setting.,0
1528,9,What is the treatment of choice  for gastric lymphoma?,Controversy remains regarding the best treatment for primary gastric lymphoma (PGL).,0
1528,10,What is the treatment of choice  for gastric lymphoma?,Recent developments in diagnosis and chemotherapy have changed strategies for this disease.,0
1528,11,What is the treatment of choice  for gastric lymphoma?,"With the exception of eradication therapy in H. pylori-positive low-grade lymphoma of stage EI and the subgroup of locally advanced high-grade lymphoma, resection remains the treatment of choice.",1
1528,12,What is the treatment of choice  for gastric lymphoma?,The treatment of primary gastric lymphoma is controversial.,1
1528,13,What is the treatment of choice  for gastric lymphoma?,The role of surgery has come to be questioned with increasing knowledge about the pathogenesis of gastric lymphoma and with new therapeutic approaches such as eradication of Helicobacter pylori.,0
1528,14,What is the treatment of choice  for gastric lymphoma?,"curative resection is the treatment of choice for gastric lymphoma, but radiation therapy may offer some benefit when complete resection is not feasible.",1
725,0,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is an autosomal recessive genetic disorder characterized by a deficiency of the enzyme responsible for degradation of lysosomal glycogen (acid α-glucosidase (GAA)),1
725,1,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is a systemic metabolic disorder characterized by lack of acid-alpha glucosidase (GAA) resulting in ubiquitous lysosomal glycogen accumulation,0
725,2,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is an autosomal recessive myopathic disorder caused by the deficiency of lysosomal acid α-glucosidase (GAA),1
725,3,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Acid α-glucosidase deficiency, that is, Pompe disease, is a glycogenosis for which enzyme replacement therapy (ERT) is available",0
725,4,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,The analysis revealed that the amino acid substitutions causing a processing or transport defect responsible for Pompe disease were widely spread over all of the five domains comprising the acid alpha-glucosidase.,0
725,5,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is a lysosomal storage disease (LSD) caused by a deficiency in the lysosomal enzyme acid alpha-glucosidase.,0
725,6,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Glycogen storage disease type II (GSDII; Pompe disease or acid maltase deficiency) is an autosomal recessive disorder caused by lysosomal acid alpha-glucosidase (AalphaGlu) deficiency and manifests predominantly as skeletal muscle weakness.,0
725,7,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Structural study on a mutant acid alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Pompe disease.,0
725,8,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"The nature of mutant acid alpha-glucosidase (AAG) in muscle was studied in 6 patients with Pompe disease, consisting of 2 each of the infantile, childhood and adult types.",0
725,9,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease (glycogen storage disease II) is caused by mutations in the acid alpha-glucosidase gene.,0
725,10,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Glycogen storage disease type II (Pompe disease) is inherited by autosomal recessive transmission and caused by a deficiency of acid alpha-glucosidase (GAA), resulting in impaired degradation and lysosomal accumulation of glycogen.",0
725,11,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is a lysosomal storage disorder (LSD) caused by mutations in the gene that encodes acid alpha-glucosidase (GAA).,0
725,12,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Demonstration of acid alpha-glucosidase in different types of Pompe disease by use of an immunochemical method.,0
725,13,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Acid alpha-glucosidase (GAA) deficiency causes Pompe disease, a lethal lysosomal glycogen storage disease for which no effective treatment currently exists.",0
725,14,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is usually fatal if onset occurs in infancy.",0
725,15,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha-glucosidase enzyme replacement therapy for Pompe disease.,0
725,16,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Infantile Pompe disease is caused by deficiency of lysosomal acid alpha-glucosidase.,0
725,17,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease.,0
725,18,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"The pharmacological chaperone AT2220 increases the specific activity and lysosomal delivery of mutant acid alpha-glucosidase, and promotes glycogen reduction in a transgenic mouse model of Pompe disease",0
725,19,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Structural study on a mutant acid alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Pompe disease,0
725,20,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme,0
725,21,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Although many lysosomal disorders are corrected by a small amount of the missing enzyme, it has been generally accepted that 20-30% of normal acid alpha-glucosidase (GAA) activity, provided by gene or enzyme replacement therapy, would be required to reverse the myopathy and cardiomyopathy in Pompe disease",0
725,22,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"The nature of mutant acid alpha-glucosidase (AAG) in muscle was studied in 6 patients with Pompe disease, consisting of 2 each of the infantile, childhood and adult types",0
725,23,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"As in the severe human infantile disease (Pompe Syndrome), mice homozygous for disruption of the acid alpha-glucosidase gene (6(neo)/6(neo)) lack enzyme activity and begin to accumulate glycogen in cardiac and skeletal muscle lysosomes by 3 weeks of age, with a progressive increase thereafter",0
725,24,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Glycogen-storage disease type II, Pompe disease, is caused by the deficiency of acid alpha-D-glucosidase in lysosome",0
725,25,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease (glycogen storage disease II) is caused by mutations in the acid alpha-glucosidase gene,0
725,26,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Glycogen storage disease type II (Pompe disease) is inherited by autosomal recessive transmission and caused by a deficiency of acid alpha-glucosidase (GAA), resulting in impaired degradation and lysosomal accumulation of glycogen",0
725,27,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme.,0
725,28,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Structural modeling of mutant alpha-glucosidases resulting in a processing/transport defect in Pompe disease.,0
725,29,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.",0
725,30,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"The pharmacological chaperone AT2220 increases the specific activity and lysosomal delivery of mutant acid alpha-glucosidase, and promotes glycogen reduction in a transgenic mouse model of Pompe disease.",0
725,31,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is an autosomal recessive muscle-wasting disorder caused by the deficiency of the lysosomal enzyme acid alpha-glucosidase.,1
725,32,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Structural study on a mutant acid alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Pompe disease.,0
725,33,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"We describe an improved method for detecting deficiency of the acid hydrolase, alpha-1,4-glucosidase in leukocytes, the enzyme defect in glycogen storage disease Type II (Pompe disease).",0
725,34,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Acid alpha-glucosidase (GAA) deficiency causes Pompe disease,",0
725,35,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?, Infantile Pompe disease is caused by deficiency of lysosomal acid alpha-glucosidase.,0
725,36,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Trials with recombinant human acid alpha-glucosidase enzyme replacement therapy (ERT) show a decrease in left ventricular mass and improved function.,0
725,37,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?, Pompe disease is an autosomal recessive muscle-wasting disorder caused by the deficiency of the lysosomal enzyme acid alpha-glucosidase.,1
725,38,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Due to virtual absence of acid alpha-glucosidase, patients with classical infantile Pompe disease develop progressive cardiomyopathy, skeletal muscle weakness and respiratory insufficiency leading to death in early infancy.",0
725,39,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is caused by the congenital deficiency of the lysosomal enzyme acid alpha-glucosidase.,0
725,40,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"The nature of mutant acid alpha-glucosidase (AAG) in muscle was studied in 6 patients with Pompe disease,",0
725,41,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?, Pompe disease is a lysosomal storage disorder (LSD) caused by mutations in the gene that encodes acid alpha-glucosidase (GAA).,0
725,42,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Recently, small molecule pharmacological chaperones have been shown to increase protein stability and cellular levels for mutant lysosomal enzymes and have emerged as a new therapeutic strategy for the treatment of LSDs.",0
725,43,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Acid alpha-glucosidase (GAA) deficiency causes Pompe disease, a lethal lysosomal glycogen storage disease for which no effective treatment currently exists.",0
725,44,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Infantile Pompe disease is caused by deficiency of lysosomal acid alpha-glucosidase.,0
725,45,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Glycogen-storage disease type II, Pompe disease, is caused by the deficiency of acid alpha-D-glucosidase in lysosome.",0
725,46,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Structural modeling of mutant alpha-glucosidases resulting in a processing/transport defect in Pompe disease.,0
725,47,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is a lysosomal storage disorder (LSD) caused by mutations in the gene that encodes acid alpha-glucosidase (GAA).,0
725,48,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Structural study on a mutant acid alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Pompe disease.,0
725,49,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha-glucosidase enzyme replacement therapy for Pompe disease.,0
725,50,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Mutations in alpha-glucosidase cause accumulation of glycogen in lysosomes, resulting in Pompe disease, a lysosomal storage disorder.",0
725,51,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,Pompe disease is an autosomal recessive muscle-wasting disorder caused by the deficiency of the lysosomal enzyme acid alpha-glucosidase.,1
725,52,Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?,"Infantile Pompe disease is a fatal genetic muscle disorder caused by a deficiency of acid alpha-glucosidase, a glycogen-degrading lysosomal enzyme.",0
3707,0,Has MLE4901 been tested in phase III clinical trials?,"METHODS

This phase 2, randomised, double-blind, placebo-controlled, single-centre, crossover trial assessed the effectiveness of an oral neurokinin 3 receptor antagonist (MLE4901) on menopausal hot flushes.",1
3707,1,Has MLE4901 been tested in phase III clinical trials?,"Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.",1
1579,0,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"Despite the correction of these metabolic disorders, the patient became comatose, and MRI, on T2 weighted image, showed hyperintense signals in the basal ganglia consistent with extra-pontine myelinolysis.",0
1579,1,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,The patient's state remained unchanged for six weeks.,0
1579,2,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"Since S. Konno and H. Wakui published cases of myelinolysis who dramatically improved after TRH treatment, the patient was given 0.6 mg i.v daily of TRH for six weeks.",0
1579,3,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"Improvement began within a few days, and continued until complete recovery.",0
1579,4,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,His CNS symptoms improved dramatically after administration of thyrotropin-releasing hormone tartrate (TRH-T).,0
1579,5,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"[Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice].",1
1579,6,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"NS-3 shortened the latent periods to the recovery of the righting reflex (0.03-0.1 mg/kg, i.v.)",0
1579,7,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"and spontaneous motor activity (0.1 mg/kg, i.v.)",0
1579,8,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,following the head concussion.,0
1579,9,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"In the case of TRH, higher doses were needed to induce such effects.",0
1579,10,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"NS-3 (0.1-0.3 mg/kg, i.v.)",0
1579,11,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,reversed the pentobarbital-induced narcosis in a dose-dependent manner.,0
1579,12,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,A similar effect was elicited by 30- to 100-fold higher doses of TRH than NS-3.,0
1579,13,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"Taken together with the finding that NS-3 did not bind to dopamine, adrenaline or muscarine receptors, it is suggested that NS-3 may restore the disturbance of consciousness by activating the brain dopamine, noradrenaline and acetylcholine neurons without stimulating these receptors directly.",0
1579,14,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"A 46-year-old female motorcyclist, who suffered injuries to the brain stem in a traffic accident, showed hypotensive and bradycardiac responses to thyrotropin-releasing hormone (TRH) given to counter consciousness disturbance.",0
1579,15,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,The direct TRH (thyrotropin releasing hormone) stimulation to the anterior lobe was responded to well.,0
1579,16,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"The neuropharmacological activities of TRH include an interesting arousal effect and an analeptic action on generalized depression of the CNS whether this depression is of natural origin, such as hibernation, or induced pharmacologically (barbiturates, ethanol) or of a traumatic origin (coma).",0
1579,17,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,This analeptic action is attributable to stimulation of cholinergic neurons in the septo-hippocampal area and to the presence of terminals containing TRH in the lateral septum and TRH receptors concentrated especially in the medial septum and diagonal band of Broca.,1
1579,18,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,It has also been suggested that TRH localized in the pineal gland has a part in activating the neuronal mechanisms of arousal.,1
1579,19,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"Associated with the arousal effect and especially evident in variously originated shock conditions are the activating effects of TRH on vegetative functions (body temperature, circulation, the gastrointestinal tract).",1
1579,20,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,These stimulatory activities on the CNS were the rationale for therapeutic use of TRH in the initial treatment of coma due to brain trauma and for the treatment of endogenous depression.,1
1579,21,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"In the vegetative group, TRH caused significant increases in MBP (from 91 +/- 8 mm Hg to 110 +/- 10 mm Hg) at 2 min after the injection [p < 0.05, analysis of variance (ANOVA) with a Scheffé F-test].",0
1579,22,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"In contrast, five of the seven BD patient showed no alterations in the measured parameter in response to the TRH injection.",0
1579,23,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"However, the remaining two BD patients, who had spinal reflexes, exhibited an elevation in MBP.",0
1579,24,What is the role of Thyrotropin Releasing Hormone in the treatment of comatose patients?,"These results indicate that in comatose patients, the hemodynamic effects of TRH may differ depending on impairments in the central nervous system; the results support previous reports indicating a mediation of the central sympathetic nervous system in the development of pressor effects of TRH.",0
1090,0,What is STARR-seq?,"We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes.",0
1090,1,What is STARR-seq?,"When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map.",1
1090,2,What is STARR-seq?,"This map reveals the highly complex regulation of transcription, with several independent enhancers for both developmental regulators and ubiquitously expressed genes.",0
1090,3,What is STARR-seq?,"STARR-seq can be used to identify and quantify enhancer activity in other eukaryotes, including humans.",0
1090,4,What is STARR-seq?,Genome-wide quantitative enhancer activity maps identified by STARR-seq.,0
1090,5,What is STARR-seq?,"STARR-seq can be used to identify and quantify enhancer activity in other eukaryotes, including humans.",0
1090,6,What is STARR-seq?,"We used STARR-seq, a recently developed enhancer-screening assay, and ecdysone signaling in two different Drosophila cell types to derive genome-wide hormone-dependent enhancer-activity maps.",0
1090,7,What is STARR-seq?,"We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes.",0
1090,8,What is STARR-seq?,"When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map.",1
1090,9,What is STARR-seq?,"We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes.",0
1090,10,What is STARR-seq?,"We used STARR-seq, a recently developed enhancer-screening assay, and ecdysone signaling in two different Drosophila cell types to derive genome-wide hormone-dependent enhancer-activity maps.",0
1090,11,What is STARR-seq?,"We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes.",0
1090,12,What is STARR-seq?,"When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map.",1
1090,13,What is STARR-seq?,"This map reveals the highly complex regulation of transcription, with several independent enhancers for both developmental regulators and ubiquitously expressed genes.",0
1090,14,What is STARR-seq?,"STARR-seq can be used to identify and quantify enhancer activity in other eukaryotes, including humans.",0
1090,15,What is STARR-seq?,"We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes.",0
1090,16,What is STARR-seq?,"When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map.",1
1090,17,What is STARR-seq?,"We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes.",0
1090,18,What is STARR-seq?,"When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map.",1
1090,19,What is STARR-seq?,"STARR-seq can be used to identify and quantify enhancer activity in other eukaryotes, including humans.",0
1090,20,What is STARR-seq?,"We used STARR-seq, a recently developed enhancer-screening assay, and ecdysone signaling in two different Drosophila cell types to derive genome-wide hormone-dependent enhancer-activity maps.",0
1090,21,What is STARR-seq?,"We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes.",0
2061,0,What is a mimotope vaccine?,"These data are proof of principle that by performing affinity selection on neutralizing antibodies, our VLP technology can identify peptide mimics of non-linear epitopes and that these mimotope based VLP vaccines provide protection against pathogens in relevant animal models.",0
2061,1,What is a mimotope vaccine?,A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation.,0
2061,2,What is a mimotope vaccine?,We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of random peptide sequences on a surface-exposed loop in the coat protein without disruption of protein folding or VLP assembly.,0
2061,3,What is a mimotope vaccine?,"This technology allows us to use the same VLP particle for both affinity selection and immunization, integrating the power of epitope discovery and epitope mimicry of traditional phage display with the high immunogenicity of VLPs.",0
2061,4,What is a mimotope vaccine?,Our data suggest that the improved tumor immunity results from the expansion of mimotope-elicited tumor-specific T cells that have increased avidity for the tumor antigen.,0
2061,5,What is a mimotope vaccine?,The enhanced T cells are phenotypically distinct and enriched for T-cell receptors previously correlated with improved antitumor immunity.,0
2061,6,What is a mimotope vaccine?,These results suggest that incorporation of native antigen into clinical mimotope vaccine regimens may improve the efficacy of antitumor T-cell responses.,0
2061,7,What is a mimotope vaccine?,"One strategy for overcoming these mechanisms is vaccination with mimotopes, or peptide mimics of tumor antigens, which alter the antigen presentation and/or T cell activation to increase the expansion of tumor-specific T cells.",1
2061,8,What is a mimotope vaccine?,The high molecular weight melanoma-associated antigen (HMW-MAA) is an attractive target for immunotherapy of malignant melanoma.,0
2061,9,What is a mimotope vaccine?,We have recently generated a vaccine based on the HMW-MAA mimotope 225D9.2+ that was able to induce anti-HMW-MAA antibodies with antitumor activity in vitro.,0
2061,10,What is a mimotope vaccine?,Peptide mimics of a conformational epitope that is recognized by a mAb with antitumor activity are promising candidates for formulations of anticancer vaccines.,0
2061,11,What is a mimotope vaccine?,These mimotope vaccines are able to induce a polyclonal Ab response focused to the determinant of the mAb.,1
2061,12,What is a mimotope vaccine?,"Carbohydrate mimetic peptides of tumor associated carbohydrate antigens (TACA) are T-cell-dependent antigens and, therefore, immunization with these surrogates is predicted to overcome the low immunogenicity of carbohydrate antigens.",0
2061,13,What is a mimotope vaccine?,"Consistent with this hypothesis, we show that among the potential immune cells involved, peptide immunization led to an increase in T-cell populations.",0
2061,14,What is a mimotope vaccine?,"To explore the mimotope vaccine approach against infectious bursal disease virus (IBDV), five IBDV-specific monoclonal antibodies (mAbs) were prepared and their binding peptides were screened against a phage-displayed 12-mer peptide library.",0
2061,15,What is a mimotope vaccine?,"After three rounds of biopanning, 12 phages were selected for each mAbs and their specificity to IBDV was verified by sandwich and competitive inhibition ELISAs.",0
2061,16,What is a mimotope vaccine?,Seven phages per mAb were sequenced and their amino acid sequences were deduced.,0
2061,17,What is a mimotope vaccine?,The five representative sequences of mimotopes corresponding mAbs were determined.,0
2061,18,What is a mimotope vaccine?,"An artificial gene, designated 5epis (5 epitopes) and consisting of the five mimotopes arranged in tandem (F1-F7-B34-2B1-2G8) with four GGGS spacers, was chemically synthesized and cloned into a prokaryotic expression plasmid pET28b.",0
2061,19,What is a mimotope vaccine?,The mimotope vaccine was then generated by coupling the most suitable candidate mimotope to tetanus toxoid as an immunogenic carrier.,0
2061,20,What is a mimotope vaccine?,"We hypothesized that boosting the mimotope vaccine with the native tumor antigen would focus the T-cell response elicited by the mimotope toward high affinity, tumor-specific T cells.",1
2061,21,What is a mimotope vaccine?,"Following the mice immunization, phage-based mimotope vaccine induced humoral immunity.",0
2061,22,What is a mimotope vaccine?,"In this article we focus on cancer vaccines for antibody production, in particular mimotope vaccines.",0
2061,23,What is a mimotope vaccine?,"Vaccines that incorporate peptide mimics of tumor antigens, or mimotope vaccines, are commonly used in cancer immunotherapy and function by eliciting increased numbers of T cells that cross-react with the native tumor antigen.",0
2061,24,What is a mimotope vaccine?,"We hypothesized that boosting the mimotope vaccine with the native tumor antigen would focus the T-cell response elicited by the mimotope toward high affinity, tumor-specific T cells.",1
2061,25,What is a mimotope vaccine?,Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.,0
2061,26,What is a mimotope vaccine?,Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.,0
2061,27,What is a mimotope vaccine?,These mimotope vaccines are able to induce a polyclonal Ab response focused to the determinant of the mAb.,1
2061,28,What is a mimotope vaccine?,We therefore suggest that mimotope gene vaccines are potential candidates for epitope-specific immunotherapy of type I allergy.,0
2061,29,What is a mimotope vaccine?,Conformational B-cell epitopes on the HCV E2 protein recognized by human antibodies were characterized by the use of a peptide mimotope named K1.,0
2061,30,What is a mimotope vaccine?,"Following the mice immunization, phage-based mimotope vaccine induced humoral immunity.",0
2061,31,What is a mimotope vaccine?,"In this article we focus on cancer vaccines for antibody production, in particular mimotope vaccines.",0
3584,0,Can PRL3-zumab inhibit PRL3+ cancer cells in vitro and in vivo?,"Here we show that PRL3-zumab specifically inhibits PRL3+ cancer cells in vivo, but not in vitro.",1
1963,0,Which protein complexes recognize centromeric (CEN) DNA in yeast?,"The Schizosaccharomyces pombe centromere-linked genes, LYS1 and CYH1 on chromosome I and TPS13 and RAN1 on chromosome II, have been isolated",1
1963,1,Which protein complexes recognize centromeric (CEN) DNA in yeast?,Histone H3 localizes to the centromeric DNA in budding yeast,1
1963,2,Which protein complexes recognize centromeric (CEN) DNA in yeast?," In budding yeast, as well as in other eukaryotes, the Cse4 histone variant (known in vertebrates as CENP-A) is believed to substitute for histone H3 at the centromeric nucleosome",1
1963,3,Which protein complexes recognize centromeric (CEN) DNA in yeast?,"Surprisingly, we observed a strong interaction of H3, as well as Cse4, H4, H2A, and H2B, but not histone chaperone Scm3 (HJURP in human) with the centromeric DNA.",1
1963,4,Which protein complexes recognize centromeric (CEN) DNA in yeast?,H3 localizes to centromeric DNA at all stages of the cell cycle.,1
1963,5,Which protein complexes recognize centromeric (CEN) DNA in yeast?,Our results favor a H3-Cse4 heterotypic octamer at the budding yeast centromere,0
1963,6,Which protein complexes recognize centromeric (CEN) DNA in yeast?,"In budding yeast, a single right-handed cenH3/H4/H2A/H2B tetramer wraps the ∼80-bp Centromere DNA Element II (CDE II) sequence of each centromere into a 'hemisome'.",0
1963,7,Which protein complexes recognize centromeric (CEN) DNA in yeast?,"Here, we show that Cse4 octamers remain intact under conditions of low salt and urea that dissociate H3 octamers.",0
1193,0,What is the effect of thapsigargin treatment?, the sarcoplasmic/endoplasmic Ca(2+)-ATPase (SERCA) inhibitor thapsigargin,1
1193,1,What is the effect of thapsigargin treatment?,"Treatment of endoplasmic stress inducers, thapsigargin",1
1193,2,What is the effect of thapsigargin treatment?,the two unrelated reversible autophagy inhibitors 3-methyladenine (3MA) and thapsigargin (TG) both blocked cargo sequestration completely.,0
1193,3,What is the effect of thapsigargin treatment?,pretreatment with the endoplasmic reticulum Ca(2+) pump inhibitor thapsigargin (TG),1
1193,4,What is the effect of thapsigargin treatment?, pharmacological ER stress agents (thapsigargin and tunicamycin).,0
1193,5,What is the effect of thapsigargin treatment?, thapsigargin-induced calcium depletion of sarcoplasmic reticular stores,0
1193,6,What is the effect of thapsigargin treatment?,"Addition of thapsigargin (Tg), that induces store-depletion and activates TRPC1-mediated Ca(2+) entry, potentiated the Cl(-) current, which was inhibited by the addition of a non-specific TRPC channel blocker SKF96365 or removal of external Ca(2+).",0
1193,7,What is the effect of thapsigargin treatment?,"we demonstrate that thapsigargin (TG) and tunicamycin (TM), two ERS inducers",0
1193,8,What is the effect of thapsigargin treatment?,"hapsigargin, a sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) Ca(2+) pump inhibitor",1
1193,9,What is the effect of thapsigargin treatment?,Thapsigargin-induced ER stress,1
1193,10,What is the effect of thapsigargin treatment?,SERCA2a inhibitor (thapsigargin),0
1193,11,What is the effect of thapsigargin treatment?,"he ER stressors, thapsigargin",0
2509,0,Is creatinine assessment included in the MELD score?,Model For End-Stage Liver Disease (MELD) scores were calculated as 3.78×ln[TB] + 11.2×ln[INR] + 9.57×ln[creatinine] + 6.43.,1
2509,1,Is creatinine assessment included in the MELD score?,A corrected creatinine was derived from the mGFR after application of the Modification of Diet in Renal Disease formula.,0
2509,2,Is creatinine assessment included in the MELD score?,"Subsequently, a corrected MELD was calculated and compared with the conventionally calculated MELD.",0
2509,3,Is creatinine assessment included in the MELD score?,"Among patients with MELD score>35, a new prognostic model based on serum creatinine, need for hemodialysis and moderate ascites could identify the sickest one.",0
2509,4,Is creatinine assessment included in the MELD score?,"Patient risk factors evaluated include age, INR (international normalized ratio), creatinine, bilirubin, and MELD score (Model for End-of-stage Liver Disease).",1
2509,5,Is creatinine assessment included in the MELD score?,Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score.,0
2509,6,Is creatinine assessment included in the MELD score?,"The model of end-stage liver disease (MELD) score is used for this purpose in most countries and incorporates bilirubin, International Normalized ratio, and creatinine.",1
2509,7,Is creatinine assessment included in the MELD score?,"The MELD score was calculated using international normalized ratio, serum billirubin and creatinine.",1
2509,8,Is creatinine assessment included in the MELD score?,"Regression analysis identified high creatinine and INR, but not bilirubin, as the MELD components predicting negative outcomes with ELAD.",0
2509,9,Is creatinine assessment included in the MELD score?,This study aimed to evaluate the impact of two creatinine measurement methods on the Model for End Stage Liver Disease (MELD) score and glomerular filtration rate estimation (eGFR) in cirrhotic patients.,1
2509,10,Is creatinine assessment included in the MELD score?,<b>OBJECTIVES</b>: The model for end-stage liver disease score (MELD = 3.8*LN[total bilirubin] + 9.6*LN[creatinine] + 11.2*[PT-INR] + 6.4) predicts mortality for tricuspid valve surgery.,0
2509,11,Is creatinine assessment included in the MELD score?,"Simplified MELD score = 3.8*LN[total bilirubin] + 9.6*LN[creatinine] + 6.4.<br><b>METHODS</b>: A total of 172 patients (male: 66, female: 106; mean age, 63.8 ± 10.3 years) who underwent tricuspid replacement (n = 18) or repair (n = 154) from January 1991 to July 2011 at a single centre were included.",0
2509,12,Is creatinine assessment included in the MELD score?,CONCLUSION Incorporating eGFR obtained by the 6-variable MDRD equation into the MELD score showed an equal predictive performance in in-hospital mortality compared to a creatinine-based MELD score.,0
2509,13,Is creatinine assessment included in the MELD score?,Simplified MELD score = 3.8*LN[total bilirubin] + 9.6*LN[creatinine] + 6.4.,0
3735,0,Which molecules are inhibited by Gilteritinib?,"ASP2215 (gilteritinib) is a novel, dual FLT3/AXL inhibitor with promising early phase trial data (NCT02014558).",1
3735,1,Which molecules are inhibited by Gilteritinib?,"Ex vivo exposure (n = 30) to FLT3 inhibitors, in particular to the FLT3-specific inhibitor gilteritinib, showed that colony-forming capacity was significantly more reduced in FLT3-ITD-AR ≥ 0.5 compared with ITD-AR-low and ITD- patient samples (P < .001).",0
3735,2,Which molecules are inhibited by Gilteritinib?,"Furthermore, overexpression of Pim-1 in 32D/TKD enhanced the mTORC1/Mcl-1 pathway and partially protected it from the PI3K/Akt inhibitors or the FLT3 inhibitor gilteritinib to confer the resistance to PI3K/Akt inhibitors.",0
3735,3,Which molecules are inhibited by Gilteritinib?,"Finally, we analyzed bone marrow samples from 80 patients with FLT3-ITD relapsed/refractory AML participating in a trial of a novel FLT3 inhibitor, gilteritinib, and demonstrated a relationship between the mutation burden, as detected by the assay, and overall survival.",0
3735,4,Which molecules are inhibited by Gilteritinib?,"Gilteritinib, a novel, highly specific, potent fms-like tyrosine kinase 3/AXL inhibitor, demonstrated antileukemic activity in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML).",0
3735,5,Which molecules are inhibited by Gilteritinib?,"Combinations of an AXL inhibitor, cabozantinib or gilteritinib, and an EGFR-TKI were more effective against HCC78R cells than monotherapy with an EGFR-TKI or AXL inhibitor.",0
3735,6,Which molecules are inhibited by Gilteritinib?,Internal tandem duplication (ITD) in Fms-like tyrosine kinase 3 (FLT3) is frequently observed in acute myeloid leukemia (AML).,0
3735,7,Which molecules are inhibited by Gilteritinib?,"Quizartinib, gilteritinib, and midostaurin are inhibitors against FLT3-ITD that have good efficacy for FLT3-ITD-positive AML patients.",0
3735,8,Which molecules are inhibited by Gilteritinib?,"In this review, we summarized the preclinical and clinical studies on new FLT3 inhibitors, including sorafenib, lestaurtinib, sunitinib, tandutinib, quizartinib, midostaurin, gilteritinib, crenolanib, cabozantinib, Sel24-B489, G-749, AMG 925, TTT-3002, and FF-10101.",0
3735,9,Which molecules are inhibited by Gilteritinib?,"Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.",0
3735,10,Which molecules are inhibited by Gilteritinib?,"In the FLT3 signaling analyses, gilteritinib inhibited FLT3 __sup__ wt __end_sup__  and FLT3-ITD to a similar degree in HEK293 and Ba/F3 cells, and similarly suppressed FLT3 downstream signaling molecules (including ERK1/2 and STAT5) in both the presence and absence of FL in MOLM-13 cells.",0
3735,11,Which molecules are inhibited by Gilteritinib?,"Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells.",0
3735,12,Which molecules are inhibited by Gilteritinib?,We aimed to assess the highly selective oral FLT3 inhibitor gilteritinib in patients with relapsed or refractory acute myeloid leukaemia.,0
3735,13,Which molecules are inhibited by Gilteritinib?,"Gilteritinib inhibits FLT3 (STK1 or FLK2), AXL (UFO or JTK11) and anaplastic lymphoma kinase (ALK or CD246).",0
3735,14,Which molecules are inhibited by Gilteritinib?,"These findings confirm that FLT3 is a high-value target for treatment of relapsed or refractory acute myeloid leukaemia; based on activity data, gilteritinib at 120 mg/day is being tested in phase 3 trials.",0
3735,15,Which molecules are inhibited by Gilteritinib?,"In contrast to other FLT3 inhibitors, FL stimulation had little effect on growth inhibition or apoptosis induction by gilteritinib.",0
3735,16,Which molecules are inhibited by Gilteritinib?,"Here, we investigated the effect of FL on the efficacy of gilteritinib, a FLT3 inhibitor, in AML-derived cells  __i_tag__ in vitro __end_i_tag__  and in mice.",0
3735,17,Which molecules are inhibited by Gilteritinib?,"Gilteritinib (ASP2215, Xospata) is a small molecule dual inhibitor of FLT3/AXL.",1
3735,18,Which molecules are inhibited by Gilteritinib?,Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia.,1
3735,19,Which molecules are inhibited by Gilteritinib?,"Gilteritinib also inhibited FLT3-F691 mutations, although to a lesser degree, in these assays.",0
3735,20,Which molecules are inhibited by Gilteritinib?,Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML.,0
3735,21,Which molecules are inhibited by Gilteritinib?,Co-crystal structure analysis showed that gilteritinib bound to the ATP-binding pocket of FLT3.,0
3735,22,Which molecules are inhibited by Gilteritinib?,"Effect of Fms-like tyrosine kinase 3 ( FLT3 ) ligand ( FL ) on antitumor activity of gilteritinib , a FLT3 inhibitor , in mice xenografted with FL-overexpressing cells .",0
3735,23,Which molecules are inhibited by Gilteritinib?,"In the FLT3 signaling analyses , gilteritinib inhibited FLT3and FLT3-ITD to a similar degree in HEK293 and Ba/F3 cells , and similarly suppressed FLT3 downstream signaling molecules ( including ERK1/2 and STAT5 ) in both the presence and absence of FL in MOLM-13 cells .",0
3735,24,Which molecules are inhibited by Gilteritinib?,"Here , we investigated the effect of FL on the efficacy of gilteritinib , a FLT3 inhibitor , in AML-derived cellsand in mice.",0
3735,25,Which molecules are inhibited by Gilteritinib?,"In contrast to other FLT3 inhibitors , FL stimulation had little effect on growth inhibition or apoptosis induction by gilteritinib .",0
3735,26,Which molecules are inhibited by Gilteritinib?,"In contrast to other FLT3 inhibitors, FL stimulation had little effect on growth inhibition or apoptosis induction by gilteritinib.",0
3735,27,Which molecules are inhibited by Gilteritinib?,"Here, we investigated the effect of FL on the efficacy of gilteritinib, a FLT3 inhibitor, in AML-derived cells in vitro and in mice.",0
3735,28,Which molecules are inhibited by Gilteritinib?,"Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia.",1
3735,29,Which molecules are inhibited by Gilteritinib?,"Initial kinase studies showed that gilteritinib, a type I tyrosine kinase inhibitor, was highly selective for both FLT3 and AXL while having weak activity against c-KIT.",0
3735,30,Which molecules are inhibited by Gilteritinib?,"The studies reported here evaluated the ability of a novel FLT3/AXL inhibitor, gilteritinib, to block mutated FLT3 in cellular and animal models of AML.",0
3735,31,Which molecules are inhibited by Gilteritinib?,"The studies reported here evaluated the ability of a novel FLT3/AXL inhibitor, gilteritinib, to block mutated FLT3 in cellular and animal models of AML.",0
3735,32,Which molecules are inhibited by Gilteritinib?,"Initial kinase studies showed that gilteritinib, a type I tyrosine kinase inhibitor, was highly selective for both FLT3 and AXL while having weak activity against c-KIT.",0
3735,33,Which molecules are inhibited by Gilteritinib?,The decreased FLT3 activity and high intratumor distribution of gilteritinib translated to tumor regression and improved survival in xenograft and intra-bone marrow transplantation models of FLT3-driven AML.,0
3735,34,Which molecules are inhibited by Gilteritinib?,These results indicate that gilteritinib may be an important next-generation FLT3 inhibitor for use in the treatment of FLT3 mutation-positive AML.,0
3735,35,Which molecules are inhibited by Gilteritinib?,Gilteritinib (Xospata®) is an orally available small molecule receptor tyrosine kinase inhibitor developed by Astellas Pharma in collaboration with Kotobuki Pharmaceutical for the treatment of acute myeloid leukaemia (AML) harbouring FMS-like tyrosine kinase 3 (FLT3) mutations.,0
3735,36,Which molecules are inhibited by Gilteritinib?,"Gilteritinib inhibits FLT3 (STK1 or FLK2), AXL (UFO or JTK11) and anaplastic lymphoma kinase (ALK or CD246).",0
3735,37,Which molecules are inhibited by Gilteritinib?,Gilteritinib is approved in Japan for the treatment of relapsed or refractory AML with FLT3 mutation.,0
3735,38,Which molecules are inhibited by Gilteritinib?,"Gilteritinib is an oral, potent, selective FLT3 inhibitor with single-agent activity in relapsed or refractory FLT3-mutated AML.",0
3735,39,Which molecules are inhibited by Gilteritinib?,The highly potent and selective FLT3 kinase inhibitor gilteritinib is the first tyrosine kinase inhibitor approved as monotherapy for the treatment of relapsed and/or refractory FLT3-mutated AML.,0
3735,40,Which molecules are inhibited by Gilteritinib?,"Gilteritinib is a highly-specific, potent FLT3/AXL inhibitor with demonstrated activity against FLT3-ITD and FLT3-TKD mutations.",1
3735,41,Which molecules are inhibited by Gilteritinib?,Gilteritinib is a potent and selective FLT3 kinase inhibitor with single-agent clinical efficacy in relapsed/refractory FLT3-mutated acute myeloid leukemia (AML).,0
3735,42,Which molecules are inhibited by Gilteritinib?,"Gilteritinib, a novel, highly specific, potent fms-like tyrosine kinase 3/AXL inhibitor, demonstrated antileukemic activity in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML).",0
4084,0,When is DELE1 exiting the mitochondrion?," stress-induced activation of OMA1 causes DELE1 to be cleaved into a short form that accumulates in the cytosol, where it binds to and activates HRI via its C-terminal portion.",1
4084,1,When is DELE1 exiting the mitochondrion?,"Mitochondrial stress stimulates OMA1-dependent cleavage of DELE1 and leads to the accumulation of DELE1 in the cytosol, where it interacts with HRI and activates the eIF2α kinase activity of HRI.",1
175,0,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,ExTopoDB: a database of experimentally derived topological models of transmembrane proteins,1
175,1,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins.,1
175,2,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,It contains information collected from studies in the literature that report the use of biochemical methods for the determination of the topology of α-helical transmembrane proteins.,0
175,3,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"Transmembrane protein topology is highly important in order to understand their function and ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of α-helical transmembrane proteins.",0
175,4,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,Topological information is combined with transmembrane topology prediction resulting in more reliable topological models.,0
175,5,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,AVAILABILITY: http://bioinformatics.biol.uoa.gr/ExTopoDB,0
175,6,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,TMPDB: a database of experimentally-characterized transmembrane topologies,0
175,7,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,TMPDB is a database of experimentally-characterized transmembrane (TM) topologies.,0
175,8,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"TMPDB release 6.2 contains a total of 302 TM protein sequences, in which 276 are alpha-helical sequences, 17 beta-stranded, and 9 alpha-helical sequences with short pore-forming helices buried in the membrane.",0
175,9,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"The TM topologies in TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation experiment and other biochemical methods.",0
175,10,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"TMPDB would be useful as a test and/or training dataset in improving the proposed TM topology prediction methods or developing novel methods with higher performance, and as a guide for both the bioinformaticians and biologists to better understand TM proteins.",0
175,11,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,TMPDB and its subsets are freely available at the following web site: http://bioinfo.si.hirosaki-u.ac.jp/~TMPDB/,0
175,12,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"Transmembrane protein topology is highly important in order to understand their function and ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of ж┴-helical transmembrane proteins.",0
175,13,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,TMPDB: a database of experimentally-characterized transmembrane topologies.,0
175,14,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,TMPDB is a database of experimentally-characterized transmembrane (TM) topologies.,0
175,15,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"The TM topologies in TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation experiment and other biochemical methods.",0
175,16,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"Transmembrane protein topology is highly important in order to understand their function and ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of α-helical transmembrane proteins.",0
175,17,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"Transmembrane protein topology is highly important in order to understand their function and ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of �-helical transmembrane proteins.",0
175,18,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,UNLABELLED: ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins.,1
175,19,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"The TM topologies in TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation experiment and other biochemical methods.",0
175,20,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"Transmembrane protein topology is highly important in order to understand their function and ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of α-helical transmembrane proteins",0
175,21,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,"The TM topologies in TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation experiment and other biochemical methods",0
175,22,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,TMPDB is a database of experimentally-characterized transmembrane (TM) topologies,0
175,23,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,ExTopoDB: a database of experimentally derived topological models of transmembrane proteins.,1
175,24,Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?,ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins,1
905,0,Are viruses involved in the etiology of human subacute thyroiditis?,"he etiology of subacute (de Quervain's) thyroiditis (SAT) is uncertain, although it probably represents a nonspecific inflammatory response by the thyroid to a variety of viruses.",1
905,1,Are viruses involved in the etiology of human subacute thyroiditis?,Subacute thyroiditis is an inflammatory disorder of the thyroid caused probably by viruses.,1
905,2,Are viruses involved in the etiology of human subacute thyroiditis?,I,0
905,3,Are viruses involved in the etiology of human subacute thyroiditis?,We believe that the etiologic agent was the Epstein-Barr virus because heterophile and Epstein-Barr virus-specific antibodies were positive.,1
905,4,Are viruses involved in the etiology of human subacute thyroiditis?,"ltogether, these results indicate that the mechanism of inhibition of Spumavirinae infection by interferon differs from that described for the other Retroviridae, and particularly for types B, C and D viruses.",1
905,5,Are viruses involved in the etiology of human subacute thyroiditis?,Our data is of therapeutic interest since Spumavirinae have been linked to pathological processes such as de Quervain thyroiditis.,1
1416,0,Is c-myc subject to regulation by the circadian clock?,"The current study encompasses the investigation of simultaneous expression of four circadian clock genes (Bmal1, Clock, Per1 and Per2) and three clock-controlled cell cycle genes (Myc, Cyclin D1 and Wee1)",0
1416,1,Is c-myc subject to regulation by the circadian clock?,Our results suggest that aberrant expression of circadian clock genes can lead to aberrant expression of their downstream targets that are involved in cell proliferation and apoptosis and hence may result in manifestation of CLL.,0
1416,2,Is c-myc subject to regulation by the circadian clock?,"Loss of Bmal1 reduced the expression of per1, per2, per3, wee1 and p53.",0
1416,3,Is c-myc subject to regulation by the circadian clock?,The expression of p21 and c-myc was also altered in certain cell lines.,1
1416,4,Is c-myc subject to regulation by the circadian clock?,"In particular, the proto-oncogene c-Myc has been documented to be under circadian regulation.",0
1416,5,Is c-myc subject to regulation by the circadian clock?,The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells.,1
1416,6,Is c-myc subject to regulation by the circadian clock?,"Our results, using the murine neuroblastoma cell line N2A, show that Per1 and c-Myc steady-state mRNA levels oscillate with the same phase.",0
1416,7,Is c-myc subject to regulation by the circadian clock?,These experiments demonstrate for the first time that a significant decrease in c-Myc transcript and protein levels can be achieved after a short TSA treatment applied only at specific circadian times.,0
1416,8,Is c-myc subject to regulation by the circadian clock?,This is also followed by a reduction in the proliferation rate of the cell population.,0
1416,9,Is c-myc subject to regulation by the circadian clock?,"Among the circadian output pathways, the rhythmic sympathetic signaling plays a key role in the central-peripheral timing mechanism that simultaneously activates the cell cycle clock via AP1-controlled Myc induction and p53 via peripheral clock-controlled ATM activation.",0
1416,10,Is c-myc subject to regulation by the circadian clock?,"Jet-lag promptly desynchronizes the central clock-SNS-peripheral clock axis, abolishes the peripheral clock-dependent ATM activation, and activates myc oncogenic potential, leading to tumor development in the same organ systems in wild-type and circadian gene-mutant mice.",0
1416,11,Is c-myc subject to regulation by the circadian clock?,"The results showed that over-expression of Per2 induced not only cell cycle arrest at G2/M phase but also an increase in apoptosis, which was confirmed by characteristic morphological changes, FCM and evident DNA fragmentation.",0
1416,12,Is c-myc subject to regulation by the circadian clock?,Further experiments confirmed both up-regulation of P53 and down-regulation of CylinB1and C-myc.,0
1416,13,Is c-myc subject to regulation by the circadian clock?,"On the other hand, while P53 was found to be down-regulated.",0
1416,14,Is c-myc subject to regulation by the circadian clock?,CylinB1 and C-myc were up-regulated.,0
1416,15,Is c-myc subject to regulation by the circadian clock?,after Per2 knockdown.,0
1416,16,Is c-myc subject to regulation by the circadian clock?,"We also show that BMAL1 epigenetic inactivation impairs the characteristic circadian clock expression pattern of genes such as C-MYC, catalase, and p300 in association with a loss of BMAL1 occupancy in their respective promoters.",1
1416,17,Is c-myc subject to regulation by the circadian clock?,Per2 mutant (Per2(m/m)) mice show an increase in lymphomas and deregulated expression of cyclin D and c-Myc genes that are key to proliferation control.,0
1416,18,Is c-myc subject to regulation by the circadian clock?,"The expression of cell cycle genes such as Wee1, Cyclins, and c-Myc are under circadian control and could be directly under the regulation of the circadian transcriptional complex.",1
1416,19,Is c-myc subject to regulation by the circadian clock?,Overexpressed mPER2 also altered the expression of apoptosis-related genes.,0
1416,20,Is c-myc subject to regulation by the circadian clock?,"The mRNA and protein levels of c-Myc, Bcl-X(L) and Bcl-2 were downregulated,",1
1416,21,Is c-myc subject to regulation by the circadian clock?,"Temporal expression of genes involved in cell cycle regulation and tumor suppression, such as c-Myc, Cyclin D1, Cyclin A, Mdm-2 and Gadd45alpha is deregulated in mPer2 mutant mice.",0
1416,22,Is c-myc subject to regulation by the circadian clock?,"The temporal expression of genes involved in cell cycle regulation and tumor suppression, such as c-Myc, Cyclin D1, Cyclin A, Mdm-2, and Gadd45alpha, is deregulated in mPer2 mutant mice.",0
1027,0,What is the treatment of Riedel disease (thyroiditis)?,IFT often is associated with a systemic extracervical fibrotic process and tobacco use.,1
1027,1,What is the treatment of Riedel disease (thyroiditis)?,Attempted thyroid resection often results in postoperative complications.,0
1027,2,What is the treatment of Riedel disease (thyroiditis)?,Long-term follow-up showed no deaths fro,0
1027,3,What is the treatment of Riedel disease (thyroiditis)?,Riedel's invasive fibrous thyroiditis is a rare disorder of unknown origin with progressive extension and invasion of adjacent structures.,1
1027,4,What is the treatment of Riedel disease (thyroiditis)?,"Clinically it is impossible to distinguish between Riedel's/thyroiditis and other diseases as undifferentiated carcinoma, Hashimoto's disease etc...",1
1027,5,What is the treatment of Riedel disease (thyroiditis)?,"Surgical treatment depends on the stage of the disease, when both lobes are involved generous wedge resection of the isthmus may be the treatment of choice to relieve tracheal compression; in earlier stages radical operation are considered.",1
1027,6,What is the treatment of Riedel disease (thyroiditis)?,"Corticosteroid treatment in Riedel's thyroiditis, as multifocal disease has been successfully used.",1
1027,7,What is the treatment of Riedel disease (thyroiditis)?,Other drugs with antifibrosing actions have also utilised in small groups of patients with encouraging results.,0
4069,0,Why is fingolimod considered a prodrug?,"FTY720/fingolimod, a prodrug for the treatment of multiple sclerosis, is phosphorylated in vivo to its active phosphorylated form by sphingosine kinase 2 and has been shown to interfere with the actions of S1P and to inhibit ceramide biosynthesis.",1
491,0,Which are the characteristics of  Andersen syndrome?,"Mutations of KCNJ2, the gene encoding the human inward rectifier potassium channel Kir2.1, cause Andersen-Tawil syndrome (ATS), a disease exhibiting ventricular arrhythmia, periodic paralysis, and dysmorphic features.",1
491,1,Which are the characteristics of  Andersen syndrome?,"Andersen cardiodysrhythmic periodic paralysis or Andersen-Tawil syndrome includes the distinct clinical features of periodic paralysis, cardiac arrhythmia, and facial and skeletal dysmorphisms and exhibits autosomal dominant inheritance.",1
491,2,Which are the characteristics of  Andersen syndrome?,"The patient was a 19-year-old woman with familial periodic paralysis, abnormal QT-U complex, and nonsustained ventricular tachycardia.",1
491,3,Which are the characteristics of  Andersen syndrome?,"Andersen-Tawil syndrome (ATS) is a rare inherited disorder, characterised by periodic paralysis, cardiac dysarrhythmias, and dysmorphic features, and is caused by mutations in the gene KCNJ2, which encodes the inward rectifier potassium channel, Kir2.1.",1
491,4,Which are the characteristics of  Andersen syndrome?,"Evaluation of candidate loci culminated in the identification of a heterozygous missense mutation (R67W) in KCNJ2, the gene encoding the inward-rectifying potassium current, Kir2.1, in 41 members of a kindred in which ventricular arrhythmias (13 of 16 female members [81%]) and periodic paralysis (10 of 25 male members [40%]) segregated as autosomal dominant traits with sex-specific variable expressivity.",0
491,5,Which are the characteristics of  Andersen syndrome?,"Some mutation carriers exhibited dysmorphic features, including hypertelorism, small mandible, syndactyly, clinodactyly, cleft palate, and scoliosis, which, together with cardiodysrhythmic periodic paralysis, have been termed ""Andersen syndrome.""",1
913,0,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,The authors report the 3-year results of the Barrow Ruptured Aneurysm Trial (BRAT).,0
913,1,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,The objective of this ongoing randomized trial is to compare the safety and efficacy of microsurgical clip occlusion and endovascular coil embolization for the treatment of acutely ruptured cerebral aneurysms and to compare functional outcomes based on clinical and angiographic data.,1
913,2,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,"We report the design of the FIAT study, a clinical care trial aiming to compare angiographic and clinical outcomes following treatment with a Flow-Diverter or with the best conventional treatment option.",1
913,3,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,The FIAT study will include both a randomized and a registry portion.,0
913,4,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,"Patients will be proposed randomization to either FD stenting or best conventional treatment option (observation, coiling, stenting, or clipping) as determined by the treating physician.",0
913,5,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,The effect of clipping and coiling in acute severe subarachnoid hemorrhage after international subarachnoid aneurysmal trial (ISAT) results.,1
913,6,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,A critical appraisal of the ISAT of microsurgical clipping versus coiling is used for comparison of our results.,0
913,7,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,"International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.",1
913,8,List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?,International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.,1
4193,0,Which gene is associated with response to abacavir?,Large studies established the effectiveness of prospective HLA-B*57:01 screening to prevent HSRs to abacavir.,1
26,0,What kind of chromatography is HILIC?,hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC LC-MS/MS) method,1
26,1,What kind of chromatography is HILIC?,Hydrophilic-interaction liquid chromatography (HILIC) is a widely used technique for small polar molecule analysis,1
26,2,What kind of chromatography is HILIC?,hydrophilic-interaction LC (HILIC),1
26,3,What kind of chromatography is HILIC?,A hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC LC-MS/MS) method,0
26,4,What kind of chromatography is HILIC?,Hydrophilic Interaction Chromatography (HILIC),1
26,5,What kind of chromatography is HILIC?,n this study a hydrophilic interaction chromatographic (HILIC) method,1
4152,0,Are there sex differences in oncogenic mutational processes?,Sex differences in oncogenic mutational processes.,1
2135,0,Are hepadnaviral minichromosomes free of nucleosomes?,"Several nucleosome-protected sites in a region of the DHBV genome [nucleotides (nt) 2000 to 2700], known to harbor various cis transcription regulatory elements, were consistently identified in all DHBV-positive liver samples.",1
2135,1,Are hepadnaviral minichromosomes free of nucleosomes?,"In addition, we observed other nucleosome protection sites in DHBV minichromosomes that may vary among individual ducks, but the pattern of MNase mapping in those regions is transmittable from the adult ducks to the newly infected ducklings.",1
2135,2,Are hepadnaviral minichromosomes free of nucleosomes?,nucleosomes along viral cccDNA in the minichromosomes are not random but sequence-specifically positioned.,1
2135,3,Are hepadnaviral minichromosomes free of nucleosomes?,"Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the nucleus of infected hepatocytes as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of nucleosomes.",0
2135,4,Are hepadnaviral minichromosomes free of nucleosomes?,Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes.,0
2135,5,Are hepadnaviral minichromosomes free of nucleosomes?,"To obtain insight on the structure of hepadnaviral cccDNA minichromosomes, we utilized ducks infected with the duck hepatitis B virus (DHBV) as a model and determined the in vivo nucleosome distribution pattern on viral cccDNA by the micrococcal nuclease (MNase) mapping and genome-wide PCR amplification of isolated mononucleosomal DHBV DNA.",1
2135,6,Are hepadnaviral minichromosomes free of nucleosomes?,"Mature SV40 minichromosomes are estimated to contain about 27 nucleosomes (error +/- 2), except for those molecules with a nucleosome-free gap, which are interpreted to contain 25 nucleosomes (error +/- 2).",0
2135,7,Are hepadnaviral minichromosomes free of nucleosomes?,In vitro replication in the presence of protein-free competitor DNA shows that replicating trypsinized minichromosomes do not lose nucleosomes and replicating competitor DNA does not gain nucleosomes.,0
2135,8,Are hepadnaviral minichromosomes free of nucleosomes?,In vitro replication in the presence of protein-free competitor DNA shows that replicating trypsinized minichromosomes do not lose nucleosomes and replicating competitor DNA does not gain nucleosomes.,0
2135,9,Are hepadnaviral minichromosomes free of nucleosomes?,"We conclude that in both cases parental nucleosomes are transferred to progeny DNA, and, in addition, that an assembly of new nucleosomes occurs during the replication of native minichromosomes.",0
2135,10,Are hepadnaviral minichromosomes free of nucleosomes?,"In contrast, the replicated untreated minichromosomes were found to be densely packed with nucleosomes, indicating that an assembly of new nucleosomes occurred during in vitro replication.",1
2135,11,Are hepadnaviral minichromosomes free of nucleosomes?,"Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the nucleus of infected hepatocytes as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of nucleosomes",0
2135,12,Are hepadnaviral minichromosomes free of nucleosomes?,"To obtain insight on the structure of hepadnaviral cccDNA minichromosomes, we utilized ducks infected with the duck hepatitis B virus (DHBV) as a model and determined the in vivo nucleosome distribution pattern on viral cccDNA by the micrococcal nuclease (MNase) mapping and genome-wide PCR amplification of isolated mononucleosomal DHBV DNA",0
2135,13,Are hepadnaviral minichromosomes free of nucleosomes?,Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes.,0
2135,14,Are hepadnaviral minichromosomes free of nucleosomes?,"To obtain insight on the structure of hepadnaviral cccDNA minichromosomes, we utilized ducks infected with the duck hepatitis B virus (DHBV) as a model and determined the in vivo nucleosome distribution pattern on viral cccDNA by the micrococcal nuclease (MNase) mapping and genome-wide PCR amplification of isolated mononucleosomal DHBV DNA.",0
2135,15,Are hepadnaviral minichromosomes free of nucleosomes?,"Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the nucleus of infected hepatocytes as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of nucleosomes..",0
877,0,Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?,"At the core of the infrastructure are three packages: IRanges, GenomicRanges, and GenomicFeatures.",1
877,1,Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?,"These packages provide scalable data structures for representing annotated ranges on the genome, with special support for transcript structures, read alignments and coverage vectors.",1
877,2,Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?,"Computational facilities include efficient algorithms for overlap and nearest neighbor detection, coverage calculation and other range operations.",1
877,3,Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?,"This infrastructure directly supports more than 80 other Bioconductor packages, including those for sequence analysis, differential expression analysis and visualization.",1
3364,0,Is PRDM9 essential for meiosis?,"Our findings do not identify the nature of the underlying DNA sequences, but argue against the proposed role of Prdm9 as an essential transcription factor in mouse meiosis",1
3364,1,Is PRDM9 essential for meiosis?,PRDM9 gene polymorphism may not be associated with defective spermatogenesis in the Chinese Han population,0
3364,2,Is PRDM9 essential for meiosis?,"PRDM9 is essential for the progression through early meiotic prophase, including double strand break repair, homologous chromosome pairing, and sex body formation during spermatogenesis.",1
3364,3,Is PRDM9 essential for meiosis?,PRDM9 (PR domain-containing protein 9) is a meiosis-specific protein that trimethylates H3K4 and controls the activation of recombination hot spots.,1
3364,4,Is PRDM9 essential for meiosis?,It is an essential enzyme in the progression of early meiotic prophase.,0
3364,5,Is PRDM9 essential for meiosis?,"In many eukaryotes, sites of meiotic recombination, also called hotspots, are regions of accessible chromatin, but in many vertebrates, their location follows a distinct pattern and is specified by PR domain-containing protein 9 (PRDM9).",0
3364,6,Is PRDM9 essential for meiosis?," We found that although the post-SET zinc finger and the KRAB domains are not essential for the methyltransferase activity of PRDM9 in cell culture, the KRAB domain mutant mice show only residual PRDM9 methyltransferase activity and undergo meiotic arrest.",0
3364,7,Is PRDM9 essential for meiosis?,"In aggregate, our data indicate that domains typically involved in regulation of gene expression do not serve that role in PRDM9, but are likely involved in setting the proper chromatin environment for initiation and completion of homologous recombination.",1
3364,8,Is PRDM9 essential for meiosis?,PRDM9 Methyltransferase Activity Is Essential for Meiotic DNA Double-Strand Break Formation at Its Binding Sites.,1
1222,0,What are piggyBAC transposons?,The Sleeping Beauty and PiggyBac DNA transposon systems have recently been developed as tools for insertional mutagenesis.,1
1222,1,What are piggyBAC transposons?,The use of nonviral gene delivery approaches in conjunction with the latest generation transposon technology based on Sleeping Beauty (SB) or piggyBac transposons may potentially overcome some of these limitations.,0
1222,2,What are piggyBAC transposons?,DNA transposons have emerged as flexible and efficient molecular vehicles to mediate stable cargo transfer.,0
1222,3,What are piggyBAC transposons?,"However, the ability to carry DNA fragments>10 kb is limited in most DNA transposons.",0
1222,4,What are piggyBAC transposons?,"Here, we show that the DNA transposon piggyBac can mobilize 100-kb DNA fragments in mouse embryonic stem (ES) cells, making it the only known transposon with such a large cargo capacity.",1
1222,5,What are piggyBAC transposons?,"The integrity of the cargo is maintained during transposition, the copy number can be controlled and the inserted giant transposons express the genomic cargo.",1
1222,6,What are piggyBAC transposons?,"Furthermore, these 100-kb transposons can also be excised from the genome without leaving a footprint.",1
1222,7,What are piggyBAC transposons?,The development of piggyBac as a large cargo vector will facilitate a wider range of genetic and genomic applications.,1
1222,8,What are piggyBAC transposons?,"In this report, we harnessed the highly efficient, nonviral, and plasmid-based piggyBac transposon system to enable concurrent genomic integration of multiple independent transposons harboring distinct protein-coding DNA sequences",0
1222,9,What are piggyBAC transposons?,"Among the transposons active in mammalian cells, the moth-derived transposon piggyBac is most promising with its highly efficient transposition, large cargo capacity, and precise repair of the donor site",0
1222,10,What are piggyBAC transposons?,"Transposons are promising systems for somatic gene integration because they can not only integrate exogenous genes efficiently, but also be delivered to a variety of organs using a range of transfection methods.",0
1222,11,What are piggyBAC transposons?,"piggyBac (PB) transposon has a high transposability in mammalian cells in vitro, and has been used for genetic and preclinical studies",0
1222,12,What are piggyBAC transposons?,Simple piggyBac transposon-based mammalian cell expression system for inducible protein production.,0
1222,13,What are piggyBAC transposons?,The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sites.,0
1222,14,What are piggyBAC transposons?,The piggyBac transposon was developed as an alternative mutagenic vector for mutagenesis of non-P-element targeted genes in Drosophila because the piggyBac transposon can more randomly integrate into the genome.,0
1222,15,What are piggyBAC transposons?,Previous studies suggested that the piggyBac transposon always excises precisely from the insertion site without initiating a deletion or leaving behind an additional footprint.,0
1222,16,What are piggyBAC transposons?,"A single injection of piggyBac transposons could achieve long-term inducible gene expression in the livers of mice in vivo, confirming our multiple-transposon strategy used in cultured cells.",0
1222,17,What are piggyBAC transposons?,The plasmid-based piggyBac transposon system enables constitutive or inducible gene expression in vivo for potential therapeutic and biological applications without using viral vectors.,0
1222,18,What are piggyBAC transposons?,"In this report, we harnessed the highly efficient, nonviral, and plasmid-based piggyBac transposon system to enable concurrent genomic integration of multiple independent transposons harboring distinct protein-coding DNA sequences.",0
1222,19,What are piggyBAC transposons?,Flow cytometry of cell clones derived from a single multiplexed transfection demonstrated approximately 60% (three transposons) or approximately 30% (four transposons) stable coexpression of all delivered transgenes with selection for a single marker transposon.,0
1219,0,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Intravenous iron should be preferred where oral iron is poorly tolerated or where it has failed in moderate to severe anemia, and in combination with erythropoietin",0
1219,1,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Ferric carboxymaltose is much more convenient, and has been shown to be more effective than iron sucrose in a large randomized tria",0
1219,2,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,nemia and iron deficiency anemia are very common in inflammatory bowel disease (IBD,0
1219,3,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,Ferric carboxymaltose was associated with cost savings of 30-44 % per patient per treatment cycle compared to iron sucrose.,0
1219,4,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Iron deficiency is common in pregnancy, postpartum, inflammatory bowel disease, chronic kidney disease, chronic heart failure, heavy uterine bleeding, cancer and following surgery.",0
1219,5,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,We estimate the budget impact (BI) on the Swiss mandatory health insurance associated with substituting iron sucrose (standard) with ferric carboxymaltose (new treatment) using real-life data.,0
1219,6,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,reating iron deficiency involves substantial costs to the Swiss MHI which may be reduced by substituting iron sucrose with ferric carboxymaltose.,0
1219,7,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"e aim of this study was to observe, in a non-interventional way, how Swedish gastroenterologists adhere to guidelines in IBD outpatients treated with intravenous ferric carboxymaltose (FCM), and the result of treatment",0
1219,8,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,FCM lowers platelet counts and platelet activation in patients with IBD-associated secondary thrombocytosis.,0
1219,9,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"We performed a randomized, single-blinded placebo-controlled trial testing the effect of ferric carboxymaltose (FCM) in patients with IBD with secondary thrombocytosis (platelets > 450 G/L)",0
1219,10,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"e performed a randomized, placebo-controlled trial to determine if administration of ferric carboxymaltose (FCM) prevents anemia in patients with IBD and low levels of serum ferritin",0
1219,11,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"FCM prevents recurrence of anemia in patients with IBD, compared with placebo.",1
1219,12,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?, A subgroup was analyzed regarding efficacy and side effects of iron supplementation with ferric carboxymaltose.,0
1219,13,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,Iron deficiency and anemia are frequent in IBD patients.,0
1219,14,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Treatment with ferric carboxymaltose is efficious, safe and well tolerated in iron-deficient IBD patients.",1
1219,15,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?," Intravenous iron avoids these concerns, especially with the development of ferric carboxymaltose, which allow up to 1000mg to be given rapidly.",0
1219,16,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,What is the optimal treatment for anemia in inflammatory bowel disease?,0
1219,17,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,We compared the efficacy and safety of a novel fixed-dose ferric carboxymaltose regimen (FCM) with individually calculated iron sucrose (IS) doses in patients with inflammatory bowel disease (IBD) and IDA,1
1219,18,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,Study drugs were well tolerated and drug-related adverse events were in line with drug-specific clinical experience,0
1219,19,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?," The simpler FCM-based dosing regimen showed better efficacy and compliance, as well as a good safety profile, compared with the Ganzoni-calculated IS dose regimen.",0
1219,20,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Ferric carboxymaltose can be rapidly administered in doses of 15 mg/kg body weight, up to a ceiling dose of 1000 mg. A test dose is not required, and it can be used more widely across a spectrum of iron deficiency and iron deficiency anemia indication",0
1219,21,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?," Intravenous iron offers a rapid means of iron repletion and is superior to oral iron in many circumstances, especially in the presence of anemia of chronic disease, where it appears to overcome the block to absorption of iron from the gastrointestinal tract and immobilization of stored iron.",0
1219,22,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,The clinical situations where high doses of iron are commonly required are reviewed.,0
1219,23,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"These include nondialysis-dependent chronic kidney disease, inflammatory bowel disease, obstetrics, menorrhagia, and anemia associated with cancer and its treatment.",0
1219,24,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Ferric carboxymaltose can be administered at 15 mg/kg body weight to a maximum dose of 1000 mg, whereas iron isomaltoside 1000 can be administered at 20 mg/kg body weight.",0
1219,25,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"The ability to give high doses of iron is important in the context of managing iron deficiency anemia in a number of clinical conditions where demands for iron are high (including chronic blood loss associated with inflammatory bowel disease, menorrhagia, and chronic kidney disease)",0
1219,26,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"erric carboxymaltose (FCM, Ferinject) was effective and well tolerated in the treatment of iron-deficiency anemia (IDA) in nine, Phase III, randomized, controlled, multicenter trials in a diverse range of indications, including patients with inflammatory bowel disease (IBD), post-partum anemia (PPA) or abnormal uterine bleeding (AUB), chronic heart failure (CHF), non-dialysis-dependent chronic kidney disease (CKD) and those undergoing hemodialysis (HD",0
1219,27,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"In patients with IBD or PPA, improvements in Hb levels were more rapid with FCM than with FeSulf.",0
1219,28,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"CM improved patient quality of life to an equivalent extent to oral FeSulf in patients with IBD or PPA, and to a greater extent than oral FeSulf in women with AUB",0
1219,29,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Four different products are principally used in clinical practice, which differ in their pharmacokinetic properties and safety profiles: iron gluconate and iron sucrose (lower single doses), and iron dextran and ferric carboxymaltose (higher single doses).",0
1219,30,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,he prevalence of anemia across studies on patients with inflammatory bowel disease (IBD) is high (30%).,1
1219,31,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?, novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.,0
1219,32,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,FeCarb is effective and safe in IBD-associated anemia.,0
1219,33,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"It is noninferior to FeSulf in terms of Hb change over 12 wk, and provides a fast Hb increase and a sufficient refill of iron stores.",0
1219,34,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Treatment-related adverse events (AEs) occurred in 28.5% of the FeCarb and 22.2% of the FeSulf groups, with discontinuation of study medication due to AEs in 1.5% and 7.9%, respectively.",0
1219,35,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"The median Hb improved from 8.7 to 12.3 g/dL in the FeCarb group and from 9.1 to 12.1 g/dL in the FeSulf group, demonstrating noninferiority (P= 0.6967).",0
1219,36,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.,1
1219,37,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Ferric carboxymaltose (FCM, Ferinject) was effective and well tolerated in the treatment of iron-deficiency anemia (IDA) in nine, Phase III, randomized, controlled, multicenter trials in a diverse range of indications, including patients with inflammatory bowel disease (IBD), post-partum anemia (PPA) or abnormal uterine bleeding (AUB), chronic heart failure (CHF), non-dialysis-dependent chronic kidney disease (CKD) and those undergoing hemodialysis (HD).",0
1219,38,Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?,"Ferric carboxymaltose (FCM, Ferinject) was effective and well tolerated in the treatment of iron-deficiency anemia (IDA) in nine, Phase III, randomized, controlled, multicenter trials in a diverse range of indications, including patients with inflammatory bowel disease (IBD), post-partum anemia (PPA) or abnormal uterine bleeding (AUB), chronic heart failure (CHF), non-dialysis-dependent chronic kidney disease (CKD) and those undergoing hemodialysis (HD)",0
1281,0,Is TNNI3K a cardiac-specific protein?,cardiomyocyte-specific kinase TNNI3K,0
1281,1,Is TNNI3K a cardiac-specific protein?,"We report that cardiac troponin I-interacting kinase (TNNI3K), a cardiomyocyte-specific kinase,",0
1281,2,Is TNNI3K a cardiac-specific protein?,"TNNI3K, a cardiac-specific kinase,",0
1281,3,Is TNNI3K a cardiac-specific protein?," The cardiac troponin I-interacting kinase (TNNI3K), a novel cardiac specific kinase, is associated with cardiomyocyte hypertrophy",0
1281,4,Is TNNI3K a cardiac-specific protein?,Human cardiac troponin I-interacting kinase (TNNI3K) is a novel cardiac-specific functional kinase that can bind to cTnI in a yeast two-hybrid screen.,1
1281,5,Is TNNI3K a cardiac-specific protein?,"Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunctio",0
1281,6,Is TNNI3K a cardiac-specific protein?,Cardiac troponin I-interacting kinase (TNNI3K) is a cardiac-specific kinase whose biological function remains largely unknown,0
1281,7,Is TNNI3K a cardiac-specific protein?, Cardiac troponin I-interacting kinase (TNNI3K) is a novel cardiac-specific kinase gene,1
1281,8,Is TNNI3K a cardiac-specific protein?," a novel cardiac-specific kinase gene (TNNI3K),",0
1281,9,Is TNNI3K a cardiac-specific protein?," TNNI3K is a novel cardiac troponin I-interacting kinase gene and its overexpression may promote cardiac myogenesis,",0
1281,10,Is TNNI3K a cardiac-specific protein?,TNNI3K is a new cardiac-specific MAP kinase whose gene is localized to 1p31.1 and that belongs to a tyrosine kinase-like branch in the kinase tree of the human genome.,1
1281,11,Is TNNI3K a cardiac-specific protein?,"The cardiac ankyrin repeat kinase (CARK) gene, also named TNNI3K for its interaction with cardiac troponin I, is both a unique expression and heart-enriched gene",0
1281,12,Is TNNI3K a cardiac-specific protein?,"Molecular cloning of cardiac troponin I-interacting kinase (TNNI3K), a novel cardiac-specific protein kinase containing seven N-terminal ankyrin (ANK) repeats followed by a protein kinase domain and a C-terminal Ser-rich domain, has previously been reported.",0
1281,13,Is TNNI3K a cardiac-specific protein?," TNNI3K is highly expressed in heart, but is undetectable in other tissues.",1
1281,14,Is TNNI3K a cardiac-specific protein?,Immunohistochemical analysis predominantly localized TNNI3K in the nucleus of cardiac myocytes.,1
1560,0,Which molecule is targeted by a monoclonal antibody Secukinumab?,We identified 3 distinct clonotypes that efficiently neutralized IL17A in a cell-based in vitro assay.,0
1560,1,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Their potencies were comparable to those of known neutralizing antibodies, including 2, AIN457 (secukinumab) and ixekizumab that are currently in clinical development for the treatment of various inflammatory disorders.",0
1560,2,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Secukinumab, a fully human anti-IL-17A monoclonal antibody, neutralizes IL-17A, a key cytokine in the pathogenesis of psoriasis.",1
1560,3,Which molecule is targeted by a monoclonal antibody Secukinumab?,BACKGROUND: Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.,1
1560,4,Which molecule is targeted by a monoclonal antibody Secukinumab?,"BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.",1
1560,5,Which molecule is targeted by a monoclonal antibody Secukinumab?,"We evaluated secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis.",1
1560,6,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Ustekinumab (a monoclonal antibody directed against the common p40 subunit of IL-23 and IL-12), secukinumab, ixekizumab (both monoclonal antibodies directed against IL-17A), and brodalumab a monoclonal antibody against the IL-17RA receptor) have been recently used in proof-of-concept and randomized trials in the ankylosing spondylitis and/or psoriatic arthritis subforms of SpA, with overall very promising clinical efficacy.",0
1560,7,Which molecule is targeted by a monoclonal antibody Secukinumab?,The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.,0
1560,8,Which molecule is targeted by a monoclonal antibody Secukinumab?,"The family of interleukin 17 receptors (IL17Rs), subtypes IL17RA-IL17RE, is targeted by the group of pro-inflammatory IL17 cytokines (IL17A-F) and moreover the newly developed anti-IL17A antibody secukinumab (AIN457) has shown promise in Phase II trials in multiple sclerosis.",0
1560,9,Which molecule is targeted by a monoclonal antibody Secukinumab?," Three agents neutralizing IL-17 (i.e., secukinumab and ixekizumab) or antagonizing its receptor (i.e., brodalumab) are currently being tested for efficacy and safety in the treatment of plaque psoriasis and PsA.",0
1560,10,Which molecule is targeted by a monoclonal antibody Secukinumab?,Secukinumab is a fully human IgG1 monoclonal antibody that selectively binds and neutralizes IL-17A whose efficacy in the therapy of chronic plaque psoriasis has been demonstrated in different phase II clinical trial.,0
1560,11,Which molecule is targeted by a monoclonal antibody Secukinumab?,Associations between IGA 0/1 responder rates and PASI scores were evaluated using data from two phase 2 studies with the anti-interleukin (IL)-17A monoclonal antibody secukinumab (AIN457) that utilized a similar 6-point IGA.,0
1560,12,Which molecule is targeted by a monoclonal antibody Secukinumab?," Several IL-17A inhibitors have advanced into clinical trials, including the anti-IL-17A monoclonal antibodies, secukinumab and ixekizumab, and the anti-17RA monoclonal antibody brodalumab.",0
1560,13,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.",0
1560,14,Which molecule is targeted by a monoclonal antibody Secukinumab?,We assessed the efficacy and safety of the anti-IL-17A monoclonal antibody secukinumab in treating patients with active ankylosing spondylitis.,0
1560,15,Which molecule is targeted by a monoclonal antibody Secukinumab?,"In a proof-of-concept study for the treatment of patients with Crohn's disease, secukinumab, a monoclonal antibody directed against IL-17A, was ineffective and associated with more adverse events than placebo.",0
1560,16,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Several IL-17A blockers, including the anti-IL-17A monoclonal antibodies secukinumab and ixekizumab, and the anti-IL-17 receptor subunit A monoclonal antibody brodalumab have been evaluated in phase II clinical trials.",0
1560,17,Which molecule is targeted by a monoclonal antibody Secukinumab?,Further studies are needed to clarify whether the therapeutic blockade of IL-17A through the anti-IL-17A monoclonal antibody secukinumab is able to counteract the fibrogenic process in CD.,0
1560,18,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Th-17A antagonism has been investigated by a randomized controlled trial in PsA patients with secukinumab, a fully human, high-affinity, monoclonal antibody in a cohort of patients with active PsA.",0
1560,19,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial.",0
1560,20,Which molecule is targeted by a monoclonal antibody Secukinumab?,"OBJECTIVE: To evaluate the efficacy and safety of secukinumab, a fully human, anti-interleukin (IL)-17A monoclonal antibody, in patients with psoriatic arthritis (PsA).",1
1560,21,Which molecule is targeted by a monoclonal antibody Secukinumab?,"PURPOSE: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A blockade, in patients with noninfectious uveitis.",0
1560,22,Which molecule is targeted by a monoclonal antibody Secukinumab?,Effect of IL-17A blockade with secukinumab in autoimmune diseases.,0
1560,23,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Early clinical data are now available on secukinumab (AIN457), a recombinant, highly selective, fully human monoclonal anti-IL-17A antibody of the IgG1/κ isotype, enabling a preliminary assessment of the effects of IL-17A inhibition in multiple autoimmune diseases.",0
1560,24,Which molecule is targeted by a monoclonal antibody Secukinumab?,"In conjunction with studies using the humanised anti-IL-17A monoclonal antibody (mAb) ixekizumab (LY2439821) and the fully human anti-IL-17RA mAb brodalumab (AMG 827), the findings on secukinumab provide evidence for the role of IL-17A in the pathophysiology of autoimmune disease and suggest the potential value of targeting this cytokine.",0
1560,25,Which molecule is targeted by a monoclonal antibody Secukinumab?,"OBJECTIVES: To assess the efficacy and safety of different doses of secukinumab, a fully human anti-IL-17A IgG1κ monoclonal antibody, in patients with moderate-to-severe plaque psoriasis.",0
1560,26,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.",0
1560,27,Which molecule is targeted by a monoclonal antibody Secukinumab?,Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.,0
1560,28,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Blockade of IL-17A by secukinumab does not appear to interfere with efficacy of influenza and meningococcal vaccinations, as assessed by the achievement of protective antibody levels.",0
1560,29,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.",0
1560,30,Which molecule is targeted by a monoclonal antibody Secukinumab?,OBJECTIVE: The authors tested whether the anti-interleukin (IL)-17A monoclonal antibody secukinumab was safe and effective for the treatment of active Crohn's disease.,0
1560,31,Which molecule is targeted by a monoclonal antibody Secukinumab?,Secukinumab is an IL-17A monoclonal antibody that is under development and preliminary results have suggested its efficacy in inflammatory mediated diseases such as psoriasis and ankylosing spondylitis.,0
1560,32,Which molecule is targeted by a monoclonal antibody Secukinumab?,Promising recent Phase II results on the anti-IL-17A antibody secukinumab (AIN457) are outlined and a short update on tabalumab (LY2127399) is given,0
1560,33,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Several IL-17A inhibitors have advanced into clinical trials, including the anti-IL-17A monoclonal antibodies, secukinumab and ixekizumab, and the anti-17RA monoclonal antibody brodalumab",0
1560,34,Which molecule is targeted by a monoclonal antibody Secukinumab?,"Several IL-17A blockers, including the anti-IL-17A monoclonal antibodies secukinumab and ixekizumab, and the anti-IL-17 receptor subunit A monoclonal antibody brodalumab have been evaluated in phase II clinical trials",0
3477,0,How is transcriptional elongation affected by nucleosome positioning?,Nucleosome arrays inhibit both initiation and elongation of transcripts,1
3477,1,How is transcriptional elongation affected by nucleosome positioning?," Both transcript initiation and elongation were inhibited, the extent of the inhibition being directly proportional to the number of nucleosome cores reconstituted onto the pT207-18 DNA templates.",1
3477,2,How is transcriptional elongation affected by nucleosome positioning?,neither partial nor complete dissociation of the histone octamer is essential for transcription elongation through arrays of nucleosome cores in vitro.,0
3477,3,How is transcriptional elongation affected by nucleosome positioning?,The high affinity of histones for single-stranded DNA observed in titration experiments performed using the purified (+) and (-) strands of the NX1 fragment suggests that nucleosome dissociation is not due to the formation of segments of single-stranded DNA by RNA polymerase in the elongation process,0
3477,4,How is transcriptional elongation affected by nucleosome positioning?,"These effects are especially pronounced on chromatin templates, where both transcription initiation and elongation are virtually halted.",1
3477,5,How is transcriptional elongation affected by nucleosome positioning?,The inhibition of transcription elongation appears to result from a dramatic increase in premature termination of transcripts.,0
3477,6,How is transcriptional elongation affected by nucleosome positioning?,"By using this system, we show that BRG1, the enzymatic motor of the SWI-SNF chromatin-remodelling complex, is recruited to the positioned nucleosome in a transcription elongation-dependent manner and facilitates traversal of the nucleosome by RNAPII.",1
3477,7,How is transcriptional elongation affected by nucleosome positioning?,"in order to elongate their products, both DNA and RNA polymerases must be able to overcome the inhibition presented by chromatin",1
3477,8,How is transcriptional elongation affected by nucleosome positioning?," We suggest a three-step model in which nucleosome remodelers, general transcription factors, and the transcriptional elongation machinery are primarily involved in generating the nucleosome positioning pattern in vivo.",0
3477,9,How is transcriptional elongation affected by nucleosome positioning?,The independent effect of lack of TFIIS on nucleosome occupancy and fuzziness supports the existence of alternative chromatin dynamics during transcription elongation.,0
3156,0,What are super-enhancers,"Super-enhancers are large clusters of enhancers covering the long region of regulatory DNA and are densely occupied by transcription factors, active histone marks, and co-activators.",1
3156,1,What are super-enhancers,"Accumulating evidence points to the critical role that super-enhancers play in cell type-specific development and differentiation, as well as in the development of various diseases.",1
2921,0,What is the normal function p53?,"The three p53 family members, p53, p63 and p73, are structurally similar and share many biochemical activities.",1
2921,1,What is the normal function p53?,"Yet, along with their common fundamental role in protecting genomic fidelity, each has acquired distinct functions related to diverse cell autonomous and non-autonomous processes.",0
2921,2,What is the normal function p53?,The tumor suppressor p53 is a key regulator of apoptosis induced by various cellular stresses.,1
2921,3,What is the normal function p53?,Direct functional restoration of p53 as a transcription factor has been difficult to achieve in the clinic.,1
2921,4,What is the normal function p53?,The tumour suppressor gene TP53 is the most frequently mutated gene in cancer.,1
2921,5,What is the normal function p53?,Wild-type p53 can suppress tumour development by multiple pathways.,1
4134,0,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,Elementary flux modes (EFMs) analysis constitutes a fundamental tool in systems biology.,0
4134,1,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,"However, the efficient calculation of EFMs in genome-scale metabolic networks (GSMNs) is still a challenge.",1
4134,2,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,"We present a novel algorithm that uses a linear programming-based tree search and efficiently enumerates a subset of EFMs in GSMNs.RESULTS: Our approach is compared with the EFMEvolver approach, demonstrating a significant improvement in computation time.",1
4134,3,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,We also validate the usefulness of our new approach by studying the acetate overflow metabolism in the Escherichia coli bacteria.,0
4134,4,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,"To do so, we computed 1 million EFMs for each energetic amino acid and then analysed the relevance of each energetic amino acid based on gene/protein expression data and the obtained EFMs.",0
4134,5,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,We found good agreement between previous experiments and the conclusions reached using EFMs.,0
4134,6,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,"Finally, we also analysed the performance of our approach when applied to large GSMNs.AVAILABILITY AND IMPLEMENTATION: The stand-alone software TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solver (CLP).",1
4134,7,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,"Elementary flux modes (EFMs) are a key tool for analyzing genome-scale metabolic networks, and several methods have been proposed to compute them.",1
4134,8,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,"Among them, those based on solving linear programming (LP) problems are known to be very efficient if the main interest lies in computing large enough sets of EFMs.RESULTS: Here, we propose a new method called EFM-Ta that boosts the efficiency rate by analyzing the information provided by the LP solver.",1
4134,9,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,We base our method on a further study of the final tableau of the simplex method.,0
4134,10,Which methods exist for efficient calculation of Elementary flux modes (EFMs) in genome-scale metabolic networks (GSMNs)?,"By performing additional elementary steps and avoiding trivial solutions consisting of two cycles, we obtain many more EFMs for each LP problem posed, improving the efficiency rate of previously proposed methods by more than one order of magnitude.",0
435,0,What is the molecular function of psoralen photobinding on DNA?,"The interaction of two water-soluble furocoumarins, 8-(omega-diethyl aminopropyloxy)psoralen hydrochloride (I) and its 5-isomer (II), with DNA has been investigated by spectroscopic, equilibrium dialysis, hydrodynamic and chiroptical techniques.",1
435,1,What is the molecular function of psoralen photobinding on DNA?,Both compounds intercalate into the polynucleotide double helix.,1
435,2,What is the molecular function of psoralen photobinding on DNA?,"Both compounds bind very efficiently to DNA, the extent of this process being modulated by the nature of substituents at position 8",1
435,3,What is the molecular function of psoralen photobinding on DNA?,"We have described an exonuclease III/photoreversal procedure to map, with base pair resolution, the bases which have photoreacted with 4,5',8-trimethylpsoralen (Me3-psoralen) forming either monoadducts or interstrand cross-links in DNA (20)",0
435,4,What is the molecular function of psoralen photobinding on DNA?,"Psoralen and light treatment removed negative superhelical turns, and extensive treatments failed to produce positive superhelical turns in covalently closed plasmid DNA.",0
435,5,What is the molecular function of psoralen photobinding on DNA?,"Like psoralen, these compounds form a molecular complex with DNA, undergoing intercalation inside the double helix of the macromolecule",1
435,6,What is the molecular function of psoralen photobinding on DNA?,"The crystal and molecular structure of 4,4&apos;,5&apos;-trimethylazapsoralen, obtained by X ray diffraction, was also reported.",0
435,7,What is the molecular function of psoralen photobinding on DNA?,"Like psoralen, these compounds form a molecular complex with DNA, undergoing intercalation inside the double helix of the macromolecule.",1
2701,0,What is the H4S47C cleavage mapping method used for?,"To identify nucleosomes with alternative structures genome-wide, we used H4S47C-anchored cleavage mapping, which revealed that 5% of budding yeast (Saccharomyces cerevisiae) nucleosome positions have asymmetric histone-DNA interactions.",1
2701,1,What is the H4S47C cleavage mapping method used for?,"Micrococcal nuclease (MNase) sequence-based profiles of asymmetric nucleosome positions revealed a corresponding asymmetry in MNase protection near the dyad axis, suggesting that the loss of DNA contacts around H4S47 is accompanied by protection of the DNA from MNase.",0
2701,2,What is the H4S47C cleavage mapping method used for?,"To resolve this controversy, we have applied H4S47C-anchored cleavage mapping, which reveals the precise position of histone H4 in every nucleosome in the genome.",1
2701,3,What is the H4S47C cleavage mapping method used for?," To map fission yeast centromeres, we applied H4S47C-anchored cleavage mapping and native and cross-linked chromatin immunoprecipitation with paired-end sequencing.",1
2701,4,What is the H4S47C cleavage mapping method used for?,"We find that cleavage patterns at centromeres are unique within the genome and are incompatible with symmetrical structures, including octameric nucleosomes and (Cse4/H4)2 tetrasomes.",1
2701,5,What is the H4S47C cleavage mapping method used for?,"Centromere cleavage patterns are compatible with a precisely positioned core structure, one in which each of the 16 yeast centromeres is occupied by oppositely oriented Cse4/H4/H2A/H2B hemisomes in two rotational phases within the population.",0
2701,6,What is the H4S47C cleavage mapping method used for?,"H3 nucleosomes are nearly absent from the central domain, which is occupied by centromere-specific H3 (cenH3 or CENP-A) nucleosomes with two H4s per particle that are mostly unpositioned and are more widely spaced than nucleosomes elsewhere.",0
2701,7,What is the H4S47C cleavage mapping method used for?,"To resolve this controversy, we have applied H4S47C-anchored cleavage mapping, which reveals the precise position of histone H4 in every nucleosome in the genome.",1
2701,8,What is the H4S47C cleavage mapping method used for?,"Centromere cleavage patterns are compatible with a precisely positioned core structure, one in which each of the 16 yeast centromeres is occupied by oppositely oriented Cse4/H4/H2A/H2B hemisomes in two rotational phases within the population.",0
2701,9,What is the H4S47C cleavage mapping method used for?,"We find that cleavage patterns at centromeres are unique within the genome and are incompatible with symmetrical structures, including octameric nucleosomes and (Cse4/H4)2 tetrasomes.",0
3615,0,Which disorders are caused by de novo mutations in ZSWIM6?,A Recurrent De Novo Nonsense Variant in ZSWIM6 Results in Severe Intellectual Disability without Frontonasal or Limb Malformations.,1
3615,1,Which disorders are caused by de novo mutations in ZSWIM6?,"A recurrent de novo missense variant within the C-terminal Sin3-like domain of ZSWIM6 was previously reported to cause acromelic frontonasal dysostosis (AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome, associated with neurocognitive and motor delay, via a proposed gain-of-function effect.",1
3615,2,Which disorders are caused by de novo mutations in ZSWIM6?,We show that the c.2737C>T variant does not trigger nonsense-mediated decay of the ZSWIM6 mRNA in affected individual-derived cells.,0
3615,3,Which disorders are caused by de novo mutations in ZSWIM6?,"This finding supports the existence of a truncated ZSWIM6 protein lacking the Sin3-like domain, which could have a dominant-negative effect.",0
3615,4,Which disorders are caused by de novo mutations in ZSWIM6?,"This study builds support for a key role for ZSWIM6 in neuronal development and function, in addition to its putative roles in limb and craniofacial development, and provides a striking example of different variants in the same gene leading to distinct phenotypes.",0
3615,5,Which disorders are caused by de novo mutations in ZSWIM6?,Exome sequencing identifies a recurrent de novo ZSWIM6 mutation associated with acromelic frontonasal dysostosis.,0
3615,6,Which disorders are caused by de novo mutations in ZSWIM6?,"Acromelic frontonasal dysostosis (AFND) is a rare disorder characterized by distinct craniofacial, brain, and limb malformations, including frontonasal dysplasia, interhemispheric lipoma, agenesis of the corpus callosum, tibial hemimelia, preaxial polydactyly of the feet, and intellectual disability.",0
3615,7,Which disorders are caused by de novo mutations in ZSWIM6?,"Exome sequencing of one trio and two unrelated probands revealed the same heterozygous variant (c.3487C>T [p. Arg1163Trp]) in a highly conserved protein domain of ZSWIM6; this variant has not been seen in the 1000 Genomes data, dbSNP, or the Exome Sequencing Project.",0
3615,8,Which disorders are caused by de novo mutations in ZSWIM6?,Sanger validation of the three trios confirmed that the variant was de novo and was also present in a fourth isolated proband.,0
3615,9,Which disorders are caused by de novo mutations in ZSWIM6?,"In situ hybridization of early zebrafish embryos at 24 hr postfertilization (hpf) demonstrated telencephalic expression of zswim6 and onset of midbrain, hindbrain, and retinal expression at 48 hpf.",0
3615,10,Which disorders are caused by de novo mutations in ZSWIM6?,Immunohistochemistry of later-stage mouse embryos demonstrated tissue-specific expression in the derivatives of all three germ layers.,0
3615,11,Which disorders are caused by de novo mutations in ZSWIM6?,"qRT-PCR expression analysis of osteoblast and fibroblast cell lines available from two probands was suggestive of Hedgehog pathway activation, indicating that the ZSWIM6 mutation associated with AFND may lead to the craniofacial, brain and limb malformations through the disruption of Hedgehog signaling.",0
3615,12,Which disorders are caused by de novo mutations in ZSWIM6?,"A recurrent de novo missense variant within the C-terminal Sin3-like domain of ZSWIM6 was previously reported to cause acromelic frontonasal dysostosis (AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome, associated with neurocognitive and motor delay, via a proposed gain-of-function effect.",1
3615,13,Which disorders are caused by de novo mutations in ZSWIM6?,We present detailed phenotypic information on seven unrelated individuals with a recurrent de novo nonsense variant (c.2737C>T [p.Arg913Ter]) in the penultimate exon of ZSWIM6 who have severe-profound intellectual disability and additional central and peripheral nervous system symptoms but an absence of frontonasal or limb malformations.,1
3615,14,Which disorders are caused by de novo mutations in ZSWIM6?,Exome sequencing identifies a recurrent de novo ZSWIM6 mutation associated with acromelic frontonasal dysostosis .,0
3615,15,Which disorders are caused by de novo mutations in ZSWIM6?,"A recurrent de novo missense variant within the C-terminal Sin3-like domain of ZSWIM6 was previously reported to cause acromelic frontonasal dysostosis (AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome, associated with neurocognitive and motor delay, via a proposed gain-of-function effect.",1
3615,16,Which disorders are caused by de novo mutations in ZSWIM6?,"A single recurrent heterozygous missense substitution in ZSWIM6, encoding a protein of unknown function, was previously shown to underlie this disorder in four unrelated cases.",0
4105,0,What methodology does the HercepTest use?, The expression of HER2 was determined by immunohistochemistry (IHC) using DAKO-HercepTest™ and gene amplification with DuoCISH using a DAKO-DuoCISH kit.,1
2251,0,What is measured through the NOMe-Seq methodology?,"Using Nucleosome Occupancy Methylome- Sequencing, NOMe-Seq, a single-molecule, high-resolution nucleosome positioning assay, we demonstrate that active, but not inactive, non-CpG island promoters display a nucleosome-depleted region (NDR) immediately upstream of the transcription start site (TSS).",1
2251,1,What is measured through the NOMe-Seq methodology?," Using Nucleosome Occupancy Methylome- Sequencing, NOMe-Seq, a single-molecule, high-resolution nucleosome positioning assay, we demonstrate that active, but not inactive, non-CpG island promoters display a nucleosome-depleted region (NDR) immediately upstream of the transcription start site (TSS)",1
2251,2,What is measured through the NOMe-Seq methodology?,"According to our genome-wide expression and DNA methylation profiles, we find that the complete re-activation of silenced genes requires the insertion of the histone variant H2A.Z, which facilitates the acquisition of regions fully depleted of nucleosome as demonstrated by NOMe-seq (Nucleosome Occupancy Methylome-sequencing) assay.",0
2251,3,What is measured through the NOMe-Seq methodology?,We have developed a method (NOMe-seq) that uses a GpC methyltransferase (M.CviPI) and next generation sequencing to generate a high resolution footprint of nucleosome positioning genome-wide using less than 1 million cells while retaining endogenous DNA methylation information from the same DNA strand.,1
2251,4,What is measured through the NOMe-Seq methodology?,Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules.,0
2251,5,What is measured through the NOMe-Seq methodology?,"Importantly, NOMe-seq obtains DNA methylation and nucleosome positioning information from the same DNA molecule, giving the first genome-wide DNA methylation and nucleosome positioning correlation at the single molecule, and thus, single cell level, that can be used to monitor disease progression and response to therapy.",1
2251,6,What is measured through the NOMe-Seq methodology?,"Here, we evaluate the scope of global epigenetic alterations at enhancers and insulator elements in prostate and breast cancer cells using simultaneous genome-wide mapping of DNA methylation and nucleosome occupancy (NOMe-seq).",0
2251,7,What is measured through the NOMe-Seq methodology?,Nucleosome Occupancy and Methylome sequencing (NOMe-seq) was used to determine the allele-specific positioning of nucleosomes around heterozygous splice site mutations in lymphoblastoid cells lines (LCLs) derived from six Lynch syndrome patients.,0
2251,8,What is measured through the NOMe-Seq methodology?,To address this we used Nucleosome Occupancy and Methylation sequencing (NOMe-seq) to compare the genome-wide DNA methylation and nucleosome occupancy profiles between normal and cancer cell line models of the breast and prostate.,0
2251,9,What is measured through the NOMe-Seq methodology?,"Here we describe the bioinformatic pipeline and methods that we developed for the processing and analysis of the NOMe-seq data published by (Taberlay et al., 2014 [1]) and deposited in the Gene Expression Omnibus with accession GSE57498.",0
2251,10,What is measured through the NOMe-Seq methodology?,"The NOMe-seq accessibility assay unexpectedly revealed symmetrical and transcription-independent nucleosomal phasing across active, poised, and inactive genomic elements.",0
2251,11,What is measured through the NOMe-Seq methodology?,"TEPIC can be applied to various open-chromatin data, e.g.",0
2251,12,What is measured through the NOMe-Seq methodology?,DNaseI-seq and NOMe-seq.,0
2251,13,What is measured through the NOMe-Seq methodology?,"Finally, these scores correctly predict known transcriptional regulators as illustrated by the application to novel DNaseI-seq and NOMe-seq data for primary human hepatocytes and CD4+ T-cells, respectively.",0
2251,14,What is measured through the NOMe-Seq methodology?,"Recently, Methyltransferase Accessibility Protocol for individual templates-Bisulfite Genome Sequencing (MAPit-BGS) and nucleosome occupancy and methylome sequencing (NOMe-seq) have been developed for simultaneously profiling chromatin accessibility and DNA methylation on single molecules.",0
2251,15,What is measured through the NOMe-Seq methodology?,Here I adapted Nucleosome Occupancy and Methylome-sequencing (NOMe-seq) to measure chromatin accessibility and endogenous DNA methylation in single cells (scNOMe-seq).,1
2251,16,What is measured through the NOMe-Seq methodology?,"Recently, Methyltransferase Accessibility Protocol for individual templates-Bisulfite Genome Sequencing (MAPit-BGS) and nucleosome occupancy and methylome sequencing (NOMe-seq) have been developed for simultaneously profiling chromatin accessibility and DNA methylation on single molecules.",0
2251,17,What is measured through the NOMe-Seq methodology?,"We develop a statistical method, epiG, to infer and differentiate between different epi-allelic haplotypes, annotated with CpG methylation status and DNA polymorphisms, from whole-genome bisulfite sequencing data, and nucleosome occupancy from NOMe-seq data.",0
2251,18,What is measured through the NOMe-Seq methodology?,"In this study, we make progress toward understanding these conflicting phenomena by implementing a bioinformatics approach that combines MNase-seq and NOMe-seq data and by comprehensively profiling DNA methylation and nucleosome occupancy throughout the human genome.",0
2251,19,What is measured through the NOMe-Seq methodology?,Nucleosome Occupancy and Methylome sequencing (NOMe-seq) was used to determine the allele-specific positioning of nucleosomes around heterozygous splice site mutations in lymphoblastoid cells lines (LCLs) derived from six Lynch syndrome patients.,0
2251,20,What is measured through the NOMe-Seq methodology?,"Here, we evaluate the scope of global epigenetic alterations at enhancers and insulator elements in prostate and breast cancer cells using simultaneous genome-wide mapping of DNA methylation and nucleosome occupancy (NOMe-seq).",0
3082,0,List two drugs that are included in the Akynzeo pill?,"OBJECTIVES: To review the latest antiemetic guideline recommendations and provide an update on the use of NEPA, a fixed combination antiemetic composed of the neurokinin-1 receptor antagonist (RA) netupitant and the 5-hydroxytryptamine-3 RA palonosetron (Akynzeo®).",0
3082,1,List two drugs that are included in the Akynzeo pill?,An oral fixed combination of netupitant/palonosetron (NEPA; Akynzeo(®)) with >85% antiemetic efficacy is available for use in the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV).,1
3082,2,List two drugs that are included in the Akynzeo pill?,An oral fixed combination of netupitant/palonosetron (NEPA; Akynzeo(®)) is available for use in the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV).,1
3082,3,List two drugs that are included in the Akynzeo pill?,Ledipasvir/sofosbuvir (Harvoni) for hepatitis C virus genotype 1 infection; dulaglutide (Trulicity) for glycemic control in type-2 diabetes; netupitant/palonosetron (Akynzeo) for prevention of nausea and vomiting related to chemotherapy; and naloxegol (Movantik) for opioid-induced constipation in patients with chronic noncancer pain.,1
3082,4,List two drugs that are included in the Akynzeo pill?,Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting.An oral fixed combination of netupitant/palonosetron (NEPA; Akynzeo(®)) is available for use in the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV).,1
3082,5,List two drugs that are included in the Akynzeo pill?,Pharmaceutical approval update.Ledipasvir/sofosbuvir (Harvoni) for hepatitis C virus genotype 1 infection; dulaglutide (Trulicity) for glycemic control in type-2 diabetes; netupitant/palonosetron (Akynzeo) for prevention of nausea and vomiting related to chemotherapy; and naloxegol (Movantik) for opioid-induced constipation in patients with chronic noncancer pain.,1
1439,0,What is the mode of inheritance in Fanconi anemia?,"Fanconi anemia (FA) is a rare inherited syndrome with diverse clinical symptoms including developmental defects, short stature, bone marrow failure, and a high risk of malignancies.",1
1439,1,What is the mode of inheritance in Fanconi anemia?,Fifteen genetic subtypes have been distinguished so far.,0
1439,2,What is the mode of inheritance in Fanconi anemia?,"The mode of inheritance for all subtypes is autosomal recessive, except for FA-B, which is X-linked",1
1439,3,What is the mode of inheritance in Fanconi anemia?,Fanconi anemia (FA) is a recessively inherited syndrome with predisposition to bone marrow failure and malignancies,1
1439,4,What is the mode of inheritance in Fanconi anemia?,"Original Fanconi anemia data, for which no information about the ascertainment was available, were then analyzed, with results that confirmed a monogenic autosomal recessive mode of inheritance",0
1439,5,What is the mode of inheritance in Fanconi anemia?,"The formal genetics of Fanconi's anemia were investigated on the basis of 21 families from different European countries, and of 69 families from the literature.",0
1439,6,What is the mode of inheritance in Fanconi anemia?,CONCLUSIONS: 1.,0
1439,7,What is the mode of inheritance in Fanconi anemia?,The result of segregation analysis is compatible with the hypothesis of a simple autosomal recessive mode of inheritance,0
1439,8,What is the mode of inheritance in Fanconi anemia?," Original Fanconi anemia data, for which no information about the ascertainment was available, were then analyzed, with results that confirmed a monogenic autosomal recessive mode of inheritance.",0
1439,9,What is the mode of inheritance in Fanconi anemia?,X-linked inheritance of Fanconi anemia complementation group B.,0
1439,10,What is the mode of inheritance in Fanconi anemia?,"Fanconi anemia (FA) is a rare genetic disease with both autosomal and X-linked inheritance, characterized by genomic instability.",0
1439,11,What is the mode of inheritance in Fanconi anemia?, X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B.,0
1439,12,What is the mode of inheritance in Fanconi anemia?,"Original Fanconi anemia data, for which no information about the ascertainment was available, were then analyzed, with results that confirmed a monogenic autosomal recessive mode of inheritance.",0
1439,13,What is the mode of inheritance in Fanconi anemia?,"Fanconi anemia (FA), a recessive syndrome with both autosomal and X-linked inheritance, features diverse clinical symptoms, such as progressive bone marrow failure, hypersensitivity to DNA cross-linking agents, chromosomal instability and susceptibility to cancer.",0
1439,14,What is the mode of inheritance in Fanconi anemia?,X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B.,0
1439,15,What is the mode of inheritance in Fanconi anemia?,Its presence as a single active copy and essentiality for a functional Fanconi anemia-BRCA pathway make FANCB a potentially vulnerable component of the cellular machinery that maintains genomic integrity.,0
1439,16,What is the mode of inheritance in Fanconi anemia?,"Fanconi anemia (FA) is a rare genetic disease, transmitted in an autosomal recessive mode.",0
1439,17,What is the mode of inheritance in Fanconi anemia?,Report of two early-onset cases with Fanconis anemia-like phenotypes suggesting an autosomal-recessive inheritance pattern.,0
1439,18,What is the mode of inheritance in Fanconi anemia?,"In the first family, an association with Fanconis anemia was observed in three of seven pregnancies (2 boys, 1 girl) suggesting an autosomal recessive mode of transmission.",0
1439,19,What is the mode of inheritance in Fanconi anemia?,"The mode of inheritance for all subtypes is autosomal recessive, except for FA-B, which is X-linked.",1
1439,20,What is the mode of inheritance in Fanconi anemia?,X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B.,0
1439,21,What is the mode of inheritance in Fanconi anemia?,"The mode of inheritance for all subtypes is autosomal recessive, except for FA-B, which is X-linked",1
1439,22,What is the mode of inheritance in Fanconi anemia?,"In the first family, an association with Fanconi's anemia was observed in three of seven pregnancies (2 boys, 1 girl) suggesting an autosomal recessive mode of transmission",0
1439,23,What is the mode of inheritance in Fanconi anemia?,X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B,0
1439,24,What is the mode of inheritance in Fanconi anemia?,"Fanconi anemia (FA) is a rare genetic disease, transmitted in an autosomal recessive mode",0
691,0,Do lincRNAs play a role in human cancer?,Long non-coding RNA H19 increases bladder cancer metastasis,0
691,1,Do lincRNAs play a role in human cancer?,These data suggest that upregulated H19 enhances bladder cancer metastasis by associating with EZH2 and inhibiting E-cad expression,0
691,2,Do lincRNAs play a role in human cancer?,lncRNA H19 is essential for human tumor growth,0
691,3,Do lincRNAs play a role in human cancer?,"Previous reports have demonstrated that HOTAIR associates with chromatin modifications in cooperation with the Polycomb complex PRC2, and promotes breast and colorectal cancer metastasis",0
691,4,Do lincRNAs play a role in human cancer?,"although the clinical significance of HOTAIR expression in HCC may not be as pronounced as that in breast and colorectal cancers, the current study demonstrates that HOTAIR expression is associated with HCC progression, warranting further studies.",1
691,5,Do lincRNAs play a role in human cancer?,Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival,1
691,6,Do lincRNAs play a role in human cancer?,Long non-coding RNA influences radiosensitivity of colorectal carcinoma cell lines by regulating cyclin D1 expression,0
691,7,Do lincRNAs play a role in human cancer?,"Long non-coding RNA urothelial carcinoma associated 1 (UCA1) promotes human bladder cancer cell proliferation, but the underlying mechanism remains unknown",0
691,8,Do lincRNAs play a role in human cancer?,UCA1 regulated cell cycle through CREB via PI3K-AKT dependent pathway in bladder cancer.,0
691,9,Do lincRNAs play a role in human cancer?,Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells,0
691,10,Do lincRNAs play a role in human cancer?,"overexpression of Yiya promotes cell cycle progression at the G1/S transition, therefore identifying Yiya as a cell-cycle-associated long non-coding RNA",0
691,11,Do lincRNAs play a role in human cancer?,The long noncoding RNA HOTAIR has been reported as a poor prognostic biomarker in patients with breast cancer.,0
691,12,Do lincRNAs play a role in human cancer?,The aim of the present study is to examine the expression pattern of HOTAIR in hepatocellular carcinoma (HCC) and its clinical significance as well as its biological role in tumor progression,1
691,13,Do lincRNAs play a role in human cancer?,The high expression level of HOTAIR in HCC could be a candidate biomarker for predicting tumor recurrence in HCC patients who have undergone liver transplant therapy and might be a potential therapeutic target,0
691,14,Do lincRNAs play a role in human cancer?,Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene,1
691,15,Do lincRNAs play a role in human cancer?,"A 42 kb region on human chromosome 9p21 encodes for three distinct tumor suppressors, p16(INK4A), p14(ARF) and p15(INK4B), and is altered in an estimated 30-40% of human tumors",1
691,16,Do lincRNAs play a role in human cancer?,These results advance our understanding of the role of lncRNA-LET as a regulator of hypoxia signaling and offer new avenues for therapeutic intervention against cancer progression.,0
691,17,Do lincRNAs play a role in human cancer?,Silencing MALAT1 is a potential novel therapeutic approach for this cancer.,0
764,0,Is insulin-like growth factor-I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients?,Tendon protein synthesis rate in classic Ehlers-Danlos patients can be stimulated with insulin-like growth factor-I,1
764,1,Is insulin-like growth factor-I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients?,IGF-I injections significantly increased FSR values in cEDS patients but not in controls,1
764,2,Is insulin-like growth factor-I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients?,"In conclusion, baseline protein synthesis rates in connective tissue appeared normal in cEDS patients, and the patients responded with an increased tendon protein synthesis rate to IGF-I injections",1
764,3,Is insulin-like growth factor-I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients?,"In conclusion, baseline protein synthesis rates in connective tissue appeared normal in cEDS patients, and the patients responded with an increased tendon protein synthesis rate to IGF-I injections",1
764,4,Is insulin-like growth factor-I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients?,IGF-I injections significantly increased FSR values in cEDS patients but not in controls (delta values: cEDS 0,1
3982,0,When did eptinezumab get its first FDA approval?," In February 2020, eptinezumab was approved in the USA for the preventive treatment of migraine in adults.",1
3982,1,When did eptinezumab get its first FDA approval?,"In February 2020, eptinezumab was approved in the USA for the preventive treatment of migraine in adults.",1
129,0,Is amantadine effective for treatment of disorders conciousness?,"We here provide a systematic overview of the therapeutic effects of amantadine, apomorphine and zolpidem in patients recovering from coma.",0
129,1,Is amantadine effective for treatment of disorders conciousness?,"Evidence from clinical trials using these commonly prescribed pharmacological agents suggests positive changes in the neurological status in patients, leading sometimes to dramatic improvements.",0
129,2,Is amantadine effective for treatment of disorders conciousness?,"Pharmaceuticals that act in the oxygen based amino acid systems of the brain include the GABAergic medications zolpidem and baclofen, while those that act in the monoamine axes include the dopaminergic medications L Dopa, amantadine, bromocriptine, apomorphine and methylphenidate, and the noradrenergic and serotonergic medications desipramine, amitriptyline, protriptyline and fluoxetine.",0
129,3,Is amantadine effective for treatment of disorders conciousness?,"Sporadic cases of recovery from a DOC have been reported after the administration of various pharmacological agents (baclofen, zolpidem, amantadine etc.",0
129,4,Is amantadine effective for treatment of disorders conciousness?,).,0
129,5,Is amantadine effective for treatment of disorders conciousness?,Amantadine hydrochloride is one of the most commonly prescribed medications for patients with prolonged disorders of consciousness after traumatic brain injury.,1
129,6,Is amantadine effective for treatment of disorders conciousness?,Preliminary studies have suggested that amantadine may promote functional recovery.,0
129,7,Is amantadine effective for treatment of disorders conciousness?," During the 4-week treatment period, recovery was significantly faster in the amantadine group than in the placebo group, as measured by the DRS score (difference in slope, 0.24 points per week; P=0.007), indicating a benefit with respect to the primary outcome measure.",0
129,8,Is amantadine effective for treatment of disorders conciousness?,Amantadine accelerated the pace of functional recovery during active treatment in patients with post-traumatic disorders of consciousness.,1
129,9,Is amantadine effective for treatment of disorders conciousness?,"Sporadic cases of dramatic recovery from DOC after the administration of various pharmacological agents, such as baclofen, zolpidem and amantadine, have been recently supported by intriguing scientific observations.",0
129,10,Is amantadine effective for treatment of disorders conciousness?,"According to the 16 eligible studies, medical management by dopaminergic agents (levodopa, amantadine), zolpidem and median nerve stimulation, or surgical management by deep brain stimulation, extradural cortical stimulation, spinal cord stimulation and intrathecal baclofen have shown to improve the level of consciousness in certain cases.",0
129,11,Is amantadine effective for treatment of disorders conciousness?,Higher exposure of amantadine (average concentration of amantadine during 6 mg/kg/day > 1.5 mg/L) may be associated with better recovery of consciousness.,1
129,12,Is amantadine effective for treatment of disorders conciousness?,"Based on the preliminary data, higher dosing may be considered in the setting of brain injury.",1
129,13,Is amantadine effective for treatment of disorders conciousness?,Patients treated with PK-Merz exhibited the more significant restoration of consciousness and better dynamics (regress) of neurological deficit with the most intensive restoration of neurological deficit in the first day that allows to recommend the use of amantadine sulfate in the first hours of ischemic stroke and for the prevention of reperfusion damage in recanalisation therapy of ischemic stroke.,1
129,14,Is amantadine effective for treatment of disorders conciousness?,"There was no significant difference in the slopes of recovery during either arm for the Coma/Near-Coma Scale (P = 0.24) or the Coma Recovery Scale-Revised (P = 0.28), although improvements in consciousness were noted by the physician during weeks when amantadine was given (P = 0.02).",0
129,15,Is amantadine effective for treatment of disorders conciousness?,This study suggests that amantadine facilitates recovery of consciousness in pediatric acquired brain injury and provides important information necessary to design future more definitive studies.,0
129,16,Is amantadine effective for treatment of disorders conciousness?,"The study has shown a positive effect of this drug at coma emergence, which manifested itself as clinical improvement and a better outcome of the disease.",0
129,17,Is amantadine effective for treatment of disorders conciousness?,"This article will review the evidence for the use of psychostimulants (methylphenidate), antidepressants (amitriptyline, selective serotonin reuptake inhibitors, and buproprion), Parkinson's medications (amantadine, bromocriptine, carbidopa/levodopa), anticonvulsants (valproic acid), modafinil (Provigil), lactate, hyperbaric oxygen chamber, electroconvulsive therapy, and transmagnetic stimulation, in patients following a head injury.",0
129,18,Is amantadine effective for treatment of disorders conciousness?,"Of the psychoactive medications, amantadine hydrochloride was associated with greater recovery and dantrolene sodium was associated with less recovery, in terms of the DRS score at 16 weeks but not the time until commands were followed.",0
595,0,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,The discovery of biallelic BRCA2 mutations in the FA-D1 complementation group allows for the first time to study the characteristics of primary BRCA2-deficient human cells.,0
595,1,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,"Although he lacked a strong family history of cancer, he was subsequently shown to carry biallelic mutations in the FANCD1/BRCA2 gene.",1
595,2,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,"These included an IVS7 splice-site mutation, which is strongly associated with early AML in homozygous or compound heterozygous carrier status in FA-D1 patients.",0
595,3,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,Biallelic BRCA2 mutations were shown recently to cause FA-D1.,0
595,4,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1),1
595,5,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,"One kindred, of Ashkenazi Jewish ancestry, had five members who were diagnosed with breast cancer and two cousins who were BRCA2*6174delT/C3069X compound heterozygotes and had Fanconi anemia and brain tumors",0
595,6,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,"In another kindred of Ashkenazi Jewish and Lithuanian Catholic ancestry, a child with Fanconi anemia and a medulloblastoma was a BRCA2*6174delT/886delGT compound heterozygote",0
595,7,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; one child was of Latin American ancestry and a compound heterozygote for BRCA2*I2490T/ 5301insA and the other was African American and a compound heterozygote for BRCA2*Q3066X/E1308X,0
595,8,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,"Surprisingly, biallelic mutations in the BRCA2 breast-cancer-susceptibility gene were found in Fanconi anemia (FA), a rare hereditary disorder characterized by chromosomal instability, hypersensitivity to DNA cross-linking agents, and cancer susceptibility",1
595,9,Which is the genetic cause for the development of Fanconi anemia complementation group D1?, The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1).,1
595,10,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,Biallelic mutations in Fanconi anemia complementation group genes disrupt DNA repair and result in the complex Fanconi anemia phenotype.,1
595,11,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,"Thirteen complementation groups and genes are identified, including BRCA2, which is defective in the FA-D1 group.",0
595,12,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,Biallelic BRCA2 mutations were shown recently to cause FA-D1.,0
595,13,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,Biallelic BRCA2 mutations were shown recently to cause FA-D1,0
595,14,Which is the genetic cause for the development of Fanconi anemia complementation group D1?,"Thirteen complementation groups and genes are identified, including BRCA2, which is defective in the FA-D1 group",0
3387,0,Has ZP-PTH been tested in a phase II clinical trial?,This system was successfully tested in a Phase 2 clinical trial for the treatment of post-menopausal women with osteoporosis.,1
1091,0,In which genomic positions is the histone variant macroH2A enriched?,"Although macroH2A1 nucleosomes are widely distributed across the genome, their local concentration varies over a range of 100-fold or more",0
1091,1,In which genomic positions is the histone variant macroH2A enriched?,"The transcribed regions of most active genes are depleted of macroH2A1, often in sharply localized domains that show depletion of 4-fold or more relative to bulk mouse liver chromatin",1
1091,2,In which genomic positions is the histone variant macroH2A enriched?,"This repressor activity is further supported by the substantial and relatively uniform macroH2A1 enrichment along the inactive X chromosome, which averages 4-fold",1
1091,3,In which genomic positions is the histone variant macroH2A enriched?,mH2A1 consistently colocalizes with a heterochromatin marker (H3K27me2; histone H3 trimethylated at lysine 27) and mH2A2 with a euchromatin marker (H3K4me3; histone H3 trimethylated at lysine 4),0
1091,4,In which genomic positions is the histone variant macroH2A enriched?,"Similar results were found for the L41gene, with enrichment of mH2A in the promoter region.",0
1091,5,In which genomic positions is the histone variant macroH2A enriched?,"By using highly specific antibodies against mH2A1 and stable HEK 293 cell lines expressing either green fluorescent protein (GFP)-mH2A1 or GFP-H2A, we found that the Xi chromosome contains approximately 1.5-fold more mH2A1 than the autosomes",0
1091,6,In which genomic positions is the histone variant macroH2A enriched?,The data show that mH2A1 is uniformly distributed across the entire Xi chromosome.,0
1091,7,In which genomic positions is the histone variant macroH2A enriched?,"Interestingly, a stronger mH2A1 enrichment along the pseudoautosomal X chromosome region was observed in both sexes.",0
1091,8,In which genomic positions is the histone variant macroH2A enriched?,"macroH2A1 nucleosomes were enriched on endogenous MLVs, with the highest enrichment occurring on the 5' end of pro-pol",0
1091,9,In which genomic positions is the histone variant macroH2A enriched?,"macroH2A1 is enriched on the inactive X chromosome in female mammalian cells, where it functions to maintain gene silencing.",1
1091,10,In which genomic positions is the histone variant macroH2A enriched?,We found that macroH2A1 was depleted on the transcribed regions of active genes,1
1091,11,In which genomic positions is the histone variant macroH2A enriched?,"In contrast, macroH2A1 was concentrated on the inactive X chromosome, consistent with our previous immunofluorescence studies.",0
1091,12,In which genomic positions is the histone variant macroH2A enriched?,These results support the hypothesis that macroH2As function as transcriptional repressors,0
1091,13,In which genomic positions is the histone variant macroH2A enriched?,Taking into account the properties of macroH2A toward chromatin structure and dynamics and its role in gene repression our data suggest that the increased expression of macroH2A and the hypermethylation of DNA which occurs upon winter-acclimatization plays a major role for the reorganization of chromatin structure and the regulation of gene expression during the physiological adaptation to a colder environment,0
1091,14,In which genomic positions is the histone variant macroH2A enriched?,"Inactivation is a multistep process that involves a large non-coding RNA termed XIST, a variety of epigenetic modifications of chromatin, and alterations in protein composition such as enrichment of the histone variant macroH2A",0
1091,15,In which genomic positions is the histone variant macroH2A enriched?,One of several features acquired by chromatin of the inactive X chromosome (Xi) is enrichment for the core histone H2A variant macroH2A within a distinct nuclear structure referred to as a macrochromatin body (MCB),0
1091,16,In which genomic positions is the histone variant macroH2A enriched?,"In addition to localizing to the MCB, macroH2A accumulates at a perinuclear structure centered at the centrosome",1
1091,17,In which genomic positions is the histone variant macroH2A enriched?,The centrosomal pool of macroH2A1 accumulates in the presence of an inhibitor of the 20S proteasome.,0
1091,18,In which genomic positions is the histone variant macroH2A enriched?,"Although the MCB dissipates during late S phase and G2 before reforming in late G1, macroH2A1 remains associated during mitosis with specific regions of the Xi, including at the X inactivation center",0
3896,0,List the core lung matrisome proteins.,"LGALS7, ASPN, HSP90AA1 and HSP90AB1.",1
3896,1,List the core lung matrisome proteins.," COL1A1, SCGB1A1, TAGLN, PSEN2, TSPAN1, CTSB, AGR2, CSPG2, and SERPINB3,",1
3896,2,List the core lung matrisome proteins., The remodeling of the scaffold was characterized by an initial phase with cell proliferation and high production of cell adhesion proteins such as emilin-1 and fibronectin.,1
3896,3,List the core lung matrisome proteins.,"f proteoglycans, such as versican and decorin",1
2065,0,How are triple negative gliomas characterized?,"According to IDH, TP53, and 1p19q status, four major subtypes of LGG are recorded: IDH+/p53-/1p19q-, IDH+/p53+/1p19q-, IDH+/p53-/1p19q+ and triple negative, this last subgroup having the worst prognosis.",1
2065,1,How are triple negative gliomas characterized?,"Low-grade gliomas were accurately classified into four groups: group 1, IDH+/p53-/1p19q-; group 2, IDH+/p53-/1p19q+; group 3, IDH+/p53+/1p19q-; and group 4, triple negative gliomas.",1
2065,2,How are triple negative gliomas characterized?,"Among 615 grade II or III gliomas, 29% had all three alterations (i.e., were triple-positive), 5% had TERT and IDH mutations, 45% had only IDH mutations, 7% were triple-negative, and 10% had only TERT mutations; 5% had other combinations.",1
2065,3,How are triple negative gliomas characterized?,"Among 472 grade IV gliomas, less than 1% were triple-positive, 2% had TERT and IDH mutations, 7% had only IDH mutations, 17% were triple-negative, and 74% had only TERT mutations",0
2065,4,How are triple negative gliomas characterized?,"Three of these markers - 1p/19q deletions, MGMT methylation status, and mutations in the IDH1 gene - are so potent that a new brain tumor subtype, the ""triple negative"" glioma (1p/19q intact, MGMT unmethylated, IDH1 non-mutated) has entered common parlance",1
2065,5,How are triple negative gliomas characterized?,"Few data are available in the literature regarding the relationship between IDH mutations and HIF expression in low-grade gliomas (LGGs), especially in a recently described aggressive molecular subtype: ""triple negative"" (IDH non mutated, 1p 19q non codeleted, p53 expression negative) gliomas.",0
2065,6,How are triple negative gliomas characterized?,"Low-grade gliomas were accurately classified into four groups: group 1, IDH+/p53-/1p19q-; group 2, IDH+/p53-/1p19q+; group 3, IDH+/p53+/1p19q-; and group 4, triple negative gliomas.",0
2065,7,How are triple negative gliomas characterized?,"Three of these markers - 1p/19q deletions, MGMT methylation status, and mutations in the IDH1 gene - are so potent that a new brain tumor subtype, the ""triple negative"" glioma (1p/19q intact, MGMT unmethylated, IDH1 non-mutated) has entered common parlance.",1
2065,8,How are triple negative gliomas characterized?,"Low-grade gliomas were accurately classified into four groups: group 1, IDH+/p53-/1p19q-; group 2, IDH+/p53-/1p19q+; group 3, IDH+/p53+/1p19q-; and group 4, triple negative gliomas",0
2065,9,How are triple negative gliomas characterized?,"Low-grade gliomas were accurately classified into four groups: group 1, IDH+/p53-/1p19q-; group 2, IDH+/p53-/1p19q+; group 3, IDH+/p53+/1p19q-; and group 4, triple negative gliomas.",0
2065,10,How are triple negative gliomas characterized?,"Few data are available in the literature regarding the relationship between IDH mutations and HIF expression in low-grade gliomas (LGGs), especially in a recently described aggressive molecular subtype: ""triple negative"" (IDH non mutated, 1p 19q non codeleted, p53 expression negative) gliomas.",0
2942,0,What is the mechanism of action of anlotinib?,"Anlotinib, a multi-kinase inhibitor, has already shown antitumor effects in various types of carcinoma in a phase I clinical trial.",0
2942,1,What is the mechanism of action of anlotinib?,"OBJECTIVES: AL3818 (anlotinib) is a receptor tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFR1, VEGFR2/KDR, and VEGFR3), stem cell factor receptor (C-kit), platelet-derived growth factor (PDGFβ), and fibroblast growth factor receptors (FGFR1, FGFR2, and FGFR3).",1
2942,2,What is the mechanism of action of anlotinib?,"In the present study, we detailed the pharmacological properties of anlotinib, a highly potent and selective VEGFR2 inhibitor, in preclinical models.",0
2942,3,What is the mechanism of action of anlotinib?,"In this research, we demonstrated that anlotinib, a potent multi-tyrosine kinases inhibitor (TKI), showed a significant inhibitory effect on VEGF/PDGF-BB/FGF-2-induced angiogenesis in vitro and in vivo.",0
2942,4,What is the mechanism of action of anlotinib?,"Wound healing assay, chamber directional migration assay and tube formation assay indicated that anlotinib inhibited VEGF/PDGF-BB/FGF-2-induced cell migration and formation of capillary-like tubes in endothelial cells.",0
2942,5,What is the mechanism of action of anlotinib?,"Mechanistically, anlotinib inhibits the activation of VEGFR2, PDGFRβ and FGFR1 as well their common downstream ERK signaling.",0
2942,6,What is the mechanism of action of anlotinib?,"Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1.",0
2942,7,What is the mechanism of action of anlotinib?,"BACKGROUND: Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumour angiogenesis and proliferative signalling.",0
2942,8,What is the mechanism of action of anlotinib?,"Anlotinib is a novel TKI targeting the vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and c-Kit.",1
2942,9,What is the mechanism of action of anlotinib?,"The tolerability profile of anlotinib is similar to that of other tyrosine kinase inhibitors that target VEGFR and other tyrosine kinase-mediated pathways; however, anlotinib has a significantly lower incidence of grade 3 or higher side effects compared to that of sunitinib.",0
2942,10,What is the mechanism of action of anlotinib?,"Importance
Anlotinib is a novel multitarget tyrosine kinase inhibitor for tumor angiogenesis and proliferative signaling.",0
2942,11,What is the mechanism of action of anlotinib?,"OBJECTIVES
Anlotinib is a novel multi-target tyrosine Kinase inhibitor that inhibits VEGFR2/3, FGFR1-4, PDGFD α/β, c-Kit and Ret.",0
2942,12,What is the mechanism of action of anlotinib?,"BACKGROUND
Anlotinib is a novel multi-target tyrosine kinase inhibitor that is designed to primarily inhibit VEGFR2/3, FGFR1-4, PDGFR α/β, c-Kit, and Ret.",0
2942,13,What is the mechanism of action of anlotinib?,Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development.,0
2942,14,What is the mechanism of action of anlotinib?,"Anlotinib is a new, orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptors (PDGFR), and c-kit.",1
2942,15,What is the mechanism of action of anlotinib?,"BACKGROUND
Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumour angiogenesis and proliferative signalling.",0
2942,16,What is the mechanism of action of anlotinib?,"Collectively, these results indicate that anlotinib is a well-tolerated, orally active VEGFR2 inhibitor that targets angiogenesis in tumor growth, and support ongoing clinical evaluation of anlotinib for a variety of malignancies.",0
2942,17,What is the mechanism of action of anlotinib?,Anlotinib occupied the ATP-binding pocket of VEGFR2 tyrosine kinase and showed high selectivity and inhibitory potency (IC50 <1 nmol/L) for VEGFR2 relative to other tyrosine kinases.,0
2942,18,What is the mechanism of action of anlotinib?,"Although anlotinib, a multi-targeted receptor tyrosine kinase inhibitor has been reported have antitumor effects in many preclinical and clinical trials, little is known about its effect on hepatocellular carcinoma (HCC).",0
2942,19,What is the mechanism of action of anlotinib?,Importance Anlotinib is a novel multitarget tyrosine kinase inhibitor for tumor angiogenesis and proliferative signaling.,1
2942,20,What is the mechanism of action of anlotinib?,"Anlotinib is an oral small molecule inhibitor of multiple receptor tyrosine kinases, with a broad spectrum of inhibitory effects on tumour angiogenesis and growth.",0
2942,21,What is the mechanism of action of anlotinib?,"BACKGROUND Anlotinib is a novel multi-target tyrosine kinase inhibitor that is designed to primarily inhibit VEGFR2/3, FGFR1-4, PDGFR α/β, c-Kit, and Ret.",0
2942,22,What is the mechanism of action of anlotinib?,"OBJECTIVES Anlotinib is a novel multi-target tyrosine Kinase inhibitor that inhibits VEGFR2/3, FGFR1-4, PDGFD α/β, c-Kit and Ret.",0
2942,23,What is the mechanism of action of anlotinib?,"BACKGROUND Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumour angiogenesis and proliferative signalling.",0
2942,24,What is the mechanism of action of anlotinib?,"<b>OBJECTIVES</b>: Anlotinib is a novel multi-target tyrosine Kinase inhibitor that inhibits VEGFR2/3, FGFR1-4, PDGFD α/β, c-Kit and Ret.",0
2942,25,What is the mechanism of action of anlotinib?,"The tolerability profile of anlotinib is similar to that of other tyrosine kinase inhibitors that target VEGFR and other tyrosine kinase-mediated pathways; however, anlotinib has a significantly lower incidence of grade 3 or higher side effects compared to that of sunitinib.",0
2942,26,What is the mechanism of action of anlotinib?,"In this research, we demonstrated that anlotinib, a potent multi-tyrosine kinases inhibitor (TKI), showed a significant inhibitory effect on VEGF/PDGF-BB/FGF-2-induced angiogenesis in vitro and in vivo.",0
2942,27,What is the mechanism of action of anlotinib?,"Anlotinib is a novel multi-target tyrosine Kinase inhibitor that inhibits VEGFR2/3, FGFR1-4, PDGFD α/β, c-Kit and Ret.",1
2942,28,What is the mechanism of action of anlotinib?,"Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species.",0
717,0,"What are the characteristics of the ""Universal Proteomics Standard 2"" (UPS2)?",the UPS2 proteomic dynamic range standard introduced by The Association of Biomolecular Resource Facilities Proteomics Standards Research Group in 2006),1
717,1,"What are the characteristics of the ""Universal Proteomics Standard 2"" (UPS2)?",Universal Proteomics Standard sample with a dynamic range of 5 orders of magnitude (UPS2).,1
807,0,Is transcapillary  albumin escape altered in diabetic patients?,"On the contrary, altered TERalb and increased carotid artery intimal thickness are shown by all hypertensive type 2 diabetic patients, both with normal and altered patterns of AER.",1
807,1,Is transcapillary  albumin escape altered in diabetic patients?,Altered systemic capillary permeability characterizes insulin-resistant hypertensive patients with Metabolic Syndrome.,1
807,2,Is transcapillary  albumin escape altered in diabetic patients?,TERalb is increased in normo-albuminuric type 1 diabetic patients.,1
1732,0,What is the association between number of pregnancies and rheumatoid arthritis,"In this unique population, greater parity significantly reduced the odds of RA;",1
1732,1,What is the association between number of pregnancies and rheumatoid arthritis,"an early age at first birth increased the odds, and the postpartum period was confirmed as high risk for RA onset.",0
1732,2,What is the association between number of pregnancies and rheumatoid arthritis,The protective effect of repeated exposure to the ameliorating hormonal and immunological changes of pregnancy may counterbalance the effect of early exposure to the postpartum reversal of these changes.,0
1732,3,What is the association between number of pregnancies and rheumatoid arthritis,We found an inverse correlation between the number of pregnancies and age at onset of RA,1
1732,4,What is the association between number of pregnancies and rheumatoid arthritis,"A larger number of pregnancies and late menopause show a protective effect, delaying the onset of the disease.",1
1732,5,What is the association between number of pregnancies and rheumatoid arthritis,"Since the landmark study on rheumatoid arthritis, many reports have suggested that physiological changes during pregnancy often induce remission of systemic and cutaneous inflammatory diseases.",0
1732,6,What is the association between number of pregnancies and rheumatoid arthritis,"Literature review shows that at best, there are weak negative associations between current estrogen use and RA, and no association with nulliparity and infertility.",0
1732,7,What is the association between number of pregnancies and rheumatoid arthritis,"It appears that infertility, the number of pregnancies, and pregnancy outcome are not strongly associated with the risk of developing RA in women of childbearing age.",1
1732,8,What is the association between number of pregnancies and rheumatoid arthritis,"However, in this study there may have been selection biases in the women with RA and the controls that differentially could have affected their reproductive outcomes.",0
1732,9,What is the association between number of pregnancies and rheumatoid arthritis,"Thus, a true association could have been missed.",0
1732,10,What is the association between number of pregnancies and rheumatoid arthritis,Most other published studies find no association between nulliparity and RA.,0
1732,11,What is the association between number of pregnancies and rheumatoid arthritis,"Number of pregnancies and children, however, were significantly higher in controls",1
2050,0,Is Dupilumab used for treatment of atopic dermatitis?,"Dupilumab has demonstrated efficacy in patients with asthma and atopic dermatitis, which are both type 2 helper T-cell-mediated diseases.",1
2050,1,Is Dupilumab used for treatment of atopic dermatitis?,"Background Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of atopic or allergic diseases such as atopic dermatitis.",0
2050,2,Is Dupilumab used for treatment of atopic dermatitis?,Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.,1
2050,3,Is Dupilumab used for treatment of atopic dermatitis?,"Dupilumab is a biologic agent targeted at TH2 cytokines, but indirectly impacts IgE and is an important biologic agent for atopic disease.",0
2050,4,Is Dupilumab used for treatment of atopic dermatitis?,Dupilumab for the treatment of atopic dermatitis: A clinical trial review.,1
2050,5,Is Dupilumab used for treatment of atopic dermatitis?,Dupilumab is a novel monoclonal antibody that was recently studied in adult patients with moderate-to-severe AD.,0
2050,6,Is Dupilumab used for treatment of atopic dermatitis?,Patients treated with dupilumab had marked and rapid improvement in all the evaluated measures of atopic dermatitis disease activity.,1
2050,7,Is Dupilumab used for treatment of atopic dermatitis?,"The robust effects of dupilumab on skin inflammation and pruritus confirm the pathogenic role of IL-4 and IL-13 signaling in adult AD, and further support the application of Th2 cytokine antagonists in the treatment of this disease.",1
412,0,"How long, in kb (kilobases),  is a ""Long interspersed nuclear element""?", A combination of molecular hybridization studies and long-range polymerase chain reaction was used to isolate a 6-kb full-length long interspersed nuclear element (LINE or L1),1
412,1,"How long, in kb (kilobases),  is a ""Long interspersed nuclear element""?","LINE (7kb long interspersed nuclear element),",1
412,2,"How long, in kb (kilobases),  is a ""Long interspersed nuclear element""?","The retrotransposon known as long interspersed nuclear element-1 (L1) is 6 kb long, although most L1s in mammalian and other eukaryotic cells are truncated.",1
2117,0,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,We studied 15 LGS patients (mean age ± 1 standard deviation [SD] = 28.7 ± 10.6 years) and 17 healthy controls (mean age ± 1 SD = 27.6 ± 6.6 years),0
2117,1,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?, children with Lennox-Gastaut syndrome,0
2117,2,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"Lennox-Gastaut syndrome (LGS) is a severe pediatric epilepsy syndrome characterized by mixed seizures, cognitive decline, and generalized slow (<3 Hz) spike wave discharges on electroencephalography",1
2117,3,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"Clinical course and results of therapy were analysed in the group of 92 children, aged between 3 and 9 years, with diagnosed Lennox-Gastaut syndrome.",0
2117,4,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"We report the case of a 27-year-old man with a neurodevelopmental syndrome due to a 15q duplication, with intellectual disability, psychiatric disturbances, and an epileptic phenotype diagnosed as late-onset Lennox-Gastaut syndrome.",0
2117,5,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"Lennox-Gastaut syndrome is a relatively rare epilepsy syndrome that usually begins in early-mid childhood and is characterized by multiple seizure types, particularly generalized seizures, which are often resistant to antiepileptic drug medication",1
2117,6,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"Lennox-Gastaut Syndrome is a severe childhood epilepsy syndrome characterised by the diagnostic triad of a slow spike and wave pattern on electroencephalogram, multiple seizure types and developmental delay",1
2117,7,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"We report the case of a 27-year-old man with a neurodevelopmental syndrome due to a 15q duplication, with intellectual disability, psychiatric disturbances, and an epileptic phenotype diagnosed as late-onset Lennox-Gastaut syndrome..",0
2117,8,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"The Lennox-Gastaut syndrome, a severe form of epilepsy that usually begins in early childhood, is difficult to treat.",1
2117,9,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"Lennox-Gastaut syndrome is a relatively rare epilepsy syndrome that usually begins in early-mid childhood and is characterized by multiple seizure types, particularly generalized seizures, which are often resistant to antiepileptic drug medication.",1
2117,10,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"The Lennox-Gastaut syndrome is an age-specific disorder, characterised by epileptic seizures, a characteristic electroencephalogram (EEG), psychomotor delay and behaviour disorders.",0
2117,11,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,"It occurs more frequently in males and onset is usually before the age of eight, with a peak between three and five years.",0
2117,12,Is Lennox-Gastaut Syndrome usually diagnosed in older adults?,Late cases occurring in adolescence and early adulthood have rarely been reported.,0
295,0,List three major features of the CCFDN syndrome.,"Because of our experience in neuromuscular disorders, we choose six, frequent, autosomal recessive disorders for these clinical and genetic studies: hereditary motor and sensory neuropathy type Lom (HMSNL), hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts facial dysmorphism syndrome (CCFDN), limb-girdle muscular dystrophy 2C (LGMD2C), congenital myasthenic syndrome (CMS) and spinal muscular atrophy (SMA).",0
295,1,List three major features of the CCFDN syndrome.,The congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome (OMIM 604168) is a recently described autosomal recessive developmental disorder.,0
295,2,List three major features of the CCFDN syndrome.,"Congenital cataracts-facial dysmorphism-neuropathy syndrome (CCFDN, MIM: 604168), is a recently delineated neurogenetic disease causing recurrent episodes of rhabdomyolysis; prevention and early diagnosis of rhabdomyolysis should be part of the clinical management of the disease.",0
295,3,List three major features of the CCFDN syndrome.,Congenital Cataracts Facial Dysmorphism Neuropathy (CCFDN) syndrome is a complex developmental disorder of autosomal recessive inheritance.,0
295,4,List three major features of the CCFDN syndrome.,OBJECTIVE: To determine the nature and course of ophthalmologic abnormalities in congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome in a genetically verified group of 9 patients.,0
295,5,List three major features of the CCFDN syndrome.,Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome (OMIM 604168) is an autosomal recessive developmental disorder that occurs in an endogamous group of Vlax Roma (Gypsies; refs.,0
295,6,List three major features of the CCFDN syndrome.,1-3).,0
295,7,List three major features of the CCFDN syndrome.,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, facial dysmorphism and peripheral neuropathy (CCFDN), which is localised to 18qter.",1
295,8,List three major features of the CCFDN syndrome.,"The CCFDN syndrome is a complex phenotype involving multiple systems, characterized by facial dysmorphism, congenital cataracts, microcorneae, delayed early motor and intellectual development, hypogonadotrop hypogonadism, hypomyelination of the peripheral nervous system, and serious complications related to general anaesthesia.",1
295,9,List three major features of the CCFDN syndrome.,"Developmental abnormalities include congenital cataracts and microcorneae, primary hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, mild facial dysmorphism and hypogonadism.",1
295,10,List three major features of the CCFDN syndrome.,Para-infectious rhabdomyolysis is a serious complication reported in an increasing number of patients.,0
295,11,List three major features of the CCFDN syndrome.,"CONCLUSIONS: Early-onset congenital cataracts associated with microcornea, microphthalmos, and micropupil are essential ocular features of the CCFDN syndrome and are the first recognizable signs during early infancy.",1
295,12,List three major features of the CCFDN syndrome.,"All patients showed a peripheral, demyelinating neuropathy and varying degrees of ataxia.",0
295,13,List three major features of the CCFDN syndrome.,"In the older patients, muscular atrophy in distal muscles and facial dysmorphism was evident.",0
295,14,List three major features of the CCFDN syndrome.,"Early-onset bilateral congenital cataracts associated with microcornea, microphthalmos, and micropupil could be found in all patients.",0
295,15,List three major features of the CCFDN syndrome.,All children had floppy eyelid syndrome and pseudoptosis.,0
295,16,List three major features of the CCFDN syndrome.,All patients had syndrome-associated nystagmus and congenital esotropia.,0
295,17,List three major features of the CCFDN syndrome.,"Distant visual acuity could be classified as severe to moderate impairment, whereas near visual acuity was much better (mild to moderate impairment).",0
295,18,List three major features of the CCFDN syndrome.,"Because these families originated from the same genetically isolated founder population as did patients with congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome, and because the two syndromes have clinical manifestations in common, we hypothesized that the two related, albeit distinct, syndromes may represent clinical variants of a single genetic disorder.",0
295,19,List three major features of the CCFDN syndrome.,Peripheral nerve abnormalities in the congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome.,0
295,20,List three major features of the CCFDN syndrome.,Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome: a novel developmental disorder in Gypsies maps to 18qter.,0
295,21,List three major features of the CCFDN syndrome.,We propose to refer to the syndrome as congenital cataracts facial dysmorphism neuropathy (CCFDN).,0
295,22,List three major features of the CCFDN syndrome.,The disorder has been termed the congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome to emphasize its salient features.,0
295,23,List three major features of the CCFDN syndrome.,Associated neurological features are a moderate nonprogressive cognitive deficit in most affected individuals together with pyramidal signs and mild chorea in some.,0
295,24,List three major features of the CCFDN syndrome.,"Accompanying nonneurological features include short stature, characteristic facial dysmorphism, and hypogonadotrophic hypogonadism.",0
295,25,List three major features of the CCFDN syndrome.,"Nerve conduction studies suggest a hypomyelinating/demyelinating neuropathy, confirmed by nerve biopsy.",0
295,26,List three major features of the CCFDN syndrome.,Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome: a rare cause of parainfectious rhabdomyolysis.,0
295,27,List three major features of the CCFDN syndrome.,"CONCLUSIONS: Early-onset congenital cataracts associated with microcornea, microphthalmos, and micropupil are essential ocular features of the CCFDN syndrome and are the first recognizable signs during early infancy.",0
295,28,List three major features of the CCFDN syndrome.,The disorder has been termed the congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome to emphasize its salient features.,0
295,29,List three major features of the CCFDN syndrome.,"Because these families originated from the same genetically isolated founder population as did patients with congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome, and because the two syndromes have clinical manifestations in common, we hypothesized that the two related, albeit distinct, syndromes may represent clinical variants of a single genetic disorder.",0
295,30,List three major features of the CCFDN syndrome.,"Congenital cataracts-facial dysmorphism-neuropathy syndrome (CCFDN, MIM: 604168), is a recently delineated neurogenetic disease causing recurrent episodes of rhabdomyolysis; prevention and early diagnosis of rhabdomyolysis should be part of the clinical management of the disease",0
295,31,List three major features of the CCFDN syndrome.,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, facial dysmorphism and peripheral neuropathy (CCFDN), which is localised to 18qter",1
472,0,How do Hsp70 and Hsp110 affect mRNA stability?,Mammalian Hsp70 and Hsp110 proteins bind to RNA motifs involved in mRNA stability,1
472,1,How do Hsp70 and Hsp110 affect mRNA stability?,Hsp/Hsc70 and Hsp110 proteins preferentially bound AU-rich RNA in vitro,1
472,2,How do Hsp70 and Hsp110 affect mRNA stability?,certain heat shock proteins may act as RNA-binding entities in vivo to guide the appropriate folding of RNA substrates for subsequent regulatory processes such as mRNA degradation and/or translation,1
472,3,How do Hsp70 and Hsp110 affect mRNA stability?,Mammalian Hsp70 and Hsp110 proteins bind to RNA motifs involved in mRNA stability.,1
4031,0,Was golimumab tested for diabetes?,"CONCLUSIONS: Among children and young adults with newly diagnosed overt type 1 diabetes, golimumab resulted in better endogenous insulin production and less exogenous insulin use than placebo.",1
4031,1,Was golimumab tested for diabetes?,Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.,1
4031,2,Was golimumab tested for diabetes?,"lticenter, placebo-controlled, double-blind, parallel-group trial, we randomly assigned, in a 2:1 ratio, children and young adults (age range, 6 to 21 years) with newly diagnosed overt type 1 diabetes to receive subcutaneous golimumab or placebo for 52 weeks.",1
4031,3,Was golimumab tested for diabetes?,The primary end point was e,1
4031,4,Was golimumab tested for diabetes?,Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes,1
75,0,List side effects of SGLT2 inhibitors?,"Due to side effects such as urinary tract and genital infections and decrease in blood pressure, proper patient selection for drug initiation and close monitoring will be important.",1
75,1,List side effects of SGLT2 inhibitors?,"Urogenital side-effects related to the enhanced glycosuria can be troublesome, yet seldom lead to discontinuation.",1
75,2,List side effects of SGLT2 inhibitors?,"Promotion of urinary loss of glucose by SGLT2 inhibitors embodies a new principle of control in type 2 diabetes that has several advantages with some urogenital side-effects, both of which are evaluated in this review.",0
75,3,List side effects of SGLT2 inhibitors?,"Promotion of urinary loss of glucose by SGLT2 inhibitors embodies a new principle of control in type 2 diabetes that has several advantages with some urogenital side-effects, both of which are evaluated in this review",0
75,4,List side effects of SGLT2 inhibitors?,Effect of SGLT2 inhibitors in a murine model of urinary tract infection with Candida albicans.,1
75,5,List side effects of SGLT2 inhibitors?,"Promotion of urinary loss of glucose by SGLT2 inhibitors embodies a new principle of control in type 2 diabetes that has several advantages with some urogenital side-effects,",1
75,6,List side effects of SGLT2 inhibitors?,"Urogenital side-effects related to the enhanced glycosuria can be troublesome, yet seldom lead to discontinuation.",1
75,7,List side effects of SGLT2 inhibitors?,"Promotion of urinary loss of glucose by SGLT2 inhibitors embodies a new principle of control in type 2 diabetes that has several advantages with some urogenital side-effects, both of which are evaluated in this review.",0
75,8,List side effects of SGLT2 inhibitors?,There are some side effects that warrant further investigation and establishing whether SGLT2 inhibition provides a renal benefit relies on future long-term studies with specific renal end-points.,0
75,9,List side effects of SGLT2 inhibitors?,"It should be noted that the currently approved agents have side effects that include an increased incidence of genital infections, predominantly in women.",0
867,0,Are psammoma bodies characteristic to meningiomas?,"Psammoma bodies (PBs) are concentric lamellated calcified structures, observed most commonly in papillary thyroid carcinoma (PTC), meningioma, and papillary serous cystadenocarcinoma of ovary but have rarely been reported in other neoplasms and nonneoplastic lesions.",1
867,1,Are psammoma bodies characteristic to meningiomas?,"Studies on serous cystadenocarcinoma of ovary and meningioma, however, revealed that collagen production by neoplastic cells and subsequent calcification was responsible for the formation of PBs.",0
867,2,Are psammoma bodies characteristic to meningiomas?,"The existence of some precursor forms of PBs was reported in meningiomas and more recently in PTC, which were mostly in the form of extracellular hyaline globules surrounded by well-preserved neoplastic cells or in a smaller number of cases intracytoplasmic bodies liberated from intact tumor cells.",0
867,3,Are psammoma bodies characteristic to meningiomas?,"Light microscopy revealed abundant microcysts of varied size throughout the tumor tissue with the presence of whorl formation and psammoma body, but no malignancy was indicated.",0
867,4,Are psammoma bodies characteristic to meningiomas?,"Electron microscopy further demonstrated interdigitation of the neighboring cell membranes, desmosomes, and intracytoplasmic filaments, which are pathognomonic findings of meningiomas.",0
867,5,Are psammoma bodies characteristic to meningiomas?,"Unlike SFT, FMs were glycogen-containing and variously exhibited a storiform pattern (13 of 20), psammoma body formation (9 of 20), and calcification of collagen (4 of 20).",0
867,6,Are psammoma bodies characteristic to meningiomas?,"Immunoreactivities included vimentin (100%), focal to patchy EMA (80%), S-100 protein (80%), collagen IV (25%), and patchy, mild-to-moderate CD34 staining (60%).",0
867,7,Are psammoma bodies characteristic to meningiomas?,"In contrast to the inner structure, three-dimensional structure of psammona bodies in meningiomas is not well defined.",0
867,8,Are psammoma bodies characteristic to meningiomas?,"This study examined three cultured meningiomas, in which surface observation of psammoma bodies might be easier than in the tumor tissues since influence of interposing connective tissue is minimized in tissue culture.",1
867,9,Are psammoma bodies characteristic to meningiomas?,"The results suggest that psammoma bodies in meningiomas arise in part from meningothelial whorls due to collagen production by tumor cells followed by obliteration and disappearance of tumor cell processes, although some of the alternative pathways for psammoma body formation proposed by other investigators cannot be ruled out by this study.",0
867,10,Are psammoma bodies characteristic to meningiomas?,To demonstrate that psammoma bodies in human meningiomas contain type VI collagen and laminin.,1
867,11,Are psammoma bodies characteristic to meningiomas?,This is the first report to describe the involvement of type VI collagen in psammoma bodies and whorl formations in meningiomas.,1
867,12,Are psammoma bodies characteristic to meningiomas?,Calcification such as psammoma body is sometimes found especially in spinal cord meningioma but ossification of the meningeal tumor was rarely observed.,0
867,13,Are psammoma bodies characteristic to meningiomas?,Histological diagnosis was transitional meningioma with psammoma body.,0
867,14,Are psammoma bodies characteristic to meningiomas?,"In this study we analyzed the morphologic and ultrastructural characteristics of the psammoma bodies in ten meningiomas of different histologic subtypes, characterizing the components of the psammoma body and the elements of the tumor, such as the capillaries and degenerative cells that have been classically considered as initiators of the formation of these calcareous is structures.",0
867,15,Are psammoma bodies characteristic to meningiomas?,"It is concluded that the mineralization of the psammoma bodies is induced principally by the collagen fibers synthesized by the meningocytes and that the form of mineralization is spherical and growth is radial, controlled by the tumoral cells.",0
867,16,Are psammoma bodies characteristic to meningiomas?,CSF cytology revealed benign fibroblastic or meningotheliomatous meningioma with whorl formation and psammoma body.,0
867,17,Are psammoma bodies characteristic to meningiomas?,Electron microscopic examination of the calculi showed membrane-bound vesicles and radially precipitated crystals that simulated hydroxyapatite of psammoma body in meningioma.,0
867,18,Are psammoma bodies characteristic to meningiomas?,Psammoma bodies in meningiomas resembled those in the choroid plexus stroma.,0
867,19,Are psammoma bodies characteristic to meningiomas?,"The results of this study suggest that psammoma bodies in the choroid plexus, as in meningiomas, form by a process of dystrophic calcification associated with arachnoid cells and collagen fibres.",0
867,20,Are psammoma bodies characteristic to meningiomas?,An early stage of psammoma body formation was seen more frequently in these villous microcores than in the meningocytic whorls.,0
867,21,Are psammoma bodies characteristic to meningiomas?,Psammoma bodies in meningocytic whorls were investigated by electron microscopy.,0
867,22,Are psammoma bodies characteristic to meningiomas?,"Psammoma body formation in the meningocytic whorls may represent degeneration in some whorls of the central cells which contain connective tissue fibers, producing cell debris such as membrane invested vesicles.",0
867,23,Are psammoma bodies characteristic to meningiomas?,"Twenty human meningiomas were examined for IgG and IgM by the direct immunofluorescence of immunoperoxidase methods, or both.",0
867,24,Are psammoma bodies characteristic to meningiomas?,"IgG was conspicuously found in and around the blood vessels, whorls, and psammoma bodies.",0
867,25,Are psammoma bodies characteristic to meningiomas?,It was also clearly present on the cytoplasmic membranes of the tumour cells.,0
867,26,Are psammoma bodies characteristic to meningiomas?,Significance of these findings is briefly discussed including possible humoral immune reactions in regard to whorl and psammoma body formation in meningioma.,0
867,27,Are psammoma bodies characteristic to meningiomas?,The fine structure of psammoma bodies was examined in four cases of fibroblastic meningioma.,1
867,28,Are psammoma bodies characteristic to meningiomas?,"In general, large numbers of various-sized calcified bodies (psammoma bodies) were scattered among the interstitial fibers.",0
867,29,Are psammoma bodies characteristic to meningiomas?,These findings suggest that both matrix giant bodies and matrix vesicles may serve as initial nidus of calcification of psammoma bodies in fibroblastic meningioma.,0
867,30,Are psammoma bodies characteristic to meningiomas?,Psammoma body formation or dystrophic mineralization and gliosis of the intervening parenchyma was observed in all three cases.,0
473,0,What is Prudent Diet?,Long-term diet was assessed by using FFQs every 4 y since 1986.,0
473,1,What is Prudent Diet?,Prudent (high in vegetables) and Western (high in meats) patterns were identified by using a principal component analysis.,1
473,2,What is Prudent Diet?,"The Prudent dietary pattern was characterised by high intakes of vegetables, fruits, whole grain products and low intakes of refined grain products and the Western dietary pattern, by high intakes of refined grain products, desserts, sweets and processed meats.",1
473,3,What is Prudent Diet?,aerobic exercise combined with diet recommendations (saturated/trans fat intake less than 10% of total calories and cholesterol less than 300 mg/day and/or fiber intake ≥ 25 g/day in women and ≥ 35 grams per day in men,1
473,4,What is Prudent Diet?," a prudent pattern (high in fish, peas, honey, nuts, juice, dry fruits, vegetable oil, liver and organic meat, and coconuts and low in hydrogenated fat and non-leafy vegetables)",1
473,5,What is Prudent Diet?," The prudent pattern was characterized by higher intakes of fruits, vegetables, legumes, fish, poultry, and whole grains, while the Western pattern was characterized by higher intakes of red and processed meats, sweets and desserts, french fries, and refined grains.",1
851,0,Describe the mechanism of action of aliskiren. ,"Preliminary assignment a direct renin inhibitor aliskiren enhances the diuretic, natriuretic and kaliyuretic effects of the drug.",0
851,1,Describe the mechanism of action of aliskiren. ,Aliskiren: An orally active renin inhibitor.,0
851,2,Describe the mechanism of action of aliskiren. ,Optimization of this compound by Novartis led to the development of aliskiren - the only direct renin inhibitor which is clinically used as an antihypertensive drug.,0
851,3,Describe the mechanism of action of aliskiren. ,Aliskiren is a new renin inhibitor of a novel structural class that has recently been shown to be efficacious in hypertensive patients after once-daily oral dosing.,0
851,4,Describe the mechanism of action of aliskiren. ,Aliskiren is a direct renin inhibitor that interrupts the renin-angiotensin-aldosterone system (RAAS) at its rate-limiting step.,1
851,5,Describe the mechanism of action of aliskiren. ,"THE READER WILL GAIN: Aliskiren, the first approved renin inhibitor to reach the market, is a low-molecular-weight, orally active, hydrophilic non-peptide molecule that blocks angiotensin I generation.",1
851,6,Describe the mechanism of action of aliskiren. ,TAKE HOME MESSAGE: The DRI aliskiren is an effective antihypertensive agent that preliminary data suggests has a beneficial effect in CVD and CKD.,0
851,7,Describe the mechanism of action of aliskiren. ,Aliskiren is a novel molecule which blocks the renin-angiotensin-aldosterone system in its rate limiting step by renin inhibition.,1
851,8,Describe the mechanism of action of aliskiren. ,"After discovery of the first direct renin inhibitor, aliskiren, which blocks the renin-angiotensin-aldosterone system in the first rate limiting step, in addition to angiotensin-converting enzymes (ACE) and angiotensin-receptor blockers (ARB), renin has become an important target nowadays.",1
851,9,Describe the mechanism of action of aliskiren. ,"Aliskiren, the first orally effective direct renin inhibitor, is an effective antihypertensive agent with distinctive properties including placebo-like tolerability, pharmacologic effects that persist after drug discontinuation, and a unique mechanism of action.",0
851,10,Describe the mechanism of action of aliskiren. ,"Aliskiren, the first direct renin inhibitor to reach the market, is a low-molecular-weight, orally active, hydrophilic nonpeptide.",1
851,11,Describe the mechanism of action of aliskiren. ,"Aliskiren blocks Ang I generation, while plasma renin concentration increases because the drugs blocks the negative feed-back exerted by Ang II on renin synthesis.",0
851,12,Describe the mechanism of action of aliskiren. ,"Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.",0
851,13,Describe the mechanism of action of aliskiren. ,"One drug that emerged from this effort is aliskiren, a direct human renin inhibitor that blocks the conversion of angiotensinogen to angiotensin I (Ang I).",0
851,14,Describe the mechanism of action of aliskiren. ,"With its unique mechanism of action, combining aliskiren with another RAAS-blocking agent that has a different mechanism of action may provide more comprehensive blockade of the RAAS, potentially conferring additional clinical benefits.",0
851,15,Describe the mechanism of action of aliskiren. ,"In the ALTITUDE trial the use of the direct renin inhibitor, aliskiren, was associated with hypotensive episodes and an excess of ischaemic stroke",0
851,16,Describe the mechanism of action of aliskiren. ,Renin is the rate limiting enzyme of the RAAS and aliskiren is a highly potent and selective inhibitor of the human renin,0
851,17,Describe the mechanism of action of aliskiren. ,"Aliskiren, the first direct renin inhibitor to be approved for the treatment of hypertension, blocks the RAAS at its point of activation",0
851,18,Describe the mechanism of action of aliskiren. ,"With its unique mechanism of action, combining aliskiren with another RAAS-blocking agent that has a different mechanism of action may provide more comprehensive blockade of the RAAS, potentially conferring additional clinical benefits",0
1747,0,Willis-Ekbom disease is also known as?,Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.,0
1747,1,Willis-Ekbom disease is also known as?,Clinical features variability between familial and sporadic restless legs syndrome/Willis-Ekbom disease (RLS/WED) has been previously reported.,0
1747,2,Willis-Ekbom disease is also known as?,"With this retrospective cohort study, we aimed to determine the clinical and polysomnographic characteristics of 400 RLS/WED patients.",0
1747,3,Willis-Ekbom disease is also known as?,"""Emplotted Narratives"" and Structured ""Behavioral Observations"" Supporting the Diagnosis of Willis-Ekbom Disease/Restless Legs Syndrome in Children with Neurodevelopmental Conditions.",0
1747,4,Willis-Ekbom disease is also known as?,"BACKGROUND: Willis-Ekbom disease/restless legs syndrome (WED/RLS) seems to be a frequent cause of intractable chronic insomnia (ICI) but is under-recognized in children/adolescents with neurodevelopmental conditions (NDCs), as many patients do not have the ability to express the underlying ""urge-to-move"".",0
1747,5,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a common movement disorder characterised by an uncontrollable urge to move because of uncomfortable, sometimes painful sensations in the legs with a diurnal variation and a release with movement.",1
1747,6,Willis-Ekbom disease is also known as?,"OBJECTIVE: In the present study, we tested the hypothesis that having migraine in middle age is related to late-life parkinsonism and a related disorder, restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED).METHODS: The AGES-Reykjavik cohort (born 1907-1935) has been followed since 1967.",0
1747,7,Willis-Ekbom disease is also known as?,"BACKGROUND: Reported prevalence of restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), varies from country to country, and methodologic inconsistencies limit comparison of data.",0
1747,8,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is a sensory-motor neurological disorder with a circadian component.",0
1747,9,Willis-Ekbom disease is also known as?,"There is no consensus about mechanisms underlying restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED)",0
1747,10,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a common sensorimotor disorder that can generally be effectively managed in the primary care clinic",1
1747,11,Willis-Ekbom disease is also known as?,"Reported prevalence of restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), varies from country to country, and methodologic inconsistencies limit comparison of data",0
1747,12,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom Disease (WED), is a sensorimotor disorder for which the exact pathophysiology remains unclear",1
1747,13,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is a sensorimotor disorder that can result in considerable sleep disruption",0
1747,14,Willis-Ekbom disease is also known as?,"The SP790 study (ClinicalTrials.gov, NCT00136045) showed benefits of rotigotine over placebo in improving symptom severity of restless legs syndrome (RLS), also known as Willis-Ekbom disease, on the International Restless Legs Syndrome Study Group rating scale (IRLS), Clinical Global Impression item 1 (CGI-1), RLS 6-item questionnaire (RLS-6), and the RLS-quality of life questionnaire (RLS-QoL) in patients with moderate to severe idiopathic RLS",0
1747,15,Willis-Ekbom disease is also known as?,"In the present study, we tested the hypothesis that having migraine in middle age is related to late-life parkinsonism and a related disorder, restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED).The AGES-Reykjavik cohort (born 1907-1935) has been followed since 1967",0
1747,16,Willis-Ekbom disease is also known as?,"Restless leg syndrome (RLS), also known as Willis-Ekbom disease, is a condition that includes sensations such as crawling, tingling, or aching in the limbs and creates an urge to move",0
1747,17,Willis-Ekbom disease is also known as?,"Recent genome-wide association studies (GWAS) for Caucasians identified several allelic variants associated with increased risk of developing restless legs syndrome (RLS), also known as Willis-Ekbom disease",0
1747,18,Willis-Ekbom disease is also known as?,"Since the publication of the first European Federation of Neurological Societies (EFNS) guidelines in 2005 on the management of restless legs syndrome (RLS; also known as Willis-Ekbom disease), there have been major therapeutic advances in the field",0
1747,19,Willis-Ekbom disease is also known as?,"BACKGROUND: Reported prevalence of restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), varies from country to country, and methodologic inconsistencies limit comparison of data.",0
1747,20,Willis-Ekbom disease is also known as?,"OBJECTIVES: Both restless legs syndrome ([RLS], also known as Willis-Ekbom Disease [WED]) and depression are common during pregnancy.",0
1747,21,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is a sensory-motor neurological disorder with a circadian component.",0
1747,22,Willis-Ekbom disease is also known as?,"OBJECTIVE: In the present study, we tested the hypothesis that having migraine in middle age is related to late-life parkinsonism and a related disorder, restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED).",0
1747,23,Willis-Ekbom disease is also known as?,"BACKGROUND: Since the publication of the first European Federation of Neurological Societies (EFNS) guidelines in 2005 on the management of restless legs syndrome (RLS; also known as Willis-Ekbom disease), there have been major therapeutic advances in the field.",0
1747,24,Willis-Ekbom disease is also known as?,"STUDY OBJECTIVES: Recent genome-wide association studies (GWAS) for Caucasians identified several allelic variants associated with increased risk of developing restless legs syndrome (RLS), also known as Willis-Ekbom disease.",0
1747,25,Willis-Ekbom disease is also known as?,"BACKGROUND: The SP790 study (ClinicalTrials.gov, NCT00136045) showed benefits of rotigotine over placebo in improving symptom severity of restless legs syndrome (RLS), also known as Willis-Ekbom disease, on the International Restless Legs Syndrome Study Group rating scale (IRLS), Clinical Global Impression item 1 (CGI-1), RLS 6-item questionnaire (RLS-6), and the RLS-quality of life questionnaire (RLS-QoL) in patients with moderate to severe idiopathic RLS.",0
1747,26,Willis-Ekbom disease is also known as?,Psychological distress in patients with restless legs syndrome (Willis-Ekbom disease): a population-based door-to-door survey in rural Ecuador.,0
1747,27,Willis-Ekbom disease is also known as?,"Since the publication of the first European Federation of Neurological Societies (EFNS) guidelines in 2005 on the management of restless legs syndrome (RLS; also known as Willis-Ekbom disease), there have been major therapeutic advances in the field.",0
1747,28,Willis-Ekbom disease is also known as?,"Restless leg syndrome/Willis-Ekbom disease has brain iron deficiency that produces excessive dopamine and known genetic risks, some of which contribute to the brain iron deficiency.",0
1747,29,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a common sensorimotor disorder that can generally be effectively managed in the primary care clinic.",1
1747,30,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is a sensorimotor disorder that can result in considerable sleep disruption.",0
1747,31,Willis-Ekbom disease is also known as?,"The SP790 study (ClinicalTrials.gov, NCT00136045) showed benefits of rotigotine over placebo in improving symptom severity of restless legs syndrome (RLS), also known as Willis-Ekbom disease, on the International Restless Legs Syndrome Study Group rating scale (IRLS), Clinical Global Impression item 1 (CGI-1), RLS 6-item questionnaire (RLS-6), and the RLS-quality of life questionnaire (RLS-QoL) in patients with moderate to severe idiopathic RLS.",0
1747,32,Willis-Ekbom disease is also known as?,"Recent genome-wide association studies (GWAS) for Caucasians identified several allelic variants associated with increased risk of developing restless legs syndrome (RLS), also known as Willis-Ekbom disease.",0
1747,33,Willis-Ekbom disease is also known as?,"In the present study, we tested the hypothesis that having migraine in middle age is related to late-life parkinsonism and a related disorder, restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED).The AGES-Reykjavik cohort (born 1907-1935) has been followed since 1967.",0
1747,34,Willis-Ekbom disease is also known as?,"Reported prevalence of restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), varies from country to country, and methodologic inconsistencies limit comparison of data.",0
1747,35,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is characterised by abnormal sensations in the legs as well as dysaesthesia.",0
1747,36,Willis-Ekbom disease is also known as?,"STUDY OBJECTIVES: Recent genome-wide association studies (GWAS) for Caucasians identified several allelic variants associated with increased risk of developing restless legs syndrome (RLS), also known as Willis-Ekbom disease.",0
1747,37,Willis-Ekbom disease is also known as?,"Although the pathogenic mechanisms of RLS are not entirely understood, it is becoming increasingly evident that many diseases such as RLS can be attributed to an epistasis.",0
1747,38,Willis-Ekbom disease is also known as?,"OBJECTIVE: Restless legs syndrome, now called Willis-Ekbom Disease (RLS/WED), is a sensorimotor-related sleep disorder.",0
1747,39,Willis-Ekbom disease is also known as?,Little is known of the effect of RLS/WED on motor function.,0
1747,40,Willis-Ekbom disease is also known as?,"OBJECTIVE: Restless legs syndrome, now called Willis-Ekbom Disease (RLS/WED), is a sensorimotor-related sleep disorder.",0
1747,41,Willis-Ekbom disease is also known as?,"STUDY OBJECTIVES: Recent genome-wide association studies (GWAS) for Caucasians identified several allelic variants associated with increased risk of developing restless legs syndrome (RLS), also known as Willis-Ekbom disease.",0
1747,42,Willis-Ekbom disease is also known as?,Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease).,0
1747,43,Willis-Ekbom disease is also known as?,"BACKGROUND: The SP790 study (ClinicalTrials.gov, NCT00136045) showed benefits of rotigotine over placebo in improving symptom severity of restless legs syndrome (RLS), also known as Willis-Ekbom disease, on the International Restless Legs Syndrome Study Group rating scale (IRLS), Clinical Global Impression item 1 (CGI-1), RLS 6-item questionnaire (RLS-6), and the RLS-quality of life questionnaire (RLS-QoL) in patients with moderate to severe idiopathic RLS.",0
1747,44,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom Disease (WED), is a sensorimotor disorder for which the exact pathophysiology remains unclear.",0
1747,45,Willis-Ekbom disease is also known as?,"Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a common movement disorder characterised by an uncontrollable urge to move because of uncomfortable, sometimes painful sensations in the legs with a diurnal variation and a release with movement.",1
1747,46,Willis-Ekbom disease is also known as?,"The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease.",0
1747,47,Willis-Ekbom disease is also known as?,Willis-Ekbom Disease or Restless Legs Syndrome?,0
1747,48,Willis-Ekbom disease is also known as?,Living with Restless Legs Syndrome/Willis-Ekbom Disease.,0
1747,49,Willis-Ekbom disease is also known as?,"Restless Legs Syndrome/Willis-Ekbom Disease Morbidity: Burden, Quality of Life, Cardiovascular Aspects, and Sleep.",0
1001,0,Which type of cell death is known as anoikis?,"As a barrier to metastasis of cancer, cells that lost contact with the neighbouring cells or extracellular matrix(Extracellular matrix, ECM) will be subjected to apoptosis.",0
1001,1,Which type of cell death is known as anoikis?,"This cell death process has been termed ""anoikis"".",0
1001,2,Which type of cell death is known as anoikis?,"When normal epithelial cells or solid tumor cells without metastatic potential detach from the primary site, and then enter into the circulatory system, the anoikis mechanism will be activated.",0
1001,3,Which type of cell death is known as anoikis?,The significance of anoikis is to prevent the shedding cells from growing and implanting into other inappropriate sites.,0
1001,4,Which type of cell death is known as anoikis?,"Anoikis is a programmed cell death induced upon cell detachment from extracellular matrix, behaving as a critical mechanism in preventing adherent-independent cell growth and attachment to an inappropriate matrix, thus avoiding colonizing of distant organs.",1
1001,5,Which type of cell death is known as anoikis?,"As a barrier to metastasis, cells normally undergo an apoptotic process known as ""anoikis,"" a form of cell death due to loss of contact with the extracellular matrix or neighboring cells.",0
1001,6,Which type of cell death is known as anoikis?,"Anoikis is a programmed cell death occurring upon cell detachment from the correct extracellular matrix, thus disrupting integrin ligation.",0
1001,7,Which type of cell death is known as anoikis?,It is a critical mechanism in preventing dysplastic cell growth or attachment to an inappropriate matrix.,0
1001,8,Which type of cell death is known as anoikis?,Anoikis prevents detached epithelial cells from colonizing elsewhere and is thus essential for tissue homeostasis and development.,0
1001,9,Which type of cell death is known as anoikis?,Detachment from the extracellular matrix induces a form of programmed cell death termed anoikis.,0
1001,10,Which type of cell death is known as anoikis?,Resistance to anoikis permits cancer cells to survive in systemic circulation and facilitates their metastasis to distant organs.,0
1001,11,Which type of cell death is known as anoikis?,Anoikis - apoptotic cell death triggered by loss of extracellular matrix (ECM) contacts - is dysregulated in many chronic debilitating and fatal diseases.,0
1001,12,Which type of cell death is known as anoikis?,"The extracellular matrix (ECM) plays a key role in cell-cell communication and signaling, and the signals it propagates are important for tissue remodeling and survival.",0
1001,13,Which type of cell death is known as anoikis?,"However, signals from disease-altered ECM may lead to anoikis-apoptotic cell death triggered by loss of ECM contacts.",0
1001,14,Which type of cell death is known as anoikis?,"Anoikis is a mode of apoptotic cell death, consequential to insufficient cell-matrix interactions and a critical player in tumor angiogenesis and metastasis.",0
1001,15,Which type of cell death is known as anoikis?,"Anoikis is also a physiologic process in normal cells used to maintain homeostasis, in which cell death is induced in response to loss of extracellular membrane (ECM) attachment.",0
1001,16,Which type of cell death is known as anoikis?,"Cancer cells are notoriously resistant to anoikis, enabling metastasis and new tumor growth beyond their original environment.",0
1001,17,Which type of cell death is known as anoikis?,Anoikis is a subtype of apoptosis induced by detachment of adherent cells from the extracellular matrix.,0
1001,18,Which type of cell death is known as anoikis?,Developed organs display strict spatial organization of differentiated cells which is required for proper organ function.,0
1001,19,Which type of cell death is known as anoikis?,"One important device that prevents tissue disorganization is the death of cells that lose anchorage to their native matrix, a signal that indicates potential loss of proper tissue context.",1
1001,20,Which type of cell death is known as anoikis?,"Termed anoikis (Greek for Homelessness), this form of cell death is a specialized form of apoptosis.",1
1001,21,Which type of cell death is known as anoikis?,"As a barrier to metastases, cells normally undergo apoptosis after they lose contact with their extra cellular matrix or their neighbouring cells.",0
1001,22,Which type of cell death is known as anoikis?,"This cell death process has been termed ""anoikis"".",0
1001,23,Which type of cell death is known as anoikis?,Tumour cells that acquire malignant potential have developed mechanisms to resist anoikis and thereby survive after detachment from their primary site and while travelling through the lymphatic and circulatory systems.,0
1001,24,Which type of cell death is known as anoikis?,Epithelial cells require attachment to extracellular matrix (ECM) to suppress an apoptotic cell death program termed anoikis.,0
1001,25,Which type of cell death is known as anoikis?,"Detachment of adherent epithelial cells from the extracellular matrix induces apoptosis, known as anoikis.",0
1001,26,Which type of cell death is known as anoikis?,"Integrin stimulation protects cells from anoikis, but the responsible mechanisms are not well known.",0
1001,27,Which type of cell death is known as anoikis?,"Apoptosis triggered by cell detachment from the extracellular matrix, which occurs during hepatocyte isolation, is a phenomenon termed ""anoikis"".",0
1001,28,Which type of cell death is known as anoikis?,"It's importance in the normal physiologic development of the human body, as well as in disease states, has been described.",0
1001,29,Which type of cell death is known as anoikis?,Cancer cells harbor anoikis resistance allowing spread to occur.,0
1001,30,Which type of cell death is known as anoikis?,Anoïkis is defined as programmed cell death induced by the loss of cell/matrix interactions.,0
1001,31,Which type of cell death is known as anoikis?,"Adhesion to structural glycoproteins of the extracellular matrix is necessary for survival of the differentiated adherent cells in the cardiovascular system, including endothelial cells, smooth muscle cells, fibroblasts, and cardiac myocytes.",1
1001,32,Which type of cell death is known as anoikis?,Adhesion is also a key factor for the differentiation of mesenchymal stem cells.,0
1001,33,Which type of cell death is known as anoikis?,"In particular, fibronectin is considered a factor of survival and differentiation for many adherent cells.",0
1001,34,Which type of cell death is known as anoikis?,"Adhesion generates cell tensional integrity (tensegrity) and repression of apoptotic signals, whereas detachment has the opposite effect.",0
1001,35,Which type of cell death is known as anoikis?,Anoïkis plays a physiological role by regulating cell homeostasis in tissues.,0
1001,36,Which type of cell death is known as anoikis?,Anoikis is a special type of programmed cell death after loss of cell-cell and cell-extracellular matrix interactions.,0
1001,37,Which type of cell death is known as anoikis?,"Detachment-induced cell death, or anoikis, is a type of apoptosis that occurs when epithelial cells lose their attachment to the extracellular matrix.",0
1001,38,Which type of cell death is known as anoikis?,Anoikis is a type of apoptosis due to the detachment from the extracellular matrix and neighboring cells.,0
1001,39,Which type of cell death is known as anoikis?,"Detachment of adherent epithelial cells from the extracellular matrix induces apoptosis, known as anoikis.",0
1001,40,Which type of cell death is known as anoikis?,"Anoikis is a programmed cell death induced upon cell detachment from extracellular matrix, behaving as a critical mechanism in preventing adherent-independent cell growth and attachment to an inappropriate matrix, thus avoiding colonization of distant organs",1
1001,41,Which type of cell death is known as anoikis?,"As a barrier to metastasis, cells normally undergo an apoptotic process known as ""anoikis,"" a form of cell death due to loss of contact with the extracellular matrix or neighboring cells",0
1001,42,Which type of cell death is known as anoikis?,"Detachment of adherent epithelial cells from the extracellular matrix induces apoptosis, known as anoikis",0
450,0,Can SUMO affect calcium homeostasis?,Increasing SUMOylation levels correlated inversely with calcium influx in sensory neurons.,1
450,1,Can SUMO affect calcium homeostasis?,CRMP2 deSUMOylation by SUMO proteases SENP1 and SENP2 normalized calcium influx to those in the CRMP2AAA mutant.,1
450,2,Can SUMO affect calcium homeostasis?,"Thus, our results identify a novel role for SUMO modification in CRMP2/CaV2.2 signaling pathway",1
450,3,Can SUMO affect calcium homeostasis?,"Moreover, SUMO1 overexpression in isolated cardiomyocytes augmented contractility and accelerated Ca(2+) decay.",0
450,4,Can SUMO affect calcium homeostasis?," RIM1α SUMOylation at lysine residue K502 facilitates the clustering of CaV2.1 calcium channels and enhances the Ca(2+) influx necessary for vesicular release, whereas non-SUMOylated RIM1α participates in the docking/priming of synaptic vesicles and maintenance of active zone structure.",1
450,5,Can SUMO affect calcium homeostasis?,Identification and characterization of a SUMO-1 conjugation system that modifies neuronal calcium/calmodulin-dependent protein kinase II in Drosophila melanogaster.,1
3870,0,Describe the mechanism of action of Givosiran.,"Givosiran acts as a conventional siRNA to trigger RNA interference (RNAi)-mediated gene silencing on delta-ALA synthase 1 (ALAS1), thus returning ALA and PBG metabolites to the physiological level to attenuate further neurotoxicity.",0
3870,1,Describe the mechanism of action of Givosiran.,Givosiran is a small interfering ribonucleic acid agent that was recently approved in the United States for the treatment of acute hepatic porphyria (AHP).,0
3870,2,Describe the mechanism of action of Givosiran.,Givosiran (Givlaari™) is an aminolevulinate synthase 1 (ALAS1)-directed small interfering RNA (siRNA) covalently linked to a ligand to enable specific delivery of the siRNA to hepatocytes.,1
3870,3,Describe the mechanism of action of Givosiran.,This results in downregulation of ALAS1 mRNA and prevents accumulation of neurotoxic δ-aminolevulinic acid and porphobilinogen levels that are associated with acute porphyria attacks.,1
3870,4,Describe the mechanism of action of Givosiran.,"Givosiran, an RNA interference therapy, inhibits ALAS1 expression.",0
3870,5,Describe the mechanism of action of Givosiran.,"A number of RNA drugs have been approved for medical use, including aptamers (e.g., pegaptanib) that mechanistically act on protein target and small interfering RNAs (e.g., patisiran and givosiran) and antisense oligonucleotides (e.g., inotersen and golodirsen) that directly interfere with RNA targets.",0
3870,6,Describe the mechanism of action of Givosiran.,Givosiran is an investigational RNA interference therapeutic agent that inhibits hepatic ALAS1 synthesis.,0
3870,7,Describe the mechanism of action of Givosiran.,"After a two-decade journey from its discovery, two approvals of siRNA therapeutics, ONPATTRO® (patisiran) and GIVLAARI™ (givosiran), have been achieved by Alnylam Pharmaceuticals.",0
3870,8,Describe the mechanism of action of Givosiran.,Reviewing the long-te,0
3870,9,Describe the mechanism of action of Givosiran.,"Givosiran, another RNAi therapeutic, targeting 5-aminolevulinic acid synthase, has been positively tested in acute intermittent porphyria in phase 1/2 and ongoing phase 3 trials.",0
3870,10,Describe the mechanism of action of Givosiran.," of RNA drugs have been approved for medical use, including aptamers (e.g., pegaptanib) that mechanistically act on protein target and small interfering RNAs (e.g., patisiran and givosiran) and antisense oligonucleotides (e.g., inotersen and golodirsen) that directly interfere with RNA targets.",0
3870,11,Describe the mechanism of action of Givosiran.,"Furthermore, gui",0
3870,12,Describe the mechanism of action of Givosiran.,"In November 2019 givosiran became the second small interfering RNA (siRNA)-based drug to receive US Food and Drug Administration (FDA) approval, it has been developed for the treatment of acute intermittent porphyria (AIP), a disorder characterized by life-threatening acute neurovisceral attacks.",1
3870,13,Describe the mechanism of action of Givosiran.,"Givosiran acts as a conventional siRNA to trigger RNA interference (RNAi)-mediated gene silencing on delta-ALA synthase 1 (ALAS1), thus returning ALA and PBG metabolites to the physiological level to attenuate further neurotoxicity.",0
3870,14,Describe the mechanism of action of Givosiran.,Givosiran (Givlaari™) is an aminolevulinate synthase 1 (ALAS1)-directed small interfering RNA (siRNA) covalently linked to a ligand to enable specific delivery of the siRNA to hepatocytes.,1
3870,15,Describe the mechanism of action of Givosiran.,osynthesis.,0
3870,16,Describe the mechanism of action of Givosiran.,Givosiran is an investigational RNA interference therapeutic agent that inhibits hepatic ALAS1 synthesis.METHODS: We conducted a phase 1 trial of givosiran in patients with acute in,0
3870,17,Describe the mechanism of action of Givosiran., porphyria.,0
3870,18,Describe the mechanism of action of Givosiran.,"Givosiran, an RNA interference therapy, inhibits ALAS1 expression.METHODS: In this double-blind, placebo-controlled, phase 3 trial, we randomly assigned symptomatic patients with acute hepatic porphyria to receive either subcutaneous givosiran (2.5 mg per kilogram of body weight) or placebo",0
3870,19,Describe the mechanism of action of Givosiran.,"State-of-the-art small interfering RNA (siRNA) therapeutics such as givosiran and fitusiran are constructed from three variable components: a fully-modified RNA core that conveys metabolic stability, a targeting moiety that mediates target-cell uptake, and a linker.",0
3870,20,Describe the mechanism of action of Givosiran.,New treatment options include givosiran (siRNA) to down-regulate ALA synthase-1 (ALAS1) and the messenger RNA of PBGD (PBGD mRNA) delivered to the liver cells of patients with AIP.,1
3870,21,Describe the mechanism of action of Givosiran.,"Management of AIP includes awareness and avoidance of triggering factors, infusions of hemin for severe acute attacks, and, if indicated for chronic suppressive therapy, maintenance treatment with hemin or givosiran, a small interfering RNA molecule that antagonizes ALA synthase 1 transcripts.",0
132,0,What is the number of long non coding RNAs in the human genome,"The recent ENCODE (Encyclopedia of DNA Elements) study reported 9,640 lncRNA loci in the human genome, which corresponds to around half the number of protein-coding genes.",1
132,1,What is the number of long non coding RNAs in the human genome,"Over 18,000 transcripts are presently annotated as lncRNA, and encompass previously annotated classes of noncoding transcripts including large intergenic noncoding RNA, antisense RNA and processed pseudogenes",1
132,2,What is the number of long non coding RNAs in the human genome,"BACKGROUND: Over 10,000 long intergenic non-coding RNAs (lincRNAs) have been identified in the human genome.",1
3217,0,Is ustekinumab a polyclonal antibody?,"Ustekinumab, a human monoclonal IgG1 antibody targeting the p40-subunit shared by interleukin (IL)12 and IL-23, represents a potential treatment for atopic dermatitis (AD).",1
616,0,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Statins have been shown in two recent small phase I/II trials to be associated with a marked reduction in clinical and transcranial Doppler (TCD) evidence of vasospasm after aneurysmal subarachnoid haemorrhage (SAH).,1
616,1,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Statins did not result in reduced TCD velocities, clinical or angiographic vasospasm, or improvements in global outcome at the time of hospital discharge.",0
616,2,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,There remains significant uncertainty as to the role of statins in preventing vasospasm after SAH.,0
616,3,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Although the results of 2 randomized clinical trials demonstrated that statin decreases the incidence of symptomatic cerebral vasospasm after aSAH, retrospective studies have failed to confirm this.",0
616,4,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"There were no differences in the incidence of symptomatic vasospasm (25.3 vs 30.5%; p = 0.277), in-hospital mortality rate (18 vs 15%; p = 0.468), length of hospitalization (21 +/- 15 vs 19 +/- 12 days; p = 0.281), or poor outcome at discharge (Glasgow Outcome Scale Scores 1-2: 21.7 vs 18.2%; p = 0.416) between the simvastatin and nonstatin cohorts.",0
616,5,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"The uniform introduction of simvastatin did not reduce the incidence of symptomatic cerebral vasospasm, death, or poor outcome in patients with aSAH.",0
616,6,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Simvastatin was well tolerated, but its benefit may be less than has been previously reported.",0
616,7,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Cholesterol-reducing agents might improve unfavourable outcomes.,0
616,8,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,We cannot draw any conclusions about the effectiveness and safety of lowering cholesterol in aneurysmal SAH because of insufficient reliable evidence from only one small trial.,0
616,9,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Experimental evidence has indicated the benefit of simvastatin in the treatment of subarachnoid hemorrhage.,0
616,10,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"There was an improvement in the functional outcome in the simvastatin group at 1, 3 or 6 months in the follow-up; however, this difference was not statistically significant.",0
616,11,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?," There was benefit of simvastatin in terms of reduction in clinical vasospasm, mortality or improved functional outcome, however, this was not statistically significant.",0
616,12,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Cerebral vasomotor reactivity, however, is significantly improved after long-term statin administration in most patients with severe small vessel disease, aneurysmal subarachnoid hemorrhage, or impaired baseline CA.",0
616,13,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.,0
616,14,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"In the overall population, cerebral vasospasm was significantly less common in the statin-treated group.",0
616,15,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Severity of vasospasm, as assessed on the most severe angiogram, was lowered with statin.",0
616,16,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Statins significantly reduced volume of ischemia in patients with vasospasm and an uncomplicated coiling procedure.,0
616,17,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"S100B levels were significantly lower in statin-treated patients, and the decrease was greatest among high-grade patients (World Federation of Neurological Surgeons 3-5).",0
616,18,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,No differences were found between statin-treated and untreated groups regarding rescue therapy intensity or 1-yr clinical outcomes.,0
616,19,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Atorvastatin reduces the incidence, the severity and the ischemic consequences of vasospasm as assessed on computed tomography.",0
616,20,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"In high-grade World Federation of Neurological Surgeons patients, atorvastatin decreases serum levels of S100B, a biomarker of brain ischemia.",0
616,21,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Despite these positive effects on biomarkers, no improvement of outcome was seen in the overall population, although there was a tendency for a better clinical outcome in high-grade patients.",0
616,22,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, have been associated with improved clinical outcomes after ischemic stroke and subarachnoid hemorrhage, but with an increased risk of incidental spontaneous intracerebral hemorrhage (ICH).",1
616,23,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Statins are known to have pleiotropic vascular effects, some of which may interrupt the pathogenesis of DNDs.",0
616,24,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Based on promising preliminary reports, many clinicians routinely administer statins to prevent DNDs.",0
616,25,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"However, observational studies have not revealed an association between statin-use and reduced DNDs or improved neurological outcomes.",0
616,26,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Results of RCTs have been inconsistent and limited by small sample size, but together suggest that statins may reduce DNDs, with no clear impact on mortality or neurological recovery.",0
616,27,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,the role of statins in the management of patients with SAH remains unclear.,0
616,28,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Although promising, statins should not, at this time, be considered standard care.",0
616,29,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"In patients with SAH, they may decrease the incidence of symptomatic vasospasm, although the effects on overall outcome are less clear.",0
616,30,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Statins treatment may have potential clinical impact in vascular disease beyond cholesterol lowering.,0
616,31,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Its benefits have been documented in cerebral ischaemia and in subarachnoid haemorrhage.,0
616,32,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"A recent meta-analysis investigating the efficacy of statin treatment in patients with aneurysmal subarachnoid hemorrhage reported a reduced incidence of vasospasm, delayed cerebral ischemia, and mortality in statin-treated patients.",1
616,33,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,The results of the present systematic review do not lend statistically significant support to the finding of a beneficial effect of statins in patients with aneurysmal subarachnoid hemorrhage as reported in a previous meta-analysis.,0
616,34,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Pre-treatment with cholesterol lowering drugs of the statin family may exert protective effects in patients with ischaemic stroke and subarachnoid haemorrhage but their effects are not clear in patients with intracerebral haemorrhage (ICH).,0
616,35,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Recently, two randomized controlled phase II studies showed that acute initiation of statin treatment directly after aneurysmal subarachnoid hemorrhage (SAH) decreases the incidence of radiologic vasospasm and clinical signs of delayed cerebral ischemia (DCI), and even reduces mortality.",1
616,36,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,We conclude that both the primary and secondary outcome results of this study do not support a beneficial effect of simvastatin in patients with SAH.,0
616,37,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Novel uses of their anti-inflammatory properties in sepsis and vasomotor properties in subarachnoid haemorrhage are being further investigated by randomised trials.,0
616,38,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,A trend towards a lower mortality within 14 days in patients receiving solely simvastatin and those receiving statin and magnesium as compared with the control group was found.,0
616,39,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Initiation of statin therapy after aneurysmal SAH significantly reduces the incidence of vasospasm, delayed ischemic deficits, and mortality.",1
616,40,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,The addition of statins to standard care was not associated with any reduction in the development of vasospasm or improvement in outcomes after aneurysmal subarachnoid hemorrhage.,0
616,41,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,We have previously demonstrated that acute pravastatin therapy after aneurysmal subarachnoid hemorrhage ameliorates vasospasm-related delayed ischemic deficits.,0
616,42,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?, This trial demonstrates that acute statin treatment reduces traditional rescue therapy for vasospasm after aneurysmal subarachnoid hemorrhage.,0
616,43,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Improvement in early outcome has proved robust at 6 months, particularly in relation to physical and psychosocial (Short Form 36) outcome.",0
616,44,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,The authors previously have demonstrated that acute treatment with pravastatin after aneurysmal subarachnoid hemorrhage (SAH) can ameliorate vasospasm-related delayed ischemic neurological deficits (DINDs).,0
616,45,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,The neuroprotective effects of acute treatment with pravastatin following aneurysmal SAH are associated with enhancement of autoregulation,0
616,46,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.,0
616,47,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,The use of simvastatin as prophylaxis against delayed cerebral ischemia after aneurysmal SAH is a safe and well-tolerated intervention.,0
616,48,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,Its use attenuates serum markers associated with brain injury and decreases the incidence of radiographic vasospasm and delayed ischemic deficit.,0
616,49,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"Acute treatment with pravastatin after aSAH is safe and ameliorates cerebral vasospasm, improves cerebral autoregulation, and reduces vasospasm-related DID.",0
616,50,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?," SAH statin users demonstrated significant improvement in 14-day functional outcome, a significantly lower incidence of DCI and cerebral infarctions of any type, as well as prevention of TCD highest mean velocity elevation.",0
616,51,Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?,"However, we did not find a significant statin impact on mortality or global outcome (Modified Rankin Scale) in this small sample.",0
2794,0,Are ultraconserved enhancers important for normal development?,Ultraconserved Enhancers Are Required for Normal Development.,1
2794,1,Are ultraconserved enhancers important for normal development?,"However, initial deletion studies in mice revealed that loss of such extraordinarily constrained sequences had no immediate impact on viability.",1
2794,2,Are ultraconserved enhancers important for normal development?,"Here, we show that ultraconserved enhancers are required for normal development.",1
2794,3,Are ultraconserved enhancers important for normal development?,"Here, we show that ultraconserved enhancers are required for normal development.",1
1626,0,Can adult humans be induced to produce fetal hemoglobin?," At the time of birth, HbF accounts for approximately 70% of the total Hb.",1
1626,1,Can adult humans be induced to produce fetal hemoglobin?, whereas in the trace amounts of HbF that is found in the adult it reverses to 40:60 because of a gamma- to beta-globin gene switch,1
1626,2,Can adult humans be induced to produce fetal hemoglobin?,"With the increased understanding and discovery of molecular regulators of haemoglobin switching, such as BCL11A, new avenues of research may lead ultimately to novel therapeutic, mechanism-based approaches to fetal haemoglobin reactivation in patients.",1
1626,3,Can adult humans be induced to produce fetal hemoglobin?,"The data suggest that TGF-beta reactivates gamma-globin expression, combined with a sequential stimulation and suppression of erythropoiesis.",1
2850,0,What is filipin staining used for?,"sequestration of cholesterol to the perinuclear area, as evident by the Filipin staining.",1
2850,1,What is filipin staining used for?,"Current diagnosis for NP-C is based on observation of the accumulated cholesterol in fibroblasts of affected individuals, using an invasive and time expensive test, called Filipin staining.",1
2850,2,What is filipin staining used for?, Membrane cholesterol content was measured by filipin staining,1
2850,3,What is filipin staining used for?,intracellular and total cholesterol (TC) were measured using filipin staining,1
2850,4,What is filipin staining used for?, filipin staining of cholesterol.,1
1604,0,Are pseudogenes enriched with housekeeping protein families?,housekeeping families tend to be enriched with a large number of pseudogenes,1
3096,0,List 3 enterotoxins produced by Clostridium difficile.,The toxins produced by the C. diff.,0
3096,1,List 3 enterotoxins produced by Clostridium difficile.,"(toxin A, toxin B, and binary toxin) are the agents that cause injury and disease.",1
3096,2,List 3 enterotoxins produced by Clostridium difficile.,Only toxin producing C. diff.,0
3096,3,List 3 enterotoxins produced by Clostridium difficile.,Strains will cause disease.,0
3096,4,List 3 enterotoxins produced by Clostridium difficile.,Binary toxin by itself is not thought to produce disease,0
3096,5,List 3 enterotoxins produced by Clostridium difficile.,"Binary toxin causes disease in humans when present with toxin A and B producing bacteria,",1
3096,6,List 3 enterotoxins produced by Clostridium difficile.," The main virulence factor is related to the release of two major exotoxins, toxin A (TcdA) and toxin B (TcdB).",1
3096,7,List 3 enterotoxins produced by Clostridium difficile.,Recent C. difficile-associated disease (CDAD) outbreaks have been caused by hypervirulent strains which secrete an additional binary toxin (CDTa/CDTb).,0
3096,8,List 3 enterotoxins produced by Clostridium difficile.,V,0
3096,9,List 3 enterotoxins produced by Clostridium difficile.,The exotoxins toxin A (TcdA) and toxin B (TcdB) are produced by the bacterial pathogen Clostridium difficile and are responsible for the pathology associated with C. difficile infection (CDI).,1
3096,10,List 3 enterotoxins produced by Clostridium difficile.,"The pathogenic organism, Clostridium difficile, produces two enterotoxins, toxin A and toxin B, that cause colonic mucosal inflammation.",1
3096,11,List 3 enterotoxins produced by Clostridium difficile.,"Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine.The action of toxins A, B, and C from Clostridium difficile was studied in the small intestine and colon of rats.",0
3746,0,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil is a novel, selective cardiac myosin activator that has been shown to improve cardiac function and to decrease ventricular volumes, heart rate, and N-terminal pro-B-type natriuretic peptide in patients with chronic HF.",1
3746,1,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil (OM), an activator of cardiac myosin, strongly affects contractile characteristics of the ventricles and, to a much lesser extent, the characteristics of atrial contraction.",0
3746,2,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil (OM) is a putative positive inotropic tool for treatment of systolic heart dysfunction, based on the finding that in vivo it increases the ejection fraction and in vitro it prolongs the actin-bond life time of the cardiac and slow-skeletal muscle isoforms of myosin.",0
3746,3,Describe the mechanism of action of Omecamtiv Mecarbil.,"Two novel cardiac myotropes, omecamtiv mecarbil and danicamtiv, target cardiac myosin to increase left ventricular systolic performance.",0
3746,4,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil, a novel activator of cardiac myosin, improves left ventricular systolic function and remodeling and reduces natriuretic peptides.",1
3746,5,Describe the mechanism of action of Omecamtiv Mecarbil.,Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.,0
3746,6,Describe the mechanism of action of Omecamtiv Mecarbil.,BACKGROUND: The selective cardiac myosin activator omecamtiv mecarbil has been shown to improve cardiac function in patients with heart failure with a reduced ejection fraction.,1
3746,7,Describe the mechanism of action of Omecamtiv Mecarbil.,The mechanism of action of omecamtiv mecarbil also provides insights into uncovering how force is generated by molecular motors.Omecamtiv mecarbil (OM) is a cardiac myosin activator that is currently in clinical trials for heart failure treatment.,0
3746,8,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil is a selective, small-molecule activator of cardiac myosin that is being developed as a potential treatment for heart failure with reduced ejection fraction.",0
3746,9,Describe the mechanism of action of Omecamtiv Mecarbil.,The myosin activator omecamtiv mecarbil: a promising new inotropic agent.,0
3746,10,Describe the mechanism of action of Omecamtiv Mecarbil.,"A novel myosin activator, omecamtiv mecarbil (OM), is a cardiac inotropic agent with a unique new mechanism of action, which is thought to arise from an increase in the transition rate of myosin into the actin-bound force-generating state without increasing calcium (Ca2+) transient.",0
3746,11,Describe the mechanism of action of Omecamtiv Mecarbil.,"There remains, howeve",0
3746,12,Describe the mechanism of action of Omecamtiv Mecarbil.,"The energy-saving effect of a new myosin activator, omecamtiv mecarbil, on LV mechanoenergetics in rat hearts with blood-perfused isovolumic contraction model.",0
3746,13,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil (OM) is a selective cardiac myosin activator (myotrope), currently in Phase 3 clinical investigation as a novel treatment for heart failure with reduced ejection fraction.",1
3746,14,Describe the mechanism of action of Omecamtiv Mecarbil.,Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil.,0
3746,15,Describe the mechanism of action of Omecamtiv Mecarbil.,OBJECTIVE: Omecamtiv mecarbil is a novel small molecule that directly activates cardiac myosin and increases cardiac contractility without increasing cardiac myocyte intracellu,0
3746,16,Describe the mechanism of action of Omecamtiv Mecarbil.,Omecamtiv mecarbil (OM) is a cardiac myosin activator that is currently in clinical trials for heart failure treatment.,1
3746,17,Describe the mechanism of action of Omecamtiv Mecarbil.,"A novel myosin activator, omecamtiv mecarbil (OM), is a cardiac inotropic agent with a unique new mechanism of action, which is thought to arise from an increase in the transition rate of myosin into the actin-bound force-generating state without increasing calcium (Ca2+) transient.",0
3746,18,Describe the mechanism of action of Omecamtiv Mecarbil.,OBJECTIVE: Omecamtiv mecarbil is a novel small molecule that directly activates cardiac myosin and increases cardiac contractility without increasing cardiac myocyte intracellul,0
3746,19,Describe the mechanism of action of Omecamtiv Mecarbil.,Omecamtiv mecarbil (OM) is a compound that has been developed to treat systolic heart failure via targeting the cardiac myosin heavy chain to increase myocardial contractility.,0
3746,20,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil is a first-in-class cardiac myosin activator, which increases the proportion of myosin heads that are tightly bound to actin and creates a force-producing state that is not associated with cytosolic calcium accumulation.",0
3746,21,Describe the mechanism of action of Omecamtiv Mecarbil.,nd mortality.,0
3746,22,Describe the mechanism of action of Omecamtiv Mecarbil.,"A novel selective cardiac myosin activator, omecamtiv mecarbil (CK-1827452/ AMG-423) is a small molecule that activates the sarcomere proteins directly, resulting in prolonged systolic ejection time and increased cardiac",0
3746,23,Describe the mechanism of action of Omecamtiv Mecarbil.,The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.,0
3746,24,Describe the mechanism of action of Omecamtiv Mecarbil.,"This study tested the hypothesis that omecamtiv mecarbil, a selective cardiac myosin activator, will augment cardiac function in human beings.",0
3746,25,Describe the mechanism of action of Omecamtiv Mecarbil.,"The small molecule drug omecamtiv mecarbil (OM) specifically targets cardiac muscle myosin and is known to enhance cardiac muscle performance, yet its impact on human cardiac myosin motor function is unclear.",0
3746,26,Describe the mechanism of action of Omecamtiv Mecarbil.,Omecamtiv Mecarbil: A Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results.,0
3746,27,Describe the mechanism of action of Omecamtiv Mecarbil.,Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure.,0
3746,28,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K.",0
3746,29,Describe the mechanism of action of Omecamtiv Mecarbil.,"A novel class of agents, the myosin motor activators, acts directly on cardiac myosin resulting in an increased force generation and prolongation of contraction.",0
3746,30,Describe the mechanism of action of Omecamtiv Mecarbil.,"Omecamtiv mecarbil, the lead molecule of this group, is now in human phase 3 displaying promising clinical performance.",0
3746,31,Describe the mechanism of action of Omecamtiv Mecarbil.,"We determined the effect of Omecamtiv Mecarbil, a novel allosteric effector of cardiac muscle myosin, on the kinetic and ""in vitro"" motility properties of the porcine ventricular heavy meromyosin (PV-HMM).",0
3746,32,Describe the mechanism of action of Omecamtiv Mecarbil.,"The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.",0
3746,33,Describe the mechanism of action of Omecamtiv Mecarbil.,"We report the first study of the cardiac myosin activator, omecamtiv mecarbil, in patients with systolic heart failure.",0
3746,34,Describe the mechanism of action of Omecamtiv Mecarbil.,"To avoid these limitations, we previously developed omecamtiv mecarbil, a small-molecule, direct activator of cardiac myosin.",0
3746,35,Describe the mechanism of action of Omecamtiv Mecarbil.,Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity.,0
3746,36,Describe the mechanism of action of Omecamtiv Mecarbil.,BACKGROUND: Omecamtiv mecarbil (OM) is a novel inotropic agent that prolongs systolic ejection time and increases ejection fraction through myosin ATPase activation.,0
3343,0,Which protein is mutated in Erythropoietic Protoporphyria?,"Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthesis pathway resulting in the accumulation of protoporphyrins in the blood, erythrocytes, and other tissues.",1
3343,1,Which protein is mutated in Erythropoietic Protoporphyria?,"Because of a gene mutation in the FECH gene, ferrochelatase, the enzyme involved in the final step of heme synthesis, is deficient in these patients.",1
3343,2,Which protein is mutated in Erythropoietic Protoporphyria?, Erythropoietic protoporphyria (EPP) is the most common inherited porphyria in children and is diagnosed in most individuals after the onset of cutaneous manifestations.,1
3343,3,Which protein is mutated in Erythropoietic Protoporphyria?, an erythropoietic protoporphyria (EPP)-associated ferrochelatase (FECH) mutation,1
2749,0,What is the origin of human breast milk bacteria?,"In the past years, results provided by different research groups suggest that certain bacteria from the maternal gastrointestinal tract could translocate through a mechanism involving mononuclear immune cells, migrate to the mammary glands via an endogenous cellular route (the bacterial entero-mammary pathway), and subsequently colonize the gastrointestinal tract of the breast-fed neonate.",1
1850,0,Describe Wellens' Syndrome.,"NTRODUCTION: Wellens Syndrome (WS) is a condition characterized by typical changes in ECG, which are biphasic T-wave inversions (less common) or symmetric and deeply inverted T waves (including 75%) in lead V2-V3 chest derivations.",1
1850,1,Describe Wellens' Syndrome.,"BACKGROUND: Reperfusion after coronary occlusion (myocardial infarction, MI), as in Wellens' syndrome, is often represented on ECG as T-wave inversion in the leads overlying the affected myocardial wall(s).",0
1850,2,Describe Wellens' Syndrome.,"Her presentation was concerning for acute coronary syndrome, Wellens syndrome in particular, given the elevated troponin levels, lack of ST segment changes, and characteristic T-wave findings.",0
1850,3,Describe Wellens' Syndrome.,Omnious T-wave inversions: Wellens' syndrome revisited.,0
1850,4,Describe Wellens' Syndrome.,Wellens' syndrome is characterized by T-wave changes in electrocardiogram (EKG) during pain-free period in a patient with intermittent angina chest pain.,1
1850,5,Describe Wellens' Syndrome.,"We describe a case of a 42-year-old man, with a previous episode of angina and a normal ECG and serum cardiac markers, and a two months later finding of biphasic T wave in leads V2-V3 and deeply inverted T wave in V4-V5 at a asymptomatic occupational evaluation.",1
1850,6,Describe Wellens' Syndrome.,This is a typical ECG pattern of Wellens' syndrome.,0
1850,7,Describe Wellens' Syndrome.,"Whereas the Wellens' syndrome is characterized by symmetrically inverted T-waves with preserved R waves in the precordial leads suggestive of impending myocardial infarction due to a critical proximal left anterior descending stenosis, the pseudo-Wellens' syndrome caused by coronary artery spasm has also rarely been reported in literature.",0
1850,8,Describe Wellens' Syndrome.,"The Wellens electrocardiogram (ECG) pattern of dynamic T-wave inversion in the anterior leads is observed in clinical conditions characterized by reversible left ventricular (LV) dysfunction (stunned myocardium), either ischemic or nonischemic",0
1850,9,Describe Wellens' Syndrome.,"Wellens Syndrome (WS) is a condition characterized by typical changes in ECG, which are biphasic T-wave inversions (less common) or symmetric and deeply inverted T waves (including 75%) in lead V2-V3 chest derivations.",1
1850,10,Describe Wellens' Syndrome.,"The initial electrocardiogram (ECG) showed biphasic T-waves in V2-V4, which was recognized as Wellens' syndrome, or acute coronary T-wave syndrome.",1
959,0,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,existing methods for ctDNA detection are restricted to genetic mutations.,0
959,1,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,"Recently, nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity.",1
959,2,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,These results demonstrate that the sensor can simultaneously detect the hot-spot mutation and epigenetic changes on the ctDNA.,1
959,3,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,"Promisingly, other specific-tumor mutants and epigenetic changes can be detected at low concentration with this platform.",0
959,4,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,"The practice of ""liquid biopsy"" as a diagnostic, prognostic and theranostic tool in non-small cell lung cancer (NSCLC) patients is an appealing approach, at least in theory, since it is noninvasive and easily repeated",1
959,5,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,"Here we introduce cancer personalized profiling by deep sequencing (CAPP-Seq), an economical and ultrasensitive method for quantifying ctDNA.",0
959,6,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,"Finally, we evaluated biopsy-free tumor screening and genotyping with CAPP-Seq.",0
959,7,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,"We envision that CAPP-Seq could be routinely applied clinically to detect and monitor diverse malignancies, thus facilitating personalized cancer therapy.",0
959,8,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,Synthesis of a new Ni-phenanthroline complex and its application as an electrochemical probe for detection of nucleic acid,0
959,9,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,A new DNA sensor using a nickel(II) phenanthroline complex ([Ni(phen)(2)PHPIP]·2ClO(4)) as the electrochemical probe was developed.,1
959,10,Which are the most common methods for ctDNA (circulating tumour DNA) detection?,The sensor is very sensitive and selective for calf thymus DNA (ctDNA) detection in aqueous medium.,1
724,0,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"To analyze whether the time (morning/evening) of administration of a compound containing 60 mg of dry soy seed extract (glycine max) with 40% of total isoflavones, primrose oil and α-tocopherol modifies the effect on the climacteric syndrome.",1
724,1,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"The object of this study was to evaluate the effect of different doses of a compound containing isoflavones 60 mg, primrose oil 440 mg and vitamin E 10 mg. (IOVE) on menopausal complaints.",1
724,2,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"This was an open, multicentre, randomised, group comparative, efficacy and safety trial.",1
724,3,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"Emphasis was placed on randomized, double-blind, placebo-controlled clinical trials, as these provide the best efficacy and safety data",1
724,4,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"Nonprescription therapies reviewed include black cohosh, dong quai, evening primrose oil, physical activity, phytoestrogens, and red clover",1
724,5,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial.,0
724,6,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,The aim of this study was to compare the efficacy of evening primrose with placebo in improvement of menopausal hot flashes.,0
724,7,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?, The application of oral evening primrose oil compared with placebo for controlling hot flashes may decrease more the intensity of attacks,0
724,8,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"Our search identified 58 randomised controlled trials of which 11 involved the use of clonidine, six for SSRIs, four for gabapentin, seven for black cohosh, seven for red clover, 18 for phytoestrogens, two for ginseng, one for evening primrose,",0
724,9,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"Single clinical trials have found no benefit for dong quai, evening primrose oil,",0
724,10,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"Single clinical trials have found that dong quai, evening primrose oil,",0
724,11,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,To evaluate the efficacy of gamolenic acid provided by evening primrose oil in treating hot flushes and sweating associated with the menopause.,0
724,12,Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?,"DESIGN: Randomised, double blind, placebo controlled study.",0
3053,0,Which enzyme is deficient in Wolman disease?,"Wolman's disease, also known as lysosomal acid lipase (LIPA) deficiency, is a rare autosomal-recessive disorder characterized by complete absence of the LIPA enzyme.",0
3053,1,Which enzyme is deficient in Wolman disease?,"The diagnosis of Wolman's disease was made postnatally by biochemical testing, which indicated absence of LIPA enzyme activity and gene sequencing, which confirmed homozygosity for the G66V mutation within the LIPA gene.",0
3053,2,Which enzyme is deficient in Wolman disease?,"These include Wolman disease (WD) and Cholesteryl Ester Storage Disease (CESD) which both result from mutations in LIPA, the gene that encodes lysosomal acid lipase (LAL).",0
3053,3,Which enzyme is deficient in Wolman disease?,BACKGROUND: Deficiency of lysosomal acid lipase (LAL) causes Wolman disease and cholesterol ester storage disease.,1
3053,4,Which enzyme is deficient in Wolman disease?,BACKGROUND: Lysosomal acid lipase deficiency is an autosomal recessive metabolic disease with a wide range of severity from Wolman Disease to Cholesterol Ester Storage Disease.,0
3053,5,Which enzyme is deficient in Wolman disease?," In humans, loss-of-function mutations of LIPA cause rare lysosomal disorders, Wolman disease, and cholesteryl ester storage disease, in which LAL enzyme replacement therapy has shown significant benefits in a phase 3 clinical trial.",0
3053,6,Which enzyme is deficient in Wolman disease?,"Cholesteryl ester storage disease (CESD, OMIM #278000) and Wolman disease (OMIM #278000) are autosomal recessive lysosomal storage disorders caused by a deficient activity of lysosomal acid lipase (cholesteryl ester hydrolase, LAL).",0
3053,7,Which enzyme is deficient in Wolman disease?,"Wolman disease, associated with deficient hLAL activity, leads to massive intracellular substrate accumulation and is always fatal in early infancy.",0
3053,8,Which enzyme is deficient in Wolman disease?,We previously reported a rat model of Wolman's disease (Wolman rat) that is deficient for LAL activity.,0
3053,9,Which enzyme is deficient in Wolman disease?,"BACKGROUND
Wolman disease (WD) is a rare lysosomal storage disorder that is caused by mutations in the LIPA gene encoding lysosomal acid lipase (LAL).",0
3053,10,Which enzyme is deficient in Wolman disease?,We report successful long-term bone marrow engraftment in a patient with Wolman disease resulting in continued normalization of peripheral leukocyte lysosomal acid lipase enzyme activity.,0
3053,11,Which enzyme is deficient in Wolman disease?,A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.,1
3053,12,Which enzyme is deficient in Wolman disease?,Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity and genetic defects of lysosomal acid lipase (LAL).,1
3053,13,Which enzyme is deficient in Wolman disease?,"In Wolman disease, LAL activity is usually absent, whereas CESD usually presents some residual LAL activity.",0
3053,14,Which enzyme is deficient in Wolman disease?,"Wolman disease, associated with deficient hLAL activity, leads to massive intracellular substrate accumulation and is always fatal in early infancy.",0
3053,15,Which enzyme is deficient in Wolman disease?,"Acta 1006, 84-88], has been administered to cultured lymphoblastoid cells from normal subjects and from a patient affected with Wolman disease, which is characterized by a deficiency of lysosomal acid lipase.",1
3053,16,Which enzyme is deficient in Wolman disease?,A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity and genetic defects of lysosomal acid lipase (LAL).,0
3053,17,Which enzyme is deficient in Wolman disease?,"Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.Cholesteryl ester storage disease (CESD, OMIM #278000) and Wolman disease (OMIM #278000) are autosomal recessive lysosomal storage disorders caused by a deficient activity of lysosomal acid lipase (cholesteryl ester hydrolase, LAL).",0
3053,18,Which enzyme is deficient in Wolman disease?,Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts.Previous studies have shown that cultured fibroblasts derived from patients with genetic defects in lysosomal acid lipase (i. e. the Wolman Syndrome and Cholesteryl Ester Storage Disease) are defective in their ability to hydrolyze the cholesteryl esters contained in plasma low density lipoprotein (LDL).,0
3053,19,Which enzyme is deficient in Wolman disease?,Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.Human lysosomal acid lipase/cholesteryl ester hydrolase (hLAL) is essential for the intralysosomal metabolism of cholesteryl esters and triglycerides taken up by receptor-mediated endocytosis of lipoprotein particles.,0
3053,20,Which enzyme is deficient in Wolman disease?,"In order to elucidate the underlying molecular defects in Wolman disease, we have characterized the hLAL gene in two female Wolman patients of German and Turkish origin by SSCP and DNA sequence analysis.",0
3053,21,Which enzyme is deficient in Wolman disease?,Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.,1
1476,0,Which is the vector of Louping ill virus?,"Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.",1
1476,1,Which is the vector of Louping ill virus?,"n Europe the primary arthropod vectors of zoonotic diseases are ticks, which transmit Borrelia burgdorferi sensu lato (the agent of Lyme disease), tick-borne encephalitis virus and louping ill virus between humans, livestock and wildlife.",0
1476,2,Which is the vector of Louping ill virus?,Ixodes ricinus ticks and reported tick-borne disease cases are currently increasing in the UK,0
1476,3,Which is the vector of Louping ill virus?,"Many vector-borne pathogens whose primary vectors are generalists, such as Ixodid ticks, can infect a wide range of host species and are often zoonotic.",0
1476,4,Which is the vector of Louping ill virus?,"Tick-borne encephalitis virus (TBEV) and Louping ill virus (LIV) are viruses in the Mammalian tick-borne virus group/genus Flavivirus, causing central nervous system disease.",1
1476,5,Which is the vector of Louping ill virus?,The complex pathogen-host-vector system of the tick-borne louping-ill virus causes economic losses to sheep and red grouse in upland United Kingdom.,1
1476,6,Which is the vector of Louping ill virus?,"For pathogens transmitted by biting vectors, one of the fundamental assumptions is often that vector bites are the sole or main route of host infection.",0
1476,7,Which is the vector of Louping ill virus?,"Here, we demonstrate experimentally a transmission route whereby hosts (red grouse, Lagopus lagopus scoticus) became infected with a member of the tick-borne encephalitis virus complex, louping ill virus, after eating the infected tick vector.",1
1476,8,Which is the vector of Louping ill virus?,We used Susceptible Infected Recovered (SIR) models parameterized for the tick-borne louping ill virus (LIV) system.,1
1476,9,Which is the vector of Louping ill virus?,"This study has examined the efficacy following intramuscular administration of a recombinant Semliki Forest virus (rSFV) vaccine, encoding the prME and NS1 proteins of louping ill virus (LIV), in sheep.",0
1476,10,Which is the vector of Louping ill virus?,"Since the recognition that louping-ill, known for well over 100 years as an epizootic disease of sheep in Scotland, was caused by a virus transmitted by arthropods, many other arthropod-borne viruses capable of causing encephalitis in domestic animals or man have been discovered.",0
2086,0,What tissue is commonly affected in Marfan's syndrome,Marfan syndrome (MS) is a connective tissue disorder that affects thousands of adolescents,1
2086,1,What tissue is commonly affected in Marfan's syndrome,"Fibrillin-1 mutations have also been found in several other related connective tissue disorders, such as severe neonatal Marfan syndrome, dominant ectopia lentis, familial ascending aortic aneurysm, isolated skeletal features of Marfan syndrome, and Shprintzen-Goldberg syndrome.",0
2086,2,What tissue is commonly affected in Marfan's syndrome,"Marfans syndrome is an Autosomal dominant disorder of the connective tissues resulting in abnormalities of the musculoskeletal system, cardiovascular system and eyes.",0
2086,3,What tissue is commonly affected in Marfan's syndrome,Marfan syndrome (MFS) is a systemic disorder of the connective tissue with pleiotropic manifestations due to heterozygous FBN1 mutations and consequent upregulation of TGFβ signaling in affected tissues,1
2086,4,What tissue is commonly affected in Marfan's syndrome,"Marfan syndrome (MFS) is an autosomal dominant disorder of connective tissue, caused by mutations of the microfibrillar protein fibrillin-1, that predisposes affected individuals to aortic aneurysm and rupture and is associated with increased TGFβ signaling",0
2086,5,What tissue is commonly affected in Marfan's syndrome,Marfan syndrome is an autosomal dominant connective tissue disorder commonly due to mutation of the fibrillin-1 (FBN-1) gene that causes disruption of elastic fibers in large- and medium-size arteries and predisposes to aneurysm formation and arterial dissection,0
2086,6,What tissue is commonly affected in Marfan's syndrome,Children affected by the Marfan syndrome carry a mutation in one of their two copies of the gene that encodes the connective tissue protein fibrillin-1,0
2086,7,What tissue is commonly affected in Marfan's syndrome,"Marfan's syndrome is an autosomal dominant disorder of connective tissue, commonly involving the cardiovascular, ocular, and skeletal systems.",0
2086,8,What tissue is commonly affected in Marfan's syndrome,Marfan syndrome is an autosomal dominant connective tissue disorder commonly due to mutation of the fibrillin-1 (FBN-1) gene that causes disruption of elastic fibers in large- and medium-size arteries and predisposes to aneurysm formation and arterial dissection.,0
2086,9,What tissue is commonly affected in Marfan's syndrome,"Marfan's syndrome is an autosomal dominant disorder of connective tissue, commonly involving the cardiovascular, ocular, and skeletal systems.",0
2086,10,What tissue is commonly affected in Marfan's syndrome,Marfan's syndrome is a heritable connective tissue disorder that has been associated with intracranial aneurysms.,1
2086,11,What tissue is commonly affected in Marfan's syndrome,"Marfan's syndrome is an inherited disorder of connective tissue associated with characteristic abnormalities of the skeletal, ocular, and cardiovascular systems.",1
2086,12,What tissue is commonly affected in Marfan's syndrome,"Therefore, Marfan's syndrome is termed a fibrillinopathy, along with other connective tissue disorders with subtle differences in clinical manifestations.",0
2086,13,What tissue is commonly affected in Marfan's syndrome,The Marfan syndrome is an inherited disorder of the connective tissue which is mainly caused by a mutation in the fibrillin-1 gene.,0
2086,14,What tissue is commonly affected in Marfan's syndrome,Marfan syndrome is an inherited multisystemic connective-tissue disease that is caused by a mutation of the fibrillin-1 gene.,1
2086,15,What tissue is commonly affected in Marfan's syndrome," Mutations in the fibrillin-1 gene give rise to Marfan syndrome, a connective tissue disorder with clinical complications in the cardiovascular, skeletal, ocular and other organ systems.",0
614,0,How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers.,1
614,1,How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,"Here, we determined that several HBS1L-MYB intergenic variants affect regulatory elements that are occupied by key erythroid transcription factors within this region.",1
614,2,How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,"These elements interact with MYB, a critical regulator of erythroid development and HbF levels.",1
614,3,How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,"We found that several HBS1L-MYB intergenic variants reduce transcription factor binding, affecting long-range interactions with MYB and MYB expression levels.",1
614,4,How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,These data provide a functional explanation for the genetic association of HBS1L-MYB intergenic polymorphisms with human erythroid traits and HbF levels.,1
614,5,How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,Our results further designate MYB as a target for therapeutic induction of HbF to ameliorate sickle cell and β-thalassemia disease severity.,0
1603,0,Which proteins are the different isoforms of the p38 MAP kinase?,"The p38 Mitogen-Activated Protein (MAP) kinase, a serine/threonine kinase, is one of the best characterized kinases in the inflammatory process.",1
1603,1,Which proteins are the different isoforms of the p38 MAP kinase?,"Among the four identified p38 isoforms (p38α, p38β, p38γ, and p38δ), the α-form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i.e.",1
1603,2,Which proteins are the different isoforms of the p38 MAP kinase?,IL-1β and TNF-α at the translational and transcriptional levels.,0
1603,3,Which proteins are the different isoforms of the p38 MAP kinase?,The p38 mitogen-activated protein kinase (MAPK) is one of the kinase pathways that regulate the production of IL-1β and TNFα.,0
1603,4,Which proteins are the different isoforms of the p38 MAP kinase?,"Importantly, small molecule inhibitors of the p38 MAPK family have been developed and show efficacy in blocking the production of IL-1β and TNFα.",0
1603,5,Which proteins are the different isoforms of the p38 MAP kinase?,"The p38 family consists of at least four isoforms (p38α, β, γ, δ) encoded by separate genes.",0
1603,6,Which proteins are the different isoforms of the p38 MAP kinase?,"Defining the roles of the various p38 family members, specifically p38alpha and p38beta, in these processes has been difficult.",0
1603,7,Which proteins are the different isoforms of the p38 MAP kinase?, The anomalous p38 inhibitor effect on IL-1alpha induction of MMP-3 and phosphorylation of p38 delta/gamma suggests complex interactions between p38 MAP kinase isoforms and their differential uses by TNFalpha and IL-1alpha in TM.,0
1603,8,Which proteins are the different isoforms of the p38 MAP kinase?,"Human and porcine TM cells expressed p38 alpha, beta, delta, and gamma isoforms, which migrate coincident with bands of specific phosphorylation.",0
1603,9,Which proteins are the different isoforms of the p38 MAP kinase?,"The mitogen-activated protein kinase (MAPK) p38 is a Ser/Thr kinase, originally isolated from lipopolysaccharide-stimulated monocytes.",0
1603,10,Which proteins are the different isoforms of the p38 MAP kinase?,"There are four isoforms of the enzyme (p38alpha, p38beta, p38gamma and p38delta), which differ in tissue distribution, regulation of kinase activation and subsequent phosphorylation of downstream substrates.",1
1603,11,Which proteins are the different isoforms of the p38 MAP kinase?,"We report the molecular cloning of a novel isoform of p38 MAP kinase, p38 beta 2.",0
1603,12,Which proteins are the different isoforms of the p38 MAP kinase?,"The p38 MAP kinase kinase MKK6 is identified as a common activator of p38 alpha, p38 beta 2, and p38 gamma MAP kinase isoforms, while MKK3 activates only p38 alpha and p38 gamma MAP kinase isoforms.",0
1603,13,Which proteins are the different isoforms of the p38 MAP kinase?," four identified p38 isoforms (p38α, p38β, p38γ, and p38δ),",0
1603,14,Which proteins are the different isoforms of the p38 MAP kinase?,"The mammalian p38 mitogen-activated protein kinases (MAPKs) family is composed of four members (p38α, p38β, p38γ, and p38δ), which are very similar in amino acid sequence but differ in their expression patterns.",1
1603,15,Which proteins are the different isoforms of the p38 MAP kinase?,"Four p38 isoforms (p38alpha, p38beta, p38gamma and p38delta) exist in mammalian cells, being p38alpha and p38gamma the most abundantly expressed isoforms in adult skeletal muscle.",0
1603,16,Which proteins are the different isoforms of the p38 MAP kinase?,"Among the four identified p38 isoforms (p38α, p38β, p38γ, and p38δ), the α-form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i",1
1603,17,Which proteins are the different isoforms of the p38 MAP kinase?,The p38 mitogen-activated protein kinases are activated in response to various extracellular signals in eukaryotic cells and play a critical role in the cellular responses to these signals.,0
1603,18,Which proteins are the different isoforms of the p38 MAP kinase?,"The four mammalian isoforms (p38alpha, p38beta, p38gamma, and p38delta) are coexpressed and coactivated in the same cells.",0
1603,19,Which proteins are the different isoforms of the p38 MAP kinase?,four p38 isoforms,0
1603,20,Which proteins are the different isoforms of the p38 MAP kinase?,p38 MAPK isoforms are becoming increasingly important for a variety of cellular functions.,0
1603,21,Which proteins are the different isoforms of the p38 MAP kinase?,The physiological functions of p38α and -β are now well documented in contrast to -γ and -δ which are comparatively under-studied and ill-defined.,0
1603,22,Which proteins are the different isoforms of the p38 MAP kinase?,"Of the four p38 isoforms known to date, two (p38alpha and p38beta) have been identified as targets for cytokine-suppressive anti-inflammatory drugs.",0
1603,23,Which proteins are the different isoforms of the p38 MAP kinase?, the contribution of each of the four p38 isoforms (encoded by different genes) to senescence induction is unclear.,0
1603,24,Which proteins are the different isoforms of the p38 MAP kinase?,"In the current study, we demonstrated that p38alpha and p38gamma, but not p38beta, play an essential role in oncogenic ras-induced senescence.",0
1603,25,Which proteins are the different isoforms of the p38 MAP kinase?,"Involvement of the p38 mitogen-activated protein kinase alpha, beta, and gamma isoforms in myogenic differentiation.",0
1603,26,Which proteins are the different isoforms of the p38 MAP kinase?,"we showed here that p38alpha, beta, and gamma are expressed with distinct expression patterns during differentiation.",0
1603,27,Which proteins are the different isoforms of the p38 MAP kinase?,The p38 family of kinases is a subgroup of the mitogen-activated protein kinase family.,0
1603,28,Which proteins are the different isoforms of the p38 MAP kinase?,It is composed of four isoforms and is involved in critical biological processes as well as in inflammatory diseases,0
1603,29,Which proteins are the different isoforms of the p38 MAP kinase?,"p38alpha and -beta2 are ubiquitously expressed, whereas p38gamma and -delta appear to have more restricted expression.",0
3766,0,What monoclonal antibody drugs are used to treat late stage melanoma?," Nivolumab, a fully human monoclonal antibody against programmed cell death protein 1 (PD-1), has shown a survival benefit in an open-label phase II trial, and was the first PD-1 inhibitor to be approved worldwide.",0
3766,1,What monoclonal antibody drugs are used to treat late stage melanoma?,"With a favorable side effect profile and ongoing trials in combination with extant therapies, nivolumab shows substantial potential to further augment the options for an effective treatment in malignant melanoma.",0
3766,2,What monoclonal antibody drugs are used to treat late stage melanoma?, Checkpoint blockade with ipilimumab provides long-term survival to a significant proportion of patients with metastatic melanoma,0
3766,3,What monoclonal antibody drugs are used to treat late stage melanoma?,ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.,1
3766,4,What monoclonal antibody drugs are used to treat late stage melanoma?,ate-stage cutaneous melanoma treated with vemurafenib.,1
3766,5,What monoclonal antibody drugs are used to treat late stage melanoma?,"ome of the drugs thus developed, such as vemurafenib and dabrafenib, show impressive responses in melanoma",1
3766,6,What monoclonal antibody drugs are used to treat late stage melanoma?,ipilimumab therapy for metastatic melanoma.,0
3766,7,What monoclonal antibody drugs are used to treat late stage melanoma?,Melanoma is the deadliest form of skin cancer.,0
3766,8,What monoclonal antibody drugs are used to treat late stage melanoma?,"Ipilimumab, a novel immunotherapy, is the first treatment shown to improve survival in patients with metastatic melanoma in large randomized controlled studies.",0
3766,9,What monoclonal antibody drugs are used to treat late stage melanoma?,"In 2011, new drugs were approved by the U.S. Food and Drug Administration, including peginterferon alfa-2b for patients with stage III disease, vemurafenib for patients with metastatic melanoma with the BRAF V600E mutation, and ipilimumab, a monoclonal antibody directed to the CTLA-4 T lymphocyte receptor, to combat metastatic melanoma in patients who do not have the BRAF V600E mutation.",0
3766,10,What monoclonal antibody drugs are used to treat late stage melanoma?,"Foremost among these was ipilimumab, a monoclonal antibody against the negative regulatory checkpoint molecule cytotoxic T-lymphocyte protein 4 (CTLA-4), which was the first drug in the management of metastatic melanoma to confer a survival benefit.",0
3766,11,What monoclonal antibody drugs are used to treat late stage melanoma?,"was ipilimumab, a monoclonal antibody against the negative regulatory checkpoint molecule cytotoxic T-lymphocyte protein 4 (CTLA-4), which was the first drug in the management of metastatic melanoma to confer a survival benefit.",0
3766,12,What monoclonal antibody drugs are used to treat late stage melanoma?,"However, treatment is",0
3766,13,What monoclonal antibody drugs are used to treat late stage melanoma?,TLA-4 monoclonal antibody ipilimumab has already been approved in advanced melanoma and two phase III trials evaluating ipilimumab in men with metastatic castrate-resistant prostate cancer are underway.,0
3766,14,What monoclonal antibody drugs are used to treat late stage melanoma?,A phase,0
3766,15,What monoclonal antibody drugs are used to treat late stage melanoma?,Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.,1
3766,16,What monoclonal antibody drugs are used to treat late stage melanoma?,"Ipilimumab, the first monoclonal antibody to be approved for the treatment of metastatic melanoma, showed significant improvements in durable response rates in patients and paved the way for next class of monoclonal antibodies.",1
3766,17,What monoclonal antibody drugs are used to treat late stage melanoma?,Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings.,0
3766,18,What monoclonal antibody drugs are used to treat late stage melanoma?,"Nivolumab and pembrolizumab (formerly lambrolizumab), the two FDA-approved anti-programmed death-1 monoclonal antibodies, show highly durable response rates and long-term safety, validating the importance of the programmed cell death protein 1 pathway blockade for treatment of malignant melanoma.",0
3766,19,What monoclonal antibody drugs are used to treat late stage melanoma?,"The anti-programmed cell death-1 (PD-1) monoclonal antibodies pembrolizumab and nivolumab have been contingently approved for the treatment of patients with advanced melanoma based on their durable response, high response rate, and favorable safety profile.",0
3766,20,What monoclonal antibody drugs are used to treat late stage melanoma?,Enhancement of the immune system by blockade of the cytotoxic T-lymphocyte associated antigen-4 by the monoclonal antibody ipilimumab is now approved by the United States Food and Drug Administration (FDA) for use in patients with unresectable melanoma.,0
3460,0,Can radiotherapy cause radiation induced osteosarcoma?,A case of radiation-induced osteosarcoma of the skull presenting as a cutaneous epidermotropic tumor with a short latent period.,0
3460,1,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced sarcoma (RIS) is an unusual but well documented tumor.,0
3460,2,Can radiotherapy cause radiation induced osteosarcoma?,"We report a case of a 34-year-old female who developed an osteosarcoma of the scalp, over a previous craniotomy scar, 3 years after excision of a frontal anaplastic oligodendroglioma which had been followed by a course of 6 weeks radiotherapy (58 Gy) and 6 cycles of temozolomide.",0
3460,3,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma after Gamma Knife surgery for vestibular schwannoma: a case report and literature review.,0
3460,4,Can radiotherapy cause radiation induced osteosarcoma?,We present a rare case of radiation-induced osteosarcoma following Gamma Knife® surgery (GKS) for a vestibular schwannoma (VS).,0
3460,5,Can radiotherapy cause radiation induced osteosarcoma?,The osteosarcoma was considered to be a radiation-induced malignancy.,0
3460,6,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma.,0
3460,7,Can radiotherapy cause radiation induced osteosarcoma?,The purpose of this study was to analyze the association of clinicopathologic characteristics with treatment outcomes and prognostic factors of patients who developed RIOSM after undergoing radiotherapy for nasopharyngeal carcinoma (NPC).,0
3460,8,Can radiotherapy cause radiation induced osteosarcoma?,"Of these patients, 47 who developed RISOM and met inclusion criteria were included in this study.",0
3460,9,Can radiotherapy cause radiation induced osteosarcoma?,CONCLUSIONS: RISOM after radiotherapy for NPC is aggressive and often eludes early detection and timely intervention.,0
3460,10,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma of the skull base after radiation therapy in a patient with nasopharyngeal carcinoma: a case report and review of the literature.,0
3460,11,Can radiotherapy cause radiation induced osteosarcoma?,BACKGROUND: Radiation-induced osteosarcomas are a recognized complication of radiation therapy.,1
3460,12,Can radiotherapy cause radiation induced osteosarcoma?,CASE PRESENTATION: We describe a rare case of a patient with a skull base radiation-induced osteosarcoma treated 11 years before with ionizing radiation for an undifferentiated carcinoma of the nasopharynx.,0
3460,13,Can radiotherapy cause radiation induced osteosarcoma?,CONCLUSIONS: Radiation-induced osteosarcoma of the skull base after treatment of nasopharyngeal carcinoma is a very rare but very aggressive complication with a poor prognosis.,0
3460,14,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-Associated Low-Grade Extraskeletal Osteosarcoma of the Neck Following Treatment for Thyroid Cancer.,0
3460,15,Can radiotherapy cause radiation induced osteosarcoma?,Low-grade extraskeletal osteosarcoma is a rare tumor that may arise de novo or following radiation therapy.,0
3460,16,Can radiotherapy cause radiation induced osteosarcoma?,"While there is a report of a low-grade extraskeletal osteosarcoma arising following radiotherapy for a benign condition, to the best of our knowledge this is the first reported case of a low-grade extraskeletal osteosarcoma occurring following radiotherapy for thyroid cancer, and the only case reported in the soft tissue of the head and neck region.",0
3460,17,Can radiotherapy cause radiation induced osteosarcoma?,Here we a report a case of radiation induced osteosarcoma which developed 11 years after a single fraction of 700 cGy.,0
3460,18,Can radiotherapy cause radiation induced osteosarcoma?,Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification.,0
3460,19,Can radiotherapy cause radiation induced osteosarcoma?,The radiotherapy dose for this patient is lower than classically reported for radiation induced sarcomas.,0
3460,20,Can radiotherapy cause radiation induced osteosarcoma?,The latency period between radiotherapy and osteosarcoma onset was 1.3 years shorter inside than outside the radiation field.,0
3460,21,Can radiotherapy cause radiation induced osteosarcoma?,Osteosarcoma after radiotherapy for prostate cancer.,0
3460,22,Can radiotherapy cause radiation induced osteosarcoma?,Osteosarcoma after external beam radiation therapy for recurrent choroidal melanoma.,0
3460,23,Can radiotherapy cause radiation induced osteosarcoma?,Diagnostic criteria were fulfilled and the lesion was classified as a radiation induced osteosarcoma,0
3460,24,Can radiotherapy cause radiation induced osteosarcoma?,"Although a rare complication of ionizing radiation, radiation-induced osteosarcoma is now more frequently recognized as radiation therapy has become common and cancer survival has increased",1
3460,25,Can radiotherapy cause radiation induced osteosarcoma?,Here we a report a case of radiation induced osteosarcoma which developed 11 years after a single fraction of 700 cGy,0
3460,26,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma usually occurs after a long latency period of more than 10 years after the radiotherapy,0
3460,27,Can radiotherapy cause radiation induced osteosarcoma?,Osteosarcoma following radiotherapy: a case report.,0
3460,28,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced fibrosarcoma after radiotherapy for osteosarcoma in the mandibular condyle.,0
3460,29,Can radiotherapy cause radiation induced osteosarcoma?,Post-radiation osteosarcoma of the scapula.,0
3460,30,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcomas generally occur 3-30 years after exposure and are most common after radiotherapy for cervical or breast carcinoma,0
3460,31,Can radiotherapy cause radiation induced osteosarcoma?,"Radiation-induced osteosarcoma is one of the rare types of radiation-induced sarcomas , with the risk of radiation-induced osteosarcomas being only 0.01 % -0.03 % among all patients treated with radiotherapy",0
3460,32,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma is a well-known but rare complication of radiotherapy for brain neoplasms with a poor prognosis,1
3460,33,Can radiotherapy cause radiation induced osteosarcoma?,"The prognosis of patients developing osteosarcoma after radiotherapy for prostate cancer is similar to other radiation-induced osteosarcomas occurring in the axial skeleton , with a 50 % overall mortality within the first year after diagnosis",0
3460,34,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma usually occurs after a long latency period of more than 10 years after the radiotherapy,0
3460,35,Can radiotherapy cause radiation induced osteosarcoma?,Twenty-seven years 11 months after orthovoltage radiotherapy of the right breast a 69-year-old woman developed a radiation-induced osteosarcoma of the right thoracic wall,0
3460,36,Can radiotherapy cause radiation induced osteosarcoma?,We report a case of radiation-induced osteosarcoma developed from skull after 7 years of craniospinal radiotherapy for pineoblastoma,0
3460,37,Can radiotherapy cause radiation induced osteosarcoma?,"Although the concepts of direct and indirect effects of radiation are fully applicable to low-LET ( linear energy transfer ) radioresistant tumor cells/normal tissues such as osteosarcoma cells and chondrocytes , it is believed that radiation-associated damage to DNA does not play a major role in the mechanism of cell death in low-LET radiosensitive tumors/normal tissues such as malignant lymphoma cells and lymphocytes",0
3460,38,Can radiotherapy cause radiation induced osteosarcoma?,"From these clinicopathological findings, both cases were diagnosed as radiation-induced osteosarcoma.",0
3460,39,Can radiotherapy cause radiation induced osteosarcoma?,Here we report two cases of radiation-induced osteosarcoma in the paranasal sinus after treatment for frontal glioma.,0
3460,40,Can radiotherapy cause radiation induced osteosarcoma?,"As the prognosis of radiation-induced osteosarcoma is poorer than that of primary osteo-sarcoma, careful attention is required for consideration of the long-term survival of patients with glioma.",0
3460,41,Can radiotherapy cause radiation induced osteosarcoma?,"Radiation-induced osteosarcomas appeared 16 and 12 years after radiotherapy in cases 1 and 2, respectively.",0
3460,42,Can radiotherapy cause radiation induced osteosarcoma?,Most radiation-induced osteosarcomas of the skull are reported to arise in the facial bone or paranasal sinus after radiotherapy for retinoblastoma and/or pituitary adenoma.,0
3460,43,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcomas after treatment for frontal gliomas: a report of two cases.,1
3460,44,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma of the skull mimicking cutaneous tumor after treatment for frontal glioma.,0
3460,45,Can radiotherapy cause radiation induced osteosarcoma?,"Radiation-induced osteosarcoma is one of the rare types of radiation-induced sarcomas, with the risk of radiation-induced osteosarcomas being only 0.01%-0.03% among all patients treated with radiotherapy.",0
3460,46,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced sarcomas are recognized complications of radiation therapy and are associated with poor prognosis.,1
3460,47,Can radiotherapy cause radiation induced osteosarcoma?,There have been only four reported cases of radiation-induced osteosarcomas after radiotherapy for gliomas.,0
3460,48,Can radiotherapy cause radiation induced osteosarcoma?,"Here, we report a unique case of radiation-induced osteosarcomas arising on the skull and extending to the skin, with a short latent period.",0
3460,49,Can radiotherapy cause radiation induced osteosarcoma?,"BACKGROUND
The increasing incidence of radiation-induced osteosarcoma of the maxilla and mandible (RIOSM) has become a significant problem that can limit long-term survival.",0
3460,50,Can radiotherapy cause radiation induced osteosarcoma?,"In this case, osteosarcoma was possibly a radiation-induced osteosarcoma with a short latency period of 3 years.",0
3460,51,Can radiotherapy cause radiation induced osteosarcoma?,Radiation-induced osteosarcoma usually occurs after a long latency period of more than 10 years after the radiotherapy.,0
3460,52,Can radiotherapy cause radiation induced osteosarcoma?,A case of osteosarcoma arising in the craniofacial bone with a short latency period of 3 years after radiotherapy for maxillary squamous cell carcinoma is described.,0
3460,53,Can radiotherapy cause radiation induced osteosarcoma?,Osteosarcoma is one of the neoplasms that may occur following exposure to radiation.,0
3460,54,Can radiotherapy cause radiation induced osteosarcoma?,"As the prognosis of radiation-induced osteosarcoma is poorer than that of primary osteo-sarcoma, careful attention is required for consideration of the long-term survival of patients with glioma.",0
3460,55,Can radiotherapy cause radiation induced osteosarcoma?,This report describes the late recurrence of choroidal melanoma and subsequent radiation-induced osteosarcoma.,0
3460,56,Can radiotherapy cause radiation induced osteosarcoma?,"Radiation-induced osteosarcoma is one of the rare types of radiation-induced sarcomas, with the risk of radiation-induced osteosarcomas being only 0.01%-0.03% among all patients treated with radiotherapy.",0
3460,57,Can radiotherapy cause radiation induced osteosarcoma?,There have been only four reported cases of radiation-induced osteosarcomas after radiotherapy for gliomas.,0
3460,58,Can radiotherapy cause radiation induced osteosarcoma?,"Although radiation-induced osteosarcoma is an uncommon but dire complication of radiotherapy, its incidence will probably increase in the future as the frequency of radiation treatment and cancer survival increase.",0
3460,59,Can radiotherapy cause radiation induced osteosarcoma?,We report a case of radiation-induced osteosarcoma developed from skull after 7 years of craniospinal radiotherapy for pineoblastoma.,0
3460,60,Can radiotherapy cause radiation induced osteosarcoma?,"The prognosis of patients developing osteosarcoma after radiotherapy for prostate cancer is similar to other radiation-induced osteosarcomas occurring in the axial skeleton, with a 50% overall mortality within the first year after diagnosis.",0
3460,61,Can radiotherapy cause radiation induced osteosarcoma?,To our knowledge the only other case report of post-radiation osteosarcoma with a short latency period was a case of osteosarcoma in the craniofacial bone 3 years after radiotherapy for maxillary squamous cell carcinoma.,0
3460,62,Can radiotherapy cause radiation induced osteosarcoma?,"Here, we report a unique case of radiation-induced osteosarcomas arising on the skull and extending to the skin, with a short latent period.",0
3460,63,Can radiotherapy cause radiation induced osteosarcoma?,Case of postradiation osteosarcoma with a short latency period of 3 years.,0
2536,0,Name curated data resources for ChIP-seq data,MGA repository: a curated data resource for ChIP-seq and other genome annotated data.,1
2536,1,Name curated data resources for ChIP-seq data,Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse.,1
2536,2,Name curated data resources for ChIP-seq data,"Although rapidly accumulating publicly available ChIP-seq, DNase-seq and ATAC-seq data are a valuable resource for the systematic investigation of gene regulation processes, a lack of standardized curation, quality control and analysis procedures have hindered extensive reuse of these data.",0
2536,3,Name curated data resources for ChIP-seq data,"To overcome this challenge, we built the Cistrome database, a collection of ChIP-seq and chromatin accessibility data (DNase-seq and ATAC-seq) published before January 1, 2016, including 13 366 human and 9953 mouse samples.",0
2536,4,Name curated data resources for ChIP-seq data,All the data have been carefully curated and processed with a streamlined analysis pipeline and evaluated with comprehensive quality control metrics.,0
2536,5,Name curated data resources for ChIP-seq data,"We have also created a user-friendly web server for data query, exploration and visualization.",0
2536,6,Name curated data resources for ChIP-seq data,"The resulting Cistrome DB (Cistrome Data Browser), available online at http://cistrome.org/db, is expected to become a valuable resource for transcriptional and epigenetic regulation studies.",1
2536,7,Name curated data resources for ChIP-seq data,CR Cistrome: a ChIP-Seq database for chromatin regulators and histone modification linkages in human and mouse.,0
2536,8,Name curated data resources for ChIP-seq data,We have created CistromeMap as a web server to provide a comprehensive knowledgebase of all of the publicly available ChIP-Seq and DNase-Seq data in mouse and human.,0
2536,9,Name curated data resources for ChIP-seq data,"To overcome this challenge, we built the Cistrome database, a collection of ChIP-seq and chromatin accessibility data (DNase-seq and ATAC-seq) published before January 1, 2016, including 13 366 human and 9953 mouse samples.",0
2536,10,Name curated data resources for ChIP-seq data,We have created CistromeMap as a web server to provide a comprehensive knowledgebase of all of the publicly available ChIP-Seq and DNase-Seq data in mouse and human.,0
2536,11,Name curated data resources for ChIP-seq data,"The resulting Cistrome DB (Cistrome Data Browser), available online at http://cistrome.org/db, is expected to become a valuable resource for transcriptional and epigenetic regulation studies.<br>",1
2536,12,Name curated data resources for ChIP-seq data,Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse.,1
3936,0,Is cabergoline used for treatment of the Nelson's syndrome ?,"Due to a rapid regrowth of the tumour, the patient did not receive gamma-knife therapy and was treated with cabergoline and somatostatin analogue for some time.",0
3936,1,Is cabergoline used for treatment of the Nelson's syndrome ?,"Identification of D(2) receptors in corticotroph tumors led to clinical trials of cabergoline therapy in limited cases of Nelson's syndrome, ectopic ACTH-secreting tumors, and recently Cushing's disease (CD).",0
3936,2,Is cabergoline used for treatment of the Nelson's syndrome ?," In our observation cabergoline at 2 mg per week seems to be efficient after a 3 and a half years follow-up, in accordance with some recent publications.",0
3936,3,Is cabergoline used for treatment of the Nelson's syndrome ?,Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment.,0
3936,4,Is cabergoline used for treatment of the Nelson's syndrome ?,"We report the results of long-term (6-year) treatment of Nelson's syndrome with the long-acting dopamine agonist, cabergoline, in a 55-year-old woman.",1
3936,5,Is cabergoline used for treatment of the Nelson's syndrome ?,This case demonstrates that long-term cabergoline treatment may be efficient in patients with Nelson's syndrome.,0
3936,6,Is cabergoline used for treatment of the Nelson's syndrome ?,"Therefore, in addition to prolactinomas, targets of dopamine agonist therapy are somatotroph tumors, nonfunctioning pituitary tumors, corticotroph pituitary tumors, Nelson's syndrome, gonadotropinomas, and thyrotropin-secreting pituitary tumors.",0
3936,7,Is cabergoline used for treatment of the Nelson's syndrome ?,Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.,0
3936,8,Is cabergoline used for treatment of the Nelson's syndrome ?,The results obtained show for the first time that a long-term treatment with cabergoline also brings about a complete remission of Nelson's syndrome in the presence of a pituitary macroadenoma.,0
3936,9,Is cabergoline used for treatment of the Nelson's syndrome ?,Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.,1
3936,10,Is cabergoline used for treatment of the Nelson's syndrome ?,In this case report we demonstrated that treatment with the long-acting D2 receptor agonist cabergoline for 1 year induced normalization of plasma ACTH levels and disappearance of the pituitary tumor in a patient with Nelson's syndrome.,0
3936,11,Is cabergoline used for treatment of the Nelson's syndrome ?,This case demonstrated that cabergoline treatment is able to induce the remission of Nelson's syndrome and may be a valid therapeutic alternative in this syndrome.,1
3936,12,Is cabergoline used for treatment of the Nelson's syndrome ?,"However, some preliminary data suggest a potential use of cabergoline in combination with ketoconazole, or alone, in selected cases of Cushing's disease or Nelson's syndrome.",0
3936,13,Is cabergoline used for treatment of the Nelson's syndrome ?,"We report the results of long-term (6-year) treatment of Nelson's syndrome with the long-acting dopamine agonist, cabergoline, in a 55-year-old woman.",1
3936,14,Is cabergoline used for treatment of the Nelson's syndrome ?,The,0
3936,15,Is cabergoline used for treatment of the Nelson's syndrome ?,actinomas.,0
3936,16,Is cabergoline used for treatment of the Nelson's syndrome ?,"Identification of D(2) receptors in corticotroph tumors led to clinical trials of cabergoline therapy in limited cases of Nelson's syndrome, ectopic ACTH-secreting tumors, and recently Cushing's diseas",0
3936,17,Is cabergoline used for treatment of the Nelson's syndrome ?,"In order to investigate on the direct effect played by cabergoline treatment on the remission of Nelson's syndrome, the treatment was withdrawn.",1
3936,18,Is cabergoline used for treatment of the Nelson's syndrome ?,lactinomas.,0
3936,19,Is cabergoline used for treatment of the Nelson's syndrome ?,"Identification of D(2) receptors in corticotroph tumors led to clinical trials of cabergoline therapy in limited cases of Nelson's syndrome, ectopic ACTH-secreting tumors, and recently Cushing's disease (CD).OBJECTIVE: To evaluate the long-term efficacy of cabergoline monotherapy in patients with CD.METHODS: Retrospective analysis of non-randomized clinical therapy with cabergoline in 30 patients with CD treated in academic cente",0
3160,0,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"The flavoenzyme dihydroorotate dehydrogenase (DHODH) catalyzes the fourth reaction of the de novo pyrimidine biosynthetic pathway, which exerts vital functions in the cells, especially within DNA and RNA biosynthesis.",1
3160,1,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,Human dihydroorotate dehydrogenase (HsDHODH) is a key enzyme of pyrimidine de novo biosynthesis pathway,0
3160,2,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,Dihydroorotate dehydrogenase (DHODH) mediates the fourth step of de novo pyrimidine biosynthesis and is a proven drug target for inducing immunosuppression in therapy of human disease as well as a rapidly emerging drug target for treatment of malaria.,0
3160,3,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"This review focuses on recent studies to exploit the fourth enzyme in the de novo pyrimidine biosynthetic pathway of P. falciparum, dihydroorotate dehydrogenase (PfDHODH), as a new target for drug discovery.",0
3160,4,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,The flavoenzyme dihydroorotate dehydrogenase catalyzes the stereoselective oxidation of (S)-dihydroorotate to orotate in the fourth of the six conserved enzymatic reactions involved in the de novo pyrimidine biosynthetic pathway.,1
3160,5,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,A set of compounds designed to inhibit the Plasmodium falciparum pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (PfDHODH) was synthesized.,0
3160,6,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Dihydroorotate dehydrogenase (DHOD) is the fourth enzyme in the de novo pyrimidine biosynthetic pathway and is essential in Trypanosoma cruzi, the parasitic protist causing Chagas' disease.",1
3160,7,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Hence, we evaluated the essentiality of one enzyme in the pyrimidine biosynthetic pathway, dihydroorotate dehydrogenase (DHODH) from the eukaryotic parasite Trypanosoma brucei through gene knockdown studies.",0
3160,8,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Dihydroorotate dehydrogenase, an enzyme catalyzing the only redox reaction of the pyrimidine biosynthesis pathway, is a well-characterized target for chemotherapeutical intervention.",0
3160,9,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Inhibition of dihydroorotate dehydrogenase (DHODH) for P. falciparum potentially represents a new treatment option for malaria, since DHODH catalyzes the rate-limiting step in the pyrimidine biosynthetic pathway and P. falciparum is unable to salvage pyrimidines and must rely on de novo biosynthesis for survival.",0
3160,10,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"An important target for antimalarial chemotherapy is the enzyme dihydroorotate dehydrogenase from Plasmodium falciparum (PfDHODH), which is responsible for the conversion of dihydroorotate to orotate in the de novo pyrimidine biosynthetic pathway.",0
3160,11,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,Dihydroorotate dehydrogenase (DHODH) is an enzyme in the pyrimidine biosynthetic pathway which is an important target for anti-hyperproliferative and anti-inflammatory drug design.,0
3160,12,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,Dihydroorotate dehydrogenase (DHODH) is the fourth enzyme in the de novo pyrimidine biosynthetic pathway and has been exploited as the target for therapy against proliferative and parasitic diseases.,1
3160,13,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,Dihydroorotate dehydrogenase (DHODH) catalyzes the rate-limiting step in the pyrimidine biosynthetic pathway and represents a potential target for anti-malarial therapy.,0
3160,14,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,The enzyme dihydroorotate dehydrogenase (DHODH) is a flavoenzyme that catalyses the oxidation of dihydroorotate to orotate in the de novo pyrimidine-biosynthesis pathway.,0
3160,15,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Dihydroorotase and dihydroorotate dehydrogenase, two enzymes of the pyrimidine biosynthetic pathway, were purified from Plasmodium berghei to apparent homogeneity.",0
3160,16,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Dihydroorotate dehydrogenase (DHOD), a mitochondrially localized flavoenzyme, catalyzes the rate-limiting step of this pathway and is therefore an attractive antimalarial chemotherapeutic target.",0
3160,17,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,Human dihydroorotate dehydrogenase (HsDHODH) is a key enzyme of pyrimidine de novo biosynthesis pathway.,0
3160,18,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Dihydroorotate dehydrogenase, an enzyme catalyzing the only redox reaction of the pyrimidine biosynthesis pathway, is a well-characterized target for chemotherapeutical intervention.",0
3160,19,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from Toxoplasma gondii.The pyrimidine biosynthesis pathway in the protozoan pathogen Toxoplasma gondii is essential for parasite growth during infection.,0
3160,20,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"This review focuses on recent studies to exploit the fourth enzyme in the de novo pyrimidine biosynthetic pathway of P. falciparum, dihydroorotate dehydrogenase (PfDHODH), as a new target for drug discovery.",0
3160,21,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"The novel anticancer drug candidate brequinar sodium (DuP 785, NSC 368390, 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinoline- carboxylic acid sodium salt) was shown previously to be an inhibitor of dihydroorotate dehydrogenase, the fourth enzyme of the de novo pyrimidine biosynthetic pathway.",0
3160,22,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"Dihydroorotate dehydrogenase (DHODH), in the de novo pyrimidine biosynthetic pathway, is the fourth enzyme of pyrimidine synthesis and is used to oxidize dihydroorotate and hence to orotat.",1
3160,23,Human dihydroorotate dehydrogenase is a drug target and is involved in what biosynthetic pathway,"The novel anticancer drug candidate brequinar sodium [DuP 785, NSC 368390, 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid sodium salt] inhibits dihydroorotate dehydrogenase, the fourth enzyme in the de novo pyrimidine biosynthetic pathway leading to the formation of UMP.",0
926,0,Is there a role for transcription factories in genome organization?,"The mammalian nucleus is a highly complex structure that carries out a diverse range of functions such as DNA replication, cell division, RNA processing, and nuclear export/import.",1
926,1,Is there a role for transcription factories in genome organization?,Many of these activities occur at discrete subcompartments that intersect with specific regions of the genome.,1
926,2,Is there a role for transcription factories in genome organization?,"Over the past few decades, evidence has accumulated to suggest that RNA transcription also occurs in specialized sites, called transcription factories, that may influence how the genome is organized.",1
926,3,Is there a role for transcription factories in genome organization?,There may be certain efficiency benefits to cluster transcriptional activity in this way.,0
926,4,Is there a role for transcription factories in genome organization?,"However, the clustering of genes at transcription factories may have consequences for genome stability, and increase the susceptibility to recurrent chromosomal translocations that lead to cancer",1
926,5,Is there a role for transcription factories in genome organization?,"In the eukaryotic nucleus, genes are transcribed in transcription factories",0
926,6,Is there a role for transcription factories in genome organization?,"Based on this analysis, we propose that transcription factories result from the aggregation of RNA polymerase II-containing pre-initiation complexes assembled next to each other in the nuclear space.",0
926,7,Is there a role for transcription factories in genome organization?,Such an aggregation can be triggered by the phosphorylation of the C-terminal domain of RNA polymerase II molecules and their interaction with various transcription factors.,0
926,8,Is there a role for transcription factories in genome organization?,"Individual transcription factories would thus incorporate tissue-specific, co-regulated as well as housekeeping genes based only on their initial proximity to each other in the nuclear space",0
926,9,Is there a role for transcription factories in genome organization?,"active polymerases cluster into replication and transcription ""factories"" in both pro- and eukaryotes.",0
926,10,Is there a role for transcription factories in genome organization?,We conclude that the second law of thermodynamics acts through nonspecific entropic forces between engaged polymerases to drive the self-organization of genomes into loops containing several thousands (and sometimes millions) of basepairs,1
926,11,Is there a role for transcription factories in genome organization?,"Since the advent of FISH (fluorescence in situ hybridization), there have been major advances in our understanding of how the genome is organized in interphase nuclei.",0
926,12,Is there a role for transcription factories in genome organization?,"Indeed, this organization is found to be non-random and individual chromosomes occupy discrete regions known as territories",0
926,13,Is there a role for transcription factories in genome organization?," in proliferating cells, there is evidently a correlation between radial positioning and gene density.",0
926,14,Is there a role for transcription factories in genome organization?,"Indeed, gene-poor chromosomes tend to be located towards the nuclear edge, while those that are more gene-rich are positioned more internally",0
926,15,Is there a role for transcription factories in genome organization?,Recently described active chromatin hubs and transcription factories also involve long-range interactions,0
926,16,Is there a role for transcription factories in genome organization?,"The transcription factory model has implications for the regulation of transcription initiation and elongation, for the organization of genes in the genome, for the co-regulation of genes and for genome instability.",0
3971,0,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene.,1
3971,1,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,Interstitial deletions of the long arm of chromosome 6 are rare.,0
3971,2,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"Clinically, these deletions are considered to be part of a unique microdeletion syndrome associated with intellectual disability and speech impairment, typical dysmorphic features, structural anomalies of the brain, microcephaly, and non-specific multiple organ anomalies.",1
3971,3,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"The critical region for the interstitial 6q microdeletion phenotype was mapped to 6q24-6q25, particularly the 6q25.3 region containing the genes ARID1B and ZDHHC14.",1
3971,4,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,It has been hypothesized that haploinsufficiency of these genes impairs normal development of the brain and is responsible for the phenotype.,0
3971,5,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"This case report describes a girl presenting with typical features of 6q microdeletion syndrome, including global developmental delay, speech impairment, distinct dysmorphic features, dysgenesis of the corpus callosum, common limb anomalies, and hearing loss.",0
3971,6,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"Chromosome analysis by array-CGH revealed a small interstitial 6q deletion spanning approximately 1.1 Mb of DNA and containing only one coding gene, ARID1B.",0
3971,7,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"We suggest that ARID1B is the key gene behind 6q microdeletion syndrome, and we discuss its possible role in the phenotypic manifestations.",0
3971,8,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"We suggest that ARID1B is the key gene behind 6q microdeletion syndrome, and we discuss its possible role in the phenotypic manifestations.",0
3971,9,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene,0
3971,10,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"itical region for the interstitial 6q microdeletion phenotype was mapped to 6q24-6q25, particularly the 6q25.3 region containing the genes ARID1B and ZDHHC14.",1
3971,11,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,It ha,0
3971,12,Which key gene is involved in interstitial 6q25 microdeletion syndrome?,"The critical region for the interstitial 6q microdeletion phenotype was mapped to 6q24-6q25, particularly the 6q25.3 region containing the genes ARID1B and ZDHHC14.",1
1108,0,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,An increase in α-synuclein levels due to gene duplications/triplications or impaired degradation is sufficient to trigger its aggregation and cause familial Parkinson disease,0
1108,1,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,"Here, we report that Polo-like kinase 2 (PLK2), an enzyme up-regulated in synucleinopathy-diseased brains, interacts with, phosphorylates and enhances α-synuclein autophagic degradation in a kinase activity-dependent manner.",1
1108,2,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo,0
1108,3,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,"Collectively, our findings demonstrate that PLK2 is a previously undescribed regulator of α-synuclein turnover and that modulating its kinase activity could be a viable target for the treatment of synucleinopathies.",0
1108,4,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?, α-Synuclein increased PLK2 levels and GSK-3β activity and increased the levels of phosphorylated α-Synuclein and Tau,0
1108,5,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system,1
1108,6,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,"Several neurological diseases, including Parkinson disease and dementia with Lewy bodies, are characterized by the accumulation of alpha-synuclein phosphorylated at Ser-129 (p-Ser-129)",0
1108,7,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,"Here we submit evidence that polo-like kinase 2 (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-synuclein phosphorylation at Ser-129 in neurons.",1
1108,8,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay,1
1108,9,Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?,These results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system.,1
2639,0,What is crenezumab?,Solanezumab and Crenezumab are two humanized antibodies targeting Amyloid-β (Aβ) which are currently tested in multiple clinical trials for the prevention of Alzheimer's disease.,1
2639,1,What is crenezumab?,"Remarkably, Solanezumab showed a strong binding affinity to plaques.",1
2639,2,What is crenezumab?,"We also reaffirmed that Bapineuzumab does not recognize N-truncated or modified Aβ, while Solanezumab and Crenezumab do detect N-terminally modified Aβ peptides Aβ4-42 and pyroglutamate Aβ3-42.",1
2639,3,What is crenezumab?,"In conclusion, the biosimilar antibodies Solanezumab, Crenezumab and Bapineuzumab strongly react with amyloid plaques, which are in contrast to the NT4X antibody that hardly recognizes plaques in human tissue.",1
3138,0,Which tools have been developed for computing split-networks?,SPECTRE: a suite of phylogenetic tools for reticulate evolution.,1
3138,1,Which tools have been developed for computing split-networks?,Split-networks are a generalization of phylogenetic trees that have proven to be a powerful tool in phylogenetics.,1
3138,2,Which tools have been developed for computing split-networks?,"Various ways have been developed for computing such networks, including split-decomposition, NeighborNet, QNet and FlatNJ.",1
3138,3,Which tools have been developed for computing split-networks?,Some of these approaches are implemented in the user-friendly SplitsTree software package.,0
3138,4,Which tools have been developed for computing split-networks?,"However, to give the user the option to adjust and extend these approaches and to facilitate their integration into analysis pipelines, there is a need for robust, open-source implementations of associated data structures and algorithms.",0
3138,5,Which tools have been developed for computing split-networks?,"Here, we present SPECTRE, a readily available, open-source library of data structures written in Java, that comes complete with new implementations of several pre-published algorithms and a basic interactive graphical interface for visualizing planar split networks.",0
3138,6,Which tools have been developed for computing split-networks?,"SPECTRE also supports the use of longer running algorithms by providing command line interfaces, which can be executed on servers or in High Performance Computing environments.",0
3138,7,Which tools have been developed for computing split-networks?,FlatNJ: a novel network-based approach to visualize evolutionary and biogeographical relationships.,0
3138,8,Which tools have been developed for computing split-networks?,Split networks are a type of phylogenetic network that allow visualization of conflict in evolutionary data.,1
3138,9,Which tools have been developed for computing split-networks?,We present a new method for constructing such networks called FlatNetJoining (FlatNJ).,1
3138,10,Which tools have been developed for computing split-networks?,QNet: an agglomerative method for the construction of phylogenetic networks from weighted quartets.,0
3138,11,Which tools have been developed for computing split-networks?,"We present QNet, a method for constructing split networks from weighted quartet trees.",0
3138,12,Which tools have been developed for computing split-networks?,QNet can be viewed as a quartet analogue of the distance-based Neighbor-Net (NNet) method for network construction.,0
3138,13,Which tools have been developed for computing split-networks?,"Just as NNet, QNet works by agglomeratively computing a collection of circular weighted splits of the taxa set which is subsequently represented by a planar split network.",0
2306,0,How many PML isoforms exist in the human genome?,The PML isoforms that are most sensitive to virus infection correspond closely to those which have recently been identified as being covalently conjugated to PIC1.,1
2306,1,How many PML isoforms exist in the human genome?,"Using a panel of different PML isoforms, we demonstrate specific co-localization between the E6 proteins and PML isoforms I-IV, but not with PML isoforms V and VI.",0
2306,2,How many PML isoforms exist in the human genome?,PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.,0
2306,3,How many PML isoforms exist in the human genome?, We report that individual expression of PML isoforms I and II partially reverses the increase in ICP0-null mutant HSV-1 plaque formation that occurs in PML-depleted cells.,0
2306,4,How many PML isoforms exist in the human genome?,"PML, the organizer of nuclear bodies (NBs), is expressed in several isoforms designated PMLI to VII which differ in their C-terminal region due to alternative splicing of a single gene.",1
2306,5,How many PML isoforms exist in the human genome?,"Using a bioluminescence resonance energy transfer (BRET) assay in living cells, we found that As₂O₃ enhanced the SUMOylation and interaction with RNF4 of nuclear PML isoforms (I to VI)",0
2306,6,How many PML isoforms exist in the human genome?,PML is the structural component of PML nuclear bodies and has several nuclear splice isoforms that share a common N-terminal region but differ in their C termini.,1
2306,7,How many PML isoforms exist in the human genome?,Several PML isoforms are generated from a single PML gene by alternative splicing.,1
2306,8,How many PML isoforms exist in the human genome?,"Six major PML isoforms are expressed as a result of alternative splicing, each of which encodes a unique C-terminal region.",1
2306,9,How many PML isoforms exist in the human genome?," However, the biochemical consequences and oncogenic alterations of PML-associated E1B-55K by SUMO-dependent PML-IV and PML-V interaction have so far remained elusive",0
2123,0,What condition is usually represented by the acronym SUDEP?,Sudden Unexpected Death in Epilepsy (SUDEP),1
2123,1,What condition is usually represented by the acronym SUDEP?," sudden unexpected death in epilepsy (SUDEP),",1
2123,2,What condition is usually represented by the acronym SUDEP?,"Sudden unexpected death in epilepsy (SUDEP) is the most important direct seizure-related cause of death, and most cases usually occur in patients with intractable, longstanding epilepsy.",0
2123,3,What condition is usually represented by the acronym SUDEP?,Sudden unexpected death in epilepsy (SUDEP): what do patients think?,0
2123,4,What condition is usually represented by the acronym SUDEP?,OBJECTIVES: Sudden unexpected death in epilepsy (SUDEP) is a major cause of mortality in epilepsy.,0
2123,5,What condition is usually represented by the acronym SUDEP?,In 11 patients cause of death was sudden unexpected death in epilepsy (SUDEP).,0
2123,6,What condition is usually represented by the acronym SUDEP?,"Epilepsy-related death, particularly sudden unexpected death in epilepsy (SUDEP), is still underestimated by healthcare professionals and this may reflect the mistaken belief that epilepsy is a benign condition",0
2123,7,What condition is usually represented by the acronym SUDEP?,Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms,0
2123,8,What condition is usually represented by the acronym SUDEP?,"Sudden unexpected death in epilepsy (SUDEP) is a - probably heterogeneous - condition where patients with epilepsy die suddenly, almost certainly during a seizure and with no other identified cause of death.",0
2123,9,What condition is usually represented by the acronym SUDEP?,"Epilepsy, the commonest serious neurological condition, is associated with an increased risk in premature deaths, including an estimated 500 sudden unexpected deaths (SUDEP) per year in the UK.",0
2123,10,What condition is usually represented by the acronym SUDEP?,Epilepsy is the most common serious neurological condition and sudden unexpected death in epilepsy (SUDEP) is the most important direct epilepsy-related cause of death.,0
2123,11,What condition is usually represented by the acronym SUDEP?,Epilepsy is the most common serious neurological condition and sudden unexpected death in epilepsy (SUDEP) is the most important direct epilepsy-related cause of death.,0
2123,12,What condition is usually represented by the acronym SUDEP?,Sudden unexpected death in epilepsy (SUDEP) is an exceptionally difficult condition to study in humans.,0
2123,13,What condition is usually represented by the acronym SUDEP?,"Sudden unexpected death in epilepsy (SUDEP): don't ask, don't tell?",0
2123,14,What condition is usually represented by the acronym SUDEP?,"Many individuals with epilepsy, as well as their partners, relatives, and friends, are unaware of the risk for sudden unexpected death in epilepsy (SUDEP).",0
2123,15,What condition is usually represented by the acronym SUDEP?,The baboon represents a natural model for genetic generalized epilepsy and sudden unexpected death in epilepsy (SUDEP).,0
2123,16,What condition is usually represented by the acronym SUDEP?,"Sudden unexpected death in epilepsy (SUDEP) refers to the sudden death of a seemingly healthy individual with epilepsy, usually occurring during, or immediately after, a tonic-clonic seizure.",0
2123,17,What condition is usually represented by the acronym SUDEP?,"This condition is called sudden unexpected death in epilepsy (SUDEP), and it accounts for a large proportion of deaths among people with epilepsy.",0
2123,18,What condition is usually represented by the acronym SUDEP?,"Epilepsy-related death, particularly sudden unexpected death in epilepsy (SUDEP), is still underestimated by healthcare professionals and this may reflect the mistaken belief that epilepsy is a benign condition.",0
2123,19,What condition is usually represented by the acronym SUDEP?,Sudden unexpected death in epilepsy (SUDEP) i,0
2123,20,What condition is usually represented by the acronym SUDEP?, sudden unexpected death in epilepsy (SUDEP),1
2123,21,What condition is usually represented by the acronym SUDEP?,sudden unexpected death in epilepsy (SUDEP) f,0
2123,22,What condition is usually represented by the acronym SUDEP?,udden unexpected death in epilepsy (SUDEP),0
2123,23,What condition is usually represented by the acronym SUDEP?,sudden and unexpected death in epilepsy (SUDEP),0
2123,24,What condition is usually represented by the acronym SUDEP?,Sudden unexpected death in epilepsy (SUDEP),1
2123,25,What condition is usually represented by the acronym SUDEP?,sudden unexpected death in epilepsy (SUDEP),1
2123,26,What condition is usually represented by the acronym SUDEP?,udden unexpected death in epilepsy (SUDEP) i,0
2123,27,What condition is usually represented by the acronym SUDEP?,Sudden unexplained death in epilepsy (SUDEP),0
2123,28,What condition is usually represented by the acronym SUDEP?,udden unexpected death in epilepsy (SUDEP),0
2123,29,What condition is usually represented by the acronym SUDEP?, sudden unexpected death in epilepsy (SUDEP),0
2123,30,What condition is usually represented by the acronym SUDEP?,udden unexpected death in epilepsy (SUDEP) is the leading cause for death in individuals with epilepsy.,0
3552,0,Is the BAGEL algorithm used for arrayed CRISPR screens?,BAGEL: a computational framework for identifying essential genes from pooled library screens.,1
3552,1,Is the BAGEL algorithm used for arrayed CRISPR screens?,"The adaptation of the CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells represents a major technological leap over RNA interference, the prior state of the art.",1
3552,2,Is the BAGEL algorithm used for arrayed CRISPR screens?,"New methods for analyzing the data and evaluating results are needed.RESULTS: We offer BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens.",1
3552,3,Is the BAGEL algorithm used for arrayed CRISPR screens?,"Coupled with gold-standard reference sets of essential and nonessential genes, BAGEL offers significantly greater sensitivity than current methods, while computational optimizations reduce runtime by an order of magnitude.CONCLUSIONS: Using BAGEL, we identify ~2000 fitness genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms.",1
3552,4,Is the BAGEL algorithm used for arrayed CRISPR screens?,BAGEL shows high sensitivity and specificity even across screens performed by different labs using different libraries and reagents.,0
3552,5,Is the BAGEL algorithm used for arrayed CRISPR screens?,"CONCLUSIONS

Using BAGEL, we identify ~2000 fitness genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms.",0
3552,6,Is the BAGEL algorithm used for arrayed CRISPR screens?,BAGEL: a computational framework for identifying essential genes from pooled library screens,1
3552,7,Is the BAGEL algorithm used for arrayed CRISPR screens?,"CONCLUSIONS
Using BAGEL, we identify ~2000 fitness genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms.",0
3552,8,Is the BAGEL algorithm used for arrayed CRISPR screens?,"CONCLUSIONS: Using BAGEL, we identify ~2000 fitness genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms.",0
3552,9,Is the BAGEL algorithm used for arrayed CRISPR screens?,"Conclusions Using BAGEL, we identify ~2000 fitness genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms.",0
944,0,Has protein citrullination been implicated in rheumatoid arthritis?,": Citrullination has become a hot topic within recent years due to its involvement in diseases such as rheumatoid arthritis (RA), multiple sclerosis and fibrosis.",0
944,1,Has protein citrullination been implicated in rheumatoid arthritis?,Current literature suggests that increased levels of citrullinated proteins are found in several if not all inflammatory diseases.,0
944,2,Has protein citrullination been implicated in rheumatoid arthritis?,Antibodies directed against citrullinated proteins and peptides (ACPAs) are the most specific serological markers available for diagnosing RA.,0
944,3,Has protein citrullination been implicated in rheumatoid arthritis?,"Citrullination of proteins is well described in rheumatoid arthritis (RA), and hypercitrullination of proteins may be related to inflammation in general.",0
944,4,Has protein citrullination been implicated in rheumatoid arthritis?,"Some ACPA are remarkably effective as diagnostics in autoimmune disorders, most notably rheumatoid arthritis (RA).",0
944,5,Has protein citrullination been implicated in rheumatoid arthritis?,Several ACPA can be observed before other clinical RA manifestations are apparent.,0
944,6,Has protein citrullination been implicated in rheumatoid arthritis?,Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the presence of rheumatoid factor (RF) and anti-citrullinated protein/peptide autoantibodies (ACPAs).,0
944,7,Has protein citrullination been implicated in rheumatoid arthritis?,Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.,1
944,8,Has protein citrullination been implicated in rheumatoid arthritis?,The implications of citrullination affecting integrin binding in disease open up a new area of study and might have implications for the pathogenesis of inflammatory diseases like rheumatoid arthritis and periodontitis.,0
944,9,Has protein citrullination been implicated in rheumatoid arthritis?,"In this paper, we will review the three of the main classes of PTMs already associated with RA: citrullination, carbamylation, and oxidation.",0
944,10,Has protein citrullination been implicated in rheumatoid arthritis?,Citrullinated collagen II (CII) is a well-known autoantigen in rheumatoid arthritis (RA).,1
944,11,Has protein citrullination been implicated in rheumatoid arthritis?,"Among the RA-associated autoantibodies, especially anti-citrullinated protein antibodies (ACPAs) have been studied intensively in the last decade.",0
944,12,Has protein citrullination been implicated in rheumatoid arthritis?,"Protein citrullination is a posttranslational modification that has attracted increased attention, especially for its involvement in rheumatoid arthritis (RA).",1
944,13,Has protein citrullination been implicated in rheumatoid arthritis?,Identification of citrullinated cellular fibronectin in synovial fluid from patients with rheumatoid arthritis.,0
944,14,Has protein citrullination been implicated in rheumatoid arthritis?,"Cellular fibronectin (cFn) has been implicated in the pathogenesis of rheumatoid arthritis (RA), and we previously demonstrated the presence of citrullinated cFn in rheumatoid synovial tissues.",1
944,15,Has protein citrullination been implicated in rheumatoid arthritis?," In rheumatoid arthritis, PAD4 and protein citrullination are increased in inflamed joints, and anti-citrullinated protein antibodies (ACPAs) form against citrullinated antigens are formed.",1
3079,0,Which was the first gene therapy to receive marketing authorization in the European Union?,"Alipogene tiparvovec (Glybera®) is the first gene therapy to receive Marketing Authorization in the European Union; GENIALL (GENetherapy In the MAnagement of Lipoprotein Lipase Deficiency), a 15-year registry focusing on LPLD was launched in 2014 as part of its Risk Management Plan.",1
1217,0,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",1
1217,1,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia.",0
1217,2,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.,0
1217,3,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",1
1217,4,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",1
1217,5,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia.Moreover, OATP1B1 and OATP1B3 null mutations may confer substantial drug toxicity risks.",0
1217,6,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia.",0
1217,7,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver,0
1217,8,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3",1
1217,9,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"The mechanistic basis of bilirubin excretion and hyperbilirubinemia syndromes is largely understood, but that of Rotor syndrome, an autosomal recessive disorder characterized by conjugated hyperbilirubinemia, coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics, has remained enigmatic.",0
1217,10,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",1
1217,11,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"The mechanistic basis of bilirubin excretion and hyperbilirubinemia syndromes is largely understood, but that of Rotor syndrome, an autosomal recessive disorder characterized by conjugated hyperbilirubinemia, coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics, has remained enigmatic.",0
1217,12,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",0
1217,13,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",0
1217,14,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,These important detoxification-limiting proteins mediate uptake and clearance of countless drugs and drug conjugates across the sinusoidal hepatocyte membrane.,0
1217,15,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",0
1217,16,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,These important detoxification-limiting proteins mediate uptake and clearance of countless drugs and drug conjugates across the sinusoidal hepatocyte membrane.,0
1217,17,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia.Moreover, OATP1B1 and OATP1B3 null mutations may confer substantial drug toxicity risks.",0
1217,18,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia.",0
1217,19,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Moreover, OATP1B1 and OATP1B3 null mutations may confer substantial drug toxicity risks.",0
1217,20,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.,0
1217,21,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",0
1217,22,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3.",0
1217,23,Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?,"Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia.",0
1442,0,What is Targeted Chromatin Capture (T2C)?,Targeted Chromatin Capture (T2C): a novel high resolution high throughput method to detect genomic interactions and regulatory elements.,1
1442,1,What is Targeted Chromatin Capture (T2C)?," Here we describe a new technique termed Targeted Chromatin Capture (T2C), to interrogate large selected regions of the genome.",1
1442,2,What is Targeted Chromatin Capture (T2C)?,"T2C provides an unbiased view of the spatial organization of selected loci at superior resolution (single restriction fragment resolution, from 2 to 6 kbp) at much lower costs than Hi-C due to the lower sequencing effort.",1
1442,3,What is Targeted Chromatin Capture (T2C)?,"T2C is an efficient, easy, and affordable with high (restriction fragment) resolution tool to address both genome compartmentalization and chromatin-interaction networks for specific genomic regions at high resolution for both clinical and non-clinical research.",1
1442,4,What is Targeted Chromatin Capture (T2C)?,"Here we describe a new technique termed Targeted Chromatin Capture (T2C), to interrogate large selected regions of the genome.",1
1442,5,What is Targeted Chromatin Capture (T2C)?,"Here we describe a new technique termed Targeted Chromatin Capture (T2C), to interrogate large selected regions of the genome.",0
609,0,What is transvection?,An unusual feature of the Diptera is that homologous chromosomes are intimately synapsed in somatic cells.,0
609,1,What is transvection?,"At a number of loci in Drosophila, this pairing can significantly influence gene expression.",0
609,2,What is transvection?,Such influences were first detected within the bithorax complex (BX-C) by E.B.,0
609,3,What is transvection?,"Lewis, who coined the term transvection to describe them.",0
609,4,What is transvection?,Most cases of transvection involve the action of enhancers in trans.,0
609,5,What is transvection?,"At several loci deletion of the promoter greatly increases this action in trans, suggesting that enhancers are normally tethered in cis by the promoter region.",0
609,6,What is transvection?,Transvection can also occur by the action of silencers in trans or by the spreading of position effect variegation from rearrangements having heterochromatic breakpoints to paired unrearranged chromosomes.,1
609,7,What is transvection?,"Although not demonstrated, other cases of transvection may involve the production of joint RNAs by trans-splicing.",0
609,8,What is transvection?,"Several cases of transvection require Zeste, a DNA-binding protein that is thought to facilitate homolog interactions by self-aggregation.",0
609,9,What is transvection?,Genes showing transvection can differ greatly in their response to pairing disruption.,0
609,10,What is transvection?,"In several cases, transvection appears to require intimate synapsis of homologs.",0
609,11,What is transvection?,"However, in at least one case (transvection of the iab-5,6,7 region of the BX-C), transvection is independent of synapsis within and surrounding the interacting gene.",1
609,12,What is transvection?,The latter example suggests that transvection could well occur in organisms that lack somatic pairing.,0
609,13,What is transvection?,"In support of this, transvection-like phenomena have been described in a number of different organisms, including plants, fungi, and mammals",0
609,14,What is transvection?,"Pairing-dependent interallelic complementation was first described for the Ultrabithorax gene of the bithorax-complex in Drosophila by Lewis and cited as an example of a new phenomenon that Lewis called the ""trans-vection effect.""",1
609,15,What is transvection?,"Several different kinds of pairing-dependent gene expression have been observed in Drosophila, and it is now clear that a variety of different molecular mechanisms probably underlie the changes in gene expression that are observed after disrupting chromosome pairing.",1
609,16,What is transvection?,Transvection in the bithorax-complex appears to result from the ability of cis-regulatory elements to regulate transcription of the promoter on the homologous chromosome.,0
609,17,What is transvection?,The same phenomenon appears to be responsible for pairing-dependent interallelic complementation at numerous other genes in Drosophila.,0
609,18,What is transvection?,"Some transvection effects are dependent on the presence of wild-type or specific mutant forms of the protein encoded by the zeste trans-regulatory gene, but other transvection effects are zeste-independent.",1
609,19,What is transvection?,The ease with which chromosome aberrations can disrupt transvection also varies widely among different genes,0
609,20,What is transvection?,The presence of homologous nucleic acid sequences can exert profound effects on chromosomal and gene function in a wide range of organisms.,0
609,21,What is transvection?,These homology effects reveal remarkable forms of regulation as well as suggest possible avenues for the development of new technologies,0
609,22,What is transvection?,Enhancers have been defined operationally as cis-regulatory sequences that can stimulate transcription of RNA polymerase-II-transcribed genes over large distances and even when located downstream of the gene.,0
609,23,What is transvection?,"Recently, it has become evident that enhancers can also stimulate transcription in trans if they are brought into close proximity to the promoter/gene.",0
609,24,What is transvection?,These reports provide clues to the mechanism of remote enhancer action.,0
609,25,What is transvection?,"In addition, the findings, together with genetic studies in Drosophila, strongly suggest that enhancer action in trans could underlie phenomena such as 'transvection', where one chromosome affects gene expression in the paired homolog",0
609,26,What is transvection?,Numerous genes contain regulatory elements located many tens of kilobases away from the promoter they control.,0
609,27,What is transvection?,Specific mechanisms must be required to ensure that such distant elements can find and interact with their proper targets but not with extraneous genes.,0
609,28,What is transvection?,"This review explores the connections between transvection phenomena, the activation of domains of homeotic gene expression, position effect variegation and silencers.",0
609,29,What is transvection?,"These various examples of long-distance effects suggest that, in all cases, related forms of chromatin packaging may be involved",0
609,30,What is transvection?,The zeste locus of Drosophila melanogaster encodes a DNA-binding protein that can influence transcription.,0
609,31,What is transvection?,"A number of sites recognized by this protein fall within genes associated with transvection, a phenomenon suggesting a form of gene regulation that is responsive to the proximity of a gene to its homologous allele on another chromosome",0
609,32,What is transvection?,"Special attention is paid to the transvection effect (synapsis-dependent interaction between white and zeste genes), cis-acting regulatory elements and the behaviour of the white genes introduced into the genome by P element-mediated DNA transformation",0
1856,0,Can beans induce apoptosis?,"A 60-kDa glucosamine binding lectin, white kidney bean lectin (WKBL), was purified from Phaseolus vulgaris cv.",1
1856,1,Can beans induce apoptosis?,"white kidney beans, by application of anion exchange chromatography on Q-Sepharose, affinity chromatography on Affi-gel blue gel, and FPLC-size exclusion on Superdex 75.",1
1856,2,Can beans induce apoptosis?,The anti-proliferative activity of WKBL on HONE1 cells and HepG2 cells was stronger than the activity on MCF7 cells and WRL68 cells,1
1856,3,Can beans induce apoptosis?,Treatment of human stomach cancer KATO III cells with hot-water extracts from adzuki beans led to their growth inhibition as well as apoptosis induction.,0
1856,4,Can beans induce apoptosis?,"Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean (Vigna angularis), a promising immunopotentiating food and dietary supplement for cancer prevention.",0
1856,5,Can beans induce apoptosis?,"Human gut flora-fermented nondigestible fraction from cooked bean ( Phaseolus vulgaris L.) modifies protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon cancer cells.",0
1856,6,Can beans induce apoptosis?,"This paper reports the effect of fermentation products (FP) by hgf (FP-hgf) from NDF of cooked beans on survival and protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon cancer cells.",0
1856,7,Can beans induce apoptosis?,"PHA-E is a natural product extracted from red kidney beans, and it has been reported to induce cell apoptosis by blocking EGFR in lung cancer cells",1
1856,8,Can beans induce apoptosis?,A Glucosamine-Specific Lectin from Green Dragon No.,0
1856,9,Can beans induce apoptosis?,8 Beans (Phaseolus vulgaris) Induced Apoptosis on Nasopharyngeal Carcinoma Cells,0
1856,10,Can beans induce apoptosis?,"PHA-E is a natural product extracted from red kidney beans, and it has been reported to induce cell apoptosis by blocking EGFR in lung cancer cells.",1
1856,11,Can beans induce apoptosis?,"The anticancer activity of δ-tocotrienol, a bioactive vitamin E present in whole grain cereals, annatto beans and palm fruit, is strongly dependent on its effect on the induction of apoptosis.",0
1856,12,Can beans induce apoptosis?,δ-Tocotrienol-induced apoptosis is associated with consistent induction in the expression of the proapoptotic protein Bcl-2-associated X protein (Bax).,0
1856,13,Can beans induce apoptosis?,"NDF of cooked common beans inhibited colon carcinogenesis at an early stage by inducing cell cycle arrest of colon cells and morphological changes linked to apoptosis, thus confirming previous results obtained with gene expression studies.",0
1856,14,Can beans induce apoptosis?,"Azuki extract also inhibited the growth of human leukemia U937 cells, leading to induction of apoptosis.",0
1856,15,Can beans induce apoptosis?,"Fermentation product of soybean, black bean, and green bean mixture induces apoptosis in a wide variety of cancer cells.",0
1856,16,Can beans induce apoptosis?,A non-digestible fraction of the common bean (Phaseolus vulgaris L.) induces cell cycle arrest and apoptosis during early carcinogenesis.,0
3162,0,Is actin present in the nucleus?,"Moreover, inhibition of ATM kinase or deficiency in nuclear actin polymerization causes carcinogenic RET/PTC chromosome rearrangements after DSBs induction in human cells.",1
3162,1,Is actin present in the nucleus?, Our findings establish that nuclear actin-based mobility shapes chromatin organization by generating repair domains that are essential for homology-directed repair in eukaryotic cells.,1
3162,2,Is actin present in the nucleus?,"The discovery of nuclear actin opened new perspective on the field, suggesting that the nuclear activities of actin reflect the functions of primordial actin-like proteins.",1
3162,3,Is actin present in the nucleus?, The revitalization of research into nuclear actin occurred after it was found that cellular stresses induce the nuclear localization and alter the structure of actin.,1
3162,4,Is actin present in the nucleus?,"While it is long known that actin is part of the nuclear proteome, its properties and functions as regulated, functional and dynamically assembled actin filaments are only recently emerging.",1
1218,0,Which type of lung cancer is afatinib used for?,"Afatinib is a novel irreversible inhibitor of the ErbB family members EGFR, tyrosine kinase-type cell surface receptors HER2 and HER4.",1
1218,1,Which type of lung cancer is afatinib used for?,It shows preclinical efficacy in NSCLC with common EGFR-activating mutations and the T790M mutation typically associated with EGFR TKI resistance,1
1218,2,Which type of lung cancer is afatinib used for?,"At present, only first-generation EGFR-tyrosine kinase inhibitors (TKIs) (erlotinib and gefitinib) are available for clinical use.",0
1218,3,Which type of lung cancer is afatinib used for?,"Second-generation irreversible EGFR-TKIs, such as afatinib, are still in clinical trials.",0
1218,4,Which type of lung cancer is afatinib used for?,"In current clinical practice, EGFR-TKI is the first-line treatment of choice for metastatic NSCLC patients with tumor EGFR mutation or as salvage therapy in NSCLC patients who received systemic chemotherapy previously",0
1218,5,Which type of lung cancer is afatinib used for?,"Afatinib is a small molecule covalently binding and inhibiting the EGFR, HER2 and HER4 receptor tyrosine kinases.",1
1218,6,Which type of lung cancer is afatinib used for?,"In preclinical studies, afatinib not only inhibited the growth of models with common activating EGFR mutations, but was also active in lung cancer models harboring wild-type EGFR or the EGFR L858R/T790M double mutant.",0
1218,7,Which type of lung cancer is afatinib used for?,Clinical efficacy of afatinib has been extensively studied in the LUX-Lung study program.,0
1218,8,Which type of lung cancer is afatinib used for?,These trials showed promising efficacy in patients with EGFR-mutant NSCLC or enriched for clinical benefit from EGFR tyrosine kinase inhibitors gefitinib or erlotinib,1
1218,9,Which type of lung cancer is afatinib used for?,BIBW2992 is an irreversible EGFR TKI that also inhibits HER2 and vascular epidermal growth factor receptors,1
1218,10,Which type of lung cancer is afatinib used for?,"In vitro work shows that this compound inhibits wild-type EGFR, EGFR exon 19 deletion, EGFR L858R, and EGFR T790M, the mutation associated with acquired resistance",0
1218,11,Which type of lung cancer is afatinib used for?,"Here, we show that BIBW2992, an anilino-quinazoline designed to irreversibly bind EGFR and HER2, potently suppresses the kinase activity of wild-type and activated EGFR and HER2 mutants, including erlotinib-resistant isoforms",0
1218,12,Which type of lung cancer is afatinib used for?,"Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial.",0
1218,13,Which type of lung cancer is afatinib used for?,Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4).,0
1218,14,Which type of lung cancer is afatinib used for?,The LUX-Lung clinical trial program of afatinib for non-small-cell lung cancer.,0
3349,0,"The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?", Library of Integrated Network-based Cellular Signatures (LINCS) L1000 dataset that measured changes in GE before and after treatment of human cells with over 20 000 small-molecule compounds including most of the FDA-approved drugs.,1
3349,1,"The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?","The Library of Integrated Network-based Cellular Signatures (LINCS) L1000 big data provide gene expression profiles induced by over 10 000 compounds, shRNAs, and kinase inhibitors using the L1000 platform.",1
3349,2,"The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",The Library of Integrated Cellular Signatures (LINCS) project provides comprehensive transcriptome profiling of human cell lines before and after chemical and genetic perturbations.,0
3349,3,"The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?"," Recently, resources such as the Library of Integrated Network-Based Cellular Signatures (LINCS) L1000 database provide gene expression profiles induced by various chemical and genetic perturbations",1
3349,4,"The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",The library of integrated network-based cellular signatures (LINCS) L1000 data set currently comprises of over a million gene expression profiles of chemically perturbed human cell lines.,1
3349,5,"The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",The LINCS L1000 data repository contains almost two million gene expression profiles for thousands of small molecules and drugs.,0
3349,6,"The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",The GE data is from the Library of Integrated Network-based Cellular Signatures (LINCS) L1000 dataset that measured changes in GE before and after treatment of human cells with over 20 000 small-molecule compounds including most of the FDA-approved drugs.,1
3659,0,Which epigenetic mark is deposited by PRC2?,"polycomb repressive complex 2 (PRC2), which mediates trimethylation of lysine 27 on histone H3 (K27me3)",1
3659,1,Which epigenetic mark is deposited by PRC2?,"PRC2, has an additional function to stimulate the PRC2 activity after binding to H3K27me3",0
3659,2,Which epigenetic mark is deposited by PRC2?,"In Arabidopsis thaliana, LHP1 co-localizes with H3K27me3 epigenetic marks throughout the genome and interacts with PRC1 and PRC2 members as well as with a long noncoding RNA",0
3659,3,Which epigenetic mark is deposited by PRC2?,"Knockdown of PRC2 H3K27-methyltransferases Ezh2 and Ezh1, or forced expression of the Trithorax/COMPASS subunit Wdr5 activates Runx2/p57 mRNA expression in both immature and mature hippocampal cells.",0
3659,4,Which epigenetic mark is deposited by PRC2?,"Here, we show that, in cancer cells, the epigenetic remodeling of chromatin into hypoacetylated domains covered with histone H3K27 trimethylation is paralleled by changes in higher-order chromatin structures.",0
3659,5,Which epigenetic mark is deposited by PRC2?," There are data showing coordinate regulation between DNAme and H3K27me3, which are both involved in the establishment and maintenance of epigenetic gene silencing",1
3659,6,Which epigenetic mark is deposited by PRC2?,"Polycomb repressive complex 2 (PRC2) trimethylates histone H3 at lysine 27, which establishes H3K27me3 repressive epigenetic marks that promote tissue-specific differentiation by silencing ectopic gene programs.",1
3659,7,Which epigenetic mark is deposited by PRC2?,"We found that the Polycomb Repressive Complex 2 (PRC2), which is responsible for di- and trimethylation of H3K27 (H3K27me2/me3), binds to its own site of methylation.",1
3659,8,Which epigenetic mark is deposited by PRC2?,"Here we provide a model to explain how trimethylated Lys 27 of histone 3 (H3K27me3), which is catalysed by the EZH2-containing Polycomb Repressive Complex 2 (PRC2), is maintained in proliferating cells.",1
1443,0,What are the reported adverse effects of topical minoxidil?,Hypertrichosis is a well-recognized adverse effect of therapy with either oral or topical minoxidil.,0
1443,1,What are the reported adverse effects of topical minoxidil?,reported increase of adverse events (additional hair growth on areas other than the scalp) with minoxidil (5%) twice daily.,0
1443,2,What are the reported adverse effects of topical minoxidil?,a case of central serous chorioretinopathy after application of topical minoxidil solution.,0
1443,3,What are the reported adverse effects of topical minoxidil?,"One month after the drug was discontinued, normal findings were found upon reexamination",0
1443,4,What are the reported adverse effects of topical minoxidil?,The incidence of adverse effects such as pruritus or local irritation was similar in the 5% minoxidil group,0
1443,5,What are the reported adverse effects of topical minoxidil?,The patients tolerated treatment with 1% topical minoxidil well without significant adverse effects.,0
1443,6,What are the reported adverse effects of topical minoxidil?,"An increased occurrence of pruritus, local irritation, and hypertrichosis was observed with 5% topical minoxidil versus 2% topical minoxidil and placebo.",0
1443,7,What are the reported adverse effects of topical minoxidil?,Allergic contact dermatitis to topical minoxidil solution: etiology and treatment.,0
1443,8,What are the reported adverse effects of topical minoxidil?,"However, some patients present with complaints of pruritus and scaling of the scalp.",1
1443,9,What are the reported adverse effects of topical minoxidil?,"The most common causes of these symptoms include irritant contact dermatitis, allergic contact dermatitis, or an exacerbation of seborrheic dermatitis.",1
1443,10,What are the reported adverse effects of topical minoxidil?,Patients suffering from allergic contact dermatitis may benefit from patch testing to determine the causative allergen.,0
1443,11,What are the reported adverse effects of topical minoxidil?,"Among the patients we patch tested, propylene glycol was found to be the contactant in a majority of cases, not the minoxidil itself.",0
1443,12,What are the reported adverse effects of topical minoxidil?,A case of acute myocardial infarction associated with topical use of minoxidil (RiUP) for treatment of baldness.,0
1443,13,What are the reported adverse effects of topical minoxidil?,A 45-year-old Japanese man with paroxysmal atrial fibrillation (AF) developed acute anteroseptal myocardial infarction (MI).,0
1443,14,What are the reported adverse effects of topical minoxidil?,He had used 1% topical minoxidil (RiUP) once a day for 4 months before the onset of MI for treatment of baldness.,0
1443,15,What are the reported adverse effects of topical minoxidil?,Diffuse hypertrichosis during treatment with 5% topical minoxidil.,0
1443,16,What are the reported adverse effects of topical minoxidil?,Five women affected by androgenetic alopecia developed severe hypertrichosis of the face and limbs after 2-3 months of treatment with 5% topical minoxidil.,0
1443,17,What are the reported adverse effects of topical minoxidil?,"Minoxidil was discontinued and in all patients the hypertrichosis disappeared from the face and arms after 1-3 months, and from legs after 4-5 months",0
1443,18,What are the reported adverse effects of topical minoxidil?,Generalized hypertrichosis after treatment with topical minoxidil.,0
1443,19,What are the reported adverse effects of topical minoxidil?,"hypertrichosis is uncommon after treatment with topical minoxidil for alopecia, and normally only occurs in areas close to the site of application.",0
1443,20,What are the reported adverse effects of topical minoxidil?,A 16-year-old girl is presented who developed generalized hypertrichosis 3 months after applying topical minoxidil for treatment of diffuse alopecia in doses greater than that prescribed,0
1443,21,What are the reported adverse effects of topical minoxidil?,Two of our patients developed smoking intolerance during treatment with topical minoxidil for androgenital alopecia.,0
1443,22,What are the reported adverse effects of topical minoxidil?,"The relation between treatment with minoxidil and smoking intolerance was emphasized by stopping treatment and the disappearance of the smoking intolerance, and then by rechallenge in both patients.",0
1443,23,What are the reported adverse effects of topical minoxidil?,"We observed an as yet unreported ""polymyalgia syndrome"" in four otherwise healthy males whose sole medication was topically applied minoxidil.",0
1443,24,What are the reported adverse effects of topical minoxidil?,"They experienced fatigue, weight loss and severe pain in the shoulders and pelvic girdle, suggesting connective tissue disease.",0
1443,25,What are the reported adverse effects of topical minoxidil?,"Three patients had a transient rise in liver enzymes, while other laboratory analyses remained normal.",0
1443,26,What are the reported adverse effects of topical minoxidil?,Tritanomaly was detected in two patients who underwent systematic color vision testing.,0
1443,27,What are the reported adverse effects of topical minoxidil?,All symptoms disappeared after withdrawal of minoxidil.,0
1443,28,What are the reported adverse effects of topical minoxidil?,Rechallenge was positive once in one patient and twice in another.,0
1443,29,What are the reported adverse effects of topical minoxidil?,"During 6 months of follow-up, blood pressure did not change, whereas minoxidil increased heart rate by 3-5 beats min-1.",0
1443,30,What are the reported adverse effects of topical minoxidil?,"Compared with placebo, topical minoxidil caused significant increases in LV end-diastolic volume, in cardiac output (by 0.751 min-1) and in LV mass (by 5 g m-2).",0
1443,31,What are the reported adverse effects of topical minoxidil?,We conclude that in healthy subjects short-term use of topical minoxidil is likely not to be detrimental.,0
1443,32,What are the reported adverse effects of topical minoxidil?,"However, safety needs to be established regarding ischaemic symptoms in patients with coronary artery disease as well as for the possible development of LV hypertrophy in healthy subjects during years of therapy.",0
1443,33,What are the reported adverse effects of topical minoxidil?,"The most frequently reported adverse reactions are mild scalp dryness and irritation and, rarely, allergic contact dermatitis.",0
1443,34,What are the reported adverse effects of topical minoxidil?,Eight deaths that occurred during Upjohn-sponsored clinical trials of topical minoxidil and two deaths in subjects who used extemporaneous formulations of the drug are summarized.,0
1443,35,What are the reported adverse effects of topical minoxidil?,"Of the eight patients in clinical trials, five had cardiovascular abnormalities and two had acquired immunodeficiency syndrome-related pneumonia.",0
1443,36,What are the reported adverse effects of topical minoxidil?,One patient died of a self-inflicted gunshot wound.,0
1443,37,What are the reported adverse effects of topical minoxidil?,One of the subjects who was using extemporaneous topical minoxidil had hypertension and arteriosclerotic disease and the other died of a myocardial infarction.,0
1443,38,What are the reported adverse effects of topical minoxidil?,There is little likelihood of significant adverse effects attributable to topical minoxidil because of its low systemic absorption.,0
1443,39,What are the reported adverse effects of topical minoxidil?,The evidence suggests that these deaths were the result of causes other than use of the drug.,0
1443,40,What are the reported adverse effects of topical minoxidil?,"Only 2% of prescribers reported complications other than local irritation that they associated with topical minoxidil therapy, but underreporting of noncutaneous side effects in this survey of dermatologists cannot be excluded.",1
1443,41,What are the reported adverse effects of topical minoxidil?,"Typical side effects of this topical treatment include irritative dermatitis going along with pruritus, erythema, scaling and dryness, which occur especially at the onset of the therapy.",1
1443,42,What are the reported adverse effects of topical minoxidil?,"In some cases, allergic contact dermatitis or exacerbation of seborrheic dermatitis has been reported.",1
1443,43,What are the reported adverse effects of topical minoxidil?,"While most of the patients with allergic contact dermatitis described in the literature showed a positive sensitization to the vehicle substance propylene glycol evaluated by patch testing, reactions to the active ingredient minoxidil are rare",0
812,0,Which cell type has the protein Chromogranin A as marker?,Neuroendocrine differentiation (chromogranin A and/or synaptophysin positivity),1
812,1,Which cell type has the protein Chromogranin A as marker?,All paragangliomas were universally positive for chromogranin A,0
812,2,Which cell type has the protein Chromogranin A as marker?,chromogranin A (CGA) is a useful marker for pancreatic neuroendocrine tumors (pNET),1
812,3,Which cell type has the protein Chromogranin A as marker?,"Together with Chromogranin B and Secretogranins, Chromogranin A (CGA) is stored in secretory (chromaffin) granules of the diffuse neuroendocrine system",1
812,4,Which cell type has the protein Chromogranin A as marker?,Chromogranin A (CgA) is the most important general tumour marker used in the diagnosis and follow-up of patients with neuroendocrine tumours (NET).,0
812,5,Which cell type has the protein Chromogranin A as marker?,"Chromogranin A (CgA) not only plays an important role in pathologic diagnosis, but is also used as a circulating biomarker in patients with gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN).",0
812,6,Which cell type has the protein Chromogranin A as marker?,numbers of chromogranin A (CHGA)-positive enteroendocrine cells (EEC,0
812,7,Which cell type has the protein Chromogranin A as marker?, CgA is a reliable serum diagnostic biomarker for PNETs,1
812,8,Which cell type has the protein Chromogranin A as marker?,Chromogranin A (CgA) was considered as the most practical and useful serum tumor marker in PNET patients.,0
812,9,Which cell type has the protein Chromogranin A as marker?,the neuroendocrine markers chromogranin A and synaptophysin;,1
2768,0,What is a GPI anchor?,Glycosylphosphatidylinositol (GPI) anchoring of proteins is a conserved posttranslational modification in the endoplasmic reticulum (ER).,1
2768,1,What is a GPI anchor?,"In eukaryotes, the glycosylphosphatidylinositol (GPI) modification of many glycoproteins on the cell surface is highly conserved.",1
2768,2,What is a GPI anchor?,The lipid moieties of GPI-anchored proteins undergo remodelling processes during their maturation.,1
2768,3,What is a GPI anchor?,Glycosylphosphatidylinositols (GPIs) are lipid anchors allowing the exposure of proteins at the outer layer of the plasma membrane.,1
2768,4,What is a GPI anchor?,"Glycosylphosphatidylinositol anchored proteins (GPI-APs) represent a class of soluble proteins attached to the external leaflet of the plasma membrane by a post-translation modification, the GPI anchor.",1
1195,0,Where is X-ray free electron laser used?,"In conjunction with the XFEL temporal profile and high-flux, it is a powerful tool for studying the dynamics of time-dependent systems.",0
1195,1,Where is X-ray free electron laser used?,"Photo-induced processes and fast catalytic reaction kinetics, ranging from femtoseconds to milliseconds, will be resolvable in a wide array of systems circumventing radiation damage.",0
1195,2,Where is X-ray free electron laser used?,"We discuss the pertinent physics of the intense X-ray-matter interactions, and illustrate the importance of electron-ion collisions.",0
1195,3,Where is X-ray free electron laser used?,Detailed simulations of the interaction process conducted with a radiative-collisional code show good qualitative agreement with the experimental results.,0
1195,4,Where is X-ray free electron laser used?,"We obtain insights into the evolution of the charge state distribution of the system, the electron density and temperature, and the timescales of collisional processes.",0
1195,5,Where is X-ray free electron laser used?,"Our results should inform future high-intensity X-ray experiments involving dense samples, such as X-ray diffractive imaging of biological systems, material science investigations, and the study of matter in extreme conditions.",0
1195,6,Where is X-ray free electron laser used?,"employment of ""exotic"" systems, such as the Free Electron LASER (FEL), that are expected to focus on the fundamental processes of life, following chemical reactions and biological processes as they happen, on unprecedented time and size scales.",0
1195,7,Where is X-ray free electron laser used?,"New data analysis approaches are outlined for the correlated fluctuations in fast WAXS, for protein nanocrystals just a few molecules on a side, and for the continuous x-ray scattering from a single virus",0
1195,8,Where is X-ray free electron laser used?,Research opportunities and techniques are reviewed for the application of hard x-ray pulsed free-electron lasers (XFEL) to structural biology.,0
1195,9,Where is X-ray free electron laser used?,"These include the imaging of protein nanocrystals, single particles such as viruses, pump--probe experiments for time-resolved nanocrystallography, and snapshot wide-angle x-ray scattering (WAXS) from molecules in solution.",0
1195,10,Where is X-ray free electron laser used?,"The use of femtosecond exposure times, rather than freezing of samples, as a means of minimizing radiation damage is shown to open up new opportunities for the molecular imaging of biochemical reactions at room temperature in solution",0
1195,11,Where is X-ray free electron laser used?,New opportunities for solving the phase problem for XFEL data are outlined.,0
1195,12,Where is X-ray free electron laser used?,"A summary of the latest results is given, which now extend to atomic resolution for nanocrystals.",0
1195,13,Where is X-ray free electron laser used?,"Possibilities for time-resolved chemistry using fast WAXS (solution scattering) from mixtures is reviewed, toward the general goal of making molecular movies of biochemical processes.",0
1195,14,Where is X-ray free electron laser used?,Molecular imaging using X-ray free-electron lasers.,0
1195,15,Where is X-ray free electron laser used?,The recent development of X-ray free-electron laser sources has created new opportunities for the structural analysis of protein nanocrystals.,0
1195,16,Where is X-ray free electron laser used?,X-ray free electron lasers hold the promise of enabling atomic-resolution diffractive imaging of single biological molecules.,0
1195,17,Where is X-ray free electron laser used?,"The emergence of femtosecond diffractive imaging with X-ray lasers has enabled pioneering structural studies of isolated particles, such as viruses, at nanometer length scales.",0
1195,18,Where is X-ray free electron laser used?,"In this paper we report room temperature X-ray diffraction data of PS II microcrystals obtained using ultrashort (< 50 fs) 9 keV X-ray pulses from a hard X-ray free electron laser, namely the Linac Coherent Light Source.",0
1195,19,Where is X-ray free electron laser used?,High-resolution protein structure determination by serial femtosecond crystallography,0
1195,20,Where is X-ray free electron laser used?,We applied serial femtosecond crystallography (SFX) using an x-ray free-electron laser (XFEL) to obtain high-resolution structural information from microcrystals (less than 1 micrometer by 1 micrometer by 3 micrometers) of the well-characterized model protein lysozyme.,0
1195,21,Where is X-ray free electron laser used?,X-ray free electron laser (X-FEL)-based serial femtosecond crystallography is an emerging method with potential to rapidly advance the challenging field of membrane protein structural biology.,0
1195,22,Where is X-ray free electron laser used?,Here we recorded interpretable diffraction data from micrometer-sized lipidic sponge phase crystals of the Blastochloris viridis photosynthetic reaction center delivered into an X-FEL beam,0
1195,23,Where is X-ray free electron laser used?,"Here we show that high-quality diffraction data can be obtained with a single X-ray pulse from a non-crystalline biological sample, a single mimivirus particle, which was injected into the pulsed beam of a hard-X-ray free-electron laser, the Linac Coherent Light Source.",0
1195,24,Where is X-ray free electron laser used?,Single mimivirus particles intercepted and imaged with an X-ray laser,0
1195,25,Where is X-ray free electron laser used?,Femtosecond X-ray protein nanocrystallography,0
1195,26,Where is X-ray free electron laser used?,"Here we present a method for structure determination where single-crystal X-ray diffraction 'snapshots' are collected from a fully hydrated stream of nanocrystals using femtosecond pulses from a hard-X-ray free-electron laser, the Linac Coherent Light Source.",0
1195,27,Where is X-ray free electron laser used?,"We prove this concept with nanocrystals of photosystem I, one of the largest membrane protein complexes.",0
1195,28,Where is X-ray free electron laser used?,These methods can be used to image biological and materials science samples at high resolution with x-ray undulator radiation and establishes the techniques to be used in atomic-resolution ultrafast imaging at x-ray free-electron laser sources.,1
1195,29,Where is X-ray free electron laser used?,"With the prospects of the x-ray free electron lasers, this approach could provide a major new opportunity for the high-resolution three-dimensional structure determination of single biomolecules.",1
1195,30,Where is X-ray free electron laser used?,X-ray free-electron lasers (XFELs) generate sequences of ultra-short spatially coherent pulses of X-ray radiation.,0
1195,31,Where is X-ray free electron laser used?,Diffractive imaging using the intense and coherent beam of X-ray free-electron lasers opens new perspectives for structural studies of single nanoparticles and biomolecules.,1
1195,32,Where is X-ray free electron laser used?,"The opening of hard X-ray free-electron laser facilities, such as the Linac Coherent Light Source (LCLS) at SLAC National Accelerator Laboratory in the United States, has ushered in a new era in structural determination.",0
1195,33,Where is X-ray free electron laser used?,"Where possible we also highlight areas that we think could push this field forward with emerging technologies, such as X-ray free electron lasers (X-feL), which could have a big impact on the membrane protein structural biology community.",0
1195,34,Where is X-ray free electron laser used?,"X-ray free electron lasers (XFELs) deliver short (<100 fs) and intense (∼10(12) photons) pulses of hard X-rays, making them excellent sources for time-resolved studies.",0
1195,35,Where is X-ray free electron laser used?,Modern imaging techniques at the molecular scale rely on utilizing novel coherent light sources like X-ray free electron lasers for the ultimate goal of visualizing such objects as individual biomolecules rather than crystals.,0
1195,36,Where is X-ray free electron laser used?,"In single-particle coherent x-ray diffraction imaging experiments, performed at x-ray free-electron lasers (XFELs), samples are exposed to intense x-ray pulses to obtain single-shot diffraction patterns.",0
1195,37,Where is X-ray free electron laser used?,"The structure reveals the mechanism of native TbCatB inhibition and demonstrates that new biomolecular information can be obtained by the ""diffraction-before-destruction"" approach of x-ray free-electron lasers from hundreds of thousands of individual microcrystals.",0
1195,38,Where is X-ray free electron laser used?,Coherent diffraction imaging (CDI) of single molecules at atomic resolution is a major goal for the x-ray free-electron lasers (XFELs).,0
1195,39,Where is X-ray free electron laser used?,Ultrashort X-ray pulses from free-electron laser X-ray sources make it feasible to conduct small- and wide-angle scattering experiments on biomolecular samples in solution at sub-picosecond timescales.,0
1195,40,Where is X-ray free electron laser used?,"The short and intense pulses of the new X-ray free electron lasers, now operational or under construction, may make possible diffraction experiments on single molecule-sized objects with high resolution, before radiation damage destroys the sample.",0
1195,41,Where is X-ray free electron laser used?,"The recent development of x-ray free electron lasers providing coherent, femtosecond-long pulses of high brilliance and variable energy opens new areas of scientific research in a variety of disciplines such as physics, chemistry, and biology.",0
1195,42,Where is X-ray free electron laser used?,X-ray free electron laser (X-FEL)-based serial femtosecond crystallography is an emerging method with potential to rapidly advance the challenging field of membrane protein structural biology.,0
1195,43,Where is X-ray free electron laser used?,"X-ray free-electron lasers (FELs) show promise for revealing the structure of single molecules or nanocrystals, but the phase problem remains largely unsolved.",0
1195,44,Where is X-ray free electron laser used?,Coherent diffractive imaging using x-ray free-electron lasers (XFELs) may provide a unique opportunity for high-resolution structural analysis of single particles sprayed from an aqueous solution into the laser beam.,1
1195,45,Where is X-ray free electron laser used?,"Here we present a method for structure determination where single-crystal X-ray diffraction 'snapshots' are collected from a fully hydrated stream of nanocrystals using femtosecond pulses from a hard-X-ray free-electron laser, the Linac Coherent Light Source.",0
1195,46,Where is X-ray free electron laser used?,"This work is directly relevant to the time-resolved imaging of magnetic dynamics using coherent and ultrafast radiation from x-ray free-electron lasers and also to broader classes of diffractive imaging experiments which suffer noisy data, missing data, or both.",0
1195,47,Where is X-ray free electron laser used?,"By combining serial nanocrystallography with x-ray free-electron laser sources in the future, it may be possible to produce molecular-resolution electron-density maps using membrane protein crystals that contain only a few hundred or thousand unit cells.",0
1195,48,Where is X-ray free electron laser used?,"Very strong soft X-ray free electron laser (FEL) pulses must be short to allow for investigations of ultra-fast wet chemistry, according to the principle of collect and destroy.",1
3350,0,What is a cytokine storm?,Endotoxins and exotoxins are among the most potent bacterial inducers of cytokines.,0
3350,1,What is a cytokine storm?,"During infectious processes, the production of inflammatory cytokines including tumor necrosis factor (TNF), interleukin-1β (IL-1β), gamma interferon (IFNγ) and chemokines orchestrates the anti-infectious innate immune response.",0
3350,2,What is a cytokine storm?,"However, an overzealous production, leading up to a cytokine storm, can be deleterious and contributes to mortality consecutive to sepsis or toxic shock syndrome",0
3350,3,What is a cytokine storm?,"undesirable elevation of cytokine levels, as may occur in response to a drug or a device, may lead to severe side effects such as systemic inflammatory response syndrome or cytokine storm.",1
3350,4,What is a cytokine storm?,"Cytokine storm is a poorly explained clinical entity caused by an undesired and aggrandized immune system response leading to unregulated activation of the proinflammatory cascade, often contributing to multisystem organ failure and even death",1
3350,5,What is a cytokine storm?,"UNLABELLED

The cytokine storm is an intensified, dysregulated, tissue-injurious inflammatory response driven by cytokine and immune cell components.",0
3350,6,What is a cytokine storm?,"Ebola virus (EBOV) disease (EVD) results from an exacerbated immunological response that is highlighted by a burst in the production of inflammatory mediators known as a ""cytokine storm.""",0
3350,7,What is a cytokine storm?,Cytokine storm defines a dysregulation of and an excessively exaggerated immune response most often accompanying selected viral infections and several autoimmune diseases.,0
3350,8,What is a cytokine storm?,The cytokine storm is an aggressive immune response characterized by the recruitment of inflammatory leukocytes and exaggerated levels of cytokines and chemokines at the site of infection .,0
3350,9,What is a cytokine storm?,"The cytokine storm is an intensified , dysregulated , tissue-injurious inflammatory response driven by cytokine and immune cell components .",1
3350,10,What is a cytokine storm?,"Cytokine storm is a poorly explained clinical entity caused by an undesired and aggrandized immune system response leading to unregulated activation of the proinflammatory cascade , often contributing to multisystem organ failure and even death .",1
3350,11,What is a cytokine storm?,Cytokine storm is an immune reaction to an acute or chronic injury and may be caused by a disease itself or by treatment directed at an underlying disease.,1
3350,12,What is a cytokine storm?,Cytokine storm defines a dysregulation of and an excessively exaggerated immune response most often accompanying selected viral infections and several autoimmune diseases.,0
3350,13,What is a cytokine storm?,"UNLABELLED
The cytokine storm is an intensified, dysregulated, tissue-injurious inflammatory response driven by cytokine and immune cell components.",0
3350,14,What is a cytokine storm?,"UNLABELLED: The cytokine storm is an intensified, dysregulated, tissue-injurious inflammatory response driven by cytokine and immune cell components.",0
3388,0,PH motifs in which genes endow breast cancer growth?,"Although emerging roles of protease-activated receptor1&2 (PAR1&2) in cancer are recognized, their underlying signalling events are poorly understood.",1
3388,1,PH motifs in which genes endow breast cancer growth?,Here we show signal-binding motifs in PAR1&2 that are critical for breast cancer growth.,0
3388,2,PH motifs in which genes endow breast cancer growth?,This occurs via the association of the pleckstrin homology (PH) domain with Akt/PKB as a key signalling event of PARs.,1
3388,3,PH motifs in which genes endow breast cancer growth?,Other PH-domain signal-proteins such as Etk/Bmx and Vav3 also associate with PAR1 and PAR2 through their PH domains.,1
3388,4,PH motifs in which genes endow breast cancer growth?,PAR1 and PAR2 bind with priority to Etk/Bmx.,0
3388,5,PH motifs in which genes endow breast cancer growth?,"A point mutation in PAR2, H349A, but not in R352A, abrogates PH-protein association and is sufficient to markedly reduce PAR2-instigated breast tumour growth in vivo and placental extravillous trophoblast (EVT) invasion in vitro.",1
3388,6,PH motifs in which genes endow breast cancer growth?,"Similarly, the PAR1 mutant hPar1-7A, which is unable to bind the PH domain, reduces mammary tumours and EVT invasion, endowing these motifs with physiological significance and underscoring the importance of these previously unknown PAR1 and PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.",1
3388,7,PH motifs in which genes endow breast cancer growth?,PH motifs in PAR1&2 endow breast cancer growth.,0
3388,8,PH motifs in which genes endow breast cancer growth?,Here we show signal-binding motifs in PAR1&2 that are critical for breast cancer growth.,0
3388,9,PH motifs in which genes endow breast cancer growth?,The identification and characterization of signal pleckstrin homology (PH)-domain-binding motifs established critical sites for breast cancer growth in PAR1&2.,0
3388,10,PH motifs in which genes endow breast cancer growth?,Here we show signal-binding motifs in PAR1&2 that are critical for breast cancer growth.,0
3388,11,PH motifs in which genes endow breast cancer growth?,The identification and characterization of signal pleckstrin homology (PH)-domain-binding motifs established critical sites for breast cancer growth in PAR1&2.,0
2537,0,Treatment of which disease was studied in the Gore REDUCE Clinical Study?,"CONCLUSIONS: Among patients with a PFO who had had a cryptogenic stroke, the risk of subsequent ischemic stroke was lower among those assigned to PFO closure combined with antiplatelet therapy than among those assigned to antiplatelet therapy alone; however, PFO closure was associated with higher rates of device complications and atrial fibrillation.",1
2537,1,Treatment of which disease was studied in the Gore REDUCE Clinical Study?,(Funded by W.L.,0
2537,2,Treatment of which disease was studied in the Gore REDUCE Clinical Study?,"Gore and Associates; Gore REDUCE ClinicalTrials.gov number, NCT00738894 .",1
2537,3,Treatment of which disease was studied in the Gore REDUCE Clinical Study?,).,0
2537,4,Treatment of which disease was studied in the Gore REDUCE Clinical Study?,Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.,1
2537,5,Treatment of which disease was studied in the Gore REDUCE Clinical Study?,Aims The Gore REDUCE Clinical Study (REDUCE) aims to establish superiority of patent foramen ovale closure in conjunction with antiplatelet therapy over antiplatelet therapy alone in reducing the risk of recurrent clinical ischemic stroke or new silent brain infarct in patients who have had a cryptogenic stroke.,1
2537,6,Treatment of which disease was studied in the Gore REDUCE Clinical Study?,Aims The Gore REDUCE Clinical Study (REDUCE) aims to establish superiority of patent foramen ovale closure in conjunction with antiplatelet therapy over antiplatelet therapy alone in reducing the risk of recurrent clinical ischemic stroke or new silent brain infarct in patients who have had a cryptogenic stroke.,1
3324,0,Which domain of the MOZ/MYST3 protein complex associates with histone H3?,"In conclusion, our data show that Moz regulates H3K9 acetylation at Hox gene loci and that RA can act independently of Moz to establish specific Hox gene expression boundaries.",1
3324,1,Which domain of the MOZ/MYST3 protein complex associates with histone H3?,The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification,1
3324,2,Which domain of the MOZ/MYST3 protein complex associates with histone H3?,ere we report novel insights into histone H3 tail structure in complex with the double PHD finger (DPF) of the lysine acetyltransferase MOZ/MYST3/KAT6A.,1
3324,3,Which domain of the MOZ/MYST3 protein complex associates with histone H3?,"In addition to sampling H3 and H4 modification status, we show that the DPF cooperates with the MYST domain to promote H3K9 and H3K14 acetylation, although not if H3K4 is trimethylated",1
538,0,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Everolimus has been approved by the FDA and the EMA for the treatment of advanced renal cell carcinoma (RCC), subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TSC), pancreatic neuroendocrine tumors (PNET), in combination with exemestane in advanced hormone-receptor (HR)-positive, HER2-negative breast cancer.",0
538,1,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.",0
538,2,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Our objective was to evaluate everolimus, an mTOR inhibitor, in the treatment of angiomyolipoma in patients with subependymal giant cell astrocytoma (SEGA) associated with TSC.",0
538,3,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"METHODS: EXamining everolimus In a Study of Tuberous Sclerosis Complex-1 (NCT00789828), a prospective, double-blind, randomized, placebo-controlled, Phase 3 study, examined everolimus in treating SEGA associated with TSC.",0
538,4,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Patients with serial SEGA growth from pre-baseline to baseline scans were randomly assigned (2:1) to receive 4.5 mg/m(2)/day everolimus (target blood trough: 5-15 ng/mL; n = 78) or placebo (n = 39).,0
538,5,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,CONCLUSIONS: Everolimus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.,0
538,6,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Everolimus has demonstrated substantial clinical benefit in randomized, controlled, phase III studies leading to approval for the treatment of advanced renal cell carcinoma, advanced neuroendocrine tumors of pancreatic origin, renal angiomyolipoma and subependymal giant-cell astrocytoma associated with tuberous sclerosis complex, as well as advanced hormone-receptor-positive (HR(+)) and human epidermal growth factor receptor-2-negative advanced breast cancer.",0
538,7,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus for the treatment of subependymal giant cell astrocytoma probably causing seizure aggravation in a child with tuberous sclerosis complex: a case report.,1
538,8,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,We are reporting on a 13.5-year-old girl with tuberous sclerosis complex (TSC) who was treated with everolimus because of giant cell astrocytoma and bilateral angiomyolipoma.,0
538,9,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus.,0
538,10,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,BACKGROUND: Brain subependymal giant cell astrocytomas (SEGAs) in patients with tuberous sclerosis have been reported to respond to everolimus.,0
538,11,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"CONCLUSIONS: We describe a rare case of metastatic SEGA, which was successfully treated with everolimus.",0
538,12,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Additional oncology indications for everolimus include renal angiomyolipoma with tuberous sclerosis complex and subependymal giant-cell astrocytoma.,0
538,13,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of advanced renal cell carcinoma, pancreatic neuroendocrine tumors, subependymal giant cell astrocytoma associated with tuberous sclerosis complex, renal angiomyolipoma and tuberous sclerosis complex, and, in combination with exemestane, for hormone receptor-positive HER2-negative advanced breast cancer after failure of treatment with letrozole or anastrozole.",0
538,14,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.,0
538,15,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,AIMS: To show the long-term safety data and the effect of everolimus treatment on epilepsy in children under the age of 3 who received everolimus for SEGAs associated with TSC.,0
538,16,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,CONCLUSIONS: This study suggests that everolimus is effective and safe in infants and young children with epilepsy and SEGA associated with TSC and offers a valuable treatment option.,0
538,17,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma.,0
538,18,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,OBJECTIVE: To report long-term efficacy and safety data for everolimus for the treatment of subependymal giant cell astrocytoma (SEGA) in patients with tuberous sclerosis complex (TSC).,1
538,19,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,CONCLUSION: Everolimus therapy is safe and effective for longer term (median exposure 34.2 months) treatment of patients with TSC with SEGA.,0
538,20,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that everolimus, titrated to trough serum levels of 5-15 ng/mL, was effective in reducing tumor size in patients with SEGA secondary to TSC for a median of 34 months.",0
538,21,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.,1
538,22,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"In patients with subependymal giant cell astrocytomas (SEGAs) associated with tuberous sclerosis complex who are not candidates for surgery, single-agent everolimus has demonstrated the ability to significantly reduce SEGA volume with good tolerability.",0
538,23,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"In the Phase III, randomized, placebo-controlled trial, everolimus was associated with a SEGA response rate of 35% compared with 0% in the placebo group.",0
538,24,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.",0
538,25,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"In an open-label, phase 1/2 study, the mTOR inhibitor everolimus substantially and significantly reduced the volume of subependymal giant cell astrocytomas.",0
538,26,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,We assessed the efficacy and safety of everolimus in patients with subependymal giant cell astrocytomas associated with tuberous sclerosis complex.,0
538,27,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,INTERPRETATION: These results support the use of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis.,0
538,28,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.,0
538,29,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"A recent phase 1/2 study demonstrated that treatment with the mammalian target of rapamycin inhibitor everolimus reduced subependymal giant cell astrocytoma volume by 30% in 75% of the patients, all of whom were poor candidates for surgical resection.",0
538,30,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,All 4 experienced over 50% initial reduction in the volume of their subependymal giant cell astrocytoma after 2 to 3 years of therapy with everolimus.,0
538,31,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"METHODS: Recently, a phase I/II trial of everolimus demonstrated significant reductions in subependymal giant cell astrocytoma (SEGA) volume and decreased seizure frequency.",0
538,32,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"TSC patients with SEGA received everolimus, titrated to tolerability to achieve target trough concentrations of 5-15 ng/mL.",0
538,33,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.,0
538,34,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus is an orally administered inhibitor of the mammalian target of rapamycin (mTOR).,0
538,35,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus (starting dosage 3.0 mg/m(2)) was associated with a significant reduction in the volume of the largest subependymal giant cell astrocytoma (SEGA) in 28 patients aged ≥3 years with tuberous sclerosis complex (TSC) in a phase II trial (C2485).,0
538,36,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"During the extension phase of this trial (median duration 34 months), the reduction in SEGA volume was maintained, with no everolimus recipient requiring surgery or other therapy for SEGA or hydrocephalus.",0
538,37,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex.",0
538,38,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,We present successful everolimus treatment of a huge subependymal giant cell astrocytoma in a 10-year old boy with tuberous sclerosis complex.,0
538,39,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus tablets for patients with subependymal giant cell astrocytoma.,1
538,40,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Recently, mTOR inhibitors such as everolimus have shown encouraging benefit for patients with SEGAs.",0
538,41,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,The authors also examine the rationale for targeted agents against this pathway therapeutically and describe the clinical evidence underlying the FDA approval of everolimus for patients with inoperable SEGAs.,0
538,42,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,EXPERT OPINION: Everolimus (Afinitor) selectively targets a molecular defect of SEGAs in TSC patients.,0
538,43,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.,0
538,44,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"An alternative may be the use of everolimus, which inhibits the mammalian target of rapamycin, a protein regulated by gene products involved in the tuberous sclerosis complex.",0
538,45,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Everolimus therapy was associated with a clinically meaningful reduction in volume of the primary subependymal giant-cell astrocytoma, as assessed on independent central review (P<0.001 for baseline vs. 6 months), with a reduction of at least 30% in 21 patients (75%) and at least 50% in 9 patients (32%).",0
538,46,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"CONCLUSIONS: Everolimus therapy was associated with marked reduction in the volume of subependymal giant-cell astrocytomas and seizure frequency and may be a potential alternative to neurosurgical resection in some cases, though long-term studies are needed.",0
538,47,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,The authors present a 21-year-old woman who has been receiving rapamycin for 5 months for bilateral subependymal giant cell astrocytomas.,0
538,48,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,We present successful everolimus treatment of a huge subependymal giant cell astrocytoma in a 10-year old boy with tuberous sclerosis complex.,0
538,49,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"A recent phase 1/2 study demonstrated that treatment with the mammalian target of rapamycin inhibitor everolimus reduced subependymal giant cell astrocytoma volume by 30% in 75% of the patients, all of whom were poor candidates for surgical resection.",0
538,50,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"This review provides an overview of TSC, everolimus, and the clinical trials that led to its approval for the treatment of TSC-associated subependymal giant cell astrocytoma and renal angiomyolipoma.",1
538,51,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex.",0
538,52,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,"In patients with subependymal giant cell astrocytomas (SEGAs) associated with tuberous sclerosis complex who are not candidates for surgery, single-agent everolimus has demonstrated the ability to significantly reduce SEGA volume with good tolerability",0
538,53,List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma,The authors also examine the rationale for targeted agents against this pathway therapeutically and describe the clinical evidence underlying the FDA approval of everolimus for patients with inoperable SEGAs.,0
2570,0,Is pregabalin effective for sciatica?,"CONCLUSIONS: Treatment with pregabalin did not significantly reduce the intensity of leg pain associated with sciatica and did not significantly improve other outcomes, as compared with placebo, over the course of 8 weeks.",1
2570,1,Is pregabalin effective for sciatica?,The incidence of adverse events was significantly higher in the pregabalin group than in the placebo group.,1
2570,2,Is pregabalin effective for sciatica?,"Whilst pregabalin (PGB) and gabapentin (GBP) are both used to treat neuropathic pain, their relative role in sciatica is unclear.",1
2570,3,Is pregabalin effective for sciatica?,GBP and PGB appeared to demonstrate comparable efficacy and SE.,1
2570,4,Is pregabalin effective for sciatica?,"However, the amount and quality of evidence was low, and only indirect comparisons were available.",1
1923,0,List available circular RNA prediction tools.,CircRNAs are novel members of the non-coding RNA family.,0
1923,1,List available circular RNA prediction tools.,"For several decades circRNAs have been known to exist, however only recently the widespread abundance has become appreciated.",0
1923,2,List available circular RNA prediction tools.,Annotation of circRNAs depends on sequencing reads spanning the backsplice junction and therefore map as non-linear reads in the genome.,1
1923,3,List available circular RNA prediction tools.,Several pipelines have been developed to specifically identify these non-linear reads and consequently predict the landscape of circRNAs based on deep sequencing datasets.,1
1923,4,List available circular RNA prediction tools.,"Here, we use common RNAseq datasets to scrutinize and compare the output from five different algorithms; circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice and evaluate the levels of bona fide and false positive circRNAs based on RNase R resistance.",1
1923,5,List available circular RNA prediction tools.,"By this approach, we observe surprisingly dramatic differences between the algorithms specifically regarding the highly expressed circRNAs and the circRNAs derived from proximal splice sites.",1
1923,6,List available circular RNA prediction tools.,"Collectively, this study emphasizes that circRNA annotation should be handled with care and that several algorithms should ideally be combined to achieve reliable predictions.",1
2907,0,What is the mechanism of action of durvalumab?,"In the phase III PACIFIC trial consolidation with durvalumab, an anti-PDL-1 antibody, was associated with survival benefit in patients diagnosed with LA-NSCLC who responded to concurrent chemoradiotherapy.",0
2907,1,What is the mechanism of action of durvalumab?,"Ipilimumab (anti-CTLA-4) is the godfather of checkpoint inhibitors, whereas several blocking monoclonal antibodies targeting PD-1 (nivolumab and pembrolizumab) and PD-L1 (atezolizumab, durvalumab, avelumab, and BMS-946559) have been developed.",0
2907,2,What is the mechanism of action of durvalumab?,"DATA SYNTHESIS: Atezolizumab, avelumab, durvalumab, nivolumab, and pembrolizumab have demonstrated clinical efficacy with tolerable toxicities in patients with metastatic UC with disease progression following platinum-based chemotherapy.",0
2907,3,What is the mechanism of action of durvalumab?,Anti-PD-1/PD-L1 therapies may provide overall survival advantage; these are currently being evaluated in ongoing phase 3 studies.,0
2907,4,What is the mechanism of action of durvalumab?,"METHODS: An electronic literature search was performed of public databases (MEDLINE, Excerpta Medica dataBASE [EMBASE], and Cochrane) and conference proceedings for trials using PD-1 inhibitors (nivolumab and pembrolizumab) and PD-L1 inhibitors (atezolizumab, durvalumab, and avelumab) in patients with NSCLC.",0
2907,5,What is the mechanism of action of durvalumab?,A formal systematic analysis was conducted with Comprehensive Meta-Analysis software (version 2.2).,0
2907,6,What is the mechanism of action of durvalumab?,"Immune checkpoint inhibitors (ICIs) are a key component of treating advanced cancer patients, principally antibodies against CTLA-4 and PD-1 or PD-L1.",1
2907,7,What is the mechanism of action of durvalumab?,"Durvalumab (MEDI4736) is a selective, high-affinity, human IgG1 monoclonal antibody that blocks PD-L1, which binds to PD-1 and CD80, but not to PD-L2.",1
2907,8,What is the mechanism of action of durvalumab?,"However, it is still unknown how atezolizumab and durvalumab specifically recognize PD-L1, although this is important for investigating novel binding sites on PD-L1 targeted by other therapeutic antibodies for the design and improvement of anti-PD-L1 agents.",0
2907,9,What is the mechanism of action of durvalumab?,"Here, we report the crystal structures of PD-L1 in complex with atezolizumab and durvalumab to elucidate the precise epitopes involved and the structural basis for PD-1/PD-L1 blockade by these antibodies.",0
2907,10,What is the mechanism of action of durvalumab?,"In 2016 and 2017, monoclonal antibodies targeting PD-L1, including atezolizumab, durvalumab, and avelumab, were approved by the FDA for the treatment of multiple advanced cancers.",0
2907,11,What is the mechanism of action of durvalumab?,"We hypothesize the programmed death-ligand 1 (PD-L1) inhibitor, durvalumab, olaparib, or cediranib combinations are tolerable and active in recurrent women's cancers.",0
2907,12,What is the mechanism of action of durvalumab?,Combination treatment with the anti-PD-L1 antibody durvalumab and the anti-CTLA-4 antibody tremelimumab might provide greater antitumour activity than either drug alone.,0
2907,13,What is the mechanism of action of durvalumab?,"Durvalumab (MEDI4736) is a high-affinity human IgG1 monoclonal antibody that binds to PD-1 and CD80, blocking PD-L1, but not PD-L2.",1
2907,14,What is the mechanism of action of durvalumab?,"The Food and Drug Administration has already approved a number of checkpoint inhibitors such as anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) monoclonal antibodies including ipilimumab; anti-PD-1 monoclonal antibodies including nivolumab and pembrolizumab; anti-PD-L1 antibodies including atezolizumab, avelumab, and durvalumab.",0
2907,15,What is the mechanism of action of durvalumab?,"Durvalumab is a human IgG1-K monoclonal antibody that targets programmed death ligand 1 and is approved by the U.S. Food and Drug Administration for locally advanced or metastatic urothelial cancer and locally advanced, unresectable stage 3 non-small cell lung cancer.",0
2907,16,What is the mechanism of action of durvalumab?,Other notable PD-L1 inhibitors under development include avelumab and durvalumab.,0
2907,17,What is the mechanism of action of durvalumab?,"Combining the anti-PD-L1 antibody durvalumab and the anti-cytotoxic T-lymphocyte antigen 4 antibody tremelimumab offers the potential for antitumor activity in patients with advanced NSCLC, regardless of PD-L1 tumor status.",0
2907,18,What is the mechanism of action of durvalumab?,"Five antibodies targeting the programmed cell death protein 1--programmed cell death 1 ligand 1 (PD-1--PD-L1) pathway have been approved by the U.S. Food and Drug Administration (FDA) for the management of various malignancies: pembrolizumab, nivolumab, atezolizumab, durvalumab and avelumab.",0
2907,19,What is the mechanism of action of durvalumab?,"Currently, the only FDA-approved indication for the anti-PD-L1 monoclonal antibody durvalumab (MEDI-4736) is locally advanced or metastatic urothelial carcinoma that has progressed during or following platinum-based chemotherapy within 12 months of treatment.",0
2907,20,What is the mechanism of action of durvalumab?,"Intravenous durvalumab (Imfinzi™; AstraZeneca) is a fully human monoclonal antibody that blocks programmed cell death ligand-1 binding to its receptors (PD-1 and CD80), resulting in enhanced T-cell responses against cancer cells.",1
2907,21,What is the mechanism of action of durvalumab?,"Here, we report a meta-analysis investigating the safety and efficacy of durvalumab (MEDI4736), an inhibitor of PD-L1, in various solid tumors.",0
2907,22,What is the mechanism of action of durvalumab?,"We hypothesize the programmed death-ligand 1 (PD-L1) inhibitor, durvalumab, olaparib, or cediranib combinations are tolerable and active in recurrent women's cancers.",0
2907,23,What is the mechanism of action of durvalumab?,"Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab.In 2016 and 2017, monoclonal antibodies targeting PD-L1, including atezolizumab, durvalumab, and avelumab, were approved by the FDA for the treatment of multiple advanced cancers.",0
2907,24,What is the mechanism of action of durvalumab?,"Here, we report the crystal structures of PD-L1 in complex with atezolizumab and durvalumab to elucidate the precise epitopes involved and the structural basis for PD-1/PD-L1 blockade by these antibodies.",0
2907,25,What is the mechanism of action of durvalumab?,"Here, we report a meta-analysis investigating the safety and efficacy of durvalumab (MEDI4736), an inhibitor of PD-L1, in various solid tumors.<br><b>Methods</b>: A systematic search of PubMed, Embase, and related articles was performed.",0
2907,26,What is the mechanism of action of durvalumab?,"Durvalumab (MEDI4736) is a high-affinity human IgG1 monoclonal antibody that binds to PD-1 and CD80, blocking PD-L1, but not PD-L2.",1
3831,0,List the major families of Histones.,"five histone families (H1, H2A, H2B, H3, and H4)",1
3831,1,List the major families of Histones.,"H2A, H2B, H3 and H4 histone families",1
3831,2,List the major families of Histones.,"six for H1, 11 for H2A, eight for H2B, five for H3 and two for H4",1
803,0,What is the function of cryptochrome-1 in mouse?,Malfunction of the circadian clock has been linked to the pathogenesis of a variety of diseases.,0
803,1,What is the function of cryptochrome-1 in mouse?,We show that mice lacking the core clock components Cryptochrome-1 (Cry1) and Cryptochrome-2 (Cry2) (Cry-null mice) show salt-sensitive hypertension due to abnormally high synthesis of the mineralocorticoid aldosterone by the adrenal gland.,0
803,2,What is the function of cryptochrome-1 in mouse?,"The Cryptochrome 1 and 2 genes are indispensable for molecular core oscillator function, as evident from the arrhythmic wheel-running behavior and lack of rhythmic clock gene expression in mCry1/mCry2 double-mutant mice in constant darkness.",0
803,3,What is the function of cryptochrome-1 in mouse?,Among the components driving the mammalian circadian clock are the Period 1 and 2 (mPer1 and mPer2) and Cryptochrome 1 and 2 (mCry1 and mCry2) genes.,0
803,4,What is the function of cryptochrome-1 in mouse?,A mutation in the mPer2 gene leads to a gradual loss of circadian rhythmicity in mice kept in constant darkness (DD).,0
803,5,What is the function of cryptochrome-1 in mouse?,Here we show that inactivation of the mCry2 gene in mPer2 mutant mice restores circadian rhythmicity and normal clock gene expression patterns.,0
803,6,What is the function of cryptochrome-1 in mouse?,"Thus, mCry2 can act as a nonallelic suppressor of mPer2, which points to direct or indirect interactions of PER2 and CRY2 proteins.",0
803,7,What is the function of cryptochrome-1 in mouse?,"In marked contrast, inactivation of mCry1 in mPer2 mutant mice does not restore circadian rhythmicity but instead results in complete behavioral arrhythmicity in DD, indicating different effects of mCry1 and mCry2 in the clock mechanism",0
803,8,What is the function of cryptochrome-1 in mouse?,"Cryptochrome 1 and 2 gene products act in the negative feedback loop and are indispensable for molecular core oscillator function, as evident from the arrhythmic wheel running behaviour and absence of cyclic clock gene expression in mCry1/mCry2 double mutant mice in constant darkness.",0
803,9,What is the function of cryptochrome-1 in mouse?,", when mCry-deficient mice are housed in normal light-dark cycles, a single non-circadian peak in neuronal activity can be detected in SCN slices prepared two hours after the beginning of the day.",0
803,10,What is the function of cryptochrome-1 in mouse?,This light-induced increase in electric activity of the SCN suggests that deletion of the mCry genes converts the core oscillator in an hour-glass-like timekeeper and may explain why in normal day-night cycles mCry-deficient mice show apparently normal behaviour.,0
803,11,What is the function of cryptochrome-1 in mouse?,Cryptochrome 1 and 2 act as essential components of the central and peripheral circadian clocks for generation of circadian rhythms in mammals,1
803,12,What is the function of cryptochrome-1 in mouse?,"cryptochrome-1 mRNA was found in DA cells, immunocytochemistry was extended to other components of the circadian clock machinery.",0
803,13,What is the function of cryptochrome-1 in mouse?,This analysis showed that DA cells contain the most common clock-related proteins.,0
803,14,What is the function of cryptochrome-1 in mouse?,Cryptochrome 1 and cryptochrome 2 proteins are core components of the mammalian circadian clock and mice mutated in both genes are arrhythmic.,1
803,15,What is the function of cryptochrome-1 in mouse?,a domain in the extreme C terminus of BMAL1 that plays an essential role in the rhythmic control of E-box-mediated circadian transcription.,0
803,16,What is the function of cryptochrome-1 in mouse?,"Remarkably, the last 43 aa of BMAL1 are required for transcriptional activation, as well as for association with the circadian transcriptional repressor CRYPTOCHROME 1 (CRY1), depending on the coexistence of CLOCK protein.",0
803,17,What is the function of cryptochrome-1 in mouse?,circadian rhythm protein cryptochrome 1 (CRY1).,0
803,18,What is the function of cryptochrome-1 in mouse?,CRY1 is a master regulator of circadian rhythm that regulates the extracellular calcification of MSCs.,0
803,19,What is the function of cryptochrome-1 in mouse?,"Studying mouse fibroblasts, we demonstrated that the nutrient-responsive adenosine monophosphate-activated protein kinase (AMPK) phosphorylates and destabilizes the clock component cryptochrome 1 (CRY1).",0
803,20,What is the function of cryptochrome-1 in mouse?,"In mouse livers, AMPK activity and nuclear localization were rhythmic and inversely correlated with CRY1 nuclear protein abundance.",0
803,21,What is the function of cryptochrome-1 in mouse?,"Stimulation of AMPK destabilized cryptochromes and altered circadian rhythms, and mice in which the AMPK pathway was genetically disrupted showed alterations in peripheral clocks.",0
803,22,What is the function of cryptochrome-1 in mouse?,"Thus, phosphorylation by AMPK enables cryptochrome to transduce nutrient signals to circadian clocks in mammalian peripheral organs.",0
803,23,What is the function of cryptochrome-1 in mouse?,Cytoplasmic hnRNP D levels displayed a pattern that was reciprocal to the mcry1 oscillation.,0
803,24,What is the function of cryptochrome-1 in mouse?,Knockdown of hnRNP D stabilized mcry1 mRNA and resulted in enhancement of the oscillation amplitude and a slight delay of the phase.,0
803,25,What is the function of cryptochrome-1 in mouse?,Our results suggest that hnRNP D plays a role as a fine regulator contributing to the mcry1 mRNA turnover rate and the modulation of circadian rhythm.,0
803,26,What is the function of cryptochrome-1 in mouse?,"more than three mutations of conserved PER2 residues impaired not only binding to CRY1 but also subsequent nuclear translocation, although mutations of non-conserved residues did not affect interaction with CRY1.",0
803,27,What is the function of cryptochrome-1 in mouse?,"Thus, the conserved amino acid residues of 1179-1198 in PER2 are apparently responsible for binding to CRY1.",0
803,28,What is the function of cryptochrome-1 in mouse?,Cryptochrome 1 and 2 (Cry1 and Cry2) are considered essential for generating circadian rhythms in mammals.,1
803,29,What is the function of cryptochrome-1 in mouse?,The role of Cry1 and Cry2 in circadian rhythm expression and acute light-induced suppression of pineal melatonin was assessed using Cry1 and Cry2 double-deficient mice (Cry1(-/-) /Cry2(-/-) ) developed from the C3H strain that synthesizes melatonin.,0
803,30,What is the function of cryptochrome-1 in mouse?,"Cryptochrome 1 (Cry1), an essential clock component, displays evening-time expression and serves as a strong repressor at morning-time elements (E box/E' box).",1
803,31,What is the function of cryptochrome-1 in mouse?,"A genetic complementation assay in Cry1(-/-):Cry2(-/-) cells revealed that substantial delay of Cry1 expression is required to restore circadian rhythmicity, and its prolonged delay slows circadian oscillation.",0
803,32,What is the function of cryptochrome-1 in mouse?,"Taken together, our data suggest that phase delay in Cry1 transcription is required for mammalian clock function.",0
803,33,What is the function of cryptochrome-1 in mouse?,"the 24-h mRNA rhythms of the following genes were suppressed in db/db mice compared with control mice: the clock genes period homolog 1/2 (Per1/2) and cryptochrome 1/2 (Cry1/2) and their target genes D site albumin promoter-binding protein (Dbp) and peroxisome proliferator-activated receptor-γ (Pparg) in the aorta and mesenteric arteries; Dbp in the heart; Per1, nuclear receptor subfamily 1, group D, member 1 (Rev-erba), and Dbp in the kidney; and Per1 in the suprachiasmatic nucleus.",0
803,34,What is the function of cryptochrome-1 in mouse?,"In mammals, circadian rhythms in behavior and physiology are controlled by a central pacemaker, the SCN, and subordinated clocks throughout the body.",0
803,35,What is the function of cryptochrome-1 in mouse?,"On the molecular level, these clocks are based on transcriptional/translational feedback loops involving a set of clock genes that regulate their own transcription.",0
803,36,What is the function of cryptochrome-1 in mouse?,Among the components driving the mammalian circadian clock are the Period 1 and 2 (Per1 and Per2) and Cryptochrome 1 and 2 (Cry1 and Cry2) genes.,0
803,37,What is the function of cryptochrome-1 in mouse?,I,0
803,38,What is the function of cryptochrome-1 in mouse?,"The mammalian clock protein, cryptochrome 1 (CRY1), is degraded via the FBXL3-mediated ubiquitination pathway, suggesting that it is also likely to be targeted by the deubiquitination pathway.",0
803,39,What is the function of cryptochrome-1 in mouse?,"Here, we identified that USP2a, a circadian-controlled deubiquitinating enzyme, interacts with CRY1 and enhances its protein stability via deubiquitination upon serum shock.",0
803,40,What is the function of cryptochrome-1 in mouse?,Depletion of Usp2a by shRNA greatly enhances the ubiquitination of CRY1 and dampens the oscillation amplitude of the CRY1 protein during a circadian cycle.,0
803,41,What is the function of cryptochrome-1 in mouse?,"By stabilizing the CRY1 protein, USP2a represses the Per2 promoter activity as well as the endogenous Per2 gene expression.",0
803,42,What is the function of cryptochrome-1 in mouse?,We also demonstrated that USP2a-dependent deubiquitination and stabilization of the CRY1 protein occur in the mouse liver.,0
803,43,What is the function of cryptochrome-1 in mouse?,The mammalian circadian clock is composed of interlocking feedback loops.,0
803,44,What is the function of cryptochrome-1 in mouse?,"Cryptochrome is a central component in the core negative feedback loop, whereas Rev-Erbα, a member of the nuclear receptor family, is an essential component of the interlocking loop.",1
803,45,What is the function of cryptochrome-1 in mouse?,"By analyzing the Fbxl3 and Cryptochrome 1 double-mutant mice, we found that FBXL3 also regulates the amplitudes of E-box-driven gene expression.",0
803,46,What is the function of cryptochrome-1 in mouse?,These two separate roles of FBXL3 in circadian feedback loops provide a mechanism that contributes to the period determination and robustness of the clock.,0
1235,0,What is the association between cell phone use and glioblastoma?,Decreased survival of glioma cases with long-term and high cumulative use of wireless phones was found.,1
1235,1,What is the association between cell phone use and glioblastoma?,"There was no significant association between glioma and alcohol consumption, smoking and mobile phone use.",1
1235,2,What is the association between cell phone use and glioblastoma?,"Regular cell phone use was not associated with an increased risk of neuroma (OR=0,92; 95% confidence interval=[0.53-1.59]), meningioma (OR=0,74; 95% confidence interval=[0.43-1.28]) or glioma (OR=1.15; 95% confidence interval=[0.65-2.05]).",1
1235,3,What is the association between cell phone use and glioblastoma?,"Although these results are not statistically significant, a general tendency was observed for an increased risk of glioma among the heaviest users: long-term users, heavy users, users with the largest numbers of telephones.",0
1235,4,What is the association between cell phone use and glioblastoma?,"No significant increased risk for glioma, meningioma or neuroma was observed among cell phone users participating in Interphone.",0
1235,5,What is the association between cell phone use and glioblastoma?," Our results, suggesting the possibility of an increased risk among the heaviest users, therefore need to be verified in the international INTERPHONE analyses.",0
1235,6,What is the association between cell phone use and glioblastoma?,"The risk for ipsilateral use was significantly increased for astrocytoma for all studied phone types, analogue phones OR=1.8,95% CI=1.1-3.2, digital phones OR=1.8, 95% CI=1.1-2.8, cordless phones OR=1.8, 95% CI=1.1-2.9.",0
1235,7,What is the association between cell phone use and glioblastoma?,"For astrocytoma and ipsilateral use the trend was for analogue phones OR=1.10, 95% CI=1.02-1.19, digital phones OR=1.11, 95% CI=1.01-1.22, and cordless phones OR=1.09, 95% CI=1.01-1.19.",0
1235,8,What is the association between cell phone use and glioblastoma?,"There was a tendency of a shorter tumour induction period for ipsilateral exposure to microwaves than for contralateral, which may indicate a tumour promotor effect.",0
1235,9,What is the association between cell phone use and glioblastoma?,Case reports of brain tumours in users initiated this case-control study on brain tumours and use of cellular telephones.,0
1235,10,What is the association between cell phone use and glioblastoma?,Increased risk was found only for use of the NMT system.,0
1235,11,What is the association between cell phone use and glioblastoma?,This increased HR was based on results for astrocytoma WHO grade IV (glioblastoma multiforme).,0
1235,12,What is the association between cell phone use and glioblastoma?,Some studies show increasing incidence of brain tumours whereas other studies do not.,1
1235,13,What is the association between cell phone use and glioblastoma?,"The meta-analysis gave for glioma in the most exposed part of the brain, the temporal lobe, odds ratio (OR)=1.71, 95% confidence interval (CI)=1.04-2.81 in the ≥10 years (>10 years in the Hardell group) latency group.",0
1235,14,What is the association between cell phone use and glioblastoma?,"Ipsilateral mobile phone use ≥1640h in total gave OR=2.29, 95% CI=1.56-3.37.",0
1235,15,What is the association between cell phone use and glioblastoma?,"After 1983 and during the period with increasing prevalence of mobile phone users, the incidence has remained relatively stable for both men and women.",1
3825,0,List types of mutations.,"NGS is utilized to novel diagnostic and rare cancer mutations, detection of translocations, inversions, insertions and deletions,",1
3825,1,List types of mutations.,"Deletions are the most common types of mutations in α-thal, followed by point mutations and small insertion/deletion.",1
3825,2,List types of mutations.,"qEva-CRISPR detects all types of mutations, including point mutations and large deletions,",1
3498,0,Has ProSavin undergone phase IV clinical trials by 2018?,"Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.",1
3498,1,Has ProSavin undergone phase IV clinical trials by 2018?,We undertook a phase 1/2 open-label trial with 12-month follow-up at two study sites (France and UK) to assess the safety and efficacy of ProSavin after bilateral injection into the putamen of patients with Parkinson's disease.,1
4171,0,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.,1
4171,1,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,"An orally administered, fixed-dose coformulation of sodium phenylbutyrate-taurursodiol (PB-TURSO) significantly slowed functional decline in a randomized, placebo-controlled, phase 2 trial in ALS (CENTAUR).",0
4171,2,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,Initiation of PB-TURSO treatment at baseline resulted in a 6.5-month longer median survival as compared with placebo.,0
4171,3,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,"Combined with results from CENTAUR, these results suggest that PB-TURSO has both functional and survival benefits in ALS.",1
4171,4,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.,1
4171,5,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,"METHODS: In this multicenter, randomized, double-blind trial, we enrolled participants with definite ALS who had had an onset of symptoms within the previous 18 months.",0
4171,6,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,"Participants were randomly assigned in a 2:1 ratio to receive sodium phenylbutyrate-taurursodiol (3 g of sodium phenylbutyrate and 1 g of taurursodiol, administered once a day for 3 weeks and then twice a day) or placebo.",0
4171,7,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,CONCLUSIONS: Sodium phenylbutyrate-taurursodiol resulted in slower functional decline than placebo as measured by the ALSFRS-R score over a period of 24 weeks.,1
4171,8,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,Secondary outcomes were not significantly different between the two groups.,0
4171,9,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,Longer and larger trials are necessary to evaluate the efficacy and safety of sodium phenylbutyrate-taurursodiol in persons with ALS.,1
4171,10,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,"An orally administered, fixed-dose coformulation of sodium phenylbutyrate-taurursodiol (PB-TURSO) significantly slowed functional decline in a randomized, placebo-controlled, phase 2 trial in ALS (CENTAUR).",0
4171,11,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,"An orally administered, fixed-dose coformulation of sodium phenylbutyrate-taurursodiol (PB-TURSO) significantly slowed functional decline in a randomized, placebo-controlled, phase 2 trial in ALS (CENTAUR).",0
4171,12,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,Her,0
4171,13,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,SIONS: Sodium phenylbutyrate-taurursodiol resulted in slower functional decline than placebo as measured by the ALSFRS-R score over a period of 24 weeks.,0
4171,14,What is the role of phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis?,Seco,0
2676,0,How are deletion breakpoints defined?,Molecular mapping of deletion breakpoints on chromosome 4 of Drosophila melanogaster.,1
2676,1,How are deletion breakpoints defined?,"In this study, we investigated the deletion breakpoints of the parkin mutations in 22 families with AR-JP and examined the possible association between these deletion events and meiotic recombinations.",1
2676,2,How are deletion breakpoints defined?,We identified 18 deletion breakpoints at the DNA nucleotide sequence level.,0
2676,3,How are deletion breakpoints defined?,Hemizygotic deletions or duplications in the large Duchenne muscular dystrophy DMD gene responsible for Duchenne and Becker muscular dystrophies are routinely identified using multiple ligation probe amplification and array-based comparative genomic hybridization.,0
2676,4,How are deletion breakpoints defined?,"Commonly used methods for the detection of CNV breakpoints include long-range PCR and primer walking, their success being limited by the deletion size, GC content and presence of DNA repeats.",1
2676,5,How are deletion breakpoints defined?,he hemizygous deletion of exons 45-50 in the DMD gene and the large autosomal heterozygous PARK2 deletion were used to demonstrate the workflow that relies on real-time quantitative PCR to narrow down the deletion region and Sanger sequencing for breakpoint confirmation.,1
2676,6,How are deletion breakpoints defined?,"Specifically, (AT)n, (GAA)n and (GAAA)n constitute the most frequent repeats at translocation breakpoints, whereas A-tracts occur preferentially at deletion breakpoints",1
2676,7,How are deletion breakpoints defined?,"Using this approach, we have efficiently defined the proximal and distal breakpoints in two cytogenetic cases, one duplication and one deletion, to within 5-20 kb.",0
2676,8,How are deletion breakpoints defined?,The results support the potential use of BAC-based PCR fragments to further improve the resolution of the microarray-CGH strategy by an order of magnitude.,0
2676,9,How are deletion breakpoints defined?,"The deletion breakpoints were defined by a combination of long polymerase chain reaction (PCR) amplifications, and conventional PCR and DNA sequencing.",0
2676,10,How are deletion breakpoints defined?,"In this investigation, polymerase chain reaction (PCR)-based techniques and sequencing were used to isolate the deletion breakpoints, utilizing the newly available dog genome sequence.",0
2676,11,How are deletion breakpoints defined?,"The deletion breakpoints were defined by a combination of long polymerase chain reaction (PCR) amplifications, and conventional PCR and DNA sequencing.",0
2676,12,How are deletion breakpoints defined?,"We used paralog-specific primers and long-range PCR to clone, sequence, and examine the distal deletion breakpoints from two patients with de novo deletions mapping to these distal LCRs.",0
2676,13,How are deletion breakpoints defined?,"To define the Thailand deletion breakpoints, we used polymerase chain reaction (PCR) to amplify the normal-sequence DNA fragments across the breakpoints.",0
1842,0,List kinases that phosphorylates the protein Bora.,"During cell division Bora becomes multiply phosphorylated by a variety of cell cycle kinases, including Aurora A and Plk1, albeit at distinctive sites.",1
1842,1,List kinases that phosphorylates the protein Bora.,"Likewise, we find that phosphorylation of Bora by Cdk1 promotes phosphorylation of human Plk1 by Aurora A suggesting that this mechanism is conserved in humans.",1
1842,2,List kinases that phosphorylates the protein Bora.,we show that the master mitotic kinase Cdk1 contributes to Plk1 activation through SPAT-1/Bora phosphorylation,1
1842,3,List kinases that phosphorylates the protein Bora.,the potential role of Bora phosphorylation by Cdk1 in this process,1
1842,4,List kinases that phosphorylates the protein Bora.,phosphorylation of Bora on the Cdk consensus site T52 blocks Bora degradation.,0
1842,5,List kinases that phosphorylates the protein Bora.,"Here, we used the LC-MS/MS phosphopeptide mapping assay to identify 13 in vivo hBora phosphorylation sites and characterized that GSK3β can interact with hBora and phosphorylate hBora at Ser274 and Ser278.",1
1031,0,List the diseases for which there are point-of-care breath tests,"Additionally, we try to clarify controversial issues concerning possible experimental malpractice in the field, and propose ways to translate the basic science results as well as the mechanistic understanding to tools (sensors) that could serve as point-of-care diagnostics of cancer.",0
1031,1,List the diseases for which there are point-of-care breath tests,Point of care monitoring of hemodialysis patients with a breath ammonia measurement device based on printed polyaniline nanoparticle sensors.,0
1031,2,List the diseases for which there are point-of-care breath tests," Excellent intraindividual correlations were demonstrated between breath ammonia and BUN (0.86 to 0.96), which demonstrates the possibility of using low cost point of care breath ammonia systems as a noninvasive means of monitoring kidney dysfunction and treatment.",0
1031,3,List the diseases for which there are point-of-care breath tests,"Recently, fractional exhaled nitric oxide (FeNO) has emerged as an important biomarker for the assessment and management of asthma.",0
1031,4,List the diseases for which there are point-of-care breath tests,"Here we discuss the potential of adapting a technology from the electronics industry, surface acoustic wave (SAW) sensors, for diagnosis of multiple markers of sepsis in real time, using non-invasive assays of exhaled breath condensate.",0
1031,5,List the diseases for which there are point-of-care breath tests,Together these data indicate that FeNO testing has an important role in the assessment and management of adult asthma.,0
1031,6,List the diseases for which there are point-of-care breath tests,Measurement of acetone in human breath samples has been previously shown to provide significant non-invasive diagnostic insight into the control of a patient's diabetic condition.,0
1031,7,List the diseases for which there are point-of-care breath tests, Urea breath testing may provide a useful diagnostic and biomarker assay for tuberculosis and treatment response.,0
1031,8,List the diseases for which there are point-of-care breath tests,These animal model results suggest that exhaled breath can be used as a point-of-care tool for the diagnosis and monitoring of sepsis.,0
1031,9,List the diseases for which there are point-of-care breath tests,Point-of-care breath test for biomarkers of active pulmonary tuberculosis.,1
1031,10,List the diseases for which there are point-of-care breath tests,RATIONALE: Volatile organic compounds (VOCs) in breath provide biomarkers of tuberculosis (TB) because Mycobacterium tuberculosis manufactures VOC metabolites that are detectable in the breath of infected patients.,0
1031,11,List the diseases for which there are point-of-care breath tests,CONCLUSIONS: A six-minute point-of-care breath test for volatile biomarkers accurately identified subjects with active pulmonary TB.,1
1031,12,List the diseases for which there are point-of-care breath tests,"Selected ion flow tube-mass spectrometry (SIFT-MS) can measure volatile compounds in breath on-line in real time and has the potential to provide accurate breath tests for a number of inflammatory, infectious and metabolic diseases, including diabetes.",0
1031,13,List the diseases for which there are point-of-care breath tests,"Breath analysis by SIFT-MS offers a rapid, reproducible and easily performed measurement of acetone concentration in ambulatory patients with type 2 diabetes.",0
1031,14,List the diseases for which there are point-of-care breath tests,"IGR is a new approach for non-invasive cardiac output measurement in mechanically ventilated individuals, but requires further investigation for clinical use.",0
1031,15,List the diseases for which there are point-of-care breath tests,"The liver metabolic breath test relies on measuring exhaled (13) C tagged methacetin, which is metabolized only by the liver.",0
1031,16,List the diseases for which there are point-of-care breath tests,"Measuring this liver-specific substrate by means of molecular correlation spectroscopy is a rapid, non-invasive method for assessing liver function at the point-of-care.",0
1031,17,List the diseases for which there are point-of-care breath tests,Our recent findings regarding the ability of point-of-care (13) C MBT to assess the hepatic functional reserve in patients with acute and chronic liver disease are reviewed along with suggested treatment algorithms for common liver disorders.,0
1031,18,List the diseases for which there are point-of-care breath tests,13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.,1
1031,19,List the diseases for which there are point-of-care breath tests,CONCLUSIONS/SIGNIFICANCE: Urea breath testing may provide a useful diagnostic and biomarker assay for tuberculosis and for treatment response.,0
1031,20,List the diseases for which there are point-of-care breath tests,"CONCLUSIONS: The non-invasive real-time BreathID GBT reliably assesses changes in liver glucose metabolism, and the degree of insulin resistance.",0
1031,21,List the diseases for which there are point-of-care breath tests,DISCUSSION: The LiMAx test can validly determine liver function capacity and is feasible in every clinical situation.,0
1031,22,List the diseases for which there are point-of-care breath tests,"A P(ET,CO(2)) of >or=36 mmHg may reliably exclude PE.",0
1031,23,List the diseases for which there are point-of-care breath tests,Accuracy is augmented by combination with Wells score.,0
1031,24,List the diseases for which there are point-of-care breath tests,"P( ET,CO(2)) should be prospectively compared to D-dimer in accuracy and simplicity to exclude PE.",0
1031,25,List the diseases for which there are point-of-care breath tests,Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial.,0
1031,26,List the diseases for which there are point-of-care breath tests,"CONCLUSION: The (13)C-MBT provides a rapid, non-invasive assessment of liver function in acute severe liver disease of diverse etiologies.",0
1031,27,List the diseases for which there are point-of-care breath tests,"CONCLUSION: The determination of CO by IGR and CWD revealed a good agreement and reproducibility with a low rate of impossible measurements, suggesting that IGR and CWD can be used interchangeably in the clinical setting.",0
1031,28,List the diseases for which there are point-of-care breath tests,BACKGROUND: Exhaled NO (FE(NO)) is a useful biomarker for the monitoring of asthma control and response to therapy.,0
1031,29,List the diseases for which there are point-of-care breath tests,"A high percentage of patients with different severities of asthma and regardless of their treatment with ICS and current smoking habit (current and/or ex-smokers) had highly elevated FE(NO) values, suggesting that their current therapy was possibly insufficient to control the underlying degree of airway inflammation and asthma symptoms.",0
1031,30,List the diseases for which there are point-of-care breath tests,"H. pylori-positive status was defined by positivity on at least 2 tests: a commercial H. pylori stool antigen enzyme immunoassay, an immunoglobulin G antibody enzyme immunoassay, and the C-urea breath test",0
1031,31,List the diseases for which there are point-of-care breath tests,End-tidal carbon dioxide measurements in children with acute asthma.,0
1031,32,List the diseases for which there are point-of-care breath tests,CONCLUSIONS: Noninvasive bedside measurement of EtCO2 values among children with acute asthma is feasible.,0
1031,33,List the diseases for which there are point-of-care breath tests,Review article: the assessment of liver function using breath tests.,0
1031,34,List the diseases for which there are point-of-care breath tests,"The recent development of a real-time, point-of-care liver function breath test has made it straightforward to assess the metabolic function of the liver.",1
1031,35,List the diseases for which there are point-of-care breath tests,"RESULTS: The (13)C-methacetin breath test enables accurate follow-up of patients with acute or chronic liver damage, where overall hepatic function is significantly suppressed by known causes of liver disorders, including acute, sub-acute or chronic conditions.",0
1031,36,List the diseases for which there are point-of-care breath tests,CONCLUSIONS: Breath testing that provides continuous quantification of methacetin metabolism may be a sensitive tool for the diagnosis and follow-up of patients with liver disorders.,0
1031,37,List the diseases for which there are point-of-care breath tests," A multi-center study in a multi-ethnic population compared the RAPIRUN urine antibody test with the (13)C-urea breath test (C-UBT) and a traditional serologic test, the high-molecular-weight cell-associated protein enzyme immunoassay (HM-CAP EIA).",0
1031,38,List the diseases for which there are point-of-care breath tests,"CONCLUSION: EGA provided non-invasive, accurate, continuous, high-resolution COHb% measurements.",0
1031,39,List the diseases for which there are point-of-care breath tests,"Applying EGA to carboxyhaemoglobin dilution, we achieved RCV measurements with accuracy equivalent to that of CO-haemoximetry, with one-fifth of the COB infusion volume.",0
1031,40,List the diseases for which there are point-of-care breath tests," These results suggest that the IR device, which is small, light-weight, and rugged may enable the foreign gas uptake method to be used in clinical, field, and point-of-care settings for Q (T) measurement.",0
1031,41,List the diseases for which there are point-of-care breath tests,UNLABELLED: The 13C-urea breath test provides non-invasive testing for Helicobacter pylori infection with the possibility of analysis at the point of care.,1
1031,42,List the diseases for which there are point-of-care breath tests,"CONCLUSION: Fdlate, a variable of VCap, had a statistically better diagnostic performance in suspected PE than the PaCO(2)-EtCO(2) gradient.",0
1031,43,List the diseases for which there are point-of-care breath tests," In conclusion, the investigated rebreathing system allows for a non-invasive determination of PBF at the bedside.",0
1031,44,List the diseases for which there are point-of-care breath tests,Non-invasive measurement of pulmonary blood flow during prone positioning in patients with early acute respiratory distress syndrome.,0
1031,45,List the diseases for which there are point-of-care breath tests,"The 13C-urea breath test provides accurate, noninvasive diagnosis of active Helicobacter pylori infection and can document posttherapy cure.",0
1031,46,List the diseases for which there are point-of-care breath tests,A portable Fourier transform infrared (FT-IR) multicomponent point-of-care analyzer was tested for the diagnosis of methanol intoxications.,0
1031,47,List the diseases for which there are point-of-care breath tests,"Breath analysis with FT-IR was fast and easy, and no sample preparation was needed.",0
1031,48,List the diseases for which there are point-of-care breath tests,CONCLUSIONS: The Fd(late) is a valuable tool for bedside screening of PE in surgical patients.,0
2598,0,Does MC1R palmitoylation reduce pigmentation?,"The melanocortin-1 receptor (MC1R), a G-protein-coupled receptor, has a crucial role in human and mouse pigmentation.",1
2598,1,Does MC1R palmitoylation reduce pigmentation?,Activation of MC1R in melanocytes by α-melanocyte-stimulating hormone (α-MSH) stimulates cAMP signalling and melanin production and enhances DNA repair after ultraviolet irradiation.,1
2598,2,Does MC1R palmitoylation reduce pigmentation?,"MC1R palmitoylation, primarily mediated by the protein-acyl transferase ZDHHC13, is essential for activating MC1R signalling, which triggers increased pigmentation, ultraviolet-B-induced G1-like cell cycle arrest and control of senescence and melanomagenesis in vitro and in vivo.",1
2598,3,Does MC1R palmitoylation reduce pigmentation?,The results highlight a central role for MC1R palmitoylation in pigmentation and protection against melanoma.,1
222,0,Is there any association between Jarid2 and miR-155 in Th17 cells?,Jarid2 links MicroRNA and chromatin in Th17 cells.,0
222,1,Is there any association between Jarid2 and miR-155 in Th17 cells?,"In this issue of Immunity, Escobar et al.",0
222,2,Is there any association between Jarid2 and miR-155 in Th17 cells?,(2014) bring microRNAs and chromatin together by showing how activation-induced miR-155 targets the chromatin protein Jarid2 to regulate proinflammatory cytokine production in T helper 17 cells.,1
222,3,Is there any association between Jarid2 and miR-155 in Th17 cells?,miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression.,1
222,4,Is there any association between Jarid2 and miR-155 in Th17 cells?,Mir155 was bound by Th17 cell transcription factors and was highly expressed during Th17 cell differentiation.,0
222,5,Is there any association between Jarid2 and miR-155 in Th17 cells?,"miR-155-deficient Th17 and T regulatory (Treg) cells expressed increased amounts of Jarid2, a DNA-binding protein that recruits the Polycomb Repressive Complex 2 (PRC2) to chromatin.",1
222,6,Is there any association between Jarid2 and miR-155 in Th17 cells?,"PRC2 binding to chromatin and H3K27 histone methylation was increased in miR-155-deficient cells, coinciding with failure to express Il22, Il10, Il9, and Atf3.",0
222,7,Is there any association between Jarid2 and miR-155 in Th17 cells?,Defects in Th17 cell cytokine expression and Treg cell homeostasis in the absence of Mir155 could be partially suppressed by Jarid2 deletion.,0
222,8,Is there any association between Jarid2 and miR-155 in Th17 cells?,"Thus, miR-155 contributes to Th17 cell function by suppressing the inhibitory effects of Jarid2.",1
222,9,Is there any association between Jarid2 and miR-155 in Th17 cells?,"Thus, miR-155 contributes to Th17 cell function by suppressing the inhibitory effects of Jarid2.",1
222,10,Is there any association between Jarid2 and miR-155 in Th17 cells?,"Thus, miR-155 contributes to Th17 cell function by suppressing the inhibitory effects of Jarid2.",0
222,11,Is there any association between Jarid2 and miR-155 in Th17 cells?,Defects in Th17 cell cytokine expression and Treg cell homeostasis in the absence of Mir155 could be partially suppressed by Jarid2 deletion.,0
222,12,Is there any association between Jarid2 and miR-155 in Th17 cells?,"Thus, miR-155 contributes to Th17 cell function by suppressing the inhibitory effects of Jarid2.",0
222,13,Is there any association between Jarid2 and miR-155 in Th17 cells?,"Thus, miR-155 contributes to Th17 cell function by suppressing the inhibitory effects of Jarid2.",0
415,0,Can protein coding exons originate from ALU sequences?,The Alu element has been a major source of new exons during primate evolution.,1
415,1,Can protein coding exons originate from ALU sequences?,Thousands of human genes contain spliced exons derived from Alu elements.,0
415,2,Can protein coding exons originate from ALU sequences?,"More than 25% of Alu exons analyzed by RNA-Seq have estimated transcript inclusion levels of at least 50% in the human cerebellum, indicating widespread establishment of Alu exons in human genes.",1
415,3,Can protein coding exons originate from ALU sequences?,his study presents genomic evidence that a major functional consequence of Alu exonization is the lineage-specific evolution of translational regulation.,0
415,4,Can protein coding exons originate from ALU sequences?,Our data suggests that lineage-specific exonization events should be determined by the combination event of the formation of splicing sites and protection against site-specific mutation pressures.,1
415,5,Can protein coding exons originate from ALU sequences?,These evolutionary mechanisms could be major sources for primate diversification.,0
415,6,Can protein coding exons originate from ALU sequences?,Exonization of Alu elements creates primate-specific genomic diversity,0
415,7,Can protein coding exons originate from ALU sequences?,"Our data show that, once acquired, some exonizations were lost again in some lineages.",0
415,8,Can protein coding exons originate from ALU sequences?,"In general, Alu exonization occurred at various time points over the evolutionary history of primate lineages, and protein-coding potential was acquired either relatively soon after integration or millions of years thereafter.",1
415,9,Can protein coding exons originate from ALU sequences?,"Once integrated, they have the potential to become exapted as functional modules, e.g., as protein-coding domains via alternative splicing.",0
415,10,Can protein coding exons originate from ALU sequences?,This particular process is also termed exonization and increases protein versatility,0
415,11,Can protein coding exons originate from ALU sequences?,"alternative ""Alu-exons"" also carry the potential to greatly enhance genetic diversity by increasing the transcriptome of primates chiefly via alternative splicing.",1
415,12,Can protein coding exons originate from ALU sequences?,"ere, we report a 5' exon generated from one of the two alternative transcripts in human tumor necrosis factor receptor gene type 2 (p75TNFR) that contains an ancient Alu-SINE, which provides an alternative N-terminal protein-coding domain.",0
567,0,What is apelin?,"Apelin, a small regulatory peptide, is the endogenous ligand for the apelin receptor (APJ) receptor.",1
567,1,What is apelin?,Apelin is an adipocyte-derived hormone that plays important roles in energy metabolism.,0
567,2,What is apelin?,"Apelin, as the endogenous ligand of G protein-coupled receptor APJ, participates in a number of physiological and pathological processes.",1
567,3,What is apelin?,Apelin is a novel bioactive peptide as the endogenous ligand for APJ.,1
567,4,What is apelin?,adipokine apelin,0
567,5,What is apelin?,"Apelin is the endogenous ligand of the APJ receptor, a member of the G protein-coupled receptor family.",1
567,6,What is apelin?,"To date four adipokines (leptin, visfatin, apelin and ghrelin) have been investigated and all affect myometrial contractility, but some more potently than others.",0
567,7,What is apelin?,"The adipocytokine apelin is a peptide, Apelin and its receptor are abundantly expressed in the nervous and cardiovascular systems.",1
567,8,What is apelin?,The aim of this study was to determine the levels of regulatory peptides apelin,0
567,9,What is apelin?,Apelin is a vaso-dilatory peptide that also has a modulatory role in pain processing.,0
3301,0,What are the effects of 14-3-3 dimers on Tau phosphorylation?,"Proteomic, biochemical and genetic evidence demonstrate that both Drosophila 14-3-3 proteins interact with human wild-type and mutant Tau on multiple sites irrespective of their phosphorylation state.",1
3301,1,What are the effects of 14-3-3 dimers on Tau phosphorylation?,"14-3-3 dimers regulate steady-state phosphorylation of both wild-type and the R406W mutant Tau, but they are not essential for toxicity of either variant.",1
3301,2,What are the effects of 14-3-3 dimers on Tau phosphorylation?,"Moreover, 14-3-3 elevation itself is not pathogenic, but recruitment of dimers on accumulating wild-type Tau increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner.",1
3301,3,What are the effects of 14-3-3 dimers on Tau phosphorylation?,"In contrast, the R406W mutant, which lacks a putative 14-3-3 binding site, responds differentially to elevation of each 14-3-3 isoform.",1
3301,4,What are the effects of 14-3-3 dimers on Tau phosphorylation?,"Although excess 14-3-3ζ stabilizes the mutant protein, elevated D14-3-3ɛ has a destabilizing effect probably because of altered 14-3-3 dimer composition.",1
1227,0,Which tool is used for promoterome mining using CAGE data?,CAGEr: precise TSS data retrieval and high-resolution promoterome mining for integrative analyses.,0
1227,1,Which tool is used for promoterome mining using CAGE data?," Despite their high resolution and functional significance, published CAGE data are still underused in promoter analysis due to the absence of tools that enable its efficient manipulation and integration with other genome data types.",1
1227,2,Which tool is used for promoterome mining using CAGE data?,"Here we present CAGEr, an R implementation of novel methods for the analysis of differential TSS usage and promoter dynamics, integrated with CAGE data processing and promoterome mining into a first comprehensive CAGE toolbox on a common analysis platform.",1
1227,3,Which tool is used for promoterome mining using CAGE data?,"Crucially, we provide collections of TSSs derived from most published CAGE datasets, as well as direct access to FANTOM5 resource of TSSs for numerous human and mouse cell/tissue types from within R, greatly increasing the accessibility of precise context-specific TSS data for integrative analyses.",0
1227,4,Which tool is used for promoterome mining using CAGE data?,The CAGEr package is freely available from Bioconductor at http://www.bioconductor.org/packages/release/bioc/html/CAGEr.html.,0
1227,5,Which tool is used for promoterome mining using CAGE data?,"Here we present CAGEr, an R implementation of novel methods for the analysis of differential TSS usage and promoter dynamics, integrated with CAGE data processing and promoterome mining into a first comprehensive CAGE toolbox on a common analysis platform",1
1227,6,Which tool is used for promoterome mining using CAGE data?,CAGEr: precise TSS data retrieval and high-resolution promoterome mining for integrative analyses,0
1227,7,Which tool is used for promoterome mining using CAGE data?,"Despite their high resolution and functional significance, published CAGE data are still underused in promoter analysis due to the absence of tools that enable its efficient manipulation and integration with other genome data types.",1
1227,8,Which tool is used for promoterome mining using CAGE data?,"Here we present CAGEr, an R implementation of novel methods for the analysis of differential TSS usage and promoter dynamics, integrated with CAGE data processing and promoterome mining into a first comprehensive CAGE toolbox on a common analysis platform.",1
605,0,What is the functionality of the Triplex R/bioconductor package?,Triplex: an R/Bioconductor package for identification and visualization of potential intramolecular triplex patterns in DNA sequences.,0
605,1,What is the functionality of the Triplex R/bioconductor package?,The new package provides functions that can be used to search Bioconductor genomes and other DNA sequence data for occurrence of nucleotide patterns capable of forming intramolecular triplexes (H-DNA).,1
605,2,What is the functionality of the Triplex R/bioconductor package?,Functions producing 2D and 3D diagrams of the identified triplexes allow instant visualization of the search results.,1
605,3,What is the functionality of the Triplex R/bioconductor package?,"Leveraging the power of Biostrings and GRanges classes, the results get fully integrated into the existing Bioconductor framework, allowing their passage to other Genome visualization and annotation packages, such as GenomeGraphs, rtracklayer or Gviz.",1
605,4,What is the functionality of the Triplex R/bioconductor package?,RESULTS: We combined a previously published implementation of a triplex DNA search algorithm with visualization to create a versatile R/Bioconductor package 'triplex'.,0
605,5,What is the functionality of the Triplex R/bioconductor package?,The new package provides functions that can be used to search Bioconductor genomes and other DNA sequence data for occurrence of nucleotide patterns capable of forming intramolecular triplexes (H-DNA).,1
605,6,What is the functionality of the Triplex R/bioconductor package?,Functions producing 2D and 3D diagrams of the identified triplexes allow instant visualization of the search results.,1
234,0,What clinical use aptamers may have?,"In murine tumor models, the aptamer-targeted siRNA-mediated NMD inhibition in tumor cells led to significant inhibition of tumor growth, which was superior to best-in-class ""conventional"" cancer vaccination protocols.",0
234,1,What clinical use aptamers may have?,"Tumor-targeted NMD inhibition forms the basis of a simple, broadly useful, and clinically feasible approach to enhance the antigenicity of disseminated tumors leading to their immune recognition and rejection.",1
234,2,What clinical use aptamers may have?,This study is focused on one aptamer (termed A2).,0
234,3,What clinical use aptamers may have?,Transfection of this molecule into HPV16-transformed cells resulted in inhibition of cell proliferation (shown using real-time cell electronic sensing and MTT assays) due to the induction of apoptosis (as demonstrated by Annexin V/propidium iodide staining).,0
234,4,What clinical use aptamers may have?,Transfection of cells with A2 was correlated with the loss of E7 and the induction of apoptosis.,0
234,5,What clinical use aptamers may have?,Aptamers specific for a number of cellular and viral proteins have been documented previously; one aptamer (Macugen) is approved for clinical use and several others are in clinical trials.,0
234,6,What clinical use aptamers may have?,The high binding affinity and specificity of aptamers allows for isolation of an artificial ligand for theoretically any therapeutic target of interest.,0
234,7,What clinical use aptamers may have?,Aptamers are a special class of nucleic acid molecules that are beginning to be investigated for clinical use.,0
234,8,What clinical use aptamers may have?,These small RNA/DNA molecules can form secondary and tertiary structures capable of specifically binding proteins or other cellular targets; they are essentially a chemical equivalent of antibodies.,0
234,9,What clinical use aptamers may have?,"Aptamers have the advantage of being highly specific, relatively small in size, and non-immunogenic.",0
234,10,What clinical use aptamers may have?,"In the last two decades, many aptamers have been clinically developed as inhibitors for targets such as vascular endothelial growth factor (VEGF) and thrombin.",1
234,11,What clinical use aptamers may have?,The first aptamer based therapeutic was FDA approved in 2004 for the treatment of age-related macular degeneration and several other aptamers are currently being evaluated in clinical trials.,0
234,12,What clinical use aptamers may have?,Preclinical studies using aptamer-siRNA chimeras and aptamer targeted nanoparticle therapeutics have been very successful in mouse models of cancer and HIV.,0
234,13,What clinical use aptamers may have?,"In summary aptamers are in several stages of development, from pre-clinical studies to clinical trials and even as FDA approved therapeutics.",0
234,14,What clinical use aptamers may have?,"In subcutaneous and metastatic tumour models, tumour-targeted delivery of NMD factor-specific siRNAs conjugated to oligonucleotide aptamer ligands led to significant inhibition of tumour growth that was superior to that of vaccination with granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing irradiated tumour cells, and could be further enhanced by co-stimulation.",0
234,15,What clinical use aptamers may have?,"An assortment of non-viral carriers including liposomes, peptides, polymers, and aptamers are being evaluated for their ability to shepherd siRNA to the target tissue and cross the plasma membrane barrier into the cell.",0
234,16,What clinical use aptamers may have?,"In addition, a new thromboxane receptor antagonist, NCX-4016, a newly discovered protease-activated receptor antagonist that targets thrombin-induced platelet aggregation, and anti-von Willebrand factor aptamers show tremendous promise in refining antiplatelet therapy by targeting different receptors and molecules.",0
234,17,What clinical use aptamers may have?,First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers,0
234,18,What clinical use aptamers may have?,"ARC1779 is a therapeutic aptamer antagonist of the A1 domain of von Willebrand Factor (vWF), the ligand for receptor glycoprotein 1b on platelets.",0
234,19,What clinical use aptamers may have?,ARC1779 is being developed as a novel antithrombotic agent for use in patients with acute coronary syndromes.,0
234,20,What clinical use aptamers may have?,This is the first-in-human evaluation of a novel aptamer antagonist of vWF.,0
234,21,What clinical use aptamers may have?,ARC1779 produced dose- and concentration-dependent inhibition of vWF activity and platelet function with duration of effect suitable for the intended clinical use in acute coronary syndromes.,0
234,22,What clinical use aptamers may have?,Wet age-related macular degeneration and diabetic retinopathy are pathological consequences of vascular endothelial growth factor (VEGF) release as a reaction to deficiency of oxygen and nutrients in the macular cells.,1
234,23,What clinical use aptamers may have?,"FDA recently approved two drugs specifically aimed at VEGF, bevacizumab, a humanized monoclonal antibody, and pegaptinib, a pegylated aptamer with application in ophthalmic pathologies.",0
234,24,What clinical use aptamers may have?,Delivery of double-stranded DNA thioaptamers into HIV-1 infected cells for antiviral activity,0
234,25,What clinical use aptamers may have?,"Our lead thioaptamer, R12-2, targets the RNase H domain of the HIV-1 reverse transcriptase (RT) and inhibits viral infection in U373-MAGI-CCR5 cells.",1
234,26,What clinical use aptamers may have?,"In this report, we demonstrate that monothioate-modified DNA duplex oligonucleotides can be efficiently delivered into cells by liposome-based transfection agents to inhibit HIV replication.",0
234,27,What clinical use aptamers may have?,Nucleic acid aptamers in therapeutic anticoagulation,0
234,28,What clinical use aptamers may have?,Pegaptanib sodium for the treatment of neovascular age-related macular degeneration,0
234,29,What clinical use aptamers may have?,Pegaptanib sodium is one of the first therapeutics belonging to the class of compounds known as aptamers.,0
234,30,What clinical use aptamers may have?,"The article highlights and summarises the results of the multi-centre, randomised, sham-controlled clinical trials with pegaptanib sodium to treat subfoveal choroidal neovascularisation in AMD.",0
234,31,What clinical use aptamers may have?,"In addition, the safety profile is reviewed.",0
234,32,What clinical use aptamers may have?,Regulatable aptamers in medicine: focus on antithrombotic strategies,0
234,33,What clinical use aptamers may have?,"After a decade of intensive research, technology development and initial clinical evaluation, aptamers have now demonstrated broad potential as direct protein ligands and inhibitors, and thus represent an exciting class of compounds for the development of new therapeutic and diagnostic agents.",0
234,34,What clinical use aptamers may have?,"Two R-aptamers (R10-60 and D-R15-8) with the predominant shared characteristics were selected for further study on primary human chronic lymphocytic leukemia (CLL) B cells, which are well known to be difficult to transfect and activate.",1
234,35,What clinical use aptamers may have?,"Together, these findings suggest that the sequence compositions in R-aptamers that promote multimerization and contain optimal ISS CpG motifs facilitate the delivery of ISS-ODN to CLL cells and enhance the activation of these cells.",0
234,36,What clinical use aptamers may have?,"In particular, the use of aptamers for the alleviation of blood clotting and the treatment of AIDS are considered.",0
234,37,What clinical use aptamers may have?,We synthesized an RNA aptamer probe specific for human CD4 using a reported sequence and investigated the potential use of this probe in cell phenotyping.,0
234,38,What clinical use aptamers may have?,Studies in cultured cells demonstrated that the synthetic CD4 aptamer had a nearly identical cell-binding specificity as the standard CD4 antibody.,0
234,39,What clinical use aptamers may have?,Fluorescent microscopy confirmed that the aptamer and antibody generated the same CD4 staining pattern in cells without competing with one another.,0
234,40,What clinical use aptamers may have?,transfection of HPV16-transformed cells with A2 appeared to result in the loss of E7 and rise in pRb levels,0
4232,0,What is the effect of Carbendazim on bees?,"Together, these results suggest that carbendazim is an environmental risk factor that likely weakens bee colonies, partially due to reduced expression of major royal jelly proteins, which may be potential causes of colony collapse disorder.",1
3864,0,Is lorcaserin associated with increased cancer risk?,Is lorcaserin really associated with increased risk of cancer?,0
3864,1,Is lorcaserin associated with increased cancer risk?,A systematic review and meta-analysis.,0
3864,2,Is lorcaserin associated with increased cancer risk?,The US Food and Drug Administration (FDA) reported in February 2020 an increased risk of cancer with lorcaserin in the follow-up of the CAMELLIA-TIMI 61 trial.,1
3864,3,Is lorcaserin associated with increased cancer risk?,"From 11 trials, comprising 21,299 individuals, four studies were included in the meta-analysis and reported 476 cases of cancer in 10,342 subjects in the lorcaserin group and 438 among 9429 individuals randomized to placebo (relative risk [RR]: 1.08; 95% confidence interval [95% CI]: 0.96-1.23).",1
3864,4,Is lorcaserin associated with increased cancer risk?,The result was heavily influenced by the CAMELLIA-TIMI 61 trial.,1
3864,5,Is lorcaserin associated with increased cancer risk?,"In this study, the lorcaserin group had a higher risk of lung and pancreatic but not colon cancer.",1
3864,6,Is lorcaserin associated with increased cancer risk?,"The current evidence does not confirm the increased risk of cancer with lorcaserin but suggests a trend in this direction, with a greater incidence of some subtypes such as lung and pancreas.",1
698,0,In which cells are gasdermins expressed?,Members of the novel gene family Gasdermin (Gsdm) are exclusively expressed in a highly tissue-specific manner in the epithelium of skin and the gastrointestinal tract.,1
698,1,In which cells are gasdermins expressed?,These results indicate that the mouse Gsdma and Gsdma3 genes share common function to regulate epithelial maintenance,1
698,2,In which cells are gasdermins expressed?,"Gasdermin (GSDM or GSDMA), expressed in the upper gastrointestinal tract but frequently silenced in gastric cancers (GCs), regulates apoptosis of the gastric epithelium.",1
698,3,In which cells are gasdermins expressed?," Immunohistochemical analysis revealed that gasdermins are expressed specifically in cells at advanced stages of differentiation in the upper epidermis, the differentiating inner root sheath and hair shaft and in the most mature sebocytes of the sebaceous gland and preputial, meibomium, ceruminous gland, and anal glands.",1
698,4,In which cells are gasdermins expressed?,This expression pattern suggests a role for gasdermins in differentiation of the epidermis and its appendages.,1
523,0,Is stop codon bypass possible?,"In 1999, proof-of-concept for treating these disorders was obtained in a mouse model of muscular dystrophy, when administration of aminoglycosides restored protein translation by inducing the ribosome to bypass a PTC.",1
523,1,Is stop codon bypass possible?,Aminoglycosides can bypass nonsense mutations and are the prototypic agents for translational bypass therapy (TBT).,0
523,2,Is stop codon bypass possible?,Expression of retroviral replication enzymes (Pol) requires a controlled translational recoding event to bypass the stop codon at the end of gag.,0
523,3,Is stop codon bypass possible?,This recoding event occurs either by direct suppression of termination via the insertion of an amino acid at the stop codon (readthrough) or by alteration of the mRNA reading frame (frameshift).,1
523,4,Is stop codon bypass possible?,"Recent studies on translation termination in the yeast Saccharomyces cerevisiae have not only enabled the identification of the key components of the termination machinery, but have also revealed several regulatory mechanisms that might enable the controlled synthesis of C-terminally extended polypeptides via stop-codon readthrough.",1
523,5,Is stop codon bypass possible?,The effects of all possible single-base mutations in the codons flanking the stop indicated that 3' contexts of the form CAR-YYA confer leakiness and that the 3' context permits read through of UAA and UGA stop codons as well as UAG.,1
523,6,Is stop codon bypass possible?,"As a first step to elucidate the mechanism(s) by which ribosomes bypass leaky stop codons in vivo, we have devised a system in which readthrough is coupled to the transient expression of beta-glucuronidase (GUS) in tobacco protoplasts.",1
3201,0,What is known about the gene MIR140?,Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling.,1
3201,1,What is known about the gene MIR140?,These results demonstrate that Mir140 is essential for normal endochondral bone development and suggest that the reduced BMP signaling caused by Dnpep upregulation plays a causal role in the skeletal defects of Mir140-null mice.,1
3201,2,What is known about the gene MIR140?,"Transcripts associated with cartilage development (e.g., Acan, miR140)",1
3201,3,What is known about the gene MIR140?,"Our findings showed the novel transcriptional role of miR140-5p in the expression of Nrf2 and miR-140-5p protected against Cisplatin induced oxidative stress by activating Nrf2-dependent antioxidant pathway, providing a potentially therapeutic target in acute kidney injury.",1
3402,0,Does promoter shape vary across populations?,Promoter shape varies across populations and affects promoter evolution and expression noise.,1
3402,1,Does promoter shape vary across populations?,"Animal promoters initiate transcription either at precise positions (narrow promoters) or dispersed regions (broad promoters), a distinction referred to as promoter shape.",0
3402,2,Does promoter shape vary across populations?,"Although highly conserved, the functional properties of promoters with different shapes and the genetic basis of their evolution remain unclear.",0
3402,3,Does promoter shape vary across populations?,"Here we used natural genetic variation across a panel of 81 Drosophila lines to measure changes in transcriptional start site (TSS) usage, identifying thousands of genetic variants affecting transcript levels (strength) or the distribution of TSSs within a promoter (shape).",0
3402,4,Does promoter shape vary across populations?,Our results identify promoter shape as a molecular trait that can evolve independently of promoter strength.,1
3402,5,Does promoter shape vary across populations?,"Broad promoters typically harbor shape-associated variants, with signatures of adaptive selection.",0
3402,6,Does promoter shape vary across populations?,"Single-cell measurements demonstrate that variants modulating promoter shape often increase expression noise, whereas heteroallelic interactions with other promoter variants alleviate these effects.",1
3402,7,Does promoter shape vary across populations?,These results uncover new functional properties of natural promoters and suggest the minimization of expression noise as an important factor in promoter evolution.,1
3402,8,Does promoter shape vary across populations?,Promoter shape varies across populations and affects promoter evolution and expression noise,1
345,0,Are circRNAs associated with diseases and traits?,Circ2Traits: a comprehensive database for circular RNA potentially associated with disease and traits.,0
345,1,Are circRNAs associated with diseases and traits?,Circular RNAs play a crucial role in fine tuning the level of miRNA mediated regulation of gene expression by sequestering the miRNAs.,1
345,2,Are circRNAs associated with diseases and traits?,Their interaction with disease associated miRNAs indicates that circular RNAs are important for disease regulation.,1
345,3,Are circRNAs associated with diseases and traits?,"Firstly, the interactions of circRNAs with disease associated miRNAs were identified, following which the likelihood of a circRNA being associated with a disease was calculated",1
345,4,Are circRNAs associated with diseases and traits?,"Emerging evidence indicates that circRNAs might play important roles in atherosclerotic vascular disease risk, neurological disorders, prion diseases and cancer; exhibit aberrant expression in colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC); and serve as diagnostic or predictive biomarkers of some diseases",0
345,5,Are circRNAs associated with diseases and traits?,In this paper we studied the potential association of circular RNAs (circRNA) with human diseases in two different ways.,0
345,6,Are circRNAs associated with diseases and traits?,"Firstly, the interactions of circRNAs with disease associated miRNAs were identified, following which the likelihood of a circRNA being associated with a disease was calculated.",1
345,7,Are circRNAs associated with diseases and traits?,"Firstly, the interactions of circRNAs with disease associated miRNAs were identified, following which the likelihood of a circRNA being associated with a disease was calculated.",1
345,8,Are circRNAs associated with diseases and traits?,"For the miRNAs associated with individual diseases, we constructed a network of predicted interactions between the miRNAs and protein coding, long non-coding and circular RNA genes.",0
1569,0,List the results of mutated casein kinase 1 epsilon. ,"These results demonstrate a role for Csnk1e in regulating not only the timing of sleep, but also the REM sleep amount and NREM sleep architecture, and support Csnk1e as a causal gene in the sleep QTL on chromosome 15.",1
1569,1,List the results of mutated casein kinase 1 epsilon. ,"mutations of CK1epsilon found in breast cancer can suppress Wnt/beta-catenin as well as promote the Wnt/Rac-1/JNK and Wnt/NFAT pathways, thus contributing to breast cancer development via effects on cell adhesion and migration",1
1569,2,List the results of mutated casein kinase 1 epsilon. ,"results in a short circadian period, abnormal entrainment to light cycles, and potentiated resetting responses to light.",1
1569,3,List the results of mutated casein kinase 1 epsilon. ,"We now demonstrate that the mutation results in a heightened sensitivity to light, suggesting that CK1epsilon also regulates the photic entrainment pathway.",1
2694,0,"Which bacteria was EcoRI, restriction endonuclease isolated from?"," Among hundreds of restriction endonucleases, the Eco R1 enzyme is the most useful and widely investigated enzyme.",1
2694,1,"Which bacteria was EcoRI, restriction endonuclease isolated from?","After sonication and ultracentrifugation, crude extracts of E. coli RY 13",1
2694,2,"Which bacteria was EcoRI, restriction endonuclease isolated from?",An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid.,1
2694,3,"Which bacteria was EcoRI, restriction endonuclease isolated from?","Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1.",0
2694,4,"Which bacteria was EcoRI, restriction endonuclease isolated from?",[Characteristics of RecA-independent recombination of plasmids in E. coli cells producing restriction endonuclease EcoRI].,1
2694,5,"Which bacteria was EcoRI, restriction endonuclease isolated from?"," The purification of the EcoRI restriction enzyme from a strain of Escherichia coli that over-produces this enzyme was hampered by the insolubility of the protein, and hence the purification procedure was modified to optimize the recovery of active enzyme",1
3665,0,What does osanetant and talnetant have in common?,Phase II clinical trials in schizophrenia with two selective NK3 antagonists (osanetant and talnetant) have demonstrated significant improvement in positive symptoms.,1
3665,1,What does osanetant and talnetant have in common?,Preclinical and Phase II clinical results of osanetant and talnetant in schizophrenic patients have indicated that NK(3) antagonists may provide significant improvement of the positive symptoms and cognitive impairment associated with this disorder.,1
630,0,List angiocrine factors,Ccl4 and neurotensin (Nts) (angiocrine factors),1
630,1,List angiocrine factors,"vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed factor,",1
630,2,List angiocrine factors,angiocrine factors tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3),1
630,3,List angiocrine factors,"We found that Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive angiocrine factor.",1
630,4,List angiocrine factors,"angiocrine factors, including hepatocyte growth factor (HGF) and Wnt2.",1
3781,0,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,GRIA3 missense mutation is cause of an x-linked developmental and epileptic encephalopathy.,1
3781,1,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,We report a patient carrying a hemizygous missense variant c.2359 G > A (p.Glu787Lys) inGRIA3 gene.,0
3781,2,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,"Following a literature search, we also reviewed clinical, electrophysiological, radiological, and genetic features of 19 patients with GRIA3 mutations.RESULTS: This 26-month-old boy had developmental delay, early onset refractory myoclonic epilepsy, and non-convulsive refractory status epilepticus.",0
3781,3,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,"In published reports, epilepsy was in 6 of 19 patients carrying different genotypes, though epilepsy and electroencephalogram features were not completely defined.",0
3781,4,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,"Out of the 6 patients, one presented with generalized tonic-clonic seizures, two with myoclonic and clonic events (one also presented with epileptic spasms), and one with atypical absences and myoclonic jerks.",0
3781,5,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,Information on type of epilepsy was unavailable for 3 cases.,0
3781,6,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,Epilepsy onset was early in life and there was potential tendency for myoclonic/clonic events.,0
3781,7,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,The epilepsy was difficult to treat and prognosis is poor.,0
3781,8,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,Severity of ID ranged from mild to severe and was variably associated with bipolar affective disorder and autistic spectrum disorders.,0
3781,9,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,"Other neurological features included hypotonia, asthenic body habitus with poor muscle bulk, and hyporeflexia.CONCLUSION: Our report expands knowledge on the electro-clinical and molecular spectrum of GRIA3 variants.",0
3781,10,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,"Larger investigations will better define the prevalence of epilepsy, the epileptic phenotype, and syndromic features underlying GRIA3 variants.",0
3781,11,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,Missense variants in the N-terminal domain of the A isoform of FHF2/FGF13 cause an X-linked developmental and epileptic encephalopathy.,1
3781,12,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,Fibroblast growth factor homologous factors (FHFs) are intracellular proteins which regulate voltage-gated sodium (Nav) channels in the brain and other tissues.,0
3781,13,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,FHF dysfunction has been linked to neurological disorders including epilepsy.,0
3781,14,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,"Here, we describe two sibling pairs and three unrelated males who presented in infancy with intractable focal seizures and severe developmental delay.",0
3781,15,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,Whole-exome sequencing identified hemi- and heterozygous variants in the N-terminal domain of the A isoform of FHF2 (FHF2A).,1
3781,16,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,The X-linked FHF2 gene (also known as FGF13) has alternative first exons which produce multiple protein isoforms that differ in their N-terminal sequence.,1
3781,17,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,The variants were located at highly conserved residues in the FHF2A inactivation particle that competes with the intrinsic fast inactivation mechanism of Nav channels.,0
3781,18,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,"Functional characterization of mutant FHF2A co-expressed with wild-type Nav1.6 (SCN8A) revealed that mutant FHF2A proteins lost the ability to induce rapid-onset, long-term blockade of the channel while retaining pro-excitatory properties.",0
3781,19,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,These gain-of-function effects are likely to increase neuronal excitability consistent with the epileptic potential of FHF2 variants.,0
3781,20,Missense mutations in which genes cause X-linked developmental and epileptic encephalopathy?,Our findings demonstrate that FHF2 variants are a cause of infantile-onset developmental and epileptic encephalopathy and underline the critical role of the FHF2A isoform in regulating Nav channel function.,1
2926,0,What part of the body is affected by Meniere's disease?,"Steroids have been widely used to treat inner-ear diseases such as sudden sensorineural hearing loss, tinnitus, and Meniere's disease.",1
2926,1,What part of the body is affected by Meniere's disease?,"Meniere's disease is an inner ear disease,",1
2926,2,What part of the body is affected by Meniere's disease?,"Ménière's Disease (MD) is a chronic, non-life threatening inner ear disease,",1
2926,3,What part of the body is affected by Meniere's disease?,The utricular duct was blocked in 16 (76%) ears affected by Meniere's disease and 11 (52%) normal ears (p = 0.112).,0
2926,4,What part of the body is affected by Meniere's disease?,"Meniere's disease is (grossly) equally common in each sex, and right and left ears are affected with fairly equal frequency.",1
2926,5,What part of the body is affected by Meniere's disease?,"Meniere's disease is a disease of the inner ear characterized by a triad of symptoms: vestibular symptoms, auditory symptoms, and pressure.",1
256,0,What is the mode of action of bedaquiline?,Bedaquiline works by inhibiting bacterial adenosine triphosphate (ATP) synthase and represents the first novel class of antituberculosis agents in more than 40 years.,1
256,1,What is the mode of action of bedaquiline?,Bedaquiline has an entirely novel mechanism of action and so should be active against otherwise highly resistant organisms.,0
256,2,What is the mode of action of bedaquiline?,It acts on the transmembrane component of adenosine triphosphate synthase and acts by preventing electron transport.,1
256,3,What is the mode of action of bedaquiline?,Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis.,1
256,4,What is the mode of action of bedaquiline?, Bedaquiline is an anti-tuberculosis drug with unique mechanism of action.,0
256,5,What is the mode of action of bedaquiline?,It selectively inhibits the mycobacterial energy metabolism i.e.,0
256,6,What is the mode of action of bedaquiline?,"ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis like active, dormant, replicating, non-replicating, intracellular and extracellular.",0
256,7,What is the mode of action of bedaquiline?,DATA SYNTHESIS: Bedaquiline possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase.,0
256,8,What is the mode of action of bedaquiline?,"By directly inhibiting adenosine triphosphate (ATP) synthase, bedaquiline is effective against both replicating and dormant mycobacteria.",1
256,9,What is the mode of action of bedaquiline?,Enhanced sterilizing capacity via synergistic depletion of ATP further exhibits the promising potential of bedaquiline with pyrazinamide.,0
256,10,What is the mode of action of bedaquiline?,Bedaquiline possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase,1
1998,0,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndromes (EDS) are a group of connective tissue disorders characterized by triad of joint hypermobility, skin extensibility, and tissue fragility.",1
1998,1,What tissue is most affected in Ehlers-Danlos syndromes?,"Ehlers-Danlos syndromes (EDSs) constitute a rare group of inherited connective tissue diseases, characterized by multisystemic manifestations and general tissue fragility.",0
1998,2,What tissue is most affected in Ehlers-Danlos syndromes?,"Ehlers-Danlos syndromes (EDS) are a heterogeneous group of hereditary connective tissue disorders characterized by joint hypermobility, widespread musculoskeletal pain and tissue fragility.",0
1998,3,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndromes (EDS) comprise a heterogenous group of heritable disorders of connective tissue, characterized by joint hypermobility, skin hyperextensibility and tissue fragility.",1
1998,4,What tissue is most affected in Ehlers-Danlos syndromes?,Ehlers-Danlos syndrome denotes a group of inherited connective tissue diseases comprising nine types.,0
1998,5,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndromes comprise a clinically and genetically heterogeneous group of heritable connective tissue disorders characterized by articular hypermobility, skin extensibility, and tissue fragility.",0
1998,6,What tissue is most affected in Ehlers-Danlos syndromes?,Ehlers-Danlos syndrome is a heterogeneous group of heritable connective tissue disorders characterized by increased fragility of various non-ossified tissues,0
1998,7,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos Syndrome (EDS) is a rare connective tissue disorder characterised by fragility of the soft connective tissues and widespread manifestations in skin, ligaments, joints, blood vessels and internal organs",0
1998,8,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndromes (EDS) comprise a heterogenous group of heritable disorders of connective tissue, characterized by joint hypermobility, skin hyperextensibility and tissue fragility",1
1998,9,What tissue is most affected in Ehlers-Danlos syndromes?,Ehlers-Danlos syndromes (EDS) are a heterogeneous group of heritable connective tissue disorders,0
1998,10,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndromes (EDS) are a heterogeneous group of inherited connective tissue disorders characterized by tissue fragility, hyperelasticity of the skin and joint hypermobility.",1
1998,11,What tissue is most affected in Ehlers-Danlos syndromes?,"Ehlers-Danlos syndrome (EDS), a heterogeneous group of inheritable connective tissue disorders, is attributed to mutations in connective tissue genes.",0
1998,12,What tissue is most affected in Ehlers-Danlos syndromes?,Ehlers-Danlos syndrome is a heterogeneous group of heritable connective tissue disorders characterized by increased fragility of various non-ossified tissues.,0
1998,13,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndrome encompasses a group of hereditary disorders of the connective tissue, characterized by hyperextensible skin, joint hypermobility; and varying degrees of vessel and tissue fragility.",0
1998,14,What tissue is most affected in Ehlers-Danlos syndromes?,Ehlers-Danlos syndrome is an inherited connective tissue disorder.,0
1998,15,What tissue is most affected in Ehlers-Danlos syndromes?,The Ehlers-Danlos syndrome is a heritable connective-tissue disorder caused by defects in fibrillar-collagen metabolism.,0
1998,16,What tissue is most affected in Ehlers-Danlos syndromes?,The Ehlers-Danlos syndrome (EDS) comprises a group of hereditary connective tissue disorders.,0
1998,17,What tissue is most affected in Ehlers-Danlos syndromes?,"Ehlers-Danlos syndrome type 4, the vascular type, is a rare, life-threatening inherited disorder of the connective tissue.",0
1998,18,What tissue is most affected in Ehlers-Danlos syndromes?,The Ehlers-Danlos syndrome is characterized by abnormal connective tissue,0
1998,19,What tissue is most affected in Ehlers-Danlos syndromes?,Ehlers-Danlos syndrome is a complex hereditary connective tissue disorder that is characterized by abnormalities of the skin and joints and visceral and neurological manifestation,0
1998,20,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndromes (EDS) are a group of heritable connective tissue disorders that share the common features of skin hyperextensibility, articular hypermobility, and tissue fragility.",0
1998,21,What tissue is most affected in Ehlers-Danlos syndromes?,"The Ehlers-Danlos syndromes (EDS) are a heterogeneous group of heritable connective tissue disorders characterised by joint hypermobility, involvement of skin and tissue fragility",1
1998,22,What tissue is most affected in Ehlers-Danlos syndromes?,"Ehlers-Danlos syndrome (EDS), inherited disorder of connective tissue, frequently leads to impairment of various functional areas,",0
1998,23,What tissue is most affected in Ehlers-Danlos syndromes?,"classic form of Ehlers-Danlos syndrome (cEDS) is an inherited connective tissue disorder, where mutations in type V collagen-encoding genes result in abnormal collagen fibrils.",0
1998,24,What tissue is most affected in Ehlers-Danlos syndromes?,"Thus the cEDS patients have pathological connective tissue morphology and low stiffness, but the rate of connective tissue protein turnover is unknown",0
1998,25,What tissue is most affected in Ehlers-Danlos syndromes?,"Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars, easy bruising, and generalized joint hypermobility",0
1771,0,Describe mechanism of action of Eteplirsen?,Eteplirsen (Exondys 51) is an antisense oligonucleotide designed to induce exon 51 skipping that is developed by Sarepta Therapeutics.,1
1771,1,Describe mechanism of action of Eteplirsen?,Intravenous eteplirsen has received accelerated approval from the US FDA for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation of the DMD gene amenable to exon 51 skipping.,1
1771,2,Describe mechanism of action of Eteplirsen?,The first AON (eteplirsen) has recently received accelerated approval by the Food and Drug Administration in the US.,0
1771,3,Describe mechanism of action of Eteplirsen?,"Currently, the most promising potential drugs are the exon-skipping agents eteplirsen and drisapersen.",0
1771,4,Describe mechanism of action of Eteplirsen?,"OBJECTIVE: In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51.",1
1771,5,Describe mechanism of action of Eteplirsen?,We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene.,0
1771,6,Describe mechanism of action of Eteplirsen?,Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen.,0
1771,7,Describe mechanism of action of Eteplirsen?,"We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.)",0
1771,8,Describe mechanism of action of Eteplirsen?,injection.,0
1771,9,Describe mechanism of action of Eteplirsen?,"To continue evaluation of the long-term efficacy and safety of eteplirsen, a phosphorodiamidate morpholino oligomer designed to skip DMD exon 51 in patients with Duchenne muscular dystrophy (DMD).",1
1771,10,Describe mechanism of action of Eteplirsen?,"In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51.",1
1771,11,Describe mechanism of action of Eteplirsen?,"The present study used a double-blind placebo-controlled protocol to test eteplirsen's ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT).DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n = 4/group).",0
1771,12,Describe mechanism of action of Eteplirsen?,"Here we describe the development of a Taqman quantitative (q)RT-PCR assay to quantify exon skipping and highlight its use to determine the levels of exon skipping in DMD patients treated intramuscularly with a morpholino AO to skip exon 51, eteplirsen (AVI-4658).",0
1771,13,Describe mechanism of action of Eteplirsen?,"The subset of patients amenable to exon 51 skipping showed a more severe disease course than those amenable to any exon skipping.Over 3 years of follow-up, eteplirsen-treated patients showed a slower rate of decline in ambulation assessed by 6MWT compared to untreated matched HC.<CopyrightInformation>© 2016 The Authors.",0
1771,14,Describe mechanism of action of Eteplirsen?,"We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.)",0
1771,15,Describe mechanism of action of Eteplirsen?,injection.,0
2736,0,What causes leishmaniasis?,"we will focus on the shape and form ofLeishmaniaspp., a group of very successful protozoan parasites that cause a range of diseases from self-healing cutaneous leishmaniasis to visceral leishmaniasis",1
2736,1,What causes leishmaniasis?,"In conclusion, our data demonstrates that in susceptible mice L. (L.) amazonensis, a causative agent of tegumentary leishmaniasis, causes pathological changes similar to those produced by Leishmania (L.) infantum in both humans and canids.",0
2736,2,What causes leishmaniasis?,"American Tegumentary Leishmaniasis is caused by parasites of the genus Leishmania, and causes significant health problems throughout the Americas.",0
2736,3,What causes leishmaniasis?,"Leishmaniasis is a tropical infection caused by the protozoan, belonging to the group of Leishmania which causes Old World and New World disease.",0
2736,4,What causes leishmaniasis?,Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani and transmitted by the bite of infected sandfly Phlebotomus argentipes.,0
2736,5,What causes leishmaniasis?,Leishmania donovani is a causative agent of visceral leishmaniasis in South East Asia and Eastern Africa.,1
2736,6,What causes leishmaniasis?,"Leishmaniasis is a neglected tropical disease caused by Leishmania protozoa and associated with three main clinical presentations: cutaneous, mucocutaneous and visceral leishmaniasis.",0
2736,7,What causes leishmaniasis?,"L. (L.) donovani usually causes visceral leishmaniasis, but in this case, the patient manifested cutaneous leishmaniasis.",0
2736,8,What causes leishmaniasis?,Leishmania donovani in India causes visceral infection (kala-azar) and dermal infection (post-kala-azar dermal leishmaniasis).,0
2736,9,What causes leishmaniasis?,Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania.,0
2736,10,What causes leishmaniasis?,Leishmaniasis is a parasitic infection caused by many species of the protozoa Leishmania.,0
2736,11,What causes leishmaniasis?,Here we report an imported case of leishmaniasis by Leishmania (Leishmania) donovani infection from Sri Lanka.,0
2736,12,What causes leishmaniasis?,"Finally, Leishmania species cause leishmaniasis, a disease that ranges from self-healing but scarring cutaneous lesions to fatal visceral leishmaniasis in which parasites disseminate to the liver, spleen, and bone marrow.",1
2736,13,What causes leishmaniasis?,Leishmania is a digenetic protozoan parasite causing leishmaniasis in humans.,1
2736,14,What causes leishmaniasis?,"In general, Leishmania species causing cutaneous leishmaniasis (CL) are more sensitive to Sb(III) than the species responsible for visceral leishmaniasis (VL).",0
2736,15,What causes leishmaniasis?,Leishmania parasites cause leishmaniasis in humans and animals worldwide.,0
2736,16,What causes leishmaniasis?,"Leishmania is an intracellular protozoan parasite which causes Leishmaniasis, a global health problem affecting millions of people throughout 89 different countries in the world.",0
2736,17,What causes leishmaniasis?,"Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which can range from a self-healing cutaneous disease to a fatal visceral disease depending on the infecting species.",1
2736,18,What causes leishmaniasis?,"Leishmania major causes leishmaniasis and is grouped within the Trypanosomatidae family, which also includes the etiologic agent for African sleeping sickness, Trypanosoma brucei.",0
2736,19,What causes leishmaniasis?,"Leishmania major is an important trypanosomatid pathogen that causes leishmaniasis, which is a serious disease in much of the Old World.",0
2736,20,What causes leishmaniasis?,"Leishmania, a protozoan parasite that causes leishmaniasis, affects 1-2 million people every year worldwide.",0
2736,21,What causes leishmaniasis?,"The intracellular protozoan parasite Leishmania causes leishmaniasis, which is the second biggest killer worldwide among parasitic diseases, after malaria.",0
2736,22,What causes leishmaniasis?,The leishmaniases are a group of diseases caused by species of Leishmania and transmitted by the bite of the female sandfly.,0
2736,23,What causes leishmaniasis?,Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37,0
2736,24,What causes leishmaniasis?,Tegumentary leishmaniasis in Latin America is caused mainly by Leishmania viannia braziliensis complex parasites.,0
2736,25,What causes leishmaniasis?,L. braziliensis and Leishmania viannia peruviana are the 2 predominant Leishmania species in Peru.,0
2736,26,What causes leishmaniasis?,"Identification of Leishmania species causing cutaneous leishmaniasis using Random Amplified Polymorphic DNA (RAPD-PCR) in Kharve, Iran.",0
3561,0,Is Niraparib effective for ovarian cancer?,Niraparib and olaparib have been approved by the US FDA for maintenance therapy after partial or complete remission in recurrent ovarian cancer.,0
3561,1,Is Niraparib effective for ovarian cancer?,"PURPOSE OF REVIEW: The recent United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers independent of BRCA status reflect a willingness to seek indications for poly-ADP-ribose polymerase (PARP) inhibitors beyond cancers with deleterious breast cancer 1 and breast cancer 2 mutations.",0
3561,2,Is Niraparib effective for ovarian cancer?,PURPOSE: Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response to platinum-based chemotherapy.,1
3561,3,Is Niraparib effective for ovarian cancer?,"Indeed, three PARP1 inhibitors (Olaparib, Rucaparib, and Niraparib) have recently been approved by the Food and Drug Administration for the treatment of ovarian cancer.",0
3561,4,Is Niraparib effective for ovarian cancer?,Niraparib is an oral poly(ADP ribose) polymerase (PARP) inhibitor that is currently approved by the United States Food and Drug Administration (US FDA) as well as recently approved by the European Medicines Agency (EMA) for the maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy.,1
3561,5,Is Niraparib effective for ovarian cancer?,"Niraparib is a poly adenosine diphosphate ribose polymerase inhibitor that has shown to be clinically effective as maintenance therapy in patients with platinum sensitive, recurrent ovarian cancer.",0
3561,6,Is Niraparib effective for ovarian cancer?,"Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.",0
3561,7,Is Niraparib effective for ovarian cancer?,Niraparib for the treatment of ovarian cancer.,0
3561,8,Is Niraparib effective for ovarian cancer?,"BACKGROUND

Niraparib is an oral poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1/2 inhibitor that has shown clinical activity in patients with ovarian cancer.",0
3561,9,Is Niraparib effective for ovarian cancer?,Niraparib Slows Ovarian Cancer Progression.,0
3561,10,Is Niraparib effective for ovarian cancer?,Niraparib for the treatment of ovarian cancer.,0
3561,11,Is Niraparib effective for ovarian cancer?,"INTRODUCTION

Niraparib, an orally available selective inhibitor of poly(adenosine diphosphate-ribose) polymerase (PARP), is the first PARP inhibitor approved for use in patients with ovarian cancer who do not harbor a germ-line or somatic mutation in the breast cancer gene (BRCA).",0
3561,12,Is Niraparib effective for ovarian cancer?,The role of niraparib as maintenance following frontline platinum-based chemotherapy as well as in the treatment of recurrent high-grade serous ovarian cancer is an active area of investigation.,0
3561,13,Is Niraparib effective for ovarian cancer?,Niraparib in ovarian cancer: results to date and clinical potential.,0
3561,14,Is Niraparib effective for ovarian cancer?,"Niraparib , an orally available selective inhibitor of poly(adenosine diphosphate-ribose ) polymerase ( PARP) , is the first PARP inhibitor approved for use in patients with ovarian cancer who do not harbor a germ-line or somatic mutation in the breast cancer gene ( BRCA) .",0
3561,15,Is Niraparib effective for ovarian cancer?,Results from a phase III trial indicate that maintenance therapy with the PARP inhibitor niraparib is more effective than placebo in slowing the progression of recurrent platinum-sensitive ovarian cancer .,0
3561,16,Is Niraparib effective for ovarian cancer?,"Niraparib (Zejula®), a poly (ADP-ribose) polymerase (PARP) inhibitor, is approved for the maintenance treatment of recurrent, epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are in complete or partial response to platinum-based chemotherapy.",1
3561,17,Is Niraparib effective for ovarian cancer?,"Niraparib, an orally available selective inhibitor of poly(adenosine diphosphate-ribose) polymerase (PARP), is the first PARP inhibitor approved for use in patients with ovarian cancer who do not harbor a germ-line or somatic mutation in the breast cancer gene (BRCA).",0
3561,18,Is Niraparib effective for ovarian cancer?,"Current evidence suggests that niraparib is an effective new option with a manageable tolerability profile for the maintenance treatment of recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancer in adults, with or without BRCA1/2 mutation or HRD.",0
3561,19,Is Niraparib effective for ovarian cancer?,"Oral niraparib, a highly-selective, potent poly(ADP-ribose) polymerase (PARP)-1 and PARP-2 inhibitor, is approved in the USA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.",1
3561,20,Is Niraparib effective for ovarian cancer?,"This article summarizes the milestones in the development of niraparib leading to its first global approval for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.",0
3561,21,Is Niraparib effective for ovarian cancer?,"Niraparib (Zejula ), a poly (ADP-ribose) polymerase (PARP) inhibitor, is approved for the maintenance treatment of recurrent, epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are in complete or partial response to platinum-based chemotherapy.",1
3561,22,Is Niraparib effective for ovarian cancer?,"INTRODUCTION: Niraparib, an orally available selective inhibitor of poly(adenosine diphosphate-ribose) polymerase (PARP), is the first PARP inhibitor approved for use in patients with ovarian cancer who do not harbor a germ-line or somatic mutation in the breast cancer gene (BRCA).",0
3294,0,Is PTEN a tumour suppressor?,PTEN is a potent tumour suppressor,1
3294,1,Is PTEN a tumour suppressor?,Genomic aberrations of the PTEN tumour suppressor gene are among the most common in prostate cancer.,1
324,0,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,Mutations in the Parkin gene (PARK2) are the major cause of autosomal recessive early-onset parkinsonism.,0
324,1,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"Early onset PD (EOPD) is particularly associated with autosomal recessive (AR) mutations, and three genes, PARK2, PARK7 and PINK1, have been found to carry mutations leading to AR disease.",0
324,2,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"Homozygous or compound heterozygous mutations in the phosphatase and tensin homolog-induced putative kinase 1 (PINK1) gene are causative of autosomal recessive, early onset Parkinson's disease.",1
324,3,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"Mutations in other genes, including ATP13A2 (PARK9), PLA2G6 (PARK14), and FBX07 (PARK15), cause more rare forms of recessive parkinsonism with very early-onset (<30 years)",0
324,4,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"In three forms, caused by mutations in parkin (PARK2), PINK1 (PARK6), or DJ-1 (PARK7),",0
324,5,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"oss-of-function mutations in Parkin, PINK1, DJ-1 and ATP13A2 cause autosomal recessive parkinsonism with early-onset.",0
324,6,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"mutations in the parkin gene, in DJ-1, PINK1 and ATP13A2 all cause autosomal-recessive parkinsonism of early onset.",0
324,7,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"mutations in the parkin gene, in DJ-1, PINK1 and ATP13A2 cause autosomal recessive parkinsonism of early onset",1
324,8,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"Mutations in the parkin gene, in DJ-1 and PINK1 all cause autosomal recessive parkinsonism of early onset.",1
324,9,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,PTEN-induced putative kinase 1 (PINK1) is a causative gene for autosomal recessive early onset parkinsonism.,1
324,10,List causative genes for autosomal recessive forms of monogenic Parkinson's disease," we focus on PARK7, a gene relates to an autosomal recessive form of early-onset Parkinsonism and encodes a protein named DJ-1.",0
324,11,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,PINK-1 for an autosomal-recessive early-onset variant,1
324,12,List causative genes for autosomal recessive forms of monogenic Parkinson's disease," Heritable mutations in alpha-synuclein, parkin, DJ-1 and PINK1 cause familial forms of PD.",0
324,13,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"we focus on PARK7, an autosomal recessive form of early-onset parkinsonism caused by mutations in the DJ-1 gene",0
324,14,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.,0
324,15,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,Autosomal recessive parkinsonism associated with mutations in the parkin gene represents a monogenic form of hereditary parkinsonism.,0
324,16,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,"Mutations of the parkin gene on chromosome 6 cause autosomal recessive, early onset parkinsonism.",0
324,17,List causative genes for autosomal recessive forms of monogenic Parkinson's disease," A gene causing autosomal recessive parkinsonism of juvenile onset has been mapped to chromosome 6 (PARK 2), and the causative gene has been identified and named parkin.",0
324,18,List causative genes for autosomal recessive forms of monogenic Parkinson's disease,The gene responsible for AR-JP was recently identified and designated parkin.,0
2396,0,Can a circRNA be translated into protein?,"However, whether circRNAs encode functional proteins remains elusive, although translation of several circRNAs was recently reported",0
2396,1,Can a circRNA be translated into protein?,"Circular RNAs (circRNAs) are long, non-coding RNAs that result from the non-canonical splicing of linear pre-mRNAs.",0
2396,2,Can a circRNA be translated into protein?,Circular RNAs (circRNAs) are a large type of noncoding RNAs characterized by their circular shape resulting from covalently closed continuous loops.,0
2396,3,Can a circRNA be translated into protein?,"They are known to serve as microRNA (miRNA) sponges, regulators of alternative splicing, transcription factors and encode for proteins.",0
2396,4,Can a circRNA be translated into protein?,Covalently closed loop structures elevate the stability of this new type of noncoding RNA.,0
2396,5,Can a circRNA be translated into protein?,Circular RNAs (circRNAs) are a novel class of non-coding RNA that assumes a covalently closed continuous conformation.,0
2396,6,Can a circRNA be translated into protein?,Circular RNAs (circRNAs) represent a large class of noncoding RNAs (ncRNAs) that have recently emerged as regulators of gene expression,0
2396,7,Can a circRNA be translated into protein?,Circular RNAs (circRNAs) are highly abundant and evolutionarily conserved non-coding RNAs produced by circularization of specific exons.,0
2396,8,Can a circRNA be translated into protein?,Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis.,1
2396,9,Can a circRNA be translated into protein?," Circ-ZNF609 is associated with heavy polysomes, and it is translated into a protein in a splicing-dependent and cap-independent manner, providing an example of a protein-coding circRNA in eukaryotes.",1
2396,10,Can a circRNA be translated into protein?,"Altogether, our study provides strong evidence for translation of circRNAs, revealing the existence of an unexplored layer of gene activity.",0
2396,11,Can a circRNA be translated into protein?,"In addition, most circRNAs were not associated with translating ribosomes, therefore, circRNAs were deemed to be noncoding.",1
2396,12,Can a circRNA be translated into protein?,"However, the latest research findings revealed that some circRNAs could generate proteins in vivo, which expands the landscape of transcriptome and proteome.",1
2396,13,Can a circRNA be translated into protein?,"To gain insights into the new area of circRNA translation, we introduce an integrated tool capable of detecting circRNAs with protein-coding potential from high-throughput sequencing data.",1
990,0,Dracorhodin perchlorate was tested for treatment of which cancers?,Dracorhodin perchlorate induced human breast cancer MCF-7 apoptosis through mitochondrial pathways.,0
990,1,Dracorhodin perchlorate was tested for treatment of which cancers?,"It was reported that DP could induce apoptosis in human prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer was not investigated.",1
990,2,Dracorhodin perchlorate was tested for treatment of which cancers?,"CONCLUSION: Therefore DP was a candidate for anti-breast cancer, DP induced apoptosis of MCF-7 through mitochondrial pathway.",0
990,3,Dracorhodin perchlorate was tested for treatment of which cancers?,Dracorhodin perchlorate has been recently shown to induce apoptotic cell death in cancer cells.,0
990,4,Dracorhodin perchlorate was tested for treatment of which cancers?,"However, the molecular mechanisms underlying these effects are unknown in human gastric tumor cells.",0
990,5,Dracorhodin perchlorate was tested for treatment of which cancers?,Dracorhodin perchlorate suppresses proliferation and induces apoptosis in human prostate cancer cell line PC-3.,0
990,6,Dracorhodin perchlorate was tested for treatment of which cancers?,The growth inhibition and pro-apoptosis effects of dracorhodin perchlorate on human prostate cancer PC-3 cell line were examined.,0
990,7,Dracorhodin perchlorate was tested for treatment of which cancers?,"Dracorhodin perchlorate, an anthocyanin red pigment, induces human premyelocytic leukemia HL-60 cell death through apoptotic pathway.",0
990,8,Dracorhodin perchlorate was tested for treatment of which cancers?,"Dracorhodin perchlorate, an anthocyanin red pigment, induces human melanoma A375-S2 cell death through the apoptotic pathway.",0
990,9,Dracorhodin perchlorate was tested for treatment of which cancers?,Dracorhodin perchlorate inhibited proliferation of several tumor cell lines.,0
990,10,Dracorhodin perchlorate was tested for treatment of which cancers?,The growth inhibition and pro-apoptosis effects of dracorhodin perchlorate on human prostate cancer PC-3 cell line were examined.,0
990,11,Dracorhodin perchlorate was tested for treatment of which cancers?,"It was reported that DP could induce apoptosis in human prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer was not investigated.",1
990,12,Dracorhodin perchlorate was tested for treatment of which cancers?, Dracorhodin perchlorate (DP) was a synthetic analogue of the antimicrobial anthocyanin red pigment dracorhodin.,0
990,13,Dracorhodin perchlorate was tested for treatment of which cancers?,"It was reported that DP could induce apoptosis in human prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer was not investigated.",1
990,14,Dracorhodin perchlorate was tested for treatment of which cancers?, The growth inhibition and pro-apoptosis effects of dracorhodin perchlorate on human prostate cancer PC-3 cell line were examined.,0
990,15,Dracorhodin perchlorate was tested for treatment of which cancers?,"After administration of 10-80 μmol/L dracorhodin perchlorate for 12-48 h, cell viability of PC-3 cells was measured by MTT colorimetry.",0
990,16,Dracorhodin perchlorate was tested for treatment of which cancers?,"It was reported that DP could induce apoptosis in human prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer was not investigated.",1
990,17,Dracorhodin perchlorate was tested for treatment of which cancers?,This study would investigate whether DP was a candidate chemical of anti-human breast cancer.,0
990,18,Dracorhodin perchlorate was tested for treatment of which cancers?,Dracorhodin perchlorate (DP) was a synthetic analogue of the antimicrobial anthocyanin red pigment dracorhodin.,0
990,19,Dracorhodin perchlorate was tested for treatment of which cancers?,"It was reported that DP could induce apoptosis in human prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer was not investigated.",1
990,20,Dracorhodin perchlorate was tested for treatment of which cancers?,The growth inhibition and pro-apoptosis effects of dracorhodin perchlorate on human prostate cancer PC-3 cell line were examined.,0
990,21,Dracorhodin perchlorate was tested for treatment of which cancers?,"After administration of 10-80 μmol/L dracorhodin perchlorate for 12-48 h, cell viability of PC-3 cells was measured by MTT colorimetry.",0
4065,0,Is ofatumumab effective for multiple sclerosis?,Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab.,1
4065,1,Is ofatumumab effective for multiple sclerosis?,"Ofatumumab, a fully human anti-CD20 monoclonal antibody, that binds a distinct epitope, has been further investigated in phase 3 trials for relapsing forms of MS.",1
4065,2,Is ofatumumab effective for multiple sclerosis?,Conclusion: Ofatumumab offers beneficial outcomes for RMS by reducing relapse and disability progression risk.,0
4065,3,Is ofatumumab effective for multiple sclerosis?,"Currently, new therapies are emerging that promise more convenience and an improved safety profile (ofatumumab) or remyelinating potential with clinical improvement (opicinumab).",0
4065,4,Is ofatumumab effective for multiple sclerosis?,"The emerging B-cell depleting therapies, particularly anti-CD20 agents such as rituximab, ocrelizumab, as well as the fully human ofatumumab, have shown promising clinical and magnetic resonance imaging benefit.",1
4065,5,Is ofatumumab effective for multiple sclerosis?,"AREAS COVERED: In this manuscript, we review mechanisms of action, efficacy, safety, and tolerance of anti-CD20 therapies for MS, including rituximab, ocrelizumab, and ofatumumab.",1
4065,6,Is ofatumumab effective for multiple sclerosis?,"Another CD20 directed mAb, ofatumumab, is in phase 3.",1
4065,7,Is ofatumumab effective for multiple sclerosis?,Ofatumumab offers beneficial outcomes for RMS by reducing relapse and disability progression risk.,0
4065,8,Is ofatumumab effective for multiple sclerosis?,"CONCLUSION: Imaging showed that all subcutaneous ofatumumab doses demonstrated efficacy (most robust: cumulative doses ≥30 mg/12 wk), with a safety profile consistent with existing ofatumumab data.",0
4065,9,Is ofatumumab effective for multiple sclerosis?,"CONCLUSIONS: Among patients with multiple sclerosis, ofatumumab was associated with lower annualized relapse rates than teriflunomide.",0
490,0,For the treatment of which conditions can atypical neuroleptic drugs be used?,"Further clinical implications are described (capability of learning the therapeutic strategies, deliverability in broader clinical settings, acceptability by patients, combination with atypical neuroleptic drugs,and treatment of choice in risk populations).",1
490,1,For the treatment of which conditions can atypical neuroleptic drugs be used?,Intervention strategies are a multimodal psychological programme for the intervention in early prodromal stages and a combination of psychotherapy with atypical neuroleptic drugs in the late prodromal stages.,1
490,2,For the treatment of which conditions can atypical neuroleptic drugs be used?,"Atypical neuroleptic drugs have enriched our treatment programs, especially in childhood and adolescent schizophrenia.",0
490,3,For the treatment of which conditions can atypical neuroleptic drugs be used?,Reviewed here is the use of atypical neuroleptics in children and adolescents with a schizophrenic disorder.,0
490,4,For the treatment of which conditions can atypical neuroleptic drugs be used?,"o prove whether weight gain is a relevant side effect of atypical neuroleptics, the charts of all patients admitted with DSM-III-R diagnoses of schizophrenia, schizoaffective disorder, or delusional disorder in the years 1991 to 1995 were evaluated.",1
490,5,For the treatment of which conditions can atypical neuroleptic drugs be used?,"The handwriting of 18 schizophrenic patients before and during treatment with typical (haloperidol, haloperidol decanoate) and atypical (clozapine, risperidone) neuroleptic drugs was examined.",1
490,6,For the treatment of which conditions can atypical neuroleptic drugs be used?,"Atypical and typical neuroleptics, when administered chronically, can bring about profound but contrasting changes in schizophrenic symptoms and motor activation and dramatically modulate brain neurochemistry",0
490,7,For the treatment of which conditions can atypical neuroleptic drugs be used?,Recent studies suggest that clozapine is more effective than typical neuroleptics for patients with treatment-resistant schizophrenia.,0
490,8,For the treatment of which conditions can atypical neuroleptic drugs be used?,"Acute and late onset movement disorders frequently complicate the treatment of psychosis with typical neuroleptic drugs like haloperidol, but not with atypical neuroleptic drugs like clozapine.",0
490,9,For the treatment of which conditions can atypical neuroleptic drugs be used?,Only the group of boys presented other comorbidities such as negativism and conduct disorders; approximately 25% of them required treatment with atypical neuroleptic drugs.,1
490,10,For the treatment of which conditions can atypical neuroleptic drugs be used?,"Atypical neuroleptic drugs are the preferred treatment for symptoms such as delusions, hallucinations, agitation and aggressive behaviour.",0
490,11,For the treatment of which conditions can atypical neuroleptic drugs be used?,Monotherapeutic treatment with new atypical neuroleptic drugs had a more positive effect on the mental health related quality of life (MCS) in comparison to treatment with polypharmacological treatment but not with oral conventional antipsychotics.,0
515,0,Which genes are regulated by MEF-2 in the heart?,"Inhibition of MEF2A using siRNA attenuated HB-EGF-induced COX-2, ANF expression and cell size.",0
515,1,Which genes are regulated by MEF-2 in the heart?,"This genetic reprogramming coincides with a pronounced increase in expression of the estrogen receptor (ER)alpha gene, which we show to be a direct MEF2 target gene",1
515,2,Which genes are regulated by MEF-2 in the heart?,cardiac calsequestrin gene (casq2),0
515,3,Which genes are regulated by MEF-2 in the heart?,"Functional studies demonstrated that site-directed mutagenesis of the proximal MEF-2 and CArG box sites significantly decreased the transcription of the gene in cardiac and skeletal muscle cells, indicating that they are important to drive cardiac and skeletal muscle-specific transcription of the casq2 gene.",0
515,4,Which genes are regulated by MEF-2 in the heart?,DTEF-1 also interacts with MEF- 2 by coimmunoprecipitation and independently or cooperatively (with MEF-2) trans-activates the cTnT promoter,0
515,5,Which genes are regulated by MEF-2 in the heart?,"An 85-bp region within the enhancer is highly conserved between human and mouse and contains a central AT-rich site, which is essential for enhancer activity.",0
515,6,Which genes are regulated by MEF-2 in the heart?,"This site binds myocyte enhancer factor (MEF)2 factors, principally MEF2D and MEF2A in cardiocyte nuclear extracts.",0
515,7,Which genes are regulated by MEF-2 in the heart?,These results are discussed in the context of MEF2 activity and of the regulation of the alpha-cardiac actin locus.,0
515,8,Which genes are regulated by MEF-2 in the heart?,"The cis-acting elements, MEF-2, E boxes and A/T rich elements present in the enhancer region of the mouse MCK gene are known to regulate the expression of the gene",0
515,9,Which genes are regulated by MEF-2 in the heart?,"The sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs) belong to a family of active calcium transport enzymes encoded by the SERCA1, 2, and 3 genes.",1
515,10,Which genes are regulated by MEF-2 in the heart?,"In this study, we describe the complete structure of the human SERCA2 gene and its 5 -regulatory region.",0
515,11,Which genes are regulated by MEF-2 in the heart?,"Among the DNA cis-elements present in these two regulatory regions there are potential binding sites for: GATA-4, -5, -6, Nkx-2.5/Csx, OTF-1, USF, MEF-2, SRF, PPAR/RXR, AP-2, and TREs.",0
515,12,Which genes are regulated by MEF-2 in the heart?,"Upstream from position -1.5 kb, there is no significant homology among the SERCA2 genes cloned.",0
515,13,Which genes are regulated by MEF-2 in the heart?,"The cardiac calsequestrin gene consists of 11 exons and its 5' flanking region is characterized by the presence of a TATA-like box, muscle specific promoter elements such as 7 E-boxes, 1 MEF-2, 1 MCBF and 1 Repeat (musS) motifs, as well as several muscle non-specific transcriptional elements (AP-2A, NRE1, NRE2, p53, Spel and TFI-IIA).",0
515,14,Which genes are regulated by MEF-2 in the heart?,"our laboratory identified a 28 bp HF-la/MEF-2 element in the MLC-2v promoter region, which confers cardiac ventricular chamber-specific gene expression during murine cardiogenesis,",0
515,15,Which genes are regulated by MEF-2 in the heart?,"In this study, we investigated T3R alpha 1-vs. T3R beta 1-specific interactions with the myocyte enhancer-specific factor-2 (MEF-2) on the expression of the SERCA 2 gene in transient transfection assays in embryonal heart-derived H9c2 cells.",0
515,16,Which genes are regulated by MEF-2 in the heart?,point to T3R isoform-specific interactions with a cell type-specific transcription factor (MEF-2) in the regulation of SERCA 2 gene expression.,1
515,17,Which genes are regulated by MEF-2 in the heart?,"In multiple independent transgenic mouse lines, we found that both a 250 base pair myosin light chain-2 ventricular promoter fragment, as well as a dimerized 28 bp sub-element (HF-1) containing binding sites for HF1a and HF1b/MEF2 factors, directed ventricular-specific reporter expression from as early as the endogenous gene, at day 7.5-8.0 post coitum.",0
515,18,Which genes are regulated by MEF-2 in the heart?,Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo,1
515,19,Which genes are regulated by MEF-2 in the heart?,"In the MLC-2 gene, an AT-rich element (HF-1b) which contains a consensus MEF-2 site is required for cardiac tissue-specific expression.",0
515,20,Which genes are regulated by MEF-2 in the heart?,Role of myocyte-specific enhancer-binding factor (MEF-2) in transcriptional regulation of the alpha-cardiac myosin heavy chain gene.,1
515,21,Which genes are regulated by MEF-2 in the heart?,"In order to analyze the transcriptional regulation of the muscle-specific subunit of the human phosphoglycerate mutase (PGAM-M) gene, chimeric genes composed of the upstream region of the PGAM-M gene",0
515,22,Which genes are regulated by MEF-2 in the heart?,These observations define the PGAM-M enhancer as the only cardiac- and skeletal-muscle-specific enhancer characterized thus far that is mainly activated through MEF-2.,0
515,23,Which genes are regulated by MEF-2 in the heart?,Transcription of each gene is independently controlled but coordinately regulated.,0
515,24,Which genes are regulated by MEF-2 in the heart?,"During each embryogenesis, the beta-MHC gene is expressed as part of the cardiac myogenic program under the control of NKX-2.5, MEF-2C, and GATA-4/5/6.",0
515,25,Which genes are regulated by MEF-2 in the heart?,We have characterized the specific DNA regulatory elements responsible for the function of the human cardiac troponin C gene (cTnC) muscle-specific enhancer in myogenic cells.,0
515,26,Which genes are regulated by MEF-2 in the heart?,We used functional transient transfection assays with deletional and site-specific mutagenesis to evaluate the role of the conserved sequence elements.,0
515,27,Which genes are regulated by MEF-2 in the heart?,Gel electrophoresis mobility shift assays (EMSA) demonstrated the ability of the functional sites to interact with nuclear proteins.,0
515,28,Which genes are regulated by MEF-2 in the heart?,"We demonstrate that three distinct transcription activator binding sites commonly found in muscle-specific enhancers (a MEF-2 site, a MEF-3 site, and at least four redundant E-box sites) all contribute to full enhancer activity but a CArG box does not.",0
1469,0,What is known about type D personality trait in cancer patients?,RESULTS: Nineteen percent of patients (n=572) had a Type D personality.,0
1469,1,What is known about type D personality trait in cancer patients?,"The perceived receipt of disease-specific (mean 46 vs. 51), medical test (56 vs. 63) and treatment information (37 vs. 42) was significantly lower for Type D patients compared with non-Type Ds as assessed with the EORTC QLQ-INFO25 (scales 0-100; all ps<0.01).",0
1469,2,What is known about type D personality trait in cancer patients?,Cancer patients with a Type D personality were less satisfied with the received information (49 vs. 58; p<0.01) and found the received information less useful (55 vs. 61; p<0.01) compared with non-Type Ds.,0
1469,3,What is known about type D personality trait in cancer patients?,"Multivariate linear regression analyses showed that Type D personality was independently associated with information about the disease (Beta=-0.09), medical tests (Beta=-0.12) and treatment (Beta=-0.08), and with satisfaction with information received (OR=0.54; 95%CI=0.44-0.66;all ps<0.01).",0
1469,4,What is known about type D personality trait in cancer patients?,CONCLUSIONS: This study showed that patients with a Type D personality perceived that they received less information and reported less satisfaction with the amount of received information as compared with non-Type D patients.,1
1469,5,What is known about type D personality trait in cancer patients?,RESULTS: 750 (19%) patients had a Type D personality.,0
1469,6,What is known about type D personality trait in cancer patients?,"They believe their illness has significantly more serious consequences, will last significantly longer, and experience significantly more symptoms that they attribute to their illness.",1
1469,7,What is known about type D personality trait in cancer patients?,"Also, they are more concerned about their illness, and their disease more often influences them emotionally.",1
1469,8,What is known about type D personality trait in cancer patients?,"Differences regarding 'consequences', 'concern' and 'emotional response' were also clinically relevant.",0
1469,9,What is known about type D personality trait in cancer patients?,"Significant differences in perceptions on cause of disease between Type Ds and non-Type Ds were found for psychological distress (16.2 vs. 10.9%; p<0.01), randomness (1.7 vs. 5.3%; p<0.01) and unknown (18.8 vs. 24.4%; p<0.01).",0
1469,10,What is known about type D personality trait in cancer patients?,"Multivariate analyses showed that Type D was negatively associated with 'coherence' and positively with 'consequences', 'timeline', 'identity', 'concern', and 'emotional representation'.",0
1469,11,What is known about type D personality trait in cancer patients?,"CONCLUSIONS: These results elucidate the associations between personality and illness perceptions, demonstrating their close interrelatedness.",0
1469,12,What is known about type D personality trait in cancer patients?,Our study may be helpful in further developing theoretical models regarding giving meaning to illness and the illness perceptions that the illness elicits.,0
1469,13,What is known about type D personality trait in cancer patients?,Future studies should investigate whether interventions can positively impact illness perceptions of Type D cancer patients.,0
1469,14,What is known about type D personality trait in cancer patients?,RESULTS: Nineteen percent of survivors had a type D personality.,0
1469,15,What is known about type D personality trait in cancer patients?,"Over a 12-month period, type D survivors significantly more often reported osteoarthritis, back pain, and depression than non-type D survivors.",0
1469,16,What is known about type D personality trait in cancer patients?,"Also, type D survivors more often reported to feel bothered by high blood pressure, osteoarthritis, heart disease, depression, diabetes and lung disease during daily activities.",0
1469,17,What is known about type D personality trait in cancer patients?,"Type D survivors more often visited their general practitioner than non-type D survivors (P<.001), also in relation to cancer (0 visits: 54% vs. 60%; 1-5: 28% vs. 22%; >5: 9% vs. 5%; P<.001), as well as their specialist (0 visits: 6% vs. 7%; 1-5 visits: 59% vs. 64%; >5 visits: 30% vs. 23%; P<.01).",0
1469,18,What is known about type D personality trait in cancer patients?,CONCLUSION: Type D personality is a vulnerability factor that may help to identify subgroups of cancer survivors who are at an increased risk for comorbidity burden and increased health care utilization.,1
1469,19,What is known about type D personality trait in cancer patients?,Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors.,1
1469,20,What is known about type D personality trait in cancer patients?,CONCLUSIONS: Cancer survivors with a Type D personality are at increased risk of impaired QoL and mental health problems that cannot be explained by socio-demographic or clinical characteristics.,0
1469,21,What is known about type D personality trait in cancer patients?,FINDINGS: Patients with type D personality experienced higher physical and psychological distress than those with non-type D personality.,0
1469,22,What is known about type D personality trait in cancer patients?,"RESULTS: Twenty-two percent of survivors (n=125) were classified as Type D. They reported a clinically and statistically significant worse general health (57.8 versus 75.6), social functioning (73.1 versus 88.7), mental health (61.7 versus 80.6), more emotional role limitations (67.8 versus 89.4) and less vitality (54.5 versus 72.8) than non-Type D patients.",0
1469,23,What is known about type D personality trait in cancer patients?,"Additionally, they reported a statistically and clinically relevant higher impact of cancer on body changes, negative self-evaluation, negative outlook on life, life interferences and health worry.",0
1469,24,What is known about type D personality trait in cancer patients?,"Furthermore, they were more worried about the influence of the sun on their skin and acted accordingly.",0
1469,25,What is known about type D personality trait in cancer patients?,No differences were found in health care utilisation.,0
1469,26,What is known about type D personality trait in cancer patients?,CONCLUSIONS: Type D personality has a distinct negative impact on health status in melanoma survivors and is an important factor to screen for in clinical practice.,0
1469,27,What is known about type D personality trait in cancer patients?,Cancer patients with a Type D personality were less satisfied with the received information (49 vs,0
858,0,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?","SERCA2a activity can be regulated at multiple levels of a signaling cascade comprised of phospholamban, protein phosphatase 1, inhibitor-1, and PKCα.",0
858,1,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",SERCA2 activity is also regulated by post-translational modifications including SUMOylation and acetylation.,0
858,2,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?","The small ubiquitin-related modifier (SUMO) can be conjugated to lysine residues of target proteins, and is involved in many cellular processes.",1
858,3,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",Here we show that SERCA2a is SUMOylated at lysines 480 and 585 and that this SUMOylation is essential for preserving SERCA2a ATPase activity and stability in mouse and human cells.,1
858,4,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",The levels of SUMO1 and the SUMOylation of SERCA2a itself were greatly reduced in failing hearts.,0
858,5,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?","Taken together, our data show that SUMOylation is a critical post-translational modification that regulates SERCA2a function, and provide a platform for the design of novel therapeutic strategies for heart failure.",0
858,6,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?","Recently, the impact of small ubiquitin-related modifier 1 (SUMO-1) on the regulation and preservation of sarcoplasmic reticulum calcium adenosine triphosphatase (SERCA2a) function was discovered.",1
858,7,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?","The amount of myocardial SUMO-1 is decreased in failing hearts, and its knockdown results in severe heart failure (HF) in mice.",0
858,8,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",SUMO-1 gene transfer therefore improved cardiac function and stabilized LV volumes in a large-animal model of HF.,0
858,9,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",These results support the critical role of SUMO-1 in SERCA2a function and underline the therapeutic potential of SUMO-1 for HF patients.,0
858,10,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?","However, the initial simple view of a PLN/SERCA regulatory complex has been modified by our recent identification of SUMO, S100 and the histidine-rich Ca-binding protein as regulators of SERCA activity.",0
858,11,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",The levels of SUMO1 and the SUMOylation of SERCA2a itself were greatly reduced in failing hearts,0
858,12,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",Here we show that SERCA2a is SUMOylated at lysines 480 and 585 and that this SUMOylation is essential for preserving SERCA2a ATPase activity and stability in mouse and human cells,1
858,13,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?","Taken together, our data show that SUMOylation is a critical post-translational modification that regulates SERCA2a function, and provide a platform for the design of novel therapeutic strategies for heart failure",0
858,14,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",SERCA2 activity is also regulated by post-translational modifications including SUMOylation and acetylation,0
858,15,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",The levels of SUMO1 and the SUMOylation of SERCA2a itself were greatly reduced in failing hearts,0
858,16,"What is the biological role of SERCA2 SUMOylation in cardiac physiology and pathophysiology, such as in heart failure?",Here we show that SERCA2a is SUMOylated at lysines 480 and 585 and that this SUMOylation is essential for preserving SERCA2a ATPase activity and stability in mouse and human cells,1
2839,0,What is DiseaseEnhancer?,DiseaseEnhancer: a resource of human disease-associated enhancer catalog.,1
2839,1,What is DiseaseEnhancer?," To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers.",0
2839,2,What is DiseaseEnhancer?,"As of July 2017, DiseaseEnhancer includes 847 disease-associated enhancers in 143 human diseases.",1
2839,3,What is DiseaseEnhancer?,Database features include basic enhancer information (i.e.,0
2839,4,What is DiseaseEnhancer?,genomic location and target genes); disease types; associated variants on the enhancer and their mediated phenotypes (i.e.,1
2839,5,What is DiseaseEnhancer?,gain/loss of enhancer and the alterations of transcription factor bindings).,1
2839,6,What is DiseaseEnhancer?,"DiseaseEnhancer provides a promising avenue for researchers to facilitate the understanding of enhancer deregulation in disease pathogenesis, and identify new biomarkers for disease diagnosis and therapy.",0
2839,7,What is DiseaseEnhancer?,"To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers.",0
2839,8,What is DiseaseEnhancer?,"As of July 2017, DiseaseEnhancer includes 847 disease-associated enhancers in 143 human diseases.",1
1703,0,What is the basic secondary structure of the variable domains of a typical antibody?,Antibodies are prototypes of multimeric proteins and consist of structurally similar domains.,1
1703,1,What is the basic secondary structure of the variable domains of a typical antibody?,The two variable domains of an antibody (VH and VL) interact through a large hydrophobic interface and can be expressed as covalently linked single-chain Fv (scFv) fragments.,1
1703,2,What is the basic secondary structure of the variable domains of a typical antibody?,"Secondary structure formation, measured by H/D-exchange protection, of a mutant scFv fragment of an antibody after short incubation in 6 M guanidinium chloride was shown to be multiphasic.",0
1703,3,What is the basic secondary structure of the variable domains of a typical antibody?,NMR analysis shows that an intermediate with significant proton protection is observed within the dead time of the manual mixing experiments.,0
1703,4,What is the basic secondary structure of the variable domains of a typical antibody?,"Subsequently, the folding reaction proceeds via a biphasic reaction and mass spectrometry analyses of the exchange experiments confirm the existence of two parallel pathways.",1
1703,5,What is the basic secondary structure of the variable domains of a typical antibody?,"In the presence of cyclophilin, however, the faster of the two phases vanishes (when followed by intrinsic tryptophan fluorescence), while the slower phase is not significantly enhanced by equimolar cyclophilin",1
1703,6,What is the basic secondary structure of the variable domains of a typical antibody?,"e formation of an early intermediate, which shows amide-proton exchange protection, is independent of proline isomerization.",0
1703,7,What is the basic secondary structure of the variable domains of a typical antibody?,"Subsequently, a proline cis-trans isomerization reaction in the rapidly formed intermediate, producing 'non-native' isomers, competes with the fast formation of native species.",0
1703,8,What is the basic secondary structure of the variable domains of a typical antibody?,Interface formation in a folding intermediate of the scFv fragment is proposed to prevent the back-isomerization of these prolines from being efficiently catalyzed by cyclophilin.,1
1703,9,What is the basic secondary structure of the variable domains of a typical antibody?, heavy chain variable domains (VH) lacking their light chain (VL) partner are prime candidates for the design of minimum-size immunoreagents.,0
2409,0,Are mouse chromosomes acrocentric?," Based on combined fluorescence in situ hybridization and linkage mapping, the gene order on CFA9 is similar to that of the homologous genes on HSA17q and mouse chromosome 11 (MMU11), but in the dog the gene order is inverted with respect to the centromere.",0
2409,1,Are mouse chromosomes acrocentric?,"In murine models of human carcinogenesis, however, karyotype analysis is technically demanding because mouse chromosomes are acrocentric and of similar size.",1
2409,2,Are mouse chromosomes acrocentric?,The minor satellite is closer to the short arms of the acrocentric chromosomes than the major satellite,0
2409,3,Are mouse chromosomes acrocentric?, These cells contain Robertsonian translocated chromosomes 1 and 7 as the only submetacentric chromosome in an otherwise acrocentric genome.,0
2409,4,Are mouse chromosomes acrocentric?, The resulting metacentric chromosomes are very different in size and in morphology from normal mouse acrocentric chromosomes.,1
2409,5,Are mouse chromosomes acrocentric?," Because of 35 independent primary hybrids used in this study were derived from two types of feral mice, each with a different combination of Robertsonian translocation chromosomes, as well as from mice with a normal complement of acrocentric chromosomes, analysis of 16 selected mouse enzyme markers provided data on the segregation of all 20 mouse chromosomes in these hybrids",0
2409,6,Are mouse chromosomes acrocentric?,The two mouse stocks exhibit karyotypes consisting of nine pairs of metacentric chromosomes as a result of centric fusions of acrocentric chromosomes in different combinations.,1
2409,7,Are mouse chromosomes acrocentric?,"Physical gene mapping by in situ hybridization is a difficult task in an all-acrocentric mouse karyotype, because all of the chromosomes are morphologically very similar.",1
2409,8,Are mouse chromosomes acrocentric?,The resulting metacentric chromosomes are very different in size and in morphology from normal mouse acrocentric chromosomes.,1
2409,9,Are mouse chromosomes acrocentric?,murine models of human carcinogenesis are exceedingly valuable tools to understand genetic mechanisms of neoplastic growth the identification of recurrent chromosomal rearrangements by cytogenetic techniques serves as an initial screening test for tumour specific aberrations in murine models of human carcinogenesis however karyotype analysis is technically demanding because mouse chromosomes are acrocentric and of similar size fluorescence in situ hybridization fish with mouse chromosome specific painting probes can complement conventional banding analysis although sensitive and specific fish analyses are restricted to the visualization of only a few mouse chromosomes at a time here we apply a novel imaging technique that we developed recently for the visualization of human chromosomes to the simultaneous discernment of all mouse chromosomes the approach is based on spectral imaging to measure chromosome specific spectra after fish with differentially labelled mouse chromosome painting probes utilizing a combination of fourier spectroscopy ccd imaging and conventional optical microscopy spectral imaging allows simultaneous measurement of the fluorescence emission spectrum at all sample points a spectrum based classification algorithm has been adapted to karyotype mouse chromosomes we have applied spectral karyotyping sky to chemically induced plasmocytomas mammary gland tumours from transgenic mice overexpressing the c myc oncogene and thymomas from mice deficient for the ataxia telangiectasia atm gene results from these analyses demonstrate the potential of sky to identify complex chromosomal aberrations in mouse models of human carcinogenesis.,0
799,0,What is the average diameter of intermediate filaments?,"Negative staining showed that supernatants from the centrifugation assays contained protofilaments, protofibrils and short particles (less than 300 nm), but pellets contained long filaments (greater than 1 micron) with an average diameter of 10 nm.",1
799,1,What is the average diameter of intermediate filaments?,"Ultrastructurally, rhabdoid cells showed paranuclear aggregates and whorls of intermediate filaments with a 9-10 nm diameter.",1
799,2,What is the average diameter of intermediate filaments?,"After removing IFs by calcination, electron microscopy revealed hollow silica nanotubes several micrometers long, with outer diameters of 35-55 nm and an average inner diameter of 10 nm (comparable to that of IFs)",1
799,3,What is the average diameter of intermediate filaments?,Intermediate filaments are filaments 10 nm in diameter that make up an important component of the cytoskeleton in most metazoan taxa.,1
799,4,What is the average diameter of intermediate filaments?,Neurofilaments (NFs) are essential cytoskeletal filaments that impart mechanical integrity to nerve cells.,0
799,5,What is the average diameter of intermediate filaments?,They are assembled from three distinct molecular mass proteins that bind to each other to form a 10-nm-diameter filamentous rod with sidearm extensions.,0
799,6,What is the average diameter of intermediate filaments?,Scanning tunneling microscope (STM) and transmission electron microscope (TEM) micrographs showed that acidic keratins and basic keratins can assemble into dimers and further into 10 nm filamentsin vitro.,0
799,7,What is the average diameter of intermediate filaments?,"Intermediate in diameter between microtubules and microfilaments, IFs constitute the third cytoskeletal filament system of metazoan cells.",0
799,8,What is the average diameter of intermediate filaments?,"Just above the bulb, the filaments are characterized by a diameter of 100 Angstroms and a low-density core.",1
799,9,What is the average diameter of intermediate filaments?,"Further, using cryo-transmission electron microscopy on native, fully hydrated, vitreous epidermis we show that the subfilametous keratin electron density pattern consists, both in corneocytes and in viable keratinocytes, of one axial subfilament surrounded by an undetermined number of peripheral subfilaments forming filaments with a diameter of approximately 8 nm.",0
3179,0,Name a CFL2 mutation which is associated with nemaline myopathy?,"Because a mutation in CFL2 was identified in a family with nemaline myopathy, we performed sequence analysis of the gene and a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met) of CFL2 was identified in both siblings.",1
844,0,Is there a genome-wide technique for the detection of R-loop formation?,Genome-wide analysis of fragile sites by chromatin immunoprecipitation (ChIP) and microarray (ChIP-chip) of phosphorylated H2A in these mutants supported a transcription-dependent mechanism of DNA damage characteristic of R loops,1
844,1,Is there a genome-wide technique for the detection of R-loop formation?,"We have used a bisulfite-sensitivity assay to demonstrate genome-wide increase in the occurrence of RNA-DNA hybrids (R-loops), including from antisense and read-through transcripts, in a nusG missense mutant defective for Rho-dependent termination.",1
844,2,Is there a genome-wide technique for the detection of R-loop formation?,"The results demonstrate a key function of FACT in the resolution of R-loop-mediated transcription-replication conflicts, likely associated with a specific chromatin organization.",1
844,3,Is there a genome-wide technique for the detection of R-loop formation?,Previous work revealed that GC skew and R-loop formation associate with a core set of unmethylated CpG island (CGI) promoters in the human genome,1
3396,0,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?","In this study, we demonstrate that autophagy is a critical mediator of the viral degradation pathway and that this pathway is not HIV-1 specific.",1
3396,1,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",Autophagy is important in cellular homeostasis for the cell survival mechanism.,1
3396,2,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",Autophagy is a cellular survival pathway that is necessary for the degradation of cellular constituents such as long-lived proteins and damaged organelles.,1
3396,3,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",Autophagy-related genes (ATGs) regulate the autophagy and also control the crosstalk with autophagy-associated cell death and apoptosis in some condition.,0
3396,4,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",Autophagy is an evolutionarily conserved cellular process in which intracellular components are eliminated via lysosomal degradation to supply nutrients for organelle biogenesis and metabolic homeostasis.,0
3396,5,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?","Autophagy is a lysosome-associated, degradative process that catabolizes cytosolic components to recycle nutrients for further use and maintain cell homeostasis.",0
3396,6,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?","Autophagy is a self-eating process, in which the damaged or excessed cell organelles and misfolded protein aggregates are removed from the cellular microenvironment.",1
3396,7,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?","Autophagy is a lysosome-associated, degradative process that catabolizes cytosolic components to recycle nutrients for further use and maintain cell homeostasis.",0
3396,8,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",Autophagy is an evolutionarily conserved cellular process in which intracellular components are eliminated via lysosomal degradation to supply nutrients for organelle biogenesis and metabolic homeostasis.,0
3396,9,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?","Autophagy is a homeostatic process involved in the turnover or elimination of cytoplasmic components, damaged organelles, and protein aggregates via a lysosomal degradation mechanism.",0
3396,10,"Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",Autophagy is known as a catabolic process for the recycling of the cytoplasmic macromolecules.,1
708,0,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"In mammals, cap synthesis is catalysed by the sequential action of RNGTT (RNA guanylyltransferase and 5'-phosphatase) and RNMT (RNA guanine-7 methyltransferase), enzymes recruited to RNA pol II (polymerase II) during the early stages of transcription.",1
708,1,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,We recently discovered that the mammalian cap methyltransferase is a heterodimer consisting of RNMT and the RNMT-activating subunit RAM (RNMT-activating mini-protein).,0
708,2,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,RAM activates and stabilizes RNMT and thus is critical for cellular cap methylation and cell viability.,0
708,3,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"Synthesis of the methyl cap initiates with the addition of 7-methylguanosine to the initiating nucleotide of RNA pol II (polymerase II) transcripts, which occurs predominantly during transcription and in mammals is catalysed by RNGTT (RNA guanylyltransferase and 5' phosphatase) and RNMT (RNA guanine-7 methyltransferase).",1
708,4,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"The RNMT-activating subunit, RAM (RNMT-activating miniprotein), is also recruited to transcription initiation sites via an interaction with RNMT.",0
708,5,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"Phosphorylation of the CTD recruits RNGTT and RNMT, the enzymes involved in mRNA capping, to the nascent transcript.",1
708,6,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"Myc induces methyl cap formation by promoting RNA polymerase II phosphorylation which recruits the capping enzymes to RNA, and by up-regulating the enzyme SAHH (S-adenosylhomocysteine hydrolase), which neutralizes the inhibitory by-product of methylation reactions.",0
708,7,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"In the present study, we identify the methyltransferase responsible for cap1 formation in human cells, which we call hMTr1 (also known as FTSJD2 and ISG95).",0
708,8,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"The guanylyltransferase (GTP:mRNA guanylyltransferase, EC 2.7.7.50) reaction responsible for cap formation usually proceeds via a covalent enzyme-GMP intermediate.",0
708,9,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"The methylation of the 5' terminal guanosine residue of the cap structure of Semliki Forest virus (SFV) mRNAs has been shown to occur in vitro concomitantly with their synthesis (R. K. Cross and P. J. Gomatos, Virology, 114, 542-554, 1981).",1
708,10,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,"The enzyme responsible for this methylation, a guanine-7-methyltransferase, is associated with the SFV replication complex",0
708,11,Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?,An RNA (guanine-7-)-methyltransferase that specifically methylates the 5'-terminal guanosine residue of RNAs ending in the dinucleoside triphosphate G(5')pppN- has been purified from the cytoplasm of HeLa cells.,1
3814,0,"List the blood group antigens, associated with blood type","ABO antigens are highly abundant in many human cell types, including platelets, vascular endothelium, and red blood cells.",1
3814,1,"List the blood group antigens, associated with blood type",We have previously developed waveguide-mode (WM) sensors for forward ABO and Rh(D) blood typing,0
3814,2,"List the blood group antigens, associated with blood type",Blood group systems based on red blood cell antigens are genetically determined and can identify patients at risk.,1
3814,3,"List the blood group antigens, associated with blood type",Type non-O of the ABO blood group system,0
3814,4,"List the blood group antigens, associated with blood type",We evaluated the ABO and Rhesus D antigen (RhD) blood types in a large cohort of chronic HF patient,0
3814,5,"List the blood group antigens, associated with blood type","The aim of this study was to investigate the association between A, B, O, Rhesus (Rh)-positive and Rh-negative blood groups",0
3814,6,"List the blood group antigens, associated with blood type",Evaluation of ABO blood groups and blood-based biomarkers as a predictor of growth kinetics of renal angiomyolipoma.,0
3814,7,"List the blood group antigens, associated with blood type",the impact of the ABO blood groups and blood-based biomarkers,0
3814,8,"List the blood group antigens, associated with blood type",Role of ABO Blood Type in Thrombosis Scoring Systems,0
3814,9,"List the blood group antigens, associated with blood type",ABO blood group antigens have been reported to be associated with inflammation and infections which have been largely implicated in the onset and progression of immune-mediated diseases.,0
3814,10,"List the blood group antigens, associated with blood type","Type A and type B antigens are Neu5Gc and Neu5Ac, respectively, and the enzyme CMAH participating in the synthesis of Neu5Gc from Neu5Ac is associated with this cat blood group system.",1
3814,11,"List the blood group antigens, associated with blood type","Specifically, we characterized and statistically evaluated the expression of histo-blood group (A, B, O) antigens on N-and O-linked glycans from BEC membrane proteins of various individuals that represented different blood group type and secretor status using a porous graphitic carbon liquid chromatography electrospray ionization mass spectrometry (PGC-LC-ESI-MS) based glycomics approach.",0
3814,12,"List the blood group antigens, associated with blood type","In the present study a panel of MoABs against different type 1 chain derived blood group antigens, comprising A, B, H type 1, Le(a), sialyl-Le(a) (CA 19-9), sialyl type 1 structure (CA 50), and Le(b) was used to investigate their immunoreactivity in 38 medullary carcinomas of the thyroid (MTC) and in normal thyroid tissue.",0
3814,13,"List the blood group antigens, associated with blood type","Recent advances in technology, biochemistry, and genetics have clarified the functional classifications of human blood group antigens, the structure of the A, B, H, and Lewis determinants and the enzymes that produce them, and the association of blood group antigens with disease risks.",0
3814,14,"List the blood group antigens, associated with blood type",ABO blood type is associated with renal outcomes in patients with IgA nephropathy.,0
3814,15,"List the blood group antigens, associated with blood type","staining for alpha-N-acetylgalactosamine and alpha-galactose, the terminal sugars in blood group A and B antigens respectively, corresponded to a large extent with ABO blood type.",1
3814,16,"List the blood group antigens, associated with blood type",One,0
3814,17,"List the blood group antigens, associated with blood type","e, we describe the history and possible functions of the histoblood ABO group and then provide evidence for a role of blood group antigens in the most common cancer types worldwide using both blood type and SNP data.",0
3814,18,"List the blood group antigens, associated with blood type",We,0
3814,19,"List the blood group antigens, associated with blood type","contrary to the situation in the fetal and adult hamster pancreas, the induced pancreatic lesion expresses antigens with human blood group type specificities, including A, B, H, Leb, Lex, and Ley, antigens that are expressed, however, by fetal and adult duodenal epithelium.",1
3814,20,"List the blood group antigens, associated with blood type",Considering the ori,0
3814,21,"List the blood group antigens, associated with blood type","ically, we characterized and statistically evaluated the expression of histo-blood group (A, B, O) antigens on N-and O-linked glycans from BEC membrane proteins of various individuals that represented different blood group type and secretor status using a porous graphitic carbon liquid chromatography electrospray ionization mass spectrometry (PGC-LC-ESI-MS) based glycomics approach.",0
3814,22,"List the blood group antigens, associated with blood type",From these,0
3814,23,"List the blood group antigens, associated with blood type",us erosions.,0
3814,24,"List the blood group antigens, associated with blood type","ABO secretor refers to those who secrete ABO blood group antigens based on their blood type in body fluids such as saliva, sweat, tears, semen,",0
3814,25,"List the blood group antigens, associated with blood type","of endothelial cells for blood group A and B antigens was confined to subjects of blood type A and B respectively, although three of nine type A specimens showed no lectin reactivity for group A antigen.",0
3814,26,"List the blood group antigens, associated with blood type",Endothel,0
3814,27,"List the blood group antigens, associated with blood type","Human blood group polymorphisms are known to be determined by the expression of A, B or H antigens and the Lewis antigens.",0
3814,28,"List the blood group antigens, associated with blood type","Protection against microbial infections has been associated with inheritance of polymorphisms in genes encoding and regulating the expression of ABH and Lewis antigens in bodily secretions and epithelial tissue surfaces, subsequently resulting in the presentation of different glycosylated terminal antigens on the cell surface.",0
3814,29,"List the blood group antigens, associated with blood type","The expression of blood group-related antigens (A, B, H, Lewis(a), Lewis(b), Lewis(x), Lewis(y), carbohydrate antigen 19-9 and carcinoembryonic antigen) was investigated immunohistochemically in 75 cases of cholangiocarcinoma (31 peripheral type and 44 hilar type).",0
3814,30,"List the blood group antigens, associated with blood type","Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.",0
3814,31,"List the blood group antigens, associated with blood type","The immunohistological distribution of blood group (BG)-related antigens including A, B, H type 2, and sialylated Lex in lung adenocarcinomas was examined using monoclonal antibodies.",0
3814,32,"List the blood group antigens, associated with blood type","Blood group A, B, H, Le, Leb, Lex, and Ley antigenicity as well as the expression of CA 19-9 were examined in pancreatic cancer specimens from 30 patients, using monoclonal antibodies to the respective antigen and immunohistochemical techniques, and the findings were correlated with the blood group types (ABO and Lewis) of the individuals.",0
3814,33,"List the blood group antigens, associated with blood type","[Expression of the blood group related antigens (Lewis(a), Lewis(b), Lewis(x), Lewis(y), and other gastroenterological tissue related antigens(CEA, APF, and NSE) in poorly differentiated adenocarcinoma of gastric cancer with medullary growth pattern].",0
3814,34,"List the blood group antigens, associated with blood type","Foveolar epithelium of normal gastric mucosa has type 1 blood group associated antigen (Lewis(a), Lewis(b)) and deep gland has type 2 antigen (Lewis(x), Lewis(y)) respectively, as the differentiation antigens.",0
3859,0,What class of drugs have been given a black box warning for suicide?,"The FDA ""Black Box"" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefit",0
3859,1,What class of drugs have been given a black box warning for suicide?,The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults,0
3859,2,What class of drugs have been given a black box warning for suicide?," However, within the past decade, an increasing number of reports have questioned the actual validity of the FDA warning, especially considering a decline in the prescription of the antidepressant drugs associated with an increase in the rate of suicidal events among people with severe depression",0
3859,3,What class of drugs have been given a black box warning for suicide?," In 2004, the European and American authorities released a black-box warning on antidepressants indicating an association with an increased risk of suicidality (suicidal ideation and behavior) in young people",1
3859,4,What class of drugs have been given a black box warning for suicide?,"In 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years.",1
3859,5,What class of drugs have been given a black box warning for suicide?,The United States Food and Drug Administration issued a Black Box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo.,1
3859,6,What class of drugs have been given a black box warning for suicide?,"Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides",0
3859,7,What class of drugs have been given a black box warning for suicide?,"OBJECTIVE: Isotretinoin (13-cis-retinoic acid), approved by the US Food and Drug Administration for the treatment of acne, carries a black box warning related to the risk of depression, suicide, and psychosis.",0
3859,8,What class of drugs have been given a black box warning for suicide?,There has been a decrease in the use of antidepressant therapy in children and adolescents following the US Food and Drug Administration black box warning for risk of suicide.,0
3859,9,What class of drugs have been given a black box warning for suicide?,This study evaluates changes in use of antidepressants in children and adolescents after the US Food and Drug Administration black box warning for increased risk of suicide.Method.,1
3859,10,What class of drugs have been given a black box warning for suicide?,"Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides.",0
3859,11,What class of drugs have been given a black box warning for suicide?,"The FDA ""Black Box"" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?",0
3859,12,What class of drugs have been given a black box warning for suicide?,"On July 10, 2008, a Food and Drug Administration scientific advisory committee voted that, yes, there was a significant positive association between AEDs and suicidality but voted against placing a black box warning on AEDs for suicidality.",0
3859,13,What class of drugs have been given a black box warning for suicide?,Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified.,0
3859,14,What class of drugs have been given a black box warning for suicide?,"Food and Drug Administration has recently introduced the so-called ""black box"" on antidepressants' packages with the aim of gaining attention to the possible risk of suicide among adolescents who are treated with antidepressants, with a warning that the risk of suicide is higher when starting a therapy or while adjusting its dosage.",0
3859,15,What class of drugs have been given a black box warning for suicide?,"OBJECTIVE: Isotretinoin (13-cis-retinoic acid), approved by the US Food and Drug Administration for the treatment of acne, carries a black box warning related to the risk of depression, suicide, and psycho",0
3859,16,What class of drugs have been given a black box warning for suicide?,"In 2004 the Food and Drug Administration (FDA) issued a ""black-box"" warning for antidepressants in children and adolescents, stating that these drugs may increase suicidality, a term encompassing both suicidal thoughts and behavior, especially in the first few weeks of treatment.",1
3859,17,What class of drugs have been given a black box warning for suicide?,"The US FDA has required that antidepressants carry a black box warning that there may be a risk of suicidal ideations in depressed pediatric patients treated with these medications, and recently extended the warning to include individuals up age 24.",0
3859,18,What class of drugs have been given a black box warning for suicide?,OBJECTIVES: To study prescribing trends for antidepressants in Hawai'i following the FDA black box warning regarding the possible risk of suicide in children and adolescents.,0
3859,19,What class of drugs have been given a black box warning for suicide?,The FDA recently linked adverse event reports of suicidal ideation among children and adolescents in randomized controlled trials to selective serotonin reuptake inhibitors (SSRIs) and consequently required a change in labeling that included a black box warning regarding SSRI use for all age groups.,0
3859,20,What class of drugs have been given a black box warning for suicide?,"Another hurdle faced by new drugs is the requirement that all antidepressants carry a black-box warning regarding the increased risk of suicide in children, adolescents and young adults, which limits their use in this population.",0
3859,21,What class of drugs have been given a black box warning for suicide?,The quality of studies regarding the psychopharmacological therapy of depressive disorders in childhood and adolescence has improved since the «black box» warning of the FDA concerning the occurrence of suicidality under treatment with selective serotonin reuptake inhibitors (SSRIs).,0
3859,22,What class of drugs have been given a black box warning for suicide?,The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults still represents a matter of controversy.,0
3859,23,What class of drugs have been given a black box warning for suicide?,To study prescribing trends for antidepressants in Hawai'i following the FDA black box warning regarding the possible risk of suicide in children and adolescents.,0
3859,24,What class of drugs have been given a black box warning for suicide?,"Regulatory agencies of different European countries and the United States have been critically examining the possible link between suicidality and antidepressant use in children and adults, which has resulted in an FDA directive to the manufacturers of all antidepressant medications to add a 'black box' warning.",0
3859,25,What class of drugs have been given a black box warning for suicide?,"OBJECTIVE: Isotretinoin (13-cis-retinoic acid), approved by the US Food and Drug Administration for the treatment of acne, carries a black box warning related to the risk of depression, suicide, and",0
4025,0,Is Lanabecestat effective for Alzheimer's disease?,INTRODUCTION: The APECS and AMARANTH trials showed that beta-secretase (BACE) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzheimer's disease.,1
4025,1,Is Lanabecestat effective for Alzheimer's disease?,Conclusions and Relevance: Treatment with lanabecestat was well tolerated and did not slow cognitive or functional decline.,1
4025,2,Is Lanabecestat effective for Alzheimer's disease?,INTRODUCTION: The APECS and AMARANTH trials showed that beta-secretase (BACE) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzheimer's disease.,1
4025,3,Is Lanabecestat effective for Alzheimer's disease?,INTRODUCTION: The APECS and AMARANTH trials showed that beta-secretase (BACE) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzheime,1
4025,4,Is Lanabecestat effective for Alzheimer's disease?,INTRODUCTION: The APECS and AMARANTH trials showed that beta-secretase (BACE) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzhei,1
3580,0,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"CONCLUSION: Our analysis identified age, lower lumbar/lumbosacral surgery, and RAPT walk score as independent predictors of discharge to SNF, and demonstrated superior predictive power compared with the total RAPT Score when combined in a novel grading scale.",0
3580,1,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"PURPOSE: The aim of this study was to evaluate the value of conventional factors, the Risk Assessment and Predictor Tool (RAPT) and performance-based functional tests as predictors of delayed recovery after total hip arthroplasty (THA).",1
3580,2,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.,0
3580,3,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"The RAPT allows for identification of patients who are likely to be discharged home or to rehabilitation, which may facilitate preoperative planning of postoperative care.",0
3580,4,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"Additionally, it identifies intermediate-risk patients and could be used to implement targeted interventions to facilitate discharge home in this group of patients.",0
3580,5,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,RESULTS: Overall predictive accuracy was 78%.,0
3580,6,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"OBJECTIVE: To assess the relevance of the RAPT (Risk Assessment and Prediction Tool), among a cohort of patients undergoing total hip arthroplasty (THA).",1
3580,7,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,CONCLUSION: This study confirmed the usefulness of the RAPT to help in patient orientation decision after total hip arthroplasty.,0
3580,8,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"CONCLUSIONS

The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",0
3580,9,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively.",0
3580,10,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"The RAPT allows for identification of patients who are likely to be discharged home or to rehabilitation, which may facilitate preoperative planning of postoperative care.",0
3580,11,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,The Risk Assessment and Prediction Tool (RAPT) is a preoperative survey constructed to predict discharge disposition after total joint arthroplasty (TJA).,1
3580,12,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,CONCLUSIONS The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.,0
3580,13,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,The Risk Assessment and Prediction Tool (RAPT) is a preoperative survey constructed to predict discharge disposition after total joint arthroplasty (TJA).,1
3580,14,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"A low RAPT score is reported to indicate a high risk of needing any form of inpatient rehabilitation after TJA, including short-term nursing facilities.",0
3580,15,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,"CONCLUSIONS
The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",0
3580,16,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.,0
3580,17,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,BACKGROUND: The Risk Assessment and Prediction Tool (RAPT) is used to predict patient discharge disposition after total joint arthroplasty.,1
3580,18,Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?,CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.,0
3211,0,Can antisense threapy be used for Huntington's disease?,"In this issue of Neuron, Kordasiewicz et al.",1
3211,1,Can antisense threapy be used for Huntington's disease?,(2012) show the benefit of transient antisense oligonucleotide (ASO) therapy to degrade Huntingtin mRNA and elicit sustained therapeutic benefit in HD mice.,1
3211,2,Can antisense threapy be used for Huntington's disease?,"""Huntingtin holiday"": progress toward an antisense therapy for Huntington's disease.",1
1830,0,Which are the types of viral meningitis?,Aseptic meningitis is the most common type of meningitis and is characterized by meningeal inflammation that is not linked to identifiable bacterial pathogens in cerebrospinal fluid (CSF).,1
1830,1,Which are the types of viral meningitis?,"The results indicate a considerable rate of herpesvirus infection in patients with aseptic meningitis, and that VZV is the most common herpesvirus to cause infection followed by HSV-1.",1
1830,2,Which are the types of viral meningitis?,Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi.,0
1830,3,Which are the types of viral meningitis?,"Of these, 59 (32 %) had proven meningitis (bacterial, tuberculous or cryptococcal), 39 (21 %) had normal CSF and 14 (8 %) had aseptic meningitis.",0
1830,4,Which are the types of viral meningitis?,"For the latter group, a herpes virus was detected in 9 (64 %): 7 (50 %) had EBV and 2 (14 %) had CMV, all were human immunodeficiency virus (HIV)-positive.",0
1830,5,Which are the types of viral meningitis?,"Results confirm that EV-specific RT-PCR can detect HRVs, and at a practical level, identify potential problems of interpretation if fecal samples are used for surrogate screening in cases of suspected viral meningitis.",0
1830,6,Which are the types of viral meningitis?,Human rhinoviruses (HRVs) can be divided into three species; HRV-A to HRV-C.,0
1830,7,Which are the types of viral meningitis?,"Enteroviruses (EV) and parechoviruses (HPeV) are the most common causes of aseptic meningitis, encephalitis and sepsis-like syndrome in neonates.",1
1830,8,Which are the types of viral meningitis?,Serous meningitis associated with primary genital herpes infection,0
1830,9,Which are the types of viral meningitis?,Aseptic meningitis is not an uncommon complication to primary genital herpes infection caused by herpes simplex virus type 2 (HSV-2).,1
1830,10,Which are the types of viral meningitis?,"Compared with other types of viral meningitis, HSV-2-meningitis is associated with a significant rate of neurological complications in the acute stage.",0
1830,11,Which are the types of viral meningitis?,"In addition, some patients will suffer from recurrent aseptic meningitis (Mollaret's meningitis) later.",0
1830,12,Which are the types of viral meningitis?,"We describe six patients, five women and one man, age 26-35 years, with aseptic meningitis caused by HSV-2.",0
1830,13,Which are the types of viral meningitis?,Viral meningitis due to echovirus types 6 and 9: epidemiological data from Western Australia.,0
1830,14,Which are the types of viral meningitis?,"During the autumn of 1992, Western Australia experienced a large viral meningitis outbreak of dual aetiology.",0
1830,15,Which are the types of viral meningitis?,"Echovirus 9 caused 41% of cases and occurred mainly in the metropolitan areas of Western Australia whereas echovirus 6, which caused 37% of cases, was more widespread.",0
1830,16,Which are the types of viral meningitis?,Sensitive virologic evaluation in suspected meningitis: study of a radioimmunotest for the detection of IgM antibodies against ECHO 9 and ECHO 11 viruses,0
1830,17,Which are the types of viral meningitis?,"The majority of viral meningitis cases is known to be due to ECHO virus infections on one hand, and mumps on the other.",1
1830,18,Which are the types of viral meningitis?,"The West Nile Virus (WNV) is a Flavivirus which is transmitted to man by means of different species of mosquitoes and causes outbreaks and sporadic cases of illness in different regions of the Old World, including the Mediterranean Basin.",0
1830,19,Which are the types of viral meningitis?,"Bearing in mind the high percentage of neurological complications found to exist in the most recent outbreaks of WNV infections recorded in the Mediterranean Basin (Bucharest, Algeria), it can be thought that the WNV plays some role in the factors contributing to viral meningitis and encephalitis which occur within the population of the areas at risk within Spain.",0
1830,20,Which are the types of viral meningitis?,"This study aimed to evaluate the frequency of aseptic meningitis caused by herpesviruses, namely herpes simplex types I and II (HSV-1, HSV-2), Epstein-Barr virus (EBV), cytomegalovirus (CMV) and varicella-zoster virus (VZV).",0
1830,21,Which are the types of viral meningitis?,We compared data obtained from patients with mumps meningitis and patients with aseptic meningitis caused by other viruses in order to identify mumps meningitis-specific cytokine/chemokine alterations in cerebrospinal fluid (CSF).METHODS:   We elucidated the cytokine/chemokine network based on the cytokine/chemokine profiles in CSF from children with mumps meningitis and meningitis due to other viral infections using multiplex cytokine measurement.,0
1830,22,Which are the types of viral meningitis?,SPORADIC OCCURRENCE OF ECHO VIRUS TYPES 27 AND 31 ASSOCIATED WITH ASEPTIC MENINGITIS IN ONTARIO.,0
1830,23,Which are the types of viral meningitis?,"Seventeen cytokines/chemokines, namely interleukin (IL)-1â, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17, interferon (IFN)-ã, tumor necrosis factor (TNF)-á, granulocyte colony-stimulating factor (G-CSF), granulocyte monocyte colony-stimulating factor (GM-CSF), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1â (MIP-1â), were measured simultaneously in CSF supernatants from eight children with mumps meningitis, 11 children with other types of viral meningitis and eight children with fever without neurological complications such as convulsion.RESULTS:   We found that IL-8, IL-10, IL-12, IL-13 and IFN-ã showed a statistically significant increase in CSF from mumps meningitis when compared to other types of viral meningitis and fever without neurological complications.CONCLUSION:   Mumps meningitis may induce a distinct immunological response when compared with other types of viral meningitis.",0
1830,24,Which are the types of viral meningitis?,"We found that IL-8, IL-10, IL-12, IL-13 and IFN-γ showed a statistically significant increase in CSF from mumps meningitis when compared to other types of viral meningitis and fever without neurological complications",0
1830,25,Which are the types of viral meningitis?,Mumps meningitis may induce a distinct immunological response when compared with other types of viral meningitis.<CopyrightInformation>© 2011 The Authors.Pediatrics International © 2011 Japan Pediatric Society.</,0
1830,26,Which are the types of viral meningitis?,[Adult cases of viral meningitis caused by echovirus type 13].,0
1830,27,Which are the types of viral meningitis?,[Epidemic outbreak of viral meningitis caused by type 30 ECHO virus].,0
1830,28,Which are the types of viral meningitis?,[Outbreak of viral meningitis caused by echovirus type 4 in Misiones province].,0
1830,29,Which are the types of viral meningitis?,"Compared with other types of viral meningitis, HSV-2-meningitis is associated with a significant rate of neurological complications in the acute stage.",0
1830,30,Which are the types of viral meningitis?,"Seventeen cytokines/chemokines, namely interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17, interferon (IFN)-γ, tumor necrosis factor (TNF)-α, granulocyte colony-stimulating factor (G-CSF), granulocyte monocyte colony-stimulating factor (GM-CSF), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β), were measured simultaneously in CSF supernatants from eight children with mumps meningitis, 11 children with other types of viral meningitis a",0
1830,31,Which are the types of viral meningitis?,"We found that IL-8, IL-10, IL-12, IL-13 and IFN-γ showed a statistically significant increase in CSF from mumps meningitis when compared to other types of viral meningitis and fever without neurological complications.",0
1830,32,Which are the types of viral meningitis?,Mumps meningitis may induce a distinct immunological response when compared with other types of viral meningitis.<CopyrightInformation>© 2011 The Authors.Pediatrics International © 2011 Japan Pediatric Society.</C,0
1830,33,Which are the types of viral meningitis?,BACKGROUND:   The mumps virus is frequently the causative agent in aseptic meningitis and mumps has still prevailed in Japan.,0
1830,34,Which are the types of viral meningitis?,We compared data obtained from patients with mumps meningitis and patients with aseptic meningitis caused by other viruses in order to identify mumps meningitis-specific cytokine/chemokine alterations in cerebrospinal fluid (CSF).METHODS:   We elucidated the cytokine/chemokine network based on the cytokine/chemokine profiles in CSF from children with mumps meningitis and meningitis due to other viral infections using multiplex cytokine measurement.,0
1830,35,Which are the types of viral meningitis?,BACKGROUND:   The mumps virus is frequently the causative agent in aseptic meningitis and mumps has still prevailed in Japan.,0
1830,36,Which are the types of viral meningitis?,We compared data obtained from patients with mumps meningitis and patients with aseptic meningitis caused by other viruses in order to identify mumps meningitis-specific cytokine/chemokine alterations in cerebrospinal fluid (CSF).METHODS:   We elucidated the cytokine/chemokine network based on the cytokine/chemokine profiles in CSF from children with mumps meningitis and meningitis due to other viral infections using multiplex cytokine measurement.,0
1830,37,Which are the types of viral meningitis?,"Seventeen cytokines/chemokines, namely interleukin (IL)-1â, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17, interferon (IFN)-ã, tumor necrosis factor (TNF)-á, granulocyte colony-stimulating factor (G-CSF), granulocyte monocyte colony-stimulating factor (GM-CSF), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1â (MIP-1â), were measured simultaneously in CSF supernatants from eight children with mumps meningitis, 11 children with other types of viral meningitis and eight children with fever without neurological complications such as convulsion.RESULTS:   We found that IL-8, IL-10, IL-12, IL-13 and IFN-ã showed a statistically significant increase in CSF from mumps meningitis when compared to other types of viral meningitis and fever without neurological complications.CONCLUSION:   Mumps meningitis may induce a distinct immunological response when compared with other types of viral meningitis.",0
1830,38,Which are the types of viral meningitis?,[Adult cases of viral meningitis caused by echovirus type 13].,0
1830,39,Which are the types of viral meningitis?,  Mumps meningitis may induce a distinct immunological response when compared with other types of viral meningitis..,0
1830,40,Which are the types of viral meningitis?,"A hospitalization with viral meningitis was defined as any discharge with diagnoses of mumps meningitis (B26.1), enteroviral meningitis (A85.0), tick-born encephalitis (A84.1) and viral undifferentiated meningitis (A87.9) due to ICD-10.",0
1830,41,Which are the types of viral meningitis?,"Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000-2002.",0
2767,0,Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,"In systemic lupus erythematosus (SLE), brain and kidney are the most frequently affected organs.",1
2767,1,Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,The heart is one of the most frequently affected organs in SLE.,1
2767,2,Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,"Any part of the heart can be affected, including the pericardium, myocardium, coronary arteries, valves, and the conduction system",1
2767,3,Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,Skin is one of the most commonly affected organs in SLE,1
2767,4,Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,"Other affected organs in SLE-AAC included kidney (11, 84.6%) and hematologic system (11, 84.6%), followed by mucocutaneous (seven, 53.8%), musculoskeletal (seven, 53.8%) and neuropsychiatric (two, 15.4%) systems.",1
2767,5,Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,Systemic lupus erythematosus (SLE) is a systemic autoimmune disease which affects multiple organs.,0
2767,6,Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,Cutaneous lupus erythematosus (CLE) includes skin symptoms seen in SLE and cutaneous-limited LE.,0
140,0,In which proteins is the chromodomain present?,Chromodomain helicase DNA-binding protein 2 affects the repair of X-ray and UV-induced DNA damage.,0
140,1,In which proteins is the chromodomain present?,Chromodomain helicase DNA-binding proteins (CHD) belong to a group of highly conserved chromatin remodeling proteins that are implicated in regulation of transcription.,0
140,2,In which proteins is the chromodomain present?,"In an effort to understand the physiological role of one of the CHD members in a mammalian model system, we developed a mutant mouse model for the Chd2 gene.",0
140,3,In which proteins is the chromodomain present?,Crystal structure of the chromodomain helicase DNA-binding protein 1 (Chd1) DNA-binding domain in complex with DNA.,0
140,4,In which proteins is the chromodomain present?,"Because, in plants, DNA methylation can serve as a signal for H3-lysine9-dimethylation (H3K9me2), and subsequently for non-CG-context DNA methylation, SET-domain histone methyltransferase and chromodomain dna methyltransferase 3 (cmt3) mutations were introgressed.",0
140,5,In which proteins is the chromodomain present?,"In suvh4 suvh5 suvh6 and cmt3 mutants, H3K9me2 associated with lacO repeats is diminished, but homologous pairing persists.",0
140,6,In which proteins is the chromodomain present?,"Mutations in CHD7, the gene encoding chromodomain helicase DNA binding protein 7, are present in 60-80% of individuals with the CHARGE syndrome.",0
140,7,In which proteins is the chromodomain present?,Chromodomain is present in the integrase structures of blastopia and 412 subgroup LTR-retrotransposons and may facilitate the process of non-specific integration.,0
140,8,In which proteins is the chromodomain present?,The CHARGE syndrome is a multiple congenital malformation syndrome that usually results from deletion or heterozygous loss of function mutations of the chromodomain helicase DNA-binding protein 7 (CHD7) gene at 8q12.1.,0
140,9,In which proteins is the chromodomain present?,"A causative mutation within the chromodomain helicase DNA-binding protein-7 gene, which plays an important role in the embryonic development, is present in 2/3 of affected patients.",0
140,10,In which proteins is the chromodomain present?,"CHD1 is a subfamily member of the CHD family, which possesses a chromodomain, a helicase domain, and a DNA-binding domain.",0
140,11,In which proteins is the chromodomain present?,The chromatin organizer modifier domain (chromodomain) is present in proteins that contribute to chromatin organization and mediates their binding to methylated histone H3.,1
140,12,In which proteins is the chromodomain present?,"Mass spectrometric analysis revealed serine-42, a conserved amino acid in the chromodomain, as a phosphorylation site of Cbx2.",0
140,13,In which proteins is the chromodomain present?,"Phosphorylation of the chromodomain of Cbx2 on this residue in vitro resulted in a reduced level of binding to an H3 peptide containing trimethylated lysine-9 as well as an increase in the extent of binding to an H3 peptide containing trimethylated lysine-27, suggesting that such phosphorylation changes the binding specificity of Cbx2 for modified histone H3.",0
140,14,In which proteins is the chromodomain present?,Phosphorylation of the chromodomain of Cbx2 may therefore serve as a molecular switch that affects the reading of the histone modification code and thereby controls epigenetic cellular memory.,0
140,15,In which proteins is the chromodomain present?,Here we identify the ATP-dependent chromatin remodeling factor chromodomain helicase DNA-binding protein 8 (CHD8) as a novel coregulator of androgen-responsive transcription.,0
140,16,In which proteins is the chromodomain present?,"Mutations in CHD7, a chromodomain gene, are present in a majority of individuals with CHARGE syndrome, a multiple anomaly disorder characterized by ocular Coloboma, Heart defects, Atresia of the choanae, Retarded growth and development, Genital hypoplasia and Ear anomalies.",0
140,17,In which proteins is the chromodomain present?,Two new chromodomain-containing proteins that associate with heterochromatin in Sciara coprophila chromosomes.,0
140,18,In which proteins is the chromodomain present?,"Both proteins, ScoHET1 of 37 kDa and ScoHET2 of 44 kDa, display two chromodomain motifs that contain the conserved residues essential for the recognition of methylated histone H3 at lysine 9.",0
140,19,In which proteins is the chromodomain present?,"In this study, we present a detailed histomorphologic characterization of mice containing a mutation in the chromodomain helicase DNA-binding protein 2 (Chd2).",0
140,20,In which proteins is the chromodomain present?,Specificity of the chromodomain Y chromosome family of chromodomains for lysine-methylated ARK(S/T) motifs.,0
140,21,In which proteins is the chromodomain present?,Previous studies have shown two homologous chromodomain modules in the HP1 and Polycomb proteins exhibit discriminatory binding to related methyllysine residues (embedded in ARKS motifs) of the histone H3 tail.,0
140,22,In which proteins is the chromodomain present?,"In vertebrates, HP1-like chromodomains are also present in the chromodomain Y chromosome (CDY) family of proteins adjacent to a putative catalytic motif.",1
140,23,In which proteins is the chromodomain present?,"The human genome encodes three CDY family proteins, CDY, CDYL, and CDYL2.",0
140,24,In which proteins is the chromodomain present?,"The CDY chromodomain exhibits discriminatory binding to lysine-methylated ARK(S/T) motifs, whereas the CDYL2 chromodomain binds with comparable strength to multiple ARK(S/T) motifs.",0
140,25,In which proteins is the chromodomain present?,"Interestingly, subtle amino acid changes in the CDYL chromodomain prohibit such binding interactions in vitro and in vivo.",0
140,26,In which proteins is the chromodomain present?,"We assessed mRNA transcript abundance of seven genes that code for proteins with established roles in epigenetically-mediated gene silencing [transcriptional co-repressor SIN3A, DNA (cytosine-5-) methyltransferase 1, methyl CpG binding protein 2, chromodomain helicase DNA binding protein 4, histone binding protein rbbp4, histone deacetylase 1 and nuclear receptor co-repressor 2] using qRT-PCR.",0
140,27,In which proteins is the chromodomain present?,CHD7 is a member of the chromodomain helicase DNA binding domain (CHD) family of ATP-dependent chromatin remodelling enzymes.,0
140,28,In which proteins is the chromodomain present?,The cysteine-rich CXXC domains of MBD1 bound to Ring1b and the chromodomain of hPc2.,0
140,29,In which proteins is the chromodomain present?,Methylation of lysine 9 within histone H3 and the subsequent binding of the chromodomain protein heterochromatin protein 1 (HP1) are thought to initiate heterochromatin formation in vivo and to propagate a heterochromatic state lasting through several cell divisions.,0
140,30,In which proteins is the chromodomain present?,"Here, we show that the SNF2-like chromodomain helicase protein CHD8 interacts with the insulator binding protein CTCF.",0
140,31,In which proteins is the chromodomain present?,C,0
140,32,In which proteins is the chromodomain present?,The chromodomain (CD) of the Drosophila Polycomb protein exhibits preferential binding affinity for histone H3 when trimethylated at lysine 27.,0
140,33,In which proteins is the chromodomain present?,"Despite a high degree of conservation, the Cbx chromodomains display significant differences in binding preferences.",0
140,34,In which proteins is the chromodomain present?,Three-dimensional solution structures of the chromodomains of cpSRP43.,0
140,35,In which proteins is the chromodomain present?,"Recently, three functionally distinct chromodomains (CDs) have been identified in cpSRP43.",0
140,36,In which proteins is the chromodomain present?,The C-terminal helical segment typically found in the nuclear chromodomains is absent in CD1.,0
140,37,In which proteins is the chromodomain present?,Critical comparison of the structures of the chromodomains of cpSRP43 with those found in nuclear chromodomain proteins revealed that the diverse protein-protein interactions mediated by the CDs appear to stem from the differences that exist in the surface charge potentials of each CD.,0
140,38,In which proteins is the chromodomain present?,"Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA-binding protein.",0
140,39,In which proteins is the chromodomain present?,The present study describes a newly identified protein named CReMM (chromatin-related mesenchymal modulator).,0
140,40,In which proteins is the chromodomain present?,The protein was studied by bioinformatic means and classified as a member of the third subfamily of chromodomain helicase DNA-binding proteins (CHD).,0
140,41,In which proteins is the chromodomain present?,"In silico translation defined CReMM as a multiple domains protein including two chromodomains, SNF2/ATPase, helicase C domain and an A/T-DNA-binding domain (DBD).",0
140,42,In which proteins is the chromodomain present?,Identification and analysis of chromodomain-containing proteins encoded in the mouse transcriptome.,0
140,43,In which proteins is the chromodomain present?,The chromodomain is 40-50 amino acids in length and is conserved in a wide range of chromatic and regulatory proteins involved in chromatin remodeling.,1
140,44,In which proteins is the chromodomain present?,"Chromodomain-containing proteins can be classified into families based on their broader characteristics, in particular the presence of other types of domains, and which correlate with different subclasses of the chromodomains themselves.",1
140,45,In which proteins is the chromodomain present?,"Here we show that the chromodomain of CMT3 can directly interact with the N-terminal tail of histone H3, but only when it is simultaneously methylated at both the H3K9 and H3K27 positions.",0
140,46,In which proteins is the chromodomain present?,"In addition to the canonical MYST HAT catalytic domain, both TgMYST-A and -B possess an atypical C2HC zinc finger and a chromodomain.",0
140,47,In which proteins is the chromodomain present?,"Clr7 and Clr8 are required for localization of the Swi6 chromodomain protein and for histone H3 lysine 9 methylation, thereby influencing not only mating-type switching but also transcriptional silencing in all previously characterized heterochromatic regions, chromosome segregation, and meiotic recombination in the mating-type region.",0
140,48,In which proteins is the chromodomain present?,"MRG15, a novel chromodomain protein, is present in two distinct multiprotein complexes involved in transcriptional activation.",0
140,49,In which proteins is the chromodomain present?,MRG15 is a novel chromodomain protein that is a member of a family of genes related to MORF4.,0
140,50,In which proteins is the chromodomain present?,MORF4 (mortality factor on chromosome 4) induces senescence in a subset of human tumor cell lines.,0
140,51,In which proteins is the chromodomain present?,Analysis of deletion mutants of MRG15 indicated that the leucine zipper at the C-terminal region of MRG15 was important for the protein associations in MAF1 and that the N-terminal chromodomain was required for the assembly of the MAF2 protein complex.,0
140,52,In which proteins is the chromodomain present?,Consistent with these data was the fact that a histone acetyltransferase activity associated with MRG15 was lost when the chromodomain was deleted and that both mutant MRG15 proteins failed to activate the B-myb promoter.,0
140,53,In which proteins is the chromodomain present?,The various mechanisms by which MRG15 could activate gene transcription are discussed.,0
140,54,In which proteins is the chromodomain present?,"The chromodomain (CD) is a highly conserved motif present in a variety of animal and plant proteins, and its probable role is to assemble a variety of macromolecular complexes in chromatin.",1
140,55,In which proteins is the chromodomain present?,Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail.,0
140,56,In which proteins is the chromodomain present?,The chromodomain of the HP1 family of proteins recognizes histone tails with specifically methylated lysines.,0
140,57,In which proteins is the chromodomain present?,"Here, we present structural, energetic, and mutational analyses of the complex between the Drosophila HP1 chromodomain and the histone H3 tail with a methyllysine at residue 9, a modification associated with epigenetic silencing.",0
140,58,In which proteins is the chromodomain present?,"The histone tail inserts as a beta strand, completing the beta-sandwich architecture of the chromodomain.",0
140,59,In which proteins is the chromodomain present?,"The methylammonium group is caged by three aromatic side chains, whereas adjacent residues form discerning contacts with one face of the chromodomain.",0
140,60,In which proteins is the chromodomain present?,The MORF4-Related Gene on chromosome 15 (MRG15) is a member of a novel family of genes originally identified in studies to reveal cell senescence-inducing factors.,0
140,61,In which proteins is the chromodomain present?,"MRG15 contains several predicted protein motifs, including a nuclear localization signal, a helix-loop-helix region, a leucine zipper, and a chromodomain.",0
140,62,In which proteins is the chromodomain present?,"Four alleles of dMi-2 mutants were further characterized in molecular nature; dMi-2(BL1) was found to have a mutation in the ATP-binding motif of the ATPase domain, dMi-2(BL7) in the core histidine of the first plant homeodomain zinc finger and dMi-2(BL12) in a conserved serine in the chromodomain.",0
140,63,In which proteins is the chromodomain present?,"These analyses also suggest that the msl-3/MRG15 duplication occurred after the fungus/animal split, while an independent duplication occurred in plants.",0
140,64,In which proteins is the chromodomain present?,"The proteins encoded by these genes have similar structures, including a putative chromodomain close to their N-terminal end and a putative leucine zipper at their C-terminus.",0
140,65,In which proteins is the chromodomain present?,CHD1 interacts with SSRP1 and depends on both its chromodomain and its ATPase/helicase-like domain for proper association with chromatin.,0
140,66,In which proteins is the chromodomain present?,Interaction between an integral protein of the nuclear envelope inner membrane and human chromodomain proteins homologous to Drosophila HP1.,0
140,67,In which proteins is the chromodomain present?,A mammalian DNA-binding protein that contains a chromodomain and an SNF2/SWI2-like helicase domain.,0
140,68,In which proteins is the chromodomain present?,"A Southern blot analysis indicated that this protein, which we have named CHD-1, for chromodomain-helicase-DNA-binding protein, is present in most, if not all, mammalian species.",0
140,69,In which proteins is the chromodomain present?,Here we show that chromodomain helicase DNA-binding protein 4 (Chd4) forms a complex with Gata3 in Th2 cells that both activates Th2 cytokine transcription and represses the Th1 cytokine IFN-γ.,0
140,70,In which proteins is the chromodomain present?,"Chromodomain helicase DNA-binding protein 4 (CHD4), the defining subunit of the nucleosome remodeling and deacetylase (NuRD) complex, is a nucleosome-remodeling protein of the SNF2/ISWI2 family, members of which contain two chromo domains and an ATP-dependent helicase module.",0
140,71,In which proteins is the chromodomain present?,Among those proteins with >40% regulation were Macrophage Capping protein (CAPG) and Chromodomain Helicase DNA binding protein 4 (CHD4) proteins which were significantly upregulated by pp32r1 and pp32r1Y140H overexpression.,0
140,72,In which proteins is the chromodomain present?,This heterochromatin coordinates expression levels by associating with a chromodomain protein Chp1 and an antisilencing factor Epe1.,0
140,73,In which proteins is the chromodomain present?,"Within NCCs, Brg1 partners with chromatin remodeler Chromodomain-helicase-DNA-binding protein 7 (Chd7) on the PlexinA2 promoter to activate PlexinA2, which encodes a receptor for semaphorin to guide NCCs into the OFT.",0
140,74,In which proteins is the chromodomain present?,"Chromodomain Helicase DNA binding protein 5 (CHD5) is a tumor suppressor mapping to 1p36, a genomic region that is frequently deleted in human cancer.",0
140,75,In which proteins is the chromodomain present?,"Here, we identify ENHANCED PHOTOMORPHOGENIC1 (EPP1), previously known as PICKLE (PKL), an ATP-dependent chromatin remodeling factor of the chromodomain/helicase/DNA binding family, as a repressor of photomorphogenesis in Arabidopsis thaliana.",0
140,76,In which proteins is the chromodomain present?,Chromodomain on Y-like (CDYL) is a chromodomain protein that has sequence homology to members of the enoyl CoA hydratase family.,0
140,77,In which proteins is the chromodomain present?,"Our previous structural work demonstrated that a coiled-coil interaction between MBD2 and GATA zinc finger domain containing 2A (GATAD2A/p66α) proteins recruits the chromodomain helicase DNA-binding protein (CHD4/Mi2β) to the NuRD complex and is necessary for MBD2-mediated DNA methylation-dependent gene silencing in vivo (Gnanapragasam, M. N., Scarsdale, J. N., Amaya, M. L., Webb, H. D., Desai, M. A., Walavalkar, N. M., Wang, S. Z., Zu Zhu, S., Ginder, G. D., and Williams, D. C., Jr. (2011) p66α-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex.",0
140,78,In which proteins is the chromodomain present?,"Sequence analysis showed that NlElp3 contains GNAT-type HAT domain and Radical SAM domain, and NlMof contains chromodomain and MOZ-SAS acetyltransferase domain.",0
140,79,In which proteins is the chromodomain present?,"We examined requirements for individual domains of chromodomain helicase DNA-binding protein 4 (CHD4), a core catalytic component of NuRD complexes, as well as the NuRD subunit methyl-binding domain protein 2 (MBD2) and methylated DNA, for NuRD function in the context of tissue-specific transcription.",0
140,80,In which proteins is the chromodomain present?,OBJECTIVE: Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1L) is an SNF2-like transcription factor involved in the development of human hepatocellular carcinoma (HCC).,0
140,81,In which proteins is the chromodomain present?,"Twelve rare copy number variants segregate with talipes equinovarus in multiplex pedigrees, and contain the developmentally expressed transcription factors and transcriptional regulators PITX1, TBX4, HOXC13, UTX, CHD (chromodomain protein)1, and RIPPLY2.",0
140,82,In which proteins is the chromodomain present?,OBJECTIVE: Chromodomain helicase DNA-binding protein 5 (CHD5) plays a role in normal neural development and in tumorigenesis of various human cancers.,0
140,83,In which proteins is the chromodomain present?,"The chromodomain, helicase, DNA-binding protein 5 (CHD5) is a chromatin remodeling enzyme which is implicated in tumor suppression.",0
140,84,In which proteins is the chromodomain present?,The methyl-mark determines a highly flexible and very dynamic interaction of the chromodomain of hHP1β with the H3-tail.,0
140,85,In which proteins is the chromodomain present?,"To test this hypothesis, we performed a comprehensive molecular dynamics study in which we analyzed a crystallographically defined complex that involves the HP1 chromodomain and an H3 tail peptide.",0
140,86,In which proteins is the chromodomain present?,"Whereas the molecular target of the MRG15 chromodomain (CD) has been suggested to be H3K36me(2/3), the precise molecular target of the Pf1 plant homeodomain 1 (PHD1) has remained elusive.",0
140,87,In which proteins is the chromodomain present?,"Chp1, a chromodomain (CD) protein, forms the Ago1-containing RNA-induced transcriptional silencing (RITS) complex and recruits siRNA-bound RITS to methylated histone H3 lysine 9 (H3K9me) via its CD.",0
140,88,In which proteins is the chromodomain present?,"In addition, cells expressing S473A also displayed defective mobilization of the HP1-β chromodomain protein.",0
140,89,In which proteins is the chromodomain present?,"CHD7 is a chromodomain-containing, ATP dependent helicase protein that is highly expressed in the developing ear and is required for semicircular canal development in both humans and mice.",0
140,90,In which proteins is the chromodomain present?,"Moreover, the LTR retrotransposon fraction in BAC clones harboring genes is disproportionately composed of chromodomain-containing Gypsy LTR retrotransposons ('chromoviruses'), and the majority of the intact chromoviruses contain tandem chromodomain duplications.",0
140,91,In which proteins is the chromodomain present?,"Stimulated by positively charged residues in the hinge region, RNA competes with methylated histone H3K9 for binding to the chromodomain of HP1(Swi6).",0
140,92,In which proteins is the chromodomain present?,CHD7 is one of the nine members of the chromodomain helicase DNA-binding family of ATP-dependent chromatin remodeling enzymes.,0
140,93,In which proteins is the chromodomain present?,"Therefore, p53, ZNF237, and Chromodomain helicase DNA-binding protein 3 inhibit the function ER Ca²⁺ leak channels to regulate both ER and cytoplasmic Ca²⁺ levels and may potentially control Ca²⁺-signaling function of PS1.",0
140,94,In which proteins is the chromodomain present?,"We show that chromodomain helicase DNA-binding domain 2 (Chd2), a SNF2 chromatin remodelling enzyme family member, interacts with MyoD and myogenic gene regulatory sequences to specifically mark these loci via deposition of the histone variant H3.3 prior to cell differentiation.",0
140,95,In which proteins is the chromodomain present?,"Analysis of the Neurospora crassa chromodomain protein CDP-2, a component of a newly characterized HP1-containing complex, reveals a second gene-silencing mechanism and provides insights into the dynamic nature of chromatin domains that possess shared components.",0
140,96,In which proteins is the chromodomain present?,"We state that the non-tumorogenic potential of bitumen transformant in nude/SCID mice can be attributed to the downregulation of galectin-1, chromodomain helicase DNA-binding protein 1-like gene, and membrane-associated guanylate kinase 2 protein.",0
140,97,In which proteins is the chromodomain present?,Mutagenesis of Tf1 integrase revealed that the complete Tf1 integrase protein (excluding its chromodomain) is required for stimulating the Tf1 RT primer removal activity.,0
140,98,In which proteins is the chromodomain present?,"About 80% of patients with a clinical diagnose, have a mutation or a deletion in the gene encoding chromodomain helicase DNA-binding protein 7 (CHD7).",0
140,99,In which proteins is the chromodomain present?,"Owing to different polyadenylation sites and alternative splicing events, the human CBX2 locus produces two transcripts: a 5-exon transcript that encodes the 532-amino acid CBX2-1 isoform that contains the conserved chromodomain and Pc box and a 4-exon transcript encoding a shorter isoform, CBX2-2, lacking the Pc box but still possessing a chromodomain.",0
140,100,In which proteins is the chromodomain present?,Chromodomain helicase DNA-binding protein 4 (Chd4) is the core catalytic subunit of the nucleosome remodeling and deacetylase (NuRD) chromatin remodeling complex.,0
140,101,In which proteins is the chromodomain present?,Chromodomain helicase DNA-binding proteins (CHD) belong to a group of highly conserved chromatin remodeling proteins that are implicated in regulation of transcription.,0
140,102,In which proteins is the chromodomain present?,"Here, we report that chromodomain helicase DNA-binding protein 4 (CHD4) is a novel BRIT1 binding partner that regulates the HR repair process.",0
140,103,In which proteins is the chromodomain present?,"Here, we report that the chromodomain-containing protein MRG-1 is an important factor for genomic integrity in meiosis in Caenorhabditis elegans.",0
140,104,In which proteins is the chromodomain present?,"The chromodomain protein, Chromator, can be divided into two main domains, a NH(2)-terminal domain (NTD) containing the chromodomain (ChD) and a COOH-terminal domain (CTD) containing a nuclear localization signal.",0
140,105,In which proteins is the chromodomain present?,Chromodomain helicase DNA binding protein 5 (CHD5) is a potent tumor suppressor that serves as a master regulator of a tumor-suppressive network.,0
140,106,In which proteins is the chromodomain present?,"By high-resolution tiling array CGH, the smallest common deletion targeted just one gene, the chromatin remodeler chromodomain helicase DNA-binding protein 1 (CHD1).",0
140,107,In which proteins is the chromodomain present?,"Here we report direct evidence for presynaptic pairing activity intrinsic to non-PC regions, which is facilitated by a conserved chromodomain protein, MRG-1.",0
140,108,In which proteins is the chromodomain present?,The chromodomain of MPP8 recognizes the dimethylated Dnmt3aK44me2.,0
140,109,In which proteins is the chromodomain present?,Members of the chromodomain helicase DNA-binding (CHD) family of proteins are thought to regulate gene expression.,0
140,110,In which proteins is the chromodomain present?,It has been shown that the methylation mark of vertebrate histone H1 is specifically recognized by the chromodomain of HP1.,0
140,111,In which proteins is the chromodomain present?,"To this end, we have performed mutation studies on the Drosophila HP1α chromodomain, which binds H3K9Me(2)  and H3K9Me(3)  with approximately equal affinities.",0
140,112,In which proteins is the chromodomain present?,We are interested in defining which elements of the chromodomain helicase DNA-binding protein 1 (Chd1) remodeler are necessary and sufficient for sliding nucleosomes.,0
140,113,In which proteins is the chromodomain present?,"Chromatin remodelers are ATP-dependent machines that dynamically alter the chromatin packaging of eukaryotic genomes by assembling, sliding, and displacing nucleosomes.",0
140,114,In which proteins is the chromodomain present?,"Ocular coloboma, heart malformation, choanal atresia, retardation of growth and/or development, genital hypoplasia, and ear anomalies associated with deafness (CHARGE) syndrome is a rare, usually sporadic, autosomal dominant disorder, caused by mutations within the CHD7 (chromodomain helicase DNA-binding protein 7) gene, in nearly 70% of cases.",0
140,115,In which proteins is the chromodomain present?,"Here we report that the chromodomain-containing protein CDYL specifically recognizes di- and tri-methylated H3K27 (H3K27me2 and H3K27me3) and directly interacts with EZH2, the catalytic subunit of PRC2.",0
140,116,In which proteins is the chromodomain present?,"Murine Chd1 (chromodomain helicase DNA-binding protein 1), a chromodomain-containing chromatin remodeling protein, is necessary for embryonic stem (ES) cell pluripotency.",0
140,117,In which proteins is the chromodomain present?,"Among those genes, zinc finger helicase (ZFH), also termed chromodomain-helicase-DNA-binding protein 3 (Chd3), was one of the highly expressed transcripts in tentative cementoblasts.",0
140,118,In which proteins is the chromodomain present?,UNLABELLED: Emerging evidence implicates the chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) as a specific oncogene in human hepatocellular carcinoma (HCC).,0
140,119,In which proteins is the chromodomain present?,"Here, we investigate the function of chromodomain helicase DNA binding protein 7 (chd7) during zebrafish somitogenesis.",0
140,120,In which proteins is the chromodomain present?,"Heterozygous mutations in the gene encoding chromodomain-DNA-binding-protein 7 (CHD7) cause CHARGE syndrome, a multiple anomaly condition which includes vestibular dysfunction and hearing loss.",0
140,121,In which proteins is the chromodomain present?,BACKGROUND: The CHD5 gene located on 1p36 encodes a protein-chromodomain helicase DNA-binding protein 5.,0
140,122,In which proteins is the chromodomain present?,CHD5 has been shown to be a tumor suppressor gene candidate.,0
140,123,In which proteins is the chromodomain present?,"Because, in plants, DNA methylation can serve as a signal for H3-lysine9-dimethylation (H3K9me2), and subsequently for non-CG-context DNA methylation, SET-domain histone methyltransferase and chromodomain dna methyltransferase 3 (cmt3) mutations were introgressed.",0
140,124,In which proteins is the chromodomain present?,"Previously, we have shown that the chromodomain protein Chriz and the zinc-finger protein Z4 are essentially required for the maintenance of polytene chromosome structure.",0
140,125,In which proteins is the chromodomain present?,"In brain, Family with sequence similarity 174 member b (Fam174b) had increased expression in 318 females, whereas Chromodomain helicase DNA binding protein 2 (Chd2-2) had reduced expression in 318 males.",0
140,126,In which proteins is the chromodomain present?,RESULTS: Here we demonstrated that chromobox protein homolog 3 (Cbx3) is crucial for SMC differentiation from stem cells and that the chromodomain and chromoshadow domain of Cbx3 are responsible for Cbx3-induced SMC differentiation.,0
140,127,In which proteins is the chromodomain present?,"Fractionation of the extract identified a single protein, chromodomain helicase DNA binding protein 1 (Chd1), capable of the remodeling activity.",0
140,128,In which proteins is the chromodomain present?,Chromodomain helicase DNA-binding protein 5 (CHD5) has been found to be a candidate tumor suppressor gene (TSG) in malignant neural tumors.,0
140,129,In which proteins is the chromodomain present?,"Similarly, CenH3-GFP distribution was altered in the absence of HP1, the chromodomain protein that binds to H3K9me3.",0
140,130,In which proteins is the chromodomain present?,ChIP-Seq reveals that KDM5B is predominantly targeted to intragenic regions and that it is recruited to H3K36me3 via an interaction with the chromodomain protein MRG15.,0
140,131,In which proteins is the chromodomain present?,OBJECTIVE: Chromodomain helicase DNA-binding protein (CHD) is a regulator of the chromatin remodelling process.,0
140,132,In which proteins is the chromodomain present?,We determined the crystal structure of MPP8 chromodomain in complex with H3K9me3 peptide.,0
140,133,In which proteins is the chromodomain present?,"On this gene the chromodomain protein HP1γ, frequently defined as a transcriptional repressor, facilitates inclusion of the alternative exons via a mechanism involving decreased RNA polymerase II elongation rate.",0
140,134,In which proteins is the chromodomain present?,Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a core component of the NuRD complex and contains a nucleosome remodeling ATPase domain along with two chromodomains and two plant homeodomain (PHD) fingers.,0
140,135,In which proteins is the chromodomain present?,H3-Lys-9-Me2 interacts with the chromodomain of Swi6/HP1.,0
140,136,In which proteins is the chromodomain present?,"The chromodomain (CD) of HP1 proteins specifically recognizes the methyl mark on H3 peptides, but the same extent of specificity is not observed within chromatin.",0
140,137,In which proteins is the chromodomain present?,We have performed simulations on models of chromodomain helicase DNA-binding protein 1 complexed with a variety of histone H3 modifications.,0
140,138,In which proteins is the chromodomain present?,"CHARGE syndrome is an autosomal dominant multisystem disorder caused by mutation in the CHD7 gene, encoding chromodomain helicase DNA-binding protein 7.",0
140,139,In which proteins is the chromodomain present?,Molecular diagnostic testing for CHD7 mutation has been available in a clinical setting since 2005.,0
140,140,In which proteins is the chromodomain present?,"In this work we identified Kismet, a chromodomain-containing protein of the SNF2-like family of ATPases, as a novel component of the hedgehog transcriptional repression mechanism in anterior compartment cells.",0
1464,0,Which hormone receptor function is altered in patients with Donohue syndrome?,This disease is caused by a defective insulin receptor and features abnormal glucose metabolism and retarded intrauterine and postnatal growth.,0
1464,1,Which hormone receptor function is altered in patients with Donohue syndrome?,Biallelic insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin resistance (SIR) known as Donohue syndrome (DS) and Rabson-Mendenhall syndrome (RMS).,0
1464,2,Which hormone receptor function is altered in patients with Donohue syndrome?,Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.,1
1464,3,Which hormone receptor function is altered in patients with Donohue syndrome?,"Donohue syndrome (leprechaunism; OMIM *246200) is a rare, recessively inherited disorder of extreme insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects in insulin binding or receptor autophosphorylation and tyrosine kinase activity.",1
1464,4,Which hormone receptor function is altered in patients with Donohue syndrome?,Leprechaunism (Donohue syndrome): a case bearing novel compound heterozygous mutations in the insulin receptor gene.,0
1464,5,Which hormone receptor function is altered in patients with Donohue syndrome?,Leprechaunism (Donohue syndrome) is the most severe type of insulin receptor (INSR) gene anomaly with the majority of patients surviving for only 2 years.,0
1464,6,Which hormone receptor function is altered in patients with Donohue syndrome?,A novel mutation of the insulin receptor gene in a preterm infant with Donohue syndrome and heart failure.,0
1464,7,Which hormone receptor function is altered in patients with Donohue syndrome?,Donohue syndrome (DS) is a rare autosomal recessive condition caused by mutations in the gene encoding the insulin receptor.,1
1464,8,Which hormone receptor function is altered in patients with Donohue syndrome?,"Any dysfunction of insulin signalling pathway as a result of insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin resistance type A, Donohue or Rabson-Mendenhall syndrome, which differ in the level of severity.",1
1464,9,Which hormone receptor function is altered in patients with Donohue syndrome?,Donohue syndrome in a neonate with homozygous deletion of exon 3 of the insulin receptor gene.,0
1464,10,Which hormone receptor function is altered in patients with Donohue syndrome?,Donohue syndrome describes the clinical consequences of the most severe genetic loss of insulin receptor function.,0
1464,11,Which hormone receptor function is altered in patients with Donohue syndrome?,"Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (""Leprechaunism""), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.",1
1464,12,Which hormone receptor function is altered in patients with Donohue syndrome?,"The former mutation has been described in homozygous form in Donohue syndrome, while the latter is novel.",0
3467,0,What is the purpose of the LINCS Project?,The Library of Integrated Cellular Signatures (LINCS) project provides comprehensive transcriptome profiling of human cell lines before and after chemical and genetic perturbations.,1
3467,1,What is the purpose of the LINCS Project?,"The National Institutes of Health Library of Integrated Network-based Cellular Signatures (LINCS) program is generating extensive multidimensional data sets, including biochemical, genome-wide transcriptional, and phenotypic cellular response signatures to a variety of small-molecule and genetic perturbations with the goal of creating a sustainable, widely applicable, and readily accessible systems biology knowledge resource.",1
3467,2,What is the purpose of the LINCS Project?,The Library of Integrated Network-Based Cellular Signatures (LINCS) project aims to create a network-based understanding of biology by cataloging changes in gene expression and signal transduction that occur when cells are exposed to a variety of perturbations.,1
3467,3,What is the purpose of the LINCS Project?,"Using transcriptome data from the L1000 database of the LINCS project, we developed a framework based on a deep-learning algorithm to predict potential drug target interactions.",1
3467,4,What is the purpose of the LINCS Project?,"First, the LINCS project can provide rich transcriptome data that reflect the responses of cells upon exposure to various drugs.",1
3365,0,What is particular about the mouse Fxy gene's chromosomal position?,"We have previously described a gene, Fxy , that spans the pseudoautosomal boundary in mice such that the first three exons of the gene are located on the X chromosome, but the remainder of the gene is located on both X and Y chromosomes.",1
3365,1,What is particular about the mouse Fxy gene's chromosomal position?,The Fxy gene in mice is also located on the X chromosome but spans the pseudoautosomal boundary in this species.,1
3365,2,What is particular about the mouse Fxy gene's chromosomal position?,"Here we describe a gene closely related to FXY/MID1, called FXY2, which also maps to the X chromosome within Xq22",1
3365,3,What is particular about the mouse Fxy gene's chromosomal position?,"The gene Fxy (also known as MID1 [7]) spans the pseudoautosomal boundary (PAB) in the laboratory mouse (Mus musculus domesticus, C57BL/6) such that the 5' three exons of the gene are located on the X chromosome but the seven exons encoding the carboxy-terminal two-thirds of the protein are located within the PAR and are therefore present on both the X and Y chromosomes",1
4210,0,Is the zelda transcription factor a chromatin remodeller?,ncreasing the number of Zelda binding sites accelerates the kinetics of nuclei transcriptional activation regardless of their transcriptional past,0
4210,1,Is the zelda transcription factor a chromatin remodeller?,Zelda facilitates transcriptional activation by accumulating in microenvironments where it could accelerate the duration of multiple pre-initiation steps.,0
4210,2,Is the zelda transcription factor a chromatin remodeller?,Zelda acts through specific chromatin patterns of histone modifications to mark developmental enhancers and active promoters,0
4210,3,Is the zelda transcription factor a chromatin remodeller?,Zelda overcomes the high intrinsic nucleosome barrier at enhancers during Drosophila zygotic genome activation.,0
4210,4,Is the zelda transcription factor a chromatin remodeller?,"The Drosophila genome activator Vielfaltig (Vfl), also known as Zelda (Zld), is thought to prime enhancers for activation by patterning transcription factors (TFs).",0
4210,5,Is the zelda transcription factor a chromatin remodeller?,Such priming is accompanied by increased chromatin accessibility,0
4210,6,Is the zelda transcription factor a chromatin remodeller?,early enhancers are characterized by an intrinsically high nucleosome barrier.,0
4210,7,Is the zelda transcription factor a chromatin remodeller?,Zld tackles this nucleosome barrier through local depletion of nucleosomes with the effect being dependent on the number and position of Zld motifs.,1
4210,8,Is the zelda transcription factor a chromatin remodeller?,"Zelda is differentially required for chromatin accessibility, transcription factor binding, and gene expression in the early Drosophila embryo",1
4210,9,Is the zelda transcription factor a chromatin remodeller?,"Open chromatin is associated with Zelda-bound loci, as well as more generally with regions of active transcriptio",0
4210,10,Is the zelda transcription factor a chromatin remodeller?,"During this developmental transition, the zygotic genome is largely transcriptionally quiescent and undergoes significant chromatin remodeling.",0
4210,11,Is the zelda transcription factor a chromatin remodeller?,"In Drosophila, the DNA-binding protein Zelda (also known as Vielfaltig) is required for this transition and for transcriptional activation of the zygotic genome.",1
4210,12,Is the zelda transcription factor a chromatin remodeller?,"Zld facilitates binding of Dl to regulatory DNA, and that this is associated with increased chromatin accessibility.",0
4210,13,Is the zelda transcription factor a chromatin remodeller?,"Importantly, the change in chromatin accessibility is strongly correlated with the change in Zld binding",0
4210,14,Is the zelda transcription factor a chromatin remodeller?,"Zelda is differentially required for chromatin accessibility, transcription factor binding, and gene expression in the early Drosophila embryo.",1
4210,15,Is the zelda transcription factor a chromatin remodeller?,We propose that both Zelda and GAGA factor function to specify sites of open chromatin and together facilitate the remodeling of the early embryonic genome.,0
4210,16,Is the zelda transcription factor a chromatin remodeller?,"is analysis highlighted a strong and specific enrichment of predicted ZGA-associated CRMs for Zelda, CBP, Trl binding sites, as well as for histone marks associated with active enhancers (H3K4me1) and for open chromatin regions.CO",0
4210,17,Is the zelda transcription factor a chromatin remodeller?,We demonstrate that Zelda is essential for hundreds of regions of open chromatin.,0
4210,18,Is the zelda transcription factor a chromatin remodeller?,"Intriguingly, some Zelda sites still maintain these chromatin patterns in Drosophila embryos lacking maternal Zelda protein.",0
4210,19,Is the zelda transcription factor a chromatin remodeller?,Zelda potentiates morphogen activity by increasing chromatin accessibility.,0
4210,20,Is the zelda transcription factor a chromatin remodeller?,"Zelda binds cis-regulatory elements (TAGteam heptamers), making chromatin accessible for gene transcription.",0
4210,21,Is the zelda transcription factor a chromatin remodeller?,"zinc-finger TF zelda (zld) is essential for the maternal-to-zygotic transition (MZT) in Drosophila melanogaster, where it directly binds over thousand cis-regulatory modules to regulate chromatin accessibility.",0
4210,22,Is the zelda transcription factor a chromatin remodeller?,D. mela,0
4210,23,Is the zelda transcription factor a chromatin remodeller?,This Zelda-mediated chromatin accessibility facilitates transcription-factor recruitment and early gene expression.,1
4210,24,Is the zelda transcription factor a chromatin remodeller?,"While analyzing chromatin immunoprecipitation data sets from 21 sequence-specific transcription factors active in the Drosophila embryo, we found that binding of all factors exhibits a dose-dependent relationship with ""TAGteam"" sequence motifs bound by the zinc finger protein Vielfaltig, also known as Zelda, a recently discovered activator of the zygotic genome.",0
4210,25,Is the zelda transcription factor a chromatin remodeller?,"These different timing classes each associate with binding sites for two transcription factors, GAGA-factor and Zelda, previously implicated in controlling chromatin accessibility at ZGA.",0
4210,26,Is the zelda transcription factor a chromatin remodeller?,Together this reveals a distinct requirement for a chromatin remodeller in promoting the activity of the pioneer factor OCT4 and regulating the pluripotency network.,0
4210,27,Is the zelda transcription factor a chromatin remodeller?,"Chromatin accessibility at OCT4-bound sites requires the chromatin remodeller BRG1, which is recruited to these sites by OCT4 to support additional transcription factor binding and expression of the pluripotency-associated transcriptome.",0
4210,28,Is the zelda transcription factor a chromatin remodeller?,The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells.,0
4210,29,Is the zelda transcription factor a chromatin remodeller?,Pioneer transcription factors recognise and bind their target sequences in inaccessible chromatin to establish new transcriptional networks throughout development and cellular reprogramming.,0
4210,30,Is the zelda transcription factor a chromatin remodeller?,"During this process, pioneer factors establish an accessible chromatin state to facilitate additional transcription factor binding, yet it remains unclear how different pioneer factors achieve this.",0
4210,31,Is the zelda transcription factor a chromatin remodeller?,"Here, we discover that the pluripotency-associated pioneer factor OCT4 binds chromatin to shape accessibility, transcription factor co-binding, and regulatory element function in mouse embryonic stem cells.",0
4210,32,Is the zelda transcription factor a chromatin remodeller?,"Open chromatin is associated with Zelda-bound loci, as well as more generally with regions of active transcription.",0
4210,33,Is the zelda transcription factor a chromatin remodeller?,"Unexpectedly, chromatin at a large subset of Zelda-bound regions remains open even in the absence of Zelda.",0
4210,34,Is the zelda transcription factor a chromatin remodeller?,"During this developmental transition, the zygotic genome is largely transcriptionally quiescent and undergoes significant chromatin remodeling.",0
4210,35,Is the zelda transcription factor a chromatin remodeller?,Here we used formaldehyde-assisted isolation of regulatory elements to determine the role of Zelda in regulating regions of open chromatin in the early embryo.,0
4210,36,Is the zelda transcription factor a chromatin remodeller?,"Pioneer transcription factors can engage nucleosomal DNA, which leads to local chromatin remodeling and to the establishment of transcriptional competence.",0
4210,37,Is the zelda transcription factor a chromatin remodeller?,"Recently, we showed that Zelda acts through specific chromatin patterns of histone modifications to mark developmental enhancers and active promoters.",0
4210,38,Is the zelda transcription factor a chromatin remodeller?,"The zinc-finger TF zelda (zld) is essential for the maternal-to-zygotic transition (MZT) in Drosophila melanogaster, where it directly binds over thousand cis-regulatory modules to regulate chromatin accessibility.",0
4210,39,Is the zelda transcription factor a chromatin remodeller?,"Nonetheless, the extent to which Zelda influences chromatin accessibility across the genome is largely unknown.",0
4210,40,Is the zelda transcription factor a chromatin remodeller?,"We present evidence that Zld facilitates binding of Dl to regulatory DNA, and that this is associated with increased chromatin accessibility.",0
4210,41,Is the zelda transcription factor a chromatin remodeller?,ZRF1 facilitates the remodeling of multiprotein complexes at chromatin and lies at the heart of signaling processes that occur at DNA damage sites and during transcriptional activation.,0
4210,42,Is the zelda transcription factor a chromatin remodeller?,We postulate that ZRF1 operates in conjunction with cellular remodeling machines and suggest that on-site remodeling might be a hallmark of many chromatin-associated signaling pathways.,0
4210,43,Is the zelda transcription factor a chromatin remodeller?,Reconstituted transcription reactions established that the Brahma (BRM) chromatin-remodeling complex is essential for Zeste-directed activation on nucleosomal templates.,0
1059,0,Are piRNAs involved in gene silencing?,"In Drosophila ovaries, the nuclear Piwi protein is required for transcriptional silencing of transposons, though the precise mechanisms by which this occurs are unknown.",0
1059,1,Are piRNAs involved in gene silencing?,"Here we show that the CG9754 protein is a component of Piwi complexes that functions downstream of Piwi and its binding partner, Asterix, in transcriptional silencing.",0
1059,2,Are piRNAs involved in gene silencing?,Enforced tethering of CG9754 to nascent messenger RNA transcripts causes cotranscriptional silencing of the source locus and the deposition of repressive chromatin marks.,1
1059,3,Are piRNAs involved in gene silencing?,"We have named CG9754 ""Panoramix,"" and we propose that this protein could act as an adaptor, scaffolding interactions between the piRNA pathway and the general silencing machinery that it recruits to enforce transcriptional repression.",0
1059,4,Are piRNAs involved in gene silencing?,piRNA-guided slicing of transposon transcripts enforces their transcriptional silencing via specifying the nuclear piRNA repertoire,1
1059,5,Are piRNAs involved in gene silencing?,Caenorhabditis elegans piRNAs interact with both transposon and nontransposon mRNAs to initiate sustained silencing via the RNAi pathway.,0
1059,6,Are piRNAs involved in gene silencing?,"To assess the dysregulation of gene silencing caused by lack of piRNAs, we restored RNA silencing in RNAi-defective animals in the presence or absence of piRNAs.",0
1059,7,Are piRNAs involved in gene silencing?,"Thus, by reanimating RNAi, we uncovered a role for piRNAs in protecting essential genes from RNA silencing.",0
1059,8,Are piRNAs involved in gene silencing?,"In different organisms, small RNAs were shown to be implicated in the posttranscriptional degradation of mRNA and/or transcriptional repression of the homologous locus.",0
1059,9,Are piRNAs involved in gene silencing?,"In Drosophila, the mechanism of piRNA-mediated silencing is still far from being understood",0
1059,10,Are piRNAs involved in gene silencing?,Analyses of piRNA-mediated transcriptional transposon silencing in Drosophila,0
1059,11,Are piRNAs involved in gene silencing?,Transcriptional silencing implies a piRNA-mediated formation of repressive chromatin which diminishes the transcriptional capacity of the target locus.,1
1059,12,Are piRNAs involved in gene silencing?,"In mice, piRNA-guided transposon repression correlates with establishment of CpG DNA methylation on their sequences, yet the mechanism and the spectrum of genomic targets of piRNA silencing are unknown",0
1059,13,Are piRNAs involved in gene silencing?,"Using a candidate gene KD-approach, we identified differences in the spatio-temporal requirements of the piRNA pathway components for piRNA-mediated silencing.",0
1059,14,Are piRNAs involved in gene silencing?,Spatio-temporal requirements for transposable element piRNA-mediated silencing during Drosophila oogenesis,0
1059,15,Are piRNAs involved in gene silencing?,"In contrast, piRNA-mediated silencing is strong in germline stem cells in which TE mobilization is tightly repressed ensuring the continued production of viable germline cysts.",0
1059,16,Are piRNAs involved in gene silencing?,Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state.,1
1059,17,Are piRNAs involved in gene silencing?,"In germ cells, early embryos, and stem cells of animals, PIWI-interacting RNAs (piRNAs) have an important role in silencing retrotransposons, which are vicious genomic parasites, through transcriptional and post-transcriptional mechanisms.",0
1059,18,Are piRNAs involved in gene silencing?,"Our results show that the piRNA pathway can be used as a tool for sequence-specific gene silencing in germ cells and support the idea that the piRNA generating regions serve as traps for retrotransposons, enabling the host cell to generate piRNAs against active retrotransposons.",0
1059,19,Are piRNAs involved in gene silencing?," Our observations confirm the pivotal role of piRNA-mediated silencing in defending the genome against selfish transposition, yet also suggest limits to the optimization of host genome defense.",0
1059,20,Are piRNAs involved in gene silencing?,Analysis of piRNA-mediated silencing of active TEs in Drosophila melanogaster suggests limits on the evolution of host genome defense,0
1059,21,Are piRNAs involved in gene silencing?,The Piwi-interacting RNA (piRNA) pathway defends animal genomes against the harmful consequences of transposable element (TE) infection by imposing small-RNA-mediated silencing.,0
1059,22,Are piRNAs involved in gene silencing?,"A novel organelle, the piNG-body, in the nuage of Drosophila male germ cells is associated with piRNA-mediated gene silencing.",0
1059,23,Are piRNAs involved in gene silencing?,Proteins of the PIWI subfamily Aub and AGO3 associated with the germline-specific perinuclear granules (nuage) are involved in the silencing of retrotransposons and other selfish repetitive elements in the Drosophila genome.,0
1059,24,Are piRNAs involved in gene silencing?,"Telomeric retroelements HeT-A, TART and TAHRE, which are involved in telomere maintenance in Drosophila, are also the targets of piRNA-mediated silencing",0
1059,25,Are piRNAs involved in gene silencing?,Mechanism of the piRNA-mediated silencing of Drosophila telomeric retrotransposons.,0
1059,26,Are piRNAs involved in gene silencing?,Gene silencing mechanisms mediated by Aubergine piRNA complexes in Drosophila male gonad.,0
1059,27,Are piRNAs involved in gene silencing?,The epigenetic trans-silencing effect in Drosophila involves maternally-transmitted small RNAs whose production depends on the piRNA pathway and HP1.,0
1059,28,Are piRNAs involved in gene silencing?,"Here, we show that mutations in squash and zucchini, which are involved in the piwi-interacting RNA (piRNA) silencing pathway, strongly affect TSE",0
1059,29,Are piRNAs involved in gene silencing?,MVH in piRNA processing and gene silencing of retrotransposons,0
1059,30,Are piRNAs involved in gene silencing?,piRNA-mediated silencing in Drosophila germlines.,0
1059,31,Are piRNAs involved in gene silencing?,"These have shed light not only on the molecular mechanisms of gene silencing mediated by piRNAs and PIWI proteins, but also on their intriguing relationship with cellular genes that have been shown to be important for gametogenesis and fertility.",0
1059,32,Are piRNAs involved in gene silencing?,The most abundant piRNAs were those corresponding to antisense transcripts of Suppressor of Stellate [Su(Ste)] genes known to be involved in Stellate gene silencing,0
1059,33,Are piRNAs involved in gene silencing?,"To determine the capacity of piRNA-mediated silencing, we introduced reporter genes into Drosophila OSS cells, which express microRNAs (miRNAs) and piRNAs, and compared the Piwi pathway to the Argonaute pathway in gene regulation",0
1059,34,Are piRNAs involved in gene silencing?,"PIWI-interacting small non-coding RNAs (piRNAs) are genetic and epigenetic regulatory factors in germline cells, where they maintain genome stability, are involved in RNA silencing and regulate gene expression",0
1059,35,Are piRNAs involved in gene silencing?,The piNG-body contains ribonucleoprotein complexes involved in piRNA-silencing of genome repeats including transposons in premeiotic spermatocytes with aid of short piRNAs,0
1059,36,Are piRNAs involved in gene silencing?,"Our results show that the piRNA pathway can be used as a tool for sequence-specific gene silencing in germ cells and support the idea that the piRNA generating regions serve as traps for retrotransposons, enabling the host cell to generate piRNAs against active retrotransposons",0
1059,37,Are piRNAs involved in gene silencing?,"Recent studies have revealed not only the biogenesis of piRNAs and their roles in transposon silencing, but also the function of the Piwi-piRNA pathway in epigenetic and post-transcriptional regulation of gene expression",1
1059,38,Are piRNAs involved in gene silencing?,"A growing number of studies on piRNAs have investigated piRNA-mediated gene silencing, including piRNA biogenesis",0
1059,39,Are piRNAs involved in gene silencing?,"These have shed light not only on the molecular mechanisms of gene silencing mediated by piRNAs and PIWI proteins, but also on their intriguing relationship with cellular genes that have been shown to be important for gametogenesis and fertility",0
1059,40,Are piRNAs involved in gene silencing?,"Telomeric retroelements HeT-A, TART and TAHRE, which are involved in telomere maintenance in Drosophila, are also the targets of piRNA-mediated silencing.",0
1059,41,Are piRNAs involved in gene silencing?,MVH in piRNA processing and gene silencing of retrotransposons.,0
1059,42,Are piRNAs involved in gene silencing?,"To determine the capacity of piRNA-mediated silencing, we introduced reporter genes into Drosophila OSS cells, which express microRNAs (miRNAs) and piRNAs, and compared the Piwi pathway to the Argonaute pathway in gene regulation.",0
1059,43,Are piRNAs involved in gene silencing?,Therefore piRNA-mediated transcriptional mode of silencing is involved in the control of retrotransposon expression in the Drosophila germline.,0
1059,44,Are piRNAs involved in gene silencing?,Panoramix enforces piRNA-dependent cotranscriptional silencing.,0
1059,45,Are piRNAs involved in gene silencing?,The most abundant piRNAs were those corresponding to antisense transcripts of Suppressor of Stellate [Su(Ste)] genes known to be involved in Stellate gene silencing.,0
1059,46,Are piRNAs involved in gene silencing?,Our results indicate that piRNAs are involved in a posttranscriptional gene-silencing mechanism resulting in RNA nuclear accumulation.,0
3185,0,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?",Cat fleas (Ctenocephalides felis) carrying Rickettsia felis and Bartonella species in Hong Kong.,1
3185,1,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?", Morphological examination of 174 fleas from dogs and cats living in Hong Kong revealed only cat fleas (Ctenocephalides felis).,1
3185,2,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?","The main arthropod reservoir and vector is the cat flea, Ctenocephalides felis, yet more than 20 other species of fleas, ticks, and mites species have been reported to harbour R. felis.",1
3185,3,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?","The cat flea, Ctenocephalides felis, is currently the only known biological vector of R. felis; however, molecular evidence of R. felis in other species of fleas as well as in ticks and mites suggests a variety of arthropod hosts.",1
3185,4,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?",Rickettsia felis: from a rare disease in the USA to a common cause of fever in sub-Saharan Africa.Rickettsia felis is a spotted fever group rickettsia that has been definitely described in 2002.,0
3185,5,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?","Within the last 20 years, there have been a growing number of reports implicating R. felis as a human pathogen, parallel to the fast-growing reports of the worldwide detection of R. felis in arthropod hosts, mainly the cat flea Ctenocephalides felis felis.",0
3185,6,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?","The main arthropod reservoir and vector is the cat flea, Ctenocephalides felis, yet more than 20 other species of fleas, ticks, and mites species have been reported to harbour R. felis.",0
3185,7,"Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?","Another rickettsia, Rickettsia felis, found in cat fleas, Ctenocephalides felis, has also been implicated as a potential human pathogen.",1
1764,0,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Besides DBS and standard thalamotomy, novel surgical approaches for ET are on the horizon.",0
1764,1,Which diseases that can be treated using the focused ultrasound thalamotomy.,The development of MRI-guided focused ultrasound technique has been the new frontier of deep brain lesional therapies.,0
1764,2,Which diseases that can be treated using the focused ultrasound thalamotomy.,"132 A Randomized, Sham-Controlled Trial of Transcranial Magnetic Resonance-Guided Focused Ultrasound Thalamotomy Trial for the Treatment of Tremor-Dominant, Idiopathic Parkinson Disease.",1
1764,3,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Recently, transcranial magnetic resonance-guided focused ultrasound (MRgFUS) has been used to successfully perform thalamotomy for essential tremor.",0
1764,4,Which diseases that can be treated using the focused ultrasound thalamotomy.,"We designed a double-blinded, randomized controlled trial to investigate the effectiveness of MRgFUS thalamotomy in tremor-dominant PD.",0
1764,5,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Thalamotomy at the ventralis intermedius nucleus has been an effective treatment method for essential tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes afterwards are not clear.",0
1764,6,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Taking advantage of a non-cranium-opening MRI-guided focused ultrasound ablation technique, we investigated functional network changes due to a focal lesion.",0
1764,7,Which diseases that can be treated using the focused ultrasound thalamotomy.,Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes.,1
1764,8,Which diseases that can be treated using the focused ultrasound thalamotomy.,"CONCLUSIONS: Our results demonstrate that MRgFUS thalamotomy is a safe, effective and less-invasive surgical method for treating medication-refractory ET.",0
1764,9,Which diseases that can be treated using the focused ultrasound thalamotomy.,"OBJECT: The authors report different MRI patterns in patients with essential tremor (ET) or obsessive-compulsive disorder (OCD) after transcranial MR-guided focused ultrasound (MRgFUS) and discuss possible causes of occasional MRgFUS failure.METHODS: Between March 2012 and August 2013, MRgFUS was used to perform unilateral thalamotomy in 11 ET patients and bilateral anterior limb capsulotomy in 6 OCD patients; in all patients symptoms were refractory to drug therapy.",0
1764,10,Which diseases that can be treated using the focused ultrasound thalamotomy.,"To discern the neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex.",0
1764,11,Which diseases that can be treated using the focused ultrasound thalamotomy.,MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson's Disease.,0
1764,12,Which diseases that can be treated using the focused ultrasound thalamotomy.,Methods.,0
1764,13,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Seven PD patients, mean age 59.4 ± 9.8 years (range, 46-74) with a mean disease duration of 5.4 ± 2.8 years (range, 2-10) suffering from severe refractory tremor, underwent ventral intermediate nucleus thalamotomy using MRI guided focused ultrasound (MRgFUS), an innovative technology that enables noninvasive surgery.",0
1764,14,Which diseases that can be treated using the focused ultrasound thalamotomy.,Thalamotomy using MRgFUS is safe and effective in PD patients.,0
1764,15,Which diseases that can be treated using the focused ultrasound thalamotomy.,Evolution of Movement Disorders Surgery Leading to Contemporary Focused Ultrasound Therapy for Tremor.,0
1764,16,Which diseases that can be treated using the focused ultrasound thalamotomy.,A noninvasive approach using transcranial high-energy focused ultrasound has emerged for the treatment of intractable tremor.,0
1764,17,Which diseases that can be treated using the focused ultrasound thalamotomy.,This article describes the evolution of magnetic resonance-guided focused ultrasound for ventrolateral thalamotomy for tremor.,0
1764,18,Which diseases that can be treated using the focused ultrasound thalamotomy.,Thalamic connectivity in patients with essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging.,0
1764,19,Which diseases that can be treated using the focused ultrasound thalamotomy.,"PURPOSE: To use diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity of the ventralis intermedius nucleus of the thalamus and determine how DT imaging changes correlated with tremor changes after lesion inducement.MATERIALS AND METHODS: With institutional review board approval, and with prospective informed consent, 15 patients with medication-refractory essential tremor were enrolled in a HIPAA-compliant pilot study and were treated with transcranial MR imaging-guided focused ultrasound surgery targeting the ventralis intermedius nucleus of the thalamus contralateral to their dominant hand.",0
1764,20,Which diseases that can be treated using the focused ultrasound thalamotomy.,A pilot study of focused ultrasound thalamotomy for essential tremor.,1
1764,21,Which diseases that can be treated using the focused ultrasound thalamotomy.,"This preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor.",0
1764,22,Which diseases that can be treated using the focused ultrasound thalamotomy.,"CONCLUSIONS: In this pilot study, essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",0
1764,23,Which diseases that can be treated using the focused ultrasound thalamotomy.,MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study.,0
1764,24,Which diseases that can be treated using the focused ultrasound thalamotomy.,MR-guided focused ultrasound has been developed as a non-invasive means of generating precisely placed focal lesions.,0
1764,25,Which diseases that can be treated using the focused ultrasound thalamotomy.,We examined its application to the management of essential tremor,0
1764,26,Which diseases that can be treated using the focused ultrasound thalamotomy.,Four patients with chronic and medication-resistant essential tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus.,0
1764,27,Which diseases that can be treated using the focused ultrasound thalamotomy.,"INTERPRETATION: MR-guided focused ultrasound might be a safe and effective approach to generation of focal intracranial lesions for the management of disabling, medication-resistant essential tremor.",0
1764,28,Which diseases that can be treated using the focused ultrasound thalamotomy.,Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain.,0
1764,29,Which diseases that can be treated using the focused ultrasound thalamotomy.,"The goal of this study was to apply the new transcranial magnetic resonance imaging-guided focused ultrasound (tcMRgFUS) technology to perform noninvasive central lateral thalamotomies (CLTs) as a treatment for chronic neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain, tcMRgFUS CLT was proposed.",0
1764,30,Which diseases that can be treated using the focused ultrasound thalamotomy.,"CONCLUSIONS: The authors assert that tcMRgFUS represents a noninvasive, precise, and radiation-free neurosurgical technique for the treatment of neuropathic pain.",0
1764,31,Which diseases that can be treated using the focused ultrasound thalamotomy.,A new less invasive treatment of tremor using MR guided focused ultrasound has started and is promising.,0
1764,32,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Quality-of-life scores improved from 37% to 11% (P=0.001).CONCLUSIONS: In this pilot study, essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",0
1764,33,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Seven PD patients, mean age 59.4 ± 9.8 years (range, 46-74) with a mean disease duration of 5.4 ± 2.8 years (range, 2-10) suffering from severe refractory tremor, underwent ventral intermediate nucleus thalamotomy using MRI guided focused ultrasound (MRgFUS), an innovative technology that enables noninvasive surgery",0
1764,34,Which diseases that can be treated using the focused ultrasound thalamotomy.,"We hypothesized that all three would effectively treat the dominant hand and positively impact functional outcomes and quality of life as measured with the Clinical Rating Scale for Tremor and the Quality of Life in Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57), unilateral Vim DBS (n = 13), or unilateral focused ultrasound Vim thalamotomy (n = 15)",0
1764,35,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Quality-of-life scores improved from 37% to 11% (P=0.001).In this pilot study, essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",0
1764,36,Which diseases that can be treated using the focused ultrasound thalamotomy.,MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinsons Disease,0
1764,37,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Seven PD patients, mean age 59.4 ± 9.8 years (range, 46-74) with a mean disease duration of 5.4 ± 2.8 years (range, 2-10) suffering from severe refractory tremor, underwent ventral intermediate nucleus thalamotomy using MRI guided focused ultrasound (MRgFUS), an innovative technology that enables noninvasive surgery.",0
1764,38,Which diseases that can be treated using the focused ultrasound thalamotomy.,Transcranial magnetic resonance imaging-guided high-intensity focused ultrasound (MRgHIFU) is gaining attention as a potent substitute for surgical intervention in the treatment of neurologic disorders.,0
1764,39,Which diseases that can be treated using the focused ultrasound thalamotomy.,"To discern the neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex.",0
1764,40,Which diseases that can be treated using the focused ultrasound thalamotomy.,Focused ultrasound sonication destroyed tissues by focusing a high-energy beam on the ventralis intermedius nucleus of the thalamus.,0
1764,41,Which diseases that can be treated using the focused ultrasound thalamotomy.,BACKGROUND: Recent advances have enabled delivery of high-intensity focused ultrasound through the intact human cranium with magnetic resonance imaging (MRI) guidance.,0
1764,42,Which diseases that can be treated using the focused ultrasound thalamotomy.,"This preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor.",0
1764,43,Which diseases that can be treated using the focused ultrasound thalamotomy.,MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson's Disease.,0
1764,44,Which diseases that can be treated using the focused ultrasound thalamotomy.,"132 A Randomized, Sham-Controlled Trial of Transcranial Magnetic Resonance-Guided Focused Ultrasound Thalamotomy Trial for the Treatment of Tremor-Dominant, Idiopathic Parkinson Disease.",1
1764,45,Which diseases that can be treated using the focused ultrasound thalamotomy.,"In this pilot study, essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",0
1764,46,Which diseases that can be treated using the focused ultrasound thalamotomy.,A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.,1
1764,47,Which diseases that can be treated using the focused ultrasound thalamotomy.,MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study.,0
1764,48,Which diseases that can be treated using the focused ultrasound thalamotomy.,Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes.,0
1764,49,Which diseases that can be treated using the focused ultrasound thalamotomy.,Functional assessment and quality of life in essential tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy.,0
1764,50,Which diseases that can be treated using the focused ultrasound thalamotomy.,Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain.,0
1764,51,Which diseases that can be treated using the focused ultrasound thalamotomy.,"This is a retrospective study of medication-refractory essential tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57), unilateral Vim DBS (n = 13), or unilateral focused ultrasound Vim thalamotomy (n = 15).",0
1764,52,Which diseases that can be treated using the focused ultrasound thalamotomy.,"Twenty-one consecutive patients suffering from chronic (mean disease duration 29.9 years), therapy-resistant ET were treated with MRgFUS CTT.",0
914,0,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.,1
914,1,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,The loss of hypothalamic hypocretin/orexin (hcrt) producing neurons causes narcolepsy with cataplexy.,0
914,2,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,An autoimmune basis for the disease has long been suspected and recent results have greatly strengthened this hypothesis.,1
914,3,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,pointing towards processes such as molecular mimicry or bystander activation as crucial for disease development.,0
914,4,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,"Although no formal link can be established, the unusual characteristics of the reported cases and the striking temporal relationship suggests that narcolepsy may be the result of an autoimmune reaction triggered by H1N1 vaccination in susceptible individuals.",0
914,5,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,"Pandemrix vaccination is a precipitating factor for narcolepsy, especially in combination with HLA-DQB1*0602.",1
914,6,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,"Recently identified autoantibodies to Tribbles homologue 2 in some patients, as well as cases associated with H1N1 vaccination, support an autoimmune mechanism.",1
914,7,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,"n China, narcolepsy onset is highly correlated with seasonal and annual patterns of upper airway infections, including H1N1 influenza.",0
914,8,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,"In 2010, the peak seasonal onset of narcolepsy was phase delayed by 6 months relative to winter H1N1 infections, and the correlation was independent of H1N1 vaccination in the majority of the sample.",0
914,9,What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?,H1N1 vaccination was strongly associated with an increased risk of narcolepsy-cataplexy in both children and adults in France,1
126,0,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","The present metaanalysis was designed to assess the effect of DPP-4 inhibitors on blood lipids, verifying possible differences across compounds of this class.METHODS: An extensive search of Medline and the Cochrane Library (any date up to December 31, 2010, restricted to randomized clinical trials, published in English) was performed for all trials containing, in any field, the words ""sitagliptin,"" ""vildagliptin,"" ""saxagliptin,"" ""alogliptin,"" ""linagliptin,"" and/or ""dutogliptin.""",0
126,1,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Sitagliptin (MK- 0431), Saxagliptin, Melogliptin, Linagliptin (BI-1356), Dutogliptin, Carmegliptin, Alogliptin and Vildagliptin (LAF237).",0
126,2,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Additionally, linagliptin, vildagliptin and alogliptin are currently in phase III development in the United States while studies with another DPP IV inhibitor, dutogliptin, have been terminated (2).",0
126,3,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Testing the therapeutic equivalence of alogliptin, linagliptin, saxagliptin, sitagliptin or vildagliptin as monotherapy or in combination with metformin in patients with type 2 diabetes.",0
126,4,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","The aim of this review is to compare the clinical pharmacokinetics of available DPP-4 inhibitors (alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin) for the purpose of identifying potential selection preferences according to individual patient variables and co-morbidities.",0
126,5,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","The reader will gain detailed pharmacological and clinical information on alogliptin, dutogliptin and linagliptin and will learn how these DPP IV inhibitors may widen the whole drug class.",0
126,6,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","When considered in total, data reviewed in this report suggest that the best overall balance between potency and the clinical pharmacokinetic characteristics of distribution, metabolism and elimination may be observed with linagliptin followed closely by vildagliptin, saxagliptin, sitagliptin and alogliptin.",0
126,7,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Currently, there are four DPP IV inhibitors available in various countries-alogliptin, sitagliptin, vildagliptin and saxagliptin (1).",0
126,8,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","The various marketed or under developmental status, potential gliptins have been opted to build a pharmacophore model, e.g.",0
126,9,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Sitagliptin (MK- 0431), Saxagliptin, Melogliptin, Linagliptin (BI-1356), Dutogliptin, Carmegliptin, Alogliptin and Vildagliptin (LAF237)",0
126,10,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Currently, there are four DPP IV inhibitors available in various countries-alogliptin, sitagliptin, vildagliptin and saxagliptin (1)",0
126,11,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Additionally, linagliptin, vildagliptin and alogliptin are currently in phase III development in the United States while studies with another DPP IV inhibitor, dutogliptin, have been terminated (2)",0
126,12,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Recently, the SAVOR TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus--Thrombolysis in Myocardial Infarction-53) reported a significant increase in the risk of hospitalizations for heart failure in patients treated with saxagliptin in comparison with placebo",0
126,13,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Of these, two have been approved for clinical use in the United States: sitagliptin and saxagliptin",0
126,14,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes",0
126,15,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","To investigate the long-term safety and efficacy of empagliflozin, a sodium glucose cotransporter 2 inhibitor; sitagliptin; and metformin in patients with type 2 diabetes",0
126,16,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","METHODS:  DATA SOURCES: an extensive Medline, Embase and Cochrane Database search for 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin' and 'dutogliptin' was performed up to 1 March 2013.",0
126,17,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","RESEARCH DESIGN AND METHODS: An extensive Medline and Embase search for 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin' was performed, collecting all randomized clinical trials on humans up to March 1, 2011.",0
126,18,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","METHODS: We conducted a search on MEDLINE, Embase and Cochrane Collaborative database for randomized controlled trials (RCTs) of DPP-4 inhibitors and metformin as initial combination therapy or as monotherapy in patients with T2DM by the end of December 2012, using the key words 'alogliptin', 'dutogliptin', 'linagliptin', 'saxagliptin', 'sitagliptin', 'vildagliptin' and 'metformin'.",0
126,19,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Sitagliptin (MK- 0431), Saxagliptin, Melogliptin, Linagliptin (BI-1356), Dutogliptin, Carmegliptin, Alogliptin and Vildagliptin (LAF237).",0
126,20,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Aim of the present meta-analysis is the systematic collection and synthesis of information on treatment-emergent cases of acute heart failure described in randomized clinical trials with DPP4.DATA SOURCES: An extensive Medline, Embase, and Cochrane Database search for ""vildagliptin"", ""sitagliptin"", ""saxagliptin"", ""alogliptin"", ""linagliptin"", and ""dutogliptin"" was performed, collecting all randomized clinical trials on humans up to October 1st, 2013.",0
126,21,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy results.",0
126,22,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","The dipeptidyl peptidase-4 (DPP-4) inhibitors linagliptin, sitagliptin, saxagliptin, vildagliptin and alogliptin are being developed and have been approved for the treatment of type-2 diabetes.",1
126,23,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","The objective of this model-based meta-analysis was to describe the time course of HbA1c response after dosing with alogliptin (ALOG), saxagliptin (SAXA), sitagliptin (SITA), or vildagliptin (VILD).",0
126,24,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?",Discovery of highly potent DPP-4 inhibitors by hybrid compound design based on linagliptin and alogliptin.,0
126,25,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","The dipeptidylpeptidase-IV inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses.",0
126,26,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","In conclusion, BI 1356 inhibited DPP-4 more effectively than vildagliptin, sitagliptin, saxagliptin, and alogliptin and has the potential to become the first truly once-a-day DPP-4 inhibitor for the treatment of type 2 diabetes.",0
126,27,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?",Highly potent DPP-4 inhibitors have been identified by hybrid compound design based on linagliptin and alogliptin.,0
126,28,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","AIM: We assessed the efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors vildagliptin, sitagliptin, saxagliptin and alogliptin to reach the haemoglobin HbA1c target of <7% in people with type 2 diabetes.",1
126,29,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Whether the DPP-IV inhibitors sitagliptin, vildagliptin or saxagliptin impair immune responses is, however, currently unknown.",0
126,30,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","OBJECTIVE: To assess the efficacy and safety of DPP-4 inhibitors, including sitagliptin, saxagliptin, vildagliptin, and linagliptin, in type 2 diabetes.",0
126,31,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Given as monotherapy, linagliptin, sitagliptin, and vildagliptin (but not saxagliptin) met the equivalence criterion when compared with one another.",0
126,32,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Given in combination with metformin, linagliptin, saxagliptin, sitagliptin, and vildagliptin showed an equivalent effect whereas alogliptin did not satisfy the equivalence criterion.",0
126,33,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","an extensive Medline, Embase and Cochrane Database search for 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin' and 'dutogliptin' was performed up to 1 March 2013.",1
126,34,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","An extensive Medline and Embase search for 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin' was performed, collecting all randomized clinical trials on humans up to March 1, 2011.",0
126,35,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","An extensive Medline, Embase, and Cochrane Database search for ""vildagliptin"", ""sitagliptin"", ""saxagliptin"", ""alogliptin"", ""linagliptin"", and ""dutogliptin"" was performed, collecting all randomized clinical trials on humans up to October 1st, 2013.",0
126,36,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?",Saxagliptin.,0
126,37,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?",Vildagliptin.,0
126,38,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","an extensive Medline, Embase and Cochrane Database search for 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin' and 'dutogliptin' was performed up to 1 March 2013.",0
126,39,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","An extensive Medline and Embase search for 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin' was performed, collecting all randomized clinical trials on humans up to March 1, 2011.",0
126,40,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","An extensive Medline, Embase, and Cochrane Database search for ""vildagliptin"", ""sitagliptin"", ""saxagliptin"", ""alogliptin"", ""linagliptin"", and ""dutogliptin"" was performed, collecting all randomized clinical trials on humans up to October 1st, 2013.",0
126,41,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","the words ""sitagliptin,"" ""vildagliptin,"" ""saxagliptin,"" ""alogliptin,"" ""linagliptin,"" and/or ""dutogliptin.""",1
126,42,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Completed but unpublished trials were identified through a search of the ClinicalTrials.gov website,",0
126,43,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Sitagliptin (MK- 0431), Saxagliptin, Melogliptin, Linagliptin (BI-1356), Dutogliptin, Carmegliptin, Alogliptin and Vildagliptin (LAF237).",0
126,44,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Of these, two have been approved for clinical use in the United States: sitagliptin and saxagliptin.",0
126,45,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Additionally, linagliptin, vildagliptin and alogliptin are currently in phase III development in the United States while studies with another DPP IV inhibitor, dutogliptin, have been terminated (2).",0
126,46,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","We conducted a search on MEDLINE, Embase and Cochrane Collaborative database for randomized controlled trials (RCTs) of DPP-4 inhibitors and metformin as initial combination therapy or as monotherapy in patients with T2DM by the end of December 2012, using the key words 'alogliptin', 'dutogliptin', 'linagliptin', 'saxagliptin', 'sitagliptin', 'vildagliptin' and 'metformin'.",0
126,47,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Given as monotherapy, linagliptin, sitagliptin, and vildagliptin (but not saxagliptin) met the equivalence criterion when compared with one another.",0
126,48,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Given in combination with metformin, linagliptin, saxagliptin, sitagliptin, and vildagliptin showed an equivalent effect whereas alogliptin did not satisfy the equivalence criterion.",0
126,49,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Additionally, linagliptin, vildagliptin and alogliptin are currently in phase III development in the United States while studies with another DPP IV inhibitor, dutogliptin, have been terminated (2).",0
126,50,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?",Alogliptin was approved for use in Japan under the trade name Nesina® in April 2010 (3).,0
126,51,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Any DPP-4 inhibitor (vildagliptin, sitagliptin, saxagliptin, linagliptin or alogliptin).",1
126,52,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","An extensive search of Medline and the Cochrane Library (any date up to December 31, 2010, restricted to randomized clinical trials, published in English) was performed for all trials containing, in any field, the words ""sitagliptin,"" ""vildagliptin,"" ""saxagliptin,"" ""alogliptin,"" ""linagliptin,"" and/or ""dutogliptin.""",0
126,53,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Completed but unpublished trials were identified through a search of the ClinicalTrials.gov website, using the same keywords as above.",0
126,54,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","A systematic review and meta-analysis of randomised controlled trials (RCTs) of DPP-4 inhibitors (vildagliptin, sitagliptin, saxagliptin, linagliptin and alogliptin) on HbA1c were conducted.",0
126,55,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Several clinical trials have studied the addition of GLP-1 receptor agonists [exenatide BID (twice daily), lixisenatide, albiglutide] or DPP-4 inhibitors (vildagliptin, sitagliptin, saxagliptin, alogliptin, linagliptin) to ongoing insulin therapy or adding insulin to ongoing therapy with a GLP-1 receptor agonist (liraglutide).",0
126,56,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Testing the therapeutic equivalence of alogliptin, linagliptin, saxagliptin, sitagliptin or vildagliptin as monotherapy or in combination with metformin in patients with type 2 diabetes.",0
126,57,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","Additionally, linagliptin, vildagliptin and alogliptin are currently in phase III development in the United States while studies with another DPP IV inhibitor, dutogliptin, have been terminated (2).",0
126,58,"What are 'vildagliptin', 'sitagliptin', 'saxagliptin', 'alogliptin', 'linagliptin', and 'dutogliptin'?","This review summarizes the available data on drug-drug interactions reported in the literature for these five DDP-4 inhibitors: sitagliptin, vildagliptin, saxagliptin, alogliptin and linagliptin.",0
260,0,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval.,0
260,1,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,Magnetic sphincter augmentation (MSA) of the gastroesophageal junction with the LINX Reflux Management System is an alternative to fundoplication for gastroesophageal reflux disease (GERD) that was approved by the U.S. Food and Drug Administration (FDA) in March 2012.,0
260,2,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,Is the LINX reflux management system an effective treatment for gastro-oesophageal reflux disease?,0
260,3,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,BACKGROUND: Laparoscopic magnetic sphincter augmentation (MSA) with the LINX device is a promising new therapy for the treatment of gastroesophageal reflux disease (GERD).,0
260,4,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,"Other nonmedical therapies include, the Stretta procedure, transoral incisionless fundoplication, and the magnetic sphincter augmentation device (LINX).",0
260,5,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux.,0
260,6,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.," The LINX(®) Reflux Management System (Torax Medical, St. Paul, MN, USA) is designed to provide a permanent solution to GERD by augmenting the sphincter barrier with a standardized, reproducible laparoscopic procedure that does not alter gastric anatomy and is easily reversible.",1
260,7,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,LINX(™) Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease.,0
260,8,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,The LINX(™) Reflux Management System (Torax Medical) is designed to provide a permanent solution to GERD by augmenting the physiologic function of the sphincter barrier with a simple and reproducible laparoscopic procedure that does not alter gastric anatomy and can be easily reversed if necessary.,1
260,9,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,The Linx sphincter augmentation device has been developed to address this gap with improvement of the barrier function of LES and reversible design if necessary.,0
260,10,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.," METHODS: A sphincter augmentation device (LINX Reflux Management System; Torax Medical, Shoreview, MN), designed to prevent reflux due to abnormal opening of the lower esophageal sphincter (LES), was laparoscopically implanted at the gastroesophageal junction in 44 patients.",1
260,11,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,"Specific topics include reviews of long-term outcomes after laparoscopic antireflux surgery, the use of surgically placed implantable device for LES augmentation (Linx), the use of mesh for hiatal hernioplasty, and prone and nonthoracic approaches to minimally invasive esophagectomy.",0
260,12,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,LINX( ) Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease.,0
260,13,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,"METHODS: A sphincter augmentation device (LINX Reflux Management System; Torax Medical, Shoreview, MN), designed to prevent reflux due to abnormal opening of the lower esophageal sphincter (LES), was laparoscopically implanted at the gastroesophageal junction in 44 patients.",1
260,14,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,BACKGROUND: Sphincter augmentation with the LINX� Reflux Management System is a surgical option for patients with chronic gastroesophageal disease (GERD) and an inadequate response to proton pump inhibitors (PPIs).,0
260,15,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,"A sphincter augmentation device (LINX Reflux Management System; Torax Medical, Shoreview, MN), designed to prevent reflux due to abnormal opening of the lower esophageal sphincter (LES), was laparoscopically implanted at the gastroesophageal junction in 44 patients",1
260,16,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,"Sphincter augmentation with the LINX Reflux Management System provided long-term clinical benefits with no safety issues, as demonstrated by reduced esophageal acid exposure, improved GERD-related quality of life, and cessation of dependence on PPIs, with minimal side effects and no safety issues",0
260,17,Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.,The limitations of current therapy for GERD have encouraged a search for more effective treatment.The Linx sphincter augmentation device has been developed to address this gap with improvement of the barrier function of LES and reversible design if necessary.,0
1326,0,What is the ubiquitin proteome?,Mass spectrometry now allows high throughput approaches for the identification of the thousands of ubiquitinated proteins and of their ubiquitination sites.,1
1326,1,What is the ubiquitin proteome?,we used Tandem repeated Ubiquitin Binding Entities (TUBEs) under non-denaturing conditions followed by mass spectrometry analysis to study global ubiquitylation events that may lead to the identification of potential drug targets.,1
1326,2,What is the ubiquitin proteome?,To study the ubiquitin proteome we have established an immunoaffinity purification method for the proteomic analysis of endogenously ubiquitinated protein complexes.,1
2294,0,What is the relationship of fyn kinase and tau?,"Fyn is an attractive target for AD therapeutics, not only based on its activation by Aβ via cellular prion protein but also due to its known interaction with tau, uniquely linking the two key pathologies in AD.",1
2294,1,What is the relationship of fyn kinase and tau?,"This PrPC-Aβo complex activates Fyn kinase which, in turn, hyperphosphorylates tau (P-Tau) resulting in synaptic dysfunction, neuronal loss and cognitive deficits.",1
51,0,Is peripheral neuroepithelioma related to Ewing sarcoma?,"The term ""small round-cell tumor"" describes a group of highly aggressive malignant tumors composed of relatively small and monotonous undifferentiated cells with high nuclear to cytoplasmic ratios.",0
51,1,Is peripheral neuroepithelioma related to Ewing sarcoma?,"This group includes Ewing's sarcoma (ES), peripheral neuroepithelioma (aka, primitive neuroectodermal tumor or extraskeletal ES), peripheral neuroblastoma (""classic-type""), rhabdomyosarcoma, desmoplastic small round-cell tumor, lymphoma, leukemia, small-cell osteosarcoma, small-cell carcinoma (either undifferentiated or neuroendocrine), olfactory neuroblastoma, cutaneous neuroendocrine carcinoma (aka, Merkel-cell carcinoma), small-cell melanoma, and mesenchymal chondrosarcoma.",0
51,2,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Their clinical presentations often overlap, thus making a definitive diagnosis problematic in some cases",0
51,3,Is peripheral neuroepithelioma related to Ewing sarcoma?,"AIMS: To retrospectively study the DNA content in a series of childhood Ewing Family Tumors (EFT), and to investigate its prognostic value.",0
51,4,Is peripheral neuroepithelioma related to Ewing sarcoma?,"METHODS: The study was performed on a series of 27 EFTs (osseous Ewing's sarcoma, 18 cases; extraosseous Ewing's sarcoma, 2; peripheral neuroepithelioma, 4; Askin Rosai tumors, 3",0
51,5,Is peripheral neuroepithelioma related to Ewing sarcoma?,To improve the prognosis of patients with poor-risk peripheral primitive neuroectodermal tumors (pPNETs; including peripheral neuroepithelioma and Ewing's sarcoma),0
51,6,Is peripheral neuroepithelioma related to Ewing sarcoma?,Large group of small-round-cell tumours of soft tissues and bone represents a complex diagnostic problem for the pathologists.,0
51,7,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Neuronal nature of many tumours from this group is proven by means of new methods--immunophenotypic analysis, tissue culture, cytogenetics.",0
51,8,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Peripheral neuroepithelioma, Ewing tumour, primitive neuroectodermal tumour (PNET), Askin tumour belong to these neoplasms",0
51,9,Is peripheral neuroepithelioma related to Ewing sarcoma?,Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma.,1
51,10,Is peripheral neuroepithelioma related to Ewing sarcoma?,An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms,0
51,11,Is peripheral neuroepithelioma related to Ewing sarcoma?,Ewing's sarcoma of bone (ESB) and peripheral neuroepithelioma (PN) are frequently considered to be different tumors.,1
51,12,Is peripheral neuroepithelioma related to Ewing sarcoma?,Some researchers have suggested that PN is morphologically a neuroectodermal Ewing's sarcoma.,0
51,13,Is peripheral neuroepithelioma related to Ewing sarcoma?,We sought to determine the extent of neuroectodermal features in conventional ESB on direct patient material (25 cases) and to compare these tumors with a similar group of readily diagnosed PNs (10 cases),0
51,14,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Neuroectodermal antigens (neuron-specific enolase, Leu-7 [HNK-1], neurofilament 200 kd, and S100) were found in nine of 10 cases of PN and in 17 of 25 cases of ESB",0
51,15,Is peripheral neuroepithelioma related to Ewing sarcoma?,"These data support the concept that ESB and PN are both peripheral primitive neuroectodermal neoplasms, differing only in extent of neuroectodermal phenotype and morphological differentiation",1
51,16,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Besides these antigenic features, Ewing sarcoma cells are characterized by a specific t(11;22)(q24;q12) translocation also observed in neuroepithelioma, a neuroectodermal tumor, suggesting a possible evolutionary related origin.",0
51,17,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Ewings sarcoma (ES) and peripheral neuroepithelioma (PN) are closely related tumors, and it can be difficult to distinguish them from other small-round-cell tumors (SRCTs).",0
51,18,Is peripheral neuroepithelioma related to Ewing sarcoma?,The presence of this translocation in Ewing sarcoma and peripheral primitive neuroectodermal tumor has been taken as evidence that these two tumors are related.,1
51,19,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Besides these antigenic features, Ewing sarcoma cells are characterized by a specific t(11;22)(q24;q12) translocation also observed in neuroepithelioma, a neuroectodermal tumor, suggesting a possible evolutionary related origin.",0
51,20,Is peripheral neuroepithelioma related to Ewing sarcoma?,Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma.,0
51,21,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Ewing's sarcoma (ES) and peripheral neuroepithelioma (PN) are related tumors, possibly of neural crest origin, which are cytogenetically characterized by the specific translocation t(11;22)(q24;q12).",0
51,22,Is peripheral neuroepithelioma related to Ewing sarcoma?,Ewing's sarcoma/peripheral primitive neuroectodermal tumors (ES/pPNET) are a group of small round cell sarcomas that show varying degrees of neuroectodermal differentiation characterized by translocation involving the EWS gene,0
51,23,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Ewing's sarcoma (ES) and peripheral neuroepithelioma (PN) are closely related tumors, and it can be difficult to distinguish them from other small-round-cell tumors (SRCTs)",0
51,24,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Ewing's sarcoma (ES) and peripheral neuroepithelioma (PN) are related tumors, possibly of neural crest origin, which are cytogenetically characterized by the specific translocation t(11;22)(q24;q12)",0
51,25,Is peripheral neuroepithelioma related to Ewing sarcoma?,"This genetical similarity further supports a nosological concept according to which Askin's tumour, Ewing's sarcoma and peripheral neuroepithelioma represent phenotypic variations of the same tumour, namely the peripheral primitive neuroectodermal tumour.",1
51,26,Is peripheral neuroepithelioma related to Ewing sarcoma?,"Besides these antigenic features, Ewing sarcoma cells are characterized by a specific t(11;22)(q24;q12) translocation also observed in neuroepithelioma, a neuroectodermal tumor, suggesting a possible evolutionary related origin",0
3300,0,How is Slc22a3 imprinted?,"Two novel imprinted genes, Slc22a2 and Slc22a3 are described here that lie 110 and 155 kb 3' to Igf2r and that are not overlapped by the Air transcript but are regulated by the Igf2r-ICE, as previously shown for Igf2r.",1
3300,1,How is Slc22a3 imprinted?,"A bidirectional silencer for a 400-kilobase region that contains three imprinted, maternally expressed protein-coding genes (Igf2r/Slc22a2/Slc22a3) has been shown by targeted deletion to be located in a sequence of 3.7 kilobases, which also contains the promoter for the imprinted, paternally expressed non-coding Air RNA",1
3300,2,How is Slc22a3 imprinted?,"Silencing of the paternal allele of three imprinted genes (Igf2r, Slc22a2 and Slc22a3) requires cis expression of the Air RNA",1
3300,3,How is Slc22a3 imprinted?," These results exclude a role for the Igf2r promoter and for transcriptional overlap between Igf2r and Air in silencing Air, Slc22a2 and Slc22a3",0
3300,4,How is Slc22a3 imprinted?,Epigenetic mechanisms restrict the expression of imprinted genes to one parental allele in diploid cells.,1
3300,5,How is Slc22a3 imprinted?,"At the Igf2r/Air imprinted cluster on mouse chromosome 17, paternal-specific expression of the Air noncoding RNA has been shown to silence three genes in cis: Igf2r, Slc22a2, and Slc22a3.",1
3300,6,How is Slc22a3 imprinted?,"Air is required for allele-specific silencing of the cis-linked Slc22a3, Slc22a2, and Igf2r genes in mouse placenta.",0
3300,7,How is Slc22a3 imprinted?,We show that Air interacts with the Slc22a3 promoter chromatin and the H3K9 histone methyltransferase G9a in placenta.,0
3300,8,How is Slc22a3 imprinted?,Air accumulates at the Slc22a3 promoter in correlation with localized H3K9 methylation and transcriptional repression,0
3300,9,How is Slc22a3 imprinted?,"One imprinted cluster includes the maternally expressed Igf2r, Slc22a2, and Slc22a3 genes and the paternally expressed long non-coding RNA (lncRNA) Airn.",0
3300,10,How is Slc22a3 imprinted?,"Our study thus provides the best candidate factor for establishing paternal silencing of marsupial IGF2R without transcriptional overlap, which is distinct from the Igf2r silencing mechanism of Airn, but which may be analogous to the mode of action for the flanking Slc22a2 and Slc22a3 gene silencing in the mouse placenta.",0
3497,0,List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain,Noncoding RNAs (ncRNAs) play increasingly appreciated gene-regulatory roles.,0
3497,1,List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain,"Here, we describe a regulatory network centered on four ncRNAs-a long ncRNA, a circular RNA, and two microRNAs-using gene editing in mice to probe the molecular consequences of disrupting key components of this network.",0
3497,2,List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain,The long ncRNA Cyrano uses an extensively paired site to miR-7 to trigger destruction of this microRNA.,1
3497,3,List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain,"Cyrano-directed miR-7 degradation is much more effective than previously described examples of target-directed microRNA degradation, which come primarily from studies of artificial and viral RNAs.",1
3497,4,List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain,"By reducing miR-7 levels, Cyrano prevents repression of miR-7-targeted mRNAs and enables accumulation of Cdr1as, a circular RNA known to regulate neuronal activity.",1
3497,5,List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain,"Without Cyrano, excess miR-7 causes cytoplasmic destruction of Cdr1as in neurons, in part through enhanced slicing of Cdr1as by a second miRNA, miR-671.",1
3497,6,List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain,"Thus, several types of ncRNAs can collaborate to establish a sophisticated regulatory network.",1
3547,0,What are the most common side effects of amantadine ER?,"The most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema.",1
3925,0,Are the major royal jelly proteins similar to the yellow proteins?,"Major royal jelly proteins (named MRJP1-5) of honeybee (Apis mellifera), yellow proteins of Drosophila, together with putative proteins found in several bacteria, form a protein family termed the MRJP/yellow family.",1
3925,1,Are the major royal jelly proteins similar to the yellow proteins?,Analysis of Drosophila yellow-B cDNA reveals a new family of proteins related to the royal jelly proteins in the honeybee,1
3925,2,Are the major royal jelly proteins similar to the yellow proteins?,he Yellow proteins are related to the Royal Jelly proteins and have no relatives in other non-insect metazoan species.,1
3159,0,What is the price of KYMRIAH treatment in 2019?,"At the time of the writing of this article, there are two CAR T cells available, Kymriah, produced by Novrtis with a price tag of US$475,000 and Yescarta produced by Gilead Pharmaceuticals with a price tag of US$373,000, neither price including the required hospital admission in order to administer the agent in addition to potential treatment of side effects.",1
1320,0,Which disease is linked to mutations within BRAG1?,Mutations in BRAG1 have been identified in families with X-linked intellectual disability (XLID),1
4052,0,Is SLIC-CAGE used for quantification of translation?,Transcription Start Site Mapping Using Super-low Input Carrier-CAGE.,0
4052,1,Is SLIC-CAGE used for quantification of translation?,SLIC-CAGE: high-resolution transcription start site mapping using nanogram-levels of total RNA.,0
4052,2,Is SLIC-CAGE used for quantification of translation?,Cap analysis of gene expression (CAGE) is a methodology for genome-wide quantitative mapping of mRNA 5' ends to precisely capture transcription start sites at a single nucleotide resolution.,0
4052,3,Is SLIC-CAGE used for quantification of translation?,"In combination with high-throughput sequencing, CAGE has revolutionized our understanding of the rules of transcription initiation, led to discovery of new core promoter sequence features, and discovered transcription initiation at enhancers genome-wide.",0
4052,4,Is SLIC-CAGE used for quantification of translation?,"The biggest limitation of CAGE is that even the most recently improved version (nAnT-iCAGE) still requires large amounts of total cellular RNA (5 µg), preventing its application to scarce biological samples such as those from early embryonic development or rare cell types.",0
4052,5,Is SLIC-CAGE used for quantification of translation?,"Here, we present SLIC-CAGE, a Super-Low Input Carrier-CAGE approach to capture 5' ends of RNA polymerase II transcripts from as little as 5-10 ng of total RNA.",0
4052,6,Is SLIC-CAGE used for quantification of translation?,"This dramatic increase in sensitivity is achieved by specially designed, selectively degradable carrier RNA.",0
4052,7,Is SLIC-CAGE used for quantification of translation?,"We demonstrate the ability of SLIC-CAGE to generate data for genome-wide promoterome with 1000-fold less material than required by existing CAGE methods, by generating a complex, high-quality library from mouse embryonic day 11.5 primordial germ cells.",0
4052,8,Is SLIC-CAGE used for quantification of translation?,Cap analysis of gene expression (CAGE) is a method used for single-nucleotide resolution detection of RNA polymerase II transcription start sites (TSSs).,1
4052,9,Is SLIC-CAGE used for quantification of translation?,Accurate detection of TSSs enhances identification and discovery of core promoters.,1
4052,10,Is SLIC-CAGE used for quantification of translation?,"In addition, active enhancers can be detected through signatures of bidirectional transcription initiation.",1
4052,11,Is SLIC-CAGE used for quantification of translation?,Described here is a protocol for performing super-low input carrier-CAGE (SLIC-CAGE).,1
4052,12,Is SLIC-CAGE used for quantification of translation?,"This SLIC adaptation of the CAGE protocol minimizes RNA losses by artificially increasing the RNA amount through use of an in vitro transcribed RNA carrier mix that is added to the sample of interest, thus enabling library preparation from nanogram-amounts of total RNA (i.e., thousands of cells).",1
4052,13,Is SLIC-CAGE used for quantification of translation?,"The carrier mimics the expected DNA library fragment length distribution, thereby eliminating biases that could be caused by the abundance of a homogenous carrier.",0
4052,14,Is SLIC-CAGE used for quantification of translation?,"In the last stages of the protocol, the carrier is removed through degradation with homing endonucleases and the target library is amplified.",0
4052,15,Is SLIC-CAGE used for quantification of translation?,"The target sample library is protected from degradation, as the homing endonuclease recognition sites are long (between 18 and 27 bp), making the probability of their existence in the eukaryotic genomes very low.",0
4052,16,Is SLIC-CAGE used for quantification of translation?,The end result is a DNA library ready for next-generation sequencing.,0
4052,17,Is SLIC-CAGE used for quantification of translation?,"All steps in the protocol, up to sequencing, can be completed within 6 days.",0
4052,18,Is SLIC-CAGE used for quantification of translation?,"The carrier preparation requires a full working day; however, it can be prepared in large quantities and kept frozen at -80 °C.",0
4052,19,Is SLIC-CAGE used for quantification of translation?,"Once sequenced, the reads can be processed to obtain genome-wide single-nucleotide resolution TSSs.",0
4052,20,Is SLIC-CAGE used for quantification of translation?,"TSSs can be used for core promoter or enhancer discovery, providing insight into gene regulation.",0
4052,21,Is SLIC-CAGE used for quantification of translation?,"Once aggregated to promoters, the data can also be used for 5'-centric expression profiling.",0
4033,0,What is Progeria?,Hutchinson-Gilford Progeria Syndrome (HGPS) is a segmental premature aging disease causing patient death by early teenage years from cardiovascular dysfunction,1
4033,1,What is Progeria?,Hutchinson Gilford progeria syndrome (HGPS) is a devastating accelerated aging disease caused by LMNA gene mutation.,1
4033,2,What is Progeria?,"Hutchinson-Gilford progeria syndrome is a rare genetic disorder, characterized by progressive premature aging and early death in the first or second decade of life, usually secondary to cardiovascular events (myocardial infarction and stroke).",1
4033,3,What is Progeria?,Hutchinson-Gilford Progeria Syndrome (HGPS) is a devastating premature aging disease.,1
4033,4,What is Progeria?,"Hutchinson-Gilford Progeria Syndrome (HGPS) is a premature aging disorder caused by mutations in LMNA, which encodes the nuclear scaffold proteins lamin A and C. In HGPS and related progerias, processing of prelamin A is blocked at a critical step mediated by the zinc metalloprotease ZMPSTE24.",1
4033,5,What is Progeria?,BACKGROUND: Progeria is a rare segmental premature aging disease with significant skeletal abnormalities.,0
4033,6,What is Progeria?,"Progeria is a rare, genetically determined condition characterized by accelerated aging in children.",0
4033,7,What is Progeria?,"Werner syndrome, also called adult progeria, is a heritable autosomal recessive human disorder characterized by the premature onset of numerous age-related diseases including juvenile cataracts, dyslipidemia, diabetes mellitus (DM), osteoporosis, atherosclerosis, and cancer.",0
4033,8,What is Progeria?,Werner sy,0
4033,9,What is Progeria?,"Werner syndrome (i.e., adult progeria) is a rare autosomal recessive disorder caused by mutations of the WRN gene, which is characterized by the premature appearance of features associated with normal aging and cancer predisposition.",0
4033,10,What is Progeria?,Patie,0
4033,11,What is Progeria?,"Werner's syndrome (adult progeria) is a rare autosomal recessive condition characterized mainly by a characteristic habitus (short stature, light body weight) scleroderma like changes of the limbs and premature aging.",0
4033,12,What is Progeria?,Chronic,0
4033,13,What is Progeria?,"The Hutchinson-Gilford syndrome or progeria is a rare autosomal dominant syndrome characterized by premature aging and involvement of internal systems, such as the circulatory and locomotor.",0
4033,14,What is Progeria?,Th,0
4033,15,What is Progeria?,The glycosylation of proteins in fibroblasts from people with the premature ageing disease Hutchinson-Gilford Progeria Syndrome (progeria) was investigated.,0
4033,16,What is Progeria?,"Hutchinson-Gilford progeria syndrome (HGPS, progeria) is an extremely rare premature aging disorder affecting children, with a disease incidence of ∼1 in 18 million individuals.",0
4033,17,What is Progeria?,INTRODUCTION: Progeria also known as Hutchinson Gilford Progeria Syndrome (HGPS) (MIM176670) is a very uncommon fatal genetic untimely aging syndrome.,0
4033,18,What is Progeria?,"Hutchinson-Gilford progeria syndrome (HGPS), a rare disease that results in what appears to be premature aging, is caused by the production of a mutant form of prelamin A known as progerin.",0
4033,19,What is Progeria?,"Although children with progeria have the appearance of premature aging or senility, the term is misleading because reported cases of progeria have not manifested most physical or biochemical aspects of old age.",0
4033,20,What is Progeria?,"The Hutchinson-Gilford syndrome or progeria is a rare autosomal dominant syndrome characterized by premature aging and involvement of internal systems, such as the circulatory and locomotor.",0
4033,21,What is Progeria?,"The basic genetic defect in the Hutchinson-Gilford Progeria Syndrome (progeria), a premature aging syndrome, is unknown.",0
4033,22,What is Progeria?,Progeria: a rare genetic premature ageing disorder.,0
4033,23,What is Progeria?,Progeria is characterized by clinical features that mimic premature ageing.,0
4033,24,What is Progeria?,Progeria is a rare fatal genetic condition characterized by an appearance of accelerated aging in children.,0
4033,25,What is Progeria?,Progeria is a rare and peculiar combination of dwarfism and premature aging.,0
4033,26,What is Progeria?,"Progeria is a rare autosomal dominant genetic disorder of premature aging characterized by marked growth retardation and specific, progressive, premature senescent changes of the skin and other tissues.",0
4033,27,What is Progeria?,"Progeria is an autosomal dominant, premature aging syndrome.",0
4033,28,What is Progeria?,Progeria is a rare genetic disease with striking features that resemble accelerated aging.,0
4033,29,What is Progeria?,"Progeria, also known as Hutchinson-Gilford syndrome, is an extremely rare, severe genetic condition wherein symptoms resembling aspects of aging are manifested at an early age.",0
4033,30,What is Progeria?,Progeria: a human-disease model of accelerated aging.,0
4033,31,What is Progeria?,"Progeria, or Hutchinson-Gilford syndrome, is a rare genetic disease, characterized by several clinical features that develop in childhood, in particular, an accelerated aging aspect.",0
2408,0,Was saracatinib being considered as a treatment for Alzheimer's disease in November 2017?,"A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease.",1
2408,1,Was saracatinib being considered as a treatment for Alzheimer's disease in November 2017?,"Herein, we present a Phase Ib trial of the repurposed investigational drug AZD0530, a Src family kinase inhibitor specific for Fyn and Src kinase, for the treatment of patients with mild-to-moderate AD.",1
2408,2,Was saracatinib being considered as a treatment for Alzheimer's disease in November 2017?,"The study was a 4-week Phase Ib multiple ascending dose, randomized, double-blind, placebo-controlled trial of AZD0530 in AD patients with Mini-Mental State Examination (MMSE) scores ranging from 16 to 26.",1
2408,3,Was saracatinib being considered as a treatment for Alzheimer's disease in November 2017?,"A total of 24 subjects were recruited in three sequential groups, with each randomized to receive oral AZD0530 at doses of 50 mg, 100 mg, 125 mg, or placebo daily for 4 weeks.",0
2408,4,Was saracatinib being considered as a treatment for Alzheimer's disease in November 2017?,"AZD0530 is reasonably safe and well tolerated in patients with mild-to-moderate AD, achieving substantial central nervous system penetration with oral dosing at 100-125 mg.",1
2408,5,Was saracatinib being considered as a treatment for Alzheimer's disease in November 2017?,"Targeting Fyn kinase may be a promising therapeutic approach in AD, and a larger Phase IIa clinical trial of AZD0530 for the treatment of patients with AD has recently launched.",1
2483,0,"Are the human bombesin receptors, GRPR and NMBR, frequently overexpressed G-protein-coupled-receptors by lung-cancers?","Members of the gastrin-releasing peptide (GRP) family and its analogs bombesin (BBN) have been implicated in the biology of several human cancers including prostate, breast, colon and lung.",1
2483,1,"Are the human bombesin receptors, GRPR and NMBR, frequently overexpressed G-protein-coupled-receptors by lung-cancers?","All 3 bombesin receptor subtypes (GRPR, NMBR, and BRS-3) were present on pulmonary and intestinal carcinoids by immunohistochemistry",1
2483,2,"Are the human bombesin receptors, GRPR and NMBR, frequently overexpressed G-protein-coupled-receptors by lung-cancers?",There is increased interest in the Bn-receptor family because they are frequently over/ectopically expressed by tumors and thus useful as targets for imaging or receptor-targeted-cytotoxicity.,1
2483,3,"Are the human bombesin receptors, GRPR and NMBR, frequently overexpressed G-protein-coupled-receptors by lung-cancers?",ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.,1
2483,4,"Are the human bombesin receptors, GRPR and NMBR, frequently overexpressed G-protein-coupled-receptors by lung-cancers?","Gastrin-releasing peptide (GRP), a member of the bombesin family of peptides, has been shown to have mitogenic activity in small cell lung carcinoma (SCLC), and to be produced by SCLC in an autocrine fashion.",1
1068,0,Which clotting factor is inhibited by betrixaban?,Evaluation of the oral direct factor Xa inhibitor - betrixaban.,0
1068,1,Which clotting factor is inhibited by betrixaban?,"Betrixaban , an orally administered direct factor Xa inhibitor, is entering a Phase III trial and undergoing investigation for similar indications as apixaban, dabigatran and rivaroxaban.",1
1068,2,Which clotting factor is inhibited by betrixaban?,"Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.",0
1068,3,Which clotting factor is inhibited by betrixaban?,"These include AZD0837, betrixaban, letaxaban, darexaban, and LY517717.",0
1068,4,Which clotting factor is inhibited by betrixaban?,Most are small synthetic molecules that target thrombin (e.g.,0
1068,5,Which clotting factor is inhibited by betrixaban?,dabigatran etexilate) or factor Xa (e.g.,0
1068,6,Which clotting factor is inhibited by betrixaban?,"rivaroxaban, apixaban, edoxaban, betrixaban, YM150).",0
1068,7,Which clotting factor is inhibited by betrixaban?,"They must be modified and standardized for the measurement of direct FXa inhibitors (rivaroxaban, apixaban, edoxaban, betrixaban and others).",0
1068,8,Which clotting factor is inhibited by betrixaban?,"Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.",0
1068,9,Which clotting factor is inhibited by betrixaban?," These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).",0
1068,10,Which clotting factor is inhibited by betrixaban?,"Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.",0
1068,11,Which clotting factor is inhibited by betrixaban?,The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).,0
1068,12,Which clotting factor is inhibited by betrixaban?,"These include betrixaban, letaxaban, darexaban, eribaxaban, and LY517717.",0
1068,13,Which clotting factor is inhibited by betrixaban?,"Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.",0
1068,14,Which clotting factor is inhibited by betrixaban?,"EXPERT OPINION: A large body of Phase II and Phase III data is now available for FXa inhibitors such as rivaroxaban, apixaban, edoxaban and betrixaban.",0
1068,15,Which clotting factor is inhibited by betrixaban?,"Another factor Xa inhibitor, edoxaban, is under evaluation in an ongoing phase III clinical trial and others such as AZD0837, betrixaban and darexaban are still in safety and tolerability phase II studies.",0
1068,16,Which clotting factor is inhibited by betrixaban?,"Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.",0
1068,17,Which clotting factor is inhibited by betrixaban?,"Novel oral anticoagulant drugs, the direct thrombin antagonist dabigatran and factor Xa inhibitors such as rivaroxaban, apixaban, edoxaban, and betrixaban are more predictable and convenient anticoagulants in comparison with warfarin, mainly because of the non-requirement of regular laboratory monitoring and dose adjustments.",0
1068,18,Which clotting factor is inhibited by betrixaban?,"Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.",0
1068,19,Which clotting factor is inhibited by betrixaban?,"Direct factor Xa inhibitors include rivaroxiban, which has shown promising results for VTE prophylaxis and is being studied for VTE treatment, as well as apixaban and betrixaban, which are at earlier stages of clinical validation.",0
1068,20,Which clotting factor is inhibited by betrixaban?,"Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.",0
1068,21,Which clotting factor is inhibited by betrixaban?,"Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.",0
1068,22,Which clotting factor is inhibited by betrixaban?,"[Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].",0
1068,23,Which clotting factor is inhibited by betrixaban?,Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).,1
1068,24,Which clotting factor is inhibited by betrixaban?,"A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).",0
1068,25,Which clotting factor is inhibited by betrixaban?,"Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.",0
1068,26,Which clotting factor is inhibited by betrixaban?,"Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.",0
1068,27,Which clotting factor is inhibited by betrixaban?,"Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].",0
1068,28,Which clotting factor is inhibited by betrixaban?,"Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.",0
1068,29,Which clotting factor is inhibited by betrixaban?,"Betrixaban , an orally administered direct factor Xa inhibitor, is entering a Phase III trial and undergoing investigation for similar indications as apixaban, dabigatran and rivaroxaban.",1
1068,30,Which clotting factor is inhibited by betrixaban?,"Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.",0
1068,31,Which clotting factor is inhibited by betrixaban?,"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.",0
1068,32,Which clotting factor is inhibited by betrixaban?,"Most are small synthetic molecules that target factor IIa (e.g., dabigatran etexilate, AZD-0837) or factor Xa (e.g., rivaroxaban, apixaban, betrixaban, DU176b, idrabiotaparinux).",0
1068,33,Which clotting factor is inhibited by betrixaban?,"Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor.",0
1068,34,Which clotting factor is inhibited by betrixaban?,"Seven compounds including rivaroxaban, apixaban, betrixaban, and eribaxaban are orally available direct inhibitors of activated factor X currently in development for the prevention and treatment of venous thromboembolism and for thromboprophylaxis in patients with atrial fibrillation or following an acute coronary syndrome.",0
1068,35,Which clotting factor is inhibited by betrixaban?,"Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa",0
1068,36,Which clotting factor is inhibited by betrixaban?,"These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin)",0
1068,37,Which clotting factor is inhibited by betrixaban?,"These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin)",0
1068,38,Which clotting factor is inhibited by betrixaban?,Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE),1
1068,39,Which clotting factor is inhibited by betrixaban?,"Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.",0
1068,40,Which clotting factor is inhibited by betrixaban?,"Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism",0
1068,41,Which clotting factor is inhibited by betrixaban?,"Betrixaban , an orally administered direct factor Xa inhibitor, is entering a Phase III trial and undergoing investigation for similar indications as apixaban, dabigatran and rivaroxaban.",1
1068,42,Which clotting factor is inhibited by betrixaban?,"Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa",0
2934,0,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"Here, we conduct a meta-review to identify predictors of response to antidepressant therapy in order to select robust input features for machine learning models of treatment response.",0
2934,1,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,machine learning framework involving EEG-based functional connectivity to diagnose major depressive disorder (MDD).,1
2934,2,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"Identification of risk factors of treatment resistance may be useful to guide treatment selection, avoid inefficient trial-and-error, and improve major depressive disorder (MDD) care.",1
2934,3,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,We extended the work in predictive modeling of treatment resistant depression (TRD) via partition of the data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort into a training and a testing dataset.,0
2934,4,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,persistence and severity of major depressive disorder from baseline self-reports,1
2934,5,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?, These results confirm that clinically useful MDD risk-stratification models can be generated from baseline patient self-reports and that ML methods improve on conventional methods in developing such models,0
2934,6,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"Furthermore, machine learning weighting factors may reflect an objective biomarker of major depressive disorder illness severity, based on abnormalities of brain structure.",1
2934,7,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"Notably, while the only information provided for training the classifiers was T(1)-weighted scans plus a categorical label (major depressive disorder versus controls), both relevance vector machine and support vector machine 'weighting factors' (used for making predictions) correlated strongly with subjective ratings of illness severity.",0
2934,8,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"BACKGROUND
Although variation in the long-term course of major depressive disorder (MDD) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods.",0
2934,9,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"BACKGROUND Although variation in the long-term course of major depressive disorder (MDD) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods.",0
2934,10,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,BACKGROUND Growing evidence documents the potential of machine learning for developing brain based diagnostic methods for major depressive disorder (MDD).,0
2934,11,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,OBJECTIVE We aimed to integrate neural data and an advanced machine learning technique to predict individual major depressive disorder (MDD) patient severity.,1
2934,12,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"Furthermore, machine learning weighting factors may reflect an objective biomarker of major depressive disorder illness severity, based on abnormalities of brain structure.",0
2934,13,Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?,"<b>BACKGROUND</b>: Although variation in the long-term course of major depressive disorder (MDD) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods.",0
951,0,What are the structures formed when keratin molecules come together?, Keratins form the intermediate filaments of the cytoskeleton and provide scaffold structures within cells.,1
951,1,What are the structures formed when keratin molecules come together?,keratin intermediate filaments,1
951,2,What are the structures formed when keratin molecules come together?,keratin intermediate filaments,0
951,3,What are the structures formed when keratin molecules come together?,keratin intermediate filament protein.,0
951,4,What are the structures formed when keratin molecules come together?,Keratin is a protein in the intermediate filament family,1
951,5,What are the structures formed when keratin molecules come together?,Keratins are the intermediate filament (IF) proteins,1
951,6,What are the structures formed when keratin molecules come together?,squamous keratinocytes contain polymerized keratin intermediate filament bundles,0
951,7,What are the structures formed when keratin molecules come together?, keratin filaments,0
951,8,What are the structures formed when keratin molecules come together?," In this study, we have examined the distribution of four groups of IFs [cytokeratins (CKs), vimentin, desmin and lamins]",0
951,9,What are the structures formed when keratin molecules come together?,keratin filament network,0
951,10,What are the structures formed when keratin molecules come together?,An intact keratin 5/keratin 14 intermediate filament cytoskeleton is vital for the integrity of basal keratinocytes and for the development and maintenance of epidermal structures.,1
951,11,What are the structures formed when keratin molecules come together?,keratin intermediate filament cytoskeleton.,0
951,12,What are the structures formed when keratin molecules come together?,"keratin filaments,",0
951,13,What are the structures formed when keratin molecules come together?,keratin filamentous network.,0
710,0,In which condition was protein S100A7 originally identified?,"Psoriasin (S100A7), originally identified in psoriasis, is a calcium-binding protein belonging to the multigenic S100 family",1
710,1,In which condition was protein S100A7 originally identified?,Psoriasin (S100 A7) was discovered two decades ago as a protein abundantly expressed in psoriatic keratinocytes.,1
710,2,In which condition was protein S100A7 originally identified?," Psoriasin, originally isolated from psoriasis as an overexpressed molecule of unknown function, has recently been identified as a principal Escherichia coli-killing antimicrobial peptide of healthy skin.",1
710,3,In which condition was protein S100A7 originally identified?,Inflammation-prone psoriatic skin constitutively expresses elevated concentrations of S100A7 (psoriasin),0
710,4,In which condition was protein S100A7 originally identified?,S100A7 (psoriasin) and S100A15 (koebnerisin) were first identified in inflamed psoriatic skin.,1
710,5,In which condition was protein S100A7 originally identified?,Human psoriasin (S100A7) has originally been described as a member of the family of S100 calcium-binding proteins which is overexpressed in patients suffering from psoriasis.,1
3806,0,Does head ct increase brain tumor risk?,"Excess relative risk of new brain tumor averaged 1.29 (95% confidence interval, 0.66-1.93) for pediatric patients exposed to one or more head CTs.",0
3806,1,Does head ct increase brain tumor risk?,"Tumor incidence increased with number of pediatric head CTs in a dose-dependent manner, with measurable excess incidence even after a single scan.",0
3806,2,Does head ct increase brain tumor risk?,Converging evidence from epidemiological studies supported a small excess risk of brain tumor incidence after even a single CT exam in pediatric patients.,1
3806,3,Does head ct increase brain tumor risk?,Recent epidemiologic evidence from a national registry of children who underwent CT scans suggests a higher-than-expected incidence of secondary tumors.,1
3806,4,Does head ct increase brain tumor risk?,"However, we found 1) a statistically significant correlation between radiation dose and age at procedure, as well as number and type of procedures, and 2) a substantial increase in lifetime predicted risk of tumor above baseline in the cohort of young children who undergo neurointerventions.CONCLUSIONS: Although neurointerventional procedures have dramatically improved the prognosis of children facing serious cerebrovascular conditions, the predicted risk of secondary tumors, particularly in the youngest patients and those undergoing multiple procedures, is sobering.",0
3806,5,Does head ct increase brain tumor risk?,"Conclusion When prevalent cases of meningioma at first exposure to CT of the head are excluded, no statistically significant increase in risk of meningioma was found among exposed subjects compared with unexposed control subjects.",0
3806,6,Does head ct increase brain tumor risk?," data suggest that 1 excess brain malignancy occurred after 4000 brain CTs (40 mSv per scan) and that the estimated risk in the 10 years following CT exposure was 1 brain tumor per 10,000 patients exposed to a 10 mGy scan at less than 10 years of age.CONCLU",0
3806,7,Does head ct increase brain tumor risk?,SIONS: The model predicts that the effective radiation dose from a single head CT is capable of inducing a thyroid or brain tumor in an infant or child.,0
3806,8,Does head ct increase brain tumor risk?,These,0
3806,9,Does head ct increase brain tumor risk?,Neither whole head CT nor cumulative brain dose to the brain increased the risk of glioma or of all brain tumours.,0
3806,10,Does head ct increase brain tumor risk?,"rison of exposed and unexposed cohorts showed that there was no statistically significant increase in the risk of meningioma after exposure to CT of the head (HR: 1.49; 95% confidence interval: 0.97, 2.30; P = .07).",0
3806,11,Does head ct increase brain tumor risk?,If incident c,0
3806,12,Does head ct increase brain tumor risk?,from epidemiological studies supported a small excess risk of brain tumor incidence after even a single CT exam in pediatric patients.,1
3806,13,Does head ct increase brain tumor risk?,"However, refined e",0
3806,14,Does head ct increase brain tumor risk?,"ve risk of new brain tumor averaged 1.29 (95% confidence interval, 0.66-1.93) for pediatric patients exposed to one or more head CTs.",0
3806,15,Does head ct increase brain tumor risk?,Tumor incidence,0
3806,16,Does head ct increase brain tumor risk?, CT nor cumulative brain dose to the brain increased the risk of glioma or of all brain tumours.,0
3806,17,Does head ct increase brain tumor risk?,Although this st,0
3806,18,Does head ct increase brain tumor risk?,o for developing a brain tumour from having a brain CT was 0.93 (95% confidence interval: 0.38-1.82).,0
3806,19,Does head ct increase brain tumor risk?,This was har,0
3806,20,Does head ct increase brain tumor risk?,"Tumor incidence increased with number of pediatric head CTs in a dose-dependent manner, with measurable excess incidence even after a single scan.",0
3806,21,Does head ct increase brain tumor risk?,Converging evidence from epidemiological studies supported a small excess risk of brain tumor incidence after even a single CT exam in pediatric patients.,0
3806,22,Does head ct increase brain tumor risk?,"Excess relative risk of new brain tumor averaged 1.29 (95% confidence interval, 0.66-1.93) for pediatric patients exposed to one or more head CTs.",0
3806,23,Does head ct increase brain tumor risk?,Epidemiological studies consistently cited increased tumor incidence in pediatric patients (ages 0-18) exposed to head CTs.,0
3806,24,Does head ct increase brain tumor risk?,RESULTS: A positive correlation between exposure to CT scans and developing central nervous system tumors was evident in all cohorts.,0
3806,25,Does head ct increase brain tumor risk?,The strength of the association varied across the studies.,0
3806,26,Does head ct increase brain tumor risk?,Exclusion of patients with predisposing factors to central nervous system tumors was examined in four studies with a decreased risk to develop central nervous system tumors noted in three studies.,0
3806,27,Does head ct increase brain tumor risk?,"Two studies reported nonsignificant reduction in the excess relative risk per milliGray of brain dose after adjusting for predisposing factors, whereas the reduction was significant in one study.",0
3806,28,Does head ct increase brain tumor risk?,The frequency of CT exposure was proportional to the risk of developing tumors in two studies although not significantly maintained in two other studies.,1
3806,29,Does head ct increase brain tumor risk?,"RESULTS: The overall risk was not significantly different in the two cohorts (incidence rate=36.72 per 100 000 person-years in the exposed cohort, 28.48 per 100 000 person-years in the unexposed cohort, hazard ratio (HR)=1.29, 95% confidence interval (CI)=0.90-1.85).",0
3806,30,Does head ct increase brain tumor risk?,"The risk of benign brain tumour was significantly higher in the exposed cohort than in the unexposed cohort (HR=2.97, 95% CI=1.49-5.93).",0
3806,31,Does head ct increase brain tumor risk?,The frequency of CT examination showed strong correlation with the subsequent overall risk of malignancy and benign brain tumour.CONCLUSIONS: We found that paediatric head CT examination was associated with an increased incidence of benign brain tumour.,0
3806,32,Does head ct increase brain tumor risk?,CONCLUSIONS: We found evidence that CT-related radiation exposure increases brain tumor risk.,0
3806,33,Does head ct increase brain tumor risk?,"Compared with the general population, incidence of brain tumors was higher in the cohort of children with CT scans, requiring cautious interpretation of the findings.",1
3806,34,Does head ct increase brain tumor risk?,BACKGROUND: Recent studies linking radiation exposure from pediatric computed tomography (CT) to increased risks of leukemia and brain tumors lacked data to control for cancer susceptibility syndromes (CSS).,0
3806,35,Does head ct increase brain tumor risk?,IMPACT: Future studies should identify TSC patients in order to avoid overestimation of brain tumor risks due to radiation exposure from CT scans.,0
3806,36,Does head ct increase brain tumor risk?,"The radiation-induced occurrence of meningiomas and other brain tumours most probably contributes to the continuously increasing incidence of these diseases which is observed in several industrial nations, as well as the exposure of the bone marrow by CT to the increase of childhood leukaemia.",0
3806,37,Does head ct increase brain tumor risk?,"1,000 annual paediatric CT investigations of the skull will lead to about 3 excess neoplasms in the head region, i.e., the probability of an induced late effect must be suspected in the range of some thousandths.",0
1728,0,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,All DNA (cytosine-5)-methyltransferases contain a single conserved cysteine.,0
1728,1,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,It has been proposed that this cysteine initiates catalysis by attacking the C6 of cytosine and thereby activating the normally inert C5 position.,0
1728,2,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Kinetic and catalytic mechanism of HhaI methyltransferase.,0
1728,3,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Kinetic and catalytic properties of the DNA (cytosine-5)-methyltransferase HhaI are described.,0
1728,4,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"With poly(dG-dC) as substrate, the reaction proceeds by an equilibrium (or processive) ordered Bi-Bi mechanism in which DNA binds to the enzyme first, followed by S-adenosylmethionine (AdoMet).",0
1728,5,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"After methyl transfer, S-adenosylhomocysteine (AdoHcy) dissociates followed by methylated DNA.",0
1728,6,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Our studies reveal that the catalytic mechanism of DNA (cytosine-5)-methyltransferases involves attack of the C6 of substrate cytosines by an enzyme nucleophile and formation of a transient covalent adduct.,1
1728,7,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Catalytic mechanism of DNA-(cytosine-C5)-methyltransferases revisited: covalent intermediate formation is not essential for methyl group transfer by the murine Dnmt3a enzyme.,0
1728,8,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,We propose that correct positioning of the flipped base and the cofactor and binding to the transition state of methyl group transfer are the most important roles of the Dnmt3a enzyme in the catalytic cycle of methyl group transfer.,1
1728,9,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Co-transfections of reporter plasmids and plasmids encoding the catalytic domain of the murine Dnmt3a DNA methyltransferase lead to inhibition of reporter gene expression.,0
1728,10,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"As Dnmt3a mutants with C-->A and E-->A exchanges in the conserved PCQ and ENV motifs in the catalytic center of the enzyme also cause repression, we checked for their catalytic activity in vitro.",0
1728,11,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"In contrast, enzyme variants carrying E-->A, E-->D or E-->Q exchanges of the ENV glutamate are catalytically almost inactive, demonstrating that this residue has a central function in catalysis.",0
1728,12,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"Therefore, covalent complex formation is not essential in the reaction mechanism of Dnmt3a.",0
1728,13,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,We propose that correct positioning of the flipped base and the cofactor and binding to the transition state of methyl group transfer are the most important roles of the Dnmt3a enzyme in the catalytic cycle of methyl group transfer.,1
1728,14,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Our results point to a possible connection between the catalytic mechanism of C5 Mtases and of enzymes that transfer methyl groups to N(4) of cytosine.,0
1728,15,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Previous X-ray crystallographic studies have revealed that the catalytic domain of a DNA methyltransferase (Mtase) generating C5-methylcytosine bears a striking structural similarity to that of a Mtase generating N6-methyladenine.,0
1728,16,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"Spontaneous and reversible proton transfer between a conserved Glu in the active site and cytosine N3 at the transition state was observed in our simulations, revealing the chemical participation of this Glu residue in the catalytic mechanism.",0
1728,17,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"The mechanism of DNA cytosine-5-methylation catalyzed by the bacterial M.HhaI enzyme has been considered as a stepwise nucleophilic addition of Cys-81-S- to cytosine C6 followed by C5 nucleophilic replacement of the methyl of S-adenosyl-L-methionine to produce 5-methyl-6-Cys-81-S-5,6-dihydrocytosine.",1
1728,18,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Hydroxide at 10(-7) mole fraction (pH = 7) is shown to be sufficient for the required catalysis.,0
1728,19,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"On the basis of amino acid sequence alignments and structural data of related enzymes, we have performed a mutational analysis of 14 amino acid residues in the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase.",0
1728,20,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,We demonstrate that Phe50 (motif I) and Glu74 (motif II) are important for AdoMet binding and catalysis.,0
1728,21,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"D96A (motif III) showed reduced AdoMet binding but increased activity under conditions of saturation with S-adenosyl-L-methionine (AdoMet), indicating that the contact of Asp96 to AdoMet is not required for catalysis.",0
1728,22,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"R130A displayed a strong reduction in catalytic activity and a complete change in flanking sequence preferences, indicating that Arg130 has an important role in the DNA interaction of Dnmt3a.",0
1728,23,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"While Asn167 might contribute to the positioning of residues from motif VI, according to structural data Arg202 has a role in catalysis of cytosine-C5 methyltransferases.",0
1728,24,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,The R295A variant was catalytically inactive most likely because of destabilization of the hinge sub-domain of the protein.,0
1728,25,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"These two methyltransferases recognize CpG and GCGC sequences, respectively, and transfer a methyl group to the C5 atom of cytosine (C).",0
1728,26,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,Most prokaryotic (cytosine-5)-DNA methyltransferases increase the frequency of deamination at the cytosine targeted for methylation in vitro in the absence of the cofactor S-adenosylmethionine (AdoMet) or the reaction product S-adenosylhomocysteine (AdoHcy).,0
1728,27,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"The target (methylatable) cytosine, if flipped out of the double helical DNA as seen for DNA methyltransferases that generate 5-methylcytosine, would fit into the concave active site next to the AdoMet.",0
1728,28,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"These methylation patterns are established and maintained by DNA cytosine-5 methyltransferase (MTase), a approximately 1500 amino acid enzyme containing a regulatory N-terminal domain and a catalytic C-terminal domain.",0
1728,29,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"These results lend strong support to a catalytic mechanism in which an enzyme sulfhydryl group undergoes Michael addition to the C5-C6 double bond, thus activating position C-5 of the substrate DNA cytosine residue for electrophilic attack by the methyl donor SAM.",0
1728,30,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,2'-Deoxyoligonucleotides with 5-fluorocytosine residues incorporated at specific positions of the nucleotide sequence are tools of great potential in the study of the catalytic mechanism by which DNA cytosine methyltransferases methylate the 5-position of DNA cytosine residues in specific sequence contexts.,1
1728,31,What is the catalytic mechanism of DNA (cytosine-5) methyltransferases? ,"The enzyme has Mr 130 000, and introduces methyl groups from S-adenosylmethionine into the 5 position of cytosines in DNA.",0
76,0,Is CD56 useful in Ewing sarcoma prognosis?,Excellent prognosis in a subset of patients with Ewing sarcoma identified at diagnosis by CD56 using flow cytometry,1
76,1,Is CD56 useful in Ewing sarcoma prognosis?,"There was a highly significant correlation between CD56 expression and progression-free survival (PFS; 69% in low/negative expression versus 30% in high expression groups, P = 0.024)",0
76,2,Is CD56 useful in Ewing sarcoma prognosis?,"In patients with localized nonpelvic disease, those expressing low/negative CD56 had 100% PFS versus 40% in the high expressing group (P = 0.02)",1
76,3,Is CD56 useful in Ewing sarcoma prognosis?,CD56 was found to be an independent prognostic marker with an 11-fold increased risk for relapse in patients with localized disease (P = 0.006),0
76,4,Is CD56 useful in Ewing sarcoma prognosis?,"CD56 expression could be used to reveal ES patients with excellent prognosis or patients predisposed to relapse, thus improving treatment stratification and implementation of personalized therapy",1
76,5,Is CD56 useful in Ewing sarcoma prognosis?,Excellent prognosis in a subset of patients with Ewing sarcoma identified at diagnosis by CD56 using flow cytometry.,0
76,6,Is CD56 useful in Ewing sarcoma prognosis?,"Three years after diagnosis the patient presented with severe respiratory difficulty and following resection, the final pathology revealed multiple tumors with foci of high grade sarcoma compatible with primitive neuroectodermal tumor/extraskeletal Ewing sarcoma based on morphology and immunohistochemistry (CD99, CD56).",0
76,7,Is CD56 useful in Ewing sarcoma prognosis?,"CD56 expression could be used to reveal ES patients with excellent prognosis or patients predisposed to relapse, thus improving treatment stratification and implementation of personalized therapy.",1
76,8,Is CD56 useful in Ewing sarcoma prognosis?,Identification of CD56 and CD57 by flow cytometry in Ewing's sarcoma or primitive neuroectodermal tumor.,0
76,9,Is CD56 useful in Ewing sarcoma prognosis?,"CD56 expression could be used to reveal ES patients with excellent prognosis or patients predisposed to relapse, thus improving treatment stratification and implementation of personalized therapy.",1
1435,0,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"The fractal globule, a self-similar compact polymer conformation where the chain is spatially segregated on all length scales, has been proposed to result from a sudden polymer collapse.",1
1435,1,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,This state has gained renewed interest as one of the prime candidates for the non-entangled states of DNA molecules inside cell nuclei,0
1435,2,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"Additionally, the strings and binders switch model reproduces the recently proposed ""fractal-globule"" model, but only as one of many possible transient conformations",0
1435,3,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,The fractal globule is a compact polymer state that emerges during polymer condensation as a result of topological constraints which prevent one region of the chain from passing across another one.,1
1435,4,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,This long-lived intermediate state was introduced in 1988 (Grosberg et al.,0
1435,5,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,1988) and has not been observed in experiments or simulations until recently (Lieberman-Aiden et al.,0
1435,6,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,2009).,0
1435,7,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,Recent characterization of human chromatin using a novel chromosome conformational capture technique brought the fractal globule into the spotlight as a structural model of human chromosome on the scale of up to 10 Mb (Lieberman-Aiden et al.,1
1435,8,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,2009).,0
1435,9,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"Next, we connect the fractal globule to recent studies that emphasize topological constraints as a primary factor driving formation of chromosomal territories.",0
1435,10,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"We discuss how theoretical predictions, made on the basis of the fractal globule model, can be tested experimentally.",0
1435,11,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"Finally, we discuss whether fractal globule architecture can be relevant for chromatin packing in other organisms such as yeast and bacteria",0
1435,12,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"Finally, ensemble analysis of the contact matrix, coupled with theoretical derivations and computational simulations, revealed that at the megabase scale Hi-C reveals features consistent with a fractal globule conformation",0
1435,13,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"At the megabase scale, the chromatin conformation is consistent with a fractal globule, a knot-free, polymer conformation that enables maximally dense packing while preserving the ability to easily fold and unfold any genomic locus.",0
1435,14,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,The fractal globule is distinct from the more commonly used globular equilibrium model.,0
1435,15,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,Our results demonstrate the power of Hi-C to map the dynamic conformations of whole genomes,0
1435,16,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"At the megabase scale, the chromatin conformation is consistent with a fractal globule, a knot-free, polymer conformation that enables maximally dense packing while preserving the ability to easily fold and unfold any genomic locus.",0
1435,17,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"The existence of these power-laws could facilitate the formation of the recently proposed ""fractal globule"" for the confined chromatin organization.",0
1435,18,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"The fractal globule, a self-similar compact polymer conformation where the chain is spatially segregated on all length scales, has been proposed to result from a sudden polymer collapse.",1
1435,19,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"At the megabase scale, the chromatin conformation is consistent with a fractal globule, a knot-free, polymer conformation that enables maximally dense packing while preserving the ability to easily fold and unfold any genomic locus.",0
1435,20,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"The existence of these power-laws could facilitate the formation of the recently proposed ""fractal globule"" for the confined chromatin organization.",0
1435,21,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"The fractal globule, a self-similar compact polymer conformation where the chain is spatially segregated on all length scales, has been proposed to result from a sudden polymer collapse",1
1435,22,What is the idea behind the fractal globule that has been proposed as a model of chromatin conformation in the nucleus of a cell?,"At the megabase scale, the chromatin conformation is consistent with a fractal globule, a knot-free, polymer conformation that enables maximally dense packing while preserving the ability to easily fold and unfold any genomic locus",0
1147,0,ROSIER scale is used for which disorder?,Validation of the use of the ROSIER scale in prehospital assessment of stroke.,0
1147,1,ROSIER scale is used for which disorder?,"MATERIALS AND METHODS: Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.",1
1147,2,ROSIER scale is used for which disorder?,CONCLUSIONS: The ROSIER is a sensitive and specific stroke recognition tool for health providers' use among Chinese patients in the prehospital setting.,0
1147,3,ROSIER scale is used for which disorder?,Can the FAST and ROSIER adult stroke recognition tools be applied to confirmed childhood arterial ischemic stroke?,0
1147,4,ROSIER scale is used for which disorder?, Two adult stroke recognition tools; ROSIER (Recognition of Stroke in the Emergency Room) and FAST (Face Arm Speech Test) scales were applied retrospectively to all patients to determine test sensitivity.,0
1147,5,ROSIER scale is used for which disorder?," DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.",0
1147,6,ROSIER scale is used for which disorder?,CONCLUSIONS: The simpler FAST scale could replace the more complex ROSIER for the initial assessment of patients with suspected acute stroke in the emergency department.,0
1147,7,ROSIER scale is used for which disorder?,The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.,1
1147,8,ROSIER scale is used for which disorder?,We designed and validated a stroke recognition tool-the Recognition of Stroke in the Emergency Room (ROSIER) scale-for use by ER physicians.,1
1147,9,ROSIER scale is used for which disorder?,INTERPRETATION: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.,0
1147,10,ROSIER scale is used for which disorder?,"DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.",0
1147,11,ROSIER scale is used for which disorder?,The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population.,0
1147,12,ROSIER scale is used for which disorder?,"If the ROSIER scale is to be clinically useful in Chinese suspected stroke patients, it requires further refinement.",0
1147,13,ROSIER scale is used for which disorder?,Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.,0
1147,14,ROSIER scale is used for which disorder?,The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.,0
1147,15,ROSIER scale is used for which disorder?,We designed and validated a stroke recognition tool-the Recognition of Stroke in the Emergency Room (ROSIER) scale-for use by ER physicians.,1
1147,16,ROSIER scale is used for which disorder?,The simpler FAST scale could replace the more complex ROSIER for the initial assessment of patients with suspected acute stroke in the emergency department.,0
1147,17,ROSIER scale is used for which disorder?,The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.,0
1147,18,ROSIER scale is used for which disorder?,"DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department",0
1147,19,ROSIER scale is used for which disorder?,The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population.,0
1147,20,ROSIER scale is used for which disorder?,The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER,0
1147,21,ROSIER scale is used for which disorder?,We designed and validated a stroke recognition tool-the Recognition of Stroke in the Emergency Room (ROSIER) scale-for use by ER physicians.,0
1147,22,ROSIER scale is used for which disorder?,To determine the utility of the Recognition of Stroke in the Emergency Room (ROSIER) scale as a stroke recognition tool among Chinese patients in the prehospital setting.,1
1019,0,Which disease has been associated to a disruptive ALX1 protein?,Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.,1
1019,1,Which disease has been associated to a disruptive ALX1 protein?,"In the second family we identified a homozygous donor-splice-site mutation (c.531+1G>A) in the ALX1 gene, providing evidence that complete loss of function of ALX1 protein causes severe disruption of early craniofacial development.",1
1019,2,Which disease has been associated to a disruptive ALX1 protein?,"expression of Alx1, an effector of scapula blade patterning, is absent in all compound mutants.",1
1019,3,Which disease has been associated to a disruptive ALX1 protein?,"Mutations in each of the transcriptional co-activator genes - CBP, p300, Cited2, Cart1 and Carm1 - result in neural tube defects in mice.",0
1019,4,Which disease has been associated to a disruptive ALX1 protein?,"Scapular truncation in triple mutants of Tbx15, Alx4 and Cart1 indicates essential functions for Alx4 and Cart1 in the anterior part of the scapula",1
1019,5,Which disease has been associated to a disruptive ALX1 protein?," Ectopic expression of Cart1 in transgenic mice does not disturb development, whereas expression of a Cart1 form from which the aristaless domain has been deleted results in severe cranial and vertebral malformations.",0
1019,6,Which disease has been associated to a disruptive ALX1 protein?,"Cart1, is essential for correct morphogenesis of the limbs and cranium.",1
1019,7,Which disease has been associated to a disruptive ALX1 protein?,"Cart1 encodes the paired-like homeodomain in the central portion of the gene, and plays a crucial role in the developmental lineage of bone and cartilage, especially in head formation.",0
1019,8,Which disease has been associated to a disruptive ALX1 protein?,we show that Cart1-homozygous mutant mice are born alive with acrania and meroanencephaly but die soon after birth-a phenotype that strikingly resembles a corresponding human syndrome caused by a neural tube closure defect.,0
1019,9,Which disease has been associated to a disruptive ALX1 protein?, 240 kilobase haplotype encompassing the ALX1 gene that encodes a transcription factor affecting craniofacial development,0
1019,10,Which disease has been associated to a disruptive ALX1 protein?,"ALX3, ALX4, and ALX1, which have been related with distinct phenotypes named FND1, FND2, and FND3 respectively",0
361,0,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab offers induction strategy for very active relapsing MS patients who have failed conventional therapy, and possibly selected treatment-naive patients.",0
361,1,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.,0
361,2,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab (anti-CD52 mAb) provides long-lasting disease activity suppression in relapsing-remitting multiple sclerosis (RRMS).,0
361,3,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab, an anti-CD52 monoclonal antibody, increased the risk of thyroid dysfunction in CAMMS223, a phase 2 trial in relapsing-remitting multiple sclerosis.",0
361,4,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Since then, one phase II and two phase III trials have shown that alemtuzumab reduces the relapse rate, compared with the active comparator interferon beta-1a (IFNβ-1a), in treatment-naïve and treatment-experienced MS up to 10 years from disease onset.",0
361,5,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Furthermore, in two of these trials, alemtuzumab reduced the risk of accumulating disability compared with IFNβ-1a; indeed alemtuzumab treatment led to an improvement in disability and reduction in cerebral atrophy.",0
361,6,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab is a humanized monoclonal antibody specific for the CD52 protein present at high levels on the surface of B and T lymphocytes.,0
361,7,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"In clinical trials, alemtuzumab has shown a clinical benefit superior to that of interferon-β in relapsing-remitting multiple sclerosis patients.",0
361,8,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,These results potentially help explain the level of immunocompetence observed in alemtuzumab-treated MS patients.,0
361,9,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab was first used in multiple sclerosis in 1991.,0
361,10,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"It is a monoclonal antibody which is directed against CD52, a protein of unknown function on lymphocytes.",0
361,11,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Against an active comparator and the current first-line therapy for relapsing-remitting multiple sclerosis (interferon-beta), alemtuzumab showed a significant reduction in annualized relapse rate as well as a significant reduction in the accumulation of disability.",0
361,12,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab (previously known as Campath(®)) is a humanized monoclonal antibody directed against the CD52 antigen on mature lymphocytes that results in lymphopenia and subsequent modification of the immune repertoire.,0
361,13,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Compared to interferon beta-1a, alemtuzumab reduced the relapse rate by 49%-74% (P < 0.0001), and in two studies it reduced the risk of sustained disability accumulation by 42%-71% (P < 0.01).",0
361,14,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"In one study (Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis; CARE-MS1), there was no significant difference compared to interferon, perhaps reflecting the surprisingly low frequency of disability events in the comparator group.",0
361,15,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab has been submitted for licensing in relapsing-remitting multiple sclerosis in the United States and Europe.,0
361,16,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab was associated with a greater chance of improved contrast sensitivity in patients with RRMS and may delay the worsening of visual function.,0
361,17,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,The anti-CD52 monoclonal antibody alemtuzumab reduced disease activity in a phase 2 trial of previously untreated patients with relapsing-remitting multiple sclerosis.,0
361,18,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab's consistent safety profile and benefit in terms of reductions of relapse support its use for patients with previously untreated relapsing-remitting multiple sclerosis; however, benefit in terms of disability endpoints noted in previous trials was not observed here.",0
361,19,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab, formally known as Campath-1H, is a humanized monoclonal antibody directed against CD52, a protein on the surface of lymphocytes and monocytes with unknown function.",0
361,20,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"A single dose of alemtuzumab leads to a rapid, profound and prolonged lymphopenia.",0
361,21,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,A Phase II trial has shown that alemtuzumab reduces the risk of relapse and accumulation of disability by over 70% compared with interferon beta in patients with early relapsing-remitting multiple sclerosis (MS).,0
361,22,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab, targeting CD52 expressed on T-cells, B-cells, monocytes and macrophages, has also shown to be effective in early RRMS and phase III trials are currently ongoing.",1
361,23,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"monoclonal antibody therapy has provided the opportunity to rationally direct the therapeutic intervention by specifically targeting mechanisms of the immune system such as CD52 (alemtuzumab), CD25 (daclizumab), VLA-4 (natalizumab) and CD20 (rituximab)",0
361,24,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab is a humanized monoclonal antibody targeting CD52, a broadly expressed cell surface molecule on immune cells.",0
361,25,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab-treatment of MS patients with relapsing-remitting forms of the disease significantly reduced the risk of relapse and accumulation of disability compared to interferon β-1a treatment in a phase II trial.,0
361,26,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab (CD52-specific humanized monoclonal antibody) was found to be an effective therapy for treatment-naive patients with relapsing-remitting multiple sclerosis.,1
361,27,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab effectively reduced relapse rates and improved clinical scores in patients with active relapsing-remitting multiple sclerosis not controlled by interferon therapy.,0
361,28,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab is an anti-CD52 monoclonal antibody with remarkable efficacy in relapsing multiple sclerosis (MS).,0
361,29,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis.,0
361,30,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"For patients with first-line treatment-refractory relapsing-remitting multiple sclerosis, alemtuzumab could be used to reduce relapse rates and sustained accumulation of disability.",0
361,31,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Campath-1H causes the immune response to change from the Th1 phenotype, suppressing multiple sclerosis disease activity, but permitting the generation of antibody-mediated thyroid autoimmunity.",0
361,32,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Campath-1H is a humanized monoclonal antibody directed at CD52 expressed on lymphocytes and other cells of the immune system.,0
361,33,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"It has been tested extensively in lymphoid malignancies, autoimmune diseases including rheumatoid arthritis, multiple sclerosis, and organ transplantation.",0
361,34,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Campath 1-H (Alemtuzumab) is a humanised monoclonal antibody which targets the CD52 antigen, a low molecular weight glycoprotein present on the surface of most lymphocyte lineages, causing complement mediated lysis and rapid and prolonged T lymphocyte depletion.",0
361,35,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Following encouraging initial data from other centres we report our open label experience of using Campath 1-H as a treatment in aggressive relapsing multiple sclerosis in a consecutive series of 39 highly selected patients treated across three regional centres and followed for a mean of 1.89 years.,0
361,36,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab, a humanized monoclonal antibody that targets CD52 on lymphocytes and monocytes, may be an effective treatment for early multiple sclerosis.",1
361,37,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"In patients with early, relapsing-remitting multiple sclerosis, alemtuzumab was more effective than interferon beta-1a but was associated with autoimmunity, most seriously manifesting as immune thrombocytopenic purpura.",0
361,38,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab, a monoclonal antibody targeting CD52, is a highly promising agent currently being studied in two phase III clinical trials.",0
361,39,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"In this review, data from the recently published phase II clinical trial in the treatment of early relapsing remitting MS is summarized and analyzed in light of the development of alemtuzumab for MS and its potential role in treating this disease is discussed.",0
361,40,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab is a humanized monoclonal antibody against CD52, an antigen found on the surface of normal and malignant lymphocytes.",0
361,41,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,It is approved for the treatment of B-cell chronic lymphocytic leukaemia and is undergoing Phase III clinical trials for the treatment of multiple sclerosis.,1
361,42,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"To assess the effect of systemic lymphocyte depletion on disease activity, seven patients with MS received a 10-day intravenous course of the humanised monoclonal antibody CAMPATH-1H (anti-CDw52).",0
361,43,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"The effect of CAMPATH-1H on disease activity provides direct, but preliminary, evidence that disease activity in MS depends on the availability of circulating lymphocytes and can be prevented by lymphocyte depletion.",0
361,44,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"The elective treatment of patients with multiple sclerosis, using a humanized anti-leukocyte (CD52) monoclonal antibody (Campath-1H), has illuminated mechanisms that underlie the clinical course of the disease.",1
361,45,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab is currently under review to treat relapsing multiple sclerosis (MS) in the United States, based on positive Phase II and Phase III trials in both treatment-naïve and treated relapsing MS patients.",0
361,46,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,"Alemtuzumab has recently been approved by the European authorities for active relapsing MS, in essence as a first-line agent.",0
361,47,What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?,Alemtuzumab is a humanized monoclonal antibody directed against CD52.,0
3031,0,Is cabozantinib effective for Hepatocellular Carcinoma?,"However, clinical trials of nonselective kinase inhibitors with c-Met activity (tivantinib, cabozantinib, foretinib, and golvatinib) in patients with HCC have failed so far to demonstrate significant efficacy.",0
3031,1,Is cabozantinib effective for Hepatocellular Carcinoma?,"Rationale for use, clinical trial data, and current recommendations for cabozantinib in renal cell cancer, thyroid cancer, prostate cancer, hepatocellular cancer, and lung cancer are detailed in this article.",0
3031,2,Is cabozantinib effective for Hepatocellular Carcinoma?,"More recently, promising outcomes have also been reported with new agents, such as nivolumab and cabozantinib.",0
3031,3,Is cabozantinib effective for Hepatocellular Carcinoma?,Positive results in recent phase III clinical trials have confirmed the high value of anti-angiogenic therapies for HCC in both first (sorafenib and lenvatinib) and second line (regorafenib and cabozantinib) treatment modalities.,0
3031,4,Is cabozantinib effective for Hepatocellular Carcinoma?,"More recently, regorafenib and nivolumab have received approval in the second-line setting after sorafenib, with further positive phase 3 studies emerging in the first line (lenvatinib non-inferior to sorafenib) and second line versus placebo (cabozantinib and ramucirumab).",0
3031,5,Is cabozantinib effective for Hepatocellular Carcinoma?,"The rapidly changing treatment landscape due to the emergence of new treatment options (sorafenib and lenvatinib equally effective in first line; regorafenib, cabozantinib, and ramucirumab showing OS benefit in second line with nivolumab approved by the FDA based on response rate) underscores the importance of re-assessing the role of the first approved systemic agent in HCC, sorafenib.",0
3031,6,Is cabozantinib effective for Hepatocellular Carcinoma?,Positive phase III-study data have been published for lenvatinib as first-line and cabozantinib as second-line therapy.,1
3031,7,Is cabozantinib effective for Hepatocellular Carcinoma?,Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.,0
3031,8,Is cabozantinib effective for Hepatocellular Carcinoma?,"BACKGROUND: Cabozantinib inhibits tyrosine kinases, including vascular endothelial growth factor receptors 1, 2, and 3, MET, and AXL, which are implicated in the progression of hepatocellular carcinoma and the development of resistance to sorafenib, the standard initial treatment for advanced disease.",0
3031,9,Is cabozantinib effective for Hepatocellular Carcinoma?,"CONCLUSIONS: Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo.",0
3031,10,Is cabozantinib effective for Hepatocellular Carcinoma?,"Expert opinion: Based on favorable phase III clinical trial data, sorafenib and lenvatinib are considered promising agents for HCC as first-line systemic chemotherapy.",0
3031,11,Is cabozantinib effective for Hepatocellular Carcinoma?,"Moreover, regorafenib and cabozantinib are useful second-line therapies after the failure of sorafenib.",1
3031,12,Is cabozantinib effective for Hepatocellular Carcinoma?,"CONCLUSIONS: Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo.",0
3031,13,Is cabozantinib effective for Hepatocellular Carcinoma?,"Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo.",0
3031,14,Is cabozantinib effective for Hepatocellular Carcinoma?,"Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo.",0
3031,15,Is cabozantinib effective for Hepatocellular Carcinoma?,"Median overall survival was 10.2 months with cabozantinib and 8.0 months with placebo (hazard ratio for death, 0.76; 95% confidence interval [CI], 0.63 to 0.92; P=0.005).",0
3031,16,Is cabozantinib effective for Hepatocellular Carcinoma?,"Median progression-free survival was 5.2 months with cabozantinib and 1.9 months with placebo (hazard ratio for disease progression or death, 0.44; 95% CI, 0.36 to 0.52; P<0.001), and the objective response rates were 4% and less than 1%, respectively (P=0.009).",0
3031,17,Is cabozantinib effective for Hepatocellular Carcinoma?,"The most common high-grade events were palmar-plantar erythrodysesthesia (17% with cabozantinib vs. 0% with placebo), hypertension (16% vs. 2%), increased aspartate aminotransferase level (12% vs. 7%), fatigue (10% vs. 4%), and diarrhea (10% vs. 2%).<br><b>CONCLUSIONS</b>: Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo.",0
3031,18,Is cabozantinib effective for Hepatocellular Carcinoma?,"CONCLUSIONS Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo.",0
3031,19,Is cabozantinib effective for Hepatocellular Carcinoma?,"CONCLUSIONS The tyrosine kinase inhibitors sorafenib (first line) and regorafenib (second line) have been approved for hepatocellular carcinoma, and the immune checkpoint inhibitor nivolumab obtained conditional approval for sorafenib-experienced patients in the United States.",0
3031,20,Is cabozantinib effective for Hepatocellular Carcinoma?,"The principal advancements in the treatment of hepatocellular carcinoma (HCC) are the use of new systemic treatments such as lenvatinib in first-line treatment and regorafenib, cabozantinib and ramucirumab in second-line treatment due to their benefits in terms of overall survival.",1
3031,21,Is cabozantinib effective for Hepatocellular Carcinoma?,"Recently, a few systemic chemotherapies proved to be effective for advanced stage HCC in phase III studies: lenvatinib as the first line of therapy, and regorafenib, cabozantinib, and ramucirumab as second-line therapy.",1
3031,22,Is cabozantinib effective for Hepatocellular Carcinoma?,"<b>BACKGROUND</b>: The approval of the tyrosine kinase inhibitor sorafenib in 2007 marked a milestone in the treatment of hepatocellular carcinoma, as sorafenib was the first systemic therapy to show a survival benefit in patients with advanced hepatocellular carcinoma.",0
3031,23,Is cabozantinib effective for Hepatocellular Carcinoma?,"We also elaborate the unmet need of biomarkers to guide treatment decisions and discuss the emerging field of immunotherapy in hepatocellular carcinoma.<br><b>CONCLUSIONS</b>: The tyrosine kinase inhibitors sorafenib (first line) and regorafenib (second line) have been approved for hepatocellular carcinoma, and the immune checkpoint inhibitor nivolumab obtained conditional approval for sorafenib-experienced patients in the United States.",0
3031,24,Is cabozantinib effective for Hepatocellular Carcinoma?,Cabozantinib in the treatment of hepatocellular carcinoma.,1
3031,25,Is cabozantinib effective for Hepatocellular Carcinoma?,"The approval of the tyrosine kinase inhibitor sorafenib in 2007 marked a milestone in the treatment of hepatocellular carcinoma, as sorafenib was the first systemic therapy to show a survival benefit in patients with advanced hepatocellular carcinoma.",0
3491,0,Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?,"After treatment with any of the xenobiotic compounds, immunolabeling demonstrated the additional presence of granulocytes in foci, and, at electron microscope level neutrophils, eosinophils and their precursors were clearly recognizable.",1
3491,1,Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?,"Cerebrospinal fluid (CSF) examination in patients with ATM in the course of SLE indicate usually pleocytosis with prevalence of granulocytes, increased protein levels, low glucose levels, significantly hindering differential diagnosis in the early stage of the disease.",1
3491,2,Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?,Granulocytes isolated from 17 patients with systemic lupus erythematosus (SLE) had a significantly increased (P less than 0.001) mean initial rate of phagocytosis (0.91 min-u).,1
3491,3,Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?,Both syndromes were refractory to conventional treatment but responded to rituximab and cyclophosphamide.,1
3491,4,Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?,"Although some Fc-independent loss of CD22 is expected from internalization by epratuzumab, the concurrent and prominent reduction of CD19, CD21, and CD79b is Fc dependent and results from their transfer from epratuzumab-opsonized B cells to FcγR-expressing monocytes, natural killer cells, and granulocytes via trogocytosis.",1
3491,5,Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?," ANCA also occurs in 30%-40% of patients with eosinophilic granulomatosis with polyangiitis (EGPA) and anti-GBM disease, but is uncommon in other forms of vasculitis.",0
2332,0,Which Janus kinase does decernotinib target?,"The aim of this study was to evaluate the potency and selectivity of the investigational JAK3 inhibitor VX-509 (decernotinib) [(R)-2-((2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide]against JAK3 kinase activity and inhibition of JAK3-mediated signaling in vitro and JAK3-dependent physiologic processes in vivo.",1
2332,1,Which Janus kinase does decernotinib target?,"These results demonstrate that VX-509 potently inhibits JAK3 in enzyme assays (Ki = 2.5 nM + 0.7 nM) and cellular assays dependent on JAK3 activity (IC50 range, 50-170 nM), with limited or no measurable potency against other JAK isotypes or non-JAK kinases.",1
2332,2,Which Janus kinase does decernotinib target?,"These findings demonstrate that VX-509 is a selective and potent inhibitor of JAK3 in vitro and modulates proinflammatory response in models of immune-mediated diseases, such as collagen-induced arthritis and delayed-type hypersensitivity.",1
2332,3,Which Janus kinase does decernotinib target?,VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease,1
3332,0,What is OAC CHV?,Open-Access Collaborative Consumer Health Vocabulary (OAC CHV),1
3332,1,What is OAC CHV?,"The Open Access and Collaborative Consumer Health Vocabulary (OAC CHV), which contains health-related terms used by lay consumers,",1
3332,2,What is OAC CHV?,"The Open Access and Collaborative Consumer Health Vocabulary (OAC CHV), which contains health-related terms used by lay consumers, has been created to bridge such a gap.",1
3332,3,What is OAC CHV?,"Specifically, the OAC CHV facilitates consumers' health information retrieval by enabling consumer-facing health applications to translate between professional language and consumer friendly language.",0
3332,4,What is OAC CHV?,"The Open Access and Collaborative Consumer Health Vocabulary ( OAC CHV) , which contains health-related terms used by lay consumers , has been created to bridge such a gap",1
3332,5,What is OAC CHV?,"Specifically , the OAC CHV facilitates consumers' health information retrieval by enabling consumer-facing health applications to translate between professional language and consumer friendly language",0
3332,6,What is OAC CHV?,"Specifically, the OAC CHV facilitates consumers' health information retrieval by enabling consumer-facing health applications to translate between professional language and consumer friendly language.",0
3332,7,What is OAC CHV?,"The Open Access and Collaborative Consumer Health Vocabulary (OAC CHV), which contains health-related terms used by lay consumers, has been created to bridge such a gap.",1
1085,0,How are human accelerated regions (HAR) defined?,regions in the human genome that show significant evolutionary acceleration,1
1085,1,How are human accelerated regions (HAR) defined?,"This identified Human Accelerated Region 1 (HAR1), a rapidly-evolving cis-antisense locus that is specifically transcribed in the nervous system",1
1085,2,How are human accelerated regions (HAR) defined?,We devised a ranking of regions in the human genome that show significant evolutionary acceleration,1
163,0,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"The synergistic effect of miR-21 and miR-1 were functionally validated for their significant influences on myocardial apoptosis, cardiac hypertrophy and fibrosis.",0
163,1,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Taken together, we found a novel reciprocal loop between miR-21 and TGFβRIII in cardiac fibrosis caused by myocardial infarction in mice, and targeting this pathway could be a new strategy for the prevention and treatment of myocardial remodeling.",0
163,2,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,It is still controversial whether microRNA-21 (miR-21) participates in the process of cardiac fibrosis.,0
163,3,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"In mice, myocardial miR-21 overexpression is related to cardiac fibrosis elicited by pressure overload.",0
163,4,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,The myocardial and plasma levels of miR-21 were significantly higher in the AS patients compared with the controls and correlated directly with the echocardiographic mean transvalvular gradients.,0
163,5,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,Our results support the role of miR-21 as a regulator of the fibrotic process that occurs in response to pressure overload in AS patients and underscore the value of circulating miR-21 as a biomarker for myocardial fibrosis.,0
163,6,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Ad-miR-21 improves LV remodeling and decreases the apoptosis of myocardial cells, suggesting the possible mechanism by which Ad-miR-21 functions in protecting against I/R injury.",0
163,7,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"In the Ad-miR-21 group, LV dimensions, myocardial infarct size, LV/BW, collagen type Ⅰ, type Ⅲ and PCNA positive cells all significantly decreased compared with the Ad-GFP group.",0
163,8,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"While miR-21, -133, -150, -195, and -214 regulate cardiomyocyte hypertrophy, miR-1/-133 and miR-208 have been elucidated to influence myocardial contractile function.",0
163,9,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"In addition, miR-21, -24, -133, -210, -494, and -499 appear to protect myocytes against I/R-induced apoptosis, whereas miR-1, -29, -199a, and -320 promote apoptosis.",0
163,10,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,Myocardial fibrosis can be regulated by the miR-29 family and miR-21.,0
163,11,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"The small regulatory RNA microRNA-21 (miR-21) plays a crucial role in a plethora of biological functions and diseases including development, cancer, cardiovascular diseases and inflammation.",0
163,12,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"During recent years, additional roles of miR-21 in cardiovascular and pulmonary diseases, including cardiac and pulmonary fibrosis as well as myocardial infarction have been described.",0
163,13,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"On the other hand, miR-21, miR-199a, miR-210, and miR-494 have been proven critical for the myocytes' adaptation and survival during hypoxia/ischemia.",0
163,14,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Studies have shown that several miRs, including miR-1, miR-133, miR-21, miR-126, miR-320, miR-92a, and miR-199a, are regulated after preconditioning and play an active role in protecting the heart against ischemia/reperfusion injury.",0
163,15,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Studies using various in vivo, ex vivo, and in vitro models have suggested the possible involvement of miR-1, miR-21, miR-29, miR-92a, miR-133, miR-199a, and miR-320 in ischemia-reperfusion injury and/or remodeling after myocardial infarction.",0
163,16,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular system.,1
163,17,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Recent studies have revealed that its expression is deregulated in heart and vasculature under cardiovascular disease conditions such as proliferative vascular disease, cardiac hypertrophy and heart failure, and ischemic heart disease.",1
163,18,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"miR-21 is found to play important roles in vascular smooth muscle cell proliferation and apoptosis, cardiac cell growth and death, and cardiac fibroblast functions.",1
163,19,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Accordingly, miR-21 is proven to be involved in the pathogenesis of the above-mentioned cardiovascular diseases as demonstrated by both loss-of-function and gain-of-function approaches.",1
163,20,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,miR-21 might be a novel therapeutic target in cardiovascular diseases.,0
163,21,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,This review article summarizes the research progress regarding the roles of miR-21 in cardiovascular disease.,0
163,22,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Remarkably, miR-21 was one of most upregulated miRNAs in hearts after IP.",0
163,23,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"In vivo, IP-mediated cardiac protection against ischaemia/reperfusion injury was inhibited by knockdown of cardiac miR-21.",0
163,24,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"In cultured cardiac myocytes, we identified that miR-21 also had a protective effect on hypoxia/reoxygenation-induced cell apoptosis that was associated with its target gene, programmed cell death 4.",0
163,25,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,The protective effect of miR-21 on cardiac cell apoptosis was further confirmed in rat hearts after ischaemia/reperfusion injury in vivo.,0
163,26,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Lately, some highlight articles revealed that the altered expression of miRNAs such as miR-1, miR-133, miR-21, miR-208 etc in hearts also contributed to cardiovascular diseases, such as heart ischemia, cardiac hypertrophy, and arrhythmias.",0
163,27,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Remarkably, miR-21 expression was significantly down-regulated in infarcted areas, but was up-regulated in border areas.",0
163,28,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"The down-regulation of miR-21 in the infarcted areas was inhibited by ischemic preconditioning, a known cardiac protective method.",0
163,29,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,Overexpression of miR-21 via adenovirus expressing miR-21 (Ad-miR-21) decreased myocardial infarct size by 29% at 24 h and decreased the dimension of left ventricles at 2 weeks after AMI.,0
163,30,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Using both gain-of-function and loss-of-function approaches in cultured cardiac myocytes, we identified that miR-21 had a protective effect on ischemia-induced cell apoptosis that was associated with its target gene programmed cell death 4 and activator protein 1 pathway.",0
163,31,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,The protective effect of miR-21 against ischemia-induced cardiac myocyte damage was further confirmed in vivo by decreased cell apoptosis in the border and infarcted areas of the infarcted rat hearts after treatment with Ad-miR-21.,0
163,32,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,The results suggest that miRNAs such as miR-21 may play critical roles in the early phase of AMI.,0
163,33,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,The results suggest that miR-21 is sensitive to H(2)O(2) stimulation.,0
163,34,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,miR-21 participates in H(2)O(2)-mediated gene regulation and functional modulation in cardiac myocytes.,0
163,35,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"miR-21 might play an essential role in heart diseases related to ROS such as cardiac hypertrophy, heart failure, myocardial infarction, and myocardial ischemia/reperfusion injury.",0
163,36,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts,0
163,37,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients,0
163,38,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis,0
163,39,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4,0
163,40,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular system.,1
163,41,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.,0
163,42,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular system,0
163,43,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,miR-21 might be a novel therapeutic target in cardiovascular diseases,0
163,44,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,MicroRNA-21 as therapeutic target in cancer and cardiovascular disease.,0
163,45,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,These findings reveal that microRNAs can contribute to myocardial disease by an effect in cardiac fibroblasts.,0
163,46,Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,Our results validate miR-21 as a disease target in heart failure and establish the therapeutic efficacy of microRNA therapeutic intervention in a cardiovascular disease setting.,0
1599,0,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,The yeast G protein alpha subunit Gpa1 represents a rare example of a protein that undergoes both mono- and poly-ubiquitination.,1
1599,1,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"Expression of p34 promotes PTEN poly-ubiquitination, leading to PTEN protein degradation, whereas p34 knockdown results in PTEN mono-ubiquitination.",0
1599,2,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"These fingers possess E3 activities of mono-ubiquitination and poly-ubiquitination, respectively, with ubiquitin-conjugating enzyme (E2)-binding capabilities.",1
1599,3,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"Instead of promoting poly-ubiquitination and degradation, we show that Smurf2 actually induces multiple mono-ubiquitination of Smad3 in vivo.",0
1599,4,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,mono-ubiquitination of CIITA dramatically increases its transactivity whereas poly-ubiquitination leads to CIITA degradation.,0
1599,5,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"This leads to a model in which Lys134 of LDB1 can be either mono-ubiquitinated, leading to stabilization, or poly-ubiquitinated, leading to degradation by the proteasome pathway.",1
1599,6,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?," mono-ubiquitination of CIITA increases its transactivity, whereas poly-ubiquitination of CIITA leads to its degradation",0
1599,7,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"PS1 ubiquitination after PI3K inhibition is represented by the multiple mono-ubiquitination, instead of poly-ubiquitination",0
1599,8,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,Our observations support a novel functional relationship between parkin and Hsc/Hsp70 and support the notion that parkin is a multi-purpose E3 ubiquitin ligase capable of modifying proteins either via attachment of alternatively linked poly-ubiquitin chains or through multiple mono-ubiquitination to achieve alternate biological outcomes,0
1599,9,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,our results indicate that Hsp70 facilitates CHIP-mediated poly-ubiquitination of Smad1 whereas it attenuates CHIP-meditated mono-ubiquitination of Smad1.,0
1599,10,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"Whereas poly-ubiquitination targets protein substrates for proteasomal degradation, mono-ubiquitination is known to regulate protein trafficking in the endosomal system and to target cargo proteins for lysosomal degradation.",0
1599,11,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"Our results suggest that oxidative stress induces not only poly-ubiquitination but also mono-ubiquitination of LDH-A, which may be involved in its lysosomal degradation during unloading.",1
1599,12,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"wild type Smad4 is a relatively stable protein that undergoes mono- or oligo-ubiquitination, a modification not linked to protein degradation",1
1599,13,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"These data suggest that oligo-ubiquitination positively regulates Smad4 function, whereas poly-ubiquitination primarily occurs in unstable cancer mutants and leads to protein degradation.",0
1599,14,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,We found that Ro52 was strongly conjugated by a single molecule of ubiquitin in cells.,0
1599,15,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,"Although the biological relevance of this mono-ubiquitination was not defined, the function of Ro52 might be modified by the mono-ubiquitination.",0
1599,16,Is there any protein that undergoes both mono-ubiquitination and poly-ubiquitination?,We also found that Ro52 was conjugated with poly-ubiquitin chain in cells (poly-ubiquitination),0
846,0,Can bioprinting use human cells?,"In this study, human adipose-derived stem cells (hASCs) were printed in a free-scalable 3D grid pattern by means of LaBP.",0
846,1,Can bioprinting use human cells?," Additionally, we provide the proof that even pre-differentiated hASCs could be utilized for the generation of 3D tissue grafts.",0
846,2,Can bioprinting use human cells?,"To explore the three dimensional(3D)bioprinting technology, using human dental pulp cells (hDPCs) mixture as bioink and to lay initial foundations for the application of the 3D bioprinting technology in tooth regeneration.",0
846,3,Can bioprinting use human cells?,"In this study, 3-D printable formulations of hybrid hydrogels are developed, based on methacrylated hyaluronic acid (Me-HA) and methacrylated gelatin (Me-Gel), and used to bioprint heart valve conduits containing encapsulated human aortic valvular interstitial cells (HAVIC).",0
846,4,Can bioprinting use human cells?,Bioprinting can be used to precisely position cells and cell-laden materials to generate controlled tissue architecture.,1
846,5,Can bioprinting use human cells?,"Bioprinting can be defined as the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies.",0
846,6,Can bioprinting use human cells?,"3D bioprinting has already been used for the generation and transplantation of several tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures.",0
846,7,Can bioprinting use human cells?,[Three dimensional bioprinting technology of human dental pulp cells mixtures].,1
846,8,Can bioprinting use human cells?,"To explore the three dimensional(3D)bioprinting technology, using human dental pulp cells (hDPCs) mixture as bioink and to lay initial  foundations for the application of the 3D bioprinting technology in tooth regeneration",0
846,9,Can bioprinting use human cells?,"Here we report the development of clinically relevant sized tissue analogs by 3-D bioprinting, delivering human nasal inferior turbinate tissue-derived mesenchymal progenitor cells encapsulated in silk fibroin-gelatin (SF-G) bioink",0
846,10,Can bioprinting use human cells?,"Sodium alginate hydrogel, stabilized with gelatin, is a suitable, biologically inert matrix that can be used for encapsulating and 3D bioprinting of bone-related SaOS-2 cells.",1
846,11,Can bioprinting use human cells?,Bioactive nanoparticles stimulate bone tissue formation in bioprinted three-dimensional scaffold and human mesenchymal stem cells.,0
846,12,Can bioprinting use human cells?,"OBJECTIVE: To explore the three dimensional(3D)bioprinting technology, using human dental pulp cells (hDPCs) mixture as bioink and to lay initial  foundations for the application of the 3D bioprinting technology in tooth regeneration.",0
846,13,Can bioprinting use human cells?,Cellular behavior in micropatterned hydrogels by bioprinting system depended on the cell types and cellular interaction.,0
846,14,Can bioprinting use human cells?,Engineering a morphogenetically active hydrogel for bioprinting of bioartificial tissue derived from human osteoblast-like SaOS-2 cells.,1
846,15,Can bioprinting use human cells?,"At the same time, the principal feasibility of bioprinting vascularized human organs as well as in vivo bioprinting has been demonstrated.",0
846,16,Can bioprinting use human cells?,"The bioprinting of complex 3D human tissues and constructs in vitro and especially in vivo are exciting, but long-term, applications.",0
846,17,Can bioprinting use human cells?,"Bioprinting can be defined as the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies.",0
846,18,Can bioprinting use human cells?,"In this study, the 3D bioprinting of hDPCs mixtures was  realized, thus laying initial foundations for the application of the 3D bioprinting technology in tooth regeneration.",0
846,19,Can bioprinting use human cells?,"To explore the three dimensional(3D)bioprinting technology, using human dental pulp cells (hDPCs) mixture as bioink and to lay initial  foundations for the application of the 3D bioprinting technology in tooth regeneration.",0
846,20,Can bioprinting use human cells?,"Furthermore, it is not known how human valve cells respond to these printed environments.",0
846,21,Can bioprinting use human cells?,"In this study, 3-D printable formulations of hybrid hydrogels are developed, based on methacrylated hyaluronic acid (Me-HA) and methacrylated gelatin (Me-Gel), and used to bioprint heart valve conduits containing encapsulated human aortic valvular interstitial cells (HAVIC).",0
846,22,Can bioprinting use human cells?,"To explore the three dimensional(3D)bioprinting technology, using human dental pulp cells (hDPCs) mixture as bioink and to lay initial  foundations for the application of the 3D bioprinting technology in tooth regeneration.",0
846,23,Can bioprinting use human cells?,[Three dimensional bioprinting technology of human dental pulp cells mixtures].,1
846,24,Can bioprinting use human cells?,"The bioprinting of complex 3D human tissues and constructs in vitro and especially in vivo are exciting, but long-term, applications.",0
846,25,Can bioprinting use human cells?,Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells.,0
846,26,Can bioprinting use human cells?,"Furthermore, it is not known how human valve cells respond to these printed environments.",0
846,27,Can bioprinting use human cells?,Engineering a morphogenetically active hydrogel for bioprinting of bioartificial tissue derived from human osteoblast-like SaOS-2 cells.,0
1559,0,Are the proteins Erbin (LAP2) and Merlin cooperating?,Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.,1
1559,1,Are the proteins Erbin (LAP2) and Merlin cooperating?,The results show that the epithelial-enriched protein Erbin controls the function of the NF2 tumor suppressor Merlin by determining the output of Merlin's physical interactions with active PAK2.,1
1559,2,Are the proteins Erbin (LAP2) and Merlin cooperating?,Erbin controls Merlin tumor suppressor function by switching the functional valence of PAK2 binding,1
4126,0,List the major royal jelly proteins in Apis mellifera.,"The exposure of nurse bees to pesticides reduced the expression of four of the major royal jelly proteins (MRJP1, MRJP2, MRJP4, and MRJP5)",1
4126,1,List the major royal jelly proteins in Apis mellifera.,The genome of the western honeybee (Apis mellifera) harbors nine transcribed major royal jelly protein genes (mrjp1-9) which originate from a single-copy precursor via gene duplication.,1
4126,2,List the major royal jelly proteins in Apis mellifera., The protein moiety of royal jelly comprises mostly major royal jelly proteins (MRJPs) of which the coding genes (mrjp1-9) have been identified on chromosome 11 in the honeybee's genome.,1
4126,3,List the major royal jelly proteins in Apis mellifera.,five belonged to the family of major royal jelly proteins 1-5,1
1369,0,Are microRNA (miR) regulated through DNA methylation of their promoters?,"We found that Tcf3 down-regulation in the context of constitutively active Wnt signaling does not result from promoter DNA methylation but is likely to be caused by a plethora of mechanisms at both the RNA and protein level as shown by the observed decrease in activating histone marks (H3K4me3 and H3-acetylation) and the upregulation of miR-211, a novel Wnt-regulated microRNA that targets Tcf3 and attenuates early neural differentiation in mouse ESCs",0
1369,1,Are microRNA (miR) regulated through DNA methylation of their promoters?,ene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation,0
1369,2,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Whereas a CpG island was identified within the promoter element of MIR22, no promoter DNA methylation was detected in these cells",0
1369,3,Are microRNA (miR) regulated through DNA methylation of their promoters?,xtensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia,0
1369,4,Are microRNA (miR) regulated through DNA methylation of their promoters?,Integration of DNA methylation and miRNA promoter data led to the identification of 128 recurrent miRNA targets for aberrant promoter DNA methylation,1
1369,5,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Together, our findings characterize the role of epigenetic changes in the regulation of miRNA transcription and create a repository of disease-specific promoter regions that may provide additional insights into the pathogenesis of CLL",0
1369,6,Are microRNA (miR) regulated through DNA methylation of their promoters?,NA methylation of microRNA genes in multiple myeloma,0
1369,7,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Recently, epigenetic dysregulation of tumor-suppressor miRNA genes by promoter DNA methylation has been implicated in human cancers, including multiple myeloma (MM)",1
1369,8,Are microRNA (miR) regulated through DNA methylation of their promoters?,ethylation of tumor suppressor microRNAs,0
1369,9,Are microRNA (miR) regulated through DNA methylation of their promoters?,Dysregulation of miRNA expression involved in cancer can be triggered by multiple mechanisms including aberrant DNA methylation of the miRNA gene promoter,1
1369,10,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Of note, DNA methylation of tumor suppressor miRNAs has been implicated in various human cancers",1
1369,11,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Moreover, miRNA silencing mediated by aberrant promoter DNA methylation can potentially be reversed by hypomethylating agents, and hence may pose a new therapeutic target in cancer",0
1369,12,Are microRNA (miR) regulated through DNA methylation of their promoters?," In this review, the authors will focus on the aberrant methylation of miRNAs in the pathogenesis of lymphoid malignancies including chronic lymphocytic leukemia, multiple myeloma and acute lymphoblastic leukemia",0
1369,13,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Here, we review those miRNAs implicated in AD that are regulated by promoter DNA methylation and/or chromatin modifications and, which frequently direct the expression of constituents of the epigenetic machinery, concluding with the delineation of a complex epigenetic-miRNA regulatory network and its alterations in AD",0
1369,14,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Furthermore, we also discuss epigenetic dysregulation of tumor-suppressor miRNA genes by promoter DNA methylation and the interaction of DNA methylation with miRNAs involved in the regulation of HSC activation and liver fibrosi",1
1369,15,Are microRNA (miR) regulated through DNA methylation of their promoters?,"Instead, the cell type-specific silencing of these genes is due to enhanced p21 mRNA degradation, 14-3-3sigma promoter DNA methylation and reduced processing of the miR-34a primary transcript",0
1369,16,Are microRNA (miR) regulated through DNA methylation of their promoters?,Some tumor-suppressive miRNAs are known to be epigenetically silenced by promoter DNA methylation in cancer,0
1369,17,Are microRNA (miR) regulated through DNA methylation of their promoters?,"In the present study, we aimed to identify miRNA genes that are silenced by DNA hypermethylation in hepatocellular carcinoma (HCC)",0
1369,18,Are microRNA (miR) regulated through DNA methylation of their promoters?,"It was found that miR-335, which is harbored within an intron of its protein-coding host gene, MEST, was downregulated by aberrant promoter hypermethylation via further methylation assays, including methylation-specific PCR, combined bisulfite and restriction analysis, bisulfite sequencing analysis and 5-aza-2'-deoxycytidine treatment",0
1369,19,Are microRNA (miR) regulated through DNA methylation of their promoters?,"he levels of miR-335/MEST methylation were significantly higher in 18 (90%) out of 20 primary HCC tumors, compared to their non-tumor tissue counterparts (P<0.001)",0
1369,20,Are microRNA (miR) regulated through DNA methylation of their promoters?,"In conclusion, our results indicate that expression of miR-335 is reduced by aberrant DNA methylation in HCC.",0
1678,0,Which is the process that Conserved noncoding elements mostly regulate?,"Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development.",1
1678,1,Which is the process that Conserved noncoding elements mostly regulate?,"This result suggests that there is widespread adaptation in mammalian conserved noncoding DNA elements, some of which have been implicated in the regulation of crucially important processes, including development.",1
1678,2,Which is the process that Conserved noncoding elements mostly regulate?,"Some characteristics of CNEs include their high frequency in mammalian genomes, their potential regulatory role in gene expression, and their enrichment in gene deserts nearby master developmental genes",0
1678,3,Which is the process that Conserved noncoding elements mostly regulate?,Animal genomes possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development.,0
1678,4,Which is the process that Conserved noncoding elements mostly regulate?,HCNEs of both human and zebrafish function as specific developmental enhancers in zebrafish.,0
1678,5,Which is the process that Conserved noncoding elements mostly regulate?,"HCNEs from the same area often drive overlapping patterns, suggesting that multiple regulatory inputs are required to achieve robust and precise complex expression patterns exhibited by developmental genes.",0
1678,6,Which is the process that Conserved noncoding elements mostly regulate?,"These results suggest important roles for SINEs in the development of the mammalian neuronal network, a part of which was initiated with the exaptation of AmnSINE1 in a common mammalian ancestor.",0
1678,7,Which is the process that Conserved noncoding elements mostly regulate?,Further positional analysis of these conserved noncoding elements (CNEs) in the genome demonstrates that they cluster around genes involved in developmental regulation.,1
1678,8,Which is the process that Conserved noncoding elements mostly regulate?,The majority of tetrapod-specific UCEs are noncoding and associated with genes involved in regulation of transcription and development.,0
1678,9,Which is the process that Conserved noncoding elements mostly regulate?,"Fish-mammal genomic comparisons have proved powerful in identifying conserved noncoding elements likely to be cis-regulatory in nature, and the majority of those tested in vivo have been shown to act as tissue-specific enhancers associated with genes involved in transcriptional regulation of development",1
1678,10,Which is the process that Conserved noncoding elements mostly regulate?,"In 74% of cases, we were able to assign a specific set of paralogous genes with annotation relating to transcriptional regulation and/or development to each family",0
1678,11,Which is the process that Conserved noncoding elements mostly regulate?,The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs).,1
1678,12,Which is the process that Conserved noncoding elements mostly regulate?,This suggests that HCNE-rich regions may contain key regulatory controls involved in development,0
4003,0,What is Hikikomori syndrome?," Hikikomori, from the Japanese words 'hiku' (to pull) and 'komoru' (to withdraw), is a clinical condition in which a subject locks himself/herself into his/her own house for more than 6 months.",1
4003,1,What is Hikikomori syndrome?,"The Characteristics and Social Functioning of Pathological Social Withdrawal, ""Hikikomori,"" in a Secondary Care Setting: a One-Year Cohort Study.",0
4003,2,What is Hikikomori syndrome?,"BACKGROUND: Pathological social withdrawal, named ""Hikikomori,"" is a Japanese culture-bound syndrome and a serious social problem in Japan.",1
4003,3,What is Hikikomori syndrome?,"Hikikomori, or severe social withdrawal, pertains to patients who have stopped participating in everyday routine and would spend the majority of time confined in their room for the period of 6 months or more, with no evident psychosis.",0
4003,4,What is Hikikomori syndrome?,The 'Hikikomori' syndrome (HS) consists of prolonged and severe social withdrawal,0
4003,5,What is Hikikomori syndrome?,"PURPOSE: To explore whether the 'hikikomori' syndrome (social withdrawal) described in Japan exists in other countries, and if so, how patients with the syndrome are diagnosed and treated.",0
4003,6,What is Hikikomori syndrome?,"This study aims to determine the socio-demographic and clinical features and possible clinical subtypes that predict the 12-month outcomes of cases with hikikomori syndrome, a severe form of social withdrawal.",0
4003,7,What is Hikikomori syndrome?,A 12-month study of the hikikomori syndrome of social withdrawal: Clinical characterization and different subtypes proposal.,0
4003,8,What is Hikikomori syndrome?,INTRODUCTION: The 'Hikikomori' syndrome (HS) consists of prolonged and severe social withdrawal.,0
4003,9,What is Hikikomori syndrome?,Does the 'hikikomori' syndrome of social withdrawal exist outside Japan?,0
4003,10,What is Hikikomori syndrome?,"In 1998 the Japanese psychiatrist Tamaki Sait¯o invented the term hikikomori, referring to a condition characterised by a state of social withdrawal and avoidance (education, work, friendships) combined with a persistent isolation and confinement in the own home for at least 6 months, due to various factors.",0
4003,11,What is Hikikomori syndrome?,Init,0
4003,12,What is Hikikomori syndrome?,"BACKGROUND: Pathological social withdrawal, named ""Hikikomori,"" is a Japanese culture-bound syndrome and a serious social problem",1
4003,13,What is Hikikomori syndrome?," history of social isolation, we diagnosed hikikomori syndrome according to the Japanese government's definition, which is as follows: lifestyle centered at home; no interest or willingness to attend school or work; persistence of symptoms beyond 6 months; and exclusion of other psychiatric and developmental disorders.",0
4003,14,What is Hikikomori syndrome?,Considering his,0
4003,15,What is Hikikomori syndrome?,INTRODUCTION: The 'Hikikomori' syndrome (HS) consists of prolonged and severe social,0
4003,16,What is Hikikomori syndrome?,"Hikikomori, a Japanese culture-bound syndrome of social withdrawal?",0
4003,17,What is Hikikomori syndrome?,"A form of severe social withdrawal, called hikikomori, has been frequently described in Japan and is characterized by adolescents and young adults who become recluses in their parents' homes, unable to work or go to school for months or years.",0
4003,18,What is Hikikomori syndrome?,T,0
4003,19,What is Hikikomori syndrome?,"n Japan, novel expressive forms of psychiatric phenomena such as ""modern-type depression"" and ""hikikomori"" (a syndrome of severe social withdrawal lasting for at least six months) have been reported especially among young people.",0
4003,20,What is Hikikomori syndrome?,Econom,0
4003,21,What is Hikikomori syndrome?,"BACKGROUND: Pathological social withdrawal, named ""Hikikomori,"" is a Japanese culture-bound syndrome and a serious social problem in Japan.",1
4003,22,What is Hikikomori syndrome?,"A form of severe social withdrawal, called hikikomori, has been frequently described in Japan and is characterized by adolescents and young adults who become recluses in their parents' homes, unable to work or go to school for months or years.",0
4003,23,What is Hikikomori syndrome?,"Hikikomori is a Japanese word describing a condition that mainly affects adolescents or young adults who live isolated from the world, cloistered within their parents' homes, locked in their bedrooms for days, months, or even years on end, and refusing to communicate even with their family.",0
4003,24,What is Hikikomori syndrome?,"However, a low ASA score was related to a psychological dysfunction in the Japanese cultural context; hikikomori symptoms, which are defined as a desire to remain in his or her own room and his or her understanding of this behavior in other people.",0
4003,25,What is Hikikomori syndrome?,Identification of the hikikomori syndrome of social withdrawal: Psychosocial features and treatment preferences in four countries.,0
4003,26,What is Hikikomori syndrome?,"PURPOSE: To explore whether the 'hikikomori' syndrome (social withdrawal) described in Japan exists in other countries, and if so, how patients with the syndrome are diagnosed and treated.M",0
4003,27,What is Hikikomori syndrome?,Does the 'hikikomori' syndrome of social withdrawal exist outside Japan?,0
4003,28,What is Hikikomori syndrome?,A preliminary international investigation.,0
4003,29,What is Hikikomori syndrome?,"Hikikomori, a Japanese culture-bound syndrome of social withdrawal?",0
4003,30,What is Hikikomori syndrome?,: A proposal for DSM-5.,0
4003,31,What is Hikikomori syndrome?,"Hikikomori, a severe form of social withdrawal syndrome, is a growing social issue in Japan and internationally.",0
4003,32,What is Hikikomori syndrome?,"BACKGROUND: Pathological social withdrawal, named ""Hikikomori,"" is a Japanese culture-bound syndrome and a serious social probl",0
4003,33,What is Hikikomori syndrome?,"OBJECTIVE: Hikikomori, from the Japanese words 'hiku' (to pull) and 'komoru' (to withdraw), is a clinical condition in which a subject locks himself/herself into his/her own house for more tha",1
4003,34,What is Hikikomori syndrome?,ea and the United States.,0
4003,35,What is Hikikomori syndrome?,"Hikikomori was defined as a 6-month or longer period of spending almost all time at home and avoiding social situations and social relationships, associated with signif",0
4003,36,What is Hikikomori syndrome?,"In 1998 the Japanese psychiatrist Tamaki Sait¯o invented the term hikikomori, referring to a condition characterised by a state of social withdrawal and avoidance (education, work, friendships) combined with a persistent isolation and confinement in the own home for at least 6 months, due to various factors.",0
4003,37,What is Hikikomori syndrome?,"PURPOSE: To explore whether the 'hikikomori' syndrome (social withdrawal) described in Japan exists in other countries, and if so, how patients with the syndrome are diagnosed and treated.METHODS: Two hikikomori case vignettes were sent to psychiatrists in Australia, Bangladesh, India, Iran, Japan, Korea, Taiwan, Tha",0
4003,38,What is Hikikomori syndrome?,"Hikikomori (social withdrawal that lasts six months or longer) is a growing problem among Japanese adolescents and young adults, with recent estimates that approximately 1% of Japanese youths will suffer from an episode of hikikomori in their lifetimes.",0
985,0,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"We compared the suppressive effect of K201 (JTV519), a multiple-channel blocker and cardiac ryanodine receptor-calcium release channel (RyR2) stabilizer, with that of diltiazem, a Ca(2+ )channel blocker, in 2 studies of isoproterenol-induced (n = 30) and ischemic-reperfusion-induced VAs (n = 38) in rats.",0
985,1,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"After administration of isoproterenol under Ca(2+) loading, fatal VA frequently occurred in the vehicle (9 of 10 animals, 90%) and diltiazem (8 of 10, 80%) groups, and K201 significantly suppressed the incidences of arrhythmia and mortality (2 of 10, 20%).",0
985,2,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"In the reperfusion study, the incidence and the time until occurrence of reperfusion-induced VA and mortality were significantly suppressed in the K201 (2 of 15 animals, 13%) and diltiazem (1 of 9 animals, 11%) groups compared to the vehicle group (8 of 14 animals, 57%).",0
985,3,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"K201 markedly suppressed both the isoproterenol-induced and the reperfusion-induced VAs, whereas diltiazem did not suppress the isoproterenol-induced VA.",0
985,4,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"JTV519 (K201) is a newly developed 1,4-benzothiazepine drug with antiarrhythmic and cardioprotective properties.",1
985,5,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,It appears to be very effective in not only preventing but also in reversing the characteristic myocardial changes and preventing lethal arrhythmias.,0
985,6,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"The novel antiarrhythmic drug K201 (4-[3-{1-(4-benzyl)piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine monohydrochloride) is currently in development for treatment of atrial fibrillation.",0
985,7,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"K201 not only controls intracellular calcium release by the ryanodine receptors, but also possesses a ventricular action that might predispose to torsade de pointes arrhythmias.",0
985,8,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"The RyR is currently used as a therapeutic target in malignant hyperthermia where dantrolene is effective and to relieve ventricular arrhythmia, with the use of JTV519 and flecainide.",0
985,9,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"Finally, KN-3 and JTV519, two compounds that stabilize RyR2 in the closed state, prevent the induction of triggered activity and suppress the inducibility of sustained AF.",0
985,10,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,JTV-519 greatly reduced the frequency of ouabain-induced arrhythmogenic events.,0
985,11,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,Stabilization of RyR2 by JTV-519 effectively reduces these triggered arrhythmias.,0
985,12,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,These findings may reveal the anti-arrhythmic potential of K201.,0
985,13,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,The preferential ryanodine receptor stabilizer (K201) possesses antiarrhythmic effects through calcium regulation.,1
985,14,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"The drug K201 (JTV-519) increases inotropy and suppresses arrhythmias in failing hearts, but the effects of K201 on normal hearts is unknown.",0
985,15,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,K201 fails to prevent DADs in RyR2(R4496C+/-) myocytes and ventricular arrhythmias in RyR2(R4496C+/-) mice,0
985,16,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,In vivo administration of K201 failed to prevent induction of polymorphic ventricular tachycardia (VT) in RyR2(R4496C+/-) mice.,0
985,17,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"The 1,4-benzothiazepine JTV519, which increases the binding affinity of calstabin-2 for RyR2, inhibited the diastolic SR Ca2+ leak, monophasic action potential alternans and triggered arrhythmias.",0
985,18,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"In arrhythmias, the calstabin2 stabiliser JTV519 did not prevent arrhythmias in calstabin2-/- mice, but reduced the arrhythmias in calstabin2+/- mice, illustrating the antiarrhythmic potential of stabilising calstablin2.",1
985,19,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"In three models of arrhythmias, the calstabin2 stabiliser JTV519 did not prevent arrhythmias in calstabin2(-/-) mice, but reduced the arrhythmias in calstabin2(+/-) mice, illustrating the antiarrhythmic potential of stabilising calstabin2.",1
985,20,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.",0
985,21,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"JTV-519 had significant protective effects on atrial fibrillation in the canine sterile pericarditis model, mainly by increasing effective refractory period, suggesting that it may have potential as a novel antiarrhythmic agent for atrial fibrillation.",0
985,22,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,"JTV-519 significantly decreased the mean number of sustained atrial fibrillation episodes (from 4.2 +/- 2.9 to 0 +/- 0, P < 0.01).",0
985,23,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,We conclude that JTV-519 can exert antiarrhythmic effects against AF by inhibiting repolarizing K(+) currents.,1
985,24,Is JTV519 (K201) a potential drug for the prevention of arrhythmias?,The drug may be useful for the treatment of AF in patients with ischaemic heart disease.,0
3189,0,Have apolipoprotein mimetics been used in clinical trials?,One of these (AEM-28) has recently been given orphan drug status and is undergoing clinical trials.,1
393,0,Is there an association between bruxism and reflux?,"Sleep bruxism is prevalent in GERD patients, and GERD is highly associated with SB.",1
393,1,Is there an association between bruxism and reflux?,There was a statistical trend towards tooth wear progression being associated with gastric risk factors (p < 0.05).,0
393,2,Is there an association between bruxism and reflux?,This article presents a case report of a 27-year-old male smoker with tooth wear and dentin sensitivity caused by GERD associated with bruxism.,1
393,3,Is there an association between bruxism and reflux?,"The aim of this cross-over, randomized, single-blinded trial was to examine whether intra-esophageal acidification induces sleep bruxism (SB).",0
393,4,Is there an association between bruxism and reflux?,RMMA episodes including SB were induced by esophageal acidification.,0
393,5,Is there an association between bruxism and reflux?,"Chronic regurgitation of gastric acids in patients with gastroesophageal reflux disease may cause dental erosion, which can lead in combination with attrition or bruxism to extensive loss of coronal tooth tissue.",1
393,6,Is there an association between bruxism and reflux?,This clinical report describes treatment of severe tooth wear of a gastroesophageal reflux disease patient who is 54-year-old Turkish male patient.,0
393,7,Is there an association between bruxism and reflux?,"After his medical treatment, severe tooth wear, bruxism and decreased vertical dimensions were determined.",0
393,8,Is there an association between bruxism and reflux?,"Gastroesophageal reflux disease by itself or in combination with attrition, abrasion or bruxism may be responsible for the loss.",1
393,9,Is there an association between bruxism and reflux?,"The association between bruxism, feeding and smoking habits and digestive disorders may lead to serious consequences to dental and related structures, involving dental alterations (wear, fractures and cracks), periodontal signs (gingival recession and tooth mobility) and muscle-joint sensitivity, demanding a multidisciplinary treatment plan.",0
393,10,Is there an association between bruxism and reflux?,"This paper presents a case report in which bruxism associated with acid feeding, smoking habit and episodes of gastric reflow caused severe tooth wear and great muscular discomfort with daily headache episodes.",0
393,11,Is there an association between bruxism and reflux?,"The frequencies of RMMA, single short-burst, and clenching episodes were significantly higher during decreased esophageal pH episodes than those during other times.",0
393,12,Is there an association between bruxism and reflux?,"These results suggest that most jaw muscle activities, ie, RMMA, single short-burst, and clenching episodes, occur in relation to gastroesophageal reflux mainly in the supine position.",0
393,13,Is there an association between bruxism and reflux?,"Nocturnal bruxism may be secondary to nocturnal gastroesophageal reflux, occurring via sleep arousal and often together with swallowing.",1
4,0,Is RANKL secreted from the cells?,Osteoprotegerin (OPG) is a soluble secreted factor that acts as a decoy receptor for receptor activator of NF-κB ligand (RANKL),1
4,1,Is RANKL secreted from the cells?,Osteoprotegerin (OPG) is a secreted glycoprotein and a member of the tumor necrosis factor receptor superfamily.,0
4,2,Is RANKL secreted from the cells?,"It usually functions in bone remodeling, by inhibiting osteoclastogenesis through interaction with a receptor activator of the nuclear factor κB (RANKL).",1
4,3,Is RANKL secreted from the cells?,"e RANKL/OPG ratio secreted by osteoblasts increased and RANK expression by osteoclasts increased, leading to increased osteoclastogenesis",0
4,4,Is RANKL secreted from the cells?,"Osteoprotegerin (OPG) is an essential secreted protein in bone turnover due to its role as a decoy receptor for the Receptor Activator of Nuclear Factor-kB ligand (RANKL) in the osteoclasts, thus inhibiting their differentiation",1
4,5,Is RANKL secreted from the cells?,We identify a TNFSF11 transcript variant that extends the originally identified transcript encoding secreted RANKL.,0
4,6,Is RANKL secreted from the cells?,Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL.,0
4,7,Is RANKL secreted from the cells?,"OPG, on the other hand, is secreted by osteoblast as a decoy receptor for RANKL, prevents RANKL from binding to RANK and thus prevents bone resorption",0
4,8,Is RANKL secreted from the cells?,Receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin (OPG) are cytokines predominantly secreted by osteoblasts and play a central role in differentiation and functional activation of osteoclasts,1
4,9,Is RANKL secreted from the cells?,"Although B. abortus-activated T cells actively secreted the pro-osteoclastogenic cytokines RANKL and IL-17, osteoclastogenesis depended on IL-17, because osteoclast generation induced by Brucella-activated T cells was completely abrogated when these cells were cultured with BMMs from IL-17 receptor knockout mice.",0
4,10,Is RANKL secreted from the cells?, osteoclastogenesis and bone destruction in autoimmune arthritis.,0
4,11,Is RANKL secreted from the cells?,"We isolated human fibroblasts from RA, pyrophosphate arthropathy (PPA) and osteoarthritis (OA) patients and analyzed their RANKL/OPG expression profile and the capacity of their secreted factors to induce osteoclastogenesis.",0
4,12,Is RANKL secreted from the cells?,Osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) are cytokines predominantly secreted by osteoblasts and play critical roles in the differentiation and function of osteoclasts.,1
1261,0,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?",The recently established reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) by Takahashi and Yamanaka represents a valuable tool for future therapeutic applications.,0
1261,1,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","In particular, the mechanisms how the Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc) directly drive reprogramming and which additional components are involved are still not yet understood.",1
1261,2,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","Here we show that Yamanaka factors (OCT4, SOX2, MYC, and KLF4)-expressing EV can also reprogram adult peripheral blood mononuclear cells (PBMNCs) into pluripotency, yet at a very low efficiency.",0
1261,3,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","The CytoTune™-iPS Reprogramming Kit contains four SeV-based reprogramming vectors, each capable of expressing one of the four Yamanaka factors (i.e., Oct4, Sox2, Klf4, and c-Myc) and are optimized for generating iPSCs from human somatic cells.",0
1261,4,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","Delivery of the transcription factors Oct4, Klf4, Sox2 and c-Myc via integrating viral vectors has been widely employed to generate induced pluripotent stem cell (iPSC) lines from both normal and disease-specific somatic tissues, providing an invaluable resource for medical research and drug development.",1
1261,5,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?",We demonstrate that residual expression of the Yamanaka factors prevents iPSCs from acquiring the transcriptional program exhibited by embryonic stem cells (ESCs) and that the expression profiles of iPSCs generated with and without c-Myc are indistinguishable.,0
1261,6,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","Fibroblasts can be reprogrammed into induced pluripotent stem cells (iPSCs) by the application of Yamanaka factors (OSKM), but the mechanisms underlying this reprogramming remain poorly understood.",1
1261,7,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","We also discovered that HMGA1 enhances cellular reprogramming of somatic cells to iPSCs together with the Yamanaka factors (OCT4, SOX2, KLF4, cMYC - OSKM).",0
1261,8,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, generating so-called induced pluripotent stem cells (iPSCs)(1-4).",1
1261,9,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?",We have shown the generation of transgene-free human iPSCs from patients with different lung diseases using a single excisable polycistronic lentiviral Stem Cell Cassette (STEMCCA) encoding the Yamanaka factors(6).,0
1261,10,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","These iPSCs were established in a feeder-free system by lentiviral transduction of the Yamanaka factors, Oct3/4, Sox2, Klf4, and c-Myc.",0
1261,11,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","Induced pluripotent stem cells (iPSCs) are created by the reprogramming of somatic cells via overexpression of certain transcription factors, such as the originally described Yamanaka factors: Oct4, Sox2, Klf4, and c-Myc (OSKM)",1
1261,12,"Which transcription factors are known as the four (4) ""Yamanaka factors"" that have been used to create induced pluripotent stem cells  (iPSCs)?","iPSC production was first achieved by transducing, with the use of retroviral vectors, four specific transcription factors: Oct4, Klf4, Sox2 and c-Myc (OKSM), into primary cells in culture Takahashi and Yamanaka, (Cell 126(4):663-676, 2006)",0
1777,0,Which gene-defect causes the Vel-blood type?,A cohort of 70 Vel- individuals was found to be uniformly homozygous for a 17 nucleotide deletion in the coding sequence of SMIM1.,1
1777,1,Which gene-defect causes the Vel-blood type?,"The SMIM1 protein carries the Vel blood group antigen, and homozygosity for a 17 bp deletion in the coding region of the SMIM1 gene represents the molecular basis of the Vel- blood group phenotype.",1
2498,0,Describe the RNA Centric Annotation System (RCAS),"Here, we present the RNA Centric Annotation System (RCAS), an R package, which is designed to ease the process of creating gene-centric annotations and analysis for the genomic regions of interest obtained from various RNA-based omics technologies.",1
2498,1,Describe the RNA Centric Annotation System (RCAS),"The design of RCAS is modular, which enables flexible usage and convenient integration with other bioinformatics workflows.",0
2498,2,Describe the RNA Centric Annotation System (RCAS),RCAS is an R/Bioconductor package but we also created graphical user interfaces including a Galaxy wrapper and a stand-alone web service.,0
2498,3,Describe the RNA Centric Annotation System (RCAS),The application of RCAS on published datasets shows that RCAS is not only able to reproduce published findings but also helps generate novel knowledge and hypotheses.,1
2498,4,Describe the RNA Centric Annotation System (RCAS),"The meta-gene profiles, gene-centric annotation, motif analysis and gene-set analysis provided by RCAS provide contextual knowledge which is necessary for understanding the functional aspects of different biological events that involve RNAs.",1
2498,5,Describe the RNA Centric Annotation System (RCAS),"In addition, the array of different interfaces and deployment options adds the convenience of use for different levels of users.",1
2498,6,Describe the RNA Centric Annotation System (RCAS),RCAS is available at http://bioconductor.org/packages/release/bioc/html/RCAS.html and http://rcas.mdc-berlin.de.,0
2498,7,Describe the RNA Centric Annotation System (RCAS),"Here, we present the RNA Centric Annotation System (RCAS), an R package, which is designed to ease the process of creating gene-centric annotations and analysis for the genomic regions of interest obtained from various RNA-based omics technologies.",1
2498,8,Describe the RNA Centric Annotation System (RCAS),RCAS: an RNA centric annotation system for transcriptome-wide regions of interest.,0
2498,9,Describe the RNA Centric Annotation System (RCAS),RCAS: an RNA centric annotation system for transcriptome-wide regions of interest.,0
1048,0,Which diseases are associated with Alu element insertion?,Alu elements are known to be the source of microsatellite repeats responsible for two other repeat expansion disorders: Friedreich ataxia and spinocerebellar ataxia type 10.,1
1048,1,Which diseases are associated with Alu element insertion?,We identified an Alu-element insertion located in intron 7 of OPA1 causing an in-frame deletion of exon 8 in 18 family members.,0
1048,2,Which diseases are associated with Alu element insertion?,Autosomal dominant optic atrophy (ADOA) is the most common form of hereditary optic neuropathy caused by mutations in the optic atrophy 1 (OPA1) gene.,1
1048,3,Which diseases are associated with Alu element insertion?,"However, this is the first report of a pathogenic OPA1 gene mutation resulting from an Alu insertion.",0
1048,4,Which diseases are associated with Alu element insertion?,The first reported case of Menkes disease caused by an Alu insertion mutation,0
1048,5,Which diseases are associated with Alu element insertion?,We present the first reported case of Menkes disease caused by an Alu element insertion mutation that interfered with splicing regulatory elements.,1
1048,6,Which diseases are associated with Alu element insertion?,HIGM syndrome caused by insertion of an AluYb8 element in exon 1 of the CD40LG gene,0
1048,7,Which diseases are associated with Alu element insertion?,A new mutation of the CD40LG gene that encodes the CD40 ligand molecule was characterized in a young patient harboring a hyper-IgM with immunodeficiency syndrome.,1
1048,8,Which diseases are associated with Alu element insertion?,Inactivation of CD40LG gene resulted from the insertion of an AluYb8 element in exon 1 responsible for a total deficiency of CD40 ligand expression by T lymphocytes.,0
1048,9,Which diseases are associated with Alu element insertion?,Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary,1
1048,10,Which diseases are associated with Alu element insertion?,"One patient, who also has retinal coloboma, carries a HESX1 defect in the homozygous state: an Alu insertion in exon 3, a sequence that encodes the major part of the homeodomain.",0
1048,11,Which diseases are associated with Alu element insertion?,Anterior pituitary aplasia is a new example of a human disease caused by a germline retrotransposition event involving an Alu sequence.,0
1048,12,Which diseases are associated with Alu element insertion?,Myotonic dystrophy (DM) is associated with abnormal expansions of the CTG repeats in the 3' untranslated region of its gene.,0
1048,13,Which diseases are associated with Alu element insertion?,Previous studies in individuals of European origin demonstrated strong linkage disequilibrium between different CTG repeat length alleles and an Alu element insertion/deletion polymorphism in intron 8 of the DM gene,0
2398,0,What protein is the most common cause of hereditary  renal amyloidosis?,"ibrinogen A alpha chain amyloidosis is an autosomal dominant disease associated with mutations in the fibrinogen A alpha chain (FGA) gene, and it is the most common cause of hereditary renal amyloidosis in the UK",1
2398,1,What protein is the most common cause of hereditary  renal amyloidosis?,Hereditary renal amyloidosis is an autosomal dominant condition with considerable overlap with other amyloidosis type,0
2398,2,What protein is the most common cause of hereditary  renal amyloidosis?,"We suspected amyloidosis with fibrinogen A alpha chain deposits, which is the most frequent cause of hereditary amyloidosis in Europe, with a glomerular preferential affectation.",0
2398,3,What protein is the most common cause of hereditary  renal amyloidosis?,Three members of a family who died with renal amyloidosis were found to share a single nucleotide substitution in the fibrinogen alpha-chain gene.,0
2398,4,What protein is the most common cause of hereditary  renal amyloidosis?,A French kindred with autosomal dominant hereditary renal amyloidosis was found to have a novel mutation in the fibrinogen Aalpha-chain gene.,0
2398,5,What protein is the most common cause of hereditary  renal amyloidosis?,Two families with hereditary renal amyloidosis were found to have a novel mutation in the fibrinogen A alpha chain gene.,0
2398,6,What protein is the most common cause of hereditary  renal amyloidosis?,"The predominant cause of hereditary renal amyloidosis is a mutation of the fibrinogen Aalpha chain (AFib), the most common being the E526V mutation.",1
2398,7,What protein is the most common cause of hereditary  renal amyloidosis?,Discovery of this new mutation confirms the association between fibrinogen A alpha chain variant and hereditary renal amyloidosis and establishes a new biochemical subtype of amyloidosis.,0
2398,8,What protein is the most common cause of hereditary  renal amyloidosis?,Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain.,0
2398,9,What protein is the most common cause of hereditary  renal amyloidosis?,Mutations in the fibrinogen Aα-chain genes are the most common cause of hereditary renal amyloidosis.,1
2398,10,What protein is the most common cause of hereditary  renal amyloidosis?,Mutant fibrinogen A-alpha-chain associated with hereditary renal amyloidosis and peripheral neuropathy.,0
2398,11,What protein is the most common cause of hereditary  renal amyloidosis?,Mutations in the fibrinogen A alpha-chain gene are the most common cause of hereditary renal amyloidosis in the United Kingdom.,1
2398,12,What protein is the most common cause of hereditary  renal amyloidosis?,"Introduction Fibrinogen A alpha chain amyloidosis is an autosomal dominant disease associated with mutations in the fibrinogen A alpha chain (FGA) gene, and it is the most common cause of hereditary renal amyloidosis in the UK.",0
2398,13,What protein is the most common cause of hereditary  renal amyloidosis?,Mutations in the fibrinogen Aα-chain genes are the most common cause of hereditary renal amyloidosis.,1
2398,14,What protein is the most common cause of hereditary  renal amyloidosis?,Hereditary amyloidosis with predominant renal disease can be caused by mutations in the gene encoding the fibrinogen Aα-chain (AFib),0
2983,0,List uniparental disomy (UPD) detection algorithms,UPDtool: a tool for detection of iso- and heterodisomy in parent-child trios using SNP microarrays.,1
2983,1,List uniparental disomy (UPD) detection algorithms,UPDtool is a computational tool for detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments.,1
2983,2,List uniparental disomy (UPD) detection algorithms,"The performance of the new algorithm, called ""AsCNAR"" (allele-specific copy-number analysis using anonymous references), was demonstrated by detecting the copy-number neutral LOH, or uniparental disomy (UPD), in a large number of acute leukemia samples.",1
2983,3,List uniparental disomy (UPD) detection algorithms,"We next applied this technique to detection of UPD involving the 9p arm in myeloproliferative disorders (MPDs), which is tightly associated with a homozygous JAK2 mutation.",1
2983,4,List uniparental disomy (UPD) detection algorithms,It revealed an unexpectedly high frequency of 9p UPD that otherwise would have been undetected and also disclosed the existence of multiple subpopulations having distinct 9p UPD within the same MPD specimen.,0
2983,5,List uniparental disomy (UPD) detection algorithms,"In conclusion, AsCNAR should substantially improve our ability to dissect the complexity of cancer genomes and should contribute to our understanding of the genetic basis of human cancers.",0
2983,6,List uniparental disomy (UPD) detection algorithms,"Our results were compared with both the gold standard, microsatellite analysis and SNPtrio, another program available for UPD detection.",1
2983,7,List uniparental disomy (UPD) detection algorithms,"Our results were compared with both the gold standard, microsatellite analysis and SNPtrio, another program available for UPD detection.",0
1061,0,Which proteins have been identified as RET ligands?,"Polymorphisms in the genes encoding the 4 RET ligands, GDNF, NTN, ARTN, PSPN, and susceptibility to Hirschsprung disease",0
1061,1,Which proteins have been identified as RET ligands?,"Given the pivotal role of RET in HSCR, the genes encoding their ligands (GDNF, NRTN, ARTN, and PSPN) are also good candidates for the disease.",0
1061,2,Which proteins have been identified as RET ligands?,"Indeed, the RET ligands persephin and GDNF robustly stimulated calcitonin mRNA, which was blocked by pretreatment with NVP-AST487",0
1061,3,Which proteins have been identified as RET ligands?,"The ligands bind RET through GDNF family receptor alpha, termed GFRalpha1-4",0
1061,4,Which proteins have been identified as RET ligands?,"RET is activated by members of the glial cell line-derived neurotrophic factor (GDNF) family of ligands, which include GDNF, neurturin, artemin, and persephin",1
1061,5,Which proteins have been identified as RET ligands?,GDNF availability determines enteric neuron number by controlling precursor proliferation,0
1061,6,Which proteins have been identified as RET ligands?,"Five germline mutations in the glial cell-line-derived neurotrophic factor (GDNF) gene, one of the RET ligands, have been detected in HSCR patients.",1
1061,7,Which proteins have been identified as RET ligands?,The glial-cell-line-derived neurotrophic factor (GDNF) family receptors alpha (GFRalpha) are cell surface bound glycoproteins that mediate interactions of the GDNF ligand family with the RET receptor,0
1061,8,Which proteins have been identified as RET ligands?,"In particular, the recent identification of neurotrophic factors acting as RET ligands (GDNF and Neurturin) provide additional candidate genes for HSCR.",0
1061,9,Which proteins have been identified as RET ligands?,"Mutations in genes that encode RET ligands (GDNF and NTN); components of another signaling pathway (EDNRB, EDN3, ECE-1); and the transcription factor, SOX10, have been identified in HSCR patients.",0
1061,10,Which proteins have been identified as RET ligands?,"Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas",0
1061,11,Which proteins have been identified as RET ligands?,"Mutations in the GDNF gene, and encoding one of the RET ligands, either alone or in combination with RET mutations, can also cause HSCR, as can mutations in four other genes (EDN3, EDNRB, ECE1, and SOX10)",0
1061,12,Which proteins have been identified as RET ligands?,"In particular, the recent identification of neurotrophic factors acting as RET ligands (GDNF and Neurturin) provide additional candidate genes for HSCR.",0
1061,13,Which proteins have been identified as RET ligands?,Ret ligands have been recently identified as the neuron survival factor GDNF (Glial-Derived Neurotrophic Factor) and Neurturin.,0
1061,14,Which proteins have been identified as RET ligands?,"Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease",0
1061,15,Which proteins have been identified as RET ligands?,"Considering that RET and glial cell line-derived neurotrophic factor (GDNF) mutations have been reported in the disease, we regarded the other RET ligand, neurturin (NTN), as an attractive candidate gene, especially as it shares large homologies with GDNF",0
1061,16,Which proteins have been identified as RET ligands?,"Given the pivotal role of RET in HSCR, the genes encoding their ligands (GDNF, NRTN, ARTN, and PSPN) are also good candidates for the disease",0
1061,17,Which proteins have been identified as RET ligands?,"The c-ret protooncogene, RET, encodes a receptor tyrosine kinase.",0
1061,18,Which proteins have been identified as RET ligands?,"RET is activated by members of the glial cell line-derived neurotrophic factor (GDNF) family of ligands, which include GDNF, neurturin, artemin, and persephin",1
1061,19,Which proteins have been identified as RET ligands?,"Glial cell line-derived neurotrophic factor (GDNF), a ligand of RET tyrosine kinase, and its family ligands promote the survival and differentiation of a variety of neurons.",0
1061,20,Which proteins have been identified as RET ligands?,"We demonstrate here that, after injury, the absence of c-Jun specifically in SCs caused impaired axonal regeneration and severely increased neuronal cell death.",0
1061,21,Which proteins have been identified as RET ligands?,"c-Jun deficiency resulted in decreased expression of several neurotrophic factors, and GDNF and Artemin, both of which encode ligands for the Ret receptor tyrosine kinase, were identified as novel direct c-Jun target genes.",0
1061,22,Which proteins have been identified as RET ligands?,"GDNF, now known to be the first identified member of a family of factors, signals through the previously known receptor tyrosine kinase, Ret.",0
1061,23,Which proteins have been identified as RET ligands?,"Unlike most ligands for receptor tyrosine kinases, GDNF does not bind and activate Ret directly, but requires the presence of GPI-linked coreceptors.",0
1061,24,Which proteins have been identified as RET ligands?,"BACKGROUND/PURPOSE: In 1996, the glial cell line-derived neurotrophic factor (GDNF) was identified as one of the ligands of the RET transmembrane receptor.",0
1061,25,Which proteins have been identified as RET ligands?,The ret proto-oncogene encodes a receptor tyrosine kinase whose ligands belong to the glial cell line-derived neurotrophic factor (GDNF) protein family.,1
1061,26,Which proteins have been identified as RET ligands?,"RET is activated by members of the glial cell line-derived neurotrophic factor (GDNF) family of ligands, which include GDNF, neurturin, artemin, and persephin.",1
1061,27,Which proteins have been identified as RET ligands?,Ret ligands have been recently identified as the neuron survival factor GDNF (Glial-Derived Neurotrophic Factor) and Neurturin,0
1061,28,Which proteins have been identified as RET ligands?,"Glial cell line-derived neurotrophic factor (GDNF) and its receptor molecule GDNFR-alpha, have recently been identified as members of the RET ligand binding complex",0
1061,29,Which proteins have been identified as RET ligands?,"Recently, the Glial cell line-derived neurotrophic factor (GDNF) has been identified to be a ligand for RET",0
1061,30,Which proteins have been identified as RET ligands?,Replacing short segments of GDNF with the homologous segments from persephin (PSPN) (which cannot bind or activate GFRalpha1.RET or GFRalpha2.RET) identified sites along the second finger of GDNF critical for activating the GFRalpha1.RET and GFRalpha2.RET receptor complexes,0
1061,31,Which proteins have been identified as RET ligands?,GDNF mediates its actions through a multicomponent receptor system composed of a ligand-binding glycosyl-phosphatidylinositol (GPI)-linked protein (designated GDNFR-alpha) and the transmembrane protein tyrosine kinase Ret,0
1370,0,Are nucleosomes positioned at DNA replication origins?,yeast origins are characterized by an asymmetric pattern of positioned nucleosomes flanking the ACS.,1
1370,1,Are nucleosomes positioned at DNA replication origins?,"The origin sequences are sufficient to maintain a nucleosome-free origin; however, ORC is required for the precise positioning of nucleosomes flanking the origin.",1
1370,2,Are nucleosomes positioned at DNA replication origins?,"Here, we identify nucleosome occupancy as a likely candidate to set up ORI distribution",0
1370,3,Are nucleosomes positioned at DNA replication origins?,"we demonstrate that open chromatin domains, characterized by nucleosome depletion, are preferentially permissive for replication",1
1370,4,Are nucleosomes positioned at DNA replication origins?,Nucleosome assembly of the template prevented DNA replication.,1
1370,5,Are nucleosomes positioned at DNA replication origins?,Replication of chromosomes was severely inhibited at more than two-thirds of physiological nucleosome density,1
839,0,Are seizures among the neurological symptoms of incontinentia pigmenti?,High-dose glucocorticoid therapy in the management of seizures in neonatal incontinentia pigmenti,0
839,1,Are seizures among the neurological symptoms of incontinentia pigmenti?,Incontinentia pigmenti is an X-linked dominant disorder resulting from a mutation of IKBKG.,1
839,2,Are seizures among the neurological symptoms of incontinentia pigmenti?,"This disorder has a classic dermatologic presentation, but neurologic involvement, with seizures and cortical infarction, can arise shortly after birth",1
839,3,Are seizures among the neurological symptoms of incontinentia pigmenti?,"Some children with incontinentia pigmenti exhibit encephalopathic features with severe seizures and disturbed consciousness, from the neonatal through the early infantile period",0
839,4,Are seizures among the neurological symptoms of incontinentia pigmenti?,"Incontinentia pigmenti (IP) is a rare X-linked dominant neurocutaneous disorder affecting ectodermal tissue: skin, eyes, central nervous system, hair, nails, and teeth.",1
839,5,Are seizures among the neurological symptoms of incontinentia pigmenti?,It is usually lethal for males in utero.,0
839,6,Are seizures among the neurological symptoms of incontinentia pigmenti?,"The involved gene is NEMO, an essential component of the nuclear factor-kappa B (NF-κB) signaling pathway.",0
839,7,Are seizures among the neurological symptoms of incontinentia pigmenti?,"Skin lesions are highly diagnostic, occurring in neonates, with a particular distribution on Blaschko lines.",0
839,8,Are seizures among the neurological symptoms of incontinentia pigmenti?,The severity of the disease is related to ocular and neurological impairment.,0
839,9,Are seizures among the neurological symptoms of incontinentia pigmenti?,"The hallmark of ocular IP is retinal vasculopathy including peripheral retinal vascular nonperfusion, macular infarction and neovascularization, and preretinal neovascularization.",0
839,10,Are seizures among the neurological symptoms of incontinentia pigmenti?,"CNS involvement consists of seizures, mental retardation, hemiparesis, spasticity, microcephaly, cerebellar ataxia, and coma",0
839,11,Are seizures among the neurological symptoms of incontinentia pigmenti?,Incontinentia Pigmenti is a rare X-linked multisystem disorder with well described and pathognomonic skin manifestations.,1
839,12,Are seizures among the neurological symptoms of incontinentia pigmenti?,"Neurological manifestations are found in 30% of IP patients, forming one of the major causes of morbidity and mortality of the condition.",0
839,13,Are seizures among the neurological symptoms of incontinentia pigmenti?,"In this review, clinical and brain imaging data of 45 IP patients with a neurological phenotype are reviewed.",0
839,14,Are seizures among the neurological symptoms of incontinentia pigmenti?,"Several clinical presentations could be identified, comprising seizures, infantile encephalopathy, acute disseminated encephalomyelitis and ischemic stroke",0
839,15,Are seizures among the neurological symptoms of incontinentia pigmenti?,Incontinentia pigmenti presenting as seizures.,0
839,16,Are seizures among the neurological symptoms of incontinentia pigmenti?,Neonatal seizures in two sisters with incontinentia pigmenti.,0
839,17,Are seizures among the neurological symptoms of incontinentia pigmenti?,High-dose glucocorticoid therapy in the management of seizures in neonatal incontinentia pigmenti: a case report.,0
839,18,Are seizures among the neurological symptoms of incontinentia pigmenti?,"Incontinentia Pigmenti is an X-linked dominant neurocutaneous disorder with central nervous system manifestations in 30% of cases, including seizures and mental retardation.",1
839,19,Are seizures among the neurological symptoms of incontinentia pigmenti?,Neonatal seizures in two sisters with incontinentia pigmenti,0
839,20,Are seizures among the neurological symptoms of incontinentia pigmenti?,A rare cause of neonatal seizure: incontinentia pigmenti.,0
839,21,Are seizures among the neurological symptoms of incontinentia pigmenti?,"Here, we describe the clinical, electrographic, and neuroradiologic effect of systemic glucocorticoid therapy in a neonate with incontinentia pigmenti manifesting an epileptic encephalopathy.",0
839,22,Are seizures among the neurological symptoms of incontinentia pigmenti?,Incontinentia pigmenti presenting as seizures.,0
839,23,Are seizures among the neurological symptoms of incontinentia pigmenti?,Neonatal seizures in two sisters with incontinentia pigmenti.,0
2729,0,"What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.", two potential reversal agents for oral direct factor Xa inhibitors (andexanet alfa and ciraparantag) are at various stages of clinical development.,1
2729,1,"What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.","Idarucizumab, a reversal agent for the oral direct thrombin inhibitor dabigatran, was approved by FDA in October 2015.",1
2729,2,"What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",Idarucizumab and andexanet alfa have been reported to produce anticoagulation reversal effects within minutes of administration.,1
2729,3,"What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.","Idarucizumab has recently been approved in United States for dabigatran reversal, whereas andexanet alfa is expected to get approved in the near future for reversal of oral factor Xa inhibitors.",0
2729,4,"What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."," Aripazine has shown promising results to reverse the effects of LMWH, fondaparinux, and direct oral anticoagulants but is still in the developmental phase.",1
2729,5,"What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",Protamine sulfate reverses the effect of unfractionated heparin completely and of low-molecular-weight heparin (LMWH) partially.,1
2729,6,"What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."," working out pharmaceutical agents (andexanet alpha, idarucizumab, aripazine) being antidotes to direct thrombin inhibitor and the factor Xa inhibitors.",0
3790,0,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,The 16569 base pairs of the mitochondrial DNA,1
3790,1,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"BACKGROUND: Somatic mutations of mitochondrial DNA (mtDNA) are increasingly being recognized in many human cancers, but automated sequencing of 16.5 kb of DNA poses an onerous task.",0
3790,2,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"The human mitochondrial genome consists of a multicopy, circular dsDNA molecule of 16,569 base pairs.",1
3790,3,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"In addition to the 3 billion base pair nuclear genome, each human cell contains thousands of copies of a small, 16.5 kb circular molecule of double stranded DNA: mitochondria have their own DNA (mtDNA) which generally accounts for only 1% of the total cellular nucleic acid content.",0
3790,4,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,The,0
3790,5,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"ntrast, human cells contain hundreds to thousands of copies of a ca.16 kB mtDNA genome tightly packed with 13 protein-coding genes along with rRNA and tRNA genes required for their expression.",0
3790,6,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,The,0
3790,7,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"Human mitochondria harbor an essential, high copy number, 16,569 base pair, circular DNA genome that encodes 13 gene products required for electron transport and oxidative phosphorylation.",0
3790,8,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,M,0
3790,9,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"The small (16,569 base pair) human mitochondrial genome plays a significant role in cell metabolism and homeostasis.",1
3790,10,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"Human mitochondria harbor an essential, high copy number, 16,569 base pair, circular DNA genome that encodes 13 gene products required for electron transport and oxidative phosphorylation.",0
3790,11,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"Mammalian mitochondrial DNA (mtDNA) is a circular double-stranded DNA genome of ~16.5 kilobase pairs (kb) that encodes 13 catalytic proteins of the ATP-producing oxidative phosphorylation system (OXPHOS), and the rRNAs and tRNAs required for the translation of the mtDNA transcripts.",0
3790,12,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"Mitochondrial DNA (mtDNA) is a circular, double-stranded, 16,569-base paired DNA containing 37 genes: 13 proteins of the mitochondrial respiratory chain, two ribosomal RNAs (rRNAs; 12S and 16S), and 22 transfer RNAs (tRNAs).",0
3790,13,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"The mitochondrial genome of humans and most vertebrates is approximately 16.5kbp, double-stranded, circular, with few non-coding bases.",1
3790,14,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"In humans, mitochondrial DNA (mtDNA) is a 16,569-bp double-stranded circular molecule, encoding 37 genes, and is exclusively transmitted from the mother.",0
3790,15,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"They are maternally inherited and in humans contain a 16,569-base-pair circular genome (mtDNA) encoding 37 genes required for oxidative phosphorylation.",0
3790,16,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,Mitochondrial DNA mutations range from single base pair changes in the 16.5 kilobase pair genome up to large deletions and rearrangements.,0
3790,17,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"In contrast, human cells contain hundreds to thousands of copies of a ca.16 kB mtDNA genome tightly packed with 13 protein-coding genes along with rRNA and tRNA genes required for their expression.",0
3790,18,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"For comprehensive mutation scanning of the whole 16.569 bp human mitochondrial genome, we developed a set of 67 primer pairs defining overlapping PCR fragments that are well suited for heteroduplex analysis.",0
3790,19,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,"Human mitochondrial DNA, the 25th chromosome, is a 16 569 base pair long circular molecule, that encoders a variety of genes for the translational machinery of the mitochondrion, as well as 13 structural proteins, that are all subunits of the respiratory chain (RC).",0
3790,20,Roughly how many base pairs are in the human mitochondrial genome or mtDNA?,Mitochondrial DNA mutations range from single base changes in the 16.5 kilobase-pair genome up to large deletions and rearrangements.,1
4047,0,What is the role of elagolix in treatment of uterine fibroids?,"One of them, Elagolix, is in the early stages of testing in women with fibroids.",0
4047,1,What is the role of elagolix in treatment of uterine fibroids?,"Recently, elagolix received US FDA approval for the treatment of moderate to severe pain caused by endometriosis.",1
4047,2,What is the role of elagolix in treatment of uterine fibroids?,Several clinical trials assessed the efficacy of elagolix for the treatment of heavy bleeding caused by UFs and the definitive results of Phase III studies are expected.,0
4047,3,What is the role of elagolix in treatment of uterine fibroids?,"INTRODUCTION: Elagolix is a novel, orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist in development for the management of endometriosis with associated pain and heavy menstrual bleeding due to uterine fibroids.",0
4047,4,What is the role of elagolix in treatment of uterine fibroids?,"In July 2018, the US FDA approved elagolix tablets for the management of moderate to severe pain associated with endometriosis.",1
4047,5,What is the role of elagolix in treatment of uterine fibroids?,Elagolix with and without low-dose hormone add-back therapy is also undergoing phase III clinical development for heavy menstrual bleeding associated with uterine fibroids in the aforementioned locations.,0
4047,6,What is the role of elagolix in treatment of uterine fibroids?,Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.,0
4047,7,What is the role of elagolix in treatment of uterine fibroids?,CONCLUSION(S): Elagolix significantly reduced heavy menstrual bleeding in women with fibroids.,0
4047,8,What is the role of elagolix in treatment of uterine fibroids?,Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.,0
4047,9,What is the role of elagolix in treatment of uterine fibroids?,CONCLUSIONS: Elagolix with add-back therapy was effective in reducing heavy menstrual bleeding in women with uterine fibroids.,0
4047,10,What is the role of elagolix in treatment of uterine fibroids?,"In Elaris Uterine Fibroids 1 and Uterine Fibroids 2, 2 replicate multicenter, double-blind, randomized, placebo-controlled, phase 3 studies, treatment of premenopausal women with elagolix with hormonal add-back therapy demonstrated reduction in heavy menstrual bleeding associated with uterine fibroids.",0
4047,11,What is the role of elagolix in treatment of uterine fibroids?,CONTEXT: Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist recently approved for the treatment of endometriosis-associated pain and being developed for heavy menstrual bleeding associated with uterine fibroids.,1
4047,12,What is the role of elagolix in treatment of uterine fibroids?,Elagolix coadministered with estradiol/norethindrone acetate is in late-stage development for the management of heavy menstrual bleeding associated with uterine fibroids.,0
4047,13,What is the role of elagolix in treatment of uterine fibroids?,CONTEXT: Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist recently approved for the treatment of endometriosis-associated pain and being developed for heavy menstrual bleeding associated with uterine fib,1
4047,14,What is the role of elagolix in treatment of uterine fibroids?,Elagolix is an oral gonadotropin-releasing hormone receptor antagonist indicated for the management of endometriosis-associated pain and in combination with estradiol/norethindrone acetate indicated for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.,0
4047,15,What is the role of elagolix in treatment of uterine fibroids?,Ela,0
4047,16,What is the role of elagolix in treatment of uterine fibroids?,CONTEXT: Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist recently approved for the treatment of endometriosis-associated pain and being developed for heavy menstrual bleeding associated with uterine f,1
4047,17,What is the role of elagolix in treatment of uterine fibroids?,"In Elaris Uterine Fibroids 1 and Uterine Fibroids 2, 2 replicate multicenter, double-blind, randomized, placebo-controlled, phase 3 studies, treatment of premenopausal women with elagolix with hormonal add-back therapy demonstrated reduction in heavy menstrual bleeding associated with uterine fibroids.O",0
4047,18,What is the role of elagolix in treatment of uterine fibroids?, ovulation.,0
4047,19,What is the role of elagolix in treatment of uterine fibroids?,"In Elaris Uterine Fibroids 1 and Uterine Fibroids 2, 2 replicate multicenter, double-blind, randomized, placebo-controlled, phase 3 studies, treatment of premenopausal women with elagolix with hormonal add-back therapy demonstrated reduction in heavy menstrual bleeding associated with uterine fibroids.OBJECTIVE: This analysis aimed to evaluate the safety and efficacy of elagolix (300 mg twice a day) with add-back therapy (1 mg estradiol/0.5 mg norethindrone acetate once a day) in reducing heavy menstrual bleeding associated with uterine fibroids in various subgroups of women over 6 months of treatment.STUDY DESIGN: Data were pooled from Elaris Uterine Fibroid-1 and Uterine Fibroid-2 studies, which evaluated premenopausal women (18-51 years) with heavy menstrual bleeding (>80 mL menstrual blood loss per cycle, alkaline hematin methodology) and ultrasound",0
4047,20,What is the role of elagolix in treatment of uterine fibroids?,"CONTEXT: Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist recently approved for the treatment of endometriosis-associated pain and being developed for heavy menstrual bleeding associated with uterine fibroids.OBJECTIVE: The objective was to evaluate the effects of elagolix on ovulation and ovarian sex hormones.DESIGN AND SETTING: This was a randomized, open-label, multicenter study.PARTICIPANTS: Participants were healthy ovulatory women aged 18 to 40 years.INTERVENTIONS: Elagolix was administered orally for 3 continuous 28-day dosing intervals at 100 to 200 mg once daily (QD), 100 to 300 mg twice daily (BID), and 300 mg BID plus estradiol/norethindrone acetate (E2/NETA) 1/0.5 mg QD.MAIN OUTCOME MEASURES: The main outcomes measures were ovulation rates measured by transvaginal ultrasound, progesterone conce",0
4047,21,What is the role of elagolix in treatment of uterine fibroids?,"Available data on elagolix and UFs showed that the drug, with or without low-dose hormone add-back therapy, is able to significantly reduce menstrual blood loss, lead to amenorrhea and improve haemoglobin concentrations in the majority of participants in comparison with placebo.",0
1941,0,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"When pretreated with a central AADC inhibitor (NSD-1015), further application of l-dopa failed to increase the motoneuron activity although the expression of DA in the AADC cells was not completely inhibited.",0
1941,1,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,Inhibition of Ddc by AADC inhibitor NSD-1015 or anti-sense morpholino oligonucleotides (MO) reduced brain volume and body length.,0
1941,2,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,We evaluated this in vivo by reverse dialysis of the aromatic-l-amino-acid decarboxylase (EC 4.1.1.28) inhibitor NSD-1015 (20μM) and selected concentrations of l- or d-tyrosine.,0
1941,3,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015,0
1941,4,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"To establish the neurotransmitter role(s) of L-3,4-dihydroxyphenylalanine (DOPA) in its own right, we attempted to clarify whether i.p.",0
1941,5,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"injection of a DOPA antagonist, DOPA cyclohexyl ester (CHE), would antagonize the behavioral responses of conscious rats to DOPA in the presence of 3-hydroxybenzylhydrazine (NSD-1015) (100 mg/kg i.p.",0
1941,6,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"), a central aromatic L-amino acid decarboxylase (AADC) inhibitor.",1
1941,7,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"TH and TPH activities were determined in tissue extracts by measuring the accumulation of L-Dopa and 5-HTP respectively, following the administration of the aromatic L-amino acid decarboxylase inhibitor, NSD-1015.",0
1941,8,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,Results of a neurochemical study of the effects of the new anxiolytic drugs afobazole and ladasten on the synthesis and metabolism of monoamines and their metabolites determined by HPLC on the model of monoamine synthesis blockade induced by NSD-1015 (aromatic L-amino acid decarboxylase) in the brain structures of Wistar rats are reported.,0
1941,9,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?, When pretreated with a central AADC inhibitor (NSD-1015),0
1941,10,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,NSD 1015 (general AADC inhibitor),0
1941,11,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,monoamine synthesis blockade induced by NSD-1015 (aromatic L-amino acid decarboxylase),1
1941,12,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,the aromatic-l-amino-acid decarboxylase (EC 4.1.1.28) inhibitor NSD-1015,0
1941,13,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"An accumulation of L-dihydroxyphenylalanine (DOPA) in the median eminence of female rats treated with 3-hydroxybenzylhydrazine (NSD 1015), and inhibitor of aromatic L-amino acid decarboxylase (DOPA decarboxylase) activity, was associated with a decreased concentration of dopamine in the median eminence and pronounced reduction in the release of dopamine into hypophysial portal blood.",0
1941,14,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"6S-BH4 increased extracellular DOPA levels in the presence of NSD 1015, an inhibitor of aromatic L-amino acid decarboxylase (an index of in vivo tyrosine hydroxylase activity), to an extent similar to the increase induced by 6R-BH4.",1
1941,15,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"5-HT synthesis was estimated by measuring the accumulation of the 5-HT precursor, 5-hydroxytryptophan (5-HTP), in the neurointermediate lobe of male Long-Evans rats following the administration of NSD 1015, an inhibitor of aromatic L-amino acid decarboxylase.",1
1941,16,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Monoamine synthesis was studied in different parts of the brain by measuring the accumulated dopa and 5-hydroxytryptophan (5-HTP), 30 min after NSD 1015 (3-hydroxybenzylhydrazine HCl, 100 mg/kg) an inhibitor of aromatic L-amino-acid decarboxylase, given i.p.",0
1941,17,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"HPLC coupled with electrochemical detection was used to make concurrent measurements of the rate of accumulation of 5-hydroxytryptophan and 3,4-dihydroxyphenylalanine in selected brain regions (striatum, nucleus accumbens, septum, medial periventricular hypothalamus) and thoracic spinal cords of rats treated with NSD 1015, an inhibitor of aromatic-L-amino-acid decarboxylase.",0
1941,18,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The activity of 5-hydroxytryptaminergic neurons has been estimated from measurements of: concentrations of 5-hydroxyindoleacetic acid; the ratio of the concentrations of 5-hydroxyindoleacetic acid to 5-hydroxytryptamine; the rate of accumulation of 5-hydroxytryptophan following the administration of an aromatic L-amino acid decarboxylase inhibitor (e.g., NSD 1015); the rate of accumulation of 5-hydroxytryptamine, and the rate of decline of 5-hydroxyindoleacetic acid following the administration of a monoamine oxidase inhibitor (e.g., pargyline).",0
1941,19,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The accumulation of dopa (3,4-dihydroxyphenylalanine) after administration of NSD 1015 to inhibit aromatic l-amino acid decarboxylase was determined as an index of NE synthesis.",0
1941,20,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.",0
1941,21,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The centrally acting aromatic amino acid dopa decarboxylase (AADC) inhibitor, 3-hydroxybenzyl hydrazine (NSD-1015), is widely used to study the neurotransmitter-like actions of L-DOPA.",0
1941,22,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The aromatic amino acid decarboxylase inhibitor, NSD-1015, increases release of dopamine: response characteristics.",0
1941,23,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,The aromatic amino acid decarboxylase inhibitor NSD 1015 markedly increased the dopa concentration.,0
1941,24,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Using a microdialysis technique, the rat striatum was perfused with NSD-1015, an inhibitor of aromatic L-amino acid decarboxylase, and the amount of L-3,4-dihydroxyphenylalanine (L-DOPA) and 5-hydroxytryptophan (5-HTP) accumulating in dialysate was measured as an index of in vivo activities of tyrosine hydroxylase and tryptophan hydroxylase.",0
1941,25,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Also, we studied the effect of MnCl2 on extracellular levels of l-Dopa in the presence of aromatic amino acid decarboxylase (AADC) inhibitor 3-hydroxybencilhydracine-HCl (NSD 1015).",0
1941,26,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The role of L-DOPA itself was investigated by administering several doses of an aromatic L-amino acid decarboxylase inhibitor, NSD 1015, prior to 100 mg/kg L-DOPA to 5-day-old rats.",0
1941,27,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"An accumulation of L-dihydroxyphenylalanine (DOPA) in the median eminence of female rats treated with 3-hydroxybenzylhydrazine (NSD 1015), and inhibitor of aromatic L-amino acid decarboxylase (DOPA decarboxylase) activity, was associated with a decreased concentration of dopamine in the median eminence and pronounced reduction in the release of dopamine into hypophysial portal blood.",0
1941,28,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,[Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015].,0
1941,29,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"DOPA was measured in the anterior pituitary and hypothalamic-hypophysial portal blood after treatment with NSD-1015, a DOPA decarboxylase inhibitor.",0
1941,30,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Central action of an inhibitor of brain dopa-decarboxylase, NSD-1015, on cyanamide-induced alcohol drinking in rats.",0
1941,31,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The role of L-DOPA itself was investigated by administering several doses of an aromatic L-amino acid decarboxylase inhibitor, NSD 1015, prior to 100 mg/kg L-DOPA to 5-day-old rats.",0
1941,32,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The centrally acting aromatic amino acid dopa decarboxylase (AADC) inhibitor, 3-hydroxybenzyl hydrazine (NSD-1015), is widely used to study the neurotransmitter-like actions of L-DOPA.",0
1941,33,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Furthermore, the ethanol-induced enhancement of 3,4-dihydroxyphenylalanine accumulation in the mesolimbic dopamine terminal area after NSD 1015 (an inhibitor of l-aromatic amino acid decarboxylase) was completely antagonized by mecamylamine in doses (3.0 and 6.0 mg/kg) that exerted no effects per se.",0
1941,34,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The acetylcholinesterase inhibitor physostigmine (0.5 mg/kg s.c.) enhanced L-dihydroxyphenylalanine (DOPA) and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in both the corpus striatum and limbic areas (nucleus accumbens) after inhibition of aromatic amino acid decarboxylase with NSD-1015, indicating an enhanced synthesis of dopamine in these brain regions.",0
1941,35,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Estradiol benzoate-treated rats had significantly lower anterior pituitary DOPA accumulation after intraperitoneal administration of 3,4-hydroxybenzyl-hydrazine dihydrochloride (NSD-1015), an irreversible inhibitor of L-aromatic amino acid decarboxylase whereas methylene blue did not affect anterior pituitary DOPA accumulation when compared to controls.",0
1941,36,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The accumulation of dihydroxyphenylalanine (DOPA) following administration of the L-aromatic amino acid decarboxylase inhibitor, NSD 1015, was used to estimate DA synthesis.",0
1941,37,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,Inhibition of PE synthesis by i.p.,0
1941,38,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"injection of the aromatic L-amino acid decarboxylase inhibitor, NSD 1015, produced a reversal of the effects of MDL 72,145 and Ro 19-6327.",1
1941,39,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"After 42 hr of abstinence, rats were challenged with either cocaine (15 mg/kg, ip) or saline, followed by the aromatic L-amino acid decarboxylase inhibitor 3-hydroxybenzylhydrazine (NSD-1015; 100 mg/kg, ip).",0
1941,40,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Following motor activity observations, the cerebral aromatic L-amino acid decarboxylase inhibitor NSD-1015 (100 mg kg-1 intraperitoneally) was administered and 30 min.",0
1941,41,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"later the animals were decapitated for subsequent analysis of the accumulated forebrain DOPA and 5-HTP levels, as an estimate of the rate of monoamine synthesis.",0
1941,42,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The utility of this technique was demonstrated by comparing the effects on the scans of halothane and pentobarbital anesthesia and by the administration of NSD 1015, a peripheral and central inhibitor of L-aromatic amino-acid decarboxylase, between back-to-back scans.",0
1941,43,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Addition of the aromatic amino acid decarboxylase inhibitor, 3-hydroxybenzylhydrazine (NSD 1015), prevented the formation of N-acetylcompounds from L-[3H]tyrosine, without resulting in an accumulation of label in L-DOPA.",0
1941,44,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The effects of the peripheral aromatic amino acid decarboxylase (AADC) inhibitors, carbidopa and benserazide, and the central AADC inhibitor, 3-hydroxybenzylhydrazine (NSD-1015) on peripheral and brain monoamine oxidase (MAO) A and B activity were investigated in the rat.",0
1941,45,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Although the putative role of NSD-1015 is as an aromatic amino acid decarboxylase inhibitor, the present results demonstrate that, either as a result of this function and/or in addition to this role, NSD-1015 is a potent activator of the release of dopamine.",0
1941,46,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The aromatic amino acid decarboxylase inhibitor, NSD-1015, increases release of dopamine: response characteristics.",0
1941,47,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.",0
1941,48,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"The L-aromatic amino acid decarboxylase inhibitor, NSD-1015 (3-hydroxybenzylhydrazine dihydrochloride) was then given ICV twice daily in a volume of 5.0 microliters in the following doses: 0.005, 0.01, 0.1 and 1.0 micrograms.",0
1941,49,Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?,"Although the putative role of NSD-1015 is as an aromatic amino acid decarboxylase inhibitor, the present results demonstrate that, either as a result of this function and/or in addition to this role, NSD-1015 is a potent activator of the release of dopamine..",0
1982,0,Is lenvatinib effective for renal cell carcinoma?,"However, the combination of lenvatinib, a multitargeted agent that inhibits VEGF as well as FGF receptors, and everolimus demonstrated promising results in a randomized phase II trial.",0
1982,1,Is lenvatinib effective for renal cell carcinoma?,The FDA has approved the combination of lenvatinib and everolimus to treat advanced or metastatic renal cell carcinoma.,1
1982,2,Is lenvatinib effective for renal cell carcinoma?,"Moreover, a recent Phase II study demonstrated a significant benefit for the second-line combination treatment with everolimus plus lenvatinib (a novel TKI) in terms of progression-free survival and overall survival compared to the single-agent everolimus.",0
1982,3,Is lenvatinib effective for renal cell carcinoma?,We then discuss two recently approved growth factor receptor antagonists i.e.,0
1982,4,Is lenvatinib effective for renal cell carcinoma?,"cabozantinib and lenvatinib, and a recently approved checkpoint inhibitor, nivolumab, and issues pertaining to drug development, and future directions in treatment of metastatic RCC.",1
1982,5,Is lenvatinib effective for renal cell carcinoma?,INTERPRETATION: Lenvatinib plus everolimus and lenvatinib alone resulted in a progression-free survival benefit for patients with metastatic renal cell carcinoma who have progressed after one previous VEGF-targeted therapy.,1
1982,6,Is lenvatinib effective for renal cell carcinoma?,Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma.,1
1982,7,Is lenvatinib effective for renal cell carcinoma?,Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma.,1
2579,0,List ribosomal biogenesis proteins.,"Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival.",1
2579,1,List ribosomal biogenesis proteins.,TGFβ/Activin signalling is required for ribosome biogenesis and cell growth in Drosophila salivary glands.,1
2579,2,List ribosomal biogenesis proteins.," our results show that TGFβ/Activin signalling is required for ribosomal biogenesis, a key aspect of cellular growth control.",1
2579,3,List ribosomal biogenesis proteins.,PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription.,1
2579,4,List ribosomal biogenesis proteins.,Nucleostemin (NS) is a nucleolar protein that controls ribosomal biogenesis,1
2579,5,List ribosomal biogenesis proteins.,"These findings reveal an important role for HEATR1 in ribosome biogenesis and further support the concept that perturbation of ribosome biosynthesis results in p53-dependent cell cycle checkpoint activation, with implications for human pathologies including cancer.",0
2362,0,What is Cellbase?,"CellBase, a comprehensive collection of RESTful web services for retrieving relevant biological information from heterogeneous sources.",1
2362,1,What is Cellbase?,CellBase provides a solution to the growing necessity of integration by easing the access to biological data.,1
2362,2,What is Cellbase?,CellBase implements a set of RESTful web services that query a centralized database containing the most relevant biological data sources.,0
2362,3,What is Cellbase?,The database is hosted in our servers and is regularly updated.,0
2362,4,What is Cellbase?,CellBase documentation can be found at http://docs.bioinfo.cipf.es/projects/cellbase.,0
2362,5,What is Cellbase?,"CellBase, a comprehensive collection of RESTful web services for retrieving relevant biological information from heterogeneous sources",1
2362,6,What is Cellbase?,CellBase implements a set of RESTful web services that query a centralized database containing the most relevant biological data sources.,0
2362,7,What is Cellbase?,"During the past years, the advances in high-throughput technologies have produced an unprecedented growth in the number and size of repositories and databases storing relevant biological data.",0
2362,8,What is Cellbase?,"Today, there is more biological information than ever but, unfortunately, the current status of many of these repositories is far from being optimal.",0
2362,9,What is Cellbase?,Some of the most common problems are that the information is spread out in many small databases; frequently there are different standards among repositories and some databases are no longer supported or they contain too specific and unconnected information.,0
2362,10,What is Cellbase?,"In addition, data size is increasingly becoming an obstacle when accessing or storing biological data.",0
2362,11,What is Cellbase?,"All these issues make very difficult to extract and integrate information from different sources, to analyze experiments or to access and query this information in a programmatic way.",0
2362,12,What is Cellbase?,CellBase provides a solution to the growing necessity of integration by easing the access to biological data.,1
2362,13,What is Cellbase?,CellBase implements a set of RESTful web services that query a centralized database containing the most relevant biological data sources.,0
2362,14,What is Cellbase?,The database is hosted in our servers and is regularly updated.,0
2362,15,What is Cellbase?,CellBase documentation can be found at http://docs.bioinfo.cipf.es/projects/cellbase.,0
2362,16,What is Cellbase?,cellbase a comprehensive collection of restful web services for retrieving relevant biological information from heterogeneous sources,1
2362,17,What is Cellbase?,"HGVA calculates population frequencies for these projects and enriches their data with variant annotation provided by CellBase, a rich and fast annotation solution.",0
3653,0,What are Drosophila's balancer chromosomes?,Balancer chromosomes are genetic reagents that are used in Drosophila melanogaster for stock maintenance and mutagenesis screens.,1
3653,1,What are Drosophila's balancer chromosomes?,This problem is of particular importance when the mutant allele has been maintained with a balancer chromosome.,1
3653,2,What are Drosophila's balancer chromosomes?,"From four isogenic lines of Drosophila melanogaster, four sets of recombinant extracted lines were constructed using standard balancer-chromosome techniques",1
3653,3,What are Drosophila's balancer chromosomes?,Multiply inverted balancer chromosomes that suppress exchange with their homologs are an essential part of the Drosophila melanogaster genetic toolkit.,1
3653,4,What are Drosophila's balancer chromosomes?,"Our results reject a simple nonrecombining, clonal mode for the laboratory evolution of balancer chromosomes and have implications for how balancer chromosomes should be used in the design and interpretation of genetic experiments in Drosophila.",1
528,0,Is there any software for automated analysis of immuno-histochemistry images?,The LIM homeobox gene Lhx2 is expressed in cortical progenitors during development and also in the superficial layers of the neocortex in maturity.,1
528,1,Is there any software for automated analysis of immuno-histochemistry images?,"However, analysis of Lhx2 function at later stages of cortical development has been hampered by severe phenotypes associated with early loss of function.",1
528,2,Is there any software for automated analysis of immuno-histochemistry images?,The vein graft samples were obtained on each time point after surgery.,0
528,3,Is there any software for automated analysis of immuno-histochemistry images?,The expression of the EDRz transfected in the vein graft was detected using a fluorescent microscope.,1
528,4,Is there any software for automated analysis of immuno-histochemistry images?,Early growth response gene-1 (Egr-1) mRNA was measured using reverse transcription-PCR and in situ hybridization.,0
528,5,Is there any software for automated analysis of immuno-histochemistry images?,And the protein expression of Egr-1 was detected by using western blot and immunohistochemistry analyses.,1
528,6,Is there any software for automated analysis of immuno-histochemistry images?,"Tissue Transglutaminase (TG2) is a multifunctional enzyme, which amongst other functions, is involved in cell differentiation.",0
528,7,Is there any software for automated analysis of immuno-histochemistry images?,"Therefore, we hypothesized that TG2 contributes to differentiation of OPCs into OLGs and thereby stimulates remyelination.",1
565,0,Is the long non- coding RNA malat-1 up or downregulated in cancer?,lncRNA MALAT-1 expression is upregulated in some tumors.,1
565,1,Is the long non- coding RNA malat-1 up or downregulated in cancer?,Metastasis-Associated-in-Lung-Adenocarcinoma-Transcript-1 (MALAT-1) is an ncRNA that is highly expressed in several tumor types,1
565,2,Is the long non- coding RNA malat-1 up or downregulated in cancer?,metastasis-associated lung adenocarcinoma transcript (MALAT)-1 is known to be consistently upregulated in several epithelial malignancies,1
565,3,Is the long non- coding RNA malat-1 up or downregulated in cancer?,MALAT-1 was up-regulated in human prostate cancer tissues and cell lines.,1
565,4,Is the long non- coding RNA malat-1 up or downregulated in cancer?,Genome-wide profiling revealed that MALAT-1 and prostate cancer gene 3 (PCA3) are overexpressed in PCa tissues,0
565,5,Is the long non- coding RNA malat-1 up or downregulated in cancer?,The level of MALAT-1 in LSCC was significantly higher than that in the corresponding adjacent non-neoplastic tissues,0
565,6,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"metastasis-associated lung adenocarcinoma transcript 1, MALAT1, is a long non-coding RNA (lncRNA) that has been discovered as a marker for lung cancer metastasis.",0
565,7,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"It is highly abundant,",0
565,8,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"(MALAT1), a long non-coding RNA (lncRNA), is up-regulated in many solid tumors and associated with cancer metastasis and recurrence",0
565,9,Is the long non- coding RNA malat-1 up or downregulated in cancer?," Quantitative analyses indicated a 6-7-fold increased RNA level in HCCs versus uninvolved liver,",0
565,10,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"(hcn), encoding a 7-kb mRNA-like transcript.",0
565,11,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"The gene appears to be the murine ortholog of the human alpha gene, that is, MALAT-1.",0
565,12,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"After suppression subtractive hybridization and differential screening, we detected the metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1) gene as one of the major genes upregulated in ESS",0
565,13,Is the long non- coding RNA malat-1 up or downregulated in cancer?,a novel non-coding RNA (MALAT-1) to be expressed at significantly higher levels in stage-I and stage-II NSCLC primary tumours that subsequently metastasised,0
565,14,Is the long non- coding RNA malat-1 up or downregulated in cancer?,quantitative RT-PCR verified overexpression in metastasizing samples.,0
565,15,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"Several of the identified genes (eIF4A1, thymosin beta4 and a novel transcript named MALAT-1) were demonstrated to be significantly associated with metastasis in NSCLC patients",0
565,16,Is the long non- coding RNA malat-1 up or downregulated in cancer?,Σ RNA is a class of conserved large non-coding RNAs (murine Hepcarcin; human MALAT-1) up-regulated in carcinomas,1
565,17,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"To date, most known NCTs studied have been relatively short, but several important regulatory NCTs, including XIST, MALAT-1, BC1 and BC200, are considerably larger in length",0
565,18,Is the long non- coding RNA malat-1 up or downregulated in cancer?,These NCTs were among the most abundantly expressed transcripts detected,0
565,19,Is the long non- coding RNA malat-1 up or downregulated in cancer?,"The nuclear transcript MALAT-1 has been functionally associated with gene regulation and alternative splicing and its regulation has been shown to impact proliferation, apoptosis, migration and invasion",0
1371,0,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,Unusual frequencies of certain alternating purine-pyrimidine runs in natural DNA sequences,0
1371,1,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,"Octanucleotides are the most deficient, occurring at only 60% of the frequency expected in random sequences.",0
1371,2,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,An unexpectedly high proportion of these octamers consists of alternating tetramers with the repeat structure (PuPyPuPy)2 or (PyPuPyPu)2,0
1371,3,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,"For dinucleotides, TA is almost universally under-represented, with the exception of vertebrate mitochondrial genomes, and CG is strongly under-represented in vertebrates and in mitochondrial genomes",1
1371,4,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,"For trinucleotides, GCA.TGC tends to be under-represented in phage, human viral, and eukaryotic sequences, and CTA.TAG is strongly under-represented in many prokaryotic, eukaryotic, and viral sequences",1
1371,5,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,The dinucleotide CpG is significantly under-represented in vertebrate DNA and is usually methylated,1
1371,6,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,"One such pattern recognition system is based on unmethylated CpG dinucleotides in particular sequence contexts (CpG motifs); these motifs are common in bacterial DNA but are under-represented (""CpG suppression"") and methylated in vertebrate DNA",1
1371,7,Which are the most under-represented oligonucleotides in higher eukaryote genomes?,"We argue that the significant under-represented motif pattern of CpG in an AU context--which is found in both the ssRNA viruses and innate genes, and has decreased throughout the history of H1N1 influenza replication in humans--is immunostimulatory and has been selected against during the co-evolution of viruses and host innate immune genes",1
1945,0,Which cells express CIDEC protein in humans?,"The expression levels of related adipocyte markers (PPARγ, C/EBPα), mature white adipose tissue specific markers (Cidec, RIP140) increased at the presence of NPY (10(-7), 10(-9), 10(-11) mol/L).",0
1945,1,Which cells express CIDEC protein in humans?,The cell death-inducing DNA fragmentation factor alpha-like effector c (CIDEC; also known in rodents as FSP27 or fat-specific protein 27) is a lipid droplet-associated protein that promotes intracellular triglyceride (TAG) storage.,1
1945,2,Which cells express CIDEC protein in humans?,"CIDEC/Fsp27 is highly expressed in adipose tissue, but undetectable in normal liver.",0
1945,3,Which cells express CIDEC protein in humans?,"However, its hepatic expression rises during fasting or under genetic or diet-induced hepatosteatosis in both mice and patients.",1
1945,4,Which cells express CIDEC protein in humans?," Our results also suggest that patients taking fibrates likely have elevated levels of hepatic CIDEC, which may limit the efficient mobilization and catabolism of hepatic TAGs.",0
1945,5,Which cells express CIDEC protein in humans?,"Fat-specific protein 27 (FSP27, CIDEC in humans) is a lipid-coating protein highly expressed in mature white adipocytes that contributes to unilocular lipid droplet formation.",0
1945,6,Which cells express CIDEC protein in humans?,"We studied mouse models and human tissues to identify molecules associated with ASH progression and focused on the mouse fat-specific protein 27 (FSP-27)/human cell death-inducing DFF45-like effector C (CIDEC) protein, which is expressed in white adipose tissues and promotes formation of fat droplets.",0
1945,7,Which cells express CIDEC protein in humans?,Hepatic CIDEC mRNA expression was increased in patients with AH and correlated with the degree of hepatic steatosis and disease severity including mortality.,0
1945,8,Which cells express CIDEC protein in humans?,Hepatic expression of FSP27/CIDEC is highly up-regulated in mice following chronic-plus-binge ethanol feeding and in patients with AH; this up-regulation contributes to alcohol-induced liver damage.,0
1945,9,Which cells express CIDEC protein in humans?,FSP27 [cell death-inducing DFFA-like effector c (CIDEC) in humans] is a protein associated with lipid droplets that downregulates the fatty acid oxidation (FAO) rate when it is overexpressed.,0
1945,10,Which cells express CIDEC protein in humans?,Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate.,0
1945,11,Which cells express CIDEC protein in humans?,"Similarly, CIDEC expression was upregulated in HepG2 cells by either etomoxir or HMGCS2 interference.",0
1945,12,Which cells express CIDEC protein in humans?,"Our data indicate that there is a kinetic mechanism of autoregulation between short- and long-term fasting, by which free FAs delivered to the liver during early fasting are accumulated/exported by FSP27/CIDEC, whereas over longer periods of fasting, they are degraded in the mitochondria through the carnitine palmitoyl transferase system.",0
1945,13,Which cells express CIDEC protein in humans?,"However, in adipose tissue the changes in Cidec mRNA did not correspond to the changes in Cidec protein levels, as a HFD decreased Cidec protein abundance.",0
1945,14,Which cells express CIDEC protein in humans?,"Cell death-inducing DFFA-like effector c (CIDEC) protein, also known as fat specific protein 27 (Fsp27), is localized to lipid droplets.",0
1945,15,Which cells express CIDEC protein in humans?,"We studied mouse models and human tissues to identify molecules associated with ASH progression and focused on the mouse fat-specific protein 27 (FSP-27)/human cell death-inducing DFF45-like effector C (CIDEC) protein, which is expressed in white adipose tissues and promotes formation of fat droplets.",0
1945,16,Which cells express CIDEC protein in humans?,"Interestingly, in adipose tissue Cidea protein expression was significantly related to body weight (R=.725), epididymal adipose tissue (EWAT) mass (R=.475) and insulin resistance (R=.706), whereas Cidec protein expression was inversely related to body weight (R=-.787), EWAT mass (R=-.706), and insulin resistance (R=-.679).",0
1945,17,Which cells express CIDEC protein in humans?,"Similar to adipose tissue, Cidea protein expression in liver was significantly related to body weight (R=.660), EWAT mass (R=.468), and insulin resistance (R=.599); however, unlike adipose tissue, Cidec protein levels in liver were not related to body weight or EWAT mass and only moderately associated with insulin resistance (R=-.422, P=0.051).",0
1945,18,Which cells express CIDEC protein in humans?,The CIDEC protein is located in lipid droplets (LDs) and the endoplasmic reticulum (ER) and is induced in fat deposition.,0
1945,19,Which cells express CIDEC protein in humans?,CIDEC protein is required for unilocular lipid droplet formation and optimal energy storage in addition to controlling lipid metabolism in adipocytes and hepatocytes.,0
1945,20,Which cells express CIDEC protein in humans?,"Similarly, CIDEC expression was upregulated in HepG2 cells by either etomoxir or HMGCS2 interference.",0
1945,21,Which cells express CIDEC protein in humans?,"The hepatic expression of the cell death-inducing DNA fragmentation factor A-like effector family (CIDEA, CIDEB, and CIDEC) genes is markedly upregulated in mouse models of obesity.",1
1945,22,Which cells express CIDEC protein in humans?,"After the differentiation of adipocyte, the expression pattern of Cidec was similar to that of PPARgamma2.",0
1945,23,Which cells express CIDEC protein in humans?,This paper examined the tissue expression profile of CIDEC gene in cattle using real-time RT-PCR to suggest that bovine CIDEC is highly expressed in adipose tissue.,0
1945,24,Which cells express CIDEC protein in humans?,"Human adipocytes express high levels of two distinct lipid droplet proteins, fat specific protein 27 (FSP27; also called CIDEC), a member of the CIDE family, and perilipin1 (PLIN1), a member of the PAT family",0
1945,25,Which cells express CIDEC protein in humans?,"These results suggest that insulin regulates CIDEA and CIDEC expression via PI3K, and it regulates expression of each protein via Akt1/2- and JNK2-dependent pathways, respectively, in human adipocytes.",0
1945,26,Which cells express CIDEC protein in humans?,Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes.,0
1945,27,Which cells express CIDEC protein in humans?,Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes.,0
1945,28,Which cells express CIDEC protein in humans?,"Human adipocytes express high levels of two distinct lipid droplet proteins, fat specific protein 27 (FSP27; also called CIDEC), a member of the CIDE family, and perilipin1 (PLIN1), a member of the PAT family.",0
1945,29,Which cells express CIDEC protein in humans?,"Fat-specific protein 27 (FSP27, CIDEC in humans) is a lipid-coating protein highly expressed in mature white adipocytes that contributes to unilocular lipid droplet formation.",0
1945,30,Which cells express CIDEC protein in humans?,"Using human primary pre-adipocytes, we confirmed that the expression of CIDEC was elevated during the differentiation of pre-adipocytes, and knockdown of CIDEC in human primary pre-adipocytes resulted in differentiation defects.",0
1945,31,Which cells express CIDEC protein in humans?,Cell death-inducing DFF45-like effector C (CIDEC) is a lipid droplet-coating protein that promotes triglyceride accumulation and inhibits lipolysis.,1
1945,32,Which cells express CIDEC protein in humans?,The cell death-inducing DNA fragmentation factor alpha-like effector c (CIDEC; also known in rodents as FSP27 or fat-specific protein 27) is a lipid droplet-associated protein that promotes intracellular triglyceride (TAG) storage.,1
1945,33,Which cells express CIDEC protein in humans?,Here we demonstrate that knockdown of the lipid droplet protein FSP27 (a.k.a.,0
1945,34,Which cells express CIDEC protein in humans?,"CIDEC) in human adipocytes increases expression of ATGL at the level of transcription, whereas overexpression of FSP27 has the opposite effect.",0
1945,35,Which cells express CIDEC protein in humans?,"However, the transcriptional regulation of Cidec in adipocyte remains unknown.",0
1945,36,Which cells express CIDEC protein in humans?,"Moreover, the hepatic expression of CIDEC is downregulated by marked weight loss.",0
1945,37,Which cells express CIDEC protein in humans?,"These data demonstrate that, consistent with previous studies conducted in rodents, hepatic expression of CIDEA and CIDEC, but not CIDEB, is increased in obese humans.",0
1945,38,Which cells express CIDEC protein in humans?,Transcriptional activation of Cidec by PPARgamma2 in adipocyte.,0
1945,39,Which cells express CIDEC protein in humans?,Our data indicated additional fatty acids stimulated hepatic CIDEC expression and an increasing level of CIDEC induced hepatic LD fusion and lipid accumulation.,0
1945,40,Which cells express CIDEC protein in humans?,"We studied mouse models and human tissues to identify molecules associated with ASH progression and focused on the mouse fat-specific protein 27 (FSP-27)/human cell death-inducing DFF45-like effector C (CIDEC) protein, which is expressed in white adipose tissues and promotes formation of fat droplets.",0
1945,41,Which cells express CIDEC protein in humans?,"By analysis of CIDEC expression in 65 human tissues, we conclude that human CIDEC is predominantly expressed in subcutaneous adipocytes.",0
1945,42,Which cells express CIDEC protein in humans?,"CIDEC/Fsp27 is highly expressed in adipose tissue, but undetectable in normal liver.",0
1945,43,Which cells express CIDEC protein in humans?,"Interestingly, FSP27/CIEDC was expressed in mouse and human livers and was upregulated in obese C57BL/6J mice.",0
1945,44,Which cells express CIDEC protein in humans?,"However, in adipose tissue the changes in Cidec mRNA did not correspond to the changes in Cidec protein levels, as a HFD decreased Cidec protein abundance.",0
130,0,What is needed for MMP proteins to be functional?,matrix metalloproteinase (MMP)-9,1
130,1,What is needed for MMP proteins to be functional?,matrix metalloproteinase-3 (MMP-3) gene,0
130,2,What is needed for MMP proteins to be functional?,matrix metalloproteinases (MMPs),1
130,3,What is needed for MMP proteins to be functional?,Matrix metalloproteinase-9 (MMP-9) is a secreted glycoprotein with a major role in shaping the extracellular matrix and a detailed understanding of the secretory mechanism could help identify methods to correct diseases resulting from dysregulation of secretion.,1
130,4,What is needed for MMP proteins to be functional?,Gelatinase B/matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) cleaves many substrates and is produced by most cell types as a zymogen,0
130,5,What is needed for MMP proteins to be functional?,"Extracellular matrix metalloproteinases (MMPs) are a family of zinc-dependent neutral endopeptidases involved in physiological and pathological processes, through the cleavage of extracellular matrix.",1
130,6,What is needed for MMP proteins to be functional?,"Extracellular matrix metalloproteinases (MMPs) are a family of endopeptydases which recquire a zinc ion at their active site, for proteolityc activity.",1
199,0,Which is the branch site consensus sequence in U12-dependent introns?,Highly conserved sequences at the 5' splice site and branch site of U12-dependent introns are important determinants for splicing by U12-dependent spliceosomes.,1
199,1,Which is the branch site consensus sequence in U12-dependent introns?,This study investigates the in vivo splicing phenotypes of mutations in the branch site consensus sequence of the U12-dependent intron F from a human NOL1 (P120) minigene.,1
199,2,Which is the branch site consensus sequence in U12-dependent introns?,Intron F contains a fully consensus branch site sequence (UUCCUUAAC).,1
199,3,Which is the branch site consensus sequence in U12-dependent introns?,Intron F contains a fully consensus branch site sequence (UUCCUUAAC).,1
199,4,Which is the branch site consensus sequence in U12-dependent introns?,Intron F contains a fully consensus branch site sequence (UUCCUUAAC),1
612,0,What species is associated with Tetrodotoxin?,"The selling and importing of puffer fish species and their products was banned in Thailand in 2002, because of possible neurotoxic effects.",0
612,1,What species is associated with Tetrodotoxin?,Efficiency of a rapid test for detection of tetrodotoxin in puffer fish.,0
612,2,What species is associated with Tetrodotoxin?,"Marine pufferfish contain tetrodotoxin (TTX), an extremely potent neurotoxin",0
612,3,What species is associated with Tetrodotoxin?,"Tetrodotoxin is a potent low weight marine toxin found in warm waters, especially of the Indian and Pacific Oceans.",1
612,4,What species is associated with Tetrodotoxin?,"Intoxications are usually linked to the consumption of the puffer fish, although TTX was already detected in several different edible taxa.",0
612,5,What species is associated with Tetrodotoxin?,"Food poisoning due to ingestion of a puffer fish occurred in Nagasaki Prefecture, Japan, in October 2008, causing neurotoxic symptoms similar to those of tetrodotoxin (TTX) poisoning.",0
612,6,What species is associated with Tetrodotoxin?," Our findings raised a concern for people, not only Thais but also inhabitants of other countries situated on the Andaman coast; consuming puffers of the Andaman seas is risky due to potential TTX intoxication.",0
612,7,What species is associated with Tetrodotoxin?,Toxic marine puffer fish in Thailand seas and tetrodotoxin they contained.,0
612,8,What species is associated with Tetrodotoxin?,"Puffer fish, Takifugu niphobles, collected from the Hong Kong coastal waters were screened for tetrodotoxin-producing bacteria.",0
612,9,What species is associated with Tetrodotoxin?,"A Gram-negative, non-acid-fast, non-sporing and rod shaped bacterial strain (designated as gutB01) was isolated from the intestine of the puffer fish and was shown to produce tetrodotoxin (TTX)",0
612,10,What species is associated with Tetrodotoxin?,"Isolation and identification of a new tetrodotoxin-producing bacterial species, Raoultella terrigena, from Hong Kong marine puffer fish Takifugu niphobles.",0
612,11,What species is associated with Tetrodotoxin?,Green toadfish Lagocephalus lunaris inhabits tropical and subtropical seas and contains high tetrodotoxin (TTX) levels in the muscle as well as liver and gonad,0
612,12,What species is associated with Tetrodotoxin?,Tetrodotoxin (TTX) is a highly potent neurotoxin that blocks the action potential by selectively binding to voltage-gated sodium channels (Na(v)),0
612,13,What species is associated with Tetrodotoxin?,Suspected tetrodotoxin (TTX) poisoning was associated with eating unknown fish in April 2009 in Taiwan,0
612,14,What species is associated with Tetrodotoxin?,"Marine pufferfish generally contain a large amount of tetrodotoxin (TTX) in their skin and viscera, and have caused many incidences of food poisoning, especially in Japan.",1
612,15,What species is associated with Tetrodotoxin?," TTX is originally produced by marine bacteria, and pufferfish are intoxicated through the food chain that starts with the bacteria.",1
612,16,What species is associated with Tetrodotoxin?,", TTX poisoning due to marine snails has recently spread through Japan, China, Taiwan, and Europe.",1
612,17,What species is associated with Tetrodotoxin?,The inhibitory effects of toxin extracted from muscle or liver of five different puffer fishes (hereafter referred as puffer(s)) captured on the Japanese sea coast,0
612,18,What species is associated with Tetrodotoxin?,"LC/MS analysis of tetrodotoxin and its deoxy analogs in the marine puffer fish Fugu niphobles from the southern coast of Korea, and in the brackishwater puffer fishes Tetraodon nigroviridis and Tetraodon biocellatus from Southeast Asia.",0
612,19,What species is associated with Tetrodotoxin?,"Toxins such as saxitoxins, tetrodotoxin, palytoxin, nodularin, okadaic acid, domoic acid, may be produced in large amounts by dinoflagellates, cyanobacteria, bacteria and diatoms and accumulate in vectors that transfer the toxin along food chains",0
612,20,What species is associated with Tetrodotoxin?,"Tetrodotoxin (TTX) is a low molecular weight (approximately 319 Da) neurotoxin found in a number of animal species, including pufferfish.",1
1662,0,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Notch receptors participate in a highly conserved signalling pathway that regulates normal development and tissue homeostasis in a context- and dose-dependent manner.,0
1662,1,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Deregulated Notch signalling has been implicated in many diseases, but the clearest example of a pathogenic role is found in T-cell lymphoblastic leukaemia/lymphoma (T-LL), in which the majority of human and murine tumours have acquired mutations that lead to aberrant increases in Notch1 signalling.",0
1662,2,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"NOTCH proteins (NOTCH1, NOTCH2, NOTCH3 and NOTCH4) play crucial roles in embryonic development.",0
1662,3,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Also, mounting evidence indicates that NOTCH contributes to the pathogenesis of hematopoietic and solid malignancies.",0
1662,4,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Recent studies reported a high incidence of gain-of-function mutations of the NOTCH1 gene in T-cell acute lymphoblastic leukemias (ALL).,0
1662,5,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Our data indicate that NOTCH1 is mutated in T-ALL, but not in other common human cancers, and that NOTCH2, NOTCH3 and NOTH4 genes are rarely mutated in common human cancers.",0
1662,6,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"The Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner.",0
1662,7,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Dysregulation of Notch signaling has been suggested to be key events in a variety of hematological malignancies.,0
1662,8,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Notch1 signaling appears to be the central oncogenic trigger in T cell acute lymphoblastic leukemia (T-ALL), in which the majority of human malignancies have acquired mutations that lead to constitutive activation of Notch1 signaling.",0
1662,9,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"T-cell acute lymphoblastic leukemia (T-ALL) is characterized as a high-risk stratified disease associated with frequent relapse, chemotherapy resistance, and a poorer prognostic outlook than B-precursor ALL.",0
1662,10,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Many of the challenges in treating T-ALL reflect the lack of prognostic cytogenetic or molecular abnormalities on which to base therapy, including targeted therapy.",0
1662,11,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Notch1 activating mutations were identified in more than 50% of T-ALL cases and can be therapeutically targeted with γ-secretase inhibitors (GSIs).,0
1662,12,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Notch1 is a transmembrane receptor that is frequently mutated in human T-cell acute lymphoblastic leukemia (T-ALL).,1
1662,13,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) is characterized by aberrant activation of NOTCH1 in over 60% of T-ALL cases.,1
1662,14,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,The high prevalence of activating NOTCH1 mutations highlights the critical role of NOTCH signaling in the pathogenesis of this disease and has prompted the development of therapeutic approaches targeting the NOTCH signaling pathway.,0
1662,15,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Activating mutations in NOTCH1, an essential regulator of T cell development, are frequently found in human T cell acute lymphoblastic leukemia (T-ALL).",1
1662,16,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,NOTCH signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-ALL).,1
1662,17,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-ALL), occurring in >50% of patients.",0
1662,18,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Mutations in NOTCH1/FBXW7 activate NOTCH signaling and are of prognostic significance in patients with T-cell acute lymphoblastic leukemia (T-ALL).,0
1662,19,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Gain-of-function mutations in Notch-1 have been reported in more than 50% of human T-cell acute lymphoblastic leukemia (T-ALL).,0
1662,20,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Notch signaling is of crucial importance in normal T-cell development and Notch 1 is frequently mutated in T-cell acute lymphoblastic leukemias (T-ALL), leading to aberrantly high Notch signaling.",0
1662,21,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Activation of the Notch pathway occurs commonly in T acute lymphoblastic leukemia (T-ALL) because of mutations in Notch1 or Fbw7 and is involved in the regulation of cell proliferation and survival.,0
1662,22,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,T-cell acute lymphoblastic leukemia (T-ALL) patients frequently display NOTCH1 activating mutations and Notch can transcriptionally down-regulate the tumor suppressor PTEN.,0
1662,23,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,The identification of activating mutations in NOTCH1 in over 50% of T-cell acute lymphoblastic leukemias (T-ALL) has generated major interest in the elucidation of the mechanisms of transformation downstream of oncogenic NOTCH and in the targeting of the NOTCH signaling pathway in this disease.,0
1662,24,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"BACKGROUND: In T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL), activating mutations of NOTCH1 are observed in more than 50% of cases, whereas the t(7;9)(q34;q34) involving NOTCH1 at 9q34 and TRB@ at 7q34 is an extremely rare but recurrent translocation.",0
1662,25,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Activating mutations in NOTCH1 consitute the most prominent genetic abnormality in T-cell acute lymphoblastic leukemia (T-ALL).,0
1662,26,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently associated with activating mutations in NOTCH1 and dysregulation of MYC,0
1662,27,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"The Notch signaling pathway has been recognized as a key factor for the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL), because of the high incidence of activating mutations of Notch1",0
1662,28,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Notch signaling is of crucial importance in normal T-cell development and Notch 1 is frequently mutated in T-cell acute lymphoblastic leukemias (T-ALL), leading to aberrantly high Notch signaling",0
1662,29,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,NOTCH signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-ALL),1
1662,30,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,"Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-ALL), occurring in >50% of patients",0
1662,31,Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?,Gain-of-function mutations in Notch-1 have been reported in more than 50% of human T-cell acute lymphoblastic leukemia (T-ALL),0
581,0,Is CD99 encoded by MIC2 gene?,"We report 2 unusual cytogenetic findings in a pediatric Ewing sarcoma, an insertion of the MIC2 gene encoding CD99 from Xp to 10p and a submicroscopic deletion of the well-known tumor supressor gene KLF6",0
581,1,Is CD99 encoded by MIC2 gene?,We obtained the final diagnosis of ES/PNET by immunohistochemical molecular study with positive staining for the MIC2 gene product (CD99) and a Ewing sarcoma breakpoint region 1 (EWSR1) gene rearrangement,0
581,2,Is CD99 encoded by MIC2 gene?,"CD99, a transmembrane protein encoded by MIC2 gene is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in physiological or pathological conditions",1
581,3,Is CD99 encoded by MIC2 gene?,CD99 is a 32-kDa transmembrane glycoprotein that is encoded by the MIC2 gene,1
581,4,Is CD99 encoded by MIC2 gene?,The surgical specimens showed small round cell tumor with positive staining for MIC2 gene product (CD99),0
581,5,Is CD99 encoded by MIC2 gene?,CD99 is a 32-kDa transmembrane glycoprotein that is encoded by the MIC2 gene.,1
581,6,Is CD99 encoded by MIC2 gene?,The leukocyte surface molecule CD99 is an integral membrane glycoprotein encoded by the E2/MIC2 gene.,0
581,7,Is CD99 encoded by MIC2 gene?,"Human CD99, which is encoded by the mic2 gene, is a ubiquitous 32 kDa transmembrane protein.",0
581,8,Is CD99 encoded by MIC2 gene?,Human CD99 is a 32-kDa cell surface protein that is encoded by the MIC2 gene localized to the PAR1.,0
581,9,Is CD99 encoded by MIC2 gene?,"The tumors displayed intense immunoreactivity in a membranous pattern for CD99, the cell surface glycoprotein encoded by the MIC2 gene.",0
581,10,Is CD99 encoded by MIC2 gene?,"CD99, a transmembrane protein encoded by MIC2 gene is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in physiological or pathological conditions.",1
581,11,Is CD99 encoded by MIC2 gene?,"CD99, the product of the MIC2 gene, exhibits an erythroid-specific quantitative polymorphism coregulated with the polymorphism of the XG blood group gene.",0
581,12,Is CD99 encoded by MIC2 gene?,"CD99, the product of the MIC2 gene, exhibits an erythroid-specific quantitative polymorphism co-regulated with the Xga blood group polymorphism.",0
581,13,Is CD99 encoded by MIC2 gene?,Homology searches resulted in finding homologous sequences (totally about 40% homology) in the human MIC2 gene product (CD99; 32-kDa) of T lymphocytes.,0
581,14,Is CD99 encoded by MIC2 gene?,"Although considered a specific marker for Ewing's sarcoma/peripheral neuroectodermal tumour, the MIC2 gene product (CD99) has been immunolocalised in a variety of human tumours.",0
581,15,Is CD99 encoded by MIC2 gene?,"MIC2, the gene encoding the CD99 antigen, is found in the pseudoautosomal region of both the X and Y chromosomes.",0
581,16,Is CD99 encoded by MIC2 gene?,Human CD99 is a 32-kDa cell surface protein that is encoded by the MIC2 gene localized to the PAR1.,0
581,17,Is CD99 encoded by MIC2 gene?,"The tumors displayed intense immunoreactivity in a membranous pattern for CD99, the cell surface glycoprotein encoded by the MIC2 gene.",0
581,18,Is CD99 encoded by MIC2 gene?,"CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion.",0
581,19,Is CD99 encoded by MIC2 gene?,Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.,0
581,20,Is CD99 encoded by MIC2 gene?,"The Ewing family of tumors (EFT) is characterized by high MIC2/CD99 expression and specific EWS/ETS gene rearrangements, resulting in different chimeric transcripts.",0
581,21,Is CD99 encoded by MIC2 gene?,"The tumors displayed intense immunoreactivity in a membranous pattern for CD99, the cell surface glycoprotein encoded by the MIC2 gene.",0
581,22,Is CD99 encoded by MIC2 gene?,"Monoclonal antibody (MAb) HBA71, which was raised against Ewing's sarcoma cells, recognizes a cell-surface glycoprotein, p30/32MIC2, that is encoded by the MIC2 gene in the pseudoautosomal region of human chromosomes X and Y.",0
581,23,Is CD99 encoded by MIC2 gene?,"Monoclonal antibodies (mAbs) directed against E2, a 32-kDa transmembrane protein encoded by the MIC2 gene located in the pseudoautosomal region, induce a transbilayer movement of phosphatidylserine and, to a lesser extent, phosphatidylethanolamine in human thymocytes and a Jurkat T lymphocytes.",0
581,24,Is CD99 encoded by MIC2 gene?,Homology searches resulted in finding homologous sequences (totally about 40% homology) in the human MIC2 gene product (CD99; 32-kDa) of T lymphocytes.,0
581,25,Is CD99 encoded by MIC2 gene?,CD99 is a 32-kDa transmembrane glycoprotein that is encoded by the MIC2 gene,0
581,26,Is CD99 encoded by MIC2 gene?,"CD99, a transmembrane protein encoded by MIC2 gene is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in physiological or pathological conditions",1
581,27,Is CD99 encoded by MIC2 gene?,The surgical specimens showed small round cell tumor with positive staining for MIC2 gene product (CD99),0
581,28,Is CD99 encoded by MIC2 gene?,"We report 2 unusual cytogenetic findings in a pediatric Ewing sarcoma, an insertion of the MIC2 gene encoding CD99 from Xp to 10p and a submicroscopic deletion of the well-known tumor supressor gene KLF6",0
581,29,Is CD99 encoded by MIC2 gene?,"MIC2, the gene encoding the CD99 antigen, is found in the pseudoautosomal region of both the X and Y chromosomes",0
581,30,Is CD99 encoded by MIC2 gene?,"Immunohistochemical analysis showed weak to moderate and partial staining for MIC2 (CD99) and WT1, respectively",0
581,31,Is CD99 encoded by MIC2 gene?,"Human CD99, which is encoded by the mic2 gene, is a ubiquitous 32 kDa transmembrane protein",0
581,32,Is CD99 encoded by MIC2 gene?,The leukocyte surface molecule CD99 is an integral membrane glycoprotein encoded by the E2/MIC2 gene,0
581,33,Is CD99 encoded by MIC2 gene?,"The tumors displayed intense immunoreactivity in a membranous pattern for CD99, the cell surface glycoprotein encoded by the MIC2 gene",0
581,34,Is CD99 encoded by MIC2 gene?,Human CD99 is a 32-kDa cell surface protein that is encoded by the MIC2 gene localized to the PAR1,0
581,35,Is CD99 encoded by MIC2 gene?,"MIC2, the gene encoding the CD99 antigen, is found in the pseudoautosomal region of both the X and Y chromosomes",0
581,36,Is CD99 encoded by MIC2 gene?,"CD99, the product of the MIC2 gene, exhibits an erythroid-specific quantitative polymorphism co-regulated with the Xga blood group polymorphism",0
3342,0,List cohesinopathies,Genetic mapping studies reveal that mutations in cohesion pathways are responsible for multispectrum developmental abnormalities termed cohesinopathies.,0
3342,1,List cohesinopathies,"These include Roberts syndrome (RBS), Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome (WABS).",1
3342,2,List cohesinopathies,"The cohesinopathies are characterized by overlapping phenotypes ranging from craniofacial deformities, limb defects, and mental retardation.",0
3342,3,List cohesinopathies,"Though these syndromes share a similar suite of phenotypes and arise due to mutations in a common cohesion pathway, the underlying mechanisms are currently believed to be distinct.",0
3342,4,List cohesinopathies,Defects in mitotic failure and apoptosis i.e.,1
3342,5,List cohesinopathies,"trans DNA tethering events are believed to be the underlying cause of RBS, whereas the underlying cause of CdLS is largely modeled as occurring through defects in transcriptional processes i.e.",1
3342,6,List cohesinopathies,cis DNA tethering events.,0
3342,7,List cohesinopathies,"Here, we review recent findings described primarily in zebrafish, paired with additional studies in other model systems, including human patient cells, which challenge the notion that cohesinopathies represent separate syndromes.",0
3342,8,List cohesinopathies,"A new study identifies homozygous missense mutations in SGOL1, which encodes a component of the cohesin complex, in a newly described disorder termed Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome.",1
3342,9,List cohesinopathies,These findings implicate cohesin in the regulation of intrinsic cardiac and intestinal rhythm and further expand the growing group of disorders termed the cohesinopathies.,1
3559,0,Describe mechanism of action of volanesorsen.," Clinical trials with Volanesorsen, an APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes.",0
3559,1,Describe mechanism of action of volanesorsen.,"An antisense oligonucleotide to apolipoprotein-C3, volanesorsen has been shown to decrease TGs by 70-80% and possibly to reduce rates of pancreatitis admissions.",1
3559,2,Describe mechanism of action of volanesorsen.,"BACKGROUND: Volanesorsen, an investigational inhibitor of apoC-III synthesis, significantly reduced triglyceride levels in clinical trials in patients with familial chylomicronemia syndrome (FCS), a rare genetic disorder characterized by marked chylomicronemia leading to a spectrum of symptoms, including recurrent abdominal pain and episodes of potentially fatal acute pancreatitis (AP).",0
3559,3,Describe mechanism of action of volanesorsen.,Further studies should address the effect of omega-3 PUFAs alone or with other lipid-lowering drugs in order to provide a final answer whether apo C-III could be an important target for prevention of cardiovascular disease New apo C-III antisense oligonucleotide drug (Volanesorsen) showed to be promising in decreasing elevated TGs by reducing levels of apo C-III mRNA.,1
3559,4,Describe mechanism of action of volanesorsen.,"Volanesorsen, is an antisense oligonucleotid that inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism because it inhibits lipoprotein lipase (LPL) and hepatic lipase activity but also hepatic uptake of TGs-rich particles.",1
3559,5,Describe mechanism of action of volanesorsen.,"Some new drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III), pemafibrate, and others.",0
3559,6,Describe mechanism of action of volanesorsen.,ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.,0
3559,7,Describe mechanism of action of volanesorsen.,Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes.,0
3559,8,Describe mechanism of action of volanesorsen.,"Discovery of the ApoCIII inhibitor volanesorsen opens a new era of lipid-lowering drugs for reduction in TG and potentially for reduction in LDL-C. Herein, this review will provide an update on the pathophysiology of ApoCIII-linked atherosclerosis and the development of the first drug to target ApoCIII, volanesorsen, as a promising lipid-lowering agent.",0
3559,9,Describe mechanism of action of volanesorsen.,"CONCLUSIONS

Volanesorsen reduced plasma apoC-III and TG while raising HDL-C levels.",0
3559,10,Describe mechanism of action of volanesorsen.,"OBJECTIVE

To determine the effects of volanesorsen (ISIS 304801), a second-generation 2'-O-methoxyethyl chimeric antisense inhibitor of apolipoprotein (apo)C-III, on triglyceride (TG) levels and insulin resistance in patients with type 2 diabetes.",0
3559,11,Describe mechanism of action of volanesorsen.,"Volanesorsen is an experimental antisense oligonucleotide that inhibits translation of Apo-CIII mRNA, thereby substantially lowering plasma levels of Apo-CIII and triglycerides.",1
3559,12,Describe mechanism of action of volanesorsen.,"RECENT FINDINGS

Evidence is now emerging that volanesorsen, a second-generation antisense oligonucleotide drug targeting ApoCIII messenger RNA resulting in decreases in TG in patients with familial chylomicronemia syndrome, severe hypertriglyceridemia, and metabolic dyslipidemia with type 2 diabetes giving support to the hypothesis that ApoCIII is a powerful inhibitor of LPL, and when reduced, endogenous clearance of TRLs can result in substantial reductions in TG levels.",0
3559,13,Describe mechanism of action of volanesorsen.,Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results.,0
3559,14,Describe mechanism of action of volanesorsen.,CONCLUSIONS Volanesorsen reduced plasma apoC-III and TG while raising HDL-C levels.,0
3559,15,Describe mechanism of action of volanesorsen.,"Some new drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III), pemafibrate, and others.",0
3559,16,Describe mechanism of action of volanesorsen.,"Some new drugs are on the horizon , such as volanesorsen ( which targets apolipoprotein C-III) , pemafibrate , and others",0
3559,17,Describe mechanism of action of volanesorsen.,"To determine the effects of volanesorsen ( ISIS 304801) , a second-generation 2'-O-methoxyethyl chimeric antisense inhibitor of apolipoprotein ( apo)C-III , on triglyceride ( TG ) levels and insulin resistance in patients with type 2 diabetes",1
3559,18,Describe mechanism of action of volanesorsen.,"Volanesorsen (previously known as ISIS 304801) is a 20-nucleotide partially 2'-O-(2-methoxyethyl) (2'-MOE)-modified antisense oligonucleotide (ASO) gapmer, which was recently approved in the European Union as a novel, first-in-class treatment in the reduction of triglyceride levels in patients with familial chylomicronemia syndrome.",0
3559,19,Describe mechanism of action of volanesorsen.,"BACKGROUND
Volanesorsen, an investigational inhibitor of apoC-III synthesis, significantly reduced triglyceride levels in clinical trials in patients with familial chylomicronemia syndrome (FCS), a rare genetic disorder characterized by marked chylomicronemia leading to a spectrum of symptoms, including recurrent abdominal pain and episodes of potentially fatal acute pancreatitis (AP).",0
3559,20,Describe mechanism of action of volanesorsen.,"Recently, volanesorsen as a promising ApoIII inhibitor was shown to improve the lipid profile in patients with diabetic dyslipidemia.",0
3559,21,Describe mechanism of action of volanesorsen.,Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen.,0
3559,22,Describe mechanism of action of volanesorsen.,"Herein, this paper will review recent advance in pathophysiology of diabetic dyslipidemia and the role of ApoCIII in this condition, with focus on describing a novel drug volanesorsen as potential treatment strategy.",0
3559,23,Describe mechanism of action of volanesorsen.,CONCLUSIONS: Volanesorsen reduced plasma apoC-III and TG while raising HDL-C levels.,0
3559,24,Describe mechanism of action of volanesorsen.,"Discovery of the ApoCIII inhibitor volanesorsen opens a new era of lipid-lowering drugs for reduction in TG and potentially for reduction in LDL-C. Herein, this review will provide an update on the pathophysiology of ApoCIII-linked atherosclerosis and the development of the first drug to target ApoCIII, volanesorsen, as a promising lipid-lowering agent.",0
3559,25,Describe mechanism of action of volanesorsen.,"ApoC-III inhibition by volanesorsen reduced plasma levels of apoC-II, apoC-III, triacylglycerols, and diacylglycerols, and increased apoA-I, apoA-II, and apoM (all p",0
3559,26,Describe mechanism of action of volanesorsen.,"Changes in apolipoprotein and lipid levels following treatment with volanesorsen, a second-generation antisense drug targeting apoC-III, were determined in 2 human intervention trials, one of which was randomized.",0
3559,27,Describe mechanism of action of volanesorsen.,"The antisense oligonucleotide (ASO) against APOC3 mRNA volanesorsen (previously called ISIS 304801, ISIS-ApoCIIIRx and IONIS-ApoCIIIRx) robustly decreases both, apo-CIII production and triglyceride concentrations and is being currently evaluated in phase 3 trials.",0
3559,28,Describe mechanism of action of volanesorsen.,"Volanesorsen (previously known as ISIS 304801) is a 20-nucleotide partially 2'-O (2 methoxyethyl) (2' MOE) modified antisense oligonucleotide (ASO) gapmer and was recently approved in the European Union as a novel, first in class treatment for reduction of triglyceride levels in patients with Familial Chylomicronemia Syndrome.",0
3559,29,Describe mechanism of action of volanesorsen.,"Recently, volanesorsen as a promising ApoIII inhibitor was shown to improve the lipid profile in patients with diabetic dyslipidemia.",0
1722,0,What is the most prominent sequence consensus for the polyadenylation site?,the cannonical polyadenylation signal sequence AATAAA,1
1722,1,What is the most prominent sequence consensus for the polyadenylation site?,Two AATAAA motifs are coded in the last exon of this gene,0
1722,2,What is the most prominent sequence consensus for the polyadenylation site?,The results demonstrate that the intact AAUAAA is not required for RNA polyadenylation but is required for the cleavage step preceding polyadenylation to occur efficiently,1
1722,3,What is the most prominent sequence consensus for the polyadenylation site?,the early poly(A) consensus signal was mutated from AAUAAA to UGUAAA,1
1722,4,What is the most prominent sequence consensus for the polyadenylation site?,"Functional polyadenylation [poly(A)] sites consist of two sequence elements, the AAUAAA and G/U box signals, that closely flank the site of mRNA 3'-end formation",1
1722,5,What is the most prominent sequence consensus for the polyadenylation site?,the appropriate spacing of the AAUAAA and G/U box signals is critical for poly(A) site function,1
1722,6,What is the most prominent sequence consensus for the polyadenylation site?, Two AATAAA hexanucleotide sequences are present in the 2092 nucleotide interval.,0
1722,7,What is the most prominent sequence consensus for the polyadenylation site?,The first one functions as the major polyA signal,0
3314,0,What percentage of patients of nasopharyngeal carcinoma (NPC) develop recurrent disease?,"IMRT group achieved better locoregional control rate, with the 5-year locoregional relapse-free survival (LRRFS) were 84.9% and 87.7% among patients received 2D-RT and IMRT, respectively (P = 0.050)",1
3314,1,What percentage of patients of nasopharyngeal carcinoma (NPC) develop recurrent disease?,"The patients were divided into the local recurrence (n = 39), fibrosis (n = 51), clivus recurrence (n = 22), and clivus nonrecurrence (n = 48) groups.",1
3314,2,What percentage of patients of nasopharyngeal carcinoma (NPC) develop recurrent disease?, Serum was collected from 40 patients with NPC [recurrence (n=20) and no recurrence (n=20)].,1
3314,3,What percentage of patients of nasopharyngeal carcinoma (NPC) develop recurrent disease?,"Compared to non‑recurrent NPC (nrNPC), we found 59 proteins to be significantly dysregulated in rNPC; most of these have been previously reported to play a role in carcinogenesis.",0
3314,4,What percentage of patients of nasopharyngeal carcinoma (NPC) develop recurrent disease?,"With a median follow up of 49.50 months, the 3- and 5- year LR-free rate were 95.43% and 94.30% respectively; the 3- and 5- year RR-free rate were 95.94% and 95.41% respectively.",0
3314,5,What percentage of patients of nasopharyngeal carcinoma (NPC) develop recurrent disease?,The overall recurrence rate was 75% in HPV negative patients and 11% in HPV positive ones.,1
3314,6,What percentage of patients of nasopharyngeal carcinoma (NPC) develop recurrent disease?,Disease recurred in a spared parotid gland in three patients (1.04%).,1
3486,0,Are there lncRNAs that control the extent of neuronal outgrowth?,Regulation of Neuroregeneration by Long Noncoding RNAs.,1
3486,1,Are there lncRNAs that control the extent of neuronal outgrowth?,"Here, we profiled gene expression following sciatic nerve crush in mice and identified long noncoding RNAs (lncRNAs) that act in the regenerating neurons and which are typically not expressed in other contexts.",1
3486,2,Are there lncRNAs that control the extent of neuronal outgrowth?,We show that two of these lncRNAs regulate the extent of neuronal outgrowth.,1
3486,3,Are there lncRNAs that control the extent of neuronal outgrowth?,"We then focus on one of these, Silc1, and show that it regulates neuroregeneration in cultured cells and in vivo, through cis-acting activation of the transcription factor Sox11.",1
1810,0,Which software package is available for the analysis of conserved genomic loci?,PHYLUCE is a software package for the analysis of conserved genomic loci,1
1810,1,Which software package is available for the analysis of conserved genomic loci?,"Prior to downstream inference, data from these types of targeted enrichment studies must undergo preprocessing to assemble contigs from sequence data; identify targeted, enriched loci from the off-target background data; align enriched contigs representing conserved loci to one another; and prepare and manipulate these alignments for subsequent phylogenomic inference.",1
1810,2,Which software package is available for the analysis of conserved genomic loci?,PHYLUCE is an efficient and easy-to-install software package that accomplishes these tasks across hundreds of taxa and thousands of enriched loci.,1
1810,3,Which software package is available for the analysis of conserved genomic loci?,PHYLUCE is a software package for the analysis of conserved genomic loci.,1
3641,0,What is another name for AZD0530?,"Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.",1
3641,1,What is another name for AZD0530?,"We evaluated the antitumor effect of a c-Src/Abl kinase inhibitor, saracatinib (AZD0530), alone or combined with chemotherapeutic agents in gastric cancer cell lines and a NCI-N87 xenograft model.",1
3182,0,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome",Noonan syndrome (NS) is an autosomal dominant disorder with vast heterogeneity in clinical and genetic features.,1
3182,1,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome","Various symptoms have been reported for this abnormality such as short stature, unusual facial characteristics, congenital heart abnormalities, developmental complications, and an elevated tumor incidence rate",1
3182,2,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome",Noonan syndrome (NS) and Noonan syndrome with multiple lentigines (NSML) are autosomal dominant developmental disorders.,0
3182,3,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome","NS and NSML are caused by abnormalities in genes that encode proteins related to the RAS-MAPK pathway, including PTPN11, RAF1, BRAF, and MAP2K.",0
3182,4,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome","In this study, we diagnosed ten NS or NSML patients via targeted sequencing or whole exome sequencing (TS/WES).METHODS: TS/WES was performed to identify mutations in ten Chinese patients who exhibited the following manifestations: potential facial dysmorphisms, short stature, congenital heart defects, and developmental delay.",1
3182,5,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome","Noonan's syndrome is an autosomal dominant genetic disorder with high phenotypic variability, characterized mainly by facial dysmorphism, congenital heart disease and short stature.",1
3182,6,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome","Noonan syndrome is an autosomal dominant disease characterized by dysmorphic features, webbed neck, cardiac anomalies, short stature and cryptorchidism.",1
3182,7,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome","Noonan syndrome or new autosomal dominant condition with coarctation of the aorta, hypertrophic cardiomyopathy, and minor anomalies.",0
3182,8,"What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome","This is a report on a father and his two children with an apparent autosomal dominant condition characterized by craniofacial anomalies, coarctation of the aorta, hypertrophic cardiomyopathy, and other structural heart abnormalities with normal psychomotor development.",0
822,0,Could transcription factors act as cell-cell signalling molecules?,"Pax6 is a transcription factor essential for the development of tissues including the eyes, central nervous system and endocrine glands of vertebrates and invertebrates.",1
822,1,Could transcription factors act as cell-cell signalling molecules?,"It regulates the expression of a broad range of molecules, including transcription factors, cell adhesion and short-range cell-cell signalling molecules, hormones and structural proteins",1
822,2,Could transcription factors act as cell-cell signalling molecules?,"Recent data support the view that transcription factors - in particular, homeoproteins - can be transferred from cell to cell and have direct non-cell-autonomous (and therefore paracrine) activities",1
2426,0,What gene is mutated in Familial Mediterranean Fever?,Familial Mediterranean fever (FMF) is caused by mutations in the MEFV gene and the spectrum of mutations among Greek-Cypriots with FMF-related symptoms was examined,1
2426,1,What gene is mutated in Familial Mediterranean Fever?,"Familial Mediterranean fever (FMF) is the most common monogenic periodic fever syndrome and characterized by recurrent episodes of fever, serositis, arthritis, dermal manifestations, and long-term renal complications.",0
2426,2,What gene is mutated in Familial Mediterranean Fever?,The MEFV gene was described in 1997 as the gene responsible for FMF and is inherited in autosomal recessive manner.,0
2426,3,What gene is mutated in Familial Mediterranean Fever?,Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that is inherited in an autosomal recessive manner and is caused by mutations in theMEFVgene,0
2426,4,What gene is mutated in Familial Mediterranean Fever?, MEditerranean FeVer (MEFV) gene encodes for the pyrin protein and a mutated pyrin is associated with a prolonged or augmented inflammation.,1
2426,5,What gene is mutated in Familial Mediterranean Fever?,"The causative mutations for familial Mediterranean fever (FMF) are located in the MEFV gene, which encodes pyrin.",1
2426,6,What gene is mutated in Familial Mediterranean Fever?,"Familial Mediterranean Fever (FMF), characterized by recurrent fever and inflammation of serous membranes, is an autosomal recessive disease caused by mutations in the Mediterranean fever (MEFV) gene.",0
2426,7,What gene is mutated in Familial Mediterranean Fever?," patients affected by familial Mediterranean fever (FMF) whether or not interleukin (IL)-1β secretion (1) is enhanced, (2) correlates with the type of MEFV mutation and (3) is mediated by NLRP3",0
2426,8,What gene is mutated in Familial Mediterranean Fever?,Familial Mediterranean fever (FMF) is a recessive inherited autoinflammatory syndrome.,0
2426,9,What gene is mutated in Familial Mediterranean Fever?,"Patients with FMF have symptoms such as recurrent fever and abdominal pain, sometimes accompanied by arthralgia.",0
2426,10,What gene is mutated in Familial Mediterranean Fever?,Biopsy specimens have revealed substantial neutrophil infiltration into synovia.,0
2426,11,What gene is mutated in Familial Mediterranean Fever?,"FMF patients have a mutation in the Mediterranean fever gene, encoding pyrin,",0
2426,12,What gene is mutated in Familial Mediterranean Fever?,Atherosclerosis is the main pathogenesis.,0
2426,13,What gene is mutated in Familial Mediterranean Fever?,Familial Mediterranean fever (FMF) is an autosomal recessive disease.,0
2426,14,What gene is mutated in Familial Mediterranean Fever?,"The gene causing FMF, designated MEFV, encodes a protein called pyrin or marenostrin",0
2426,15,What gene is mutated in Familial Mediterranean Fever?,Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder due to MEFV mutations and one of the most frequent Mediterranean genetic diseases.,0
2426,16,What gene is mutated in Familial Mediterranean Fever?,The aim of this study was to determine the relationship between clinical findings and the most common mutated alleles of MEFV gene in a childhood population and to determine the sensitivity of the 12-mutation-strip assay test in familial Mediterranean fever (FMF).,0
2426,17,What gene is mutated in Familial Mediterranean Fever?,Familial Mediterranean fever (FMF) has been traced to mutations in the MEFV gene.,1
2426,18,What gene is mutated in Familial Mediterranean Fever?,"BACKGROUND Familial Mediterranean Fever (FMF), characterized by recurrent fever and inflammation of serous membranes, is an autosomal recessive disease caused by mutations in the Mediterranean fever (MEFV) gene.",0
2426,19,What gene is mutated in Familial Mediterranean Fever?,"On the other hand, asthma is less frequent in individuals with familial Mediterranean fever, an autoinflammatory disease prevalent in the Iraqi Jewish community and linked to mutations in the familial Mediterranean fever gene, designated MEFV.",0
2426,20,What gene is mutated in Familial Mediterranean Fever?,familial mediterranean fever associated with mefv mutations in a large cohort of cypriot patients,0
2426,21,What gene is mutated in Familial Mediterranean Fever?,"FMF is caused by mutations in MEFV gene, which encodes pyrin.",1
2426,22,What gene is mutated in Familial Mediterranean Fever?,"he familial Mediterranean fever gene, designated MEFV, was recently cloned, and at least three missense mutations (M6801, M694V, and V726A) that account for a large percentage of patients with this disease were identified.",0
2426,23,What gene is mutated in Familial Mediterranean Fever?,"Molecular genetic testing of the MEFV gene, the only gene currently known to be associated with familial Mediterranean fever,",0
2426,24,What gene is mutated in Familial Mediterranean Fever?,To analyze 70 individuals who were found to have the Mediterranean fever (MEFV) gene for the presence of definite familial Mediterranean fever (FMF) and to assess if they were prone to clinical and laboratory inflammation,0
2426,25,What gene is mutated in Familial Mediterranean Fever?,"Familial Mediterranean fever is a recessive  autoinflammatory disease that is frequent in Armenians, Jews, Arabs, and Turks.",0
2426,26,What gene is mutated in Familial Mediterranean Fever?,The MEFV gene is responsible for this disease.,0
2426,27,What gene is mutated in Familial Mediterranean Fever?,"FMF is caused by mutations in the Mediterranean fever gene (MEFV),",0
1398,0,What is the most probable defect underlying triple negative breast cancer?,"We have previously reported an array comparative genomic hybridization profile that identifies triple-negative breast cancers (TNBC), with BRCA1 dysfunction",1
1398,1,What is the most probable defect underlying triple negative breast cancer?,BRCA1-like status was assessed in 101 patients with early-stage TNBC receiving adjuvant cyclophosphamide-based chemotherapy.,1
1398,2,What is the most probable defect underlying triple negative breast cancer?,Sixty-six tumors (65%) had a BRCA1-like profile.,1
2437,0,Which clinical trials for psoriasis involved tofacitinib? (November 2017),A Phase 3 withdrawal/re-treatment study (NCT01186744; OPT Retreatment) showed tofacitinib re-treatment was effective in patients with chronic plaque psoriasis.,1
2437,1,Which clinical trials for psoriasis involved tofacitinib? (November 2017),"In 2 identical phase 3 studies (OPT Pivotal 1 and 2), patients were randomized 2:2:1 to receive tofacitinib 5 mg, tofacitinib 10 mg, or placebo, twice daily.",1
2437,2,Which clinical trials for psoriasis involved tofacitinib? (November 2017),"To evaluate HRQoL with tofacitinib, vs. placebo or etanercept, in the Phase 3, randomized, placebo-controlled, non-inferiority, Oral-treatment Psoriasis Trial (OPT) Compare Study (NCT01241591).",1
3489,0,Can radiation induced meningiomas be treated with radiosurgery?,"This is a case report of a patient treated with radiosurgery for radiation induced meningiomas, 30 years after childhood whole brain radiation.",1
3489,1,Can radiation induced meningiomas be treated with radiosurgery?,This article reviews the unique characteristics and unusual response to the radiation induced meningiomas to radiosurgery.,0
3489,2,Can radiation induced meningiomas be treated with radiosurgery?,Gamma knife stereotactic radiosurgery for radiation-induced meningiomas.,0
3489,3,Can radiation induced meningiomas be treated with radiosurgery?,RESULTS: We present our series of 12 patients with radiation-induced meningiomas treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution.,1
3489,4,Can radiation induced meningiomas be treated with radiosurgery?,"With a median follow-up of 35 months, local control was 100%.",0
3489,5,Can radiation induced meningiomas be treated with radiosurgery?,CONCLUSIONS: Gamma Knife radiosurgery is both a safe and effective treatment for radiation-induced meningiomas.,0
3489,6,Can radiation induced meningiomas be treated with radiosurgery?,Favorable outcomes of pediatric patients treated with radiotherapy to the central nervous system who develop radiation-induced meningiomas.,0
3489,7,Can radiation induced meningiomas be treated with radiosurgery?,"All cases were managed with a single modality: resection alone (n = 7), fractionated radiotherapy (n = 2), and stereotactic radiosurgery (n = 1).",0
3489,8,Can radiation induced meningiomas be treated with radiosurgery?,Stereotactic radiosurgery for radiation-induced meningiomas.,0
3489,9,Can radiation induced meningiomas be treated with radiosurgery?,The patients met criteria for a radiation-induced meningioma and underwent gamma knife radiosurgery.,0
3489,10,Can radiation induced meningiomas be treated with radiosurgery?,CONCLUSION: SRS provides satisfactory control rates either after resection or as an alternative to resection.,0
3489,11,Can radiation induced meningiomas be treated with radiosurgery?,"This is a case report of a patient treated with radiosurgery for radiation induced meningiomas, 30 years after childhood whole brain radiation.",1
3489,12,Can radiation induced meningiomas be treated with radiosurgery?,This article reviews the unique characteristics and unusual response to the radiation induced meningiomas to radiosurgery.,0
3489,13,Can radiation induced meningiomas be treated with radiosurgery?,"CONCLUSIONS

Gamma Knife radiosurgery is both a safe and effective treatment for radiation-induced meningiomas.",0
3489,14,Can radiation induced meningiomas be treated with radiosurgery?,"RESULTS

We present our series of 12 patients with radiation-induced meningiomas treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution.",0
3489,15,Can radiation induced meningiomas be treated with radiosurgery?,CONCLUSIONS Gamma Knife radiosurgery is both a safe and effective treatment for radiation-induced meningiomas.,0
3489,16,Can radiation induced meningiomas be treated with radiosurgery?,This article reviews the unique characteristics and unusual response to the radiation induced meningiomas to radiosurgery,0
3489,17,Can radiation induced meningiomas be treated with radiosurgery?,Stereotactic radiosurgery for radiation-induced meningiomas,0
3489,18,Can radiation induced meningiomas be treated with radiosurgery?,"Also, LC rates with radiosurgery are at least comparable to those of surgical series for radiation-induced meningiomas",0
3489,19,Can radiation induced meningiomas be treated with radiosurgery?,Gamma Knife radiosurgery for meningiomas: four cases of radiation-induced edema.,0
3489,20,Can radiation induced meningiomas be treated with radiosurgery?,"This is a case report of a patient treated with radiosurgery for radiation induced meningiomas , 30 years after childhood whole brain radiation",0
3489,21,Can radiation induced meningiomas be treated with radiosurgery?,"Stereotactic radiosurgery ( SRS ) has become an important primary or adjuvant management for patients with intracranial meningiomas , but the value of this approach for radiation-induced tumors is unclear",0
3489,22,Can radiation induced meningiomas be treated with radiosurgery?,This article reviews the unique characteristics and unusual response to the radiation induced meningiomas to radiosurgery,0
3489,23,Can radiation induced meningiomas be treated with radiosurgery?,"RESULTS
We present our series of 12 patients with radiation-induced meningiomas treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution.",0
3489,24,Can radiation induced meningiomas be treated with radiosurgery?,"OBJECTIVES
To ascertain the safety and efficacy of Gamma Knife radiosurgery as a treatment for radiation-induced meningiomas.",0
3489,25,Can radiation induced meningiomas be treated with radiosurgery?,"As such, traditional radiotherapy is limited by lifetime tissue tolerances to radiation, leaving surgery and radiosurgery as attractive treatment options.",0
3489,26,Can radiation induced meningiomas be treated with radiosurgery?,"CONCLUSIONS
Gamma Knife radiosurgery is both a safe and effective treatment for radiation-induced meningiomas.",0
3489,27,Can radiation induced meningiomas be treated with radiosurgery?,"Stereotactic radiosurgery (SRS) has become an important primary or adjuvant management for patients with intracranial meningiomas, but the value of this approach for radiation-induced tumors is unclear.",0
3489,28,Can radiation induced meningiomas be treated with radiosurgery?,The patients met criteria for a radiation-induced meningioma and underwent gamma knife radiosurgery.,0
3489,29,Can radiation induced meningiomas be treated with radiosurgery?,OBJECTIVES: To ascertain the safety and efficacy of Gamma Knife radiosurgery as a treatment for radiation-induced meningiomas.,0
3489,30,Can radiation induced meningiomas be treated with radiosurgery?,RESULTS: We present our series of 12 patients with radiation-induced meningiomas treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution.,1
3489,31,Can radiation induced meningiomas be treated with radiosurgery?,METHODS: A retrospective chart review was conducted to identify patients who received Gamma Knife radiosurgery for a meningioma and met the criteria for this being a radiation-induced tumor.,0
3489,32,Can radiation induced meningiomas be treated with radiosurgery?,We present our series of 12 patients with radiation-induced meningiomas treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution.,1
3489,33,Can radiation induced meningiomas be treated with radiosurgery?,"Stereotactic radiosurgery (SRS) has become an important primary or adjuvant management for patients with intracranial meningiomas, but the value of this approach for radiation-induced tumors is unclear.",0
23,0,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,autosomal dominant FSHD1,1
23,1,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.",1
23,2,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"Facioscapulohumeral dystrophy (FSHD) is an autosomal-dominant disorder characterized by weakness of the face, upper arm, shoulder, and lower limb musculature, with an onset between the first and third decades.",0
23,3,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"Clinical diagnosis is made from the distinctive pattern of weakness, autosomal-dominant inheritance, and confirmed by genetic testing.",0
23,4,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?," In one family together with prenatal diagnosis founder mutation in FSHD A1 gene was detected, according to the autosomal dominant (AD) inheritance.",0
23,5,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,Facioscapulohumeral muscular dystrophy (FSHD) is a primary muscle disorder with autosomal dominant inheritance.,1
23,6,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive myopathy with autosomal dominant inheritance remarkable for its early involvement of facial musculature.,1
23,7,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"Consensual diagnostic criteria for facioscapulohumeral dystrophy (FSHD) include onset of the disease in facial or shoulder girdle muscles, facial weakness in more than 50% of affected family members, autosomal dominant inheritance in familial cases, and evidence of myopathic disease in at least one affected member without biopsy features specific to alternative diagnoses",0
23,8,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,Facioscapulohumeral dystrophy (FSHD) is an autosomal-dominant muscular disorder associated with a short (<35 kb) EcoRI/BlnI fragment resulting from deletion of an integral number of units of a 3.3-kb repeat located at 4q35.,1
23,9,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"In 139 families, dominant inheritance was observed in 97, a pattern compatible with germline mosaicism in 6, while sporadic cases were found in 36 families.",0
23,10,What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"In 139 families, dominant inheritance was observed in 97, a pattern compatible with germline mosaicism in 6, while sporadic cases were found in 36 families.",0
3171,0,What are DMARDs?,To determine the utility of ultrasonography in guiding modification of disease-modifying anti-rheumatic drug (DMARD) and steroid therapy for inflammatory arthritis (IA),1
3171,1,What are DMARDs?,disease-modifying antirheumatic drugs (DMARDs),1
3171,2,What are DMARDs?,Treatment with disease-modifying antirheumatic drugs (DMARDs),1
3171,3,What are DMARDs?,[DMARDs (disease-modifying antirheumatic drugs)].,1
3171,4,What are DMARDs?,Disease-modifying antirheumatic drugs (DMARDs) have largely contributed to recent paradigm shift of rheumatoid arthritis (RA) treatment strategy.,0
3171,5,What are DMARDs?,"BACKGROUND
Biologic disease-modifying antirheumatic drugs (DMARDs) are increasingly used for rheumatoid arthritis (RA) treatment.",0
3171,6,What are DMARDs?,Tocilizumab (TCZ) and tumour necrosis factor inhibitors (TNFi) are recommended for the treatment of rheumatoid arthritis (RA) in patients with inadequate response (IR) to prior disease-modifying antirheumatic drugs (DMARDs).,0
3171,7,What are DMARDs?,"BACKGROUND
Rheumatoid arthritis (RA) is a progressive autoimmune disorder of joints that is associated with high health care costs, yet guidance is lacking on how early to initiate biologic disease-modifying antirheumatic drugs (DMARDs), a class of medications that is the major cost driver in RA management.",0
3171,8,What are DMARDs?,"BACKGROUND
Therapy of rheumatoid arthritis (RA) is typically characterized by the sequential use of disease-modifying anti-rheumatic drugs (DMARDs).",0
3171,9,What are DMARDs?,"There are only six DMARDs (disease modifying anti-rheumatic drugs) available in the clinical practice, such as gold sodium thiomalate, D-penicillamine, bucillamine, auranofin, salazosulphapyridine, and lobenzarit disodium.",0
3171,10,What are DMARDs?,"Tofacitinib (Xeljanz(®)) is the first approved drug in a new class of disease modifying antirheumatic drugs (DMARDs), the Janus kinase (JAK) inhibitors.",0
3171,11,What are DMARDs?,"OBJECTIVE
Disease-modifying antirheumatic drugs (DMARDs) are the standard of care for rheumatoid arthritis (RA); however, studies have found that many patients do not receive them.",0
3171,12,What are DMARDs?,Disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of rheumatoid arthritis (RA) pharmacotherapy and should be initiated promptly after RA diagnosis.,0
3171,13,What are DMARDs?,"OBJECTIVES
When rheumatoid arthritis (RA) patients have achieved sustained good clinical responses can their disease-modifying anti-rheumatic drugs (DMARDs) be reduced or discontinued?",0
3171,14,What are DMARDs?,"BACKGROUND
Given the availability of a number of alternative biologic treatment options and other novel disease-modifying antirheumatic drugs (DMARDs) for the treatment of patients with rheumatoid arthritis (RA), clinicians are faced with an increasingly challenging choice regarding optimal treatment.",0
3171,15,What are DMARDs?,"BACKGROUND
Treatment of juvenile idiopathic arthritis (JIA) with disease-modifying antirheumatic drugs (DMARDs) may improve outcomes compared to conventional therapy (e.g., non-steroidal anti-inflammatory drugs, intra-articular corticosteroids).",0
3171,16,What are DMARDs?,Disease modifying antirheumatic drugs (DMARDs) is a category of drugs which is used as medication in various arthritic conditions to arrest the progression of disease along with relief from pain.,0
3171,17,What are DMARDs?,"For this purpose, all patients with the diagnosis of RA should be treated by disease-modifying antirheumatic drugs (DMARDs) including biologic DMARDs and non-biologic DMARDs.",0
3171,18,What are DMARDs?,(2) What is the search volume for disease-modifying antirheumatic drugs (DMARDs)?,1
3171,19,What are DMARDs?,"<b>OBJECTIVES</b>: Patients and rheumatologists have a number of options to consider for the treatment of rheumatoid arthritis (RA), including biologic response modifier (BRM) therapy and diseasemodifying antirheumatic drugs (DMARDs).",0
3171,20,What are DMARDs?,To explore what considerations patients have when deciding about disease-modifying antirheumatic drugs (DMARDs) and what information patients need to participate in the decision-making process.,0
3171,21,What are DMARDs?,"Disease-modifying antirheumatic drug (DMARD) therapy is now clearly accepted as the primary treatment for rheumatoid arthritis, with an increasing emphasis on use of combination therapy.",0
3171,22,What are DMARDs?,(2) What is the search volume for disease-modifying antirheumatic drugs (DMARDs)?,0
3171,23,What are DMARDs?,The efficacy of the biologic disease-modifying antirheumatic drugs (DMARDs) shown in clinical trials may be jeopardized due to prevalent poor patient adherence.,0
3171,24,What are DMARDs?,"Although methotrexate has retained its place as the first-line agent, there has been great interest in comparing biologicals to conventional Disease Modifying Anti Rheumatic Drugs (DMARDs) over the past few years with the updated guidelines from both the American College of Rheumatology and European League Against Rheumatism.",0
1316,0,What is known about potential implication of thyroid hormone receptors in arterial hypertension?,"For the first time, our study showed associations between the THRA rs939348 polymorphism and systolic BP and the risk of hypertension but not with CHD, although we admit that the statistical power available to study any relationship with CHD was very limited.",1
1316,1,What is known about potential implication of thyroid hormone receptors in arterial hypertension?,"The results of Western blot analyses showed that the levels of the three TR isoforms do not differ significantly between SHRs and control rats of the same age, either in the left or in the right ventricle.",1
255,0,Name monoclonal antibody against SLAMF7.,"BACKGROUND: Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with lenalidomide and dexamethasone in a phase 1b-2 study in patients with relapsed or refractory multiple myeloma.",1
255,1,Name monoclonal antibody against SLAMF7.,"Elotuzumab is a humanized monoclonal antibody specific for signaling lymphocytic activation molecule-F7 (SLAMF7, also known as CS1, CD319, or CRACC) that enhances natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC) of SLAMF7-expressing myeloma cells.",1
255,2,Name monoclonal antibody against SLAMF7.,"This led to development of an anti-SLAMF7 antibody, elotuzumab, showing efficacy against MM.",0
255,3,Name monoclonal antibody against SLAMF7.,"One of the most promising MoAb is elotuzumab, the only humanized IgG1 MoAb specifically targeting CS1 (SLAMF7), a cell surface glycoprotein that is highly expressed in plasma cells.",1
255,4,Name monoclonal antibody against SLAMF7.,"This led to development of an anti-SLAMF7 antibody, elotuzumab, showing efficacy against MM.",0
255,5,Name monoclonal antibody against SLAMF7.,"Elotuzumab is a humanized monoclonal antibody specific for signaling lymphocytic activation molecule-F7 (SLAMF7, also known as CS1, CD319, or CRACC) that enhances natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC) of SLAMF7-expressing myeloma cells.",1
255,6,Name monoclonal antibody against SLAMF7., New agents are awaited for the treatment of multiple myeloma and research is ongoing for the development of monoclonal antibodies (MoAbs) targeting the tumor cells.,0
255,7,Name monoclonal antibody against SLAMF7.,"One of the most promising MoAb is elotuzumab, the only humanized IgG1 MoAb specifically targeting CS1 (SLAMF7), a cell surface glycoprotein that is highly expressed in plasma cells.",0
255,8,Name monoclonal antibody against SLAMF7.,"This led to development of an anti-SLAMF7 antibody, elotuzumab, showing efficacy against MM.",0
255,9,Name monoclonal antibody against SLAMF7.,"Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with lenalidomide and dexamethasone in a phase 1b-2 study in patients with relapsed or refractory multiple myeloma.",1
2844,0,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?, We retrospectively analyzed 93 consecutive single-pregnancy patients who underwent cesarean section with combined spinal-epidural anesthesia.,1
2844,1,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?,"The patients were divided into two groups, depending on the use of 6% HES 130/0.4: group A (461 ± 167 ml of saline-based HES was administered; 43 patients) and group B (HES not administered; 50 patients).",1
2844,2,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?,The major outcome was umbilical cord chloride level at delivery.,0
2844,3,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?,The volume infused from operating room admission until delivery was not significantly different between groups.,1
2844,4,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?,"The umbilical cord chloride level at delivery was statistically significantly higher in group A than in group B, but clinically similar (108 ± 2 vs. 107 ± 2 mmol/l, P = 0.02).",0
2844,5,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?,"No differences were observed in the Apgar score or other umbilical cord laboratory data at delivery (Na+, K+, pH, base excess)",1
2844,6,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?,"CONCLUSION
Subarachnoid or epidural sufentanil, in the doses used in this study, associated with local anesthetics, had the same effect on the duration of labor after analgesia and in the Apgar score of newborns.",0
2844,7,Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?,"CONCLUSION Subarachnoid or epidural sufentanil, in the doses used in this study, associated with local anesthetics, had the same effect on the duration of labor after analgesia and in the Apgar score of newborns.",1
4169,0,Has dupilumab been FDA approved for atopic dermatitis?,Recent advances and understanding of the pathogenesis of AD have resulted in new therapies that target specific pathways with increased efficacy and the potential for less systemic side effects.,1
4169,1,Has dupilumab been FDA approved for atopic dermatitis?,New FDA-approved therapies for AD are crisaborole and dupilumab.,1
4169,2,Has dupilumab been FDA approved for atopic dermatitis?,"In March of 2017, the United States Food and Drug Administration (FDA) approved dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults that is uncontrolled with topical medications, becoming the first biologic agent approved to treat this chronic skin condition.",1
4169,3,Has dupilumab been FDA approved for atopic dermatitis?,Dupilumab is the first US FDA approved biologic for treatment of atopic dermatitis.,1
4169,4,Has dupilumab been FDA approved for atopic dermatitis?,Dupilumab is the first biological treatment approved for moderate-to-severe atopic dermatitis (AD).,1
2019,0,Which gene is mutated in the Karak syndrome?,"Mutations in PLA2G6 have been associated with disorders such as infantile neuroaxonal dystrophy, neurodegeneration with brain iron accumulation type II and Karak syndrome",0
2019,1,Which gene is mutated in the Karak syndrome?,"Mutations in PLA2G6 gene have variable phenotypic outcome including infantile neuroaxonal dystrophy, atypical neuroaxonal dystrophy, idiopathic neurodegeneration with brain iron accumulation and Karak syndrome.",1
2019,2,Which gene is mutated in the Karak syndrome?,"BACKGROUND: PLA2G6 is the causative gene for infantile neuroaxonal dystrophy, neurodegeneration associated with brain iron accumulation, and Karak syndrome.",1
2019,3,Which gene is mutated in the Karak syndrome?,"PLA2G6 is the causative gene for infantile neuroaxonal dystrophy, neurodegeneration associated with brain iron accumulation, and Karak syndrome.",1
2019,4,Which gene is mutated in the Karak syndrome?,"Mutations in PLA2G6 gene have variable phenotypic outcome including infantile neuroaxonal dystrophy, atypical neuroaxonal dystrophy, idiopathic neurodegeneration with brain iron accumulation and Karak syndrome.",1
2019,5,Which gene is mutated in the Karak syndrome?,"Recessively inherited mutations of the PLA2G6 gene are causative of infantile neuroaxonal dystrophy and other PLA2G6-associated neurodegeneration, which includes conditions known as atypical neuroaxonal dystrophy, Karak syndrome and early-onset dystonia-parkinsonism with cognitive impairment.",0
2019,6,Which gene is mutated in the Karak syndrome?,"Mutations in PLA2G6 have been associated with disorders such as infantile neuroaxonal dystrophy, neurodegeneration with brain iron accumulation type II and Karak syndrome.",0
2019,7,Which gene is mutated in the Karak syndrome?,"We mapped a locus for infantile neuroaxonal dystrophy (INAD) and neurodegeneration with brain iron accumulation (NBIA) to chromosome 22q12-q13 and identified mutations in PLA2G6, encoding a calcium-independent group VI phospholipase A2, in NBIA, INAD and the related Karak syndrome.",1
2019,8,Which gene is mutated in the Karak syndrome?,"We mapped a locus for infantile neuroaxonal dystrophy (INAD) and neurodegeneration with brain iron accumulation (NBIA) to chromosome 22q12-q13 and identified mutations in PLA2G6, encoding a calcium-independent group VI phospholipase A2, in NBIA, INAD and the related Karak syndrome.",0
2019,9,Which gene is mutated in the Karak syndrome?,"Mutations in PLA2G6 have been associated with disorders such as infantile neuroaxonal dystrophy, neurodegeneration with brain iron accumulation type II and Karak syndrome.",0
2019,10,Which gene is mutated in the Karak syndrome?,"Recessively inherited mutations of the PLA2G6 gene are causative of infantile neuroaxonal dystrophy and other PLA2G6-associated neurodegeneration, which includes conditions known as atypical neuroaxonal dystrophy, Karak syndrome and early-onset dystonia-parkinsonism with cognitive impairment.",0
2019,11,Which gene is mutated in the Karak syndrome?,"Mutations in PLA2G6 have been associated with disorders such as infantile neuroaxonal dystrophy, neurodegeneration with brain iron accumulation type II and Karak syndrome.",0
2019,12,Which gene is mutated in the Karak syndrome?,"We mapped a locus for infantile neuroaxonal dystrophy (INAD) and neurodegeneration with brain iron accumulation (NBIA) to chromosome 22q12-q13 and identified mutations in PLA2G6, encoding a calcium-independent group VI phospholipase A2, in NBIA, INAD and the related Karak syndrome.",0
3101,0,What is the mechanism of action of Solriamfetol?,"Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor.",0
3101,1,What is the mechanism of action of Solriamfetol?,The dual activity of solriamfetol at DA and NE transporters and the lack of significant monoamine-releasing properties of solriamfetol might explain the differences in the in vivo effects of solriamfetol compared with modafinil or amphetamine.,0
3101,2,What is the mechanism of action of Solriamfetol?,"BACKGROUND:: This study evaluated the human abuse potential of solriamfetol (formerly JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects.",0
3101,3,What is the mechanism of action of Solriamfetol?,"A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.",0
3101,4,What is the mechanism of action of Solriamfetol?," A new drug, solriamfetol, a selective norepinephrine-dopamine reuptake inhibitor, is the first drug of its class that is being considered by the US Food and Drug Administration (FDA) to treat excessive sleepiness in OSA and narcolepsy patients.",1
3101,5,What is the mechanism of action of Solriamfetol?,"OBJECTIVES: To evaluate the efficacy and safety of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects, for the treatment of excessive sleepiness in participants with obstructive sleep apnea with current or prior sleep apnea treatment.",1
3101,6,What is the mechanism of action of Solriamfetol?,"Moreover, the wake-promoting effects of solriamfetol are probably owing to activity at DA and NE transporters rather than other neurotransmitter systems, such as histamine or orexin.",0
3101,7,What is the mechanism of action of Solriamfetol?,"Results indicate that solriamfetol has dual reuptake inhibition activity at dopamine (DA; IC50 = 2.9 μM) and norepinephrine (NE; IC50 = 4.4 μM) transporters, and this activity is associated in vivo with increased extracellular concentration of DA and NE as measured by microdialysis.",0
3101,8,What is the mechanism of action of Solriamfetol?,"A new drug, solriamfetol, a selective norepinephrine-dopamine reuptake inhibitor, is the first drug of its class that is being considered by the US Food and Drug Administration (FDA) to treat excessive sleepiness in OSA and narcolepsy patients.",1
3101,9,What is the mechanism of action of Solriamfetol?,"BACKGROUND:
This study evaluated the human abuse potential of solriamfetol (formerly JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects.",0
3101,10,What is the mechanism of action of Solriamfetol?,"A new drug, solriamfetol, a selective norepinephrine-dopamine reuptake inhibitor, is the first drug of its class that is being considered by the US Food and Drug Administration (FDA) to treat excessive sleepiness in OSA and narcolepsy patients.",1
3101,11,What is the mechanism of action of Solriamfetol?,"A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.Solriamfetol appears to have abuse potential similar to or lower than phentermine.",0
3101,12,What is the mechanism of action of Solriamfetol?,Results indicate that solriamfetol has dual reuptake inhibition activity at dopamine (DA; IC<br>,0
3101,13,What is the mechanism of action of Solriamfetol?,"Moreover, the wake-promoting effects of solriamfetol are probably owing to activity at DA and NE transporters rather than other neurotransmitter systems, such as histamine or orexin.",0
3101,14,What is the mechanism of action of Solriamfetol?,"To evaluate the efficacy and safety of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects, for the treatment of excessive sleepiness in participants with obstructive sleep apnea with current or prior sleep apnea treatment.",1
2419,0,What is the HPG pore?,HPG pore: an efficient and scalable framework for nanopore sequencing data.,0
2419,1,What is the HPG pore?,The use of nanopore technologies is expected to spread in the future because they are portable and can sequence long fragments of DNA molecules without prior amplification.,1
2419,2,What is the HPG pore?,"The first nanopore sequencer available, the MinION™ from Oxford Nanopore Technologies, is a USB-connected, portable device that allows real-time DNA analysis.",0
2419,3,What is the HPG pore?,"In addition, other new instruments are expected to be released soon, which promise to outperform the current short-read technologies in terms of throughput.",0
2419,4,What is the HPG pore?,"Despite the flood of data expected from this technology, the data analysis solutions currently available are only designed to manage small projects and are not scalable.RESULTS: Here we present HPG Pore, a toolkit for exploring and analysing nanopore sequencing data.",1
2419,5,What is the HPG pore?,"HPG Pore can run on both individual computers and in the Hadoop distributed computing framework, which allows easy scale-up to manage the large amounts of data expected to result from extensive use of nanopore technologies in the future.",1
2419,6,What is the HPG pore?,"Here we present HPG Pore, a toolkit for exploring and analysing nanopore sequencing data.",0
2419,7,What is the HPG pore?,"Despite the flood of data expected from this technology, the data analysis solutions currently available are only designed to manage small projects and are not scalable.<br><b>RESULTS</b>: Here we present HPG Pore, a toolkit for exploring and analysing nanopore sequencing data.",1
2419,8,What is the HPG pore?,"RESULTS Here we present HPG Pore, a toolkit for exploring and analysing nanopore sequencing data.",0
2419,9,What is the HPG pore?,the use of nanopore technologies is expected to spread in the future because they are portable and can sequence long fragments of dna molecules without prior amplification the first nanopore sequencer available the minion from oxford nanopore technologies is a usb connected portable device that allows real time dna analysis in addition other new instruments are expected to be released soon which promise to outperform the current short read technologies in terms of throughput despite the flood of data expected from this technology the data analysis solutions currently available are only designed to manage small projects and are not scalable here we present hpg pore a toolkit for exploring and analysing nanopore sequencing data hpg pore can run on both individual computers and in the hadoop distributed computing framework which allows easy scale up to manage the large amounts of data expected to result from extensive use of nanopore technologies in the future hpg pore allows for virtually unlimited sequencing data scalability thus guaranteeing its continued management in near future scenarios hpg pore is available in github at http github com opencb hpg pore.,1
2419,10,What is the HPG pore?,hpg pore an efficient and scalable framework for nanopore sequencing data,0
1237,0,Has the protein GFP been used in transgenesis for live protein imaging?,"we review recent advancement in the functional studies of the three different GnRH neuron systems, mainly focusing on the electrophysiological analysis of the GnRH-green fluorescent protein (GFP) transgenic animals.",0
1237,1,Has the protein GFP been used in transgenesis for live protein imaging?,founders were found to be transgenic for GFP.,0
1237,2,Has the protein GFP been used in transgenesis for live protein imaging?,GFP expression was detected in a wide range of murine tissues,0
1237,3,Has the protein GFP been used in transgenesis for live protein imaging?,Transgenic Xenopus laevis for live imaging in cell and developmental biology.,1
1237,4,Has the protein GFP been used in transgenesis for live protein imaging?,"The stable transgenesis of genes encoding functional or spatially localized proteins, fused to fluorescent proteins such as green fluorescent protein (GFP) or red fluorescent protein (RFP), is an extremely important research tool in cell and developmental biology.",1
1237,5,Has the protein GFP been used in transgenesis for live protein imaging?,"GFP-transgenic animals for in vivo imaging: rats, rabbits, and pigs.",0
1237,6,Has the protein GFP been used in transgenesis for live protein imaging?,"We have further extended the techniques of genetic engineering to rats, rabbits, and pigs, and have created corresponding GFP-transgenic animals.",0
1237,7,Has the protein GFP been used in transgenesis for live protein imaging?,The results revealed that the 3.6-GFP transgenic animals provide a unique model for direct analysis of cellular and molecular mechanisms of pulp repair and tertiary dentinogenesis in vivo.,0
1237,8,Has the protein GFP been used in transgenesis for live protein imaging?,Long-term effects of PERV-specific RNA interference in transgenic pigs.,0
1237,9,Has the protein GFP been used in transgenesis for live protein imaging?,green fluorescent protein (GFP) as reporter of the vector system were consistently expressed in transgenic animals.,0
1237,10,Has the protein GFP been used in transgenesis for live protein imaging?,The ability to specify the expression levels of exogenous genes inserted in the genomes of transgenic animals is critical for the success of a wide variety of experimental manipulations.,0
1237,11,Has the protein GFP been used in transgenesis for live protein imaging?,Welfare assessment in transgenic pigs expressing green fluorescent protein (GFP).,0
1237,12,Has the protein GFP been used in transgenesis for live protein imaging?,transgenic animals expressing GFP with wildtype animals along various stages of post natal development,0
1237,13,Has the protein GFP been used in transgenesis for live protein imaging?,Production of transgenic chickens expressing a tetracycline-inducible GFP gene.,0
1237,14,Has the protein GFP been used in transgenesis for live protein imaging?,transgenic animals can be readily created to express fluorescently tagged proteins or reporters,0
1237,15,Has the protein GFP been used in transgenesis for live protein imaging?,These findings suggest that mhc2dab:GFP and cd45:DsRed transgenic lines will be instrumental in elucidating the immune response in the zebrafish.,0
1237,16,Has the protein GFP been used in transgenesis for live protein imaging?,"f 33 mice born, 28 (81%) carried the transgene DNA and 15 (55.5%) were GFP-positive.",0
1237,17,Has the protein GFP been used in transgenesis for live protein imaging?,Lentiviral vectors containing the green fluorescent protein gene have been successfully used to select transgenic embryos before transfer to a surrogate mother,0
1237,18,Has the protein GFP been used in transgenesis for live protein imaging?,"Typically transgenes are generated by placing a promoter upstream of a GFP reporter gene or cDNA of interest, and this often produces a representative expression pattern.",0
1237,19,Has the protein GFP been used in transgenesis for live protein imaging?,Survival and immunogenicity of mesenchymal stem cells from the green fluorescent protein transgenic rat in the adult rat brain.,0
1237,20,Has the protein GFP been used in transgenesis for live protein imaging?,"This problem has been lessened by the availability of transgenic animals that express ""reporter"" genes, such as green fluorescent protein (GFP)",1
1237,21,Has the protein GFP been used in transgenesis for live protein imaging?," full-length GFP fusion proteins was examined, in transgenic animals,",0
1237,22,Has the protein GFP been used in transgenesis for live protein imaging?,Two stable transgenic lines express GFP prior to hair-bundle formation,0
1237,23,Has the protein GFP been used in transgenesis for live protein imaging?,we generated two transgenic pigs by somatic cell nuclear transfer (SCNT) that express green fluorescent protein (GFP) driven by cytomegalovirus (CMV).,0
1237,24,Has the protein GFP been used in transgenesis for live protein imaging?,Fluorescent proteins such as the green fluorescent protein (GFP) have widely been used in transgenic animals as reporter genes.,1
1237,25,Has the protein GFP been used in transgenesis for live protein imaging?,Green Fluorescent Protein (GFP) is used extensively as a reporter for transgene expression in Drosophila and other organisms.,1
3631,0,Which medication are included in the Polycap polypill?,"Patients in the intervention arm will receive Polycap DS® (containing aspirin, 100 mg; atenolol, 50 mg; ramipril, 5 mg; thiazide, 12.5 mg; simvastatin, 20 mg) taken as two capsules once daily.",1
3631,1,Which medication are included in the Polycap polypill?,"This study aims to determine whether the Polycap (comprised of atenolol, ramipril, hydrochlorothiazide, and a statin) reduces CV events in persons without a history of CVD, but who are at least at intermediate CVD risk.",0
3631,2,Which medication are included in the Polycap polypill?,"BACKGROUND: A daily single capsule (polycap) of 3 blood pressure (BP) lowering drugs (hydrochlorthiazide, 12.5 mg; atenolol, 50 mg; ramipril, 5 mg) at low doses, simvastatin (20 mg), and aspirin (100 mg) has been demonstrated to be well tolerated and to reduce BP and low-density lipoprotein cholesterol.",1
3631,3,Which medication are included in the Polycap polypill?,"BACKGROUND: The Polycap (polypill; aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol, and hydrochlorothiazide) was found to be safe and effective for reducing multiple cardiovascular risk factors in The Indian Polycap Study (TIPS).",1
3631,4,Which medication are included in the Polycap polypill?,"The Indian Polycap Study (TIPS) was the first to systematically test the clinical application of the polypill; it included ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin",1
3631,5,Which medication are included in the Polycap polypill?,"METHODS: In a double-blind trial in 50 centres in India, 2053 individuals without cardiovascular disease, aged 45-80 years, and with one risk factor were randomly assigned, by a central secure website, to the Polycap (n=412) consisting of low doses of thiazide (12.5 mg), atenolol (50 mg), ramipril (5 mg), simvastatin (20 mg), and aspirin (100 mg) per day, or to eight other groups, each with about 200 individuals, of aspirin alone, simvastatin alone, hydrochlorthiazide alone, three combinations of the two blood-pressure-lowering drugs, three blood-pressure-lowering drugs alone, or three blood-pressure-lowering drugs plus aspirin.",1
3631,6,Which medication are included in the Polycap polypill?,"BACKGROUND

The Polycap (polypill; aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol, and hydrochlorothiazide) was found to be safe and effective for reducing multiple cardiovascular risk factors in The Indian Polycap Study (TIPS).",0
3631,7,Which medication are included in the Polycap polypill?,"The Indian Polycap Study (TIPS) was the first to systematically test the clinical application of the polypill; it included ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin.",0
3631,8,Which medication are included in the Polycap polypill?,"The Indian Polycap Study ( TIPS ) was the first to systematically test the clinical application of the polypill; it included ramipril , hydrochlorothiazide , atenolol , aspirin , and simvastatin",0
2309,0,Which receptor does GDF15 bind?,GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.,1
2309,1,Which receptor does GDF15 bind?,"Here we show that GDF15 binds specifically to GDNF family receptor α-like (GFRAL) with high affinity, and that GFRAL requires association with the coreceptor RET to elicit intracellular signaling in response to GDF15 stimulation.",1
3049,0,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.,1
3049,1,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,"To this end, a number of approaches for estimating telomere length from whole-genome sequencing data have been proposed.",0
3049,2,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,"Here we present Telomerecat, a novel approach to the estimation of telomere length.",0
3049,3,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,"Previous methods have been dependent on the number of telomeres present in a cell being known, which may be problematic when analysing aneuploid cancer data and non-human samples.",1
3049,4,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,"Telomerecat is designed to be agnostic to the number of telomeres present, making it suited for the purpose of estimating telomere length in cancer studies.",1
3049,5,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,Telomerecat also accounts for interstitial telomeric reads and presents a novel approach to dealing with sequencing errors.,1
3049,6,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,We show that Telomerecat performs well at telomere length estimation when compared to leading experimental and computational methods.,0
3049,7,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,"Furthermore, we show that it detects expected patterns in longitudinal data, repeated measurements, and cross-species comparisons.",0
3049,8,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,"We also apply the method to a cancer cell data, uncovering an interesting relationship with the underlying telomerase genotype.",0
3049,9,Which ploidy-agnostic method has been developed for estimating telomere length from whole genome sequencing data?,Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.Telomere length is a risk factor in disease and the dynamics of telomere length are crucial to our understanding of cell replication and vitality.,1
6,0,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Finally, five promising differentially miRNAs (miR-200a, miR-100, miR-141, miR-200b, and miR-200c) were reported with the consistent direction in four or more studies.",1
6,1,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"MiR-200a, miR-200b, miR-200c, and miR-141, all of them belong to miR-200 family, were reported with consistently up-regulated in at least 4 studies, whereas miR-100 was reported with down-regulated in 4 studies",0
6,2,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer,0
6,3,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,multivariate analysis showed that the status of miR-203 expression was an independent predictor for both overall survival and progression-free survival in EOC.,0
6,4,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,These findings provide the convincing evidence for the first time that the upregulation of miR-203 may serve as a novel molecular marker to predict the aggressive tumor progression and unfavorable prognosis of EOC patients,0
6,5,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Some, but not all, of the data indicated that the miR-200 family was dysregulated in a variety of malignancies.",0
6,6,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"In this study, we demonstrated that miR-200a and E-cadherin were significantly upregulated in EOC compared to benign epithelial ovarian cysts and normal ovarian tissues",0
6,7,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,There was a significantly positive correlation between miR-200a and E-cadherin in EOC.,0
6,8,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"The biphasic expression pattern suggested that miR-200a levels may serve as novel biomarkers for the early detection of EOC, and miR-200a and E-cadherin are candidate targets for the development of new treatment modalities against ovarian cancer",0
6,9,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Kaplan-Meier analysis showed low miR-510 expression, low miR-509-5p expression, and advanced FIGO stage, and chemotherapy resistance were significantly associated with poorer overall survival (P < 0.05).",0
6,10,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Our results suggest that miRNAs may play a role in the progression of OSC, and miR-510 and miR-509-5p may be considered novel-candidate clinical biomarkers for predicting OSC outcome",0
6,11,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"The qRT-PCR results showed that miR-510, miR-509-5p, and miR-508-3p were significantly downregulated and that miR-483-5p was upregulated in stage III OSC compared with stage I, which was consistent with the microarray results",0
6,12,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"In this study, we examined serum miR-21 levels in epithelial ovarian cancer (EOC) patients, and explored its association with clinicopathological factors and prognosis.",0
6,13,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,The results showed significantly higher serum miR-21 levels in EOC patients than in healthy controls.,0
6,14,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"In addition, increased serum miR-21 expression was correlated with advanced FIGO stage, high tumor grade, and shortened overall survival.",0
6,15,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"These findings indicate that serum miR-21 may serve as a novel diagnostic and prognostic marker, and be used as a therapeutic target for the treatment of EOC",0
6,16,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer,0
6,17,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Serum miR-132, miR-26a, let-7b, and miR-145 could be considered as potential candidates as novel biomarkers in serous ovarian cancer.",1
6,18,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Among the miRNAs that showed a consistent regulation tendency through all specimens and showed more than a 2-fold difference in serum, 5 miRNAs (miR-132, miR-26a, let-7b, miR-145, and miR-143) were determined as the 5 most markedly down-regulated miRNAs in the serum from ovarian cancer patients with respect to those of controls.",1
6,19,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Four miRNAs (miR-132, miR-26a, let-7b, and miR-145) out of 5 selected miRNAs were significantly underexpressed in the serum of ovarian cancer patients in qRT-PCR",1
6,20,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?," microRNA (miR)-182, miR-200a, miR-200b and miR-200c were highly overexpressed in the SEOC cell lines relative to normal human ovarian surface epithelial cells and were assessed in RNA extracted from serum as candidate biomarkers",0
6,21,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Together, these results suggest that low miR-100 expression             may be an independent poor prognostic factor and miR-100 can function as a tumor             suppressor by targeting PLK1 in human EOCs",0
6,22,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,Prognostic implications of microRNA-100 and its functional roles in             human epithelial ovarian cancer,0
6,23,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Taken together, miR-152 and miR-148a may be involved             in the carcinogenesis of ovarian cancer through deregulation of cell proliferation.",0
6,24,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,They may be novel biomarkers for early detection or therapeutic targets of ovarian             cancer,0
6,25,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management,0
6,26,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?," The study suggests that the beneficial impact of the addition of paclitaxel on EOC survival was significantly linked to let-7a levels, and that miRNAs such as let-7a may be a useful marker for selection of chemotherapeutic agents in EOC management",0
6,27,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"miR-200c has potential as a predictor of survival, and is a biomarker of relapse, in stage I EOC",0
6,28,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer,0
6,29,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?, our results strongly suggest that let-7i might be used as a therapeutic target to modulate platinum-based chemotherapy and as a biomarker to predict chemotherapy response and survival in patients with ovarian cancer,0
6,30,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"miRNAs-21, 92 and 93 are known oncogenes with therapeutic and biomarker potential",0
6,31,Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?,"Serum miR-132, miR-26a, let-7b, and miR-145 could be considered as potential candidates as novel biomarkers in serous ovarian cancer",1
2359,0,Describe mechanism of action of Ozanimod.,"The sphingosine-1-phosphate receptor-1 (S1P1) agonist ozanimod ameliorates ulcerative colitis, yet its mechanism of action is unknown.",0
2359,1,Describe mechanism of action of Ozanimod.,"Finally, the S1P1 receptor agonist ozanimod showed promise in early trials in ulcerative colitis.",0
2359,2,Describe mechanism of action of Ozanimod.,"ntil recently, three S1P modulators with differing selectivity for S1P receptors were in clinical development for IBD: ozanimod (RPC1063), etrasimod (APD334) and amiselimod (MT-1303).",0
2359,3,Describe mechanism of action of Ozanimod.,"Ozanimod is an oral selective modulator of S1P1Rand S1P5Rreceptors in clinical development for the treatment of chronic immune-mediated, inflammatory diseases.",1
2359,4,Describe mechanism of action of Ozanimod.,"Ozanimod is a novel, selective, oral sphingosine-1-phosphate (1 and 5) receptor modulator in development for multiple sclerosis and inflammatory bowel disease.",1
2359,5,Describe mechanism of action of Ozanimod.,"Emerging strategies to interfere with cellular adhesion processes involved in lymphocyte recruitment are discussed, including both integrin blockade (natalizumab, vedolizumab, etrolizumab) and sphingosine-1-phosphate receptor inhibition (fingolimod, ozanimod).",0
2359,6,Describe mechanism of action of Ozanimod.,"RECENT FINDINGS: We discuss the most important findings of one published phase II trial that targeted the β7 integrin (etrolizumab), two phase II trials that targeted the α4β7 integrin ligand: mucosal addressin cell adhesion molecule 1 (MAdCAM-1, PF-00547659), a phase II trial targeting the chemokine IP-10 (CXCL10) in Crohn's, and a phase II trial that targeted the sphingosine-1-phosphate receptor-1: ozanimod in patients with ulcerative colitis.",0
2359,7,Describe mechanism of action of Ozanimod.," As such, agents that more selectively target subtype 1 of the S1PR are of interest and are at various stages of development.",0
2359,8,Describe mechanism of action of Ozanimod.,"These include ponesimod (ACT128800), siponimod (BAF312), ozanimod (RPC1063), ceralifimod (ONO-4641), GSK2018682, and MT-1303.",0
2359,9,Describe mechanism of action of Ozanimod.,"Effects of High- and Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator.",0
2359,10,Describe mechanism of action of Ozanimod.,Ozanimod (RPC1063) is an oral selective modulator of the sphingosine-1-phosphate 1 and 5 receptors under development for the treatment of relapsing multiple sclerosis and inflammatory bowel disease.,1
2359,11,Describe mechanism of action of Ozanimod.,"Ozanimod is a novel, selective, oral sphingosine-1-phosphate (1 and 5) receptor modulator in development for multiple sclerosis and inflammatory bowel disease.",1
2359,12,Describe mechanism of action of Ozanimod.,"Cardiac Safety of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator:",0
2359,13,Describe mechanism of action of Ozanimod.,Ozanimod (RPC1063) is an oral selective modulator of the sphingosine-1-phosphate 1 and 5 receptors under development for the treatment of relapsing multiple sclerosis and inflammatory bowel disease.,1
2359,14,Describe mechanism of action of Ozanimod.,"<b>BACKGROUND</b>: Ozanimod (RPC1063) is an oral agonist of the sphingosine-1-phosphate receptor subtypes 1 and 5 that induces peripheral lymphocyte sequestration, potentially decreasing the number of activated lymphocytes circulating to the gastrointestinal tract.<br><b>METHODS</b>: We conducted a double-blind, placebo-controlled phase 2 trial of ozanimod in 197 adults with moderate-to-severe ulcerative colitis.",0
2359,15,Describe mechanism of action of Ozanimod.,several new medications are being investigated in late phase studies for the treatment of patients with relapsing or progressive multiple sclerosis ms these agents represent a variety of mechanisms of action and provide not only lower relapse rates but also improvement in disabilities the majority of investigational trials involve selective sphingosine 1 phosphate receptor 1 immunomodulators such as laquinimod ozanimod ponesimod and siponimod in an effort to build on the success of fingolimod ocrelizumab is a cd20 positive b cell targeting monoclonal antibody with a promising new mechanism of action ofatumumab is also a cd20 inhibitor daclizumab an interleukin 2 inhibitor has evidence of good efficacy but is associated with unfavorable side effects masitinib is a mast cell inhibitor that also has shown efficacy in alzheimer s disease and amyotrophic lateral sclerosis phase 3 trials for some of these agents will conclude in the next 12 months and their manufacturers are expected to apply for us food and drug administration approval soon thereafter this review article summarizes data for newly approved and late phase investigational agents for the treatment of patients with ms.,0
2359,16,Describe mechanism of action of Ozanimod.,sphingosine 1 phosphate s1p receptor modulators possess a unique mechanism of action as disease modifying therapy for multiple sclerosis ms subtype 1 s1p receptors are expressed on the surfaces of lymphocytes and are important in regulating egression from lymph nodes the s1p receptor modulators indirectly antagonize the receptor s function and sequester lymphocytes in lymph nodes fingolimod was the first s1p agent approved in the usa in 2010 for relapsing ms after two phase iii trials freedoms and transforms demonstrated potent efficacy and good safety and tolerability post marketing experience as well as a third phase iii trial freedoms ii also showed favorable results more selective s1p receptor agents ponesimod act128800 siponimod baf312 ozanimod rpc1063 ceralifimod ono 4641 gsk2018682 and mt 1303 are still in relatively early stages of development but phase i and ii trials showed promising efficacy and safety however these observations have yet to be reproduced in phase iii clinical trials.,0
2359,17,Describe mechanism of action of Ozanimod.,results from the first in human study with ozanimod a novel selective sphingosine 1 phosphate receptor modulator,0
2359,18,Describe mechanism of action of Ozanimod.,cardiac safety of ozanimod a novel sphingosine 1 phosphate receptor modulator results of a thorough qt qtc study,0
2359,19,Describe mechanism of action of Ozanimod.,effects of high and low fat meals on the pharmacokinetics of ozanimod a novel sphingosine 1 phosphate receptor modulator,0
2359,20,Describe mechanism of action of Ozanimod.,ozanimod rpc1063 is a potent sphingosine 1 phosphate receptor 1 s1p1 and receptor 5 s1p5 agonist with autoimmune disease modifying activity,0
2359,21,Describe mechanism of action of Ozanimod.,sphingosine 1 phosphate receptor s1pr modulators possess a unique mechanism of action in the treatment of multiple sclerosis ms subtype 1 of the s1pr is expressed on the surface of lymphocytes and is important in regulating egression from lymph nodes the s1pr modulators indirectly antagonize the receptor s function leading to sequestration of lymphocytes in the lymph nodes fingolimod was the first s1pr modulator to receive regulatory approval for relapsing remitting ms after 2 phase iii trials demonstrated potent efficacy safety and tolerability fingolimod can cause undesirable effects as a result of its interaction with other s1pr subtypes which are expressed in diverse tissues including cardiac myocytes as such agents that more selectively target subtype 1 of the s1pr are of interest and are at various stages of development these include ponesimod act128800 siponimod baf312 ozanimod rpc1063 ceralifimod ono 4641 gsk2018682 and mt 1303 data from phase ii trials and early results from phase iii studies have been promising and will be presented in this review of special interest are results from the expand study of siponimod which suggest a potential role for s1pr modulators in secondary progressive ms.,0
2359,22,Describe mechanism of action of Ozanimod.,the sphingosine 1 phosphate receptor 1 s1p agonist ozanimod ameliorates ulcerative colitis yet its mechanism of action is unknown here we examine the cell subsets that express s1p in intestine using s1p egfp mice the regulation of s1p expression in lymphocytes after administration of dextran sulfate sodium dss after colitis induced by transfer of cd4 cd45rb cells and by crossing a mouse with tnf driven ileitis with s1p egfp mice we then assayed the expression of enzymes that regulate intestinal s1p levels and the effect of fty720 on lymphocyte behavior and s1p expression we found that not only t and b cells express s1p but also dendritic dc and endothelial cells furthermore chronic but not acute inflammatory signals increased s1p expression while the enzymes that control tissue s1p levels in mice and humans with inflammatory bowel disease ibd were uniformly dysregulated favoring synthesis over degradation finally we observed that fty720 reduced t cell velocity and induced s1p degradation and retention of naïve but not effector t cells our data demonstrate that chronic inflammation modulates s1p expression and tissue s1p levels and suggests that the anti inflammatory properties of s1pr agonists might not be solely due to their lymphopenic effects but also due to potential effects on dc migration and vascular barrier function.,0
2359,23,Describe mechanism of action of Ozanimod.,ozanimod rpc1063 is an oral selective modulator of the sphingosine 1 phosphate 1 and 5 receptors under development for the treatment of relapsing multiple sclerosis and inflammatory bowel disease the effects of high fat and low fat meals on the pharmacokinetics pk of a single oral dose of ozanimod were evaluated in 24 healthy volunteers in a randomized open label crossover trial each subject received a 1 mg dose of ozanimod hydrochloride under 3 meal conditions fasted high fat and low fat each separated by 7 days mean plasma concentration time profiles for ozanimod and its active metabolites rp101988 major rp101075 minor were similar under all 3 conditions moreover all pk parameters for ozanimod rp101988 and rp101075 were similar under the 3 meal conditions the 90 confidence intervals cis for the ratios of geometric least squares mean fed fasted were within the equivalence limits of 0 80 to 1 25 for area under the concentration time curve from time 0 to infinity auc and maximum plasma concentration c for ozanimod rp101988 and rp101075 except for the high fat effect on rp101075 c 90 ci 0 76 0 88 given this lack of a food effect on the exposure of ozanimod and its active metabolites ozanimod can be taken without regard to meals.,0
2359,24,Describe mechanism of action of Ozanimod.,ozanimod is a novel selective oral sphingosine 1 phosphate 1 and 5 receptor modulator in development for multiple sclerosis and inflammatory bowel disease this randomized double blind placebo controlled positive controlled parallel group thorough qt study characterized the effects of ozanimod on cardiac repolarization in healthy subjects eligible subjects were randomized to 1 of 2 groups ozanimod escalated from 0 25 to 2 mg over 14 days or placebo for 14 days a single dose of moxifloxacin 400 mg or placebo was administered on days 2 and 17 the primary end point was the time matched placebo corrected baseline adjusted mean qtcf δδqtcf a total of 113 124 91 1 subjects completed the study the upper limits of the 2 sided 90 confidence intervals for δδqtcf for both ozanimod 1 and 2 mg were below the 10 millisecond regulatory threshold no qtcf 480 milliseconds or postdose change in qtcf of 60 milliseconds was observed there was no evidence of a positive relationship between concentrations of ozanimod and its active metabolites and δδqtcf although ozanimod blunted the observed diurnal increase in heart rate excursions below predose heart rates were no greater than with placebo results demonstrate that ozanimod does not prolong the qtc interval or cause clinically significant bradycardia supporting ozanimod s evolving favorable cardiac safety profile.,0
3632,0,Describe the mechanism of action of Luspatercept.,"The method is a modification of a recently published protocol for Luspatercept (ACE-536, ACVR2B-Fc), another erythropoiesis stimulating fusion protein.",0
3632,1,Describe the mechanism of action of Luspatercept.,They are dimeric recombinant fusion proteins composed of the extracellular domain of a human activin receptor (ActRIIA or IIB) linked to the Fc part of human IgG1.,0
3632,2,Describe the mechanism of action of Luspatercept.,Sotatercept (ActRIIA-Fc) and Luspatercept (a modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia and included in the prohibited list established by the World Anti-Doping Agency.,0
3632,3,Describe the mechanism of action of Luspatercept.,"PURPOSE OF REVIEW: Sotatercept and luspatercept are recombinant soluble activin type-II receptor-IgG-Fc fusion proteins that are tested in clinical trials for the treatment of various types of anemias, including renal anemia.",1
3632,4,Describe the mechanism of action of Luspatercept.,"Other newly developed ESAs - luspatercept and sotatercept, both activin receptor type II-Fc fusion proteins (ActRII-Fc) - are also now prohibited and could be used in combination with rEPOs.",0
3632,5,Describe the mechanism of action of Luspatercept.,"Recently, activin inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs and further clinical trials are ongoing to explore this further.",0
3632,6,Describe the mechanism of action of Luspatercept.,"Combined detection of the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC-MS/MS.",0
3632,7,Describe the mechanism of action of Luspatercept.,"In particular, activin receptor competitors, such as the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc), have the potential for being misused as doping agents in sports as they were found to inhibit negative regulators of late-stage erythropoiesis.",0
3632,8,Describe the mechanism of action of Luspatercept.,"An example is luspatercept, an activin-receptor trap that modifies transforming growth factor-β signaling, thereby increasing the efficiency of erythropoiesis.",0
3632,9,Describe the mechanism of action of Luspatercept.,BACKGROUND: Myelodysplastic syndromes are characterised by ineffective erythropoiesis.,0
3632,10,Describe the mechanism of action of Luspatercept.,"Luspatercept (ACE-536) is a novel fusion protein that blocks transforming growth factor beta (TGF β) superfamily inhibitors of erythropoiesis, giving rise to a promising new investigative therapy.",1
3632,11,Describe the mechanism of action of Luspatercept.,"Luspatercept (ACE-536) is a novel fusion protein that blocks transforming growth factor beta (TGF β) superfamily inhibitors of erythropoiesis, giving rise to a promising new investigative therapy.",1
3632,12,Describe the mechanism of action of Luspatercept.,"Luspatercept (ACE-536, ACVR2B-Fc), a fusion protein consisting of the extracellular domain of ActRIIB receptor and the Fc-part of human immunoglobulin G1 (IgG1), is currently under clinical development (Phase III).",0
3632,13,Describe the mechanism of action of Luspatercept.,"Sotatercept and luspatercept are recombinant soluble activin type-II receptor-IgG-Fc fusion proteins that are tested in clinical trials for the treatment of various types of anemias , including renal anemia",1
3632,14,Describe the mechanism of action of Luspatercept.,"Luspatercept (ACE-536) is a novel fusion protein that blocks transforming growth factor beta (TGF β) superfamily inhibitors of erythropoiesis, giving rise to a promising new investigative therapy.",1
3632,15,Describe the mechanism of action of Luspatercept.,"Several antibody-based strategies for the detection of Luspatercept and other ACVR2B-Fc fusion proteins in human serum were evaluated (ELISA; IEF-, SDS-, and SAR-PAGE followed by Western blotting; immunoprecipitation).",0
3632,16,Describe the mechanism of action of Luspatercept.,"Luspatercept (ACE-536, ACVR2B-Fc), a fusion protein consisting of the extracellular domain of ActRIIB receptor and the Fc-part of human immunoglobulin G1 (IgG1), is currently under clinical development (Phase III).",0
3632,17,Describe the mechanism of action of Luspatercept.,"PURPOSE OF REVIEW
Sotatercept and luspatercept are recombinant soluble activin type-II receptor-IgG-Fc fusion proteins that are tested in clinical trials for the treatment of various types of anemias, including renal anemia.",0
3632,18,Describe the mechanism of action of Luspatercept.,"Several antibody-based strategies for the detection of Luspatercept and other ACVR2B-Fc fusion proteins in human serum were evaluated (ELISA; IEF-, SDS-, and SAR-PAGE followed by Western blotting; immunoprecipitation).",0
2242,0,What is the function of the exosome?,Exosomes-secreted microRNAs play an important role in metastatic spread,0
2242,1,What is the function of the exosome?,Exosome-mediated communication,0
2242,2,What is the function of the exosome?,"Cells are able to produce and release different types of vesicles, such as microvesicles and exosomes, in the extracellular microenvironment.",1
2242,3,What is the function of the exosome?,"According to the scientific community, both microvesicles and exosomes are able to take on and transfer different macromolecules from and to other cells, and in this way, they can influence the recipient cell function",1
2242,4,What is the function of the exosome?, Exosomes are 40-100-nm vesicles released by most cell types after fusion of multivesicular endosomes with the plasma membrane.,1
2242,5,What is the function of the exosome?,"Exosomes, ubiquitary in body fluids including urines, contain proteins and RNA species specific of the tissue of origin.",1
2242,6,What is the function of the exosome?," Exosomes, small membrane vesicles secreted into the extracellular environment, are emerging as another important intercellular messenger in immune responses.",1
2242,7,What is the function of the exosome?,the exosome is a complex of 3' -->5' exoribonucleases that plays a key role in the processing and degradation of a wide variety of RNA substrates,0
2242,8,What is the function of the exosome?,RNA exosome is responsible for a wide variety of RNA processing and degradation reactions,0
2242,9,What is the function of the exosome?,"ability of exosomes to carry and selectively deliver bioactive molecules (e.g., lipids, proteins, and nucleic acids) confers on them the capacity to modulate the activity of receptor cells, even if these cells are located in distant tissues or organs.",0
2242,10,What is the function of the exosome?,Our data show that NKG2D is a likely physiological target for exosome-mediated immune evasion in cancer.,0
2242,11,What is the function of the exosome?,"Exosomes, a key component of cell paracrine secretion, can exert protective effects in various disease models",0
2242,12,What is the function of the exosome?,"Exosome secretion participates in the eradication of obsolete proteins but several findings, essentially in the immune system, indicate that exosomes constitute a potential mode of intercellular communication",0
2242,13,What is the function of the exosome?,"Exosomes, nano-sized extracellular vesicles, are believed to play important roles in intercellular communications.",0
2242,14,What is the function of the exosome?,This study demonstrates that exosomes released from human macrophages negatively regulate endothelial cell migration through control of integrin trafficking.,0
2242,15,What is the function of the exosome?,"We found that the majority of extracellular vesicles in the AH were in the exosome size range, suggesting that miRNAs housed within exosomes may function in communication between AH inflow and outflow tissues.",0
2242,16,What is the function of the exosome?,umor cell-derived exosomes (TEX) suppress functions of immune cells.,0
2439,0,What is a potential side effect for Tymlos?,"Thus, near life-long treatment with abaloparatide in rats resulted in dose and time dependent formation of osteosarcomas, with a comparable response to hPTH(1-34) at similar exposure.",1
3048,0,Can pazopanib be used for treatment von Hippel-Lindau disease?,Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.,0
3048,1,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Treatment of RCCs with tyrosine kinase inhibitors (TKIs) such as Pazopanib is now first line therapy, but their effect on VHL-associated CNS HBs remains unknown.",0
3048,2,Can pazopanib be used for treatment von Hippel-Lindau disease?,We report the use of Pazopanib in a patient with VHL disease for treatment of RCC who also harbored multiple CNS HBs.,0
3048,3,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.",1
3048,4,Can pazopanib be used for treatment von Hippel-Lindau disease?,"INTERPRETATION: Pazopanib was associated with encouraging preliminary activity in von Hippel-Lindau disease, with a side-effect profile consistent with that seen in previous trials.",0
3048,5,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Pazopanib could be considered as a treatment choice for patients with von Hippel-Lindau disease and growing lesions, or to reduce the size of unresectable lesions in these patients.",0
3048,6,Can pazopanib be used for treatment von Hippel-Lindau disease?,Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.,0
3048,7,Can pazopanib be used for treatment von Hippel-Lindau disease?," Here, we report a 37-year-old woman's case with recurrent and rapidly progressive VHL-associated hemangioblastomas, causing severe disability.",0
3048,8,Can pazopanib be used for treatment von Hippel-Lindau disease?,"She was treated 24 months with pazopanib, a multityrosine kinase inhibitor (TKI) targeting VEGF and PDGF-β pathways.",0
3048,9,Can pazopanib be used for treatment von Hippel-Lindau disease?,Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.,1
3048,10,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Here we provide the first report demonstrating clinical and radiological anti-tumor response using pazopanib, a small molecule multi-receptor tyrosine kinase inhibitor, in a patient with treatment-refractory VHL-associated CNS hemangioblastoma.",0
3048,11,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Pazopanib could be considered as a treatment choice for patients with von Hippel-Lindau disease and growing lesions, or to reduce the size of unresectable lesions in these patients.",0
3048,12,Can pazopanib be used for treatment von Hippel-Lindau disease?,"METHODS
In this non-randomised, single-centre, open-label, phase 2 trial, adult patients with clinical manifestations of von Hippel-Lindau disease were recruited from the University of Texas MD Anderson Cancer Center (Houston, TX, USA) and were treated with pazopanib (800 mg orally daily) for 24 weeks, with an option to continue treatment if desired by the patient and treating physician.",0
3048,13,Can pazopanib be used for treatment von Hippel-Lindau disease?,We aimed to assess the activity and safety of pazopanib in patients with von Hippel-Lindau disease.,1
3048,14,Can pazopanib be used for treatment von Hippel-Lindau disease?,"INTERPRETATION
Pazopanib was associated with encouraging preliminary activity in von Hippel-Lindau disease, with a side-effect profile consistent with that seen in previous trials.",0
3048,15,Can pazopanib be used for treatment von Hippel-Lindau disease?,"FINDINGS
Between Jan 18, 2012, and Aug 10, 2016, we screened 37 patients with genetically confirmed or clinical features consistent with von Hippel-Lindau disease, of whom 31 eligible patients were treated with pazopanib.",0
3048,16,Can pazopanib be used for treatment von Hippel-Lindau disease?,Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.von Hippel-Lindau (VHL) disease is a genetically acquired multisystem tumor syndrome of the viscera and central nervous system (CNS).,0
3048,17,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.Hemangioblastoma is a rare benign neoplasm, accounting for less than 2% of all primitive brain tumors.",0
3048,18,Can pazopanib be used for treatment von Hippel-Lindau disease?,"We aimed to assess the activity and safety of pazopanib in patients with von Hippel-Lindau disease.<br><b>METHODS</b>: In this non-randomised, single-centre, open-label, phase 2 trial, adult patients with clinical manifestations of von Hippel-Lindau disease were recruited from the University of Texas MD Anderson Cancer Center (Houston, TX, USA) and were treated with pazopanib (800 mg orally daily) for 24 weeks, with an option to continue treatment if desired by the patient and treating physician.",1
3048,19,Can pazopanib be used for treatment von Hippel-Lindau disease?,"This study is registered with ClinicalTrials.gov, number NCT01436227, and is closed to accrual.<br><b>FINDINGS</b>: Between Jan 18, 2012, and Aug 10, 2016, we screened 37 patients with genetically confirmed or clinical features consistent with von Hippel-Lindau disease, of whom 31 eligible patients were treated with pazopanib.",0
3048,20,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Treatment-related serious adverse events included one case each of appendicitis and gastritis and one patient had a fatal CNS bleed.<br><b>INTERPRETATION</b>: Pazopanib was associated with encouraging preliminary activity in von Hippel-Lindau disease, with a side-effect profile consistent with that seen in previous trials.",0
3048,21,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Pazopanib could be considered as a treatment choice for patients with von Hippel-Lindau disease and growing lesions, or to reduce the size of unresectable lesions in these patients.",0
3048,22,Can pazopanib be used for treatment von Hippel-Lindau disease?,We aimed to assess the activity and safety of pazopanib in patients with von Hippel-Lindau disease.,1
3048,23,Can pazopanib be used for treatment von Hippel-Lindau disease?,"In this non-randomised, single-centre, open-label, phase 2 trial, adult patients with clinical manifestations of von Hippel-Lindau disease were recruited from the University of Texas MD Anderson Cancer Center (Houston, TX, USA) and were treated with pazopanib (800 mg orally daily) for 24 weeks, with an option to continue treatment if desired by the patient and treating physician.",0
3048,24,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Pazopanib was associated with encouraging preliminary activity in von Hippel-Lindau disease, with a side-effect profile consistent with that seen in previous trials.",0
3048,25,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Pazopanib could be considered as a treatment choice for patients with von Hippel-Lindau disease and growing lesions, or to reduce the size of unresectable lesions in these patients.",0
3048,26,Can pazopanib be used for treatment von Hippel-Lindau disease?,"Between Jan 18, 2012, and Aug 10, 2016, we screened 37 patients with genetically confirmed or clinical features consistent with von Hippel-Lindau disease, of whom 31 eligible patients were treated with pazopanib.",0
1489,0,Is there any role for long noncoding RNAs in adipogenesis?,Long noncoding RNAs regulate adipogenesis.,0
1489,1,Is there any role for long noncoding RNAs in adipogenesis?,"Here we profiled the transcriptome of primary brown and white adipocytes, preadipocytes, and cultured adipocytes and identified 175 lncRNAs that are specifically regulated during adipogenesis.",1
1489,2,Is there any role for long noncoding RNAs in adipogenesis?,"Many lncRNAs are adipose-enriched, strongly induced during adipogenesis, and bound at their promoters by key transcription factors such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer-binding protein α (CEBPα).",1
1489,3,Is there any role for long noncoding RNAs in adipogenesis?,RNAi-mediated loss of function screens identified functional lncRNAs with varying impact on adipogenesis.,1
1489,4,Is there any role for long noncoding RNAs in adipogenesis?,"Collectively, we have identified numerous lncRNAs that are functionally required for proper adipogenesis.",1
1489,5,Is there any role for long noncoding RNAs in adipogenesis?,"Here we profiled the transcriptome of primary brown and white adipocytes, preadipocytes, and cultured adipocytes and identified 175 lncRNAs that are specifically regulated during adipogenesis.",0
1489,6,Is there any role for long noncoding RNAs in adipogenesis?,"Many lncRNAs are adipose-enriched, strongly induced during adipogenesis, and bound at their promoters by key transcription factors such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer-binding protein α (CEBPα).",1
912,0,What is the mode of inheritance of short QT syndrome?,"Congenital short QT syndrome is a new familial primary electrical disease of the heart, which is characterized by abnormally short QT interval and paroxysmal atrial and ventricular tachyarrhythmias, including sudden cardiac death.",1
912,1,What is the mode of inheritance of short QT syndrome?,An autosomal dominant mode of inheritance has been suggested.,1
912,2,What is the mode of inheritance of short QT syndrome?,"From 1993, the Short QT Syndrome (SQTS) came to our attention, as a new inherited ""electrical disease"" associated with increased risk of sudden cardiac death and atrial fibrillation.",1
912,3,What is the mode of inheritance of short QT syndrome?,"Mutations of Ikr, Iks, Ikl channels cause dysfunctional Iks, Ikr, Ikl channels with an increase in the net outward K current leading to shortening of repolarization.",1
912,4,What is the mode of inheritance of short QT syndrome?,This in turn leads to a shorter QT interval on the ECG and shorter atrial and ventricular refractory periods with increased susceptibility to VF and AF.,0
912,5,What is the mode of inheritance of short QT syndrome?,There seems to be an autosomal dominant mode of inheritance.,1
1570,0,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,"Neuroglobin has shown rich neuroprotective effects against cerebral hypoxia, and therefore has the potential to impact outcomes after traumatic brain injury (TBI).",1
1570,1,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,"Neuroglobin (Ngb) is proposed to be a neuron-specific, hypoxia-responsive, neuroprotective protein.",0
1570,2,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,CONCLUSION: The increased expression of neuroglobin in traumatic brain injury informed us that neuroglobin had anti-apoptosis action in post-injury neuron.,1
1570,3,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,It could protect the neuron from traumatic stress and secondary ischemia and hypoxia insults during ultra-early and acute stages.,0
1570,4,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,Neuroglobin-overexpression reduces traumatic brain lesion size in mice.,1
1570,5,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,BACKGROUND: Accumulating evidence has demonstrated that over-expression of Neuroglobin (Ngb) is neuroprotective against hypoxic/ischemic brain injuries.,0
1570,6,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,"CONCLUSION: Ngb over-expression reduced traumatic lesion volume, which might partially be achieved by decreasing oxidative stress.",0
1570,7,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,Neuroglobin upregulation offers neuroprotection in traumatic brain injury.,1
1570,8,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,OBJECTIVES: The aim of this study was to investigate rat neuroglobin (rNGB) expression level after traumatic brain injury (TBI) and further study its neuroprotective effects in TBI when it was overexpressed in adenoviral vector.,0
1570,9,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,CONCLUSIONS: NGB was upregulated in TBI and overexpressed rNGB had a significant neuroprotection in TBI.,0
1570,10,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,This study suggested that rNGB overexpression may be a new strategy for treating of TBI.,0
1570,11,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,"Neuroglobin has shown rich neuroprotective effects against cerebral hypoxia, and therefore has the potential to impact outcomes after traumatic brain injury (TBI).",1
1570,12,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,The aim of this study was to investigate rat neuroglobin (rNGB) expression level after traumatic brain injury (TBI) and further study its neuroprotective effects in TBI when it was overexpressed in adenoviral vector.,0
1570,13,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,Accumulating evidence has demonstrated that over-expression of Neuroglobin (Ngb) is neuroprotective against hypoxic/ischemic brain injuries.,0
1570,14,Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?,"Various studies seem to indicate that neuroglobin is a neuroprotective agent when overexpressed, acting as a potent inhibitor of oxidative and nitrosative stress.",0
2825,0,"What forms part of the senescence associated secretory phenotype, or SASP?",SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells,0
2825,1,"What forms part of the senescence associated secretory phenotype, or SASP?","Numerous activities of senescent cells depend on the aptitude of these cells to secrete myriads of bioactive molecules, a behavior termed the senescence-associated secretory phenotype (SASP)",1
2825,2,"What forms part of the senescence associated secretory phenotype, or SASP?","The SASP supports cell-autonomous functions like the senescence-associated growth arrest, and mediates paracrine interactions between senescent cells and their surrounding microenvironment.",1
2825,3,"What forms part of the senescence associated secretory phenotype, or SASP?","Cultures enriched with not-diploid cells acquired a senescence-associated secretory phenotype (SASP) characterized by IL1B, CXCL8, CCL2, TNF, CCL27 and other pro-inflammatory factors including a novel SASP component CLEC11A.",1
2825,4,"What forms part of the senescence associated secretory phenotype, or SASP?",Senescent cells secrete cytokines and other factors of the senescence-associated secretory phenotype (SASP) that contribute to tumor suppression by enforcing arrest and recruiting immune cells that remove these damaged or oncogene-expressing cells from organisms.,0
2825,5,"What forms part of the senescence associated secretory phenotype, or SASP?","Aim of this study was to evaluate whether and how adalimumab, a monoclonal antibody directed against tumor necrosis factor-α (TNF-α), a major SASP component, can prevent the SASP",0
2825,6,"What forms part of the senescence associated secretory phenotype, or SASP?","Endothelial cell senescence is characterized by acquisition of senescence-associated secretory phenotype (SASP), able to promote inflammaging and cancer progression.",0
2825,7,"What forms part of the senescence associated secretory phenotype, or SASP?","We have shown that the mitochondria are essential for development of senescence and many of the associated phenotypes, including the often detrimental senescence-associated secretory phenotype (SASP)",0
2825,8,"What forms part of the senescence associated secretory phenotype, or SASP?",The diverse arrays of proteins secreted by senescent cells have been described to influence aging and to have both pro-tumorigenic and anti-tumorigenic influences on the surrounding microenvironment.,1
2825,9,"What forms part of the senescence associated secretory phenotype, or SASP?","Further characterization of these proteins, known as the senescence-associated secretory phenotype (SASP), and their regulators is required to understand and further manipulate such activities.",1
4172,0,What is known about growth arrest-specific 6 protein?,"Growth arrest-specific 6 (GAS6) is a gene encoding the Gas6 protein, which is expressed in fibroblasts, and its related signaling might be associated with adipose tissue inflammation, glucose intolerance and insulin resistance.",1
4172,1,What is known about growth arrest-specific 6 protein?," Growth arrest-specific 6 (Gas6) is a vitamin K-dependent protein secreted by immune cells, endothelial cells, vascular smooth muscle cells, and adipocytes.",1
4172,2,What is known about growth arrest-specific 6 protein?,"Recent studies indicate that Gas6 and receptors of the TAM (Tyro3, Axl, and Mer) family may be involved in the pathogenesis of obesity, systemic inflammation, and insulin resistance.",1
4172,3,What is known about growth arrest-specific 6 protein?,Gamma-glutamyl-carboxylated Gas6 mediates positive role of vitamin K on lowering hyperglycemia in type 2 diabetes.,1
46,0,Are there web based self management strategies for chronic pain ?,"Fibromyalgia Symptom Reduction by Online Behavioral Self-monitoring,",0
46,1,Are there web based self management strategies for chronic pain ?,"This study aimed to evaluate effects of a web-based, self-monitoring and symptom management system (SMARTLog) that analyzes personal self-monitoring data and delivers data-based feedback over time.",1
46,2,Are there web based self management strategies for chronic pain ?,"Moderate use (3 times weekly x 3 months) increased likelihood of clinically significant improvements in pain, memory, gastrointestinal problems, depression, fatigue, and concentration; heavy use (4.5 times weekly x five months) produced the above plus improvement in stiffness and sleep difficulties.",0
46,3,Are there web based self management strategies for chronic pain ?,Results suggest that the tailored online chronic pain management program showed promising effects on pain at 1 and 6 months posttreatment and quality of life at 6 months posttreatment in this naturalistic study.,1
46,4,Are there web based self management strategies for chronic pain ?,Results suggest the potential value of self-management for chronic pain patients and the potential acceptability of web-based delivery of intervention content.,1
46,5,Are there web based self management strategies for chronic pain ?,Patient involvement can be fostered by web-based applications combining health information with decision support or behaviour change support.,0
46,6,Are there web based self management strategies for chronic pain ?,"These so-called Interactive Health Communication Applications (IHCAs) can reach great numbers of patients at low financial cost and provide information and support at the time, place and learning speed patients prefer.",0
46,7,Are there web based self management strategies for chronic pain ?,"Web-based interventions may also be effective in enhancing self-management for individuals with chronic pain, but little is known about long-term effects.",1
46,8,Are there web based self management strategies for chronic pain ?,Research on Web-based interventions to support self-management following participation in pain management programs is limited.,1
46,9,Are there web based self management strategies for chronic pain ?,OBJECTIVE: The aim is to examine the long-term effects of a 4-week smartphone-intervention,0
577,0,Is paramyxovirus involved in human subacute thyroiditis?,"Most cases of subacute thyroiditis are caused by a variety of viruses, for example, Coxsackie, cytomegalovirus, Epstein-Barr virus, and adenovirus.",1
577,1,Is paramyxovirus involved in human subacute thyroiditis?,Influenza immunization or infection may cause subacute thyroiditis.,1
577,2,Is paramyxovirus involved in human subacute thyroiditis?,Coxsackie virus has been reported to be one of the viruses associated with the disease.,0
577,3,Is paramyxovirus involved in human subacute thyroiditis?,"The etiology of subacute granulomatous thyroiditis (SAT) is obscure, although it is postulated to be associated with viral infections and genetic factors.",1
577,4,Is paramyxovirus involved in human subacute thyroiditis?,The results suggest that SAT is not usually associated with acute infections,1
577,5,Is paramyxovirus involved in human subacute thyroiditis?,No evidence was obtained to support the proposed role of enteroviruses as an important etiologic agent of SAT.,1
577,6,Is paramyxovirus involved in human subacute thyroiditis?,"The viral antibodies evaluated were those of Influenza A and B, Coxsackie A9, B1, B2, B3, B4, B5 and B6, Echo 3, 7, 11 and 12, Parainfluenza 1, 2, 3 and 4, and Adeno 8 virus.",0
577,7,Is paramyxovirus involved in human subacute thyroiditis?,"The following results were obtained: In class I HLA typing, the frequency of HLA-Bw35 in SAT was 67.4%, which was significantly (p less than 0.0001) higher than that in the control (14.1%).",0
577,8,Is paramyxovirus involved in human subacute thyroiditis?,"On the other hand, the frequency of Cw1 in SAT (14.6%) was significantly (p less than 0.01) lower than that of the control (32.1%), and that of Cw3 (65.2%) was significantly (p less than 0.01) higher than that of the control (46.5%).",0
2497,0,"In November 2017,  in what phase  was  the clinical trial for the drug SYL040012?","This review addresses nine small-interfering RNAs (siRNAs) and one unique microRNA (miRNA) inhibitor, which entered the phase 2-3 clinical trials.",1
2497,1,"In November 2017,  in what phase  was  the clinical trial for the drug SYL040012?","The siRNAs in focus are PF-04523655, TKM-080301, Atu027, SYL040012, SYL1001, siG12D-LODER (phase 2), QPI-1002, QPI-1007, and patisiran (phase 3).",1
509,0,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"The membrane protein complex between the sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) and phospholamban (PLN) controls Ca(2+) transport in cardiomyocytes, thereby modulating cardiac contractility.",1
509,1,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,β-Adrenergic-stimulated phosphorylation of PLN at Ser-16 enhances SERCA activity via an unknown mechanism.,0
509,2,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Phospholamban (PLN) is a type II membrane protein that inhibits the sarcoplasmic reticulum Ca(2+)-ATPase (SERCA), thereby regulating calcium homeostasis in cardiac muscle.",1
509,3,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"In membranes, PLN forms pentamers that have been proposed to function either as a storage for active monomers or as ion channels.",0
509,4,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,Regulation of the SERCA calcium pump by phospholamban (PLB) is largely due to interactions between their respective transmembrane domains.,0
509,5,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"In spite of numerous mutagenesis and kinetic studies, we still do not have a clear mechanistic picture of how PLB influences the calcium transport cycle of SERCA.",0
509,6,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,Calcium transport across the membrane of the sarcoplasmic reticulum (SR) plays an important role in the regulation of heart muscle contraction and relaxation.,0
509,7,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"The sarco(endo)plasmic reticulum Ca(2+) ATPase (SERCA) 2a is responsible for Ca(2+) up-take by this organelle and is inhibited in a reversible manner by phospholamban, another SR membrane protein.",1
509,8,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Thus, alleviation of phospholamban-mediated inhibition of SERCA2a is a potential therapeutic option for heart failure and cardiomyopathy.",0
509,9,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,Phospholamban has been suggested to be a key regulator of cardiac sarcoplasmic reticulum (SR) Ca cycling and contractility and a potential therapeutic target in restoring the depressed Ca cycling in failing hearts.,0
509,10,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"In larger mammals, a higher fraction of SERCA2a pumps are regulated by phospholamban, and this may influence therapeutic strategies to enhance cardiac contractility and functional cardiac reserve.",0
509,11,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Phospholamban (PLB) inhibits the sarcoplasmic reticulum (SR) Ca(2+)-ATPase (SERCA), and this inhibition is relieved by Ca(2+) calmodulin-dependent protein kinase II (CaM kinase II) phosphorylation",0
509,12,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,These findings suggest that PLB is an important modulator of gastric antrum smooth muscle contractility by modulation of SR Ca(2+) release and CaM kinase II activity.,0
509,13,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"The function of the SERCA pump is modulated by the endogenous molecules phospholamban (PLB) and sarcolipin (SLN), expressed in cardiac and skeletal muscles.",0
509,14,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"The mechanism of action of PLB on SERCA is well characterized, whereas that of SLN is only beginning to be understood.",0
509,15,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?, Phospholamban (PLB) is an inhibitor of the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA).,0
509,16,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,These results show that alteration of the PLB:SERCA ratio can significantly modulate smooth muscle [Ca2+]i.,0
509,17,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,Phospholamban expressed in cardiac muscle and sarcolipin expressed in skeletal muscle regulate SERCA activity.,0
509,18,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,Phospholamban (PLB) is a 24- to 27-kDa phosphoprotein that modulates activity of the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA).,1
509,19,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Expression of PLB is reportedly limited to cardiac, slow-twitch skeletal and smooth muscle in which PLB is an important regulator of [Ca2+]i and contractility in these muscles.",1
509,20,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,Regulation of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA 2a) depends on the phosphorylation state of phospholamban (PLB).,0
509,21,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"When PLB is phosphorylated, its inhibitory effect towards SERCA 2a is relieved, leading to an enhanced myocardial performance.",0
509,22,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?, Ca(2+) reuptake occurs via sarcoendoplasmic reticulum Ca(2+) ATPase (SERCA) and is regulated by the inhibitory protein phospholamban (PLB) in many cell types.,0
509,23,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Phospholamban (PLN) is a small integral membrane protein, which binds and inhibits in a yet unknown fashion the Ca(2+)-ATPase (SERCA) in the sarcoplasmic reticulum.",0
509,24,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Phospholamban (PLN) is the endogenous inhibitor of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA), the integral membrane enzyme responsible for 70�% of the removal of Ca(2+) from the cytosol, inducing cardiac muscle relaxation in humans.",0
509,25,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,Phospholamban (PLB) is an integral membrane protein regulating Ca(2+) transport through inhibitory interaction with sarco(endo)plasmic reticulum calcium ATPase (SERCA).,0
509,26,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Phosphorylation by protein kinase A and dephosphorylation by protein phosphatase 1 modulate the inhibitory activity of phospholamban (PLN), the endogenous regulator of the sarco(endo)plasmic reticulum calcium Ca(2+) ATPase (SERCA).",0
509,27,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"Phosphorylation by protein kinase A and dephosphorylation by protein phosphatase 1 modulate the inhibitory activity of phospholamban (PLN), the endogenous regulator of the sarco(endo)plasmic reticulum calcium Ca(2+) ATPase (SERCA)",0
509,28,Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?,"We used EPR spectroscopy to probe directly the interaction between phospholamban (PLB) and its regulatory target, the sarcoplasmic reticulum Ca-ATPase (SERCA)",0
3337,0,Are Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors(MPNST) rare in neurofibromatosis patients?,Spinal intradural primary malignant peripheral nerve sheath tumors (MPNST) are rare in patients without neurofibromatosis.,1
3337,1,Are Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors(MPNST) rare in neurofibromatosis patients?,Primary malignant peripheral nerve sheath tumors (MPNSTs) are extremely rare in patients without a history of neurofibromatosis; only 18 cases have been reported in the English-language literature to this point.,1
3605,0,Which organs are primarily damaged in SLE?,"The patients with SLE and SS had the greatest renal, peripheral vascular, and musculoskeletal damage (24, 19, 38% of patients, respectively) followed by the SLE group",1
3605,1,Which organs are primarily damaged in SLE?,Observations from lupus centres worldwide revealed that the prevalence of damage occurring in the cardiovascular system in patients with SLE has increased over the past four decades.,1
3605,2,Which organs are primarily damaged in SLE?,lupus-related organ damage involving the neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease.,1
3605,3,Which organs are primarily damaged in SLE?,"This Review discusses the pattern and trend of organ damage in patients with SLE worldwide, the potential serological and genetic mechanisms of organ damage, and the advances in research on potential tools for early detection of lupus-related organ damage, such as functional brain imaging techniques, measurement of endothelial function, identification of biomarkers from body fluids, and development of risk calculation models.",1
3605,4,Which organs are primarily damaged in SLE?, Patients with SLE treated with long-term belimumab plus SoC had a low incidence of organ damage accrual and no unexpected AEs.,1
3605,5,Which organs are primarily damaged in SLE?,"High-risk patients with pre-existing organ damage also had low accrual, suggesting a favorable effect on future damage development.",0
3362,0,Is CTCF bound at nucleosome free regions?,Nucleosome depletion at 5'-HS4 was dependent on interaction of the insulator protein CCCTC-binding factor (CTCF) and was required for enhancer blocking.,1
3362,1,Is CTCF bound at nucleosome free regions?,"Here, we show that promoter classes are significantly differentiated by nucleosome organization and chromatin structure.",0
3362,2,Is CTCF bound at nucleosome free regions?,"Dispersed promoters display higher associations with well-positioned nucleosomes downstream of the TSS and a more clearly defined nucleosome free region upstream, while focused promoters have a less organized nucleosome structure, yet higher presence of RNA polymerase II.",1
3362,3,Is CTCF bound at nucleosome free regions?,"hese differences extend to histone variants (H2A.Z) and marks (H3K4 methylation), as well as insulator binding (such as CTCF), independent of the expression levels of affected genes.",0
3362,4,Is CTCF bound at nucleosome free regions?,"nucleosome occupancy at nucleosome-free regions (NFRs), many of which are located at sites occupied by the multivalent factors Ctcf and cohesin.",1
3362,5,Is CTCF bound at nucleosome free regions?,This general architectural change correlates with enhanced binding of CTCF and cohesins and more pronounced insulation of contacts across chromatin boundaries in lineage-committed cells.,1
3362,6,Is CTCF bound at nucleosome free regions?,"robust inter-nucleosomal interactions exist around transcription start site (TSS), transcription termination sites (TTS) or around CTCF binding sites",1
3962,0,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Much remains unknown about the risk factors, pathogenesis, prognosis, and specific therapy for this emerging manifestation of COVID-19 known as Multisystem Inflammatory Syndrome in Children (MIS-C).",0
3962,1,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series,0
3962,2,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children,0
3962,3,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?," This study aims to assess COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) in Latin American children,",0
3962,4,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"A complication is the rare multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, presenting 4-6 weeks after infection as high fever, organ dysfunction, and strongly elevated markers of inflammation.",0
3962,5,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"We apply systems-level analyses of blood immune cells, cytokines, and autoantibodies in healthy children, children with Kawasaki disease enrolled prior to COVID-19, children infected with SARS-CoV-2, and children presenting with MIS-C. We find that the inflammatory response in MIS-C differs from the cytokine storm of severe acute COVID-19, shares several features with Kawasaki disease, but also differs from this condition with respect to T cell subsets, interleukin (IL)-17A, and biomarkers associated with arterial damage.",0
3962,6,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,OBJECTIVE: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease (COVID-19) is a rare and challenging diagnosis requiring early treatment.,0
3962,7,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"This syndrome is now known as either ""Pediatric Inflammatory Multisystem Syndrome temporally related with COVID-19"" (PIMS-TS) (1), or Multisystem Inflammatory Syndrome in Children (MIS-C) (2) and is currently considered a rare post-COVID-19 complication which, in a minority of cases, can lead to death.",0
3962,8,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Multisystem Inflammatory Syndrome in Children (MIS-C) associated with Coronavirus Disease 2019 (COVID-19) is a newly recognized condition in which children with recent SARS-CoV-2 infection present with a constellation of symptoms including hypotension, multiorgan involvement, and elevated inflammatory markers.",0
3962,9,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Thes,0
3962,10,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Background: Kawasaki-like syndrome occurring in children during the COVID-19 pandemic has been labelled multisystem inflammatory syndrome in children (MIS-C) by the CDC and paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) by,0
3962,11,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"em inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or toxic shock syndrome in children with evidence of SARS-CoV-2 infection.",0
3962,12,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,This revie,0
3962,13,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,BACKGROUND: A small subset of pediatric patients develop a rare syndrome associated with Coronavirus Disease 2019 (COVID-19) infection called multisystem inflammatory syndrome in childr,0
3962,14,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?, adults.,0
3962,15,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"However, the newly described multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been associated with cardiac complicat",0
3962,16,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,BACKGROUND: Multisystem inflammatory syndrome temporally associated with COVID-19 (MIS-C) has been described as a novel and often severe presentation of SARS-CoV-2 infection i,0
3962,17,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,OBJECTIVE: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease (COVID-19) is a rare and challenging diagnosis requiring early tr,0
3962,18,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Background: Multisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that is temporally associated with coronavirus disease 2019 (",0
3962,19,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Recent COVID-19 publications describe a variety of clinical presentations including an asymptomatic state, pneumonia, a hemophagocytic lymphohistiocytosis like syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C) but, also called Pediatric Inflammatory Multisystem Syndrome-Toxic Shock (PIMS-TS), Kawasaki Disease, and myocarditis.",0
3962,20,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"We analyzed peripheral blood immune responses in hospitalized SARS-CoV-2 infected pediatric patients (pediatric COVID-19) and patients with MIS-C. MIS-C patients had patterns of T cell-biased lymphopenia and T cell activation similar to severely ill adults, and all patients with MIS-C had SARS-CoV-2 spike-specific antibodies at admission.",0
3962,21,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or toxic shock syndrome in children with evidence of SARS-CoV-2 infection.",1
3962,22,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"It includes a discussion of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, as well as other aspects of the COVID-19 pandemic that are affecting children and families, such as poisonings, childhood immunizations, mental health, nonaccidental trauma, and neglect.",0
3962,23,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Importance: To date, no study has characterized the mucocutaneous features seen in hospitalized children with multisystem inflammatory syndrome in children (MIS-C) or the temporal association of these findings with the onset of systemic symptoms.Objective: To describe the mucocutaneous findings seen in children with MIS-C during the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City in 2020.Design, Setting, and Participants: A retrospective case series was conducted of 35 children admitted to 2 hospitals in New York City between April 1 and July 14, 2020, who met Centers for Disease Control and Prevention and/or epidemiologic criteria for MIS-C.Main Outcomes and Measures: Laboratory and clinical characteristics, with emphasis on mucocutaneous findings, of children who met criteria for MIS-C.",0
3962,24,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"This condition, since defined as the multisystem inflammatory syndrome in children (MIS-C), is assumed to be a delayed immune response to coronavirus disease 2019 (COVID-19), and there are frequently cardiac manifestations of ventricular dysfunction and/or coronary artery dilation.Methods: We surveyed the inpatient MIS-C management approaches of the members of the International Kawasaki Disease Registry across 38 institutions and 11 countries.Results: Among the respondents, 56% reported using immunomodulatory treatment for all MIS-C patients, regardless of presentation.",0
3962,25,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,DESIGN: Children ages 0-22 years with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection presenting to urgent care clinics or being hospitalized for confirmed/suspected SARS-CoV-2 infection or multisystem inflammatory syndrome in children (MIS-C) at Massachusetts General Hospital were offered enrollment in the Massachusetts General Hospital Pediatric COVID-19 Biorepository.,0
3962,26,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"We recently discovered a superantigen-like motif, similar to Staphylococcal enterotoxin B (SEB), near the S1/S2 cleavage site of SARS-CoV-2 Spike protein, which might explain the multisystem-inflammatory syndrome (MIS-C) observed in children and cytokine storm in severe COVID-19 patients.",0
3962,27,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"METHODS: An extensive search strategy was conducted by combining the terms multisystem inflammatory syndrome in children and coronavirus infection or using the term multisystem inflammatory syndrome in children in bibliographic electronic databases (PubMed, EMBASE, and CINAHL) and in preprint servers (BioRxiv.org and MedRxiv.org) following the Preferred Reporting Items for Systematic Reviews and Metaanalyses guidelines to retrieve all articles published from January 1, 2020, to July 31, 2020.",0
3962,28,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.",0
3962,29,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.",0
3962,30,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV2 infection in otherwise healthy children.,0
3962,31,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Data on multisystem inflammatory syndrome in children (MIS-C) related to coronavirus disease-19 (COVID-19) is increasing in the current COVID-19 pandemic.,0
3962,32,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Introduction Multisystem inflammatory syndrome in children (MIS-C) is a unique clinical complication of SARS-CoV-2 infection observed in pediatric patients.,1
3962,33,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19.,0
3962,34,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"Case presentation An eight-year-old female presented with hyperglycemia, ketosis and metabolic acidosis consistent with diabetic ketoacidosis (DKA) in the setting of fever, rash, respiratory distress, hemodynamic instability, reduced systolic function with dilation of the left anterior descending artery, and positive SARS-CoV-2 antibodies suggestive of MIS-C.",0
3962,35,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"However, the newly described multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been associated with cardiac complications.M",0
3962,36,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children (MIS-C).,1
3962,37,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Many of these cases feature a toxic shock-like syndrome or Kawasaki-like syndrome in the setting of SARS-CoV-2 positive diagnostic testing and the CDC has termed this presentation Multisystem Inflammatory Syndrome (MIS-C).,0
3962,38,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"We describe a case of MIS-C in a child who presented to our Emergency Department (ED) twice and on the second visit was found to have signs of distributive shock, multi-organ injury and systemic inflammation associated with COVID-19.",0
3962,39,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"PURPOSE OF REVIEW: Here we summarize current knowledge about multisystem inflammatory syndrome in children (MIS-C), a presumed postinfectious inflammatory condition that has emerged as an important COVID-19-associated complication, to help clinicians identify and manage cases.RECENT FINDINGS: Clinical presentation of MIS-C is do",0
3962,40,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"MIS-C is a rare yet severe and highly critical complication of COVID-19 infection in pediatrics, leading to serious and life-threatening illnesses.",0
3962,41,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,BACKGROUND: A multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) has recently been described.OBJECTIVE: To evaluate imaging findings of MIS-C associated with COVID-19.SUBJECTS AND METHODS: Imaging studies and medical records of sixteen patients (0-20 years) admit,0
3962,42,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"BACKGROUND: Recently, cases of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 have been reporte",1
3962,43,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Recent reports have described a secondary Multisystem Inflammatory Syndrome in Children (MIS-C) after a prior COVID-19 infection that often has features of Kawasaki disease (KD).,1
3962,44,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?, discharged home (length of hospital stay 3-20 days).,0
3962,45,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,"There were no mortalities.CONCLUSION: MIS-C associated with COVID-19 is characterized predominantly by cardiovascular abnormalities, though also solid visceral organ, gallbladder, and bowel abnormalities as well as ascites, reflecting a multisystemic inflammatory process.CLINICAL IMPACT: The constellation of imaging findings in the setting of COVID-19 may alert pediatr",0
3962,46,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Multisystem Inflammatory Syndrome in Children Temporally Related to COVID-19: A Case Report From Saudi Arabia.,0
3962,47,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,BACKGROUND: Multisystem inflammatory syndrome temporally associated with COVID-19 (MIS-C) has been described as a novel and often severe presentation of SARS-CoV-2 infection,0
3962,48,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,ric patients.,0
3962,49,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,An association between COVID-19 and a Kawasaki-like inflammatory syndrome has recently presented in pediatric patients.CASE REPORT: We report a unique case of multisystem inflammatory syndrome in children presenting with characteristic findings in a child who later developed cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation.CONCLUSION: Recognition of these early signs and symptoms facilitates screening and risk stratification of pediatric COVID-19 cas,0
3962,50,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation.,0
3962,51,Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?,A case report.,0
2824,0,Which is the main component of the Lewy body?,neuronal inclusions composed of α-synuclein (Lewy bodies) is considered the typical pathologic correlate of PD,1
2824,1,Which is the main component of the Lewy body?," the era of alpha-synuclein, the protein present in Lewy bodies.",1
2824,2,Which is the main component of the Lewy body?,Lewy bodies comprise of aggregated intracellular vesicles and proteins and α-synuclein is reported to be a major protein component.,1
2824,3,Which is the main component of the Lewy body?,"he Lewy body constituents, α-synuclein and small ubiquitin-related modifier-1(SUMO-1)",1
2558,0,Is the gene CDKN2A nevogenic?,Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated with increased atypical nevus counts.,1
2558,1,Is the gene CDKN2A nevogenic?,Phenotypic characteristics of members of a melanoma prone kindred with a V126D CDKN2A gene mutation were monitored over approximately 15 y.,1
2558,2,Is the gene CDKN2A nevogenic?," Rare germline mutations in CDKN2A predispose to melanoma and appear to be nevogenic, although the correlation between nevus phenotype and mutation status is poor.",1
2558,3,Is the gene CDKN2A nevogenic?,It is plausible that more common CDKN2A variants may influence both melanoma susceptibility and nevus susceptibility.,1
2558,4,Is the gene CDKN2A nevogenic?,supporting the view that CDKN2A is nevogenic.,1
2473,0,Which are the constitutive parts of a Genomic Regulatory Block (GRB)?,"We found the largest mammal-teleost conserved chromosomal segments to be spanned by highly conserved noncoding elements (HCNEs), their developmental regulatory target genes, and phylogenetically and functionally unrelated ""bystander"" genes.",1
2473,1,Which are the constitutive parts of a Genomic Regulatory Block (GRB)?,Bystander genes are not specifically under the control of the regulatory elements that drive the target genes and are expressed in patterns that are different from those of the target genes.,1
2473,2,Which are the constitutive parts of a Genomic Regulatory Block (GRB)?,"Reporter insertions distal to zebrafish developmental regulatory genes pax6.1/2, rx3, id1, and fgf8 and miRNA genes mirn9-1 and mirn9-5 recapitulate the expression patterns of these genes even if located inside or beyond bystander genes, suggesting that the regulatory domain of a developmental regulatory gene can extend into and beyond adjacent transcriptional units.",1
2473,3,Which are the constitutive parts of a Genomic Regulatory Block (GRB)?,We termed these chromosomal segments genomic regulatory blocks (GRBs).,1
2473,4,Which are the constitutive parts of a Genomic Regulatory Block (GRB)?,"We found the largest mammal-teleost conserved chromosomal segments to be spanned by highly conserved noncoding elements (HCNEs), their developmental regulatory target genes, and phylogenetically and functionally unrelated ""bystander"" genes.",1
1365,0,Is Mammaprint approved by the United States Food and Drug Administration?,an FDA-cleared 70-gene signature of MammaPrint panel,1
1365,1,Is Mammaprint approved by the United States Food and Drug Administration?,"on MammaPrint, the first and only assay for breast cancer management that has been cleared by the FDA.",1
1365,2,Is Mammaprint approved by the United States Food and Drug Administration?,"The MammaPrint assay has the advantages of a 510(k) clearance by the US Food and Drug Administration, a larger gene number which may enhance further utility, and the potentially wider patient eligibility including lymph node-positive, ER-negative,",1
1365,3,Is Mammaprint approved by the United States Food and Drug Administration?,"The MammaPrint assay has the advantages of a 510(k) clearance by the U.S. Food and Drug Administration, a larger gene number, which may enhance further utility, and a potentially wider patient eligibility, including lymph node-positive, estrogen receptor (ER)-negative, and younger patients being accrued into the prospective trial (Microarray in Node-Negative Disease May Avoid Chemotherapy).",1
2970,0,Does allele phasing improve the phylogenetic utility of ultraconserved elements?,Allele Phasing Greatly Improves the Phylogenetic Utility of Ultraconserved Elements.,1
2970,1,Does allele phasing improve the phylogenetic utility of ultraconserved elements?,"Our empirical analyses of Ultraconserved Element (UCE) locus data collected from the South American hummingbird genus Topaza demonstrate that phased allele sequences carry sufficient phylogenetic information to infer the genetic structure, lineage divergence, and biogeographic history of a genus that diversified during the last three million years.",1
2970,2,Does allele phasing improve the phylogenetic utility of ultraconserved elements?,"The phylogenetic results support the recognition of two species, and suggest a high rate of gene flow across large distances of rainforest habitats but rare admixture across the Amazon River.",1
2970,3,Does allele phasing improve the phylogenetic utility of ultraconserved elements?,Our simulations provide evidence that analyzing allele sequences leads to more accurate estimates of tree topology and divergence times than the more common approach of using contig sequences.,1
2970,4,Does allele phasing improve the phylogenetic utility of ultraconserved elements?,"Allele Phasing Greatly Improves the Phylogenetic Utility of Ultraconserved Elements.Advances in high-throughput sequencing techniques now allow relatively easy and affordable sequencing of large portions of the genome, even for nonmodel organisms.",1
290,0,Mutation of which gene is associated with Achondroplasia?,"She was subsequently diagnosed with hypochondroplasia at the age of 6 years when disproportional short stature, stocky habitus and macrocephaly were observed.",0
290,1,Mutation of which gene is associated with Achondroplasia?,These phenotypic findings were later confirmed by the presence of fibroblast growth factor receptor 3 (FGFR3) gene mutation N540K.,1
290,2,Mutation of which gene is associated with Achondroplasia?,Achondroplasia can be diagnosed by characteristic clinical and radiographic findings in most affected individuals.,0
290,3,Mutation of which gene is associated with Achondroplasia?,"In individuals who may be too young to diagnose with certainty or in individuals with atypical findings, molecular genetic testing can be used to detect a mutation in FGFR3.",0
290,4,Mutation of which gene is associated with Achondroplasia?,"Achondroplasia comes from the genetic point mutations in the fibroblastic growth factor receptor 3 gene (FGFR3), which enables abnormal cartilage growth-plate differentiation and insufficient bony development.",1
290,5,Mutation of which gene is associated with Achondroplasia?,"The most common genetic mutations in this receptor are G to A at position 1138 (G1138A), which result in the substitution of glycine to arginine at codon 380.",0
290,6,Mutation of which gene is associated with Achondroplasia?,To investigate the mutation at the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) nucleotide 1138 site for identifying the major pathologic mechanism of achondroplasia (ACH) and to evaluate the efficacy of denaturing gradient gel electrophoresis(DGGE) method for screening the point mutations.,0
290,7,Mutation of which gene is associated with Achondroplasia?,Nucleotide 1138 in transmembrane domain of FGFR3 gene is the hot point for mutation in ACH and hence its major pathologic cause.,0
290,8,Mutation of which gene is associated with Achondroplasia?,The nucleotide 1138 of FGFR3 gene is also the hotspot of mutation in Chinese patients with ACH.,0
290,9,Mutation of which gene is associated with Achondroplasia?,A simple and rapid molecular diagnostic method has been set up to differentiate ACH from other similar genetic dwarfism.,0
290,10,Mutation of which gene is associated with Achondroplasia?,The diagnosis of achondroplasia was based on the presence of clinical and radiographic findings and confirmed by the presence of a common FGFR3 gene mutation (Gly380Arg) detected by restriction enzyme analysis and sequencing of the polymerase chain reaction products.,0
290,11,Mutation of which gene is associated with Achondroplasia?,All patients carried the same glycine-to-arginine mutation at codon 380(G380R) of the transmembrane domain of FGFR3.,0
290,12,Mutation of which gene is associated with Achondroplasia?,The results suggest that the G380R mutation of FGFR3 is also a frequent mutation causing achondroplasia in Chinese.,0
290,13,Mutation of which gene is associated with Achondroplasia?,"Detecting FGFR 3 gene mutation with PCR-SSCP and restriction enzymes analysis is a convenient, rapid and reliable molecular diagnostic assay for prenatal and early diagnosis of achondroplasia.",0
290,14,Mutation of which gene is associated with Achondroplasia?,To evaluate whether mutation in the exon 10 of the fibroblast growth factor receptor 3(FGFR3) gene in common in Chinese patients with achondroplasia.,1
290,15,Mutation of which gene is associated with Achondroplasia?,Achondroplasia (ACH) is the most frequent form of short-limb dwarfism.,0
290,16,Mutation of which gene is associated with Achondroplasia?,"Recently, the gene mutation responsible for ACH has been identified in the transmembrane domain of the fibroblast growth factor receptor 3 gene.",1
290,17,Mutation of which gene is associated with Achondroplasia?,"The cause of ACH is a point mutation at nucleotide 1138 of the cDNA, resulting in the substitution of an arginine residue for a glycine.",0
290,18,Mutation of which gene is associated with Achondroplasia?,Recent studies mapped the achondroplasia gene on chromosome region 4p16.3 and identified a common mutation in the gene encoding the fibroblast growth factor receptor 3 (FGFR3).,1
1242,0,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"This article discusses some of these unresolved issues, including the use of medications such as nimodipine, antifibrinolytics, statins, and magnesium; coiling or clipping for aneurysm securement; and the prevention and treatment of potential complications.",1
1242,1,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"The results of this study were as follows: nimodipine demonstrated benefit following aneurysmal SAH; other calcium channel blockers, including nicardipine, do not provide unequivocal benefit; triple-H therapy, fasudil, transluminal balloon angioplasty, thrombolytics, endothelin receptor antagonists, magnesium, statins, and miscellaneous therapies such as free radical scavengers and antifibrinolytics require additional study.",0
1242,2,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,The present results suggest that fasudil is equally or more effective than nimodipine for the prevention of cerebral vasospasm and subsequent ischemic injury in patients undergoing surgery for SAH.,1
1242,3,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,Three studies (2 meta-analyses and 1 randomized controlled trial) demonstrated that nimodipine use confers benefits (reduced morbidity and mortality) for patients with aneurysmatic subarachnoid hemorrhage.,0
1242,4,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,Nimodipine is the only preventative treatment that can be recommended.,0
1242,5,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Nimodipine (Nimotop), HMG Co-A reductase inhibitor (statins) and enoxaparin (Lovenox) were the only drugs with level-1 evidence available for the treatment of vasospasm from aneurysmal subarachnoid hemorrhage as defined by the US Preventative Services Task Force.",0
1242,6,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,The calcium antagonist nimodipine has been shown to reduce the incidence of ischemic complications following aneurysmal subarachnoid hemorrhage (SAH).,1
1242,7,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"There was no significant difference in the incidence of DINDs (28 vs 30% in the peroral and intravenous groups, respectively) or middle cerebral artery blood flow velocities (> 120 cm/second, 50 vs 45%, respectively).",0
1242,8,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Clinical outcome according to the Glasgow Outcome Scale was the same in both groups, and there was no difference in the number of patients with new infarctions on MR imaging.",0
1242,9,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,The results suggest that there is no clinically relevant difference in efficacy between peroral and intravenous administration of nimodipine in preventing DINDs or cerebral vasospasm following SAH.,0
1242,10,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,the risk of delayed cerebral ischemia is reduced with nimodipine and avoiding hypovolemia,0
1242,11,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,A recommendations (standard) for the prophylaxis and treatment of cerebral vasospasm with oral Nimodipine in good grade patients.,0
1242,12,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Of the 75 patients initially considered for active treatment, 83% underwent surgery within 48 hours of rupture, all received nimodipine, 16% received tissue plasminogen activator to lyse subarachnoid or intraventricular clots, 40% underwent hypertensive treatment, and 7% underwent transluminal balloon angioplasty for vasospasm.",0
1242,13,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"All patients with aneurysmal SAH should be treated with the calcium antagonist nimodipine, and in certain circumstances patients should receive anticonvulsants.",0
1242,14,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"The following review gives an account of pathophysiological mechanisms; the importance of treatment with calcium antagonists, hypervolaemic haemodilution, and induced arterial hypertension is discussed in light of the current literature.",0
1242,15,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,Seven placebo-controlled clinical studies have shown that nimodipine improves the outcome of patients with severe neurological damage due to cerebral vasospasm.,0
1242,16,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"In a series of 100 individuals with a ruptured supratentorial aneurysm, who were subjected to aneurysm operation in the acute stage and who subsequently received intravenous treatment with the calcium channel blocker nimodipine, the occurrence of DID with FND was reduced to 5%.",0
1242,17,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"There are many possible successful treatment options for preventing vasospasm, delayed ischemic neurologic deficits, and poor neurologic outcome following aneurysmal subarachnoid hemorrhage; however, further multicenter RCTs need to be performed to determine if there is a significant benefit from their use.",0
1242,18,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,Nimodipine is the only treatment that provided a significant benefit across multiple studies.,0
1242,19,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Absence of symptomatic vasospasm, occurrence of low density areas associated with vasospasm on CT, and occurrence of adverse events were similar between the two groups.",0
1242,20,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,The clinical outcomes were more favorable in the fasudil group than in the nimodipine group (p = 0.040).,0
1242,21,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,The proportion of patients with good clinical outcome was 74.5% (41/55) in the fasudil group and 61.7% (37/60) in the nimodipine group.,0
1242,22,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Cerebral vasospasm is the classic cause of delayed neurological deterioration leading to cerebral ischemia and infarction, and thus, poor outcome and occasionally death, after aneurysmal subarachnoid hemorrhage (SAH).",0
1242,23,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Advances in diagnosis and treatment, principally nimodipine, intensive care management, hemodynamic manipulations, and endovascular neuroradiology procedures, have improved the prospects for these patients, but outcomes remain disappointing.",0
1242,24,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Cerebral vasospasm is the classic cause of delayed neurological deterioration after aneurysmal subarachnoid hemorrhage, leading to cerebral ischemia and infarction, and thus to poor outcome and occasionally death.",1
1242,25,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Advances in diagnosis and treatment-principally the use of nimodipine, intensive care management, hemodynamic manipulations and endovascular neuroradiology procedures-have improved the prospects for these patients, but outcomes remain disappointing.",0
1242,26,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Cerebral vasospasm and delayed cerebral ischemia remain common complications of aneurysmal subarachnoid hemorrhage (SAH), and yet therapies for cerebral vasospasm are limited.",1
1242,27,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"Despite a large number of clinical trials, only calcium antagonists have strong evidence supporting their effectiveness.",0
1242,28,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,The only proven therapy for vasospasm is nimodipine.,0
1242,29,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,nimodipine is indicated after SAH and tirilazad is not effective.,0
1242,30,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,Fasudil hydrochloride and nimodipine both showed inhibitory effects on cerebral vasospasm.,0
1242,31,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,The incidence of symptomatic vasospasm was five of 33 patients in the fasudil group and nine of 32 patients in the nimodipine group.,0
1242,32,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,Good recovery evaluated by the Glasgow Outcome Scale was achieved by 23 of 33 patients in the fasudil group and 19 of 34 patients in the nimodipine group.,0
1242,33,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,Both drugs significantly improved consciousness levels and neurological deficits such as aphasia.,0
1242,34,Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?,"However, fasudil hydrochloride improved motor disturbance more than nimodipine.",0
2296,0,Which algorithm is used by the UCSC Genome Browser?,The UCSC Genome Browser organizes data and annotations (called tracks) around the reference sequences or draft assemblies of many eukaryotic genomes and presents them using a powerful web-based graphical interface.,1
2296,1,Which algorithm is used by the UCSC Genome Browser?,"The database is optimized to support fast interactive performance with the web-based UCSC Genome Browser, a tool built on top of the database for rapid visualization and querying of the data at many levels.",1
2296,2,Which algorithm is used by the UCSC Genome Browser?,The annotations for a given genome are displayed in the browser as a series of tracks aligned with the genomic sequence.,1
2296,3,Which algorithm is used by the UCSC Genome Browser?,Sequence data and annotations may also be viewed in a text-based tabular format or downloaded as tab-delimited flat files.,0
2296,4,Which algorithm is used by the UCSC Genome Browser?,"The University of California Santa Cruz (UCSC) Genome Browser (genome.ucsc.edu) is a popular Web-based tool for quickly displaying a requested portion of a genome at any scale, accompanied by a series of aligned annotation ""tracks"".",0
2296,5,Which algorithm is used by the UCSC Genome Browser?," The database tables underlying the Genome Browser tracks can be viewed, downloaded, and manipulated using another Web-based application, the UCSC Table Browser.",1
2296,6,Which algorithm is used by the UCSC Genome Browser?,"The University of California Santa Cruz (UCSC) Genome Browser is a popular Web-based tool for quickly displaying a requested portion of a genome at any scale, accompanied by a series of aligned annotation ""tracks.",0
2296,7,Which algorithm is used by the UCSC Genome Browser?,"The Saved Session feature allows users to store and share customized views, enhancing the utility of the system for organizing multiple trains of thought.",0
2296,8,Which algorithm is used by the UCSC Genome Browser?,"Binary Alignment/Map (BAM), Variant Call Format and the Personal Genome Single Nucleotide Polymorphisms (SNPs) data formats are useful for visualizing a large sequencing experiment (whole-genome or whole-exome), where the differences between the data set and the reference assembly may be displayed graphically.",0
2296,9,Which algorithm is used by the UCSC Genome Browser?,"Support for high-throughput sequencing extends to compact, indexed data formats, such as BAM, bigBed and bigWig, allowing rapid visualization of large datasets from RNA-seq and ChIP-seq experiments via local hosting.",0
2296,10,Which algorithm is used by the UCSC Genome Browser?,"The database tables underlying the Genome Browser tracks can be viewed, downloaded, and manipulated using another Web-based application, the UCSC Table Browser.",1
2296,11,Which algorithm is used by the UCSC Genome Browser?,"The database tables underlying the Genome Browser tracks can be viewed, downloaded, and manipulated using another Web-based application, the UCSC Table Browser.",0
2296,12,Which algorithm is used by the UCSC Genome Browser?,"The database tables underlying the Genome Browser tracks can be viewed, downloaded, and manipulated using another Web-based application, the UCSC Table Browser.",0
2296,13,Which algorithm is used by the UCSC Genome Browser?,"The comparative genomics annotations in the browser include pairwise alignments, which aid in the identification of orthologous regions between species, and conservation tracks that show measures of evolutionary conservation among sets of multiply aligned species, highlighting regions of the genome that may be functionally important.",0
2296,14,Which algorithm is used by the UCSC Genome Browser?,"Genome Bioinformatics group has developed several tools and methodologies in its study of comparative genomics, many of which have been incorporated into the UCSC Genome Browser (http://genome.ucsc.edu), an easy-to-use online tool for browsing genomic data and aligned annotation ""tracks"" in a single window.",0
2296,15,Which algorithm is used by the UCSC Genome Browser?,"This protocol describes how to use the UCSC Genome Browser to visualize selected tracks at specified genomic regions, download the data and annotations for further analysis, and retrieve multiple sequence alignments and their conservation scores.",0
2296,16,Which algorithm is used by the UCSC Genome Browser?,"This unit describes how to use the Genome Browser and Table Browser for genome analysis, download the underlying database tables, and create and display custom annotation tracks.",0
2296,17,Which algorithm is used by the UCSC Genome Browser?,"The University of California Santa Cruz (UCSC) Genome Browser (genome.ucsc.edu) is a popular Web-based tool for quickly displaying a requested portion of a genome at any scale, accompanied by a series of aligned annotation ""tracks"".",0
2296,18,Which algorithm is used by the UCSC Genome Browser?,"The University of California Santa Cruz (UCSC) Genome Bioinformatics group has developed several tools and methodologies in its study of comparative genomics, many of which have been incorporated into the UCSC Genome Browser (http://genome.ucsc.edu), an easy-to-use online tool for browsing genomic data and aligned annotation ""tracks"" in a single window.",0
2296,19,Which algorithm is used by the UCSC Genome Browser?,"A related tool, the UCSC Table Browser, provides a simple interface for querying, analyzing, and downloading the data underlying the Genome Browser annotation tracks.",0
2296,20,Which algorithm is used by the UCSC Genome Browser?,"Some of the recently developed or enhanced tracks visualize data from published high-throughput RNA-sequencing studies, the NCBI Conserved Domain Database, sequences from pre-genome sequencing studies, predicted gene boundaries from three different protein gene prediction algorithms, tRNAscan-SE gene predictions with RNA secondary structures and CRISPR locus predictions.",0
963,0,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,STAT3 may act as a competitive inhibitor of EIF2AK2.,0
963,1,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Indeed, pharmacological or genetic inhibition of STAT3 stimulates EIF2AK2-dependent EIF2S1 phosphorylation and autophagy.",1
963,2,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Conversely, the overexpression of wild-type STAT3 as well as of STAT3 mutants that cannot be phosphorylated by JAK2 or are excluded from the nucleus inhibits autophagy.",1
963,3,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"However, STAT3 mutants that fail to interact with EIF2AK2 are unable to suppress autophagy",1
963,4,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Both STAT3-targeting agents (i.e., Stattic, JSI-124 and WP1066) and EIF2AK2 activators (such as the double-strand RNA mimetic polyinosinic:polycytidylic acid) are capable of disrupting the inhibitory interaction between STAT3 and EIF2AK2 in cellula",0
963,5,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,A further screen designed to identify EIF2AK2-dependent autophagy inducers revealed that several fatty acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3-EIF2AK2 complex,0
963,6,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"These results reveal an unsuspected crosstalk between cellular metabolism (fatty acids), pro-inflammatory signaling (STAT3), innate immunity (EIF2AK2), and translational control (EIF2S1) that regulates autophagy",0
963,7,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity,0
963,8,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"The SH2 domain of STAT3 was found to interact with the catalytic domain of the eIF2α kinase 2 EIF2AK2, best known as protein kinase R (PKR).",0
963,9,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,Pharmacological and genetic inhibition of STAT3 stimulated the activating phosphorylation of PKR and consequent eIF2α hyperphosphorylation.,0
963,10,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Moreover, PKR depletion inhibited autophagy as initiated by chemical STAT3 inhibitors or free fatty acids like palmitate",0
963,11,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"STAT3-targeting chemicals and palmitate caused the disruption of inhibitory STAT3-PKR interactions, followed by PKR-dependent eIF2α phosphorylation, which facilitates autophagy induction",0
963,12,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Indeed, pharmacological or genetic inhibition of STAT3 stimulates EIF2AK2-dependent EIF2S1 phosphorylation and autophagy.",0
963,13,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,A further screen designed to identify EIF2AK2-dependent autophagy inducers revealed that several fatty acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3-EIF2AK2 complex as well as the phosphorylation of mitogen-activated protein kinase 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and EIF2S1.,0
963,14,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,A further screen designed to identify EIF2AK2-dependent autophagy inducers revealed that several fatty acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3-EIF2AK2 complex as well as the phosphorylation of mitogen-activated protein kinase 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and EIF2S1,0
963,15,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Indeed, pharmacological or genetic inhibition of STAT3 stimulates EIF2AK2-dependent EIF2S1 phosphorylation and autophagy",0
963,16,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"However, STAT3 mutants that fail to interact with EIF2AK2 are unable to suppress autophagy",1
963,17,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy,0
963,18,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,A further screen designed to identify EIF2AK2-dependent autophagy inducers revealed that several fatty acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3-EIF2AK2 complex as well as the phosphorylation of mitogen-activated protein kinase 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and EIF2S1.,0
963,19,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Indeed, pharmacological or genetic inhibition of STAT3 stimulates EIF2AK2-dependent EIF2S1 phosphorylation and autophagy.",0
963,20,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy.,0
963,21,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,These results unravel an unsuspected mechanism of autophagy control that involves STAT3 and PKR as interacting partners.,0
963,22,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Both STAT3-targeting agents (i.e., Stattic, JSI-124 and WP1066) and EIF2AK2 activators (such as the double-strand RNA mimetic polyinosinic:polycytidylic acid) are capable of disrupting the inhibitory interaction between STAT3 and EIF2AK2 in cellula, yet only the latter does so in cell-free systems in vitro.",0
963,23,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,A further screen designed to identify EIF2AK2-dependent autophagy inducers revealed that several fatty acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3-EIF2AK2 complex as well as the phosphorylation of mitogen-activated protein kinase 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and EIF2S1.,0
963,24,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,A further screen designed to identify EIF2AK2-dependent autophagy inducers revealed that several fatty acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3-EIF2AK2 complex as well as the phosphorylation of mitogen-activated protein kinase 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and EIF2S1.,0
963,25,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"These results reveal an unsuspected crosstalk between cellular metabolism (fatty acids), pro-inflammatory signaling (STAT3), innate immunity (EIF2AK2), and translational control (EIF2S1) that regulates autophagy.",0
963,26,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Thus, STAT3 may act as a competitive inhibitor of EIF2AK2.",0
963,27,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Indeed, pharmacological or genetic inhibition of STAT3 stimulates EIF2AK2-dependent EIF2S1 phosphorylation and autophagy.",0
963,28,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Indeed, pharmacological or genetic inhibition of STAT3 stimulates EIF2AK2-dependent EIF2S1 phosphorylation and autophagy.",0
963,29,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,"Conversely, the overexpression of wild-type STAT3 as well as of STAT3 mutants that cannot be phosphorylated by JAK2 or are excluded from the nucleus inhibits autophagy.",1
963,30,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,", Stattic, JSI-124 and WP1066) and EIF2AK2 activators (such as the double-strand RNA mimetic polyinosinic:polycytidylic acid) are capable of disrupting the inhibitory interaction between STAT3 and EIF2AK2 in cellula, yet only the latter does so in cell-free systems in vitro.",0
963,31,Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?,A further screen designed to identify EIF2AK2-dependent autophagy inducers revealed that several fatty acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3-EIF2AK2 complex as well as the phosphorylation of mitogen-activated protein kinase 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and EIF2S1.,0
1564,0,Are adenylyl cyclases always transmembrane proteins?,ransmembrane adenylyl cyclase,0
1564,1,Are adenylyl cyclases always transmembrane proteins?, Transmembrane adenylyl cyclase (tmAC) and soluble AC (sAC),1
1564,2,Are adenylyl cyclases always transmembrane proteins?,Soluble adenylyl cyclase (sAC) is a recently recognized source of the signaling molecule cyclic AMP (cAMP) that is genetically and biochemically distinct from the classic G-protein-regulated transmembrane adenylyl cyclases (tmACs).,0
1564,3,Are adenylyl cyclases always transmembrane proteins?,Soluble adenylyl cyclase,1
1564,4,Are adenylyl cyclases always transmembrane proteins?,"transmembrane adenylyl cyclases (tmACs), and soluble adenylyl cyclase (sAC).",1
1564,5,Are adenylyl cyclases always transmembrane proteins?," Here, we showed that both transmembrane AC (tmAC) and soluble AC (sAC) are distinctly involved in the regulation of sperm motility in the ascidian Ciona intestinalis.",1
1564,6,Are adenylyl cyclases always transmembrane proteins?,"cAMP production in beta cells is mediated not simply by transmembrane adenylyl cyclases (TMACs), but also by sAC.",0
1564,7,Are adenylyl cyclases always transmembrane proteins?,"In contrast to tmAC, sAC produces cAMP in various intracellular microdomains close to specific cAMP targets, e.g., in nucleus and mitochondria",0
1564,8,Are adenylyl cyclases always transmembrane proteins?,"soluble adenylyl cyclase (sAC, ADCY10), the ubiquitous, non-transmembrane adenylyl cyclase, was found to play a key role in neuronal survival and axon growth.",0
1564,9,Are adenylyl cyclases always transmembrane proteins?,Central role of soluble adenylyl cyclase,1
3022,0,Which enzyme is inhibited by a drug Lorlatinib?,"PURPOSE OF REVIEW: We describe recent developments in the rapidly evolving field of anaplastic lymphoma kinase-targeting agents.RECENT FINDINGS: Five targeted drugs are currently available in the clinic via regular approval or named patient programs, including crizotinib, ceritinib, alectinib, brigatinib and lorlatinib.",1
3022,1,Which enzyme is inhibited by a drug Lorlatinib?,IMPORTANCE: The identification of anaplastic lymphoma kinase (ALK) rearrangements in 2-5% of non-small cell lung cancer (NSCLC) patients led to the rapid clinical development of its oral tyrosine kinase inhibitor (TKI).,1
3022,2,Which enzyme is inhibited by a drug Lorlatinib?,Crizotinib was the first ALK inhibitor approved and utilised in the treatment of ALK+ NSCLC patients in the second line setting first and subsequently in the first line one.,0
3022,3,Which enzyme is inhibited by a drug Lorlatinib?,"Since then many other ALK inhibitors have been developed (ceritinib, alectinib, brigatinib, lorlatinib,etc) and the treatment paradigm of these patients has considerably drifted.",0
3022,4,Which enzyme is inhibited by a drug Lorlatinib?,The questions regarding their treatment at progression remains unanswered at the moment.,0
3022,5,Which enzyme is inhibited by a drug Lorlatinib?,"RESULTS: ALK T1151Sins mutation was detected when the patient developed resistance to ceritinib, and undetectable when she responded to lorlatinib.",0
3022,6,Which enzyme is inhibited by a drug Lorlatinib?,"ALK G1202R, the most frequent plasma mutation detected after progression on a second-generation TKI, was consistently suppressed during treatment with lorlatinib.",0
3022,7,Which enzyme is inhibited by a drug Lorlatinib?,"Among patients treated with the third-generation ALK TKI lorlatinib, variant 3 was associated with a significantly longer progression-free survival than variant 1 (hazard ratio, 0.31; 95% CI, 0.12 to 0.79; P = .011).",0
3022,8,Which enzyme is inhibited by a drug Lorlatinib?,Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PET.F-labeling strategies to synthesize isotopologs of lorlatinib (PF-06463922) which is undergoing phase III clinical trial investigations for treatment of non-small-cell lung cancers with specific molecular alterations.,0
3022,9,Which enzyme is inhibited by a drug Lorlatinib?,"In addition, further functional in vitro studies demonstrated that ALK harboring the T1151Sins mutation, while conferring resistance to ceritinib, was inhibited by lorlatinib.",0
3022,10,Which enzyme is inhibited by a drug Lorlatinib?,Lorlatinib (PF-06463922) is a promising oral anaplastic lymphoma kinase (ALK) and ROS1 inhibitor currently in Phase III clinical trials for treatment of non-small-cell lung cancer (NSCLC) containing an ALK rearrangement.,1
3022,11,Which enzyme is inhibited by a drug Lorlatinib?,P-glycoprotein (MDR1/ABCB1) restricts brain accumulation and cytochrome P450-3A (CYP3A) limits oral availability of the novel ALK/ROS1 inhibitor lorlatinib.,0
3022,12,Which enzyme is inhibited by a drug Lorlatinib?,Lorlatinib is a third generation ALK inhibitor that inhibits most ALK mutants resistant to current ALK inhibitors.,1
3022,13,Which enzyme is inhibited by a drug Lorlatinib?,"Lorlatinib (PF-06463922) is a next-generation small-molecule inhibitor of the orphan receptor tyrosine kinase c-ros oncogene 1 (ROS1), which has a kinase domain that is physiologically related to anaplastic lymphoma kinase (ALK), and is undergoing Phase I/II clinical trial investigations for non-small cell lung cancers.",1
3022,14,Which enzyme is inhibited by a drug Lorlatinib?,"BACKGROUND
Lorlatinib is a potent, brain-penetrant, third-generation inhibitor of ALK and ROS1 tyrosine kinases with broad coverage of ALK mutations.",0
3022,15,Which enzyme is inhibited by a drug Lorlatinib?,"The next-generation ALK inhibitor lorlatinib (PF-06463922) has therefore been developed to inhibit resistant ALK mutations, including ALK G1202R, and to penetrate the blood-brain barrier.",0
3022,16,Which enzyme is inhibited by a drug Lorlatinib?,"BACKGROUND Lorlatinib is a potent, brain-penetrant, third-generation inhibitor of ALK and ROS1 tyrosine kinases with broad coverage of ALK mutations.",0
2017,0,What is known about telomere length shortening and stress?,A significant relationship between more perceived stress and shorter telomere length is consistent with theoretical frameworks positing that stress induces physiological changes that result in shortened telomeres.,1
2017,1,What is known about telomere length shortening and stress?,"Psychological stress contributes to numerous diseases and may do so in part through damage to telomeres, protective non-coding segments on the ends of chromosomes.",1
2017,2,What is known about telomere length shortening and stress?,Our results support the hypothesis that depression is associated with accelerated cell aging.,1
2017,3,What is known about telomere length shortening and stress?,"Future studies are required to clarify whether the association is mediated through environmental stress, and whether effective treatment can halt cell aging.",1
2017,4,What is known about telomere length shortening and stress?,"Telomere length, a reliable predictor of disease pathogenesis, can be affected by genetics, chronic stress and health behaviors.",1
2017,5,What is known about telomere length shortening and stress?,"Cross-sectionally, highly stressed postmenopausal women have shorter telomeres, but only if they are inactive.",0
1295,0,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,factors involved in RNA polymerase (RNAP) processivity or transcriptional derepression contribute to the generation of stress-induced mutations.,1
1295,1,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,"In Bacillus subtilis, transcription-associated mutagenesis has been shown to be independent of recombination-dependent repair and, in some cases, of the Y DNA polymerases.",0
1295,2,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,"Central to stationary-phase mutagenesis in B. subtilis is the requirement for Mfd, transcription coupling repair factor",1
1295,3,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,Adaptive (stationary phase) mutagenesis is a phenomenon by which nondividing cells acquire beneficial mutations as a response to stress.,0
1295,4,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,the level of Leu(+) reversions increased significantly in parallel with the induced increase in transcription levels.,0
1295,5,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,This mutagenic response was not observed under conditions of exponential growth.,1
1295,6,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,"Since transcription is a ubiquitous biological process, transcription-associated mutagenesis may influence evolutionary processes in all organisms.",0
1295,7,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,Transcription-associated mutation in Bacillus subtilis cells under stress.,0
1295,8,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,Transcription-associated mutagenesis is increased under stress and depends on the DNA sequence.,1
1295,9,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,Nonrandom transcription-associated mutagenesis under stress should improve the survival of E.,0
1295,10,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,Transcription-associated mutagenesis is increased under stress and depends on the DNA sequence.,1
1295,11,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,"Stress-induced mutagenesis describes the accumulation of mutations that occur in nongrowing cells, in contrast to mutagenesis that occurs in actively dividing populations, and has been referred to as stationary-phase or adaptive mutagenesis.",0
1295,12,In which phase of cell cycle does  stress-induced transcription-associated mutagenesis (TAM) occur?,Central to stationary-phase mutagenesis in B,0
3946,0,In what clinical trials has SAR425899 been tested?,"A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials.",1
3946,1,In what clinical trials has SAR425899 been tested?,"Subcutaneous administrations of SAR425899 were tested in two randomized, placebo-controlled, double-blind clinical trials.",1
3946,2,In what clinical trials has SAR425899 been tested?,"In the first trial, healthy overweight volunteers (body mass index [BMI] 25-30 kg/m2 ; n = 32) received single-ascending doses (0.01-0.1 mg) of SAR425899 or placebo.",1
3946,3,In what clinical trials has SAR425899 been tested?,"In the second, a multiple-ascending-dose trial (NCT02411825), healthy normal- to overweight volunteers (BMI 20-30 kg/m2 ; n = 40) and overweight/obese patients with T2D (BMI 28-42 kg/m2 ; n = 36) received daily doses of SAR425899 or placebo over 21 or 28 days, respectively.",1
288,0,Can zinc finger nucleases be used to combat disease?,Genetic engineering has emerged as a powerful mechanism for understanding biological systems and a potential approach for redressing congenital disease.,0
288,1,Can zinc finger nucleases be used to combat disease?,"This is of particular importance, given the momentum currently behind ZFNs in moving into phase I clinical trials.",0
288,2,Can zinc finger nucleases be used to combat disease?,"This study provides a historical account of the origins of ZFN technology, an analysis of current techniques and applications, and an examination of the ethical issues applicable to translational ZFN genetic engineering in early phase clinical trials.",0
288,3,Can zinc finger nucleases be used to combat disease?,"This broad range of tractable species renders ZFNs a useful tool for improving the understanding of complex physiological systems, to produce transgenic animals, cell lines, and plants, and to treat human disease.",0
288,4,Can zinc finger nucleases be used to combat disease?,"We observe comparably high frequencies in human T cells, raising the possibility of strategies based on zinc-finger nucleases for the treatment of disease.",1
288,5,Can zinc finger nucleases be used to combat disease?,"Using engineered nucleases, such as Zinc Finger Nucleases (ZFNs) or Transcription Activator-Like Effector Nucleases (TALENs), to make targeted genomic modifications has become a common technique to create new model organisms and custom cell lines, and has shown great promise for disease treatment.",0
288,6,Can zinc finger nucleases be used to combat disease?,Zinc Finger nucleases (ZFNs) have been used to create precise genome modifications at frequencies that might be therapeutically useful in gene therapy.,0
288,7,Can zinc finger nucleases be used to combat disease?,Zinc finger nucleases as tools to understand and treat human diseases.,1
288,8,Can zinc finger nucleases be used to combat disease?,Evaluation of novel design strategies for developing zinc finger nucleases tools for treating human diseases.,1
288,9,Can zinc finger nucleases be used to combat disease?,An over expression APP model for anti-Alzheimer disease drug screening created by zinc finger nuclease technology.,0
288,10,Can zinc finger nucleases be used to combat disease?,Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.,0
288,11,Can zinc finger nucleases be used to combat disease?,"Recently, it has been shown that targeted mutagenesis using zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) can be used to generate knockout zebrafish lines for analysis of their function and/or developing disease models",0
288,12,Can zinc finger nucleases be used to combat disease?,"Using engineered nucleases, such as Zinc Finger Nucleases (ZFNs) or Transcription Activator-Like Effector Nucleases (TALENs), to make targeted genomic modifications has become a common technique to create new model organisms and custom cell lines, and has shown great promise for disease treatment",0
288,13,Can zinc finger nucleases be used to combat disease?,Gene correction by homologous recombination with zinc finger nucleases in primary cells from a mouse model of a generic recessive genetic disease.,1
288,14,Can zinc finger nucleases be used to combat disease?,raising the possibility of strategies based on zinc-finger nucleases for the treatment of disease.,1
4074,0,What is the function of HP1a in the nucleus?,"Drosophila heterochromatin-associated protein 1 (HP1) is an abundant component of heterochromatin, a highly condensed compartment of the nucleus that comprises a major fraction of complex genomes.",1
4074,1,What is the function of HP1a in the nucleus?,"Both the HP1a hinge and chromo shadow domain independently target heterochromatin, while the HP1c chromo shadow domain is implicated solely in euchromatin localization.",0
4074,2,What is the function of HP1a in the nucleus?,"Recently, Drosophila melanogaster Piwi was recently reported to associate with chromatin and to interact directly with the Heterochromatin Protein 1 (HP1a)",0
4074,3,What is the function of HP1a in the nucleus?,These results suggest that silkworm Piwi proteins function as a chromatin regulator in collaboration with HP1a and HP1b.,0
4074,4,What is the function of HP1a in the nucleus?,Heterochromatin protein 1 (HP1) was first described in Drosophila melanogaster as a heterochromatin associated protein required for epigenetic gene silencing.,1
4074,5,What is the function of HP1a in the nucleus?,"Here we characterized the genome-wide effect of nuclear Piwi elimination on the presence of the heterochromatic H3K9me3 mark and HP1a, as well as on the transcription-associated mark H3K4me2.",0
4074,6,What is the function of HP1a in the nucleus?,"Our results demonstrate that a significant increase in the H3K4me2 level upon nuclear Piwi loss is not accompanied by the alterations in H3K9me3 and HP1a levels for several germline-expressed transposons, suggesting that in this case Piwi prevents transcription by a mechanism distinct from H3K9 methylation.",0
4074,7,What is the function of HP1a in the nucleus?,"Heterochromatin is highly enriched for repetitive sequences, and is defined epigenetically by methylation of histone H3 at lysine 9 and recruitment of its binding partner heterochromatin protein 1 (HP1)",0
4074,8,What is the function of HP1a in the nucleus?,The large fraction of heterochromatin in Drosophila neurons is bound by both B-type lamin and HP1a.,0
4074,9,What is the function of HP1a in the nucleus?,"However, in Kc167 cell culture, the only Drosophilla cell type where LADs have previously been mapped, they are neither H3K9me2-enriched nor overlapped with the domains of heterochromatin protein 1a (HP1a)",0
4074,10,What is the function of HP1a in the nucleus?,"Strikingly, contrary to Kc167 cells of embryonic origin, in neurons and, to a lesser extent, in glia and the fat body, HP1a domains appear to overlap strongly with LADs in both the chromosome arms and pericentromeric regions.",0
4074,11,What is the function of HP1a in the nucleus?,Heterochromatin protein 1a (HP1a) has been proposed to function downstream of Piwi-piRNA complex in Drosophila.,0
4074,12,What is the function of HP1a in the nucleus?,The chromatin of all transgene-associated piRNA clusters contain high levels of trimethylated lysine 9 of histone H3 (H3K9me3) and HP1a,0
4074,13,What is the function of HP1a in the nucleus?,"Su(var) 3-9 protein was found to be localized in the nucleus in Sf9 cells, and interact with histone H3, and the heterochromatin protein 1a (HP1a) and HP1b.",0
4074,14,What is the function of HP1a in the nucleus?,An important component of the telomeres is the heterochromatin protein 1a (HP1a).,0
4074,15,What is the function of HP1a in the nucleus?,Heterochromatin protein 1a (HP1a) is a chromatin-associated protein important for the formation and maintenance of heterochromatin.,0
4074,16,What is the function of HP1a in the nucleus?,"Drosophila heterochromatin-associated protein 1 (HP1) is an abundant component of heterochromatin, a highly condensed compartment of the nucleus that comprises a major fraction of complex genomes.",1
4074,17,What is the function of HP1a in the nucleus?,S,0
4074,18,What is the function of HP1a in the nucleus?,"ophila HP1a protein undergoes liquid-liquid demixing in vitro, and nucleates into foci that display liquid properties during the first stages of heterochromatin domain formation in early Drosophila embryos.",0
4074,19,What is the function of HP1a in the nucleus?,"Furthermore, in",0
4074,20,What is the function of HP1a in the nucleus?,"Expression of transposable elements in the germline is controlled by Piwi-interacting (pi) RNAs produced by genomic loci termed piRNA clusters and associated with Rhino, a heterochromatin protein 1 (HP1) homolog.",0
4074,21,What is the function of HP1a in the nucleus?,Pre,0
4074,22,What is the function of HP1a in the nucleus?,Heterochromatin protein 1 (HP1) is an epigenetic regulator of chromatin structure and genome function in eukaryotes.,1
4074,23,What is the function of HP1a in the nucleus?,"9 protein was found to be localized in the nucleus in Sf9 cells, and interact with histone H3, and the heterochromatin protein 1a (HP1a) and HP1b.",0
4074,24,What is the function of HP1a in the nucleus?,A dose-depend,0
4074,25,What is the function of HP1a in the nucleus?,Heterochromatin protein 1a (HP1a) is a highly conserved and versatile epigenetic factor that can both silence and activate transcription.,0
4074,26,What is the function of HP1a in the nucleus?,"Here, we show that Eyg forms a protein complex with heterochromatin protein 1a (HP1a).",0
4074,27,What is the function of HP1a in the nucleus?,"The recruitment of HP1a prevents transcription by favoring a closed, heterochromatin-like structure.",0
4074,28,What is the function of HP1a in the nucleus?,"Using position effect variegation (PEV) experiments, we demonstrated that eyg has a dose-dependent effect on heterochromatin gene silencing and identified a genetic interaction with HP1a in this process.",0
4074,29,What is the function of HP1a in the nucleus?,"HP1a is an evolutionarily conserved heterochromatin-associated protein, which plays an essential role in heterochromatin-mediated gene silencing.",0
4074,30,What is the function of HP1a in the nucleus?,Heterochromatin Protein 1 (HP1a) is a well-known conserved protein involved in heterochromatin formation and gene silencing in different species including humans.,0
4074,31,What is the function of HP1a in the nucleus?,Heterochromatin protein 1 (HP1a in Drosophila) is a conserved eukaryotic chromosomal protein that is prominently associated with pericentric heterochromatin and mediates the concomitant gene silencing.,0
4074,32,What is the function of HP1a in the nucleus?,Heterochromatin protein 1a functions for piRNA biogenesis predominantly from pericentric and telomeric regions in Drosophila.,0
4074,33,What is the function of HP1a in the nucleus?,Heterochromatin protein 1 (HP1) is an epigenetic regulator of chromatin structure and genome function in eukaryotes.,1
3926,0,Which R packages have been developed for studying TADs?,TADCompare: An R Package for Differential and Temporal Analysis of Topologically Associated Domains.,0
3926,1,Which R packages have been developed for studying TADs?,"We developed TADCompare, a method for differential analysis of boundaries of interacting domains between two or more Hi-C datasets.",1
3926,2,Which R packages have been developed for studying TADs?,"TADCompare is based on a spectral clustering-derived measure called the eigenvector gap, which enables a loci-by-loci comparison of boundary differences.",0
3926,3,Which R packages have been developed for studying TADs?,"Using this measure, we introduce methods for identifying differential and consensus boundaries of interacting domains and tracking boundary changes over time.",0
3926,4,Which R packages have been developed for studying TADs?,We further propose a novel framework for the systematic classification of boundary changes.,0
3926,5,Which R packages have been developed for studying TADs?,Colocalization- and gene enrichment analysis of different types of boundary changes demonstrated distinct biological functionality associated with them.,0
3926,6,Which R packages have been developed for studying TADs?,TADCompare is available on https://github.com/dozmorovlab/TADCompare and Bioconductor (submitted).,0
3926,7,Which R packages have been developed for studying TADs?,SpectralTAD: an R package for defining a hierarchy of topologically associated domains using spectral clustering.,1
3926,8,Which R packages have been developed for studying TADs?,"Our method, implemented in an R package, SpectralTAD, detects hierarchical, biologically relevant TADs, has automatic parameter selection, is robust to sequencing depth, resolution, and sparsity of Hi-C data.",0
3926,9,Which R packages have been developed for studying TADs?,SpectralTAD outperforms four state-of-the-art TAD callers in simulated and experimental settings.,0
3926,10,Which R packages have been developed for studying TADs?,We demonstrate that TAD boundaries shared among multiple levels of the TAD hierarchy were more enriched in classical boundary marks and more conserved across cell lines and tissues.,0
3926,11,Which R packages have been developed for studying TADs?,"In contrast, boundaries of TADs that cannot be split into sub-TADs showed less enrichment and conservation, suggesting their more dynamic role in genome regulation.CONCLUSION: SpectralTAD is available on Bioconductor, http://bioconductor.org/packages/SpectralTAD/ .",0
3926,12,Which R packages have been developed for studying TADs?,"LTS: Our method, implemented in an R package, SpectralTAD, detects hierarchical, biologically relevant TADs, has automatic parameter selection, is robust to sequencing depth, resolution, and sparsity of Hi-C data.",0
3926,13,Which R packages have been developed for studying TADs?,Spe,0
3926,14,Which R packages have been developed for studying TADs?,TADCompare: An R Package for Differential and Temporal Analysis of Topologically Associated Domains,0
3926,15,Which R packages have been developed for studying TADs?,SpectralTAD: an R package for defining a hierarchy of topologically associated domains using spectral clustering,1
3926,16,Which R packages have been developed for studying TADs?,"d TADCompare, a method for differential analysis of boundaries of interacting domains between two or more Hi-C datasets.",1
3926,17,Which R packages have been developed for studying TADs?,TADCompare,0
3926,18,Which R packages have been developed for studying TADs?,"r method, implemented in an R package, SpectralTAD, detects hierarchical, biologically relevant TADs, has automatic parameter selection, is robust to sequencing depth, resolution, and sparsity of Hi-C data.",0
3926,19,Which R packages have been developed for studying TADs?,S,0
3926,20,Which R packages have been developed for studying TADs?,regulation.,0
3926,21,Which R packages have been developed for studying TADs?,"Existing tools for TAD calling are frequently sensitive to biases in Hi-C data, depend on tunable parameters, and are computationally inefficient.METHODS: To address these challenges, we developed a novel sliding window-based spectral clustering framework that uses gaps between consecutive eigenvectors for TAD boundary identification.RESULTS: Our method, implemented in an R package, SpectralTAD, detects hierarchical, biologically relevant TADs, has automatic parameter selection, is robust to sequencing depth, resoluti",0
3926,22,Which R packages have been developed for studying TADs?,cross cell lines and tissues.,0
3926,23,Which R packages have been developed for studying TADs?,"In contrast, boundaries of TADs that cannot be split into sub-TADs showed less enrichment and conservation, suggesting their more dynamic role in genome regulation.CONCLUSION: SpectralTAD is available on Bioconductor, http:",0
3926,24,Which R packages have been developed for studying TADs?,"We developed TADCompare, a method for differential analysis of boundaries of interacting domains between two or more Hi-C datasets.",1
3926,25,Which R packages have been developed for studying TADs?,"TADCompare is based on a spectral clustering-derived measure called the eigenvector gap, which enables a loci-by-loci comparison of boundary differences.",0
3134,0,Which was the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body?,"On May 23, 2017, the US Food and Drug Administration (FDA) approved a treatment for cancer patients with positive microsatellite instability-high (MSI-H) markers or mismatch repair deficient (dMMR) markers.",1
3134,1,Which was the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body?,This approach is the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body.,1
3259,0,List the cancers that are associated with SBLA syndrome.,"Li-Fraumeni syndrome is an autosomal dominant inherited disorder also known as the SBLA cancer syndrome (sarcoma, breast, leukemia, and adrenal).",1
3259,1,List the cancers that are associated with SBLA syndrome.,"Li-Fraumeni syndrome (LFS) is characterized by a plethora of cancers, most prominent of which is carcinoma of the breast followed by sarcomas, brain tumors, leukemia, lymphoma, lung carcinoma, and adrenocortical carcinom",0
3259,2,List the cancers that are associated with SBLA syndrome.,"sarcoma, breast cancer and brain tumors, lung and laryngeal cancer, leukemia, lymphoma, and adrenalcortical carcinoma syndrome.",1
3259,3,List the cancers that are associated with SBLA syndrome.,"sarcomas, brain tumors, leukemia, lymphoma, and adrenal cortical carcinoma",0
3259,4,List the cancers that are associated with SBLA syndrome.,"The SBLA syndrome is a complex familial cancer syndrome characterized by a proclivity to Sarcomas, Breast cancers, brain tumors, Lung and laryngeal cancers, leukemia, and Adrenocortical carcinomas.",0
3259,5,List the cancers that are associated with SBLA syndrome.,"In addition to HBOC, one sees a variety of putative breast cancer-prone genotypes inclusive of hereditary site-specific breast cancer, and the Li-Fraumeni (SBLA) syndrome that is characterized by cancers involving all three germinal layers including sarcomas, brain tumors, leukemia, lymphoma, and adrenal cortical carcinoma in addition to often markedly early-onset breast cancer.",0
3259,6,List the cancers that are associated with SBLA syndrome.,"BACKGROUND

Li-Fraumeni syndrome (LFS) is characterized by a plethora of cancers, most prominent of which is carcinoma of the breast followed by sarcomas, brain tumors, leukemia, lymphoma, lung carcinoma, and adrenocortical carcinoma (therefore, also referred to by the acronym SBLA syndrome).",0
3259,7,List the cancers that are associated with SBLA syndrome.,"Li-Fraumeni syndrome is an autosomal dominant inherited disorder also known as the SBLA cancer syndrome ( sarcoma , breast , leukemia , and adrenal) .",1
3259,8,List the cancers that are associated with SBLA syndrome.,"A carcinoma of the choroid plexus occurred in a child from a family with the breast cancer-sarcoma syndrome ( Li-Fraumeni or SBLA syndrome) , an inherited condition characterized by the development of diverse neoplasms ( sarcoma , breast cancer , brain tumors , leukemia , adrenal cortical carcinoma , and others) .",1
3259,9,List the cancers that are associated with SBLA syndrome.,"The SBLA syndrome is a complex familial cancer syndrome characterized by a proclivity to Sarcomas , Breast cancers , brain tumors , Lung and laryngeal cancers , leukemia , and Adrenocortical carcinomas .",0
3259,10,List the cancers that are associated with SBLA syndrome.,"Evidence from extended pedigrees , however , indicates that at least four of the children could be members of families with the SBLA ( sarcoma , breast and brain tumour , leukaemia , laryngeal and lung cancer , and adrenal cortical carcinoma ) cancer family syndrome , and that other relatives may be at risk of developing such neoplasms .",0
3259,11,List the cancers that are associated with SBLA syndrome.,"The SBLA syndrome is a complex familial cancer syndrome characterized by a proclivity to Sarcomas, Breast cancers, brain tumors, Lung and laryngeal cancers, leukemia, and Adrenocortical carcinomas.",0
3259,12,List the cancers that are associated with SBLA syndrome.,"In addition to HBOC, one sees a variety of putative breast cancer-prone genotypes inclusive of hereditary site-specific breast cancer, and the Li-Fraumeni (SBLA) syndrome that is characterized by cancers involving all three germinal layers including sarcomas, brain tumors, leukemia, lymphoma, and adrenal cortical carcinoma in addition to often markedly early-onset breast cancer.",0
3259,13,List the cancers that are associated with SBLA syndrome.,"Li-Fraumeni syndrome (LFS) is characterized by a plethora of cancers, most prominent of which is carcinoma of the breast followed by sarcomas, brain tumors, leukemia, lymphoma, lung carcinoma, and adrenocortical carcinoma (therefore, also referred to by the acronym SBLA syndrome).",1
3259,14,List the cancers that are associated with SBLA syndrome.,"Evidence from extended pedigrees, however, indicates that at least four of the children could be members of families with the SBLA (sarcoma, breast and brain tumour, leukaemia, laryngeal and lung cancer, and adrenal cortical carcinoma) cancer family syndrome, and that other relatives may be at risk of developing such neoplasms.",0
2324,0,Are mutations in the nf1 gene associated with memory?,We hypothesized that NF1 mutations disturb the expression of genes important for memory formation,1
2324,1,Are mutations in the nf1 gene associated with memory?,Our previous work has shown that defective cAMP signaling leads to the learning phenotype in Drosophila Nf1 mutants.,1
2324,2,Are mutations in the nf1 gene associated with memory?,"In the present report, our experiments showed that in addition to learning, long-term memory was also abolished in Nf1 mutants.",1
2324,3,Are mutations in the nf1 gene associated with memory?,Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.,1
87,0,Can Levoxyl (levothyroxine sodium) cause insomnia?,METHODS: Seventy-one patients diagnosed with primary hypothyroidism were randomly allocated into two study groups: the first group received usual dose of levothyroxine and the second group received combination of levothyroxine and liothyronine for at least 4 months.,1
87,1,Can Levoxyl (levothyroxine sodium) cause insomnia?,"The main outcomes were psychosocial problems (Goldberg's General Health Questionnaire, GHQ-28), bodyweight, heart rate, blood pressure, and serum lipid levels.",1
87,2,Can Levoxyl (levothyroxine sodium) cause insomnia?,RESULTS: In both groups serum thyroid-stimulating hormone levels remained unchanged compared with baseline.,1
87,3,Can Levoxyl (levothyroxine sodium) cause insomnia?,"Psychosocial scores, body weight, heart rate, blood pressure, and lipid profile in the two groups remained constant.",1
87,4,Can Levoxyl (levothyroxine sodium) cause insomnia?,The only exception was a small but significant reduction in anxiety/insomnia in combined treatment group as compared with monotherapy.,1
4011,0,Are there small molecule CGRPs under development for the treatment of migraine?,"Meanwhile, 1 small-molecule CGRP receptor antagonist (ubrogepant, MK-1602) is currently in phase 3 studies for the acute treatment of migraine.",1
4011,1,Are there small molecule CGRPs under development for the treatment of migraine?,Several other small-molecular CGRP receptor antagonists are in earlier stages of development for acute migraine treatment or prevention.,1
1674,0,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,"A linear error model for the raw intensity data and Burrows-Wheeler transform (BWT) based alignment are combined utilizing a Bayesian score function, which is then globally optimized over all possible genomic locations using an efficient branch-and-bound approach.",1
1674,1,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,The algorithm has been implemented in soft- and hardware [field-programmable gate array (FPGA)] to achieve real-time performance.,1
1674,2,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,"we have designed and built a high-performance FPGA-accelerated version of BLASTP, Mercury BLASTP.",0
1674,3,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,"In this paper, we describe the architecture of the portions of the application that are accelerated in the FPGA, and we also describe the integration of these FPGA-accelerated portions with the existing BLASTP software.",0
1674,4,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,We have implemented Mercury BLASTP on a commodity workstation with two Xilinx Virtex-II 6000 FPGAs.,0
1674,5,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,This paper shows how reconfigurable architectures can be used to derive an efficient fine-grained parallelization of the dynamic programming calculation.,0
1674,6,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,We describe how this technique leads to significant runtime savings for HMM database scanning on a standard off-the-shelf field-programmable gate array (FPGA).,0
1674,7,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,We have constructed a linear systolic array to perform pairwise sequence distance computations using dynamic programming.,0
1674,8,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,This results in an implementation with significant runtime savings on a standard FPGA.,0
1674,9,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,"in this paper, we focused on accelerating the Smith-Waterman algorithm by modifying the computationally repeated portion of the algorithm by FPGA hardware custom instructions.",0
1674,10,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,"We present a reconfigurable systolic architecture that can be applied for the efficient treatment of several dynamic programming methods for resolving well-known problems, such as global and local sequence alignment, approximate string matching and longest common subsequence.",1
1674,11,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,The dynamicity of the reconfigurability was found to be useful for practical applications in the construction of sequence alignments.,1
1674,12,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,A VHDL (VHSIC hardware description language) version of this new architecture was implemented on an APEX FPGA (Field programmable gate array).,0
1674,13,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,This results in an implementation of ClustalW with significant runtime savings on a standard off-the-shelf FPGA.,0
1674,14,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,The accelerator implements a version of the Needleman-Wunsch algorithm for nucleotide sequence alignment.,1
1674,15,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,Sequence lengths are constrained only by available memory; the product of sequence lengths in the current implementation can be up to 2(22).,0
1674,16,Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?,"The machine is implemented as two NuBus boards connected to a Mac IIf/x, using a mixture of TTL and FPGA technology clocked at 10 MHz.",0
1340,0,Are there enhancer RNAs (eRNAs)?,"active enhancers are transcribed, producing a class of noncoding RNAs called enhancer RNAs (eRNAs).",1
1340,1,Are there enhancer RNAs (eRNAs)?,"eRNAs are distinct from long noncoding RNAs (lncRNAs), but these two species of noncoding RNAs may share a similar role in the activation of mRNA transcription",1
1340,2,Are there enhancer RNAs (eRNAs)?, eRNAs may then facilitate enhancer-promoter interaction or activate promoter-driven transcription,0
1340,3,Are there enhancer RNAs (eRNAs)?,Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers,0
1340,4,Are there enhancer RNAs (eRNAs)?,Enhancer RNAs and regulated transcriptional programs,0
1340,5,Are there enhancer RNAs (eRNAs)?,"enhancers have been found to be broadly transcribed, resulting in the production of enhancer-derived RNAs, or eRNAs",0
1340,6,Are there enhancer RNAs (eRNAs)?,The emerging roles of eRNAs in transcriptional regulatory networks,0
1340,7,Are there enhancer RNAs (eRNAs)?,"we found certain enhancer RNAs (eRNAs) regulate chromatin accessibility of the transcriptional machinery at loci encoding master regulators of myogenesis (i.e., MyoD/MyoG), thus suggesting their significance and site-specific impact in cellular programming",0
1340,8,Are there enhancer RNAs (eRNAs)?,Enhancer RNAs: the new molecules of transcription,0
1340,9,Are there enhancer RNAs (eRNAs)?, the discovery that distal regulatory elements known as enhancers are transcribed and such enhancer-derived transcripts (eRNAs) serve a critical function in transcriptional activation has added a new dimension to transcriptional regulation,0
1340,10,Are there enhancer RNAs (eRNAs)?,eRNAs reach the heart of transcription,0
1340,11,Are there enhancer RNAs (eRNAs)?,"Recent studies have disclosed the function of enhancer RNAs (eRNAs), which are long non-coding RNAs transcribed from gene enhancer regions, in transcriptional regulation.",0
1340,12,Are there enhancer RNAs (eRNAs)?,"Since the discovery that many transcriptional enhancers are transcribed into long noncoding RNAs termed ""enhancer RNAs"" (eRNAs), their putative role in enhancer function has been debated.",0
1340,13,Are there enhancer RNAs (eRNAs)?,"Recent studies have revealed that active enhancers are transcribed, producing a class of noncoding RNAs called enhancer RNAs (eRNAs).",1
1340,14,Are there enhancer RNAs (eRNAs)?,"Enhancer RNAs (eRNAs) are a class of long noncoding RNAs (lncRNA) expressed from active enhancers, whose function and action mechanism are yet to be firmly established.",0
1340,15,Are there enhancer RNAs (eRNAs)?,"In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs).",0
1340,16,Are there enhancer RNAs (eRNAs)?,"In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs).",0
1340,17,Are there enhancer RNAs (eRNAs)?,A subset of enhancers are occupied by RNA polymerase II (RNAP II) and transcribed to produce long non-coding RNAs termed eRNAs.,0
1340,18,Are there enhancer RNAs (eRNAs)?,"Very recent evidence has indicted that some eRNAs play a role in initiating or activating transcription, possibly by helping recruit and/or stabilize binding of the general transcription machinery to the proximal promoter of their target genes.",0
1340,19,Are there enhancer RNAs (eRNAs)?,"In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs).",0
1340,20,Are there enhancer RNAs (eRNAs)?,"However, it has remained unclear whether these eRNAs are functional or merely a reflection of enhancer activation.",0
1340,21,Are there enhancer RNAs (eRNAs)?,"Notably, RNAPII at enhancers transcribes bi-directionally a novel class of enhancer RNAs (eRNAs) within enhancer domains defined by the presence of histone H3 monomethylated at lysine 4.",0
1340,22,Are there enhancer RNAs (eRNAs)?,"The level of eRNA expression at neuronal enhancers positively correlates with the level of messenger RNA synthesis at nearby genes, suggesting that eRNA synthesis occurs specifically at enhancers that are actively engaged in promoting mRNA synthesis.",0
1340,23,Are there enhancer RNAs (eRNAs)?,"A function of CBP at enhancers may be to recruit RNA polymerase II (RNAPII), as we also observed activity-regulated RNAPII binding to thousands of enhancers.",0
1340,24,Are there enhancer RNAs (eRNAs)?,"Notably, RNAPII at enhancers transcribes bi-directionally a novel class of enhancer RNAs (eRNAs) within enhancer domains defined by the presence of histone H3 monomethylated at lysine 4.",0
1340,25,Are there enhancer RNAs (eRNAs)?," Enhancer RNAs (eRNAs) are a class of long noncoding RNAs (lncRNA) expressed from active enhancers, whose function and action mechanism are yet to be firmly established.",0
1340,26,Are there enhancer RNAs (eRNAs)?,Here we show that eRNAs facilitate the transition of paused RNA polymerase II (RNAPII) into productive elongation by acting as a decoy for the negative elongation factor (NELF) complex upon induction of immediate early genes (IEGs) in neurons.,0
1340,27,Are there enhancer RNAs (eRNAs)?,"Recent studies have disclosed the function of enhancer RNAs (eRNAs), which are long non-coding RNAs transcribed from gene enhancer regions, in transcriptional regulation.",0
1340,28,Are there enhancer RNAs (eRNAs)?,"Recent studies have revealed that active enhancers are transcribed, producing a class of noncoding RNAs called enhancer RNAs (eRNAs).",0
1340,29,Are there enhancer RNAs (eRNAs)?,"eRNAs are distinct from long noncoding RNAs (lncRNAs), but these two species of noncoding RNAs may share a similar role in the activation of mRNA transcription.",1
1340,30,Are there enhancer RNAs (eRNAs)?,"Enhancer RNAs (eRNAs) are a class of long noncoding RNAs (lncRNA) expressed from active enhancers,",0
1340,31,Are there enhancer RNAs (eRNAs)?,"In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs).",0
1340,32,Are there enhancer RNAs (eRNAs)?,"However, it has remained unclear whether these eRNAs are functional or merely a reflection of enhancer activation.",0
1340,33,Are there enhancer RNAs (eRNAs)?," Recent studies have revealed that active enhancers are transcribed, producing a class of noncoding RNAs called enhancer RNAs (eRNAs).",0
1340,34,Are there enhancer RNAs (eRNAs)?,"eRNAs are distinct from long noncoding RNAs (lncRNAs), but these two species of noncoding RNAs may share a similar role in the activation of mRNA transcription.",1
1766,0,Is ocrelizumab effective for treatment of multiple sclerosis?," Advances made in immunomodulation are driving the progress being made in the treatment of MS. Ocrelizumab is the first treatment with positive results in the primarily progressive forms and tocilizumab, a drug product for rheumatoid arthritis, stands out as a potential candidate for the treatment of neuromyelitis optica.",0
1766,1,Is ocrelizumab effective for treatment of multiple sclerosis?," Expert commentary: The recent encouraging results of the ocrelizumab trial in PP MS, the first to reach the primary disability endpoint, indicate B cells as a promising therapeutic target to prevent disease progression.",0
1766,2,Is ocrelizumab effective for treatment of multiple sclerosis?,Ocrelizumab also shows efficacy in the primary progressive form of multiple sclerosis.,1
1766,3,Is ocrelizumab effective for treatment of multiple sclerosis?,Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.,1
1766,4,Is ocrelizumab effective for treatment of multiple sclerosis?,Expert commentary: The topline results of two phase-III randomized clinical trials demonstrate superiority of ocrelizumab over interferon beta in RRMS patients with regards to clinical and paraclinical outcome parameters.,0
1766,5,Is ocrelizumab effective for treatment of multiple sclerosis?,"The efficacy of three of them, rituximab, ocrelizumab and ofatumumab in MS has been confirmed by placebo-controlled clinical trials demonstrating a significant reduction of the annualized relapsing rate (ARR), new gadolinium-enhancing (GdE) and T2 lesions.",0
1766,6,Is ocrelizumab effective for treatment of multiple sclerosis?,"Ongoing PMS trials are currently being conducted with the phosphodiesterase inhibitor ibudilast, S1P modulator siponimod and anti-B-cell therapy ocrelizumab.",0
1766,7,Is ocrelizumab effective for treatment of multiple sclerosis?,"RECENT FINDINGS: Novel and imminently emerging DMTs for the treatment of RRMS include alemtuzumab, daclizumab, ocrelizumab, pegylated interferon-β-1a, and three times weekly glatiramer acetate.",0
1766,8,Is ocrelizumab effective for treatment of multiple sclerosis?,"To summarize mechanisms of action, efficacy, and safety of novel and imminently emerging disease-modifying treatments (DMTs) intended to be used in relapsing-remitting multiple sclerosis (RRMS).Novel and imminently emerging DMTs for the treatment of RRMS include alemtuzumab, daclizumab, ocrelizumab, pegylated interferon-β-1a, and three times weekly glatiramer acetate",0
1766,9,Is ocrelizumab effective for treatment of multiple sclerosis?,"Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.",0
1766,10,Is ocrelizumab effective for treatment of multiple sclerosis?,We aimed to assess efficacy and safety of two dose regimens of the humanised anti-CD20 monoclonal antibody ocrelizumab in patients with relapsing-remitting multiple sclerosis.,0
1766,11,Is ocrelizumab effective for treatment of multiple sclerosis?,"In multiple sclerosis (MS), B cell-depleting therapy using monoclonal anti-CD20 Abs, including rituximab (RTX) and ocrelizumab, effectively reduces disease activity.",0
1766,12,Is ocrelizumab effective for treatment of multiple sclerosis?,Ocrelizumab also shows efficacy in the primary progressive form of multiple sclerosis.Most of the presented cell-depleting and myeloablative therapies are highly effective treatment options but are also accompanied by significant risks.,1
1766,13,Is ocrelizumab effective for treatment of multiple sclerosis?,"The armamentarium of approved disease-modifying therapies in MS and those in development include: (1) the first approved, moderately effective, injectable interferon-β and glatiramer acetate; (2) oral drugs (fingolimod, laquinimod, teriflunomide, dimethyl fumarate); (3) monoclonal antibodies (rituximab, ocrelizumab, ofatumumab, daclizumab, alemtuzumab); and (4) immunosuppressive agents (e.g.",0
1766,14,Is ocrelizumab effective for treatment of multiple sclerosis?,mitoxantrone).,0
1766,15,Is ocrelizumab effective for treatment of multiple sclerosis?,BACKGROUND: B lymphocytes are implicated in the pathogenesis of multiple sclerosis.,0
1766,16,Is ocrelizumab effective for treatment of multiple sclerosis?,"We aimed to assess efficacy and safety of two dose regimens of the humanised anti-CD20 monoclonal antibody ocrelizumab in patients with relapsing-remitting multiple sclerosis.METHODS: We did a multicentre, randomised, parallel, double-blind, placebo-controlled study involving 79 centres in 20 countries.",0
1766,17,Is ocrelizumab effective for treatment of multiple sclerosis?,"Patients aged 18-55 years with relapsing-remitting multiple sclerosis were randomly assigned (1:1:1:1) via an interactive voice response system to receive either placebo, low-dose (600 mg) or high-dose (2000 mg) ocrelizumab in two doses on days 1 and 15, or intramuscular interferon beta-1a (30 ìg) once a week.",0
1766,18,Is ocrelizumab effective for treatment of multiple sclerosis?,Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.,1
1766,19,Is ocrelizumab effective for treatment of multiple sclerosis?,The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.,0
1766,20,Is ocrelizumab effective for treatment of multiple sclerosis?,"Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.",0
1766,21,Is ocrelizumab effective for treatment of multiple sclerosis?,Ocrelizumab also shows efficacy in the primary progressive form of multiple sclerosis.,1
2250,0,What is metaSPAdes?,metaSPAdes: a new versatile metagenomic assembler.,0
2250,1,What is metaSPAdes?,"While metagenomics has emerged as a technology of choice for analyzing bacterial populations, the assembly of metagenomic data remains challenging, thus stifling biological discoveries.",1
2250,2,What is metaSPAdes?,"Moreover, recent studies revealed that complex bacterial populations may be composed from dozens of related strains, thus further amplifying the challenge of metagenomic assembly.",1
2250,3,What is metaSPAdes?,metaSPAdes addresses various challenges of metagenomic assembly by capitalizing on computational ideas that proved to be useful in assemblies of single cells and highly polymorphic diploid genomes.,1
2250,4,What is metaSPAdes?,metaSPAdes addresses various challenges of metagenomic assembly by capitalizing on computational ideas that proved to be useful in assemblies of single cells and highly polymorphic diploid genomes.,1
2250,5,What is metaSPAdes?,"Faucet used orders of magnitude less time and disk space than the specialized metagenome assemblers MetaSPAdes and Megahit, while also improving on their memory use; this broadly matched performance of other assemblers optimizing resource efficiency-namely, Minia and LightAssembler.",0
2250,6,What is metaSPAdes?,metaspades a new versatile metagenomic assembler.,0
2250,7,What is metaSPAdes?,metaspades addresses various challenges of metagenomic assembly by capitalizing on computational ideas that proved to be useful in assemblies of single cells and highly polymorphic diploid genomes.,1
2250,8,What is metaSPAdes?,we benchmark metaspades against other state-of-the-art metagenome assemblers and demonstrate that it results in high quality assemblies across diverse data sets.,0
2250,9,What is metaSPAdes?,"Tools specifically designed for metagenomes, specifically metaSPAdes, MEGAHIT, and IDBA-UD, were the most effective at assembling viromes.",0
2250,10,What is metaSPAdes?,"Faucet used orders of magnitude less time and disk space than the specialized metagenome assemblers MetaSPAdes and Megahit, while also improving on their memory use; this broadly matched performance of other assemblers optimizing resource efficiency-namely, Minia and LightAssembler.",0
2807,0,Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,An Ultraconserved Element Containing lncRNA Preserves Transcriptional Dynamics and Maintains ESC Self-Renewal.,0
2807,1,Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,"Ultraconserved elements (UCEs) show the peculiar feature to retain extended perfect sequence identity among human, mouse, and rat genomes.",1
2807,2,Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,"Most of them are transcribed and represent a new family of long non-coding RNAs (lncRNAs), the transcribed UCEs (T-UCEs).",1
2807,3,Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,"Despite their involvement in human cancer, the physiological role of T-UCEs is still unknown.",1
2807,4,Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,"Here, we identify a lncRNA containing the uc.170+, named T-UCstem1, and provide in vitro and in vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics.",1
2807,5,Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,"Here, we identify a lncRNA containing the uc.170+, named T-UCstem1, and provide in vitro and in vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics.",1
1025,0,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"In the budding yeast, cohesin is loaded onto the chromosome during the late G1 phase, establishes sister chromatid cohesion concomitant with DNA replication, and dissociates by the telophase.",1
1025,1,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"Sister chromatid cohesion is mediated by cohesin, but the process of cohesion establishment during S-phase is still enigmatic.",1
1025,2,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"Instead, we find that cohesin stability increases at the time of S-phase in a reaction that can be uncoupled from DNA replication.",1
1025,3,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"By using ""single-copy"" derivatives of the 2-microm plasmid, we demonstrate that recruitment of cohesin at STB during S phase indeed translates into cohesion between plasmid molecules.",0
1025,4,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"In cells recovering from nocodazole-induced spindle depolymerization and G(2)/M arrest, cohesin-STB association can be established coincident with spindle restoration.",0
1025,5,During which stage of the cell cycle is cohesin deposited on the yeast genome?,This postreplication recruitment of cohesin is not functional in equipartitioning.,0
1025,6,During which stage of the cell cycle is cohesin deposited on the yeast genome?,We have used chromatin immunoprecipitation coupled with microarray analysis (ChIP chip) to produce a genome-wide description of cohesin binding to meiotic and mitotic chromosomes of Saccharomyces cerevisiae.,0
1025,7,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"Cohesin sites are highly conserved in meiosis and mitosis, suggesting that chromosomes share a common underlying structure during different developmental programs.",0
1025,8,During which stage of the cell cycle is cohesin deposited on the yeast genome?,Cohesin complex acts in the formation and maintenance of sister chromatid cohesion during and after S phase.,1
1025,9,During which stage of the cell cycle is cohesin deposited on the yeast genome?, Proteolytic cleavage of cohesin's Sccl subunit at the metaphase to anaphase transition is essential for sister chromatid separation and depends on a conserved protein called separin.,0
1025,10,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"Four of these proteins, Scc1p, Scc3p, Smc1p, and Smc3p, are subunits of a 'Cohesin' complex that binds chromosomes from late G1 until the onset of anaphase.",0
1025,11,During which stage of the cell cycle is cohesin deposited on the yeast genome?,It is necessary for the establishment of cohesion during DNA replication but not for its maintenance during G2 and M phases.,0
1025,12,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"Here, we show that cohesin destruction in metaphase is sufficient for segregation of much of the budding yeast genome, but not of the long arm of chromosome XII that contains the rDNA repeats.",0
1025,13,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"In this review, we have discussed the life cycle of cohesin during both mitotic and meiotic cell divisions including the structure and architecture of cohesin complex, relevance of cohesin associated proteins, mechanism of cohesin loading onto the chromatin, cohesion establishment and the mechanism of cohesin disassembly during anaphase to separate the sister chromatids.",0
1025,14,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"Cohesin association with G1 chromosomes requires continued activity of the cohesin loader Mis4/Ssl3, suggesting that repeated loading cycles maintain cohesin binding.",1
1025,15,During which stage of the cell cycle is cohesin deposited on the yeast genome?,Cdc14 phosphatase induces rDNA condensation and resolves cohesin-independent cohesion during budding yeast anaphase.,0
1025,16,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"Cohesins are deposited by a conserved heterodimeric loading complex composed of the Scc2 and Scc4 proteins in Saccharomyces cerevisiae, but how the Scc2/Scc4 deposition complex regulates the spatiotemporal association of cohesin with chromosomes is not understood.",0
1025,17,During which stage of the cell cycle is cohesin deposited on the yeast genome?,"We examined Scc2 chromatin association during the cell division cycle and found that the affinity of Scc2 for chromatin increases biphasically during the cell cycle, increasing first transiently in late G1 phase and then again later in G2/M.",0
4202,0,Which protein is encoded by the protein APOBEC3C?,"apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3; shortened here to A3), act by deaminating cytidines to uridines during the reverse transcription reaction of HIV-1.",1
4202,1,Which protein is encoded by the protein APOBEC3C?,apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3C (APOBEC3C),1
4202,2,Which protein is encoded by the protein APOBEC3C?,"apolipoprotein B mRNA editing enzyme catalytic subunit (APOBEC)3A,",1
4202,3,Which protein is encoded by the protein APOBEC3C?,"apolipoprotein B mRNA-editing enzyme catalytic subunit 3C (APOBEC3C, a nucleic acid-editing deaminase)",1
4202,4,Which protein is encoded by the protein APOBEC3C?, APOBEC3C (apolipoprotein-B mRNA-editing catalytic polypeptide-like 3C (A3C)),1
3293,0,List targeted genome editing methodologies,TALEN and CRISPR/Cas9-mediated genome editing in the early-branching metazoan Nematostella vectensis.,0
3293,1,List targeted genome editing methodologies,Non-bilaterian phyla represent key lineages for exploring the evolutionary history of early animals.,0
3293,2,List targeted genome editing methodologies,"However, despite an increasing number of sequenced genomes from early-branching metazoans, efficient and reproducible methodologies for analysis of gene function remain a major challenge.",0
3293,3,List targeted genome editing methodologies,Here we report the utilization of the TALEN and CRISPR/Cas9 systems to induce targeted mutations and homologous recombination-mediated transgenesis in the sea anemone Nematostella vectensis.,0
3293,4,List targeted genome editing methodologies,We also present a new method to isolate genetically modified animals using engineered selection cassettes introduced by homologous recombination.,0
3293,5,List targeted genome editing methodologies,"Taken together, these methods will permit sophisticated gain- and loss-of-function analyses in Nematostella and perhaps other early metazoan species that allow for zygotic injection.",0
3293,6,List targeted genome editing methodologies,Comparison of CRISPR/Cas9 and TALENs on editing an integrated EGFP gene in the genome of HEK293FT cells.,0
3293,7,List targeted genome editing methodologies,Genome editors such as CRISPR/Cas9 and TALENs are at the forefront of research into methodologies for targeted modification of the mammalian genome.,1
3293,8,List targeted genome editing methodologies,To date few comparative studies have been carried out to investigate the difference of genome editing characteristics between CRISPR/Cas9 and TALENs.,1
3293,9,List targeted genome editing methodologies,"While the CRISPR/Cas9 system has overtaken TALENs as the tool of choice for most research groups working in this field, we hypothesized that there could be certain applications whereby the application of TALENs would have specific benefits.",1
3293,10,List targeted genome editing methodologies,Here we compare CRISPR/Cas9 and TALEN as tools for introducing site-specific editing events at an integrated EGFP gene in the genome of HEK293FT cells.RESULTS: Guide RNAs and TALEN pairs were designed to target two loci within the EGFP gene.,0
3293,11,List targeted genome editing methodologies,We found that paired Cas9 nucleases induced targeted genomic deletion more efficiently and precisely than two TALEN pairs.,0
3293,12,List targeted genome editing methodologies,"However, when concurrently supplied with a plasmid template spanning the two DNA double-strand breaks (DSBs) within EGFP, TALENs stimulated homology directed repair (HDR) more efficiently than CRISPR/Cas9 and caused fewer targeted genomic deletions.CONCLUSIONS: Our data suggest that the choice of genome editing tool should be determined by the desired genome editing outcome.",1
3293,13,List targeted genome editing methodologies,"Such a rational approach is likely to benefit research outputs for groups working in fields as diverse as modification of cell lines, to animal models for disease studies, or gene therapy strategies.",1
2661,0,Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)," The use of rintatolimod and rituximab as well as counselling, behavioural and rehabilitation therapy programs may be of benefit for CFS/ME, but the evidence of their effectiveness is still limited.",1
2258,0,What is the FIRE (Functional Inference of Regulators of Expression) tool?,"Methods to predict whether or not individual SNVs are likely to regulate gene expression would aid interpretation of variants of unknown significance identified in whole-genome sequencing studies.Results: We developed FIRE (Functional Inference of Regulators of Expression), a tool to score both noncoding and coding SNVs based on their potential to regulate the expression levels of nearby genes.",1
2258,1,What is the FIRE (Functional Inference of Regulators of Expression) tool?,FIRE consists of 23 random forests trained to recognize SNVs in cis -expression quantitative trait loci ( cis -eQTLs) using a set of 92 genomic annotations as predictive features.,1
2258,2,What is the FIRE (Functional Inference of Regulators of Expression) tool?,"FIRE scores discriminate cis -eQTL SNVs from non-eQTL SNVs in the training set with a cross-validated area under the receiver operating characteristic curve (AUC) of 0.807, and discriminate cis -eQTL SNVs shared across six populations of different ancestry from non-eQTL SNVs with an AUC of 0.939.",0
2258,3,What is the FIRE (Functional Inference of Regulators of Expression) tool?,FIRE scores are also predictive of cis -eQTL SNVs across a variety of tissue types.,1
2258,4,What is the FIRE (Functional Inference of Regulators of Expression) tool?,"We developed FIRE (Functional Inference of Regulators of Expression), a tool to score both noncoding and coding SNVs based on their potential to regulate the expression levels of nearby genes.",1
2258,5,What is the FIRE (Functional Inference of Regulators of Expression) tool?,"Results We developed FIRE (Functional Inference of Regulators of Expression), a tool to score both noncoding and coding SNVs based on their potential to regulate the expression levels of nearby genes.",1
3043,0,Which molecule is inhibited by ivosidenib?,"Different combinations and new formulations of cytotoxic agents, such as clofarabine or CPX-351, are newer options for specific subsets of patients.",0
3043,1,Which molecule is inhibited by ivosidenib?,"Finally, targeted agents inhibiting multiple kinases (rigosertib), BCL2 (venetoclax) or mutant IDH1 (ivosidenib), IDH2 (enasidenib), FLT3 (sorafenib, midostaurin) or spliceosome components (H3B-8800) are other novel options.",0
3043,2,Which molecule is inhibited by ivosidenib?,Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.,1
3043,3,Which molecule is inhibited by ivosidenib?,"Here, we report the discovery of AG-120 (ivosidenib), an inhibitor of the IDH1 mutant enzyme that exhibits profound 2-HG lowering in tumor models and the ability to effect differentiation of primary patient AML samples ex vivo.",0
3043,4,Which molecule is inhibited by ivosidenib?," Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1.",1
3043,5,Which molecule is inhibited by ivosidenib?,A phase I study suggests that ivosidenib can induce remission in patients with relapsed or refractory acute myeloid leukemia characterized by IDH1 mutations.,0
3043,6,Which molecule is inhibited by ivosidenib?,"Biochemical studies predicted that resistance to allosteric IDH inhibitors could also occur via IDH dimer-interface mutations in cis, which was confirmed in a patient with acquired resistance to the IDH1 inhibitor ivosidenib (AG-120).",0
3043,7,Which molecule is inhibited by ivosidenib?,The FDA approved ivosidenib for patients with IDH1-mutant relapsed/refractory acute myeloid leukemia.,0
3043,8,Which molecule is inhibited by ivosidenib?,"Ivosidenib (Tibsovo®) is a small molecule, orally available inhibitor of mutated cytosolic isocitrate dehydrogenase 1 (IDH1) that is being developed by Agios Pharmaceuticals for the treatment of cancer in patients with IDH1 mutations.",0
3043,9,Which molecule is inhibited by ivosidenib?,This article summarizes the milestones in the development of ivosidenib leading to this first approval in the USA for the treatment of patients with relapsed or refractory AML with a susceptible IDH1 mutation.,0
3043,10,Which molecule is inhibited by ivosidenib?,Ivosidenib targets the IDH1 metabolic pathway to prevent a build-up of the oncometabolite 2-HG.,0
3043,11,Which molecule is inhibited by ivosidenib?,"Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1.",1
3043,12,Which molecule is inhibited by ivosidenib?,Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.,0
3043,13,Which molecule is inhibited by ivosidenib?,"METHODS
We conducted a phase 1 dose-escalation and dose-expansion study of ivosidenib monotherapy in IDH1-mutated AML.",0
3043,14,Which molecule is inhibited by ivosidenib?,"CONCLUSIONS
In patients with advanced IDH1-mutated relapsed or refractory AML, ivosidenib at a dose of 500 mg daily was associated with a low frequency of grade 3 or higher treatment-related adverse events and with transfusion independence, durable remissions, and molecular remissions in some patients with complete remission.",0
3043,15,Which molecule is inhibited by ivosidenib?,"Here, we report the discovery of AG-120 (ivosidenib), an inhibitor of the IDH1 mutant enzyme that exhibits profound 2-HG lowering in tumor models and the ability to effect differentiation of primary patient AML samples ex vivo.",0
3043,16,Which molecule is inhibited by ivosidenib?,"Finally, targeted agents inhibiting multiple kinases (rigosertib), BCL2 (venetoclax) or mutant IDH1 (ivosidenib), IDH2 (enasidenib), FLT3 (sorafenib, midostaurin) or spliceosome components (H3B-8800) are other novel options.",0
3043,17,Which molecule is inhibited by ivosidenib?,The FDA approved ivosidenib for patients with IDH1-mutant relapsed/refractory acute myeloid leukemia.,0
3043,18,Which molecule is inhibited by ivosidenib?,"Biochemical studies predicted that resistance to allosteric IDH inhibitors could also occur via IDH dimer-interface mutations in cis, which was confirmed in a patient with acquired resistance to the IDH1 inhibitor ivosidenib (AG-120).",0
3043,19,Which molecule is inhibited by ivosidenib?,"Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.Somatic point mutations at a key arginine residue (R132) within the active site of the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) confer a novel gain of function in cancer cells, resulting in the production of d-2-hydroxyglutarate (2-HG), an oncometabolite.",0
3043,20,Which molecule is inhibited by ivosidenib?,"Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.In patients with advanced IDH1-mutated relapsed or refractory AML, ivosidenib at a dose of 500 mg daily was associated with a low frequency of grade 3 or higher treatment-related adverse events and with transfusion independence, durable remissions, and molecular remissions in some patients with complete remission.",0
3043,21,Which molecule is inhibited by ivosidenib?,"Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1.<br><b>METHODS</b>: We conducted a phase 1 dose-escalation and dose-expansion study of ivosidenib monotherapy in IDH1-mutated AML.",1
3043,22,Which molecule is inhibited by ivosidenib?,"Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1.",1
3043,23,Which molecule is inhibited by ivosidenib?,We conducted a phase 1 dose-escalation and dose-expansion study of ivosidenib monotherapy in IDH1-mutated AML.,0
3043,24,Which molecule is inhibited by ivosidenib?,"In patients with advanced IDH1-mutated relapsed or refractory AML, ivosidenib at a dose of 500 mg daily was associated with a low frequency of grade 3 or higher treatment-related adverse events and with transfusion independence, durable remissions, and molecular remissions in some patients with complete remission.",0
2435,0,Which are the main transcriptional activators of circadian oscillations?,Mammalian CLOCK and BMAL1 are two members of bHLH-PAS-containing family of transcription factors that represent the positive elements of circadian autoregulatory feedback loop.,1
2435,1,Which are the main transcriptional activators of circadian oscillations?," We have examined abundance, posttranslational modifications, cellular localization of endogenous and ectopically expressed CLOCK and BMAL1 proteins.",1
2435,2,Which are the main transcriptional activators of circadian oscillations?,Nuclear/cytoplasm distribution of CLOCK was found to be under circadian regulation.,0
2435,3,Which are the main transcriptional activators of circadian oscillations?,"Formation of CLOCK/BMAL1 complex following ectopic coexpression of both proteins is followed by their codependent phosphorylation, which is tightly coupled to CLOCK nuclear translocation and degradation",0
2435,4,Which are the main transcriptional activators of circadian oscillations?,"Altogether, these results provide evidence for an additional level of circadian system control, which is based on regulation of transcriptional activity or/and availability of CLOCK/BMAL1 complex.",0
2435,5,Which are the main transcriptional activators of circadian oscillations?," Two basic helix-loop-helix (bHLH) PAS (for Period-Arnt-Sim) domain-containing transcriptional activators, CLOCK and BMAL1, are known to regulate gene expression by interacting with a promoter element termed the E-box (CACGTG).",1
2435,6,Which are the main transcriptional activators of circadian oscillations?,"Circadian rhythms in mammals are generated by a transcriptional negative feedback loop that is driven primarily by oscillations of PER and CRY, which inhibit their own transcriptional activators, CLOCK and BMAL1.",0
2435,7,Which are the main transcriptional activators of circadian oscillations?,"Our biochemical evidence supports an elegant mechanism for the disparity: PER2 directly and rhythmically binds to CLOCK:BMAL1, while CRY only interacts indirectly; PER2 bridges CRY and CLOCK:BMAL1 to drive the circadian negative feedback loop.<br>",0
2435,8,Which are the main transcriptional activators of circadian oscillations?,"Two basic helix-loop-helix (bHLH) PAS (for Period-Arnt-Sim) domain-containing transcriptional activators, CLOCK and BMAL1, are known to regulate gene expression by interacting with a promoter element termed the E-box (CACGTG).",1
2435,9,Which are the main transcriptional activators of circadian oscillations?,The CRY proteins in turn inhibit CLOCK:BMAL-mediated transcription closing the negative feedback loop.,0
2435,10,Which are the main transcriptional activators of circadian oscillations?,"In the vertebrate circadian feedback loop, CLOCK:BMAL heterodimers induce the expression of Cry genes.",0
2435,11,Which are the main transcriptional activators of circadian oscillations?,"Two basic helix-loop-helix (bHLH) PAS (for Period-Arnt-Sim) domain-containing transcriptional activators, CLOCK and BMAL1, are known to regulate gene expression by interacting with a promoter element termed the E-box (CACGTG).",1
2435,12,Which are the main transcriptional activators of circadian oscillations?,"In the present study, we demonstrate that Id2 is involved in stabilization of the amplitudes of the circadian oscillations by suppressing transcriptional activation of clock genes Clock and Bmal1.",0
2435,13,Which are the main transcriptional activators of circadian oscillations?,bmal1 is an essential transcriptional activator within the mammalian circadian clock we report here that the suprachiasmatic nucleus scn of bmal1 null mutant mice unexpectedly generates stochastic oscillations with periods that overlap the circadian range dissociated scn neurons expressed fluctuating levels of per2 detected by bioluminescence imaging but could not generate circadian oscillations intrinsically inhibition of intercellular communication or cyclic amp signaling in scn slices which provide a positive feed forward signal to drive the intracellular negative feedback loop abolished the stochastic oscillations propagation of this feed forward signal between scn neurons then promotes quasi circadian oscillations that arise as an emergent property of the scn network experimental analysis and mathematical modeling argue that both intercellular coupling and molecular noise are required for the stochastic rhythms providing a novel biological example of noise induced oscillations the emergence of stochastic circadian oscillations from the scn network in the absence of cell autonomous circadian oscillatory function highlights a previously unrecognized level of circadian organization.,0
2435,14,Which are the main transcriptional activators of circadian oscillations?,transcriptional regulation appears to be fundamental to circadian oscillations of clock gene expression these oscillations are believed to control output rhythms the transcriptional feedback loop and a model of interlocked loops have been proposed as the basis for these oscillations we characterized the genomic structure of the mouse bmal1 gene mbmal1 and defined the mbmal1 promoter region transcription of mbmal1 was activated by cry1 cry2 and per2 and was repressed by bmal1 clock dimers therefore cry per2 and bmal1 clock play bidirectional roles in transcription when they are at high levels by late day and midnight respectively this underlies the opposite phase of bmal1 compared to cry and per we propose that a bmal1 negative feedback loop interlocks with the cry and per2 negative feedback loop by inter activation forming a third positive forward loop this transcriptional model suggests a molecular basis for the maintenance of stability persistence and period of circadian rhythms the transcriptional potency of cry is predominant within the mammalian clock suggesting a clearance mechanism for cry in period maintenance c 2002 elsevier science usa.,0
2435,15,Which are the main transcriptional activators of circadian oscillations?,the circadian expression of the mammalian clock genes is based on transcriptional feedback loops two basic helix loop helix bhlh pas for period arnt sim domain containing transcriptional activators clock and bmal1 are known to regulate gene expression by interacting with a promoter element termed the e box cacgtg the non canonical e boxes or e box like sequences have also been reported to be necessary for circadian oscillation we report a new cis element required for cell autonomous circadian transcription of clock genes this new element consists of a canonical e box or a non canonical e box and an e box like sequence in tandem with the latter with a short interval 6 base pairs between them we demonstrate that both e box or e box like sequences are needed to generate cell autonomous oscillation we also verify that the spacing nucleotides with constant length between these 2 e elements are crucial for robust oscillation furthermore by in silico analysis we conclude that several clock and clock controlled genes possess a direct repeat of the e box like elements in their promoter region we propose a novel possible mechanism regulated by double e box like elements not to a single e box for circadian transcriptional oscillation the direct repeat of the e box like elements identified in this study is the minimal required element for the generation of cell autonomous transcriptional oscillation of clock and clock controlled genes.,0
2435,16,Which are the main transcriptional activators of circadian oscillations?,clock bmal independent circadian oscillation of zebrafish cryptochrome1a gene,0
3574,0,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"An LMNB1 Duplication Caused Adult-Onset Autosomal Dominant Leukodystrophy in Chinese Family: Clinical Manifestations, Neuroradiology and Genetic Diagnosis.",0
3574,1,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Duplication or over expression of the lamin B1 (LMNB1) gene causes ADLD.,0
3574,2,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"In this study, we undertook a comprehensive clinical evaluation and genetic detection for a Chinese family with ADLD.",0
3574,3,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"The proband is a 52-year old man manifested with autonomic abnormalities, pyramidal tract dysfunction.",0
3574,4,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"MRI brain scan identified bilateral symmetric white matter (WM) hyper-intensities in periventricular and semi-oval WM, cerebral peduncles and middle cerebellar peduncles.",0
3574,5,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,The proband has a positive autosomal dominant family history with similar clinical manifestations with a trend of genetic anticipation.,0
3574,6,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"In order to understand the genetic cause of the disease in this family, target exome capture based next generation sequencing has been done, but no causative variants or possibly pathogenic variants has been identified.",0
3574,7,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"However, Multiplex ligand-dependent probe amplification (MLPA) showed whole duplication of LMNB1 gene which is co-segregated with the disease phenotype in this family.",0
3574,8,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,This is the first genetically confirmed LMNB1 associated ADLD pedigree from China.,0
3574,9,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Chromosomal rearrangements with duplication of the lamin B1 (LMNB1) gene underlie autosomal dominant adult-onset demyelinating leukodystrophy (ADLD), a rare neurological disorder in which overexpression of LMNB1 causes progressive central nervous system demyelination.",0
3574,10,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Autosomal dominant leukodystrophy (ADLD) is an adult onset demyelinating disorder that is caused by duplications of the lamin B1 (LMNB1) gene.,1
3574,11,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"However, as only a few cases have been analyzed in detail, the mechanisms underlying LMNB1 duplications are unclear.",0
3574,12,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"We report the detailed molecular analysis of the largest collection of ADLD families studied, to date.",0
3574,13,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"We have identified the minimal duplicated region necessary for the disease, defined all the duplication junctions at the nucleotide level and identified the first inverted LMNB1 duplication.",0
3574,14,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Duplication of the LMNB1 gene is the genetic cause of ADLD, yet the pathogenetic mechanism is not defined.",0
3574,15,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"In this study, we analysed cells and muscle tissue from three patients affected by ADLD, carrying an extra copy of the LMNB1 gene.",0
3574,16,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Adult-onset autosomal-dominant leukodystrophy (ADLD) is a progressive and fatal neurological disorder characterized by early autonomic dysfunction, cognitive impairment, pyramidal tract and cerebellar dysfunction, and white matter loss in the central nervous system.",0
3574,17,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"ADLD is caused by duplication of the LMNB1 gene, which results in increased lamin B1 transcripts and protein expression.",0
3574,18,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,How duplication of LMNB1 leads to myelin defects is unknown.,0
3574,19,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Lamin B1 duplications cause autosomal dominant leukodystrophy.,0
3574,20,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,ADLD is associated with duplications of the lamin B1 (LMNB1) gene but the mechanism by which the rearrangement conveys the phenotype is not fully defined.,0
3574,21,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,We analyzed four unrelated families segregating ADLD with autonomic symptoms for duplications of the LMNB1 gene.,0
3574,22,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,A single nucleotide polymorphism (SNP) array analysis revealed novel duplications spanning the entire LMNB1 gene in probands from each of the four families.,0
3574,23,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,We then analyzed the expression of lamin B1 in peripheral leukocytes by Western blot analysis in five patients from two available families.,0
3574,24,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,The protein levels of lamin B1 were found significantly increased.,0
3574,25,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,These results indicate that the ADLD phenotype associated with LMNB1 duplications is mediated by increased levels of the lamin B1 protein.,0
3574,26,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Furthermore, we show that a molecular diagnosis for ADLD with autonomic symptoms can be obtained by a direct analysis of lamin B1 in peripheral leukocytes.",0
3574,27,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms.,0
3574,28,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Objective

To characterize the genetic and clinical features of patients with autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) carrying duplication and deletion upstream of lamin B1 ( __i_tag__ LMNB1 __end_i_tag__ ).",0
3574,29,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Duplication or over expression of the lamin B1 (LMNB1) gene causes ADLD.,0
3574,30,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Duplication and deletion upstream of  __i_tag__ LMNB1 __end_i_tag__  in autosomal dominant adult-onset leukodystrophy.,0
3574,31,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"We have previously shown that LMNB1 gene duplications cause autosomal dominant leukodystrophy (ADLD), a fatal adult onset demyelinating disease.",0
3574,32,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Duplication and deletion upstream of LMNB1 in autosomal dominant adult-onset leukodystrophy.,0
3574,33,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"We have previously shown that LMNB1 gene duplications cause autosomal dominant leukodystrophy (ADLD), a fatal adult onset demyelinating disease.",0
3574,34,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,INTRODUCTION adult-onset autosomal dominant leukodystrophy (ADLD) is a rare inherited disorder due to a duplication of lamin-B1 (LMNB1) gene.,0
3574,35,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Autosomal dominant leukodystrophy (ADLD) is an adult onset demyelinating disorder that is caused by duplications of the lamin B1 (LMNB1) gene.,1
3574,36,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,To characterize the genetic and clinical features of patients with autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) carrying duplication and deletion upstream of lamin B1 ( LMNB1 ).,0
3574,37,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Autosomal dominant leukodystrophy ( ADLD ) is an adult onset demyelinating disorder that is caused by duplications of the lamin B1 ( LMNB1 ) gene.,1
3574,38,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Autosomal Dominant Leukodystrophy ( ADLD) , a fatal adult onset demyelinating disorder , is the only human disease that has been linked to mutations of the nuclear lamina protein , lamin B1 , and is primarily caused by duplications of the LMNB1 gene.",1
3574,39,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"As a proof-of-concept , we studied autosomal dominant adult-onset demyelinating leukodystrophy ( ADLD ) due to lamin B1 ( LMNB1 ) duplication , a hereditary , progressive and fatal disorder affecting myelin in the CNS.",0
3574,40,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"We have previously shown that LMNB1 gene duplications cause autosomal dominant leukodystrophy ( ADLD) , a fatal adult onset demyelinating disease.",0
3574,41,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Chromosomal rearrangements with duplication of the lamin B1 ( LMNB1 ) gene underlie autosomal dominant adult-onset demyelinating leukodystrophy ( ADLD) , a rare neurological disorder in which overexpression of LMNB1 causes progressive central nervous system demyelination .",0
3574,42,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Duplication or over expression of the lamin B1 ( LMNB1 ) gene causes ADLD .,0
3574,43,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Chromosomal rearrangements with duplication of the lamin B1 (LMNB1) gene underlie autosomal dominant adult-onset demyelinating leukodystrophy (ADLD), a rare neurological disorder in which overexpression of LMNB1 causes progressive central nervous system demyelination.",0
3574,44,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"However, we previously reported an ADLD family (ADLD-1-TO) without evidence of duplication or other mutation in LMNB1 despite linkage to the LMNB1 locus and lamin B1 overexpression.",0
3574,45,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Through parallel studies, we investigated both loss of genetic material and chromosomal rearrangement as possible causes of LMNB1 overexpression, and found that ADLD-1-TO plausibly results from an enhancer adoption mechanism.",0
3574,46,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"Autosomal Dominant Leukodystrophy (ADLD), a fatal adult onset demyelinating disorder, is the only human disease that has been linked to mutations of the nuclear lamina protein, lamin B1, and is primarily caused by duplications of the LMNB1 gene.",0
3574,47,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,Objective To characterize the genetic and clinical features of patients with autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) carrying duplication and deletion upstream of lamin B1 (LMNB1).,0
3574,48,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,ABSTRACT Autosomal dominant leukodystrophy (ADLD) is an adult onset demyelinating disorder that is caused by duplications of the lamin B1 (LMNB1) gene.,1
3574,49,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,BACKGROUND AND PURPOSE: Duplications of lamin B1 (LMNB1) at 5q23 are implicated in adult-onset autosomal dominant leukodystrophy (ADLD) having been described in six families with diverse ethnic background but with a homogeneous phenotype.,0
3574,50,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,INTRODUCTION: adult-onset autosomal dominant leukodystrophy (ADLD) is a rare inherited disorder due to a duplication of lamin-B1 (LMNB1) gene.,0
3574,51,Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?,"While at least a dozen disorders are associated with LMNA, the focus of this review is Autosomal Dominant Leukodystrophy (ADLD), the only disease associated with the lamin B1 gene (LMNB1).",0
1545,0,Which is the most common editing modification in eukaryotic mRNA?,"One of the most common forms of pre-mRNA editing is A-to-I editing, in which adenosine is deaminated to inosine, which is read as guanosine during translation.",1
1545,1,Which is the most common editing modification in eukaryotic mRNA?,Deamination of adenine by adenosine deaminases that act on RNA (ADARs) leads to the conversion of adenine into inosine (A-I editing) recognized by the splicing and translation systems as guanine.,0
1545,2,Which is the most common editing modification in eukaryotic mRNA?,"denosine deaminases editing adenines in transport RNAs (ADATs) convert adenine into inosine in tRNAs of all eukaryotes; as a result, the diversity of tRNA forms in the cell increases.",0
1545,3,Which is the most common editing modification in eukaryotic mRNA?,A-to-I editing events in normal and cancerous human keratinocytes,0
1545,4,Which is the most common editing modification in eukaryotic mRNA?,"A-to-I RNA editing can alter codons, substitute amino acids and affect protein sequence, structure, and function.",0
1545,5,Which is the most common editing modification in eukaryotic mRNA?,-to-I RNA editing is a post-transcriptional mechanism frequently used to expand and diversify transcriptome and proteome repertoire in eukaryotic cells,0
1545,6,Which is the most common editing modification in eukaryotic mRNA?,"This study describes for the first time A-to-I editing in the coding sequence of a tumor suppressor gene in humans, and suggests that IGFBP7 editing serves as a fine-tuning mechanism to maintain the equilibrium between proliferation and senescence in normal skin.",0
1545,7,Which is the most common editing modification in eukaryotic mRNA?,"Adenosine deaminases that act on RNA (ADARs) catalyze the adenosine-to-inosine (A-to-I) conversion, the most common type of RNA editing in higher eukaryotes.",1
1545,8,Which is the most common editing modification in eukaryotic mRNA?,"RNA editing is observed in eukaryotic mRNA, transfer RNA, ribosomal RNA, and non-coding RNAs (ncRNA).",0
1545,9,Which is the most common editing modification in eukaryotic mRNA?,"The most common RNA editing in the mammalian central nervous system is a base modification, where the adenosine residue is base-modified to inosine (A to I).",1
1545,10,Which is the most common editing modification in eukaryotic mRNA?,It occurs in a wide variety of eukaryotic organisms and in some viruses.,0
1545,11,Which is the most common editing modification in eukaryotic mRNA?,"One of the most common forms of pre-mRNA editing is A-to-I editing, in which adenosine is deaminated to inosine, which is read as guanosine during translation.",1
1545,12,Which is the most common editing modification in eukaryotic mRNA?,"The most common RNA editing in the mammalian central nervous system is a base modification, where the adenosine residue is base-modified to inosine (A to I).",0
1545,13,Which is the most common editing modification in eukaryotic mRNA?,"One of the most common forms of pre-mRNA editing is A-to-I editing, in which adenosine is deaminated to inosine, which is read as guanosine during translation.",1
1545,14,Which is the most common editing modification in eukaryotic mRNA?,RNA editing by adenosine deamination (A-to-I) is widespread in humans and can lead to a variety of biological effects depending on the RNA type or the RNA region involved in the editing modification.,0
3869,0,Roflumilast Cream is effective for which disease?,BACKGROUND: Systemic oral phosphodiesterase type 4 (PDE-4) inhibitors have been effective in the treatment of psoriasis.,1
3869,1,Roflumilast Cream is effective for which disease?,Roflumilast cream contains a PDE-4 inhibitor that is being investigated for the topical treatment of psoriasis.,1
3869,2,Roflumilast Cream is effective for which disease?,Trial of Roflumilast Cream for Chronic Plaque Psoriasis.,1
3869,3,Roflumilast Cream is effective for which disease?,CONCLUSIONS: Roflumilast cream administered once daily to affected areas of psoriasis was superior to vehicle cream in leading to a state of clear or almost clear at 6 weeks.,1
3869,4,Roflumilast Cream is effective for which disease?,Longer and larger trials are needed to determine the durability and safety of roflumilast in psoriasis.,0
3869,5,Roflumilast Cream is effective for which disease?,"Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.",0
3869,6,Roflumilast Cream is effective for which disease?,"Background: Roflumilast cream (ARQ-151) is a highly potent, selective phosphodiesterase-4 inhibitor in development for once-daily topical treatment of chronic plaque psoriasis.",0
3869,7,Roflumilast Cream is effective for which disease?,Conclusion: Roflumilast cream was safe and highly effective at doses of 0.5% and 0.15% and represents a potential novel once-daily topical therapy for the treatment of chronic plaque psoriasis.,0
3869,8,Roflumilast Cream is effective for which disease?,"In chronic plaque psoriasis, roflumilast cream safely increased likelihood of clear or almost clear state at 6 weeks.",0
3869,9,Roflumilast Cream is effective for which disease?,"SOURCE CITATION: Lebwohl MG, Papp KA, Stein Gold L, et al.",0
3869,10,Roflumilast Cream is effective for which disease?,Trial of roflumilast cream for chronic plaque psoriasis.,1
3869,11,Roflumilast Cream is effective for which disease?,N Engl J Med.,0
3869,12,Roflumilast Cream is effective for which disease?,2020;383:229-39.,0
3869,13,Roflumilast Cream is effective for which disease?,32668113.,0
3869,14,Roflumilast Cream is effective for which disease?,"CONCLUSIONS: Topical treatment with cream formulations of the PDE4 inhibitors roflumilast and TAK-084 reduced inflammation, measured as a change in skin infiltrate thickness, and reduced psoriasis severity.",0
2491,0,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,"aken together, we discovered a novel axis of BCL10-regulated OSCC progression via STAT1/ATF4/S100P/P65 signaling, which could predict the prognosis of OSCC and will be beneficial for developing therapeutic strategy against advanced OSCC",0
2491,1,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,"s a result, the level of phosphorylated Eukaryotic Initiation Factor 2 alpha (eIF2α) is markedly elevated, resulting in the promotion of a pro-adaptive signaling pathway by the inhibition of global protein synthesis and selective translation of Activating Transcription Factor 4 (ATF4).",0
2491,2,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,"Many cancers overexpress ATF4, a stress-induced transcription factor that promotes cell survival under hypoxic conditions and other stresses of the tumor microenvironment, but the potential contributions of ATF4 to oncogenesis itself have been little explored.",1
2491,3,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,"Here, we report that ATF4 promotes oncogene-induced neoplastic transformation by suppressing the expression of cellular senescence-associated genes.",0
2491,4,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,"Here, we report that ATF4 promotes oncogene-induced neoplastic transformation by suppressing the expression of cellular senescence-associated genes.",0
2491,5,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,Elevated levels of ATF4 were sufficient to suppress expression of these proteins and drive oncogenic transformation.,0
2491,6,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,Our findings define a central function for ATF4 in promoting oncogenic transformation by suppressing a central pathway of cellular senescence.<br>,0
2491,7,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,ATF4 expression is upregulated in cancer.,0
2491,8,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,"Activating transcription factor 4 (ATF4), an endoplasmic reticulum stress-inducible transcription factor, plays important roles in cancer progression and resistance to therapy.",1
2491,9,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,Activating transcription factor 4 (ATF4) is a stress-induced transcription factor that is frequently upregulated in cancer cells.,1
2491,10,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,Our findings define a central function for ATF4 in promoting oncogenic transformation by suppressing a central pathway of cellular senescence.,0
2491,11,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors.,1
2491,12,Has ATF4 transcription factor been linked to cancer and neoplastic transformation?,"Activating transcription factor 4 (ATF4), a member of the ATF/CREB family, has been reported to be related to tumor angiogenesis",1
2246,0,Is NEMO a zinc finger protein?,To better understand the thermodynamics and dynamics of the zinc finger of NEMO (NF-κB essential modulator),1
2246,1,Is NEMO a zinc finger protein?,an alteration in the zinc finger domain of NEMO (K392R),1
2246,2,Is NEMO a zinc finger protein?,CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.,0
2246,3,Is NEMO a zinc finger protein?,our simulations of the zinc finger NEMO,0
2246,4,Is NEMO a zinc finger protein?,"An important regulatory domain of NF-[Formula: see text]B Essential Modulator (NEMO) is a ubiquitin-binding zinc finger, with a tetrahedral CYS3HIS1 zinc-coordinating binding site.",1
2246,5,Is NEMO a zinc finger protein?,NEMO function is mediated by two distal ubiquitin binding domains located in the regulatory C-terminal domain of the protein: the coiled-coil 2-leucine zipper (CC2-LZ) domain and the zinc finger (ZF) domain.,1
2246,6,Is NEMO a zinc finger protein?," We show here that the NEMO C terminus, comprising the ubiquitin binding region and a zinc finger,",1
2522,0,Does Uc.160 promote cancer?,"We previously discovered the downregulation of T-UCR expression in gastric cancer (GC), indicating that T-UCRs could play an important role in GC biology.",0
2522,1,Does Uc.160 promote cancer?,"Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC.METHODS: We analyzed the expression pattern of Uc.160+ in nonneoplastic and tumor tissues of the stomach by using uantitative reverse transcription polymerase chain reaction (qRT-PCR) and in situ hybridization (ISH), specifically focusing on the mechanism of transcriptional regulation and target genes that are regulated by T-UCRs.",0
2522,2,Does Uc.160 promote cancer?,"We also attempted to determine the effect of Uc.160+ expression on biological features of GC cell lines by Western blotting.RESULTS: On the basis of the qRT-PCR and ISH results, Uc.160+ expression in adenoma and GC tissues was clearly downregulated compared with that in nonneoplastic mucosa tissues of the stomach.",0
2522,3,Does Uc.160 promote cancer?,Cancer-specific DNA methylation in the promoter region of Uc.160 was observed by bisulfite genomic DNA sequencing analysis.,0
2522,4,Does Uc.160 promote cancer?,The effect of DNA methylation on Uc.160+ expression was further confirmed by reporter gene assay.,0
2522,5,Does Uc.160 promote cancer?,We also revealed that Uc.160+ inhibited the phosphorylation of Akt by regulating phosphatase and tensin homolog (PTEN) expression.CONCLUSIONS: These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC.,0
2522,6,Does Uc.160 promote cancer?,"Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC.<br><b>METHODS</b>: We analyzed the expression pattern of Uc.160+ in nonneoplastic and tumor tissues of the stomach by using uantitative reverse transcription polymerase chain reaction (qRT-PCR) and in situ hybridization (ISH), specifically focusing on the mechanism of transcriptional regulation and target genes that are regulated by T-UCRs.",1
2522,7,Does Uc.160 promote cancer?,We also revealed that Uc.160+ inhibited the phosphorylation of Akt by regulating phosphatase and tensin homolog (PTEN) expression.<br><b>CONCLUSIONS</b>: These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC.<br>,0
2522,8,Does Uc.160 promote cancer?,"We also attempted to determine the effect of Uc.160+ expression on biological features of GC cell lines by Western blotting.<br><b>RESULTS</b>: On the basis of the qRT-PCR and ISH results, Uc.160+ expression in adenoma and GC tissues was clearly downregulated compared with that in nonneoplastic mucosa tissues of the stomach.",0
2522,9,Does Uc.160 promote cancer?,CONCLUSIONS These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC.,1
2522,10,Does Uc.160 promote cancer?,"Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC.",1
2522,11,Does Uc.160 promote cancer?,"Among the T-UCRs that were reactivated upon drug treatment, Uc.160+, Uc283+A and Uc.346+ were found to undergo specific CpG island hypermethylation-associated silencing in cancer cells compared with normal tissues.",0
2522,12,Does Uc.160 promote cancer?,"Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC.",1
2522,13,Does Uc.160 promote cancer?,These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC..,1
111,0,What enzyme is inhibied by Opicapone?,PURPOSE: Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson's disease.,1
111,1,What enzyme is inhibied by Opicapone?,"Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor.",0
111,2,What enzyme is inhibied by Opicapone?,"OBJECTIVE: The present study aimed at evaluating the effect of opicapone, a third generation nitrocatechol catechol-O-methyltransferase (COMT) inhibitor, on the systemic and central bioavailability of 3,4-dihydroxy-l-phenylalanine (levodopa) and related metabolites in the cynomolgus monkey.",0
111,3,What enzyme is inhibied by Opicapone?,CONCLUSIONS: Opicapone behaved as long-acting COMT inhibitor that markedly increased systemic and central levodopa bioavailability.,0
111,4,What enzyme is inhibied by Opicapone?,BACKGROUND AND OBJECTIVES: Opicapone is a novel third generation catechol-O-methyltransferase (COMT) inhibitor.,1
111,5,What enzyme is inhibied by Opicapone?,The purpose of this study was to compare the levodopa pharmacokinetic profile throughout a day driven by the COMT inhibition either following repeated doses of opicapone or concomitant administration with entacapone.,0
111,6,What enzyme is inhibied by Opicapone?,"CONCLUSION: Opicapone, a novel third generation COMT inhibitor, when compared to entacapone, provides a superior response upon the bioavailability of levodopa associated to more pronounced, long-lasting, and sustained COMT inhibition.",0
111,7,What enzyme is inhibied by Opicapone?,"Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor.",1
111,8,What enzyme is inhibied by Opicapone?,Opicapone is a novel catechol-O-methyltransferase (COMT) inhibitor.,1
111,9,What enzyme is inhibied by Opicapone?,Opicapone is a novel third generation catechol-O-methyltransferase (COMT) inhibitor.,1
111,10,What enzyme is inhibied by Opicapone?,"The purpose of this study was to evaluate the tolerability, pharmacokinetics (including the effect of food) and pharmacodynamics (effect on COMT activity) following single oral doses of opicapone in young healthy male volunteers.",0
111,11,What enzyme is inhibied by Opicapone?,"AIMS: The aim of this study was to assess the tolerability, pharmacokinetics and inhibitory effect on erythrocyte soluble catechol-O-methyltransferase (S-COMT) activity following repeated doses of opicapone.",0
111,12,What enzyme is inhibied by Opicapone?,"CONCLUSION: Despite its short elimination half-life, opicapone markedly and sustainably inhibited erythrocyte S-COMT activity making it suitable for a once daily regimen.",0
111,13,What enzyme is inhibied by Opicapone?,Opicapone demonstrated marked and sustained inhibition of erythrocyte soluble COMT activity.,0
111,14,What enzyme is inhibied by Opicapone?,"The long duration of COMT inhibition by opicapone, however, tended to be independent from the dose taken.",0
3339,0,Can MVA85A confer immunity against smallpox?,"We assessed the safety, immunogenicity, and efficacy of a candidate tuberculosis vaccine, modified vaccinia virus Ankara expressing antigen 85A (MVA85A), in adults infected with HIV-1.",1
3339,1,Can MVA85A confer immunity against smallpox?,"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.",1
331,0,Which R/bioconductor package is used for integrative genomics visualizations?,"Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures.",1
331,1,Which R/bioconductor package is used for integrative genomics visualizations?,"Interpretation and communication of genomic data require flexible and quantitative tools to analyze and visualize diverse data types, and yet, a comprehensive tool to display all common genomic data types in publication quality figures does not exist to date.",1
331,2,Which R/bioconductor package is used for integrative genomics visualizations?,"To address this shortcoming, we present Sushi.R, an R/Bioconductor package that allows flexible integration of genomic visualizations into highly customizable, publication-ready, multi-panel figures from common genomic data formats including Browser Extensible Data (BED), bedGraph and Browser Extensible Data Paired-End (BEDPE).",1
331,3,Which R/bioconductor package is used for integrative genomics visualizations?,Sushi.R is open source and made publicly available through GitHub (https://github.com/dphansti/Sushi) and Bioconductor (http://bioconductor.org/packages/release/bioc/html/Sushi.html).,1
331,4,Which R/bioconductor package is used for integrative genomics visualizations?,"To address this shortcoming, we present Sushi.R, an R/Bioconductor package that allows flexible integration of genomic visualizations into highly customizable, publication-ready, multi-panel figures from common genomic data formats including Browser Extensible Data (BED), bedGraph and Browser Extensible Data Paired-End (BEDPE)",1
1803,0,Describe what is athelia syndrome?,Athelia is a very rare entity that is defined by the absence of the nipple-areola complex.,1
1803,1,Describe what is athelia syndrome?,"Absence of the nipple, areola (athelia), or the breast tissue (amastia) is less frequent.",1
1803,2,Describe what is athelia syndrome?,The absence of nipple-areola complex is a rare entity and is always associated with other anomalies.,1
1803,3,Describe what is athelia syndrome?,This paper described a case of bilateral athelia without other alterations.,0
1803,4,Describe what is athelia syndrome?,Athelia is a very rare entity that is defined by the absence of the nipple-areola complex.,1
1803,5,Describe what is athelia syndrome?,"It can affect either sex and is mostly part of syndromes including other congenital or ectodermal anomalies, such as limb-mammary syndrome, scalp-ear-nipple syndrome, or ectodermal dysplasias.",0
1803,6,Describe what is athelia syndrome?,"Here, we report on three children from two branches of an extended consanguineous Israeli Arab family, a girl and two boys, who presented with a spectrum of nipple anomalies ranging from unilateral hypothelia to bilateral athelia but no other consistently associated anomalies except a characteristic eyebrow shape.",0
1803,7,Describe what is athelia syndrome?,Athelia is a very rare entity that is defined by the absence of the nipple-areola complex.,1
3794,0,What is the risk for secondary cancer after proton beam therapy?,"In pediatric patients who had undergone PBT, the LAR of PBT was significantly lower than the LAR of IMXT estimated by in silico modeling.",0
3794,1,What is the risk for secondary cancer after proton beam therapy?,"Proton beam therapy (PBT) is a potential new alternative to treatment with photon radiotherapy that may reduce the risk of late toxicity and secondary cancer, especially for pediatric tumors.",0
3794,2,What is the risk for secondary cancer after proton beam therapy?,No malignant secondary tumors occurred within the irradiated field.,0
3794,3,What is the risk for secondary cancer after proton beam therapy?,"The 10- and 20-year cumulative rates for all secondary tumors, malignant secondary tumors, and malignant nonhematologic secondary tumors were 8% and 16%, 5% and 13%, and 3% and 11%, respectively.",0
3794,4,What is the risk for secondary cancer after proton beam therapy?,Our data indicate that PBT has the potential to reduce the risk of late mortality and secondary malignancy.,0
3794,5,What is the risk for secondary cancer after proton beam therapy?,"However, treatment-related toxicities have also occurred, particularly for radiotherapy, after which secondary cancer, reduced function of irradiated organs, and retarded growth are significant problems.",0
3794,6,What is the risk for secondary cancer after proton beam therapy?,Proton beam therapy (PBT) is a particle radiotherapy with excellent dose localization that permits treatment of liver and lung cancer by administration of a high dose to the tumor while minimizing damage to surrounding normal tissues.,1
3794,7,What is the risk for secondary cancer after proton beam therapy?,"Notably, proton beam therapy is very useful for pediatric cancer; since the pediatric radiation dose to normal tissues should be reduced as much as possible because of the effect of radiation on growth, intellectual development, endocrine organ function and secondary cancer development.",0
3794,8,What is the risk for secondary cancer after proton beam therapy?,"After proton beam therapy (low-LET radiation), the risk of secondary cancer induction, relative to photons, can be divided by a factor of 3, due to the reduction of integral dose (as an average).",1
3794,9,What is the risk for secondary cancer after proton beam therapy?,"However, after heavy-ion beam therapy, the risk should be divided by 3, as after proton therapy due to the excellent physical selectivity of the irradiation.",0
3794,10,What is the risk for secondary cancer after proton beam therapy?,"Proton beam therapy (PT) offers improved sparing of normal tissue, thus potentially reducing the risk for treatment related late sequelae and induction of secondary cancer.",0
3794,11,What is the risk for secondary cancer after proton beam therapy?,INTRODUCTION: The concern of secondary cancer induction and normal tissue complications have motivated a more frequent use of protons in radiotherapy (RT) of children.,0
3794,12,What is the risk for secondary cancer after proton beam therapy?,"However, activation, neutron production, and the associated secondary cancer risk in proton beam should be an important consideration which is evaluated.",0
3794,13,What is the risk for secondary cancer after proton beam therapy?,"RESULTS: In all evaluated organs, the mean dose in PBT was 20-80% of that in CRT.",0
3794,14,What is the risk for secondary cancer after proton beam therapy?,"The risk of secondary cancer in PBT was 24-83% of that in CRT for five organs, but 121% of that in CRT for pancreas.",0
3794,15,What is the risk for secondary cancer after proton beam therapy?,"Assessments of secondary cancer risk showed that PBT reduces the risk of secondary cancer in most organs, whereas IMRT is associated with a higher risk than CRT.",0
3794,16,What is the risk for secondary cancer after proton beam therapy?,A recent study suggested reduced secondary cancer and other late toxicities after proton beam therapy (PBT) due to dosimetric advantages.,0
3794,17,What is the risk for secondary cancer after proton beam therapy?,"After proton beam therapy (low-LET radiation), the risk of secondary cancer induction, relative to photons, can be divided by a factor of 3, due to the reduction of integral dose (as an average).",1
3794,18,What is the risk for secondary cancer after proton beam therapy?,"The incidence of secondary malignancies after proton beam therapy is low but not negligible, therefore, it must be taken into account when planning a treatment as secondary tumors may present with a highly aggressive behaviour.",0
3794,19,What is the risk for secondary cancer after proton beam therapy?,"We show that compared with photon therapy, proton therapy markedly reduces the risk of secondary malignancies and for equivalent dosing regimens achieves better tumour control as well as a reduced primary recurrence outcome, especially within a hypo-fractionated regimen.",0
3794,20,What is the risk for secondary cancer after proton beam therapy?,Purpose: Proton radiotherapy (PRT) is potentially associated with a lower risk for secondary malignancies due to a decreased integral dose to the surrounding organs at risk (OARs).,1
3794,21,What is the risk for secondary cancer after proton beam therapy?,Our data indicate that PBT has the potential to reduce the risk of late mortality and secondary malignancy.,0
3794,22,What is the risk for secondary cancer after proton beam therapy?,The total lifetime risk of second cancer due exclusively to stray radiation was 1.5% for the passively scattered treatment versus 0.8% for the scanned proton beam treatment.,0
3794,23,What is the risk for secondary cancer after proton beam therapy?,"In general, the risk for developing a second malignancy in out-of-field organs for PBS remains much lower compared to PPT even if apertures are being applied.",0
3794,24,What is the risk for secondary cancer after proton beam therapy?,CONCLUSIONS: PBS PT is associated to significant SCR reduction in BC patients compared to photon radiotherapy.,0
3794,25,What is the risk for secondary cancer after proton beam therapy?,Calculations of out-of-field organ doses following a brain tumor treatment indicated that proton PBS therapy of brain tumors is associated with a low risk of radiation-induced cancer.,1
3794,26,What is the risk for secondary cancer after proton beam therapy?,"CONCLUSIONS: When considering exposure to primary and secondary radiation, proton therapy can reduce the risk of an SMN in prostate patients compared with contemporary IMRT.",0
3794,27,What is the risk for secondary cancer after proton beam therapy?,"CONCLUSION: The findings of this study indicate that the risks of radiation-induced secondary cancers after radiosurgery of liver metastases may be reduced, if IMPT is used instead of photon-beam based SBRT.",0
3794,28,What is the risk for secondary cancer after proton beam therapy?,"Clinical data are emerging supporting the lower incidence of secondary malignancies after PRT compared with historical photon data, though longer follow-up in proton treated cohorts is awaited.",0
3794,29,What is the risk for secondary cancer after proton beam therapy?,"However, proton treatment can result in a lower cancer incidence than photon treatment.",0
1199,0,What is the disorder in which mutations in U4atac snRNA are detected?,"Biallelic mutations of the human RNU4ATAC gene, which codes for the minor spliceosomal U4atac snRNA, cause the developmental disorder, MOPD I/TALS",1
1199,1,What is the disorder in which mutations in U4atac snRNA are detected?,"To date, nine separate mutations in RNU4ATAC have been identified in MOPD I patients.",0
1199,2,What is the disorder in which mutations in U4atac snRNA are detected?,"In this report, we establish a mechanistic basis for MOPD I disease and show that the inefficient splicing of genes containing U12-dependent introns in patient cells is due to defects in minor tri-snRNP formation, and the MOPD I-associated RNU4ATAC mutations can affect multiple facets of minor snRNA function.",0
1199,3,What is the disorder in which mutations in U4atac snRNA are detected?,A homozygous mutation in RNU4ATAC as a cause of microcephalic osteodysplastic primordial dwarfism type I (MOPD I) with associated pigmentary disorder.,1
1199,4,What is the disorder in which mutations in U4atac snRNA are detected?,"We describe two brothers, born to healthy, consanguineous parents, with intrauterine and postnatal growth retardation, microcephaly with abnormal gyral pattern and partial agenesis of corpus callosum, and skeletal anomalies reminiscent of those described in MOPD type I.",0
1199,5,What is the disorder in which mutations in U4atac snRNA are detected?,This was confirmed by the identification of the homozygous g.55G > A mutation of RNU4ATAC encoding U4atac snRNA.,0
1199,6,What is the disorder in which mutations in U4atac snRNA are detected?,Microcephalic osteodysplastic primordial dwarfism type I with biallelic mutations in the RNU4ATAC gene.,1
1199,7,What is the disorder in which mutations in U4atac snRNA are detected?,"Recently, mutations in the RNU4ATAC gene, which encodes U4atac, a small nuclear RNA that is a crucial component of the minor spliceosome, were found to cause MOPD I",0
1199,8,What is the disorder in which mutations in U4atac snRNA are detected?,"We describe here the clinical and molecular data for 17 cases of MOPD I, including 15 previously unreported cases, all carrying biallelic mutations in the RNU4ATAC gene.",0
1199,9,What is the disorder in which mutations in U4atac snRNA are detected?,"Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I.",1
1199,10,What is the disorder in which mutations in U4atac snRNA are detected?,"By means of homozygosity mapping and deep sequencing, we show that a gene encoding U4atac snRNA, a component of the minor U12-dependent spliceosome, is mutated in individuals with microcephalic osteodysplastic primordial dwarfism type I (MOPD I), a severe developmental disorder characterized by extreme intrauterine growth retardation and multiple organ abnormalities.",0
1199,11,What is the disorder in which mutations in U4atac snRNA are detected?,The introduction of wild-type U4atac snRNA into MOPD I cells enhanced U12-dependent splicing.,0
1199,12,What is the disorder in which mutations in U4atac snRNA are detected?,Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA.,0
1199,13,What is the disorder in which mutations in U4atac snRNA are detected?,We identified four point mutations in the U4atac snRNA component of the minor spliceosome in patients with brain and bone malformations and unexplained postnatal death [microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) or Taybi-Linder syndrome (TALS); Mendelian Inheritance in Man ID no.,0
1199,14,What is the disorder in which mutations in U4atac snRNA are detected?,210710].,0
1199,15,What is the disorder in which mutations in U4atac snRNA are detected?,"Biallelic mutations of the human RNU4ATAC gene, which codes for the minor spliceosomal U4atac snRNA, cause the developmental disorder, MOPD I/TALS",1
1199,16,What is the disorder in which mutations in U4atac snRNA are detected?,We identified four point mutations in the U4atac snRNA component of the minor spliceosome in patients with brain and bone malformations and unexplained postnatal death [microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) or Taybi-Linder syndrome (TALS); Mendelian Inheritance in Man ID no,0
1199,17,What is the disorder in which mutations in U4atac snRNA are detected?,"Recently, mutations in the RNU4ATAC gene, which encodes U4atac, a small nuclear RNA that is a crucial component of the minor spliceosome, were found to cause MOPD I",0
1199,18,What is the disorder in which mutations in U4atac snRNA are detected?,"To date, nine separate mutations in RNU4ATAC have been identified in MOPD I patients",0
1199,19,What is the disorder in which mutations in U4atac snRNA are detected?,"In this report, we establish a mechanistic basis for MOPD I disease and show that the inefficient splicing of genes containing U12-dependent introns in patient cells is due to defects in minor tri-snRNP formation, and the MOPD I-associated RNU4ATAC mutations can affect multiple facets of minor snRNA function",0
1199,20,What is the disorder in which mutations in U4atac snRNA are detected?,MOPD I is the first disease known to be associated with a defect in small nuclear RNAs,0
1199,21,What is the disorder in which mutations in U4atac snRNA are detected?,"By means of homozygosity mapping and deep sequencing, we show that a gene encoding U4atac snRNA, a component of the minor U12-dependent spliceosome, is mutated in individuals with microcephalic osteodysplastic primordial dwarfism type I (MOPD I), a severe developmental disorder characterized by extreme intrauterine growth retardation and multiple organ abnormalities",0
1157,0,A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants.,protease autolysis or keratin contaminants.,1
1157,1,A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants.,Most of the interfering masses originate from trypsin autolysis and human keratins.,1
1157,2,A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants.,5-15% FBS.,0
1157,3,A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants.,Contamination by bovine proteins is difficult to avoid because of adherence to the plastic vessel and the cultured cells.,1
1157,4,A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants.,The main disadvantage of traditional IP and co-IP is that the conditions used to elute the precipitated antigen also release the antibody thus contaminating the antigen,1
1157,5,A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants.,MaConDa: a publicly accessible mass spectrometry contaminants database.,1
3520,0,What is the role of the Hof1-Cyk3 interaction in yeast?,Role of the Hof1-Cyk3 interaction in cleavage-furrow ingression and primary-septum formation during yeast cytokinesis.,0
3520,1,What is the role of the Hof1-Cyk3 interaction in yeast?,"In Saccharomyces cerevisiae, it is well established that Hof1, Cyk3, and Inn1 contribute to septum formation and cytokinesis.",1
3520,2,What is the role of the Hof1-Cyk3 interaction in yeast?,"Because hof1∆ and cyk3∆ single mutants have relatively mild defects but hof1∆ cyk3∆ double mutants are nearly dead, it has been hypothesized that these proteins contribute to parallel pathways.",0
3520,3,What is the role of the Hof1-Cyk3 interaction in yeast?,"However, there is also evidence that they interact physically.",0
3520,4,What is the role of the Hof1-Cyk3 interaction in yeast?,"In this study, we examined this interaction and its functional significance in detail.",0
3520,5,What is the role of the Hof1-Cyk3 interaction in yeast?,Our data indicate that the interaction 1) is mediated by a direct binding of the Hof1 SH3 domain to a proline-rich motif in Cyk3; 2) occurs specifically at the time of cytokinesis but is independent of the (hyper)phosphorylation of both proteins that occurs at about the same time; 3) is dispensable for the normal localization of both proteins; 4) is essential for normal primary-septum formation and a normal rate of cleavage-furrow ingression; and 5) becomes critical for growth when either Inn1 or the type II myosin Myo1 (a key component of the contractile actomyosin ring) is absent.,1
3520,6,What is the role of the Hof1-Cyk3 interaction in yeast?,"The similarity in phenotype between cyk3∆ mutants and mutants specifically lacking the Hof1-Cyk3 interaction suggests that the interaction is particularly important for Cyk3 function, but it may be important for Hof1 function as well.",1
3520,7,What is the role of the Hof1-Cyk3 interaction in yeast?,"The similarity in phenotype between cyk3∆ mutants and mutants specifically lacking the Hof1-Cyk3 interaction suggests that the interaction is particularly important for Cyk3 function, but it may be important for Hof1 function as well.",1
3520,8,What is the role of the Hof1-Cyk3 interaction in yeast?,"The similarity in phenotype between cyk3∆ mutants and mutants specifically lacking the Hof1-Cyk3 interaction suggests that the interaction is particularly important for Cyk3 function, but it may be important for Hof1 function as well.",1
4177,0,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,No significant difference was detected in the proportion of patients with favorable six-month GOSE in either study group (odds ratio (OR): 1.49; 95% confidence interval (CI): 0.43-5.17).,1
4177,1,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,Secondary functional outcome measures for favorable six-month recovery i.e.,0
4177,2,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,a mRS of 0 to 3 (OR: 3.45; 95% CI 0.79-15.01) were comparable for both groups.,1
4177,3,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,"Similarly, there was no difference in MOCA neurocognitive performance (p-value: 0.75) and in the incidence of DCI (OR: 0.85 95% CI: 0.28-2.59).CONCLUSIONS: Use of Cerebrolysin in addition to standard-of-care management of aneurysmal SAH is safe, well tolerated and feasible.",1
4177,4,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,"However, the neutral results of this trial suggest that it does not improve the six-month global functional performance of patients.",1
4177,5,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,"CONCLUSION: Cerebrolysin injection during the acute period of SAH appeared to reduce the mortality rate, especially in poor-grade patients.",0
4177,6,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,This study suggests the potential of Cerebrolysin for treating aneurysmal SAH.,1
4177,7,Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?,Further studies are needed to confirm our results.,0
97,0,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"Hypertrophic cardiomyopathy (HCM) is a primary disease of the cardiac muscle that occurs mainly due to mutations (>1,400 variants) in genes encoding for the cardiac sarcomere.",0
97,1,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"HCM, the most common familial form of cardiomyopathy, affecting one in every 500 people in the general population, is typically inherited in an autosomal dominant pattern, and presents variable expressivity and age-related penetrance.",0
97,2,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"Familial hypertrophic cardiomyopathy (HCM), due to point mutations in genes for sarcomere proteins such as myosin, occurs in 1/500 people and is the most common cause of sudden death in young individuals.",0
97,3,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"n HCM, the modified protein function leads, over years to decades, to secondary remodeling with substantial morphological changes, such as hypertrophy, myofibrillar disarray, and extensive fibrosis associated with severe functional deterioration.",0
97,4,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in the young, particularly among athletes.",1
97,5,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"Familial hypertrophic cardiomyopathy (HCM) is one the most common heart disorders, with gene mutations in the cardiac sarcomere.",0
97,6,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"Hypertrophic cardiomyopathy (HCM) has been recently recognized as the most common inherited cardiovascular disorder, affecting 1 in 500 adults worldwide.",1
97,7,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"HCM is characterized by myocyte hypertrophy resulting in thickening of the ventricular wall, myocyte disarray, interstitial and/or replacement fibrosis, decreased ventricular cavity volume and diastolic dysfunction.",1
97,8,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,HCM is also the most common cause of sudden death in the young.,1
97,9,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,A large proportion of patients diagnosed with HCM have mutations in sarcomeric proteins.,0
97,10,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,Hypertrophic cardiomyopathy (HCM) is a genetic cardiomyopathy.,0
97,11,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"The prevalence of phenotypic expression, in the absence of another systemic or cardiac disease causing increased left ventricular (LV) wall thickness, is estimated to be 1:500.",0
97,12,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,"HCM is the most prevalent genetic disorder affecting the heart, it often goes undiagnosed until midlife after patients show symptoms of myocardial remodeling.",0
97,13,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,Adults with cardiomyopathy suffer SCD or adverse events such as stroke and heart failure from HCM.,1
97,14,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,Hypertrophic cardiomyopathy (HCM) is a clinically heterogeneous autosomal dominant heart disease characterised by left ventricular hypertrophy in the absence of another cardiac or systemic disease that is capable of producing significant wall thickening.,0
97,15,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited genetic disease characterized by compensatory pathological left ventricle (LV) hypertrophy due to sarcomere dysfunction.,0
97,16,Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?,Hypertrophic cardiomyopathy (HCM) is a clinically heterogeneous genetic heart disease characterized by left ventricular hypertrophy in the absence of another disease that could explain the wall thickening.,0
3407,0,What is Telangiectasia?,"Telangiectasias are prominent small vessels (venules, capillaries or arterioles) that are visible as small red-purple focal lesions in the skin and mucous membranes.",1
3407,1,What is Telangiectasia?,"Telangiectasias are small focal red macules and papules created by abnormally prominent capillaries, venules, and arterioles",1
3407,2,What is Telangiectasia?,Telangiectasia (macroscopically visible dilated skin vessels),1
3407,3,What is Telangiectasia?,"Hereditary hemorrhagic telangiectasia is a dominant disorder characterized by epistaxis, visceral arteriovenous malformations, and telangiectasias.",1
3407,4,What is Telangiectasia?,"Telangiectasia (macroscopically visible dilated skin vessels) occurring primarily on the hands and face, are a prominent feature in scleroderma and are present in the majority of patients.",1
4230,0,List R packages for lipidomics,We have developed massPix-an R package for analysing and interpreting data from MSI of lipids in tissue.,0
4230,1,List R packages for lipidomics,Lipid Mini-On: mining and ontology tool for enrichment analysis of lipidomic data.,1
4230,2,List R packages for lipidomics,"Here we introduce Lipid Mini-On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data.",1
4230,3,List R packages for lipidomics,Lipid Mini-On uses a text-mining process to bin individual lipid names into multiple lipid ontology groups based on the classification (e.g.,0
4230,4,List R packages for lipidomics,"LipidMaps) and other characteristics, such as chain length.",0
4230,5,List R packages for lipidomics,Lipid Mini-On provides users with the capability to conduct enrichment analysis of the lipid ontology terms using a Shiny app with options of five statistical approaches.,0
4230,6,List R packages for lipidomics,lipidr: A Software Tool for Data Mining and Analysis of Lipidomics Datasets.,1
4230,7,List R packages for lipidomics,The rapid evolution of mass spectrometry (MS)-based lipidomics has enabled the simultaneous measurement of numerous lipid classes.,0
4230,8,List R packages for lipidomics,"With lipidomics datasets becoming increasingly available, lipidomic-focused software tools are required to facilitate data analysis as well as mining of public datasets, integrating lipidomics-unique molecular information such as lipid class, chain length, and unsaturation.",0
4230,9,List R packages for lipidomics,"To address this need, we developed lipidr, an open-source R/Bioconductor package for data mining and analysis of lipidomics datasets.",1
4230,10,List R packages for lipidomics,lipidr implements a comprehensive lipidomic-focused analysis workflow for targeted and untargeted lipidomics.,0
4230,11,List R packages for lipidomics,"lipidr imports numerical matrices, Skyline exports, and Metabolomics Workbench files directly into R, automatically inferring lipid class and chain information from lipid names.",0
4230,12,List R packages for lipidomics,"Through integration with the Metabolomics Workbench API, users can search, download, and reanalyze public lipidomics datasets seamlessly.",0
4230,13,List R packages for lipidomics,"lipidr allows thorough data inspection, normalization, and uni- and multivariate analyses, displaying results as interactive visualizations.",0
4230,14,List R packages for lipidomics,"To enable interpretation of lipid class, chain length, and total unsaturation data, we also developed and implemented a novel lipid set enrichment analysis.",0
4230,15,List R packages for lipidomics,A companion online guide with two live example datasets is presented at https://www.lipidr.org/.,0
4230,16,List R packages for lipidomics,We expect that the ease of use and innovative features of lipidr will allow the lipidomics research community to gain novel detailed insights from lipidomics data.,0
4230,17,List R packages for lipidomics,LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics.,1
4230,18,List R packages for lipidomics,"High resolution LC-MS untargeted lipidomics using data independent acquisition (DIA) has the potential to increase lipidome coverage, as it enables the continuous and unbiased acquisition of all eluting ions.",0
4230,19,List R packages for lipidomics,"However, the loss of the link between the precursor and the product ions combined with the high dimensionality of DIA data sets hinder accurate feature annotation.",0
4230,20,List R packages for lipidomics,"Here, we present LipidMS, an R package aimed to confidently identify lipid species in untargeted LC-DIA-MS.",0
3627,0,What is circulating free DNA ( cfDNA)?,"Cell-free DNA (cfDNA) and cell-free RNA (cfRNA), RNA associated to platelets and circulating tumor cells (CTCs) are some of the materials that can be derived from the blood of cancer patients.",1
3627,1,What is circulating free DNA ( cfDNA)?,"Known to be present in the blood of cancer patients for decades, cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance.",1
3627,2,What is circulating free DNA ( cfDNA)?,This study aimed to determine the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell-free DNA (cfDNA) to replace conventional screening.,1
3627,3,What is circulating free DNA ( cfDNA)?,cfDNA was isolated from a serum specimen before chemotherapy.,0
3627,4,What is circulating free DNA ( cfDNA)?,Its value was correlated to recurrence-free and overall survival using Kaplan-Meier curves.,1
3627,5,What is circulating free DNA ( cfDNA)?,Cell-free fetal DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use.,1
1198,0,Which enzyme is inhibited by Orteronel?,"PURPOSE: Orteronel (TAK-700) is a non-steroidal, selective, reversible inhibitor of 17,20-lyase.",0
1198,1,Which enzyme is inhibited by Orteronel?,The drug orteronel selectively blocked the lyase reaction of P450 17A1 but only in the case of Prog.,0
1198,2,Which enzyme is inhibited by Orteronel?,"Preclinical assessment of Orteronel(®), a CYP17A1 enzyme inhibitor in rats.",0
1198,3,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700) is a novel and selective inhibitor of CYP17A1, which is expressed in testicular, adrenal and prostate tumor tissues.",0
1198,4,Which enzyme is inhibited by Orteronel?,"Orteronel is a nonsteroidal, selective inhibitor of 17,20-lyase that was recently in phase 3 clinical development as a treatment for castration-resistant prostate cancer.",0
1198,5,Which enzyme is inhibited by Orteronel?,"Human liver microsomal studies indicated that orteronel weakly inhibits CYP1A2, 2C8, 2C9 and 2C19, with IC50 values of 17.8, 27.7, 30.8 and 38.8 µm, respectively, whereas orteronel does not inhibit CYP2B6, 2D6 or 3A4/5 (IC50  > 100 µm).",0
1198,6,Which enzyme is inhibited by Orteronel?,"PURPOSE: Orteronel (TAK-700) is an investigational, nonsteroidal, oral, inhibitor of androgen synthesis with greater specificity for 17,20-lyase than for 17α-hydroxylase.",0
1198,7,Which enzyme is inhibited by Orteronel?,"Based on these observations, potent agents targeting the AR axis were developed: 1) inhibitors of CYP17 (a key enzyme in the production of androgens), such as abiraterone and orteronel; 2) AR antagonists that bind to AR and impair AR activation, such as enzalutamide and ARN-509.",0
1198,8,Which enzyme is inhibited by Orteronel?,"Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.",1
1198,9,Which enzyme is inhibited by Orteronel?,"Inhibition of 17α-hydroxylase by abiraterone results in accumulation of upstream mineralocorticoids due to loss of cortisol-mediated suppression of pituitary adrenocorticotropic hormone (ACTH), providing a rationale for development of CYP17 inhibitors with increased specificity for 17,20-lyase (orteronel, galeterone and VT-464) that can potentially be administered without exogenous corticosteroids.",0
1198,10,Which enzyme is inhibited by Orteronel?,"Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer.",0
1198,11,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700) is an investigational, oral, nonsteroidal, selective, reversible inhibitor of 17,20-lyase, a key enzyme in the production of androgenic hormones.",0
1198,12,Which enzyme is inhibited by Orteronel?,"Hence, some molecules target the androgen biosynthesis, as abiraterone acetate and orteronel, which are selective inhibitors of the enzyme CYP17.",0
1198,13,Which enzyme is inhibited by Orteronel?,"To achieve enhanced clinical benefits, new strategies are being explored that include selective inhibition of the C17,20-lyase activity of CYP17 and multi-targeting strategies that affect androgen synthesis and signalling at different points.",0
1198,14,Which enzyme is inhibited by Orteronel?,"Some of these strategies-including the drugs orteronel, VT-464 and galeterone--are supported by preclinical data and are being explored in the clinic.",0
1198,15,Which enzyme is inhibited by Orteronel?,"Besides further CYP17 inhibitors (Orteronel, Galeterone, VT-464 and CFG920), androgen receptor antagonists (ARN-509, ODM-201, AZD-3514 and EZN-4176) and vaccine Prostvac, more drug candidates with various mechanisms or new indications of launched drugs are currently under evaluation in different stages of clinical trials, including various kinase inhibitors and platinum complexes.",0
1198,16,Which enzyme is inhibited by Orteronel?,"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.",0
1198,17,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.",0
1198,18,Which enzyme is inhibited by Orteronel?,"In summary, orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity, suggesting that orteronel might be effective for hormone-dependent breast cancers and estrogen-dependent diseases.",0
1198,19,Which enzyme is inhibited by Orteronel?,"Development and validation of an RP-HPLC method for the quantitation of Orteronel (TAK-700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study.",0
1198,20,Which enzyme is inhibited by Orteronel?,"Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor.",0
1198,21,Which enzyme is inhibited by Orteronel?,"A new CYP17 inhibitor, with more selective inhibition of 17,20-lyase over 17α-hydroxylase, orteronel (TAK-700), is currently undergoing phase III clinical trials in pre- and postchemotherapy CRPC.",0
1198,22,Which enzyme is inhibited by Orteronel?,"Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats.",0
1198,23,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700), 6-[(7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide, is a novel, non-steroidal, selective inhibitor of the 17,20-lyase activity of CYP17A--a key enzyme in the production of steroidal hormones--and is being developed as a therapy for PC.",0
1198,24,Which enzyme is inhibited by Orteronel?,"Orteronel inhibited 17,20-lyase activity in rats with an IC(50) of 1200 nM but did not inhibit 17α-hydroxylase or 11β-hydroxylase (CYP11B1) activity in rats at concentrations up to 10 μM.",0
1198,25,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.",0
1198,26,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700), a novel, selective, and potent inhibitor of 17,20-lyase is under development as a drug to inhibit androgen synthesis.",0
1198,27,Which enzyme is inhibited by Orteronel?,"In this study, we quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on CYP17A1 enzymatic activity, steroid production in monkey adrenal cells and human adrenal tumor cells, and serum levels of dehydroepiandrosterone (DHEA), cortisol, and testosterone after oral dosing in castrated and intact male cynomolgus monkeys.",0
1198,28,Which enzyme is inhibited by Orteronel?," In summary, orteronel potently inhibited the 17,20-lyase activity of monkey and human CYP17A1 and reduced serum androgen levels in vivo in monkeys.",1
1198,29,Which enzyme is inhibited by Orteronel?,"Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer.",0
1198,30,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700), 6-[(7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide, is a novel, non-steroidal, selective inhibitor of the 17,20-lyase activity of CYP17A--a key enzyme in the production of steroidal hormones--and is being developed as a therapy for PC.",0
1198,31,Which enzyme is inhibited by Orteronel?,"The purpose of this study was to elucidate the inhibitory activity of orteronel, in particular its specificity for androgen synthesis enzymes, in male rats--an androgen-synthesis model that largely reflects this pathway in humans.",0
1198,32,Which enzyme is inhibited by Orteronel?,"In terms of human CYP17A1 and human adrenal tumor cells, orteronel inhibited 17,20-lyase activity 5.4 times more potently than 17-hydroxylase activity in cell-free enzyme assays and DHEA production 27 times more potently than cortisol production in human adrenal tumor cells, suggesting greater specificity of inhibition between 17,20-lyase and 17-hydroxylase activities in humans vs monkeys.",0
1198,33,Which enzyme is inhibited by Orteronel?,"In summary, orteronel potently inhibited the 17,20-lyase activity of monkey and human CYP17A1 and reduced serum androgen levels in vivo in monkeys.",1
1198,34,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700) is a novel and selective inhibitor of CYP17A1, which is expressed in testicular, adrenal and prostate tumor tissues",0
1198,35,Which enzyme is inhibited by Orteronel?,"Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells",1
1198,36,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700), a novel, selective, and potent inhibitor of 17,20-lyase is under development as a drug to inhibit androgen synthesis",0
1198,37,Which enzyme is inhibited by Orteronel?,"In summary, orteronel potently inhibited the 17,20-lyase activity of monkey and human CYP17A1 and reduced serum androgen levels in vivo in monkeys",1
1198,38,Which enzyme is inhibited by Orteronel?,"Orteronel inhibited 17,20-lyase activity in rats with an IC(50) of 1200 nM but did not inhibit 17α-hydroxylase or 11β-hydroxylase (CYP11B1) activity in rats at concentrations up to 10 μM",0
1198,39,Which enzyme is inhibited by Orteronel?,"In terms of human CYP17A1 and human adrenal tumor cells, orteronel inhibited 17,20-lyase activity 5.4 times more potently than 17-hydroxylase activity in cell-free enzyme assays and DHEA production 27 times more potently than cortisol production in human adrenal tumor cells, suggesting greater specificity of inhibition between 17,20-lyase and 17-hydroxylase activities in humans vs monkeys",0
1198,40,Which enzyme is inhibited by Orteronel?,"In summary, orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity, suggesting that orteronel might be effective for hormone-dependent breast cancers and estrogen-dependent diseases",0
1198,41,Which enzyme is inhibited by Orteronel?,"Hence, some molecules target the androgen biosynthesis, as abiraterone acetate and orteronel, which are selective inhibitors of the enzyme CYP17",0
1198,42,Which enzyme is inhibited by Orteronel?,"Orteronel (TAK-700) is an investigational, oral, nonsteroidal, selective, reversible inhibitor of 17,20-lyase, a key enzyme in the production of androgenic hormones.",0
3592,0,Which receptor is inhibited by Teprotumumab?,"A recently completed therapeutic trial of teprotumumab, a human IGF1R inhibiting antibody, in patients with moderate to severe, active TAO, indicates the potential effectiveness and safety of the drug.",0
3592,1,Which receptor is inhibited by Teprotumumab?,"Results from a very recently published clinical trial assessing the safety and efficacy of teprotumumab, an inhibitory human anti-IGF-IR monoclonal antibody, in active, moderate to severe TAO are extremely encouraging.",0
3592,2,Which receptor is inhibited by Teprotumumab?,The induction in fibrocytes is a consequence of increased TNF-α gene promoter activity and is independent of ongoing protein synthesis.,0
3592,3,Which receptor is inhibited by Teprotumumab?,"It could be attenuated by dexamethasone and the IGF-1 receptor inhibiting antibody, teprotumumab.",0
3592,4,Which receptor is inhibited by Teprotumumab?,"These observations served as the rationale for implementing a recently completed therapeutic trial of teprotumumab, a monoclonal inhibitory antibody targeting IGF-IR in TAO.",1
3592,5,Which receptor is inhibited by Teprotumumab?,Results of randomised controlled trials investigating the efficacy of the IGF-1 receptor antibody teprotumumab and the interleukin-6 receptor antibody tocilizumab are expected shortly.,0
3592,6,Which receptor is inhibited by Teprotumumab?,"Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy.",0
3592,7,Which receptor is inhibited by Teprotumumab?,"METHODS: We conducted a multicenter, double-masked, randomized, placebo-controlled trial to determine the efficacy and safety of teprotumumab, a human monoclonal antibody inhibitor of IGF-IR, in patients with active, moderate-to-severe ophthalmopathy.",0
3592,8,Which receptor is inhibited by Teprotumumab?,"TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.",0
3592,9,Which receptor is inhibited by Teprotumumab?,Teprotumumab (TMB) is a human monoclonal IGF-1R blocking antibody currently in clinical trial for GO and inhibits TSHR-mediated actions in FCs.,1
3592,10,Which receptor is inhibited by Teprotumumab?,CONCLUSIONS Teprotumumab attenuates the actions of both IGF-1 and TSH in fibrocytes.,0
3592,11,Which receptor is inhibited by Teprotumumab?,"Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.",1
3592,12,Which receptor is inhibited by Teprotumumab?,DESIGN Fibrocytes were treated without or with teprotumumab in combination with IGF-1 or TSH.,0
3592,13,Which receptor is inhibited by Teprotumumab?,"Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis.",0
3592,14,Which receptor is inhibited by Teprotumumab?,"TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab , an IGF-1R Antagonist",0
3592,15,Which receptor is inhibited by Teprotumumab?,Teprotumumab ( TMB ) is a human monoclonal IGF-1R blocking antibody currently in clinical trial for GO and inhibits TSHR-mediated actions in FCs,1
3592,16,Which receptor is inhibited by Teprotumumab?,Teprotumumab (TMB) is a human monoclonal IGF-1R blocking antibody currently in clinical trial for GO and inhibits TSHR-mediated actions in FCs.,1
3592,17,Which receptor is inhibited by Teprotumumab?,"Teprotumumab, a monoclonal IGF-1R antagonist, has demonstrated previously in a 24 week, randomized, controlled trial to produce significant changes in composite outcomes of proptosis and clinical activity score as compared with placebo.",0
3592,18,Which receptor is inhibited by Teprotumumab?,"METHODS
We conducted a multicenter, double-masked, randomized, placebo-controlled trial to determine the efficacy and safety of teprotumumab, a human monoclonal antibody inhibitor of IGF-IR, in patients with active, moderate-to-severe ophthalmopathy.",0
3592,19,Which receptor is inhibited by Teprotumumab?,"Teprotumumab (RV 001, R1507) is a human monoclonal anti-IGF-1R blocking antibody currently undergoing a phase 2 clinical trial in patients with active TAO.",0
3592,20,Which receptor is inhibited by Teprotumumab?,The most promising results are observed with small thyroid stimulating hormone receptor molecules interacting with the receptor on thyrocytes and fibroblasts and with the anti-IGF-1 receptor antibody teprotumumab.,0
3592,21,Which receptor is inhibited by Teprotumumab?,"The induction could be attenuated by dexamethasone and by IGF-I receptor-blocking antibodies, teprotumumab and 1H7.",0
3592,22,Which receptor is inhibited by Teprotumumab?,"Teprotumumab (RV 001, R1507) is a human monoclonal anti-IGF-1R blocking antibody currently undergoing a phase 2 clinical trial in patients with active TAO.",0
3592,23,Which receptor is inhibited by Teprotumumab?,The most promising results are observed with small thyroid stimulating hormone receptor molecules interacting with the receptor on thyrocytes and fibroblasts and with the anti-IGF-1 receptor antibody teprotumumab.,0
3592,24,Which receptor is inhibited by Teprotumumab?,"Teprotumumab, a monoclonal IGF-1R antagonist, has demonstrated previously in a 24 week, randomized, controlled trial to produce significant changes in composite outcomes of proptosis and clinical activity score as compared with placebo.",0
516,0,Is there an association between TERT promoter mutation and survival of glioma patients?,Mutations lead to TERT upregulation and are associated with aggressive clinical behavior in glioblastomas.,0
516,1,Is there an association between TERT promoter mutation and survival of glioma patients?,"Kaplan-Meier's survival analysis showed that TERT promoter mutation (P=0.037), Isocitrate dehydrogenase (IDH) mutation (P<0.001), and 1p/19q codeletion (P<0.001) were associated with favorable overall survival (OS).",0
516,2,Is there an association between TERT promoter mutation and survival of glioma patients?,"In the subset of 116 IDH-mutated lower-grade gliomas lacking 1p/19q codeletion, 19 TERT promoter-mutated tumors exhibited longer progression-free survival (PFS) (P=0.027) and OS (P=0.004).",0
516,3,Is there an association between TERT promoter mutation and survival of glioma patients?,"Consistent with this observation, in the subset of 97 IDH-mutated astrocytomas, 14 TERT promoter-mutated tumors showed longer PFS (P=0.001) and OS (P=0.001).",0
516,4,Is there an association between TERT promoter mutation and survival of glioma patients?,"In contrast, among the subset of 74 IDH wild-type lower-grade gliomas with intact 1p/19q, TERT promoter mutation was associated with shorter PFS (P=0.001) and OS (P=0.001).",1
516,5,Is there an association between TERT promoter mutation and survival of glioma patients?,"Similarly, in the subset of 65 IDH wild-type astrocytomas, 16 TERT promoter-mutated tumors exhibited unfavorable PFS (P=0.007) and OS (P=0.008).",0
516,6,Is there an association between TERT promoter mutation and survival of glioma patients?,"Our results indicate that when combined with IDH status, TERT promoter mutation contributes to prognostic subgroups of lower-grade astrocytic tumors or 1p/19q intact lower-grade gliomas and this may further refine future molecular classification of lower-grade gliomas.",0
516,7,Is there an association between TERT promoter mutation and survival of glioma patients?,RESULTS: TERTp-mut identified in 60.8% of gliomas (491 out of 807) was globally associated with poorer outcome (Hazard ratio (HR)=1.50).,0
516,8,Is there an association between TERT promoter mutation and survival of glioma patients?,TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas.,0
516,9,Is there an association between TERT promoter mutation and survival of glioma patients?,"Patients with TERT promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of mutation was correlated with patient age.",1
516,10,Is there an association between TERT promoter mutation and survival of glioma patients?,"TERT promoter mutations maintained its ability of inducing high transcriptional activity even under hypoxic and TMZ treatment conditions, and the presence of mutations was associated with poor prognosis in glioma patients.",1
516,11,Is there an association between TERT promoter mutation and survival of glioma patients?,Patients whose Grade III-IV gliomas exhibit TERT promoter mutations alone predominately have primary GBMs associated with poor median OS (11.5 months).,0
516,12,Is there an association between TERT promoter mutation and survival of glioma patients?,Patients whose Grade III-IV gliomas exhibit IDH1/2 mutations alone predominately have astrocytic morphologies and exhibit a median OS of 57 months while patients whose tumors exhibit both TERT promoter and IDH1/2 mutations predominately exhibit oligodendroglial morphologies and exhibit median OS of 125 months.,0
516,13,Is there an association between TERT promoter mutation and survival of glioma patients?,"Patients with TERT promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of mutation was correlated with patient age.CONCLUSION: TERT promoter mutations were specific to gliomas.",0
516,14,Is there an association between TERT promoter mutation and survival of glioma patients?,"We defined, based on TERTp-mut and IDH mutation status, four prognostic groups: (1) TERTp-mut and IDH-mut associated with 1p19q codeletion, overall survival (OS)>17 years; (2) TERTp-wt and IDH-mut, associated with TP53 mutation, OS=97.5 months; (3) TERTp-wt and IDH-wt, with no specific association, OS=31.6 months; (4) TERTp-mut and IDH-wt, associated with EGFR amplification, OS=15.4 months.",0
516,15,Is there an association between TERT promoter mutation and survival of glioma patients?,Mutations lead to TERT upregulation and are associated with aggressive clinical behavior in glioblastomas.,0
516,16,Is there an association between TERT promoter mutation and survival of glioma patients?,"In the subset of 116 IDH-mutated lower-grade gliomas lacking 1p/19q codeletion, 19 TERT promoter-mutated tumors exhibited longer progression-free survival (PFS) (P=0.027) and OS (P=0.004).",0
516,17,Is there an association between TERT promoter mutation and survival of glioma patients?,The mean age at diagnosis was lowest (37 years) among patients who had gliomas with only IDH mutations and was highest (59 years) among patients who had gliomas with only TERT mutations.,0
516,18,Is there an association between TERT promoter mutation and survival of glioma patients?,The molecular groups were independently associated with overall survival among patients with grade II or III gliomas but not among patients with grade IV gliomas.,1
516,19,Is there an association between TERT promoter mutation and survival of glioma patients?,"Mutations were detected in gliomas, but not in meningiomas, pituitary adenomas, cavernomas, intracranial metastases, normal brain tissues, or peripheral blood of glioma patients.",0
516,20,Is there an association between TERT promoter mutation and survival of glioma patients?,"Patients with TERT promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of mutation was correlated with patient age.",1
2897,0,Is lucatumumab a polyclonal antibody?,"A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.",1
2897,1,Is lucatumumab a polyclonal antibody?,"In this open-label, multicentre, phase 1 study a fully human anti-CD40 antagonist monoclonal antibody, lucatumumab, was evaluated in patients with relapsed/refractory multiple myeloma (MM).",1
1692,0,How is mTORC1 involved in the regulation of heat stress?,PI3K-mTORC1 attenuates stress response by inhibiting cap-independent Hsp70 translation,1
1692,1,How is mTORC1 involved in the regulation of heat stress?,stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling,1
1692,2,How is mTORC1 involved in the regulation of heat stress?,"Conversely, Hsp70 synthesis is enhanced under the reduced PI3K-mTORC1 signaling",1
1692,3,How is mTORC1 involved in the regulation of heat stress?,Our findings imply a plausible mechanism for how persistent PI3K-mTORC1 signaling favors the development of age-related pathologies by attenuating stress resistance,0
1692,4,How is mTORC1 involved in the regulation of heat stress?,One prominent example is the selective translation of heat shock proteins (Hsps) under stress conditions.,0
1692,5,How is mTORC1 involved in the regulation of heat stress?,"Although the transcriptional regulation of Hsp genes has been well established, neither the specific translation-promoting features nor the regulatory mechanism of the translation machinery have been clearly defined.",0
1692,6,How is mTORC1 involved in the regulation of heat stress?,Here we show that the stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling.,1
1692,7,How is mTORC1 involved in the regulation of heat stress?,PI3K-mTORC1 attenuates stress response by inhibiting cap-independent Hsp70 translation.,1
2600,0,What are pQTLs?,A genome-wide association study identifies protein quantitative trait loci (pQTLs).,1
2600,1,What are pQTLs?,The identification of protein quantitative trait loci (pQTLs) may be a powerful complementary method of improving our understanding of disease pathways.,1
2600,2,What are pQTLs?," Yet the impact of genetic variation, including eQTLs, on protein levels remains poorly understood.",0
2600,3,What are pQTLs?,"To address this, we mapped genetic variants that are associated with eQTLs, ribosome occupancy (rQTLs), or protein abundance (pQTLs).",0
2600,4,What are pQTLs?,"We found that most QTLs are associated with transcript expression levels, with consequent effects on ribosome and protein levels.",0
2600,5,What are pQTLs?,"By studying the genetic variation affecting gene expression levels (cis expression quantitative trait loci [cis-eQTLs]) and protein levels (cis protein QTLs [cis-pQTLs]), we determined that young, primate-specific genes are enriched in cis-eQTLs and cis-pQTLs.",1
2600,6,What are pQTLs?," Quantitative trait locus (QTL) analysis identified seven genomic loci influencing fibrosis phenotypes (pQTLs) with genome-wide significance on chromosomes 4, 5, 7, 12, and 17.",0
2600,7,What are pQTLs?,We observed enrichment of protein quantitative trait loci (pQTLs) for cellular sensitivity to two commonly used chemotherapeutics: cisplatin and paclitaxel.,1
2600,8,What are pQTLs?," Here, we assayed the abundance levels of proteins in plasma from 96 elderly Europeans using a new aptamer-based proteomic technology and performed genome-wide local (cis-) regulatory association analysis to identify protein quantitative trait loci (pQTL).",1
2600,9,What are pQTLs?,we describe a proteomic quantitative trait locus (pQTL) study of plasma proteome screens in an F(2) intercross of 455 mice mapped with 177 genetic markers across the genome.,0
2111,0,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia,0
2111,1,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype.,1
2111,2,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,Another interesting finding is that high ratios of TOP2B/RRM2 and TOP2B/TOP2 alpha (TOP2A) in a combined analysis were also shown to have a prognostic impact for longer survival with improved accuracy.,0
2111,3,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,"Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (HR, 0.24; P=0.002) and overall survival (HR, 0.29; P=0.005)",1
2111,4,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.,0
2111,5,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,"Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (HR, 0.24; P=0.002) and overall survival (HR, 0.29; P=0.005).Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype",1
2111,6,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,CONCLUSION: Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype.,0
2111,7,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype..,1
2111,8,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.,0
2111,9,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,"Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (HR, 0.24; P=0.002) and overall survival (HR, 0.29; P=0.005).",1
2111,10,Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?,Another interesting finding is that high ratios of TOP2B/RRM2 and TOP2B/TOP2 alpha (TOP2A) in a combined analysis were also shown to have a prognostic impact for longer survival with improved accuracy.,0
2371,0,What does the human IVIG treatment for Alzheimer's disease contain?,Human intravenous immunoglobulin (IVIG) is a mixture of polyclonal IgG antibodies isolated and pooled from thousands of healthy human donors.,1
123,0,Which genes have been associated with Cerebral Cavernous Malformation?,Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene,0
123,1,Which genes have been associated with Cerebral Cavernous Malformation?,we outline a consistent association between PDCD10 mutations and a syndrome of CCMs with multiple meningiomas,0
123,2,Which genes have been associated with Cerebral Cavernous Malformation?,"Cerebral cavernous malformation (CCM) is a disease of vascular malformations known to be caused by mutations in one of three genes: CCM1, CCM2 or CCM3",0
123,3,Which genes have been associated with Cerebral Cavernous Malformation?,"To study the molecular genetic and clinical features of cerebral cavernous malformations (CCM) in a cohort of Spanish patients.METHODS: We analyzed the CCM1, CCM2, and CCM3 genes",0
123,4,Which genes have been associated with Cerebral Cavernous Malformation?,"Loss-of-function mutations in genes encoding KRIT1 (also known as CCM1), CCM2 (also known as OSM and malcavernin) or PDCD10 (also known as CCM3) cause cerebral cavernous malformations (CCMs)",1
123,5,Which genes have been associated with Cerebral Cavernous Malformation?,"Surveying genetic variants and molecular phylogeny of cerebral cavernous malformation gene, CCM3/PDCD10",0
123,6,Which genes have been associated with Cerebral Cavernous Malformation?,"The three cerebral cavernous malformations (CCMs) genes namely CCM1/KRIT1, CCM2/MGC4607 and CCM3/PDCD10 have been identified for which mutations cause cerebral cavernous malformations",0
123,7,Which genes have been associated with Cerebral Cavernous Malformation?,"At least 45% of families affected with cerebral cavernous malformations harbour a mutation in Krev interaction trapped-1 (Krit1) gene (cerebral cavernous malformation gene-1, CCM1).",0
123,8,Which genes have been associated with Cerebral Cavernous Malformation?,"Mutations in Krev1 interaction trapped gene 1 (KRIT1) cause cerebral cavernous malformation, an autosomal dominant disease featuring malformation of cerebral capillaries resulting in cerebral hemorrhage, strokes, and seizures.",0
123,9,Which genes have been associated with Cerebral Cavernous Malformation?,"KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein.",0
123,10,Which genes have been associated with Cerebral Cavernous Malformation?,"Germline mutations in the CCM1 gene, encoding Krit1, cause cerebral cavernous malformations.",1
123,11,Which genes have been associated with Cerebral Cavernous Malformation?,Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.,0
123,12,Which genes have been associated with Cerebral Cavernous Malformation?,Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations.,0
123,13,Which genes have been associated with Cerebral Cavernous Malformation?,These findings document a de novo germline mutation in Kritl gene that causes cerebral cavernous malformations.,0
123,14,Which genes have been associated with Cerebral Cavernous Malformation?,"Cerebral cavernous malformation is a common human vascular disease that arises due to loss-of-function mutations in genes encoding three intracellular adaptor proteins, cerebral cavernous malformations 1 protein (CCM1), CCM2, and CCM3.",1
123,15,Which genes have been associated with Cerebral Cavernous Malformation?,"Cerebral cavernous malformation is a common human vascular disease that arises due to loss-of-function mutations in genes encoding three intracellular adaptor proteins, cerebral cavernous malformations 1 protein (CCM1), CCM2, and CCM3",1
123,16,Which genes have been associated with Cerebral Cavernous Malformation?,Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1).,0
123,17,Which genes have been associated with Cerebral Cavernous Malformation?,Variable expression of cerebral cavernous malformations in carriers of a premature termination codon in exon 17 of the Krit1 gene.,0
123,18,Which genes have been associated with Cerebral Cavernous Malformation?,"Loss-of-function mutations in CCM1/KRIT1, CCM2/MGC4607 and CCM3/PDCD10 genes are identified in the vast majority of familial cases with multiple cerebral cavernous malformations (CCMs).",1
123,19,Which genes have been associated with Cerebral Cavernous Malformation?,Mutations in three genes are associated with CCM.,0
123,20,Which genes have been associated with Cerebral Cavernous Malformation?,"These genes encode for the proteins KRIT1/CCM1 (krev interaction trapped 1/cerebral cavernous malformations 1), cerebral cavernous malformations 2, osmosensing scaffold for MEKK3 (CCM2/malcavernin/OSM), and cerebral cavernous malformations 3/programmed cell death 10 (CCM3/PDCD10).",0
123,21,Which genes have been associated with Cerebral Cavernous Malformation?,"At least 45% of families affected with cerebral cavernous malformations harbour a mutation in Krev interaction trapped-1 (Krit1) gene (cerebral cavernous malformation gene-1,",0
123,22,Which genes have been associated with Cerebral Cavernous Malformation?,Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.,0
123,23,Which genes have been associated with Cerebral Cavernous Malformation?,A novel CCM1 mutation associated with multiple cerebral and vertebral cavernous malformations.,0
123,24,Which genes have been associated with Cerebral Cavernous Malformation?,"These genes encode for the proteins KRIT1/CCM1 (krev interaction trapped 1/cerebral cavernous malformations 1), cerebral cavernous malformations 2, osmosensing scaffold for MEKK3 (CCM2/malcavernin/OSM), and cerebral cavernous malformations 3/programmed cell death 10 (CCM3/PDCD10).",0
123,25,Which genes have been associated with Cerebral Cavernous Malformation?,"CCM1 is caused by a mutation in the KRIT1 gene and CCM2 is caused by a mutation in the MGC4607 gene, while the gene for CCM3 is not yet identified.",0
123,26,Which genes have been associated with Cerebral Cavernous Malformation?,Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1).,0
123,27,Which genes have been associated with Cerebral Cavernous Malformation?,"At least 45% of families affected with cerebral cavernous malformations harbour a mutation in Krev interaction trapped-1 (Krit1) gene (cerebral cavernous malformation gene-1, CCM1).",0
123,28,Which genes have been associated with Cerebral Cavernous Malformation?,"KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein.",0
433,0,List symptoms of Meigs' Syndrome.,Meigs' syndrome is a benign ovarian tumor associated with ascites and pleural effusion.,1
433,1,List symptoms of Meigs' Syndrome.,"Although postmenopausal women with ovarian tumor, ascites, pleural effusion, and elevation of CA-125 levels probably have malignant ovarian tumors, Meigs' syndrome must be considered in the differential diagnosis.",1
433,2,List symptoms of Meigs' Syndrome.,"BACKGROUND: The Demons-Meigs syndrome should usually be evoked in case of presence of a typical triad: abdominopelvic mass, ascites and hydrothorax.",0
433,3,List symptoms of Meigs' Syndrome.,"CONCLUSION: Meigs' syndrome should be considered at the differential diagnosis for a patient with pelvic mass, pleural effusion and ascites with normal cytology, increased CA125 levels.",0
433,4,List symptoms of Meigs' Syndrome.,"BACKGROUND: The Meigs' syndrome is a rare but well-known syndrome defined as the triad of benign solid ovarian tumor, ascites, and pleural effusion.",1
433,5,List symptoms of Meigs' Syndrome.,"Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome.",1
433,6,List symptoms of Meigs' Syndrome.,When benign ovarian fibroma is associated with ascites and/or pleural effusion it is termed Meigs syndrome.,1
433,7,List symptoms of Meigs' Syndrome.,"Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome",0
3931,0,Is cadherin a plasma membrane marker?,the plasma membrane-bound E-cadherin protein,1
3931,1,Is cadherin a plasma membrane marker?,VE-cadherin protein levels were also increased in the plasma membrane fraction.,1
3931,2,Is cadherin a plasma membrane marker?," recycling of VE-cadherin to the plasma membrane,",1
3931,3,Is cadherin a plasma membrane marker?,"E-cadherin, a central component of the adherens junction (AJ), is a single-pass transmembrane protein",1
4204,0,What is the major sequence determinant for nucleosome positioning?,"Many yeast promoter and terminator regions intrinsically disfavor nucleosome formation, and nucleosomes assembled in vitro show strong rotational positioning.",0
4204,1,What is the major sequence determinant for nucleosome positioning?,"Sequence analysis of 284,091 putative nucleosome cores obtained in this manner from a mixed-stage population of C. elegans reveals a combined picture of flexibility and constraint in nucleosome positioning",0
4204,2,What is the major sequence determinant for nucleosome positioning?,Nucleosome positioning influences the overall rate of sequence evolution.,1
4204,3,What is the major sequence determinant for nucleosome positioning?,"However, its impacts on specific patterns of sequence evolution are still poorly understood.",0
4204,4,What is the major sequence determinant for nucleosome positioning?,his strongly affects nucleosome positioning data and especially sequence-dependent models for nucleosome positioning.,0
4204,5,What is the major sequence determinant for nucleosome positioning?,"e argue that, in budding yeast, while DNA sequence-specified nucleosome positioning may contribute to positions flanking the regions lacking nucleosomes, DNA thermodynamic stability is a major component determinant of the genetic organization of this organism.",1
4204,6,What is the major sequence determinant for nucleosome positioning?,DNA sequence preferences are associated with heterogeneous chromatin organization around transcription start sites.,0
4204,7,What is the major sequence determinant for nucleosome positioning?,"This paper rigorously quantifies the contribution of hitherto-debated sequence features-including G+C content, 10.5 bp periodicity, and poly(dA:dT) tracts-to three distinct aspects of genome-wide nucleosome landscape: occupancy, translational positioning and rotational positioning.",1
4204,8,What is the major sequence determinant for nucleosome positioning?,We further show that the 10.5 bp nucleotide periodicity facilitates rotational but not translational positioning.,0
4204,9,What is the major sequence determinant for nucleosome positioning?,"We find that although G+C content is the primary determinant of MNase-derived nucleosome occupancy, MNase digestion biases may substantially influence this GC dependence.",1
4204,10,What is the major sequence determinant for nucleosome positioning?,"By contrast, poly(dA:dT) tracts are seen to deter nucleosome formation, regardless of the experimental method used",1
4204,11,What is the major sequence determinant for nucleosome positioning?,"we consider the anisotropic flexibility of pyrimidine-purine (YR) dimeric steps in the context of their neighbors (e.g., YYRR versus RYRY); (iii) we postulate that alternating AT-rich and GC-rich motifs reflect sequence-dependent interactions between histone arginines and DNA in the minor groove.",0
759,0,"In which kingdom do microsporidia belong, according to their current classification scheme?","Microsporidia are a diverse group of obligate, intracellular, eukaryotic, spore-forming parasites.",1
759,1,"In which kingdom do microsporidia belong, according to their current classification scheme?","Traditionally, these were considered as protozoans but recently have been reclassified as fungi.",1
759,2,"In which kingdom do microsporidia belong, according to their current classification scheme?",Microsporidia are ubiquitous fungi with genomes that have undergone a strong reduction,1
759,3,"In which kingdom do microsporidia belong, according to their current classification scheme?",Microsporidia are unicellular fungi that are obligate endoparasites.,0
759,4,"In which kingdom do microsporidia belong, according to their current classification scheme?",Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.,1
759,5,"In which kingdom do microsporidia belong, according to their current classification scheme?",A combined analysis of thousands of gene trees supports a topology in which microsporidia is a sister group to all other sequenced fungi.,0
759,6,"In which kingdom do microsporidia belong, according to their current classification scheme?","Altogether, our data strongly support a scenario in which microsporidia is the earliest-diverging clade of sequenced fungi.",0
759,7,"In which kingdom do microsporidia belong, according to their current classification scheme?",Microsporidia are a large diverse group of intracellular parasites now considered as fungi.,1
759,8,"In which kingdom do microsporidia belong, according to their current classification scheme?",The unique genomic hallmarks between microsporidia and fungi are independent of sequence based phylogenetic comparisons and further contribute to define the borders of the fungal kingdom and support the classification of microsporidia as unusual derived fungi.,0
759,9,"In which kingdom do microsporidia belong, according to their current classification scheme?","The kingdom Fungi is expanded by adding Microsporidia, because of protein sequence evidence that these amitochondrial intracellular parasites are related to conventional Fungi, not Protozoa.",0
759,10,"In which kingdom do microsporidia belong, according to their current classification scheme?","The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.",0
759,11,"In which kingdom do microsporidia belong, according to their current classification scheme?","In a subsequent analysis, we excluded the other Microsporidia from the analysis to look for relationships before the divergence of Microsporidia, and found that 43% of the microsporidial genes scored highest with fungal genes, and a higher mean LPI was found with Fungi than with other kingdoms, suggesting that Microsporidia is closely related to Fungi at the genomic level.",0
759,12,"In which kingdom do microsporidia belong, according to their current classification scheme?",CONCLUSION/SIGNIFICANCE: The unique genomic hallmarks between microsporidia and fungi are independent of sequence based phylogenetic comparisons and further contribute to define the borders of the fungal kingdom and support the classification of microsporidia as unusual derived fungi.,0
759,13,"In which kingdom do microsporidia belong, according to their current classification scheme?",The unique genomic hallmarks between microsporidia and fungi are independent of sequence based phylogenetic comparisons and further contribute to define the borders of the fungal kingdom and support the classification of microsporidia as unusual derived fungi.,0
759,14,"In which kingdom do microsporidia belong, according to their current classification scheme?","The kingdom Fungi is expanded by adding Microsporidia, because of protein sequence evidence that these amitochondrial intracellular parasites are related to conventional Fungi, not Protozoa.",0
759,15,"In which kingdom do microsporidia belong, according to their current classification scheme?",Microorganisms of the microsporidia group are obligated intracellular protozoa that belong to the phylum Microspora; currently they are considered to be related or belong to the fungi reign,0
220,0,Has depression been shown to be a predictor of frailty?,significant role of frailty as a predictor of depression in a relatively younger old Chinese population,1
220,1,Has depression been shown to be a predictor of frailty?,significant relationships between frailty and depressive symptoms and mortality at 1 year,1
220,2,Has depression been shown to be a predictor of frailty?,"These findings suggest that malnutrition is a major predictor of frailty or the ""failure to thrive"" syndrome in older persons.",1
220,3,Has depression been shown to be a predictor of frailty?,Depression is a major cause of poor nutritional status in older persons.,1
220,4,Has depression been shown to be a predictor of frailty?,"Depressed mood was associated with increased risk of steep strength decline, in particular in older men with low body weight.",1
220,5,Has depression been shown to be a predictor of frailty?,Low body weight in combination with depressed mood may be an indicator of frailty or severe disease status that leads to accelerated strength loss and disability.,0
220,6,Has depression been shown to be a predictor of frailty?,"Longitudinally, depressed mood was the only independent predictor of decline in cognition, functional ability, physician-rated health, and mortality;",0
3878,0,Which drugs are included in the VIFUP regimen for breast cancer?,"PATIENTS AND METHODS: Breast cancer patients, clinical stages T2-T3, N0-N2, M0, and Ki-67 labelling index >/= 20%, were treated every 3 weeks with a maximum of six courses of vinorelbine 20 mg total dose intravenously (i.v.)",0
3878,1,Which drugs are included in the VIFUP regimen for breast cancer?,"on days 1 and 3, cisplatin 60 mg/ m(2) i.v.",0
3878,2,Which drugs are included in the VIFUP regimen for breast cancer?,on day 1 and 5-FU 200 mg/m(2)/day as a continuous infusion (ViFuP regimen).,0
3878,3,Which drugs are included in the VIFUP regimen for breast cancer?,METHODS: 25 patients with locally advanced head and neck cancer were treated with 4 cycles of vinorelbine (20 mg i.v.,0
3878,4,Which drugs are included in the VIFUP regimen for breast cancer?,"day 1, 3), cisplatin (60 mg/m(2) i.v.",0
3878,5,Which drugs are included in the VIFUP regimen for breast cancer?,day 1) and 5-fluorouracil (200 mg/m(2) continuous i.v.,0
3878,6,Which drugs are included in the VIFUP regimen for breast cancer?,infusion day 1-21) (ViFuP regimen) followed by bifractionated radiotherapy (bidRT) up to 74.4 Gy in 62 fractions of 1.2 Gy twice daily.,0
3878,7,Which drugs are included in the VIFUP regimen for breast cancer?,"Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study.",1
3878,8,Which drugs are included in the VIFUP regimen for breast cancer?,"We assessed efficacy in terms of response rate and time to progression of a combination with continuous infusion 5-fluorouracil (5-FU), vinorelbine and cisplatin (ViFuP regimen), as a first or subsequent line treatment for metastatic breast cancer patients.",0
3878,9,Which drugs are included in the VIFUP regimen for breast cancer?,"The feasibility and efficacy of a regimen containing vinorelbine (V), cisplatin (P) and 5-fluorouracil (5-Fu) as continuous infusion (ViFuP regimen) for patients with locally advanced breast cancer were evaluated.",1
3878,10,Which drugs are included in the VIFUP regimen for breast cancer?,"Patients with large operable (cT2-T3, N0-2, M0), ER > or =10% breast cancer were treated in two consecutive studies with preoperative chemotherapy (Study I: six courses of either fluorouracil, leucovorin, vinorelbine (FLN), or vinorelbine, cisplatin, and continuous infusion of fluorouracil (ViFuP), at the discretion of the treating physician; Study II: capecitabine and oral vinorelbine (CAVINO)).",1
3878,11,Which drugs are included in the VIFUP regimen for breast cancer?,"The feasibility and efficacy of a regimen containing vinorelbine (V), cisplatin (P) and 5-fluorouracil (5-Fu) as continuous infusion (ViFuP regimen) for patients with locally advanced breast cancer were evaluated.",1
3878,12,Which drugs are included in the VIFUP regimen for breast cancer?,"Patients with large operable (cT2-T3, N0-2, M0), ER > or =10% breast cancer were treated in two consecutive studies with preoperative chemotherapy (Study I: six courses of either fluorouracil, leucovorin, vinorelbine (FLN), or vinorelbine, cisplatin, and continuous infusion of fluorouracil (ViFuP), at the discretion of the treating physician; Study II: capecitabine and oral vinorelbine (CAVINO)).",0
3878,13,Which drugs are included in the VIFUP regimen for breast cancer?,"e feasibility and efficacy of a regimen containing vinorelbine (V), cisplatin (P) and 5-fluorouracil (5-Fu) as continuous infusion (ViFuP regimen) for patients with locally advanced breast cancer were evaluated.",1
3878,14,Which drugs are included in the VIFUP regimen for breast cancer?,Twenty-s,0
3878,15,Which drugs are included in the VIFUP regimen for breast cancer?,"We assessed efficacy in terms of response rate and time to progression of a combination with continuous infusion 5-fluorouracil (5-FU), vinorelbine and cisplatin (ViFuP regimen), as a first or subsequent line treatment for metastatic breast cancer patients.P",0
3878,16,Which drugs are included in the VIFUP regimen for breast cancer?,uitable.,0
3878,17,Which drugs are included in the VIFUP regimen for breast cancer?,"We assessed efficacy in terms of response rate and time to progression of a combination with continuous infusion 5-fluorouracil (5-FU), vinorelbine and cisplatin (ViFuP regimen), as a first or subsequent line treatment for metastatic breast cancer patients.PATIENTS AND METHODS: One hundred consecutive patients with advanced breast cancer were treated with 5-FU 200 mg/m2 administered continuously through a permanent central venous line; vinorelbine was given on days 1 and 3 at a dose of 20 mg and cisplatin was admin",0
3857,0,Which interleukin receptors are targeted with rilonacept?,"Rilonacept, a soluble IL-1 receptor chimeric fusion protein neutralizing IL-1α and IL-1β, has also shown promising results in a phase II study in recurrent/refractory pericarditis.",1
3857,1,Which interleukin receptors are targeted with rilonacept?,"These agents have slightly different pharmacological properties, being canakinumab a specific IL-1ß antagonist while anakinra and rilonacept are unselective IL-1α and IL-1ß blockers.",1
3857,2,Which interleukin receptors are targeted with rilonacept?,"They include agents that act against TNFα (etanercept, infliximab, adalimumab, golimumab, and certolizumab pegol), IL-6 receptor (tocilizumab and sarilumab), IL-1 (anakinra, canakinumab, and rilonacept), IL-17 (secukinumab and ixekizumab) and IL12/23 (ustekinumab).",0
3857,3,Which interleukin receptors are targeted with rilonacept?,"The efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β cytokine trap, were studied previously in a phase 2 trial involving patients with recurrent pericarditis.",1
3857,4,Which interleukin receptors are targeted with rilonacept?,Rilonacept inhibits both interleukin-1 alpha (IL-1α) and IL-1β; these cytokines are thought to play a major role in RP.,1
3857,5,Which interleukin receptors are targeted with rilonacept?,Rilonacept is a soluble decoy receptor that neutralizes primarily IL-1β but also IL-1α.,1
168,0,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,"Humans lack a functional cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) protein and cannot synthesize the sugar Neu5Gc, an innate mammalian signal of self",1
168,1,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,N-glycolylneuraminic acid (Neu5Gc) is an immunogenic sugar of dietary origin that metabolically incorporates into diverse native glycoconjugates in humans.,1
168,2,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,"N-Glycolylneuraminic acid (Neu5Gc) is a sialic acid synthesized by animals, but not by humans or birds.",0
168,3,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,"However, it can be incorporated in human cells and can trigger immune response.",1
168,4,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,Human heterophile antibodies that agglutinate animal erythrocytes are known to detect the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc).,0
168,5,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?, the human anti-Neu5Gc antibody response is diverse and polyclonal.,1
168,6,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,"As dietary Neu5Gc is primarily found in red meat and milk products, we suggest that this ongoing antigen-antibody reaction may generate chronic inflammation, possibly contributing to the high frequency of diet-related carcinomas and other diseases in humans.",1
168,7,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,These data suggest that anti-Neu5Gc Abs represent a barrier for long-term acceptance of porcine xenografts.,0
168,8,What is the function of Neu5Gc (N-Glycolylneuraminic acid)?,"Because anti-Neu5Gc Abs can promote chronic inflammation, the long-term safety of living and acellular pig tissue implants in recipients warrants further evaluation.",0
3783,0,List human antibody isotypes.,"production of human antibody isotypes including immunoglobulin M (IgM), IgG1, IgG2, IgG3 and IgG4",1
3783,1,List human antibody isotypes.,Human immunoglobulin D (IgD) occurs most abundantly as a membrane-bound antibody on the surface of mature B cells (mIgD).,1
3783,2,List human antibody isotypes.,"antibody isotypes [immunoglobulin (Ig)A, IgE, IgG and IgM]",1
3783,3,List human antibody isotypes.,"Hybridomas generated by electrofusion produced IgG (48%), IgM (34%) and IgA (18%) antibody isotypes",1
3783,4,List human antibody isotypes.,"The antibodies investigated [IgA, IgM, total IgG (all subclasses measured together)",1
514,0,What is the main characteristic of Amyotrophic Lateral Sclerosis?,"Motor neuron diseases (MND), such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), are progressive neurodegenerative diseases that share the common characteristic of upper and/or lower motor neuron degeneration.",1
514,1,What is the main characteristic of Amyotrophic Lateral Sclerosis?,Amyotrophic lateral sclerosis (ALS) is a progressive degeneration of upper and lower motor neurons.,1
514,2,What is the main characteristic of Amyotrophic Lateral Sclerosis?,There are four main hypotheses about the cause of ALS: excitotoxicity linked to glutamate receptor overactivation; mutation of the superoxide dismutase gene; production of autoantibodies to calcium channels; neurofilament accumulation.,1
514,3,What is the main characteristic of Amyotrophic Lateral Sclerosis?,The motoneuron degeneration characteristic of ALS could be caused by any one or a combination of these mechanisms.,1
514,4,What is the main characteristic of Amyotrophic Lateral Sclerosis?,Amyotrophic lateral sclerosis is the most common adult-onset motor neuron disease and evidence from mice expressing amyotrophic lateral sclerosis-causing SOD1 mutations suggest that neurodegeneration is a non-cell autonomous process where microglial cells influence disease progression,1
1568,0,Which deficiency is the cause of restless leg syndrome,Homozygosity for the T-allele of BTBD9 rs9296249 was associated with lower serum ferritin,0
1568,1,Which deficiency is the cause of restless leg syndrome,"This polymorphism has previously been associated with RLS, but not low iron stores in blood donors.",0
1568,2,Which deficiency is the cause of restless leg syndrome,Iron deficiency is a common cause of anemia in patients with end stage renal disease (ESRD).,1
1568,3,Which deficiency is the cause of restless leg syndrome,"Intravenous iron administration, especially in those requiring treatment with erythropoiesis stimulating agents (ESA) is an essential component of the management of anemia in ESRD patients.",0
1568,4,Which deficiency is the cause of restless leg syndrome,"Iron improves hemoglobin, reduces ESA dose requirement and also has nonerythropoietic effects including improvement in physical performance, cognition and amelioration of restless leg syndrome.",0
1568,5,Which deficiency is the cause of restless leg syndrome,The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome.,1
1568,6,Which deficiency is the cause of restless leg syndrome,RLS subjects had significantly lower DAT binding in the striatum compared to controls on both the Day and the Night scans.,0
1568,7,Which deficiency is the cause of restless leg syndrome,Secondary RLS is a complication of PD.,0
1568,8,Which deficiency is the cause of restless leg syndrome,Deficiency of iron and decreased inhibition function of spinal cord may lead to the occurrence of RLS in PD patients.,0
1568,9,Which deficiency is the cause of restless leg syndrome,"Association of iron deficiency with febrile seizures, pica, breath holding spells, restless leg syndrome and thrombosis is increasingly being recognized",0
1568,10,Which deficiency is the cause of restless leg syndrome,Iron depletion is common in regular blood donors.,0
1568,11,Which deficiency is the cause of restless leg syndrome,"The objective of the study was to investigate the frequency and severity of iron depletion in regular blood donors and whether IV iron is more effective than oral to avoid iron depletion and symptoms thereof, especially restless legs syndrome (RLS).",0
1568,12,Which deficiency is the cause of restless leg syndrome,"Iron status is poor in regular blood donors, restless legs syndrome is common,",1
1568,13,Which deficiency is the cause of restless leg syndrome,"Furthermore, there appears to be an association between iron deficiency and those suffering from Restless Leg Syndrome (RLS).",0
1568,14,Which deficiency is the cause of restless leg syndrome,"Clinical studies have implicated the dopaminergic system in RLS, while others have suggested that it is associated with insufficient levels of brain iron",0
1568,15,Which deficiency is the cause of restless leg syndrome," Iron deficiency is associated with paediatric sleep disturbances; in particular, restless leg syndrome (RLS)",0
1568,16,Which deficiency is the cause of restless leg syndrome,Here we described seven pediatric RLS patients.,0
1568,17,Which deficiency is the cause of restless leg syndrome,"All of the parents of our patients had difficult times to make their children sleep due to irritability, restlessness, and demanding bedtime routines.",0
1568,18,Which deficiency is the cause of restless leg syndrome,"All patients had asked their parents to rub their feet in bed, and it took more than half an hour to soothe them until they fell asleep.",0
1568,19,Which deficiency is the cause of restless leg syndrome,Their mothers had been exhausted from this night-time routine.,0
1568,20,Which deficiency is the cause of restless leg syndrome,"However, they did not consider the routine abnormal, as it had been their habitual behavior since infancy.",0
1568,21,Which deficiency is the cause of restless leg syndrome,Some parents were too distressed or embarrassed to describe the symptoms of their child properly.,0
1568,22,Which deficiency is the cause of restless leg syndrome,Five patients had clear family history and none had obvious periodic leg movements during sleep.,0
1568,23,Which deficiency is the cause of restless leg syndrome,All patients showed low levels of ferritin and iron supplementation was effective in five cases.,0
1568,24,Which deficiency is the cause of restless leg syndrome,"RLS may also be secondary to a number of conditions including iron deficiency, pregnancy and end-stage renal failure and, perhaps, neuropathy.",0
1568,25,Which deficiency is the cause of restless leg syndrome,The pathogenesis of RLS probably involves the interplay of systemic or brain iron deficiency and impaired dopaminergic neurotransmission in the subcortex of the brain.,1
1568,26,Which deficiency is the cause of restless leg syndrome,Restless leg syndrome manifested by iron deficiency from chronic hemoptysis in cystic fibrosis.,0
1568,27,Which deficiency is the cause of restless leg syndrome,Restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are considered to be a continuum of a neurological sleep disorder associated with abnormal iron metabolism or deficiency.,0
1568,28,Which deficiency is the cause of restless leg syndrome,I describe a case of RLS and PLMD in a cystic fibrosis patient with iron deficiency from chronic hemoptysis.,0
1568,29,Which deficiency is the cause of restless leg syndrome,"Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology of the restless leg syndrome.",1
1568,30,Which deficiency is the cause of restless leg syndrome,"The syndrome is increasingly often diagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy.",0
1568,31,Which deficiency is the cause of restless leg syndrome,"Clinical, EEG, electromyographic and polysomnographic studies in restless legs syndrome caused by magnesium deficiency.",0
1450,0,Does the 3D structure of  the genome remain stable during cell differentiation?,"We identify large, megabase-sized local chromatin interaction domains, which we term 'topological domains', as a pervasive structural feature of the genome organization.",1
1450,1,Does the 3D structure of  the genome remain stable during cell differentiation?,"The domains are stable across different cell types and highly conserved across species, indicating that topological domains are an inherent property of mammalian genomes",0
1450,2,Does the 3D structure of  the genome remain stable during cell differentiation?,Insulators are involved in 3D genome organization at multiple spatial scales and are important for dynamic reorganization of chromatin structure during reprogramming and differentiation.,1
1450,3,Does the 3D structure of  the genome remain stable during cell differentiation?,The relation between alterations in chromatin structure and changes in gene expression during cell differentiation has served as a paradigm to understand the link between genome organization and function.,1
1450,4,Does the 3D structure of  the genome remain stable during cell differentiation?,Architectural proteins orchestrate higher-order chromatin organization through the establishment of interactions between regulatory elements across multiple spatial scales.,0
1450,5,Does the 3D structure of  the genome remain stable during cell differentiation?,"The regulation of these proteins, their interaction with DNA, and their co-occurrence in the genome, may be responsible for the plasticity of 3D chromatin architecture that dictates cell and time-specific blueprints of gene expression.",1
1450,6,Does the 3D structure of  the genome remain stable during cell differentiation?,The role of 3D genome organisation in the control and execution of lineage-specific transcription programmes during the development and differentiation of multipotent stem cells into specialised cell types remains poorly understood.,0
1450,7,Does the 3D structure of  the genome remain stable during cell differentiation?,"Chromatin structural states and their remodelling, including higher-order chromatin folding and three-dimensional (3D) genome organisation, play an important role in the control of gene expression",0
1450,8,Does the 3D structure of  the genome remain stable during cell differentiation?,"Here, we show that substantial remodelling of the higher-order chromatin structure of the epidermal differentiation complex (EDC), a keratinocyte lineage-specific gene locus on mouse chromosome 3, occurs during epidermal morphogenesis.",0
1450,9,Does the 3D structure of  the genome remain stable during cell differentiation?,"Many studies have suggested a link between the spatial organization of genomes and fundamental biological processes such as genome reprogramming, gene expression, and differentiation.",1
1450,10,Does the 3D structure of  the genome remain stable during cell differentiation?,"Moreover, we reveal that formation of such highly condensed, transcriptionally repressed heterochromatin promotes transcriptional activation of differentiation genes and loss of pluripotency.",0
1450,11,Does the 3D structure of  the genome remain stable during cell differentiation?,The open chromatin of embryonic stem cells (ESCs) condenses into repressive heterochromatin as cells exit the pluripotent state.,0
1450,12,Does the 3D structure of  the genome remain stable during cell differentiation?,we find that localized heterochromatin condensation of ribosomal RNA genes initiates establishment of highly condensed chromatin structures outside of the nucleolus,0
1450,13,Does the 3D structure of  the genome remain stable during cell differentiation?,"We focus on the emerging relationship between genome organization and lineage-specific transcriptional regulation, which we argue are inextricably linked.",0
1450,14,Does the 3D structure of  the genome remain stable during cell differentiation?,Cells face the challenge of storing two meters of DNA in the three-dimensional (3D) space of the nucleus that spans only a few microns.,0
1450,15,Does the 3D structure of  the genome remain stable during cell differentiation?,"The nuclear organization that is required to overcome this challenge must allow for the accessibility of the gene regulatory machinery to the DNA and, in the case of embryonic stem cells (ESCs), for the transcriptional and epigenetic changes that accompany differentiation",0
1450,16,Does the 3D structure of  the genome remain stable during cell differentiation?,"In this review we summarize some of the recent findings illuminating the 3D structure of the eukaryotic genome, as well as the relationship between genome topology and function from the level of whole chromosomes to enhancer-promoter loops with a focus on features affecting genome organization in ESCs and changes in nuclear organization during differentiation",0
1450,17,Does the 3D structure of  the genome remain stable during cell differentiation?,"We observe that although self-associating chromatin domains are stable during differentiation, chromatin interactions both within and between domains change in a striking manner, altering 36% of active and inactive chromosomal compartments throughout the genome",0
1884,0,List RNA modifications databases,RMBase: a resource for decoding the landscape of RNA modifications from high-throughput sequencing data.,1
1884,1,List RNA modifications databases,"we developed a novel resource, RMBase (RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase/), to decode the genome-wide landscape of RNA modifications identified from high-throughput modification data generated by 18 independent studies.",1
1884,2,List RNA modifications databases, known pathways of RNA modification from the MODOMICS database,1
1884,3,List RNA modifications databases,"MODOMICS is a database of RNA modifications that provides comprehensive information concerning the chemical structures of modified ribonucleosides, their biosynthetic pathways, RNA-modifying enzymes and location of modified residues in RNA sequences.",1
1521,0,How can DUF families be deciphered?," These families include proteins with domain of unknown function (DUF) DUF23, DUF246, and DUF266.",1
1521,1,How can DUF families be deciphered?,The evidence for these proteins being GTs and their possible roles in cell wall biosynthesis is discussed.,0
1521,2,How can DUF families be deciphered?,The genome projects have unearthed an enormous diversity of genes of unknown function that are still awaiting biological and biochemical characterization.,1
1521,3,How can DUF families be deciphered?,"These genes, as most others, can be grouped into families based on sequence similarity.",1
1521,4,How can DUF families be deciphered?,"The PFAM database currently contains over 2,200 such families, referred to as domains of unknown function (DUF)",1
1521,5,How can DUF families be deciphered?,"In a coordinated effort, the four large-scale centers of the NIH Protein Structure Initiative have determined the first three-dimensional structures for more than 250 of these DUF families.",0
1521,6,How can DUF families be deciphered?,Critically examining domain covariation across metagenomic datasets can grant new perspectives on the roles and associations of DUFs in an ecological setting.,0
1521,7,How can DUF families be deciphered?,Targeted attempts at DUF characterization in the laboratory or in silico may draw from these insights and opportunities to discover new associations and corroborate existing ones will arise as more large-scale metagenomic datasets emerge.,0
1521,8,How can DUF families be deciphered?,"Crystal structures of three members (BACOVA_00364 from Bacteroides ovatus, BACUNI_03039 from Bacteroides uniformis and BACEGG_00036 from Bacteroides eggerthii) of the Pfam domain of unknown function (DUF4488) were determined to 1.95, 1.66, and 1.81 Å resolutions, respectively",0
1521,9,How can DUF families be deciphered?,Bacterial species in the Enterobacteriaceae typically contain multiple paralogues of a small domain of unknown function (DUF1471) from a family of conserved proteins also known as YhcN or BhsA/McbA.,0
1521,10,How can DUF families be deciphered?,Proteins containing DUF1471 may have a single or three copies of this domain.,0
1521,11,How can DUF families be deciphered?,"Representatives of this family have been demonstrated to play roles in several cellular processes including stress response, biofilm formation, and pathogenesis.",0
1521,12,How can DUF families be deciphered?,"We have conducted NMR and X-ray crystallographic studies of four DUF1471 domains from Salmonella representing three different paralogous DUF1471 subfamilies: SrfN, YahO, and SssB/YdgH (two of its three DUF1471 domains: the N-terminal domain I (residues 21-91), and the C-terminal domain III (residues 244-314)).",0
1521,13,How can DUF families be deciphered?,"Notably, SrfN has been shown to have a role in intracellular infection by Salmonella Typhimurium",0
1521,14,How can DUF families be deciphered?,Domain of unknown function (DUF) proteins represent a number of gene families that encode functionally uncharacterized proteins in eukaryotes.,1
1521,15,How can DUF families be deciphered?,"For example, DUF1618 family members in plants possess a 56-199-amino acid conserved domain and this family has not been described previously.",0
1521,16,How can DUF families be deciphered?,"Here, we report the characterization of 121 DUF1618 genes identified in the rice genome.",0
1521,17,How can DUF families be deciphered?,"Based on phylogenetic analysis, the rice DUF1618 family was divided into two major groups, each group consisting of two clades.",0
1521,18,How can DUF families be deciphered?,"In this study we identified that a plant specific domain of unknown function, DUF581 is a zf-FCS type zinc finger.",0
1521,19,How can DUF families be deciphered?,"DUF2233, a domain of unknown function (DUF), is present in many bacterial and several viral proteins and was also identified in the mammalian transmembrane glycoprotein N-acetylglucosamine-1-phosphodiester α-N-acetylglucosaminidase (""uncovering enzyme"" (UCE)).",0
3816,0,What is the outcome of COVID-19 patients treated with tocilizumab?," Preliminary clinical results have indicated that antagonism of the IL-6 receptor (IL-6R), including with the FDA-approved humanized monoclonal antibody tocilizumab, can improve the outcomes of patients with severe or critical COVID-19 while maintaining a good safety profile.",1
966,0,What is the vibrational theory of olfaction?,"The vibrational theory of olfaction assumes that electron transfer occurs across odorants at the active sites of odorant receptors (ORs), serving as a sensitive measure of odorant vibrational frequencies, ultimately leading to olfactory perception.",1
966,1,What is the vibrational theory of olfaction?,It proposes that olfactory receptors respond not to the shape of the molecules but to their vibrations.,0
966,2,What is the vibrational theory of olfaction?,"It differs from previous vibrational theories (Dyson, Wright) in providing a detailed and plausible mechanism for biological transduction of molecular vibrations: inelastic electron tunnelling.",1
966,3,What is the vibrational theory of olfaction?,Elements of the tunnelling spectroscope are identified in putative olfactory receptors and their associated G-protein.,0
966,4,What is the vibrational theory of olfaction?,"The evidence presented here suggests instead that olfaction, like colour vision and hearing, is a spectral sense.",0
966,5,What is the vibrational theory of olfaction?,"The vibrational theory of olfaction assumes that electron transfer occurs across odorants at the active sites of odorant receptors (ORs), serving as a sensitive measure of odorant vibrational frequencies, ultimately leading to olfactory perception.",1
966,6,What is the vibrational theory of olfaction?,A previous study reported that human subjects differentiated hydrogen/deuterium isotopomers (isomers with isotopic atoms) of the musk compound cyclopentadecanone as evidence supporting the theory.,0
966,7,What is the vibrational theory of olfaction?,"The vibrational theory of olfaction assumes that electron transfer occurs across odorants at the active sites of odorant receptors (ORs),",1
966,8,What is the vibrational theory of olfaction?,"The vibrational theory of olfaction assumes that electron transfer occurs across odorants at the active sites of odorant receptors (ORs), serving as a sensitive measure of odorant vibrational frequencies, ultimately leading to olfactory perception.",1
634,0,Could Arimidex (anastrozole) cause hot flashes?,More than a third of breast cancer patients undergoing aromatase inhibitor (AI) treatment report joint pain.,0
634,1,Could Arimidex (anastrozole) cause hot flashes?,"In the first 6 weeks, emergence of joint pain was associated with increase in general pain, fatigue, disturbed sleep, hot flashes, vaginal dryness, and decreased sexual activity.",0
634,2,Could Arimidex (anastrozole) cause hot flashes?,"Antiestrogen therapy can cause vasomotor symptoms similar to those occurring during menopause, including hot flashes.",0
634,3,Could Arimidex (anastrozole) cause hot flashes?,The purpose of this study was to assess the feasibility and safety of acupuncture for treatment of hot flashes in Korean patients with breast cancer receiving antiestrogen therapy.,0
634,4,Could Arimidex (anastrozole) cause hot flashes?,10 patients with breast cancer who were undergoing antiestrogen therapy with tamoxifen or anastrozole and who were suffering from hot flashes.,0
634,5,Could Arimidex (anastrozole) cause hot flashes?,"During treatment, severity of hot flashes was reduced by 70%-95% in all patients.",0
634,6,Could Arimidex (anastrozole) cause hot flashes?,"anastrozole has been widely used in Japan as an adjuvant treatment for postmenopausal, hormone-responsive breast cancer patients.",0
634,7,Could Arimidex (anastrozole) cause hot flashes?,The aim of this study is to evaluate the rate of bone fracture and bone mineral density (BMD) during anastrozole treatment in Japanese patients.,0
634,8,Could Arimidex (anastrozole) cause hot flashes?,"Musculoskeletal disorders were the most common (26.1 %), and hot flashes were the second most common adverse event (7.9 %).",1
634,9,Could Arimidex (anastrozole) cause hot flashes?,To compare the effect of therapy with anastrozole versus a combination of fulvestrant and anastrozole in women in first relapse of endocrine-responsive breast cancer.,0
634,10,Could Arimidex (anastrozole) cause hot flashes?,fulvestrant loading dose (LD) regimen followed by monthly injection plus 1 mg of anastrozole daily or to 1 mg of anastrozole daily alone.,0
634,11,Could Arimidex (anastrozole) cause hot flashes?,Incidences of prespecified adverse events (AEs) were similar.,0
634,12,Could Arimidex (anastrozole) cause hot flashes?,Hot flashes were more common in the experimental arm: 63 patients (24.6%) versus 35 patients (13.8%) in the standard arm (P = .0023).,0
634,13,Could Arimidex (anastrozole) cause hot flashes?,"The third-generation agents (anastrozole, letrozole, and exemestane) have been shown to be more effective and safer than the selective estrogen receptor modulators tamoxifen and raloxifen.",0
634,14,Could Arimidex (anastrozole) cause hot flashes?,"AIs are well tolerated and cause a lower incidence of gynecological symptoms (vaginal bleeding, discharge, and endometrial neoplasia), venous thromboembolic events, and hot flashes compared with tamoxifen.",0
634,15,Could Arimidex (anastrozole) cause hot flashes?,"Mood disturbances, somnolence, anxiety, fatigue, hot flashes, and memory impairment have been reported among patients receiving anastrozole as adjuvant therapy.",0
634,16,Could Arimidex (anastrozole) cause hot flashes?,"Twenty-five PM-BC patients received, in sequence, leuprorelin, taxane-anthracycline induction chemotherapy, radiation therapy, a platinum-based intensification high-dose CT, followed by leuprorelin and anastrazole for five years.",0
634,17,Could Arimidex (anastrozole) cause hot flashes?,"Grade 4 hematologic toxicity was observed in all patients, no patient showed a decrease of cardiac ejection fraction and hot flashes and arthralgias were of moderate intensity.",0
634,18,Could Arimidex (anastrozole) cause hot flashes?,"Of the patients treated with anastrozole, 3 (37.5%) reported toxicity, with 1 report each of decreased libido, leg swelling, and depression (12.5%).",0
634,19,Could Arimidex (anastrozole) cause hot flashes?,"Toxicity was reported in 2 patients taking letrozole (40%), with both reporting peripheral edema, and 1 reporting hot flashes.",0
634,20,Could Arimidex (anastrozole) cause hot flashes?,Patients were treated with goserelin 3.6 mg subcutaneous monthly and began anastrozole 1-mg daily 21 days after the first injection of goserelin.,0
634,21,Could Arimidex (anastrozole) cause hot flashes?,"The most common adverse events were fatigue (50%), arthralgias (53%), and hot flashes (59%).",1
634,22,Could Arimidex (anastrozole) cause hot flashes?,"These studies were designed to evaluate the safety and efficacy of AIs in the following clinical settings: 1) as initial adjuvant therapy (the Arimidex, Tamoxifen, Alone or in Combination trial, Breast International Group Trial 1-98),",0
634,23,Could Arimidex (anastrozole) cause hot flashes?,"AIs were tolerated well, and patients who received them experienced fewer thrombolic events and less endometrial cancer, hot flashes, night sweats, and vaginal bleeding compared with patients who receive tamoxifen.",0
634,24,Could Arimidex (anastrozole) cause hot flashes?,"It has been suggested that the association of AI and GnRh analogues and AI could block the two routes of oestrogen production in males, and therefore this approach could increase efficacy.",0
634,25,Could Arimidex (anastrozole) cause hot flashes?,"However, it could also enhance the rate of adverse events (hot flashes, sexual impotence, etc.",1
634,26,Could Arimidex (anastrozole) cause hot flashes?,).,0
634,27,Could Arimidex (anastrozole) cause hot flashes?,We reviewed therapeutic effects and harmful side effects in 33 patients with advanced or recurrent breast cancer who underwent treatment with Anastrozole 1 mg/day in our department.,0
634,28,Could Arimidex (anastrozole) cause hot flashes?,"The most frequent harmful side effects were rise in total cholesterol, general fatigue, hot flashes and arthralgia (9.1%).",1
634,29,Could Arimidex (anastrozole) cause hot flashes?,We analyzed the changes in frequency and severity of menopausal symptoms in patients receiving tamoxifen or aromatase inhibitors and identified factors influencing these symptoms.,0
634,30,Could Arimidex (anastrozole) cause hot flashes?,"Both first-line tamoxifen and aromatase inhibitors induced an increase in the occurrence and severity of hot flashes (p<0.0001 and p=0.014, respectively).",0
634,31,Could Arimidex (anastrozole) cause hot flashes?,"To evaluate the efficacy and toxicity of the selective aromatase inhibitor anastrozole (Arimidex), we conducted a phase II trial in 53 women with asymptomatic recurrent/persistent müllerian cancer.",0
634,32,Could Arimidex (anastrozole) cause hot flashes?,"Toxicity was modest (grade I) and infrequent, with the most common toxicities being fatigue and hot flashes.",1
634,33,Could Arimidex (anastrozole) cause hot flashes?,"The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow-up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer, anastrozole was superior to tamoxifen in terms of disease-free survival (DFS), time to recurrence (TTR), and incidence of contralateral breast cancer (CLBC).",0
634,34,Could Arimidex (anastrozole) cause hot flashes?,"in that endometrial cancer (P = 0.007), vaginal bleeding and discharge (P < 0.001 for both), cerebrovascular events (P < 0.001), venous thromboembolic events (P < 0.001), and hot flashes (P < 0.001) all occurred less frequently in the anastrozole group, whereas musculoskeletal disorders and fractures (P < 0.001 for both) continued to occur less frequently in the tamoxifen group.",0
634,35,Could Arimidex (anastrozole) cause hot flashes?,"reduced nausea, hot flashes, and abdominal discomfort caused almost twice as many patients to prefer to continue with letrozole therapy than with anastrozole",0
3949,0,List pore forming toxins.,Application of this algorithm to prototypical α-PFT (cytolysin A) and β-PFT (α-hemolysin),1
3949,1,List pore forming toxins.,"Staphylococcal bi-component pore-forming toxins, also known as leukocidins,",1
3949,2,List pore forming toxins.,Streptolysin O (SLO) is a bacterial pore-forming toxin that is employed to permeabilize cell membranes in some biological experiments.,1
3949,3,List pore forming toxins., S. pneumoniae pneumolysin,1
3949,4,List pore forming toxins.,streptolysin O (SLO)-type and listeriolysin,1
3949,5,List pore forming toxins.,"ere we report the structures of a staphylococcal pore-forming cytotoxin, leukocidin",0
3949,6,List pore forming toxins.,"Glabralysins, Potential New β-Pore-Forming Toxin Family Members from the Schistosomiasis Vector Snail Biomphalaria glabrata",0
3647,0,What is the Match BAM to VCF method?,MBV: a method to solve sample mislabeling and detect technical bias in large combined genotype and sequencing assay datasets.,1
3647,1,What is the Match BAM to VCF method?,"Large genomic datasets combining genotype and sequence data, such as for expression quantitative trait loci (eQTL) detection, require perfect matching between both data types.Results: We described here MBV (Match BAM to VCF); a method to quickly solve sample mislabeling and detect cross-sample contamination and PCR amplification bias.Availability and Implementation: MBV is implemented in C ++ as an independent component of the QTLtools software package, the binary and source codes are freely available at https://qtltools.github.io/qtltools/ .",1
3647,2,What is the Match BAM to VCF method?,"Results

We described here MBV (Match BAM to VCF); a method to quickly solve sample mislabeling and detect cross-sample contamination and PCR amplification bias.",0
3647,3,What is the Match BAM to VCF method?,Results We described here MBV (Match BAM to VCF); a method to quickly solve sample mislabeling and detect cross-sample contamination and PCR amplification bias.,1
3647,4,What is the Match BAM to VCF method?,"Results
We described here MBV (Match BAM to VCF); a method to quickly solve sample mislabeling and detect cross-sample contamination and PCR amplification bias.",0
3647,5,What is the Match BAM to VCF method?,"Motivation: Large genomic datasets combining genotype and sequence data, such as for expression quantitative trait loci (eQTL) detection, require perfect matching between both data types.Results: We described here MBV (Match BAM to VCF); a method to quickly solve sample mislabeling and detect cross-sample contamination and PCR amplification bias.Availability and Implementation: MBV is implemented in C ++ as an independent component of the QTLtools software package, the binary and source codes are freely available at https://qtltools.github.io/qtltools/ .Contact: olivier.delaneau@unige.ch or emmanouil.dermitzakis@unige.ch.Supplementary information: Supplementary data are available at Bioinformatics online.",1
3647,6,What is the Match BAM to VCF method?,We described here MBV (Match BAM to VCF); a method to quickly solve sample mislabeling and detect cross-sample contamination and PCR amplification bias.,1
2487,0,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,The postnatal functions of the Dlx1&2 transcription factors in cortical interneurons (CINs) are unknown.,0
2487,1,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"Here, using conditional Dlx1, Dlx2, and Dlx1&2 knockouts (CKOs), we defined their roles in specific CINs.",1
2487,2,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"The CKOs had dendritic, synaptic, and survival defects, affecting even PV+ CINs.",0
2487,3,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"We provide evidence that DLX2 directly drives Gad1, Gad2, and Vgat expression, and show that mutants had reduced mIPSC amplitude.",1
2487,4,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"In addition, the mutants formed fewer GABAergic synapses on excitatory neurons and had reduced mIPSC frequency.",1
2487,5,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"Furthermore, Dlx1/2 CKO had hypoplastic dendrites, fewer excitatory synapses, and reduced excitatory input.",1
2487,6,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"We provide evidence that some of these phenotypes were due to reduced expression of GRIN2B (a subunit of the NMDA receptor), a high confidence Autism gene.",0
2487,7,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"Thus, Dlx1&2 coordinate key components of CIN postnatal development by promoting their excitability, inhibitory output, and survival.",0
2487,8,Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?,"Furthermore, Dlx1/2 CKO had hypoplastic dendrites, fewer excitatory synapses, and reduced excitatory input.",1
2079,0,What is the role of peptide aptamers?,Peptide aptamers: The versatile role of specific protein function inhibitors in plant biotechnology.,0
2079,1,What is the role of peptide aptamers?," These artificial short peptides are able to specifically bind, track, and inhibit a given target molecule with high affinity, even molecules with poor immunogenicity or high toxicity, and represent a remarkable alternative to antibodies in many different applications.",1
2079,2,What is the role of peptide aptamers?,"To inhibit the oncogenic action of Stat3 in tumor cells, we have selected short peptides, so-called peptide aptamers, which specifically interact with defined functional domains of this transcription factor.",1
2079,3,What is the role of peptide aptamers?,Aptasensors utilize aptamers as bioreceptors.,0
2079,4,What is the role of peptide aptamers?,"Aptamers are highly efficient, have a high specificity and are reusable.",0
2079,5,What is the role of peptide aptamers?,Within the biosensor the aptamers are immobilized to maximize their access to target molecules.,0
2079,6,What is the role of peptide aptamers?,Knowledge of the orientation and location of the aptamer and peptide during binding could be gained through computational modeling.,0
2079,7,What is the role of peptide aptamers?,Understanding orientation and location of the binding region for a peptide-aptamer complex is critical in their biosensor applicability.,0
2079,8,What is the role of peptide aptamers?," Our study clearly demonstrates the ability of MD simulations to obtain molecular insights for peptide-aptamer binding, and to provide details on the orientation and location of binding between the peptide-aptamer that can be instrumental in biosensor development.",0
2079,9,What is the role of peptide aptamers?,"Peptide aptamers are artificial short peptides that potentially interfere with the biological roles of their target proteins; however, this technology has not yet been applied to plant functional genomics.",1
2079,10,What is the role of peptide aptamers?,To extend such strategies we selected peptide aptamers binding to PrP from a combinatorial peptide library presented on the Escherichia coli thioredoxin A (trxA) protein as a scaffold.,0
2079,11,What is the role of peptide aptamers?,"These peptide aptamers retained their binding properties to PrPc and, depending on peptide sequence and C-terminal modification, interfered with endogenous PrPSc conversion upon expression in prion-infected cells.",0
2079,12,What is the role of peptide aptamers?,"Binding to the nonfarnesylated peptide was at least 10-fold weaker, showing that the aptamers can recognize the hydrophobic farnesyl moiety.",0
2079,13,What is the role of peptide aptamers?,Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding.,0
2079,14,What is the role of peptide aptamers?,"Typically, peptide aptamers are generated by screening a randomized peptide expression library, displayed from the Escherichia coli thioredoxin A (TrxA) protein.",0
2079,15,What is the role of peptide aptamers?,Peptide aptamers define distinct EB1- and EB3-binding motifs and interfere with microtubule dynamics.,0
2079,16,What is the role of peptide aptamers?,Reverse analysis with peptide aptamers involves isolating aptamers that interact with a specific protein and monitoring the resulting aptamer-induced phenotype.,0
2079,17,What is the role of peptide aptamers?,"Peptide aptamers are combinatorial protein reagents that bind to targets with a high specificity and a strong affinity thus providing a molecular tool kit for modulating the function of their targets in vivo.Here we report the isolation of a peptide aptamer named swiggle that interacts with the very short (21 amino acid long) intracellular domain of membrane type 1-metalloproteinase (MT1-MMP), a key cell surface protease involved in numerous and crucial physiological and pathological cellular events",0
2079,18,What is the role of peptide aptamers?,"Peptide aptamers are simple structures, often made up of a single-variable peptide loop constrained within a constant scaffold protein",0
2079,19,What is the role of peptide aptamers?,Peptide aptamers are small peptide sequences that have been selected to recognise a predetermined target protein domain and are potentially able to interfere with its function,0
2079,20,What is the role of peptide aptamers?,"Aptamers, including DNA, RNA and peptide aptamers, are a group of promising recognition units that can specifically bind to target molecules and cells",1
2079,21,What is the role of peptide aptamers?,"Aptamers are a group of molecules, which can specifically bind, track, and inhibit target molecules, comprising DNA aptamers, RNA aptamers, and peptide aptamers",1
2079,22,What is the role of peptide aptamers?,Peptide aptamers: The versatile role of specific protein function inhibitors in plant biotechnology,0
2079,23,What is the role of peptide aptamers?,"Peptide aptamers are small proteins containing a randomized peptide sequence embedded into a stable protein scaffold, such as Thioredoxin",0
2079,24,What is the role of peptide aptamers?,"Peptide aptamers can subsequently be used to guide the discovery of small molecule drugs specific for these molecular surfaces.Here, we present a high-throughput screening assay that identifies small molecules that displace interactions between proteins and their cognate peptide aptamers",0
2079,25,What is the role of peptide aptamers?,These peptide aptamers are target-specific peptides expressed within a protein scaffold engineered from the human protease inhibitor stefin A.,0
2079,26,What is the role of peptide aptamers?,The scaffold provides stability to the inserted peptides and increases their binding affinity owing to the resulting three-dimensional constraints,0
2079,27,What is the role of peptide aptamers?,Isolation of Peptide aptamers to target protein function.,0
2079,28,What is the role of peptide aptamers?,Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.,0
2079,29,What is the role of peptide aptamers?,Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy.,0
2079,30,What is the role of peptide aptamers?,Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity.,0
2079,31,What is the role of peptide aptamers?,These data highlight the utility of peptide aptamers to identify novel binding interfaces and highlight a role for MAP1B in DAPK-1-dependent signaling in autophagy and membrane blebbing.,0
2079,32,What is the role of peptide aptamers?,"Therapeutic application depends on binding specificities and affinities, as well as on the production and purification characteristics of the peptide aptamers and their delivery into cells.",0
2079,33,What is the role of peptide aptamers?,"While antibodies are known to recognize the sequence and conformation of protein surface features (epitopes), very little is known about the precise interactions between aptamers and their epitopes.",0
2079,34,What is the role of peptide aptamers?,Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition.,0
2079,35,What is the role of peptide aptamers?,The use of small peptide aptamers to competitively inhibit protein interaction and function is becoming increasingly recognized as a powerful technique.,0
2079,36,What is the role of peptide aptamers?,"For the first time, we show that trxA-based peptide aptamers can be targeted to the secretory pathway, thereby not losing the affinity for their target protein.",0
2079,37,What is the role of peptide aptamers?,"Moreover, the aptamers appeared to be able to bind peptides with different solution conformations, implying an induced fit mechanism for binding.",0
2079,38,What is the role of peptide aptamers?,"Peptide aptamers are small proteins containing a randomized peptide sequence embedded into a stable protein scaffold, such as Thioredoxin.",0
2079,39,What is the role of peptide aptamers?,"Peptide aptamers are the newest in the class of ""genetic"" agents that aid in the analysis of cellular processes.",0
2079,40,What is the role of peptide aptamers?,Peptide aptamers: The versatile role of specific protein function inhibitors in plant biotechnology.,0
2079,41,What is the role of peptide aptamers?,"Here we present a detailed protocol for the creation of a peptide aptamer plasmid library, selection of peptide aptamers using the LiRP scaffold in a yeast two-hybrid system, and the screening of those peptide aptamers for a ligand-regulated interaction..",0
2645,0,What is the biological role of Neddylation?,Neddylation plays an important role in the regulation of murine and human dendritic cell function.,0
2645,1,What is the biological role of Neddylation?,"Utilizing multiple but complementary approaches, we determined the role of an important but less understood type of PTM, namely, neddylation, in regulating DC functions.",1
2645,2,What is the biological role of Neddylation?,"nhibition of neddylation suppressed the release of proinflammatory cytokines by DCs in response to Toll-like receptor, nucleotide oligomerization domain-like receptor, and noninfectious CD40L stimulation.",0
2645,3,What is the biological role of Neddylation?,blocking neddylation could be a novel strategy for mitigating immune-mediated disease processes.,0
2645,4,What is the biological role of Neddylation?,Neddylation is a process that is similar to ubiquitination.,0
2645,5,What is the biological role of Neddylation?,It however has its own enzyme machinery.,0
2645,6,What is the biological role of Neddylation?,It is coupled to ubiquitination and is important for maintaining cellular homeostasis.,1
2645,7,What is the biological role of Neddylation?,Proteins in the neddylation pathway have also been linked to regulating DDR.,1
2645,8,What is the biological role of Neddylation?,NEDDylation is a post-translational protein modification that is tightly linked to ubiquitination and thereby protein degradation.,1
2645,9,What is the biological role of Neddylation?,The neddylation conjugation pathway has a pivotal role in mediating ubiquitination of proteins and regulation of numerous biological processes.,0
2645,10,What is the biological role of Neddylation?,The present review describes the biological significance of NEDDylation for the novel identified substrates and the emerging evidence for the co-operation between the ubiquitin and NEDD8 pathways to control protein function.,0
2645,11,What is the biological role of Neddylation?,"By altering the substrate's conformation, stability, subcellular localization or binding affinity to DNA or proteins, neddylation regulates diverse cellular processes including the ubiquitin-proteasome system-mediated protein degradation, protein transcription, cell signaling etc.",0
2645,12,What is the biological role of Neddylation?,"Similar to ubiquitination, neddylation is mediated by a cascade of three NEDD8 specific enzymes, an E1 activating enzyme, an E2 conjugating enzyme and one of the several E3 ligases.",0
2645,13,What is the biological role of Neddylation?,Neddylation is a post-translational protein modification that conjugates a ubiquitin-like protein NEDD8 to target proteins.,1
2645,14,What is the biological role of Neddylation?,"Neddylation is commonly mediated by NEDD8-specific enzymes (typical neddylation) and, sometimes, by ubiquitin enzymes (atypical neddylation).",0
2645,15,What is the biological role of Neddylation?,"The activity of cullin-RING type ubiquitination E3 ligases is regulated by neddylation, a process analogous to ubiquitination that culminates in covalent attachment of the ubiquitin-like protein Nedd8 to cullins.",0
2645,16,What is the biological role of Neddylation?,The Cullin-RING E3 ubiquitin ligases (CRLs) regulate homeostasis of ~20% of cellular proteins and their activation require neddylation of their cullin subunit.,0
2645,17,What is the biological role of Neddylation?,"Protein neddylation, a newly characterized posttranslational modification that adds the ubiquitin-like molecule NEDD8 to substrates, modulates important biological processes, whereas dysfunction of neddylation may cause several serious diseases, such as cancer.",0
2645,18,What is the biological role of Neddylation?,"However, it is unknown whether and how UBE2F, a less characterized neddylation E2, regulates lung cancer cell survival, and whether and how NOXA, a proapoptotic protein, is ubiquitylated and degraded by which E3 and via which ubiquitin linkage.Experimental Design: Methods of immunohistochemistry and immunoblotting were utilized to examine UBE2F protein expression.",0
2645,19,What is the biological role of Neddylation?,Dysregulation in the ubiquitination and neddylation pathways is associated with many cancers.,0
2645,20,What is the biological role of Neddylation?,Neddylation is a posttranslational modification that controls diverse biological processes by covalently conjugating the ubiquitin-like protein NEDD8 to specific targets.,0
2645,21,What is the biological role of Neddylation?,"Ubiquitin can form diverse polyubiquitin chains, on its seven lysines, which play important functions in various biological processes.",0
1327,0,Which major signaling pathways are regulated by RIP1?,"Major signaling pathways regulated by RIP1 include necroptosis, apoptosis, and pro-survival/inflammation NF-κB activation.",1
1327,1,Which major signaling pathways are regulated by RIP1?,receptor-interacting protein-1 (RIP1)-mediated necroptosis,1
1327,2,Which major signaling pathways are regulated by RIP1?,"TNF-induced apoptotic signaling pathways were assessed by monitoring levels of the anti-apoptotic protein, A20, and cleavage products of the caspase-8 substrate, RIP1.",1
1327,3,Which major signaling pathways are regulated by RIP1?,Receptor-interacting protein (RIP) kinases promote the induction of necrotic cell death pathways.,1
1327,4,Which major signaling pathways are regulated by RIP1?,Together our results reveal a specific role for the RIP1-RIP3-DRP1 pathway in RNA virus-induced activation of the NLRP3 inflammasome and establish a direct link between inflammation and cell-death signaling pathways.,1
1327,5,Which major signaling pathways are regulated by RIP1?,"Necroptosis exhibits a unique signaling pathway that requires the involvement of receptor interaction protein kinases 1 and 3 (RIP1 and RIP3),",0
2836,0,Describe information obtained by immunophenotyping.,both CD4+ absolute counts (cells/μL) and percentages; and CD8+ absolute counts (cells/μL) and percentages.,1
2836,1,Describe information obtained by immunophenotyping.," Circulating B, T, and dendritic cells were defined using flow cytometric analysis as recommended by the Human Immunology Project Consortium.",1
2836,2,Describe information obtained by immunophenotyping.,"Mass cytomety enables comprehensive single-cell immunophenotyping and functional assessments, capturing the complexity of the immune system, and the molecularly heterogeneous consequences of primary immunodeficiency defects.",1
2836,3,Describe information obtained by immunophenotyping.,"Clinical applications of flow cytometry currently utilized in the laboratory include cell surface antigen determinations or immunophenotyping of hematologic cells, DNA analysis of hematopoietic malignancies and solid tumors, and measurement of CD4 (T helper/inducer cell) absolute counts and T helper/T suppressor (CD4/CD8) ratios in the evaluation of immune deficiency.",1
2836,4,Describe information obtained by immunophenotyping., The workup of lymphoproliferative disorders (LPDs) involves the combined use of flow cytometry (FC) and immunohistochemistry (IHC).,1
2836,5,Describe information obtained by immunophenotyping.,This often results in duplicate immunophenotypic testing,0
1407,0,What is the suggested clinical management of Fanconi anemia?,Hematopoietic stem cell transplantation is the only proven cure for the hematopoietic manifestations of FA and aggressive lifelong surveillance for solid tumors is essential.,1
1407,1,What is the suggested clinical management of Fanconi anemia?,Bone marrow surveillance is an important part of the clinical management of FA and often reveals cytogenetic aberrations,1
1407,2,What is the suggested clinical management of Fanconi anemia?,"In patients with FA, there is a high incidence of aggressive HNSCC at a young age.",1
1407,3,What is the suggested clinical management of Fanconi anemia?,"Surgery remains the mainstay of treatment because patients with FA tolerate radiation therapy and chemotherapy poorly, with significant morbidity",1
1683,0,What is the Orco protein in mosquitos?,"Insect odorant receptors function as heteromeric odorant-gated cation channels comprising a conventional odorant-sensitive tuning receptor, and a conserved co-receptor (Orco)",1
1683,1,What is the Orco protein in mosquitos?,"Insects sense odours via several chemosensory receptor families, including the odorant receptors (ORs), membrane proteins that form heteromeric odour-gated ion channels comprising a variable ligand-selective subunit and an obligate co-receptor called Orco",1
1683,2,What is the Orco protein in mosquitos?,"Surprisingly, mutation of the obligate olfactory coreceptor (Orco) does not abolish CO(2) aversion during walking yet eliminates CO(2) tracking in flight.",0
1683,3,What is the Orco protein in mosquitos?," Most odors are detected via a family of odorant receptors (ORs), which form heteromeric complexes consisting of a well-conserved OR co-receptor (Orco) ion channel and a non-conserved tuning OR that provides coding specificity to each complex.",1
1683,4,What is the Orco protein in mosquitos?,Orco functions as a non-selective cation channel and is expressed in the majority of olfactory receptor neurons (ORNs).,0
1683,5,What is the Orco protein in mosquitos?,a novel OR co-receptor (Orco),1
1683,6,What is the Orco protein in mosquitos?,"In insects, odor cues are discriminated through a divergent family of odorant receptors (ORs).",1
1683,7,What is the Orco protein in mosquitos?,A functional OR complex consists of both a conventional odorant-binding OR and a nonconventional coreceptor (Orco) that is highly conserved across insect taxa.,0
1683,8,What is the Orco protein in mosquitos?,"Insect odorant receptors (ORs) function as odorant-gated ion channels consisting of a conventional, odorant-binding OR and the Orco coreceptor.",0
2352,0,What is the name of the RNAi investigational drug being developed against hereditary amyloidosis?,"Patisiran is an investigational RNA interference (RNAi) therapeutic in development for the treatment of hereditary ATTR (hATTR) amyloidosis, a progressive disease associated with significant disability, morbidity, and mortality.",1
4067,0,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"Ubrogepant (Ubrelvy™) is an orally administered, small molecule, highly-selective, calcitonin gene-related peptide (CGRP) antagonist that was developed by Allergan under license to Merck & Co. as an acute treatment for migraine",0
4067,1,Please list 3 small molecule CGRP-Receptor antagonists for migraine, This article summarizes the milestones in the development of ubrogepant leading to its first global approval for the acute treatment of migraine (± aura) in adults.,1
4067,2,Please list 3 small molecule CGRP-Receptor antagonists for migraine," a small molecule CGRP receptor antagonist and an anti-CGRP receptor antibody, can be used concomitantly to treat refractory migraine.METHODS: Case reports are presented of 2 patients participating in a long-term safety study of rimegepant 75 mg oral tablets for acute treatment",0
4067,3,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"The pivotal role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology was identified over 30 years ago, but the successful clinical development of targeted therapies has only recently been realized.",0
4067,4,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"This Perspective traces the decades long evolution of medicinal chemistry required to advance small molecule CGRP receptor antagonists, also called gepants, including the current clinical agents rimegepant, vazegepant, ubrogepant, and atogepant.",0
4067,5,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"Currently, rimegepant and ubrogepant have been developed for acute migraine treatment, while atogepant is studied for migraine prophylaxis",1
4067,6,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"Small molecule CGRP receptor antagonists, gepants, are effective for acute relief of migraine headache, whereas monoclonal antibodies against CGRP (Eptinezumab, Fremanezumab, and Galcanezumab) or the CGRP receptor (Erenumab) effectively prevent migraine attacks.",0
4067,7,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"vel classes of drugs, i.e., the 5-HT1F receptor agonists (lasmiditan) and the small molecule CGRP receptor antagonists (gepants).",0
4067,8,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"Data on the effects of 5-HT1F receptor agonism in relation to MOH, as well as the effects of chronic CGRP recepto",0
4067,9,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"small-molecule CGRP receptor antagonist (ubrogepant, MK-1602) is currently in phase 3 studies for the acute treatment of migraine.",1
4067,10,Please list 3 small molecule CGRP-Receptor antagonists for migraine,Two of these an,0
4067,11,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.",0
4067,12,Please list 3 small molecule CGRP-Receptor antagonists for migraine,OBJECTIVE: Evaluate the safety and tolerability of oral rimegepant when used for acute treatment concomitantly with a monoclonal antibody (mAb) targeting the calcitonin gene-related peptide (CGRP) ligand or receptor (CGRP mAb) for the preventive treatment of migraine,0
4067,13,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"Meanwhile, 1 small-molecule CGRP receptor antagonist (ubrogepant, MK-1602) is currently in phase 3 studies for the acute treatment of migraine.",1
4067,14,Please list 3 small molecule CGRP-Receptor antagonists for migraine,ithin the past decade.,0
4067,15,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"The commentary is supplemented by information presented in journal articles and focuses on the activity of several major pharmaceutical companies in the field.CONCLUSION: Two small molecule CGRP receptor antagonists, olcegepant and telcagepant, have been shown to be clinically efficacious in the treatment of migraine, and thus provide validation o",0
4067,16,Please list 3 small molecule CGRP-Receptor antagonists for migraine,"Recently, orally administered next-generation small molecule CGRP-RAs have been shown to have safety and efficacy in acute treatment (ubrogepant and rimegepant) and prevention (atogepant) of migraine, giving additional CGRP-based therapeutic options for migraine patients.",1
2801,0,Is ibudilast effective for multiple sclerosis?,Ibudilast slowed brain atrophy in PPMS and SPMS patients in a multicenter phase 2b study.,1
2801,1,Is ibudilast effective for multiple sclerosis?," Ibudilast inhibits several cyclic nucleotide phosphodiesterases, macrophage migration inhibitory factor, and toll-like receptor 4 and can cross the blood-brain barrier, with potential salutary effects in progressive multiple sclerosis.",0
2801,2,Is ibudilast effective for multiple sclerosis?,"CONCLUSIONS: In a phase 2 trial involving patients with progressive multiple sclerosis, ibudilast was associated with slower progression of brain atrophy than placebo but was associated with higher rates of gastrointestinal side effects, headache, and depression.",1
2801,3,Is ibudilast effective for multiple sclerosis?,"Specifically, the current evidence regarding treatment of progressive MS with ocrelizumab, simvastatin, ibudilast, alpha-lipoic acid, high-dose biotin, siponimod, and cell-based therapies are discussed.",0
2801,4,Is ibudilast effective for multiple sclerosis?,"Based on our knowledge of pathophysiology, three therapeutic strategies are proposed: anti-inflammatory (ocrelizumab, siponimod…); remyelinating (opicinumab); and neuroprotective (high-dose biotin, ibudilast, simvastatin…).",0
2801,5,Is ibudilast effective for multiple sclerosis?,"Current article provides an overview of the pharmacology of IBD with a focus on preclinical and clinical data supporting its potential neuroprotective benefits for neurological conditions, including multiple sclerosis, neuropathic pain, medication overuse headache, stroke, opioid, alcohol and methamphetamine abuse.",0
2801,6,Is ibudilast effective for multiple sclerosis?,"Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.",1
2801,7,Is ibudilast effective for multiple sclerosis?,"METHODS: SPRINT-MS is a randomized, placebo-controlled, phase II trial of ibudilast in patients with PMS.",1
2801,8,Is ibudilast effective for multiple sclerosis?,CONCLUSION: SPRINT-MS is designed to evaluate the safety and efficacy of ibudilast as a treatment for PMS while simultaneously validating five different imaging biomarkers as outcome metrics for use in future phase II proof-of-concept PMS trials.,0
2801,9,Is ibudilast effective for multiple sclerosis?,Ibudilast for the treatment of multiple sclerosis.,0
2801,10,Is ibudilast effective for multiple sclerosis?,AREAS COVERED: This article reviews various studies looking at ibudilast as a potential therapy for MS.,0
2801,11,Is ibudilast effective for multiple sclerosis?,"It summarizes prior and current clinical trials of ibudilast in MS as well as its pharmacology.EXPERT OPINION: Although ibudilast has not been found to decrease the focal inflammatory activity in relapsing MS, it was shown to have an effect on preserving brain volume and disability progression.",0
2801,12,Is ibudilast effective for multiple sclerosis?,Ibudilast may have a role in the treatment of progressive MS phenotypes.,0
2801,13,Is ibudilast effective for multiple sclerosis?,"Adverse events with ibudilast included gastrointestinal symptoms, headache, and depression.<br><b>CONCLUSIONS</b>: In a phase 2 trial involving patients with progressive multiple sclerosis, ibudilast was associated with slower progression of brain atrophy than placebo but was associated with higher rates of gastrointestinal side effects, headache, and depression.",1
2801,14,Is ibudilast effective for multiple sclerosis?,"It summarizes prior and current clinical trials of ibudilast in MS as well as its pharmacology.<br><b>EXPERT OPINION</b>: Although ibudilast has not been found to decrease the focal inflammatory activity in relapsing MS, it was shown to have an effect on preserving brain volume and disability progression.",0
1454,0,What is the association between moon cycle and rupture risk of intracranial aneurysms?,"An incidence peak for aneurysm rupture (28 patients) was seen during the phase of new moon, which was statistically significant (p < 0.001)",1
1454,1,What is the association between moon cycle and rupture risk of intracranial aneurysms?,"The lunar cycle seems to affect the incidence of intracranial aneurysm rupture, with the new moon being associated with an increased risk of aneurysmal SAH.",1
3383,0,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?"," Based on our review of the data, there is little evidence to support the indiscriminate exclusion of AhR activators/Cyp1a1 inducers from early drug developmental pipelines.",1
3383,1,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","We also found no evidence that short-term treatment with RMAhRLs produce ""dioxin-like toxicity""",0
3383,2,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","However, recent discoveries of new AhR ligands with potential therapeutic applications have been reported, inviting reconsideration of this policy.",1
3383,3,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","Based on our review of the data, there is little evidence to support the indiscriminate exclusion of AhR activators/Cyp1a1 inducers from early drug developmental pipelines.",1
3383,4,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","Based on our review of the data , there is little evidence to support the indiscriminate exclusion of AhR activators/Cyp1a1 inducers from early drug developmental pipelines",1
3383,5,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","However , recent discoveries of new AhR ligands with potential therapeutic applications have been reported , inviting reconsideration of this policy",0
3383,6,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","Based on our review of the data, there is little evidence to support the indiscriminate exclusion of AhR activators/Cyp1a1 inducers from early drug developmental pipelines.",1
3383,7,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","However, recent discoveries of new AhR ligands with potential therapeutic applications have been reported, inviting reconsideration of this policy.",0
3383,8,"AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?","Combining in vivo and in vitro findings, we identified nine AhR agonists, six of which are marketed therapeutics and have been approved by the U.S. Food and Drug Administration, including leflunomide, flutamide, and nimodipine.",0
2610,0,Which algorithm has been developed for prediction of protein subcellular localization using deep learning?,DeepLoc: prediction of protein subcellular localization using deep learning.,1
2610,1,Which algorithm has been developed for prediction of protein subcellular localization using deep learning?,DeepLoc: prediction of protein subcellular localization using deep learning.,1
440,0,Which are the main causes of fetal echogenic bowel?,"In group 2 and 3, two anomalies, anorectal malformation and cystic fibrosis, were detected postnatally",0
440,1,Which are the main causes of fetal echogenic bowel?,"Six had chromosomal/genetic abnormalities, two had congenital cytomegalovirus, none had cystic fibrosis",0
440,2,Which are the main causes of fetal echogenic bowel?,Primary bowel pathology is rare following the finding of FEB,0
440,3,Which are the main causes of fetal echogenic bowel?,Maternal serology for cytomegalovirus (CMV) was performed in 49 (78%) cases,0
440,4,Which are the main causes of fetal echogenic bowel?,Thirty-three pregnancies (53%) were tested for cystic fibrosis (CF) and 1 baby was confirmed to have CF postnatally,0
440,5,Which are the main causes of fetal echogenic bowel?,"This study reiterates the increased prevalence of aneuploidy, CMV, CF and fetal growth restriction in pregnancies complicated by the midtrimester sonographic finding of FEB",0
440,6,Which are the main causes of fetal echogenic bowel?,"Primary outcomes were IUGR, defined as birth weight less than the 10th percentile for gestational age and intrauterine fetal demise at 20 weeks or more of gestatio",0
440,7,Which are the main causes of fetal echogenic bowel?,"Analyses were repeated after excluding cases of aneuploidy, cytomegalovirus (CMV) infection,",0
440,8,Which are the main causes of fetal echogenic bowel?,The presence of echogenic bowel on ultrasonography is independently associated with an increased risk for both IUGR and intrauterine fetal demise,0
440,9,Which are the main causes of fetal echogenic bowel?,This study highlights the importance of pregnancy ultrasound examinations and their efficiency in detecting cystic fibrosis,0
440,10,Which are the main causes of fetal echogenic bowel?,"A disorder was diagnosed in 32.2% of the fetuses, cystic fibrosis being the most commonly identified (7.6%).",1
440,11,Which are the main causes of fetal echogenic bowel?,"We also found digestive malformations (7.0%), chromosomal abnormalities (3.7%), and maternofetal infections (3.7%).",1
440,12,Which are the main causes of fetal echogenic bowel?,A potential association with placental abnormalities and a low prevalence of viral infections was observed,0
440,13,Which are the main causes of fetal echogenic bowel?,Our data suggests an inverse relationship between the maternal BMI and the detection of fetal EIF and/or EB,0
440,14,Which are the main causes of fetal echogenic bowel?,Fetal echogenic bowel at 17 weeks' gestational age as the early and only sign of a very long segment of Hirschsprung disease.,0
440,15,Which are the main causes of fetal echogenic bowel?,fetal ultrasound findings associated with intrauterine cytomegalovirus (CMV) infection,0
440,16,Which are the main causes of fetal echogenic bowel?,"the combination of hydrops fetalis, cerebral hemorrhage, and hyperechoic bowel should raise the possibility of a CMV infection",0
440,17,Which are the main causes of fetal echogenic bowel?,"strongly associated with adverse pregnancy outcome due to utero-placental insufficiency, particularly in women with elevated maternal serum alpha-fetoprotein concentration due to severe feto-maternal bleeding",0
440,18,Which are the main causes of fetal echogenic bowel?,Congenital cytomegalovirus infection presenting with echogenic bowel and oligohydramnios.,0
440,19,Which are the main causes of fetal echogenic bowel?,Five cases of trisomy 21 and one case of trisomy 18 were detected,0
440,20,Which are the main causes of fetal echogenic bowel?,Brightly echogenic bowel in the second trimester was found to be associated with a significant risk of fetal aneuploidy.,1
440,21,Which are the main causes of fetal echogenic bowel?,echogenic bowel does not uniformly herald an abnormal outcome.,0
440,22,Which are the main causes of fetal echogenic bowel?,Echogenic bowel coexistent with other abnormalities (such as growth deficiency or structural malformations) may be a comarker for aneuploidy.,1
440,23,Which are the main causes of fetal echogenic bowel?,Congenital cytomegalovirus infection with oligohydramnios and echogenic bowel at 14 weeks' gestation,0
440,24,Which are the main causes of fetal echogenic bowel?,Parental CF carrier testing and amniocentesis to identify aneuploidy or fetal CF status has a high positive ascertainment rate in fetuses with echogenic bowel grades 2 and 3.,0
440,25,Which are the main causes of fetal echogenic bowel?,Swallowing of amniotic fluid after intraamniotic bleeding seems implicated in the etiology of second-trimester echogenic bowel in both euploid and aneuploid fetuses,0
440,26,Which are the main causes of fetal echogenic bowel?,Fetal echogenic bowel and a dilated loop of bowel associated with cystic fibrosis (CF) mutations delta F508 and 2183AA-->G,0
440,27,Which are the main causes of fetal echogenic bowel?,Fifteen cases (19%) were associated with maternal vaginal bleeding,0
440,28,Which are the main causes of fetal echogenic bowel?,Five fetuses (6.3%) had evidence of bowel obstruction or perforation not associated with cystic fibrosis (CF),0
440,29,Which are the main causes of fetal echogenic bowel?,Chromosomal aberrations were found in 5 fetuses (6.3%).,0
440,30,Which are the main causes of fetal echogenic bowel?,"Intrauterine infection with cytomegalovirus, herpes simplex virus, varicella-zoster virus, or parvovirus B-19 was documented in 5 patients (6.3%).",0
440,31,Which are the main causes of fetal echogenic bowel?,"Fetal echogenic bowel has been reported as a normal variant in the second trimester, and has also been associated with an adverse fetal outcome, including cystic fibrosis (CF)",0
440,32,Which are the main causes of fetal echogenic bowel?,Intra-amniotic bleeding can lead to echogenic bowel,0
440,33,Which are the main causes of fetal echogenic bowel?,"112 cases (57%) had a known etiology, which included chromosomal abnormality (7%), infection (4%), cystic fibrosis (1.5%), bowel abnormality (3%), bleeding or stained amniotic fluid (11%), Doppler abnormality (14%), malformation (16%) and miscellaneous (0.5%)",1
4056,0,What is the target of adalimumab?,"The objective of this study was to assess the relative importance of local versus systemic interactions between adalimumab and tumour necrosis factor (TNF)-α in rheumatoid arthritis (RA), identify localization of the site of adalimumab action and assess the efficacy of local (intra-articular) versus systemic adalimumab administration for treatment of RA",1
4056,1,What is the target of adalimumab?,The kinetics of adalimumab permeation to the synovial fluid (0.00422 L/h clearance of permeation) versus the rate of TNFα turnover in the affected joints (1.84 pmol/h synthesis rate and 0.877 h(-1) degradation rate constant) are apparently the major parameters that determine the time course of TNFα concentrations in the synovial fluid and the TNFα-neutralizing effects of adalimumab in RA patients.,0
4056,2,What is the target of adalimumab?,Adalimumab is the first fully human monoclonal antibody directed against TNF.,0
4056,3,What is the target of adalimumab?,"Adalimumab (ADA) is able to induce a comprehensive disease control in RA by achieving clinical, functional and radiographic control",0
4056,4,What is the target of adalimumab?,Targeted drugs against key pathogenetic molecules such as TNF-alpha have significantly improved outcomes in rheumatoid arthritis (RA).,0
4056,5,What is the target of adalimumab?,They are widely used in clinical practice and drug registries give us information to support their use,0
4056,6,What is the target of adalimumab?,"Adalimumab is a fully human monoclonal antibody directed against tumor necrosis factor-alpha, a central cytokine in the immune response in psoriasis that has already been shown to be an effective target for therapy.",1
4056,7,What is the target of adalimumab?,"Adalimumab is a human anti-TNFα monoclonal antibody that has been reported to demonstrate clinical efficacy and safety, resulting in reversal of epidermal hyperplasia and cutaneous inflammation.",1
4056,8,What is the target of adalimumab?,"major pathway of TNFα elimination from the synovial fluid (∼77% for subcutaneous administration, and ∼72% for intravenous and intra-articular administration of adalimumab 40 mg) is interaction with adalimumab, which reaches the joints following local or systemic administration.CONC",0
4056,9,What is the target of adalimumab?,"eability of TNFα, which is excessively secreted in the joints, is even higher than that of adalimumab.",0
4056,10,What is the target of adalimumab?,As,0
4056,11,What is the target of adalimumab?,Adalimumab is the first fully human monoclonal antibody directed against TNF.,0
4056,12,What is the target of adalimumab?,"Most currently available molecules target TNF-alfa with different strategies (i.e., etanercept, infliximab, adalimumab, golimumab, and certolizumab pegol), IL-6 (tocilizumab), CTLA-4 (abatacept), and B cells (rituximab, belimumab) as they are key mediators in the cascade of inflammation.",0
4056,13,What is the target of adalimumab?,"ces in knowledge of the pathogenesis of psoriasis have enabled the development of new drugs that target cytokines (e.g., etanercept, adalimumab, and infliximab, which target TNF α , and ustekinumab, which targets the p40 subunit of IL23 and IL12).",0
4056,14,What is the target of adalimumab?,These drugs,0
4056,15,What is the target of adalimumab?,"There are currently two Food and Drug Administration-approved classes of biologic agents that target tumor necrosis factor-alpha (TNF-alpha): anti-TNF monoclonal antibodies (mAbs) (adalimumab and infliximab), and soluble TNF receptors (etanercept).",0
4056,16,What is the target of adalimumab?,This st,0
4056,17,What is the target of adalimumab?,"meric anti-TNFalpha monoclonal antibody, infliximab, full human anti-TNFalpha monoclonal antibody, adalimumab, and TNF receptor II (p75) -IgGFc fusion protein, etanercept, are widely used in the inflammatory disorders including RA.",0
4056,18,What is the target of adalimumab?,This review arti,0
4056,19,What is the target of adalimumab?,"urrently available molecules target TNF-alfa with different strategies (i.e., etanercept, infliximab, adalimumab, golimumab, and certolizumab pegol), IL-6 (tocilizumab), CTLA-4 (abatacept), and B cells (rituximab, belimumab) as they are key mediators in the cascade of inflammation.",0
4056,20,What is the target of adalimumab?,"Further, small molecu",0
4056,21,What is the target of adalimumab?,"clonal antibodies against VEGF and TNF-alpha such as bevacizumab, ranibizumab, infliximab and adalimumab have been used to control neovascularization and inflammation in eye with significant positive results whereas others have been used to target CD20, CD52, CD11a, and IL-2.",0
4056,22,What is the target of adalimumab?,The growin,0
4056,23,What is the target of adalimumab?,"eview focuses on five biologics which target either T-cells (alefacept) or TNF-alpha (etanercept, adalimumab and infliximab) or interleukin IL-12/IL-23 (ustekinumab)--their efficacy, safety, patient monitoring and recommended dosage.",0
4056,24,What is the target of adalimumab?,The purpose of,0
4056,25,What is the target of adalimumab?,Adalimumab is a human monoclonal antibody against tumor necrosis factor (TNF) alpha approved for moderate-to-severe plaque-type psoriasis and psoriatic arthritis (PsA).,0
4056,26,What is the target of adalimumab?,In clinical practice patients who have not responded to one TNF antagonist may respond to another TNF antagonist.,0
4056,27,What is the target of adalimumab?,The ADAbs can diminish the therapeutic effects of adalimumab by neutralizing the TNFα binding site or increasing its clearance from circulation.M,0
4056,28,What is the target of adalimumab?,Adalimumab is a fully human monoclonal antibody targeted toward tumor necrosis factor alpha (TNF-alpha).,1
4056,29,What is the target of adalimumab?,"Adalimumab (Humira, Abbott Laboratories) is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF.",0
4056,30,What is the target of adalimumab?,"Adalimumab blocks the interaction of TNF with the p55 and p75 cell surface TNF receptors, thereby neutralising the activity of this cytokine.",0
4056,31,What is the target of adalimumab?,Adalimumab is a human monoclonal antibody which targets tumor necrosis factor (TNF)-alpha.,1
91,0,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,RESULTS: Individuals with scores in the top quartile of neuroticism (hazard ratio = 3.1; 95% confidence interval = 1.6-6.0) or the lowest quartile of conscientiousness (hazard ratio = 3.3; 95% confidence interval = 1.4-7.4) had a threefold increased risk of incident AD.,0
91,1,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Five of nine studies found that higher neuroticism was associated with greater dementia risk (pooled hazard ratio [HR] per unit increase on neuroticism score, HR = 1.13, 95% confidence interval [CI] = 1.08-1.18, z = 5.11, p <0.001, N = 3,285), and two studies showed it increased risk of MCI.",0
91,2,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"CONCLUSIONS: Neuroticism increased risk for dementia, and conscientiousness reduced risk.",0
91,3,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,RESULTS: Fully adjusted multivariate analyses showed that the association between the presence of APOE [Latin Small Letter Open E]-4 allele(s) and both outcomes was evident among individuals with high levels of neuroticism and extraversion but not among persons with low levels of these traits.,0
91,4,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"CONCLUSIONS: Phenotypic personality dimensions, primarily neuroticism and extraversion, moderate the relationship between APOE [Latin Small Letter Open E]-4 genotype and cognitive outcomes among older adults.",1
91,5,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?," Individuals with higher baseline scores on vulnerability to stress, anxiety, and depression (neuroticism: odds ratio, 2.0; 95% confidence interval, 1.2-3.5), or lower scores on order and competence (conscientiousness: odds ratio, 0.4; 95% confidence interval, 0.2-0.9) were less likely to remain asymptomatic in the presence of AD neuropathology.",0
91,6,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Neuroticism (r = 0.26), low agreeableness (r = -0.34), and some facets were also significantly associated with advanced stages of neurofibrillary tangles, but the associations between personality traits and risk of clinical dementia were mostly unchanged by controlling for the extent of neurofibrillary tangles and Aβ neuritic plaques.",0
91,7,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Using mixed models adjusted for age, sex, education, race, social network size, depression, chronic conditions, disability, neuroticism, extraversion, cognitive activity, and physical activity, more social activity was associated with less cognitive decline during average follow-up of 5.2 years (SD = 2.7).",0
91,8,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"RESULTS: After controlling for age, the Alzheimer disease group presented significantly higher scores than normal control subjects on current neuroticism, and significantly lower scores on current extraversion, openness, and conscientiousness, while no significant difference was observed on agreeableness.",0
91,9,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?," In analyses of specific cognitive systems, neuroticism subscales were related to decline in episodic memory, working memory, and perceptual speed, but not in semantic memory or visuospatial ability.",0
91,10,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,No component of neuroticism was related to the neuropathologic lesions most commonly associated with late-life dementia.,0
91,11,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,CONCLUSIONS: Neuroticism's association with late-life dementia mainly reflects vulnerability to stress and anxiety and their correlation with decline in the ability to process and retain new information.,1
91,12,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,The finding that AD risk is associated with elevated Neuroticism and lower Conscientiousness can be added to the accumulating literature documenting the pathogenic effects of these two traits.,0
91,13,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"tau was also correlated with the psychometric measures of episodic/semantic memory, working memory, and processing speed, and with the personality traits of neuroticism and conscientiousness.",0
91,14,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"The pre-morbid personality domain of Neuroticism constituted an interesting and theoretically plausible, yet uninvestigated, candidate for such an association.",0
91,15,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,RESULTS: Midlife Neuroticism predicted younger age of dementia onset in females but not in males.,0
91,16,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Preliminary research suggests that cognitively impaired MS patients exhibit elevation in Neuroticism, and diminution in Extraversion, Agreeableness, and Conscientiousness, as do patients with Alzheimer's disease.",0
91,17,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"On the basis of both self-report and informant report, there was an increase in neuroticism and a decrease in conscientiousness in persons with very mild DAT relative to healthy individuals without it, and in persons with mild DAT relative to those with very mild DAT.",0
91,18,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"CONCLUSIONS: As subjective cognitive complaints in the AACD group were related to neuroticism and gender rather than to cognitive performance, their inclusion in diagnostic concepts such as AACD should be revaluated.",0
91,19,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Multiple studies of individuals with Alzheimer disease have substantiated significant levels of informant-rated change in several domains and facets of the Neuroticism-Extraversion-Openness Personality Inventory, including increases in Neuroticism and decreases in Extraversion and Conscientiousness relative to premorbid personality traits.",1
91,20,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,RESULTS: The AD patients showed higher neuroticism than the controls with PD (p=0.013).,0
91,21,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"CONCLUSION: Our results support the assumption of specific premorbid characteristics in AD patients, ie increased neuroticism and rigidity.",0
91,22,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Personality change in DAT was consistent with previous reports of increased neuroticism, decreased extraversion, and decreased conscientiousness, with smaller decreases in openness and agreeableness.",0
91,23,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Neuroticism (r = 0.26), low agreeableness (r = -0.34), and some facets were also significantly associated with advanced stages of neurofibrillary tangles, but the associations between personality traits and risk of clinical dementia were mostly unchanged by controlling for the extent of neurofibrillary tangles and A� neuritic plaques.",0
91,24,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Multiple studies of individuals with Alzheimer disease have substantiated significant levels of informant-rated change in several domains and facets of the Neuroticism-Extraversion-Openness Personality Inventory, including increases in Neuroticism and decreases in Extraversion and Conscientiousness relative to premorbid personality traits",1
91,25,What is the association between personality trait of neuroticism and risk for Alzheimer's disease?,"Multiple studies of individuals with Alzheimer disease have substantiated significant levels of informant-rated change in several domains and facets of the Neuroticism-Extraversion-Openness Personality Inventory, including increases in Neuroticism and decreases in Extraversion and Conscientiousness relative to premorbid personality traits",1
1067,0,Can RG7112 inhibit MDM2?,"To assess the influence of the p53 regulatory pathway further, we studied the effect of RG7112, a small molecule MDM2 antagonist that activates p53 by preventing its interaction with MDM2, on normal megakaryocytopoiesis and platelet production.",0
1067,1,Can RG7112 inhibit MDM2?,RG7112 (2g) is the first clinical small-molecule MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.,1
1067,2,Can RG7112 inhibit MDM2?,"Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.",0
1067,3,Can RG7112 inhibit MDM2?,"We report a proof-of-mechanism study of RG7112, a small-molecule MDM2 antagonist, in patients with chemotherapy-naive primary or relapsed well-differentiated or dedifferentiated MDM2-amplified liposarcoma who were eligible for resection.",1
1067,4,Can RG7112 inhibit MDM2?,"To assess the influence of the p53 regulatory pathway further, we studied the effect of RG7112, a small molecule MDM2 antagonist that activates p53 by preventing its interaction with MDM2, on normal megakaryocytopoiesis and platelet production.",0
1067,5,Can RG7112 inhibit MDM2?,Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.,1
1067,6,Can RG7112 inhibit MDM2?,RG7112 was the first small-molecule p53-MDM2 inhibitor in clinical development.,1
1067,7,Can RG7112 inhibit MDM2?,"RG7112 binds MDM2 with high affinity (K(D) ~ 11 nmol/L), blocking its interactions with p53 in vitro.",0
1067,8,Can RG7112 inhibit MDM2?,"RG7112 is a selective inhibitor of p53-MDM2 binding that frees p53 from negative control, activating the p53 pathway in cancer cells leading to cell cycle arrest and apoptosis.",0
1067,9,Can RG7112 inhibit MDM2?,"The effects of RG7112 and Peg-IFNα 2a on MPN progenitor cells were dependent on blocking p53-MDM2 interactions and activating the p53 pathway, thereby increasing MPN CD34(+) cell apoptosis",0
1067,10,Can RG7112 inhibit MDM2?,The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells,0
1067,11,Can RG7112 inhibit MDM2?,Initial testing of the MDM2 inhibitor RG7112 by the Pediatric Preclinical Testing Program,0
1067,12,Can RG7112 inhibit MDM2?,"In this issue of Blood, Lu et al describe the cooperation between an orally bioavailable mouse double minute 2 (MDM2) antagonist (RG7112) and the pegylated interferon α (Peg-IFNα 2a) to target JAK2V617F hematopoietic progenitors and stem cells",0
1067,13,Can RG7112 inhibit MDM2?,MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.,0
1067,14,Can RG7112 inhibit MDM2?,Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesis.,0
1067,15,Can RG7112 inhibit MDM2?,The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.,0
1067,16,Can RG7112 inhibit MDM2?,Initial testing of the MDM2 inhibitor RG7112 by the Pediatric Preclinical Testing Program.,0
1067,17,Can RG7112 inhibit MDM2?,"The primary endpoint was to assess markers of RG7112-dependent MDM2 inhibition and P53 pathway activation (P53, P21, MDM2, Ki-67, macrophage inhibitory cytokine-1 [MIC-1], and apoptosis).",0
1067,18,Can RG7112 inhibit MDM2?,"RG7112 is a selective inhibitor of p53-MDM2 binding that frees p53 from negative control, activating the p53 pathway in cancer cells leading to cell cycle arrest and apoptosis.",0
1067,19,Can RG7112 inhibit MDM2?,RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (PPTP) due to the relatively low incidence of p53 mutations in pediatric cancers compared with adult malignancies.,0
1067,20,Can RG7112 inhibit MDM2?,"However, the hydrophobic protein-protein interaction surface represents a significant challenge for the development of small-molecule inhibitors with desirable pharmacological profiles.",0
1067,21,Can RG7112 inhibit MDM2?,RG7112 was the first small-molecule p53-MDM2 inhibitor in clinical development.,1
1067,22,Can RG7112 inhibit MDM2?,"Treatment with low doses of RG7112, an orally available small-molecule inhibitor of p53-MDM2, both alone and combined with pegylated interferon α 2a (Peg-IFNα 2a), significantly decreased MPN colony-forming unit-granulocyte macrophage and burst-forming unit-erythroid numbers and preferentially eliminated the total number of JAKV617F(+) MPN hematopoietic progenitor cells.",0
1067,23,Can RG7112 inhibit MDM2?,"The effects of RG7112 and Peg-IFNα 2a on MPN progenitor cells were dependent on blocking p53-MDM2 interactions and activating the p53 pathway, thereby increasing MPN CD34(+) cell apoptosis.",0
1067,24,Can RG7112 inhibit MDM2?,RG7112 (2g) is the first clinical small-molecule MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.,0
1067,25,Can RG7112 inhibit MDM2?,"In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.",0
1779,0,List selective estrogen receptor degraders.,"For women with hormone receptor-positive advanced breast cancer, endocrine therapies, including the selective estrogen receptor modulator tamoxifen, the aromatase inhibitors anastrozole, letrozole, and exemestane, and the selective estrogen receptor degrader fulvestrant, are recommended in clinical guidelines.",0
1779,1,List selective estrogen receptor degraders.,"Here we describe and characterize a novel, orally bioavailable small-molecule selective estrogen receptor degrader, RAD1901, and evaluate its therapeutic potential for the treatment of breast cancer.",1
1779,2,List selective estrogen receptor degraders.,"Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.",0
1779,3,List selective estrogen receptor degraders.,"Fulvestrant is a steroid-based, selective estrogen receptor degrader (SERD) that both antagonizes and degrades ER-α and is active in patients who have progressed on antihormonal agents.",0
1779,4,List selective estrogen receptor degraders.,"Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader.",0
1779,5,List selective estrogen receptor degraders.,"However, being the only SERD currently known to access the brain, RAD1901 merits evaluation as a targeted therapy for the treatment of breast cancer brain metastases.",1
1779,6,List selective estrogen receptor degraders.,"Tamoxifen, toremifene, and the selective estrogen receptor degrader fulvestrant are used to treat breast cancer, and tamoxifen and raloxifene protect against breast cancer in high-risk women.",1
1779,7,List selective estrogen receptor degraders.,The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy.,1
1779,8,List selective estrogen receptor degraders.,"Currently, ICI 182,780 (ICI, fulvestrant) is the only SERD approved for the treatment of breast cancer.",1
1779,9,List selective estrogen receptor degraders.,"Fulvestrant is a steroid-based, selective estrogen receptor degrader (SERD) that both antagonizes and degrades ER-á and is active in patients who have progressed on antihormonal agents.",0
1779,10,List selective estrogen receptor degraders.,"Fulvestrant is a steroid-based, selective estrogen receptor degrader (SERD) that both antagonizes and degrades ER-α and is active in patients who have progressed on antihormonal agents",0
1779,11,List selective estrogen receptor degraders.,"RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models.",0
1779,12,List selective estrogen receptor degraders.,RAD1901 selectively binds to and degrades the ER and is a potent antagonist of ER-positive breast cancer cell proliferation.,0
1779,13,List selective estrogen receptor degraders.,"The selective estrogen receptor degrader, fulvestrant, significantly reduced the anchorage-independent growth of ESR1 mutant-expressing cells, while combination treatments with the mTOR inhibitor everolimus, or an inhibitor blocking IGF1R, and the insulin receptor significantly enhanced anti-proliferative responses.",0
1779,14,List selective estrogen receptor degraders.,"SUM-44 cells do not require exogenous estrogen for growth in vitro; however, they are dependent on ERα expression, as ESR1 knock-down or exposure to the selective estrogen receptor degrader fulvestrant resulted in growth inhibition.",0
1779,15,List selective estrogen receptor degraders.,"Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader.",0
1779,16,List selective estrogen receptor degraders.,"Fulvestrant is a steroid-based, selective estrogen receptor degrader (SERD) that both antagonizes and degrades ER-α and is active in patients who have progressed on antihormonal agents.",0
3538,0,What is the genetic basis for Cornelia de Lange's syndrome?,"Mutations in five genes (NIPBL, SMC1A, SMC3, RAD21, and HDAC8), all regulators or structural components of cohesin, have been identified.",1
3538,1,What is the genetic basis for Cornelia de Lange's syndrome?,"60% of CdLS cases are due to NIPBL mutations, 5% caused by mutations in SMC1A, RAD21, and HDAC8 and one proband was found to carry a mutation in SMC3.",1
112,0,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,Most luminal lysosomal proteins are synthesized as precursors containing mannose 6-phosphate (Man6-P) and a number of recent studies have conducted affinity purification of Man6-P containing proteins as a step toward defining the composition of the lysosome,0
112,1,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"This chapter describes the process of production, purification, separation, and mass spectrometry identification of soluble lysosomal proteins.",0
112,2,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"The rationale for purification of these proteins resides in their characteristic sugar, the mannose-6-phosphate (M6P), which allows an easy purification by affinity chromatography on immobilized M6P receptor (MPR",1
112,3,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,ecretions of these cells were affinity purified using an affinity matrix derivatized with MPR46 and MPR300.,0
112,4,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"In the protein fraction bound to the affinity matrix and eluted with mannose 6-phosphate,",0
112,5,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"Proteins containing mannose 6-phosphate (Man6-P), a carbohydrate modification used for targeting resident soluble lysosomal proteins to the lysosome, were affinity-purified using immobilized Man6-P receptor.",1
112,6,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?, We purified mannose 6-phosphorylated proteins by affinity chromatography,0
112,7,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"Since lysosomal soluble proteins are characterized by the presence of mannose-6-phosphate, they were purified on an affinity support bearing mannose-6-phosphate receptor",1
112,8,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,The most abundant lysosomal substrates of Acp2 and Acp5 were identified by Man6P affinity chromatography and mass spectrometry.,0
112,9,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"urinary proteins were affinity purified on immobilized Man-6-P receptors,",0
112,10,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"A number of proteomic studies have focused on lysosomal proteins, exploiting the fact that Man-6-P-containing forms can be purified by affinity chromatography on immobilized MPRs.",1
112,11,What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?,"In this study, we purified the Man-6-P glycoforms of proteins from human plasma by affinity chromatography on immobilized MPRs",1
3908,0,What was fingolimod synthesized from?,"Pioneering in this field was the synthesis of FTY720 (fingolimod, Gilenya®) from myriocin, one of the metabolites of the fungus Isaria sinclairii known from traditional Chinese medicine for its antibacterial and energy boosting effect.",1
540,0,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Maintenance of cellular calcium homeostasis is critical to regulating mitochondrial ATP production and cardiac contraction.,1
540,1,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"the Ca(2+) signal regulates the most important activities of the cell, from the expression of genes, to heart and muscle contraction and other motility processes, to diverse metabolic pathways involved in the generation of cell fuels",0
540,2,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Pharmacologic modification of cellular calcium handling recently moved into focus as an alternative for prevention and treatment of ventricular tachyarrhythmias,0
540,3,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"diabetic rats displayed abnormal cardiac structure and systolic and diastolic dysfunction, and spermine (CaSR agonist) could prevent or slow its progression.",0
540,4,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"These results indicate that the CaSR expression of myocardium is reduced in the progress of DCM, and its potential mechanism is related to the impaired intracellular calcium homeostasis.",0
540,5,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,calcium-sensing receptor (CaSR),0
540,6,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Na(+)/Ca(2+) exchanger (NCX) plays important roles in cardiac electrical activity and calcium homeostasis.,0
540,7,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,NCX current (I(NCX)) shows transmural gradient across left ventricle in many species.,0
540,8,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Previous studies demonstrated that NCX expression was increased and transmural gradient of I(NCX) was disrupted in failing heart,0
540,9,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"calcium homeostasis, the key process underlying excitation-contraction coupling",0
540,10,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,The results indicate the calcium handling properties of hiPSC-derived cardiomyocytes are relatively immature to hESC counterparts,0
540,11,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Our understanding of the molecular processes which regulate cardiac function has grown immeasurably in recent years.,0
540,12,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Even with the advent of β-blockers, angiotensin inhibitors and calcium modulating agents, heart failure (HF) still remains a seriously debilitating and life-threatening condition.",0
540,13,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Here, we review the molecular changes which occur in the heart in response to increased load and the pathways which control cardiac hypertrophy, calcium homeostasis, and immune activation during HF.",0
540,14,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Calcium-sensing receptors (CaSRs) are G-protein coupled receptors which maintain systemic calcium homeostasis and participate in hormone secretion, activation of ion channels, cell apoptosis, proliferation, and differentiation.",0
540,15,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,CaSRs are associated with I/R injury and apoptosis in neonatal rat ventricular cardiomyocytes via suppressing Bcl-2 and promoting caspase-3 expression.,0
540,16,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Important insights into the molecular basis of hypertrophic cardiomyopathy and related diseases have been gained by studying families with inherited cardiac hypertrophy.,0
540,17,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Integrated clinical and genetic investigations have demonstrated that different genetic defects can give rise to the common phenotype of cardiac hypertrophy.,0
540,18,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Diverse pathways have been identified, implicating perturbations in force generation, force transmission, intracellular calcium homeostasis, myocardial energetics, and cardiac metabolism in causing disease",0
540,19,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,HAX-1 as a regulator of contractility and calcium cycling in the heart.,0
540,20,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"HAX-1 overexpression reduced sarcoplasmic reticulum Ca-ATPase (SERCA2) pump activity in isolated cardiomyocytes and in vivo, leading to depressed myocyte calcium kinetics and mechanics.",0
540,21,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Thus, HAX-1 represents a regulatory mechanism in cardiac calcium cycling and its responses to sympathetic stimulation, implicating its importance in calcium homeostasis and cell survival.",0
540,22,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Calcium ions are the most ubiquitous and versatile signaling molecules in eukaryotic cells.,0
540,23,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Calcium homeostasis and signaling systems are crucial for both the normal growth of the budding yeast Saccharomyces cerevisiae and the intricate working of the mammalian heart.,0
540,24,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,this knowledge can be used to help treat relevant human diseases such as pathological cardiac hypertrophy and heart failure,0
540,25,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"With aging, the heart develops myocyte hypertrophy associated with impaired relaxation indices.",0
540,26,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"To define the cellular basis of this adaptation, we examined the physiological changes that arise in calcium handling in the aging heart and contrasted the adaptations that occur following the imposition of a stimulus that alters calcium homeostasis in a young and an old heart",0
540,27,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,alterations in the calcium-handling machinery of the cardiocyte differ in the context of age and as such may predispose the older heart to the development of a hypertrophic phenotype.,0
540,28,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,The cardiac sodium-calcium exchanger (NCX1) is a key sarcolemmal protein for the maintenance of calcium homeostasis in the heart.,0
540,29,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Thus exchanger overexpression in mice leads to abnormal calcium handling and a decompensatory transition to heart failure with stress,0
540,30,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Central to controlling intracellular calcium concentration ([Ca(2+)](i)) are a number of Ca(2+) transporters and channels with the L-type Ca(2+) channel, Na(+)-Ca(2+) exchanger and sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) being of particular note in the heart.",0
540,31,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,This review concentrates on the regulation of [Ca(2+)](i) in cardiac muscle and the homeostatic mechanisms employed to ensure that the heart can operate under steady-state conditions on a beat by beat basis.,0
540,32,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"the tight regulation of SR Ca(2+) content is also required to prevent the abnormal, spontaneous or diastolic release of Ca(2+) from the SR.",0
540,33,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Such diastolic events are a major factor contributing to the genesis of cardiac arrhythmias in disease situations and in recently identified familial mutations in the SR Ca(2+) release channel (ryanodine receptor, RyR).",0
540,34,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Calcium channels have a unique functional role, because not only do they participate in this activity, they form the means by which electrical signals are converted to responses within the cell.",0
540,35,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Calcium channels play an integral role in excitation in the heart and shaping the cardiac action potential.,0
540,36,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"In addition, calcium influx through calcium channels is responsible for initiating contraction.",0
540,37,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"Abnormalities in calcium homeostasis underlie cardiac arrhythmia, contractile dysfunction and cardiac remodelling.",1
540,38,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Cardiac calcium (Ca(2+)) handling subsumes the mechanisms maintaining the myocardial Ca(2+) homeostasis that contribute essentially to cardiac performance.,0
540,39,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Calcium is an important mediator in cardiac excitation and disorders in cardiac Ca(2+) homeostasis have great influence on the cardiac action potential.,1
540,40,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"We review the physiology of the cardiac calcium homeostasis, including the cardiac excitation contraction coupling and myocyte calcium cycling.",1
540,41,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"We review the physiology of the cardiac calcium homeostasis, including the cardiac excitation contraction coupling and myocyte calcium cycling",0
540,42,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Calcium is an important mediator in cardiac excitation and disorders in cardiac Ca(2+) homeostasis have great influence on the cardiac action potential,1
540,43,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,"The role of calcium in cardiac and vascular smooth muscle physiology was reviewed, highlighting the major mechanisms responsible for maintaining calcium homeostasis in these cells",0
540,44,Is Calcium homeostasis important in cardiac physiology and pathophysiology?,Energy metabolism and Ca(2+) handling serve critical roles in cardiac physiology and pathophysiology,0
3058,0,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"A complete ophthalmic examination is not routinely performed on infants with Miller-Dieker syndrome (MDS, chromosome 17p13.3 microdeletion).",0
3058,1,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Chromosome microdeletions within 17p13.3 can result in either isolated lissencephaly sequence (ILS) or Miller-Dieker syndrome (MDS).,0
3058,2,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,We report a fetus with lissencephaly diagnosed as Miller-Dieker Syndrome postnatally.,0
3058,3,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"G banded chromosome analysis revealed 45,X,psu dic(17;Y)(p13;p11.32).ish dic (17;Y)(LIS1-,RARA+, SRY+, DYZ3+) by G-banding analysis using high resolution banding technique.",0
3058,4,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Fetal delayed cortical development will be the findings to perform further investigations including fluorescence in situ hybridization analysis for MDS, a 17p13.3 microdeletion syndrome, pre/postnatally.",0
3058,5,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,This will be the first case of MDS with unbalanced translocation between deleted short arm of chromosome 17 and Y chromosome.,0
3058,6,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?, We report the finding of a 2.5-Mb gene region quadruplication of Chromosome 17p13.3.,0
3058,7,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,This region is well characterized for the deletion leading to Miller-Dieker syndrome but has an unclear replication phenotype.,0
3058,8,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Both deletions have overlapped with the critical region of Miller-Dieker syndrome (MDS) and involved candidate genes such as PAFAH1B1, YWHAE and CRK.",0
3058,9,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"In addition, SNP array and FISH analyses on the parental peripheral blood samples demonstrated that both 17p13.3 and 17p13.3p13.2 deletions were of de novo origin.",0
3058,10,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Miller-Dieker syndrome (MDS) is caused by a heterozygous deletion of chromosome 17p13.3 involving the genes LIS1 and YWHAE (coding for 14.3.3ε) and leads to malformations during cortical development.,1
3058,11,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"We studied after death a 3-month-old girl whose karyotype was 45,XX,-15,-17,+der(17),t(15;17)(q13;p13.3) and thus combines abnormalities of chromosome 15 associated with the Prader-Willi syndrome and of chromosome 17 associated with the Miller-Dieker syndrome.",0
3058,12,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"The Miller-Dieker syndrome (MDS), a syndrome with lissencephaly, distinctive craniofacial features, growth impairment, and profound developmental failure, has been associated with a deletion of the distal part of chromosome band 17p13.",0
3058,13,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,The Miller-Dieker syndrome (type I lissencephaly) is a neuronal migration disorder which is associated with microdeletions in the short arm of chromosome 17.,0
3058,14,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Detection of submicroscopic deletions in band 17p13 in patients with the Miller-Dieker syndrome.,0
3058,15,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"A 15-month-old girl with Miller-Dieker syndrome, a contiguous gene deletion syndrome involving chromosome 17p13.3 and resulting in lissencephaly, was diagnosed with precursor B-cell acute lymphoblastic leukemia.",0
3058,16,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"A computed tomography scan revealed evidence of lissencephaly, and chromosomal analysis showed a microdeletion on the short arm of chromosome 17 (17p13.3), confirming the diagnosis as Miller-Dieker syndrome.",0
3058,17,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Familial Miller-Dieker syndrome associated with pericentric inversion of chromosome 17.,0
3058,18,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"The Miller-Dieker syndrome (MDS), a rare congenital disorder manifested by characteristic facial abnormalities and lissencephaly (smooth brain), is associated with microdeletions of the distal 17p region.",0
3058,19,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Miller-Dieker syndrome (MDS), a disorder manifesting the severe brain malformation lissencephaly (""smooth brain""), is caused, in the majority of cases, by a chromosomal microdeletion of the distal short arm of chromosome 17.",0
3058,20,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"The Miller-Dieker syndrome (MDS), composed of characteristic facial abnormalities and a severe neuronal migration disorder affecting the cerebral cortex, is caused by visible or submicroscopic deletions of chromosome band 17p13.",0
3058,21,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment.",0
3058,22,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Identification of the functional profilin gene, its localization to chromosome subband 17p13.3, and demonstration of its deletion in some patients with Miller-Dieker syndrome.",0
3058,23,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"HIC1 is a candidate tumor suppressor gene which is frequently hypermethylated in human tumors, and its location within the Miller-Dieker syndrome's critical deletion region at chromosome 17p13.3 makes it a candidate gene for involvement in this gene deletion syndrome.",0
3058,24,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"A complete ophthalmic examination is not routinely performed on infants with Miller-Dieker syndrome (MDS, chromosome 17p13.3 microdeletion).",0
3058,25,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,About 15% of patients with isolated lissencephaly and more than 90% of patients with Miller-Dieker syndrome have microdeletions in a critical 350-kilobase region in chromosome 17p13.3 (ref.,0
3058,26,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Chromosome aberrations in which epilepsy is a major and consistent finding include Angelman syndrome due to loss of the maternal 15q11.2-q12 segment, tetrasomy of the maternal segment 15pter-q13 due to an additional inv dup chromosome, Miller-Dieker syndrome due to deletion of the 17p13.3 segment including the lissencephaly1 gene, ring chromosome 20, and Wolf-Hirschhorn syndrome due to deletion of at least the 4p16.3 segment.",0
3058,27,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Miller-Dieker syndrome and trisomy 5p in a child carrying a derivative chromosome with a microdeletion in 17p13.3 telomeric to the LIS1 and the D17S379 loci.,1
3058,28,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"The Miller-Dieker syndrome, a disorder of neuronal migration, is caused by deletions of chromosome 17p13.3.",1
3058,29,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"The girl was diagnosed by subtelomeric FISH and array-CGH, showing a 4.43-Mb heterozygous deletion on chromosome 10p that involved 14 genes and a 3.22-Mb single-copy gain on chromosome 17p, which includes the critical region of the Miller-Dieker syndrome and 61 genes.",0
3058,30,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Detection of submicroscopic deletions in band 17p13 in patients with the Miller-Dieker syndrome.The Miller-Dieker syndrome (MDS), a syndrome with lissencephaly, distinctive craniofacial features, growth impairment, and profound developmental failure, has been associated with a deletion of the distal part of chromosome band 17p13.",0
3058,31,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment.Microdeletions of chromosome 17p13.3 involving YWHAE present with growth restriction, craniofacial dysmorphisms, structural abnormalities of brain and cognitive impairment.",0
3058,32,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Unbalanced translocation (15;17)(q13;13.3) with apparent Prader-Willi syndrome but without Miller-Dieker syndrome.We studied after death a 3-month-old girl whose karyotype was 45,XX,-15,-17,+der(17),t(15;17)(q13;p13.3) and thus combines abnormalities of chromosome 15 associated with the Prader-Willi syndrome and of chromosome 17 associated with the Miller-Dieker syndrome.",0
3058,33,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"The Miller-Dieker syndrome (MDS), a rare congenital disorder manifested by characteristic facial abnormalities and lissencephaly (smooth brain), is associated with microdeletions of the distal 17p region.",0
3058,34,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3.Miller-Dieker syndrome (MDS) is a multiple malformation syndrome characterized by classical lissencephaly and a characteristic facies.,1
3058,35,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Case Report of Proliferative Peripheral Retinopathy in Two Familial Lissencephaly Infants with Miller-Dieker Syndrome.A complete ophthalmic examination is not routinely performed on infants with Miller-Dieker syndrome (MDS, chromosome 17p13.3 microdeletion).",0
3058,36,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Identification of the functional profilin gene, its localization to chromosome subband 17p13.3, and demonstration of its deletion in some patients with Miller-Dieker syndrome.Profilin is a conserved actin-monomer-binding protein which is found in all eukaryotes, including yeast.",0
3058,37,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,We propose that essentially no loss of 17p material has occurred and confirm previous reports that the critical region for the production of the Miller-Dieker phenotype is located subterminally in the 17p13.3 region.<br>,0
3058,38,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"A review of the literature revealed five additional patients in three families, who had Miller-Dieker syndrome and an abnormality of 17p.",0
3058,39,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,We propose that essentially no loss of 17p material has occurred and confirm previous reports that the critical region for the production of the Miller-Dieker phenotype is located subterminally in the 17p13.3 region.,0
3058,40,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Miller-Dieker syndrome: lissencephaly and monosomy 17p.,0
3058,41,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,"Thus, we propose that monosomy of distal 17p may be the cause of Miller-Dieker syndrome in some patients.",0
3058,42,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Miller-Dieker syndrome with der(17)t(12;17)(q24.33;p13.3)pat presenting with a potential risk of mis-identification as a de novo submicroscopic deletion of 17p13.3.,0
3058,43,Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?,Most cases of Miller-Dieker syndrome have a de novo deletion involving 17p13.3.,1
3518,0,What is Hemochromatosis?,Hereditary hemochromatosis (HH) is one of the most common genetically transmitted conditions in individuals of Northern European ancestry.,0
3518,1,What is Hemochromatosis?,"The disease is characterized by excessive intestinal absorption of dietary iron, resulting in pathologically high iron storage in tissues and organs",0
3518,2,What is Hemochromatosis?,HFE hemochromatosis is an inborn error of iron metabolism linked to a defect in the regulation of hepcidin synthesis,0
3518,3,What is Hemochromatosis?,"Hereditary hemochromatosis (HH) is a group of genetic iron overload disorders that manifest with various symptoms, including hepatic dysfunction, diabetes, and cardiomyopathy.",1
3518,4,What is Hemochromatosis?,"hereditary hemochromatosis, an autosomal dominant iron overload condition with variable phenotypic manifestations.",0
3518,5,What is Hemochromatosis?,Hereditary hemochromatosis (HH) is a genetic disorder of iron metabolism that may lead to iron overload.,1
3518,6,What is Hemochromatosis?,"OBJECTIVE

Hemochromatosis is an inherited disease with iron overload and joint involvement resembling osteoarthritis.",0
3518,7,What is Hemochromatosis?,Hereditary hemochromatosis is an autosomal recessive disorder that disturbs iron metabolism and results in iron deposition throughout the body .,0
3518,8,What is Hemochromatosis?,Hereditary hemochromatosis is an inherited disorder of iron metabolism in the Caucasian population with an autosomal recessive inheritance and a prevalence between 1 in 200 and 1 in 500 .,0
3518,9,What is Hemochromatosis?,Hereditary hemochromatosis is a disorder that can cause iron overload and organ damage.,1
3518,10,What is Hemochromatosis?,Hemochromatosis is a common disorder characterized by excess iron absorption and accumulation of iron in tissues .,0
3518,11,What is Hemochromatosis?,Hereditary hemochromatosis is an iron overload disorder that can lead to the impairment of multiple organs and is caused by mutations in one or more different genes .,1
3518,12,What is Hemochromatosis?,Hereditary hemochromatosis is an autosomal recessive disorder that disrupts the body's regulation of iron.,0
3518,13,What is Hemochromatosis?,"Hereditary hemochromatosis type 1, also known as hereditary hemochromatosis classical (HHC), is an iron overload disorder associated, in most cases, with mutations of the hemochromatosis (HFE) gene.",0
3518,14,What is Hemochromatosis?,Hereditary hemochromatosis (HH) is a disorder of iron regulation that leads to excessive iron absorption.,1
3518,15,What is Hemochromatosis?,The primary cause of excessive iron storage in humans is hereditary hemochromatosis.,0
1745,0,Are microtubules marked by glutamylation?,"Together with detyrosination, glutamylation and other modifications, tubulin acetylation may form a unique 'language' to regulate microtubule structure and function.",1
1745,1,Are microtubules marked by glutamylation?,"Glutamylation, the most prevalent tubulin posttranslational modification, marks stable microtubules and regulates recruitment and activity of microtubule- interacting proteins.",1
1745,2,Are microtubules marked by glutamylation?,"Enzymes of the tubulin tyrosine ligase-like (TTLL) family posttranslationally modify and thereby mark microtubules by glutamylation, generating specific recognition sites for microtubule-interacting proteins.",1
1745,3,Are microtubules marked by glutamylation?," PTMs of the cytoskeleton, including phosphorylation, glycosylation, ubiquitination, detyrosination/tyrosination, (poly)glutamylation and (poly)glycylation, acetylation, sumoylation, and palmitoylation, will be addressed in this chapter.",0
1745,4,Are microtubules marked by glutamylation?,"The tubulin posttranslational modifications: acetylation, detyrosination, polyglutamylation, and polyglycylation play important roles in microtubule functions",1
1745,5,Are microtubules marked by glutamylation?,"In most eukaryotic cells, tubulin is subjected to posttranslational glutamylation, a conserved modification of unclear function.",1
4008,0,Which are the parts of a flaggelum?,"The bacterial flagellum is a supramolecular motility machine consisting of the basal body, the hook, and the filament.",1
4008,1,Which are the parts of a flaggelum?,"The flagellum of Salmonella enterica serovar Typhimurium is composed of a bi-directional rotary motor, a universal joint and a helical propeller.",1
4008,2,Which are the parts of a flaggelum?,"The axial structure of the flagellum consists of the rod, hook, junction, filament, and cap.",1
517,0,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.,1
517,1,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,Tofacitinib is the first oral Janus kinase inhibitor indicated for treatment of moderate to severe RA.,0
517,2,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.",0
517,3,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).",0
517,4,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"With tofacitinib, the first Janus kinase (JAK) inhibitor has been approved in the USA, as well as in Switzerland and other countries.",0
517,5,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Tofacitinib, which is a Janus kinase (JAK) inhibitor, has shown clinical effects in the treatment of rheumatoid arthritis.",1
517,6,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Tofacitinib is an oral janus kinase (JAK) inhibitor that inhibits JAK family kinase members, in particular JAK1 and JAK3, achieving a broad limitation of inflammation by interfering with several cytokine receptors.",1
517,7,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"It first proved its efficacy as an immunosuppressive regimen after renal transplantation, and was recently approved by the FDA for rheumatoid arthritis.",1
517,8,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?," In patients treated with the JAK inhibitor tofacitinib, RR for hypercholesterolaemia was 1.70 (1.10 to 2.63) that was dose related.",0
517,9,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"After two decades of research and development activity focussed on orally active kinase inhibitors, the first such drug (the JAK inhibitor Xeljanz, tofacitinib) was approved by the FDA in November 2012 for the treatment of rheumatoid arthritis (RA).",0
517,10,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.,0
517,11,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"An orally available JAK3 inhibitor, tofacitinib, has been applied for RA, with satisfactory effects and acceptable safety in multiple clinical examinations.",0
517,12,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Subsequently, multiple phase 3 studies were carried out, and tofacitinib with or without methotrexate (MTX) is efficacious and has a manageable safety profile in active RA patients who are MTX naïve or show inadequate response to methotrexate (MTX-IR), disease-modifying antirheumatic drugs (DMARD)-IR, or tumor necrosis factor (TNF)-inhibitor-IR.",0
517,13,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Taken together, an orally available kinase inhibitor tofacitinib targeting JAK-mediated signals would be expected to be a new option for RA treatment.",0
517,14,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"A non-selective JAK inhibitor, ruxolitinib, has recently been approved to treat myelofibrosis whereas tofacitinib is poised for approval to treat rheumatoid arthritis.",0
517,15,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,The recent disclosure of the clinical efficacy of a selective JAK1 inhibitor (GLPG-0634) in rheumatoid arthritis and detailed disclosure of the some potent and highly selective JAK1 inhibitors provide a clear stimulus for further activity in this area.,0
517,16,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"These results suggest that the JAK inhibitor tofacitinib suppresses osteoclast-mediated structural damage to arthritic joints, and this effect is secondary to decreased RANKL production.",0
517,17,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"More recently, the Janus kinase (JAK) inhibitor tofacitinib has been evaluated as a potential new treatment option in RA and is awaiting approval.",0
517,18,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"A total of 140 patients were randomised to tofacitinib 1, 3, 5, 10 mg or placebo twice daily and the American College of Rheumatology 20% improvement criteria (ACR20) response rate at week 12, a primary end point, was significant for all tofacitinib treatment groups.",0
517,19,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Thus, an orally available tofacitinib in combination with MTX was efficacious and had a manageable safety profile.",0
517,20,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,Tofacitinib at 5 and 10 mg twice a day appears suitable for further evaluation to optimise the treatment of RA.,0
517,21,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Moreover, induction of IL-10 production by DCs can be one mechanism of action of the JAK inhibitor (tofacitinib) which have shown high efficiency on active rheumatoid arthritis in clinical trials.",0
517,22,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Recently, CP-690,550 (tofacitinib), originally developed as a JAK3 inhibitor, has been shown to be effective in phase III clinical trials of rheumatoid arthritis and collagen-induced arthritis (CIA) models, but the precise mechanism of the effect, especially with respect to Th17 cells, is poorly understood.",0
517,23,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?," Tofacitinib (CP-690,550) is a novel JAK inhibitor that is currently in clinical trials for the treatment of rheumatoid arthritis (RA).",1
517,24,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"To compare the efficacy, safety, and tolerability of 6 dosages of oral tofacitinib (CP-690,550) with placebo for the treatment of active rheumatoid arthritis (RA) in patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.",0
517,25,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"In patients with active RA in whom the response to MTX has been inadequate, the addition of tofacitinib at a dosage ≥3 mg twice daily showed sustained efficacy and a manageable safety profile over 24 weeks.",0
517,26,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"OBJECTIVE: To compare the efficacy, safety, and tolerability of 5 doses of oral tofacitinib (CP-690,550) or adalimumab monotherapy with placebo for the treatment of active rheumatoid arthritis (RA) in patients with an inadequate response to disease-modifying antirheumatic drugs.",0
517,27,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,Tofacitinib monotherapy at ≥3 mg twice a day was efficacious in the treatment of patients with active RA over 24 weeks and demonstrated a manageable safety profile.,0
517,28,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"The new JAK3 inhibitor, CP690,550, has shown efficacy in the treatment of rheumatoid arthritis.",0
517,29,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"CP-690,550 is a potent and selective JAK inhibitor currently in clinical trials for rheumatoid arthritis (RA) and other autoimmune disease indications.",0
517,30,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment.",0
517,31,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"To investigate the effects of methotrexate (MTX) on the pharmacokinetics (PK) of CP-690,550, a novel Janus kinase (JAK) inhibitor in development as a therapy for rheumatoid arthritis (RA), to determine the effects of multiple doses of CP-690,550 on the PK of MTX, and to evaluate the short-term safety and tolerability of co-administration of CP-690,550 and MTX.",0
517,32,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial.",0
517,33,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"CP-690,550 was efficacious in improving the pain, function and health status of patients with RA, from week 1 to week 6.",0
517,34,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"Our findings indicate that CP-690,550 is efficacious in the treatment of RA, resulting in rapid, statistically significant, and clinically meaningful reductions in the signs and symptoms of RA.",0
517,35,Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?,"INCB18424 targeting Jak1/2 and CP690,550 targeting Jak3 has been developed and is now on phase II clinical study for RA.",0
1012,0,List interaction partners for the protein GATA1.,"Our work describes, for the first time, distinct GATA-1 interactions with the essential hematopoietic factor Gfi-1b, the repressive MeCP1 complex, and the chromatin remodeling ACF/WCRF complex, in addition to the known GATA-1/FOG-1 and GATA-1/TAL-1 complexes.",1
1012,1,List interaction partners for the protein GATA1.,"We also provide evidence that distinct GATA-1 complexes are associated with specific GATA-1 functions in erythroid differentiation, for example, GATA-1/Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1/MeCP1 with the repression of other hematopoietic transcription programs.",1
1012,2,List interaction partners for the protein GATA1.,"We next applied the biotinylation tag to Ldb-1, a known partner of GATA-1, and characterized a number of novel interaction partners that are essential in erythroid development, in particular, Eto-2, Lmo4, and CdK9.",0
1012,3,List interaction partners for the protein GATA1.,Endogenous GATA1 and LDB1 proteins were confirmed to bind to LMO2-C by MBP pull down analysis.,0
1012,4,List interaction partners for the protein GATA1.,LMO2-C can bind endogenous GATA1 and LDB1 protein in K562 cells and down regulates the expression of GPA.,0
1012,5,List interaction partners for the protein GATA1.,"We identify novel transcription factor binding partners for PIAS3 including ETS, EGR1, NR1I2, and GATA1.",0
1012,6,List interaction partners for the protein GATA1.,"At other differentiation stages, additional combinatorial interactions occurred between RUNX1 and its coregulators, GATA1 and ETS.",0
1012,7,List interaction partners for the protein GATA1.,"Ldb1, a ubiquitously expressed LIM domain binding protein, is essential in a number of tissues during development.",0
1012,8,List interaction partners for the protein GATA1.,"It interacts with Gata1, Tal1, E2A and Lmo2 to form a transcription factor complex regulating late erythroid genes.",0
1012,9,List interaction partners for the protein GATA1.,"Using a biotinylation tagging/proteomics approach in erythroid cells, we describe distinct GATA-1 interactions with the essential hematopoietic factor Gfi-1b, the repressive MeCP1 complex and the chromatin remodeling ACF/WCRF complex, in addition to the known GATA-1/FOG-1 and GATA-1/TAL-1 complexes.",1
1012,10,List interaction partners for the protein GATA1.,"Importantly, we show that FOG-1 mediates GATA-1 interactions with the MeCP1 complex, thus providing an explanation for the overlapping functions of these two factors in erythropoiesis.",1
1012,11,List interaction partners for the protein GATA1.,"Here we show that Ski interacts with GATA1, a transcription factor essential in erythropoiesis.",0
1012,12,List interaction partners for the protein GATA1.,"Using a Ski mutant deficient in GATA1 binding, we show that this Ski-GATA1 interaction is critical for Ski's ability to repress GATA1-mediated transcription and block erythroid differentiation.",0
1012,13,List interaction partners for the protein GATA1.,"The zinc finger transcription factor GATA-1, a central mediator of erythroid gene expression, interacts with multiple proteins including FOG-1, EKLF, SP1, CBP/p300 and PU.1.",1
1012,14,List interaction partners for the protein GATA1.,tudies involving point mutants of GATA-1 have shown that a direct physical interaction between GATA-1 and FOG-1 is essential for normal human erythroid and megakaryocyte maturation in vivo.,0
1012,15,List interaction partners for the protein GATA1.,"In addition, evidence has emerged that physical interaction between GATA-1 and the myeloid/lymphoid specific factor PU.1, an oncogene implicated in murine erythroleukemia, acts to functionally cross-antagonize one another.",0
2573,0,Which sequence-based algorithm for branch point prediction has been proposed?,BPP: a sequence-based algorithm for branch point prediction.,1
2573,1,Which sequence-based algorithm for branch point prediction has been proposed?,BPP: a sequence-based algorithm for branch point prediction.,1
3535,0,What is RiboTag profiling?,RiboTag is a flexible tool for measuring the translational state of targeted cells in heterogeneous cell cultures.,1
3535,1,What is RiboTag profiling?,"Here we describe our adaptation of a ribosomal capture strategy that was designed to be used in transgenic mice expressing tagged ribosomal subunits (RiboTag) in specific cell types, thereby allowing measurement of translating RNAs from desired cell types within complex tissues.",1
3535,2,What is RiboTag profiling?,Using this strategy we were able to isolate and analyze neuron-specific RNA despite the presence of glia by co-transfecting experimental plasmids with plasmids that selectively express RiboTag in neurons.,0
3535,3,What is RiboTag profiling?,"RiboTag immunoprecipitation was capable of recovering high integrity RNA from small numbers of transfected cells that can then be interrogated by a variety of methods (e.g., RT-qPCR, PCR array, RNA-Seq) and compared with basal RNA expression of the entire culture.",1
3535,4,What is RiboTag profiling?,"Additionally, we demonstrate how co-transfection of RiboTag with small hairpin RNA (shRNA) constructs can validate and accurately assess the degree of gene expression knockdown, and how RiboTag can be used to measure receptor-mediated gene regulation with transiently expressed designer receptors exclusively activated by designer drugs (DREADDs).",1
3535,5,What is RiboTag profiling?,RiboTag co-transfection represents a convenient and powerful tool to isolate RNA from a specific subset of cultured cells with a variety of applications for experiments in vitro.,1
348,0,What is the rate of survival after commotio cordis?,"At their commotio cordis event, 216 study patients were 0.2-51 years old (mean age 15±9 years); 95% were males.",1
348,1,What is the rate of survival after commotio cordis?,"Death occurred in 156 individuals (72%), while the other 60 (28%) survived.",0
348,2,What is the rate of survival after commotio cordis?,"In the 2 groups, events were largely similar demographically, including frequency of survival (26% in U.S. vs 25%; P = .84),",1
348,3,What is the rate of survival after commotio cordis?,Survival of commotio cordis has risen from 10% to 15% since 2001.,1
348,4,What is the rate of survival after commotio cordis?,"Only 21 (16%) individuals survived their event, with particularly prompt cardiopulmonary resuscitation/defibrillation (most commonly reversing ventricular fibrillation) the only identifiable factor associated with a favorable outcome.",0
348,5,What is the rate of survival after commotio cordis?,"Survival rates for commotio cordis are low, even with prompt CPR and defibrillation.",1
348,6,What is the rate of survival after commotio cordis?,"Survival is low, even when resuscitation is performed.",1
2247,0,Does TFIIS affect nucleosome positioning?,Transcript cleavage factor TFIIS reactivates the backtracked complexes and promotes pol II transcription through the nucleosome.,1
2247,1,Does TFIIS affect nucleosome positioning?,"The same nucleosomes transcribed in the opposite orientation form a weaker, more diffuse barrier that is largely relieved by higher salt, TFIIS, or FACT",1
2247,2,Does TFIIS affect nucleosome positioning?,"The system contains natural or recombinant histones, chromatin assembly factors, the histone-acetyltransferase p300, all components of the general transcription machinery, general coactivators and the elongation factor SII (TFIIS).",0
2247,3,Does TFIIS affect nucleosome positioning?,Efficient and rapid nucleosome traversal by RNA polymerase II depends on a combination of transcript elongation factors.,0
2247,4,Does TFIIS affect nucleosome positioning?,"We now show that although TFIIF or TFIIS alone is modestly stimulatory for nucleosome traversal, both factors together increase transcription through nucleosomes in a synergistic manner.",1
2247,5,Does TFIIS affect nucleosome positioning?,"Significantly, we found that nucleosomes with a Sin mutant histone are traversed to the same extent and at nearly the same rate as equivalent pure DNA templates if both TFIIS and TFIIF are present.",0
2247,6,Does TFIIS affect nucleosome positioning?,"After partial uncoiling of nucleosomal DNA from histone octamer by Pol II and backtracking of the enzyme, nucleosomal DNA recoils on the octamer, locking Pol II in the arrested state.",1
2247,7,Does TFIIS affect nucleosome positioning?,"Histone chaperones and transcription factors TFIIS, TFIIF and FACT facilitate transcription through chromatin using different molecular mechanisms.",0
2247,8,Does TFIIS affect nucleosome positioning?,Transcript cleavage factor TFIIS reactivates the backtracked complexes and promotes pol II transcription through the nucleosome.,1
2247,9,Does TFIIS affect nucleosome positioning?,"The highly conserved eukaryotic transcriptional elongation factor TFIIS enables RNA polymerase II (RNAPII) to read though pause or termination sites, nucleosomes and sequence-specific DNA-binding proteins.",0
2247,10,Does TFIIS affect nucleosome positioning?,We also studied the effect of TFIIF and TFIIS on transcription of nucleosomes containing a Sin mutant histone.,0
2247,11,Does TFIIS affect nucleosome positioning?,"The same nucleosomes transcribed in the opposite orientation form a weaker, more diffuse barrier that is largely relieved by higher salt, TFIIS, or FACT.",0
3173,0,Can prevnar 13 be used in children?,"PCV13 is approved for routine vaccination of all infants as a 4-dose series at age 2, 4, 6, and 12-15 months for children who previously received 1 or more doses of the 7-valent pneumococcal conjugate vaccine (PCV7), and for children with underlying medical conditions that increase their risk for pneumococcal disease or its complications.",1
3173,1,Can prevnar 13 be used in children?,"Based on published immunogenicity and safety data, as well as the recent recommendations by the ACIP for routine use in infants and indications for high-risk pediatric patients, PCV13 is a revised formulation of pneumococcal vaccine that should be included on pharmacy formularies.",1
3173,2,Can prevnar 13 be used in children?,"To review the immunogenicity, efficacy, and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) for use in pediatric patients.",1
833,0,Which is the protein implicated in Spinocerebellar ataxia type 3?,"Spinocerebellar ataxia type 3 (SCA3) is the most frequent inherited cerebellar ataxia in Europe, the US and Japan, leading to disability and death through motor complications.",1
833,1,Which is the protein implicated in Spinocerebellar ataxia type 3?,"Although the affected protein ataxin-3 is found ubiquitously in the brain, grey matter atrophy is predominant in the cerebellum and the brainstem",1
833,2,Which is the protein implicated in Spinocerebellar ataxia type 3?,Spinocerebellar ataxia type 3 (SCA3) is an inherited spinocerebellar ataxia caused by the expansion of trinucleotide CAG repeats in the gene encoding ataxin-3,0
833,3,Which is the protein implicated in Spinocerebellar ataxia type 3?,Ataxin-3 is a ubiquitously expressed deubiqutinating enzyme with important functions in the proteasomal protein degradation pathway and regulation of transcription.,1
833,4,Which is the protein implicated in Spinocerebellar ataxia type 3?,"The C-terminus of the ataxin-3 protein contains a polyglutamine (PolyQ) region that, when mutationally expanded to over 52 glutamines, causes the neurodegenerative disease spinocerebellar ataxia 3 (SCA3)",1
833,5,Which is the protein implicated in Spinocerebellar ataxia type 3?,Spinocerebellar ataxia type 3 is a neurodegenerative disorder caused by the expansion of the polyglutamine repeat region within the ataxin-3 protein.,0
833,6,Which is the protein implicated in Spinocerebellar ataxia type 3?,"Spinocerebellar ataxia type 3 is caused by a polyglutamine expansion in the ataxin-3 protein, resulting in gain of toxic function of the mutant protein.",0
833,7,Which is the protein implicated in Spinocerebellar ataxia type 3?,"Here, we provide insight into the mechanism by which ubiquitination directly enhances the activity of ataxin-3, a DUb implicated in protein quality control and the disease protein in the polyglutamine neurodegenerative disorder, Spinocerebellar Ataxia Type 3",0
833,8,Which is the protein implicated in Spinocerebellar ataxia type 3?,"Ataxin-3, the disease protein in the neurodegenerative disorder Spinocerebellar Ataxia Type 3 or Machado Joseph disease, is a cysteine protease implicated in the ubiquitin proteasome pathway",0
833,9,Which is the protein implicated in Spinocerebellar ataxia type 3?,Ataxin-3 (AT3) is the protein that triggers the inherited neurodegenerative disorder spinocerebellar ataxia type 3 when its polyglutamine (polyQ) stretch close to the C-terminus exceeds a critical length,1
833,10,Which is the protein implicated in Spinocerebellar ataxia type 3?,"Here, in studies of spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/MJD), we show that the disease protein ataxin-3 accumulates in ubiquitinated intranuclear inclusions selectively in neurons of affected brain regions.",0
833,11,Which is the protein implicated in Spinocerebellar ataxia type 3?,"This pathogenic repeat in MJD/SCA3 encodes an expanded tract of the amino acid glutamine in the disease protein, which is known as ataxin-3.",0
833,12,Which is the protein implicated in Spinocerebellar ataxia type 3?,"Machado-Joseph disease (MJD), also called spinocerebellar ataxia type 3, is caused by mutant ataxin-3 with a polyglutamine expansion.",0
833,13,Which is the protein implicated in Spinocerebellar ataxia type 3?, Mutant ataxin-3 is aberrantly folded and proteolytically cleaved in spinocerebellar ataxia type 3.,0
833,14,Which is the protein implicated in Spinocerebellar ataxia type 3?,The C-terminal region of the protein includes a polyglutamine stretch that is expanded in spinocerebellar ataxia type 3.,0
833,15,Which is the protein implicated in Spinocerebellar ataxia type 3?,Spinocerebellar ataxia type 3 is a neurodegenerative disorder caused by the expansion of the polyglutamine repeat region within the ataxin-3 protein.,0
149,0,Which are the drugs utilized for the burning mouth syndrome?,"On average, treatment with placebos produced a response that was 72% as large as the response to active drugs.",1
149,1,Which are the drugs utilized for the burning mouth syndrome?,The concomitant prescription of tongue protector and AV is effective for treating patients with BMS.,1
149,2,Which are the drugs utilized for the burning mouth syndrome?,We suggest that a subset of patients with BMS may be a phenotypic variant of RLS and a trial of dopaminergic drugs should be given in patients with BMS who has a history suggestive of RLS or in a patient who do not show a response to usual therapies for BMS.,1
149,3,Which are the drugs utilized for the burning mouth syndrome?,The systemic administration of Catuama reduces the symptoms of BMS and may be a novel therapeutic strategy for the treatment of this disease.,0
149,4,Which are the drugs utilized for the burning mouth syndrome?,"Therapies that used capsaicin, alpha-lipoic acid (ALA), and clonazepam were those that showed more reduction in symptoms of BMS.",1
149,5,Which are the drugs utilized for the burning mouth syndrome?,"Topical clonazepam, which previous analyses of clinical evidence have shown to be the drug of choice for BMS, also proved to be the most cost-effective of the drugs analysed for this condition.",1
3297,0,What is the route of administration of vaxchora?,Vaxchora: A Single-Dose Oral Cholera Vaccine.,1
3297,1,What is the route of administration of vaxchora?,"To review trials evaluating the efficacy and safety of Vaxchora, a reformulated, single-dose, oral, lyophilized Vibrio cholerae CVD 103-HgR vaccine for the prevention of travel-related cholera caused by V cholerae serogroup O1.",1
3297,2,What is the route of administration of vaxchora?,"Studies that addressed the safety and efficacy of Vaxchora, the reformulated, single-dose oral CVD 103-HgR cholera vaccine, were selected for analysis.",1
3297,3,What is the route of administration of vaxchora?,"Vaxchora is the only FDA-approved, single-dose oral vaccine for the prevention of cholera caused by V cholerae serogroup O1 in adult travelers from the United States going to cholera-affected areas.",1
2351,0,What is masitinib an inhibitor of?,"This study evaluated the therapeutic potential of masitinib, an oral tyrosine kinase inhibitor with activity against c-Kit and platelet-derived growth factor receptors (PDGFR), to reduce ischemic brain area and neurological deficit.",1
2351,1,What is masitinib an inhibitor of?,"Masitinib, a selective tyrosine kinase inhibitor, was investigated as a radiosensitizer in three primary feline injection-site sarcoma (ISS) cell lines.",1
2351,2,What is masitinib an inhibitor of?,Dual actions of masitinib as an inhibitor of mast cell-glia axis and a Fyn kinase blocker are discussed in the context of AD pathology.,1
3703,0,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"Risks of lung, breast, and gastrointestinal (GI) cancers increase with higher radiation dose.",0
3703,1,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"CONCLUSIONS: RT treatment, especially with doses higher than 42 Gy, and smoking increase the risk of SN after HL.",0
3703,2,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"In this series, LC patients with early stages had a shorter elapsed time from HL diagnosis and longer OS, therefore the role of LC screening in HL survivors should be prospectively evaluated and smoking cessation counseling ought to be a key aspect during follow-up.",0
3703,3,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,BACKGROUND: Long-term Hodgkin lymphoma (HL) survivors have an increased risk of late cardiac morbidity and secondary lung cancer after chemotherapy and mediastinal radiotherapy.,0
3703,4,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"PURPOSE: Hodgkin lymphoma (HL) survivors have an increased risk of cardiovascular disease (CD), lung cancer, and breast cancer.",0
3703,5,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"Lung cancer (LC) represents the most common solid tumor in survivors of Hodgkin's disease (HD), and the assessment of the mutational status of oncogenic driver mutations in LC is now standard.",0
3703,6,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,PURPOSE: Hodgkin lymphoma (HL) survivors face an increased risk of treatment-related lung cancer.,0
3703,7,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.,1
3703,8,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,BACKGROUND: Patients treated for Hodgkin's lymphoma (HL) have a higher risk of developing second lung cancer (SLC) compared with the general population.,0
3703,9,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"The pooled relative risk (RR) of SLC was 4.62 (95 % confidence interval [CI], 3.18-6.70], I (2) = 98 %), with a median absolute excess rate of 10.4 per 10,000 person-years.",0
3703,10,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,CONCLUSIONS: The current meta-analysis provided a detailed estimate of the risk of SLC among HL survivors.,0
3703,11,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"CONCLUSIONS

The excess risk of lung cancer in Hodgkin's disease patients treated with radiotherapy is related to the radiation dose received by the affected area of the lung.",0
3703,12,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"BACKGROUND

Lung cancer is a frequent cause of death in patients cured of Hodgkin's disease, but the contributions of chemotherapy, radiotherapy, and smoking are not well described.",0
3703,13,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"CONCLUSIONS

Past treatments with alkylating agents and radiation therapy for Hodgkin's disease were associated with an increased risk of lung cancer in a dose-dependent and additive fashion.",0
3703,14,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"BACKGROUND

Several studies have shown that survivors of Hodgkin's disease have increased risk of lung cancer, but the factors responsible for this excess risk are not well known.",0
3703,15,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"PURPOSE

This study was undertaken to investigate the effects of radiation dose, chemotherapy, and smoking on the risk of lung cancer following treatment of Hodgkin's disease.",0
3703,16,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.",1
3703,17,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,It is recognized that survivors of Hodgkin's disease are at a substantially increased risk of lung cancer.,1
3703,18,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"The risk of lung and breast cancer is significantly increased after therapy for Hodgkin 's disease ( HD) , but there are few data that describe the molecular profiles of these tumors .",0
3703,19,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"Hodgkin lymphoma ( HL ) survivors have an increased risk of cardiovascular disease ( CD) , lung cancer , and breast cancer .",0
3703,20,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"BACKGROUND
Lung cancer is a frequent cause of death in patients cured of Hodgkin's disease, but the contributions of chemotherapy, radiotherapy, and smoking are not well described.",0
3703,21,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"CONCLUSIONS
Past treatments with alkylating agents and radiation therapy for Hodgkin's disease were associated with an increased risk of lung cancer in a dose-dependent and additive fashion.",0
3703,22,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,Lung cancer in Hodgkin's disease: association with previous radiotherapy.,1
3703,23,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,Twenty-eight (94%) of 30 patients developing metachronous lung cancer received supradiaphragmatic irradiation as primary therapy for HD.,0
3703,24,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,The risk ratio for the development of lung cancer among HD patients was 5.6 times that expected in the general population.,0
3703,25,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,Seven cases of lung cancer were observed in patients with Hodgkin's disease (HD) since 1970.,0
3703,26,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"BACKGROUND
Several studies have shown that survivors of Hodgkin's disease have increased risk of lung cancer, but the factors responsible for this excess risk are not well known.",0
3703,27,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,The excess risk of lung cancer in Hodgkin's disease patients treated with radiotherapy is related to the radiation dose received by the affected area of the lung.,0
3703,28,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"Lung cancer is a frequent cause of death in patients cured of Hodgkin's disease, but the contributions of chemotherapy, radiotherapy, and smoking are not well described.",0
3703,29,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,Past treatments with alkylating agents and radiation therapy for Hodgkin's disease were associated with an increased risk of lung cancer in a dose-dependent and additive fashion.,1
3703,30,Does radiotherapy for Hodgkin disease increases risk for lung cancer?,"Several studies have shown that survivors of Hodgkin's disease have increased risk of lung cancer, but the factors responsible for this excess risk are not well known.",0
773,0,Is corpus callosum involved in the Mowat–Wilson syndrome?," The syndrome is characterized by typical facial features, moderate-to-severe mental retardation, epilepsy and variable congenital malformations, including Hirschsprung disease, genital anomalies, congenital heart disease, agenesis of the corpus callosum, and eye defects.",1
773,1,Is corpus callosum involved in the Mowat–Wilson syndrome?,Mowat-Wilson syndrome in a fetus with antenatal diagnosis of short corpus callosum: advocacy for standard autopsy.,0
773,2,Is corpus callosum involved in the Mowat–Wilson syndrome?,"It is mainly characterized by moderate-to-severe intellectual disability, epilepsy, facial dysmorphism and various malformations including Hirschsprung disease and corpus callosum anomalies.",0
773,3,Is corpus callosum involved in the Mowat–Wilson syndrome?,The association of a corpus callosum hypoplasia with a histological Hirschsprung disease and a typical facial gestalt allowed the guiding of genetic testing.,0
773,4,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is a severe intellectual disability (ID)-distinctive facial gestalt-multiple congenital anomaly syndrome, commonly associating microcephaly, epilepsy, corpus callosum agenesis, conotruncal heart defects, urogenital malformations and Hirschsprung disease (HSCR).",0
773,5,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is characterized by severe mental retardation with seizures, specific facial dysmorphism, Hirschsprung disease, anomalies of the corpus callosum, and genitourinary and cardiac malformations.",0
773,6,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene and is characterized by distinctive facial features, epilepsy, moderate to severe intellectual disability, corpus callosum abnormalities and other congenital malformations.",0
773,7,Is corpus callosum involved in the Mowat–Wilson syndrome?,"The striking facial phenotype in addition to other features such as severely impaired speech, hypotonia, microcephaly, short stature, seizures, corpus callosum agenesis, congenital heart defects, hypospadias, and Hirschsprung disease are particularly important clues for the initial clinical diagnosis.",0
773,8,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome is a genetic disorder characterized by a distinct facial appearance, moderate-to-severe mental retardation, microcephaly, agenesis of the corpus callosum, Hirschsprung disease, congenital heart disease, and genital anomalies.",1
773,9,Is corpus callosum involved in the Mowat–Wilson syndrome?,"It is characterized by a distinctive facial appearance in association with intellectual disability (ID) and variable other features including agenesis of the corpus callosum, seizures, congenital heart defects, microcephaly, short stature, hypotonia, and Hirschsprung disease.",0
773,10,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is an autosomal dominant intellectual disability syndrome characterised by unique facial features and congenital anomalies such as Hirschsprung disease, congenital heart defects, corpus callosum agenesis and urinary tract anomalies.",0
773,11,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is a recently delineated mental retardation; a multiple congenital anomaly syndrome characterised by a typical facial gestalt, Hirschsprung disease or severe constipation, genitourinary anomaly, congenital heart defects, agenesis of corpus callosum and eye defects.",0
773,12,Is corpus callosum involved in the Mowat–Wilson syndrome?,Agenesis or hypogenesis of the corpus callosum.,0
773,13,Is corpus callosum involved in the Mowat–Wilson syndrome?,"The anomalies may include Hirschsprung disease, heart defects, structural eye anomalies including microphthalmia, agenesis of the corpus callosum, and urogenital anomalies.",0
773,14,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS; OMIM #235730) is a genetic condition caused by heterozygous mutations or deletions of the ZEB2 gene, and characterized by typical face, moderate-to-severe mental retardation, epilepsy, Hirschsprung disease, and multiple congenital anomalies, including genital anomalies (particularly hypospadias in males), congenital heart defects, agenesis of the corpus callosum, and eye defects.",1
773,15,Is corpus callosum involved in the Mowat–Wilson syndrome?,"In 11 of the 28 patients with ACC, the following diagnoses could be established: Mowat-Wilson syndrome (n = 2), Walker-Warburg syndrome (n = 1), oro-facial-digital syndrome type 1 (n = 1), and chromosomal rearrangements (n = 7), including a patient with an apparently balanced reciprocal translocation, which led to the disruption and a predicted loss of function in the FOXG1B gene.",0
773,16,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a distinct facial phenotype (high forehead, frontal bossing, large eyebrows, medially flaring and sparse in the middle part, hypertelorism, deep set but large eyes, large and uplifted ear lobes, with a central depression, saddle nose with prominent rounded nasal tip, prominent columella, open mouth, with M-shaped upper lip, frequent smiling, and a prominent but narrow and triangular pointed chin), moderate-to-severe intellectual deficiency, epilepsy and variable congenital malformations including Hirschsprung disease (HSCR), genitourinary anomalies (in particular hypospadias in males), congenital heart defects, agenesis of the corpus callosum and eye anomalies.",0
773,17,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome is a mental retardation-multiple congenital anomaly syndrome characterized by a typical facies, developmental delay, epilepsy, and variable congenital malformations, including Hirschsprung disease, urogenital anomalies, congenital heart disease, and agenesis of the corpus callosum.",1
773,18,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is a recently delineated mental retardation (MR)-multiple congenital anomaly syndrome, characterized by typical facies, severe MR, epilepsy, and variable congenital malformations, including Hirschsprung disease (HSCR), genital anomalies, congenital heart disease (CHD), and agenesis of the corpus callosum (ACC).",1
773,19,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Medical issues in our cohort of patients included seizures (75%) with no predeliction for any particular seizure type; agenesis of the corpus callosum (60% of our patients studied); congenital heart defects (75%), particularly involving the pulmonary arteries and/or valves; hypospadias (55% of males); severely impaired or absent speech (100% of individuals over 1 year of age) with relatively spared receptive language; and Hirschsprung disease (50%) or chronic constipation (25%).",0
773,20,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Mowat-Wilson syndrome (MWS) is a mental retardation syndrome associated with distinctive facial features, microcephaly, epilepsy, and a variable spectrum of congenital anomalies, including Hirschsprung disease (HSCR), agenesis of the corpus callosum, genitourinary abnormalities, and congenital heart disease.",0
773,21,Is corpus callosum involved in the Mowat–Wilson syndrome?,"ACC is found in 40% of the cases of Mowat-Wilson syndrome (MWS), a polytopic embryonic defect including a distinctive facial gestalt, severe mental retardation, epilepsy and postnatal microcephaly as constant features.",0
773,22,Is corpus callosum involved in the Mowat–Wilson syndrome?,"However, analysis of MWS should be considered in the differential diagnosis of ACC, especially when the facial features raise the possibility of MWS.",0
773,23,Is corpus callosum involved in the Mowat–Wilson syndrome?,Frameshift mutation of the zinc finger homeo box 1 B gene in syndromic corpus callosum agenesis (Mowat-Wilson syndrome).,0
773,24,Is corpus callosum involved in the Mowat–Wilson syndrome?,"We report a girl who had Hirschsprung disease in association with distinct facial appearance, microcephaly, agenesis of the corpus callosum and mental retardation (Mowat-Wilson syndrome).",0
773,25,Is corpus callosum involved in the Mowat–Wilson syndrome?,"Congenital anomalies, including Hirschsprung disease (HSCR), congenital heart disease, hypospadias, genitourinary anomalies, agenesis of the corpus callosum, and short stature are common.",0
2541,0,What is the link between psoriatic arthritis and depression,Depression Is Associated with an Increased Risk of Psoriatic Arthritis among Patients with Psoriasis,1
2541,1,What is the link between psoriatic arthritis and depression,"merging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders.",0
2541,2,What is the link between psoriatic arthritis and depression,Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis?,0
2541,3,What is the link between psoriatic arthritis and depression,To investigate the predictive value of baseline depression/anxiety on the likelihood of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) as well as the associations between baseline depression/anxiety and the components of the remission criteria at follow-up.,0
2541,4,What is the link between psoriatic arthritis and depression,Rate of depression was higher in patients with PsA compared to non-PsA patients.,0
2541,5,What is the link between psoriatic arthritis and depression,The rate of suicidal behaviors was similar between the two cohorts.,0
2541,6,What is the link between psoriatic arthritis and depression,"Over the past decade, multiple studies have shown that not only is there an association between psoriasis and psoriatic arthritis, depression, and substance abuse, but psoriasis patients also have a higher incidence of obesity, diabetes, heart disease and stroke.",0
2541,7,What is the link between psoriatic arthritis and depression,Psoriasis is a chronic disease that affects more than the skin.,1
2541,8,What is the link between psoriatic arthritis and depression,"It has an impact on every facet of an individual's life and is associated with numerous comorbidities, such as obesity, diabetes, cardiovascular disease, psoriatic arthritis, metabolic syndrome, squamous cell carcinoma, lymphoma, depression, anxiety and other immune-related conditions, such as Crohn's disease.",0
2541,9,What is the link between psoriatic arthritis and depression,We found an increased risk of depression in US women with psoriasis compared with those without psoriasis.,1
2541,10,What is the link between psoriatic arthritis and depression,"The impact of comorbidities (psoriatic arthritis, cardiovascular disease, diabetes, and depression) on relative importance scores of each attribute was assessed by analyses of varianc",0
2541,11,What is the link between psoriatic arthritis and depression,"Furthermore, obesity and psychological diseases such as depression and anxiety disorders are linked with psoriasis and play a central role in its management.",0
2541,12,What is the link between psoriatic arthritis and depression," Recommendations were synthesized into 19 final recommendations ranging mainly from grade C to D, and relating to a large spectrum of comorbidities observed in clinical practice: CVD, obesity, osteoporosis, depression, infections, and cancer.",0
2541,13,What is the link between psoriatic arthritis and depression,"Level of agreement ranged from 80.9% to 95.8%.CONCLUSION: These practical evidence-based recommendations can guide management of comorbidities in patients with RA, PsA, and PsO and optimize outcome",0
2541,14,What is the link between psoriatic arthritis and depression,Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life.,0
2541,15,What is the link between psoriatic arthritis and depression, The rate of depression and anxiety is significantly higher in patients with PsA than in those with PsC.,0
2541,16,What is the link between psoriatic arthritis and depression,Depression and anxiety are associated with disease-related factors.,1
2541,17,What is the link between psoriatic arthritis and depression,The prevalence of anxiety symptoms and the prevalence of depression symptoms are high among patients suffering psoriatic arthritis in the studied population.,0
2541,18,What is the link between psoriatic arthritis and depression,Psoriasis (Pso) is a common chronic cutaneous inflammatory disease involving the skin that is associated with serious comorbidities.,1
2541,19,What is the link between psoriatic arthritis and depression,"Comorbidities in Pso include psoriatic arthritis (PsA), reduced quality of life, malignancy, depression, but also a constellation of associated conditions that enhance the cardiovascular (CV) risk.",0
2541,20,What is the link between psoriatic arthritis and depression,"Dermatologists and primary care providers share roles in screening for associated comorbidities (including cardiovascular disorders, chronic kidney disease, Crohn disease, dyslipidemia, diabetes mellitus/insulin resistance, depression, metabolic syndrome, obesity, and psoriatic arthritis),",0
1845,0,Can the Micro-C XL method achieve mononucleosome resolution?,"We present Micro-C XL, an improved method for analysis of chromosome folding at mononucleosome resolution",1
1845,1,Can the Micro-C XL method achieve mononucleosome resolution?,"We present Micro-C XL, an improved method for analysis of chromosome folding at mononucleosome resolution.",1
1845,2,Can the Micro-C XL method achieve mononucleosome resolution?,Micro-C XL: assaying chromosome conformation from the nucleosome to the entire genome.,1
1845,3,Can the Micro-C XL method achieve mononucleosome resolution?,Micro-C XL provides a single assay to interrogate chromosome folding at length scales from the nucleosome to the full genome.,1
186,0,Which syndrome is associated with mutant DVL1?,Mutations in DVL1 cause an osteosclerotic form of Robinow syndrome.,1
186,1,Which syndrome is associated with mutant DVL1?,"Here, we identified de novo frameshift mutations in DVL1, a mediator of both canonical and non-canonical Wnt signaling, as the cause of RS-OS, an RS subtype involving osteosclerosis, in three unrelated individuals.",1
186,2,Which syndrome is associated with mutant DVL1?,DVL1 frameshift mutations clustering in the penultimate exon cause autosomal-dominant Robinow syndrome.,1
186,3,Which syndrome is associated with mutant DVL1?,"argeted Sanger sequencing in additional subjects with DRS uncovered DVL1 exon 14 mutations in five individuals, including a pair of monozygotic twins.",1
3476,0,What is Heterochromia Iridis?,The purpose of this study is to report a new and promising method for changing iris color in a sectorial heterochromia iridis patient.,1
3476,1,What is Heterochromia Iridis?,A 22-year-old man with a complaint of innate color disparity between his eyes presented to our clinic to seek medical advice.,1
3476,2,What is Heterochromia Iridis?,To present a case of iatrogenic Horner's syndrome seen together with the heterochromia in the post-thyroidectomy period.METHODS: A 23-year-old female patient was admitted to our clinic with complaints of low vision in the eye and difference in eye color that developed over the past two years.,1
3476,3,What is Heterochromia Iridis?,"Heterochromia iridis, asymmetry of iris pigmentation, has been well described with congenital Horner syndrome.",1
3476,4,What is Heterochromia Iridis?,"BACKGROUND

Heterochromia iridis, asymmetry of iris pigmentation, has been well described with congenital Horner syndrome.",0
3476,5,What is Heterochromia Iridis?,"BACKGROUND Heterochromia iridis, asymmetry of iris pigmentation, has been well described with congenital Horner syndrome.",1
1437,0,What is SHAPE-Seq?,"This article contains a protocol for selective 2'-hydroxyl acylation analyzed by primer extension and sequencing (SHAPE-Seq) that, through a combination of structure-dependent chemical probing and next-generation sequencing technologies, achieves structural characterization of hundreds of RNAs in a single experiment.",0
1437,1,What is SHAPE-Seq?,"This protocol is applicable in a variety of conditions, and represents an important tool for understanding RNA biology.",0
1437,2,What is SHAPE-Seq?,"The protocol includes methods for the design and synthesis of RNA mixtures for study, and the construction and analysis of structure-dependent sequencing libraries that reveal structural information of the RNAs in the mixtures.",0
1437,3,What is SHAPE-Seq?,"The methods are generally applicable to studying RNA structure and interactions in vitro in a variety of conditions, and allows for the rapid characterization of RNA structures in a high-throughput manner.",0
1437,4,What is SHAPE-Seq?,"We focus on a novel assay utilizing this approach, called selective 2'-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq), that can be used to characterize RNA secondary and tertiary structure.",0
1437,5,What is SHAPE-Seq?,"We describe a fully automated data analysis pipeline for SHAPE-Seq analysis that includes read processing, mapping, and structural inference based on a model of the experiment.",0
1437,6,What is SHAPE-Seq?,Our methods rely on the solution of a series of convex optimization problems for which we develop efficient and effective numerical algorithms.,0
1437,7,What is SHAPE-Seq?,"We have developed a high-throughput technique, SHAPE-Seq, that can simultaneously measure quantitative, single nucleotide-resolution secondary and tertiary structural information for hundreds of RNA molecules of arbitrary sequence.",0
1437,8,What is SHAPE-Seq?,SHAPE-Seq combines selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) chemistry with multiplexed paired-end deep sequencing of primer extension products.,0
1437,9,What is SHAPE-Seq?,"This generates millions of sequencing reads, which are then analyzed using a fully automated data analysis pipeline, based on a rigorous maximum likelihood model of the SHAPE-Seq experiment.",0
1437,10,What is SHAPE-Seq?,"We demonstrate the ability of SHAPE-Seq to accurately infer secondary and tertiary structural information, detect subtle conformational changes due to single nucleotide point mutations, and simultaneously measure the structures of a complex pool of different RNA molecules.",1
1437,11,What is SHAPE-Seq?,"SHAPE-Seq thus represents a powerful step toward making the study of RNA secondary and tertiary structures high throughput and accessible to a wide array of scientific pursuits, from fundamental biological investigations to engineering RNA for synthetic biological systems.",1
1437,12,What is SHAPE-Seq?,"As part of this optimization, we present SHAPE-Seq v2.0, a 'universal' method that can obtain reactivity information for every nucleotide of an RNA without having to use or introduce a specific reverse transcriptase priming site within the RNA.",0
1437,13,What is SHAPE-Seq?,"We show that SHAPE-Seq v2.0 is highly reproducible, with reactivity data that can be used as constraints in RNA folding algorithms to predict structures on par with those generated using data from other SHAPE methods.",0
1437,14,What is SHAPE-Seq?,We anticipate SHAPE-Seq v2.0 to be broadly applicable to understanding the RNA sequence-structure relationship at the heart of some of life's most fundamental processes.,0
1437,15,What is SHAPE-Seq?,"We demonstrate the ability of SHAPE-Seq to accurately infer secondary and tertiary structural information, detect subtle conformational changes due to single nucleotide point mutations, and simultaneously measure the structures of a complex pool of different RNA molecules.",0
1437,16,What is SHAPE-Seq?,"SHAPE-Seq thus represents a powerful step toward making the study of RNA secondary and tertiary structures high throughput and accessible to a wide array of scientific pursuits, from fundamental biological investigations to engineering RNA for synthetic biological systems.",1
1437,17,What is SHAPE-Seq?,"SHAPE-Seq thus represents a powerful step toward making the study of RNA secondary and tertiary structures high throughput and accessible to a wide array of scientific pursuits, from fundamental biological investigations to engineering RNA for synthetic biological systems.",1
1437,18,What is SHAPE-Seq?,"We have developed a high-throughput technique, SHAPE-Seq, that can simultaneously measure quantitative, single nucleotide-resolution secondary and tertiary structural information for hundreds of RNA molecules of arbitrary sequence.",0
1437,19,What is SHAPE-Seq?,SHAPE-Seq combines selective 2&apos;-hydroxyl acylation analyzed by primer extension (SHAPE) chemistry with multiplexed paired-end deep sequencing of primer extension products.,0
1437,20,What is SHAPE-Seq?,"This generates millions of sequencing reads, which are then analyzed using a fully automated data analysis pipeline, based on a rigorous maximum likelihood model of the SHAPE-Seq experiment.",0
1437,21,What is SHAPE-Seq?,"We demonstrate the ability of SHAPE-Seq to accurately infer secondary and tertiary structural information, detect subtle conformational changes due to single nucleotide point mutations, and simultaneously measure the structures of a complex pool of different RNA molecules.",0
1437,22,What is SHAPE-Seq?,"We demonstrate the ability of SHAPE-Seq to accurately infer secondary and tertiary structural information, detect subtle conformational changes due to single nucleotide point mutations, and simultaneously measure the structures of a complex pool of different RNA molecules.",0
1437,23,What is SHAPE-Seq?,"SHAPE-Seq thus represents a powerful step toward making the study of RNA secondary and tertiary structures high throughput and accessible to a wide array of scientific pursuits, from fundamental biological investigations to engineering RNA for synthetic biological systems.",1
2450,0,What is BBCAnalyzer?,BBCAnalyzer: a visual approach to facilitate variant calling.,0
2450,1,What is BBCAnalyzer?,"BBCAnalyzer (Bases By CIGAR Analyzer) provides a novel visual approach to facilitate this step of time-consuming, manual inspection of common mutation sites.",1
2450,2,What is BBCAnalyzer?,BBCAnalyzer is able to visualize base counts at predefined positions or regions in any sequence alignment data that are available as BAM files.,1
2450,3,What is BBCAnalyzer?,"Thereby, the tool provides a straightforward solution for evaluating any list of expected mutations like hotspot mutations, or even whole regions of interest.",0
2450,4,What is BBCAnalyzer?,"In addition to an ordinary textual report, BBCAnalyzer reports highly customizable plots.",0
2450,5,What is BBCAnalyzer?,"Information on the counted number of bases, the reference bases, known mutations or polymorphisms, called mutations and base qualities is summarized in a single plot.",1
2450,6,What is BBCAnalyzer?,"By uniting this information in a graphical way, the user may easily decide on a variant being present or not - completely independent of any internal filters or frequency thresholds.",1
2450,7,What is BBCAnalyzer?,"BBCAnalyzer provides a unique, novel approach to facilitate variant calling where classical tools frequently fail to call.",0
2450,8,What is BBCAnalyzer?,The R package is freely available at http://bioconductor.org .,0
2450,9,What is BBCAnalyzer?,BBCAnalyzer is able to visualize base counts at predefined positions or regions in any sequence alignment data that are available as BAM files.,0
2450,10,What is BBCAnalyzer?,"BBCAnalyzer (Bases By CIGAR Analyzer) provides a novel visual approach to facilitate this step of time-consuming, manual inspection of common mutation sites.",0
2450,11,What is BBCAnalyzer?,"BBCAnalyzer provides a unique, novel approach to facilitate variant calling where classical tools frequently fail to call.",0
2450,12,What is BBCAnalyzer?,"By uniting this information in a graphical way, the user may easily decide on a variant being present or not - completely independent of any internal filters or frequency thresholds.<br><b>CONCLUSIONS</b>: BBCAnalyzer provides a unique, novel approach to facilitate variant calling where classical tools frequently fail to call.",1
2450,13,What is BBCAnalyzer?,"hotspot mutations), that have not been called by the software, need to be investigated manually.<br><b>RESULTS</b>: BBCAnalyzer (Bases By CIGAR Analyzer) provides a novel visual approach to facilitate this step of time-consuming, manual inspection of common mutation sites.",0
2450,14,What is BBCAnalyzer?,"BBCAnalyzer (Bases By CIGAR Analyzer) provides a novel visual approach to facilitate this step of time-consuming, manual inspection of common mutation sites.",0
2450,15,What is BBCAnalyzer?,"BBCAnalyzer provides a unique, novel approach to facilitate variant calling where classical tools frequently fail to call.",0
2450,16,What is BBCAnalyzer?,BBCAnalyzer is able to visualize base counts at predefined positions or regions in any sequence alignment data that are available as BAM files.,0
2450,17,What is BBCAnalyzer?,"RESULTS BBCAnalyzer (Bases By CIGAR Analyzer) provides a novel visual approach to facilitate this step of time-consuming, manual inspection of common mutation sites.",0
2450,18,What is BBCAnalyzer?,"CONCLUSIONS BBCAnalyzer provides a unique, novel approach to facilitate variant calling where classical tools frequently fail to call.",0
2450,19,What is BBCAnalyzer?,BBCAnalyzer: a visual approach to facilitate variant calling.,0
3499,0,List approved radioprotective compounds,"Only two radioprotective compounds, amifostine and palifermin, currently have the US FDA approval for use in radiation therapy.",1
4189,0,What is the mechanisms of action of Evinacumab?,"Evinacumab, a monoclonal antibody against ANGPTL3, has been shown to substantially reduce LDL-C of an average of 49%, independently of residual LDLR activity.",1
4189,1,What is the mechanisms of action of Evinacumab?,"RECENT FINDINGS: Novel therapies, not dependent on a functioning LDLR include lomitapide and mipomersen, which decrease hepatic apolipoprotein B secretion, and evinacumab, directed at the angiopoietin like-3 protein (ANGPLT-3).",0
4189,2,What is the mechanisms of action of Evinacumab?,"Multiple ANGPLT3 inhibitors (evinacumab, IONIS-ANGPTL3-LRx, ARO-ANG3) effectuate TG reductions up to 70% with concomitant potent reduction in all other apoB containing lipoprotein fractions.",0
4189,3,What is the mechanisms of action of Evinacumab?,"Moreover, regarding TG a monoclonal antibody called evinacumab and an antisense-oligonucleotide against ANGPTL3 showed effective TG-lowering.",0
4189,4,What is the mechanisms of action of Evinacumab?,"Current therapies reduce plaque volume, but targeting all apoB-containing lipoproteins with intensive combinations that include alirocumab or evinacumab, monoclonal antibodies against cholesterol-regulating proprotein convertase subtilisin/kexin type 9 and angiopoietin-like protein 3, may provide more benefit.",0
4189,5,What is the mechanisms of action of Evinacumab?,"Evinacumab, a monoclonal antibody against ANGPTL3, has shown potential benefit in patients with homozygous familial hypercholesterolemia.",0
4189,6,What is the mechanisms of action of Evinacumab?,"These include an antisense oligonucleotide against apoC-III (volanesorsen), a monoclonal antibody against angiopoietin-like protein-3 (evinacumab), and other agents currently in development.",0
4189,7,What is the mechanisms of action of Evinacumab?,"BACKGROUND AND AIMS: Evinacumab, an angiopoietin-like protein 3 monoclonal antibody, reduced low-density lipoprotein cholesterol (LDL-C) significantly in a Phase 2 study of patients with homozygous familial hypercholesterolemia.",1
4189,8,What is the mechanisms of action of Evinacumab?,e I clinical trials with a monoclonal anti-ANGPTL3 antibody (evinacumab) and anti-sense oligonucleotide (ASO) clearly show a significant lipid lowering effect.,0
4189,9,What is the mechanisms of action of Evinacumab?,"In addition, from t",0
4189,10,What is the mechanisms of action of Evinacumab?,ease.,0
4189,11,What is the mechanisms of action of Evinacumab?,"A phase 2, proof-of-concept study (NCT02265952) demonstrated that evinacumab, a fully human monoclonal antibody to ANGPTL3 (angiopoietin-like 3 protein), reduced LDL-C levels in 9 patients with genotypically confirmed homozygous familial hypercholesterolemia and was well tolerated",0
4189,12,What is the mechanisms of action of Evinacumab?,ng TG a monoclonal antibody called evinacumab and an antisense-oligonucleotide against ANGPTL3 showed effective TG-lowering.,0
4189,13,What is the mechanisms of action of Evinacumab?,"At least, using",0
4189,14,What is the mechanisms of action of Evinacumab?,Evinacumab is a monoclonal antibody against angiopoietin-like protein 3 (ANGPTL3) and it seems that it can substantially lower elevated TGs levels because ANGPTL3 also regulates TGs metabolism.,1
4189,15,What is the mechanisms of action of Evinacumab?,"fter an attentive literature search, the authors resumed here information on proprotein convertase subtilisin/kexin 9 inhibitors (evolocumab and alirocumab), small interfering RNA molecule inclisiran, antisense oligonucleotides (mipomersen, volanesorsen, ISIS 681257), and drugs targeting angiopoietin-like protein 3 (evinacumab, IONIS-ANGPTL3Rx).E",0
4189,16,What is the mechanisms of action of Evinacumab?," Evinacumab, an ANGPTL3 inhibitor, reduced triglycerides in healthy human volunteers and in homozygous familial hypercholesterolemic individuals",0
4189,17,What is the mechanisms of action of Evinacumab?,"A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects.",0
4189,18,What is the mechanisms of action of Evinacumab?,"BACKGROUND AND AIMS: Evinacumab, an angiopoietin-like protein 3 monoclonal antibody, reduced low-density lipoprotein cholesterol (LDL-C) significantly in a Phase 2 study of patients with homozygous familial hypercholesterolemia",1
4189,19,What is the mechanisms of action of Evinacumab?,her lipids.,0
4189,20,What is the mechanisms of action of Evinacumab?,"Evinacumab, an ANGPTL3 inhibitor, reduced triglycerides in healthy human volunteers and in homozygous familial hypercholesterolemic",0
4189,21,What is the mechanisms of action of Evinacumab?,"BACKGROUND AND AIMS: Evinacumab, an angiopoietin-like protein 3 monoclonal antibody, reduced low-density lipoprotein cholesterol (LDL-C) significantly in a Phase 2 study of patients with homozygous familial",1
4189,22,What is the mechanisms of action of Evinacumab?,ar disease.,0
4189,23,What is the mechanisms of action of Evinacumab?,"Evinacumab, a monoclonal antibody against ANGPTL3, has shown potential benefit in patients with homozygous familial hypercholesterolemia.METHODS: In this double-blind, placebo-controlled, phase 3 trial, we randomly assigned in a 2:1 ratio 65 patients with homozygous familial hypercholesterolemia who were receiving stable lipid-lowering therapy to receive an intravenous infusion of evinacumab (at a dose of 15 mg per kilogram of body weight) ever",0
4189,24,What is the mechanisms of action of Evinacumab?,r disease.,0
4189,25,What is the mechanisms of action of Evinacumab?,"A phase 2, proof-of-concept study (NCT02265952) demonstrated that evinacumab, a fully human monoclonal antibody to ANGPTL3 (angiopoietin-like 3 protein), reduced LDL-C levels in 9 patients with genotypically confirmed homozygous familial hypercholesterolemia and was well",0
4189,26,What is the mechanisms of action of Evinacumab?,equire LDL receptor (LDLR) activity.,0
4189,27,What is the mechanisms of action of Evinacumab?,"Evinacumab, a novel monoclonal antibody against angiopoetin-like 3 (ANGPTL3), reduces LDL-C by 50% independent of LDLR activity.SUMMARY: Achieving a target LDL-C in familial hypercholesterolemia can be challenging with standard LLT; however, novel therapeutic modalities show remarkable reductions in LDL-C allowing nearly all patients with HeFH and a significant proportion of patients",0
4189,28,What is the mechanisms of action of Evinacumab?," In such patients, the efficacy and safety of subcutaneous and intravenous evinacumab, a fully human monoclonal antibody against angiopoietin-like 3, are not known",0
4189,29,What is the mechanisms of action of Evinacumab?,"We also tested the effects of a human monoclonal antibody, evinacumab, against Angptl3 in dyslipidemic mice and against ANGPTL3 in healthy human volunteers with elevated levels of triglycerides or LDL cholesterol.",0
2470,0,Describe mechanism of action of Nusinersen.,"In 2016, the US Food and Drug Administration (FDA)-approved Exondys 51 (eteplirsen) and Spinraza (nusinersen), the first exon skipping and exon inclusion drugs, to treat patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA), respectively.",0
2470,1,Describe mechanism of action of Nusinersen.,"Notably, the first new central nervous system (CNS)-targeted oligonucleotide-based drug (nusinersen/Spinraza) was approved by US Food and Drug Administration (FDA) in late 2016 and several other compounds are in advanced clinical trials.",0
2470,2,Describe mechanism of action of Nusinersen.,"Nusinersen (SPINRAZA™) is a modified antisense oligonucleotide that binds to a specific sequence in the intron, downstream of exon 7 on the pre-messenger ribonucleic acid (pre-mRNA) of the SMN2 gene.",1
2470,3,Describe mechanism of action of Nusinersen.,"This modulates the splicing of the SMN2 mRNA transcript to include exon 7, thereby increasing the production of full-length SMN protein.",1
2470,4,Describe mechanism of action of Nusinersen.,Nusinersen is an antisense oligonucleotide that targets intronic splicing silencer N1 (ISS-N1) discovered in 2004 at the University of Massachusetts Medical School.,0
2470,5,Describe mechanism of action of Nusinersen.,"Spinraza™showed very promising results at all steps of the clinical development and was approved by US Food and Drug Administration (FDA) on December 23, 2016.",0
2470,6,Describe mechanism of action of Nusinersen.,Spinraza™is the first FDA-approved treatment for SMA and the first antisense drug to restore expression of a fully functional protein via splicing correction.,0
2470,7,Describe mechanism of action of Nusinersen.,"To examine safety, tolerability, pharmacokinetics, and preliminary clinical efficacy of intrathecal nusinersen (previously ISIS-SMNRx), an antisense oligonucleotide designed to alter splicing of SMN2 mRNA, in patients with childhood spinal muscular atrophy (SMA).",0
2470,8,Describe mechanism of action of Nusinersen.,"Nusinersen is specifically designed to alter splicing of SMN2 pre-mRNA and thus increase the amount of functional survival motor neuron (SMN) protein that is deficient in patients with spinal muscular atrophy.<br><b>METHODS</b>: This open-label, phase 2, escalating dose clinical study assessed the safety and tolerability, pharmacokinetics, and clinical efficacy of multiple intrathecal doses of nusinersen (6 mg and 12 mg dose equivalents) in patients with infantile-onset spinal muscular atrophy.",1
2470,9,Describe mechanism of action of Nusinersen.,"Nusinersen is an antisense oligonucleotide drug that modifies pre-messenger RNA splicing of the SMN2 gene and thus promotes increased production of full-length SMN protein.<br><b>METHODS</b>: We conducted a randomized, double-blind, sham-controlled, phase 3 efficacy and safety trial of nusinersen in infants with spinal muscular atrophy.",1
2470,10,Describe mechanism of action of Nusinersen.,Nusinersen is an antisense oligonucleotide that targets intronic splicing silencer N1 (ISS-N1) discovered in 2004 at the University of Massachusetts Medical School.,0
2470,11,Describe mechanism of action of Nusinersen.,"Nusinersen (SPINRAZA™) is a modified antisense oligonucleotide that binds to a specific sequence in the intron, downstream of exon 7 on the pre-messenger ribonucleic acid (pre-mRNA) of the SMN2 gene.",1
2470,12,Describe mechanism of action of Nusinersen.,"OBJECTIVE To examine safety, tolerability, pharmacokinetics, and preliminary clinical efficacy of intrathecal nusinersen (previously ISIS-SMNRx), an antisense oligonucleotide designed to alter splicing of SMN2 mRNA, in patients with childhood spinal muscular atrophy (SMA).",0
2470,13,Describe mechanism of action of Nusinersen.,"With the recent US Food and Drug Administration approval of nusinersen (Spinraza), the potential for correction of SMN2 exon 7 splicing as an SMA therapy has been affirmed.",0
3130,0,Are apoE mimetics being considered as a treatment against Alzheimer's disease?,The apolipoprotein-E-mimetic COG112 protects amyloid precursor protein intracellular domain-overexpressing animals from Alzheimer's disease-like pathological features.,1
3130,1,Are apoE mimetics being considered as a treatment against Alzheimer's disease?,Studies show that administration of apolipoprotein E (apoE) and apoE-derived small peptide mimetics protect AD mouse models against these AD-like features.,1
3140,0,What are there sex differences in SAMHD1 activity?,Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages.,1
3140,1,What are there sex differences in SAMHD1 activity?,"Investigations into the mechanism governing these sex-dependent differences revealed that the host restriction factor SAMHD1 exists in a hyperphosphorylated, less active state in male-derived macrophages.",1
3140,2,What are there sex differences in SAMHD1 activity?,"In addition, the major kinase responsible for SAMHD1 phosphorylation, CDK1, exhibited lower levels of expression in female-derived macrophages in all tested donor pairs.",1
3140,3,What are there sex differences in SAMHD1 activity?,The sex-dependent differences in viral restriction imposed by SAMHD1 were abrogated upon its depletion.,1
3140,4,What are there sex differences in SAMHD1 activity?,"We conclude that SAMHD1 is an essential modulator of infectivity in a sex-dependent manner in macrophages, constituting a novel component of sex differences in innate immune control of HIV-1.",1
378,0,Which deficiency is the cause of restless leg syndrome?,"We describe a unique case of a 23-yr-old female patient affected by a homozygous loss of function mutation in the L-ferritin gene, idiopathic generalized seizures, and atypical restless leg syndrome (RLS).",0
378,1,Which deficiency is the cause of restless leg syndrome?,"We show that L chain ferritin is undetectable in primary fibroblasts from the patient, and thus ferritin consists only of H chains.",0
378,2,Which deficiency is the cause of restless leg syndrome?,Our results demonstrate for the first time the pathophysiological consequences of L-ferritin deficiency in a human and help to define the concept for a new disease entity hallmarked by idiopathic generalized seizure and atypical RLS.,0
378,3,Which deficiency is the cause of restless leg syndrome?,"These results when viewed along with prior RLS SPECT and autopsy studies of DAT, and cell culture studies with iron deficiency and DAT, suggest that membrane-bound striatal DAT, but not total cellular DAT, may be decreased in RLS.",0
378,4,Which deficiency is the cause of restless leg syndrome?," Compared with the PD or healthy group, the level of serum ferritin and the H-reflex latency of tibial nerve were significantly decreased in PD with RLS group (P < 0.05).",0
378,5,Which deficiency is the cause of restless leg syndrome?,Deficiency of iron and decreased inhibition function of spinal cord may lead to the occurrence of RLS in PD patients.,0
378,6,Which deficiency is the cause of restless leg syndrome?,"Association of iron deficiency with febrile seizures, pica, breath holding spells, restless leg syndrome and thrombosis is increasingly being recognized.",1
378,7,Which deficiency is the cause of restless leg syndrome?," Iron status was generally poor among regular blood donors, especially in women, with a high incidence of iron depletion (>20%) and RLS (18%).",0
378,8,Which deficiency is the cause of restless leg syndrome?,"Iron status is poor in regular blood donors, restless legs syndrome is common, and the routine iron supplementation is insufficient.",0
378,9,Which deficiency is the cause of restless leg syndrome?,"Furthermore, there appears to be an association between iron deficiency and those suffering from Restless Leg Syndrome (RLS).",0
378,10,Which deficiency is the cause of restless leg syndrome?,"The authors propose that PPIs, such as omeprazole, may interfere with iron absorption in certain patients and that a subpopulation of patients who develop significant iron deficiency characterized by low serum ferritin levels while on PPIs may also develop RLS-like symptoms (including RLSAP).",0
378,11,Which deficiency is the cause of restless leg syndrome?,"Clinical studies have implicated the dopaminergic system in RLS, while others have suggested that it is associated with insufficient levels of brain iron.",0
378,12,Which deficiency is the cause of restless leg syndrome?,The results are consistent with the hypothesis that a primary iron insufficiency produces a dopaminergic abnormality characterized as an overly activated dopaminergic system as part of the RLS pathology.,0
378,13,Which deficiency is the cause of restless leg syndrome?,"RLS may also be secondary to a number of conditions including iron deficiency, pregnancy and end-stage renal failure and, perhaps, neuropathy.",0
378,14,Which deficiency is the cause of restless leg syndrome?,The pathogenesis of RLS probably involves the interplay of systemic or brain iron deficiency and impaired dopaminergic neurotransmission in the subcortex of the brain.,0
378,15,Which deficiency is the cause of restless leg syndrome?,All patients showed low levels of ferritin and iron supplementation was effective in five cases.,0
378,16,Which deficiency is the cause of restless leg syndrome?,"Clinical and animal studies that support the benefits of iron supplementation, independent of increasing hemoglobin, such as those on immune function, physical performance, thermoregulation, cognition, and restless leg syndrome and aluminum absorption is the subject of this narrative review.",1
378,17,Which deficiency is the cause of restless leg syndrome?,Restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are considered to be a continuum of a neurological sleep disorder associated with abnormal iron metabolism or deficiency.,0
378,18,Which deficiency is the cause of restless leg syndrome?,I describe a case of RLS and PLMD in a cystic fibrosis patient with iron deficiency from chronic hemoptysis.,0
378,19,Which deficiency is the cause of restless leg syndrome?,This is the first case that reports RLS and PLMD manifesting from iron deficiency caused by chronic hemoptysis in advanced cystic fibrosis lung disease.,0
378,20,Which deficiency is the cause of restless leg syndrome?,Restless leg syndrome manifested by iron deficiency from chronic hemoptysis in cystic fibrosis.,0
378,21,Which deficiency is the cause of restless leg syndrome?,"Diurnal effects on motor control are evident in the human disease of Restless Leg Syndrome (RLS), which is purported to be linked to brain iron deficiency as well as alterations in dopaminergic systems.",1
378,22,Which deficiency is the cause of restless leg syndrome?,"Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology of the restless leg syndrome.",1
378,23,Which deficiency is the cause of restless leg syndrome?,"Restless leg syndrome (RLS), aging, pregnancy, uraemia, iron deficiency, polyneuropathy are some of the common causes of secondary PLMD.",1
378,24,Which deficiency is the cause of restless leg syndrome?,"The syndrome is increasingly often diagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy.",0
378,25,Which deficiency is the cause of restless leg syndrome?,"Clinical, EEG, electromyographic and polysomnographic studies in restless legs syndrome caused by magnesium deficiency.",0
378,26,Which deficiency is the cause of restless leg syndrome?,A frequent polymorphism in BTBD9 was significantly associated with serum ferritin.,0
378,27,Which deficiency is the cause of restless leg syndrome?,"This polymorphism has previously been associated with RLS, but not low iron stores in blood donors.",0
560,0,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"Cas9, an RNA-guided DNA endonuclease found in clustered regularly interspaced short palindromic repeats (CRISPR) bacterial immune systems, is a versatile tool for genome editing, transcriptional regulation, and cellular imaging applications.",0
560,1,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,Structures of Streptococcus pyogenes Cas9 alone or bound to single-guide RNA (sgRNA) and target DNA revealed a bilobed protein architecture that undergoes major conformational changes upon guide RNA and DNA binding.,0
560,2,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"Although the lobes do not interact on their own, the sgRNA recruits them into a ternary complex that recapitulates the activity of full-length Cas9 and catalyzes site-specific DNA cleavage.",0
560,3,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"The use of a modified sgRNA abrogates split-Cas9 activity by preventing dimerization, allowing for the development of an inducible dimerization system.",0
560,4,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,This new type of genetic library is constructed through the lentiviral delivery of single-guide RNA collections that direct Cas9 or inactive dead Cas9 fused with effectors to interrogate gene function or regulate gene transcription in targeted cells.,0
560,5,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,The CRISPR/Cas9 system has recently emerged as a powerful tool for functional genomic studies in Drosophila melanogaster.,1
560,6,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"However, single-guide RNA (sgRNA) parameters affecting the specificity and efficiency of the system in flies are still not clear.",1
560,7,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"Here, we found that off-target effects did not occur in regions of genomic DNA with three or more nucleotide mismatches to sgRNAs.",0
560,8,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,Our work demonstrates a comprehensive optimization of sgRNA and promises to vastly simplify CRISPR/Cas9 experiments in Drosophila.,0
560,9,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"Targeted genome engineering is expected to contribute significantly to future varietal improvement, and genome editing technologies using zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9/single guide RNA (sgRNA) have already been successfully used to genetically modify plants.",0
560,10,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,A unique capability of the CRISPR/Cas9 system is multiplex genome engineering by delivering a single Cas9 enzyme and two or more single guide RNAs (sgRNAs) targeted to distinct genomic sites.,1
560,11,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"To determine if the Cas9 and single guide RNA (sgRNA) genes were functional in C. reinhardtii, we tested the ability of a codon-optimized Cas9 gene along with one of four different sgRNAs to cause targeted gene disruption during a 24-h period immediately following transformation.",0
560,12,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"Recently, compared to the wildtype nuclease, paired Cas9 nickase (Cas9n) combined with single guide RNA (sgRNA) molecules has been found to enhance the specificity of genome editing while reducing off-target effects.",0
560,13,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,Here we utilized a CRISPR/CAS9-based system with single guide RNAs to disrupt genes in T. gondii.,1
560,14,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"To address the need for uniform and sustained delivery of multiplex CRISPR/Cas9-based genome engineering tools, we developed a single lentiviral system to express a Cas9 variant, a reporter gene and up to four sgRNAs from independent RNA polymerase III promoters that are incorporated into the vector by a convenient Golden Gate cloning method.",0
560,15,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,A unique capability of the CRISPR/Cas9 system is multiplex genome engineering by delivering a single Cas9 enzyme and two or more single guide RNAs (sgRNAs) targeted to distinct genomic sites.,1
560,16,Is single guide RNA part of the CRISPR/Cas9 tool or an inhibitor of its function?,"Using synthetic single RNA guides, Cas9 can be reprogrammed to create specific double-stranded DNA breaks in the genomes of a variety of organisms, ranging from human cells to bacteria, and thus constitutes a powerful tool for genetic engineering.",0
663,0,List fish anti-freeze proteins.,"the anti-freeze glycoprotein of Antarctic and Arctic notothenoids,",1
663,1,List fish anti-freeze proteins.,pe III anti-freeze protein (AFP),1
663,2,List fish anti-freeze proteins.,AFP I or AFP III,1
663,3,List fish anti-freeze proteins.,type III anti-freeze proteins,1
663,4,List fish anti-freeze proteins.,wild type III thermal hysteresis protein,1
663,5,List fish anti-freeze proteins.,"Thermal hysteresis proteins (THPs) have been found in vertebrates, invertebrates, plants, bacteria and fungi and are able to depress the freezing point of water (in the presence of ice crystals) in a non-colligative manner by binding to the surface of nascent ice crystals",0
663,6,List fish anti-freeze proteins.,skin-type anti-freeze protein-3,0
542,0,What was the purpose of the FANTOM5 project?,The FANTOM5 and ENCODE projects represent two independent large scale efforts to map regulatory and transcriptional features to the human genome.,1
542,1,What was the purpose of the FANTOM5 project?,The functional annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles and functional annotation of mammalian cell-type-specific transcriptomes with wide applications in biomedical research,1
542,2,What was the purpose of the FANTOM5 project?,The functional annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles and functional annotation of mammalian cell-type-specific transcriptomes with wide applications in biomedical research.,1
542,3,What was the purpose of the FANTOM5 project?,The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation.,0
542,4,What was the purpose of the FANTOM5 project?,The FANTOM5 and ENCODE projects represent two independent large scale efforts to map regulatory and transcriptional features to the human genome.,0
542,5,What was the purpose of the FANTOM5 project?,The functional annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles and functional annotation of mammalian cell-type-specific transcriptomes with wide applications in biomedical research.,1
542,6,What was the purpose of the FANTOM5 project?,The FANTOM5 and ENCODE projects represent two independent large scale efforts to map regulatory and transcriptional features to the human genome.,0
542,7,What was the purpose of the FANTOM5 project?,The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation.,0
542,8,What was the purpose of the FANTOM5 project?,"Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers.",0
542,9,What was the purpose of the FANTOM5 project?,The FANTOM5 and ENCODE projects represent two independent large scale efforts to map regulatory and transcriptional features to the human genome.,0
542,10,What was the purpose of the FANTOM5 project?,Here we investigate chromatin features around a comprehensive set of transcription start sites in four cell lines by integrating data from these two projects.,0
542,11,What was the purpose of the FANTOM5 project?,The functional annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles and functional annotation of mammalian cell-type-specific transcriptomes with wide applications in biomedical research.,1
542,12,What was the purpose of the FANTOM5 project?,The FANTOM5 and ENCODE projects represent two independent large scale efforts to map regulatory and transcriptional features to the human genome.,0
2788,0,Is pembrolizumab effective against Ewing's sarcoma?,None of the 13 patients with Ewing's sarcoma had an objective response.,1
2788,1,Is pembrolizumab effective against Ewing's sarcoma?,"Between March 13, 2015, and Feb 18, 2016, we enrolled 86 patients, 84 of whom received pembrolizumab (42 in each disease cohort) and 80 of whom were evaluable for response (40 in each disease cohort).",1
3456,0,Is Apremilast effective for Behçet’s Syndrome?,"AREAS COVERED: This review provides a digest of all current experience and evidence about pharmacological agents recently described as having a role in the treatment of BS, including interleukin (IL)-1 inhibitors, tocilizumab, rituximab, alemtuzumab, ustekinumab, interferon-alpha-2a, and apremilast.",1
3456,1,Is Apremilast effective for Behçet’s Syndrome?,"CONCLUSIONS

Apremilast was effective in treating oral ulcers, which are the cardinal manifestation of Behçet's syndrome.",0
3456,2,Is Apremilast effective for Behçet’s Syndrome?,"CONCLUSIONS Apremilast was effective in treating oral ulcers, which are the cardinal manifestation of Behçet's syndrome.",1
3456,3,Is Apremilast effective for Behçet’s Syndrome?,"CONCLUSIONS
Apremilast was effective in treating oral ulcers, which are the cardinal manifestation of Behçet's syndrome.",0
3456,4,Is Apremilast effective for Behçet’s Syndrome?,"Apremilast was effective in treating oral ulcers, which are the cardinal manifestation of Behçet's syndrome.",1
3456,5,Is Apremilast effective for Behçet’s Syndrome?,"In patients with oral ulcers associated with Behçet's syndrome, apremilast resulted in a greater reduction in the number of oral ulcers than placebo but was associated with adverse events, including diarrhea, nausea, and headache.",1
3456,6,Is Apremilast effective for Behçet’s Syndrome?,(,0
3456,7,Is Apremilast effective for Behçet’s Syndrome?,Apremilast is now approved for the treatment of oral ulcer of Behçet syndrome in the United States.,1
3029,0,List search engines used in proteomics.,"We compared the contribution of each of the eight search engines (X!Tandem, MS-GF[Formula: see text], MS Amanda, MyriMatch, Comet, Tide, Andromeda, and OMSSA) integrated in an open-source graphical user interface SearchGUI ( http://searchgui.googlecode.com ) into total result of proteoforms identification and optimized set of engines working simultaneously.",1
3029,1,List search engines used in proteomics.," This software is also highly compatible with the identification and quantification results of various frequently used search engines, such as MaxQuant, Proteome Discoverer, or Mascot.",1
3029,2,List search engines used in proteomics.," database search engines: Mascot, X!Tandem, and MS-GF+.",1
3029,3,List search engines used in proteomics.,"applied an integrative approach based on the results obtained from Comet, Mascot, OMSSA, and X!Tandem.",1
368,0,Which deiodinase polymorphisms are implicated in arterial hypertension?,"However, rs7140952 polymorphism is associated with components of metabolic syndrome including blood pressure and central obesity.",1
368,1,Which deiodinase polymorphisms are implicated in arterial hypertension?,"Among euthyroid adults, the common Ala92 allele of the type 2 iodothyronine deiodinase increases risk for the development of hypertension.",1
368,2,Which deiodinase polymorphisms are implicated in arterial hypertension?,Ala92 type 2 deiodinase allele increases risk for the development of hypertension.,1
368,3,Which deiodinase polymorphisms are implicated in arterial hypertension?,This study investigates the clinical and biochemical response to L-T4 replacement therapy in hypothyroid patients in correlation with genetic variation in Deiodinase type || (DIO2) gene.,1
4064,0,Describe LowMACA,LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.,0
4064,1,Describe LowMACA,The increasing availability of resequencing data has led to a better understanding of the most important genes in cancer development.,0
4064,2,Describe LowMACA,"Nevertheless, the mutational landscape of many tumor types is heterogeneous and encompasses a long tail of potential driver genes that are systematically excluded by currently available methods due to the low frequency of their mutations.",0
4064,3,Describe LowMACA,"We developed LowMACA (Low frequency Mutations Analysis via Consensus Alignment), a method that combines the mutations of various proteins sharing the same functional domains to identify conserved residues that harbor clustered mutations in multiple sequence alignments.",1
4064,4,Describe LowMACA,LowMACA is designed to visualize and statistically assess potential driver genes through the identification of their mutational hotspots.,1
4064,5,Describe LowMACA,"LowMACA is a software for the identification of gain-of-function mutations in putative oncogenic families, increasing the amount of information on functional domains and their possible role in cancer.",1
4064,6,Describe LowMACA,In this context LowMACA emphasizes the role of genes mutated at low frequency otherwise undetectable by classical single gene analysis.,1
4064,7,Describe LowMACA,LowMACA is an R package available at http://www.bioconductor.org/packages/release/bioc/html/LowMACA.html.,1
4064,8,Describe LowMACA,It is also available as a GUI standalone downloadable at: https://cgsb.genomics.iit.it/wiki/projects/LowMACA.,0
3913,0,Explain the action of Balovaptan.,"Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder.",1
3913,1,Explain the action of Balovaptan.,"Balovaptan, an investigational vasopressin 1a receptor antagonist that has been evaluated for improvement of social communication and interaction,",1
3913,2,Explain the action of Balovaptan.,"balovaptan, an orally administered selective vasopressin V1a receptor antagonis",0
3913,3,Explain the action of Balovaptan.,"INTRODUCTION: Balovaptan, an investigational vasopressin 1a receptor antagonist that has been evaluated for improvement of social communication and interaction, is primarily metabolized by cytochrome P450 3A4 (CYP3A4).",1
3913,4,Explain the action of Balovaptan.,"INTRODUCTION: Balovaptan, an investigational vasopressin 1a receptor antagonist that has been evaluated for improvement of social communication and interaction, is primarily metabolized by cytochrome P450",1
3913,5,Explain the action of Balovaptan.,"ek clinical phase 2 study in adults with autism spectrum disorder balovaptan demonstrated improvements in Vineland-II Adaptive Behavior Scales, a secondary end point comprising communication, socialization, and daily living skills.",0
3913,6,Explain the action of Balovaptan.,Balovaptan,0
3913,7,Explain the action of Balovaptan.,"Balovaptan, an investigational vasopressin 1a receptor antagonist that has been evaluated for improvement of social communication and interaction, is primarily metabolized by cytochrome P450 3A4",1
3913,8,Explain the action of Balovaptan.,"In a 12-week clinical phase 2 study in adults with autism spectrum disorder balovaptan demonstrated improvements in Vineland-II Adaptive Behavior Scales, a secondary end point comprising communication, socialization, and daily living skills.",0
3913,9,Explain the action of Balovaptan.,"INTRODUCTION: Balovaptan, an investigational vasopressin 1a receptor antagonist that has been evaluated for improvement of social communication and interaction, is primarily metabolized by cytochrome P450 3A4 (CYP3A4).METHODS: Two single-center, non-randomized, two-period, phase 1 studies assessed the effect of the strong CYP3A4 inhibitor itraconazole (study NCT03579719) or the strong CYP3A4 inducer rifampicin (study NCT03586726) at steady state on the pharmacokinetics (PK) of steady-state balovaptan",0
3913,10,Explain the action of Balovaptan.,These results support further study of balovaptan as a potential treatment for the socialization and communication deficits in ASD.,0
482,0,Which genes are involved in patient response to warfarin?,We identified ORM1 as another polymorphic gene affecting warfarin dose requirements.,0
482,1,Which genes are involved in patient response to warfarin?,ORM1 *S carriers require lower maintenance doses to achieve and maintain an optimal level of anticoagulation.,0
482,2,Which genes are involved in patient response to warfarin?,Detecting genetic polymorphism of CYP2C9 and VKORC1 could guide clinical use of warfarin to reduce the risk of adverse reactions including bleeding in patients receiving chronic anticoagulation therapy,0
482,3,Which genes are involved in patient response to warfarin?,"The genes encoding for cytochrome P450 (CYP) 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1) are the major genetic determinants of warfarin pharmacokinetics and pharmacodynamics, respectively.",0
482,4,Which genes are involved in patient response to warfarin?,Numerous studies have demonstrated significant contributions of these genes to warfarin dose requirements.,0
482,5,Which genes are involved in patient response to warfarin?,The CYP2C9 gene has also been associated with bleeding risk with warfarin.,1
482,6,Which genes are involved in patient response to warfarin?,The CYP4F2 gene influences vitamin K availability and makes minor contributions to warfarin dose requirements,0
482,7,Which genes are involved in patient response to warfarin?,There are other genetic polymorphisms that may further explain the response to warfarin.,0
482,8,Which genes are involved in patient response to warfarin?,"The VKORC1 genotype is an important determinant of response to warfarin in Chinese, but some genetic variants found in other ethnic groups that have a large effect on warfarin response and dosing are not commonly found in Chinese",0
482,9,Which genes are involved in patient response to warfarin?,"the alleles rs1799853 (*2) and rs1057910 (*3) of the CYP2C9 gene, as well as rs9923231 of the VKORC1 gene were associated with warfarin dose required to achieve anticoagulation with INR of 2-3.",0
482,10,Which genes are involved in patient response to warfarin?,Polymorphisms in the genes encoding the cytochrome P450 2C9 enzyme (CYP2C9) and the vitamin K epoxide reductase (VKORC1) are known to contribute to variability in sensitivity to coumarins.,0
482,11,Which genes are involved in patient response to warfarin?,VKORC1 and CYP2C9 polymorphisms are important factors that influence warfarin dose response in Sudanese patients,0
482,12,Which genes are involved in patient response to warfarin?,he response to the anticoagulant drug warfarin is greatly affected by genetic polymorphisms in the VKORC1 and CYP2C9 genes.,1
482,13,Which genes are involved in patient response to warfarin?,"The HDA-based assays demonstrated a clinically acceptable performance for genotyping the VKORC1 -1639G>A SNP and two SNPs (430C>T and 1075A>C) for the CYP2C9 enzyme (CYP2C9*2 and CYP2C9*3), all of which are relevant in warfarin pharmacogenentics.",0
482,14,Which genes are involved in patient response to warfarin?,Genetic variability in the VKORC1 and CYP2C9 genes is associated with increased warfarin sensitivity,1
482,15,Which genes are involved in patient response to warfarin?,CYP2C9 and VKORC1 polymorphisms known to affect warfarin response,0
482,16,Which genes are involved in patient response to warfarin?,"genetic variants of VKORC1, CYP2C9, CYP4F2, and EPHX1 were found to be significant predictor variables for the maintenance dose of warfarin, explaining 26.6% of dose variability.",0
482,17,Which genes are involved in patient response to warfarin?,"CYP2C9 was the most important gene determining initial anticoagulant control, whereas VKORC1 was more important for stable anticoagulation.",0
482,18,Which genes are involved in patient response to warfarin?,"Novel associations with some clinical outcomes were found with single nucleotide polymorphisms in the cytochrome 450 genes CYP2C18 and CYP2C19, which were independent of the associations observed with CYP2C9 and in genes encoding CYP3A5, protein S and clotting factor V, although the variability explained by these genes was small.",1
482,19,Which genes are involved in patient response to warfarin?,"VKORC1 -1639 G>A polymorphism, body weight, age, and serum albumin were found to affect the inter-individual variabilit",0
482,20,Which genes are involved in patient response to warfarin?,the CYP2C9 and VKORC1 genes have been demonstrated to be determinants of warfarin response.,1
482,21,Which genes are involved in patient response to warfarin?,"On the basis of these observations, the Food and Drug Administration (FDA) approved a labeling change for warfarin that includes the genetic information of VKORC1 and CYP2C9 as factors influencing interindividual variability in warfarin dosing.",0
482,22,Which genes are involved in patient response to warfarin?,T,0
482,23,Which genes are involved in patient response to warfarin?,"the two key genes of interest, the cytochrome P450 2C9 gene, CYP2C9, and the vitamin K epoxide reductase complex 1 gene, VKORC1, on warfarin response",0
482,24,Which genes are involved in patient response to warfarin?,The influence of CYP2C9 and VKORC1 genotypes on warfarin dose requirements has been consistently demonstrated in diverse racial and ethnic patient groups in observational studies and randomized clinical trials.,0
482,25,Which genes are involved in patient response to warfarin?,genetic factors influencing drug pharmacokinetics (CYP2C9) and pharmacodynamic response (VKORC1).,0
482,26,Which genes are involved in patient response to warfarin?,"In particular, the discovery of polymorphisms in the VKORC1 gene that strongly impact oral anticoagulant dose has heightened expectations that genetic testing",0
482,27,Which genes are involved in patient response to warfarin?,"Our data suggest that CYP2C9 genotype, age and body size are important determinants of warfarin dose requirements in African-Americans.",0
482,28,Which genes are involved in patient response to warfarin?,Our data further suggest that the VKORC1 G6853C polymorphism alone may not be useful for predicting warfarin dose requirements in this racial group.,0
482,29,Which genes are involved in patient response to warfarin?,"A strong association was found between genetic polymorphisms in six genes, including VKORC1, CYP2C9, PROC, EPHX1, GGCX, and ORM1, and interindividual variability in the anticoagulant effect of warfarin; the strongest predictors were VKORC1 and CYP2C9.",0
482,30,Which genes are involved in patient response to warfarin?,Three of six VKORC1 SNPs were found to be very strongly associated with the average warfarin dose required to achieve the target international normalised ratio (INR; p<0.0001),0
482,31,Which genes are involved in patient response to warfarin?,These results are of considerable clinical interest and confirm recently published results regarding the role of these two genes in modifying warfarin metabolism and maintenance dosage.,0
482,32,Which genes are involved in patient response to warfarin?,The consistent findings regarding the role of VKORC1 and CYP2C9 in warfarin metabolism and maintenance dosage represent a clinically useful proof of principal for the use of pharmacogenomic information in medicine and may lead to improved understanding of warfarin's actions.,0
482,33,Which genes are involved in patient response to warfarin?,"Clinical studies showed an increased plasma level of S-warfarin, decreased clearance of S-warfarin, increased frequency of bleeding, and prolongation of hospitalization in patients with variant CYP2C9 alleles.",0
1908,0,Which syndromes are associated with heterochromia iridum?,"To our knowledge, this is the first reported case of Ascher's syndrome associated with iris coloboma, heterochromia iridum, and narrowing of horizontal palpebral fissure and decreased outer intercanthal distance secondary to lengthening of lateral canthal ligament.",1
1908,1,Which syndromes are associated with heterochromia iridum?," Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2 patients.",0
1908,2,Which syndromes are associated with heterochromia iridum?,"Waardenburg Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss and pigmentary abnormalities of the eyes, hair, and skin.",0
1908,3,Which syndromes are associated with heterochromia iridum?,Microphthalmia-associated transcription factor (MITF) gene mutations account for about 15% of WS type II (WS2) cases.,0
1908,4,Which syndromes are associated with heterochromia iridum?,The association of congenital Horner's syndrome and hypochromia iridum without anhidrosis is highly suggestive of sympathetic pathway injury early in life.,0
1908,5,Which syndromes are associated with heterochromia iridum?,The Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders.,0
1908,6,Which syndromes are associated with heterochromia iridum?,WS Type I has been mapped to the distal part of chromosome 2q and the gene identified as PAX3.,0
1908,7,Which syndromes are associated with heterochromia iridum?,Other gene(s) are responsible for WS Type II.,0
1908,8,Which syndromes are associated with heterochromia iridum?,Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II.,0
1908,9,Which syndromes are associated with heterochromia iridum?,WAARDENBURG'S SYNDROME AND HETEROCHROMIA IRIDUM IN A DEAF SCHOOL POPULATION.,0
1908,10,Which syndromes are associated with heterochromia iridum?,"Waardenburg's syndrome consists of lateral displacement of the inner canthi of the eyes (dystopia canthorum), a broad nasal root and confluent eyebrows, heterochromia iridum, a white forelock and congenital deafness.",0
1908,11,Which syndromes are associated with heterochromia iridum?,"To our knowledge, this is the first reported case of Ascher's syndrome associated with iris coloboma, heterochromia iridum, and narrowing of horizontal palpebral fissure and decreased outer intercanthal distance secondary to lengthening of lateral canthal ligament.",1
1908,12,Which syndromes are associated with heterochromia iridum?,Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II.,0
1908,13,Which syndromes are associated with heterochromia iridum?,"Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2 patients.",0
1908,14,Which syndromes are associated with heterochromia iridum?,"We present the genetic analyses conducted on a three-generation family (14 individuals) with three members affected with isolated-Hirschsprung disease (HSCR) and one with HSCR and heterochromia iridum (syndromic-HSCR), a phenotype reminiscent of Waardenburg-Shah syndrome (WS4).",0
1908,15,Which syndromes are associated with heterochromia iridum?,Heterochromia iridis and Horner's syndrome due to paravertebral neurilemmoma.,0
1908,16,Which syndromes are associated with heterochromia iridum?,[Iris heterochromia in acquired Horner's syndrome].,0
1908,17,Which syndromes are associated with heterochromia iridum?,"BACKGROUND: Heterochromia iridis, asymmetry of iris pigmentation, has been well described with congenital Horner syndrome.",0
1908,18,Which syndromes are associated with heterochromia iridum?,A case of heterochromia iridis and Horner's syndrome is reported in a 7-year old girl with paravertebral neurilemmoma.,0
1908,19,Which syndromes are associated with heterochromia iridum?,"We present the genetic analyses conducted on a three-generation family (14 individuals) with three members affected with isolated-Hirschsprung disease (HSCR) and one with HSCR and heterochromia iridum (syndromic-HSCR), a phenotype reminiscent of Waardenburg-Shah syndrome (WS4)",0
1908,20,Which syndromes are associated with heterochromia iridum?,"To our knowledge, this is the first reported case of Aschers syndrome associated with iris coloboma, heterochromia iridum, and narrowing of horizontal palpebral fissure and decreased outer intercanthal distance secondary to lengthening of lateral canthal ligament",1
1908,21,Which syndromes are associated with heterochromia iridum?,WAARDENBURGS SYNDROME AND HETEROCHROMIA IRIDUM IN A DEAF SCHOOL POPULATION,1
1908,22,Which syndromes are associated with heterochromia iridum?,"Waardenburgs syndrome consists of lateral displacement of the inner canthi of the eyes (dystopia canthorum), a broad nasal root and confluent eyebrows, heterochromia iridum, a white forelock and congenital deafness",0
1908,23,Which syndromes are associated with heterochromia iridum?,"Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2 patients",0
1908,24,Which syndromes are associated with heterochromia iridum?,"Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2 patients.",0
1908,25,Which syndromes are associated with heterochromia iridum?,"A dominantly inherited syndrome associated with hypopigmentation, heterochromia irides, colobomatous eyes and bilateral hearing loss has been ascertained in Fleckvieh cattle (German White Fleckvieh syndrome).",1
1908,26,Which syndromes are associated with heterochromia iridum?,Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II.,0
1908,27,Which syndromes are associated with heterochromia iridum?,"Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2 patients.",0
1908,28,Which syndromes are associated with heterochromia iridum?,WAARDENBURG'S SYNDROME AND HETEROCHROMIA IRIDUM IN A DEAF SCHOOL POPULATION.,0
2761,0,Which tool has been developed for coverage calculation for genomes?,Mosdepth: quick coverage calculation for genomes and exomes.,0
2761,1,Which tool has been developed for coverage calculation for genomes?,Mosdepth is a new command-line tool for rapidly calculating genome-wide sequencing coverage.,1
2761,2,Which tool has been developed for coverage calculation for genomes?,It measures depth from BAM or CRAM files at either each nucleotide position in a genome or for sets of genomic regions.,1
2761,3,Which tool has been developed for coverage calculation for genomes?,"Genomic regions may be specified as either a BED file to evaluate coverage across capture regions, or as a fixed-size window as required for copy-number calling.",1
2761,4,Which tool has been developed for coverage calculation for genomes?,Mosdepth uses a simple algorithm that is computationally efficient and enables it to quickly produce coverage summaries.,1
2761,5,Which tool has been developed for coverage calculation for genomes?,We demonstrate that mosdepth is faster than existing tools and provides flexibility in the types of coverage profiles produced.Availability and implementation: mosdepth is available from https://github.com/brentp/mosdepth under the MIT license.,1
3446,0,What gene is mutated in Huntington's Disease patients?,Huntington's disease (HD) is a fully penetrant neurodegenerative disease caused by a dominantly inherited CAG trinucleotide repeat expansion in the huntingtin gene on chromosome 4,1
3446,1,What gene is mutated in Huntington's Disease patients?,"Huntington's disease (HD) is caused by a CAG repeat expansion that encodes a polyglutamine (polyQ) expansion in the HD disease protein, huntingtin (HTT).",1
3446,2,What gene is mutated in Huntington's Disease patients?,PolyQ expansion promotes misfolding and aggregation of mutant HTT (mHTT) within neurons.,0
3446,3,What gene is mutated in Huntington's Disease patients?,Huntington's disease (HD) is a neurodegenerative disorder that is caused by abnormal expansion of CAG repeats in the HTT gene.,1
3446,4,What gene is mutated in Huntington's Disease patients?,"Two decades ago, researchers identified that a CAG expansion mutation in the huntingtin (HTT) gene was involved in the pathogenesis of Huntington's disease (HD).",0
3446,5,What gene is mutated in Huntington's Disease patients?,"However, since the identification of the HTT gene, there has been no advance in the development of therapeutic strategies to prevent or reduce the progression of HD",0
3446,6,What gene is mutated in Huntington's Disease patients?,"Mutations in the HTT gene , consisting of expansion of CAG triplets , cause the Huntington 's disease ( HD) , one of the major neurodegenerative disorders .",0
3446,7,What gene is mutated in Huntington's Disease patients?,Huntington 's disease is a neurodegenerative disorder of the brain that is caused by the mutation of the gene which produces a protein called huntingtin ( htt) .,0
3446,8,What gene is mutated in Huntington's Disease patients?,Huntington 's disease ( HD ) is an autosomal dominant neurodegenerative disorder of the central nervous system ( CNS ) that is defined by a CAG expansion in exon 1 of the huntingtin gene leading to the production of mutant huntingtin ( mHtt) .,0
3446,9,What gene is mutated in Huntington's Disease patients?,"A mutation in the huntingtin ( Htt ) gene produces mutant Htt and Huntington 's disease ( HD) , a neurodegenerative disorder .",0
3446,10,What gene is mutated in Huntington's Disease patients?,Huntington 's disease ( HD ) is a devastating neurodegenerative disorder that occurs in patients with a mutation in the huntingtin or IT15 gene.,1
3446,11,What gene is mutated in Huntington's Disease patients?,"Huntington's disease is an inherited disorder caused by expanded stretch of consecutive trinucleotides (cytosine-adenosine-guanine, CAG) within the first exon of the huntingtin (HTT) gene on chromosome 4 (p16.3).",0
3446,12,What gene is mutated in Huntington's Disease patients?,"Huntington's disease is an inherited disorder caused by expansion of a CAG trinucleotide repeat in the IT15 gene, which leads to expansion of a polyglutamine tract within the protein called huntingtin.",0
3446,13,What gene is mutated in Huntington's Disease patients?,Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by high instability and extension of CAG sequences within the coding region of IT15 gene.,0
3446,14,What gene is mutated in Huntington's Disease patients?,"Huntington's disorder (HD), caused by mutations of the IT-15 gene, is an autosomal genetic disease that causes the breakdown of the nerve cells in the brain.",0
3446,15,What gene is mutated in Huntington's Disease patients?,Huntington's disease is caused by an expanded trinucleotide CAG repeat in the HD gene on chromosome 4.,1
3446,16,What gene is mutated in Huntington's Disease patients?,Positional cloning has shown that the Huntington disease (HD) mutation is an expanded trinucleotide repeat in the IT15 gene.,0
3558,0,Describe the mechanism of action of a drug Elagolix.,"Compound 12c showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist, Elagolix.",0
3558,1,Describe the mechanism of action of a drug Elagolix.,"INTRODUCTION: Elagolix is a novel, orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist in development for the management of endometriosis with associated pain and heavy menstrual bleeding due to uterine fibroids.",1
3558,2,Describe the mechanism of action of a drug Elagolix.,"OBJECTIVE: To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain.",1
3558,3,Describe the mechanism of action of a drug Elagolix.,"Phase III trials on elagolix, a new oral GnRH antagonist but non-inferiority RCT data are required to compare elagolix with first-line therapies for endometriosis.",0
3558,4,Describe the mechanism of action of a drug Elagolix.,"Elagolix (ORILISSA™), an orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist, is being developed AbbVie and Neurocrine Biosciences for the treatment of reproductive hormone-dependent disorders in women.",1
3558,5,Describe the mechanism of action of a drug Elagolix.,"OBJECTIVE: To evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy, in premenopausal women with heavy menstrual bleeding (greater than 80 mL per month) associated with uterine leiomyomas.",0
3558,6,Describe the mechanism of action of a drug Elagolix.,Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature.,0
3558,7,Describe the mechanism of action of a drug Elagolix.,"Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis.",1
3558,8,Describe the mechanism of action of a drug Elagolix.,"Elagolix is a novel, orally available nonpeptide GnRH antagonist.",0
3558,9,Describe the mechanism of action of a drug Elagolix.,"Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.",0
3558,10,Describe the mechanism of action of a drug Elagolix.,"Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study.",0
3558,11,Describe the mechanism of action of a drug Elagolix.,"In addition to already established medications, a new GnRH antagonist, elagolix, is in development.",0
3558,12,Describe the mechanism of action of a drug Elagolix.,Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis.,1
3558,13,Describe the mechanism of action of a drug Elagolix.,"Context: Elagolix is a nonpeptide, oral gonadotropin-releasing hormone (GnRH) antagonist being developed for sex-hormone-dependent diseases in women.Objective: We evaluated the pharmacokinetics and pharmacodynamics of elagolix.Design, Setting, and Participants: This study was a randomized, double-blind, placebo-controlled, multiple-ascending dose study in 45 healthy premenopausal women at a research unit.Interventions: Elagolix [150 mg once daily or 100, 200, 300, or 400 mg twice daily (BID)] or placebo was administered for 21 days.Main Outcome Measures: Main outcome measures were elagolix pharmacokinetics, suppression of gonadotropics [follicle-stimulating hormone (FSH), luteinizing hormone (LH)] and ovarian hormones [estradiol (E2), progesterone (P)], and adverse events.Results: Elagolix was rapidly absorbed after oral dosing, reaching maximum concentrations at 1.0 to 1.5 hours, with a half-life of 4 to 6 hours.",0
3558,14,Describe the mechanism of action of a drug Elagolix.,"Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density.",0
3558,15,Describe the mechanism of action of a drug Elagolix.,"While elagolix may have an advantage over established GnRH agonists, in that it does not lead to a 'flare-up' effect, it too, takes a toll on bone mineral density.",0
3700,0,What is the function of a viral peplomer?,The coronavirus peplomer protein S is responsible for attachment and fusion during viral entry as well as for the induction of cell to cell fusion.,1
3700,1,What is the function of a viral peplomer?,"Since tissue affinities are a function of the viral peplomer-mediated attachment of virus to cells and are often directly related to pathogenicity,",1
3700,2,What is the function of a viral peplomer?,"Thus, inhibition of the N-glycosylation of the S and HE structural proteins prevented their incorporation into progeny virions, an indication that they are dispensable for virion morphogenesis, unlike the M protein.",1
3700,3,What is the function of a viral peplomer?,Numerous studies have demonstrated that the spike glycoprotein of coronaviruses bears major determinants of pathogenesis.,1
3713,0,What is the interaction between WAPL and PDS5 proteins?,We propose that Wapl and Pds5 directly modulate conformational changes of cohesin to make it competent for dissociation from chromatin during prophase.,1
3713,1,What is the interaction between WAPL and PDS5 proteins?,"Nipped-B, Pds5, and the Wapl protein that interacts with Pds5 all play unique roles in cohesin chromosome binding.",1
3713,2,What is the interaction between WAPL and PDS5 proteins?,Translocation ability is suppressed in the presence of Wapl-Pds5 and Sororin,0
3713,3,What is the interaction between WAPL and PDS5 proteins?,Cohesin acetylation and Wapl-Pds5 oppositely regulate translocation of cohesin along DNA.,0
3713,4,What is the interaction between WAPL and PDS5 proteins?, the cohesin unloading factor WAPL and its PDS5 binding partners control the length of loops.,0
3713,5,What is the interaction between WAPL and PDS5 proteins?,the cohesin regulators Pds5 and Wapl release cohesin from chromosomes.,0
3713,6,What is the interaction between WAPL and PDS5 proteins?,"a requirement for ATP hydrolysis in ring opening, suggested regulation of the cohesin ATPase activity by DNA and Smc3 acetylation, and provided insights into how Pds5 and Wapl open this exit gate.",0
3713,7,What is the interaction between WAPL and PDS5 proteins?,"Pds5, Wapl, and SA1/2 form a rigid scaffold that docks on Scc1 and anchors the N-terminal domain of Scc1 (Scc1N) to the Smc1 ATPase head",1
3713,8,What is the interaction between WAPL and PDS5 proteins?,"ds5 and Wapl, but not Brca2, limit the distance that cohesin extends from origins, thereby determining which active genes, enhancers and silencers bind cohesin.",1
3713,9,What is the interaction between WAPL and PDS5 proteins?,"Using RNA-seq we find that Brca2, Pds5 and Wapl influence the expression of most genes sensitive to Nipped-B and cohesin, largely in the same direction.",1
2022,0,What are Degrons?,Specific signals (degrons) regulate protein turnover mediated by the ubiquitin-proteasome system.,1
2022,1,What are Degrons?,"Portable degradation sequences, or degrons, have the ability to bind to E3 ligases and promote substrate ubiquitination when the sequence is presented in isolation or appended to other entities such as fluorescent peptide-based reporters.",1
2022,2,What are Degrons?,"The N-degrons, a set of degradation signals recognized by the N-end rule pathway, comprise a protein's destabilizing N-terminal residue and an internal lysine residue.",0
2022,3,What are Degrons?,"The ubiquitin-proteasome system degrades an enormous variety of proteins that contain specific degradation signals, or 'degrons'.",1
2022,4,What are Degrons?,"Degron refers to an amino acid sequence that encodes a protein degradation signal, which is oftentimes a poly-ubiquitin chain that can be transferred to other proteins.",0
2022,5,What are Degrons?,Degradation signals (degrons) that are targeted by the N-end rule pathway include a set called N-degrons.,1
2022,6,What are Degrons?,The main determinant of an N-degron is a destabilizing N-terminal residue of a protein,0
2022,7,What are Degrons?,"The N-end rule pathway is a proteolytic system in which destabilizing N-terminal amino acids of short lived proteins are recognized by recognition components (N-recognins) as an essential element of degrons, called N-degrons",0
2022,8,What are Degrons?,The N-end rule pathway is a regulated proteolytic system that targets proteins containing destabilizing N-terminal residues (N-degrons) for ubiquitination and proteasomal degradation in eukaryotes,1
2022,9,What are Degrons?,"More than 25 years ago, the first degradation signal was discovered and defined as destabilizing N-terminal amino-acid residue (or N-degron) of protein substrates",0
2022,10,What are Degrons?,"A protein domain called ""degron"", which induces rapid proteolysis by the proteasome, can be used for this purpose.",0
2022,11,What are Degrons?,Degron-based technologies for the conditional depletion of POI--degron fusion proteins have been developed by exploiting various pathways leading to proteasomal degradation.,0
3111,0,Does Axitinib prolong survival of Pancreatic Cancer patients?,"CONCLUSIONS: Axitinib/gemcitabine, while tolerated, did not provide survival benefit over gemcitabine alone in patients with advanced pancreatic cancer from Japan or other regions.",1
3111,1,Does Axitinib prolong survival of Pancreatic Cancer patients?,"RESULTS: Among Japanese patients, median overall survival was not estimable (95% confidence interval, 7.4 months-not estimable) with axitinib/gemcitabine (n = 58) and 9.9 months (95% confidence interval, 7.4-10.5) with placebo/gemcitabine (n = 56) (hazard ratio 1.093 [95% confidence interval, 0.525-2.274]).",0
3111,2,Does Axitinib prolong survival of Pancreatic Cancer patients?,Median survival follow-up (range) was 5.1 months (0.02-12.3) with axitinib/gemcitabine vs. 5.4 months (1.8-10.5) with placebo/gemcitabine.,0
3111,3,Does Axitinib prolong survival of Pancreatic Cancer patients?,"Similarly, no difference was detected in overall survival between axitinib/gemcitabine and placebo/gemcitabine in patients from North America or the European Union.",0
3111,4,Does Axitinib prolong survival of Pancreatic Cancer patients?,"At an interim analysis in January, 2009, the independent data monitoring committee concluded that the futility boundary had been crossed.",0
3111,5,Does Axitinib prolong survival of Pancreatic Cancer patients?,"Median overall survival was 8·5 months (95% CI 6·9-9·5) for gemcitabine plus axitinib (n=314, data missing for two patients) and 8·3 months (6·9-10·3) for gemcitabine plus placebo (n=316; hazard ratio 1·014, 95% CI 0·786-1·309; one-sided p=0·5436).",0
3111,6,Does Axitinib prolong survival of Pancreatic Cancer patients?,INTERPRETATION: The addition of axitinib to gemcitabine does not improve overall survival in advanced pancreatic cancer.,1
3111,7,Does Axitinib prolong survival of Pancreatic Cancer patients?,"INTERPRETATION
The addition of axitinib to gemcitabine does not improve overall survival in advanced pancreatic cancer.",0
3111,8,Does Axitinib prolong survival of Pancreatic Cancer patients?,"However, as with other tyrosine kinase inhibitors of the same class, axitinib does not prolong overall survival; therefore, selection of second-line tyrosine kinase inhibitor therapy, including axitinib, must be carefully considered to maximize outcomes for each patient.",1
3111,9,Does Axitinib prolong survival of Pancreatic Cancer patients?,"CONCLUSIONS
Axitinib/gemcitabine, while tolerated, did not provide survival benefit over gemcitabine alone in patients with advanced pancreatic cancer from Japan or other regions.",0
3111,10,Does Axitinib prolong survival of Pancreatic Cancer patients?,"Similarly, no difference was detected in overall survival between axitinib/gemcitabine and placebo/gemcitabine in patients from North America or the European Union.",0
3111,11,Does Axitinib prolong survival of Pancreatic Cancer patients?,"Axitinib/gemcitabine, while tolerated, did not provide survival benefit over gemcitabine alone in patients with advanced pancreatic cancer from Japan or other regions.",1
3111,12,Does Axitinib prolong survival of Pancreatic Cancer patients?,The addition of axitinib to gemcitabine does not improve overall survival in advanced pancreatic cancer.,1
3153,0,What is another name for the plant Sideritis scardica?,Sideritis scardica Griseb.,1
3153,1,What is another name for the plant Sideritis scardica?,"(ironwort, mountain tea), an endemic plant of the Balkan Peninsula, has been used in traditional medicine in the treatment of gastrointestinal complaints, inflammation, and rheumatic disorders.",1
394,0,What is known about the value of mindfulness interventions in prostate cancer patients?,"Participants reported regular mindfulness training practice, and there was a significant correlation between mindfulness training practice and changes in both initiation and maintenance of the change in A:V. These pilot results provide encouraging evidence for the feasibility of a dietary program that includes mindfulness training in supporting dietary change for men with recurrent prostate cancer and invite further study to explore the possible role of mindfulness training as a means of supporting both initiation of dietary changes and maintenance of those changes over time.",1
394,1,What is known about the value of mindfulness interventions in prostate cancer patients?,"FINDINGS: Following the 6-week MBSR program, patients showed improvements in stress and anxiety (p < .05); caregivers' psychological and QOL also improved but were not statistically significant.",0
394,2,What is known about the value of mindfulness interventions in prostate cancer patients?,Both patients and caregivers had decreases in cortisol at Weeks 1 and 3 (p < .05) but not at Week 6.,0
394,3,What is known about the value of mindfulness interventions in prostate cancer patients?,"Similar to cortisol levels at Week 6, salivary interleukin-6 levels were lower overall (before/after an MBSR-C session), compared with Week 1 for patients and caregivers.",0
394,4,What is known about the value of mindfulness interventions in prostate cancer patients?,"CONCLUSIONS: MBSR-C may be a beneficial intervention for reducing stress, anxiety, cortisol levels, and symptoms in advanced-stage cancer patients and may also benefit caregivers.",0
394,5,What is known about the value of mindfulness interventions in prostate cancer patients?,"ESULTS: Significant improvements were observed for anxiety (p = 0.027), avoidance (p = 0.032), and mindfulness skills (p = 0.019), with a trend for a reduction in fear of cancer recurrence (p = 0.062).",0
394,6,What is known about the value of mindfulness interventions in prostate cancer patients?,"CONCLUSIONS: Mindfulness-based group interventions appear to have utility in this patient group and show promise for reducing anxiety, avoidance, and fear of cancer recurrence.",1
394,7,What is known about the value of mindfulness interventions in prostate cancer patients?, Linear mixed modeling showed significant improvements in overall symptoms of stress which were maintained over the follow-up period.,0
394,8,What is known about the value of mindfulness interventions in prostate cancer patients?,Cortisol levels decreased systematically over the course of the follow-up.,0
394,9,What is known about the value of mindfulness interventions in prostate cancer patients?,Immune patterns over the year supported a continued reduction in Th1 (pro-inflammatory) cytokines.,0
394,10,What is known about the value of mindfulness interventions in prostate cancer patients?,Systolic blood pressure (SBP) decreased from pre- to post-intervention and HR was positively associated with self-reported symptoms of stress.,0
394,11,What is known about the value of mindfulness interventions in prostate cancer patients?,"CONCLUSIONS: MBSR program participation was associated with enhanced quality of life and decreased stress symptoms, altered cortisol and immune patterns consistent with less stress and mood disturbance, and decreased blood pressure.",0
394,12,What is known about the value of mindfulness interventions in prostate cancer patients?,"Significant improvements were seen in overall quality of life, symptoms of stress, and sleep quality, but these improvements were not significantly correlated with the degree of program attendance or minutes of home practice.",1
394,13,What is known about the value of mindfulness interventions in prostate cancer patients?,"CONCLUSIONS: MBSR program enrollment was associated with enhanced quality of life and decreased stress symptoms in breast and prostate cancer patients, and resulted in possibly beneficial changes in hypothalamic-pituitary-adrenal (HPA) axis functioning.",1
394,14,What is known about the value of mindfulness interventions in prostate cancer patients?,"Significant improvements were seen in overall quality of life, symptoms of stress, and sleep quality.",0
394,15,What is known about the value of mindfulness interventions in prostate cancer patients?,"Although there were no significant changes in the overall number of lymphocytes or cell subsets, T cell production of IL-4 increased and IFN-gamma decreased, whereas NK cell production of IL-10 decreased.",0
394,16,What is known about the value of mindfulness interventions in prostate cancer patients?,CONCLUSIONS: MBSR participation was associated with enhanced quality of life and decreased stress symptoms in breast and prostate cancer patients.,0
394,17,What is known about the value of mindfulness interventions in prostate cancer patients?,This study is also the first to show changes in cancer-related cytokine production associated with program participation.,0
394,18,What is known about the value of mindfulness interventions in prostate cancer patients?,CONCLUSIONS: Our small study provides evidence that a plant-based diet delivered in the context of MBSR decreases the rate of PSA increase and may slow the rate of tumor progression in cases of biochemically recurrent prostate cancer.,1
3025,0,How does the Cholera toxin enter a cell?,"Cholera toxin (CT), which is secreted by V. cholerae, can enter host cells by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface of various animal epithelial cells.",1
3025,1,How does the Cholera toxin enter a cell?,The five B-subunits (CTB5) of the Vibrio cholerae (cholera) toxin can bind to the intestinal cell surface so the entire AB5 toxin can enter the cell.,1
3025,2,How does the Cholera toxin enter a cell?,Simultaneous binding can occur on more than one of the monosialotetrahexosylganglioside (GM1) units present on the cell surface.,1
3025,3,How does the Cholera toxin enter a cell?,we test the role of glycolipid crosslinking as a raft targeting and ordering mechanism using the well-studied raft marker cholera toxin B pentamer (CTxB) that binds up to five GM1 glycosphingolipids to enter host cells.,1
3421,0,What is the target of the drug Olmesartan?,"Olmesartan (OL) is the pharmacologically active metabolite of Olmesartan medoxomil (OM), an FDA-approved angiotensin II receptor antagonist for administrating cardiovascular diseases.",1
3421,1,What is the target of the drug Olmesartan?,Either angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor 1 blocker (ARB) attenuates cardiac remodeling.,1
3421,2,What is the target of the drug Olmesartan?,"However, the overall molecular modulation of the reversing remodeling process in response to the ACEI or ARB treatment is not yet well determined.",1
3421,3,What is the target of the drug Olmesartan?,"In this study, we examined whether gene expressions are modulated by ACEI (temocapril), ARB (olmesartan)",1
3421,4,What is the target of the drug Olmesartan?, ARB olmesartan (OLM),1
3233,0,What is aphasia?,"Aphasia, the language disorder following brain damage, is frequently accompanied by deficits of working memor",1
3233,1,What is aphasia?,"People with aphasia (PWA) use pantomime, gesture in absence of speech,",1
1719,0,Which compound is a specific inhibitor for Nox1 and Nox4?,"The efficacy of the Nox1/Nox4 inhibitor GKT137831 on the manifestations of DN was studied in OVE26 mice, a model of type 1 diabetes.",1
1719,1,Which compound is a specific inhibitor for Nox1 and Nox4?,"At both doses, GKT137831 inhibited NADPH oxidase activity, superoxide generation, and hydrogen peroxide production in the renal cortex from diabetic mice without affecting Nox1 or Nox4 protein expression",0
1719,2,Which compound is a specific inhibitor for Nox1 and Nox4?,"GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions.",1
1719,3,Which compound is a specific inhibitor for Nox1 and Nox4?,Basal NAD(P)H oxidase activity was blocked by GKT136901 (Nox1/4 inhibitor) and by Nox1 siRNA in WKY cells and by siNOX1 and siNOX2 in SHR.,0
1719,4,Which compound is a specific inhibitor for Nox1 and Nox4?,"GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions",1
1719,5,Which compound is a specific inhibitor for Nox1 and Nox4?,"Importantly, administration of the most specific Nox1/4 inhibitor, GKT137831, replicated these renoprotective effects of Nox4 deletion",1
1719,6,Which compound is a specific inhibitor for Nox1 and Nox4?,"The efficacy of the Nox1/Nox4 inhibitor GKT137831 on the manifestations of DN was studied in OVE26 mice, a model of type 1 diabetes",0
1719,7,Which compound is a specific inhibitor for Nox1 and Nox4?,"Importantly, administration of the most specific Nox1/4 inhibitor, GKT137831, replicated these renoprotective effects of Nox4 deletion.",1
929,0,What type of enzyme is peroxiredoxin 2 (PRDX2)?,Peroxiredoxin-2 (PRDX-2) is an antioxidant and chaperone-like protein critical for cell function.,1
929,1,What type of enzyme is peroxiredoxin 2 (PRDX2)?,We found that the antioxidant enzyme peroxiredoxin-2 (Prx2) inversely correlated with the metastatic capacity of human melanoma cells.,0
929,2,What type of enzyme is peroxiredoxin 2 (PRDX2)?,The aim of this study was to examine gonadotropin regulation of antioxidant enzyme sulfiredoxin (Srx) and peroxiredoxin 2 (PRDX2) expressions and modification during the ovulatory process in rats.,0
929,3,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"The mRNA profiler array showed more than 2-fold differential expression of 32 oxidative stress-related genes in unstimulated moDCs, including peroxiredoxin-2 (PRDX2), an enzyme reducing hydrogen peroxide and lipid peroxides.",0
929,4,What type of enzyme is peroxiredoxin 2 (PRDX2)?,Peroxiredoxin-2 (Prx-2) is an abundant mammalian enzyme that protects against oxidative stress.,1
929,5,What type of enzyme is peroxiredoxin 2 (PRDX2)?,Peroxiredoxin 2 (PRDX2) has been known to act as an antioxidant enzyme whose main function is H(2)O(2) reduction in cells.,0
929,6,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"These data indicate that Srx1 activity protects mice from the lethality of endotoxic shock, adding this enzyme to other host factors, as NRF2 and peroxiredoxin 2, which by regulating cellular reactive oxygen species levels act as important modifiers in the pathogenesis of sepsis.",0
929,7,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"One of the identified proteins was peroxiredoxin 2 (Prx2), an anti-oxidant enzyme.",0
929,8,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"Peroxiredoxin-2 (Prdx2), a potent peroxide reductant, is the third most abundant protein in the erythrocyte and might be expected to play a major role in the cell's oxidative defenses.",0
929,9,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"Importantly, we also demonstrate the antioxidant enzyme Prx2 (peroxiredoxin 2) as a critical cytoplasmic target of cdk5.",0
929,10,What type of enzyme is peroxiredoxin 2 (PRDX2)?,Human erythrocyte peroxiredoxin 2 (Prx2) is a typical 2-cys cytosolic peroxiredoxin with thiol-dependent hydrogen peroxide scavenger activity.,0
929,11,What type of enzyme is peroxiredoxin 2 (PRDX2)?,Peroxiredoxin 2 (Prx2) is an antioxidant enzyme that uses cysteine residues to decompose peroxides.,1
929,12,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, was the most upregulated while tribbles homolog 3 (TRB3), a pro-apoptotic protein, was the most downregulated, implying a beneficial effect of lithium on neuronal cells.",1
929,13,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"After 5 Gy irradiation, the relative abundance of peroxiredoxin 2, an antioxidant enzyme, and latexin, an inhibitor of carboxypeptidase, increased.",1
929,14,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"Peroxiredoxin 2 (Prx2), a thiol-dependent peroxidase, is the third most abundant protein in the erythrocyte, and its absence in knock-out mice gives rise to hemolytic anemia.",0
929,15,What type of enzyme is peroxiredoxin 2 (PRDX2)?,"Suppression subtractive hybridization performed on Down syndrome (DS) versus control fetal brains revealed differential expression of peroxiredoxin 2 (PRDX2), mapped at 13q12.",0
929,16,What type of enzyme is peroxiredoxin 2 (PRDX2)?,Peroxiredoxins are antioxidant enzymes involved in protein and lipid protection against oxidative injury and in cellular signalling pathways regulating apoptosis.,0
929,17,What type of enzyme is peroxiredoxin 2 (PRDX2)?,T,0
2038,0,Which disease(s) are caused by HEX A deficiency?,Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative disorder due to mutations in the HEXA gene resulting in a beta-hexosaminidase A (Hex A) deficiency.,1
2038,1,Which disease(s) are caused by HEX A deficiency?,Rapid identification of HEXA mutations in Tay-Sachs patients.,0
2038,2,Which disease(s) are caused by HEX A deficiency?,Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative disorder caused by mutations in the HEXA gene resulting in β-hexosaminidase A (HEX A) deficiency and neuronal accumulation of GM2 ganglioside.,1
2038,3,Which disease(s) are caused by HEX A deficiency?,"Tay-Sachs disease is a genetically determined neurodegenerative disorder, resulting from mutations of the hexosaminidase (Hex) A gene coding for the alpha-subunit of beta-D-N-acetyl-hexosaminidase.",1
2038,4,Which disease(s) are caused by HEX A deficiency?,Tay-Sachs disease (TSD) results from mutations in HEXA that cause Hex A deficiency.,1
2038,5,Which disease(s) are caused by HEX A deficiency?,"Mutations in the HEX A gene, encoding the alpha-subunit of beta-hexosaminidase A (Hex A), are the cause of Tay-Sachs disease as well as of juvenile, chronic, and adult GM2 gangliosidoses.",1
379,0,What histone modification is recognized by the bromodomain?,acetyllysine-specific protein-protein interaction with bromodomain reader modules,0
379,1,What histone modification is recognized by the bromodomain?,"Bromodomains bind acetylated lysines, acting as readers of the histone-acetylation code",1
379,2,What histone modification is recognized by the bromodomain?, three acetyllysine ligands are indentified for a PHD-adjacent bromodomain in BPTF via systematic screening and biophysical characterization.,0
379,3,What histone modification is recognized by the bromodomain?,acetyl-lysine binding bromodomain (BRD),0
379,4,What histone modification is recognized by the bromodomain?,bromodomain proteins bind to acetylated lysines in histones,1
379,5,What histone modification is recognized by the bromodomain?,"romodomains are present in many chromatin-associated proteins such as the SWI/SNF and RSC chromatin remodelling and the SAGA HAT (histone acetyltransferase) complexes, and can bind to acetylated lysine residues in the N-terminal tails of the histones",0
379,6,What histone modification is recognized by the bromodomain?,recognition of acetylated histones by bromodomains,1
379,7,What histone modification is recognized by the bromodomain?,"BRD7, a novel bromodomain gene",0
379,8,What histone modification is recognized by the bromodomain?,BRD7 interacted with H3 peptide acetylated,0
379,9,What histone modification is recognized by the bromodomain?,bromodomain-containing proteins that recognize histone acetylation sites,0
379,10,What histone modification is recognized by the bromodomain?,"bromodomains of Gcn5, PCAF, TAF1 and CBP are able to recognize acetyllysine residues in histones",1
379,11,What histone modification is recognized by the bromodomain?,romodomain factor 1 (Bdf1,0
379,12,What histone modification is recognized by the bromodomain?, Bdf1 binds preferentially to acetylated histone H4,0
379,13,What histone modification is recognized by the bromodomain?,"chromatin remodeling complex RSC bears multiple bromodomains, motifs for acetyl-lysine and histone tail interaction",0
379,14,What histone modification is recognized by the bromodomain?, in vitro binding of a HAT bromodomain with acetylated lysines within H3 and H4 amino-terminal peptides,1
379,15,What histone modification is recognized by the bromodomain?,"bromodomain, that recognizes acetylated residues",0
894,0,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum is an uncommon cause of blepharoconjunctivitis in which Pthirus pubis infest the eyelashes.,0
894,1,What is the cause of Phthiriasis Palpebrarum?,We report a case of unilateral phthiriasis palpebrarum with crab louse.,0
894,2,What is the cause of Phthiriasis Palpebrarum?,"BACKGROUND: Pediculosis capitis is a common parasitic infestation, whereas phthiriasis palpebrarum is an uncommon infection due to Phthirus pubis (pubic lice) inoculating the eyelashes and surrounding tissues of the eye.",0
894,3,What is the cause of Phthiriasis Palpebrarum?,"Head lice typically do not infect the eyes, and given the different morphology of the lice on the patient's head and eyes, a diagnosis of phthiriasis palpebrarum was made.",0
894,4,What is the cause of Phthiriasis Palpebrarum?,P. pubis can cause pruritic eyelid margins or unusual blepharoconjunctivitis.,0
894,5,What is the cause of Phthiriasis Palpebrarum?,We present a case of phthiriasis palpebrarum in a 4-year-old boy.,0
894,6,What is the cause of Phthiriasis Palpebrarum?,INTRODUCTION: Phthiriasis palpebrarum is an ectoparasitosis in which Phthirus pubis infest the eyelashes.,0
894,7,What is the cause of Phthiriasis Palpebrarum?,"In all cases, the diagnosis of phthiriasis palpebrarum was confirmed by parasitological examination of eyelashes, which revealed the presence of adult and nit forms of Phthirus pubis.",0
894,8,What is the cause of Phthiriasis Palpebrarum?," Based on the observation of numerous nits at the base of the eyelashes and the ectoparasite in the palpebral margin, a diagnosis of phthiriasis palpebrarum was made.",0
894,9,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum (lice infestation of palpabrae) is a rarely reported disorder and may present as blepharoconjuctivitis.,0
894,10,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum (PP) is a rare eyelid infestation caused by phthirus pubis.,1
894,11,What is the cause of Phthiriasis Palpebrarum?,"Phthiriasis palpebrarum, caused by Phthirus pubis, is an uncommon cause of blepharoconjunctivitis; therefore, this condition is easily misdiagnosed",0
894,12,What is the cause of Phthiriasis Palpebrarum?,"Phthiriasis palpebrarum, caused by the phthirus pubis, is a rare cause of blepharoconjunctivitis, and is therefore often neglected",1
894,13,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum is an uncommon cause of blepharoconjunctivitis in which Pthirus pubis infest the eyelashes,0
894,14,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum is an unusual cause of blepharoconjunctivitis and may easily be overlooked because of the failure of physicians to recognize Phthirus pubis,0
894,15,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum (PP) is a rare eyelid infestation caused by phthirus pubis,1
894,16,What is the cause of Phthiriasis Palpebrarum?,"Phthiriasis palpebrarum, caused by the phthirus pubis, is a rare cause of blepharoconjunctivitis, and is therefore often neglected.",1
894,17,What is the cause of Phthiriasis Palpebrarum?,"Phthiriasis palpebrarum is an infestation of the eyelashes caused by the louse Pthirus pubis (Linnaeus, 1758).",0
894,18,What is the cause of Phthiriasis Palpebrarum?,"Phthiriasis palpebrarum, caused by Phthirus pubis, is an uncommon cause of blepharoconjunctivitis; therefore, this condition is easily misdiagnosed.",0
894,19,What is the cause of Phthiriasis Palpebrarum?,"Phthiriasis palpebrarum, caused by the phthirus pubis, is a rare cause of blepharoconjunctivitis, and is therefore often neglected.",1
894,20,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum is an uncommon cause of blepharoconjunctivitis in which Pthirus pubis infest the eyelashes.,0
894,21,What is the cause of Phthiriasis Palpebrarum?,We report a case of unilateral phthiriasis palpebrarum with crab louse.,0
894,22,What is the cause of Phthiriasis Palpebrarum?,"Phthiriasis palpebrarum is an infestation of the eyelashes caused by the louse Pthirus pubis (Linnaeus, 1758).",0
894,23,What is the cause of Phthiriasis Palpebrarum?,"We report a case of phthiriasis palpebrarum in a 6-year-old girl, which was initially misdiagnosed as allergic blepharoconjunctivitis.",0
894,24,What is the cause of Phthiriasis Palpebrarum?,Phthiriasis palpebrarum is an unusual cause of blepharoconjunctivitis and may easily be overlooked because of the failure of physicians to recognize Phthirus pubis.,0
3225,0,What is a SMR based BCI?, sensorimotor rhythm-based brain-computer interfaces (SMR-BCI),1
3225,1,What is a SMR based BCI?,"Here, we studied the immediate and therapeutic effects of BCI-based training to control pre-movement sensorimotor rhythm (SMR) amplitude on robot-assisted finger extension in people with stroke.",0
3225,2,What is a SMR based BCI?, Especially for BCIs based on the modulation of the Sensorimotor Rhythm (SMR),1
3225,3,What is a SMR based BCI?,Brain Computer Interface (BCI) and neurofeedback studies have investigated the impact of sensorimotor rhythm (SMR),1
3225,4,What is a SMR based BCI?,Modulation of sensorimotor rhythms (SMR) was suggested as a control signal for brain-computer interfaces (BCI).,0
3225,5,What is a SMR based BCI?,Sensorimotor rhythm (SMR) based Brain-Computer Interfaces (BCI) typically require lengthy user training.,1
3225,6,What is a SMR based BCI?,All brain-computer interface (BCI) groups that have published results of studies involving a large number of users performing BCI control based on the voluntary modulation of sensorimotor rhythms (SMR) report that BCI control could not be achieved by a non-negligible number of subjects (estimated 20% to 25%).,1
3225,7,What is a SMR based BCI?,"OBJECTIVE
Connect-Four, a new sensorimotor rhythm (SMR) based brain-computer interface (BCI) gaming application, was evaluated by four severely motor restricted end-users; two were in the locked-in state and had unreliable eye-movement.",0
3225,8,What is a SMR based BCI?,"OBJECTIVE
It is well known that to acquire sensorimotor (SMR)-based brain-computer interface (BCI) control requires a training period before users can achieve their best possible performances.",0
1350,0,"Which are the bioinformatics tools for gene structure prediction?
","The prediction of the complete structure of genes is one of the very important tasks of bioinformatics, especially in eukaryotes.",1
1350,1,"Which are the bioinformatics tools for gene structure prediction?
",A crucial part in the gene structure prediction is to determine the splice sites in the coding region.,1
1350,2,"Which are the bioinformatics tools for gene structure prediction?
",Identification of splice sites depends on the precise recognition of the boundaries between exons and introns of a given DNA sequence.,0
1350,3,"Which are the bioinformatics tools for gene structure prediction?
","This problem can be formulated as a classification of sequence elements into 'exon-intron' (EI), 'intron-exon' (IE) or 'None' (N) boundary classes.",0
1350,4,"Which are the bioinformatics tools for gene structure prediction?
",The proposed WPSS method poses efficient results compared with the performance of many methods proposed in the literature.,0
1350,5,"Which are the bioinformatics tools for gene structure prediction?
",SCGPred: a score-based method for gene structure prediction by combining multiple sources of evidence.,1
1350,6,"Which are the bioinformatics tools for gene structure prediction?
","Moreover, computational gene finding in newly sequenced genomes is especially a difficult task due to the absence of a training set of abundant validated genes.",0
1350,7,"Which are the bioinformatics tools for gene structure prediction?
","Here we present a new gene-finding program, SCGPred, to improve the accuracy of prediction by combining multiple sources of evidence.",0
1350,8,"Which are the bioinformatics tools for gene structure prediction?
","Therefore, SCG-Pred can serve as an alternative gene-finding tool for newly sequenced eukaryotic genomes.",0
1350,9,"Which are the bioinformatics tools for gene structure prediction?
",The program is freely available at http://bio.scu.edu.cn/SCGPred/.,0
1350,10,"Which are the bioinformatics tools for gene structure prediction?
",Incorporation of splice site probability models for non-canonical introns improves gene structure prediction in plants.,0
1350,11,"Which are the bioinformatics tools for gene structure prediction?
","We pursued one such approach and describe the training and implementation of GC-donor splice site models for Arabidopsis and rice, with the goal of exploring whether specific modeling of non-canonical introns can enhance gene structure prediction accuracy.",0
1350,12,"Which are the bioinformatics tools for gene structure prediction?
",Source code for the updated versions of GeneSeqer and SplicePredictor (distributed with the GeneSeqer code) isavailable at http://bioinformatics.iastate.edu/bioinformatics2go/gs/download.html.,0
1350,13,"Which are the bioinformatics tools for gene structure prediction?
","Web servers for Arabidopsis, rice and other plant species are accessible at http://www.plantgdb.org/PlantGDB-cgi/GeneSeqer/AtGDBgs.cgi, http://www.plantgdb.org/PlantGDB-cgi/GeneSeqer/OsGDBgs.cgi and http://www.plantgdb.org/PlantGDB-cgi/GeneSeqer/PlantGDBgs.cgi, respectively.",0
1350,14,"Which are the bioinformatics tools for gene structure prediction?
",A SplicePredictor web server is available at http://bioinformatics.iastate.edu/cgi-bin/sp.cgi.,0
1350,15,"Which are the bioinformatics tools for gene structure prediction?
",Software to generate training data and parameterizations for Bayesian splice site models is available at http://gremlin1.gdcb.iastate.edu/~volker/SB05B/BSSM4GSQ/,0
1350,16,"Which are the bioinformatics tools for gene structure prediction?
",Prediction of splice sites with dependency graphs and their expanded bayesian networks.,0
1350,17,"Which are the bioinformatics tools for gene structure prediction?
","A crucial part in the gene structure prediction is to determine the precise exon-intron boundaries, i.e.",1
1350,18,"Which are the bioinformatics tools for gene structure prediction?
","the splice sites, in the coding region.",0
1350,19,"Which are the bioinformatics tools for gene structure prediction?
",Software (a program called DGSplicer) and datasets used are available at http://csrl.ee.nthu.edu.tw/bioinf/ BACKGROUND: cclu@ee.nthu.edu.tw.,0
1350,20,"Which are the bioinformatics tools for gene structure prediction?
",Gene structure prediction from consensus spliced alignment of multiple ESTs matching the same genomic locus.,0
1350,21,"Which are the bioinformatics tools for gene structure prediction?
",Accurate gene structure annotation is a challenging computational problem in genomics.,0
1350,22,"Which are the bioinformatics tools for gene structure prediction?
",The splice site prediction tool (SplicePredictor) is distributed with the GeneSeqer code.,0
1350,23,"Which are the bioinformatics tools for gene structure prediction?
",A SplicePredictor web server is available at http://bioinformatics.iastate.edu/cgi-bin/sp.cgi,0
1350,24,"Which are the bioinformatics tools for gene structure prediction?
","We have developed a software tool, Transcript Assembly Program (TAP), to delineate gene structures using genomically aligned EST sequences.",0
1350,25,"Which are the bioinformatics tools for gene structure prediction?
",GeneBuilder: interactive in silico prediction of gene structure.,0
1350,26,"Which are the bioinformatics tools for gene structure prediction?
","In the case of low homology, GeneBuilder is still able to predict the gene structure.",0
1350,27,"Which are the bioinformatics tools for gene structure prediction?
","The GeneBuilder system has been tested by using the standard set (Burset and Guigo, Genomics, 34, 353-367, 1996) and the performances are: 0.89 sensitivity and 0.91 specificity at the nucleotide level.",0
1350,28,"Which are the bioinformatics tools for gene structure prediction?
","The computer program SeqHelp organizes information from database searches, gene structure prediction, and other information to generate multiply aligned, hypertext-linked reports to allow for fast analysis of molecular sequences.",0
1350,29,"Which are the bioinformatics tools for gene structure prediction?
",Identification of human gene structure using linear discriminant functions and dynamic programming.,0
1350,30,"Which are the bioinformatics tools for gene structure prediction?
",Development of advanced technique to identify gene structure is one of the main challenges of the Human Genome Project.,1
1350,31,"Which are the bioinformatics tools for gene structure prediction?
",A gene structure prediction system FGENE has been developed based on the exon recognition functions.,0
1350,32,"Which are the bioinformatics tools for gene structure prediction?
","Analysis of uncharacterized human sequences based on our methods for splice site (HSPL, RNASPL), internal exons (HEXON), all type of exons (FEXH) and human (FGENEH) and bacterial (CDSB) gene structure prediction and recognition of human and bacterial sequences (HBR) (to test a library for E. coli contamination) is available through the University of Houston, Weizmann Institute of Science network server and a WWW page of the Human Genome Center at Baylor College of Medicine.",0
1350,33,"Which are the bioinformatics tools for gene structure prediction?
","In the bioinformatics field, many computer algorithmic and data mining technologies have been developed for gene prediction, protein-protein interaction analysis, sequence analysis, and protein folding predictions, to name a few.",0
1350,34,"Which are the bioinformatics tools for gene structure prediction?
",The accurate prediction of intron boundaries largely facilitates the correct prediction of gene structure in nuclear genomes.,0
2835,0,Describe the mechanism of action of ibalizumab.,"TaiMed Biologics is developing ibalizumab (Trogarzo™, ibalizumab-uiyk)-a humanised IgG4 monoclonal antibody-as a treatment for HIV-1 infection.",1
2835,1,Describe the mechanism of action of ibalizumab.,Ibalizumab blocks HIV entry into CD4 cells while preserving normal immunological function and is the first CD4-directed post-attachment HIV-1 inhibitor and the first humanised monoclonal antibody for the treatment of HIV/AIDS.,0
2835,2,Describe the mechanism of action of ibalizumab.,"Investigational HIV entry inhibitors include the new CD4 attachment inhibitor fostemsavir, which targets HIV envelope glycoprotein 120, and recently approved ibalizumab, which binds the CD4 receptor.",0
2835,3,Describe the mechanism of action of ibalizumab.,"Here we review one such agent, ibalizumab, a parenteral CD4 postattachment inhibitor that has demonstrated efficacy as part of combination antiretroviral therapy in the treatment of HIV-1.",0
2835,4,Describe the mechanism of action of ibalizumab.,"Trogarzo (ibalizumab-uiyk) is a CD4-directed post-attachment HIV-1 inhibitor, indicated for use with other antiretroviral inhibitors in adults with multidrug resistant HIV-1 infection who aren't responding to their antiretroviral regimen.",1
2835,5,Describe the mechanism of action of ibalizumab.,"BACKGROUND: Ibalizumab, a humanized IgG4 monoclonal antibody, blocks the entry of human immunodeficiency virus type 1 (HIV-1) by noncompetitive binding to CD4.",1
2835,6,Describe the mechanism of action of ibalizumab.,RESULTS: Ibalizumab is a new humanized monoclonal antibody.,1
2835,7,Describe the mechanism of action of ibalizumab.,It acts as post-attachment inhibitor by binding CD4 2nd domain of T lymphocyte and preventing HIV connection to CCR5 or CXCR4 and has been recently approved by Food and Drug Administration in the United States of America as a new intravenous antiretroviral agent for heavily treated HIV adults with multi -drug resistant infection.,1
2835,8,Describe the mechanism of action of ibalizumab.,"Furthermore, we found that a broad neutralizing antibody, ibalizumab, which targets CD4 in the absence of gp120, occupies the same binding surface as the second interface identified here on gp120.",0
2835,9,Describe the mechanism of action of ibalizumab.,"Here we review one such agent, ibalizumab, a parenteral CD4 postattachment inhibitor that has demonstrated efficacy as part of combination antiretroviral therapy in the treatment of HIV-1.<br><b>RECENT FINDINGS</b>: In a phase III clinical trial in HIV-infected participants with multiclass antiretroviral drug resistance, the intravenous administration of ibalizumab led to declines in plasma HIV-1 RNA more than 0.5 log in 83% of participants at 1 week.",0
3750,0,Which are the predominant rotavirus genotypes around the world?,"The predominant RV genotypes circulating all over the world are G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8], while G12[P6] and G12[P8] are emerging genotypes.",1
3750,1,Which are the predominant rotavirus genotypes around the world?,"The predominant RV genotypes circulating all over the world are G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8], while G12[P6] and G12[P8] are emerging genotypes.",1
3750,2,Which are the predominant rotavirus genotypes around the world?,"Comprehensive reviews of pre licensure rotavirus strain prevalence data indicated the global importance of six rotavirus genotypes, G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8].",1
2884,0,List proteins interacting with Star-PAP,Star-PAP and PIPKIalpha function together in a complex,1
2884,1,List proteins interacting with Star-PAP,Phosphorylation regulates the Star-PAP-PIPKIα interaction and directs specificity toward mRNA targets.,1
2884,2,List proteins interacting with Star-PAP,", we show that Larp7 interacts with a poly(A) polymerase Star-PAP to maintain Lin28 mRNA stability.",1
2884,3,List proteins interacting with Star-PAP,Star-PAP directly associated with cleavage and polyadenylation specificity factor (CPSF) 160 and 73 subunits and also the targeted pre-mRNA.,1
2186,0,Can acupuncture cause spinal epidural hematoma?,"RESULTS: A 54-year-old woman, a 38-year-old woman, and a 60-year-old man with hemiplegia by cervical subdural or epidural hematoma after cervical posterior paraspinal muscle needling without direct invasion (intramuscular stimulation, acupuncture, or intramuscular lidocaine) were observed.",0
2186,1,Can acupuncture cause spinal epidural hematoma?,Acute spinal subdural hematoma with hemiplegia after acupuncture: a case report and review of the literature.,0
2186,2,Can acupuncture cause spinal epidural hematoma?,"Although acupuncture has been a popular method for the management of pain control, we encountered the first case of SDH after acupuncture.PURPOSE: The purpose of this case report was to present the first case of subdural hematoma after acupuncture and the reasons for the risks of blind cervical acupuncture.",0
2186,3,Can acupuncture cause spinal epidural hematoma?,SUMMARY OF BACKGROUND DATA: Epidural hematomas after dry needling are quite unusual and only a few cases of epidural hematoma after acupuncture have been reported in the literature.,0
2186,4,Can acupuncture cause spinal epidural hematoma?,"Spinal epidural hematoma is a rare complication associated with pain control procedures such as facet block, acupuncture, epidural injection, etc.",0
2186,5,Can acupuncture cause spinal epidural hematoma?,Unintentional acupuncture needling of the thoracic spinal canal produced a spinal epidural hematoma and subarachnoid hemorrhage.,1
2186,6,Can acupuncture cause spinal epidural hematoma?,"Spinal epidural hematoma is a rare complication associated with pain control procedures such as facet block, acupuncture, epidural injection, etc.",0
2186,7,Can acupuncture cause spinal epidural hematoma?,Spinal epidural hematoma with subarachnoid hemorrhage caused by acupuncture.,1
2186,8,Can acupuncture cause spinal epidural hematoma?,"However, subarachnoid hemorrhage and spinal epidural hematoma have been reported to occur after acupuncture in the posterior neck.",0
2186,9,Can acupuncture cause spinal epidural hematoma?,A retrospective case report.The objective of this article is to report an unusual complication of dry needling.Epidural hematomas after dry needling are quite unusual and only a few cases of epidural hematoma after acupuncture have been reported in the literature,0
2186,10,Can acupuncture cause spinal epidural hematoma?,Spinal epidural hematoma with subarachnoid hemorrhage caused by acupuncture,1
2186,11,Can acupuncture cause spinal epidural hematoma?,"Spinal epidural hematoma is a rare complication associated with pain control procedures such as facet block, acupuncture, epidural injection, etc",0
2186,12,Can acupuncture cause spinal epidural hematoma?,Unintentional acupuncture needling of the thoracic spinal canal produced a spinal epidural hematoma and subarachnoid hemorrhage,1
2186,13,Can acupuncture cause spinal epidural hematoma?,Spinal epidural hematoma with subarachnoid hemorrhage caused by acupuncture.,1
1144,0,Which histone modification is primarily linked to elongating transcription?,"Similarly, H3K36 trimethylation, a mark associated with transcription elongation, was specifically increased at the HD locus in the striatum and not in the cerebellum.",1
1144,1,Which histone modification is primarily linked to elongating transcription?,"y expressing Myc protein fused with the estrogen receptor (Myc-ER) in fibroblasts, we observed that Myc, binding to the regulatory elements of Suz12, Ezh2, and Eed, induces the acetylation of histones H3 and H4 and the recruitment of elongating RNA polymerase II at their promoters",0
1144,2,Which histone modification is primarily linked to elongating transcription?,"A basal level of JIL-1 binding can be defined that correlates best with the methylation of histone H3 at lysine 36, a mark that is placed co-transcriptionally",1
1144,3,Which histone modification is primarily linked to elongating transcription?,"RNA polymerase II signals for deacetylation through the methylation of histone H3 lysine 36 (H3K36), which provides the recruitment signal for the Rpd3S histone deacetylase complex (HDAC)",1
1144,4,Which histone modification is primarily linked to elongating transcription?,Recent studies reviewed here demonstrate that histone deacetylation on the body of a transcribed gene is regulated via Set2-mediated methylation of histone H3-K36,1
1144,5,Which histone modification is primarily linked to elongating transcription?,H3K56 acetylation: a chromatin mark associated with the elongating RNA polymerase II,0
1144,6,Which histone modification is primarily linked to elongating transcription?,"Furthermore, Rtt109 and H3K56 acetylation appear to correlate with actively transcribed genes and associate with the elongating form of polymerase II in yeast",0
1144,7,Which histone modification is primarily linked to elongating transcription?,"In addition to coordinating the processing of the nascent transcript, elongating RNA polymerase II recruits histone methyltransferases to methylate lysines 4 and 36 of histone H3 in nucleosomes in the body of actively transcribed genes",1
1144,8,Which histone modification is primarily linked to elongating transcription?,"Set1, the yeast histone H3-lysine 4 (H3-K4) methylase, is recruited by the Pol II elongation machinery to a highly localized domain at the 5' portion of active mRNA coding regions.",0
3321,0,Is there a vaccine for rotavirus?,Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5),1
3321,1,Is there a vaccine for rotavirus?,This study compares the safety and immunogenicity of pentavalent rotavirus vaccine (RV5),1
3321,2,Is there a vaccine for rotavirus?,Effectiveness of rotavirus pentavalent vaccine,1
3321,3,Is there a vaccine for rotavirus?, rotavirus pentavalent vaccine (RotaTeq®) as a sole vaccine,1
3321,4,Is there a vaccine for rotavirus?,We describe rotavirus vaccine coverage and missed opportunities for rotavirus vaccination.,0
3321,5,Is there a vaccine for rotavirus?,"CONCLUSIONS

Addressing missed opportunities for rotavirus vaccination is essential to achieving the 80% rotavirus vaccine coverage target outlined by Healthy People 2020.",0
3321,6,Is there a vaccine for rotavirus?,Complete rotavirus vaccine coverage could be improved to 81% if all missed opportunities within the ACIP-recommended schedule were addressed.,0
3321,7,Is there a vaccine for rotavirus?,"RESULTS

The national coverage for rotavirus vaccine achieved a year after the introduction was 89% for one dose and 82% for two doses, respectively.",0
3321,8,Is there a vaccine for rotavirus?,"CONCLUSIONS

Norway achieved a high national coverage and excellent adherence with the strict age limits for rotavirus vaccine administration during the first year of introduction, indicating robustness of the national immunisation programme.",0
3321,9,Is there a vaccine for rotavirus?,Upper age limit recommendations for rotavirus vaccine administration contributed to suboptimal vaccination coverage.,0
3321,10,Is there a vaccine for rotavirus?,Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador.,0
3321,11,Is there a vaccine for rotavirus?,US Rotavirus Vaccine Efficacy Group.,0
3321,12,Is there a vaccine for rotavirus?,We describe rotavirus vaccine coverage and missed opportunities for rotavirus vaccination.,0
3321,13,Is there a vaccine for rotavirus?,Rotavirus vaccines: a story of success.,0
3321,14,Is there a vaccine for rotavirus?,Clinical and immunological studies of rotavirus vaccines.,0
3321,15,Is there a vaccine for rotavirus?,Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.,0
3321,16,Is there a vaccine for rotavirus?,Rotavirus diarrheal episodes were identified by ELISA.,0
3321,17,Is there a vaccine for rotavirus?,The decrease in rotavirus positivity was inversely related to increase in rotavirus vaccine coverage showing impact of rotavirus vaccines.,0
3321,18,Is there a vaccine for rotavirus?,We described trends in rotavirus positivity among tested stool samples before and after rotavirus vaccine introduction.,0
3321,19,Is there a vaccine for rotavirus?,"The RIT 4237 bovine rotavirus vaccine has served as a useful model for rotavirus vaccination, but the vaccine will not be further developed or tested.",0
3321,20,Is there a vaccine for rotavirus?,Only the RRV vaccine induced a low level of protection against rotavirus diarrhea mainly of serotype G1 specificity.,0
3321,21,Is there a vaccine for rotavirus?,It is recommended that new rotavirus vaccine candidates be developed at cheaper price to speed up the introduction of rotavirus immunization in the developing world in general.,0
3321,22,Is there a vaccine for rotavirus?,Review of rotavirus vaccine trials in Finland.,0
3321,23,Is there a vaccine for rotavirus?,Risk of intussusception after monovalent rotavirus vaccination.,0
3321,24,Is there a vaccine for rotavirus?,Rotavirus vaccines are underused compared with other routine vaccines.,0
3321,25,Is there a vaccine for rotavirus?,"With rotavirus vaccines now available globally , it will be useful to assemble the available evidence on the epidemiology and burden of rotavirus gastroenteritis in India , in order to weigh the urgency of introducing a vaccine to help control rotavirus disease",0
3321,26,Is there a vaccine for rotavirus?,Is there evidence that rotavirus vaccines are effective in preventing acute gastroenteritis complications such as dehydration and hospitalization,0
3321,27,Is there a vaccine for rotavirus?,"With the introduction of new rotavirus vaccines in sight , rotavirus gastroenteritis may be regarded as the single most frequent vaccine-preventable disease among children in the EU",0
3321,28,Is there a vaccine for rotavirus?,"With the recent introduction of the two rotavirus vaccines , RotaTeq and Rotarix , in many countries , it appears that the total number of hospitalizations due to rotavirus infections is being reduced , at least in developed countries that implemented a universal immunization program",0
3321,29,Is there a vaccine for rotavirus?,Change in rotavirus epidemiology in northeast Florida after the introduction of rotavirus vaccine,0
3321,30,Is there a vaccine for rotavirus?,"With the recent postlicensure identification of an increased risk of intussusception with rotavirus vaccine , the 14 Latin American countries currently using rotavirus vaccine must now weigh the health benefits versus risks to assess whether to continue vaccination",0
3321,31,Is there a vaccine for rotavirus?,Impact of rotavirus vaccines on rotavirus disease,0
3321,32,Is there a vaccine for rotavirus?,"With safe and efficacious rotavirus vaccines now on the verge of widespread adoption , researchers can be vital advocates for their uptake into routine immunization programs",0
3321,33,Is there a vaccine for rotavirus?,Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.,0
3321,34,Is there a vaccine for rotavirus?,"In addition, various naturalistic studies have demonstrated 'real-world' effectiveness after the introduction of widespread rotavirus vaccination programmes in the community setting.",0
3321,35,Is there a vaccine for rotavirus?,The monovalent rotavirus vaccine RIX4414 (Rotarix™) is administered as a two-dose oral series in infants and has demonstrated protective efficacy against RVGE in clinical trials conducted in developed countries.,0
3321,36,Is there a vaccine for rotavirus?,Numerous cost-effectiveness analyses have been conducted in developed countries in which a universal rotavirus vaccination programme using RIX4414 was compared with no universal rotavirus vaccination programme.,0
3321,37,Is there a vaccine for rotavirus?,"It is also difficult to draw conclusions regarding the cost effectiveness of rotavirus vaccine RIX4414 relative to that of the pentavalent rotavirus vaccine, which is administered as a three-dose oral series.",0
3321,38,Is there a vaccine for rotavirus?,"Although indirect comparisons in cost-effectiveness analyses indicate that RIX4414 provided more favourable incremental cost-effectiveness ratios when each vaccine was compared with no universal rotavirus vaccination programme, results were generally sensitive to vaccine costs.",0
3321,39,Is there a vaccine for rotavirus?,A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis.,1
3321,40,Is there a vaccine for rotavirus?,A live attenuated monovalent rotavirus vaccine (Rotarix) containing human rotavirus strain RIX4414 of G1P1A P[8] specificity is being developed to meet the global need.,0
3321,41,Is there a vaccine for rotavirus?,Rotarix significantly reduced rotavirus gastroenteritis episodes and rotavirus-related hospitalizations in vaccinated infants compared with placebo recipients (P < 0.05).,0
3321,42,Is there a vaccine for rotavirus?,"We describe the intussusception epidemiology prior to rotavirus vaccine, temporal association of intussusception cases to administration of rotavirus vaccine, and estimate the additional number of intussusception cases that may be associated with rotavirus vaccine.",0
3321,43,Is there a vaccine for rotavirus?,Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji.,0
3321,44,Is there a vaccine for rotavirus?,"In 2012, Fiji introduced rotavirus vaccine (Rotarix, GSK) into the national immunisation schedule.",0
3321,45,Is there a vaccine for rotavirus?,"Four trials of RIT 4237 bovine rotavirus vaccine, one trial of group A RRV-1 rhesus rotavirus vaccine, and one trial of rhesus-human reassortant rotavirus vaccines D x RRV and DS1 x RRV were carried out between 1983-1989.",0
3321,46,Is there a vaccine for rotavirus?,"Problems associated with the use of any oral rotavirus vaccine include acid lability of the vaccine virus, which requires buffering, and a slight but significant interference of oral poliovirus vaccine with the uptake of rotavirus vaccine.",0
3321,47,Is there a vaccine for rotavirus?,"In the near future, oral heterologous rotavirus vaccines may be available for prevention of severe rotavirus gastroenteritis.",0
3321,48,Is there a vaccine for rotavirus?,There was no apparent difference between bovine and rhesus-based rotavirus vaccines in the protective efficacy against severe rotavirus gastroenteritis.,0
3321,49,Is there a vaccine for rotavirus?,"Efficacy studies of this vaccine in 6-12 month-old children gave results characteristic of the performance of oral rotavirus vaccines in general: 58% protective efficacy against any rotavirus gastroenteritis and 82% against ""clinically significant"" gastroenteritis.",0
3321,50,Is there a vaccine for rotavirus?,"Live oral rotavirus vaccine strain RIT 4237, derived from group A bovine rotavirus NCDV, was given to human volunteers in Tampere, Finland in 1982.",0
3321,51,Is there a vaccine for rotavirus?,Targeted efforts to evaluate indirect effects of rotavirus vaccine in low income countries are required to understand the total impact of rotavirus vaccine on the global burden of rotavirus disease.,0
3321,52,Is there a vaccine for rotavirus?,Widespread introduction of rotavirus vaccines has led to major reductions in the burden of rotavirus gastroenteritis worldwide.,0
3321,53,Is there a vaccine for rotavirus?,"While rotavirus vaccine indirect effects have been demonstrated in high and middle income countries, there are very little data from low income countries where force of infection, population structures and vaccine schedules differ.",0
3321,54,Is there a vaccine for rotavirus?,Measuring indirect effects of rotavirus vaccine in low income countries.,0
3321,55,Is there a vaccine for rotavirus?,Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.,0
3321,56,Is there a vaccine for rotavirus?,"Rotavirus vaccine was licensed on August 31, 1998, and subsequently recommended for routine use among infants.",0
3321,57,Is there a vaccine for rotavirus?,To describe the cases of intussusception among rotavirus vaccine recipients reported to the Vaccine Adverse Event Reporting System from October 1998 through December 1999.,0
3321,58,Is there a vaccine for rotavirus?,Infants vaccinated with rotavirus vaccine in the United States.,0
3321,59,Is there a vaccine for rotavirus?,There were 98 confirmed cases of intussusception after vaccination with rotavirus vaccine reported to the Vaccine Adverse Event Reporting System; 60 of these developed intussusception within 1 week after vaccination.,0
3321,60,Is there a vaccine for rotavirus?,"Using a passive surveillance system for vaccine adverse events, we observed at least a fourfold increase over the expected number of intussusception cases occurring within 1 week of receipt of rotavirus vaccine.",0
3321,61,Is there a vaccine for rotavirus?,Other studies were initiated to further define the relationship between rotavirus vaccine and intussusception.,0
3321,62,Is there a vaccine for rotavirus?,"In light of these and other data, the rotavirus vaccine manufacturer voluntarily removed its product from the market, and the recommendation for routine use of rotavirus vaccine among US infants has been withdrawn.",0
3321,63,Is there a vaccine for rotavirus?,"To review the biology, immunology, and virology of rotavirus infections and describe the efforts towards the construction of vaccines using human and animal rotaviruses.",0
3321,64,Is there a vaccine for rotavirus?,In August 1998 the Food and Drug Administration in the United States approved the licensure of a rotavirus vaccine.,0
890,0,"What is the mode of inheritance of Facioscapulohumeral muscular
dystrophy (FSHD)?",autosomal dominant mode of inheritance,1
2822,0,Which molecule is targeted by Caplacizumab?,"Caplacizumab, a nanobody that blocks the interaction between VWF and platelets, has shown promising results in decreasing the time to recover from the acute events that will hopefully translate into long-term clinical benefit for patients.",1
2822,1,Which molecule is targeted by Caplacizumab?,"Ablynx, a Sanofi Company, has developed the anti-von Willebrand factor Nanobody® caplacizumab (Cablivi™) for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP).",1
2822,2,Which molecule is targeted by Caplacizumab?,"Promising agents under evaluation include N-acetylcysteine, bortezomib, recombinant ADAMTS13 and caplacizumab, an inhibitor of the glycoprotein-Ib/IX-von Willebrand factor axis.",0
2822,3,Which molecule is targeted by Caplacizumab?,"The most promising candidates for future treatment of TTP are: rituximab for termination of the autoimmune process, caplacizumab for prevention of platelet-VWF-interaction, and recombinant ADAMTS13 for replacement of the inhibited or missing enzyme.",1
2822,4,Which molecule is targeted by Caplacizumab?,"Promising agents under evaluation include caplacizumab (an inhibitor of the glycoprotein-Ib/IX-Von-Willebrand factor axis), N-acetylcysteine, recombinant ADAMTS13, and anti-plasmocyte compounds.",0
2822,5,Which molecule is targeted by Caplacizumab?," In the phase II TITAN study, treatment with caplacizumab, an anti-von Willebrand factor Nanobody® was shown to reduce the time to confirmed platelet count normalization and exacerbations during treatment.",1
2822,6,Which molecule is targeted by Caplacizumab?,"It is now anticipated that the first VHH-based antibody drug, Caplacizumab, a bivalent anti-vWF antibody for treating rare blood clotting disorders, may be approved and commercialized in 2018 or shortly thereafter.",1
2822,7,Which molecule is targeted by Caplacizumab?,"Daily plasma exchange and immunosuppressive therapies induce remission, but mortality and morbidity due to microthrombosis remain high.<br><b>METHODS</b>: Caplacizumab, an anti-von Willebrand factor humanized single-variable-domain immunoglobulin (Nanobody), inhibits the interaction between ultralarge von Willebrand factor multimers and platelets.",0
47,0,Is Weaver syndrome similar to Sotos?,"Overgrowth conditions are a heterogeneous group of disorders characterised by increased growth and variable features, including macrocephaly, distinctive facial appearance and various degrees of learning difficulties and intellectual disability.",1
47,1,Is Weaver syndrome similar to Sotos?,"Among them, Sotos and Weaver syndromes are clinically well defined and due to heterozygous mutations in NSD1 and EZH2, respectively.",1
47,2,Is Weaver syndrome similar to Sotos?,NSD1 and EZH2 are both histone-modifying enzymes,1
47,3,Is Weaver syndrome similar to Sotos?,"NSD1 and EZH2 are SET domain-containing histone methyltransferases that play key roles in the regulation of transcription through histone modification and chromatin modeling: NSD1 preferentially methylates lysine residue 36 of histone 3 (H3K36) and is primarily associated with active transcription, while EZH2 shows specificity for lysine residue 27 (H3K27) and is associated with transcriptional repression",1
47,4,Is Weaver syndrome similar to Sotos?,"Constitutional NSD1 and EZH2 mutations cause Sotos and Weaver syndromes respectively, overgrowth syndromes with considerable phenotypic overlap",1
47,5,Is Weaver syndrome similar to Sotos?,"Clinically, Weaver syndrome is closely related to Sotos syndrome, which is frequently caused by mutations in NSD1",0
47,6,Is Weaver syndrome similar to Sotos?,"Overgrowth syndromes such as Beckwith-Wiedemann syndrome, Sotos syndrome, and Weaver syndrome have an increased risk of neoplasia.",0
47,7,Is Weaver syndrome similar to Sotos?,"Thus, it is not surprising that prenatal overgrowth occurs in several syndromes, including the Sotos and Weaver syndromes.",0
47,8,Is Weaver syndrome similar to Sotos?,NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.,0
47,9,Is Weaver syndrome similar to Sotos?,We conclude therefore that NSD1 mutations account for most cases of Sotos syndrome and a significant number of Weaver syndrome cases in our series.,0
47,10,Is Weaver syndrome similar to Sotos?,We conclude that intragenic mutations of NSD1 are the major cause of Sotos syndrome and account for some Weaver syndrome cases but rarely occur in other childhood overgrowth phenotypes.,0
47,11,Is Weaver syndrome similar to Sotos?,"Overgrowth syndromes such as Beckwith-Wiedemann syndrome, Sotos syndrome, and Weaver syndrome have an increased risk of neoplasia",0
47,12,Is Weaver syndrome similar to Sotos?,NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes,0
47,13,Is Weaver syndrome similar to Sotos?,We conclude that intragenic mutations of NSD1 are the major cause of Sotos syndrome and account for some Weaver syndrome cases but rarely occur in other childhood overgrowth phenotypes,0
47,14,Is Weaver syndrome similar to Sotos?,Considerable phenotypic overlap between Sotos and Weaver syndromes is also evident.,0
47,15,Is Weaver syndrome similar to Sotos?,Considerable phenotypic overlap between Sotos and Weaver syndromes is also evident.,0
47,16,Is Weaver syndrome similar to Sotos?,The identification of an EZH2 mutation can therefore provide an objective means of confirming a subtle presentation of Weaver syndrome and/or distinguishing Weaver and Sotos syndromes.,0
47,17,Is Weaver syndrome similar to Sotos?," Overgrowth syndromes such as Beckwith-Wiedemann syndrome, Sotos syndrome, and Weaver syndrome have an increased risk of neoplasia.",0
47,18,Is Weaver syndrome similar to Sotos?,Two previous cases of neuroblastoma have been reported in children with Weaver syndrome.,0
47,19,Is Weaver syndrome similar to Sotos?,"Weaver syndrome is closely related to Sotos syndrome,",0
47,20,Is Weaver syndrome similar to Sotos?,"Overgrowth syndromes such as Beckwith-Wiedemann syndrome, Sotos syndrome, and Weaver syndrome have an increased risk of neoplasia.",0
47,21,Is Weaver syndrome similar to Sotos?,Considerable phenotypic overlap between Sotos and Weaver syndromes is also evident.,0
47,22,Is Weaver syndrome similar to Sotos?,"Clinically, Weaver syndrome is closely related to Sotos syndrome, which is frequently caused by mutations in NSD1.",0
3174,0,Was stelara developed by Amgen?,"NICE does not specifically recommend switching from one biologic to another, and only ustekinumab (UST; STELARA®, Janssen Pharmaceuticals, Inc., Horsham, PA, USA) is recommended after anti-tumour necrosis factor failure.",1
3295,0,Which is the function of the PRDM9 protein in mammals?,Developmental progress of germ cells through meiotic phases is closely tied to ongoing meiotic recombination.,1
3295,1,Which is the function of the PRDM9 protein in mammals?,"In mammals, recombination preferentially occurs in genomic regions known as hotspots; the protein that activates these hotspots is PRDM9,",1
3295,2,Which is the function of the PRDM9 protein in mammals?,"In mammals, genetic recombination during meiosis is limited to a set of 1- to 2-kb regions termed hotspots.",1
3295,3,Which is the function of the PRDM9 protein in mammals?,"Their locations are predominantly determined by the zinc finger protein PRDM9, which binds to DNA in hotspots",0
3295,4,Which is the function of the PRDM9 protein in mammals?,Meiotic recombination ensures proper segregation of homologous chromosomes and creates genetic variation.,0
3295,5,Which is the function of the PRDM9 protein in mammals?,"In many organisms, recombination occurs at limited sites, termed 'hotspots', whose positions in mammals are determined by PR domain member 9 (PRDM9)",1
3295,6,Which is the function of the PRDM9 protein in mammals?,"These results, which provide the first detailed mapping of PRDM9 binding to DNA and, to our knowledge, the most detailed analysis yet of DNA binding by a long zinc-finger array, make clear that the binding specificities of PRDM9, and possibly other long-array zinc-finger proteins, are unusually complex.",0
3295,7,Which is the function of the PRDM9 protein in mammals?,PRDM9 is a major determinant of meiotic recombination hotspots in humans and mice.,0
3295,8,Which is the function of the PRDM9 protein in mammals?," Here, we demonstrate that a major player for hotspot specification is the Prdm9 gene.",0
3295,9,Which is the function of the PRDM9 protein in mammals?,"During mammalian meiosis, double-strand breaks are deliberately made throughout the genome and then repaired, leading to the exchange of genetic material between copies of chromosomes.",0
3295,10,Which is the function of the PRDM9 protein in mammals?,"How the locations of breaks are specified was largely unknown until a fortuitous confluence of statistical genetics and molecular biology uncovered the role of PRDM9, a DNA binding protein",0
3295,11,Which is the function of the PRDM9 protein in mammals?,"In many mammals, including humans and mice, the zinc finger histone methyltransferase PRDM9 performs the first step in meiotic recombination by specifying the locations of hotspots, the sites of genetic recombination.",1
3295,12,Which is the function of the PRDM9 protein in mammals?,"These results, together with the fact that PRDM9 is the only known mammalian histone methyltransferase with both H3K4 and H3K36 trimethylation activity, suggest that trimethylation of H3K36 plays an important role in the recombination process.",0
3645,0,Which application is the backbone of BioPAXViz?,BioPAXViz: a cytoscape application for the visual exploration of metabolic pathway evolution.,0
3645,1,Which application is the backbone of BioPAXViz?,"BioPAXViz is a Cytoscape (version 3) application, providing a comprehensive framework for metabolic pathway visualization.",1
3645,2,Which application is the backbone of BioPAXViz?,"Beyond the basic parsing, viewing and browsing roles, the main novel function that BioPAXViz provides is a visual comparative analysis of metabolic pathway topologies across pre-computed pathway phylogenomic profiles given a species phylogeny.",1
3645,3,Which application is the backbone of BioPAXViz?,"Furthermore, BioPAXViz supports the display of hierarchical trees that allow efficient navigation through sets of variants of a single reference pathway.",0
3645,4,Which application is the backbone of BioPAXViz?,"Thus, BioPAXViz can significantly facilitate, and contribute to, the study of metabolic pathway evolution and engineering.Availability and Implementation: BioPAXViz has been developed as a Cytoscape app and is available at: https://github.com/CGU-CERTH/BioPAX.Viz.",0
3645,5,Which application is the backbone of BioPAXViz?,"Summary

BioPAXViz is a Cytoscape (version 3) application, providing a comprehensive framework for metabolic pathway visualization.",0
3645,6,Which application is the backbone of BioPAXViz?,"Summary BioPAXViz is a Cytoscape (version 3) application, providing a comprehensive framework for metabolic pathway visualization.",1
3645,7,Which application is the backbone of BioPAXViz?,Availability and Implementation BioPAXViz has been developed as a Cytoscape app and is available at: https://github.com/CGU-CERTH/BioPAX.Viz.,0
3645,8,Which application is the backbone of BioPAXViz?,"BioPAXViz is a Cytoscape ( version 3 ) application , providing a comprehensive framework for metabolic pathway visualization",1
3645,9,Which application is the backbone of BioPAXViz?,BioPAXViz: a cytoscape application for the visual exploration of metabolic pathway evolution,0
3645,10,Which application is the backbone of BioPAXViz?,"Summary
BioPAXViz is a Cytoscape (version 3) application, providing a comprehensive framework for metabolic pathway visualization.",0
3645,11,Which application is the backbone of BioPAXViz?,"Summary: BioPAXViz is a Cytoscape (version 3) application, providing a comprehensive framework for metabolic pathway visualization.",0
3645,12,Which application is the backbone of BioPAXViz?,"BioPAXViz is a Cytoscape (version 3) application, providing a comprehensive framework for metabolic pathway visualization.",1
3645,13,Which application is the backbone of BioPAXViz?,BioPAXViz has been developed as a Cytoscape app and is available at: https://github.com/CGU-CERTH/BioPAX.Viz.,0
1004,0,Which SLC family is FLVCR1 a member of?,"Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.",1
1004,1,Which SLC family is FLVCR1 a member of?,"Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.",1
1004,2,Which SLC family is FLVCR1 a member of?,"Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.",1
1004,3,Which SLC family is FLVCR1 a member of?,"Disruption of FLVCR1 function blocks development of erythroid progenitors, likely due to heme toxicity.",0
1004,4,Which SLC family is FLVCR1 a member of?," Heme is critical for a variety of cellular processes, but excess intracellular heme may result in oxidative stress and membrane injury.",0
1004,5,Which SLC family is FLVCR1 a member of?,"Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.",1
1004,6,Which SLC family is FLVCR1 a member of?,"Heme is critical for a variety of cellular processes, but excess intracellular heme may result in oxidative stress and membrane injury.",0
1004,7,Which SLC family is FLVCR1 a member of?,"Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family of four paralogous genes, is a cell surface heme exporter, essential for erythropoiesis and systemic iron homeostasis.",1
245,0,Is the Drosophila Translational Control Element (TCE) involved in spermatogenesis?,Gene regulation in Drosophila spermatogenesis: analysis of protein binding at the translational control element TCE.,1
245,1,Is the Drosophila Translational Control Element (TCE) involved in spermatogenesis?,"We have previously identified a 12 nucleotide long sequence element, the TCE, that was demonstrated to be necessary for translational control of expression in the male germ line of Drosophila melanogaster (Schäfer et al., 1990).",1
245,2,Is the Drosophila Translational Control Element (TCE) involved in spermatogenesis?,Gene regulation in Drosophila spermatogenesis: analysis of protein binding at the translational control element TCE,1
245,3,Is the Drosophila Translational Control Element (TCE) involved in spermatogenesis?,The Drosophila Translational Control Element (TCE) is required for high-level transcription of many genes that are specifically expressed in testes,1
245,4,Is the Drosophila Translational Control Element (TCE) involved in spermatogenesis?,Bioinformatic analyses of core promoter sequences from 190 genes that are specifically expressed in testes identified a 10 bp A/T-rich motif that is identical to the translational control element (TCE),0
245,5,Is the Drosophila Translational Control Element (TCE) involved in spermatogenesis?,The Drosophila Translational Control Element (TCE) is required for high-level transcription of many genes that are specifically expressed in testes.,1
2291,0,How many Groucho-related genes (GRG) are contained in the mouse genome?, We describe here the genomic organization of the mouse Grg gene.,0
2291,1,How many Groucho-related genes (GRG) are contained in the mouse genome?,It spans approximately 7 kb on chromosome 10 and consists of seven exons.,0
2291,2,How many Groucho-related genes (GRG) are contained in the mouse genome?,The Grg gene encodes a 197 amino acid protein homologous to the amino-terminal domain of the product of the groucho gene of the Drosophila Enhancer of split complex,1
2291,3,How many Groucho-related genes (GRG) are contained in the mouse genome?,The mouse Grg gene encodes a 197 amino acid nuclear protein homologous to the amino-terminal domain of the product of the groucho (gro) gene of the Drosophila Enhancer of split complex.,1
2291,4,How many Groucho-related genes (GRG) are contained in the mouse genome?,The groucho-related genes (Grg) of the mouse comprise at least four family members.,1
2291,5,How many Groucho-related genes (GRG) are contained in the mouse genome?,"The murine grg (Groucho-related gene) products are believed to interact with transcription factors and repress transcription, thereby regulating cell proliferation and differentiation.",1
2291,6,How many Groucho-related genes (GRG) are contained in the mouse genome?,"We have isolated cDNAs representing multiple members of murine groucho homologues, designated Grg for groucho-related genes.",1
3944,0,What is holoprosencephaly?,"Holoprosencephaly (HPE) is a congenital defect of the brain, median structures, and face resulting from an incomplete cleavage of the primitive brain during early embryogenesis.",1
3944,1,What is holoprosencephaly?,"Holoprosencephaly (HPE) is the most common developmental defect of the forebrain characterized by inadequate or absent midline division of the forebrain into cerebral hemispheres, with concomitant midline facial defects in the majority of cases.",1
3944,2,What is holoprosencephaly?, Holoprosencephaly (HPE) is a severe brain malformation characterized by abnormal cleavage of the prosencephalon in the 5th gestational week.,0
3944,3,What is holoprosencephaly?,BACKGROUND AND PURPOSE: Holoprosencephaly is a rare developmental brain abnormality with a range of severity.,0
3944,4,What is holoprosencephaly?,BACKGROUND: Holoprosencephaly is the most common malformation of the forebrain (1 in 250 embryos) with severe consequences for fetal and child development.,0
3944,5,What is holoprosencephaly?,PURPOSE: Holoprosencephaly is a rare developmental brain abnormality with a range of severity.,0
3944,6,What is holoprosencephaly?,Holoprosencephaly is the most common malformation of the forebrain and typically results in severe neurocognitive impairment with accompanying midline facial anomalies.,0
3944,7,What is holoprosencephaly?,Holoprosencephaly is a rare brain abnormality resulting from an incomplete cleavage of the primitive prosencephalon of forebrain during early embryogenesis.,1
3944,8,What is holoprosencephaly?,Holoprosencephaly is a brain malformation that develops as a result of a defect in development of prosencephalon during early gestation.,0
3944,9,What is holoprosencephaly?,PURPOSE OF REVIEW: Holoprosencephaly is a disorder of forebrain development characterized by a failure of the brain to separate into two hemispheres during early development.,0
3944,10,What is holoprosencephaly?,Holoprosencephaly (HPE) is a severe brain malformation characterized by abnormal cleavage of the prosencephalon in the 5th gestational week.,0
3944,11,What is holoprosencephaly?,Holoprosencephaly is a brain defect resulting from incomplete cleavage of the embryonic forebrain.,1
3944,12,What is holoprosencephaly?,Holoprosencephaly is a spectrum of congenital defects of forebrain development characterized by incomplete separation of the cerebral hemispheres.,1
3944,13,What is holoprosencephaly?,"Holoprosencephaly is a brain anomaly of varying severity with associated extracranial, symptomatic abnormalities in only a minority of cases.",0
3944,14,What is holoprosencephaly?,PURPOSE OF REVIEW: Holoprosencephaly is a disorder of forebrain development characterized by a failure of the brain to separate into two hemispheres during,0
3944,15,What is holoprosencephaly?,"BACKGROUND: Holoprosencephaly is a structural anomaly of the brain that consists in a defect of the prosencephalon development that leads to face and neurological defects of variable intensity.AIM: To estimate holoprosencephaly prevalence at birth.PATIENTS AND METHODS: All cases of holoprosencephaly, born alive or stillbirths, registered in the 15 Chilean Hospitals of the Latin American Collaborative Study of Congenital Malformations (ECLAM",0
3944,16,What is holoprosencephaly?,"Holoprosencephaly is a clinically and genetically heterogeneous midline brain malformation associated with neurologic manifestations including developmental delay, intellectual disability and seizures.",0
360,0,Have thyronamines  effects on fat tissue?,"In conclusion, trace amines and thyronamines are negative inotropic agents.",1
360,1,Have thyronamines  effects on fat tissue?,"Their in vivo administration induces effects opposite to those induced by thyroid hormone, including lowering of body temperature.",1
2527,0,Can doxycycline cause photosensitivity?,"Phototoxicity of Doxycycline: A Systematic Review on Clinical Manifestations, Frequency, Cofactors, and Prevention.",1
2527,1,Can doxycycline cause photosensitivity?,BACKGROUND: One of the most important dermatologic side effects of doxycycline is photosensitivity.,1
2527,2,Can doxycycline cause photosensitivity?,"While there are many publications on the phototoxicity of tetracyclines in general, only a few exist focusing on doxycycline.",0
2527,3,Can doxycycline cause photosensitivity?,"Clinical symptoms vary from light sunburn-like sensation (burning, erythema) to large-area photodermatitis.",1
2527,4,Can doxycycline cause photosensitivity?,CONCLUSION: Evidence base must be improved for giving advice on appropriate prevention measures to travelers taking doxycycline and having a risk of significant sun exposure.,0
2527,5,Can doxycycline cause photosensitivity?,"Based on the available evidence, our best estimates of absolute effect for mefloquine versus doxycyline were: 2% versus 2% for discontinuation, 12% versus 3% for insomnia, 31% versus 3% for abnormal dreams, 18% versus 1% for anxiety, 11% versus 1% for depressed mood, 4% versus 14% for dyspepsia, 2% versus 19% for photosensitivity, 1% versus 5% for vomiting, and 2% versus 16% for vaginal thrush.",0
2527,6,Can doxycycline cause photosensitivity?,"Many drugs are responsible for this phototoxic reaction, especially tetracyclines, psoralens, chloramphenicol, non-steroidal anti-inflammatory drugs, fluoroquinolones, and, rarely, doxycycline.",0
2527,7,Can doxycycline cause photosensitivity?,OBJECTIVES: Many patients undergoing long-term doxycycline treatment do not regularly take their treatment because of photosensitivity.,0
2527,8,Can doxycycline cause photosensitivity?,Modulation of Melanogenesis and Antioxidant Status of Melanocytes in Response to Phototoxic Action of Doxycycline.,0
2527,9,Can doxycycline cause photosensitivity?,Doxycycline is a commonly used tetracycline antibiotic showing the broad spectrum of antibacterial action.,0
2527,10,Can doxycycline cause photosensitivity?,"However, the use of this antibiotic is often connected with the risk of phototoxic reactions that lead to various skin disorders.",0
2527,11,Can doxycycline cause photosensitivity?,The results obtained in vitro may explain the mechanisms of phototoxic reactions that occur in normal human epidermal melanocytes in vivo after exposure of skin to doxycycline and UVA radiation.,0
2527,12,Can doxycycline cause photosensitivity?,"Treatment with doxycycline is cheap and relatively safe, but gastrointestinal symptoms and photosensitivity reactions can be expected more often than with ceftriaxone.<br>",0
2527,13,Can doxycycline cause photosensitivity?,<b>OBJECTIVES</b>: Many patients undergoing long-term doxycycline treatment do not regularly take their treatment because of photosensitivity.,0
2527,14,Can doxycycline cause photosensitivity?,Photosensitivity reactions and gastrointestinal symptoms were noted more often among patients receiving doxycycline than in those receiving ceftriaxone.,0
2527,15,Can doxycycline cause photosensitivity?,"Thus, the action spectra of the drug photosensitivity patients were plotted and compared with those of 12 nonphotosensitive control patients: 10 patients were found to be photosensitive in the UVA range; the implicated drugs included quinine, sparfloxacin, amiodarone, doxycycline, mefenamic acid, nalidixic acid, fenbrufen, diclofenac, enalapril, diltiazem and prochlorperazine maleate.",0
2527,16,Can doxycycline cause photosensitivity?,One patient on doxycycline was photosensitive in both the UVA and UVB ranges.,0
2527,17,Can doxycycline cause photosensitivity?,"Treatment with doxycycline is cheap and relatively safe, but gastrointestinal symptoms and photosensitivity reactions can be expected more often than with ceftriaxone.",0
2527,18,Can doxycycline cause photosensitivity?,"Anti-inflammatory-dose doxycycline should not be used by individuals with known hypersensitivity to tetracyclines or increased photosensitivity, or by pregnant or nursing women (anti-inflammatory-dose doxycycline is a pregnancy category-D medication).",0
2527,19,Can doxycycline cause photosensitivity?,<b>BACKGROUND</b>: One of the most important dermatologic side effects of doxycycline is photosensitivity.,0
2527,20,Can doxycycline cause photosensitivity?,One of the most important dermatologic side effects of doxycycline is photosensitivity.,1
2527,21,Can doxycycline cause photosensitivity?,One patient experienced mild photosensitivity from doxycycline but continued to take it.,1
2527,22,Can doxycycline cause photosensitivity?,Participants in the doxycycline group had a higher incidence of nausea and photosensitivity.,0
2527,23,Can doxycycline cause photosensitivity?,Photosensitivity reactions and gastrointestinal symptoms were noted more often among patients receiving doxycycline than in those receiving ceftriaxone.,0
3590,0,Does association with the nuclear pore promote gene silencing?,"Here, we show that the nucleoporin Nup358 plays an important role in this process.",1
3590,1,Does association with the nuclear pore promote gene silencing?,"Nup358 localizes to the nuclear pore complex and to the cytoplasmic annulate lamellae (AL), and these structures dynamically associate with two mRNP granules: processing bodies (P bodies) and stress granules (SGs).",1
3590,2,Does association with the nuclear pore promote gene silencing?,"MicroRNA (miRNA)-guided mRNA repression, mediated by the miRNA-induced silencing complex (miRISC), is an important component of post-transcriptional gene silencing.",1
3590,3,Does association with the nuclear pore promote gene silencing?,"To assess Tpr's role as an architectural element of the NPC, we have studied the sequential disassembly and reassembly of NPCs in mitotic cells, paralleled by studies of cells depleted of Tpr as a result of posttranscriptional tpr gene silencing by RNA interference (RNAi).",1
3590,4,Does association with the nuclear pore promote gene silencing?,The results raise the possibility that NPC-localized protein desumoylation may be a key regulatory event preventing inappropriate pre-mRNA export.,1
3590,5,Does association with the nuclear pore promote gene silencing?,Silencing nuclear pore protein Tpr elicits a senescent-like phenotype in cancer cells.,0
3042,0,Is Semagacestat effective for treatment of Alzheimer's disease?,"However, a large phase 3 trial of semagacestat, a potential non-transition state analog (non-TSA) GSI, in patients with Alzheimer's disease (AD) was terminated due to unexpected aggravation of cognitive deficits and side effects.",0
3042,1,Is Semagacestat effective for treatment of Alzheimer's disease?,"BACKGROUND: In a recent report, 76 weeks' treatment with a gamma-secretase inhibitor (semagacestat) was associated with poorer cognitive outcomes in Alzheimer's disease (AD).",0
3042,2,Is Semagacestat effective for treatment of Alzheimer's disease?,"A clinical trial with the wide-spectrum γ-secretase inhibitor semagacestat has, however, demonstrated that global inhibition of all γ-secretases causes serious toxicity.",0
3042,3,Is Semagacestat effective for treatment of Alzheimer's disease?,"OBJECTIVE: Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted.",0
3042,4,Is Semagacestat effective for treatment of Alzheimer's disease?,"CONCLUSIONS: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.",1
3042,5,Is Semagacestat effective for treatment of Alzheimer's disease?,"Semagacestat was associated with more adverse events, including skin cancers and infections.",1
3042,6,Is Semagacestat effective for treatment of Alzheimer's disease?,"BACKGROUND
In a recent report, 76 weeks' treatment with a gamma-secretase inhibitor (semagacestat) was associated with poorer cognitive outcomes in Alzheimer's disease (AD).",0
3042,7,Is Semagacestat effective for treatment of Alzheimer's disease?,"Semagacestat was associated with more adverse events, including skin cancers and infections.",1
3042,8,Is Semagacestat effective for treatment of Alzheimer's disease?,"CONCLUSIONS
As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.",0
3042,9,Is Semagacestat effective for treatment of Alzheimer's disease?,"OBJECTIVE
Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted.",0
3042,10,Is Semagacestat effective for treatment of Alzheimer's disease?,Recently disclosed Phase III findings on semagacestat indicated that Alzheimer's disease (AD) patients on this drug showed significantly worsened cognitive function compared to those treated with placebo.,0
3042,11,Is Semagacestat effective for treatment of Alzheimer's disease?,The recent failure of semagacestat in two large Phase III studies questions the value of γ-secretase inhibitors in treating Alzheimer's disease.,0
3042,12,Is Semagacestat effective for treatment of Alzheimer's disease?,"A phase 3 trial of semagacestat for treatment of Alzheimer's disease.As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.",1
3042,13,Is Semagacestat effective for treatment of Alzheimer's disease?,"Preliminary results from Phase III studies showed that semagacestat failed to slow disease progression, and it was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living.",0
3042,14,Is Semagacestat effective for treatment of Alzheimer's disease?,"Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.In participants with mild to moderate AD, high dose semagacestat treatment was associated with greater severity and faster worsening of NPS in a pattern resembling an agitated depression.",0
3042,15,Is Semagacestat effective for treatment of Alzheimer's disease?,"Patients treated with semagacestat lost more weight and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo).",1
3042,16,Is Semagacestat effective for treatment of Alzheimer's disease?,"<b>OBJECTIVE</b>: Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted.",0
3042,17,Is Semagacestat effective for treatment of Alzheimer's disease?,"Other relevant safety findings associated with semagacestat treatment included cognitive and functional worsening, skin-related TEAEs, renal and hepatic changes, increased QT interval, and weight loss.",0
3042,18,Is Semagacestat effective for treatment of Alzheimer's disease?,"Patients treated with semagacestat lost more weight and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P&lt;0.001 for all comparisons with placebo).",0
3042,19,Is Semagacestat effective for treatment of Alzheimer's disease?,"Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted.",0
2727,0,What is an exosome?,Exosomes are small extracellular membrane-based vesicles with a variety of cargoes that are involved in numerous physiological and pathological processes in the nervous system.,1
2727,1,What is an exosome?,Exosomes are a subset of extracellular vesicles (EVs) that have important roles in intercellular communication.,1
2727,2,What is an exosome?,They contain and carry bioactive molecules within their membranes which are delivered to target cells.,1
2727,3,What is an exosome?,Extracellular vesicles (EVs) are released by cells and can be found in cell culture supernatants and biofluids.,1
2727,4,What is an exosome?,"EVs carry proteins, nucleic acids, and other cellular components and can deliver these to nearby or distant cells, making EVs of interest as both disease biomarkers and therapeutic targets",0
2727,5,What is an exosome?,Exosomes are released by cells as self-contained vesicles with an intact lipid bilayer that encapsulates a small portion of the parent cell.,1
2642,0,What is calciphylaxis,Calcific uraemic arteriolopathy (calciphylaxis) is an unusual and potentially fatal condition characterised by small-vessel calcification and ischaemic skin necrosis.,1
2642,1,What is calciphylaxis,"Renal failure-associated calciphylaxis, also termed calcific uremic arteriolopathy (CUA), is a life-threatening condition usually observed in patients with end-stage renal disease on chronic dialysis or after renal transplantation",0
2642,2,What is calciphylaxis,"Calcific uraemic arteriolopathy (CUA, calciphylaxis) is a rare disease predominantly in dialysis patients and associated with high mortality.",1
2642,3,What is calciphylaxis,Painful skin ulcerations and calcification of cutaneous arterioles characterize calciphylaxis,0
2642,4,What is calciphylaxis,<b>WHAT IS KNOWN AND OBJECTIVE</b>: Calciphylaxis is a rare and potentially life-threatening cause of skin necrosis and is poorly recognized by clinicians in non-uraemic patients.<br><b>CASE DESCRIPTION</b>: We report five cases of warfarin-induced calciphylaxis in patients with normal renal function.,0
2642,5,What is calciphylaxis,"BACKGROUND AND OBJECTIVES: Calciphylaxis, or calcific uremic arteriolopathy, is a well-described entity in end-stage kidney disease and renal transplant patients; however, little systematic information is available on calciphylaxis from nonuremic causes.",0
2642,6,What is calciphylaxis,WHAT IS KNOWN AND OBJECTIVE Calciphylaxis is a rare and potentially life-threatening cause of skin necrosis and is poorly recognized by clinicians in non-uraemic patients.,1
2642,7,What is calciphylaxis,"OBJECTIVE Calciphylaxis, a rare disorder typically affecting renal failure patients, results in vascular calcification with subsequent skin necrosis, gangrene, and often death from sepsis.",0
2642,8,What is calciphylaxis,Calciphylaxis is a metastatic calcification-induced vasculopathy that results in the occlusion of small blood vessels.,0
2642,9,What is calciphylaxis,"Calciphylaxis is a small vessel vasculopathy, characterized by medial wall calcification that develops in a few patients with chronic renal failure.",0
2642,10,What is calciphylaxis,"BACKGROUND Calciphylaxis is a syndrome consisting of vascular calcification, thrombosis, and skin necrosis.",1
2642,11,What is calciphylaxis,Calciphylaxis is characterized by calcification in the medium and small vessel arterioles and can be a life-threatening complication often associated with chronic kidney disease (CKD).,0
2642,12,What is calciphylaxis,"Calciphylaxis is characterized by painful, violaceous, mottled skin lesions (livedo reticularis) that may progress to tissue necrosis, nonhealing ulcers, gangrene, and potentially amputation, sepsis, or death.",0
2642,13,What is calciphylaxis,"Calciphylaxis is a relatively rare disease, observed mainly in patients on dialysis, associated with high mortality rates, and characterized by painful skin ulceration.",0
2642,14,What is calciphylaxis,Calciphylaxis is a rare condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.,0
2642,15,What is calciphylaxis,"It is characterized by acute calcium deposition in the medial layer of small and intermediate dermal vasculature that can lead to epidermal ischemia, ulceration, and necrosis",0
2642,16,What is calciphylaxis,Calciphylaxis is a rare condition characterized by medial calcification of small- and medium-sized vessels that subsequently leads to ischemic necrosis.,0
2642,17,What is calciphylaxis,Calciphylaxis is a disease in which metastatic calcification affects small- and medium-sized vessels resulting in significant dermatologic manifestations.,0
2642,18,What is calciphylaxis,"Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy.",0
2642,19,What is calciphylaxis,"Histological characteristics of calciphylaxis include small-vessel calcifications of skin, subcutaneous tissue, and visceral organs.",0
2642,20,What is calciphylaxis,These vascular changes promote tissue ischemia that often results in tissue necrosis,0
2642,21,What is calciphylaxis,"Calcific uraemic arteriolopathy, also named calciphylaxis, is a rare but serious disorder characterized by medial mural calcification of small vessel leading to tissue ischaemia.",1
2642,22,What is calciphylaxis,Calciphylaxis is a rare complication that occurs in 1% of patients with end-stage renal disease (ESRD) each year.,0
2642,23,What is calciphylaxis,"Extensive microvascular calcification and occlusion/thrombosis lead to violaceous skin lesions, which progress to nonhealing ulcers with secondary infection, often leading to sepsis and death.",0
2642,24,What is calciphylaxis,"Calciphylaxis is a rare, usually fatal vasculopathic disorder characterized by cutaneous ischemia and necrosis due to calcification of arterioles",0
2642,25,What is calciphylaxis,Calciphylaxis is a rare and potentially fatal complication of end stage renal disease (ESRD) and secondary hyperparathyroidism associated with abnormal calcium metabolism.,0
2642,26,What is calciphylaxis,"Calciphylaxis causes calcification, thrombosis, cutaneous ischemia, and necrosis in the skin and subcutaneous tissue",0
2642,27,What is calciphylaxis,Calciphylaxis is a rare phenomenon of medium- and small-vessel calcifications leading to cutaneous necrosis mimicking vasculitis.,0
2642,28,What is calciphylaxis, Calciphylaxis combines features of vascular thrombotic occlusion and endoluminal calcification.,0
2642,29,What is calciphylaxis,I,0
2642,30,What is calciphylaxis,"Calciphylaxis refers to a syndrome of calcium deposition in the small and intermediate dermal vasculature which can lead to epidermal ischaemia, ulceration and necrosis.",0
838,0,Which is the prevalence of cystic fibrosis in the human population?,The allelic frequency of this variant was calculated to be 0.7% for this population,1
838,1,Which is the prevalence of cystic fibrosis in the human population?,"The results of literature reviews, surveys, and registry analyses revealed a mean prevalence of 0.737/10,000 in the 27 EU countries, which is similar to the value of 0.797 in the United States, and only one outlier, namely the Republic of Ireland at 2.98",1
838,2,Which is the prevalence of cystic fibrosis in the human population?,"The age related prevalence of CF among the South Asian and general populations was: 0-14 years, 1:9200 versus 1:6600; 15-24 years, 1:13,200 versus 1:7600; older than 25 years, 1:56,600 versus 1:12,400.",0
838,3,Which is the prevalence of cystic fibrosis in the human population?,"A theoretical estimate of the prevalence of cystic fibrosis based on anthropological data suggested a frequency of 25 affected individuals/100,000 inhabitants.",1
838,4,Which is the prevalence of cystic fibrosis in the human population?,"However, our data indicated that the true prevalence in the population was considerably lower (6.9 cases/100,000 inhabitants)",1
838,5,Which is the prevalence of cystic fibrosis in the human population?,CF mutations were identified in 374 (4.0%) individuals.,0
838,6,Which is the prevalence of cystic fibrosis in the human population?,The aim of this study was to evaluate the screening policies of cystic fibrosis (CF) in the Jewish population.,1
1571,0,What gene test is recommended for clopidogrel?,polymorphisms in the CYP2C19 gene affect clopidogrel pharmacokinetics.,1
1571,1,What gene test is recommended for clopidogrel?,This study sought to evaluate the influence of single nucleotide polymorphisms (SNPs) on the pharmacodynamic effect of high- or standard-dose clopidogrel after percutaneous coronary intervention (PCI).,0
1571,2,What gene test is recommended for clopidogrel?,"CYP2C19, but not PON1 or ABCB1, is a significant determinant of the pharmacodynamic effects of clopidogrel, both early and late after PCI.",1
1571,3,What gene test is recommended for clopidogrel?,"In patients with high OTR identified by platelet function testing, the CYP2C19 genotype provides limited incremental information regarding the risk of persistently high reactivity with clopidogrel 150-mg maintenance dosing.",0
1571,4,What gene test is recommended for clopidogrel?,(Genotype Information and Functional Testing Study [GIFT]; NCT00992420).,0
1571,5,What gene test is recommended for clopidogrel?,Variants in the CYP2C19 gene influence the pharmacologic and clinical response to the standard 75-mg daily maintenance dose of the antiplatelet drug clopidogrel.,0
1571,6,What gene test is recommended for clopidogrel?,OBJECTIVE: To test whether higher doses (up to 300 mg daily) improve the response to clopidogrel in the setting of loss-of-function CYP2C19 genotypes.,0
1571,7,What gene test is recommended for clopidogrel?,polymorphisms in the CYP2C19 gene affect clopidogrel pharmacokinetics.,1
1571,8,What gene test is recommended for clopidogrel?,These polymorphisms may be useful to identify clopidogrel nonresponders who may benefit from taking an alternative antiplatelet agent such as prasugrel and ticagrelor.,0
1571,9,What gene test is recommended for clopidogrel?,"Although both drugs have pharmacogenomic tests available for clinical use,",0
1571,10,What gene test is recommended for clopidogrel?,The CYP2C19*2 allele is a common genetic variant associated with increased rates of major adverse events in individuals given clopidogrel after percutaneous coronary intervention (PCI).,0
1571,11,What gene test is recommended for clopidogrel?,We used a novel point-of-care genetic test to identify carriers of the CYP2C19*2 allele and aimed to assess a pharmacogenetic approach to dual antiplatelet treatment after PCI,0
1571,12,What gene test is recommended for clopidogrel?,The antiplatelet effect of clopidogrel has been linked to cytochrome P450 2C19 (CYP2C19) carrier status.,1
1571,13,What gene test is recommended for clopidogrel?,The presence of loss of function and gain of function variants were found to have a gene-dose effect on clopidogrel metabolism.,0
1571,14,What gene test is recommended for clopidogrel?,"However, genotyping is only one aspect of predicting response to clopidogrel and several platelet function tests are available to measure platelet response.",0
1571,15,What gene test is recommended for clopidogrel?,The cytochrome P450 (CYP) 2C19*2 loss-of-function allele has been associated with impaired clopidogrel response and worse prognosis in clopidogrel-treated patients.,0
1571,16,What gene test is recommended for clopidogrel?,The present study was designed to evaluate the benefit of tailored therapy with a higher maintenance dose according to CYP2C19 genotypes in patients identified as nonresponders who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.,0
1571,17,What gene test is recommended for clopidogrel?,identify genes and mutations with known associations with disease and drug response.,0
1571,18,What gene test is recommended for clopidogrel?,"The patient had a heterozygous null mutation in CYP2C19 suggesting probable clopidogrel resistance,",1
1571,19,What gene test is recommended for clopidogrel?,The cytochrome P450 (CYP) 2C19 isoenzyme plays an important role in clopidogrel metabolization.,0
1571,20,What gene test is recommended for clopidogrel?,"A recently explored CYP2C19*17 allelic variant has been linked to increased transcriptional activity, resulting in extensive metabolization of CYP2C19 substrates, which may lead to an enhanced platelet response to clopidogrel treatment.",0
1571,21,What gene test is recommended for clopidogrel?,To identify gene variants that influence clopidogrel response.,0
1571,22,What gene test is recommended for clopidogrel?,A genome-wide association study was performed followed by genotyping the loss-of-function cytochrome P450 (CYP) 2C19*2 variant (rs4244285).,0
1571,23,What gene test is recommended for clopidogrel?,Findings in the PAPI Study were extended by examining the relation of CYP2C19*2 genotype to platelet function and cardiovascular outcomes in an independent sample of 227 patients undergoing percutaneous coronary intervention.,0
1571,24,What gene test is recommended for clopidogrel?,Coexisting polymorphisms of the genes affecting clopiogrel resistance may influence platelet activation.,0
1571,25,What gene test is recommended for clopidogrel?,"Genotyping revealed 7 carriers of both the C allele of P2Y12 and A allele of CYP2C19 (group 1), 14 carriers of the T allele of P2Y12 and A allele of CYP2C19 (group 2), 17 carriers of the C allele of P2Y12 and G allele of CYP2C19 (group 3) and 67 carriers of the T allele of P2Y12 and G allele of CYP2C19 (controls).",0
1571,26,What gene test is recommended for clopidogrel?,to evaluate the effect of polymorphisms affecting the clopidogrel metabolism (CYP3A4 IVS10+12G/A and CYP2C19*2) and the P2Y12 receptor (P2Y12 T744C) on modulating platelet function in acute coronary syndrome patients on dual antiplatelet treatment.,0
1571,27,What gene test is recommended for clopidogrel?,to test the influence of the CYP 2C19*2 allele on clopidogrel responsiveness.,0
1571,28,What gene test is recommended for clopidogrel?,Genetic polymorphisms significantly influence responses to warfarin and clopidogrel.,0
1571,29,What gene test is recommended for clopidogrel?,"A recent clinical trial has demonstrated that patients with acute coronary syndromes (ACS) and the reduced function allele CYP2C19*2 (*2 allele), who are treated with thienopyridines, have an increased risk of adverse cardiac events with clopidogrel, but not with prasugrel.",0
3773,0,Do circular exons increase gene expression?,"Each of these species was present at very low copy numbers in primary and cultured cells; however, only the expression of ANRIL isoforms containing exons proximal to the INK4/ARF locus correlated with the ASVD risk alleles.",1
3773,1,Do circular exons increase gene expression?,These results identify novel circular RNA products emanating from the ANRIL locus and suggest causal variants at 9p21.3 regulate INK4/ARF expression and ASVD risk by modulating ANRIL expression and/or structure.,0
3773,2,Do circular exons increase gene expression?,"To explore the potential for using this methodology to express circular RNA in vivo, circular forms of the HDV ribozyme and RNaseP RNA were produced in E. coli.",0
3773,3,Do circular exons increase gene expression?,The activity of in vivo expressed circular ribozymes could be demonstrated indicating that they fold into active conformation,0
3773,4,Do circular exons increase gene expression?,"We found that: i) the circRNA expression profile revealed 1,285 significant differences in circRNA expression, with circRNA expression downregulated in 594 samples and upregulated in 691 samples via interactions with miRNAs.",0
3773,5,Do circular exons increase gene expression?,These circRNAs regulated the expression of target genes through interactions with miRNAs and might become new molecular biomarkers for GC in the future,1
3773,6,Do circular exons increase gene expression?,69 differentially expressed circRNAs were found that might adsorb specific miRNAs to regulate the expression of their target gene mRNAs.,1
3773,7,Do circular exons increase gene expression?,"Novel coding, translation, and gene expression of a replicating covalently closed circular RNA of 220 nt.",1
3773,8,Do circular exons increase gene expression?,"The highly structured (64% GC) covalently closed circular (CCC) RNA (220 nt) of the virusoid associated with rice yellow mottle virus codes for a 16-kDa highly basic protein using novel modalities for coding, translation, and gene expression",0
3773,9,Do circular exons increase gene expression?,Recent evidence has demonstrated that circular RNAs (circRNAs) played crucial roles in fine-tuning the levels of gene expression by sequestering the corresponding microRNA (miRNAs).,1
3773,10,Do circular exons increase gene expression?,It has been proposed that circRNA regulate gene expression at the transcriptional or post-transcriptional level by interacting with miRNAs and that circRNAs may have a role in regulating miRNA function in cancer initiation and progression.,0
2548,0,Milwaukee protocol was tested for treatment of which disease?,Caring for a patient with rabies: implications of the Milwaukee protocol for infection control and public health measures.,0
2548,1,Milwaukee protocol was tested for treatment of which disease?,"The Milwaukee protocol, which to date has five reported human rabies survivors associated with its use, has been suggested as a potential management pathway for human rabies.",0
2548,2,Milwaukee protocol was tested for treatment of which disease?,Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned.,1
2548,3,Milwaukee protocol was tested for treatment of which disease?,"Therapies suggested in the Milwaukee protocol include therapeutic coma, ketamine infusion, amantadine, and the screening/prophylaxis/management of cerebral vasospasm.",1
2548,4,Milwaukee protocol was tested for treatment of which disease?,None of these therapies can be substantiated in rabies or other forms of acute viral encephalitis.,0
2548,5,Milwaukee protocol was tested for treatment of which disease?,The Milwaukee protocol has been attributed to survival in rabies encephalitis despite a lack of scientific evidence supporting its therapeutic measures.,0
2548,6,Milwaukee protocol was tested for treatment of which disease?,"Rabies is virtually always fatal after clinical disease develops, and there have only been rare survivors.",0
2548,7,Milwaukee protocol was tested for treatment of which disease?,"The Milwaukee protocol, which includes therapeutic coma, has been shown to be ineffective and should no longer be used.",1
2548,8,Milwaukee protocol was tested for treatment of which disease?,The Milwaukee Protocol has proved to be ineffective for rabies and should no longer be used.,1
2548,9,Milwaukee protocol was tested for treatment of which disease?,The Milwaukee protocol has been attributed to survival in rabies encephalitis despite a lack of scientific evidence supporting its therapeutic measures.,0
2548,10,Milwaukee protocol was tested for treatment of which disease?,"This report summarizes the clinical course of disease in that patient, who was treated using the Milwaukee Protocol, an experimental treatment protocol similar to one used for the rabies survivor described in 2005.",1
2548,11,Milwaukee protocol was tested for treatment of which disease?,"In this first report of rabies in Equatorial Guinea, problems accompanying the application of the Milwaukee Protocol are described.",0
2548,12,Milwaukee protocol was tested for treatment of which disease?,"BACKGROUND Human rabies infection continues to be a significant public health burden globally, and is occasionally imported to high income settings where the Milwaukee Protocol for intensive care management has recently been employed, with limited success in improving survival.",0
2548,13,Milwaukee protocol was tested for treatment of which disease?,Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea.,0
1629,0,Which diseases have been associated with the PTPN22 620W allele?,"The frequency of the minor allele (620W) was significantly higher in GPA patients than in controls [P = 0.005, χ(2 )= 7.858, odds ratio (OR) = 1.91], while no statistically significant association was found with MPA or CSS.",0
1629,1,Which diseases have been associated with the PTPN22 620W allele?,"Among GPA patients, the 620W allele was particularly enriched in ANCA-positive patients as compared with controls (P = 0.00012, χ(2 )=���14.73, OR = 2.31)",0
1629,2,Which diseases have been associated with the PTPN22 620W allele?,"The PTPN22 620W allele confers susceptibility to the development of GPA (but not of MPA or CSS), and particularly of its ANCA-positive subset",0
1629,3,Which diseases have been associated with the PTPN22 620W allele?,The PTPN22 620W allele is a risk factor for Wegener's granulomatosis,0
1629,4,Which diseases have been associated with the PTPN22 620W allele?,"Analyses of families with multiple autoimmune disorders have revealed a functional polymorphism, 620W, in the intracellular tyrosine phosphatase gene PTPN22 as a predisposing factor for type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis, and the presence of the PTPN22 protein appears to herald the development of autoantibodies in these disorders",1
1629,5,Which diseases have been associated with the PTPN22 620W allele?,The PTPN22 620W allele frequency was significantly increased in antineutrophil cytoplasmic antibody (ANCA)-positive WG patients compared with healthy controls,0
1629,6,Which diseases have been associated with the PTPN22 620W allele?,"The PTPN22 620W allele appears to be involved in the pathogenesis of WG, and ANCA positivity seems to be the hallmark",0
1629,7,Which diseases have been associated with the PTPN22 620W allele?,Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele,0
1629,8,Which diseases have been associated with the PTPN22 620W allele?,"The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes for lymphoid tyrosine phosphatase LYP, involved in the negative regulation of early T-cell activation.",0
1629,9,Which diseases have been associated with the PTPN22 620W allele?,"An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases",0
1629,10,Which diseases have been associated with the PTPN22 620W allele?,A functional variant (R620W) of the intracellular protein tyrosine phosphatase N22 (PTPN22) has now been conclusively shown to confer approximately two-fold risk for seropositive RA as well as several other autoimmune disorders,0
1629,11,Which diseases have been associated with the PTPN22 620W allele?,the PTPN22 620W allele associates with multiple autoimmune phenotypes,0
1629,12,Which diseases have been associated with the PTPN22 620W allele?,"We report that a recently described functional single-nucleotide polymorphism (rs2476601, encoding R620W) in the intracellular tyrosine phosphatase (PTPN22) confers risk of four separate autoimmune phenotypes in these families: T1D, RA, SLE, and Hashimoto thyroiditis",0
1629,13,Which diseases have been associated with the PTPN22 620W allele?,"The 620W allele of PTPN22 has been associated with susceptibility to several different forms of chronic inflammatory disease, including Type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and autoimmune thyroiditis (AIT).",1
1629,14,Which diseases have been associated with the PTPN22 620W allele?,"The risk of developing RA later in life in patients with type 1 DM may be attributed, in part, to the presence of the 620W PTPN22 allele, suggesting that this risk factor may represent a common pathway for the pathogenesis of these 2 diseases.",0
1629,15,Which diseases have been associated with the PTPN22 620W allele?,"The minor allele of the R620W missense single-nucleotide polymorphism (SNP; rs2476601) in the PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been reported to be associated with multiple autoimmune diseases, including type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, autoimmune thyroiditis and vitiligo.",1
1629,16,Which diseases have been associated with the PTPN22 620W allele?,"An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases",0
1629,17,Which diseases have been associated with the PTPN22 620W allele?,"The minor allele of the R620W missense single-nucleotide polymorphism (SNP; rs2476601) in the PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been reported to be associated with multiple autoimmune diseases, including type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, autoimmune thyroiditis and vitiligo",0
1629,18,Which diseases have been associated with the PTPN22 620W allele?,"The 620W allele of PTPN22 has been associated with susceptibility to several different forms of chronic inflammatory disease, including Type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and autoimmune thyroiditis (AIT)",1
1629,19,Which diseases have been associated with the PTPN22 620W allele?,"The 620W allele of PTPN22 has been associated with susceptibility to several different forms of chronic inflammatory disease, including Type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and autoimmune thyroiditis (AIT)",1
1629,20,Which diseases have been associated with the PTPN22 620W allele?,"PTPN22 620W risk allele was associated with ACPA production [odds ratio (OR) = 2.21, 95% CI 1.4, 3.4, P < 0.0001]",0
1629,21,Which diseases have been associated with the PTPN22 620W allele?,"An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases",0
2933,0,Is there a deep-learning algorithm for protein solubility prediction?,DeepSol: a deep learning framework for sequence-based protein solubility prediction.,1
2933,1,Is there a deep-learning algorithm for protein solubility prediction?,Protein solubility plays a vital role in pharmaceutical research and production yield.,0
2933,2,Is there a deep-learning algorithm for protein solubility prediction?,"For a given protein, the extent of its solubility can represent the quality of its function, and is ultimately defined by its sequence.",0
2933,3,Is there a deep-learning algorithm for protein solubility prediction?,"Thus, it is imperative to develop novel, highly accurate in silico sequence-based protein solubility predictors.",1
2933,4,Is there a deep-learning algorithm for protein solubility prediction?,"In this work we propose, DeepSol, a novel Deep Learning-based protein solubility predictor.",1
2933,5,Is there a deep-learning algorithm for protein solubility prediction?,The backbone of our framework is a convolutional neural network that exploits k-mer structure and additional sequence and structural features extracted from the protein sequence.,1
2933,6,Is there a deep-learning algorithm for protein solubility prediction?,"DeepSol: a deep learning framework for sequence-based protein solubility prediction.<AbstractText Label=""Motivation"" NlmCategory=""UNASSIGNED"">Protein solubility plays a vital role in pharmaceutical research and production yield.",1
3466,0,Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?," severely affect iron homeostasis causing type 4 hereditary hemochromatosis, an autosomal dominant iron overload condition with variable phenotypic manifestations",1
3466,1,Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?,"Hemochromatosis type 4, also known as ferroportin disease, is an autosomal dominant genetic disorder caused by pathogenic mutations in the SLC40A1 gene, which encodes ferroportin 1 (FPN1).",1
3466,2,Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?,Hemochromatosis type 4 is a rare form of primary iron overload transmitted as an autosomal dominant trait caused by mutations in the gene encoding the iron transport protein ferroportin 1 (SLC40A1).,1
3466,3,Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?,Type 4 hemochromatosis follows an autosomal dominant trait; the corresponding mutation affects the basolateral iron carrier ferroportin 1.,1
3466,4,Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?,Type 4 hemochromatosis follows an autosomal dominant trait; the corresponding mutation affects the basolateral iron carrier ferroportin 1,1
3466,5,Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?,Type 4 hemochromatosis follows an autosomal dominant trait; the corresponding mutation affects the basolateral iron carrier ferroportin 1.,0
2013,0,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"OBJECTIVE MR-guided laser-induced thermal therapy (MRgLITT) can be used to treat intracranial tumors, epilepsy, and chronic pain syndromes.",0
2013,1,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Eight patients had glioblastoma multiforme (GBM), 1 had a previously treated GBM with radiation necrosis, and 1 had a melanoma brain metastasis.",0
2013,2,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"CONCLUSIONS Laser interstitial thermal therapy followed by minimally invasive transsulcal resection, reported here for the first time, is a novel option for patients with large, DTA, malignant brain neoplasms.",0
2013,3,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"MRI-guided laser interstitial thermal therapy is currently used as a minimally invasive treatment for brain metastases, radiation necrosis, glioma, and epilepsy.",0
2013,4,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study.,1
2013,5,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,We report our multicenter results of laser interstitial thermal therapy (LITT) in DTA-HGGs.,0
2013,6,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"We retrospectively reviewed 34 consecutive DTA-HGG patients (24 glioblastoma, 10 anaplastic) who underwent LITT at Cleveland Clinic, Washington University, and Wake Forest University (May 2011-December 2012) using the NeuroBlate(®) System.",0
2013,7,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,LITT can be used effectively for treatment of DTA-HGGs.,1
2013,8,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,More complete coverage of tumor by TDT lines improves PFS which can be translated as the extent of resection concept for surgery.,1
2013,9,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Stereotactic laser ablation of high-grade gliomas.,0
2013,10,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Recent advances in intraoperative imaging have spurred the use of stereotactic laser ablation (laser interstitial thermal therapy [LITT]) for intracranial lesions.,0
2013,11,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Among other targets, laser ablation has been used in the focal treatment of high-grade gliomas (HGGs).",0
2013,12,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article.,0
2013,13,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"OBJECT: Laser interstitial thermal therapy has been used as an ablative treatment for glioma; however, its development was limited due to technical issues.",0
2013,14,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"CONCLUSIONS: NeuroBlate represents new technology for delivering laser interstitial thermal therapy, allowing controlled thermal ablation of deep hemispheric rGBM.",0
2013,15,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Ongoing researches concern the adjunction of local treatments within the surgical field (photodynamic therapy, chemotherapy, convection immunotherapy...), but also the development of minimal invasive procedures (radiosurgery, high intensity focalized ultrasounds, laser interstitial thermal therapy).",0
2013,16,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Current commercially available LITT systems have been used for the treatment of neurosurgical soft-tissue lesions, including difficult to access brain tumors, malignant gliomas, and radiosurgery-resistant metastases, as well as for the ablation of such lesions as epileptogenic foci and radiation necrosis.",0
2013,17,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?," The authors report a Phase I, thermal dose-escalation trial assessing the safety and efficacy of NeuroBlate in recurrent glioblastoma multiforme (rGBM).",0
2013,18,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"MRI-guided laser interstitial thermal therapy is currently used as a minimally invasive treatment for brain metastases, radiation necrosis, glioma, and epilepsy.",0
2013,19,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Laser interstitial thermal therapy has been used as an ablative treatment for glioma; however, its development was limited due to technical issues.",0
2013,20,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"MRI-guided laser interstitial thermal therapy for the treatment of low-grade gliomas in children: a case-series review, description of the current technologies and perspectives.",0
2013,21,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"MRI-guided laser interstitial thermal therapy is currently used as a minimally invasive treatment for brain metastases, radiation necrosis, glioma, and epilepsy",0
2013,22,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Laser interstitial thermal therapy has been used as an ablative treatment for glioma; however, its development was limited due to technical issues",0
2013,23,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Thermal ablation (radiofrequency, microwave, cryosurgery, laser interstitial thermal therapy) is being used more frequently as a local treatment of secondary but also primary cancers and benign lesions",0
2013,24,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study,1
2013,25,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Current Applications of MRI-Guided Laser Interstitial Thermal Therapy in the Treatment of Brain Neoplasms and Epilepsy: A Radiologic and Neurosurgical Overview,0
2013,26,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Magnetic resonance imaging-guided laser interstitial thermal therapy (LITT) is a minimally invasive treatment modality with recent increasing use to ablate brain tumors,0
2013,27,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Further study is needed to assess the role of laser-induced thermal therapy for the treatment of intracranial tumors,0
2013,28,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"OBJECT: Laser interstitial thermal therapy has been used as an ablative treatment for glioma; however, its development was limited due to technical issues.",0
2013,29,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"Three had Grade 3 adverse events at the highest dose.CONCLUSIONS: NeuroBlate represents new technology for delivering laser interstitial thermal therapy, allowing controlled thermal ablation of deep hemispheric rGBM.",0
2013,30,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study.,1
2013,31,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Stereotactic Laser Interstitial Thermal Therapy for Recurrent High-Grade Gliomas.,0
2013,32,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"MRI-guided laser interstitial thermal therapy for the treatment of low-grade gliomas in children: a case-series review, description of the current technologies and perspectives.",0
2013,33,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"MRI-guided laser interstitial thermal therapy is currently used as a minimally invasive treatment for brain metastases, radiation necrosis, glioma, and epilepsy.",0
2013,34,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,"NeuroBlate represents new technology for delivering laser interstitial thermal therapy, allowing controlled thermal ablation of deep hemispheric rGBM.",0
2013,35,What is the role of Laser Interstitial Thermal Therapy in glioma treatment?,Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors.,0
2562,0,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a potentially fatal complication of measles.,1
2562,1,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a fatal complication of measles.,1
2562,2,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,We reviewed California cases from 1998-2015 to understand risk f,0
2562,3,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis should be eliminated by measles vaccination,0
2562,4,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,The mean interval between measles infection and onset of subacute sclerosing panencephalitis was 6.5 years (range = 3-11 years).,0
2562,5,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Active surveillance of subacute sclerosing panencephalitis for those with measles infection during the 1988 outbreak is necessary to conduct multicenter drug trials for this devastating disease.<br>,0
2562,6,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,There has been an increasing trend of subacute sclerosing panencephalitis in southern China after the measles outbreak in 1988.,0
2562,7,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,The prevalence rate of subacute sclerosing panencephalitis in Hong Kong and Macau in 2002 was 1 per million total population or 5.5 per million children.,0
2562,8,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Because a positive correlation was found between the prevalence of measles and the onset of subacute sclerosing panencephalitis, particularly among children infected at an early age, it is vital to eradicate measles infection by vaccination.<br>",0
2562,9,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.,0
2562,10,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"UNLABELLED Subacute sclerosing panencephalitis (SSPE), in the majority of cases, is caused by the wild measles virus, although there are some reports relating SSPE to vaccination.",0
2562,11,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a progressive neurodegenerative disease caused by the measles (rubeola) virus and is most often seen in children.,0
2562,12,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,There was no indication that measles vaccine can induce SSPE.,0
2562,13,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Subacute Sclerosing Panencephalitis (SSPE), a rare lethal disease of children and young adults due to persistence of measles virus (MeV) in the brain, is caused by wild type (wt) MeV.",0
2562,14,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder of childhood and early adolescence caused by persistent defective measles virus.,0
2562,15,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a devastating disease of the central nervous system (CNS) caused by persistent mutant measles virus infection.,0
2562,16,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Subacute sclerosing panencephalitis (SSPE) caused by persistent defective measles virus strains, is a progressive neurological disorder of children and adolescents.",0
2562,17,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Subacute sclerosing panencephalitis (SSPE), in the majority of cases, is caused by the wild measles virus, although there are some reports relating SSPE to vaccination.",0
2562,18,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Measles can persist in the central nervous system and cause subacute sclerosing panencephalitis (SSPE), a progressive disease that is almost always fatal.",0
2562,19,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"However, because of the median 8-year interval between measles and onset of SSPE,",0
2562,20,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"The prevention of endemic circulation of measles virus in England and Wales through the high coverage achieved with MMR vaccine, together with the measles/rubella vaccination campaign of 1994, has resulted in the near elimination of SSPE.",0
2562,21,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,We applied the polymerase chain reaction (PCR) to detect the measles virus genome in specimens from a 12-year-old boy with SSPE who had received measles vaccine 10 years before and had no history of apparent natural measles.,0
2562,22,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,The oligonucleotide primers for PCR were prepared based on the nucleotide sequence of the F and NP genes of the measles virus Edmonston strain.RESULTS: F and NP genes were detected in both the cerebrospinal fluid and peripheral blood lymphocytes.,0
2562,23,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Nucleotide and deduced amino acid sequence analysis of the F gene showed that the patient's virus was different from that of the vaccine strain.,0
2562,24,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Judging from these results, it was likely that the SSPE-associated strain in this case was derived from the wild-type rather than the vaccine strain",0
2562,25,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"subacute sclerosing panencephalitis (SSPE) is a late, rare and usually fatal complication of measles infection.",1
2562,26,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a chronic central nervous (CNS) system infection caused by measles virus,0
2562,27,Is subacute sclerosing panencephalitis caused by the Measles vaccine?, Epidemiological and virological data suggest that measles vaccine does not cause SSPE.,0
2562,28,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Subacute sclerosing panencephalitis, a rare, progressive, fatal central nervous system disease of children, is caused by measles virus.",0
2562,29,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis is a form of chronic persistent measles encephalitis in childhood which rarely manifests after wild virus infection.,0
2562,30,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis is a fatal infectious disease of childhood caused by persistence of the measles virus in the brain.,0
2562,31,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a fatal encephalitis manifesting a number of years after a primary measles infection.,1
2562,32,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute sclerosing panencephalitis (SSPE) is a fatal complication of measles infection.,1
2562,33,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"In 2015, the Oregon Health Authority was notified of the death of a boy with subacute sclerosing panencephalitis (SSPE), a rare and fatal complication of measles.",0
2562,34,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,"Subacute sclerosing panencephalitis (SSPE) is a rare progressive neurological disorder of early adolescence caused by persistent infection of the measles virus, which remains prevalent worldwide despite an effective vaccine.",0
2562,35,Is subacute sclerosing panencephalitis caused by the Measles vaccine?,Subacute Sclerosing Panencephalitis (SSPE) is a debilitating disorder associated with the measles infection in childhood.,0
3626,0,Which disease can be classified using the Koos Classification?,INTRODUCTION: Grade IV vestibular schwannoma (Koos classification) is generally considered to be an indication for microsurgical resection or combined radiosurgery-microsurgery.,0
3626,1,Which disease can be classified using the Koos Classification?,METHODS: The study included a total of 142 patients with VS stage 1 or 2 according to the Koos classification and treated between January 2004 and December 2015.,0
3626,2,Which disease can be classified using the Koos Classification?,Koos Classification of Vestibular Schwannomas: A Reliability Study.,1
3626,3,Which disease can be classified using the Koos Classification?,BACKGROUND: The Koos classification of vestibular schwannomas is designed to stratify tumors based on extrameatal extension and compression of the brainstem.,1
3626,4,Which disease can be classified using the Koos Classification?,CONCLUSION: We have demonstrated that the Koos classification system for vestibular schwannoma is a reliable method for tumor classification.,1
3626,5,Which disease can be classified using the Koos Classification?,PATIENTS: Eighteen patients who underwent a middle fossa craniotomy for vestibular schwannoma (stage I or II of Koos classification) with attempted hearing preservation from January 2008 to February 2016 were retrospectively reviewed.,0
3626,6,Which disease can be classified using the Koos Classification?,"BACKGROUND

The Koos classification of vestibular schwannomas is designed to stratify tumors based on extrameatal extension and compression of the brainstem.",0
3626,7,Which disease can be classified using the Koos Classification?,"CONCLUSION

We have demonstrated that the Koos classification system for vestibular schwannoma is a reliable method for tumor classification.",0
3626,8,Which disease can be classified using the Koos Classification?,CONCLUSION We have demonstrated that the Koos classification system for vestibular schwannoma is a reliable method for tumor classification.,1
3626,9,Which disease can be classified using the Koos Classification?,Grade IV vestibular schwannoma ( Koos classification ) is generally considered to be an indication for microsurgical resection or combined radiosurgery-microsurgery .,0
3626,10,Which disease can be classified using the Koos Classification?,"CONCLUSION
We have demonstrated that the Koos classification system for vestibular schwannoma is a reliable method for tumor classification.",0
3626,11,Which disease can be classified using the Koos Classification?,"BACKGROUND
The Koos classification of vestibular schwannomas is designed to stratify tumors based on extrameatal extension and compression of the brainstem.",0
3626,12,Which disease can be classified using the Koos Classification?,CONCLUSION: We have demonstrated that the Koos classification system for vestibular schwannoma is a reliable method for tumor classification.,1
485,0,What is the gene mutated in the Gaucher disease?,"The glucocerebrosidase gene (GBA), located in a gene-rich region on chromosome 1q 21, is mutated in Gaucher disease",1
485,1,What is the gene mutated in the Gaucher disease?,(GD) is the most common of the lysosomal storage disorders and is caused by defects in the GBA gene encoding glucocerebrosidase,0
485,2,What is the gene mutated in the Gaucher disease?,(GD) results from a deficiency of the lysosomal enzyme glucocerebrosidase,0
485,3,What is the gene mutated in the Gaucher disease?,Gaucher disease is caused by defective glucocerebrosidase activity,0
485,4,What is the gene mutated in the Gaucher disease?,"Gaucher disease (GD), the inherited deficiency of glucocerebrosidase",0
485,5,What is the gene mutated in the Gaucher disease?,utations in the glucocerebrosidase (GBA) gene cause Gaucher disease (GD),1
485,6,What is the gene mutated in the Gaucher disease?,mutations in glucocerebrosidase (GBA) gene,1
485,7,What is the gene mutated in the Gaucher disease?,GD) is a disorder of glycosphinglipid metabolism caused by deficiency of lysosomal acid beta-glucosidase,0
485,8,What is the gene mutated in the Gaucher disease?,Gaucher disease (GD) is a heterogeneous disease characterized by an impaired activity of the lysosomal glucocerebrosidase.,0
485,9,What is the gene mutated in the Gaucher disease?,Mutations in GBA may lead to Gaucher disease,0
485,10,What is the gene mutated in the Gaucher disease?,Gaucher's disease (GD) is an autosomal recessive disease produced by mutations of the Glucocerebrosidase gene,0
485,11,What is the gene mutated in the Gaucher disease?,"aucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase",0
485,12,What is the gene mutated in the Gaucher disease?,mutations in the glucocerebrosidase gene,1
485,13,What is the gene mutated in the Gaucher disease?,type I Gaucher disease,0
485,14,What is the gene mutated in the Gaucher disease?,complete deletion of the beta-glucocerebrosidase gene was investigated in 25 unrelated non-Jewish patients with Gaucher's disease,0
485,15,What is the gene mutated in the Gaucher disease?,aucher disease is a heterogeneous disease characterized by impaired activity of the lysosomal enzyme glucocerebrosidase,0
485,16,What is the gene mutated in the Gaucher disease?,"aucher disease, resulting from the decreased activity of the lysosomal enzyme glucocerebrosidase",0
485,17,What is the gene mutated in the Gaucher disease?,screening of the glucocerebrosidase gene by SSCP analysis revealed an abnormal pattern of exon 10 in two unrelated Italian Gaucher patients,0
485,18,What is the gene mutated in the Gaucher disease?,GD) is an inherited deficiency of beta-glucocerebrosidase,0
485,19,What is the gene mutated in the Gaucher disease?,Gaucher disease is type 1.,0
485,20,What is the gene mutated in the Gaucher disease?,The N370S glucocerebrosidase gene mutation accounts for 63% of mutated alleles,1
485,21,What is the gene mutated in the Gaucher disease?,mutated glucocerebrosidase alleles of Portuguese type 1 Gaucher patients,0
485,22,What is the gene mutated in the Gaucher disease?,mutated alleles known to occur in the glucocerebrosidase gene was determined in 247 Gaucher patients,0
485,23,What is the gene mutated in the Gaucher disease?,"Gaucher disease has marked phenotypic variation and molecular heterogeneity, and several simple and complex alleles of the acid beta-glucosidase gene",0
485,24,What is the gene mutated in the Gaucher disease?,Gaucher disease in 3 successive generations were tested for the presence of the 2 common mutations known to occur in the glucocerebrosidase gene,0
485,25,What is the gene mutated in the Gaucher disease?,"Gaucher disease has marked phenotypic variation and molecular heterogeneity, and seven point mutations in the acid beta-glucosidase (beta-Glc) gene",0
485,26,What is the gene mutated in the Gaucher disease?,cDNA clones containing the entire coding sequence of human glucocerebrosidase were isolated from libraries originated from Gaucher patients,0
3143,0,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?",The deletion of chromosome 22q11.2 is involved in the majority of DiGeorge or velo-cardiofacial syndrome.,1
3143,1,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","deletions of chromosome 7q11.23 (Williams syndrome), 15q11-q13 (Angelman syndrome, Prader-Willi syndrome) and 22q11 (Di George syndrome)",0
3143,2,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","Submicroscopic deletions of chromosome 22q11 have been reported in a multiple anomaly syndrome variously labelled as velocardiofacial syndrome, conotruncal anomaly face syndrome, and Di George syndrome",1
3143,3,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?",The 22q11.2 deletion syndrome (di George syndrome) is one of the most prevalent genetic disorders.,1
3143,4,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","UNLABELLED
Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within chromosome 22q11.",0
3143,5,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","Submicroscopic deletions of chromosome 22q11 have been reported in a multiple anomaly syndrome variously labelled as velocardiofacial syndrome, conotruncal anomaly face syndrome, and Di George syndrome.",1
3143,6,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","22q11.2DS has several presentations including Di George's syndrome, velo-cardio-facial syndrome or Shprintzen's syndrome and it is the most frequent microdeletion syndrome in the general population (prevalence estimated at 1/4000 births, de novo: 90%).",0
3143,7,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","Di George syndrome due to mutation on 22q or 10q) and can also result from microdeletion or point mutation (in the Shprintzen syndrome 70% represent microdeletion and 30% point mutation at 22q11, in Rubinstein-Taybi syndrome 10% cases result from microdeletions and 90% from point mutations); 7) Population incidence of microdeletions is high (1:4000 to 1:30,000) because their etiologic mechanism is related to the common unequal crossing over; 8) Imprinting plays a role in some cases, e.g.",0
3143,8,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","[Microdeletion of the chromosome 22q11 in children: apropos of a series of 49 patients].<AbstractText Label=""UNLABELLED"">Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within chromosome 22q11.",1
3143,9,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?","22q11.2DS has several presentations including Di George's syndrome, velo-cardio-facial syndrome or Shprintzen's syndrome and it is the most frequent microdeletion syndrome in the general population (prevalence estimated at 1/4000 births, de novo: 90%).",0
3143,10,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?",<b>UNLABELLED</b>: Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within chromosome 22q11.,0
3143,11,"Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?",Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within chromosome 22q11.,0
2564,0,What is maternal spindle transfer?,"In October 2015 the UK enacted legislation to permit the clinical use of two cutting edge germline-altering, IVF-based embryonic techniques: pronuclear transfer and maternal spindle transfer (PNT and MST).",1
2564,1,What is maternal spindle transfer?,The aim is to use these techniques to prevent the maternal transmission of serious mitochondrial diseases.,1
550,0,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,An integrated model describing the interaction of nondepolarizing neuromuscular blocking agents with reversible anticholinesterase agents is derived and compared with a naive model using experimental data obtained from four anesthetized dogs.,0
550,1,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,"Three consecutive but separate steady-state d-tubocurarine blocks (approximately 50, 70, and 90%) were induced in each of the four dogs and reversed by short edrophonium infusions.",0
550,2,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,The ability of hexamethonium (C6) to reverse the neuromuscular blocking action of tubocurarine (Tc),1
550,3,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,Volatile anesthetics enhance the neuromuscular blockade produced by nondepolarizing muscle relaxants (NDMRs).,0
550,4,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,The neuromuscular junction is a postulated site of this interaction.,0
550,5,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,We tested the hypothesis that volatile anesthetic enhancement of muscle relaxation is the result of combined drug effects on the nicotinic acetylcholine receptor.,0
550,6,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,"Concentration-effect curves for the inhibition of acetylcholine-induced currents were established for vecuronium, d-tubocurarine, isoflurane, and sevoflurane.",1
550,7,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,"Subsequently, inhibitory effects of NDMRs were studied in the presence of the volatile anesthetics at a concentration equivalent to half the concentration producing a 50% inhibition alone.",0
550,8,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,All individually tested compounds produced rapid and readily reversible concentration-dependent inhibition.,0
550,9,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,The pharmacological diversity of the different isoforms of the nicotinic acetylcholine receptor arises from the diversity of the subunits that assemble to form the native receptors.,0
550,10,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,"The aim of this study was to investigate the actions of the muscle relaxants d-tubocurarine, pancuronium and vecuronium on different isoforms of nicotinic acetylcholine receptors",1
550,11,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,"At all three receptor types, d-tubocurarine and pancuronium blocked the responses elicited by acetylcholine in a reversible manner.",0
550,12,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,"As further evidence of anticholinesterase activity, methamidophos (1-100 microM) was able to reverse the blockade by d-tubocurarine",0
550,13,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,There was an initial partial reversal of the neuromuscular inhibition caused by tubocurarine,0
550,14,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,Isoflurane and sevoflurane enhance the receptor blocking effects of nondepolarizing muscle relaxants on nicotinic acetylcholine receptors.,1
550,15,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,"Because other purinergic 2X (P2X) receptor antagonists, NF023 and NF279, do not have the reverse effects on the neuromuscular blockade of d-TC, the effect of NF449 seems irrelevant to inhibition of P2X receptors.",0
550,16,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,The association rate constant for Tc binding to sites on the nicotinic acetylcholine receptor appears to be very fast (k+D = 8.9 x 10(8) M-1 s-1) and comparable to that for acetylcholine (ACh).,0
550,17,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,The aim of this study was to investigate the mechanism for the reversal effect of NF449 (a suramin analogue) on the neuromuscular block induced by d-tubocurarine (d-TC).,1
550,18,Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?,Study of the reversal effect of NF449 on neuromuscular blockade induced by d-tubocurarine.,0
3309,0,Is induction of interferon by TLR7 higher in males?,ur results suggest that variations of TLR7 impair the immune response to HCV and imply a gender-specific effect of this X-chromosomal variation.,1
3309,1,Is induction of interferon by TLR7 higher in males?,The c.32A>T variation was over-represented in female patients with chronic HCV-infection compared to patients with other chronic liver diseases and to healthy controls (P < 0.05).,1
3309,2,Is induction of interferon by TLR7 higher in males?,"In contrast, c.2403 G>A was less prevalent in male patients with chronic HCV-infection (P < 0.05).",1
3309,3,Is induction of interferon by TLR7 higher in males?,"No association was observed for the third variant, c.1-120T>G.",0
3309,4,Is induction of interferon by TLR7 higher in males?,Haplotype analysis confirmed the differential distribution of TLR7 variants between the groups.,1
3309,5,Is induction of interferon by TLR7 higher in males?,"Within the group of female patients with chronic HCV-infection, c.32T was predictive of an unfavourable outcome of interferon-alpha therapy (P < 0.05)",1
61,0,Is c-met involved in the activation of the Akt pathway?,Amplification of MET has been reported in approximately 5%-22% of lung tumors with acquired resistance to small-molecule inhibitors of the epidermal growth factor receptor (EGFR).,0
61,1,Is c-met involved in the activation of the Akt pathway?,Resistance to EGFR inhibitors is likely mediated through downstream activation of the phosphoinositide 3-kinase /AKT pathway.,0
61,2,Is c-met involved in the activation of the Akt pathway?,"Simultaneous treatment of resistant tumors with a MET inhibitor plus an EGFR inhibitor can abrogate activation of downstream effectors of cell growth, proliferation, and survival, thereby overcoming acquired resistance to EGFR inhibitors.",0
61,3,Is c-met involved in the activation of the Akt pathway?,HGF mediated both ERK and Akt phosphorylation.,0
61,4,Is c-met involved in the activation of the Akt pathway?,"ERK/Akt signaling, but not the Smad pathway, may be one of the main processes in HGF-induced EMT,",0
61,5,Is c-met involved in the activation of the Akt pathway?,The MAPK/Akt pathway is indispensable in HGF/c-Met signaling.,0
61,6,Is c-met involved in the activation of the Akt pathway?,Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling,0
61,7,Is c-met involved in the activation of the Akt pathway?,"Specifically, we demonstrated that inhibition of c-Met activity led to suppression of the PI3K-Akt pathway, thus enhancing cisplatin chemosensitivity.",0
61,8,Is c-met involved in the activation of the Akt pathway?,Our study clearly suggests that inhibition of c-Met activity can effectively sensitize osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling.,0
61,9,Is c-met involved in the activation of the Akt pathway?,"We found that a dual Met/VEGF receptor 2 kinase inhibitor, E7050, circumvented HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer cell lines by inhibiting the Met/Gab1/PI3K/Akt pathway in vitro.",0
61,10,Is c-met involved in the activation of the Akt pathway?,"Here, we report that i) treatment of RL95-2 cells with HGF resulted in phosphorylation of the HGF receptor c-Met, activation of Akt and IκB, translocation of NF-κB into the nucleus, and up-regulation of COX-2 mRNA;",1
61,11,Is c-met involved in the activation of the Akt pathway?,"Our data suggest that HGF possesses chemotactic ability, has anti-apoptosis action, and induces cellular infiltration via the PI3K/Akt pathway;",0
61,12,Is c-met involved in the activation of the Akt pathway?,Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IκB kinase activity,1
61,13,Is c-met involved in the activation of the Akt pathway?,"Activation of c-Src in turn establishes a complex consisting of phosphatidylinositol 3-kinase and c-MET, and promotes downstream activation of the phosphatidylinositol 3-kinase/AKT pathway and mammalian target of rapamycin.",1
61,14,Is c-met involved in the activation of the Akt pathway?,"Notably, hepatocyte growth factor-stimulated c-Src activation results in induction of phosphatidylinositol 3-kinase complexes p85α/p110α and p85α/p110δ, which is required for activation of mammalian target of rapamycin, and consequent inhibition of IκB kinase and nuclear factor-κB activation.",1
61,15,Is c-met involved in the activation of the Akt pathway?,"Our findings, for the first time, have identified the c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway that plays a pivotal role in mediating the inhibitory effects of hepatocyte growth factor on dendritic cell activation by blocking nuclear factor-κB signaling.",1
61,16,Is c-met involved in the activation of the Akt pathway?,Cyr61 siRNA inhibited a second phase of Akt phosphorylation measured 12 hours after cell stimulation with HGF and also inhibited HGF-induced phosphorylation of the Akt target glycogen synthase kinase 3alpha.,0
61,17,Is c-met involved in the activation of the Akt pathway?,HGF+EGF treatment increased the duration of ERK1/2 and AKT activation compared to HGF or EGF alone.,0
61,18,Is c-met involved in the activation of the Akt pathway?,All these data indicate that a crosstalk between the EGF and HGF pathways in mammary epithelial cells may modulate the development of the mammary gland.,0
61,19,Is c-met involved in the activation of the Akt pathway?,Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway,0
61,20,Is c-met involved in the activation of the Akt pathway?,"Consistent with these results, HGF activated Akt, which phosphorylates glycogen synthase kinase-3beta (GSK-3beta) to inactivate it, and reduced phosphorylation of microtubule-associated protein 2 (MAP2), which can promote microtubule polymerization and dendrite elongation when dephosphorylated.",0
61,21,Is c-met involved in the activation of the Akt pathway?,"Conversely, pharmacological inhibition of c-Met with its specific inhibitor, PHA-665752, or genetic knock-down of c-Met with short hairpin RNAs (shRNAs) suppressed HGF-induced phosphorylation of Akt and GSK-3beta, increased phosphorylation of MAP2, and reduced dendrite number and length in cultured hippocampal neurons.",0
61,22,Is c-met involved in the activation of the Akt pathway?,"Inhibiting Akt activity with the phosphoinositide-3-kinase inhibitor LY294002 or Akt inhibitor X suppressed HGF-induced phosphorylation of GSK-3beta, increased MAP2 phosphorylation, and blocked the ability of HGF to enhance dendritic length.",0
61,23,Is c-met involved in the activation of the Akt pathway?,These observations indicate that HGF and c-Met can regulate the early stages of dendrite maturation via activation of the Akt/GSK-3beta pathway.,0
61,24,Is c-met involved in the activation of the Akt pathway?,Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells,0
61,25,Is c-met involved in the activation of the Akt pathway?,"HGF was found to enhance cell migration, and that HGF-induced migration depends on PI3K/Akt pathway.",0
61,26,Is c-met involved in the activation of the Akt pathway?,"The activation of PI3K/Akt pathway induced by the HGF/c-Met axis is involved in the downregulation of cell adhesion molecules E-cadherin and beta-catenin, contributing to the attenuation of cell-cell adhesion and promoting the enhanced motility and migration of uveal melanoma cells.",0
61,27,Is c-met involved in the activation of the Akt pathway?,HGF protects cultured cortical neurons against hypoxia/reoxygenation induced cell injury via ERK1/2 and PI-3K/Akt pathways,0
61,28,Is c-met involved in the activation of the Akt pathway?,HGF stimulated both ERK1/2 and Akt activities in cortical neurons.,0
61,29,Is c-met involved in the activation of the Akt pathway?,"Inhibition of ERK activation completely abolished the protective effects of HGF, and inhibition of Akt activation reduced, but did not completely eliminate the HGF mediated neuroprotection.",0
61,30,Is c-met involved in the activation of the Akt pathway?,"It is suggested that the neuroprotection of HGF depend on ERK1/2 pathway, and, to a lesser extent, PI-3K/Akt pathway.",0
61,31,Is c-met involved in the activation of the Akt pathway?,Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner,0
61,32,Is c-met involved in the activation of the Akt pathway?,"Thus, Met acting on PI3K and Akt ensures high levels of FLIPL, and disruption of this pathway contributes to hepatic apoptosis and possibly to Fas-related liver diseases.",0
61,33,Is c-met involved in the activation of the Akt pathway?,"The HGF-induced increase in Nkx 2.5 expression was inhibited by co-treatment with the PI3 kinase inhibitors Wortmannin and LY294002, but not by its inactive homolog LY303511, suggesting an involvement of the PI3 kinase/Akt pathway in this effect.",0
61,34,Is c-met involved in the activation of the Akt pathway?,X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling,0
61,35,Is c-met involved in the activation of the Akt pathway?,Activation of XIAP expression by HGF was inhibited by siRNA targeting Akt1 and Akt2.,0
61,36,Is c-met involved in the activation of the Akt pathway?,Activation of C-MET enhances XIAP through the Akt pathway.,0
61,37,Is c-met involved in the activation of the Akt pathway?,Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis,0
61,38,Is c-met involved in the activation of the Akt pathway?,"A significant reduction in apoptosis in the HGF-treated hearts was observed compared with control hearts, and was strongly associated with increased Akt activation.",0
61,39,Is c-met involved in the activation of the Akt pathway?,The antiapoptotic effect of HGF was mediated by activation of PI3-kinase/Akt pathway.,0
61,40,Is c-met involved in the activation of the Akt pathway?,"The protective effect of HGF/SF against the ADR-induced apoptosis was abolished in the presence of either LY294002, an inhibitor of phosphatidylinositol-3'-OH kinase (PI3-K) or 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate, an inhibitor of Akt, thus implicating the activation of PI3-K-Akt signaling in the antiapoptotic action of HGF/SF.",0
61,41,Is c-met involved in the activation of the Akt pathway?,Immunoblotting analysis revealed that HGF/SF stimulated the sustained phosphorylation of Akt for several hours,0
61,42,Is c-met involved in the activation of the Akt pathway?,"Furthermore, ADR-induced activation of caspase-9, a downstream molecule of Akt, was inhibited for at least 24 h after HGF/SF stimulation,",0
61,43,Is c-met involved in the activation of the Akt pathway?,"These results indicate that HGF/SF, but not EGF, transmitted protective signals against ADR-induced apoptosis by causing sustained activation of the PI3-K-Akt signaling pathway.",0
61,44,Is c-met involved in the activation of the Akt pathway?,Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway,0
61,45,Is c-met involved in the activation of the Akt pathway?,"When we analyzed the signaling pathways initiated by the HGF/SF receptor c-met, we found that the phosphatidylinositol (PI) 3-kinase and its downstream-element AKT and the mitogen-activated protein (MAP) kinase were activated.",0
61,46,Is c-met involved in the activation of the Akt pathway?,"Inhibition of PI 3-kinase led to a complete abrogation of the anti-apoptotic effect of HGF/SF, whereas blockade of the MAP kinase pathway had no effect.",0
61,47,Is c-met involved in the activation of the Akt pathway?,We now show in detached cells a cooperative effect of HGF and FN in the activation of PI 3-kinase and on the phosphorylation of PKB/Akt at serine 473.,0
61,48,Is c-met involved in the activation of the Akt pathway?,"PI 3-kinase activity is also required for the HGF- and fibronectin-induced survival responses, as well as anchorage-independent colony growth.",0
61,49,Is c-met involved in the activation of the Akt pathway?,"Together, these results demonstrate that the PI 3-kinase/Akt pathway is a key effector of the HGF- and fibronectin-induced survival response of breast carcinoma cells under detached conditions and corroborate an interaction between integrin and HGF/ Met signalling pathways in the development of invasive breast cancer.",0
122,0,Which viruses are best known to cause myocarditis?,"Enteroviruses (EV) are an important cause of neonatal disease including hepatitis, meningoencephalitis, and myocarditis that can lead to death or severe long-term sequelae",1
122,1,Which viruses are best known to cause myocarditis?,Enteroviruses have been considered to be the most common cause of acute myocarditis and possible consequence of dilated cardiomyopathy.,1
122,2,Which viruses are best known to cause myocarditis?,n our study the adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.,1
122,3,Which viruses are best known to cause myocarditis?,Coxsackie B viruses (types 1 to 5) are the most frequent reported cause of acute viral myocarditis.,1
2912,0,Which disease can be classified with the Awaji Criteria?,"Adoption of the Awaji criteria significantly increased the yield of EMG-positive segments in the cervical (P < 0.0005) and lumbosacral (P < 0.0001) regions, and upgraded 19 patients into the probable category and 1 patient into the definite category.",0
2912,1,Which disease can be classified with the Awaji Criteria?,The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population.,1
2912,2,Which disease can be classified with the Awaji Criteria?,"However, previous studies that have assessed the diagnostic sensitivities of the Awaji criteria (AC) and the revised El Escorial criteria (rEEC) in patients with ALS have been inconsistent, most of them were consensual regarding the advantage of Awaji over conventional criteria.",0
2912,3,Which disease can be classified with the Awaji Criteria?,Our study sought to compare the roles of AC and rEEC in the diagnosis of ALS.,0
2912,4,Which disease can be classified with the Awaji Criteria?,CONCLUSIONS: Our data demonstrated that the AC exhibited greater diagnostic sensitivity than the rEEC in a Chinese ALS population.,0
2912,5,Which disease can be classified with the Awaji Criteria?,"OBJECTIVE: To assess the added prognostic value of the aggregated clinical and electrodiagnostic data, which define a given diagnostic category according to the Awaji or revised El Escorial criteria at time of diagnosis in patients with amyotrophic lateral sclerosis (ALS).",0
2912,6,Which disease can be classified with the Awaji Criteria?,"Diagnostic category according to Awaji (p < 0.0001) or to revised El Escorial (p = 0.0177) criteria, definite ALS according to Awaji (p < 0.0001) or to revised El Escorial (p = 0.0343) and number of regions with LMN involvement (p < 0.0001) were all associated with shorter survival.",0
2912,7,Which disease can be classified with the Awaji Criteria?,Methods: This is a cross-sectional and descriptive study including a consecutive series of patients with sporadic amyotrophic lateral sclerosis according to Awaji's criteria.,1
2912,8,Which disease can be classified with the Awaji Criteria?,The importance of fasciculation potentials in the diagnosis of ALS led to changes in electrophysiological criteria at Awaji consensus conference.,0
2912,9,Which disease can be classified with the Awaji Criteria?,"Application of Awaji criteria led to a 23% (95% CI, 12% to 33%; I2=84%) increase in the proportion of patients classified as having probable/definite ALS.",0
2912,10,Which disease can be classified with the Awaji Criteria?,"OBJECTIVE
To estimate the potential diagnostic added value of the Awaji criteria for diagnosis of a myotrophiclateral sclerosis (ALS), which have been compared with the previously accepted gold standard the revised El Escorial criteria in several studies.",0
2912,11,Which disease can be classified with the Awaji Criteria?,"STUDY SELECTION
We searched for studies testing the diagnostic accuracy of the Awaji criteria vs the revised El Escorial criteria in patients referred with suspected ALS.",0
2912,12,Which disease can be classified with the Awaji Criteria?,"CONCLUSION
The Awaji criteria have a significant clinical impact allowing earlier diagnosis and clinical trial entry in ALS.",0
2912,13,Which disease can be classified with the Awaji Criteria?,"In 2006, the Awaji criteria for the diagnosis of ALS were proposed, adding two major points to the diagnostic criteria: electromyography is considered equivalent to clinical examination for the identification of LMN signs and fasciculation potentials resume their prominent place in the diagnosis.",0
2912,14,Which disease can be classified with the Awaji Criteria?,"CLASSIFICATION OF EVIDENCE
This study provides Class IV evidence that the Awaji criteria have a higher sensitivity and the same specificity as the rEEC in identifying patients with ALS.",0
2912,15,Which disease can be classified with the Awaji Criteria?,"OBJECTIVE To estimate the potential diagnostic added value of the Awaji criteria for diagnosis of a myotrophiclateral sclerosis (ALS), which have been compared with the previously accepted gold standard the revised El Escorial criteria in several studies.",0
2912,16,Which disease can be classified with the Awaji Criteria?,CLASSIFICATION OF EVIDENCE This study provides Class IV evidence that the Awaji criteria have a higher sensitivity and the same specificity as the rEEC in identifying patients with ALS.,0
2912,17,Which disease can be classified with the Awaji Criteria?,OBJECTIVE To assess the sensitivity and specificity of the Awaji and revised El Escorial diagnostic criteria (rEEC) in amyotrophic lateral sclerosis (ALS).,1
2912,18,Which disease can be classified with the Awaji Criteria?,The Awaji Commission recently proposed a modification of the electrodiagnostic criteria for ALS.,1
2912,19,Which disease can be classified with the Awaji Criteria?,"INTRODUCTION Recently, some authors have claimed that the Awaji criteria (AC) are not always more sensitive than the revised El Escorial criteria (rEEC) in amyotrophic lateral sclerosis (ALS).",1
2912,20,Which disease can be classified with the Awaji Criteria?,The updated Awaji criteria enhanced the diagnostic sensitivity in limb-onset ALS.,0
2912,21,Which disease can be classified with the Awaji Criteria?,"BACKGROUND Recently, new electrophysiological ALS criteria incorporating fasciculation potentials (FPs) as evidence for lower motor neuron signs (Awaji Criteria (AC)) was proposed to provide earlier detection of early-stage ALS than revised El Escorial electrophysiological criteria (REEC).",0
2912,22,Which disease can be classified with the Awaji Criteria?,"The Awaji criteria, recently introduced to increase diagnosis sensitivity in amyotrophic lateral sclerosis (ALS), equate the diagnostic significance of neurogenic electrophysiological changes to clinical signs of lower motor neuron dysfunction.",0
2912,23,Which disease can be classified with the Awaji Criteria?,"Participants had definite, probable, or possible ALS, as defined by the Awaji criteria; or pure motor disorder with clinical features of upper and lower motor neuron dysfunction in at least one body region, progressing over a 6 month follow-up period; or muscle wasting and weakness for at least 6 months.",0
2912,24,Which disease can be classified with the Awaji Criteria?,"New diagnostic criteria for ALS, the Awaji algorithm, reintroduced fasciculations as evidence of acute denervation equivalent to that of fibrillations and positive sharp waves.",0
2912,25,Which disease can be classified with the Awaji Criteria?,"Given that cortical hyperexcitability appears to be an early feature in ALS, the present study assessed the diagnostic utility of a threshold tracking transcranial magnetic stimulation technique as an aid to the research-based Awaji criteria in establishing an earlier diagnosis of ALS.",0
2912,26,Which disease can be classified with the Awaji Criteria?,"The specificity of the both criteria were identical, 99.5%, indicating the number needed to test in order to diagnose one extra case of ALS was 1.8 (1.5-2) for Awaji criteria and 2.4 (2-2.6) for rEEC.",0
2912,27,Which disease can be classified with the Awaji Criteria?,We assessed whether the Awaji recommendations improve the sensitivity of the early diagnosis of ALS.,0
2912,28,Which disease can be classified with the Awaji Criteria?,Our retrospective analysis of patients referred over a 6-month period to the electromyography (EMG) laboratory for suspected motor neuron disease (MND) showed a higher agreement of the Awaji modifications than the Airlie House criteria with the clinical diagnosis of ALS.,0
2912,29,Which disease can be classified with the Awaji Criteria?,"Participants had definite, probable, or possible ALS, as defined by the Awaji criteria; or pure motor disorder with clinical features of upper and lower motor neuron dysfunction in at least one body region, progressing over a 6 month follow-up period; or muscle wasting and weakness for at least 6 months.",0
2912,30,Which disease can be classified with the Awaji Criteria?,"Of the 14 patients diagnosed with probable laboratory-supported ALS, eight switched to probable ALS and six to possible ALS using the Awaji recommendations; none of the patients with an ALS mimic was diagnosed with ALS according to the Awaji recommendations.",0
2912,31,Which disease can be classified with the Awaji Criteria?,"<b>OBJECTIVE</b>: To estimate the potential diagnostic added value of the Awaji criteria for diagnosis of a myotrophiclateral sclerosis (ALS), which have been compared with the previously accepted gold standard the revised El Escorial criteria in several studies.<br><b>DATA SOURCES</b>: MEDLINE and Web of Science (until October2011).<br><b>STUDY SELECTION</b>: We searched for studies testing the diagnostic accuracy of the Awaji criteria vs the revised El Escorial criteria in patients referred with suspected ALS.<br><b>DATA EXTRACTION</b>: Evaluation and data extraction of identified studies were done independently.",0
2912,32,Which disease can be classified with the Awaji Criteria?,"Application of Awaji criteria led to a 23% (95% CI, 12% to 33%; I2=84%) increase in the proportion of patients classified as having probable/definite ALS.",0
2912,33,Which disease can be classified with the Awaji Criteria?,Diagnostic accuracy of Awaji criteria was higher in bulbar- than in limb-onset cases.<br><b>CONCLUSION</b>: The Awaji criteria have a significant clinical impact allowing earlier diagnosis and clinical trial entry in ALS.<br>,0
2912,34,Which disease can be classified with the Awaji Criteria?,We assessed whether the Awaji recommendations improve the sensitivity of the early diagnosis of ALS.,0
2912,35,Which disease can be classified with the Awaji Criteria?,"Using the El Escorial criteria, 51 patients were diagnosed with definite or probable ALS, 14 with probable laboratory-supported ALS, and 28 with possible ALS.",0
2912,36,Which disease can be classified with the Awaji Criteria?,"Applying the Awaji recommendations, 66 patients were diagnosed with either definite or probable ALS, and 27 with possible ALS.",0
2912,37,Which disease can be classified with the Awaji Criteria?,"Of the 14 patients diagnosed with probable laboratory-supported ALS, eight switched to probable ALS and six to possible ALS using the Awaji recommendations; none of the patients with an ALS mimic was diagnosed with ALS according to the Awaji recommendations.",0
756,0,Which is the E3 ubiquitin ligase of Hsp90?,C-terminal Hsp-interacting protein (CHIP) is an HSP70 and HSP90 interacting co-chaperone and an E3 ubiquitin ligase.,0
756,1,Which is the E3 ubiquitin ligase of Hsp90?,Previous studies have reported the role of CHIP in cancer progression by targeting protein degradation.,0
756,2,Which is the E3 ubiquitin ligase of Hsp90?,"The U-box E3 ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein) binds Hsp90 and/or Hsp70 via its tetratricopeptide repeat (TPR), facilitating ubiquitination of the chaperone-bound client proteins.",1
756,3,Which is the E3 ubiquitin ligase of Hsp90?,"In vitro ubiquitination assays indicated that Ca(2+)/S100A2 and S100P are efficient and specific inhibitors of CHIP-mediated ubiquitination of Hsp70, Hsp90, HSF1, and Smad1.",1
756,4,Which is the E3 ubiquitin ligase of Hsp90?,"The E3 ubiquitin ligase CHIP (C-terminus of Hsc70-interacting protein) is believed to be a central player in the cellular triage decision, as it links the molecular chaperones Hsp70/Hsc70 and Hsp90 to the ubiquitin proteasomal degradation pathway.",1
756,5,Which is the E3 ubiquitin ligase of Hsp90?,We found that CHIP has a sixfold higher affinity for Hsp90 compared with Hsc70.,0
756,6,Which is the E3 ubiquitin ligase of Hsp90?,Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90) in vitro,1
756,7,Which is the E3 ubiquitin ligase of Hsp90?,The analysis of the sucrose-gradient-fractionated in vitro translated AhR complexes revealed that CHIP can mediate hsp90 ubiquitination while cooperating with unidentified factors to promote the ubiquitination of mature unliganded AhR complexes.,1
1969,0,What are Kupffer cells and what is their role?,Kupffer cells (KCs) play a role in the development of drug induced liver injury (DILI).,1
1969,1,What are Kupffer cells and what is their role?,"Hepatic macrophages consist of Kupffer cells, which are originated from the fetal yolk-sack, and infiltrated bone marrow-derived monocytes/macrophages.",1
1969,2,What are Kupffer cells and what is their role?,Kupffer cells (KCs) are the main source of MMP.,1
1969,3,What are Kupffer cells and what is their role?,"liver, both Kupffer cells and recruited hepatic macrophages can contribute to decreased hepatic insulin sensitivity.",1
1969,4,What are Kupffer cells and what is their role?,Macrophages such as Kupffer cells in the liver are multifunctional cells.,0
1969,5,What are Kupffer cells and what is their role?,"Kupffer cells--the resident macrophages of the liver--are able to release a tremendous array of mediators upon inflammatory conditions, such as infection, and their role in innate immunity is well described in the literature.",0
1969,6,What are Kupffer cells and what is their role?,Kupffer cells are the tissue macrophages in the liver and play an important role in the defense mechanisms of the body,1
2385,0,"What is LHON, also known as Lebers syndrome?",Mitochondrial diseases are a clinically hetyerogenous group of disorders.,0
2385,1,"What is LHON, also known as Lebers syndrome?",They can be caused by mutations of nuclear or mitochondrial DNA (mtDNA).,0
2385,2,"What is LHON, also known as Lebers syndrome?","Some affect a single organ, but many involve multiple organ systems and often present with prominent neurologic and myopathic features.",0
2385,3,"What is LHON, also known as Lebers syndrome?","The eye is frequently affected, along with muscles and brain, but multisystem disease is common.",0
2385,4,"What is LHON, also known as Lebers syndrome?","Ophthalmic manifestations include cataract, retinopathy, optic atrophy, cortical visual loss, ptosis and ophthalmoplegia.",0
2385,5,"What is LHON, also known as Lebers syndrome?","Kearns-Sayre Syndrome (KSS), Mitochondrial Encephalopathy, Lactic Acidosis Stroke (MELAS), Myoclonic Epilepsy and Ragged Red Fiber myopathy (MERRF) and Lebers Hereditary Optic Neuropathy (LHON) are well known clinical entities that are secondary to mtDNA abnormalities, which has ophthalmic manifestations.",0
2385,6,"What is LHON, also known as Lebers syndrome?",Genetic counseling in Leber hereditary optic neuropathy (LHON).,0
2385,7,"What is LHON, also known as Lebers syndrome?",To demonstrate the importance of mitochondrial DNA (mtDNA) analysis in the diagnosis of Leber hereditary optic neuropathy (LHON) and illustrate the difficulties in genetic counseling of the disease.,0
2385,8,"What is LHON, also known as Lebers syndrome?","To discuss recent advances in potential treatments for Leber hereditary optic neuropathy (LHON), a typically visually devastating hereditary optic neuropathy caused by mutations in the mitochondrial genome.",0
2385,9,"What is LHON, also known as Lebers syndrome?","Kearns-Sayre Syndrome (KSS), Mitochondrial Encephalopathy, Lactic Acidosis Stroke (MELAS), Myoclonic Epilepsy and Ragged Red Fiber myopathy (MERRF) and Lebers Hereditary Optic Neuropathy (LHON) are well known clinical entities that are secondary to mtDNA abnormalities, which has ophthalmic manifestations.",0
2385,10,"What is LHON, also known as Lebers syndrome?","Leber's hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder with bilateral loss of central vision primarily due to mitochondrial DNA (mtDNA) mutations in subunits of complex I in the respiratory chain (primary LHON mutations), while other mtDNA mutations can also be causative.",0
2385,11,"What is LHON, also known as Lebers syndrome?",The phenotypic characteristics of the syndrome resemble those found in other mitochondrial (mt)DNA mediated disorders such as Leber's hereditary optic neuropathy (LHON) or maternally inherited diabetes and deafness (MIDD).,0
2385,12,"What is LHON, also known as Lebers syndrome?",BACKGROUND Leber's hereditary optic neuropathy (LHON) is a maternally inherited optic neuropathy caused by mutations in mitochondrial DNA (mtDNA).,1
2385,13,"What is LHON, also known as Lebers syndrome?",Leber's hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by bilateral acute or subacute progressive central visual loss.,1
2385,14,"What is LHON, also known as Lebers syndrome?","Leigh's syndrome (LS) is a fatal neurodegenerative disorder of infants, and Leber's hereditary optic neuropathy (LHON) causes blindness in young adults.",0
2385,15,"What is LHON, also known as Lebers syndrome?",BACKGROUND Leber's hereditary optic neuropathy (LHON) co-occuring with multiple sclerosis-like disease (LHON-MS) is suggested to be a separate disease entity denoted Harding's disease.,0
2385,16,"What is LHON, also known as Lebers syndrome?",To investigate the prevalence and spectrum of mitochondrial ND4 mutations in subjects with Leber's hereditary optic neuropathy (LHON,0
2385,17,"What is LHON, also known as Lebers syndrome?",Three mitochondrial mutations account for 95% of Leber's hereditary optic neuropathy (LHON) in,0
2385,18,"What is LHON, also known as Lebers syndrome?","Leber hereditary optic neuropathy (LHON) and mitochondrial encephalopathy, myopathy",0
2385,19,"What is LHON, also known as Lebers syndrome?",Leber's hereditary optic neuropathy (LHON) is a maternally transmitted disease.,1
2385,20,"What is LHON, also known as Lebers syndrome?",Leber hereditary optic neuropathy (LHON) is a mitochondrial disorder characterized by bilateral painless optic atrophy and blindness.,1
2385,21,"What is LHON, also known as Lebers syndrome?",Leber hereditary optic neuropathy (LHON) is an inherited form of bilateral optic atrophy leading to the loss of central vision.,1
2385,22,"What is LHON, also known as Lebers syndrome?","3 Leber's hereditary optic neuropathy (LHON),",0
2385,23,"What is LHON, also known as Lebers syndrome?", Leber's hereditary optic neuropathy (LHON),0
2385,24,"What is LHON, also known as Lebers syndrome?",LHON (Leber's Hereditary Optic Neuropathy),0
2385,25,"What is LHON, also known as Lebers syndrome?",eber's hereditary optic neuropathy (LHON),0
2385,26,"What is LHON, also known as Lebers syndrome?",Leber's hereditary optic neuropathy (LHON),0
2385,27,"What is LHON, also known as Lebers syndrome?",Leber's hereditary optic neuropathy (LHON),0
2385,28,"What is LHON, also known as Lebers syndrome?",Leber's hereditary optic neuropathy (LHON),0
2385,29,"What is LHON, also known as Lebers syndrome?",Lebers hereditary optic neuropathy (LHON),0
2385,30,"What is LHON, also known as Lebers syndrome?",Leber hereditary optic neuropathy (LHON),0
2385,31,"What is LHON, also known as Lebers syndrome?",Lebers hereditary optic neuropathy (LHON),0
2385,32,"What is LHON, also known as Lebers syndrome?",Leber hereditary optic neuropathy (LHON),0
2385,33,"What is LHON, also known as Lebers syndrome?", Leber hereditary optic neuropathy (LHON),0
2385,34,"What is LHON, also known as Lebers syndrome?",Leber hereditary optic neuropathy (LHON),0
2385,35,"What is LHON, also known as Lebers syndrome?",Leber hereditary optic neuropathy (LHON),0
124,0,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,DITPA normalized the elevated serum T(3) and TSH when the dose reached 1 mg/kg · d and T(4) and rT(3) increased to the lower normal range.,0
124,1,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,"The identification of 3,5-diiodothyropropionic acid (DITPA) that binds to both α- and β-type TRs with relatively low affinity was unique in that this analog improves left ventricular function in heart failure as well as lowers cholesterol.",1
124,2,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,Treatment with DITPA attenuates the acute inflammatory response and reduces myocardial infarct size.,0
124,3,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,Thus DITPA administration impairs baseline cardiac parameters in mice and can be fatal during in vivo acute myocardial I/R.,0
124,4,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,"DITPA improved some hemodynamic and metabolic parameters, but there was no evidence for symptomatic benefit in congestive heart failure",1
124,5,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,The results suggested that DITPA can promote a healthy vasculature independently from its thyroid-related metabolic effects.,1
124,6,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies," Moreover, DITPA and T(4) were efficacious in preventing effects of hypothyroidism on cardiac function and BVD",1
124,7,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,"Both T4 and DITPA had beneficial effects on chamber remodeling, which was most likely due to beneficial changes in cell shape and improved vascular supply.",0
124,8,Is DITPA a thyroid hormone analog utilized in experimental and clinical studies,The thyroid analog DITPA enhances endothelial nitric oxide and beta-adrenergic-mediated vasorelaxation by increasing nitric oxide in the vasculature.,1
323,0,What is the treatment of acute myocarditis?,ibuprofen 400 mg twice a day as therapy,0
323,1,What is the treatment of acute myocarditis?,"Acute fulminant myocarditis commonly manifests itself as severe, rapidly progressive hemodynamic deterioration and circulatory collapse that may be resistant to high doses of inotropic agents and steroids and to mechanical support by intra-aortic balloon pump",1
323,2,What is the treatment of acute myocarditis?,"the TandemHeart percutaneous ventricular assist device, can enable patients to recover in a few days.",1
323,3,What is the treatment of acute myocarditis?,"he authors report a typical case of fulminating myocarditis with electromechanical dissociation, which recovered completely after a period of circulatory assistance.",1
323,4,What is the treatment of acute myocarditis?,To clarify the effects of Astragalus Membranaceus (AM) combined with taurine and/or coenzyme Q10(CoQ10) on coxsackievirus B3 (CVB3) murine myocarditis,1
323,5,What is the treatment of acute myocarditis?,"AM, taurine and CoQ10 have some curative effects on CVB3 murine myocarditis, AM combined with taurine and CoQ10 is the best.",1
3642,0,Which is the effect of the HP1a protein on chromatin?,"Here we show that PIWI, an ARGONAUTE/PIWI protein family member that binds to Piwi-interacting RNAs (piRNAs), strongly and specifically interacts with heterochromatin protein 1a (HP1a), a central player in heterochromatic gene silencing.",0
3642,1,Which is the effect of the HP1a protein on chromatin?,Heterochromatin protein 1 (HP1a) positively regulates euchromatic gene expression through RNA transcript association and interaction with hnRNPs in Drosophila.,0
3642,2,Which is the effect of the HP1a protein on chromatin?,Heterochromatin Protein 1 (HP1a) is a well-known conserved protein involved in heterochromatin formation and gene silencing in different species including humans.,1
3642,3,Which is the effect of the HP1a protein on chromatin?,HP1a is associated with transcripts of more than one hundred euchromatic genes.,0
3642,4,Which is the effect of the HP1a protein on chromatin?,"Heterochromatin protein 1 (HP1) proteins, recognized readers of the heterochromatin mark methylation of histone H3 lysine 9 (H3K9me), are important regulators of heterochromatin-mediated gene silencing and chromosome structure.",1
3642,5,Which is the effect of the HP1a protein on chromatin?,heterochromatin protein 1a (HP1a).,0
3642,6,Which is the effect of the HP1a protein on chromatin?,HP1a targets the Drosophila KDM4A demethylase to a subset of heterochromatic genes to regulate H3K36me3 levels.,0
3642,7,Which is the effect of the HP1a protein on chromatin?,Enrichment of HP1a on Drosophila chromosome 4 genes creates an alternate chromatin structure critical for regulation in this heterochromatic domain.,0
3642,8,Which is the effect of the HP1a protein on chromatin?,HP1a: a structural chromosomal protein regulating transcription.,0
3642,9,Which is the effect of the HP1a protein on chromatin?,Heterochromatin protein 1 (HP1a in Drosophila) is a conserved eukaryotic chromosomal protein that is prominently associated with pericentric heterochromatin and mediates the concomitant gene silencing.,1
3642,10,Which is the effect of the HP1a protein on chromatin?,"Heterochromatin-associated interactions of Drosophila HP1a with dADD1, HIPP1, and repetitive RNAs.",0
3642,11,Which is the effect of the HP1a protein on chromatin?,"Heterochromatin protein 1 (HP1a) has conserved roles in gene silencing and heterochromatin and is also implicated in transcription, DNA replication, and repair.",1
3642,12,Which is the effect of the HP1a protein on chromatin?,Maintenance of Heterochromatin by the Large Subunit of the CAF-1 Replication-Coupled Histone Chaperone Requires Its Interaction with HP1a Through a Conserved Motif.,0
3642,13,Which is the effect of the HP1a protein on chromatin?,"The chromatin assembly factor 1 (CAF-1) is involved in the assembly of H3-H4 histone dimers on newly synthesized DNA and in the maintenance of a higher order structure, the heterochromatin, through an interaction of its large subunit with the heterochromatin protein HP1a",1
3642,14,Which is the effect of the HP1a protein on chromatin?,"As expected, active gene promoters are mostly not present in LADs, HP1a and Pc domains.",0
3642,15,Which is the effect of the HP1a protein on chromatin?,"Finally, we find that HP1a also specifies initiation sites of nuclear envelope reassembly on undamaged chromatin.",0
2665,0,Is Lysyl oxidase crosslinking collagen?,Lysyl oxidase (LOX) and LOX-like (LOXL) proteins play crucial roles in ECM remodeling due to their collagen crosslinking and intracellular functions.,1
2665,1,Is Lysyl oxidase crosslinking collagen?,"Lysyl oxidase-like 1, a crosslinking enzyme implicated in collagen and elastin biogenesis",1
2665,2,Is Lysyl oxidase crosslinking collagen?,LOXL2 mediates collagen crosslinking,1
2665,3,Is Lysyl oxidase crosslinking collagen?,"The same was true for assaying lysyl oxidase, an enzyme involved in crosslinking of matrix molecules.",1
2665,4,Is Lysyl oxidase crosslinking collagen?," In addition, collagen fibers in metastatic lung tumors exhibit greater linearity and organization as a result of collagen crosslinking by the lysyl oxidase (LOX) family of enzymes.",1
981,0,Which medication should be administered when managing patients with suspected acute opioid overdose?,"Opioid overdose has a high mortality, but is often reversible with appropriate overdose management and naloxone (opioid antagonist).",1
981,1,Which medication should be administered when managing patients with suspected acute opioid overdose?,Training clinicians how to manage an opioid overdose and administer naloxone was effective.,0
981,2,Which medication should be administered when managing patients with suspected acute opioid overdose?,"For patients who have ingested dextromethorphan and are sedated or comatose, naloxone, in the usual doses for treatment of opioid overdose, can be considered for prehospital administration, particularly if the patient has respiratory depression",1
981,3,Which medication should be administered when managing patients with suspected acute opioid overdose?,"Naloxone hydrochloride, an injectable opioid antagonist which reverses the respiratory depression, sedation and hypotension associated with opioids, has long been used to treat opioid overdose.",0
981,4,Which medication should be administered when managing patients with suspected acute opioid overdose?,"Experts have suggested that, as part of a comprehensive overdose prevention strategy, naloxone should be provided to heroin users for peer administration after an overdose.",0
981,5,Which medication should be administered when managing patients with suspected acute opioid overdose?,Patients who received naloxone for known or presumed opioid overdose were formally evaluated one hour later for multiple potential predictor variables.,0
981,6,Which medication should be administered when managing patients with suspected acute opioid overdose?,Patients with presumed opioid overdose can be safely discharged one hour after naloxone administration,1
981,7,Which medication should be administered when managing patients with suspected acute opioid overdose?,To determine whether naloxone administered i.v.,0
981,8,Which medication should be administered when managing patients with suspected acute opioid overdose?,to out-of-hospital patients with suspected opioid overdose would have a more rapid therapeutic onset than naloxone given subcutaneously (s.q.,1
981,9,Which medication should be administered when managing patients with suspected acute opioid overdose?,).,0
981,10,Which medication should be administered when managing patients with suspected acute opioid overdose?,Subjects received either naloxone 0.4 mg i.v.,0
981,11,Which medication should be administered when managing patients with suspected acute opioid overdose?,(n = 74) or naloxone 0.8 mg s.q.,0
981,12,Which medication should be administered when managing patients with suspected acute opioid overdose?,"(n = 122), for respiratory depression of <10 breaths/min.",0
981,13,Which medication should be administered when managing patients with suspected acute opioid overdose?,There was no clinical difference in the time interval to respiratory rate > or =10 breaths/min between naloxone 0.8 mg s.q.,0
981,14,Which medication should be administered when managing patients with suspected acute opioid overdose?,and naloxone 0.4 mg i.v.,0
981,15,Which medication should be administered when managing patients with suspected acute opioid overdose?,for the out-of-hospital management of patients with suspected opioid overdose.,1
981,16,Which medication should be administered when managing patients with suspected acute opioid overdose?,"To illustrate this problem, we report the case of a patient inappropriately treated with naloxone and the results of a retrospective review of the medical records of 15 consecutive patients with cancer treated with naloxone in the emergency department over a 5-month period.",0
981,17,Which medication should be administered when managing patients with suspected acute opioid overdose?,"Management of opioid overdose, whether illicit or iatrogenic, requires the prompt and skillful use of opioid overdose, whether illicit or iatrogenic, requires the prompt and skillful use of opioid antagonists.",0
981,18,Which medication should be administered when managing patients with suspected acute opioid overdose?, The proportion of clinicians willing to use naloxone in an opioid overdose rose from 77% to 99% after training.,0
981,19,Which medication should be administered when managing patients with suspected acute opioid overdose?,"Barriers to implementing training were clinician time and confidence, service resources, client willingness and naloxone formulation.",0
981,20,Which medication should be administered when managing patients with suspected acute opioid overdose?,Opioid overdose is rarely the primary cause of altered mental status in cancer patients receiving opioid therapy.,0
981,21,Which medication should be administered when managing patients with suspected acute opioid overdose?,The inappropriate administration of naloxone to reverse an abnormal mental status can cause severe withdrawal symptoms and pain.,0
707,0,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,To characterize disease-modifying antirheumatic drug (DMARD) use for children with juvenile idiopathic arthritis (JIA) in the United States and to determine patient factors associated with medication use.,1
707,1,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,"Among children without systemic arthritis, methotrexate use was most strongly associated with uveitis (OR 5.2, 95% CI 3.6-7.6), anticitrullinated protein antibodies (OR 4.5, 95% CI 1.7-12), and extended oligoarthritis (OR 4.1, 95% CI 2.5-6.6)",0
707,2,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,About three-quarters of all children with JIA in the CARRA Registry received nonbiologic DMARD.,0
707,3,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,"Nearly one-half received biologic DMARD, and their use was strongly associated with RF-positive polyarthritis, PsA, uveitis, and systemic arthritis.",0
707,4,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,pediatric JIA patients who were being treated with MTX for active uveitis,0
707,5,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,Eighteen patients (18/22; 82%) showed improvement of their uveitis with a significant decrease in activity of AC inflammation after a minimal period of 3 months of MTX treatment.,0
707,6,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,A topical steroid-sparing effect was observed when MTX was administered for a period of 3 to 9 months,1
707,7,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,Most experience among DMARD's/ immunosuppressive drugs has been obtained with methotrexate (MTX) in juvenile idiopathic arthritis.,1
707,8,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,"However, controlled studies in uveitis are still missing, so that treatment with MTX and all other immunosuppressive drugs (ciclosporine A, azathioprine, mycophenolate mofetil) only reaches an evidence level III (expert opinion, clinical experience or descriptive study)",1
707,9,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,The data suggest that MTX is very effective in controlling inflammation of uveitis in patients with JIA.,0
707,10,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,"However, additional topical steroids or systemic immunosuppressive drugs are often required.",0
707,11,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,The risk factor for development of early cataract requiring surgery in children with JIA-associated uveitis is the presence of posterior synechia at the time of diagnosis of uveitis.,0
707,12,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,"However, early treatment with MTX is associated with a mean delay in the development of cataract requiring surgery of 3.5 years.",1
707,13,What is the effect of methotrexate in treating uveitis due to juvenile idiopathic arthritis ?,MTX seems to be an effective therapy for JIA associated uveitis.,0
2197,0,Is Pfh1 a component of the replisome?,Pfh1 Is an Accessory Replicative Helicase that Interacts with the Replisome to Facilitate Fork Progression and Preserve Genome Integrity,1
2197,1,Is Pfh1 a component of the replisome?,"Although the Schizosaccharomyces pombe 5'-to-3' DNA helicase Pfh1 is known to promote fork progression, its genomic targets, dynamics, and mechanisms of action are largely unknown.",0
2197,2,Is Pfh1 a component of the replisome?,"Here we address these questions by integrating genome-wide identification of Pfh1 binding sites, comprehensive analysis of the effects of Pfh1 depletion on replication and DNA damage, and proteomic analysis of Pfh1 interaction partners by immunoaffinity purification mass spectrometry.",0
2197,3,Is Pfh1 a component of the replisome?,"DNA replication through hard-to-replicate sites, including both highly transcribed RNA Pol II and Pol III genes, requires the S. pombe Pfh1 helicase.",1
2197,4,Is Pfh1 a component of the replisome?,"Here, we show that Pfh1 is required for efficient fork movement in the ribosomal DNA, the mating type locus, tRNA, 5S ribosomal RNA genes, and genes that are highly transcribed by RNA polymerase II.",0
2197,5,Is Pfh1 a component of the replisome?," Thus, Pfh1 promotes DNA replication and separation of converged replication forks and suppresses DNA damage at hard-to-replicate sites.",0
2197,6,Is Pfh1 a component of the replisome?,"Cells depleted of Pfh1 were inviable if they also lacked the human TIMELESS homolog Swi1, a replisome component that stabilizes stalled forks.",0
2197,7,Is Pfh1 a component of the replisome?,Pfh1 Is an Accessory Replicative Helicase that Interacts with the Replisome to Facilitate Fork Progression and Preserve Genome Integrity.,1
2197,8,Is Pfh1 a component of the replisome?,"Thus, we conclude that Pfh1 is an accessory DNA helicase that interacts with the replisome and promotes replication and suppresses DNA damage at hard-to-replicate sites.",1
2197,9,Is Pfh1 a component of the replisome?,"Consistent with this interpretation, Pfh1 co-purified with many key replisome components, including the hexameric MCM helicase, replicative DNA polymerases, RPA, and the processivity clamp PCNA in an S phase dependent manner.",0
2197,10,Is Pfh1 a component of the replisome?,"Although Pfh1 affected replication and suppressed DNA damage at discrete sites throughout the genome, Pfh1 and the replicative DNA polymerase bound to similar extents to both Pfh1-dependent and independent sites, suggesting that Pfh1 is proximal to the replication machinery during S phase.",0
2197,11,Is Pfh1 a component of the replisome?,"Cells depleted of Pfh1 were inviable if they also lacked the human TIMELESS homolog Swi1, a replisome component that stabilizes stalled forks",0
2197,12,Is Pfh1 a component of the replisome?,"Here, we show that Pfh1 is required for efficient fork movement in the ribosomal DNA, the mating type locus, tRNA, 5S ribosomal RNA genes, and genes that are highly transcribed by RNA polymerase II",0
2197,13,Is Pfh1 a component of the replisome?,"Thus, Pfh1 promotes DNA replication and separation of converged replication forks and suppresses DNA damage at hard-to-replicate sites",0
2197,14,Is Pfh1 a component of the replisome?,"Cells depleted of Pfh1 were inviable if they also lacked the human TIMELESS homolog Swi1, a replisome component that stabilizes stalled forks.",0
2197,15,Is Pfh1 a component of the replisome?,"Thus, we conclude that Pfh1 is an accessory DNA helicase that interacts with the replisome and promotes replication and suppresses DNA damage at hard-to-replicate sites.",0
2197,16,Is Pfh1 a component of the replisome?,"Consistent with this interpretation, Pfh1 co-purified with many key replisome components, including the hexameric MCM helicase, replicative DNA polymerases, RPA, and the processivity clamp PCNA in an S phase dependent manner.",0
2197,17,Is Pfh1 a component of the replisome?,Pfh1 Is an Accessory Replicative Helicase that Interacts with the Replisome to Facilitate Fork Progression and Preserve Genome Integrity.,1
33,0,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?", It is important to identify what proteins are substrates of proteases and where their cleavage sites are so as to reveal the molecular mechanisms and specificity of signaling.,0
33,1,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?",It is important to identify what proteins are substrates of proteases and where their cleavage sites are so as to reveal the molecular mechanisms and specificity of signaling.,0
33,2,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?","analysis of N- terminomics data generated by terminal amine isotopic labeling of substrates (TAILS) enables high confidence peptide to protein assignment, protein N-terminal characterization and annotation, and for protease analysis readily allows protease substrate discovery with high confidence.",1
33,3,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?","Several approaches to studying proteolytic activity as it relates to biology, pathophysiology, and drug therapy have been published, including the recently described terminal amine isotopic labeling of substrates (TAILS) strategy by Kleifeld and colleagues",1
33,4,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?"," The degradomics screen terminal amine isotopic labeling of substrates (TAILS), which enriches for neo-N-terminal peptides of cleaved substrates, was used to identify 58 new native substrates in fibroblast secretomes after incubation with MT6-MMP.",1
33,5,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?"," Here we present in detail the steps required to perform our recently described approach we call Terminal Amine Isotopic Labeling of Substrates (TAILS), a combined N-terminomics and protease substrate discovery degradomics platform for the simultaneous quantitative and global analysis of the N-terminome and proteolysis in one MS/MS experiment.",0
33,6,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?",Identification of proteolytic products and natural protein N-termini by Terminal Amine Isotopic Labeling of Substrates (TAILS).,1
33,7,"What is the meaning of the acronym ""TAILS"" used in protein N-terminomics?", Incorporating iTRAQ whole protein labeling with terminal amine isotopic labeling of substrates (iTRAQ-TAILS) to enrich the N-terminome by negative selection of the blocked mature original N-termini and neo-N-termini has many advantages.,1
319,0,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,"Myocardial ischaemia/reperfusion (I/R)-induced remodelling generally includes cell death (necrosis and apoptosis), myocyte hypertrophy, angiogenesis, cardiac fibrosis, and myocardial dysfunction.",0
319,1,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,I,0
319,2,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,"In addition, miR-21, -24, -133, -210, -494, and -499 appear to protect myocytes against I/R-induced apoptosis, whereas miR-1, -29, -199a, and -320 promote apoptosis",0
319,3,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,Myocardial fibrosis can be regulated by the miR-29 family,1
319,4,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,"Studies using various in vivo, ex vivo, and in vitro models have suggested the possible involvement of miR-1, miR-21, miR-29, miR-92a, miR-133, miR-199a, and miR-320 in ischemia-reperfusion injury and/or remodeling after myocardial infarction.",1
319,5,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,"Among the MI-regulated miRNAs are members of the miR-29 family, which are down-regulated in the region of the heart adjacent to the infarct.",0
319,6,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,"The miR-29 family targets a cadre of mRNAs that encode proteins involved in fibrosis, including multiple collagens, fibrillins, and elastin.",1
319,7,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,"Thus, down-regulation of miR-29 would be predicted to derepress the expression of these mRNAs and enhance the fibrotic response.",1
319,8,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,"Indeed, down-regulation of miR-29 with anti-miRs in vitro and in vivo induces the expression of collagens, whereas over-expression of miR-29 in fibroblasts reduces collagen expression.",1
319,9,Is microRNA(miRNA) 29 involved in post-ischemic cardiac remodeling?,We conclude that miR-29 acts as a regulator of cardiac fibrosis and represents a potential therapeutic target for tissue fibrosis in general.,0
2621,0,List drugs that are included in the Vosevi polypill.,"On July 18, 2017, the US Food and Drug Administration (FDA) approved sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) (Vosevi) fixed-dose combination (FDC), an interferon-free, complete regimen for adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have: genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor; and genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor.",1
2731,0,What biologic process in the body is associated with Mast cells?,Mast cells (MCs) may play an important role in plaque destabilization and atherosclerotic coronary complications.,0
2731,1,What biologic process in the body is associated with Mast cells?,Mast cells are significantly involved in IgE-mediated allergic reactions,1
2731,2,What biologic process in the body is associated with Mast cells?, Mast cells (MCs) are innate immune cells that are a major source of costimulatory signals and inflammatory mediators in the intestinal mucosa,1
2731,3,What biologic process in the body is associated with Mast cells?,Mast cells and basophils are innate immune cells with overlapping functions that contribute to anti-helminth immunity.,1
2731,4,What biologic process in the body is associated with Mast cells?,"Mast cells are widely distributed throughout the body, predominantly near blood vessels and nerves, and express effector functions in allergic reactions, inflammatory diseases, and host defense.",0
2731,5,What biologic process in the body is associated with Mast cells?,The mast cell is the cellular basis for immediate hypersensitivity reactions.,0
2731,6,What biologic process in the body is associated with Mast cells?,"Mast cells are important elements of the body response to foreign antigens, being those represented either by small molecules (allergic response) or harbored by foreign microorganisms (response to parasite infection).",0
2731,7,What biologic process in the body is associated with Mast cells?,"Mast cells are ubiquitous in the body and multifunctional immune cells; they are known to be primary responders in allergic reactions, orchestrating strong responses to minute amounts of allergens.",1
2731,8,What biologic process in the body is associated with Mast cells?,"In IgE-associated biological responses, the crosslinking of Fc&#949;RI-bound IgE with multivalent antigens initiate the activation of mast cells by promoting aggregation of FceRI.",0
2731,9,What biologic process in the body is associated with Mast cells?,Mast cell activation has been shown to be an initiator and a key determinant of foreign body reactions,0
2731,10,What biologic process in the body is associated with Mast cells?,Mast cells are one of the major effector cells in the pathogenesis of the immediate-type hypersensitivity reaction in a number of non-allergic immune disorders as well as in normal physiological processes.,0
2731,11,What biologic process in the body is associated with Mast cells?,Mast cells act as sensors in innate immunity and as effector cells in adaptive immune reactions.,0
2731,12,What biologic process in the body is associated with Mast cells?,": Allergic rhinitis is characterized by the epithelial accumulation of cells, particularly mast cells and eosinophils.",0
2731,13,What biologic process in the body is associated with Mast cells?,Mast cells are important effector cells of the immune system and recent studies show that they have immunomodulatory roles in diverse processes in both health and disease.,0
2731,14,What biologic process in the body is associated with Mast cells?,"Biological functions of mast cells appear to include a role in innate immunity, involvement in host defense mechanisms against parasitic infestations, immunomodulation of the immune system, and tissue repair and angiogenesis",0
2731,15,What biologic process in the body is associated with Mast cells?,Mast cells have long been known to play a detrimental role in the pathogenesis of IgE-associated allergic disorders by their ability to release a wide variety of pro-inflammatory mediators.,0
2731,16,What biologic process in the body is associated with Mast cells?,Mast cells are long-lived resident cells that are of great importance in an allergic reaction.,1
2731,17,What biologic process in the body is associated with Mast cells?,"Several chronic inflammatory diseases are associated with increased mast cell numbers and upregulation of the TNF receptor family member CD30, but the role of elevated CD30 expression is poorly understood.",0
2327,0,Is ACI-35 a passive vaccine?,Two active vaccines targeting either nonphosphorylated (AAD-vac1) and phosphorylated tau (ACI-35) have entered Phase I testing.,1
1007,0,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element,0
1007,1,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,Deamination of cytidine residues in viral DNA is a major mechanism by which APOBEC3G (A3G) inhibits vif-deficient human immunodeficiency virus type 1 (HIV-1) replication.,0
1007,2,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,"dC-to-dU transition following RNase-H activity leads to viral cDNA degradation, production of non-functional proteins, formation of undesired stop codons and decreased viral protein synthesis",1
1007,3,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,"HIV-1 transcription elongation is regulated by the trans-activation response (TAR) element, a short stem-loop RNA structure required for elongation factors binding.",1
1007,4,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,"Vif-deficient HIV-1-infected cells accumulate short viral transcripts and produce lower amounts of full-length HIV-1 transcripts due to A3G deamination of the TAR apical loop cytidine, highlighting the requirement for TAR loop integrity in HIV-1 transcription",1
1007,5,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,The APOBEC3 deoxycytidine deaminase family functions as host restriction factors that can block replication of Vif (virus infectivity factor) deficient HIV-1 virions to differing degrees by deaminating cytosines to uracils in single-stranded (-)HIV-1 DNA.,0
1007,6,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,"Upon replication of the (-)DNA to (+)DNA, the HIV-1 reverse transcriptase incorporates adenines opposite the uracils, thereby inducing C/G→T/A mutations that can functionally inactivate HIV-1",0
1007,7,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,APOBEC3G is a member of this family that inhibits HIV-1 replication in the absence of the viral infectivity factor Vif.,0
1007,8,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,Inhibition of HIV replication occurs by both deamination of viral single-stranded DNA and a deamination-independent mechanism,0
1007,9,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination,0
1007,10,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,These proteins exert their suppressive effects through the inhibition of viral reverse transcription as well as the induction of cytidine deamination within nascent viral cDNA,0
1007,11,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,"We demonstrate that APOBEC3 proteins impart a profound deficiency to reverse transcription from the initial stages of cDNA synthesis, as well as excessive cytidine deamination (hypermutation) of the DNAs that are synthesized",0
1007,12,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,"Without Vif, A3 proteins, particularly APOBEC3G (A3G) and APOBEC3F (A3F), inhibit HIV-1 replication by blocking reverse transcription and/or integration and hypermutating nascent viral cDNA.",0
1007,13,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,The molecular mechanisms of this antiviral activity have been primarily attributed to two biochemical characteristics common to A3 proteins: catalyzing cytidine deamination in single-stranded DNA (ssDNA) and a nucleic acid-binding capability that is specific to ssDNA or ssRNA,0
1007,14,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,"A host cytidine deaminase, APOBEC3G (A3G), inhibits replication of human immunodeficiency virus type 1 (HIV-1) by incorporating into virions in the absence of the virally encoded Vif protein (Deltavif virions), at least in part by causing G-to-A hypermutation.",1
1007,15,What is the mechanism of action of APOBEC3G cytidine deaminase to inhibit HIV-1 replication?,APOBEC3F and APOBEC3G cytidine deaminases potently inhibit human immunodeficiency virus type 1 (HIV-1) replication by enzymatically inserting G-to-A mutations in viral DNA and/or impairing viral reverse transcription independently of their deaminase activity,1
2821,0,Which algorithm has been developed for trio-based benchmarking of variant calls?,geck: trio-based comparative benchmarking of variant calls.,1
2821,1,Which algorithm has been developed for trio-based benchmarking of variant calls?,Classical methods of comparing the accuracies of variant calling pipelines are based on truth sets of variants whose genotypes are previously determined with high confidence.,1
2821,2,Which algorithm has been developed for trio-based benchmarking of variant calls?,An alternative way of performing benchmarking is based on Mendelian constraints between related individuals.,1
2821,3,Which algorithm has been developed for trio-based benchmarking of variant calls?,"Statistical analysis of Mendelian violations can provide truth set-independent benchmarking information, and enable benchmarking less-studied variants and diverse populations.Results: We introduce a statistical mixture model for comparing two variant calling pipelines from genotype data they produce after running on individual members of a trio.",1
2821,4,Which algorithm has been developed for trio-based benchmarking of variant calls?,We determine the accuracy of our model by comparing the precision and recall of GATK Unified Genotyper and Haplotype Caller on the high-confidence SNPs of the NIST Ashkenazim trio and the two independent Platinum Genome trios.,1
2821,5,Which algorithm has been developed for trio-based benchmarking of variant calls?,We show that our method is able to estimate differential precision and recall between the two pipelines with 10-3 uncertainty.,0
2814,0,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries.,1
2814,1,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,"Here, we discover that nearly all disease-associated STRs (daSTRs) are located at boundaries demarcating 3D chromatin domains.",1
2814,2,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,We identify a subset of boundaries with markedly higher CpG island density compared to the rest of the genome.,1
2814,3,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,"daSTRs specifically localize to ultra-high-density CpG island boundaries, suggesting they might be hotspots for epigenetic misregulation or topological disruption linked to STR expansion.",0
2814,4,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,Fragile X syndrome patients exhibit severe boundary disruption in a manner that correlates with local loss of CTCF occupancy and the degree of FMR1 silencing.,1
2814,5,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,Our data uncover higher-order chromatin architecture as a new dimension in understanding repeat expansion disorders.,0
2814,6,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,"Here, we discover that nearly all disease-associated STRs (daSTRs) are located at boundaries demarcating 3D chromatin domains.",1
2814,7,What is the association of Disease-Associated STRs (daSTRs) with domain boundaries?,"daSTRs specifically localize to ultra-high-density CpG island boundaries, suggesting they might be hotspots for epigenetic misregulation or topological disruption linked to STR expansion.",0
3114,0,"Is there any association between suicide and autism in adolescents, yes or no?",": In all subjects from our research on PubMed, 21.3% of subjects with autism spectrum disorder reported suicidal ideation, have attempted suicide or died by suicide (115 out of 539 subjects) and 7.7% of subjects supported for suicidal thoughts or attempted suicide exhibited an autism spectrum disorder (62 out of 806 subjects), all ages combined.",0
3114,1,"Is there any association between suicide and autism in adolescents, yes or no?",Suicide attempts are accompanied by a willingness for death and can lead to suicide.,0
3114,2,"Is there any association between suicide and autism in adolescents, yes or no?",They are more common in high-functioning autism and Asperger subjects.,0
3114,3,"Is there any association between suicide and autism in adolescents, yes or no?", A total sample of 10 adolescents and young adults diagnosed with AS was obtained.,0
3114,4,"Is there any association between suicide and autism in adolescents, yes or no?",The high proportion of respondents with scores above the cutoff point on the overt victimization and relational victimization scales suggests that these adolescents and young adults experienced high levels of victimization.,0
3114,5,"Is there any association between suicide and autism in adolescents, yes or no?","Of the sample, 20 percent met criteria for a diagnosis of Major Depressive Disorder, 30 percent met criteria for Generalized Anxiety Disorder and 50 percent had clinically significant level of suicidal ideation.",0
3114,6,"Is there any association between suicide and autism in adolescents, yes or no?",Previous studies reported a high prevalence of depression among patients with autism spectrum disorder (ASD) and suggested a relationship between ASD and suicidality,1
3114,7,"Is there any association between suicide and autism in adolescents, yes or no?",Patients with ASD had an increased risk of suicide attempts compared with those without ASD.,1
3114,8,"Is there any association between suicide and autism in adolescents, yes or no?",The suicidal behaviors are frequently observed in the adolescents and adults with an ASD without intellectual deficience.,0
3114,9,"Is there any association between suicide and autism in adolescents, yes or no?",Suicide is a major problem in Western society.,0
3114,10,"Is there any association between suicide and autism in adolescents, yes or no?",However we have very little understanding of suicidal behaviour among individuals with autism spectrum disorders.,0
3114,11,"Is there any association between suicide and autism in adolescents, yes or no?",The available research provides little empirical evidence for the processes underlying suicidal behaviour in adolescents and young adults with autism,0
3114,12,"Is there any association between suicide and autism in adolescents, yes or no?"," The present study aims to assess the rate of suicidality (suicidal ideation, behaviors and attempts) and associated risk factors for suicidality in high functioning ASD",0
3114,13,"Is there any association between suicide and autism in adolescents, yes or no?",here is a lack of clinical awareness on suicidal behaviors of children and adolescents with autism spectrum disorder (ASD),1
3114,14,"Is there any association between suicide and autism in adolescents, yes or no?",suicidality in children and adolescents with diagnosis of high functioning autism spectrum disorder,0
3114,15,"Is there any association between suicide and autism in adolescents, yes or no?","Consistent with the previous findings, rate of suicidality is higher in individuals with ASD",0
3114,16,"Is there any association between suicide and autism in adolescents, yes or no?",Detection of Suicidality in Adolescents with Autism Spectrum Disorders,0
3114,17,"Is there any association between suicide and autism in adolescents, yes or no?",Over 15% of young people with autism spectrum disorders (ASD) will contemplate or attempt suicide during adolescence.,0
3114,18,"Is there any association between suicide and autism in adolescents, yes or no?","Yet,",0
3114,19,"Is there any association between suicide and autism in adolescents, yes or no?","Until recently, suicidality in autism spectrum disorder (ASD) was rarely discussed.",1
3114,20,"Is there any association between suicide and autism in adolescents, yes or no?",Suicidality in Autism Spectrum Disorder.,0
3114,21,"Is there any association between suicide and autism in adolescents, yes or no?","highlighted not only that suicidal thoughts and suicide attempts can occur in adolescents and young adults with ASD, but also that suicidality is likely more common in ASD than in the general population.",0
3114,22,"Is there any association between suicide and autism in adolescents, yes or no?","The emerging studies indicate that the increased risk of self-injurious behavior in younger and less cognitively able children with ASD3,4 is matched by an increased risk of suicidality in those at a more advanced developmental level.",0
3114,23,"Is there any association between suicide and autism in adolescents, yes or no?","RESULTS
In all subjects from our research on PubMed, 21.3% of subjects with autism spectrum disorder reported suicidal ideation, have attempted suicide or died by suicide (115 out of 539 subjects) and 7.7% of subjects supported for suicidal thoughts or attempted suicide exhibited an autism spectrum disorder (62 out of 806 subjects), all ages combined.",0
3114,24,"Is there any association between suicide and autism in adolescents, yes or no?",Risk of Suicide Attempts Among Adolescents and Young Adults With Autism Spectrum Disorder: A Nationwide Longitudinal Follow-Up Study.,1
3114,25,"Is there any association between suicide and autism in adolescents, yes or no?","Although the suicide risk of autism spectrum disorder (ASD) has been suggested to be higher than previously recognized, there are few case reports focusing on the process for preventing suicide reattempts.",0
2328,0,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?," From May 2013 to May 2014, an outbreak of C. difficile ribotype 027 occurred in a Dutch tertiary care hospital, involving 72 patients.",0
2328,1,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?," During this period, 70 endemic cases of CDI occurred as well as 78 cases of CDI related to an outbreak of C. difficile ribotype 027",1
2328,2,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?,The outbreak of the hypervirulent strain belonging to ribotype 027 has increased the incidence and severity of CDI in some countries.,1
2328,3,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?,An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.,0
2328,4,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?, The aim of this study was to determine whether early recurrence risk was higher after infection with ribotype 027 (outbreak strain) compared with infection with endemic strain types of C. difficile.,1
2328,5,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?,The rapid spread of Clostridium difficile NAP1/BI/027 (C. difficile 027) has become one of the leading threats of healthcare-associated infections worldwide.,1
2328,6,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?,"An outbreak of Clostridium difficile ribotype 027 infection (CDI) occurred at an university hospital, involving 19 departments.",0
2328,7,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?,The majority of strains from Bosnia and Herzegovina and Serbia belonged to PCR ribotype 027 (65.8%).,1
2328,8,Which main ribotype of Clostridium difficile is responsible of the recent outbreak?,"Ribotype 027 is highly prevalent in Germany, but its infections are restricted to older patients, while absent in children.",0
2786,0,Do yeast LTR give rise to circular DNA?,Circular retrotransposition products generated by a LINE retrotransposon,1
2786,1,Do yeast LTR give rise to circular DNA?,Formation of Extrachromosomal Circular DNA from Long Terminal Repeats of Retrotransposons in Saccharomyces cerevisiae,0
2786,2,Do yeast LTR give rise to circular DNA?,"Ty eccDNA can arise from the circularization of extrachromosomal linear DNA during the transpositional life cycle of retrotransposons, or from circularization of genomic Ty DNA",0
2786,3,Do yeast LTR give rise to circular DNA?,"Circularization may happen through nonhomologous end-joining (NHEJ) of long terminal repeats (LTRs) flanking Ty elements, by Ty autointegration, or by LTR-LTR recombination",1
2786,4,Do yeast LTR give rise to circular DNA?,We have recently shown that yeast LTR elements generate circular DNAs through recombination events between their flanking long terminal repeats (LTRs).,1
2786,5,Do yeast LTR give rise to circular DNA?,"Similarly, circular DNAs can be generated by recombination between LTRs residing at different genomic loci, in which case the circular DNA will contain the intervening sequence.",1
2786,6,Do yeast LTR give rise to circular DNA?,A recent study on circular DNAs in yeast found that transposable element sequence residing in circular structures mostly corresponded to full-length transposable elements.,1
2580,0,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response.,1
2580,1,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"In this study, we identified the Tudor-interacting repair regulator (TIRR) that specifically associates with the ionizing radiation-induced foci formation region of 53BP1.",0
2580,2,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"53BP1 and TIRR form a stable complex, which is required for their expression.",0
2580,3,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"Moreover, the 53BP1-TIRR complex dissociates after DNA damage, and this dissociation may be ataxia telangiectasia mutated-dependent.",0
2580,4,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"Similar to 53BP1, loss of TIRR restores PARPi resistance in BRCA1-deficient cells.",0
2580,5,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"Collectively, our data identified a novel 53BP1-TIRR complex in DNA damage response.",0
2580,6,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,TIRR may play both positive and negative roles in 53BP1 regulation.,0
2580,7,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"On the one hand, it stabilizes 53BP1 and thus positively regulates 53BP1.",0
2580,8,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"On the other hand, its association with 53BP1 prevents 53BP1 localization to sites of DNA damage, and thus TIRR is also an inhibitor of 53BP1.",0
2580,9,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.,1
2580,10,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,P53-binding protein 1 (53BP1) is a multi-functional double-strand break repair protein that is essential for class switch recombination in B lymphocytes and for sensitizing BRCA1-deficient tumours to poly-ADP-ribose polymerase-1 (PARP) inhibitors.,0
2580,11,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,Central to all 53BP1 activities is its recruitment to double-strand breaks via the interaction of the tandem Tudor domain with dimethylated lysine 20 of histone H4 (H4K20me2).,0
2580,12,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"Here we identify an uncharacterized protein, Tudor interacting repair regulator (TIRR), that directly binds the tandem Tudor domain and masks its H4K20me2 binding motif.",0
2580,13,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"Upon DNA damage, the protein kinase ataxia-telangiectasia mutated (ATM) phosphorylates 53BP1 and recruits RAP1-interacting factor 1 (RIF1) to dissociate the 53BP1-TIRR complex.",0
2580,14,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"However, overexpression of TIRR impedes 53BP1 function by blocking its localization to double-strand breaks.",0
2580,15,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,Depletion of TIRR destabilizes 53BP1 in the nuclear-soluble fraction and alters the double-strand break-induced protein complex centring 53BP1.,0
2580,16,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,These findings identify TIRR as a new factor that influences double-strand break repair using a unique mechanism of masking the histone methyl-lysine binding function of 53BP1.,1
2580,17,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"In this study, we identified the Tudor-interacting repair regulator (TIRR) that specifically associates with the ionizing radiation-induced foci formation region of 53BP1.",0
2580,18,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,These findings identify TIRR as a new factor that influences double-strand break repair using a unique mechanism of masking the histone methyl-lysine binding function of 53BP1.<br>,0
2580,19,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"Upon DNA damage, the protein kinase ataxia-telangiectasia mutated (ATM) phosphorylates 53BP1 and recruits RAP1-interacting factor 1 (RIF1) to dissociate the 53BP1-TIRR complex.",0
2580,20,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"53BP1 and TIRR form a stable complex, which is required for their expression.",0
2580,21,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,Depletion of TIRR destabilizes 53BP1 in the nuclear-soluble fraction and alters the double-strand break-induced protein complex centring 53BP1.,0
2580,22,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"However, overexpression of TIRR impedes 53BP1 function by blocking its localization to double-strand breaks.",0
2580,23,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response.,1
2580,24,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,"Moreover, p53 stimulates the topoisomerase I-induced recombination repair (TIRR) reaction.",0
2580,25,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.,1
2580,26,Which protein is regulated by Tudor interacting repair regulator (TIRR)?,These findings identify TIRR as a new factor that influences double-strand break repair using a unique mechanism of masking the histone methyl-lysine binding function of 53BP1.,0
1885,0,Please list the 3 findings in HELLP syndrome.,"HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) is an obstetric complication with heterogonous presentation and multisystemic involvement.",1
1885,1,Please list the 3 findings in HELLP syndrome.,"It is characterized by microangiopathic hemolytic anemia, elevated liver enzymes by intravascular breakdown of fibrin in hepatic sinusoids and reduction of platelet circulation by its increased consumption",1
1885,2,Please list the 3 findings in HELLP syndrome.,"Hemolysis, elevated liver enzymes and low platelets constitute the HELLP syndrome.",1
1885,3,Please list the 3 findings in HELLP syndrome.,"Our objective was to describe the hepatic imaging findings in selected patients with HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) and to correlate these findings with the severity of concurrent clinical and laboratory abnormalities.",0
1885,4,Please list the 3 findings in HELLP syndrome.,"Our objective was to categorize the histologic findings in the liver in patients with HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) and to correlate these findings with the severity of clinical laboratory abnormalities.",0
1885,5,Please list the 3 findings in HELLP syndrome.,"OBJECTIVE: Our purpose was to test the hypothesis that the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome is the result of excessive vasoconstriction of the hepatic arterial circulation.STUDY DESIGN: Doppler ultrasonography was used to measure the pulsatility index of the common hepatic artery in 14 women with preeclampsia, 15 with preeclampsia complicated by HELLP syndrome, and 8 with HELLP syndrome but without proteinuria.",0
1885,6,Please list the 3 findings in HELLP syndrome.,"Extensive hepatic infarction in severe preeclampsia as part of the HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): evolution of CT findings and successful treatment with plasma exchange therapy.",0
1885,7,Please list the 3 findings in HELLP syndrome.,"OBJECTIVE: Our objective was to categorize the histologic findings in the liver in patients with HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) and to correlate these findings with the severity of clinical laboratory abnormalities.",0
1885,8,Please list the 3 findings in HELLP syndrome.,"The syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP syndrome) is a life threatening, severe complication of pre-eclampsia with typical laboratory findings.",0
1885,9,Please list the 3 findings in HELLP syndrome.,"Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome",0
1885,10,Please list the 3 findings in HELLP syndrome.,"hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome",0
1885,11,Please list the 3 findings in HELLP syndrome.,"HELLP syndrome, a syndrome of hemolysis, elevated liver enzymes and low platelets",0
1885,12,Please list the 3 findings in HELLP syndrome.,"HELLP syndrome is a collection of symptoms described as hemolysis, elevated liver enzymes and low platelets",0
1885,13,Please list the 3 findings in HELLP syndrome.,"The HELLP syndrome is characterized by the presence of hypertension disorder more a triad: microangiopathic hemolysis, elevated liver enzymes and low platelet count.",0
1885,14,Please list the 3 findings in HELLP syndrome.,"HELLP (hemolysis, elevated liver enzymes, and low platelets)",0
1885,15,Please list the 3 findings in HELLP syndrome.," HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome,",1
1885,16,Please list the 3 findings in HELLP syndrome.,"Hepatic hemorrhage occurs in less than 5% of patients with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome",0
1885,17,Please list the 3 findings in HELLP syndrome.," HELLP (haemolysis, elevated liver enzymes and low platelets)",0
1885,18,Please list the 3 findings in HELLP syndrome.,"Hemolysis, elevated liver enzymes, and low platelet count syndrome (HELLP syndrome)",0
1885,19,Please list the 3 findings in HELLP syndrome.," hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome",0
1885,20,Please list the 3 findings in HELLP syndrome.," hemolysis, elevated liver enzymes and low platelet (HELLP) syndrome, i",0
1885,21,Please list the 3 findings in HELLP syndrome.,"Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome",1
1885,22,Please list the 3 findings in HELLP syndrome.,"HELLP (hemolysis, elevated liver enzymes, and low platelet count)",0
1885,23,Please list the 3 findings in HELLP syndrome.,"HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome",0
1885,24,Please list the 3 findings in HELLP syndrome.,"hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome",0
1885,25,Please list the 3 findings in HELLP syndrome.,"hemolysis, elevated liver enzymes, and low platelets (HELLP),",0
1456,0,Which molecule is targeted by Daratumumab?,"Daratumumab, an investigated anti-cancer drug targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",1
1456,1,Which molecule is targeted by Daratumumab?,"Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38 epitope with broad-spectrum killing activity.",1
1456,2,Which molecule is targeted by Daratumumab?,This review focuses on the CD38 antigen and its targeting with daratumumab and provides an update on the results of recent clinical studies involving daratumumab.,0
1456,3,Which molecule is targeted by Daratumumab?,"BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple myeloma, is an IgG1κ monoclonal antibody that recognizes CD38 on myeloma cells.",0
1456,4,Which molecule is targeted by Daratumumab?,CONCLUSION: DARA causes panreactivity in vitro by binding to CD38 on reagent RBCs.,0
1456,5,Which molecule is targeted by Daratumumab?,"Here, we describe that treatment of multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive indirect antiglobulin tests (IATs) for all patients for 2 to 6 months after infusion.",0
1456,6,Which molecule is targeted by Daratumumab?,Interference of daratumumab and three other anti-CD38 MoAbs was studied using fresh-frozen plasma spiked with different MoAb concentrations.,0
1456,7,Which molecule is targeted by Daratumumab?,"Daratumumab, an investigated anti-cancer drug targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",1
1456,8,Which molecule is targeted by Daratumumab?,"Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38 epitope with broad-spectrum killing activity.",1
1456,9,Which molecule is targeted by Daratumumab?,"This article focuses on the basic and clinical aspects of several emerging and promising novel MoAbs for MM, such as elotuzumab which targets CS1 and daratumumab which targets CD38.",0
1456,10,Which molecule is targeted by Daratumumab?,"This is likely to change within the next few years with a number of mAb therapies being assessed in late stage clinical trials, most notably, the anti-CS-1 mAb, elotuzumab, and the anti-CD38 mAb, daratumumab, which are currently being evaluated in Phase III clinical trials for MM.",0
1456,11,Which molecule is targeted by Daratumumab?,"Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM",0
1456,12,Which molecule is targeted by Daratumumab?,"Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM",0
1456,13,Which molecule is targeted by Daratumumab?,"Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.",0
1456,14,Which molecule is targeted by Daratumumab?,"In this study, we describe the cytotoxic mechanisms of action of daratumumab, a novel, high-affinity, therapeutic human mAb against a unique CD38 epitope.",0
1456,15,Which molecule is targeted by Daratumumab?,"Daratumumab induced potent Ab-dependent cellular cytotoxicity in CD38-expressing lymphoma- and MM-derived cell lines as well as in patient MM cells, both with autologous and allogeneic effector cells.",0
1456,16,Which molecule is targeted by Daratumumab?,Daratumumab stood out from other CD38 mAbs in its strong ability to induce complement-dependent cytotoxicity in patient MM cells.,0
1456,17,Which molecule is targeted by Daratumumab?,"Importantly, daratumumab-induced Ab-dependent cellular cytotoxicity and complement-dependent cytotoxicity were not affected by the presence of bone marrow stromal cells, indicating that daratumumab can effectively kill MM tumor cells in a tumor-preserving bone marrow microenvironment.",0
1456,18,Which molecule is targeted by Daratumumab?,"In vivo, daratumumab was highly active and interrupted xenograft tumor growth at low dosing.",0
1456,19,Which molecule is targeted by Daratumumab?,This review focuses on the CD38 antigen and its targeting with daratumumab and provides an update on the results of recent clinical studies involving daratumumab.,0
1456,20,Which molecule is targeted by Daratumumab?,elotuzumab which targets CS1 and daratumumab which targets CD38.,0
1456,21,Which molecule is targeted by Daratumumab?,such as elotuzumab which targets CS1 and daratumumab which targets CD38.,0
1456,22,Which molecule is targeted by Daratumumab?,Novel therapy strategies include targeted and stroma-directed approaches.,0
1456,23,Which molecule is targeted by Daratumumab?,Antibodies targeting CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.,0
1456,24,Which molecule is targeted by Daratumumab?,an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM.,0
1456,25,Which molecule is targeted by Daratumumab?,"This review focuses on the basic and clinical aspects of two emerging and promising novel MoAbs for MM, elotuzumab which targets CS1 and daratumumab which targets CD38.",0
1456,26,Which molecule is targeted by Daratumumab?,Antibodies targeting CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.,0
1456,27,Which molecule is targeted by Daratumumab?,"Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM.",0
1456,28,Which molecule is targeted by Daratumumab?,"Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM.",0
1456,29,Which molecule is targeted by Daratumumab?,These findings support clinical development of daratumumab for the treatment of CD38-positive MM tumors.,0
1456,30,Which molecule is targeted by Daratumumab?,Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.,0
1456,31,Which molecule is targeted by Daratumumab?,Antibodies targeting CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.,0
1456,32,Which molecule is targeted by Daratumumab?,"In this study, we describe the cytotoxic mechanisms of action of daratumumab, a novel, high-affinity, therapeutic human mAb against a unique CD38 epitope.",0
1456,33,Which molecule is targeted by Daratumumab?,"Daratumumab is a novel human CD38 monoclonal antibody which kills CD38+ multiple myeloma cells via antibody-dependent cell-mediated cytotoxicity, complement-dependent cytotoxicity and apoptosis.",0
1456,34,Which molecule is targeted by Daratumumab?,"DESIGN AND METHODS: To explore the effect of lenalidomide combined with daratumumab, we first carried out standard antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity assays in which the CD38+ multiple myeloma cell line UM-9 and primary multiple myeloma cells isolated from patients were used as target cells.",0
1456,35,Which molecule is targeted by Daratumumab?,These findings support clinical development of daratumumab for the treatment of CD38-positive MM tumors.,0
1456,36,Which molecule is targeted by Daratumumab?,"In this study, we describe the cytotoxic mechanisms of action of daratumumab, a novel, high-affinity, therapeutic human mAb against a unique CD38 epitope.",0
1456,37,Which molecule is targeted by Daratumumab?,A novel therapeutic strategy that effectively targets specific molecules on myeloma cells and also potentially overcomes tumor microenvironment-mediated drug resistance and the downstream effects of genetic instability is thus urgently needed.,0
1456,38,Which molecule is targeted by Daratumumab?,"Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM.",0
1456,39,Which molecule is targeted by Daratumumab?,This review focuses on the CD38 antigen and its targeting with daratumumab and provides an update on the results of recent clinical studies involving daratumumab.,0
1456,40,Which molecule is targeted by Daratumumab?,.,0
1456,41,Which molecule is targeted by Daratumumab?,an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM.,0
1456,42,Which molecule is targeted by Daratumumab?,"This review focuses on the basic and clinical aspects of two emerging and promising novel MoAbs for MM, elotuzumab which targets CS1 and daratumumab which targets CD38.",0
1456,43,Which molecule is targeted by Daratumumab?,"Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM.",0
1456,44,Which molecule is targeted by Daratumumab?,"Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM.",0
1456,45,Which molecule is targeted by Daratumumab?,"This article focuses on the basic and clinical aspects of several emerging and promising novel MoAbs for MM, such as elotuzumab which targets CS1 and daratumumab which targets CD38.",0
1456,46,Which molecule is targeted by Daratumumab?,Antibodies targeting CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.,0
1456,47,Which molecule is targeted by Daratumumab?,"Daratumumab, an investigated anti-cancer drug targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",1
1456,48,Which molecule is targeted by Daratumumab?,"We hypothesized that the observed panreactivity reflected DARA binding to CD38 on reagent RBCs, and we investigated methods to prevent this binding.STUDY DESIGN AND METHODS: DARA binding to CD38+ or CD38- HL60 cells was assessed by flow cytometry.",0
1456,49,Which molecule is targeted by Daratumumab?,"Flow cytometry experiments confirmed DARA binding to CD38+ HL60 cells, but not to CD38- controls.",0
1456,50,Which molecule is targeted by Daratumumab?,DTT treatment of CD38+ HL60 cells reduced DARA binding by 92% by denaturing cell surface CD38.,0
762,0,What is the effect of a defective CLN3 gene?,Juvenile neuronal ceroid lipofuscinosis (Batten disease) is a neurodegenerative disorder caused by defective function of the lysosomal membrane glycoprotein CLN3.,1
762,1,What is the effect of a defective CLN3 gene?,"human CLN3 that is defective in Batten disease, localizes to the vacuole",0
762,2,What is the effect of a defective CLN3 gene?,JNCL results from mutations in CLN3 on chromosome 16p12.1.,0
762,3,What is the effect of a defective CLN3 gene?,"Mutations in the CLN3 gene, which encodes a lysosomal membrane protein, are responsible for the neurodegenerative disorder juvenile Batten disease.",1
762,4,What is the effect of a defective CLN3 gene?,"Batten disease [juvenile-onset neuronal ceroid lipofuscinosis (JNCL)], the most common progressive encephalopathy of childhood, is caused by mutations in a novel lysosomal membrane protein (CLN3) with unknown function.",1
762,5,What is the effect of a defective CLN3 gene?,"the human CLN3 gene that is defective in Batten disease,",0
762,6,What is the effect of a defective CLN3 gene?,"ln3 was recently identified as the gene defective in juvenile Batten disease, an inherited neurodegenerative disease of childhood",1
762,7,What is the effect of a defective CLN3 gene?,"Batten disease (juvenile-onset neuronal ceroid lipofuscinosis, JNCL), the most common neurodegenerative disorder of childhood, is caused by mutations in a recently identified gene ( CLN3 ) localized to chromosome 16p11.2-12.1.",1
334,0,Is exome sequencing efficient for the detection of germline mutations?,Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas,1
334,1,Is exome sequencing efficient for the detection of germline mutations?,"Whole exome sequencing is sensitive, rapid and efficient for detection of PCC/PGL germline mutations.",1
334,2,Is exome sequencing efficient for the detection of germline mutations?,These results from deep sequencing demonstrate a higher mutational detection rate than reported with conventional sequencing methodology.,1
334,3,Is exome sequencing efficient for the detection of germline mutations?,We performed exome sequencing of germline DNA from members of the affected family.,1
334,4,Is exome sequencing efficient for the detection of germline mutations?,"Exome-wide analysis identified a novel loss-of-function mutation in the BAP1 gene, previously suggested as a tumor suppressor.",0
334,5,Is exome sequencing efficient for the detection of germline mutations?,"whole-exome sequencing has been widely applied in the identification of germline mutations underlying Mendelian disorders, somatic mutations in various cancers and de novo mutations in neurodevelopmental disorders.",1
392,0,What is the association between h-index and academic rank in academic neurosurgery?, The contemporary h-index was found to be significantly predictive of NIH funding (p<0.001).,1
392,1,What is the association between h-index and academic rank in academic neurosurgery?,"Bibliometric indices are higher for those with NIH funding compared to those without, but only the contemporary h-index was shown to be predictive of NIH funding.",1
392,2,What is the association between h-index and academic rank in academic neurosurgery?,"However, when stratified by academic rank, a trend was observed showing greater mean h-index scores for those who completed fellowships.",0
392,3,What is the association between h-index and academic rank in academic neurosurgery?,"Overall, being a senior faculty member corresponds with a greater h-index score, regardless of whether a fellowship was completed.",0
392,4,What is the association between h-index and academic rank in academic neurosurgery?,"There was a positive association between the h-index, academic rank, and years posttraining.",0
392,5,What is the association between h-index and academic rank in academic neurosurgery?,"Application of the h-index as a bibliometric in neurosurgery can distinguish academic productivity on the basis of academic rank, years posttraining, and neurosurgical subspecialties.",0
392,6,What is the association between h-index and academic rank in academic neurosurgery?,"Overall, the authors conclude that the h index metric is a reasonable measure of academic productivity in the pediatric neurosurgery arena that provides a robust measure of an individual's contribution to the pediatric neurosurgery literature.",0
392,7,What is the association between h-index and academic rank in academic neurosurgery?,The h index calculation also reveals the productivity of the pediatric neurosurgeons to be on par with the productivity of neurosurgeons in general.,0
392,8,What is the association between h-index and academic rank in academic neurosurgery?,The h-index frequency distribution conformed to both the log-linear variation of a power law (r                         (2) = .99) and the beta distribution with the same fitting exponents as previously described in a power law analysis of the productivity of neurosurgeons.,0
392,9,What is the association between h-index and academic rank in academic neurosurgery?,"The h indices increased significantly with increasing academic rank, with the median for instructors, assistant professors, associate professors, and professors being 2, 5, 10, and 19, respectively (p < 0.0001, Kruskal-Wallis; all groups significantly different from each other except the difference between instructor and assistant professor [Conover]).",1
392,10,What is the association between h-index and academic rank in academic neurosurgery?,Departmental chairs had a median h index of 22 (range 3-55) and program directors a median of 17 (range 0-62).,0
392,11,What is the association between h-index and academic rank in academic neurosurgery?,"Plot of the log of the rank versus h index demonstrated a remarkable linear pattern (R(2) = 0.995, p < 0.0001), suggesting that this is a power-law relationship.",0
392,12,What is the association between h-index and academic rank in academic neurosurgery?,The distribution of the h index within an academic population is described for the first time and appears related to the ubiquitous power-law distribution.,0
392,13,What is the association between h-index and academic rank in academic neurosurgery?,"As expected, the h index increased with academic rank and there was a statistically significant difference between each rank.",1
392,14,What is the association between h-index and academic rank in academic neurosurgery?,"Within the field of academic neurosurgery, clear differences of h indices between academic ranks exist.",0
392,15,What is the association between h-index and academic rank in academic neurosurgery?,"On average, an increase of the h index by 5 appears to correspond to the next highest academic rank, with the exception of chairperson.",1
392,16,What is the association between h-index and academic rank in academic neurosurgery?,Scopus h-index was of borderline significance in predicting physician salary (P = 0.12).,0
1342,0,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,"IFNAR1 ubiquitination is facilitated by the βTrcp E3 ubiquitin ligase that is recruited to IFNAR1 upon its degron phosphorylation, which is induced by the ligand.",0
1342,1,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.,0
1342,2,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,The SCF(betaTrcp) (Skp1-Cullin1-F-box complex) E3 ubiquitin ligase that mediates IFNAR1 ubiquitination and degradation in cells can conjugate both types of chains in vitro.,0
1342,3,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?, Levels of IFNAR1 (regulated via degradation mediated by the betaTrcp E3 ubiquitin ligase) and IFNalpha signaling were reduced in 1205Lu melanoma cell line that harbors activated BRAF and exhibits high levels of betaTrcp ubiquitin ligase.,0
1342,4,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,"IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis.",1
1342,5,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,"Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.",1
1342,6,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,"Here we show that IFNAR1 interacts with the Homolog of Slimb (HOS) F-box protein in a phosphorylation-dependent manner, and that this interaction is promoted by interferon alpha (IFNalpha).",1
1342,7,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,IFNAR1 is ubiquitinated by the Skp1-Cullin1-HOS-Roc1 (SCF(HOS)) ubiquitin ligase in vitro.,0
1342,8,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,The SCF(betaTrcp) (Skp1-Cullin1-F-box complex) E3 ubiquitin ligase that mediates IFNAR1 ubiquitination and degradation in cells can conjugate both types of chains in vitro.,0
1342,9,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,"IFNAR1 ubiquitination is facilitated by the βTrcp E3 ubiquitin ligase that is recruited to IFNAR1 upon its degron phosphorylation, which is induced by the ligand.",0
1342,10,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,"IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis.",1
1342,11,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.,0
1342,12,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,"Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner",1
1342,13,Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?,The SCF(betaTrcp) (Skp1-Cullin1-F-box complex) E3 ubiquitin ligase that mediates IFNAR1 ubiquitination and degradation in cells can conjugate both types of chains in vitro,0
3780,0,"What was the predominant rotavirus genotype in the pre-vaccine era, in Australia?",G1P[8] was the dominant genotype nationally in the prevaccine era (1995-2006).,1
3780,1,"What was the predominant rotavirus genotype in the pre-vaccine era, in Australia?","From 1995 to 2015, the Australian Rotavirus Surveillance Program conducted genotypic analysis on 13051 rotavirus-positive samples from children <5 years of age, hospitalized with acute gastroenteritis.",1
3780,2,"What was the predominant rotavirus genotype in the pre-vaccine era, in Australia?","In the pre-vaccine era, G1P[8] was most prevalent, ranging from 39% (411/1,057) to 74% (527/709) per year.",1
1957,0,What is the applicability of the MCAST algorithm?,MCAST: scanning for cis-regulatory motif clusters.,0
1957,1,What is the applicability of the MCAST algorithm?, The MCAST algorithm uses a hidden Markov model with a P-value-based scoring scheme to identify candidate CRMs.,1
1957,2,What is the applicability of the MCAST algorithm?,"Here, we introduce a new version of MCAST that offers improved graphical output, a dynamic background model, statistical confidence estimates based on false discovery rate estimation and, most significantly, the ability to predict CRMs while taking into account epigenomic data such as DNase I sensitivity or histone modification data.",0
1957,3,What is the applicability of the MCAST algorithm?,We demonstrate the validity of MCAST's statistical confidence estimates and the utility of epigenomic priors in identifying CRMs.AVAILABILITY AND IMPLEMENTATION: MCAST is part of the MEME Suite software toolkit.,0
1957,4,What is the applicability of the MCAST algorithm?,A web server and source code are available at http://meme-suite.org and http://alternate.meme-suite.org,0
1957,5,What is the applicability of the MCAST algorithm?,"On a data set of 16 gap and pair-rule genes containing 52 known CRMs, predictions made by HexDiff had a higher correlation with the known CRMs than several existing CRM prediction algorithms: Ahab, Cluster Buster, MSCAN, MCAST, and LWF.",0
1957,6,What is the applicability of the MCAST algorithm?,"The p-value scoring also allows mcast to only accept motif occurrences with significance below a user-specified threshold, while still assigning better scores to motif occurrences with lower p-values.",1
1957,7,What is the applicability of the MCAST algorithm?,"mcast can search long DNA sequences, modeling length distributions between motifs within a regulatory module, but ignoring length distributions between modules.",0
1957,8,What is the applicability of the MCAST algorithm?,"Given a collection of known transcription factor binding motifs, many bioinformatics methods have been proposed over the past 15 years for identifying within a genomic sequence candidate CRMs consisting of clusters of those motifs.The MCAST algorithm uses a hidden Markov model with a P-value-based scoring scheme to identify candidate CRMs.",1
1957,9,What is the applicability of the MCAST algorithm?,"The algorithm, called mcast, takes as input a DNA database and a collection of binding site motifs that are known to operate in concert.",1
1957,10,What is the applicability of the MCAST algorithm?,mcast uses a motif-based hidden Markov model with several novel features.,1
1957,11,What is the applicability of the MCAST algorithm?,"The algorithm, called mcast, takes as input a DNA database and a collection of binding site motifs that are known to operate in concert.",0
1957,12,What is the applicability of the MCAST algorithm?,"On a data set of 16 gap and pair-rule genes containing 52 known CRMs, predictions made by HexDiff had a higher correlation with the known CRMs than several existing CRM prediction algorithms: Ahab, Cluster Buster, MSCAN, MCAST, and LWF.",0
1957,13,What is the applicability of the MCAST algorithm?,MCAST: scanning for cis-regulatory motif clusters.,0
166,0,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,ChIPnorm: a statistical method for normalizing and identifying differential regions in histone modification ChIP-seq libraries.,0
166,1,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",1
166,2,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,We show that the ChIPnorm method removes most of the noise and bias in the data and outperforms other normalization methods.,0
166,3,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,We correlate the histone marks with gene expression data and confirm that histone modifications H3K27me3 and H3K4me3 act as respectively a repressor and an activator of genes.,0
166,4,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"Compared to what was previously reported in the literature, we find that a substantially higher fraction of bivalent marks in ES cells for H3K27me3 and H3K4me3 move into a K27-only state.",0
166,5,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,We find that most of the promoter regions in protein-coding genes have differential histone-modification sites.,0
166,6,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",1
166,7,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",1
166,8,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",1
166,9,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,We show that the ChIPnorm method removes most of the noise and bias in the data and outperforms other normalization methods.,0
166,10,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",1
166,11,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",0
166,12,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,We show that the ChIPnorm method removes most of the noise and bias in the data and outperforms other normalization methods.,0
166,13,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"This problem turns out to be surprisingly difficult, even in simple pairwise comparisons, because of the significant level of noise in ChIP-seq data.",0
166,14,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",0
166,15,Are there any statistical methods for normalizing and identifying differential regions in histone modification ChIP-seq data?,"In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types.",0
12,0,Which are the different isoforms of the mammalian Notch receptor?,"Here, we investigate protein interactions between NOTCH3 and other vascular Notch isoforms and characterize the effects of elevated NOTCH3 on smooth muscle gene regulation.",0
12,1,Which are the different isoforms of the mammalian Notch receptor?,"We demonstrate that NOTCH3 forms heterodimers with NOTCH1, NOTCH3, and NOTCH4.",0
12,2,Which are the different isoforms of the mammalian Notch receptor?,"We conclude that CADASIL mutants of NOTCH3 complex with NOTCH1, 3, and 4, slow NOTCH3 clearance, and that overexpressed wild type and mutant NOTCH3 protein interfere with key NOTCH-mediated functions in smooth muscle cells.",0
12,3,Which are the different isoforms of the mammalian Notch receptor?,"In the vertebrate embryo, skeletal muscle is derived from the myotome of the somites.",0
12,4,Which are the different isoforms of the mammalian Notch receptor?,Notch1-3 demonstrate overlapping and distinct expression patterns in mouse somites.,0
12,5,Which are the different isoforms of the mammalian Notch receptor?,Notch1 and Notch2 have been shown to be inhibitors of skeletal myogenesis.,0
12,6,Which are the different isoforms of the mammalian Notch receptor?,"In this study, we analyzed the immunohistochemical staining pattern of four Notch receptors (Notch1-4) and their ligands (Delta1 and Jagged1) in 14 synovial tissues obtained from 14 RA patients.",1
12,7,Which are the different isoforms of the mammalian Notch receptor?,"Notch signaling is an evolutionarily conserved mechanism, used to regulate cell fate decisions.",1
12,8,Which are the different isoforms of the mammalian Notch receptor?,Four Notch receptors have been identified in man (Notch-1 to -4).,1
12,9,Which are the different isoforms of the mammalian Notch receptor?,"All 4 receptors were expressed in the adult liver, with no significant differences in the levels of Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver.",1
12,10,Which are the different isoforms of the mammalian Notch receptor?,"However, Notch-3 expression appeared to be increased in diseased tissue.",0
12,11,Which are the different isoforms of the mammalian Notch receptor?,"We studied the immunohistochemical expression of NOTCH2 and its isoforms NOTCH1, NOTCH3, and NOTCH4 and the NOTCH2 primary ligand JAGGED1 in hepatoblastomas.",0
12,12,Which are the different isoforms of the mammalian Notch receptor?,There are four different mammalian Notch receptors that can be activated by five cell surface ligands,0
12,13,Which are the different isoforms of the mammalian Notch receptor?,There are four mammalian Notch receptors that have only partially overlapping functions despite sharing similar structures and ligands.,1
2698,0,Which method is Proseek based on?,"We used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n = 75) and age-matched healthy control subjects (n = 23).",1
2698,1,Which method is Proseek based on?,Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek,1
3047,0,Is there any approved treatment for NAFLD?,Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited.,1
3047,1,Is there any approved treatment for NAFLD?,"Non-alcoholic fatty liver disease (NAFLD) has become one of the most prominent forms of chronic liver disease worldwide, reflecting the epidemic of global obesity.",1
3047,2,Is there any approved treatment for NAFLD?,"Those with the progressive variant of NAFLD, non-alcoholic steatohepatitis (NASH), are at significantly increased risk of multisystem morbidity and mortality.",1
3047,3,Is there any approved treatment for NAFLD?,"However, there are currently no approved pharmacologic therapies for NASH.",1
3047,4,Is there any approved treatment for NAFLD?,"Although much progress has been made in enhancing our understanding of NAFLD pathogenesis, development of pharmacologic treatments has been hindered by challenges in clinical trial enrollment and complexities in clinical trial design.",1
3047,5,Is there any approved treatment for NAFLD?,"Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and there is no approved pharmacotherapy.",0
3047,6,Is there any approved treatment for NAFLD?,Nonalcoholic fatty liver disease (NAFLD) has an increasing prevalence worldwide.,0
3047,7,Is there any approved treatment for NAFLD?,"At present, no specific pharmacotherapy is approved for NAFLD.",0
1172,0,Which is the chromosomal location of the gene MAOA?,Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism.,1
1172,1,Which is the chromosomal location of the gene MAOA?," Using rodent-human somatic cell hybrids containing all or part of the human X chromosome, we have mapped these fragments to the region Xp21-p11.",1
282,0,Is the Wnt protein modified by notum?,Notum deacylates Wnt proteins to suppress signalling activity.,1
282,1,Is the Wnt protein modified by notum?,Kinetic and mass spectrometric analyses of human proteins show that Notum is a carboxylesterase that removes an essential palmitoleate moiety from Wnt proteins and thus constitutes the first known extracellular protein deacylase.,1
282,2,Is the Wnt protein modified by notum?,the Wnt inhibitor notum,1
282,3,Is the Wnt protein modified by notum?,the WNT-inhibitor notum.,1
1822,0,When did the polio vaccine becomes available?,"Inactivated poliovirus vaccine (IPV), developed in the USA by Jonas Salk in the early 1950s, was field tested in 1954,",1
1822,1,When did the polio vaccine becomes available?,"the use of an oral polio vaccine (OPV) during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959.",1
2270,0,Are there ultraconserved genomic regions in the budding yeast?,"Here, we present a systematic study of ultraconserved genomic regions in the budding yeast based on the publicly available genome sequences, in order to reveal their relationship with the adaptability or fitness advantages of the budding yeast.Results: Our results indicate that, in addition to some fundamental biological functions, the UCSs play an important role in the adaptation of S. cerevisiae to the acidic environment, which is backed up by the previous observation.",1
2270,1,Are there ultraconserved genomic regions in the budding yeast?,"Besides that, we also find the highly unchanged genes (HUGs) are enriched in some other pathways, such as the nutrient-sensitive signaling pathway.",1
2270,2,Are there ultraconserved genomic regions in the budding yeast?,"To facilitate the investigation of unique UCSs, the UCSC Genome Browser was utilized to visualize the chromosomal position and related annotations of UCSs in S. cerevisiae genome.",1
2270,3,Are there ultraconserved genomic regions in the budding yeast?,"Here, we present a systematic study of ultraconserved genomic regions in the budding yeast based on the publicly available genome sequences, in order to reveal their relationship with the adaptability or fitness advantages of the budding yeast.",1
3513,0,What is the role of Scc2/Nipbl?,Scc2 (Nipbl) stimulates cohesin's ABC-like ATPase and is essential for loading cohesin onto chromosomes.,1
3513,1,What is the role of Scc2/Nipbl?,"However, it is possible that the stimulation of cohesin's ATPase by Scc2 also has a post-loading function, for example driving loop extrusion.",0
3513,2,What is the role of Scc2/Nipbl?,"Using fluorescence recovery after photobleaching (FRAP) and single-molecule tracking in human cells, we show that Scc2 binds dynamically to chromatin, principally through an association with cohesin.",1
3513,3,What is the role of Scc2/Nipbl?,Scc2's movement within chromatin is consistent with a 'stop-and-go' or 'hopping' motion.,1
3513,4,What is the role of Scc2/Nipbl?,"We suggest that a low diffusion coefficient, a low stoichiometry relative to cohesin, and a high affinity for chromosomal cohesin enables Scc2 to move rapidly from one chromosomal cohesin complex to another, performing a function distinct from loading.",1
3513,5,What is the role of Scc2/Nipbl?,Scc2 (Nipbl) stimulates cohesin's ABC-like ATPase and is essential for loading cohesin onto chromosomes.,1
2210,0,Is dupilumab an antibody targeting the IL-1 receptor?,Atopic dermatitis (AD) is characterized by type 2 helper T (Th2) cell-driven inflammation.,0
2210,1,Is dupilumab an antibody targeting the IL-1 receptor?,"Dupilumab is a fully human monoclonal antibody directed against the IL-4 receptor α subunit that blocks the signaling of IL-4 and IL-13, both key cytokines in Th2-mediated pathways.",1
2210,2,Is dupilumab an antibody targeting the IL-1 receptor?,"Dupilumab, a humanized monoclonal antibody to the interteukin-4R is the first antibody (i.e.",1
2210,3,Is dupilumab an antibody targeting the IL-1 receptor?,'biological') with published efficacy shown in controlled prospective studies in atopic dermatitis.,0
2210,4,Is dupilumab an antibody targeting the IL-1 receptor?,"Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of atopic or allergic diseases such as atopic dermatitis.",1
2210,5,Is dupilumab an antibody targeting the IL-1 receptor?,"Best evidence of the clinical efficacy of novel immunologic approaches using biological agents in patients with AD is available for the anti-IL-4 receptor α-chain antibody dupilumab, but a number of studies are currently ongoing with other specific antagonists to immune system players.",0
2210,6,Is dupilumab an antibody targeting the IL-1 receptor?," Dupilumab, a fully human anti-interleukin-4 receptor α monoclonal antibody, inhibits interleukin-4 and interleukin-13 signalling, key drivers of type-2-mediated inflammation.",1
2210,7,Is dupilumab an antibody targeting the IL-1 receptor?,Dupilumab was also introduced as a possible treatment for patients with severe pemphigus.,0
2210,8,Is dupilumab an antibody targeting the IL-1 receptor?,It can directly inhibit IL-4 by targeting IL-4 α-chain receptor.,0
2210,9,Is dupilumab an antibody targeting the IL-1 receptor?,"We evaluated the efficacy and safety of dupilumab (SAR231893/REGN668), a fully human monoclonal antibody to the alpha subunit of the interleukin-4 receptor",1
2165,0,Which NGS alignment software implement the Burrows-Wheeler Transform?,"For the human genome, Burrows-Wheeler indexing allows Bowtie to align more than 25 million reads per CPU hour with a memory footprint of approximately 1.3 gigabytes.",0
2165,1,Which NGS alignment software implement the Burrows-Wheeler Transform?,Bowtie extends previous Burrows-Wheeler techniques with a novel quality-aware backtracking algorithm that permits mismatches.,0
2165,2,Which NGS alignment software implement the Burrows-Wheeler Transform?,"We implemented Burrows-Wheeler Alignment tool (BWA), a new read alignment package that is based on backward search with Burrows-Wheeler Transform (BWT), to efficiently align short sequencing reads against a large reference sequence such as the human genome, allowing mismatches and gaps.",0
2165,3,Which NGS alignment software implement the Burrows-Wheeler Transform?,SOAP2 is a significantly improved version of the short oligonucleotide alignment program that both reduces computer memory usage and increases alignment speed at an unprecedented rate.,0
2165,4,Which NGS alignment software implement the Burrows-Wheeler Transform?,We used a Burrows Wheeler Transformation (BWT) compression index to substitute the seed strategy for indexing the reference sequence in the main memory.,1
2165,5,Which NGS alignment software implement the Burrows-Wheeler Transform?,"We designed and implemented a new algorithm, Burrows-Wheeler Aligner's Smith-Waterman Alignment (BWA-SW), to align long sequences up to 1 Mb against a large sequence database (e.g.",0
2165,6,Which NGS alignment software implement the Burrows-Wheeler Transform?,the human genome) with a few gigabytes of memory.,0
2165,7,Which NGS alignment software implement the Burrows-Wheeler Transform?,"Here, we propose a new base-calling algorithm, TotalReCaller, to achieve improved performance.",0
2165,8,Which NGS alignment software implement the Burrows-Wheeler Transform?,"A linear error model for the raw intensity data and Burrows-Wheeler transform (BWT) based alignment are combined utilizing a Bayesian score function, which is then globally optimized over all possible genomic locations using an efficient branch-and-bound approach.",0
2165,9,Which NGS alignment software implement the Burrows-Wheeler Transform?,"To tackle this problem, a new alignment tool BWBBLE is introduced in this article.",0
2165,10,Which NGS alignment software implement the Burrows-Wheeler Transform?,"We (i) introduce a new compressed representation of a collection of genomes, which explicitly tackles the genomic variation observed at every position, and (ii) design a new alignment algorithm based on the Burrows-Wheeler transform that maps short reads from a newly sequenced genome to an arbitrary collection of two or more (up to millions of) genomes with high accuracy and no inherent bias to one specific genome.",0
2165,11,Which NGS alignment software implement the Burrows-Wheeler Transform?,"Seed-based algorithms are generally slow but robust, while Burrows-Wheeler Transform (BWT) based algorithms are fast but less robust.",0
2165,12,Which NGS alignment software implement the Burrows-Wheeler Transform?,"To have both advantages, we developed an algorithm FANSe2 with iterative mapping strategy based on the statistics of real-world sequencing error distribution to substantially accelerate the mapping without compromising the accuracy.",0
2165,13,Which NGS alignment software implement the Burrows-Wheeler Transform?,"Therefore, in this paper, we introduce Burrows-Wheeler Aligner's Smith-Waterman Alignment on Parallel MapReduce (BWASW-PMR) cloud platform for long sequence alignment.",1
2165,14,Which NGS alignment software implement the Burrows-Wheeler Transform?,"In this paper, we propose a BWA-MT tool, evolved from BWA but supporting multi-thread computation, designed to fully utilize the underlying multi-core architecture of computing resources.",0
2165,15,Which NGS alignment software implement the Burrows-Wheeler Transform?,"By using multi-thread computation, BWA-MT can significantly shorten the time needed to generate an alignment for single-end read sequences.",0
2165,16,Which NGS alignment software implement the Burrows-Wheeler Transform?,"The speed of MAQ is also a concern when the alignment is scaled up to the resequencing of hundreds of individuals.We implemented Burrows-Wheeler Alignment tool (BWA), a new read alignment package that is based on backward search with Burrows-Wheeler Transform (BWT), to efficiently align short sequencing reads against a large reference sequence such as the human genome, allowing mismatches and gaps",1
2165,17,Which NGS alignment software implement the Burrows-Wheeler Transform?,"Although the Burrows-Wheeler Aligner (BWA) tool is one of the most widely used open-source software tools to align read sequences, it is still limited in that it does not fully support multi-thread mechanisms during the alignment steps",1
2165,18,Which NGS alignment software implement the Burrows-Wheeler Transform?,"We implemented Burrows-Wheeler Alignment tool (BWA), a new read alignment package that is based on backward search with Burrows-Wheeler Transform (BWT), to efficiently align short sequencing reads against a large reference sequence such as the human genome, allowing mismatches and gaps.",0
2165,19,Which NGS alignment software implement the Burrows-Wheeler Transform?,"We designed and implemented a new algorithm, Burrows-Wheeler Aligner's Smith-Waterman Alignment (BWA-SW), to align long sequences up to 1 Mb against a large sequence database (e.g.",0
2165,20,Which NGS alignment software implement the Burrows-Wheeler Transform?,"Although the Burrows-Wheeler Aligner (BWA) tool is one of the most widely used open-source software tools to align read sequences, it is still limited in that it does not fully support multi-thread mechanisms during the alignment steps.",1
564,0,The drug JTV519 is derivative of which group of chemical compounds?,"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.",1
564,1,The drug JTV519 is derivative of which group of chemical compounds?,"The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.",0
564,2,The drug JTV519 is derivative of which group of chemical compounds?,"In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.",0
564,3,The drug JTV519 is derivative of which group of chemical compounds?,"K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.",0
564,4,The drug JTV519 is derivative of which group of chemical compounds?,"K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.",0
564,5,The drug JTV519 is derivative of which group of chemical compounds?,"A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.",0
564,6,The drug JTV519 is derivative of which group of chemical compounds?,"We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.",0
564,7,The drug JTV519 is derivative of which group of chemical compounds?,JTV519 is known to have a protective effect against Ca2+ overload-induced myocardial injury.,0
564,8,The drug JTV519 is derivative of which group of chemical compounds?,"In conclusion, JTV519, a new 1,4-benzothiazepine derivative, corrected the defective channel gating in RyR (increase in both the rapid conformational change and the subsequent Ca(2+) release rate) in HF.",0
564,9,The drug JTV519 is derivative of which group of chemical compounds?,"A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively.",0
564,10,The drug JTV519 is derivative of which group of chemical compounds?,"JTV-519, which has potential use as an antiarrhythmic [285800].",1
564,11,The drug JTV519 is derivative of which group of chemical compounds?,"The drug is a novel cardioprotectant derivative of 1,4-benzothiazepine for which phase I trials were completed in the third quarter of 1998",1
564,12,The drug JTV519 is derivative of which group of chemical compounds?,"The 1,4-benzothiazepine derivative JTV-519 is a new type of calcium ion channel modulator.",1
564,13,The drug JTV519 is derivative of which group of chemical compounds?,"A new 1,4-benzothiazepine derivative, JTV519 (JTV), has strong protective effects against isoproterenol-induced myocardial injury.",0
564,14,The drug JTV519 is derivative of which group of chemical compounds?,"A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective.",0
564,15,The drug JTV519 is derivative of which group of chemical compounds?,"Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation",0
564,16,The drug JTV519 is derivative of which group of chemical compounds?,"A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.",0
564,17,The drug JTV519 is derivative of which group of chemical compounds?," We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.",0
564,18,The drug JTV519 is derivative of which group of chemical compounds?,"Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.",0
564,19,The drug JTV519 is derivative of which group of chemical compounds?,"A new 1,4-benzothiazepine derivative, JTV519 (JTV), has strong protective effects against isoproterenol-induced myocardial injury.",0
564,20,The drug JTV519 is derivative of which group of chemical compounds?,"A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.",0
564,21,The drug JTV519 is derivative of which group of chemical compounds?," In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca?⁺ leak.",1
564,22,The drug JTV519 is derivative of which group of chemical compounds?,"The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.",0
564,23,The drug JTV519 is derivative of which group of chemical compounds?,"We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process",0
1750,0,Is synapsin a phosphoprotein?,Synapsin is an evolutionarily conserved presynaptic phosphoprotein.,1
1750,1,Is synapsin a phosphoprotein?,Synapsins as a family of presynaptic terminal phosphoprotein participates in neuronal development,1
1750,2,Is synapsin a phosphoprotein?,Synapsin III (SynIII) is a phosphoprotein,1
1750,3,Is synapsin a phosphoprotein?,The neuronal phosphoprotein synapsin III,1
1750,4,Is synapsin a phosphoprotein?,Synapsin II is a member of the neuronal phosphoprotein family.,1
1750,5,Is synapsin a phosphoprotein?,phosphoprotein synapsin,0
1058,0,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex",1
1058,1,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"We identified an interaction between the FA protein, FANCA and brm-related gene 1 (BRG1) product.",0
1058,2,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"BRG1 is a subunit of the SWI/SNF complex, which remodels chromatin structure through a DNA-dependent ATPase activity",1
1058,3,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,FANCA was demonstrated to associate with the endogenous SWI/SNF complex,1
1058,4,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"FANCA may recruit the SWI/SNF complex to target genes, thereby enabling coupled nuclear functions such as transcription and DNA repair",1
1058,5,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.",1
1058,6,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"We identified an interaction between the FA protein, FANCA and brm-related gene 1 (BRG1) product.",0
1058,7,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"Finally, we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.",0
1058,8,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"We identified an interaction between the FA protein, FANCA and brm-related gene 1 (BRG1) product",0
1058,9,Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?,"Finally, we demonstrated co-localization in the nucleus between transfected FANCA and BRG1",0
172,0,Is cytisine superior to nicotine replacement therapy for smoking cessation?,"The effectiveness of cytisine for continuous abstinence was superior to that of nicotine-replacement therapy at 1 week, 2 months, and 6 months.",1
172,1,Is cytisine superior to nicotine replacement therapy for smoking cessation?,"In a prespecified subgroup analysis of the primary outcome, cytisine was superior to nicotine-replacement therapy among women and noninferior among men.",1
172,2,Is cytisine superior to nicotine replacement therapy for smoking cessation?,"CONCLUSIONS: When combined with brief behavioral support, cytisine was found to be superior to nicotine-replacement therapy in helping smokers quit smoking, but it was associated with a higher frequency of self-reported adverse events.",1
1101,0,What is the minimal genome build?,"As a key focus of synthetic biology, building a minimal artificial cell has given rise to many discussions.",0
1101,1,What is the minimal genome build?,"A synthetic minimal cell will provide an appropriate chassis to integrate functional synthetic parts, devices and systems with functions that cannot generally be found in nature.",0
1101,2,What is the minimal genome build?,The design and construction of a functional minimal genome is a key step while building such a cell/chassis since all the cell functions can be traced back to the genome.,0
1101,3,What is the minimal genome build?,The field of Synthetic Biology seeks to apply engineering principles to biology in order to produce novel biological systems.,1
1101,4,What is the minimal genome build?,"One approach to accomplish this goal is the genome-driven cell engineering approach, which searches for functioning minimal genomes in naturally occurring microorganisms, which can then be used as a template for future systems.",1
1101,5,What is the minimal genome build?,Currently a prototypical minimal genome has not been discovered.,1
1101,6,What is the minimal genome build?,"The identification of the essential genes of bacteria and the minimal genome for the free-living cellular life could provide insights into the origin, evolution, and essence of life forms.",1
1101,7,What is the minimal genome build?,Minimal bacterial gene set comprises the genetic elements needed for survival of engineered bacterium on a rich medium.,0
1101,8,What is the minimal genome build?,This set is estimated to include 300-350 protein-coding genes.,0
1101,9,What is the minimal genome build?,One way of simplifying an organism with such a minimal genome even further is to constrain the amino acid content of its proteins.,0
1101,10,What is the minimal genome build?,A central undertaking in synthetic biology (SB) is the quest for the 'minimal genome'.,0
1101,11,What is the minimal genome build?,"However, 'minimal sets' of essential genes are strongly context-dependent and, in all prokaryotic genomes sequenced to date, not a single protein-coding gene is entirely conserved.",0
1101,12,What is the minimal genome build?,"Furthermore, a lack of consensus in the field as to what attributes make a gene truly essential adds another aspect of variation.",0
1101,13,What is the minimal genome build?,"Thus, a universal minimal genome remains elusive.",0
1101,14,What is the minimal genome build?,The minimal cell concept represents a pragmatic approach to the question of how few genes are required to run a cell.,0
1101,15,What is the minimal genome build?,"This is a helpful way to build a parts-list, and has been more successful than attempts to deduce a minimal gene set for life by inferring the gene repertoire of the last universal common ancestor, as few genes trace back to this hypothetical ancestral state.",1
770,0,What is the function of the yeast protein Aft1?,"Using a scheme for selecting mutants of Saccharomyces cerevisiae with abnormalities of iron metabolism, we have identified a gene, AFT1, that mediates the control of iron uptake",0
770,1,What is the function of the yeast protein Aft1?,AFT1 functions to activate transcription of target genes in response to iron deprivation and thereby plays a central role in iron homeostasis.,0
770,2,What is the function of the yeast protein Aft1?,Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast,0
770,3,What is the function of the yeast protein Aft1?,Iron deprivation of Saccharomyces cerevisiae induces transcription of genes required for high-affinity iron uptake.,0
770,4,What is the function of the yeast protein Aft1?,AFT1 mediates this transcriptional control.,0
770,5,What is the function of the yeast protein Aft1?,The AFT1 transcriptional factor is differentially required for expression of high-affinity iron uptake genes in Saccharomyces cerevisiae.,0
770,6,What is the function of the yeast protein Aft1?,"Aft1 displays phosphorylation modifications depending on the growth stage of the cells, and it might link induction of genes for iron uptake to other metabolically dominant requirement for cell growth.",0
770,7,What is the function of the yeast protein Aft1?,an aft1 mutation in S. cerevisiae that makes cells dependent on iron for growth,0
770,8,What is the function of the yeast protein Aft1?,Subcellular localization of Aft1 transcription factor responds to iron status in Saccharomyces cerevisiae.,0
770,9,What is the function of the yeast protein Aft1?,The Aft1 transcription factor regulates the iron regulon in response to iron availability in Saccharomyces cerevisiae.,1
770,10,What is the function of the yeast protein Aft1?,"Aft1 activates a battery of genes required for iron uptake under iron-starved conditions, whereas Aft1 function is inactivated under iron-replete conditions",1
770,11,What is the function of the yeast protein Aft1?,the nuclear export of Aft1 is critical for ensuring iron-responsive transcriptional activation of the Aft1 regulon and that the nuclear import/export systems are involved in iron sensing by Aft1 in S. cerevisiae.,0
770,12,What is the function of the yeast protein Aft1?,the Aft1 iron-responsive DNA-binding factor,0
770,13,What is the function of the yeast protein Aft1?,"Two transcriptional activators, Aft1 and Aft2, regulate iron homeostasis in Saccharomyces cerevisiae.",0
770,14,What is the function of the yeast protein Aft1?,iron sensing by Aft1/Aft2 is not linked to the maturation of cytosolic/nuclear Fe-S proteins,0
770,15,What is the function of the yeast protein Aft1?,"The yeast Saccharomyces cerevisiae contains a pair of paralogous iron-responsive transcription activators, Aft1 and Aft2.",0
770,16,What is the function of the yeast protein Aft1?,"Aft1 activates the cell surface iron uptake systems in iron depletion,",0
770,17,What is the function of the yeast protein Aft1?,the absence of either Aft1 or Aft2 showed an iron-dependent increase in the amount of the remaining paralog,0
770,18,What is the function of the yeast protein Aft1?,The transcription factors Aft1 and Aft2 from Saccharomyces cerevisiae regulate the expression of genes involved in iron homeostasis.,0
770,19,What is the function of the yeast protein Aft1?,iron insufficiency-responsive transcription factor Aft1,0
770,20,What is the function of the yeast protein Aft1?,The mRNA levels of 14 proteins involved in iron homeostasis were shown to be increased by cisplatin.,0
770,21,What is the function of the yeast protein Aft1?,"Interestingly, the expression of all 14 genes is known to be regulated by Aft1, a transcription factor activated in response to iron insufficiency",0
770,22,What is the function of the yeast protein Aft1?,Aft1 is a transcriptional activator in Saccharomyces cerevisiae that responds to iron availability and regulates the expression of genes in the iron regulon,0
770,23,What is the function of the yeast protein Aft1?,we found that Aft1 physically interacts with the FOB (ferrioxamine B) transporter Arn3,0
770,24,What is the function of the yeast protein Aft1?,These results suggest that Aft1 interacts with Arn3 and may regulate the ubiquitination of Arn3 in the cytosolic compartment,1
770,25,What is the function of the yeast protein Aft1?,"The Saccharomyces cerevisiae transcription factor Aft1 is activated in iron-deficient cells to induce the expression of iron regulon genes, which coordinate the increase of iron uptake and remodel cellular metabolism to survive low-iron conditions",0
770,26,What is the function of the yeast protein Aft1?,Aft1 has been implicated in numerous cellular processes including cell-cycle progression and chromosome stability,1
770,27,What is the function of the yeast protein Aft1?,We demonstrate that Aft1 works in parallel with the RIM101 pH pathway and the role of Aft1 in DNA damage repair is mediated by iron.,0
770,28,What is the function of the yeast protein Aft1?,"In contrast, through both directed studies and microarray transcriptional profiling, we show that the role of Aft1 in chromosome maintenance and benomyl resistance is independent of its iron regulatory role, potentially through a nontranscriptional mechanism.",0
770,29,What is the function of the yeast protein Aft1?,Aft1p is a major iron regulator in budding yeast Saccharomyces cerevisiae.,0
770,30,What is the function of the yeast protein Aft1?,It indirectly senses cytosolic Fe status and responds by activating or repressing iron regulon genes,0
770,31,What is the function of the yeast protein Aft1?,Expression of components of the high-affinity system is controlled by the Aft1 transcriptional factor,0
770,32,What is the function of the yeast protein Aft1?,Iron-responsive transcription factor Aft1 interacts with kinetochore protein Iml3 and promotes pericentromeric cohesin,0
770,33,What is the function of the yeast protein Aft1?,"The Saccharomyces cerevisiae iron-responsive transcription factor, Aft1, has a well established role in regulating iron homeostasis through the transcriptional induction of iron-regulon genes",0
770,34,What is the function of the yeast protein Aft1?,recent studies have implicated Aft1 in other cellular processes independent of iron regulation such as chromosome stability,0
770,35,What is the function of the yeast protein Aft1?,Aft1 interacts with and co-localizes with kinetochore proteins,0
770,36,What is the function of the yeast protein Aft1?,Our work defines a new role for Aft1 in chromosome stability and transmission.,0
770,37,What is the function of the yeast protein Aft1?,"Our genetic network reveals that Aft1 affects a diverse range of cellular processes, including the RIM101 pH pathway, cell-wall stability, DNA damage, protein transport, chromosome stability, and mitochondrial function.",1
3338,0,What does MVA85A stand for?,"A non-randomised, open-label, Phase I safety and immunogenicity dose-finding study to assess the safety and immunogenicity of the candidate TB vaccine Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) from Mycobacterium tuberculosis (MTB) in healthy adult volunteers previously vaccinated with BCG.",1
3116,0,What is CVT-301?,"Further approaches to enhance LD efficacy are focused on new non-oral administration routes, including nasal, intra-duodenal, intrapulmonary (CVT-301) and subcutaneous (ND0612), as well as on novel ER formulations, including IPX066, which recently concluded phase III trial.",0
3116,1,What is CVT-301?,Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease.,0
3116,2,What is CVT-301?,"BACKGROUND: CVT-301, an inhaled levodopa (LD) formulation, is under development for relief of OFF periods in Parkinson's disease (PD).",1
3116,3,What is CVT-301?,"Previously, we reported that CVT-301 improved OFF symptoms relative to placebo.",0
3116,4,What is CVT-301?,Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson's disease.,0
3116,5,What is CVT-301?,Areas covered: CVT-301 is a self-administered dry powder aerosol inhaled formulation of LD that is being developed as a self-administered treatment for OFF periods.,1
3116,6,What is CVT-301?,"During a placebo-controlled trial of an inhaled levodopa formulation, CVT-301, in PD patients with ≥2 h/d of OFF time, spirometry was performed by American Thoracic Society (ATS) guidelines at screening and throughout the 4-week treatment period.",0
3116,7,What is CVT-301?,"ND0612 is a proprietary liquid formulation of LD/CD that enables subcutaneous administration via a small patch-pump device, and CVT-301 is a levodopa inhalation powder with rapid onset of action; both are currently in active studies.",0
3116,8,What is CVT-301?,CVT-301 is a powder formulation of levodopa delivered by a breath-actuated inhaler that has been developed for treating OFF episodes (motor fluctuations between doses of standard oral levodopa) in patients with Parkinson's disease (PD).,0
3116,9,What is CVT-301?,CVT-301 is a levodopa inhalation powder with the potential for rapid onset of action.,0
3116,10,What is CVT-301?,The objective of this study was to evaluate CVT-301 self-administered by PD patients to relieve OFF episodes.,0
3116,11,What is CVT-301?,"CONCLUSIONS: CVT-301 self-administered during OFF episodes provided rapid improvement of motor function, and daily OFF time was significantly reduced at the higher dose.",1
3116,12,What is CVT-301?,"BACKGROUND
CVT-301, an inhaled levodopa (LD) formulation, is under development for relief of OFF periods in Parkinson's disease (PD).",0
3116,13,What is CVT-301?,CVT-301 is a levodopa inhalation powder with the potential for rapid onset of action.,0
3116,14,What is CVT-301?,A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.,1
3116,15,What is CVT-301?,CVT-301 is a powder formulation of levodopa delivered by a breath-actuated inhaler that has been developed for treating OFF episodes (motor fluctuations between doses of standard oral levodopa) in patients with Parkinson's disease (PD).,0
3116,16,What is CVT-301?,Areas covered: CVT-301 is a self-administered dry powder aerosol inhaled formulation of LD that is being developed as a self-administered treatment for OFF periods.,1
3116,17,What is CVT-301?,CVT-301 is a levodopa inhalation powder with the potential for rapid onset of action.,0
1080,0,How is bladder wall thickness measured?,Modifications of the bladder wall (organ damage) in patients with bladder outlet obstruction: ultrasound parameters.,1
1080,1,How is bladder wall thickness measured?,Early identification of bladder changes by noninvasive transabdominal ultrasound,1
1080,2,How is bladder wall thickness measured?,"Measurement of the bladder wall thickness (BWT) or detrusor wall thickness (DWT) by US is reliable,",1
1080,3,How is bladder wall thickness measured?,"Also conventional US detects established signs of bladder damage: diverticulosis, trabecolations in the bladder wall (pseudo-diverticula),",1
1080,4,How is bladder wall thickness measured?,non-invasive US of the bladder wall,1
1080,5,How is bladder wall thickness measured?,"BladderScan BVM 9500 device (Diagnostic Ultrasound, Bothell, WA) was used to measure bladder wall thickness",0
1080,6,How is bladder wall thickness measured?,ultrasonography-estimated bladder weight and bladder wall thickness,0
1080,7,How is bladder wall thickness measured?,To identify measurements of ultrasonography (US)-derived bladder wall thickness (BWT),0
1080,8,How is bladder wall thickness measured?,transabdominal US measurements of BWT and,0
1080,9,How is bladder wall thickness measured?,Transvaginal ultrasound measurement of bladder wall thickness:,0
1080,10,How is bladder wall thickness measured?,ultrasound (US) techniques to measure bladder wall thickness (BWT).,0
1080,11,How is bladder wall thickness measured?,Women underwent US measurement of BWT,0
1080,12,How is bladder wall thickness measured?,Transabdominal and transperineal US for measuring BWT,0
1080,13,How is bladder wall thickness measured?,ultrasound bladder and detrusor wall thickness,0
1080,14,How is bladder wall thickness measured?,Ultrasonic measurements of urinary bladders are suitable to quantify bladder wall hypertrophy,0
1080,15,How is bladder wall thickness measured?,ultrasonic bladder wall measurements t,0
1080,16,How is bladder wall thickness measured?,"Preliminary data on the automatic measurement of bladder wall thickness were reported, suggesting a good repeatability and agreement with conventional ultrasound imaging",0
1080,17,How is bladder wall thickness measured?, conventional ultrasound bladder wall thickness (BWT) measurements,0
1080,18,How is bladder wall thickness measured?,Ultrasonographic measurement of bladder wall thickness,0
1080,19,How is bladder wall thickness measured?,All children underwent ultrasonography to measure bladder wall thickness,0
1080,20,How is bladder wall thickness measured?,Ultrasonographic assessment of bladder wall thickness is a sensitive screening tool,0
1080,21,How is bladder wall thickness measured?,ultrasound for bladder wall thickness (BWT),0
1080,22,How is bladder wall thickness measured?,transabdominal ultrasonography for bladder volume and detrusor muscle thickness,0
1080,23,How is bladder wall thickness measured?,"Transabdominal ultrasonography with a high-frequency probe was performed to obtain the anterior, posterior, and lateral bladder wall thicknesses.",0
1080,24,How is bladder wall thickness measured?,ultrasonographic estimate of bladder wall thickness.,0
1080,25,How is bladder wall thickness measured?,ultrasonographic estimate of bladder wall thickness.,0
1080,26,How is bladder wall thickness measured?,"there are marked differences in sonographic findings in male and female neonates in regard to renal pelvic dilatation, renal size and bladder wall thickness",0
1080,27,How is bladder wall thickness measured?,BWT was measured by suprapubic ultrasonography.,0
1080,28,How is bladder wall thickness measured?,transvaginal ultrasound measurement of bladder wall thickness,0
1080,29,How is bladder wall thickness measured?,The measurement of a mean bladder wall thickness greater than 5 mm with transvaginal ultrasound,0
1615,0,Are high-flow nasal cannulae effective for treatment of preterm infants?,"The use of high-flow nasal cannulae is an increasingly popular alternative to nasal continuous positive airway pressure (CPAP) for noninvasive respiratory support of very preterm infants (gestational age, <32 weeks) after extubation.",1
1615,1,Are high-flow nasal cannulae effective for treatment of preterm infants?,"The use of high-flow nasal cannulae was noninferior to the use of nasal CPAP, with treatment failure occurring in 52 of 152 infants (34.2%) in the nasal-cannulae group and in 39 of 151 infants (25.8%) in the CPAP group (risk difference, 8.4 percentage points; 95% confidence interval, -1.9 to 18.7).",1
1615,2,Are high-flow nasal cannulae effective for treatment of preterm infants?,"Although the result for the primary outcome was close to the margin of noninferiority, the efficacy of high-flow nasal cannulae was similar to that of CPAP as respiratory support for very preterm infants after extubation.",1
1615,3,Are high-flow nasal cannulae effective for treatment of preterm infants?,"Recently high flow nasal cannula (HFNC) is emerging as an efficient, better tolerated form of NIV, allowing better access to the baby's face, which may improve nursing, feeding and bonding.",0
1615,4,Are high-flow nasal cannulae effective for treatment of preterm infants?,"In conclusion, there is a growing evidence of the feasibility of HFNC as an alternative mode of NIV.",0
1615,5,Are high-flow nasal cannulae effective for treatment of preterm infants?,HHHFNC and NCPAP produced similar rates of extubation failure.,0
1615,6,Are high-flow nasal cannulae effective for treatment of preterm infants?,"The use of HFNC as a respiratory support modality is increasing in the infant, pediatric, and adult populations as an alternative to non-invasive positive pressure ventilation.",0
1615,7,Are high-flow nasal cannulae effective for treatment of preterm infants?,Current evidence suggests that HFNC is well tolerated and may be feasible in a subset of patients who require ventilatory support with non-invasive ventilation.,0
1615,8,Are high-flow nasal cannulae effective for treatment of preterm infants?,"Heated, humidified, high-flow nasal cannula oxygen therapy (HHHFNC) has been used to improve ventilation in preterm infants.",0
1615,9,Are high-flow nasal cannulae effective for treatment of preterm infants?,Increasing flow rates of HHHFNC therapy are associated with linear increases in NP pressures in bronchiolitis patients.,0
1615,10,Are high-flow nasal cannulae effective for treatment of preterm infants?,An alternative to the use of nasal continuous positive airway pressure (NCPAP) as a non-invasive modality to support respiratory distress in premature infants has been the recent introduction of high flow nasal cannula (HFNC) devices in many neonatal units.,1
1615,11,Are high-flow nasal cannulae effective for treatment of preterm infants?,"There has been increased use of HFNC presumably because of anecdotal reports and experience that it is easy to use, and well tolerated by the infants, while experiencing decreased nasal septumerosion.",0
1615,12,Are high-flow nasal cannulae effective for treatment of preterm infants?,High-flow nasal cannulae (HFNC) are gaining in popularity as a form of non-invasive respiratory support for preterm infants in neonatal intensive care units around the world.,0
1615,13,Are high-flow nasal cannulae effective for treatment of preterm infants?,"HFNC may be as effective as NCPAP at improving respiratory parameters such as tidal volume and work of breathing in preterm infants, but probably only at flow rates >2 litres/min.",0
1615,14,Are high-flow nasal cannulae effective for treatment of preterm infants?,There is growing evidence of the feasibility of HFNC as an alternative to other forms of non-invasive ventilation in preterm infants.,0
1615,15,Are high-flow nasal cannulae effective for treatment of preterm infants?,"When used as primary respiratory support after birth, one trial found similar rates of treatment failure in infants treated with HFNC and nasal CPAP.",0
1615,16,Are high-flow nasal cannulae effective for treatment of preterm infants?,"Following extubation, one trial found that infants treated with HFNC had a significantly higher rate of reintubation than those treated with nasal CPAP.",0
1615,17,Are high-flow nasal cannulae effective for treatment of preterm infants?,"Another trial found similar rates of reintubation for humidified and non-humidified HFNC, and the fourth trial found no difference between two different models of equipment used to deliver humidified HFNC.",0
1615,18,Are high-flow nasal cannulae effective for treatment of preterm infants?,"When used following extubation, HFNC may be associated with a higher rate of reintubation than nasal CPAP.",0
1615,19,Are high-flow nasal cannulae effective for treatment of preterm infants?,Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial.,0
1615,20,Are high-flow nasal cannulae effective for treatment of preterm infants?,"After randomization, the no-NC group had fewer days on oxygen [median (interquartile range): 5 (1-8) vs 14 (7.5-19.25) days, p<0.001] and shorter duration of respiratory support [10.5 (4-21) vs 18 (11.5-29) days, p=0.03].",0
1615,21,Are high-flow nasal cannulae effective for treatment of preterm infants?,There were no differences between groups regarding success of weaning from NCPAP.,0
1615,22,Are high-flow nasal cannulae effective for treatment of preterm infants?,Weaning preterm infants from NCPAP to NC is associated with increased exposure to oxygen and longer duration of respiratory support.,1
1615,23,Are high-flow nasal cannulae effective for treatment of preterm infants?,A number of centers use high-flow nasal cannula (HFNC) in the management of AOP without measuring the positive distending pressure (PDP) generated.,0
1615,24,Are high-flow nasal cannulae effective for treatment of preterm infants?,HFNC is as effective as NCPAP in the management of AOP.,0
1789,0,What causes Scurvy?,"They presented with limp, and an elaborate panel of tests and procedures were undertaken before the diagnosis of scurvy was made.",0
1789,1,What causes Scurvy?,Treatment with vitamin C led to rapid recovery of symptoms.,0
1789,2,What causes Scurvy?," Scurvy, or ""Barlow's disease"", is a widely described disease involving cutaneous and mucosal lesions resulting from vitamin C deficiency.",1
1789,3,What causes Scurvy?,"Scurvy, a disease of dietary deficiency of vitamin C, is uncommon today.",1
1789,4,What causes Scurvy?,"Because many of the early symptoms of vitamin C deficiency (fatigue, malaise, depression and irritability) are non-specific, the diagnostic possibility of scurvy is usually delayed until haemorrhagic manifestations occur.",0
1789,5,What causes Scurvy?,"Scurvy is caused by prolonged dietary deficiency of vitamin C, the plasma concentration of which appears inversely related to mortality from all causes",0
1789,6,What causes Scurvy?,Scurvy is a rarely seen disease resulting from a deficiency of vitamin C. We present a case of scurvy in a 65-year-old man,1
1789,7,What causes Scurvy?,Ascorbic acid is a vitamin soluble in water and its deficiency in human body causes scurvy.,0
1789,8,What causes Scurvy?,"Deficiencies in vitamin C can lead to conditions such as scurvy, which, among other ailments, causes gingivia, bone pain, and impaired wound healing.",0
1789,9,What causes Scurvy?,"Severe deficiency leads to scurvy, whereas a limited vitamin C intake causes general symptoms, such as increased susceptibility to infections, fatigue, insomnia, and weight loss.",0
1789,10,What causes Scurvy?,"Vitamin C deficiency causes scurvy a serious and painful disease in which defective collagen prevents the formation of strong connective tissue, gums deteriorate and bleed, with loss of teeth; skin discolors, and wounds do not heal.",0
1789,11,What causes Scurvy?,The human body is unable to synthesise Vitamin C and a diet deficient in Vitamin C leads to scurvy.,0
1789,12,What causes Scurvy?,"Scurvy may mimic other medical conditions, like bleeding diasthesis or deep vein thrombosis, leading to delay in diagnosis and treatment, thus prolonging sufferings of patients.",0
1789,13,What causes Scurvy?,"Often, scurvy could have been diagnosed if it is thought of and features of scurvy carefully looked for.",0
1789,14,What causes Scurvy?,"Scurvy, a disease of dietary deficiency of vitamin C, is uncommon today.",0
1789,15,What causes Scurvy?,"Among diseases, scurvy has a rich history and an ancient past.",0
1789,16,What causes Scurvy?,"Scurvy may mimic other medical conditions, like bleeding diasthesis or deep vein thrombosis, leading to delay in diagnosis and treatment, thus prolonging sufferings of patients.",0
1789,17,What causes Scurvy?,"Often, scurvy could have been diagnosed if it is thought of and features of scurvy carefully looked for.",0
1789,18,What causes Scurvy?,Scurvy is easily treated with high dose of oral vitamin C.,0
1789,19,What causes Scurvy?,Scurvy is caused by prolonged severe dietary deficiency of vitamin C.,0
1789,20,What causes Scurvy?,"Scurvy, caused by lack of vitamin C, was a major problem for polar explorers.",0
1789,21,What causes Scurvy?,curvy is the clinical manifestation of vitamin C deficiency.,0
1789,22,What causes Scurvy?,Scurvy is a nondiscriminatory disease process resulting from a nutritional deficiency of ascorbic acid (vitamin C).,1
1789,23,What causes Scurvy?,In modern times scurvy is a rarely encountered disease caused by ascorbic acid (vitamin C) deficiency.,1
152,0,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Importantly, ceftriaxone is currently in clinical trials for the treatment of amyotrophic lateral sclerosis.",1
152,1,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,Ceftriaxone delays loss of neurons in genetic animal models of amyotrophic lateral sclerosis through upregulation of astrocytic glutamate transporter expression (GLT-1).,1
152,2,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"OBJECTIVES: Ceftriaxone increases expression of the astrocytic glutamate transporter, EAAT2, which might protect from glutamate-mediated excitotoxicity.",0
152,3,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Thirty-four compounds (including riluzole, ceftriaxone, minocyclin, PBA, lithium, acetylcysteine) in human and mouse ALS trials and an additional set of 1040 FDA-approved compounds also showed no effect on SOD1 promoter activity.",0
152,4,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,Two of these patients received ceftriaxone for 1 month without clinical improvement.,0
152,5,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"In amyotrophic lateral sclerosis, down-regulation of the astrocyte-specific glutamate excitatory amino acid transporter 2 is hypothesized to increase extracellular glutamate, thereby leading to excitotoxic motor neuron death.",0
152,6,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,The antibiotic ceftriaxone was recently reported to induce excitatory amino acid transporter 2 and to prolong the survival of mutant superoxide dismutase 1 transgenic mice.,0
152,7,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"OBJECTIVE: Ceftriaxone has been reported to reduce neuronal damage in amyotrophic lateral sclerosis and in an in-vitro model of neuronal ischaemia through increased expression and activity of the glutamate transporter, GLT1.",1
152,8,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Dysfunction of EAAT2 is implicated in acute and chronic neurological disorders, including stroke/ischemia, temporal lobe epilepsy, amyotrophic lateral sclerosis, Alzheimer disease, human immunodeficiency virus 1-associated dementia, and growth of malignant gliomas.",0
152,9,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Ceftriaxone, one of the beta-lactam antibiotics, is a stimulator of EAAT2 expression with neuroprotective effects in both in vitro and in vivo models based in part on its ability to inhibit neuronal cell death by glutamate excitotoxicity.",0
152,10,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy.,0
152,11,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,This report summarizes what we believe to be the first verifiable case of a significant and progressive motor neuron disease (MND) consistent with amyotrophic lateral sclerosis that resolved during treatment with i.v.,0
152,12,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,ceftriaxone plus oral atovaquone and mefloquine.,0
152,13,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Other agents (ceftriaxone, minocycline, ONO-2506, and IGF-1 polypeptide) are already in phase III trials involving large numbers of patients with ALS.",0
152,14,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Ongoing trials are exploring the value of antiglutamatergic agents, including the cephalosporin antibiotic ceftriaxone, as well as antioxidants, mitochondrial enhancers and anti-apoptotic drugs.",0
152,15,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Recently, Rothstein et al.",0
152,16,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"reported that beta-lactam antibiotics, including penicillin and ceftriaxone, are potential therapeutic drugs to treat some neurological disorders, e.g., amyotrophic lateral sclerosis (ALS), by modulating the expression of glutamate transporter GLT1 via gene activation.",1
152,17,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Ceftriaxone was neuroprotective in vitro when used in models of ischaemic injury and motor neuron degeneration, both based in part on glutamate toxicity.",0
152,18,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"When used in an animal model of the fatal disease ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival.",0
152,19,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"We describe two patients with lateral amyotrophic sclerosis who, after informed consent, received empirical treatment with intravenous cephtriaxone at a dose of 2 g/24 hours for three weeks, with no positive results.",0
152,20,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,"Despite promising stage 2 data, stage 3 of this trial of ceftriaxone in amyotrophic lateral sclerosis did not show clinical efficacy.",0
152,21,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?," Importantly, ceftriaxone is currently in clinical trials for the treatment of amyotrophic lateral sclerosis.",1
152,22,What is known about clinical efficacy of ceftriaxone for treatment of amyotrophic lateral sclerosis?,The cephalosporin antibiotic ceftriaxone was evaluated as a potential therapeutic agent for the treatment of amyotrophic lateral sclerosis (ALS).,0
2802,0,Does gepotidacin activate bacterial topoisomerase?,GSK2140944 is a novel bacterial topoisomerase inhibitor in development for the treatment of bacterial infections.,1
2743,0,What does the pembrolizumab companion diagnostic test assess?,"The initial approval and subsequent studies of pembrolizumab required and utilized a companion diagnostic test, Dako's IHC 22C3, to assess PD-L1 status of patients.",1
2155,0,What is a miR?,"As novel molecules, microRNAs (miRs) take part in regulating protein-coding gene expression at the post-transcriptional level,",1
2155,1,What is a miR?,The discovery of microRNA (miRNA) regulation in tumorigenesis,1
2155,2,What is a miR?,MiRs are small (~23 nt) noncoding RNAs that regulate gene expression by specifically interacting with the 3' untranslated region (UTR) of target gene mRNA to repress translation or enhance mRNA cleavage.,1
2155,3,What is a miR?,The discovery of microRNAs (miRNAs) has opened an entire new avenue for drug development.,1
2155,4,What is a miR?,"These short (15-22 nucleotides) noncoding RNAs, which function in RNA silencing and posttranscriptional regulation of gene expression, have been shown to critically affect numerous pathways in both development and disease progression.",1
3204,0,What is the function of the cGAS pathway?,Cyclic di-AMP (c-di-AMP) is a bacterial signaling nucleotide synthesized by several human pathogens.,0
3204,1,What is the function of the cGAS pathway?,Cyclic GMP-AMP synthase (cGAS) has recently been identified as the primary protein that detects cytosolic double stranded DNA to invoke a type I interferon response.,0
3204,2,What is the function of the cGAS pathway?,The cGAS pathway is vital in the recognition of DNA encoded viruses as well as self-DNA leaked from the nucleus of damaged cells.,1
3204,3,What is the function of the cGAS pathway?,These results indicate that activation of the cGAS pathway is important for intrinsic antitumor immunity and that cGAMP may be used directly for cancer immunotherapy.,1
3204,4,What is the function of the cGAS pathway?, this work identifies long DNA as the molecular entity stimulating the cGAS pathway upon cytosolic DNA challenge such as viral infections.,1
3204,5,What is the function of the cGAS pathway?,"these data suggest that inactivation of the cGAS pathway plays a critical role in tumour progression, and reveal a direct link between hypoxia-responsive miRNAs and adaptive immune responses to the hypoxic tumour microenvironment, thus unveiling potential new therapeutic strategies.",0
3204,6,What is the function of the cGAS pathway?,dysregulation of the cGAS pathway is linked to autoimmune diseases while targeted stimulation may be of benefit in immunoncology.,0
3204,7,What is the function of the cGAS pathway?,The cGAS-STING pathway not only mediates protective immune defense against infection by a large variety of DNA-containing pathogens but also detects tumor-derived DNA and generates intrinsic antitumor immunity.,1
3204,8,What is the function of the cGAS pathway?,our data indicate that the cGAS-STING pathway plays a role in the surveillance of HBV infection and may be exploited for development of novel anti-HBV strategies.,1
1997,0,Which are the typical symptoms of Ménière's disease?,"To evaluate the onset of vertigo, hearing loss and tinnitus in Ménière's disease and the associated endolymphatic hydrops (EH) of the inner ear.",1
1997,1,Which are the typical symptoms of Ménière's disease?,"We suggest that a 3T MRI measurement should be carried out in patients with sensory-neural hearing loss, vertigo and tinnitus, 4 h after the intravenous injection of a gadolinium-contrast agent to verify the inner ear pathology.",0
1997,2,Which are the typical symptoms of Ménière's disease?,Eleven of the 17425 veterans appeared to have typical Ménière's Disease.,1
1997,3,Which are the typical symptoms of Ménière's disease?,"Their symptoms included attacks of vertigo, lasting between half an hour and a few hours and no more than 24 hours; the sensation of aural fullness; and tinnitus accompanied by a fluctuating or permanent low-tone hearing loss.",0
1997,4,Which are the typical symptoms of Ménière's disease?,"Diagnosis of Menière's Disease is based upon the wellknown labyrinthic syndrome (hypoacusia, tinnitus and dizziness) which manifests with the typical abscessual, recurrent and unforeseeable course.",0
1997,5,Which are the typical symptoms of Ménière's disease?,"Typical clinical manifestations of Ménière's disease (vertigo, sensorineural hearing loss and tinnitus) were found in 6/11 patients (54.5%) in the Lyme disease group.",1
1997,6,Which are the typical symptoms of Ménière's disease?,"Among 93 patients presenting the typical symptoms of a Ménière's disease associating an unilateral fluctuating hearing loss of sensorineural type, tinnitus and vertiginous attacks lasting minutes to hours, 40 patients (43%) presented in their personal history a particular otologic insult in the ear which later on developed into the full Ménière's symptomatology, or a particular systemic disease with otologic manifestations.",0
1997,7,Which are the typical symptoms of Ménière's disease?,"Fourteen children (aged 14 years or younger) with typical Ménière's triad with cochlear sensorineural hearing loss, tinnitus, and intermittent vertigo attacks lasting from minutes to hours were investigated in four different neuro-otologic centers.",0
1997,8,Which are the typical symptoms of Ménière's disease?,"Among 93 patients presenting the typical symptoms of a Ménière's disease associating an unilateral fluctuating hearing loss of sensorineural type, tinnitus and vertiginous attacks lasting minutes to hours, 40 patients (43%) presented in their personal history a particular otologic insult in the ear which later on developed into the full Ménière's symptomatology, or a particular systemic disease with otologic manifestations.",0
1997,9,Which are the typical symptoms of Ménière's disease?,"To evaluate the onset of vertigo, hearing loss and tinnitus in Ménières disease and the associated endolymphatic hydrops (EH) of the inner ear.Multicentre evaluation of three patient groups.Disease-specific symptoms were reviewed among referred patients in a tertiary referral hospital in Finland and in members of a Finnish Ménière Association in Finland",0
1997,10,Which are the typical symptoms of Ménière's disease?,"In monosymptomatic patients with vertigo, tinnitus or hearing loss; EH was demonstrated in 55-90% of the patients either in the cochlea and/or the vestibulum of the symptomatic ear.Ménières disease often shows bilateral EH and comprises a continuum from a monosymptomatic disease to the typical symptom complex of the disease",0
1997,11,Which are the typical symptoms of Ménière's disease?,"Typical clinical manifestations of Ménière's disease (vertigo, sensorineural hearing loss and tinnitus) were found in 6/11 patients (54.5%) in the Lyme disease group.",1
1997,12,Which are the typical symptoms of Ménière's disease?,"Nine children, labeled as having ""idiopathic Ménière's disease,"" developed the auditory and vestibular symptoms without any detectable causative factor.",1
1997,13,Which are the typical symptoms of Ménière's disease?,"To evaluate the onset of vertigo, hearing loss and tinnitus in Ménière's disease and the associated endolymphatic hydrops (EH) of the inner ear.Multicentre evaluation of three patient groups.Disease-specific symptoms were reviewed among referred patients in a tertiary referral hospital in Finland and in members of a Finnish Ménière Association in Finland.",0
1997,14,Which are the typical symptoms of Ménière's disease?,"In each twin pair, one twin had migraine and Ménière's disease, whereas the other experienced migraine and episodic vertigo without auditory symptoms.The frequent association of episodic vertigo, migraine, and Ménière's disease in closely related individuals, including identical twins supports the heritability of a migraine-Ménière's syndrome, with variable expression of the individual features of hearing loss, episodic vertigo, and migraine headaches.",0
1997,15,Which are the typical symptoms of Ménière's disease?,"There has been literature, beginning with Ménière himself, suggesting a relationship between Ménière's disease and migraine-associated dizziness.",0
1997,16,Which are the typical symptoms of Ménière's disease?,"In the characterizations of the migraine-associated dizziness, the signs and symptoms show overlap with those characterizing Meniere's disease.",0
4037,0,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Preliminary clinical results have indicated that antagonism of the IL-6 receptor (IL-6R), including with the FDA-approved humanized monoclonal antibody tocilizumab, can improve the outcomes of patients with severe or critical COVID-19 while maintaining a good safety profile.",0
4037,1,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab, an anti-IL-6 receptor antibody, and corticosteroids were initially used to treat the increase in acute inflammatory proteins and the anasarca, resulting in decreased cytokine levels.",0
4037,2,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab, a monoclonal antibody against the IL-6 receptor, was initiated at a dose of 8 mg/kg every 4 weeks.",0
4037,3,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,we randomly assigned patients with type 2 diabetes or obesity to intravenous tocilizumab (an IL-6 receptor antagonist),0
4037,4,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?, Clinical studies are investigating whether tocilizumab (anti-IL-6 receptor) can help preserve beta cell function in patients recently diagnosed with T1D,0
4037,5,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab (RoActemra or Actemra) is a recombinant humanized monoclonal antibody that acts as an interleukin (IL)-6 receptor antagonist.,1
4037,6,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"To increase the number of cycles of antigen binding and lysosomal degradation, we engineered tocilizumab (Actemra), an antibody against the IL-6 receptor (IL-6R), to rapidly dissociate from IL-6R within the acidic environment of the endosome (pH 6.0) while maintaining its binding affinity to IL-6R in plasma (pH 7.4).",0
4037,7,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab (Actemra; Genentech, Inc) is the first biologic therapy targeting the cytokine interleukin 6 (IL-6).",0
4037,8,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"over, our findings showed that combination of tocilizumab (Actemra; Roche), an anti-IL-6R monoclonal antibody, with carboplatin synergistically inhibited growth and proliferation of the EOC cells and the most direct axis for IL-6 gene expression was NF-κB pathway.CONC",0
4037,9,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Roche is co-developing tocilizumab (Actemra, RoActemra), a humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody, with Chugai Pharmaceutical.",0
4037,10,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab (TCZ) is a compound that inhibits the IL-6 receptor.,1
4037,11,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab (TCZ), is a recombinant humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody which has a main use in the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis (sJIA) and polyarticular juvenile idiopathic arthritis (pJIA).",0
4037,12,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"the US Food and Drug Administration accepted a complete-response submission for the use of Actemra (tocilizumab), the first humanized IL-6 receptor-inhibiting monoclonal antibody, for the treatment of RA.",0
4037,13,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Although thi,0
4037,14,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"increase the number of cycles of antigen binding and lysosomal degradation, we engineered tocilizumab (Actemra), an antibody against the IL-6 receptor (IL-6R), to rapidly dissociate from IL-6R within the acidic environment of the endosome (pH 6.0) while maintaining its binding affinity to IL-6R in plasma (pH 7.4).",0
4037,15,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Studies usin,0
4037,16,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?," present study, we have shown that the humanized anti-IL-6 receptor tocilizumab (Actemra) is also a potent inhibitor of IL-8 in TNBC cells.",0
4037,17,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Similar ef,0
4037,18,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Roche is co-developing tocilizumab (Actemra, RoActemra), a humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody, with Chugai Pharmaceutical.",0
4037,19,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocili,0
4037,20,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"tory gene activation is inhibited in vitro by tocilizumab, a humanized antibody to IL6 receptor (IL6R).",0
4037,21,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab,0
4037,22,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"These lines of evidence indicate that tocilizumab is able to bind to both sIL-6R and mIL-6R and to inhibit IL-6 binding to its receptors, leading to the blockade of the IL-6 signaling through both sIL-6R and mIL-6R, but not block the signaling of other IL-6 family cytokines.",0
4037,23,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.",0
4037,24,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"In addition, tocilizumab had the ability to bind to human IL-6R expressing COS-7 cells and to suppress the growth of the IL-6-dependent myeloma cell line, KPMM2.",0
4037,25,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"To characterize the biological activity of tocilizumab, a humanized anti-human interleukin-6 receptor (IL-6R) monoclonal antibody, we examined its binding activity to both soluble IL-6R (sIL-6R) and membrane bound IL-6R (mIL-6R) and its neutralizing activity to other IL-6 family cytokines.",0
4037,26,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab inhibited the proliferation of BaF/IL-6R induced by IL-6, but did not inhibit the proliferation of BaF/IL-11R, BaF/OSMR, BaF/LIFR and BaF/CNTFR cells induced by their corresponding cytokines.",0
4037,27,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Moreover, tocilizumab suppressed the IL-6/sIL-6R complex-induced proliferation of human gp130-transfected cell, BAF-h130.",0
4037,28,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"In addition, tocilizumab had the ability to dissociate IL-6 and sIL-6R from their preformed complex.",0
4037,29,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,ELISA assay demonstrated that tocilizumab bound to sIL-6R and inhibited IL-6 binding to sIL-6R in a dose-dependent manner.,0
4037,30,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab recognizes both the membrane-bound and the soluble form IL-6R and specifically blocks IL-6 actions.,0
4037,31,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Humanized antihuman IL-6 receptor antibody, tocilizumab.",0
4037,32,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab is a humanized antihuman IL-6 receptor antibody designed using genetic engineering technology.,0
4037,33,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab is expected to ameliorate the autoimmune inflammatory diseases with IL-6 overproduction and has been clinically developed as a therapeutic agent for RA, systemic-onset and articular types of JIA, Crohn's disease, etc.",0
4037,34,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"Tocilizumab/Actemra is an anti-IL-6R antibody, which can competitively block IL-6 binding to the IL-6R.",1
4037,35,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab (TCZ; RoActemra® or Actemra®) is a recombinant humanized monoclonal antibody that acts as an interleukin 6 (IL-6) receptor antagonist.,1
4037,36,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,"In 2009 the US Food and Drug Administration accepted a complete-response submission for the use of Actemra (tocilizumab), the first humanized IL-6 receptor-inhibiting monoclonal antibody, for the treatment of RA.",0
4037,37,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab binds to the interleukin-6 receptor (IL-6R) and thereby blocks signaling of the pro-inflammatory cytokine IL-6.,0
4037,38,Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?,Tocilizumab (RoActemra(®); Actemra(®)) is a recombinant humanized monoclonal antibody that acts as an interleukin-6 receptor antagonist.,1
998,0,List mutations that are implicated in the Gray Platelet Syndrome.,A dominant-negative GFI1B mutation in the gray platelet syndrome,1
998,1,List mutations that are implicated in the Gray Platelet Syndrome.,We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome.,0
998,2,List mutations that are implicated in the Gray Platelet Syndrome.,The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2 gene.,1
998,3,List mutations that are implicated in the Gray Platelet Syndrome.,"Mutations in NBEAL2 underlie gray platelet syndrome (GPS), a rare inherited bleeding disorder characterized by a lack of α-granules within blood platelets and progressive bone marrow fibrosis.",0
998,4,List mutations that are implicated in the Gray Platelet Syndrome.,NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules.,1
998,5,List mutations that are implicated in the Gray Platelet Syndrome.,"Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome.",0
998,6,List mutations that are implicated in the Gray Platelet Syndrome.,"Mutations in NBEAL2 underlie gray platelet syndrome (GPS), a rare inherited bleeding disorder characterized by a lack of α-granules within blood platelets and progressive bone marrow fibrosis.",0
998,7,List mutations that are implicated in the Gray Platelet Syndrome.,The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2 gene.,0
998,8,List mutations that are implicated in the Gray Platelet Syndrome.,"Our studies show that GFI1B, in addition to being causally related to the gray platelet syndrome, is key to megakaryocyte and platelet development.",0
998,9,List mutations that are implicated in the Gray Platelet Syndrome.,A dominant-negative GFI1B mutation in the gray platelet syndrome.,1
998,10,List mutations that are implicated in the Gray Platelet Syndrome.,We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome.,0
998,11,List mutations that are implicated in the Gray Platelet Syndrome.,"GPS has been linked to loss of function mutations in NEABL2 (neurobeachin-like 2), and we describe here a murine GPS model, the Nbeal2(-/-) mouse.",0
998,12,List mutations that are implicated in the Gray Platelet Syndrome.,"Here we show that mutations in NBEAL2 (neurobeachin-like 2), which encodes a BEACH/ARM/WD40 domain protein, cause GPS and that megakaryocytes and platelets from individuals with GPS express a unique combination of NBEAL2 transcripts.",0
998,13,List mutations that are implicated in the Gray Platelet Syndrome., The gray platelet syndrome is a rare inherited bleeding disorder characterized by macrothrombocytopenia and deficiency of alpha (α)-granules in platelets.,0
998,14,List mutations that are implicated in the Gray Platelet Syndrome.,The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2 gene.,0
998,15,List mutations that are implicated in the Gray Platelet Syndrome.,The gray platelet syndrome is a rare inherited bleeding disorder characterized by macrothrombocytopenia and deficiency of alpha (α)-granules in platelets.,0
998,16,List mutations that are implicated in the Gray Platelet Syndrome.,The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2 gene.,0
998,17,List mutations that are implicated in the Gray Platelet Syndrome.,"The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding disorder caused by a deficiency of alpha granules in platelets.",0
998,18,List mutations that are implicated in the Gray Platelet Syndrome.,We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome.,0
998,19,List mutations that are implicated in the Gray Platelet Syndrome.,"Mutations in NBEAL2 underlie gray platelet syndrome (GPS),",1
998,20,List mutations that are implicated in the Gray Platelet Syndrome.," The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding disorder caused by a deficiency of alpha granules in platelets.",0
998,21,List mutations that are implicated in the Gray Platelet Syndrome.,We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome.,0
1581,0,Can the iPS cell technology be used in Fanconi anemia therapy?,"We explain a protocol for the reproducible generation of genetically corrected iPSCs starting from the skin biopsies of Fanconi anemia patients using retroviral transduction with OCT4, SOX2 and KLF4",1
1581,1,Can the iPS cell technology be used in Fanconi anemia therapy?,"Before reprogramming, the fibroblasts and/or keratinocytes of the patients are genetically corrected with lentiviruses expressing FANCA.",1
1581,2,Can the iPS cell technology be used in Fanconi anemia therapy?,Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells,1
1581,3,Can the iPS cell technology be used in Fanconi anemia therapy?,"Here we show that, on correction of the genetic defect, somatic cells from Fanconi anaemia patients can be reprogrammed to pluripotency to generate patient-specific iPS cells.",1
1581,4,Can the iPS cell technology be used in Fanconi anemia therapy?,These cell lines appear indistinguishable from human embryonic stem cells and iPS cells from healthy individuals,0
1581,5,Can the iPS cell technology be used in Fanconi anemia therapy?,"Most importantly, we show that corrected Fanconi-anaemia-specific iPS cells can give rise to haematopoietic progenitors of the myeloid and erythroid lineages that are phenotypically normal, that is, disease-free",1
4164,0,What is the role of Adamts18 in hormone receptor signaling?,The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche.,1
4164,1,What is the role of Adamts18 in hormone receptor signaling?,Estrogens and progesterone control breast development and carcinogenesis via their cognate receptors expressed in a subset of luminal cells in the mammary epithelium.,0
4164,2,What is the role of Adamts18 in hormone receptor signaling?,"How they control the extracellular matrix, important to breast physiology and tumorigenesis, remains unclear.",0
4164,3,What is the role of Adamts18 in hormone receptor signaling?,Here we report that both hormones induce the secreted protease Adamts18 in myoepithelial cells by controlling Wnt4 expression with consequent paracrine canonical Wnt signaling activation.,0
4164,4,What is the role of Adamts18 in hormone receptor signaling?,"Adamts18 is required for stem cell activation, has multiple binding partners in the basement membrane and interacts genetically with the basal membrane-specific proteoglycan, Col18a1, pointing to the basement membrane as part of the stem cell niche.",1
4164,5,What is the role of Adamts18 in hormone receptor signaling?,"In vitro, ADAMTS18 cleaves fibronectin; in vivo, Adamts18 deletion causes increased collagen deposition during puberty, which results in impaired Hippo signaling and reduced Fgfr2 expression both of which control stem cell function.",1
4164,6,What is the role of Adamts18 in hormone receptor signaling?,"Thus, Adamts18 links luminal hormone receptor signaling to basement membrane remodeling and stem cell activation.",1
4164,7,What is the role of Adamts18 in hormone receptor signaling?,"Thus, Adamts18 links luminal hormone receptor signaling to basement membrane remodeling and stem cell activation.",1
3907,0,Which S1P receptors does fingolimod bind to?,"harmacologically, fingolimod was characterized as a non-selective agonist of all of the S1P receptors (S1PR), with the exception of S1P2, and in addition, as a selective S1P1 functional antagonist by induction of irreversible S1P1 internalization and degradation.",1
347,0,Could the Menzerath-Altmann law be proved mathematically trivial in genomes?,Here we review the statistical foundations of that test and consider three non-parametric tests based upon different correlation metrics and one parametric test to evaluate if Z ∼ 1/X in genomes.,1
347,1,Could the Menzerath-Altmann law be proved mathematically trivial in genomes?,"The most powerful test is a new non-parametric one based upon the correlation ratio, which is able to reject Z ∼ 1/X in nine out of 11 taxonomic groups and detect a borderline group.",0
347,2,Could the Menzerath-Altmann law be proved mathematically trivial in genomes?,"Rather than a fact, Z ∼ 1/X is a baseline that real genomes do not meet.",0
347,3,Could the Menzerath-Altmann law be proved mathematically trivial in genomes?,The view of Menzerath-Altmann law as inevitable is seriously flawed.,1
347,4,Could the Menzerath-Altmann law be proved mathematically trivial in genomes?,The view of Menzerath-Altmann law as inevitable is seriously flawed.,1
347,5,Could the Menzerath-Altmann law be proved mathematically trivial in genomes?,The view of Menzerath-Altmann law as inevitable is seriously flawed.,1
347,6,Could the Menzerath-Altmann law be proved mathematically trivial in genomes?,The view of Menzerath-Altmann law as inevitable is seriously flawed.,1
3258,0,When was Fluzone Intradermal replaced with Fluzone Intradermal Quadrivalent?,"In advance of the 2015-2016 season, Fluzone Intradermal was replaced with Fluzone Intradermal Quadrivalent vaccine, which contains 9 µg hemagglutinin per strain of the two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata).",1
3069,0,Which receptor is targeted by Erenumab?,Monoclonal antibodies (mAbs) targeting calcitonin gene-related peptide (CGRP) signaling are being explored as prophylactic treatments for migraine.,0
3069,1,Which receptor is targeted by Erenumab?,"Erenumab (AMG 334) is the first potent, selective, and competitive human mAb antagonist of the CGRP receptor.",0
3069,2,Which receptor is targeted by Erenumab?,Erratum: Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab [Corrigendum].,0
3069,3,Which receptor is targeted by Erenumab?,"PURPOSE OF REVIEW: Monoclonal antibodies (mAbs) targeting the calcitonin-gene-related peptide (CGRP) pathway have been developed for episodic and chronic migraine prevention, either through binding the CGRP ligand (eptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (erenumab).",0
3069,4,Which receptor is targeted by Erenumab?,"Erenumab, a human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, is being evaluated for migraine prevention.",1
3069,5,Which receptor is targeted by Erenumab?,"Currently, there is considerable excitement regarding monoclonal antibodies against calcitonin gene-related peptide (eptinezumab, galcanezumab, fremanezumab) and the calcitonin gene-related peptide receptor (erenumab).",1
3069,6,Which receptor is targeted by Erenumab?,Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab.,0
3069,7,Which receptor is targeted by Erenumab?,"Erenumab is the only mAb that targets the CGRP receptor instead of the ligand, with high specificity and affinity of binding.",0
3069,8,Which receptor is targeted by Erenumab?,"BACKGROUND
We tested erenumab, a fully human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, for the prevention of episodic migraine.",0
3069,9,Which receptor is targeted by Erenumab?,"We assessed the efficacy and safety of erenumab, a fully human monoclonal antibody against the CGRP receptor, in patients with chronic migraine.",0
3069,10,Which receptor is targeted by Erenumab?,Erenumab is a novel CGRP-receptor antibody with preventive efficacy in migraine.,0
3069,11,Which receptor is targeted by Erenumab?,"Currently, there is considerable excitement regarding monoclonal antibodies against calcitonin gene-related peptide (eptinezumab, galcanezumab, fremanezumab) and the calcitonin gene-related peptide receptor (erenumab).",1
3069,12,Which receptor is targeted by Erenumab?,"Erenumab (AMG 334) is the first potent, selective, and competitive human mAb antagonist of the CGRP receptor.",0
3069,13,Which receptor is targeted by Erenumab?,"OBJECTIVE
To assess long-term safety and efficacy of anti-calcitonin gene-related peptide receptor erenumab in patients with episodic migraine (EM).",0
3069,14,Which receptor is targeted by Erenumab?,"CGRP receptor antagonists such as ubrogepant are effective for acute relief of migraine headache, whereas monoclonal antibodies against CGRP (eptinezumab, fremanezumab and galcanezumab) or the CGRP receptor (erenumab) effectively prevent migraine attacks.",0
3069,15,Which receptor is targeted by Erenumab?,"Currently, 4 monoclonal antibodies targeting either the CGRP ligand or receptor are being studied for migraine prevention: ALD403 (eptinezumab), AMG 334 (erenumab), LY2951742 (galcanezumab), and TEV-48125 (fremanezumab).",0
3069,16,Which receptor is targeted by Erenumab?,"Amgen and Novartis are developing erenumab (AIMOVIG™, erenumab-aooe)-a fully human monoclonal antibody calcitonin gene-related peptide (CGRP) receptor antagonist-for the prevention of migraine.",1
3069,17,Which receptor is targeted by Erenumab?,"OBJECTIVE
To determine the potential impact of erenumab, a human anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, on total exercise time (TET), time to exercise-induced angina, and ST depression in a double-blind, placebo-controlled study in patients with stable angina due to documented coronary artery disease.",0
3069,18,Which receptor is targeted by Erenumab?,"Background We evaluated the effect of erenumab, a fully human monoclonal antibody that inhibits the canonical calcitonin gene-related peptide receptor, on migraine-related disability, impact, and health-related quality of life among patients with episodic migraine.",1
3069,19,Which receptor is targeted by Erenumab?,"METHODS
Thirteen migraine patients, previously enrolled in erenumab anti-CGRP receptor monoclonal antibody trials, received CGRP in a double-blind, placebo-controlled, randomized cross-over design to investigate their susceptibility to migraine induction.",0
3069,20,Which receptor is targeted by Erenumab?,"Currently, 4 monoclonal antibodies targeting either the CGRP ligand or receptor are being studied for migraine prevention: ALD403 (eptinezumab), AMG 334 (erenumab), LY2951742 (galcanezumab), and TEV-48125 (fremanezumab).",0
3069,21,Which receptor is targeted by Erenumab?,"Erenumab did not adversely affect exercise time in a high cardiovascular risk population of patients, supporting that inhibition of the canonical CGRP receptor does not worsen myocardial ischemia.",0
3069,22,Which receptor is targeted by Erenumab?,"To determine the potential impact of erenumab, a human anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, on total exercise time (TET), time to exercise-induced angina, and ST depression in a double-blind, placebo-controlled study in patients with stable angina due to documented coronary artery disease.",0
3463,0,Are male or female persons more prone to autoimmunity?, Estrogens cause a marked acceleration of autoimmunity and a reduction in thymus weight.,0
3463,1,Are male or female persons more prone to autoimmunity?,"we found that a number of problems or variables arise in studying sex hormone effects, including: 1) X-linked genes, 2) metabolism of testosterone to estrogens, 3) dose of hormone, 4) age at which administration is initiated, 5) differential effects of sex hormones on different autoantibodies and various immune responses.",0
3463,2,Are male or female persons more prone to autoimmunity?,"Examples of this autoimmune dimorphism include (but are not limited to) lupus, rheumatoid arthritis and multiple sclerosis with the two former more prevalent in females than males and the latter more severe during pregnancy.",1
3463,3,Are male or female persons more prone to autoimmunity?,Sex hormones have long been implicated in autoimmune diseases because women account for 80% of cases.,1
3463,4,Are male or female persons more prone to autoimmunity?,"Sex hormones have definitive roles in lymphocyte maturation, activation, and synthesis of antibodies and cytokines.",1
3463,5,Are male or female persons more prone to autoimmunity?,"Sex hormone expression is altered among patients with autoimmune disease, and this variation of expression contributes to immune dysregulation.",1
3463,6,Are male or female persons more prone to autoimmunity?,"ex hormones affect the function of the mammalian immune system, and sex hormone expression is different in patients with systemic lupus erythematosus than in healthy subjects.",0
3463,7,Are male or female persons more prone to autoimmunity?,Sex hormones play a role in the genesis of autoimmunity.,0
3463,8,Are male or female persons more prone to autoimmunity?,"Most recently, sex chromosome abnormalities and skewed X chromosome inactivation have been suggested as novel players, particularly in later-onset diseases.",1
3463,9,Are male or female persons more prone to autoimmunity?,As a result we may hypothesize that more than one mechanism may contribute to the female susceptibility to tolerance breakdown while the possibility that unknown factors may indeed protect men from AID should not be overlooked.,0
3463,10,Are male or female persons more prone to autoimmunity?," The gut microbiome, which impacts the innate and adaptive branches of immunity, not only influences the development of autoimmune disorders but may interact with sex-hormones to modulate disease progression and sex-bias.",0
3463,11,Are male or female persons more prone to autoimmunity?,"Recent studies investigating the origins of sex bias in autoimmune disease have revealed an extensive and interconnected network of genetic, hormonal, microbial, and environmental influences.",0
3463,12,Are male or female persons more prone to autoimmunity?,Investigation of sex hormones has moved beyond profiling the effects of hormones on activity and prevalence of immune cell types to defining the specific immunity-related genes driving these changes,0
718,0,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,Ataxin-2 is an evolutionarily conserved protein first identified in humans as responsible for spinocerebellar ataxia type 2 (SCA2).,1
718,1,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,"The molecular basis of SCA2 is the expansion of a polyglutamine tract in Ataxin-2, encoding a Lsm domain that may bind RNA and a PAM2 motif that enables interaction with the poly (A) binding protein.",1
718,2,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,"In SCA2 brains, we found cytoplasmic, but not nuclear, microaggregates.",0
718,3,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,Mice expressing ataxin-2 with Q58 showed progressive functional deficits accompanied by loss of the Purkinje cell dendritic arbor and finally loss of Purkinje cells.,0
718,4,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,"Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited, neurodegenerative disease caused by an expansion of polyglutamine tracts in the cytosolic protein ataxin-2 (Atx2).",1
718,5,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,Our analysis provides valuable information on the evolution and domain structure of Ataxin-2 proteins.,0
718,6,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,"Proline-rich motifs that may mediate protein interactions are widespread in Ataxin-2 proteins, but expansion of polyglutamine tracts associated with spinocerebellar ataxia type 2, is present only in primates, as well as some insects.",1
718,7,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,The expansion of a polyQ repeat within the ataxin-2 protein causes spinocerebellar ataxia type 2 (SCA2).,1
718,8,Which polyQ tract protein is linked to Spinocerebellar Ataxia type 2?,"However, neither the precise pathological mechanism nor the physiological functions of ataxin-2 are known.",0
1753,0,How many cysteines have alpha-defensins?,"Alpha defensins contain six cysteines, which form three well defined disulfide bridges under oxidizing conditions.",1
1753,1,How many cysteines have alpha-defensins?,All three kinds of defensins have six conserved cysteines,1
1753,2,How many cysteines have alpha-defensins?," There are six cysteines in the sequence of mature CFBD peptide,",1
1753,3,How many cysteines have alpha-defensins?,They typically contain six conserved cysteines whose three intramolecular disulfides stabilize a largely β-sheet structure.,1
4060,0,What is the cause of the Kleefstra syndrome?,Kleefstra syndrome is a rare neurogenetic disorder caused by a subtelomeric 9q34.3 deletion or by an intragenic mutation of the euchromatin histone methyl transferase 1 gene (EHMT1).,1
4060,1,What is the cause of the Kleefstra syndrome?,"Kleefstra syndrome is a disorder caused by a mutation in the EHMT1 gene characterized in humans by general developmental delay, mild to severe intellectual disability and autism.",1
4060,2,What is the cause of the Kleefstra syndrome?,"Kleefstra syndrome (KS) is an autosomal dominant disorder caused by a chromosomal deletion at 9q34.3 resulting in pathogenic variants of the gene that codes for the enzyme, euchromatin histone methyltransferase 1 (EHMT1).",1
4060,3,What is the cause of the Kleefstra syndrome?,"Mutations in the Euchromatic Histone Methyltransferase 1 (EHMT1) gene cause Kleefstra syndrome, a rare form of intellectual disability (ID) with strong autistic traits and sensory processing deficits.",1
4060,4,What is the cause of the Kleefstra syndrome?,Kleefstra syndrome (chromosome 9q34.3 deletion) is a rare genetic disorder with less than 110 patients reported till date.,1
3445,0,Does radiation for tinea capitis increases brain tumor risk?,"Emphasis is placed on meningiomas resulting from childhood treatment for primary brain tumor or tinea capitis, exposure to dental x-rays, and exposure to atomic explosions in Hiroshima and Nagasaki.",0
3445,1,Does radiation for tinea capitis increases brain tumor risk?,It is well known that radiation can induce meningiomas.,0
3445,2,Does radiation for tinea capitis increases brain tumor risk?,These tumors usually arise in patients with a history of low-dose radiation to the scalp for treatment of tinea capitis or high-dose radiation for a previous brain tumor.,0
3445,3,Does radiation for tinea capitis increases brain tumor risk?,This paper describes six cases of radiation-associated intracranial meningiomas in patients previously treated with low-dose radiation to the scalp for tinea capitis.,1
3445,4,Does radiation for tinea capitis increases brain tumor risk?,"After a median follow-up of 40 years, an ERR/Gy of 4.63 and 1.98 (95% CI = 2.43-9.12 and 0.73-4.69) and an EAR/Gy per 10(4) PY of 0.48 and 0.31 (95% CI = 0.28-0.73 and 0.12-0.53) were observed for benign meningiomas and malignant brain tumors, respectively.",0
3445,5,Does radiation for tinea capitis increases brain tumor risk?,"The estimated ERR/Gy for malignant brain tumors decreased with increasing age at irradiation from 3.56 to 0.47 (P = 0.037), while no trend with age was seen for benign meningiomas.",0
3445,6,Does radiation for tinea capitis increases brain tumor risk?,The ERR for both types of tumor remains elevated at 30-plus years after exposure.,0
3445,7,Does radiation for tinea capitis increases brain tumor risk?,"Although meningiomas are known to be induced by low doses of cranial irradiation, such as those given to treat tinea capitis, little experience has been reported on the induction of meningiomas by high-dose cranial irradiation.",0
3445,8,Does radiation for tinea capitis increases brain tumor risk?,"The exposed rats had a greater incidence of pituitary chromophobe adenomas, epithelial and mesothelial cell tumors than the unexposed controls but the excessive occurrence of malignant gliomas that was observed in the monkeys was absent in the rats.",0
3445,9,Does radiation for tinea capitis increases brain tumor risk?,We have analyzed 60 cases of intra-axial brain tumors associated with antecedent radiation therapy.,0
3445,10,Does radiation for tinea capitis increases brain tumor risk?,These include four new cases.,0
3445,11,Does radiation for tinea capitis increases brain tumor risk?,"The patients had originally received radiation therapy for three reasons: (a) cranial irradiation for acute lymphoblastic leukemia (ALL), (b) definitive treatment of CNS neoplasia, and (c) treatment of benign disease (mostly cutaneous infections).",0
3445,12,Does radiation for tinea capitis increases brain tumor risk?,Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis.,1
3445,13,Does radiation for tinea capitis increases brain tumor risk?,Benign and malignant thyroid neoplasms after childhood irradiation for tinea capitis.,0
3445,14,Does radiation for tinea capitis increases brain tumor risk?,There is evidence to show that moderate doses of ionising radiations given in childhood for tinea capitis are associated with a late risk of developing a meningioma,1
3445,15,Does radiation for tinea capitis increases brain tumor risk?,This paper describes six cases of radiation-associated intracranial meningiomas in patients previously treated with low-dose radiation to the scalp for tinea capitis.,1
3445,16,Does radiation for tinea capitis increases brain tumor risk?,These tumors usually arise in patients with a history of low-dose radiation to the scalp for treatment of tinea capitis or high-dose radiation for a previous brain tumor.,0
3445,17,Does radiation for tinea capitis increases brain tumor risk?,There is evidence to show that moderate doses of ionising radiations given in childhood for tinea capitis are associated with a late risk of developing a meningioma.,1
3445,18,Does radiation for tinea capitis increases brain tumor risk?,"In addition to high dose radiation-induced meningiomas, intracranial meningiomas were observed in patients who underwent low-dose radiation for tinea capitis in childhood, applied en mass to immigrants coming to Israel from the North Africa and the Middle East during the 1950.",0
3445,19,Does radiation for tinea capitis increases brain tumor risk?,A 39-year-old male developed primary brain lymphoma 33 years after receiving scalp irradiation for tinea capitis.,0
3445,20,Does radiation for tinea capitis increases brain tumor risk?,"Secondary glioblastoma multiforme (sGBM) can occur after a long latency period following radiation treatment of various diseases including brain tumors, leukemia, and more benign disorders like tinea capitis.",0
3445,21,Does radiation for tinea capitis increases brain tumor risk?,"The main data come from series of patients who underwent radiotherapy during childhood: a high incidence of tumors of the nervous system is found after irradiation of one to a few grays as treatment of a benign disease (especially tinea capitis), as well as after irradiation at higher doses of a few tens of grays for the treatment of cancer (in particular cerebral irradiation in acute lymphoblastic leukaemia).",0
1798,0,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","It is unlike the ""wearing-off"" phenomenon that occurs when dopaminergic drug levels decline and responds to dopaminergic rescue drugs.",0
1798,1,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Unfortunately, chronic use of traditional levodopa/dopa decarboxylase inhibitor formulations is associated with the development of complications, such as wearing-off and dyskinesia.",1
1798,2,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","One of the first complications observed with levodopa therapy is wearing-off, which can emerge within 1-3 years of initiation of levodopa treatment.",0
1798,3,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Wearing-off is characterized by the predictable emergence of motor and nonmotor PD symptoms before the next scheduled dose of medication.,1
1798,4,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Despite effective treatment options to tackle wearing-off, it remains underrecognized and under treated.",0
1798,5,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Shortness of breath, a 'wearing-off' symptom in Parkinson's disease.",0
1798,6,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Although levodopa is considered the gold standard for Parkinson's disease therapy, prolonged use of this drug can result in motor complications such as a 'wearing-off' phenomenon.",1
1798,7,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","This outcome is seen in a significant number of patients with Parkinson's disease taking levodopa and, in some cases, is observed only a few hours after intake of the last dose of levodopa.",0
1798,8,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Patients experiencing the wearing-off period may present with sensory, autonomic, psychiatric and motor fluctuations.",0
1798,9,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Although infrequent, shortness of breath is an important non-motor wearing-off symptom experienced by patients with Parkinson's disease.",0
1798,10,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",We report here on a patient with Parkinson's disease who was taking levodopa and developed both shortness of breath and hyperventilation during wearing-off periods.,0
1798,11,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",His shortness of breath was determined to be a wearing-off phenomenon and his condition improved with the addition of a catechol-O-methyltransferase inhibitor (entacapone).,0
1798,12,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",The wearing-off phenomenon in patients with Parkinson's disease (PD) is a complication of prolonged levodopa usage.,0
1798,13,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","During this phenomenon, motor symptoms such as rigidity and freezing re-emerge.",0
1798,14,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","This is often accompanied by non-motor symptoms, including anxiety, the so-called wearing-off related anxiety (WRA).",0
1798,15,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Patients with wearing-off tended to receive higher L-dopa dosage and endure longer duration of L-dopa treatment.,0
1798,16,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",The wearing-off phenomenon frequently complicates levodopa therapy of Parkinson's disease (PD).,0
1798,17,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","The effects of tolcapone, a catechol-O-methyltransferase inhibitor, on the bioavailability and efficacy of levodopa were evaluated in 12 patients with Parkinson's disease (PD), 8 of whom showed signs of daily motor fluctuations (wearing-off phenomenon).",0
1798,18,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Although infrequent, shortness of breath is an important non-motor wearing-off symptom experienced by patients with Parkinson's disease.",0
1798,19,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Although levodopa is considered the gold standard for Parkinson's disease therapy, prolonged use of this drug can result in motor complications such as a 'wearing-off' phenomenon.",0
1798,20,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","More than 50% of patients with Parkinsons disease develop motor response fluctuations (the wearing off"" phenomenon) after more than five years of levodopa therapy",0
1798,21,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","More than 50% of patients with Parkinsons disease develop motor response fluctuations (the ""wearing off"" phenomenon) after more than five years of levodopa therapy",0
1798,22,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",The wearing-off phenomenon in patients with Parkinsons disease (PD) is a complication of prolonged levodopa usage,0
1798,23,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Short-term effect of a single levodopa dose on micturition disturbance in Parkinsons disease patients with the wearing-off phenomenon,0
1798,24,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","To evaluate the effectiveness of entacapone in the management of levodopa wearing-off in Parkinsons disease (PD) in a naturalistic, real-life setting.This prospective, open-label, observational study included patients with idiopathic PD.",0
1798,25,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Patients were eligible for inclusion if they had been taking 3-5 doses of levodopa per day for ≥2 months and had shown signs of levodopa wearing-off for ≥1 month,0
1798,26,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","The duration of clinical control of motor symptoms of Parkinson disease (PD) treated with levodopa/carbidopa preparations eventually starts to shorten, a phenomenon known as end-of-dose ""wearing off.""",0
1798,27,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","The involvement of core nonmotor symptoms of ""wearing off"" (depressed mood, pain/aching, anxiety, and cloudy/slowed thinking) is not well understood.",0
1798,28,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Efficacy and tolerability of entacapone in patients with Parkinsons disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations,0
1798,29,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","The efficacy and tolerability of entacapone was investigated in a randomized, double-blind, placebo-controlled, 3-month study of 162 patients with Parkinsons disease (PD) treated with levodopa and a dopamine agonist and experiencing wearing-off motor fluctuations",0
1798,30,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinsons disease patients with wearing-off,0
1798,31,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","We conclude that tolcapone as an adjunct offers promise for the relief of the ""wearing-off "" phenomenon in levodopa-treated parkinsonian patients.",0
1798,32,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","We conclude that tolcapone as an adjunct offers promise for the relief of the ""wearing-off"" phenomenon in levodopa-treated parkinsonian patients.",0
1798,33,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Our data also support the involvement of postsynaptic dopamine receptor mechanisms in the wearing-off phenomenon seen in levodopa-treated parkinsonian patients.,0
1798,34,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon.,0
1798,35,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","It is unlike the ""wearing-off"" phenomenon that occurs when dopaminergic drug levels decline and responds to dopaminergic rescue drugs.",0
1798,36,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","More than 50% of patients with Parkinson's disease develop motor response fluctuations (the 'wearing off"" phenomenon) after more than five years of levodopa therapy.",0
1798,37,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","The primary objective of this study was to assess the effect of tolcapone on levodopa dosage in parkinsonian patients whose ""wearing-off"" phenomenon has been controlled with more frequent levodopa dosage.",0
1798,38,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","More than 50% of patients with Parkinson's disease develop motor response fluctuations (the ""wearing off"" phenomenon) after more than five years of levodopa therapy.",0
1798,39,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","To evaluate the role of the practicing pharmacist in the identification and current treatment of the levodopa wearing-off phenomenon experienced by patients with Parkinson's disease (PD) who are receiving chronic levodopa therapy.Literature retrieval was accessed through MEDLINE (1967-June 2007) using the terms levodopa, wearing-off, and Parkinson's disease.",1
1798,40,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","This study investigated the effects of OPC in comparison with placebo on levodopa pharmacokinetics, tolerability and safety, COMT activity and motor response to levodopa in Parkinson's disease (PD) patients with motor fluctuations.This was a randomized, multicentre, double-blind and placebo-controlled study in four parallel groups of PD patients treated with standard-release 100/25 mg levodopa/carbidopa or levodopa/benserazide and with motor fluctuations (wearing-OFF phenomenon).",0
1798,41,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Patients experiencing the wearing-off period may present with sensory, autonomic, psychiatric and motor fluctuations.",0
1798,42,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Although infrequent, shortness of breath is an important non-motor wearing-off symptom experienced by patients with Parkinson's disease.",0
1798,43,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","This outcome is seen in a significant number of patients with Parkinson's disease taking levodopa and, in some cases, is observed only a few hours after intake of the last dose of levodopa.",0
1798,44,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Patients experiencing the wearing-off period may present with sensory, autonomic, psychiatric and motor fluctuations.",0
1798,45,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Although infrequent, shortness of breath is an important non-motor wearing-off symptom experienced by patients with Parkinson's disease.",0
1798,46,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Although levodopa is considered the gold standard for Parkinson's disease therapy, prolonged use of this drug can result in motor complications such as a 'wearing-off' phenomenon.",0
1798,47,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","This outcome is seen in a significant number of patients with Parkinson's disease taking levodopa and, in some cases, is observed only a few hours after intake of the last dose of levodopa.",0
1798,48,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Patients experiencing the wearing-off period may present with sensory, autonomic, psychiatric and motor fluctuations.",0
1798,49,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",It is suggested that tolcapone may be useful drug adjunct to levodopa in treating patients with PD with wearing-off phenomena.,0
1798,50,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",It is suggested that tolcapone may be useful drug adjunct to levodopa in treating patients with PD with wearing-off phenomena..,0
1798,51,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Levodopa-treated Parkinson's disease is often complicated by the occurrence of motor fluctuations, which can be predictable ('wearing-off') or unpredictable ('on-off').",0
1798,52,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","She was treated with 400 mg/day of levodopa-carbidopa, which improved her symptoms, however, she developed wearing off phenomenon 3 years after the initiation of levodopa treatment.",0
1798,53,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",[Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].,0
1798,54,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?",To evaluate the role of the practicing pharmacist in the identification and current treatment of the levodopa wearing-off phenomenon experienced by patients with Parkinson's disease (PD) who are receiving chronic levodopa therapy.,1
1798,55,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","However, once the decision to initiate levodopa therapy has been made, studies generally support the use of entacapone as an adjunct to levodopa in patients with Parkinson's disease and the 'wearing off' phenomenon..",0
1798,56,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","These results suggest that wearing-off phenomenon may arise as a consequence of the degeneration of dopamine terminals due to natural disease progression with a resultant inability to buffer variations in levodopa availability; on-off phenomenon, may reflect additional postsynaptic dopamine receptor dysregulation, possibly in response to the resultant, nonphysiologic fluctuations in synaptic dopamine..",0
1798,57,"What is the ""wearing-off"" phenomenon in levodopa-treated patients with Parkinson's Disease?","Conversion from oral to intravenous levodopa treatment immediately stabilized plasma levodopa levels in both the wearing-off and on-off groups; motor variability also decreased, especially in those with wearing-off phenomenon.",0
3424,0,When was vaxchora first licensed by the FDA?,"After a decade in obscurity it (Vaxchora) has resurfaced again, now produced in the U.S. and equipped with a U.S. FDA license (June 10, 2016).",1
2337,0,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,a new member of the Prevotellaceae family that was isolated from stool samples from a 45-year-old patient.,1
2337,1,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,"Using univariate non-parametric statistics, there were no differences regarding alpha or beta diversity between AH8.1 carriers (categories I and II) and non-carriers (categories III and IV), however four different taxa (Prevotellaceae, Clostridium XVIII, Coprococcus, Enterorhabdus) had nominally significant lower abundances in AH8.1 carriers than non-carriers.",0
2337,2,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,The increase in Bacteroidetes was found to be due to an increase in members of the families Bacteroidaceae or Prevotellaceae.,1
2337,3,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,Fecal communities clustered into previously described enterotypes distinguished primarily by levels of Bacteroides and Prevotella.,0
2337,4,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,"Although the distinction of enterotypes as either discrete clusters or a continuum will require additional investigation, numerous studies have demonstrated the co-exclusion of the closely related Prevotellaceae and Bacteroides genera in the gut microbiota of healthy human subjects where Prevotella appears to be a discriminatory taxon for residence in more agrarian societies",1
2337,5,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,"Lachnospiraceae, Ruminococcaceae, Bacteroidaceae, Prevotellaceae, and Rickenellaceae were the predominant families detected in the active microbiota",1
2337,6,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,"Specifically, Firmicutes were dominant in normal-weight and obese individuals but significantly decreased in post-gastric-bypass individuals, who had a proportional increase of Gammaproteobacteria.",0
2337,7,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,Numbers of the H(2)-producing Prevotellaceae were highly enriched in the obese individuals.,1
2337,8,Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?,"A comparative sequence analysis revealed that these two species are members of the family 'Prevotellaceae' but are phylogenetically distant (<88% sequence similarity) from the known genera belonging to this family, including Prevotella, Hallela and Xylanibacter.",0
4102,0,What is the function of lysozyme?,Lysozyme activity (a marker of Paneth cell function),1
4102,1,What is the function of lysozyme?,Lysozymes are an ancient group of antimicrobial enzymes of the innate immune system.,1
4102,2,What is the function of lysozyme?," It displays chitinase and lysozyme activity, which could be important for the defense against pathogenic fungi, insects and bacteria.",1
2590,0,Does temsirolimus improve survival of glioblastoma patients?,"RESULTS: fourteen randomized clinical trials were identified (7 with bevacizumab, 2 cilengitide, 1 enzastaurin, 1 dasatinib, 1 vandetanib, 1 temsirolimus, 1 cediranib) including 4330 patients.",0
2590,1,Does temsirolimus improve survival of glioblastoma patients?,"Antiangiogenic drugs showed no improvement in overall survival with a pooled HR of 1.00, a trend for an inferior outcome, in terms of overall survival, was observed in the group of patients receiving antiangiogenic drug alone compared to cytotoxic drug alone (HR=1.24, p=0.056).",0
2590,2,Does temsirolimus improve survival of glioblastoma patients?,CONCLUSIONS: Temsirolimus was not superior to temozolomide in patients with an unmethylated MGMT promoter.,1
2590,3,Does temsirolimus improve survival of glioblastoma patients?,"The actuarial 1-year survival was 72.2% [95% confidence interval (CI), 58.2-82.2] in the temozolomide arm and 69.6% (95% CI, 55.8-79.9) in the temsirolimus arm [hazard ratio (HR) 1.16; 95% CI, 0.77-1.76; P = 0.47].",0
2590,4,Does temsirolimus improve survival of glioblastoma patients?,CONCLUSION: The combination of bevacizumab with temsirolimus was well-tolerated and resulted in stable disease of at least four months/partial response in three out of six pediatric patients with chemorefractory CNS tumors.,0
2590,5,Does temsirolimus improve survival of glioblastoma patients?,"CONCLUSIONS: Temsirolimus administered weekly at the dose of 75 mg/m(2) did not meet the primary objective efficacy threshold in children with high-grade glioma, neuroblastoma or rhabdomyosarcoma; however, meaningful prolonged stable disease merits further evaluation in combination therapy.",0
2590,6,Does temsirolimus improve survival of glioblastoma patients?,"Novel targeted agents such as bevacizumab, imatinib, erlotinib, temsirolimus, immunotherapy, cilengitide, talampanel, etc.",0
2590,7,Does temsirolimus improve survival of glioblastoma patients?,"are helping classical chemotherapeutic agents, like temozolomide, to achieve an increase in overall survival.",0
2590,8,Does temsirolimus improve survival of glioblastoma patients?,"CONCLUSIONS: CCI-779 was well tolerated at this dose schedule; however, there was no evidence of efficacy in patients with recurrent GBM",1
2590,9,Does temsirolimus improve survival of glioblastoma patients?,The addition of temsirolimus to interferon did not improve survival.,1
2590,10,Does temsirolimus improve survival of glioblastoma patients?,CONCLUSIONS Temsirolimus was not superior to temozolomide in patients with an unmethylated MGMT promoter.,1
2590,11,Does temsirolimus improve survival of glioblastoma patients?,The addition of temsirolimus to interferon did not improve survival.,1
2302,0,Which are the best methods for the prediction of circular RNA (circRNA)?,"Numerous algorithms that are used to detect genome-wide circRNA expression from RNA sequencing (RNA-seq) data have been developed in the past few years, but there is little overlap in their predictions and no clear gold-standard method to assess the accuracy of these algorithms.",1
2302,1,Which are the best methods for the prediction of circular RNA (circRNA)?,"We developed the software tandem, DCC and CircTest DCC uses output from the STAR read mapper to systematically detect back-splice junctions in next-generation sequencing data.",1
2302,2,Which are the best methods for the prediction of circular RNA (circRNA)?,Circular RNA profile in gliomas revealed by identification tool UROBORUS.,0
2302,3,Which are the best methods for the prediction of circular RNA (circRNA)?,"In this work, we have developed a computational pipeline named UROBORUS to detect circRNAs in total RNA-seq data.",0
2302,4,Which are the best methods for the prediction of circular RNA (circRNA)?," Here, we use common RNAseq datasets to scrutinize and compare the output from five different algorithms; circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice and evaluate the levels of bona fide and false positive circRNAs based on RNase R resistance.",1
2302,5,Which are the best methods for the prediction of circular RNA (circRNA)?,"miARma-Seq: a comprehensive tool for miRNA, mRNA and circRNA analysis.",0
2302,6,Which are the best methods for the prediction of circular RNA (circRNA)?,PcircRNA_finder: a software for circRNA prediction in plants.,0
2302,7,Which are the best methods for the prediction of circular RNA (circRNA)?,A circRNA prediction software for plants (termed PcircRNA_finder) was developed that is more sensitive in detecting circRNAs than other frequently used programs (such as find_circ and CIRCexplorer),1
2302,8,Which are the best methods for the prediction of circular RNA (circRNA)?,"Recently, circular RNA (circRNA), a class of endogenous non-protein coding RNAs that contain a circular loop, was found to exhibit multiple biological effects.",0
2302,9,Which are the best methods for the prediction of circular RNA (circRNA)?,"RESULTS A circRNA prediction software for plants (termed PcircRNA_finder) was developed that is more sensitive in detecting circRNAs than other frequently used programs (such as find_circ and CIRCexplorer), Based on analysis of simulated and real rRNA-/RNAase R RNA-Seq data from Arabidopsis thaliana and rice PcircRNA_finder provides a more comprehensive sensitive, precise prediction method for plants circRNAs.",1
849,0,Which calcium channels does ethosuximide target?,"In the present study, we examined whether ethosuximide (ETX), a T-channel antagonist, could decrease the severity of ethanol withdrawal seizures by evaluating electrographical and behavioral correlates of seizure activity.",0
849,1,Which calcium channels does ethosuximide target?,"In rats, intraplantar (i.pl.)",0
849,2,Which calcium channels does ethosuximide target?,"administration of db-cAMP or PGE(2)  caused mechanical hyperalgesia, an effect suppressed by AKAPI, two distinct T-channel blockers, NNC 55-0396 and ethosuximide, or ZnCl(2) , known to inhibit Ca(v) 3.2 among T channels.",0
849,3,Which calcium channels does ethosuximide target?,Theta rhythms remained disrupted during a subsequent week of withdrawal but were restored with the T-type channel blocker ethosuximide.,1
849,4,Which calcium channels does ethosuximide target?,"Given evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-γ-lyase (CSE), a major H₂S-forming enzyme in the peripheral tissue, are capable of reversing the neuropathic pain evoked by paclitaxel, an anti-cancer drug.",0
849,5,Which calcium channels does ethosuximide target?,"The results demonstrate that both ethosuximide and the active metabolite of methsuximide, alpha-methyl-alpha-phenylsuccinimide (MPS), block human T-type channels in a state-dependent manner, with higher affinity for inactivated channels.",0
849,6,Which calcium channels does ethosuximide target?,"T-type channels display current at the end of long pulses (persistent current), and this current was especially sensitive to block (ethosuximide IC(50) = 0.6 mM).",0
849,7,Which calcium channels does ethosuximide target?,"We tested the effects of several T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride, mibefradil, and NCC 55-0396, a mibefradil derivative, on tacrine-induced tremulous jaw movements (TJMs), an animal model of parkinsonian tremor.",0
849,8,Which calcium channels does ethosuximide target?,"The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil.",1
849,9,Which calcium channels does ethosuximide target?,"Gallopamil and another T-type-channel blocker, ethosuximide, were included for comparison.",1
849,10,Which calcium channels does ethosuximide target?,"The Ca(v)3.2 channel is sensitive to ethosuximide, amlodipine and amiloride.",0
849,11,Which calcium channels does ethosuximide target?,"The purpose of the present study was to explore the analgesic effects of the low voltage-activated T-type Ca2+ channel blockers ethosuximide, trimethadione, and mibefradil in persistent and acute nociceptive tests.",0
849,12,Which calcium channels does ethosuximide target?,"We tested the effects of several T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride, mibefradil, and NCC 55-0396, a mibefradil derivative, on tacrine-induced tremulous jaw movements (TJMs), an animal model of parkinsonian tremor.",0
849,13,Which calcium channels does ethosuximide target?,"We focused on two T-type calcium blockers, trimethadione and ethosuximide, which are anti-epileptics approved by the Food and Drug Administration.",1
849,14,Which calcium channels does ethosuximide target?,"Gallopamil and another T-type-channel blocker, ethosuximide, were included for comparison.",1
2700,0,What is the function of HDAC  proteins?,"Histone deacetylases (HDACs) prevent the relaxation of chromatin, and positively or negatively regulate transcription.",1
2700,1,What is the function of HDAC  proteins?,Histone deacetylases (HDACs) influence diverse cellular processes and may contribute to tumor development and progression by multiple mechanisms,1
2700,2,What is the function of HDAC  proteins?,"Accumulating evidence has implicated histone deacetylase (HDAC) proteins in cell specification, proliferation, and differentiation in diverse embryonic and adult tissues.",0
2700,3,What is the function of HDAC  proteins?,The function of eukaryotic histone deacetylase (HDAC) has been extensively studied for its critical role in transcriptional regulation and carcinogenesis.,0
2700,4,What is the function of HDAC  proteins?,Histone deacetylases (HDACs) are key regulators of gene expression that require assembly into larger protein complexes for activity.,0
2700,5,What is the function of HDAC  proteins?,Histone deacetylase (HDAC) proteins have a major role in epigenetic regulation of chromatin structure.,0
2700,6,What is the function of HDAC  proteins?,HDAC is a family of enzymes involved in deacetylation of lysine residues on histone and non-histone proteins.,0
2700,7,What is the function of HDAC  proteins?,Gene expression is in part controlled by chromatin remodeling factors and the acetylation state of nucleosomal histones.,0
2700,8,What is the function of HDAC  proteins?,The latter process is regulated by histone acetyltransferases and histone deacetylases (HDACs),1
2700,9,What is the function of HDAC  proteins?,Class I histone deacetylases (HDACs) are known to remove acetyl groups from histone tails.,0
2700,10,What is the function of HDAC  proteins?,"This liberates positive charges on the histone tail and allows for tighter winding of DNA, preventing transcription factor binding and gene activation",0
2700,11,What is the function of HDAC  proteins?,Histone deacetylases (HDACs) and histone acetyl transferases catalyze the reversible acetylation of histones and nonhistone substrates to control the epigenetic and transcriptomic landscape of normal and tumor cells,1
2700,12,What is the function of HDAC  proteins?,Histone deacetylases (HDACs) modify core histones and participate in large regulatory complexes that both suppress and enhance transcription,0
2700,13,What is the function of HDAC  proteins?,Transcription is controlled in part by the dynamic acetylation and deacetylation of histone proteins.,0
2700,14,What is the function of HDAC  proteins?,The latter process is mediated by histone deacetylases (HDACs).,1
2700,15,What is the function of HDAC  proteins?,"Specifically, the histone deacetylase (HDAC) family of proteins modulate chromatin compaction and are commonly dysregulated in many tumors, including colorectal cancer (CRC)",0
2700,16,What is the function of HDAC  proteins?,"Specifically, histone deacetylase (HDAC) proteins repress transcription by deacetylating histones.",0
2067,0,Can glyburide reduce cerebral edema?,Preclinical studies have shown that a continuous infusion of glyburide blocks edema formation and improves outcome.,0
2067,1,Can glyburide reduce cerebral edema?,We hypothesize that treatment with RP-1127 (Glyburide for Injection) reduces formation of brain edema in patients after large anterior circulation infarction.,0
2067,2,Can glyburide reduce cerebral edema?,CONCLUSIONS: GAMES-RP was designed to provide critical information regarding glyburide for injection in patients with large hemispheric stroke and will inform the design of future studies.,0
2067,3,Can glyburide reduce cerebral edema?,Glyburide is associated with attenuated vasogenic edema in stroke patients.,0
2067,4,Can glyburide reduce cerebral edema?,Glyburide is reported to prevent brain swelling in preclinical rodent models of ischemic stroke through inhibition of a non-selective channel composed of sulfonylurea receptor 1 and transient receptor potential cation channel subfamily M member 4.,1
2067,5,Can glyburide reduce cerebral edema?,"RESULTS: We report that IV glyburide was associated with T2 fluid-attenuated inversion recovery signal intensity ratio on brain MRI, diminished the lesional water diffusivity between days 1 and 2 (pseudo-normalization), and reduced blood MMP-9 level.CONCLUSIONS: Several surrogate markers of vasogenic edema appear to be reduced in the setting of IV glyburide treatment in human stroke.",0
2067,6,Can glyburide reduce cerebral edema?,Pilot study of intravenous glyburide in patients with a large ischemic stroke.,0
2067,7,Can glyburide reduce cerebral edema?,"BACKGROUND AND PURPOSE: Preclinical and retrospective clinical data indicate that glyburide, a selective inhibitor of sulfonylurea receptor 1-transient receptor potential melastatin 4, is effective in preventing edema and improving outcome after focal ischemia.",1
2067,8,Can glyburide reduce cerebral edema?,"Preclinical data suggest that glyburide, an inhibitor of SUR1-TRPM4, is effective in preventing edema.",1
2067,9,Can glyburide reduce cerebral edema?,Glyburide in Treating Malignant Cerebral Edema.,0
2067,10,Can glyburide reduce cerebral edema?,Glyburide in Treating Malignant Cerebral Edema.,0
2067,11,Can glyburide reduce cerebral edema?,Blocking Sulfonyl Urea One (SUR1) Receptors.,0
2067,12,Can glyburide reduce cerebral edema?,"The sulfonylurea receptor 1-regulated NC(Ca-ATP) channel is upregulated in rodent models of stroke with block of the channel by the sulfonylurea, glibenclamide (glyburide), significantly reducing mortality, cerebral edema, and infarct volume.",0
2067,13,Can glyburide reduce cerebral edema?,"Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic edema.",0
2067,14,Can glyburide reduce cerebral edema?,"In this focused review, we explore preclinical data linking Sur1 channel formation to development of edema and reference evidence suggesting that the antidiabetic sulfonylurea drug glyburide (a Sur1 inhibitor) is an inexpensive and well-tolerated agent that can be clinically tested to reduce or prevent malignancy and/or treatment-associated edema.",0
2067,15,Can glyburide reduce cerebral edema?,Potential of glyburide to reduce intracerebral edema in brain metastases.,0
2067,16,Can glyburide reduce cerebral edema?,Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design.,0
2067,17,Can glyburide reduce cerebral edema?,"Preclinical data suggest that glyburide, an inhibitor of SUR1-TRPM4, is effective in preventing edema.",1
2067,18,Can glyburide reduce cerebral edema?,Inhibition of sulfonylurea receptor 1 (SUR1) by glyburide has been shown to decrease edema after subarachnoid hemorrhage.,0
2067,19,Can glyburide reduce cerebral edema?,"Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic edema",0
2067,20,Can glyburide reduce cerebral edema?,"RESULTS: We report that IV glyburide was associated with T2 fluid-attenuated inversion recovery signal intensity ratio on brain MRI, diminished the lesional water diffusivity between days 1 and 2 (pseudo-normalization), and reduced blood MMP-9 level.",0
2067,21,Can glyburide reduce cerebral edema?,"Preclinical data suggest that glyburide, an inhibitor of SUR1-TRPM4, is effective in preventing edema.",0
2067,22,Can glyburide reduce cerebral edema?,Exploratory analysis of glyburide as a novel therapy for preventing brain swelling.,0
2067,23,Can glyburide reduce cerebral edema?,Inhibition of sulfonylurea receptor 1 (SUR1) by glyburide has been shown to decrease edema after subarachnoid hemorrhage.,0
2067,24,Can glyburide reduce cerebral edema?,"In this focused review, we explore preclinical data linking Sur1 channel formation to development of edema and reference evidence suggesting that the antidiabetic sulfonylurea drug glyburide (a Sur1 inhibitor) is an inexpensive and well-tolerated agent that can be clinically tested to reduce or prevent malignancy and/or treatment-associated edema.",0
2067,25,Can glyburide reduce cerebral edema?,"Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic edema.",0
2067,26,Can glyburide reduce cerebral edema?,Glyburide is reported to prevent brain swelling in preclinical rodent models of ischemic stroke through inhibition of a non-selective channel composed of sulfonylurea receptor 1 and transient receptor potential cation channel subfamily M member 4.,1
2067,27,Can glyburide reduce cerebral edema?,Several surrogate markers of vasogenic edema appear to be reduced in the setting of IV glyburide treatment in human stroke.,0
2067,28,Can glyburide reduce cerebral edema?,We hypothesize that treatment with RP-1127 (Glyburide for Injection) reduces formation of brain edema in patients after large anterior circulation infarction.,0
2067,29,Can glyburide reduce cerebral edema?,"Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic edema..",0
2067,30,Can glyburide reduce cerebral edema?,Glyburide is associated with attenuated vasogenic edema in stroke patients.,0
3999,0,What is another name for the drug AMG334?,"The results of phase 2 randomized controlled trials for the prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab), LY2951742 (galcanezumab) and TEV48125 (fremanezumab)] have been published recently, and phase 3 trials are in process.",1
2655,0,What is measured with the Proseek panels?,A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit,1
2655,1,What is measured with the Proseek panels?, PROSEEK Multiplex CVD and PROSEEK Multiplex INF,1
2655,2,What is measured with the Proseek panels?,"A multiplex proximity extension assay allowed us to measure 157 cardiovascular disease (CVD) and inflammatory disease-related biomarkers in patients from the international, multicenter, and randomized trial;",1
2655,3,What is measured with the Proseek panels?,Plasma concentrations of MMP12 were measured at baseline in 3394 subjects with high-risk for cardiovascular disease (CVD) using the Olink ProSeek CVD I array.,0
2655,4,What is measured with the Proseek panels?,"The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden).",0
2655,5,What is measured with the Proseek panels?, A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 min afterward with the Proseek Multiplex Neurology I kit.,0
2655,6,What is measured with the Proseek panels?,"We used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n = 75) and age-matched healthy control subjects (n = 23)",0
2655,7,What is measured with the Proseek panels?,"Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink),",0
2655,8,What is measured with the Proseek panels?,This new technology (Proseek®Multiplex Oncology Plates) can simultaneously measure the expression of 92 proteins in serum based on a proximity extension assay.,0
2655,9,What is measured with the Proseek panels?,"Levels of 82 proteins were assessed in plasma by a proximity extension assay (Proseek Multiplex CVD,",0
2655,10,What is measured with the Proseek panels?,"92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)",1
2655,11,What is measured with the Proseek panels?,erum concentrations of 92 inflammation-associated proteins were measured in samples obtained from 80 aHSCT patients 14 days after transplantation and from 23 healthy control subjects by a novel sensitive proximity extension assay technology using Proseek Multiplex Inflammation I kit.,0
2655,12,What is measured with the Proseek panels?," Laboratory analyses were performed by Proximity Extension Assay (Proseek Multiplex CVD I(96 × 96)), ELISAs and RT-PCR.",1
3650,0,Which company produces ORMD-0801?,"In efforts to provide patients with a more compliable treatment method, Oramed Pharmaceuticals tested the capacity of its oral insulin capsule (ORMD-0801, 8 mg insulin) in addressing this resistant clinical state.",1
941,0,Do selenoproteins and selenium play a role in prostate cancer prevention?,"The selenoprotein-deficient mice exhibited accelerated development of lesions associated with prostate cancer progression, implicating selenoproteins in cancer risk and development and raising the possibility that selenium prevents cancer by modulating the levels of these selenoproteins",1
941,1,Do selenoproteins and selenium play a role in prostate cancer prevention?,"Notably and in contrast to previous studies, RWPE-1 cells were significantly more sensitive to selenite than either of the prostate cancer cell lines.",1
941,2,Do selenoproteins and selenium play a role in prostate cancer prevention?,These results demonstrate that selenoproteins and selenium metabolism are regulated at multiple levels in prostate cells,0
941,3,Do selenoproteins and selenium play a role in prostate cancer prevention?,"In a low-selenium population, SOD2-Ala16+ men homozygous for SEPP1-Ala234 are at an increased risk of prostate cancer/aggressive prostate cancer especially if ever-smokers, because they are likely to produce more mitochondrial H(2)O(2) that they cannot remove, thereby promoting prostate tumor cell proliferation and migration.",0
941,4,Do selenoproteins and selenium play a role in prostate cancer prevention?,"Our results support a role of selenium and polymorphisms in selenoenzymes in prostate cancer etiology, which warrants confirmation in future studies.",1
941,5,Do selenoproteins and selenium play a role in prostate cancer prevention?,This study provides evidence that SEP15 genetic variation may influence PCa mortality.,0
941,6,Do selenoproteins and selenium play a role in prostate cancer prevention?,"Additionally, the association of selenium with PCa mortality was modified by a variant, suggesting the possibility that some men with PCa may benefit more from selenium than others, depending on their genotype.",1
941,7,Do selenoproteins and selenium play a role in prostate cancer prevention?,We conclude that decreased SEPP concentration in serum might represent an additional valuable marker for prostate cancer diagnostics.,0
941,8,Do selenoproteins and selenium play a role in prostate cancer prevention?,The recently completed Selenium and Vitamin E Cancer Prevention Trial (SELECT) was one of the largest human cancer prevention trials ever undertaken.,0
941,9,Do selenoproteins and selenium play a role in prostate cancer prevention?,"Its purpose was to assess the role of selenium and vitamin E in prostate cancer prevention, but SELECT found no decline in prostate cancer.",1
941,10,Do selenoproteins and selenium play a role in prostate cancer prevention?,"We studied Se levels in whole blood, plasma and prostate of 32 PC and 40 benign prostate hyperplasia (BPH) patients and in the control group composed of 39 healthy subjects.",0
941,11,Do selenoproteins and selenium play a role in prostate cancer prevention?,"The selenoenzyme glutathione peroxidase (GSH-Px) was also measured in the patients' red cells, plasma and prostate tissue.",0
941,12,Do selenoproteins and selenium play a role in prostate cancer prevention?,"Se concentration in whole blood and plasma in both groups of patients was lower as compared with controls, while in prostate gland it was significantly higher in PC than in BPH patients and controls.",0
941,13,Do selenoproteins and selenium play a role in prostate cancer prevention?,Red cell GSH-Px activity was the same in PC patients and controls but significantly lower in BPH patients.,0
941,14,Do selenoproteins and selenium play a role in prostate cancer prevention?,"Of particular interest was the positive correlation between tissue GPx activity and Gleason score, with this relationship achieving statistical significance among African-Americans (r = 0.67, P = 0.02)",0
3495,0,What is the function of the Spt6 gene in yeast?,Spt6 is a highly conserved histone chaperone that interacts directly with both RNA polymerase II and histones to regulate gene expression.,1
3495,1,What is the function of the Spt6 gene in yeast?,Spt6 is a highly conserved factor required for normal transcription and chromatin structure.,1
3495,2,What is the function of the Spt6 gene in yeast?,"Binding of elongation factor Spt6 to Iws1 provides an effective means for coupling eukaryotic mRNA synthesis, chromatin remodelling and mRNA export.",1
3495,3,What is the function of the Spt6 gene in yeast?,Spt6 Is Essential for rRNA Synthesis by RNA Polymerase I.,0
3495,4,What is the function of the Spt6 gene in yeast?,Spt6 (suppressor of Ty6) has many roles in transcription initiation and elongation by RNA polymerase (Pol) II.,0
3495,5,What is the function of the Spt6 gene in yeast?,"These effects are mediated through interactions with histones, transcription factors, and the RNA polymerase.",1
3495,6,What is the function of the Spt6 gene in yeast?,Two lines of evidence suggest that Spt6 also plays a role in rRNA synthesis.,0
3495,7,What is the function of the Spt6 gene in yeast?,"We identify the histone H3-H4 chaperone Spt6 as the factor that mediates nucleosome reassembly onto the PHO5, PHO8, ADH2, ADY2, and SUC2 promoters during transcriptional repression.",1
3495,8,What is the function of the Spt6 gene in yeast?,"Previous characterization of the Saccharomyces cerevisiae Spt4, Spt5, and Spt6 proteins suggested that these proteins act as transcription factors that modify chromatin structure.",0
3495,9,What is the function of the Spt6 gene in yeast?,"The SPT4, SPT5, and SPT6 gene products define a class of transcriptional repressors in Saccharomyces cerevisiae that are thought to function through their effects on chromatin assembly or stability.",0
3495,10,What is the function of the Spt6 gene in yeast?,"The SPT4, SPT5 and SPT6 genes of Saccharomyces cerevisiae were identified originally by mutations that suppress delta insertion mutations at HIS4 and LYS2.",0
3495,11,What is the function of the Spt6 gene in yeast?,"Taken together, these genetic and biochemical results indicate that SPT4, SPT5 and SPT6 function together in a transcriptional process that is essential for viability in yeast.",0
3495,12,What is the function of the Spt6 gene in yeast?,"Next, we showed that CK2 interacts with the major histone chaperone Spt6, and phosphorylates it in vivo and in vitro.",0
3495,13,What is the function of the Spt6 gene in yeast?,CK2 phosphorylation of Spt6 is required for its cellular levels,0
757,0,Which are the major phycobiliproteins present in cyanobacteria?,An extensive range of pigments including phycobiliproteins are present in algae.,0
757,1,Which are the major phycobiliproteins present in cyanobacteria?,"C-phycocyanin (C-PC), a phycobiliprotein, is one of the key pigments of Spirulina",0
757,2,Which are the major phycobiliproteins present in cyanobacteria?,Spirulina platensis produces nutraceutical product C-phycocyanin (C-PC),0
757,3,Which are the major phycobiliproteins present in cyanobacteria?,C-Phycocyanin (C-Pc) is one of the major biliprotein pigments of unicellular cyanbacterium of Spirulina platenesis,1
757,4,Which are the major phycobiliproteins present in cyanobacteria?,"Marine Synechococcus owe their specific vivid color (ranging from blue-green to orange) to their large extrinsic antenna complexes called phycobilisomes, comprising a central allophycocyanin core and rods of variable phycobiliprotein composition.",1
757,5,Which are the major phycobiliproteins present in cyanobacteria?,"Three major pigment types can be defined depending on the major phycobiliprotein found in the rods (phycocyanin, phycoerythrin I or phycoerythrin II)",0
757,6,Which are the major phycobiliproteins present in cyanobacteria?,Phycocyanin--a major phycobiliprotein constitutively produced by many cyanobacteria--,0
757,7,Which are the major phycobiliproteins present in cyanobacteria?,"R-phycoerythrin was isolated and purified from a red alga, Polysiphonia urceolata Grev",0
757,8,Which are the major phycobiliproteins present in cyanobacteria?,"C-phycocyanin (C-PC), one of the major phycobiliproteins of Spirulina platensis (a blue-green alga)",0
757,9,Which are the major phycobiliproteins present in cyanobacteria?,"C-Phycocyanin (C-PC), the major light harvesting biliprotein from Spirulina platensis is of greater importance because of its various biological and pharmacological properties.",0
757,10,Which are the major phycobiliproteins present in cyanobacteria?,B-Phycoerythrin (B-PE) is a major light-harvesting pigment of microalgae.,0
757,11,Which are the major phycobiliproteins present in cyanobacteria?,Phycoerythrin is a major light-harvesting pigment of red algae and cyanobacteria that is widely used as a fluorescent probe and analytical reagent.,0
757,12,Which are the major phycobiliproteins present in cyanobacteria?,"In this paper, B-phycoerythrin and R-phycocyanin in native state, from the red alga Porphyridium cruentum were obtained by an inexpensive and simple process.",0
757,13,Which are the major phycobiliproteins present in cyanobacteria?,Phycobiliproteins are derived from the photosynthetic apparatus of cyanobacteria and eukaryotic algae.,1
757,14,Which are the major phycobiliproteins present in cyanobacteria?,"the three major phycobiliprotein types, namely allophycocyanin, phycocyanin, and phycoerythrin",0
757,15,Which are the major phycobiliproteins present in cyanobacteria?,Phycoerythrin is a major light-harvesting pigment of red algae and cyanobacteria widely used as a fluorescent probe.,1
757,16,Which are the major phycobiliproteins present in cyanobacteria?,allophycocyanin (APC),0
757,17,Which are the major phycobiliproteins present in cyanobacteria?,R-phycoerythrin is the major light-harvesting pigment protein of most red algal phycobilisomes.,1
757,18,Which are the major phycobiliproteins present in cyanobacteria?,"The purified protein had three absorption peaks at 498, 535, and 565 nm and displayed a fluorescence maximum at 580 nm, which was consistent with the typical spectrum of R-phycoerythrin.",0
757,19,Which are the major phycobiliproteins present in cyanobacteria?,The purified R-PE was also identified with electrophoresis.,0
757,20,Which are the major phycobiliproteins present in cyanobacteria?,"Phycobilisomes, the major light-harvesting complexes of cyanobacteria are multimolecular structures made up of chromophoric proteins called phycobiliproteins and non chromophoric linker polypeptides.",0
757,21,Which are the major phycobiliproteins present in cyanobacteria?,"We report here the isolation and nucleotide sequence of the genes, cpeA and cpeB, which in Calothrix PCC 7601 encode the alpha and beta subunits of phycoerythrin, one of the major phycobiliproteins.",0
757,22,Which are the major phycobiliproteins present in cyanobacteria?,"The major light-harvesting complex in eukaryotic red algae and prokaryotic cyanobacteria is the phycobilisome, a water-soluble complex located on the outer surface of the photosynthetic membranes and composed of both pigmented phycobiliproteins (85%) and non-pigmented linker (15%) polypeptides.",0
757,23,Which are the major phycobiliproteins present in cyanobacteria?,"Phycocyanin is a major protein produced by cyanobacteria, but very few phycocyanin-producing strains have been reported.",0
757,24,Which are the major phycobiliproteins present in cyanobacteria?,"In the present work, phycocyanin (PC) and phycoerythrin (PE) from a Nostoc species are proposed as protein markers for electrophoretic techniques.",0
757,25,Which are the major phycobiliproteins present in cyanobacteria?,Rod structure of a phycoerythrin II-containing phycobilisome.,0
757,26,Which are the major phycobiliproteins present in cyanobacteria?,I.,0
757,27,Which are the major phycobiliproteins present in cyanobacteria?,Organization and sequence of the gene cluster encoding the major phycobiliprotein rod components in the genome of marine Synechococcus sp.,0
757,28,Which are the major phycobiliproteins present in cyanobacteria?,WH8020.,0
757,29,Which are the major phycobiliproteins present in cyanobacteria?,"We now present data showing that the allophycocyanin genes and a second set of phycocyanin genes are transcribed into major mRNAs of 1400 and 1600 bases, respectively",0
757,30,Which are the major phycobiliproteins present in cyanobacteria?,"The amino acid sequences deduced from both rpeA and rpeB present strong homologies with those previously reported for phycoerythrin subunits of cyanobacteria, rhodophyta, and cryptomonads",0
757,31,Which are the major phycobiliproteins present in cyanobacteria?,"These transcripts are present in RNA isolated from cultures grown in red and green light, although lower levels of the 1600-base phycocyanin transcript are present in cells grown in green light",0
757,32,Which are the major phycobiliproteins present in cyanobacteria?,"Phycocyanin is a major protein produced by cyanobacteria, but very few phycocyanin-producing strains have been reported",0
757,33,Which are the major phycobiliproteins present in cyanobacteria?,"The major light-harvesting complex in eukaryotic red algae and prokaryotic cyanobacteria is the phycobilisome, a water-soluble complex located on the outer surface of the photosynthetic membranes and composed of both pigmented phycobiliproteins (85%) and non-pigmented linker (15%) polypeptides",0
757,34,Which are the major phycobiliproteins present in cyanobacteria?,"Phycocyanin--a major phycobiliprotein constitutively produced by many cyanobacteria--holds several promising applications in diagnostics, biomedical research, and therapeutics",0
757,35,Which are the major phycobiliproteins present in cyanobacteria?,"Phycobilisomes, the major light-harvesting complexes of cyanobacteria are multimolecular structures made up of chromophoric proteins called phycobiliproteins and non chromophoric linker polypeptides",0
2932,0,Which two drugs are included in the Entresto pill?,"A novel antihypertensive drug, LCZ696 (Entresto®), has recently been introduced, which combines the action of an antagonist of the renin-angiotensin-aldosterone system (RAAS), effectively decreasing the blood pressure, with an inhibition of neprilysin, which is responsible for metabolizing natriuretic peptides exerting antihypertensive and antifibrotic effects.",0
2932,1,Which two drugs are included in the Entresto pill?,"METHODS AND RESULTS: The ENTRESTO-SAS trial is a 3-month, multicentric, prospective, open-label real-life cohort study.",0
2932,2,Which two drugs are included in the Entresto pill?,Patients eligible for sacubitril-valsartan treatment (i.e.,1
2932,3,Which two drugs are included in the Entresto pill?,"adults with left ventricular ejection fraction ≤35%, who remain symptomatic despite optimal treatment with an angiotensin-converting enzyme inhibitor, a beta-blocker, and a mineralocorticoid receptor antagonist) will be evaluated before and after 3 months of treatment (nocturnal ventilatory polygraphy, echocardiography, laboratory testing, and quality-of-life and SDB questionnaires).",0
2932,4,Which two drugs are included in the Entresto pill?, We sought to assess in the ENTRESTO-SAS trial whether sacubitril-valsartan could improve the outcome of SDB in CHF patients.,1
2932,5,Which two drugs are included in the Entresto pill?,"This positive change in regulatory perspective coupled with successful commercialization of valsartan-sacubitril co-crystal (Entresto, Novartis) has now brought co-crystals into focus, in both industries as well as academia.",0
2932,6,Which two drugs are included in the Entresto pill?,"We present a case of a 61-year-old man with ischemic cardiomyopathy receiving sacubitril/valsartan (Entresto; Novartis, Cambridge, MA) who developed profound hypotension after HT.",0
2932,7,Which two drugs are included in the Entresto pill?,"Recently, the Food and Drug Administration (FDA) approved a drug with brand name Entresto (Sacubitril/Valsartan or LCZ696), an angiotensin receptor neprilysin inhibitor for the use in Heart Failure with Reduced Ejection Fraction (HFrEF) patients instead of ACEI's and ARBs.",1
2932,8,Which two drugs are included in the Entresto pill?,"A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.",0
2932,9,Which two drugs are included in the Entresto pill?,"This review of the literature highlights the new generation of HF drug, sacubitril-valsartan (SV), trade name Entresto (researched as LCZ696, Novartis) which simultaneously blocks RAAS and NP.",1
2932,10,Which two drugs are included in the Entresto pill?,▼ Sacubitril valsartan (Entresto-Novartis) is a new oral drug licensed for the treatment of symptomatic chronic heart failure in adults with reduced ejection fraction.,0
2932,11,Which two drugs are included in the Entresto pill?,Sacubitril/valsartan (Entresto) for chronic heart failure; brexpiprazole (Rexulti) for major depressive disorder and schizophrenia; and lumacaftor/ivacaftor (Orkambi) for cystic fibrosis involving specific CFTR mutations.,1
2932,12,Which two drugs are included in the Entresto pill?,Correction to: Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?The original version of this article unfortunately contained a mistake.,0
3207,0,What is the mode of action of the Tc toxins?,Tc toxins secrete toxic enzymes into host cells using a unique syringe-like injection mechanism.,0
3207,1,What is the mode of action of the Tc toxins?,"They are composed of three subunits, TcA, TcB and TcC.",0
3207,2,What is the mode of action of the Tc toxins?,TcA forms the translocation channel and the TcB-TcC heterodimer functions as a cocoon that shields the toxic enzyme.,0
3207,3,What is the mode of action of the Tc toxins?,"The toxin complex (tc) genes of Photorhabdus encode insecticidal, high molecular weight Tc toxins.",0
3207,4,What is the mode of action of the Tc toxins?,The toxin complex (tc) genes of bacteria comprise a large and growing family whose mode of action remains obscure.,1
3207,5,What is the mode of action of the Tc toxins?,"Tc toxins are widely distributed among different gram-negative and gram-positive bacteria, where they act as pathogenicity factors.",1
3207,6,What is the mode of action of the Tc toxins?,"Tripartite Tc toxin complexes of bacterial pathogens perforate the host membrane and translocate toxic enzymes into the host cell, including in humans.",1
3207,7,What is the mode of action of the Tc toxins?,The underlying mechanism is complex but poorly understood.,1
3207,8,What is the mode of action of the Tc toxins?,Tc toxins from pathogenic bacteria use a special syringe-like mechanism to perforate the host cell membrane and inject a deadly enzyme into the host cytosol.,1
3207,9,What is the mode of action of the Tc toxins?,The molecular mechanism of this unusual injection system is poorly understood.,0
3207,10,What is the mode of action of the Tc toxins?,Various bacterial toxins have potent insecticidal activity.,0
3207,11,What is the mode of action of the Tc toxins?,"Recently, the Toxin complexes (Tc's) of Photorhabdus and Xenorhabdus species have become an increased focus of current research.",0
1212,0,List Pentalogy of Fallot.,Pentalogy of Fallot (POF) is a rare form of congenital heart disease characterized by the association of Tetralogy of Fallot (TOF) with an atrial septal defect (ASD).,0
1212,1,List Pentalogy of Fallot.,"Additionally, an atrial septal defect was found on necropsy, resulting in the final diagnosis of Tetralogy of Fallot with an atrial septal defect (a subclass of Pentalogy of Fallot).",0
1212,2,List Pentalogy of Fallot.,"Pentalogy of Fallot is a rare cyanotic congenital heart disease characterized by biventricular origin of the aorta above a large ventricular septal defect, obstruction of the pulmonary outflow, right ventricular hypertrophy (tetralogy of Fallot), and an atrial septal defect.",1
1212,3,List Pentalogy of Fallot.,"Postmortem examination of the ram's heart showed a pentalogy of Fallot, consisting of a pulmonic stenosis, a ventricular septal defect, an overriding aorta, a right ventricular hypertrophy and a patent foramen ovale.",1
1212,4,List Pentalogy of Fallot.,"Additionally, an atrial septal defect was found on necropsy, resulting in the final diagnosis of Tetralogy of Fallot with an atrial septal defect (a subclass of Pentalogy of Fallot).",0
1212,5,List Pentalogy of Fallot.,"Pentalogy of Fallot is a rare cyanotic congenital heart disease characterized by biventricular origin of the aorta above a large ventricular septal defect, obstruction of the pulmonary outflow, right ventricular hypertrophy (tetralogy of Fallot), and an atrial septal defect.",1
1212,6,List Pentalogy of Fallot.,"Based on these findings, the dog was diagnosed as a case of tetralogy of Fallot with atrial septal defect (pentalogy of Fallot).",0
1212,7,List Pentalogy of Fallot.,the dog was diagnosed as a case of tetralogy of Fallot with atrial septal defect (pentalogy of Fallot).,0
1212,8,List Pentalogy of Fallot.,"In conclusion, whenever the diagnosis pentalogy of fallot is suspected, a multidisciplinary approach is essential.",0
1212,9,List Pentalogy of Fallot.,Pentalogy of fallot; Overriding Aorta; Ventricular Septal Defect; Atrial Septal Defect; Pulmonary Atresia; Doppler Echocardiography.,1
1212,10,List Pentalogy of Fallot.,resulting in the final diagnosis of Tetralogy of Fallot with an atrial septal defect (a subclass of Pentalogy of Fallot).,0
1212,11,List Pentalogy of Fallot.,Pentalogy of Fallot (POF) is a rare form of congenital heart disease characterized by the association of Tetralogy of Fallot (TOF) with an atrial septal defect (ASD).,0
1212,12,List Pentalogy of Fallot.,"In conclusion, whenever the diagnosis pentalogy of fallot is suspected, a multidisciplinary approach is essential.Pentalogy of fallot; Overriding Aorta; Ventricular Septal Defect; Atrial Septal Defect; Pulmonary Atresia; Doppler Echocardiography.",1
589,0,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2) gene have been associated with different clinical phenotypes including Silver syndrome/spastic paraplegia 17, distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease type 2 (CMT2) with predominant hand involvement",1
589,1,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Distal hereditary motor neuropathy type V (dHMN-V) and Charcot-Marie-Tooth syndrome (CMT) type 2 presenting with predominant hand involvement, also known as CMT2D and Silver syndrome (SS) are rare phenotypically overlapping diseases which can be caused by mutations in the Berardinelli-Seip Congenital Lipodystrophy 2 (BSCL2) and in the glycyl-tRNA synthetase encoding (GARS) genes",0
589,2,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2) gene have been associated with different clinical phenotypes including Silver syndrome/spastic paraplegia 17, distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease type 2 (CMT2) with predominant hand involvement.",1
589,3,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"In 2004, heterozygous mutations (N88S, S90L) in the Seipin/BSCL2 gene were identified in two autosomal dominant motor neuron diseases, distal hereditary motor neuropathy type V (OMIM #182960) and Silver syndrome (OMIM #270685).",0
589,4,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"We recently found heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2, seipin) gene causing SPG17 and distal hereditary motor neuropathy type V (distal HMN V).",0
589,5,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,Distal hereditary motor neuropathy type V (dHMN-V) and Silver syndrome are rare phenotypically overlapping diseases which can be caused by mutations in the Berardinelli-Seip Congenital Lipodystrophy 2 (BSCL2) gene or Seipin.,0
589,6,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome.,0
589,7,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Heterozygous mutations in the Seipin/BSCL2 gene have recently been identified in two autosomal dominant motor neuron diseases, distal hereditary motor neuropathy type V and Silver's syndrome.",0
589,8,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"We recently found heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2, seipin) gene causing SPG17 and distal hereditary motor neuropathy type V (distal HMN V)",0
589,9,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome,0
589,10,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"In 2004, heterozygous mutations (N88S, S90L) in the Seipin/BSCL2 gene were identified in two autosomal dominant motor neuron diseases, distal hereditary motor neuropathy type V (OMIM #182960) and Silver syndrome (OMIM #270685)",0
589,11,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2) gene have been associated with different clinical phenotypes including Silver syndrome/spastic paraplegia 17, distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease type 2 (CMT2) with predominant hand involvement.",1
589,12,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2) gene have been associated with different clinical phenotypes including Silver syndrome/spastic paraplegia 17,",1
589,13,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"We recently found heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2, seipin) gene causing SPG17 and distal hereditary motor neuropathy type V (distal HMN V).",0
589,14,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,Here we report the clinical features of two families with heterozygous BSCL2 mutations.,0
589,15,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2) gene have been associated with different clinical phenotypes including Silver syndrome/spastic paraplegia 17, distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease type 2 (CMT2) with predominant hand involvement.",1
589,16,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome.,0
589,17,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"We recently found heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2, seipin) gene causing SPG17 and distal hereditary motor neuropathy type V (distal HMN V).",0
589,18,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"In 2004, heterozygous mutations (N88S, S90L) in the Seipin/BSCL2 gene were identified in two autosomal dominant motor neuron diseases, distal hereditary motor neuropathy type V (OMIM #182960) and Silver syndrome (OMIM #270685).",0
589,19,Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?,"Heterozygous mutations in the Seipin/BSCL2 gene have recently been identified in two autosomal dominant motor neuron diseases, distal hereditary motor neuropathy type V and Silver's syndrome.",0
487,0,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?,The in vitro enhancement of chromosome breakage by diepoxybutane (DEB) and mitomycin C (MMC) was studied in 24 Fanconi's anemia (FA) homozygotes and 28 heterozygotes.,1
487,1,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?,Both drugs were shown to enhance chromosome breakage significantly in the homozygotes,0
487,2,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?,"In the great majority of cases, DEB and MMC stressing are reliable techniques for the definitive cytogenetic diagnosis of FA homozygosity",1
487,3,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?," In the great majority of cases, DEB and MMC stressing are reliable techniques for the definitive cytogenetic diagnosis of FA homozygosity.",1
487,4,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?,The diagnosis of Fanconi anemia was confirmed by increased chromosomal breakage abnormalities observed in cultured cells that were treated with cross-linking agents.,0
487,5,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?,"In the great majority of cases, DEB and MMC stressing are reliable techniques for the definitive cytogenetic diagnosis of FA homozygosity.",1
487,6,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?,The cytogenetic test was shown to be reliable in ascertaining the diagnosis of FA,1
487,7,What is considered a reliable technique for the definitive cytogenetic diagnosis of Fanconi anemia homozygosity?,"For that purpose, the flow-based mitomycin C sensitivity test here described proved to be a reliable alternative method to evaluate Fanconi anemia phenotype in fibroblasts",0
355,0,How many TAp73 isoforms have been identified in humans?,"A member of the p53 family, p73, has several isoforms and differentially regulates transcription of genes involved in the control of the cell cycle and apoptosis.",0
355,1,How many TAp73 isoforms have been identified in humans?,"The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and ΔN isoforms.",0
355,2,How many TAp73 isoforms have been identified in humans?,TAp73 has similar activity as p53 and functions as a tumor suppressor whereas ΔNp73 has both pro- and anti-survival functions.,0
355,3,How many TAp73 isoforms have been identified in humans?,Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.,1
355,4,How many TAp73 isoforms have been identified in humans?,"We have evaluated the differential expression and subcellular localization of the functionally distinct apoptotic (TA) and anti-apoptotic (DeltaN) isoforms of p73 in non-small cell lung cancer (NSCLC), their possible association with p53 expression and determined the methylation status of the two p73 gene promoters (P1 and P2) in this tumor type.",1
355,5,How many TAp73 isoforms have been identified in humans?,The role of various p73 isoforms in tumorigenesis has been controversial.,0
355,6,How many TAp73 isoforms have been identified in humans?,"However, as we have recently shown, the generation of TAp73-deficient (TAp73(-/-)) mice reveals that TAp73 isoforms exert tumor-suppressive functions, indicating an emerging role for Trp-73 in the maintenance of genomic stability.",0
355,7,How many TAp73 isoforms have been identified in humans?,"Unlike mice lacking all p73 isoforms, TAp73(-/-) mice show a high incidence of spontaneous tumors.",0
355,8,How many TAp73 isoforms have been identified in humans?,Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (deltaN) p73 isoforms.,0
355,9,How many TAp73 isoforms have been identified in humans?,"TAp73 possesses pro-apoptotic functions, while deltaNp73 has anti-apoptotic properties via functional inhibition of TAp73 and p53.",1
355,10,How many TAp73 isoforms have been identified in humans?,"The p73 gene is able to encode transcriptionaly active TAp73, as well as a dominant-negatively acting DeltaNp73 transcript isoforms.",0
355,11,How many TAp73 isoforms have been identified in humans?,"Since some mutant p53 proteins and ΔNp73 isoforms form heterocomplexes with TAp73, we asked whether p53 isoforms can do the same and potentially act as dominant-negative inhibitors of TAp73.",0
355,12,How many TAp73 isoforms have been identified in humans?,"p73, a p53 family tumor suppressor, is expressed as TA and ΔN isoforms.",0
355,13,How many TAp73 isoforms have been identified in humans?,"p73 is expressed as TA and ΔN isoforms, both of which are implicated in tumor suppression and/or promotion.",0
355,14,How many TAp73 isoforms have been identified in humans?,We found that TAp73 isoforms are down regulated in oocytes from women older than 38 years.,0
355,15,How many TAp73 isoforms have been identified in humans?,p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.,1
355,16,How many TAp73 isoforms have been identified in humans?,"BRCA1-deficient ovarian carcinoma cells exhibit hypermethylation within a p73 regulatory region, which includes the binding site for the p73 transcriptional repressor ZEB1, leading to the abrogation of ZEB1 binding and increased expression of transactivating p73 isoforms (TAp73).",0
355,17,How many TAp73 isoforms have been identified in humans?,"In this study, we investigated the expression and subcellular distribution of two N-terminal isoforms, TAp73 and ΔNp73, in medulloblastoma cells using immunofluorescence microscopy.",0
355,18,How many TAp73 isoforms have been identified in humans?,"Proteasomal degradation of p73 is mediated by polyubiquitination-dependent and -independent processes both of which appear, thus far, to lack selectivity for the TAp73 and DeltaNp73 isoforms.",0
355,19,How many TAp73 isoforms have been identified in humans?,"In general, TAp73 isoforms show proapoptotic activities, whereas members of the N-terminally truncated (ΔN) p73 subfamily that lack the transactivation domain show antiapoptotic functions.",0
355,20,How many TAp73 isoforms have been identified in humans?,"The p73 gene possesses an extrinsic P1 promoter and an intrinsic P2 promoter, resulting in TAp73 and DeltaNup73 isoforms, respectively.",0
355,21,How many TAp73 isoforms have been identified in humans?,Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.,0
355,22,How many TAp73 isoforms have been identified in humans?,"Moreover, we also found that subcellular location of p73 isoforms changes with the culture density increases.",0
355,23,How many TAp73 isoforms have been identified in humans?,"Moreover, ectopic expression of DeltaNp73alpha (but not other p73 isoforms) increased alphaB-crystallin mRNA levels in the absence of p53.",0
355,24,How many TAp73 isoforms have been identified in humans?,"Like wt p53, TAp63 and TAp73 isoforms transactivate target genes that activate apoptosis signaling pathways.",0
355,25,How many TAp73 isoforms have been identified in humans?,The TP73 gene gives rise to transactivation domain-p73 isoforms (TAp73) as well as DeltaNp73 variants with a truncated N terminus.,0
355,26,How many TAp73 isoforms have been identified in humans?,"In contrast, antiapoptotic DeltaNp73 isoforms lack the TA domain and are dominant-negative inhibitors of p53 and TAp73.",0
355,27,How many TAp73 isoforms have been identified in humans?,"The isoforms TAp63 and TAp73 transactivate p53 target genes and induce apoptosis, whereas the isoforms DeltaNp63 and DeltaNp73 lack transactivation and might have dominant-negative effects in p53 family members.",0
355,28,How many TAp73 isoforms have been identified in humans?,"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.",0
355,29,How many TAp73 isoforms have been identified in humans?,"TAp73, DeltaNp73 and DeltaN'p73 were significantly upregulated in tumors.",0
355,30,How many TAp73 isoforms have been identified in humans?,"Consequently, different p73 isoforms can be degraded by calpains, i.e., both N-terminal isoforms (TAp73 and DeltaNp73) as well as the C-terminal isoforms (alpha, beta, gamma, delta).",0
355,31,How many TAp73 isoforms have been identified in humans?,"Variants lacking the TA domain (DeltaN isoforms) are induced by TAp73 and by p53, and inhibit their transcriptional activity.",0
355,32,How many TAp73 isoforms have been identified in humans?,"Indeed, tazarotene modulates the expression of the p73 gene in immortalized keratinocyte cell lines by inducing the pro-apoptotic and anti-proliferative TAp73 isoforms and by repressing the anti-apoptotic and pro-proliferative DeltaNp73 isoforms.",1
355,33,How many TAp73 isoforms have been identified in humans?,"p73, the first p53 gene homologue, encodes an array of p73 proteins including p73 alpha full-length (TAp73 alpha) and amino-truncated isoforms (Delta Np73 alpha), two proteins with opposite biological functions.",0
355,34,How many TAp73 isoforms have been identified in humans?,"We further showed that DeltaNp73 is a potent transdominant inhibitor of wild-type p53 and TAp73 in cultured human tumor cells by efficiently counteracting their target gene transactivations, apoptosis, and growth suppression functions (A.",0
355,35,How many TAp73 isoforms have been identified in humans?,"In developing sympathetic neurons of mice, p73 is predominantly expressed as a truncated anti-apoptotic isoform (DeltaNp73), which antagonizes both p53 and the full-length p73 protein (TAp73).",0
355,36,How many TAp73 isoforms have been identified in humans?,"Interestingly, expression of the Delta Np73 is strongly up-regulated by the TA isoforms and by p53, thus creating a feedback loop that tightly regulates the function of TAp73 and more importantly of p53.",0
2149,0,Is apremilast effective for psoriasis?,CONCLUSION: Apremilast reduces the severity of nail/scalp psoriasis.,0
2149,1,Is apremilast effective for psoriasis?,CONCLUSIONS: Apremilast demonstrated clinically meaningful improvements in psoriatic arthritis and psoriasis at week 16; sustained improvements were seen with continued treatment through 52 weeks.,0
2149,2,Is apremilast effective for psoriasis?,Apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis.,1
2149,3,Is apremilast effective for psoriasis?,"In those that involved doses of 30 mg twice daily, a significantly greater percentage of patients receiving apremilast (28.8% to 40.9%) compared with placebo (5.3% to 5.8%) achieved at least 75% improvement from baseline in Psoriasis Area and Severity Index score at 16 weeks.",0
2149,4,Is apremilast effective for psoriasis?,CONCLUSIONS: Apremilast has a novel mechanism of action and is safe and effective for the management of psoriasis and psoriatic arthritis.,1
2149,5,Is apremilast effective for psoriasis?,"At this time, apremilast should be reserved for patients unable to take disease-modifying antirheumatic drugs.",0
2149,6,Is apremilast effective for psoriasis?,"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).",0
2149,7,Is apremilast effective for psoriasis?,"More recently, three larger double-blinded, and randomized multicenter studies demonstrate that apremilast is efficacious in the treatment of psoriasis and PsA, with significantly higher numbers of apremilast-treated patients achieving endpoints of a 75% reduction compared to baseline in Psoriasis Area and Severity Index (PASI-75) or American College of Rheumatology-20 scores, relative to placebo.",0
2149,8,Is apremilast effective for psoriasis?,"No new significant adverse events emerged with continued apremilast exposure versus the placebo-controlled period.Data were limited to 52 weeks and may not generalize to nonplaque psoriasis.Apremilast was effective in moderate to severe plaque psoriasis.<CopyrightInformation>Copyright © 2015 American Academy of Dermatology, Inc.",0
2149,9,Is apremilast effective for psoriasis?,Published by Elsevier Inc. All rights reserved.</,0
2149,10,Is apremilast effective for psoriasis?,"Apremilast, a small molecule specific inhibitor of phosphodiesterase 4, works intracellularly to modulate pro-inflammatory and anti-inflammatory mediator production.Assess apremilast efficacy and safety in moderate to severe plaque psoriasis.Phase II, 12-week, multicenter, double-blind, placebo-controlled, parallel-group, dose-comparison study of 259 subjects randomized 1 : 1 : 1 to placebo, apremilast 20 mg QD or apremilast 20 mg BID.More subjects receiving apremilast 20 mg BID achieved ≥ 75% reduction in Psoriasis Area and Severity Index (PASI-75) vs. placebo (24.4% vs. 10.3%; P = 0.023)",0
2149,11,Is apremilast effective for psoriasis?,"Apremilast, a specific inhibitor of phosphodiesterase 4, modulates pro-inflammatory and anti-inflammatory cytokine production.Apremilasts effect on patient-reported outcomes (PROs) in patients with moderate to severe psoriasis was evaluated in a phase IIb randomized, controlled trial (NCT00773734).In this 16-week, placebo-controlled study, 352 patients with moderate to severe plaque psoriasis received placebo or apremilast (10, 20, or 30 mg BID)",0
2149,12,Is apremilast effective for psoriasis?,"Although further longer-term and comparative efficacy and tolerability data would be beneficial, the current clinical data indicate that apremilast is an effective and well tolerated option for the management of psoriasis and PsA in adults",0
2149,13,Is apremilast effective for psoriasis?,"More recently, three larger double-blinded, and randomized multicenter studies demonstrate that apremilast is efficacious in the treatment of psoriasis and PsA, with significantly higher numbers of apremilast-treated patients achieving endpoints of a 75% reduction compared to baseline in Psoriasis Area and Severity Index (PASI-75) or American College of Rheumatology-20 scores, relative to placebo",0
2149,14,Is apremilast effective for psoriasis?,No deaths or opportunistic infections were reported.Apremilast 20 mg BID for 12 weeks was effective and well tolerated in subjects with moderate to severe plaque psoriasis.<CopyrightInformation>© 2012 The Authors,0
2149,15,Is apremilast effective for psoriasis?,"In addition, GlaxoSmithKline plc is developing 256066, an inhaled formulation of a PDE4 inhibitor that has demonstrated efficacy in trials in asthma, and apremilast from Celgene Corp has been reported to be effective for the treatment of psoriasis.",0
2149,16,Is apremilast effective for psoriasis?,"Although further longer-term and comparative efficacy and tolerability data would be beneficial, the current clinical data indicate that apremilast is an effective and well tolerated option for the management of psoriasis and PsA in adults.",0
2149,17,Is apremilast effective for psoriasis?,"No new significant adverse events emerged with continued apremilast exposure versus the placebo-controlled period.Data were limited to 52 weeks and may not generalize to nonplaque psoriasis.Apremilast was effective in moderate to severe plaque psoriasis.<CopyrightInformation>Copyright © 2015 American Academy of Dermatology, Inc.",0
2149,18,Is apremilast effective for psoriasis?,Published by Elsevier Inc. All rights reserved.</C,0
2149,19,Is apremilast effective for psoriasis?,"Several drug peculiarities, such as the low frequency of adverse events and the oral route of administration, make apremilast an innovative treatment for moderate-to-severe psoriasis.",0
2149,20,Is apremilast effective for psoriasis?,"Two new oral medications, apremilast and tofacitinib, have been developed for their immunomodulatory properties, and their potential efficacy in treating psoriasis is being evaluated.We reviewed phase III randomized, placebo-controlled clinical trial results for apremilast and tofacitinib for efficacy and safety in psoriasis.Psoriasis Area and Severity Index (PASI) 75 after 16 weeks for apremilast was between 28.8% and 33.1%.",0
2149,21,Is apremilast effective for psoriasis?,Apremilast was effective in moderate to severe plaque psoriasis..,0
2149,22,Is apremilast effective for psoriasis?,"Both new oral medications, apremilast and tofacitinib, appear to be effective in treating psoriasis.",0
2149,23,Is apremilast effective for psoriasis?,Apremilast was effective in the treatment of moderate-to-severe plaque psoriasis over 52 weeks..,1
2149,24,Is apremilast effective for psoriasis?,Apremilast is an effective and well-tolerated option in treating moderate-to-severe plaque psoriasis.,0
2149,25,Is apremilast effective for psoriasis?,Apremilast has a novel mechanism of action and is safe and effective for the management of psoriasis and psoriatic arthritis.,1
2149,26,Is apremilast effective for psoriasis?,Apremilast 20 mg BID for 12 weeks was effective and well tolerated in subjects with moderate to severe plaque psoriasis..,0
2149,27,Is apremilast effective for psoriasis?,Apremilast for the treatment of psoriasis.,1
2149,28,Is apremilast effective for psoriasis?,"Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.",0
4174,0,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,Anti-tumour necrosis factor (TNF) agents have revolutionized the treatment of patients with rheumatoid arthritis (RA).,1
4174,1,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"These therapies are, however, expensive and 30% of patients fail to respond.",1
4174,2,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"By contrast, those patients who had failed to respond to 2 or more anti-TNF agents had a 72.5% lower probability of achieving a moderate to good EULAR response",1
4174,3,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"A 12-month EULAR non-response was observed in 153/821 (18.6%) associated with a higher baseline HAQ score (AOR 1.51, 95% CI 1.03-2.20, p: 0.033), prior treatment with >3 DMARDs (AOR 1.76, 95% CI 1.09-2.85; p: 0.021) and corticosteroid >5 mg/day (AOR 2.05, 95% CI 1.06-3.97; p: 0.034)",0
4174,4,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,We found that only a minority of patients with long-standing RA treated with anti-TNF agents achieve a good clinical response or remission.,0
4174,5,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"Agreement between responses was substantial at the overall/ACR20 level (about 95%, kappa = 0.7 or better) for all criteria.",0
4174,6,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"After 6 months, 18% had a good EULAR response, of whom 9% were considered to be in remission and 50% had a moderate response.",0
4174,7,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"Anti-TNF treatments are effective and safe, reducing the activity of the disease, disability, and the need for corticosteroids.",0
4174,8,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,Patients who displayed good adherence prior to the anti-TNF treatment and were treated with etanercept or with increasing doses of infliximab had the best chance of displaying a response.,0
4174,9,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"BACKGROUND: Anti-tumour necrosis factor (anti-TNF) therapy has proved to be highly successful in treating rheumatoid arthritis (RA), although 30-40% of patients have little or no r",0
4174,10,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"Although anti-TNF drugs have changed the clinical course of rheumatoid arthritis (RA), survival rates and resistance-to-therapy data confirm that about 30% of RA patients fail to respond.",1
4174,11,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,T,0
4174,12,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"However, 20-30% of patients do not respond sufficiently to a given anti-TNF drug.",0
4174,13,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"These therapies are, however, expensive and 30% of patients fail to respond.",1
4174,14,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,UNLABELLED: Approximately 30% of rheumatoid arthritis patients achieve inadequate response to anti-TN,0
4174,15,What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?,"Although TNF inhibitors have dramatically improved the outcome of patients with rheumatoid arthritis, 30-40% of patients do not respond well to them and treatment needs to be changed.",0
2014,0,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"The chromatin remodeler SWR1 mediates site-specific incorporation of H2A.Z by a multi-step histone replacement reaction, evicting histone H2A-H2B from the canonical nucleosome and depositing the H2A.Z-H2B dimer",1
2014,1,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"he multisubunit nucleosome-remodeling enzyme complex SWR1, conserved from yeast to mammals, catalyzes the ATP-dependent replacement of histone H2A in canonical nucleosomes with H2A.Z.",1
2014,2,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,Our results show that the Swr1-Z domain can deliver the H2A.Z-H2B dimer to the DNA-(H3-H4)2 tetrasome to form the nucleosome by a histone chaperone mechanism.,0
2014,3,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,H2A.Z is deposited into chromatin by the SWR1 complex and is subject to acetylation of its four N-terminal tail lysine residues by the NuA4 and SAGA histone acetyltransferase complexes.,0
2014,4,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,H2A.Z deposition is controlled by SWR-C chromatin remodeling enzymes that catalyze the nucleosomal exchange of canonical H2A with H2A.Z.,0
2014,5,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"Saccharomyces cerevisiae Swr1, a Swi2/Snf2-related ATPase, is the catalytic core of a multisubunit chromatin remodeling enzyme, called the SWR1 complex, that efficiently replaces conventional histone H2A in nucleosomes with histone H2A.Z.",1
2014,6,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,The system demonstrates ATP- and SWR1-complex-dependent replacement of histone H2A for histone H2A.Z on a preassembled nucleosome array.,0
2014,7,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,We identified a complex containing 13 different polypeptides associated with a soluble pool of H2A.Z in Saccharomyces cerevisiae.,0
2014,8,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"This complex was designated SWR1-Com in reference to the Swr1p subunit, a Swi2/Snf2-paralog.",0
2014,9,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,The SWR1 complex replaces the canonical histone H2A with the variant H2A.Z (Htz1 in yeast) at specific chromatin regions.,0
2014,10,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"In Saccharomyces cerevisiae, deposition of histone H2AZ is mediated by the multiprotein SWR1 complex, which catalyzes ATP-dependent exchange of nucleosomal histone H2A for H2AZ.",0
2014,11,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"In Saccharomyces cerevisiae, chromatin deposition of histone H2AZ is mediated by the fourteen-subunit SWR1 complex, which catalyzes ATP-dependent exchange of nucleosomal histone H2A for H2AZ.",0
2014,12,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"This incorporation is mediated by the conserved SWR1 complex, which replaces histone H2A in canonical nucleosomes with H2A.Z in an ATP-dependent manner.",0
2014,13,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"Saccharomyces cerevisiae Swr1, a Swi2/Snf2-related ATPase, is the catalytic core of a multisubunit chromatin remodeling enzyme, called the SWR1 complex, that efficiently replaces conventional histone H2A in nucleosomes with histone H2A.Z.",1
2014,14,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"In Saccharomyces cerevisiae, chromatin deposition of histone H2AZ is mediated by the fourteen-subunit SWR1 complex, which catalyzes ATP-dependent exchange of nucleosomal histone H2A for H2AZ.",0
2014,15,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"In Saccharomyces cerevisiae, deposition of histone H2AZ is mediated by the multiprotein SWR1 complex, which catalyzes ATP-dependent exchange of nucleosomal histone H2A for H2AZ.",0
2014,16,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"The Swc4p protein, encoded by an essential gene, is shared by two chromatin-remodeling complexes in Saccharomyces cerevisiae cells: NuA4 (nucleosome acetyltransferase of H4) and SWR1.",0
2014,17,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"The Saccharomyces cerevisiae protein Yaf9 is a subunit of both the essential histone acetyltransferase complex NuA4 and the ATP-dependent chromatin remodeling complex SWR1-C, which deposits histone variant H2A.Z into euchromatin.",0
2014,18,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"Here, we identify and characterize SERRATED LEAVES AND EARLY FLOWERING (SEF), an Arabidopsis (Arabidopsis thaliana) homolog of the yeast SWC6 protein, a conserved subunit of the SWR1/SRCAP complex.",0
2014,19,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,The SWR1/SRCAP complex is a chromatin-remodeling complex that has been shown to be involved in substitution of histone H2A by the histone variant H2A.Z in yeast (Saccharomyces cerevisiae) and animals.,0
2014,20,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"The Swc4p protein, encoded by an essential gene, is shared by two chromatin-remodeling complexes in Saccharomyces cerevisiae cells: NuA4 (nucleosome acetyltransferase of H4) and SWR1.",0
2014,21,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"The SWR1 complex (SWR1C) in yeast catalyzes the replacement of nucleosomal H2A with the H2AZ variant, which ensures full activation of underlying genes.",0
2014,22,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"In addition, H2AZ, a substrate of SWR1C, interacts with both PIE1 and AtSWC2.",0
2014,23,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"The incorporation of H2AZ into chromatin is dependent on the SWR1 complex, which catalyses the replacement of conventional histone H2A with H2AZ.",0
2014,24,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,H2A histone-fold and DNA elements in nucleosome activate SWR1-mediated H2A.Z replacement in budding yeast.,0
2014,25,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,They report that reversal of H2A.Z replacement is mediated by SWR1 and related INO80 on an H2A.Z nucleosome carrying H3K56Q.,0
2014,26,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"The chromatin remodeler SWR1 mediates site-specific incorporation of H2A.Z by a multi-step histone replacement reaction, evicting histone H2A-H2B from the canonical nucleosome and depositing the H2A.Z-H2B dimer.",1
2014,27,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"This incorporation is mediated by the conserved SWR1 complex, which replaces histone H2A in canonical nucleosomes with H2A.Z in an ATP-dependent manner.",0
2014,28,Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?,"Here, we show that the JmjC domain protein Msc1 is a novel component of the fission yeast Swr1 complex and is required for Swr1-mediated incorporation of H2A.Z into nucleosomes at gene promoters.",0
1665,0,Which is the substrate of the haspin kinase during mitosis?,aspin phosphorylates histone H3 at Thr3 (H3T3ph) during mitosis,1
1665,1,Which is the substrate of the haspin kinase during mitosis?,protein kinase Haspin-mediated spreading of H3T3ph,0
1665,2,Which is the substrate of the haspin kinase during mitosis?,Haspin localizes predominantly to chromosomes and phosphorylates histone H3 at threonine-3 during mitosis,1
1665,3,Which is the substrate of the haspin kinase during mitosis?,"haspin/Gsg2 plays an important role in mitosis, where it specifically phosphorylates Thr-3 in histone H3 (H3T3",0
1665,4,Which is the substrate of the haspin kinase during mitosis?,aspin/Gsg2 is a kinase that phosphorylates histone H3 at Thr-3 (H3T3ph) during mitosis.,1
1665,5,Which is the substrate of the haspin kinase during mitosis?,H3T3 phosphorylation is catalyzed by Haspin,0
1665,6,Which is the substrate of the haspin kinase during mitosis?,aspin is an atypical protein kinase that in several organisms phosphorylates histone H3Thr3,0
1665,7,Which is the substrate of the haspin kinase during mitosis?,histone H3 that is phosphorylated at T3 (H3T3ph) by Aurora B-stimulated Haspin.,0
1665,8,Which is the substrate of the haspin kinase during mitosis?,"phosphorylating Thr3 of histone H3, Haspin promotes centromeric recruitment of the chromosome passenger complex (CPC) during mitosis.",0
1665,9,Which is the substrate of the haspin kinase during mitosis?,"aspin phosphorylates histone H3 at threonine-3 (H3T3ph),",1
1665,10,Which is the substrate of the haspin kinase during mitosis?,Haspin-dependent histone H3 phosphorylatio,0
1665,11,Which is the substrate of the haspin kinase during mitosis?,aspin is a serine/threonine kinase that phosphorylates Thr-3 of histone H3 in mitosis,0
1665,12,Which is the substrate of the haspin kinase during mitosis?,Haspin is a protein kinase the only known target of which is phosphorylation of histone H3 at Thr3 residue (H3T3ph),0
1665,13,Which is the substrate of the haspin kinase during mitosis?,Haspin in vitro phosphorylates histone H3 at threonine 3,1
1665,14,Which is the substrate of the haspin kinase during mitosis?,Haspin is a histone H3 Thr3 kinase that has important roles in chromosome cohesion during mitosis,0
1665,15,Which is the substrate of the haspin kinase during mitosis?,phosphorylation of histone H3 threonine 3 (H3-pT3) mediated by Haspin,0
1665,16,Which is the substrate of the haspin kinase during mitosis?,"histone H3 specifically when it is phosphorylated at threonine 3, a mark that is placed by the mitotic kinase, haspin",0
1665,17,Which is the substrate of the haspin kinase during mitosis?,H3T3 kinase haspin,0
1665,18,Which is the substrate of the haspin kinase during mitosis?,phosphorylation of histone H3-threonine 3 (H3-pT3) mediated by Haspin,0
1665,19,Which is the substrate of the haspin kinase during mitosis?,"kinase activity of Haspin, which phosphorylates H3T3,",0
1665,20,Which is the substrate of the haspin kinase during mitosis?,istone H3 Thr-3 phosphorylation by Haspin,0
1665,21,Which is the substrate of the haspin kinase during mitosis?,phosphorylation of histone H3 threonine 3 (H3T3ph) by Haspin,0
1665,22,Which is the substrate of the haspin kinase during mitosis?,Haspin/Gsg2 is a histone H3 threonine-3 kinase,0
1665,23,Which is the substrate of the haspin kinase during mitosis?,"During mitosis haspin is phosphorylated, associates with the chromosomes, centrosomes and spindle, and is responsible for phosphorylation of histone H3 at threonine-3",0
1665,24,Which is the substrate of the haspin kinase during mitosis?,"haspin, a member of a distinctive group of protein kinases present in diverse eukaryotes, phosphorylates H3 at Thr 3",0
1665,25,Which is the substrate of the haspin kinase during mitosis?,Haspin phosphorylated histone H3 at both Thr3 and Thr11 in vitro.,0
1665,26,Which is the substrate of the haspin kinase during mitosis?,Haspin kinase is a histone H3 threonine kinase,0
1665,27,Which is the substrate of the haspin kinase during mitosis?,Haspin phosphorylated histone H3 at both Thr3 and Thr11 in vitro,0
2742,0,What is Mendelian randomization?,Instrumental variable analysis is an approach for obtaining causal inferences on the effect of an exposure (risk factor) on an outcome from observational data.,1
2742,1,What is Mendelian randomization?,"It has gained in popularity over the past decade with the use of genetic variants as instrumental variables, known as Mendelian randomization.",1
2742,2,What is Mendelian randomization?,"We use Mendelian randomization, with the genetic score as an instrumental variable (IV) for height to account for potential confounders that are related to socioeconomic background, early life conditions and parental investments, which are otherwise very difficult to fully account for when using covariates in observational studies.",1
2533,0,Are paralog genes co-regulated?,Co-regulation of paralog genes in the three-dimensional chromatin architecture.,1
2533,1,Are paralog genes co-regulated?,"Consequently, paralogs show correlation in gene expression whereby the mechanisms of co-regulation remain unclear.",1
2533,2,Are paralog genes co-regulated?,"In eukaryotes, genes are regulated in part by distal enhancer elements through looping interactions with gene promoters.",0
2533,3,Are paralog genes co-regulated?,"These looping interactions can be measured by genome-wide chromatin conformation capture (Hi-C) experiments, which revealed self-interacting regions called topologically associating domains (TADs).",0
2533,4,Are paralog genes co-regulated?,We hypothesize that paralogs share common regulatory mechanisms to enable coordinated expression according to TADs.,0
2533,5,Are paralog genes co-regulated?,"To test this hypothesis, we integrated paralogy annotations with human gene expression data in diverse tissues, genome-wide enhancer-promoter associations and Hi-C experiments in human, mouse and dog genomes.",0
2533,6,Are paralog genes co-regulated?,"We show that paralog gene pairs are enriched for co-localization in the same TAD, share more often common enhancer elements than expected and have increased contact frequencies over large genomic distances.",0
2533,7,Are paralog genes co-regulated?,"Combined, our results indicate that paralogs share common regulatory mechanisms and cluster not only in the linear genome but also in the three-dimensional chromatin architecture.",0
2533,8,Are paralog genes co-regulated?,This enables concerted expression of paralogs over diverse cell-types and indicate evolutionary constraints in functional genome organization.,1
2533,9,Are paralog genes co-regulated?,"Paralog genes arise from gene duplication events during evolution, which often lead to similar proteins that cooperate in common pathways and in protein complexes.",0
2533,10,Are paralog genes co-regulated?,"Consequently, paralogs show correlation in gene expression",0
2533,11,Are paralog genes co-regulated?,We hypothesize that paralogs share common regulatory mechanisms to enable coordinated expression according to TADs.,0
2533,12,Are paralog genes co-regulated?,"Further, interspecific changes in testis bias of expression are generally correlated within the co-regulated pairs and are anti-correlated within the anti-regulated pairs, suggesting coordinated regulation within both types of paralogous gene pairs.",0
2533,13,Are paralog genes co-regulated?,Analysis of the Drosophila melanogaster testes transcriptome reveals coordinate regulation of paralogous genes.,0
2533,14,Are paralog genes co-regulated?,"Further, interspecific changes in testis bias of expression are generally correlated within the co-regulated pairs and are anti-correlated within the anti-regulated pairs, suggesting coordinated regulation within both types of paralogous gene pairs.<br>",0
2533,15,Are paralog genes co-regulated?,"Consequently, paralogs show correlation in gene expression whereby the mechanisms of co-regulation remain unclear.",1
2533,16,Are paralog genes co-regulated?,Co-regulation of paralog genes in the three-dimensional chromatin architecture.,1
2533,17,Are paralog genes co-regulated?,"Further, interspecific changes in testis bias of expression are generally correlated within the co-regulated pairs and are anti-correlated within the anti-regulated pairs, suggesting coordinated regulation within both types of paralogous gene pairs..",0
2533,18,Are paralog genes co-regulated?,"We show that paralog gene pairs are enriched for co-localization in the same TAD, share more often common enhancer elements than expected and have increased contact frequencies over large genomic distances.",0
2533,19,Are paralog genes co-regulated?,"MiRNA genes are often subject to co-evolutionary changes together with their target transcripts, which may be reflected by differences between paralog mouse and primate miRNA/mRNA pairs.",0
2533,20,Are paralog genes co-regulated?,We characterize the collapse over time through the distribution of runs of reduced paralog pairs in duplicated segments.,0
2533,21,Are paralog genes co-regulated?,"In addition, we identified 81 co-regulated regions on the human genome (RIDGEs) by using expression data from all cancers.",0
2533,22,Are paralog genes co-regulated?,Some RIDGEs (28%) consist of paralog genes while another subset (30%) are specifically dysregulated in tumors but not in normal tissues.,0
2533,23,Are paralog genes co-regulated?,We conclude that the similarity of hoxb3a/Hoxa3 regulatory mechanisms reflect the shared descent of both genes from a single ancestral paralog group 3 gene.,0
2533,24,Are paralog genes co-regulated?,Conserved co-regulation and promoter sharing of hoxb3a and hoxb4a in zebrafish.,0
2533,25,Are paralog genes co-regulated?,"By analyzing paralogs of testis-biased genes, we identified ""co-regulated"" paralogous pairs in which both genes are testis biased, ""anti-regulated"" pairs in which one paralog is testis biased and the other downregulated in testes, and ""neutral"" pairs in which one paralog is testis biased and the other constitutively expressed.",0
3611,0,Which algorithm has been developed for finding conserved non-coding elements (CNEs)?,CNEFinder: finding conserved non-coding elements in genomes.,1
3611,1,Which algorithm has been developed for finding conserved non-coding elements (CNEs)?,"Towards this direction, identifying sets of CNEs in a wide range of organisms is an important first step.",1
3611,2,Which algorithm has been developed for finding conserved non-coding elements (CNEs)?,"Currently, there are no tools published in the literature for systematically identifying CNEs in genomes.Results: We fill this gap by presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria.",1
3611,3,Which algorithm has been developed for finding conserved non-coding elements (CNEs)?,"Results
We fill this gap by presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria.",1
2314,0,What does davunetide do to microtubules?,Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).,1
2314,1,What does davunetide do to microtubules?,"We have recently described the effects of NAP in neurodegenerative disorders, and we now review the beneficial effects of NAP and other microtubule-stabilizing agents on impairments in axonal transport",1
304,0,The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?,we find that using an anti-PD-1 antibody (CT-011),1
304,1,The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?,"PD-1 blockade by CT-011, anti-PD-1 antibody,",1
304,2,The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?," Presence of CT-011, an anti-PD1 antibody,",1
304,3,The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?,"CT-011, a novel monoclonal anti-PD-1 antibody",1
304,4,The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?,"CT-011, a humanized antibody interacting with PD-1,",1
304,5,The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?,Anti-PD1 (nivolumab and MK-3475),0
304,6,The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?,anti-PD-1 antibodies MK-3475,0
312,0,"Why do we use ""N-terminal proteomics""?","ChaFRADIC is a powerful and practicable tool for protease and peptidase research,",1
312,1,"Why do we use ""N-terminal proteomics""?","systematic identification of protease cleavage events by quantitative N-terminal proteomics,",1
312,2,"Why do we use ""N-terminal proteomics""?", identifying the largest set of protein protease substrates ever reported and gaining novel insight into substrate specificity differences of these cathepsins.,1
312,3,"Why do we use ""N-terminal proteomics""?",new insights into the structure-function relationship of protease targets and their validation from large-scale approaches.,1
312,4,"Why do we use ""N-terminal proteomics""?","revealed unknown cleavage specificities, uncharacterized extended specificity profiles, and macromolecular determinants in substrate selection that were confirmed by molecular modeling.",1
604,0,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleated Ashbya gossypii cells.,1
604,1,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleated Ashbya gossypii fungal cells,0
604,2,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,"Nuclei in the filamentous, multinucleated fungus Ashbya gossypii divide asynchronously.",0
604,3,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleated Ashbya gossypii cells,1
604,4,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,"We analyzed a unique asynchronous nuclear division cycle in a multinucleated filamentous fungus, Ashbya gossypii.",0
604,5,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?, multinucleated hyphae in Ashbya gossypii.,0
604,6,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,We have followed the migration of GFP-labelled nuclei in multinucleate hyphae of Ashbya gossypii,0
604,7,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleate fungus Ashbya gossypii,0
604,8,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,Ashbya gossypii grows as multinucleated and constantly elongating hyphae,1
604,9,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleated hyphae of Ashbya gossypii.,0
604,10,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,We report the mechanistic basis guiding the migration pattern of multiple nuclei in hyphae of Ashbya gossypii.,0
604,11,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleate fungal cells,0
604,12,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleate Ashbya gossypii cells relies on a minimal network of genes,1
604,13,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,Clustering of nuclei in multinucleated hyphae is prevented by dynein-driven bidirectional nuclear movements and microtubule growth control in Ashbya gossypii.,0
604,14,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,"In the multinucleate fungus Ashbya gossypii, cytoplasmic microtubules (cMTs) emerge from the spindle pole body outer plaque (OP) in perpendicular and tangential directions.",0
604,15,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multinucleated hyphae of Ashbya gossypii.,0
604,16,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,multiple nuclei in Ashbya gossypii hyphae,0
604,17,Has the fungus Ashbya gossypii got many nuclei that share cytoplasm?,Ashbya gossypii has a budding yeast-like genome but grows exclusively as multinucleated hyphae.,1
3483,0,Is Ubrogepant effective for migraine?,"CGRP receptor antagonists such as ubrogepant are effective for acute relief of migraine headache, whereas monoclonal antibodies against CGRP (eptinezumab, fremanezumab and galcanezumab) or the CGRP receptor (erenumab) effectively prevent migraine attacks.",0
3483,1,Is Ubrogepant effective for migraine?,"Despite the clear safety concerns, clinical trial data suggests that their intermittent use remains a viable and safe alternative, with 2 molecules remaining in clinical development (ubrogepant and rimegepant).",0
3483,2,Is Ubrogepant effective for migraine?,"Two gepants, ubrogepant and rimegepant, have completed positive pivotal trials for acute treatment of migraine, but have not yet been submitted to the FDA for this indication.",0
3483,3,Is Ubrogepant effective for migraine?,"Two gepants, ubrogepant and rimegepant, have completed positive pivotal trials for the acute treatment of migraine, but have not yet been submitted to the FDA for this indication.",0
3483,4,Is Ubrogepant effective for migraine?,"Area covered: This review reports on compounds currently under development for the oral treatment of acute migraine attacks, focusing on Calcitonin-Gene-Related-Peptide receptor antagonists, specifically ubrogepant and rimegepant.",0
3483,5,Is Ubrogepant effective for migraine?,"Furthermore, new hope rises for the CGRP (calcitonin-gene related peptide)-antagonists, as the data for ubrogepant do not suggest hepatotoxicity but efficacy.",0
3483,6,Is Ubrogepant effective for migraine?,"We applied this strategy for another late-stage clinical program: ubrogepant (MK-1602), a novel oral calcitonin gene-related peptide receptor antagonist for acute treatment of migraine.",0
3483,7,Is Ubrogepant effective for migraine?,"A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.",1
3483,8,Is Ubrogepant effective for migraine?,"AIM: The aim of this trial was to evaluate the efficacy and tolerability of ubrogepant (MK-1602), a calcitonin gene-related peptide receptor antagonist (CGRP-RA), for the acute treatment of migraine.",0
3483,9,Is Ubrogepant effective for migraine?,Ubrogepant 100 mg was significantly superior to placebo for two-hour pain freedom (25.5% vs 8.9%) but not for two-hour headache response.,0
3483,10,Is Ubrogepant effective for migraine?,CONCLUSION: This trial supports ubrogepant's efficacy and provides further evidence that CGRP-RAs are viable options for the acute treatment of migraine.,0
3483,11,Is Ubrogepant effective for migraine?,"Meanwhile, 1 small-molecule CGRP receptor antagonist (ubrogepant, MK-1602) is currently in phase 3 studies for the acute treatment of migraine.",1
3483,12,Is Ubrogepant effective for migraine?,"CGRP receptor antagonists such as ubrogepant are effective for acute relief of migraine headache, whereas monoclonal antibodies against CGRP (eptinezumab, fremanezumab and galcanezumab) or the CGRP receptor (erenumab) effectively prevent migraine attacks.",0
3483,13,Is Ubrogepant effective for migraine?,"Recent findings

Calcitonin gene-related peptide (CGRP) receptor antagonists (gepants-rimegepant and ubrogepant) and serotonin 5-HT __sub__ 1F __end_sub__  receptor agonists (ditans-lasmiditan) have completed phase 3 clinical trials and will soon offer novel, effective, well-tolerated nonvasoconstrictor options to treat acute migraine.",0
3483,14,Is Ubrogepant effective for migraine?,"We applied this strategy for another late-stage clinical program: ubrogepant (MK-1602), a novel oral calcitonin gene-related peptide receptor antagonist for acute treatment of migraine.",0
3483,15,Is Ubrogepant effective for migraine?,"Recently, orally administered next-generation small molecule CGRP-RAs have been shown to have safety and efficacy in acute treatment (ubrogepant and rimegepant) and prevention (atogepant) of migraine, giving additional CGRP-based therapeutic options for migraine patients.",0
3483,16,Is Ubrogepant effective for migraine?,Ubrogepant 100 mg was significantly superior to placebo for two-hour pain freedom (25.5% vs 8.9%) but not for two-hour headache response.,0
3483,17,Is Ubrogepant effective for migraine?,"Lasmiditan, rimegepant and ubrogepant will extend our therapeutic armamentarium for managing acute migraine attacks when triptans are not effective or contraindicated due to cardiovascular disorders.",0
3483,18,Is Ubrogepant effective for migraine?,"Lasmiditan, rimegepant and ubrogepant will extend our therapeutic armamentarium for managing acute migraine attacks when triptans are not effective or contraindicated due to cardiovascular disorders.",0
3483,19,Is Ubrogepant effective for migraine?,"Lasmiditan, ubrogepant, and rimegepant are currently emerging acute migraine therapies that may be added to the arsenal of current migraine management.",0
3483,20,Is Ubrogepant effective for migraine?,Ubrogepant for the Treatment of Migraine .,1
3483,21,Is Ubrogepant effective for migraine?,Ubrogepant 100 mg was significantly superior to placebo for two-hour pain freedom (25.5% vs 8.9%) but not for two-hour headache response.,0
3483,22,Is Ubrogepant effective for migraine?,"CONCLUSION
This trial supports ubrogepant's efficacy and provides further evidence that CGRP-RAs are viable options for the acute treatment of migraine.",0
3483,23,Is Ubrogepant effective for migraine?,"Ubrogepant (MK-1602) is a novel, oral, calcitonin gene-related peptide receptor antagonist in clinical development with positive Phase III outcomes for acute treatment of migraine.",1
3483,24,Is Ubrogepant effective for migraine?,CONCLUSION: This trial supports ubrogepant's efficacy and provides further evidence that CGRP-RAs are viable options for the acute treatment of migraine.,0
3483,25,Is Ubrogepant effective for migraine?,This trial supports ubrogepant's efficacy and provides further evidence that CGRP-RAs are viable options for the acute treatment of migraine.,0
3483,26,Is Ubrogepant effective for migraine?,Ubrogepant for the Treatment of Migraine.,1
3483,27,Is Ubrogepant effective for migraine?,"Ubrogepant is an oral, small-molecule calcitonin gene-related peptide receptor antagonist for acute migraine treatment.",0
2636,0,What is the drug Tecfidera used against?,Dimethyl fumarate (Tecfidera™) is an effective therapy for relapsing forms of multiple sclerosis (MS).,1
2636,1,What is the drug Tecfidera used against?,dimethyl fumarate (Tecfidera(®)) for multiple sclerosis.,1
2636,2,What is the drug Tecfidera used against?,Tecifidera is approved for the treatment of relapsing-remitting multiple sclerosis,1
2636,3,What is the drug Tecfidera used against?,Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis.,1
3478,0,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,"These lncRNAs have specific characteristics, such as broader expression domains, that set them apart from other lncRNAs.",0
3478,1,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,Fourteen lncRNAs have sequence similarity with the loci of the contemporary homologs of the lost protein-coding genes.,0
3478,2,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,We propose that selection acting on enhancer sequences is mostly responsible for retention of these regions.,0
3478,3,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,"As an example of an RNA element from a protein-coding ancestor that was retained in the lncRNA, we describe in detail a short translated ORF in the JPX lncRNA that was derived from an upstream ORF in a protein-coding gene and retains some of its functionality.CONCLUSIONS: We estimate that ~ 55 annotated conserved human lncRNAs are derived from parts of ancestral protein-coding genes, and loss of coding potential is thus a non-negligible source of new lncRNAs.",1
3478,4,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,Some lncRNAs inherited regulatory elements influencing transcription and translation from their protein-coding ancestors and those elements can influence the expression breadth and functionality of these lncRNAs.,1
3478,5,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,"CONCLUSIONS

We estimate that ~ 55 annotated conserved human lncRNAs are derived from parts of ancestral protein-coding genes, and loss of coding potential is thus a non-negligible source of new lncRNAs.",0
3478,6,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,"CONCLUSIONS We estimate that ~ 55 annotated conserved human lncRNAs are derived from parts of ancestral protein-coding genes, and loss of coding potential is thus a non-negligible source of new lncRNAs.",1
3478,7,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,"CONCLUSIONS
We estimate that ~ 55 annotated conserved human lncRNAs are derived from parts of ancestral protein-coding genes, and loss of coding potential is thus a non-negligible source of new lncRNAs.",0
3478,8,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,"CONCLUSIONS: We estimate that ~ 55 annotated conserved human lncRNAs are derived from parts of ancestral protein-coding genes, and loss of coding potential is thus a non-negligible source of new lncRNAs.",1
3478,9,How many annotated conserved human lncRNAs come from ancestral protein-coding genes?,"We estimate that ~ 55 annotated conserved human lncRNAs are derived from parts of ancestral protein-coding genes, and loss of coding potential is thus a non-negligible source of new lncRNAs.",1
2442,0,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"The Aux/IAA proteins are auxin-sensitive repressors that mediate diverse physiological and developmental processes in plants [1, 2].",1
2442,1,Which genes belong to the AUX/IAA family of transcription repressors in plants?,There are 29 Aux/IAA genes in Arabidopsis that exhibit unique but partially overlapping patterns of expression,0
2442,2,Which genes belong to the AUX/IAA family of transcription repressors in plants?,Plant Stress Tolerance Requires Auxin-Sensitive Aux/IAA Transcriptional Repressors,0
2442,3,Which genes belong to the AUX/IAA family of transcription repressors in plants?,Several DREB/CBF TFs directly promote transcription of the IAA5 and IAA19 genes in response to abiotic stress.,0
2442,4,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"Here, we systematically dissect auxin sensing by SCFTIR1-IAA6 and SCFTIR1-IAA19 co-receptor complexes, and assess IAA6/IAA19 ubiquitylation in vitro and IAA6/IAA19 degradation in vivo.",1
2442,5,Which genes belong to the AUX/IAA family of transcription repressors in plants?,We showed that EgrIAA4 protein is localized in the nucleus and functions as an auxin-responsive repressor.,0
2442,6,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"Auxin-induced, SCF(TIR1)-mediated poly-ubiquitination marks AUX/IAA proteins for degradation.",0
2442,7,Which genes belong to the AUX/IAA family of transcription repressors in plants?,evidence for SCF(TIR1)-mediated ubiquitination of the Aux/IAA proteins SHY2/IAA3 and BDL/IAA12,0
2442,8,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"Auxin enhances the binding of Aux/IAA proteins to the receptor TIR1, which is an F-box protein that is part of the E3 ubiquitin ligase complex SCF(TIR1).",0
2442,9,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"Binding of Aux/IAA proteins leads to degradation via the 26S proteasome, but evidence for SCF(TIR1)-mediated poly-ubiquitination of Aux/IAA proteins is lacking",0
2442,10,Which genes belong to the AUX/IAA family of transcription repressors in plants?,The tomato Aux/IAA transcription factor IAA9 is involved in fruit development and leaf morphogenesis,0
2442,11,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"We report here that the downregulation of IAA9, a tomato (Solanum lycopersicum) gene from a distinct subfamily of Aux/IAA genes, results in a pleiotropic phenotype, consistent with its ubiquitous expression pattern",0
2442,12,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"Auxin dose-response assays revealed that IAA9 downregulated lines were hypersensitive to auxin, although the only early auxin-responsive gene that was found to be upregulated in the antisense lines was IAA3",0
2442,13,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"The activity of the IAA3 promoter was stimulated in the IAA9 antisense genetic background, indicating that IAA9 acts in planta as a transcriptional repressor of auxin signaling.",0
2442,14,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"While no mutation in any member of subfamily IV has been reported to date, the phenotypes associated with the downregulation of IAA9 reveal distinct and novel roles for members of the Aux/IAA gene family.",1
2442,15,Which genes belong to the AUX/IAA family of transcription repressors in plants?,Aux/IAA proteins are short-lived nuclear proteins that repress expression of primary/early auxin response genes in protoplast transfection assays.,0
2442,16,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"AUX/IAA proteins are active repressors, and their stability and activity are modulated by auxin.",0
2442,17,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"The Aux/IAA proteins are auxin-sensitive repressors that mediate diverse physiological and developmental processes in plants [1, 2].",1
2442,18,Which genes belong to the AUX/IAA family of transcription repressors in plants?,There are 29 Aux/IAA genes in Arabidopsis that exhibit unique but partially overlapping patterns of expression [3].,0
2442,19,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"Functional characterization of SlIAA15, a member of the tomato (Solanum lycopersicum)",0
2442,20,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"Functional characterization of SlIAA15, a member of the tomato (Solanum lycopersicum) Aux/IAA family, shows that the encoded protein acts as a strong repressor of auxin-dependent transcription.",0
2442,21,Which genes belong to the AUX/IAA family of transcription repressors in plants?,"The Aux/IAA genes are best characterized among the early auxin-responsive genes, which encode short-lived transcriptional repressors.",0
2442,22,Which genes belong to the AUX/IAA family of transcription repressors in plants?,plant stress tolerance requires auxin sensitive aux iaa transcriptional repressors,0
2442,23,Which genes belong to the AUX/IAA family of transcription repressors in plants?,genome wide analysis and characterization of aux iaa family genes in brassica rapa,0
2442,24,Which genes belong to the AUX/IAA family of transcription repressors in plants?,the aux iaa proteins are auxin sensitive repressors that mediate diverse physiological and developmental processes in plants 1 2 there are 29 aux iaa genes in arabidopsis that exhibit unique but partially overlapping patterns of expression 3 although some studies have suggested that individual aux iaa genes have specialized function genetic analyses of the family have been limited by the scarcity of loss of function phenotypes 4 furthermore with a few exceptions our knowledge of the factors that regulate aux iaa expression is limited 1 5 we hypothesize that transcriptional control of aux iaa genes plays a central role in the establishment of the auxin signaling pathways that regulate organogenesis growth and environmental response here we describe a screen for transcription factors tfs that regulate the aux iaa genes we identify tfs from 38 families including 26 members of the dreb cbf family several dreb cbf tfs directly promote transcription of the iaa5 and iaa19 genes in response to abiotic stress recessive mutations in these iaa genes result in decreased tolerance to stress conditions demonstrating a role for auxin in abiotic stress our results demonstrate that stress pathways interact with the auxin gene regulatory network grn through transcription of the aux iaa genes we propose that the aux iaa genes function as hubs that integrate genetic and environmental information to achieve the appropriate developmental or physiological outcome.,1
2442,25,Which genes belong to the AUX/IAA family of transcription repressors in plants?,auxin is a central hormone that exerts pleiotropic effects on plant growth including the development of roots shoots flowers and fruit the perception and signaling of the plant hormone auxin rely on the cooperative action of several components among which auxin indole 3 acetic acid aux iaa proteins play a pivotal role in this study we identified and comprehensively analyzed the entire aux iaa gene family in tomato solanum lycopersicum a reference species for solanaceae plants and the model plant for fleshy fruit development functional characterization using a dedicated single cell system revealed that tomato aux iaa proteins function as active repressors of auxin dependent gene transcription with however different aux iaa members displaying varying levels of repression phylogenetic analysis indicated that the aux iaa gene family is slightly contracted in tomato compared with arabidopsis with a lower representation of non canonical proteins sl iaa genes display distinctive expression pattern in different tomato organs and tissues and some of them display differential responses to auxin and ethylene suggesting that aux iaas may play a role in linking both hormone signaling pathways the data presented here shed more light on sl iaa genes and provides new leads towards the elucidation of their function during plant development and in mediating hormone cross talk.,0
2442,26,Which genes belong to the AUX/IAA family of transcription repressors in plants?,the aux iaa genes encode a large family of short lived proteins known to regulate auxin signalling in plants functional characterization of sliaa15 a member of the tomato solanum lycopersicum aux iaa family shows that the encoded protein acts as a strong repressor of auxin dependent transcription the physiological significance of sliaa15 was addressed by a reverse genetics approach revealing that sliaa15 plays multiple roles in plant developmental processes the sliaa15 down regulated lines display lower trichome number reduced apical dominance with associated modified pattern of axillary shoot development increased lateral root formation and decreased fruit set moreover the leaves of sliaa15 inhibited plants are dark green and thick with larger pavement cells longer palisade cells and larger intercellular space of spongy mesophyll cells the sliaa15 suppressed plants exhibit a strong reduction in type i v and vi trichome formation suggesting that auxin dependent transcriptional regulation is required for trichome initiation concomitant with reduced trichome formation the expression of some r2r3 myb genes putatively involved in the control of trichome differentiation is altered these phenotypes uncover novel and specialized roles for aux iaas in plant developmental processes clearly indicating that members of the aux iaa gene family in tomato perform both overlapping and specific functions.,0
2442,27,Which genes belong to the AUX/IAA family of transcription repressors in plants?,auxins are the key players in plant growth development involving leaf formation phototropism root fruit and embryo development auxin indole 3 acetic acid aux iaa are early auxin response genes noted as transcriptional repressors in plant auxin signaling however many studies focus on aux arf gene families and much less is known about the aux iaa gene family in brassica rapa b rapa here we performed a comprehensive genome wide analysis and identified 55 aux iaa genes in b rapa using four conserved motifs of aux iaa family pf02309 chromosomal mapping of the b rapa aux iaa briaa genes facilitated understanding cluster rearrangement of the crucifer building blocks in the genome phylogenetic analysis of briaa with arabidopsis thaliana oryza sativa and zea mays identified 51 sister pairs including 15 same species briaa briaa and 36 cross species briaa atiaa iaa genes among the 55 briaa genes expression of 43 and 45 genes were verified using genebank b rapa ests and in home developed microarray data from mature leaves of chiifu and rcbr lines despite their huge morphological difference tissue specific expression analysis of briaa genes between the parental lines chiifu and rcbr showed that the genes followed a similar pattern of expression during leaf development and a different pattern during bud flower and siliqua development stages the response of the briaa genes to abiotic and auxin stress at different time intervals revealed their involvement in stress response single nucleotide polymorphisms between iaa genes of reference genome chiifu and rcbr were focused and identified our study examines the scope of conservation and divergence of aux iaa genes and their structures in b rapa analyzing the expression and structural variation between two parental lines will significantly contribute to functional genomics of brassica crops and we belive our study would provide a foundation in understanding the aux iaa genes in b rapa.,0
2442,28,Which genes belong to the AUX/IAA family of transcription repressors in plants?,the plant hormone auxin plays a central role in regulating many aspects of plant growth and development this largely occurs as a consequence of changes in gene expression the aux iaa genes are best characterized among the early auxin responsive genes which encode short lived transcriptional repressors in most plants examined including arabidopsis soybean and rice the aux iaa genes constitute a large gene family by screening the available databases at least 15 expressed sequence tags ests have been identified from wheat triticum aestivum which exhibit high sequence identity with aux iaa homologues in other species one of these aux iaa genes taiaa1 harbouring all the four conserved domains characteristic of the aux iaa proteins has been characterized in detail the expression of taiaa1 is light sensitive tissue specific and is induced within 15 30 min of exogenous auxin application also the taiaa1 transcript levels increase in the presence of a divalent cation ca 2 and this effect is reversed by the calcium chelating agent egta the taiaa1 gene qualifies as the primary response gene because an increase in its transcript levels by auxin is unaffected by cycloheximide in addition to auxin the taiaa1 gene is also induced by brassinosteroid providing evidence that interplay between hormones is crucial for the regulation of plant growth and development.,0
2442,29,Which genes belong to the AUX/IAA family of transcription repressors in plants?,auxin regulates various aspects of plant growth and development the auxin indole 3 acetic acid aux iaa genes encode short lived transcriptional repressors that are targeted by the transport inhibitor response1 auxin receptor f box proteins the aux iaa proteins regulate auxin mediated gene expression by interacting with members of the auxin response factor protein family aux iaa function is poorly understood herein we report the identification and characterization of insertion mutants in 12 of the 29 aux iaa family members the mutants show no visible developmental defects compared with the wild type double or triple mutants of closely related aux iaa genes such as iaa8 1 iaa9 1 or iaa5 1 iaa6 1 iaa19 1 also exhibit wild type phenotypes global gene expression analysis reveals that the molecular phenotypes of auxin treated and untreated light grown seedlings are unaffected in the iaa17 6 and iaa5 1 iaa6 1 iaa19 1 mutants by contrast similar analysis with the gain of function axr3 1 iaa17 1 mutant seedlings reveals dramatic changes in basal and auxin induced gene expression compared with the wild type expression of several type a arabidopsis response regulator genes and a number of genes involved in cell wall biosynthesis and degradation is repressed in axr3 1 iaa17 1 the data suggest extensive functional redundancy among aux iaa gene family members and that enhanced stability of the axr3 iaa17 protein severely alters the molecular phenotype resulting in developmental defects.,0
2442,30,Which genes belong to the AUX/IAA family of transcription repressors in plants?,the regulatory interactions between auxin response factors arfs and aux iaa repressors play a central role in auxin signal transduction yet the systems properties of this regulatory network are not well established we generated a steroid inducible arf5 monopteros mp transgenic background to survey the involvement of this factor in the transcriptional regulation of the entire aux iaa family in arabidopsis thaliana target genes of arf5 mp identified by this approach were confirmed by chromatin immunoprecipitation in vitro gel retardation assays and gene expression analyses our study shows that arf5 mp is indispensable for the correct regulation of nearly one half of all aux iaa genes and that these targets coincide with distinct subclades further genetic analyses demonstrate that the protein products of multiple aux iaa targets negatively feed back onto arf5 mp activity this work indicates that arf5 mp broadly influences the expression of the aux iaa gene family and suggests that such regulation involves the activation of specific subsets of redundantly functioning factors these groups of factors may then act together to control various processes within the plant through negative feedback on arf5 similar detailed analyses of other aux iaa arf regulatory modules will be required to fully understand how auxin signal transduction influences virtually every aspect of plant growth and development.,0
2442,31,Which genes belong to the AUX/IAA family of transcription repressors in plants?,a well known physiological adaptation process of plants encountering drying soil is to achieve water balance by reducing shoot growth and maintaining or promoting root elongation but little is known about the molecular basis of this process this study investigated the role of a drought up regulated triticum aestivum nac69 1 tanac69 1 in the modulation of root growth in wheat tanac69 1 was predominantly expressed in wheat roots at the early vegetative stage overexpression of tanac69 1 in wheat roots using osrsp3 essentially root specific and ospip2 3 root predominant promoters resulted in enhanced primary seminal root length and a marked increase in maturity root biomass competitive growth analysis under water limited conditions showed that osrsp3 promoter driven tanac69 1 transgenic lines produced 32 and 35 more above ground biomass and grains than wild type plants respectively tanac69 1 overexpression in the roots down regulated the expression of tashy2 and taiaa7 which are from the auxin iaa aux iaa transcriptional repressor gene family and are the homologs of negative root growth regulators shy2 iaa3 and iaa7 in arabidopsis the expression of tashy2 and taiaa7 in roots was down regulated by drought stress and up regulated by cytokinin treatment which inhibited root growth dna binding and transient expression analyses revealed that tanac69 1 bound to the promoters of tashy2 and taiaa7 acted as a transcriptional repressor and repressed the expression of reporter genes driven by the tashy2 or taiaa7 promoter these data suggest that tanac69 1 is a transcriptional repressor of tashy2 and taiaa7 homologous to arabidopsis negative root growth regulators and is likely to be involved in promoting root elongation in drying soil.,0
2442,32,Which genes belong to the AUX/IAA family of transcription repressors in plants?,auxin mediates numerous plant responses some of which have been shown to require transcriptional regulation one auxin response pathway which depends on the relief of transcriptional repression is mediated by tir1 transport inhibitor response protein 1 tir1 is an auxin receptor and also a subunit of an scf type ubiquitin ligase in the presence of a low concentration of auxin in the nucleus members of the aux iaa family of transcriptional repressors bind to arf proteins and inhibit the transcription of specific auxin response genes increased nuclear concentrations of auxin promote auxin binding to tir1 causing the aux iaa proteins to associate with tir1 and leading to their degradation by a proteasome mediated pathway this decreases the concentration of aux iaa proteins in the nucleus and thereby enables the expression of certain auxin response genes.,0
2442,33,Which genes belong to the AUX/IAA family of transcription repressors in plants?,recent studies of auxin response have focused on the functions of three sets of proteins the auxin aux response factors arfs the aux iaas and the f box protein tir1 the arf proteins bind dna and directly activate or repress transcription of target genes while the aux iaa proteins repress arf function tir1 is part of a ubiquitin protein ligase required for degradation of aux iaa proteins here we report the isolation and characterization of a novel mutant of arabidopsis called axr5 1 mutant plants are resistant to auxin and display a variety of auxin related growth defects including defects in root and shoot tropisms further the axr5 1 mutation results in a decrease in auxin regulated transcription the molecular cloning of axr5 revealed that the gene encodes the iaa1 protein a member of the aux iaa family of proteins axr5 is expressed throughout plant development consistent with the pleiotropic mutant phenotype the axr5 1 mutation results in an amino acid substitution in conserved domain ii of the protein similar to gain of function mutations recovered in other members of this gene family biochemical studies show that iaa1 axr5 interacts with tir1 in an auxin dependent manner the mutation prevents this interaction suggesting that the mutant phenotype is caused by the accumulation of iaa1 axr5 our results provide further support for a model in which most members of the aux iaa family are targeted for degradation by scftir1 in response to auxin.,0
2173,0,Which mutated gene causes the Chédiak–Higashi Syndrome?,"We detected a homozygous missense mutation (c.4189T>G, p.F1397V) in the lysosomal trafficking regulator (LYST) gene, which is described as the causative gene for Chédiak-Higashi syndrome (CHS).",1
2173,1,Which mutated gene causes the Chédiak–Higashi Syndrome?,A frameshift mutation in the LYST gene is responsible for the Aleutian color and the associated Chédiak-Higashi syndrome in American mink.,1
2173,2,Which mutated gene causes the Chédiak–Higashi Syndrome?,"As with forms of CHS in other species, we report that the mink CHS is linked to the lysosomal trafficking regulator ( LYST ) gene.",1
2173,3,Which mutated gene causes the Chédiak–Higashi Syndrome?,"LYST analysis was performed for 10 patients; seven different mutations were detected in seven patients, whereas no mutation was identified in three patients.",0
2173,4,Which mutated gene causes the Chédiak–Higashi Syndrome?,"Chédiak-Higashi syndrome (CHS) is a rare autosomal recessive disorder characterized by immunodeficiency, neurological dysfunction, and oculocutaneous albinism.",0
2173,5,Which mutated gene causes the Chédiak–Higashi Syndrome?,"Mutations in LYST, a gene encoding a putative lysosomal trafficking protein, cause Chédiak-Higashi syndrome (CHS), an autosomal recessive disorder typically characterized by infantile-onset hemophagocytic syndrome and immunodeficiency, and oculocutaneous albinism.",1
2173,6,Which mutated gene causes the Chédiak–Higashi Syndrome?,"This phenotype is similar to that reported previously in lvsB mutant cells where the ortholog of the LYST gene, involved in CHS, is mutated",0
2173,7,Which mutated gene causes the Chédiak–Higashi Syndrome?,"Rarely, an association of parkinsonism with PN may be encountered in other neurodegenerative diseases such as fragile X-associated tremor and ataxia syndrome related to premutation CGG repeat expansion in the fragile X mental retardation (FMR1) gene, Machado-Joseph disease related to an abnormal CAG repeat expansion in ataxin-3 (ATXN3) gene, Kufor-Rakeb syndrome caused by mutations in ATP13A2 gene, or in hereditary systemic disorders such as Gaucher disease due to mutations in the β-glucocerebrosidase (GBA) gene and Chediak-Higashi syndrome due to LYST gene mutations.",0
2173,8,Which mutated gene causes the Chédiak–Higashi Syndrome?,"LYST is a large cytosolic protein that influences the biogenesis of lysosome-related organelles, and mutation of the encoding gene, LYST, can cause Chediak-Higashi syndrome.",0
2173,9,Which mutated gene causes the Chédiak–Higashi Syndrome?,"Chediak-Higashi syndrome (CHS) is an autosomal recessive hereditary disorder in Japanese Black cattle, caused by a mutation of the Lyst gene.",0
2173,10,Which mutated gene causes the Chédiak–Higashi Syndrome?,"Chediak-Higashi syndrome (CHS) is caused by mutations in the gene encoding LYST protein, the function of which remains poorly understood.",1
2173,11,Which mutated gene causes the Chédiak–Higashi Syndrome?,Mutations of genes other than LYST were suspected in some cases.,0
835,0,Is metabolic syndrome related with cardiovascular disease?,"The metabolic syndrome (MetS) is characterized by a cluster of risk factors including central obesity, hypertension, dyslipidemia and insulin resistance, The MetS is associated with an increased risk for cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM).",1
835,1,Is metabolic syndrome related with cardiovascular disease?,"As a molecular link between metabolic signals, inflammation, and vascular dysfunction, resistin can be proposed as playing a significant role in the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for metabolic syndrome (MetS), type 2 diabetes (T2DM), and cardiovascular disease (CVD).",1
835,2,Is metabolic syndrome related with cardiovascular disease?,"The metabolic syndrome (MetS) is associated with a higher risk for both, type 2 diabetes mellitus and cardiovascular disease.",1
835,3,Is metabolic syndrome related with cardiovascular disease?,arotid intima-media thickness (CIMT) has been widely used as a surrogate marker of atherosclerosis and cardiovascular disease (CVD),1
2154,0,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"The general definition has been expanded into five subtypes: CRS type 1 = acute worsening of heart function (acute heart failure-acute coronary syndrome) leading to kidney injury and/or dysfunction; CRS type 2 = chronic abnormalities in heart function (chronic heart failure-chronic heart disease) leading to kidney injury or dysfunction; CRS type 3 = acute worsening of kidney function (acute kidney injury) leading to heart injury and/or dysfunction; CRS type 4 = chronic kidney disease (chronic kidney disease) leading to heart injury, disease and/or dysfunction; and CRS type 5 = systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.",0
2154,1,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"Cardiorenal syndromes (CRS) have been recently classified into five distinct entities, each with different major pathophysiologic mechanisms.",1
2154,2,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,CRS type 1 most commonly occurs in the setting of acutely decompensated heart failure where approximately 25% of patients develop a rise in serum creatinine and a reduction of urine output after the first several doses of intravenous diuretics.,0
2154,3,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,CRS type 2 is the hastened progression of chronic kidney disease (CKD) in the setting of chronic heart failure.,0
2154,4,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"CRS type 3 is acutely decompensated heart failure after acute kidney injury from inflammatory, toxic, or ischemic insults.",0
2154,5,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,CRS type 4 is manifested by the acceleration of the progression of chronic heart failure in the setting of CKD.,0
2154,6,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"Cardiac myocyte dysfunction and fibrosis, so-called 'CKD cardiomyopathy', is believed to be the predominant pathophysiologic mechanism.",0
2154,7,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,Type 5 CRS is simultaneous acute cardiac and renal injury in the setting of an overwhelming systemic insult such as sepsis.,0
2154,8,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,CRS type I: acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction.,0
2154,9,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,CRS type II: chronic abnormalities in heart function (CHF-CHD) leading to kidney injury or dysfunction.,0
2154,10,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,CRS type III: acute worsening of kidney function (AKI) leading to heart injury and/or dysfunction.,0
2154,11,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"CRS type IV: chronic kidney disease (CKD) leading to heart injury, disease and/or dysfunction.",0
2154,12,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,CRS type V: systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.,0
2154,13,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,Acute CRS (type 1): acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction.,0
2154,14,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,Chronic cardio-renal syndrome (type 2): chronic abnormalities in heart function (CHF-CHD) leading to kidney injury and/or dysfunction.,0
2154,15,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,Acute reno-cardiac syndrome (type 3): acute worsening of kidney function (AKI) leading to heart injury and/or dysfunction.,0
2154,16,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"Chronic reno-cardiac syndrome (type 4): chronic kidney disease leading to heart injury, disease, and/or dysfunction.",0
2154,17,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,Secondary CRS (type 5): systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.,0
2154,18,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"For mentioning the interaction of cardiovascular and renal diseases the cardiorenal syndrome (CRS) term was introduced, with its classification on 5 types, according to the presence of acute/chronic heart failure and primary/secondary origination of heart and kidney injury.",1
2154,19,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"For mentioning the interaction of cardiovascular and renal diseases the cardiorenal syndrome (CRS) term was introduced, with its classification on 5 types, according to the presence of acute/chronic heart failure and primary/secondary origination of heart and kidney injury",1
2154,20,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"The most recent classification recognizes five types of CRS: types I and II originate from heart failure (acute and chronic, respectively), type III and IV from kidney failure (again acute and chronic), while type V originates from a range of systemic diseases",0
2154,21,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"The most recent classification recognizes five types of CRS: types I and II originate from heart failure (acute and chronic, respectively), type III and IV from kidney failure (again acute and chronic), while type V originates from a range of systemic diseases.",0
2154,22,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"For mentioning the interaction of cardiovascular and renal diseases the cardiorenal syndrome (CRS) term was introduced, with its classification on 5 types, according to the presence of acute/chronic heart failure and primary/secondary origination of heart and kidney injury.",1
2154,23,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"Based on the pathophysiological primum movens, the actual classification recognizes five CRS types: in type I and II CRS, the initiating event is heart failure (acute or chronic), while it is kidney failure in type III and IV CRS; type V is linked to systemic diseases.",0
2154,24,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"An effective classification of CRS in 2008 essentially divides CRS in two main groups, cardiorenal and renocardiac CRS, based on primum movens of disease (cardiac or renal); both cardiorenal and renocardiac CRS are then divided into acute and chronic, according to onset of disease.",1
2154,25,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,Of particular interest to the critical care specialist are CRS type 1 (acute cardiorenal syndrome) and type 3 (acute renocardiac syndrome).,0
2154,26,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"At present, the classification of the syndrome includes five types of CRS: types I and II which are strictly related to initial heart failure (both acute and chronic), types III and IV which include initial kidney failure, and type V which includes several systemic diseases.",0
2154,27,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"The general definition has been expanded into five subtypes: CRS type 1 = acute worsening of heart function (acute heart failure-acute coronary syndrome) leading to kidney injury and/or dysfunction; CRS type 2 = chronic abnormalities in heart function (chronic heart failure-chronic heart disease) leading to kidney injury or dysfunction; CRS type 3 = acute worsening of kidney function (acute kidney injury) leading to heart injury and/or dysfunction; CRS type 4 = chronic kidney disease (chronic kidney disease) leading to heart injury, disease and/or dysfunction; and CRS type 5 = systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.",0
2154,28,List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.,"The general definition has been expanded into five subtypes reflecting the primacy of organ dysfunction and the time-frame of the syndrome: CRS type 1 = acute worsening of heart function leading to kidney injury and/or dysfunction; CRS type 2 = chronic abnormalities in heart function leading to kidney injury or dysfunction; CRS type 3 = acute worsening of kidney function leading to heart injury and/or dysfunction; CRS type 4 = chronic kidney disease leading to heart injury, disease and/or dysfunction, and CRS type 5 = systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.",0
3737,0,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.,1
3737,1,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,"The genetic cause of primary immunodeficiency disease (PID) carries prognostic information.OBJECTIVE: We conducted a whole-genome sequencing study assessing a large proportion of the NIHR BioResource-Rare Diseases cohort.METHODS: In the predominantly European study population of principally sporadic unrelated PID cases (n = 846), a novel Bayesian method identified nuclear factor κB subunit 1 (NFKB1) as one of the genes most strongly associated with PID, and the association was explained by 16 novel heterozygous truncating, missense, and gene deletion variants.",1
3737,2,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,This accounted for 4% of common variable immunodeficiency (CVID) cases (n = 390) in the cohort.,1
3737,3,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,Amino acid substitutions predicted to be pathogenic were assessed by means of analysis of structural protein data.,0
3737,4,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,"Immunophenotyping, immunoblotting, and ex vivo stimulation of lymphocytes determined the functional effects of these variants.",0
3737,5,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,Detailed clinical and pedigree information was collected for genotype-phenotype cosegregation analyses.,0
3737,6,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,"We show that heterozygous loss-of-function variants in NFKB1 are the most common known monogenic cause of CVID, which results in a temporally progressive defect in the formation of immunoglobulin-producing B cells.",1
3737,7,Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,Monoallelic loss-of-function mutations in NFKB1 were recently recognized as the most common monogenic cause of common variable immunodeficiency (CVID).,1
3024,0,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.,0
3024,1,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"We found that loss at 6q24.2-26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR = 0.06, 95%CI = 0.01-0.43, Padj = 0.005).",1
3024,2,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"The prognostic value of this deletion was validated in two independent series, one consisting of 36 HGSOCs analyzed by fluorescent in situ hybridization (P = 0.04) and another comprised of 411 HGSOCs from the Cancer Genome Atlas study (TCGA) (HR = 0.67, 95%CI = 0.48-0.93, Padj = 0.019).",1
3024,3,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"In addition, we confirmed the association of low expression of the genes from the region with longer survival in 799 HGSOCs (HR = 0.74, 95%CI = 0.61-0.90, log-rank P = 0.002) and 675 high-FIGO stage HGSOCs (HR = 0.76, 95%CI = 0.61-0.96, log-rank P = 0.02) available from the online tool KM-plotter.",1
3024,4,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"Finally, by integrating copy number, RNAseq and survival data of 296 HGSOCs from TCGA we propose a few candidate genes that can potentially explain the association.",0
3024,5,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,Altogether our findings indicate that the 6q24.2-26 deletion is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life.,0
3024,6,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,Altogether our findings indicate that the 6q24.2-26 deletion is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life.,0
3024,7,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"OBJECTIVE
We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients.",0
3024,8,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"OBJECTIVE We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients.",1
3024,9,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,Altogether our findings indicate that the 6q24.2-26 deletion is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life.<br>,0
3024,10,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"<b>OBJECTIVE</b>: We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients.<br><b>METHODS</b>: In order to test if protein levels of GTF2H5 are associated with patients' outcome, we performed GTF2H5 immunohistochemical staining in 139 high-grade serous ovarian carcinomas included in tissue microarrays.",0
3024,11,Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?,"We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients.",1
213,0,Is protein M3/6 a dual specificity phosphatase?,Involvement of the dual-specificity phosphatase M3/6 in c-Jun N-terminal kinase inactivation following cerebral ischemia in the rat hippocampus.,0
213,1,Is protein M3/6 a dual specificity phosphatase?,The results revealed upregulation of dual-specificity phosphatase M3/6 (DUSP8) activity at 4 h of reperfusion in rat hippocampi.,0
213,2,Is protein M3/6 a dual specificity phosphatase?,This study examines the molecular mechanism underlying JNK dephosphorylation and inactivation evoked by dual-specificity phosphates following cerebral ischemia.,0
213,3,Is protein M3/6 a dual specificity phosphatase?,"Phosphatases play a particularly important role in this respect, by tightly controlling MAPK phosphorylation and activation.",1
213,4,Is protein M3/6 a dual specificity phosphatase?,"M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK and, to a lesser extent, p38 MAPKs and is found in a complex with these kinases, along with other pathway components, held together by scaffold proteins.",1
213,5,Is protein M3/6 a dual specificity phosphatase?,Dual-specificity phosphatases (DUSPs) play a very important role in these events by modulating the extent of JNK phosphorylation and activation and thus regulating cellular responses to stress.,0
213,6,Is protein M3/6 a dual specificity phosphatase?,M3/6 (DUSP8) is one of the dual-specificity protein phosphatases with distinct specificity towards JNK.,0
213,7,Is protein M3/6 a dual specificity phosphatase?,"M3/6 is a dual-specificity phosphatase selective for JNK [7, 8].",1
213,8,Is protein M3/6 a dual specificity phosphatase?,Here we describe two new dual specificity phosphatases of the CL100/MKP-1 family that are selective for inactivating ERK or JNK/SAPK and p38 MAP kinases when expressed in COS-7 cells.,0
213,9,Is protein M3/6 a dual specificity phosphatase?,M3/6 is the first phosphatase of this family to display highly specific inactivation of JNK/SAPK and p38 MAP kinases.,0
213,10,Is protein M3/6 a dual specificity phosphatase?,We previously demonstrated that the dual specificity phosphatases (DSPs) MKP7 and M3/6 bind the scaffold JNK-interacting protein-1 (JIP-1) and inactivate the bound subset of JNK (1).,0
213,11,Is protein M3/6 a dual specificity phosphatase?,the dual-specificity phosphatase M3/6,0
213,12,Is protein M3/6 a dual specificity phosphatase?, dual-specificity phosphatase M3/6 (DUSP8),0
213,13,Is protein M3/6 a dual specificity phosphatase?,M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK,1
213,14,Is protein M3/6 a dual specificity phosphatase?,the M3/6 dual-specificity phosphatase,0
213,15,Is protein M3/6 a dual specificity phosphatase?,M3/6 (DUSP8) is one of the dual-specificity protein phosphatases with distinct specificity towards JNK,0
213,16,Is protein M3/6 a dual specificity phosphatase?,M3/6 is a dual-specificity phosphatase selective for JNK,1
213,17,Is protein M3/6 a dual specificity phosphatase?,The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases.,0
213,18,Is protein M3/6 a dual specificity phosphatase?,Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite.,0
213,19,Is protein M3/6 a dual specificity phosphatase?,"Indeed, expanded polyglutamine impaired the solubility of the dual-specificity JNK phosphatase M3/6.",0
213,20,Is protein M3/6 a dual specificity phosphatase?,Regulation of dual-specificity phosphatases M3/6 and hVH5 by phorbol esters.,0
213,21,Is protein M3/6 a dual specificity phosphatase?,M3/6 (DUSP8) is one of the dual-specificity protein phosphatases with distinct specificity towards JNK.,0
213,22,Is protein M3/6 a dual specificity phosphatase?,"M3/6 is a dual-specificity phosphatase selective for JNK [7, 8]",0
213,23,Is protein M3/6 a dual specificity phosphatase?,M3/6 (DUSP8) is one of the dual-specificity protein phosphatases with distinct specificity towards JNK,0
213,24,Is protein M3/6 a dual specificity phosphatase?,Here we describe how diverse cellular stresses affect differently the stability and activity of a JNK-inactivating dual-specificity threonine-tyrosine phosphatase M3/6,0
213,25,Is protein M3/6 a dual specificity phosphatase?,"M3/6 is a dual-specificity phosphatase selective for JNK [7, 8]",0
213,26,Is protein M3/6 a dual specificity phosphatase?,Regulation of dual-specificity phosphatases M3/6 and hVH5 by phorbol esters.,0
213,27,Is protein M3/6 a dual specificity phosphatase?,Analysis of a delta-like domain.,0
213,28,Is protein M3/6 a dual specificity phosphatase?,The results revealed upregulation of dual-specificity phosphatase M3/6 (DUSP8) activity at 4 h of reperfusion in rat hippocampi,0
213,29,Is protein M3/6 a dual specificity phosphatase?,"Indeed, expanded polyglutamine impaired the solubility of the dual-specificity JNK phosphatase M3/6",0
213,30,Is protein M3/6 a dual specificity phosphatase?,Here we report that JIP-1 also binds the dual-specificity phosphatases MKP7 and M3/6 via a region independent of its JNK binding domain.,0
213,31,Is protein M3/6 a dual specificity phosphatase?,Differential regulation of M3/6 (DUSP8) signaling,0
2687,0,What nerve is involved in carpal tunnel syndrome?,"In this study, it was aimed to determine whether median nerve epineurectomy is beneficial in the surgical management of carpal tunnel syndrome",0
2687,1,What nerve is involved in carpal tunnel syndrome?,We believe that median nerve epineurectomy is unnecessary in the surgical management of primary CTS since it has no influence on the midterm,0
2687,2,What nerve is involved in carpal tunnel syndrome?,Carpal tunnel syndrome (CTS) is a focal compressive neuropathy of the median nerve at the level of the wrist.,1
2687,3,What nerve is involved in carpal tunnel syndrome?," CTS, which may occur in as many as 25% of patients who undergo carpal tunnel release, most commonly results from an incomplete transverse carpal ligament release or an incorrect initial diagnosis.",0
2687,4,What nerve is involved in carpal tunnel syndrome?,Patients with recurrent symptoms often have perineural fibrosis that tethers the median nerve.,0
2687,5,What nerve is involved in carpal tunnel syndrome?, Ultrasound is an established method of viewing the median nerve in the carpal tunnel syndrome (CTS),1
2687,6,What nerve is involved in carpal tunnel syndrome?,"The carpal tunnel syndrome is a neuropathy due to trapping (focal lesion of the peripheral nerve due to a local cause); in this case, the median nerve is the most commonly involved.",1
2687,7,What nerve is involved in carpal tunnel syndrome?,Carpal tunnel syndrome is a complex of symptoms as a result of compression of the median nerve in the carpal tunnel.,1
2687,8,What nerve is involved in carpal tunnel syndrome?,"To define the relationship between body indices of healthy adults and cross-sectional areas of the carpal tunnel and median nerve and to obtain the nerve/tunnel index, which represents a new standard for diagnosing carpal tunnel syndrome using sonography.",0
2687,9,What nerve is involved in carpal tunnel syndrome?,Restricted motion of the median nerve in carpal tunnel syndrome.,0
2687,10,What nerve is involved in carpal tunnel syndrome?,"Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies",0
2687,11,What nerve is involved in carpal tunnel syndrome?,"Compression of the median nerve at the wrist, or carpal tunnel syndrome, is the most commonly recognized nerve entrapment syndrome.",1
655,0,Which protein does empagliflozin inhibit?,Empagliflozin (Jardiance): a novel SGLT2 inhibitor for the treatment of type-2 diabetes.,1
655,1,Which protein does empagliflozin inhibit?,AIMS: Empagliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that inhibits renal glucose reabsorption and is being investigated for the treatment of type 2 diabetes mellitus (T2DM).,0
655,2,Which protein does empagliflozin inhibit?,"Effect of food on the pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, and assessment of dose proportionality in healthy volunteers.",0
655,3,Which protein does empagliflozin inhibit?,"Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects.",0
655,4,Which protein does empagliflozin inhibit?,"Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia.",0
655,5,Which protein does empagliflozin inhibit?,"Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment.",1
655,6,Which protein does empagliflozin inhibit?,"Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, and metformin following co-administration in healthy volunteers.",1
655,7,Which protein does empagliflozin inhibit?,"Exposure-response modelling for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes.",0
655,8,Which protein does empagliflozin inhibit?,"Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control.",0
655,9,Which protein does empagliflozin inhibit?,"By inhibiting reabsorption of glucose from the proximal tubules in the kidney via inhibition of SGLT2, empagliflozin provides a novel insulin-independent mechanism of lowering blood glucose.",0
655,10,Which protein does empagliflozin inhibit?,"Sodium glucose cotransporter 2 (SGLT2) inhibitors are a new class of treatment for T2DM that reduce hyperglycemia by reducing renal glucose reabsorption and thereby increasing urinary glucose excretion.This paper reviews the pharmacokinetic and pharmacodynamic properties of the SGLT2 inhibitor empagliflozin , the results of clinical trials investigating the efficacy of empagliflozin given as monotherapy or as add-on therapy on glycemic control, body weight, and blood pressure in patients with T2DM, and the safety and tolerability profile of empagliflozin.Empagliflozin offers good glycemic efficacy, weight loss, blood pressure reduction, and a low risk of hypoglycemia.",0
655,11,Which protein does empagliflozin inhibit?,"Oral empagliflozin (Jardiance()), a sodium glucose cotransporter-2 (SGLT2) inhibitor, is a convenient once-daily treatment for adult patients with type 2 diabetes mellitus.",1
655,12,Which protein does empagliflozin inhibit?," This randomized, open-label, crossover study investigated potential drug-drug interactions between the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin and the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin.",0
655,13,Which protein does empagliflozin inhibit?,"Empagliflozin is a potent and selective SGLT-2 inhibitor that lowers blood glucose levels by inhibiting renal glucose reabsorption, leading to an increase in urinary glucose excretion.",0
655,14,Which protein does empagliflozin inhibit?,"Empagliflozin is a potent, oral, selective inhibitor of sodium glucose cotransporter 2 in development for the treatment of type 2 diabetes mellitus.",1
655,15,Which protein does empagliflozin inhibit?,"The goal of these studies was to investigate potential drug-drug interactions between empagliflozin and gemfibrozil (an organic anion-transporting polypeptide 1B1 [OATP1B1]/1B3 and organic anion transporter 3 [OAT3] inhibitor), rifampicin (an OATP1B1/1B3 inhibitor), or probenecid (an OAT3 and uridine diphosphate glucuronosyltransferase inhibitor).",0
655,16,Which protein does empagliflozin inhibit?,"Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.",0
655,17,Which protein does empagliflozin inhibit?, Empagliflozin is a potent and competitive SGLT-2 inhibitor with an excellent selectivity profile and the highest selectivity window of the tested SGLT-2 inhibitors over hSGLT-1.,0
655,18,Which protein does empagliflozin inhibit?,Empagliflozin represents an innovative therapeutic approach to treat diabetes.,0
655,19,Which protein does empagliflozin inhibit?,"Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.",0
655,20,Which protein does empagliflozin inhibit?,Empagliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that inhibits renal glucose reabsorption and is being investigated for the treatment of type 2 diabetes mellitus (T2DM).,0
655,21,Which protein does empagliflozin inhibit?,Empagliflozin is a potent and competitive SGLT-2 inhibitor with an excellent selectivity profile and the highest selectivity window of the tested SGLT-2 inhibitors over hSGLT-1.,0
655,22,Which protein does empagliflozin inhibit?,"Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment.",0
655,23,Which protein does empagliflozin inhibit?,"Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment.",0
655,24,Which protein does empagliflozin inhibit?,"Compared with other SGLT-2 inhibitors, empagliflozin has a high degree of selectivity over SGLT-1, 4, 5 and 6.",0
655,25,Which protein does empagliflozin inhibit?,"Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects.",0
655,26,Which protein does empagliflozin inhibit?,The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.,0
655,27,Which protein does empagliflozin inhibit?,"Empagliflozin is an orally available, potent and highly selective inhibitor of the sodium glucose cotransporter 2 (SGLT2).",0
655,28,Which protein does empagliflozin inhibit?,"This randomized, open-label, crossover study investigated potential drug-drug interactions between the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin and the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin.",0
655,29,Which protein does empagliflozin inhibit?,"Empagliflozin is a potent and selective SGLT-2 inhibitor that lowers blood glucose levels by inhibiting renal glucose reabsorption, leading to an increase in urinary glucose excretion.",0
1572,0,What is the role of eteplirsen in DMD patients?,"Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.)",1
1572,1,What is the role of eteplirsen in DMD patients?,injection,0
1572,2,What is the role of eteplirsen in DMD patients?,"In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51.",0
1572,3,What is the role of eteplirsen in DMD patients?,Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen.,0
1572,4,What is the role of eteplirsen in DMD patients?,"morpholino AO to skip exon 51, eteplirsen (AVI-4658).",0
1572,5,What is the role of eteplirsen in DMD patients?,We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene,1
1572,6,What is the role of eteplirsen in DMD patients?,"We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.)",1
1572,7,What is the role of eteplirsen in DMD patients?,We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene.,0
1572,8,What is the role of eteplirsen in DMD patients?,"Here we describe the development of a Taqman quantitative (q)RT-PCR assay to quantify exon skipping and highlight its use to determine the levels of exon skipping in DMD patients treated intramuscularly with a morpholino AO to skip exon 51, eteplirsen (AVI-4658).",0
1572,9,What is the role of eteplirsen in DMD patients?,"In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51.",0
1572,10,What is the role of eteplirsen in DMD patients?,"Here we describe the development of a Taqman quantitative (q)RT-PCR assay to quantify exon skipping and highlight its use to determine the levels of exon skipping in DMD patients treated intramuscularly with a morpholino AO to skip exon 51, eteplirsen (AVI-4658).",0
1572,11,What is the role of eteplirsen in DMD patients?,"METHODS: DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n = 4/group).",0
1572,12,What is the role of eteplirsen in DMD patients?,There was no significant difference in the level of the dystromirs in BMD compared to controls.,0
1572,13,What is the role of eteplirsen in DMD patients?,We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene.,0
1572,14,What is the role of eteplirsen in DMD patients?,The dystromirs were also analysed in muscle biopsies of DMD patients included in a single dose intramuscular eteplirsen clinical trial.,0
1572,15,What is the role of eteplirsen in DMD patients?,"We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions, restores the open reading frame and induces dystrophin protein expression after intramuscular (i.m.)",1
1572,16,What is the role of eteplirsen in DMD patients?,injection.,0
1572,17,What is the role of eteplirsen in DMD patients?,"We now show that this dystrophin expression was accompanied by an elevated expression of α-sarcoglycan, β-dystroglycan (BDG) and--in relevant cases--neuronal nitric oxide synthase (nNOS) at the sarcolemma, each of which is a component of a different subcomplex of the dystrophin-associated glycoprotein complex (DAPC).",0
1572,18,What is the role of eteplirsen in DMD patients?,"OBJECTIVE: In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51.",0
1572,19,What is the role of eteplirsen in DMD patients?,The present study used a double-blind placebo-controlled protocol to test eteplirsen's ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT).,0
1572,20,What is the role of eteplirsen in DMD patients?,We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene.,0
1572,21,What is the role of eteplirsen in DMD patients?,The dystromirs were also analysed in muscle biopsies of DMD patients included in a single dose intramuscular eteplirsen clinical trial.,0
1572,22,What is the role of eteplirsen in DMD patients?,"In prior open-label studies, eteplirsen, a phosphorodiamidate morpholino oligomer, enabled dystrophin production in Duchenne muscular dystrophy (DMD) with genetic mutations amenable to skipping exon 51.",0
1572,23,What is the role of eteplirsen in DMD patients?,The present study used a double-blind placebo-controlled protocol to test eteplirsen&apos;s ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT).,0
1572,24,What is the role of eteplirsen in DMD patients?,"DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n = 4/group).",0
1572,25,What is the role of eteplirsen in DMD patients?,Placebo patients switched to 30 or 50 mg/kg eteplirsen (n=2/group) at week 25; treatment was open label thereafter.,0
1572,26,What is the role of eteplirsen in DMD patients?,The present study used a double-blind placebo-controlled protocol to test eteplirsen&apos;s ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT).,0
1572,27,What is the role of eteplirsen in DMD patients?,"DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n = 4/group).",0
1572,28,What is the role of eteplirsen in DMD patients?,"DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n = 4/group).",0
1572,29,What is the role of eteplirsen in DMD patients?,Placebo patients switched to 30 or 50 mg/kg eteplirsen (n=2/group) at week 25; treatment was open label thereafter.,0
1572,30,What is the role of eteplirsen in DMD patients?,"The present study used a double-blind placebo-controlled protocol to test eteplirsen&apos;s ability to induce dystrophin production and improve distance walked on the 6-minute walk test (6MWT).DMD boys aged 7 to 13 years, with confirmed deletions correctable by skipping exon 51 and ability to walk 200 to 400 m on 6 MWT, were randomized to weekly intravenous infusions of 30 or 50 mg/kg/wk eteplirsen or placebo for 24 weeks (n = 4/group).",0
1572,31,What is the role of eteplirsen in DMD patients?,"We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy (DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen) that induces skipping of dystrophin exon 51 in patients with relevant deletions,",1
202,0,What is the treatment of acute pericarditis?,Recurrences develop in up to 20-50% of patients with acute pericarditis.,0
202,1,What is the treatment of acute pericarditis?,"Although different causes of recurrent pericarditis have been identified, the etiology remains obscure in most cases which are therefore labelled as idiopathic.",1
202,2,What is the treatment of acute pericarditis?,A poor response to colchicine treatment and/or a steroid-dependence may be the clue to investigate TNFRSF1A mutations in patients with idiopathic recurrent pericarditis.,0
202,3,What is the treatment of acute pericarditis?,intravenous infusion of inotropic agents,0
202,4,What is the treatment of acute pericarditis?,medical treatment may be changed in these patients with a slower tapering of the dosage of steroidal and non-steroidal antiinflammatory drugs.,1
202,5,What is the treatment of acute pericarditis?,The incidence of purulent pericarditis has decreased considerably since the antibiotic era.,0
202,6,What is the treatment of acute pericarditis?,"It is typically an acute and potentially lethal disease, necessitating rapid diagnosis and adequate therapy to improve prognosis.",1
202,7,What is the treatment of acute pericarditis?,Standard treatment combines appropriate antibiotic therapy with surgical drainage.,0
202,8,What is the treatment of acute pericarditis?,We report successful treatment of a non-resolving fibrino-purulent pericardial effusion by combined intrapericardial irrigation of fibrinolytics and systemic corticosteroids administration as an alternative to pericardectomy.,1
202,9,What is the treatment of acute pericarditis?,Prednisolone (20-30 mg/d) was used in addition to antituberculous chemotherapy in 11 of the 17 patients with effusive pericarditis,1
202,10,What is the treatment of acute pericarditis?,antibiotic therapy has been initiated.,0
202,11,What is the treatment of acute pericarditis?,"Use of appropriate parenterally administered antibiotics, in combination with early surgical pericardial drainage or partial pericardiectomy, should minimize morbidity and mortality and prevent acute constrictive sequelae.",0
2973,0,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,Endogenous yeast amyloids that control heritable traits and are frequently used as models for human amyloid diseases are termed yeast prions,1
2973,1,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,Fibrous cross-β aggregates (amyloids) and their transmissible forms (prions) cause diseases in mammals (including humans) and control heritable traits in yeast.,0
2973,2,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,These infectious yeast amyloidoses are outstanding models for the many common human amyloid-based diseases that are increasingly found to have some infectious characteristics.,1
2973,3,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,Yeast prions (infectious proteins) were discovered by their outré genetic properties and have become important models for an array of human prion and amyloid diseases.,1
2973,4,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,"Yeast prions are models for both rare mammalian prion diseases and for several very common amyloidoses such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease.",0
2973,5,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,"Yeast prions are important models for human amyloid diseases in general, particularly because new evidence is showing infectious aspects of several human amyloidoses not previously classified as prions.",0
2973,6,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,Mechanism of amyloid formation is critical for a complete understanding of the yeast prion phenomenon and human amyloid-related diseases.,0
2973,7,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,"Yeast prions are important models for human amyloid diseases in general, particularly because new evidence is showing infectious aspects of several human amyloidoses not previously classified as prions.",0
2973,8,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,Endogenous yeast amyloids that control heritable traits and are frequently used as models for human amyloid diseases are termed yeast prions.,1
2973,9,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,Mechanism of amyloid formation is critical for a complete understanding of the yeast prion phenomenon and human amyloid-related diseases.,0
2973,10,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,"Here we summarize the results of studies of prions of the yeast Saccharomyces cerevisiae and of the use of yeast model for investigation of some human amyloidoses, such as prion diseases, Alzheimer's, Parkinson's, and Huntington's diseases.",0
2973,11,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,Yeast prions increasingly are serving as models for the understanding and treatment of many mammalian amyloidoses.,0
2973,12,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,"Yeast prions, based on self-seeded highly ordered fibrous aggregates (amyloids), serve as a model for human amyloid diseases.",0
2973,13,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,These infectious yeast amyloidoses are outstanding models for the many common human amyloid-based diseases that are increasingly found to have some infectious characteristics.<br>,1
2973,14,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,The yeast system has provided considerable insight into the biology of amyloid and prions.,0
2973,15,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,"Yeast prions are important models for human amyloid diseases in general, particularly because new evidence is showing infectious aspects of several human amyloidoses not previously classified as prions.",0
2973,16,Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?,"We also review studies of the roles of chaperones, aggregate-collecting proteins, and other cellular components using yeast that have led the way in improving the understanding of similar processes that must be operating in many human amyloidoses.",0
1220,0,Which disease is treated with Eliglustat?,"Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.",0
1220,1,Which disease is treated with Eliglustat?,"We investigated whether patients stable on such treatment would remain so after switching to oral eliglustat, a selective inhibitor of glucosylceramide synthase.",0
1220,2,Which disease is treated with Eliglustat?,Patients were randomly allocated 2:1 at 39 clinics (stratified by ERT dose; block sizes of four; computer-generated centrally) to receive either oral eliglustat or imiglucerase infusions for 12 months.,0
1220,3,Which disease is treated with Eliglustat?,"The non-inferiority margin was 25% for eliglustat relative to imiglucerase, assessed in all patients who completed 12 months of treatment.",0
1220,4,Which disease is treated with Eliglustat?,NTERPRETATION: Oral eliglustat maintained haematological and organ volume stability in adults with Gaucher's disease type 1 already controlled by intravenous ERT and could be a useful therapeutic option.,0
1220,5,Which disease is treated with Eliglustat?,Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial.,0
1220,6,Which disease is treated with Eliglustat?,"OBJECTIVE: To determine whether eliglustat, a novel oral substrate reduction therapy, safely reverses clinical manifestations in untreated adults with Gaucher disease type 1.",0
1220,7,Which disease is treated with Eliglustat?,"CONCLUSIONS AND RELEVANCE: Among previously untreated adults with Gaucher disease type 1, treatment with eliglustat compared with placebo for 9 months resulted in significant improvements in spleen volume, hemoglobin level, liver volume, and platelet count.",0
1220,8,Which disease is treated with Eliglustat?,"To explore the relationship between B-cell malignancy and the biochemical defect, we treated Gaucher mice with eliglustat tartrate (GENZ 112638), a potent and selective inhibitor of the first committed step in glycosphingolipid biosynthesis.",0
1220,9,Which disease is treated with Eliglustat?,OBJECTIVE: Eliglustat is an investigational oral substrate reduction therapy for Gaucher disease type 1 (GD1).,0
1220,10,Which disease is treated with Eliglustat?,CONCLUSIONS: Eliglustat may be a therapeutic option for treating the skeletal manifestations of GD1.,0
1220,11,Which disease is treated with Eliglustat?,Eliglustat is an investigational oral substrate reduction therapy for Gaucher disease type 1 (GD1).,1
1220,12,Which disease is treated with Eliglustat?,Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat.,0
1220,13,Which disease is treated with Eliglustat?,"A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.",0
1220,14,Which disease is treated with Eliglustat?,Synthesis inhibition is the basis for the treatment of type 1 Gaucher disease by the glucosylceramide synthase (GCS) inhibitor eliglustat tartrate.,1
1220,15,Which disease is treated with Eliglustat?,"Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study.",0
1220,16,Which disease is treated with Eliglustat?,Eliglustat tartrate is an investigational oral substrate reduction therapy for Gaucher disease type 1 that is pharmacologically distinct from intravenous enzyme replacement therapy.,0
1220,17,Which disease is treated with Eliglustat?,"Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment.",0
1220,18,Which disease is treated with Eliglustat?,"Three phase 1 studies of eliglustat tartrate (Genz-112638), an oral inhibitor of glucosylceramide synthase under development for treating Gaucher disease type 1 (GD1), evaluated the safety, tolerability, and pharmacokinetics in healthy volunteers after escalating single doses (n = 99), escalating multiple doses (n = 36), and food (n = 24).",0
1220,19,Which disease is treated with Eliglustat?,"At year 4, one new asymptomatic, indeterminate bone lesion was discovered that subsequently resolved.CONCLUSIONS: Eliglustat may be a therapeutic option for treating the skeletal manifestations of GD1.",0
1220,20,Which disease is treated with Eliglustat?,Synthesis inhibition is the basis for the treatment of type 1 Gaucher disease by the glucosylceramide synthase (GCS) inhibitor eliglustat tartrate.,1
1220,21,Which disease is treated with Eliglustat?,"However, the extended use of eliglustat and related compounds for the treatment of glycosphingolipid storage diseases with CNS manifestations is limited by the lack of brain penetration of this drug.",0
1220,22,Which disease is treated with Eliglustat?,"A safe, effective oral therapy is needed.OBJECTIVE: To determine whether eliglustat, a novel oral substrate reduction therapy, safely reverses clinical manifestations in untreated adults with Gaucher disease type 1.DESIGN, SETTING, AND PARTICIPANTS: Phase 3, randomized, double-blind, placebo-controlled trial conducted at 18 sites in 12 countries from November 2009 to July 2012 among eligible patients with splenomegaly plus thrombocytopenia and/or anemia.",0
1220,23,Which disease is treated with Eliglustat?,"One patient in the eliglustat group withdrew (non-treatment related); 39 of the 40 patients transitioned to an open-label extension study.CONCLUSIONS AND RELEVANCE: Among previously untreated adults with Gaucher disease type 1, treatment with eliglustat compared with placebo for 9 months resulted in significant improvements in spleen volume, hemoglobin level, liver volume, and platelet count.",0
1220,24,Which disease is treated with Eliglustat?,"A multinational, open-label, single-arm phase 2 study of 26 GD1 patients (16 female, 10 male; mean age, 34 years) evaluated the efficacy, safety, and pharmacokinetics of eliglustat tartrate administered twice daily by mouth at 50- or 100-mg doses based on plasma drug concentrations.",0
1220,25,Which disease is treated with Eliglustat?, Eliglustat may be a therapeutic option for treating the skeletal manifestations of GD1.,0
1220,26,Which disease is treated with Eliglustat?,.,0
1220,27,Which disease is treated with Eliglustat?,"At year 4, one new asymptomatic, indeterminate bone lesion was discovered that subsequently resolved.",0
1220,28,Which disease is treated with Eliglustat?,Eliglustat may be a therapeutic option for treating the skeletal manifestations of GD1.,0
1220,29,Which disease is treated with Eliglustat?, Synthesis inhibition is the basis for the treatment of type 1 Gaucher disease by the glucosylceramide synthase (GCS) inhibitor eliglustat tartrate.,1
1220,30,Which disease is treated with Eliglustat?,"However, the extended use of eliglustat and related compounds for the treatment of glycosphingolipid storage diseases with CNS manifestations is limited by the lack of brain penetration of this drug.",0
1220,31,Which disease is treated with Eliglustat?,Eliglustat tartrate is an investigational oral substrate reduction therapy for Gaucher disease type 1 that is pharmacologically distinct from intravenous enzyme replacement therapy.,0
1220,32,Which disease is treated with Eliglustat?,Eliglustat tartrate improved clinical manifestations in patients who received 50 or 100 mg twice daily for 1 year during an open-label phase 2 study (Blood.,0
1220,33,Which disease is treated with Eliglustat?,One patient in the eliglustat group withdrew (non-treatment related); 39 of the 40 patients transitioned to an open-label extension study.,0
1220,34,Which disease is treated with Eliglustat?,"Among previously untreated adults with Gaucher disease type 1, treatment with eliglustat compared with placebo for 9 months resulted in significant improvements in spleen volume, hemoglobin level, liver volume, and platelet count.",0
1220,35,Which disease is treated with Eliglustat?,Eliglustat may be a therapeutic option for treating the skeletal manifestations of GD1.,0
1220,36,Which disease is treated with Eliglustat?,Synthesis inhibition is the basis for the treatment of type 1 Gaucher disease by the glucosylceramide synthase (GCS) inhibitor eliglustat tartrate.,1
1220,37,Which disease is treated with Eliglustat?,"However, the extended use of eliglustat and related compounds for the treatment of glycosphingolipid storage diseases with CNS manifestations is limited by the lack of brain penetration of this drug.",0
1220,38,Which disease is treated with Eliglustat?,"One patient in the eliglustat group withdrew (non-treatment related); 39 of the 40 patients transitioned to an open-label extension study.Among previously untreated adults with Gaucher disease type 1, treatment with eliglustat compared with placebo for 9 months resulted in significant improvements in spleen volume, hemoglobin level, liver volume, and platelet count.",0
1220,39,Which disease is treated with Eliglustat?,"Three phase 1 studies of eliglustat tartrate (Genz-112638), an oral inhibitor of glucosylceramide synthase under development for treating Gaucher disease type 1 (GD1), evaluated the safety, tolerability, and pharmacokinetics in healthy volunteers after escalating single doses (n = 99), escalating multiple doses (n = 36), and food (n = 24).",0
1220,40,Which disease is treated with Eliglustat?,"Eliglustat tartrate was well tolerated at single doses ≤ 20 mg/kg and multiple doses ≤ 200 mg bid, with 50 mg bid producing plasma concentrations in the predicted therapeutic range.",0
639,0,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,Hirschsprung's disease (HSCR) is a fairly frequent cause of intestinal obstruction in children.,0
639,1,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,It is characterized as a sex-linked heterogonous disorder with variable severity and incomplete penetrance giving rise to a variable pattern of inheritance.,0
639,2,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"Although Hirschsprung's disease occurs as an isolated phenotype in at least 70% of cases, it is not infrequently associated with a number of congenital abnormalities and associated syndromes, demonstrating a spectrum of congenital anomalies.",0
639,3,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"Certain of these syndromic phenotypes have been linked to distinct genetic sites, indicating underlying genetic associations of the disease and probable gene-gene interaction, in its pathogenesis.",0
639,4,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"These associations with HSCR include Down's syndrome and other chromosomal anomalies, Waardenburg syndrome and other Dominant sensorineural deafness, the Congenital Central Hypoventilation and Mowat-Wilson and other brain-related syndromes, as well as the MEN2 and other tumour associations",0
639,5,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"On the other hand, about 30% of HSCR are syndromic.",0
639,6,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"Hitherto, the disease causing gene has been identified for eight Mendelian syndromes with HSCR: congenital central hypoventilation (CCHS), Mowat-Wilson (MWS), Bardet-Biedl (BBS), Shah-Waardenburg (WS4), cartilage-hair-hypoplasia (CHH), Smith-Lemli-Opitz (SLO), Goldberg-Sprintzsen (GSS), and hydrocephalus due to congenital stenosis of the aqueduct of sylvius (HSAS)",1
639,7,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"The syndromic HSCR entities studied were congenital central hypoventilation (CCHS) and Mowat-Wilson syndrome (MWS), caused by PHOX2B and ZFHX1B gene mutations, respectively",0
639,8,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"The RET locus was genotyped in 143 CCHS patients, among whom 44 had HSCR, and in 30 MWS patients, among whom 20 had HSCR",0
639,9,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,RET was shown to act as a modifier gene for the HSCR phenotype in patients with CCHS but not with MWS,0
639,10,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"These associations with HSCR include Down's syndrome and other chromosomal anomalies, Waardenburg syndrome and other Dominant sensorineural deafness, the Congenital Central Hypoventilation and Mowat-Wilson and other brain-related syndromes, as well as the MEN2 and other tumour associations",0
639,11,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"Hitherto, the disease causing gene has been identified for eight Mendelian syndromes with HSCR: congenital central hypoventilation (CCHS), Mowat-Wilson (MWS), Bardet-Biedl (BBS), Shah-Waardenburg (WS4), cartilage-hair-hypoplasia (CHH), Smith-Lemli-Opitz (SLO), Goldberg-Sprintzsen (GSS), and hydrocephalus due to congenital stenosis of the aqueduct of sylvius (HSAS).",1
639,12,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"The syndromic HSCR entities studied were congenital central hypoventilation (CCHS) and Mowat-Wilson syndrome (MWS), caused by PHOX2B and ZFHX1B gene mutations, respectively.",0
639,13,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,RET was shown to act as a modifier gene for the HSCR phenotype in patients with CCHS but not with MWS.,0
639,14,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"In CCHS patients, the weak predisposing haplotype of the RET gene can be regarded as a quantitative trait, being a risk factor for the HSCR phenotype, while in MWS, for which the HSCR penetrance is high, the role of the RET predisposing haplotype is not significant.",0
639,15,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"These associations with HSCR include Down's syndrome and other chromosomal anomalies, Waardenburg syndrome and other Dominant sensorineural deafness, the Congenital Central Hypoventilation and Mowat-Wilson and other brain-related syndromes, as well as the MEN2 and other tumour associations.",0
639,16,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"Hitherto, the disease causing gene has been identified for eight Mendelian syndromes with HSCR: congenital central hypoventilation (CCHS), Mowat-Wilson (MWS), Bardet-Biedl (BBS), Shah-Waardenburg (WS4), cartilage-hair-hypoplasia (CHH), Smith-Lemli-Opitz (SLO), Goldberg-Sprintzsen (GSS), and hydrocephalus due to congenital stenosis of the aqueduct of sylvius (HSAS).",1
639,17,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"The syndromic HSCR entities studied were congenital central hypoventilation (CCHS) and Mowat-Wilson syndrome (MWS), caused by PHOX2B and ZFHX1B gene mutations, respectively.",0
639,18,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"These associations with HSCR include Downs syndrome and other chromosomal anomalies, Waardenburg syndrome and other Dominant sensorineural deafness, the Congenital Central Hypoventilation and Mowat-Wilson and other brain-related syndromes, as well as the MEN2 and other tumour associations.",0
639,19,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"METHODS: The syndromic HSCR entities studied were congenital central hypoventilation (CCHS) and Mowat-Wilson syndrome (MWS), caused by PHOX2B and ZFHX1B gene mutations, respectively.",0
639,20,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"These associations with HSCR include Down's syndrome and other chromosomal anomalies, Waardenburg syndrome and other Dominant sensorineural deafness, the Congenital Central Hypoventilation and Mowat-Wilson and other brain-related syndromes, as well as the MEN2 and other tumour associations.",0
639,21,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"Hitherto, the disease causing gene has been identified for eight Mendelian syndromes with HSCR: congenital central hypoventilation (CCHS), Mowat-Wilson (MWS), Bardet-Biedl (BBS), Shah-Waardenburg (WS4), cartilage-hair-hypoplasia (CHH), Smith-Lemli-Opitz (SLO), Goldberg-Sprintzsen (GSS), and hydrocephalus due to congenital stenosis of the aqueduct of sylvius (HSAS)",1
639,22,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"These associations with HSCR include Down's syndrome and other chromosomal anomalies, Waardenburg syndrome and other Dominant sensorineural deafness, the Congenital Central Hypoventilation and Mowat-Wilson and other brain-related syndromes, as well as the MEN2 and other tumour associations",0
639,23,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"The frequent, low penetrant, predisposing allele of the RET gene can be regarded as a risk factor for the HSCR phenotype in CCHS, BBS, and Down syndrome, while its role is not significant in MWS and WS4",0
639,24,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"RET acts as a modifier gene for the HSCR phenotype in patients with CCHS, BBS, and Down syndrome, but not in patients with MWS and WS4",0
639,25,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"The syndromic HSCR entities studied were congenital central hypoventilation (CCHS) and Mowat-Wilson syndrome (MWS), caused by PHOX2B and ZFHX1B gene mutations, respectively",0
639,26,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,"Hitherto, the disease causing gene has been identified for eight Mendelian syndromes with HSCR: congenital central hypoventilation (CCHS), Mowat-Wilson (MWS), Bardet-Biedl (BBS), Shah-Waardenburg (WS4), cartilage-hair-hypoplasia (CHH), Smith-Lemli-Opitz (SLO), Goldberg-Sprintzsen (GSS), and hydrocephalus due to congenital stenosis of the aqueduct of sylvius (HSAS)",1
639,27,What is the common feature in congenital central hypoventilation and Mowat-Wilson syndromes?,These data highlight the pivotal role of the RET gene in both isolated and syndromic HSCR.,0
4136,0,"What is the ""flight-or-fight response""?","Although the function of the autonomic nervous system (ANS) in mediating the flight-or-fight response was recognized decades ago, the crucial role of peripheral innervation in regulating cell behavior and response to the microenvironment has only recently emerged.",1
4136,1,"What is the ""flight-or-fight response""?"," Beyond the ""flight-or-fight"" response to acute stress, there are events in daily life that produce a type of chronic stress and lead over time to wear and tear on the body (""allostatic load"").",1
4136,2,"What is the ""flight-or-fight response""?","The fear, flight or fight response serves as the fundamental physiological basis for examining an organism's awareness of its environment under an impending predator attack.",1
4136,3,"What is the ""flight-or-fight response""?","The cAMP intracellular signaling pathway is an important system for signal transmission responsible for the ancestral 'flight or fight' response and involved in the control of critical functions including frequency and strength of heart contraction, energy metabolism and gene transcription.",1
618,0,Does molindone affect body weight?,"Mean weight increased by 0.54 kg, and mean body mass index by 0.24 kg/m(2).",0
618,1,Does molindone affect body weight?,"A large-scale trial comparing a first-generation antipsychotic (molindone) with newer agents did not find significant differences in treatment response, although the newer antipsychotics were associated with more severe weight gain.",0
618,2,Does molindone affect body weight?,"No agent demonstrated superior efficacy, and all were associated with side effects, including weight gain.",0
618,3,Does molindone affect body weight?,The three treatment arms did not significantly differ in symptom decrease or time to discontinuation.,0
618,4,Does molindone affect body weight?,Akathisia was more common with molindone and elevated prolactin concentrations more common with risperidone.,0
618,5,Does molindone affect body weight?,"Although weight gain and metabolic adverse events had occurred more often with olanzapine and risperidone during the acute trial, no significant between-drug differences emerged in most of these parameters during maintenance treatment.",0
618,6,Does molindone affect body weight?,Olanzapine and risperidone were associated with significantly greater weight gain.,0
618,7,Does molindone affect body weight?,"Olanzapine showed the greatest risk of weight gain and significant increases in fasting cholesterol, low density lipoprotein, insulin, and liver transaminase levels.",0
618,8,Does molindone affect body weight?,Molindone led to more self-reports of akathisia.,1
618,9,Does molindone affect body weight?,"Molindone is no more or less likely than typical drugs to cause movement disorders, but it does cause significantly more weight loss (2RCTs n=60 RR 2.78, CI 1.10 to 6.99, NNH 5 CI 2 to 77).",1
618,10,Does molindone affect body weight?,Molindone may be an effective antipsychotic but its adverse effect profile does not differ significantly from that of typical antipsychotics (apart from the event of weight loss).,0
618,11,Does molindone affect body weight?,"Convergent evidence suggests a hierarchy in the magnitude of BWG that may be induced by diverse agents, being very high for clozapine and olanzapine; high for quetiapine, zotepin, chlorpromazine, and thioridazine; moderate for risperidone and sertindole; and low for ziprazidone, amisulpiride, haloperidol, fluphenazine, pimozide, and molindone.",0
618,12,Does molindone affect body weight?,"Loxapine and molindone induce weight decreases, and these exceptions are difficult to explain.",0
618,13,Does molindone affect body weight?,"It is no more or less likely than typical drugs to cause movement disorders, but causes significantly more weight loss (RR 2.78, CI 1.10 to 6.99).",1
618,14,Does molindone affect body weight?,"Molindone may be an effective antipsychotic; however, its adverse effect profile does not differ significantly from that of typical antipsychotics, apart from the event of weight loss.",0
618,15,Does molindone affect body weight?,"Among conventional agents, mean weight change ranged from a reduction of 0.39 kg with molindone to an increase of 3.19 kg with thioridazine.",0
618,16,Does molindone affect body weight?,Weight gain has been reported with nearly every antipsychotic drug on the market (molindone is an exception).,0
618,17,Does molindone affect body weight?,"Although almost all antipsychotics induce bodyweight gain, molindone and loxapine appear to induce bodyweight loss.",1
618,18,Does molindone affect body weight?,"Clozapine and low-potency phenothiazines are associated with the largest gains and molindone with weight loss, but the mechanism is not known.",0
618,19,Does molindone affect body weight?,"On average, molindone patients lost 5 pounds over the 6 weeks of treatment, whereas thioridazine patients gained 6 pounds.",0
618,20,Does molindone affect body weight?,"Clinically, molindone has a tendency to cause weight loss and may have less effect on seizure threshold than conventional antipsychotic agents",1
618,21,Does molindone affect body weight?," Monthly weights and neuroleptic dosages during the first three months of psychiatric hospitalization were compared between matched groups of patients receiving molindone, a combination of molindone and other neuroleptics, or other neuroleptic drugs.",0
618,22,Does molindone affect body weight?,We found no significant differences in weight gain among the three groups.,0
618,23,Does molindone affect body weight?,"The weight-reducing property of molindone, a recently introduced antipsychotic drug, was tested in 9 hospitalized chronic schizophrenic patients.",0
618,24,Does molindone affect body weight?,There was an average weight loss of 7.6 kg after 3 months on molindone; most of the loss occurred during the first month.,0
558,0,What is generic name of drug Adempas?,Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.,1
558,1,What is generic name of drug Adempas?,Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.,1
558,2,What is generic name of drug Adempas?,"Riociguat (Adempas(®)), a soluble guanylate cyclase stimulator, is a new, first-in-class drug approved for the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) [inoperable or persistent/recurrent following surgery] or pulmonary arterial hypertension (PAH).",1
558,3,What is generic name of drug Adempas?,"On October 8, 2013, riociguat (Adempas®) became the first medication approved for multiple etiologies of PH.",0
558,4,What is generic name of drug Adempas?,"Duavee, an oral contraceptive; riociguat (Adempas) for two types of pulmonary hypertension; and macitentan (Opsumit) for pulmonary arterial hypertension.",0
558,5,What is generic name of drug Adempas?,"Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).",1
558,6,What is generic name of drug Adempas?,Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension,1
558,7,What is generic name of drug Adempas?,"Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc",0
558,8,What is generic name of drug Adempas?,"Duavee, an oral contraceptive; riociguat (Adempas) for two types of pulmonary hypertension; and macitentan (Opsumit) for pulmonary arterial hypertension",0
2984,0,Describe the mechanism of action of apalutamide.,"Second-generation NSAA receptor antagonists (enzalutamide, apalutamide and darolutamide) are emerging as additional new options to treat castration-resistant prostate cancer.",1
2984,1,Describe the mechanism of action of apalutamide.,"BACKGROUND: Apalutamide, a competitive inhibitor of the androgen receptor, is under development for the treatment of prostate cancer.",0
2984,2,Describe the mechanism of action of apalutamide.,Apalutamide (ARN-509) is an antiandrogen that binds selectively to androgen receptors (AR) and does not show antagonist-to-agonist switch like bicalutamide.,1
2984,3,Describe the mechanism of action of apalutamide.,Apalutamide is a pure androgen antagonist with a very high affinity with the androgen receptor.,0
2984,4,Describe the mechanism of action of apalutamide.,"Apalutamide (ARN-509), a second-generation androgen receptor antagonist, recently received approval in the nonmetastatic (M0) CRPC space.",0
2984,5,Describe the mechanism of action of apalutamide.,"Similar to enzalutamide, apalutamide inhibits the binding of androgen to androgen receptor (AR), nuclear translocation of the androgen-AR complex, and binding of AR transcription complex to DNA-binding sites and transcription elements.",1
2984,6,Describe the mechanism of action of apalutamide.,Apalutamide (ErleadaTM) is a next-generation oral androgen receptor (AR) inhibitor that is being developed by Janssen for the treatment of prostate cancer (PC).,0
2984,7,Describe the mechanism of action of apalutamide.,It binds directly to the ligand-binding domain of the AR and blocks the effects of androgens.,0
2984,8,Describe the mechanism of action of apalutamide.,"Ongoing clinical trials for different subgroups of prostate cancer patients include the evaluation of the second-generation AR antagonists enzalutamide, apalutamide and darolutamide, of inhibitors of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway, of inhibitors of DNA damage response, of targeted alpha therapy and of prostate-specific membrane antigen (PSMA) targeting approaches.",0
2984,9,Describe the mechanism of action of apalutamide.," One of these agents is apalutamide, which seems to be a promising AR antagonist for the treatment of CRPC.",0
2984,10,Describe the mechanism of action of apalutamide.,"Expert opinion: Apalutamide is an oral, investigational, AR antagonist that targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets.",0
2984,11,Describe the mechanism of action of apalutamide.,"Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort.",0
2984,12,Describe the mechanism of action of apalutamide.,"BACKGROUND
Apalutamide is a potent androgen receptor (AR) antagonist that targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets.",0
2984,13,Describe the mechanism of action of apalutamide.,"BACKGROUND
Apalutamide, a competitive inhibitor of the androgen receptor, is under development for the treatment of prostate cancer.",0
2984,14,Describe the mechanism of action of apalutamide.,Apalutamide is a pure androgen antagonist with a very high affinity with the androgen receptor.,0
2984,15,Describe the mechanism of action of apalutamide.,"Similar to enzalutamide, apalutamide inhibits the binding of androgen to androgen receptor (AR), nuclear translocation of the androgen-AR complex, and binding of AR transcription complex to DNA-binding sites and transcription elements.",1
2984,16,Describe the mechanism of action of apalutamide.,"Apalutamide (ARN-509), a second-generation androgen receptor antagonist, recently received approval in the nonmetastatic (M0) CRPC space.",0
2984,17,Describe the mechanism of action of apalutamide.,Apalutamide (ErleadaTM) is a next-generation oral androgen receptor (AR) inhibitor that is being developed by Janssen for the treatment of prostate cancer (PC).,0
2984,18,Describe the mechanism of action of apalutamide.,"Expert opinion: Apalutamide is an oral, investigational, AR antagonist that targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets.",0
2984,19,Describe the mechanism of action of apalutamide.,"Apalutamide, an androgen receptor inhibitor, has substantial clinical response in nonmetastatic castration-resistant prostate cancer.",0
2984,20,Describe the mechanism of action of apalutamide.,"BACKGROUND Apalutamide is a potent androgen receptor (AR) antagonist that targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets.",1
2984,21,Describe the mechanism of action of apalutamide.,"BACKGROUND Apalutamide, a competitive inhibitor of the androgen receptor, is under development for the treatment of prostate cancer.",0
2493,0,Describe JACUSA,JACUSA: site-specific identification of RNA editing events from replicate sequencing data.,0
2493,1,Describe JACUSA,"We present JACUSA, a versatile one-stop solution to detect single nucleotide variant positions from comparing RNA-DNA and/or RNA-RNA sequencing samples.",1
2493,2,Describe JACUSA,The performance of JACUSA has been carefully evaluated and compared to other variant callers in an in silico benchmark.,0
2493,3,Describe JACUSA,"JACUSA outperforms other algorithms in terms of the F measure, which combines precision and recall, in all benchmark scenarios.",0
2493,4,Describe JACUSA,This performance margin is highest for the RNA-RNA comparison scenario.,0
2493,5,Describe JACUSA,We further validated JACUSA's performance by testing its ability to detect A→I events using sequencing data from a human cell culture experiment and publicly available RNA-seq data from Drosophila melanogaster heads.,0
2493,6,Describe JACUSA,"To this end, we performed whole genome and RNA sequencing of HEK-293 cells on samples with lowered activity of candidate RNA editing enzymes.",0
2493,7,Describe JACUSA,JACUSA has a higher recall and comparable precision for detecting true editing sites in RDD comparisons of HEK-293 data.,1
2493,8,Describe JACUSA,"Intriguingly, JACUSA captures most A→I events from RRD comparisons of RNA sequencing data derived from Drosophila and HEK-293 data sets.",0
2493,9,Describe JACUSA,Our software JACUSA detects single nucleotide variants by comparing data from next-generation sequencing experiments (RNA-DNA or RNA-RNA).,1
2493,10,Describe JACUSA,"In practice, JACUSA shows higher recall and comparable precision in detecting A→I sites from RNA-DNA comparisons, while showing higher precision and recall in RNA-RNA comparisons.",1
2493,11,Describe JACUSA,"Even more surprising, condition-specific editing events, which would show up as differences in RNA-RNA comparisons (RRDs) and depend on particular cellular states, are rarely discussed in the literature.<br><b>RESULTS</b>: We present JACUSA, a versatile one-stop solution to detect single nucleotide variant positions from comparing RNA-DNA and/or RNA-RNA sequencing samples.",0
2493,12,Describe JACUSA,"Intriguingly, JACUSA captures most A→I events from RRD comparisons of RNA sequencing data derived from Drosophila and HEK-293 data sets.<br><b>CONCLUSION</b>: Our software JACUSA detects single nucleotide variants by comparing data from next-generation sequencing experiments (RNA-DNA or RNA-RNA).",0
2493,13,Describe JACUSA,CONCLUSION Our software JACUSA detects single nucleotide variants by comparing data from next-generation sequencing experiments (RNA-DNA or RNA-RNA).,1
2493,14,Describe JACUSA,"RESULTS We present JACUSA, a versatile one-stop solution to detect single nucleotide variant positions from comparing RNA-DNA and/or RNA-RNA sequencing samples.",0
2493,15,Describe JACUSA,"We present JACUSA, a versatile one-stop solution to detect single nucleotide variant positions from comparing RNA-DNA and/or RNA-RNA sequencing samples.",0
721,0,List clinical trials for prevention of sarcopenia,several clinical trials with androgen replacement therapy have failed to show clinical benefit.,1
721,1,List clinical trials for prevention of sarcopenia,Clinical trials are needed to find better interventions for this syndrome.,1
721,2,List clinical trials for prevention of sarcopenia,"emergence of many promising interventions towards this age-related condition (e.g., physical exercise [in particular, resistance training], testosterone, antioxidant supplementations), the need for Phase II trial designs is high.",1
721,3,List clinical trials for prevention of sarcopenia,The objective of this study was to evaluate the effect of omega-3 fatty acid supplementation on the rate of muscle protein synthesis in older adults.,0
721,4,List clinical trials for prevention of sarcopenia,This trial was registered at clinical trials.gov as NCT00794079.,1
721,5,List clinical trials for prevention of sarcopenia,The extreme paucity of clinical trials on sarcopenia in literature is mainly due to difficulties in designing studies able to isolate the aging process from its multiple and interconnected consequences.,1
285,0,Is ospemifene effective for treatment of dyspareunia?,"Ospemifene, a novel selective estrogen receptor modulator, has been developed for the treatment of vulvovaginal atrophy and dyspareunia in postmenopausal women.",0
285,1,Is ospemifene effective for treatment of dyspareunia?,"For the comparison of short-term ospemifene with placebo, parabasal cells (the standardized mean difference [SMD] = -37.5, 95% confidence interval [CI] = -41.83 to -33.17, P < 0.00001), superficial cells (SMD = 9.24, 95% CI = 7.70 to 10.79, P < 0.00001), vaginal PH (SMD = -0.89, 95% CI = -0.98 to -0.80, P = 0.00001), and dyspareunia (SMD = -0.37, 95% CI = -0.43 to -0.30, P = 0.00001) indicated that ospemifene was more effective than the placebo.",0
285,2,Is ospemifene effective for treatment of dyspareunia?,This meta-analysis indicates that ospemifene to be an effective and safe treatment for dyspareunia associated with postmenopausal vulvar and vaginal atrophy.,0
285,3,Is ospemifene effective for treatment of dyspareunia?,"Ospemifene is a selective estrogen receptor modulator (SERM), or estrogen receptor agonist/antagonist, that was recently approved by the US Food and Drug Administration for the treatment of dyspareunia associated with vulvar and vaginal atrophy, a chronic condition that affects up to 60% of postmenopausal women.",1
285,4,Is ospemifene effective for treatment of dyspareunia?,"In conclusion, ospemifene is a SERM with a unique estrogen agonist/antagonist tissue profile that was recently approved in the US for the treatment of dyspareunia associated with vulvar and vaginal atrophy in postmenopausal women.",1
285,5,Is ospemifene effective for treatment of dyspareunia?,"To characterize the pharmacokinetics of the oral, non-estrogen agent ospemifene, an estrogen agonist/antagonist with tissue-selective effects (also called a selective estrogen receptor modulator) that was recently approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy in postmenopausal women.",1
285,6,Is ospemifene effective for treatment of dyspareunia?,"Here, we review the estrogen agonist/antagonist profile of ospemifene, a novel triphenylethylene derivative recently approved to treat dyspareunia, a symptom of vulvar and vaginal atrophy (VVA) due to menopause, both preclinically and clinically.",0
285,7,Is ospemifene effective for treatment of dyspareunia?, Long-term studies on the endometrial safety of local estrogen and ospemifene are lacking.,0
285,8,Is ospemifene effective for treatment of dyspareunia?,"Ospemifene is a tissue-selective estrogen agonist/antagonist (a selective estrogen receptor modulator) recently approved by the US Food and Drug Administration for treatment of dyspareunia, a symptom of VVA, due to menopause.",1
285,9,Is ospemifene effective for treatment of dyspareunia?,"SERMs with positive vaginal effects (such as improvement in the vaginal maturation index, reduced vaginal pH, and improvement in the signs and symptoms of VVA) on postmenopausal symptomatic women include lasofoxifene (clinical development on hold) and ospemifene, which was recently approved for the treatment of VVA-related dyspareunia, with a class effect warning of potential venous thrombosis risk.",0
285,10,Is ospemifene effective for treatment of dyspareunia?,Ospemifene is the first non-estrogen treatment approved for moderate to severe dyspareunia in women with menopause-related vulvar and vaginal atrophy.,1
285,11,Is ospemifene effective for treatment of dyspareunia?,"This article summarizes the milestones in the development of ospemifene leading to this first approval for moderate to severe dyspareunia, a symptom of postmenopausal vulvar and vaginal atrophy.",0
285,12,Is ospemifene effective for treatment of dyspareunia?,"The aim of this work was to study the role of ospemifene, a novel selective estrogen receptor modulator, in the treatment of vulvar and vaginal atrophy in postmenopausal women with moderate to severe dyspareunia and physiological vaginal changes.",0
285,13,Is ospemifene effective for treatment of dyspareunia?,"In this study, once-daily oral ospemifene 60 mg was effective for the treatment of vulvar and vaginal atrophy in postmenopausal women with dyspareunia.",0
285,14,Is ospemifene effective for treatment of dyspareunia?,Clinical trials have confirmed that daily doses are well-tolerated and that it is effective in normalizing vaginal maturation index and pH as well as improving the symptoms associated with VVA including dyspareunia.,0
285,15,Is ospemifene effective for treatment of dyspareunia?,Ospemifene was shown to be effective and well tolerated for the treatment of the symptoms of vaginal dryness and dyspareunia associated with vulvovaginal atrophy over and above the use of provided lubricants.,0
2277,0,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"Furthermore, we find that these TAD boundaries are present irrespective of the expression and looping of genes located between them.",1
2277,1,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"In particular, Hi-C revealed that chromosomes of animals are organized into topologically associating domains (TADs), evolutionary conserved compact chromatin domains that influence gene expression.",0
2277,2,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,Drosophila inter-TADs harbor active chromatin and constitutively transcribed (housekeeping) genes.,1
2277,3,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"The insulator-like, TAD-boundary-like, and TAD-interior-like regions are each enriched for distinct epigenetic marks and are each correlated with different gene expression levels",0
2277,4,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"We conclude that epigenetic modifications, gene density, and transcriptional activity combine to shape the local packing of the A. thaliana nuclear genome.",1
2277,5,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions.,0
2277,6,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"Our results demonstrate the functional importance of TADs for orchestrating gene expression via genome architecture and indicate criteria for predicting the pathogenicity of human structural variants, particularly in non-coding regions of the human genome.",1
2277,7,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"The three-dimensional organization of a genome plays a critical role in regulating gene expression, yet little is known about the machinery and mechanisms that determine higher-order chromosome structure.",0
2277,8,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"Ectopically expressed roX1 and roX2 RNAs target HAS on the X chromosome in trans and, via spatial proximity, induce spreading of the MSL complex in cis, leading to increased expression of neighboring autosomal genes.",0
2277,9,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"Collectively, our results suggest that TADs are condensed chromatin domains depleted in active chromatin marks, separated by regions of active chromatin.",0
2277,10,Are TAD boundaries in Drosophila depleted in highly-expressed genes?,"However, Drosophila inter-TADs harbor active chromatin and constitutively transcribed (housekeeping) genes.",1
1432,0,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"SMN also interacts with at least two of the U6-associated Sm-like (Lsm) proteins, Lsm4 and Lsm6.",1
1432,1,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Interestingly, SMN also interacts with at least two of the U6-associated Sm-like (Lsm) proteins, Lsm4 and Lsm6",1
1432,2,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Furthermore, we present evidence for two separate binding sites in SMN for Sm/Lsm proteins.",0
1432,3,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Interestingly, SMN also interacts with at least two of the U6-associated Sm-like (Lsm) proteins, Lsm4 and Lsm6.",1
1432,4,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein.",1
1432,5,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Interestingly, SMN also interacts with at least two of the U6-associated Sm-like (Lsm) proteins, Lsm4 and Lsm6.",1
1432,6,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Furthermore, the carboxyl-terminal arginine- and glycine-rich domain of Lsm4 directly interacts with SMN.",0
1432,7,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"This entity promotes the binding of a set of factors, termed LSm/Sm proteins, onto snRNA to form the core structure of these particles.",0
1432,8,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,Toward an assembly line for U7 snRNPs: interactions of U7-specific Lsm proteins with PRMT5 and SMN complexes.,0
1432,9,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"In this report, we demonstrate that the coilin C-terminal domain binds directly to various Sm and Lsm proteins via their Sm motifs.",0
1432,10,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,We show that the region of coilin responsible for this binding activity is separable from that which binds to SMN.,0
1432,11,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Thus, the ability to interact with free Sm (and Lsm) proteins as well as with intact snRNPs, indicates that coilin and CBs may facilitate the modification of newly formed snRNPs, the regeneration of 'mature' snRNPs, or the reclamation of unassembled snRNP components.",0
1432,12,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Moreover this structure has important consequences for snRNP assembly that is mediated by two complexes containing the PRMT5 methyltransferase and the SMN (survival of motor neurons) protein, respectively.",0
1432,13,Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?,"Arginine/glycine (RG)-rich domains in components of the SMN complex interact with Sm, like-Sm (LSm), fibrillarin, RNA helicase A (Gu), and coilin proteins, all of which are antigen targets in a variety of diseases.",0
3867,0,Which cancers can be treated with Selpercatinib?,BACKGROUND: Selpercatinib (LOXO-292) and pralsetinib (BLU-667) are highly potent RET-selective protein tyrosine kinase inhibitors (TKIs) for treating advanced RET-altered thyroid cancers and non-small cell lung cancer (NSCLC).,0
3867,1,Which cancers can be treated with Selpercatinib?,"Based on results from the phase I/II LIBRETTO-001 trial, selpercatinib was recently approved by the US FDA for the treatment of RET fusion-positive non-small-cell lung cancer, RET fusion-positive thyroid cancer and RET-mutant medullary thyroid cancer.",1
3867,2,Which cancers can be treated with Selpercatinib?,"The FDA has greenlighted selpercatinib, the first targeted therapy for RET-altered non-small cell lung cancer (NSCLC) and certain types of thyroid cancer.",1
3867,3,Which cancers can be treated with Selpercatinib?,"INTRODUCTION: Novel rearranged in transfection (RET)-specific tyrosine kinase inhibitors (TKIs) such as selpercatinib (LOXO-292) have shown unprecedented efficacy in tumors positive for RET fusions or mutations, notably RET fusion-positive NSCLC and RET-mutated medullary thyroid cancer (MTC).",0
3867,4,Which cancers can be treated with Selpercatinib?,Neoadjuvant selpercatinib for advanced medullary thyroid cancer.,0
3867,5,Which cancers can be treated with Selpercatinib?,"Recently, highly potent next generation selective RET inhibitors have been clinically validated, and selpercatinib was recently Food and Drug Administration (FDA)-approved for advanced MTC.",0
3867,6,Which cancers can be treated with Selpercatinib?,PURPOSE: Selpercatinib and pralsetinib induce deep and durable responses in advanced RET fusion-positive lung and thyroid cancer patients.,0
3867,7,Which cancers can be treated with Selpercatinib?,"RET-selective inhibitors selpercatinib (LOXO-292) and pralsetinib (BLU-667) recently demonstrated favorable antitumor activity and safety profiles in advanced RET fusion-positive NSCLC, and both have received approval by the US Food and Drug Administration for this indication.",0
3867,8,Which cancers can be treated with Selpercatinib?,"CONCLUSIONS: In this phase 1-2 trial, selpercatinib showed durable efficacy with mainly low-grade toxic effects in patients with medullary thyroid cancer with and without previous vandetanib or cabozantinib treatment.",0
3867,9,Which cancers can be treated with Selpercatinib?,Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib.,0
3867,10,Which cancers can be treated with Selpercatinib?,BACKGROUND: Selpercatinib (LOXO-292) and pralsetinib (BLU-667) are highly potent RET-selective protein tyrosine kinase inhibitors (TKIs) for treating advanced RET-altered thyroid cancers and non-small cell lung cancer (NSCLC).,0
3867,11,Which cancers can be treated with Selpercatinib?,"On May 8, 2020, the Food and Drug Administration granted accelerated approval to selpercatinib for 1) adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), 2) adult and pediatric patients ≥12 years of age with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy, and 3) adult and pediatric patients ≥12 years of age with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).",0
3867,12,Which cancers can be treated with Selpercatinib?,Approval was granted based on the clinically importa,0
3867,13,Which cancers can be treated with Selpercatinib?," on results from the phase I/II LIBRETTO-001 trial, selpercatinib was recently approved by the US FDA for the treatment of RET fusion-positive non-small-cell lung cancer, RET fusion-positive thyroid cancer and RET-mutant medullary thyroid cancer.",1
3867,14,Which cancers can be treated with Selpercatinib?,This art,0
3867,15,Which cancers can be treated with Selpercatinib?,"Selpercatinib, a novel, highly selective and potent, inhibitor of RET, demonstrated clinically meaningful antitumor activity with manageable toxicity in heavily pretreated and treatment-naive RET fusion-positive non-small-cell lung cancer patients in a Phase I/II clinical tr",1
3867,16,Which cancers can be treated with Selpercatinib?,"The FDA has greenlighted selpercatinib, the first targeted therapy for RET-altered non-small cell lung cancer (NSCLC) and certain types of thyroid cancer.",1
3867,17,Which cancers can be treated with Selpercatinib?,BACKGROUND: Selpercatinib (LOXO-292) and pralsetinib (BLU-667) are highly potent RET-selective protein tyrosine kinase inhibitors (TKIs) for treating advanced RET-altered thyroid cancers and non-small cell lung cancer (NSCL,0
3867,18,Which cancers can be treated with Selpercatinib?,NSCLC).,0
3867,19,Which cancers can be treated with Selpercatinib?,"RET-selective inhibitors selpercatinib (LOXO-292) and pralsetinib (BLU-667) recently demonstrated favorable antitumor activity and safety profiles in advanced RET fusion-positive NSCLC, and both have received approval by the US Food and Drug Administration for this indication",0
3867,20,Which cancers can be treated with Selpercatinib?,ial.,0
3867,21,Which cancers can be treated with Selpercatinib?,"LIBRETTO-431 (NCT04194944) is a randomized, global, multicenter, open-label, Phase III trial, evaluating selpercatinib versus carboplatin or cisplatin and pemetrexed chemotherapy with or without pembrolizumab in treatment-naive patients with locally advanced/metastatic RET fusion-positive nonsquamous non-small-cell lung cancer",0
3867,22,Which cancers can be treated with Selpercatinib?,Selpercatinib is a highly selective RET kinase inhibitor that has recently been approved by the FDA in lung and thyroid cancers with activating RET gene fusions and mutations.,0
3867,23,Which cancers can be treated with Selpercatinib?,BACKGROUND: Selpercatinib (LOXO-292) and pralsetinib (BLU-667) are highly potent RET-selective protein tyrosine kinase inhibitors (TKIs) for treating advanced RET-altered thyroid cancers and non-small cell lung can,0
3867,24,Which cancers can be treated with Selpercatinib?,"On May 8, 2020, the Food and Drug Administration granted accelerated approval to selpercatinib for 1) adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), 2) adult and pediatric patients ≥12 years of age with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy, and 3) adult and pediatric patients ≥12 years of age with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).",0
3867,25,Which cancers can be treated with Selpercatinib?,"Selpercatinib, a novel, highly selective and potent, inhibitor of RET, demonstrated clinically meaningful antitumor activity with manageable toxicity in heavily pretreated and treatment-naive RET fusion-positive non-small-cell lung cancer patients in a Phase I/II clinical trial.",0
3867,26,Which cancers can be treated with Selpercatinib?,"CONCLUSIONS: Selpercatinib had durable efficacy, including intracranial activity, with mainly low-grade toxic effects in patients with RET fusion-positive NSCLC who had previously received platinum-based chemotherapy and those who were previously untreated.",0
1352,0,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Using a chemical carcinogenesis model in Sparc-deficient mice and their wild-type littermates, we found that loss of SPARC accelerated the development of urothelial preneoplasia (atypia and dysplasia), neoplasia, and metastasis and was associated with decreased survival.",1
1352,1,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Our studies showed that inhibition of HDAC decreased NB proliferation, and induced caspase activity and G1 growth arrest.",0
1352,2,What is the correlation between SPARC expression and growth inhibition in human cancer?,Expression patterns of cancer-related genes were modulated by VPA.,0
1352,3,What is the correlation between SPARC expression and growth inhibition in human cancer?,"The expression of THBS1, CASP8, SPARC, CDKN1A, HIC1, CDKN1B, and HIN1 was upregulated, and that of MYCN and TIG1 was downregulated.",0
1352,4,What is the correlation between SPARC expression and growth inhibition in human cancer?,"In this study, we demonstrate that expression of SPARC inhibits medulloblastoma cell proliferation.",0
1352,5,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Concomitantly, SPARC was upregulated in all ccRCC cells, suggesting that Ukrain could also affect cell proliferation by cell cycle inhibition, as supported by the cell cycle analysis, as SPARC also acts as a cell cycle inhibitor.",1
1352,6,What is the correlation between SPARC expression and growth inhibition in human cancer?,"SPARC silencing in IM-R cells restored imatinib sensitivity, whereas enforced SPARC expression in imatinib-sensitive cells promoted viability as well as protection against imatinib-mediated apoptosis.",0
1352,7,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Notably, we found that the protective effect of SPARC required intracellular retention inside cells",0
1352,8,What is the correlation between SPARC expression and growth inhibition in human cancer?,"We found that depletion of SPARC induces G2/M cell cycle arrest and tumor growth inhibition with activation of p53 and induction of p21(Cip1/Waf1) acting as a checkpoint, preventing efficient mitotic progression.",1
1352,9,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Knockdown of SPARC expression in H322 and A549 cells led to suppression of cell invasion, comparable to that observed in KLF4-transfected cells.",0
1352,10,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Moreover, retrovirus-mediated restoration of SPARC expression in KLF4-transfected cells abrogated KLF4-induced anti-invasion activity.",0
1352,11,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Together, our results indicate that KLF4 inhibits lung cancer cell invasion by suppressing SPARC gene expression.",0
1352,12,What is the correlation between SPARC expression and growth inhibition in human cancer?,"To validate the potential of SPARC as a therapeutic target, we examined the effect of the knockdown of SPARC with SPARC-specific siRNA on the growth of human melanoma cell lines.",1
1352,13,What is the correlation between SPARC expression and growth inhibition in human cancer?,SPARC siRNAs exerted a potent knockdown effect.,0
1352,14,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Silencing of SPARC resulted in growth inhibition with G(1) arrest accompanied by accumulation of p21, a G(1) cyclin-dependent kinase inhibitor, in MeWo and CRL1579 cells.",0
1352,15,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Moreover, the induction of p53 was observed in MeWo cells, but not in CRL1579 cells.",0
1352,16,What is the correlation between SPARC expression and growth inhibition in human cancer?,Conditioned media containing SPARC from MeWo cells could not restore the growth of SPARC-silenced MeWo cells.,0
1352,17,What is the correlation between SPARC expression and growth inhibition in human cancer?,"This result suggests that intracellular SPARC, but not secreted SPARC, is involved in cell proliferation",0
1352,18,What is the correlation between SPARC expression and growth inhibition in human cancer?,In vivo experiments revealed that SPARC overexpression in HCC cells inhibited their tumorigenic capacity and increased animal survival through a mechanism that partially involves host macrophages.,0
1352,19,What is the correlation between SPARC expression and growth inhibition in human cancer?,Our data suggest that SPARC overexpression in HCC cells results in a reduced tumorigenicity partially through the induction of mesenchymal-to-epithelial transition (MET).,0
1352,20,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Finally, we demonstrated that SPARC, which has been previously associated with meningioma invasiveness, was increased in aggressive meningiomas.",0
1352,21,What is the correlation between SPARC expression and growth inhibition in human cancer?,We found that the leukemic cells of AML patients with MLL gene rearrangements express low to undetectable amounts of SPARC whereas normal hematopoietic progenitors and most AML patients express this gene.,0
1352,22,What is the correlation between SPARC expression and growth inhibition in human cancer?,SPARC RNA and protein levels were also low or undetectable in AML cell lines with MLL translocations.,0
1352,23,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Consistent with its tumor suppressive effects in various solid tumor models, exogenous SPARC protein selectively reduced the growth of cell lines with MLL rearrangements by inhibiting cell cycle progression from G1 to S phase.",0
1352,24,What is the correlation between SPARC expression and growth inhibition in human cancer?,These data indicate that SPARC plays an essential role in tumor evasion from immune surveillance through the inhibition of the antitumor PMN activity.,0
1352,25,What is the correlation between SPARC expression and growth inhibition in human cancer?,"We conclude that SPARC is inhibitory to human breast cancer cell proliferation, and does not stimulate migration, in contrast to its stimulatory effects reported for melanoma (proliferation and migration) and glioma (migration) cells.",0
1352,26,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Similar growth repression by SPARC has been reported for ovarian cancer cells, and this may be a common feature among carcinomas.",0
1352,27,What is the correlation between SPARC expression and growth inhibition in human cancer?,"Furthermore, SPARC delayed but did not inhibit tumor growth.",0
1352,28,What is the correlation between SPARC expression and growth inhibition in human cancer?,The patterns of invasion and the extent of growth delay correlated with the level of SPARC expression.,1
1202,0,Elaborate on the TREAT-NMD initiative for DMD patients,TREAT-NMD is a worldwide network for neuromuscular diseases that provides an infrastructure to support the delivery of promising new therapies for patients.,1
1202,1,Elaborate on the TREAT-NMD initiative for DMD patients,The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases.,0
1202,2,Elaborate on the TREAT-NMD initiative for DMD patients,"TREAT-NMD Care and Trial Site Registry (CTSR), an initiative of an EU-funded Network of Excellence, and its utility in providing an infrastructure for clinical trial feasibility, recruitment, and other studies.",0
1202,3,Elaborate on the TREAT-NMD initiative for DMD patients,"A worldwide effort is underway to generate care guidelines for DMD, which involves the Centre for Disease Control in the USA and the TREAT-NMD network of excellence for neuromuscular diseases in Europe.",0
1202,4,Elaborate on the TREAT-NMD initiative for DMD patients,"In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (http://www.treat-nmd.eu).",0
1202,5,Elaborate on the TREAT-NMD initiative for DMD patients,"Guidelines are presented for diagnostics, neurological follow up, gastrointestinal and nutritional issues, respiratory and cardiac care as well as orthopaedics, rehabilitation, psychosocial interventions and oral care.",1
1202,6,Elaborate on the TREAT-NMD initiative for DMD patients,"In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (http://www.treat-nmd.eu).",0
1202,7,Elaborate on the TREAT-NMD initiative for DMD patients,TREAT-NMD is a worldwide network for neuromuscular diseases that provides an infrastructure to support the delivery of promising new therapies for patients.,1
1202,8,Elaborate on the TREAT-NMD initiative for DMD patients,TREAT-NMD is a worldwide network for neuromuscular diseases that provides an infrastructure to support the delivery of promising new therapies for patients,1
1202,9,Elaborate on the TREAT-NMD initiative for DMD patients,"In Europe, TREAT-NMD, a clinical research network for neuromuscular disorders, developeda global database for dystrophinopathy patients",0
1202,10,Elaborate on the TREAT-NMD initiative for DMD patients,"METHODS: This paper describes the development of the TREAT-NMD Care and Trial Site Registry (CTSR), an initiative of an EU-funded Network of Excellence, and its utility in providing an infrastructure for clinical trial feasibility, recruitment, and other studies.",0
1202,11,Elaborate on the TREAT-NMD initiative for DMD patients,"In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (http://www.treat-nmd.eu).",0
1202,12,Elaborate on the TREAT-NMD initiative for DMD patients,"This paper describes the development of the TREAT-NMD Care and Trial Site Registry (CTSR), an initiative of an EU-funded Network of Excellence, and its utility in providing an infrastructure for clinical trial feasibility, recruitment, and other studies.",0
1202,13,Elaborate on the TREAT-NMD initiative for DMD patients,"In Europe, TREAT-NMD, a clinical research network for neuromuscular disorders, developeda global database for dystrophinopathy patients.",0
1202,14,Elaborate on the TREAT-NMD initiative for DMD patients,We developed a national registry of Japanese DMD/BMD patients in collaboration with TREAT-NMD.,0
1202,15,Elaborate on the TREAT-NMD initiative for DMD patients,The harmonized implementation of national and ultimately global patient registries has been central to the success of TREAT-NMD.,0
1202,16,Elaborate on the TREAT-NMD initiative for DMD patients,"For the DMD registries within TREAT-NMD, individual countries have chosen to collect patient information in the form of standardized patient registries to increase the overall patient population on which clinical outcomes and new technologies can be assessed.",0
1202,17,Elaborate on the TREAT-NMD initiative for DMD patients,"In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (http://www.treat-nmd.",0
1202,18,Elaborate on the TREAT-NMD initiative for DMD patients,"A worldwide effort is underway to generate care guidelines for DMD, which involves the Centre for Disease Control in the USA and the TREAT-NMD network of excellence for neuromuscular diseases in Europe.",0
1202,19,Elaborate on the TREAT-NMD initiative for DMD patients,"In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (http://www.",0
1202,20,Elaborate on the TREAT-NMD initiative for DMD patients,TREAT-NMD is a worldwide network for neuromuscular diseases that provides an infrastructure to support the delivery of promising new therapies for patients.,0
1202,21,Elaborate on the TREAT-NMD initiative for DMD patients,The harmonized implementation of national and ultimately global patient registries has been central to the success of TREAT-NMD.,0
1202,22,Elaborate on the TREAT-NMD initiative for DMD patients,"A worldwide effort is underway to generate care guidelines for DMD, which involves the Centre for Disease Control in the USA and the TREAT-NMD network of excellence for neuromuscular diseases in Europe.",0
1202,23,Elaborate on the TREAT-NMD initiative for DMD patients,"In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (http://www.treat-nmd.eu).",0
1202,24,Elaborate on the TREAT-NMD initiative for DMD patients,"In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (http://www.treat-nmd.eu).",0
1202,25,Elaborate on the TREAT-NMD initiative for DMD patients,"Guidelines are presented for diagnostics, neurological follow up, gastrointestinal and nutritional issues, respiratory and cardiac care as well as orthopaedics, rehabilitation, psychosocial interventions and oral care.",1
1659,0,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"Recently, a novel CPVT RyR2 mutation, G230C, was found to increase the cytosolic, but not the luminal, Ca2+ sensitivity of single RyR2 channels in lipid bilayers.",1
1659,1,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"These data suggest that the G230C mutation enhances the propensity for SOICR by sensitizing the channel to luminal and cytosolic Ca2+ activation, and that G230C has an intrinsic structural impact on the N-terminal domains of RyR2.",0
1659,2,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,The novel RYR2-S4153R mutation has been implicated as a cause of CPVT and atrial fibrillation.,1
1659,3,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,The mutation has been functionally characterized via store-overload-induced Ca(2+) release (SOICR) and tritium-labelled ryanodine ([(3)H]ryanodine) binding assays.,0
1659,4,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"The S4153R mutation enhanced propensity for spontaneous Ca(2+) release and reduced SOICR threshold but did not alter Ca(2+) activation of [(3)H]ryanodine binding, a common feature of other CPVT gain-of-function RYR2 mutations.",0
1659,5,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,We conclude that the S4153R mutation is a gain-of-function RYR2 mutation associated with a clinical phenotype characterized by both CPVT and atrial fibrillation.,0
1659,6,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,To determine the molecular and cellular mechanisms by which a novel RyR2-V2475F mutation associated with CPVT in humans triggers Ca(2+)-dependent arrhythmias in whole hearts and intact mice.,0
1659,7,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,The mutation RyR2-V2475F is phenotypically strong among other CPVT mutations and produces heterogeneous mechanisms of RyR2 dysfunction.,0
1659,8,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,We generated 3 knock-in mice with mutations introduced into RyR2 that result in leaky channels and cause exercise induced polymorphic ventricular tachycardia in humans [catecholaminergic polymorphic ventricular tachycardia (CPVT)].,0
1659,9,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,We examined AF susceptibility in these three CPVT mouse models harboring RyR2 mutations to explore the role of diastolic SR Ca2+ leak in AF.,0
1659,10,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"AF was stimulated with an intra-esophageal burst pacing protocol in the 3 CPVT mouse models (RyR2-R2474S+/-, 70%; RyR2-N2386I+/-, 60%; RyR2-L433P+/-, 35.71%) but not in wild-type (WT) mice (P<0.05).",0
1659,11,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"The RyR2-G230C mutant exhibits similar biophysical defects compared with previously characterized CPVT mutations: decreased binding of the stabilizing subunit calstabin2 and a leftward shift in the Ca(2+) dependence for activation under conditions that simulate exercise, consistent with a ""leaky"" channel.",0
1659,12,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,Both RyR2-G230C and RyR2-P2328S channels exhibit normal luminal Ca(2+) activation.,0
1659,13,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"Thus, diastolic sarcoplasmic reticulum Ca(2+) leak caused by reduced calstabin2 binding and a leftward shift in the Ca(2+) dependence for activation by diastolic levels of cytosolic Ca(2+) is a common mechanism underlying CPVT.",0
1659,14,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"A novel CPVT mutation, E189D, was identified.",0
1659,15,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"The E189D mutation does not alter the affinity of the channel for FKBP12.6, but it increases the propensity for store-overload-induced Ca(2+) release (SOICR).",0
1659,16,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"Furthermore, the E189D mutation enhances the basal channel activity of RyR2 and its sensitivity to activation by caffeine.",0
1659,17,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,The E189D RyR2 mutation is causative for CPVT and functionally increases the propensity for SOICR without altering the affinity for FKBP12.6.,0
1659,18,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"We found that mice heterozygous for the R2474S mutation in Ryr2 (Ryr2-R2474S mice) exhibited spontaneous generalized tonic-clonic seizures (which occurred in the absence of cardiac arrhythmias), exercise-induced ventricular arrhythmias, and sudden cardiac death.",0
1659,19,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?," Thus, CPVT-associated mutant leaky Ryr2-R2474S channels in the brain can cause seizures in mice, independent of cardiac arrhythmias.",0
1659,20,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"We screened 12 Finnish CPVT probands for mutations in these genes and identified three novel RYR2 mutations (V2306I, P4902L, R4959Q), which were absent in unaffected and control individuals.",1
1659,21,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,RyR2 mutations suggested to cause defective Ca2+ channel function have recently been identified in catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia (ARVD) affected individuals.,0
1659,22,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"We report expression of three CPVT-linked human RyR2 (hRyR2) mutations (S2246L, N4104K, and R4497C) in HL-1 cardiomyocytes displaying correct targeting to the endoplasmic reticulum.",0
1659,23,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"We developed a conditional knock-in mouse model carrier of the R4496C mutation, the mouse equivalent to the R4497C mutations identified in CPVT families, to evaluate if the animals would develop a CPVT phenotype and if beta blockers would prevent arrhythmias.",1
1659,24,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,These data provide the first experimental demonstration that the R4496C RyR2 mutation predisposes the murine heart to VT and VF in response caffeine and/or adrenergic stimulation.,0
1659,25,Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?,"We developed a conditional knock-in mouse model carrier of the R4496C mutation, the mouse equivalent to the R4497C mutations identified in CPVT families, to evaluate if the animals would develop a CPVT phenotype and if beta blockers would prevent arrhythmias",1
815,0,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"We and others have published observational epidemiologic studies in support of vitamins in the primary prevention of CVD, but the results from intervention studies are mixed.",1
815,1,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"For vitamin E, observational data suggest benefit at doses of 100 to 400 IU/d.",0
815,2,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"Results from recent large-scale trials are mixed, with some showing modest benefit but others suggesting no benefit, especially for secondary prevention.",0
815,3,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,Results for B vitamins are also mixed and further complicated by the recent folate fortification of the flour supply.,0
815,4,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"If greater B vitamin intake does reduce CVD, the benefits are likely to be greatest for primary prevention and in populations with intake below dietary reference standards.",0
815,5,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"In the dose-response meta-analysis, each 30 mg/day increase in vitamin C, 30 IU/day increase in vitamin E, and 1 mg/day increase in beta-carotene yielded the estimated overall relative risk for CHD of 1.01 (95% CI, 0.99-1.02), 0.96 (95% CI, 0.94-0.99), and 1.00 (95% CI, 0.88-1.14), respectively.",0
815,6,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,CONCLUSIONS: Our findings in this meta-analysis suggest that an increase in dietary intake of antioxidant vitamins has encouraging prospects for possible CHD prevention.,1
815,7,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,High levels of α-tocopherol in serum were associated with 30% lower CAD risk in another study (HR 0.71; 95%CI 0.53-0.94).,0
815,8,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"Among minerals (zinc, selenium, and chromium), an inverse association between zinc and CAD was observed; levels lower than 14.1 µmol/L were associated with an increased risk for CAD (RR 1.70; 95%CI 1.21-2.38).",0
815,9,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,The information available on this issue is scarce.,0
815,10,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,Further prospective studies are needed to elucidate the role of these nutrients in the cardiovascular risk of patients with diabetes.,0
815,11,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,Coenzyme Q10 supplementation at a dosage of 150 mg appears to decrease the inflammatory marker IL-6 in patients with CAD.,0
815,12,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?, Coenzyme Q10 supplements at a dose of 150 mg can decrease oxidative stress and increase antioxidant enzyme activity in patients with CAD.,1
815,13,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,A higher dose of coenzyme Q10 supplements (>150 mg/d) might promote rapid and sustainable antioxidation in patients with CAD.,0
815,14,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,Alpha-tocopherol or beta-carotene supplementation has no protective effect on macrovascular outcomes or total mortality of diabetic male smokers.,0
815,15,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,Sodium selenite supplementation increases GPx-1 activity in endothelial cells and in CAD patients.,0
815,16,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,Future studies have to demonstrate whether long-term CAD outcome can be improved.,0
815,17,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"After 7.3 years of treatment and follow-up, a combination pill of folic acid, vitamin B6, and vitamin B12 did not reduce a combined end point of total cardiovascular events among high-risk women, despite significant homocysteine lowering.",0
815,18,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?," In this population-based study, vitamin E use was unrelated to mortality, but this apparently null finding seems to represent a combination of increased mortality in those with severe cardiovascular disease and a possible protective effect in those without.",0
815,19,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?," In this large cohort of apparently healthy US male physicians, self-selected supplementation with vitamin E, vitamin C, or multivitamins was not associated with a significant decrease in total CVD or CHD mortality.",0
815,20,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,The American Heart Association has recommended consumption of a balanced diet with emphasis on antioxidant-rich fruits and vegetables but has made no recommendations regarding vitamin E supplementation for the general population.,1
815,21,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"Although vitamin E supplementation seems to be safe for most people, recommendations from health care professionals should reflect the uncertainty of established benefit as demonstrated in clinical trials",0
815,22,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"Recent studies show that supplementation with antioxidant vitamins E and C have benefits in CHD prevention; however, supplementation with beta-carotene may have deleterious effects and is not recommended.",1
815,23,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"Current evidence suggests that patients with CHD would probably benefit from taking vitamin E in a dosage of 400 IU per day and vitamin C in a dosage of 500 to 1,000 mg per day.",0
815,24,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,Clinicians may also want to consider vitamin supplementation for CHD prevention in high-risk patients.,0
815,25,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"Folate lowers elevated homocysteine levels, but evidence for routine supplemental use does not yet exist.",0
815,26,Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?,"In patients at high risk for cardiovascular events, treatment with vitamin E for a mean of 4.5 years had no apparent effect on cardiovascular outcomes.",0
530,0,Is there an association between bruxism and reflux,"Rhythmic masticatory muscle activity, including sleep bruxism (SB), can be induced in healthy individuals by experimental esophageal acidification, which plays an important role in the pathogenesis of gastroesophageal reflux disease (GERD).",0
530,1,Is there an association between bruxism and reflux,"However, no robust evidence supports the association between SB and GERD.",1
530,2,Is there an association between bruxism and reflux,"Sleep bruxism is prevalent in GERD patients, and GERD is highly associated with SB.",1
530,3,Is there an association between bruxism and reflux,"Our large-scale cross-sectional study found that problem behaviors in adolescents were associated with sleep problems, including sleep bruxism, as well as lifestyle and food habits and GERD symptoms.",0
530,4,Is there an association between bruxism and reflux,"The frequencies of EMG bursts, rhythmic masticatory muscle activity (RMMA) episodes, grinding noise, and the RMMA/microarousal ratio were significantly higher in the 20-minute period after acidic infusion than after saline infusion.",0
530,5,Is there an association between bruxism and reflux,RMMA episodes including SB were induced by esophageal acidification.,0
530,6,Is there an association between bruxism and reflux,Direct restorative treatment of dental erosion caused by gastroesophageal reflux disease associated with bruxism:,0
530,7,Is there an association between bruxism and reflux,This article presents a case report of a 27-year-old male smoker with tooth wear and dentin sensitivity caused by GERD associated with bruxism,0
530,8,Is there an association between bruxism and reflux,Dental wear caused by association between bruxism and gastroesophageal reflux disease:,1
530,9,Is there an association between bruxism and reflux,"This paper presents a case report in which bruxism associated with acid feeding, smoking habit and episodes of gastric reflow caused severe tooth wear and great muscular discomfort with daily headache episodes.",0
530,10,Is there an association between bruxism and reflux,"most jaw muscle activities, ie, RMMA, single short-burst, and clenching episodes, occur in relation to gastroesophageal reflux mainly in the supine position.",0
530,11,Is there an association between bruxism and reflux,Association between nocturnal bruxism and gastroesophageal reflux.,1
530,12,Is there an association between bruxism and reflux,"Nocturnal bruxism may be secondary to nocturnal gastroesophageal reflux, occurring via sleep arousal and often together with swallowing.",1
1421,0,is there an increase in ultrasound comets after intense exercise?,"Healthy athletes developed subclinical increase in pulmonary water content immediately after an Ironman race at sea level, as shown by the increased number of ULCs related to cardiac changes occurring during exercise.",1
1421,1,is there an increase in ultrasound comets after intense exercise?,Increased EVLW is associated with estimated PCWP and indices of left ventricular systolic and diastolic dysfunction.,1
1421,2,is there an increase in ultrasound comets after intense exercise?,"The additional exercise-induced increase of PCWP, the worsening of left ventricular diastolic function, and extensive wall-motion abnormalities correlate with variations of EVLW.",1
1421,3,is there an increase in ultrasound comets after intense exercise?," Among them chest ultrasonography can detect and quantify the extravascular lung water, creating ""comet-tail"" ultrasound artefacts (ULCs) from water-thickened pulmonary interlobular septa.",1
1421,4,is there an increase in ultrasound comets after intense exercise?," In top-level breath-hold divers, chest sonography frequently reveals an increased number of ULCs after immersion, indicating a relatively high prevalence of (often subclinical) reversible extravascular lung water accumulation.",1
2567,0,Which molecules are inhibited by anticancer drug Dovitinib?,"Dovitinib, a potent FGFR inhibitor, has demonstrated antitumor activity in heavily pretreated patients with FGFR pathway-amplified breast cancer.",0
2567,1,Which molecules are inhibited by anticancer drug Dovitinib?,"Dovitinib inhibits multiple tyrosine receptor kinases, predominantly the vascular endothelial growth factor receptors (VEGFR), but also FGFRs, and could be active in MPM.",0
2567,2,Which molecules are inhibited by anticancer drug Dovitinib?,"Dovitinib (TKI-258/CHIR-258) is a pan receptor tyrosine kinase (RTK) inhibitor that targets VEGFR, FGFR, PDGFR, and KIT.",1
2567,3,Which molecules are inhibited by anticancer drug Dovitinib?,"Dovitinib, a suppressor of FGFR activity, may be active in ACC.",0
2567,4,Which molecules are inhibited by anticancer drug Dovitinib?,"We tested dovitinib, an inhibitor of both FGF and VEGF receptors, in patients progressing on anti-VEGF treatment.",0
2567,5,Which molecules are inhibited by anticancer drug Dovitinib?,"Five HNSCC cell lines were characterized based on VEGFR1-3 and FGFR1-4 expression by sqRT-PCR and treated with three different tyrosine kinase inhibitors (TKIs) (nintedanib, dovitinib and pazopanib), all of which are effective against VEGFR and FGFR family members.",0
2567,6,Which molecules are inhibited by anticancer drug Dovitinib?,"PURPOSE: Dovitinib is an orally available multi tyrosine kinase inhibitor which inhibits VEGFR 1-3, FGFR 1-3, and PDGFR.",1
2567,7,Which molecules are inhibited by anticancer drug Dovitinib?,".RESULTS: Four trials involving the selective VEGFR inhibitors axitinib, tivozanib and dovitinib were analysed, all using sorafenib as the comparator.",0
2567,8,Which molecules are inhibited by anticancer drug Dovitinib?,"PURPOSE: Dovitinib (TKI258) is an oral multi-tyrosine kinase inhibitor of FGFR, VEGFR, PDGFR β, and c-Kit.",1
2567,9,Which molecules are inhibited by anticancer drug Dovitinib?,"Using this PDX model, we confirmed the ability of the FGFR inhibitors, ponatinib, dovitinib and BGJ398, to modulate FGFR signaling, inhibit cell proliferation and induce cell apoptosis in cholangiocarcinoma tumors harboring FGFR2 fusions.",0
2567,10,Which molecules are inhibited by anticancer drug Dovitinib?,"In addition to VEGFR and PDGFR, dovitinib inhibits FGFR.",0
2567,11,Which molecules are inhibited by anticancer drug Dovitinib?,"AZD4547, BGJ398 (infigratinib), Debio-1347 and dovitinib are FGFR1/2/3 inhibitors; BLU9931 is a selective FGFR4 inhibitor; FIIN-2, JNJ-42756493, LY2874455 and ponatinib are pan-FGFR inhibitors.",0
2567,12,Which molecules are inhibited by anticancer drug Dovitinib?,"AZD4547, dovitinib and ponatinib are multi-kinase inhibitors targeting FGFRs, colony stimulating factor 1 receptor (CSF1R), vascular endothelial growth factor (VEGF)R2, and others.",0
2567,13,Which molecules are inhibited by anticancer drug Dovitinib?,"In vitro, N87-TR cell lines demonstrated a higher sensitivity than did trastuzumab-sensitive parental cells to the FGFR3 inhibitor dovitinib, which reduced expression of pAKT, ZEB1, and cell migration.",0
2567,14,Which molecules are inhibited by anticancer drug Dovitinib?,"The current phase 2 study evaluated the efficacy and tolerability of dovitinib, an FGFR inhibitor, in patients with advanced SCC of the lung.",0
2567,15,Which molecules are inhibited by anticancer drug Dovitinib?,Dovitinib (TKI258) is a small molecule multi-kinase inhibitor currently in clinical phase I/II/III development for the treatment of various types of cancers.,1
2567,16,Which molecules are inhibited by anticancer drug Dovitinib?,"We tested various T-ALL cell lines against a small-molecule inhibitor screen of 66 compounds targeting two-thirds of the tyrosine kinome and found that combined treatment of T-ALL cells with dovitinib, an orally active multi-targeted small-molecule receptor tyrosine kinase inhibitor, and OP449 synergistically reduced the viability of all tested T-ALL cell lines.",0
2567,17,Which molecules are inhibited by anticancer drug Dovitinib?,"We sought to identify fibroblast growth factor receptor 2 (FGFR2) kinase domain mutations that confer resistance to the pan-FGFR inhibitor, dovitinib, and explore the mechanism of action of the drug-resistant mutations.",0
2567,18,Which molecules are inhibited by anticancer drug Dovitinib?,"Dovitinib is a novel multi-target tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor-1-3, platelet-derived growth factor receptor-β, Fms-like tyrosine kinase 3, c-Kit and fibroblast growth factor receptor-1-3.",0
2567,19,Which molecules are inhibited by anticancer drug Dovitinib?,Dovitinib (TKI258/CHIR258) is a multi-kinase inhibitor in phase III development for the treatment of several cancers.,1
2567,20,Which molecules are inhibited by anticancer drug Dovitinib?,INTRODUCTION Erlotinib is a FDA approved small molecule inhibitor of epidermal growth factor receptor and dovitinib is a novel small molecule inhibitor of fibroblast growth factor and vascular endothelial growth factor receptor.,0
2567,21,Which molecules are inhibited by anticancer drug Dovitinib?,"Here, we explore the therapeutic potential of 2 FGFR inhibitors, the multikinase inhibitor dovitinib (TKI258) and the more selective FGFR inhibitor NVP-BGJ398 for the treatment of endometrial cancer.",0
2567,22,Which molecules are inhibited by anticancer drug Dovitinib?,"PURPOSE Dovitinib is an orally available multi tyrosine kinase inhibitor which inhibits VEGFR 1-3, FGFR 1-3, and PDGFR.",0
2567,23,Which molecules are inhibited by anticancer drug Dovitinib?,The multiple kinase inhibitor dovitinib is currently under clinical investigation for hepatocellular carcinoma (HCC).,0
715,0,What does the SAGA complex acronym stands for?,SAGA (Spt-Ada-Gcn5 Acetyltransferase),1
715,1,What does the SAGA complex acronym stands for?,SAGA (Spt-Ada-Gcn5-acetyltransferase),1
715,2,What does the SAGA complex acronym stands for?,Spt-Ada-Gcn5-acetyltransferase (SAGA),1
715,3,What does the SAGA complex acronym stands for?,Spt-Ada-Gcn5-acetyltransferase (SAGA) complex is a transcription coactivator,1
715,4,What does the SAGA complex acronym stands for?,the yeast transcriptional coactivator Spt-Ada-Gcn5 acetyltransferase (SAGA),1
2184,0,Is hydroxyurea usually used to treated infectious disease?,"Hydroxyurea represents the only available disease-modifying therapy for SCA, and has proven safety and efficacy in high-resource countries",1
2184,1,Is hydroxyurea usually used to treated infectious disease?,"In conclusion, the data here presented suggests that hydroxyurea may prevent priapism attacks in sickle cell disease, probably at higher doses than usually prescribed for painful crisis prevention..",0
2184,2,Is hydroxyurea usually used to treated infectious disease?,Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.,1
2184,3,Is hydroxyurea usually used to treated infectious disease?,"t may also attenuate optimal response to hydroxyurea therapy, the only effective and practical treatment option for SCD in sub-Saharan Africa",1
2184,4,Is hydroxyurea usually used to treated infectious disease?,Hydroxyurea is one of the most successfully used therapies for sickle cell disease,1
2184,5,Is hydroxyurea usually used to treated infectious disease?,Clinical experience with hydroxyurea for patients with sickle cell disease (SCD) has been accumulating for the past 25 years.,1
2184,6,Is hydroxyurea usually used to treated infectious disease?,"The bulk of the current evidence suggests that hydroxyurea is well-tolerated, safe, and efficacious for most patients with SCD",0
666,0,Name the major classes of small  non coding RNAs in mammalians?,"Some of these RNA classes, in particular microRNAs and snoRNAs, undergo maturation processes that lead to the production of shorter RNAs.",1
1017,0,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The second method, ""functional class scoring"" (FCS), examines the statistical distribution of individual gene scores among all genes in the gene ontology class and does not involve an initial gene selection step.",1
1017,1,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","We aimed at examining such discrepancies on the level of apparently affected biologically related groups of genes, e.g.",0
1017,2,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?",metabolic or signalling pathways.,0
1017,3,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","This can be achieved by group testing procedures, e.g.",0
1017,4,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","over-representation analysis, functional class scoring (FCS), or global tests.",0
1017,5,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?",They also suggest that functional class scoring methods appear to perform better and more consistently than overrepresentation analysis and distributional score methods.,0
1017,6,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","With the use of functional class scoring, a semi-supervised method exploring both the expression pattern and the functional annotation of the genes, the Gene Ontology classes were ranked according to the significance of the impact of D3T treatment.",0
1017,7,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","Most of the existing pathway analysis methods focus on either the number of DE genes observed in a given pathway (enrichment analysis methods), or on the correlation between the pathway genes and the class of the samples (functional class scoring methods)",0
1017,8,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?"," There are three main classes of these methods: over-representation analysis, functional class scoring, and pathway topology based methods.",0
1017,9,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","Here, we show that all three major categories of pathway analysis methods (enrichment analysis, functional class scoring, and topology-based methods) are severely influenced by crosstalk phenomena",0
1017,10,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","Proteomics Expansion Pipeline (PEP), Functional Class Scoring (FCS), and Maxlink, in a test scenario of valproic acid (VPA)-treated mice.",0
1017,11,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","We propose and examine personalized extensions of pathway statistics, overrepresentation analysis and functional class scoring, to generate individualized pathway aberrance score.",0
1017,12,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The comparison of two analytical approaches, based on either Over Representation Analysis or Functional Class Scoring, by a meta-analysis-based approach, led to the retrieval of known information about the biological situation - thus validating the model - but also more importantly to the discovery of the previously unknown implication of the spliceosome, the cellular machinery responsible for mRNA splicing, in the development of metastasis.",0
1017,13,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The second method, ""functional class scoring"" (FCS), examines the statistical distribution of individual gene scores among all genes in the gene ontology class and does not involve an initial gene selection step.",1
1017,14,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The second method, &quot;functional class scoring&quot; (FCS), examines the statistical distribution of individual gene scores among all genes in the gene ontology class and does not involve an initial gene selection step",1
1017,15,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The first method, &quot;overrepresentation analysis&quot; (ORA), is based on statistically evaluating the fraction of genes in a particular gene ontology class found among the set of genes showing age-related changes in expression",0
1017,16,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?",Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex,0
1017,17,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The second method, ""functional class scoring"" (FCS), examines the statistical distribution of individual gene scores among all genes in the gene ontology class and does not involve an initial gene selection step.",1
1017,18,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The first method, &quot;overrepresentation analysis&quot; (ORA), is based on statistically evaluating the fraction of genes in a particular gene ontology class found among the set of genes showing age-related changes in expression.",0
1017,19,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The second method, &quot;functional class scoring&quot; (FCS), examines the statistical distribution of individual gene scores among all genes in the gene ontology class and does not involve an initial gene selection step.",1
1017,20,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","The second method, &quot;functional class scoring&quot; (FCS), examines the statistical distribution of individual gene scores among all genes in the gene ontology class and does not involve an initial gene selection step.",0
1017,21,"What is the basis of the methodology of ""functional class scoring"" (FCS) for the analysis of gene expression data?","We find that FCS yields more consistent results than ORA, and the results of ORA depended strongly on the gene selection threshold.",0
1787,0,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"The formation of neurofibrillary tangles from the assembly of hyperphosphorylated tau leads to dendritic and axonal instability, synaptic degeneration, and neuronal loss.",0
1787,1,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation.,0
1787,2,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"In neurodegenerative diseases including Alzheimer's disease and frontotemporal dementia, the protein tau is hyperphosphorylated and eventually aggregates to develop neurofibrillary tangles.",0
1787,3,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Neurofibrillary tangles (NFTs), a marker of neuronal alterations in Alzheimer's disease (AD) and other tauopathies, are comprised of aggregates of hyperphosphorylated tau protein.",0
1787,4,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"At 24 months, NFTs progress, tau inclusions propagate to the dentate gyrus, and neuronal loss is evident.",0
1787,5,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"At autopsy, brains of AD and a subset of TBI victims display some similarities including accumulation of Aβ peptides and neurofibrillary tangles of hyperphosphorylated tau proteins.",0
1787,6,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"The pathological hallmarks of Alzheimer's disease (AD)--widespread synaptic and neuronal loss and the pathological accumulation of amyloid-beta peptide (Aβ) in senile plaques, as well as hyperphosphorylated tau in neurofibrillary tangles--have been known for many decades, but the links between AD pathology and dementia and effective therapeutic strategies remain elusive.",0
1787,7,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"The microtubule-associated protein tau, in a hyperphosphorylated form, aggregates into insoluble paired-helical filaments (PHFs) in Alzheimer's disease (AD) and other tauopathies.",0
1787,8,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,Pseudohyperphosphorylation causing AD-like changes in tau has significant effects on its polymerization.,0
1787,9,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"In AD, kinases such as glycogen synthase kinase-3beta (GSK-3beta) are believed to be involved in the generation of hyperphosphorylated tau.",0
1787,10,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"However, the functional consequences of hyperphosphorylation on the microtubule binding and polymerization of tau are not well understood.",1
1787,11,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Pseudophosphorylation of tau decreases its affinity for microtubules, and pseudohyperphosphorylated forms of tau do not have significantly decreased levels of microtubule binding as compared to single and double sites.",0
1787,12,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"On the basis of the observations that pseudohyperphosphorylated tau has decreased affinity for microtubules and reduced inducer-initiated rates of nucleation and polymerization, we propose that this combination could be the cause of the increased cytotoxicity of hyperphosphorylated tau in Alzheimer's disease and also explain the potentially beneficial role of tau polymerization and NFT formation.",0
1787,13,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated in affected neurons of Alzheimer disease brain.,0
1787,14,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"In several neurodegenerative diseases, including Alzheimer disease, the neuronal microtubule-associated protein tau becomes hyperphosphorylated, accumulates in the somatodendritic compartment, and aggregates into insoluble filaments.",0
1787,15,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,Tau is the major component of the neurofibrillar tangles that are a pathological hallmark of Alzheimers' disease.,1
1787,16,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Aggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimers disease",0
1787,17,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"In several neurodegenerative diseases, including Alzheimer disease, the neuronal microtubule-associated protein tau becomes hyperphosphorylated, accumulates in the somatodendritic compartment, and aggregates into insoluble filaments",0
1787,18,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"On the basis of the observations that pseudohyperphosphorylated tau has decreased affinity for microtubules and reduced inducer-initiated rates of nucleation and polymerization, we propose that this combination could be the cause of the increased cytotoxicity of hyperphosphorylated tau in Alzheimers disease and also explain the potentially beneficial role of tau polymerization and NFT formation",0
1787,19,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"In the brains of individuals with Alzheimers disease, tau is hyperphosphorylated and aggregated into intraneuronal deposits called neurofibrillary tangles (NFTs)",1
1787,20,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Neurofibrillary tangles and neuropil threads, both made of hyperphosphorylated tau proteins, point to an alteration of microtubules in Alzheimers disease",1
1787,21,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Hyperphosphorylation, which diminishes the microtubule-binding capacity of tau, destabilizes microtubules and may enhance the formation of paired helical filaments that constitute neurofibrillary tangles in Alzheimer's disease.",0
1787,22,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"In several neurodegenerative diseases, including Alzheimer disease, the neuronal microtubule-associated protein tau becomes hyperphosphorylated, accumulates in the somatodendritic compartment, and aggregates into insoluble filaments.",0
1787,23,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,The consequences of the accumulation of hyperphosphorylated tau in the somatodendritic compartment remain poorly characterized at the early stage of disease before the formation of tau insoluble filaments.,1
1787,24,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated in affected neurons of Alzheimer disease brain.,0
1787,25,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"This hyperphosphorylated tau can be dephosphorylated at some of the abnormal phosphorylated sites by purified protein phosphatase-1, 2A, and 2B in vitro.",0
1787,26,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Adult human nerve cells contain tau protein, a phosphorylated microtubule-associated protein, that is hyperphosphorylated in the fetus and in patients with Alzheimer's disease.",0
1787,27,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Hyperphosphorylation, which diminishes the microtubule-binding capacity of tau, destabilizes microtubules and may enhance the formation of paired helical filaments that constitute neurofibrillary tangles in Alzheimer's disease.",0
1787,28,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,"Importantly, hyperphosphorylated tau comprises the paired helical filament, whose pathological deposition as neurofibrillary tangles is implicated in Alzheimer's disease; hyperphosphorylated tau is also implicated in the pathogenesis of other neurodegenerative disorders.",0
1787,29,Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?,In Alzheimer disease (AD) brain tau is ~three to four-fold more hyperphosphorylated than the normal adult brain tau and in this hyperphosphorylated state it is polymerized into paired helical filaments ([PHF) admixed with straight filaments (SF) forming neurofibrillary tangles.,0
656,0,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is characterized by coronal craniosynostosis (bilateral more often than unilateral), hearing loss, developmental delay, and carpal and/or tarsal bone coalition.",0
656,1,What symptoms characterize the Muenke syndrome?,Tarsal coalition is a distinct feature of Muenke syndrome and has been reported since the initial description of the disorder in the 1990s.,0
656,2,What symptoms characterize the Muenke syndrome?,"Muenke syndrome caused by the FGFR3 Pro250Arg mutation is associated with craniosynostosis, hearing loss, and various bony anomalies.",0
656,3,What symptoms characterize the Muenke syndrome?,"Muenke syndrome caused by the FGFR3(P250R) mutation is an autosomal dominant disorder mostly identified with coronal suture synostosis, but it also presents with other craniofacial phenotypes that include mild to moderate midface hypoplasia.",0
656,4,What symptoms characterize the Muenke syndrome?,Sensorineural hearing loss at lower frequencies was found only in patients with Muenke syndrome.,0
656,5,What symptoms characterize the Muenke syndrome?, Sensorineural hearing loss can occur in all 4 syndromes studied but is the primary cause of hearing loss in children and young adults with Muenke syndrome.,0
656,6,What symptoms characterize the Muenke syndrome?,The facial features of children with FGFR3Pro250Arg mutation (Muenke syndrome) differ from those with the other eponymous craniosynostotic disorders.,0
656,7,What symptoms characterize the Muenke syndrome?,We documented midfacial growth and position of the forehead after fronto-orbital advancement (FOA) in patients with the FGFR3 mutation.,0
656,8,What symptoms characterize the Muenke syndrome?,"The Muenke syndrome (MS) is characterized by unicoronal or bicoronal craniosynostosis, midfacial hypoplasia, ocular hypertelorism, and a variety of minor abnormalities associated with a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.",0
656,9,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is characterized by considerable phenotypic variability: features may include coronal synostosis (more often bilateral than unilateral); synostosis of other sutures, all sutures (pansynostosis), or no sutures; or macrocephaly.",0
656,10,What symptoms characterize the Muenke syndrome?,"Bilateral coronal synostosis typically results in brachycephaly (broad skull), although turribrachycephaly (a ""tower-shaped"" skull) or a cloverleaf skull can be observed.",0
656,11,What symptoms characterize the Muenke syndrome?,Unilateral coronal synostosis results in anterior plagiocephaly (asymmetry of the skull and face).,0
656,12,What symptoms characterize the Muenke syndrome?,"Other craniofacial findings typically include: ocular hypertelorism, ptosis or proptosis (usually mild), midface hypoplasia, temporal bossing, and a highly arched palate.",0
656,13,What symptoms characterize the Muenke syndrome?,Strabismus is common.,0
656,14,What symptoms characterize the Muenke syndrome?,"Extracranial findings can include: hearing loss (in 33%-100% of affected individuals); developmental delay (~33%); intellectual disability; carpal bone and/or tarsal bone fusions; brachydactyly, broad toes, broad thumbs, and/or clinodactyly; and radiographic findings of thimble-like (short and broad) middle phalanges and/or cone-shaped epiphyses.",1
656,15,What symptoms characterize the Muenke syndrome?,Phenotypic variability is considerable even within the same family.,0
656,16,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is an autosomal dominant disorder characterized by coronal suture craniosynostosis, hearing loss, developmental delay, carpal and tarsal fusions, and the presence of the Pro250Arg mutation in the FGFR3 gene.",1
656,17,What symptoms characterize the Muenke syndrome?,"A majority of the patients (95%) demonstrated a mild-to-moderate, low frequency sensorineural hearing loss.",0
656,18,What symptoms characterize the Muenke syndrome?,Increased digital markings were more severe posteriorly in Muenke patients than in non-Muenke patients.,0
656,19,What symptoms characterize the Muenke syndrome?,The Muenke patients with unilateral coronal synostosis showed a somewhat more severe asymmetry in the anterior part of the skull than the non-Muenke patients.,0
656,20,What symptoms characterize the Muenke syndrome?,Muenke syndrome is a genetically determined craniosynostosis that involves one or both coronal sutures.,0
656,21,What symptoms characterize the Muenke syndrome?,"In some patients it is associated with skeletal abnormalities such as thimble-like middle phalanges, coned epiphysis, and/or neurological impairment, namely sensorineural hearing loss or mental retardation.",0
656,22,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is an autosomal dominant disorder characterized by coronal suture craniosynostosis, hearing loss, developmental delay, carpal and tarsal fusions, and the presence of the Pro250Arg mutation in the FGFR3 gene.",1
656,23,What symptoms characterize the Muenke syndrome?,Muenke syndrome is characterized by various craniofacial deformities and is caused by an autosomal-dominant activating mutation in fibroblast growth factor receptor 3 (FGFR3(P250R)               ).,0
656,24,What symptoms characterize the Muenke syndrome?,"The Muenke syndrome (MS) is characterized by unicoronal or bicoronal craniosynostosis, midfacial hypoplasia, ocular hypertelorism, and a variety of minor abnormalities associated with a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.",0
656,25,What symptoms characterize the Muenke syndrome?,"Muenke syndrome and FGFR2-related isolated coronal synostosis are characterized only by uni- or bicoronal craniosynostosis; the remainder are characterized by bicoronal craniosynostosis or cloverleaf skull, distinctive facial features, and variable hand and foot findings.",0
656,26,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is an autosomal-dominant craniosynostosis syndrome characterized by unilateral or bilateral coronal craniosynostosis, hearing loss, intellectual disability, and relatively subtle limb findings such as carpal bone fusion and tarsal bone fusion.",0
656,27,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is an autosomal dominant disorder characterized by coronal suture craniosynostosis, hearing loss, developmental delay, carpal and tarsal fusions, and the presence of the Pro250Arg mutation in the FGFR3 gene",1
656,28,What symptoms characterize the Muenke syndrome?,"Muenke syndrome caused by the FGFR3 Pro250Arg mutation is associated with craniosynostosis, hearing loss, and various bony anomalies",0
656,29,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is characterized by coronal suture synostosis, midface hypoplasia, subtle limb anomalies, and hearing loss",0
656,30,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is an autosomal-dominant craniosynostosis syndrome characterized by unilateral or bilateral coronal craniosynostosis, hearing loss, intellectual disability, and relatively subtle limb findings such as carpal bone fusion and tarsal bone fusion",0
656,31,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is characterized by coronal craniosynostosis (bilateral more often than unilateral), hearing loss, developmental delay, and carpal and/or tarsal bone coalition",0
656,32,What symptoms characterize the Muenke syndrome?,Muenke syndrome is characterized by various craniofacial deformities and is caused by an autosomal-dominant activating mutation in fibroblast growth factor receptor 3 (FGFR3(P250R)               ),0
656,33,What symptoms characterize the Muenke syndrome?,"Muenke syndrome is an autosomal dominant disorder characterized by coronal suture craniosynostosis, hearing loss, developmental delay, carpal and tarsal fusions, and the presence of the Pro250Arg mutation in the FGFR3 gene",1
4024,0,Is the apilimod inhibitor effective against SARS-CoV-2?,"To identify therapeutics that can be repurposed as SARS-CoV-2 antivirals, we profiled a library of known drugs encompassing approximately 12,000 clinical-stage or FDA-approved small molecules.",1
4024,1,Is the apilimod inhibitor effective against SARS-CoV-2?,"Here, we report the identification of 30 known drugs that inhibit viral replication.",1
4024,2,Is the apilimod inhibitor effective against SARS-CoV-2?,"Of these, six were characterized for cellular dose-activity relationships, and showed effective concentrations likely to be commensurate with therapeutic doses in patients.",1
4024,3,Is the apilimod inhibitor effective against SARS-CoV-2?,"These include the PIKfyve kinase inhibitor Apilimod, cysteine protease inhibitors MDL-28170, Z LVG CHN2, VBY-825, and ONO 5334, and the CCR1 antagonist MLN-3897.",1
4024,4,Is the apilimod inhibitor effective against SARS-CoV-2?,"Since many of these molecules have advanced into the clinic, the known pharmacological and human safety profiles of these compounds will accelerate their preclinical and clinical evaluation for COVID-19 treatment.",1
195,0,What is the prognostic role of thyroid hormone in patients with heart failure?, Cumulative survival was significantly lower among patients with free triiodothyronine < 2.12 pg/mL and among patients with brain natriuretic peptide > 686 pg/mL.,0
195,1,What is the prognostic role of thyroid hormone in patients with heart failure?,"In multivariate analysis, the significant independent predictors of major cardiac events were age, free triiodothyronine, and brain natriuretic peptide",1
195,2,What is the prognostic role of thyroid hormone in patients with heart failure?,The T3 was more meaningful than the BNP in the prognosis of CHF.,0
195,3,What is the prognostic role of thyroid hormone in patients with heart failure?,The BNP and T3 combination detection was more valuable in determining the severity of CHF and prognosis.,0
195,4,What is the prognostic role of thyroid hormone in patients with heart failure?,fT3 and BNP hold an independent and additive prognostic value in HF.,1
195,5,What is the prognostic role of thyroid hormone in patients with heart failure?,"Univariate regression analysis showed that TSH (p<0.0001), fT3 (p<0.0001), fT4 (p=0.016) and fT3/fT4 (p<0.0001) were associated with heart failure progression but multivariate analysis showed that only TSH considered as a continuous variable (p = 0.001) as well as subclinical hypothyroidism (TSH > 5.5 mUI/l; p=0.014) remained significantly associated with the events.",0
195,6,What is the prognostic role of thyroid hormone in patients with heart failure?,"Low T(3) levels are an independent predictor of mortality in patients with chronic heart failure, adding prognostic information to conventional clinical and functional cardiac parameters.",1
195,7,What is the prognostic role of thyroid hormone in patients with heart failure?,"Sixteen patients (14%) died during the follow-up period; their fT3/fT4 ratio was significantly lower than the patients who survived (1.31+/-0.37 vs. 2.01+/-0.72, p<0.001).",0
195,8,What is the prognostic role of thyroid hormone in patients with heart failure?,"The authors conclude that among elderly patients with heart failure, lower triiodothyronine concentrations are more prevalent and are associated with a worse prognosis.",1
195,9,What is the prognostic role of thyroid hormone in patients with heart failure?,A low free T3 index/reverse T3 ratio is associated with poor ventricular function and nutritional status and is the strongest predictor yet identified for short-term outcome in patients with advanced heart failure.,1
3426,0,Which company produces Eligard?,"We evaluated the efficacy and tolerability of 3- and 6-month leuprorelin acetate (LA) depot formulations (Eligard®, Astellas Pharma GmbH) in patients with advanced prostate cancer treated in routine clinical practice in Germany.",1
11,0,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"Class II agents are antisympathetic drugs, particularly the beta-adrenoceptor blockers",1
11,1,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Class III antiarrhythmic agents include sotalol and amiodarone.,0
11,2,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Class IV antiarrhythmic drugs are the calcium channel blockers verapamil and diltiazem.,0
11,3,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Other agents which do not fall neatly into the Vaughan Williams classification include digoxin and perhexiline.,0
11,4,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Antiarrhythmic drugs can be divided into four Vaughan Williams classes (I-IV) according to defined electrophysiological effects on the myocardium.,1
11,5,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"Thus, the Vaughan Williams classification also coincides with the main myocardial targets of the antiarrhythmics, i.e., myocardial sodium-, potassium-, and calcium-channels or beta-adrenergic receptors.",0
11,6,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,The sodium-channel blockade induced by class-I substances is enhanced with increasing heart rates.,0
11,7,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"Thus, class-I antiarrhythmics can be subclassified as substances showing a more exponential, an approximately linear, or rather saturated block-frequency relation.",0
11,8,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Class-III antiarrhythmics (potassium-channel blockade) can be further differentiated according to the component of the delayed rectifier potassium current (IK) which is inhibited by a drug.,0
11,9,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Class-III substances inhibiting the slowly activating IKs component are currently under investigation and are expected to show a direct rate dependence.,0
11,10,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action.,0
11,11,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics, and have as a common action, blockade of the fast-inward sodium channel on myocardium.",1
11,12,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Antiarrhythmic drugs can be divided into four Vaughan Williams classes (I-IV) according to defined electrophysiological effects on the myocardium,1
11,13,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,The classification of antiarrhythmic agents according to Vaughan Williams is based on electrophysiological findings in isolated heart muscle and defines four classes of drug actions.,0
11,14,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action.,0
11,15,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics, and have as a common action, blockade of the fast-inward sodium channel on myocardium.",1
11,16,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"Class II agents are antisympathetic drugs, particularly the b-adrenoceptor blockers.",0
11,17,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Class III antiarrhythmic agents include sotalol and amiodarone.,0
11,18,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Class IV antiarrhythmic drugs are the calcium channel blockers verapamil and diltiazem.,0
11,19,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"These are classified according to their electrophysiological effects observed in isolated cardiac tissues in vitro (Vaughan Williams, 1989).",0
11,20,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,"Fast sodium channel blockers (class I) which reduce the upstroke velocity of the action potential are usually subclassified into three groups, class I A-C, according to their effect on the action potential duration.",0
11,21,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Beta-adrenergic antagonists (class II) exert their effects by antagonizing the electrophysiological effects of beta-adrenergic catecholamines.,0
11,22,Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?,Class III antiarrhythmic agents (eg amiodarone) prolong the action potential and slow calcium channel blockers (class IV) suppress the calcium inward current and calcium-dependent action potentials.,0
3254,0,Which T-UCRs have been implicated in lung cancer?,uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.,0
3254,1,Which T-UCRs have been implicated in lung cancer?,Transcribed ultraconserved regions (T-UCRs) classified as long non-coding RNAs (Lnc-RNAs) are transcripts longer than 200-nt RNA with no protein-coding capacity.,1
3254,2,Which T-UCRs have been implicated in lung cancer?,"Previous studies showed that T-UCRs serve as novel oncogenes, or tumor suppressors are involved in tumorigenesis and cancer progressive.",0
3254,3,Which T-UCRs have been implicated in lung cancer?,"Nevertheless, the clinicopathologic significance and regulatory mechanism of T-UCRs in lung cancer (LC) remain largely unknown.",0
3254,4,Which T-UCRs have been implicated in lung cancer?,"We found that uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454 is associated with tumor size and tumors with more advanced stages.",1
3254,5,Which T-UCRs have been implicated in lung cancer?,Transfection with uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines.,0
3254,6,Which T-UCRs have been implicated in lung cancer?,Above results suggested that uc.454 played a suppressive role in LC.,0
3254,7,Which T-UCRs have been implicated in lung cancer?,"Heat shock protein family A member 12B (HSPA12B) protein was negatively regulated by uc.454 at the posttranscriptional level by dual-luciferase reporter assay and affected the expressions of Bcl-2 family members, which finally induced LC apoptosis.",0
3254,8,Which T-UCRs have been implicated in lung cancer?,"The uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target for lung carcinoma.",0
3254,9,Which T-UCRs have been implicated in lung cancer?,Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.,0
3254,10,Which T-UCRs have been implicated in lung cancer?,The transcribed ultraconserved regions (T-UCRs) encode long non-coding RNAs implicated in human carcinogenesis.,0
3254,11,Which T-UCRs have been implicated in lung cancer?,Their mechanisms of action and the factors regulating their expression in cancers are poorly understood.,0
3254,12,Which T-UCRs have been implicated in lung cancer?,Here we show that high expression of uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients.,0
3254,13,Which T-UCRs have been implicated in lung cancer?,We provide evidence from cell lines and primary samples that TP53 directly regulates uc.339.,0
3254,14,Which T-UCRs have been implicated in lung cancer?,"We find that transcribed uc.339 is upregulated in archival NSCLC samples, functioning as a decoy RNA for miR-339-3p, -663b-3p, and -95-5p.",1
3254,15,Which T-UCRs have been implicated in lung cancer?,"As a result, Cyclin E2, a direct target of all these microRNAs is upregulated, promoting cancer growth and migration.",1
3254,16,Which T-UCRs have been implicated in lung cancer?,"Finally, we find that modulation of uc.339 affects microRNA expression.",0
3254,17,Which T-UCRs have been implicated in lung cancer?,"However, overexpression or downregulation of these microRNAs causes no significant variations in uc.339 levels, suggesting a type of interaction for uc.339 that we call ""entrapping"".",0
3254,18,Which T-UCRs have been implicated in lung cancer?,Our results support a key role for uc.339 in lung cancer.,0
3254,19,Which T-UCRs have been implicated in lung cancer?,Our results support a key role for uc.339 in lung cancer.,0
3254,20,Which T-UCRs have been implicated in lung cancer?,Here we show that high expression of uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients.,0
3254,21,Which T-UCRs have been implicated in lung cancer?,"The uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target for lung carcinoma.",0
3254,22,Which T-UCRs have been implicated in lung cancer?,Above results suggested that uc.454 played a suppressive role in LC.,0
3254,23,Which T-UCRs have been implicated in lung cancer?,"The uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target for lung carcinoma.",0
3254,24,Which T-UCRs have been implicated in lung cancer?,"We found that uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454 is associated with tumor size and tumors with more advanced stages.",1
3254,25,Which T-UCRs have been implicated in lung cancer?,Transfection with uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines.,0
3254,26,Which T-UCRs have been implicated in lung cancer?,Our results support a key role for uc.339 in lung cancer.,0
3254,27,Which T-UCRs have been implicated in lung cancer?,Here we show that high expression of uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients.,0
145,0,Are there drugs for Tick-borne Encephalitis?, tick-borne encephalitis (TBE) have been detected in Bulgaria.,1
145,1,Are there drugs for Tick-borne Encephalitis?,"Considering the remarkable increase in TBE morbidity in Europe over the past two decades, we conducted a study of TBE among patients with acute viral meningitis who were hospitalised in Bulgaria during 2009 to 2012.",1
145,2,Are there drugs for Tick-borne Encephalitis?,"Viruses belonging to the Flaviviridae family primarily spread through arthropod vectors, and are the major causes of illness and death around the globe.",1
145,3,Are there drugs for Tick-borne Encephalitis?,"The Flaviviridae family consists of 3 genera which include the Flavivirus genus (type species, yellow fever virus) as the largest genus, the Hepacivirus (type species, hepatitis C virus) and the Pestivirus (type species, bovine virus diarrhea).",1
145,4,Are there drugs for Tick-borne Encephalitis?,The flaviviruses (Flavivirus genus) are small RNA viruses transmitted by mosquitoes and ticks that take over host cell machinery in order to propagate.,0
145,5,Are there drugs for Tick-borne Encephalitis?,"However, hepaciviruses and pestiviruses are not antropod-borne.",0
145,6,Are there drugs for Tick-borne Encephalitis?,"Despite the extensive research and public health concern associated with flavivirus diseases, to date, there is no specific treatment available for any flavivirus infections, though commercially available vaccines for yellow fever, Japanese encephalitis and tick-born encephalitis exist.",1
2816,0,"What are the ""Ohnologs""?","Paralogs retained from WGD, also coined 'ohnologs' after Susumu Ohno, have been shown to be typically associated with development, signaling and gene regulation.",1
2816,1,"What are the ""Ohnologs""?","Ohnologs -paralogous gene pairs generated by whole genome duplication- are enriched for dosage sensitive genes, that is, genes that have a phenotype due to copy number changes",1
2816,2,"What are the ""Ohnologs""?","Ohnologs are paralogs stemming from such genome duplication events, and some zebrafish genes said to be ""novel"" are more appropriately interpreted as ""ohnologs gone missing"", cases in which ohnologs are preserved differentially in different evolutionary lineages.",1
2816,3,"What are the ""Ohnologs""?","Copy number variations are distributed non-randomly in vertebrate genomes, and it was recently reported that ohnologs, which are duplicated genes derived from whole genome duplication, are refractory to copy number variations.",1
2994,0,What 2 biological processes are regulated by STAMP2 in adipocytes?,"Recently, we found that Stamp2 has a critical role in the integration of inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues.",1
2994,1,What 2 biological processes are regulated by STAMP2 in adipocytes?,we identified the six-transmembrane protein STAMP2 as a critical modulator of this integrated response system of inflammation and metabolism in adipocytes.,1
2994,2,What 2 biological processes are regulated by STAMP2 in adipocytes?,Six transmembrane protein of prostate 2 (STAMP2) is a counterregulator of adipose inflammation and insulin resistance in mice.,1
2994,3,What 2 biological processes are regulated by STAMP2 in adipocytes?,"Recently, we found that Stamp2 has a critical role in the integration of inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues.",1
2994,4,What 2 biological processes are regulated by STAMP2 in adipocytes?,"These results suggest that Stamp1 and Stamp2 play critical roles in adipogenesis, but through different mechanisms.",0
2994,5,What 2 biological processes are regulated by STAMP2 in adipocytes?,"CONTEXT
Six transmembrane protein of prostate 2 (STAMP2) is a counterregulator of adipose inflammation and insulin resistance in mice.",0
2994,6,What 2 biological processes are regulated by STAMP2 in adipocytes?,"These results suggest that STAMP2 is crucial for normal ASC conversion into adipocytes and their metabolic function, as well as their ability to facilitate PCa growth in vivo.",0
2994,7,What 2 biological processes are regulated by STAMP2 in adipocytes?,"We report that Stamp2 is expressed in human and mouse macrophages, is regulated upon differentiation or activation, acts as an anti-inflammatory protein, and regulates foam cell formation.",0
2994,8,What 2 biological processes are regulated by STAMP2 in adipocytes?,CONTEXT Six-transmembrane protein of prostate 2 (STAMP2) is a counter-regulator of inflammation and insulin resistance according to findings in mice.,1
2994,9,What 2 biological processes are regulated by STAMP2 in adipocytes?,"Taken together, TIARP/STAMP2 is highly upregulated in 3T3-L1 cells and hMSC-Ad by IL-1beta and might, therefore, modulate proinflammatory and insulin resistance-inducing effects of IL-1beta.<br>",0
2994,10,What 2 biological processes are regulated by STAMP2 in adipocytes?,<b>CONTEXT</b>: Six transmembrane protein of prostate 2 (STAMP2) is a counterregulator of adipose inflammation and insulin resistance in mice.,0
2994,11,What 2 biological processes are regulated by STAMP2 in adipocytes?,"Our hypothesis was that STAMP2 could be involved in human obesity and insulin resistance.<br><b>OBJECTIVE</b>: The objective of the study was to elucidate the role of adipose STAMP2 expression in human obesity and insulin resistance.<br><b>DESIGN</b>: The design was to quantify STAMP2 in human abdominal sc and omental white adipose tissue (WAT), isolated adipocytes, and stroma and in vitro differentiated preadipocytes and relate levels of STAMP2 in sc WAT to clinical and adipocyte phenotypes involved in insulin resistance.<br><b>PARTICIPANTS</b>: Nonobese and obese women and men (n = 236) recruited from an obesity clinic or through local advertisement.<br><b>MAIN OUTCOME MEASUREMENT</b>: Clinical measures included body mass index, body fat, total adiponectin, and homeostasis model assessment as measure of overall insulin resistance.",0
2994,12,What 2 biological processes are regulated by STAMP2 in adipocytes?,"Taken together, TIARP/STAMP2 is highly upregulated in 3T3-L1 cells and hMSC-Ad by IL-1beta and might, therefore, modulate proinflammatory and insulin resistance-inducing effects of IL-1beta.",0
1633,0,What are the major classes of retrotransposons active in the human genome?,"Half of the human genome is composed of repeated DNA, and some types are mobile within our genome (transposons and retrotransposons).",0
1633,1,What are the major classes of retrotransposons active in the human genome?,"Despite their abundance, only a small fraction of them are currently active in our genome (Long Interspersed Element-1 (LINE-1), Alu, and SVA elements).",1
1633,2,What are the major classes of retrotransposons active in the human genome?,"Since certain types of retrotransposons, particularly members of the Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity/polymorphism",1
1633,3,What are the major classes of retrotransposons active in the human genome?,"Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1,000,000 copies in the human genome",1
1633,4,What are the major classes of retrotransposons active in the human genome?,"1 and Alu represent the most prolific human LINE and SINE families, respectively.",1
1633,5,What are the major classes of retrotransposons active in the human genome?,"Only a few Alu elements are able to retropose, and the factors determining their retroposition capacity are poorly understood.",1
2977,0,What is anophthalmia?,"Microphthalmia, anophthalmia are the malformations of the eye, referring to a congenital absence, and a reduced size of the eyeball.",1
2977,1,What is anophthalmia?,Anophthalmia is the congenital absence of ocular tissue from the orbit.,1
2977,2,What is anophthalmia?,Anophthalmia is a condition of the absence of an eye and the presence of a small eye within the orbit.,1
2977,3,What is anophthalmia?,Congenital anophthalmia is a rare eye anomaly which lacks a recognizable eye in the orbit.,0
2977,4,What is anophthalmia?,"SOX2 anophthalmia syndrome is an uncommon autosomal dominant syndrome caused by mutations in the SOX2 gene and clinically characterized by severe eye malformations (anophthalmia/microphthalmia) and extraocular anomalies mainly involving brain, esophagus, and genitalia.",0
2977,5,What is anophthalmia?,"Introduction
Anophthalmia is congenital absence of the eyes; it may be unilateral or bilateral.",0
2977,6,What is anophthalmia?,Clinical anophthalmia is a rare inherited disease of the eye and phenotype refers to the absence of ocular tissue in the orbit of eye.,1
2977,7,What is anophthalmia?,Introduction Anophthalmia is congenital absence of the eyes; it may be unilateral or bilateral.,1
2977,8,What is anophthalmia?,"BACKGROUND Developmental eye anomalies, which include anophthalmia (absent eye) or microphthalmia (small eye) are an important cause of severe visual impairment in infants and young children.",0
2977,9,What is anophthalmia?,Anophthalmia is a rare eye development anomaly resulting in absent ocular globes or tissue in the orbit since birth.,0
1082,0,Are there any Decision support systems for chronic pain management ?,a project to operationalize the 2003 VA/DOD Clinical Practice Guideline for Opioid Therapy for Chronic Non-Cancer Pain into a computerized decision support system (DSS),1
1082,1,Are there any Decision support systems for chronic pain management ?,We based the DSS on the existing ATHENA-DSS,0
1082,2,Are there any Decision support systems for chronic pain management ?,Use of this iterative process led to development of a multifunctional DSS,0
1082,3,Are there any Decision support systems for chronic pain management ?,interactive decision dashboard format,0
1082,4,Are there any Decision support systems for chronic pain management ?,"We created a computerized, interactive clinical decision dashboard",0
1082,5,Are there any Decision support systems for chronic pain management ?,Interactive decision dashboards can be adapted for clinical use and have the potential to foster informed decision making.,0
1082,6,Are there any Decision support systems for chronic pain management ?,Clinical decision support systems are promising tools for improving behavioral medicine care for chronic pain.,1
1082,7,Are there any Decision support systems for chronic pain management ?,Improving Patient Safety Using ATHENA-Decision Support System Technology:,1
1082,8,Are there any Decision support systems for chronic pain management ?,ATHENA-DSS is an automated decision support system developed in a collaboration between Stanford University and the U.S. Department of Veterans Affairs (VA) to increase guideline-adherent prescribing and to change physician behavior.,0
1082,9,Are there any Decision support systems for chronic pain management ?,The use of a computer-based decision support system facilitates primary care physicians' management of chronic pain.,1
1082,10,Are there any Decision support systems for chronic pain management ?,The use of a CBDS system may improve the ability of PCPs to manage chronic pain and may also facilitate screening of consults to optimize specialist utilization.,1
1225,0,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,Growth phase-dependent regulation of Vsr endonuclease,1
1225,1,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,Vsr endonuclease levels are growth phase dependent.,1
1225,2,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,Growth phase-dependent regulation of Vsr endonuclease may contribute to 5-methylcytosine mutational hot spots in Escherichia coli.,1
1225,3,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,"Using rabbit polyclonal antibodies, we have shown that the Dcm cytosine methylase of Escherichia coli is maintained at a constant level during cell growth, while Vsr endonuclease levels are growth phase dependent.",1
1225,4,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,"Vsr endonuclease, which initiates very short patch repair, has been hypothesized to regulate mutation in stationary-phase cells.",0
1225,5,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,The efficiency of the two pathways changes during the bacterial life cycle; MMR is more efficient during exponential growth and VSP repair is more efficient during the stationary phase.,0
1225,6,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,"Overexpression of Vsr does dramatically increase the stationary-phase reversion of a Lac- frameshift allele, but the absence of Vsr has no effect.",0
1225,7,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,"Using rabbit polyclonal antibodies, we have shown that the Dcm cytosine methylase of Escherichia coli is maintained at a constant level during cell growth, while Vsr endonuclease levels are growth phase dependent",1
1225,8,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,The efficiency of the two pathways changes during the bacterial life cycle; MMR is more efficient during exponential growth and VSP repair is more efficient during the stationary phase,0
1225,9,Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?,"Vsr endonuclease, which initiates very short patch repair, has been hypothesized to regulate mutation in stationary-phase cells",0
1415,0,What hand deformities do patients with Apert syndrome present with?,"Five patients, ranging from Upton type 1 to type 3 Apert hand deformities, have had preoperative computed tomography angiography that delineated the vascular anatomy.",0
1415,1,What hand deformities do patients with Apert syndrome present with?,This allowed planning and execution of a single-stage syndactyly release in all patients.,0
1415,2,What hand deformities do patients with Apert syndrome present with?,The protocol presented allows preoperative planning and single-stage operation for complete release of syndactyly in patients with Apert syndrome.,0
1415,3,What hand deformities do patients with Apert syndrome present with?,"In patients with Apert syndrome, the hands demonstrate many disturbances of soft tissue and bony structures.",1
1415,4,What hand deformities do patients with Apert syndrome present with?,"These include a short thumb with radial clinodactyly, complex syndactyly with a bony fusion involving the index, long and ring fingers, symphalangism and simple syndactyly of the fourth web space.",1
1415,5,What hand deformities do patients with Apert syndrome present with?,"The soft tissue anomalies involve the intrinsic muscles, the extrinsic tendon insertions and the neurovascular bundles.",1
1415,6,What hand deformities do patients with Apert syndrome present with?,Two of the patients had Apert syndrome (syndromic craniosynostosis with symmetrical syndactyly) and two had polydactyly.,0
1415,7,What hand deformities do patients with Apert syndrome present with?,"The overall strategy involved early bilateral separation of syndactylous border digits at 1 year of age, followed by sequential unilateral middle syndactyly mass separation with thumb osteotomy and bone grafting as needed.",0
1415,8,What hand deformities do patients with Apert syndrome present with?,"In these 10 patients, a total of 53 web spaces were released, 49 of which involved osteotomies for complex syndactyly.",0
1415,9,What hand deformities do patients with Apert syndrome present with?,"Apert syndrome, characterised by craniosynostosis, craniofacial anomalies, and symmetrical syndactyly of the digits (cutaneous and bony fusion), has been associated with two canonical mutations in the FGFR2 gene (S252W, P253R) in the great majority of cases.",1
1415,10,What hand deformities do patients with Apert syndrome present with?,"The Apert syndrome hand demonstrates many typical clinical features including syndactyly, symbrachyphalangism, and growth disturbances.",0
1415,11,What hand deformities do patients with Apert syndrome present with?,"In Apert syndrome, characterised by syndactyly of the hands and feet, recurrent mutations of a serine-proline dipeptide (either Ser252Trp or Pro253Arg) in the linker between the IgII and IgIII extracellular immunoglobulin-like domains, have been documented in more than 160 unrelated individuals.",1
1415,12,What hand deformities do patients with Apert syndrome present with?,urgical correction of syndactyly of the Apert hand should begin by 6 months and be completed by 3 years of age.,0
1415,13,What hand deformities do patients with Apert syndrome present with?,As much surgery as possible is carried out at each sitting.,0
1415,14,What hand deformities do patients with Apert syndrome present with?,"The syndactyly cases were more complicated than the average, among them 4 cases of Apert syndrome were noted.",0
3835,0,Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?,A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome.,1
3835,1,Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?,"To investigate if specific exon 38 or 39 KMT2D missense variants (MVs) cause a condition distinct from Kabuki syndrome type 1 (KS1).METHODS: Multiple individuals, with MVs in exons 38 or 39 of KMT2D that encode a highly conserved region of 54 amino acids flanked by Val3527 and Lys3583, were identified and phenotyped.",1
3835,2,Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?,"Functional tests were performed to study their pathogenicity and understand the disease mechanism.RESULTS: The consistent clinical features of the affected individuals, from seven unrelated families, included choanal atresia, athelia or hypoplastic nipples, branchial sinus abnormalities, neck pits, lacrimal duct anomalies, hearing loss, external ear malformations, and thyroid abnormalities.",0
3835,3,Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?,None of the individuals had intellectual disability.,0
3835,4,Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?,"The frequency of clinical features, objective software-based facial analysis metrics, and genome-wide peripheral blood DNA methylation patterns in these patients were significantly different from that of KS1.",1
3835,5,Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?,Circular dichroism spectroscopy indicated that these MVs perturb KMT2D secondary structure through an increased disordered to ɑ-helical transition.CONCLUSION: KMT2D MVs located in a specific region spanning exons 38 and 39 and affecting highly conserved residues cause a novel multiple malformations syndrome distinct from KS1.,1
3835,6,Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?,"Unlike KMT2D haploinsufficiency in KS1, these MVs likely result in disease through a dominant negative mechanism.",1
3037,0,Are there graph kernel libraries available implemented in JAVA?,graphkernels: R and Python packages for graph comparison.,0
3037,1,Are there graph kernel libraries available implemented in JAVA?,"Measuring the similarity of graphs is a fundamental step in the analysis of graph-structured data, which is omnipresent in computational biology.",1
3037,2,Are there graph kernel libraries available implemented in JAVA?,Graph kernels have been proposed as a powerful and efficient approach to this problem of graph comparison.,1
3037,3,Are there graph kernel libraries available implemented in JAVA?,"Here we provide graphkernels, the first R and Python graph kernel libraries including baseline kernels such as label histogram based kernels, classic graph kernels such as random walk based kernels, and the state-of-the-art Weisfeiler-Lehman graph kernel.",1
3037,4,Are there graph kernel libraries available implemented in JAVA?,The core of all graph kernels is implemented in C ++ for efficiency.,1
3037,5,Are there graph kernel libraries available implemented in JAVA?,"Using the kernel matrices computed by the package, we can easily perform tasks such as classification, regression and clustering on graph-structured samples.",1
3296,0,Which graph database is used by the Reactome graph database?,"Reactome is a free, open-source, open-data, curated and peer-reviewed knowledgebase of biomolecular pathways.",0
3296,1,Which graph database is used by the Reactome graph database?,One of its main priorities is to provide easy and efficient access to its high quality curated data.,0
3296,2,Which graph database is used by the Reactome graph database?,"At present, biological pathway databases typically store their contents in relational databases.",0
3296,3,Which graph database is used by the Reactome graph database?,This limits access efficiency because there are performance issues associated with queries traversing highly interconnected data.,0
3296,4,Which graph database is used by the Reactome graph database?,The same data in a graph database can be queried more efficiently.,0
3296,5,Which graph database is used by the Reactome graph database?,Here we present the rationale behind the adoption of a graph database (Neo4j) as well as the new ContentService (REST API) that provides access to these data.,0
3296,6,Which graph database is used by the Reactome graph database?,"The Neo4j graph database and its query language, Cypher, provide efficient access to the complex Reactome data model, facilitating easy traversal and knowledge discovery.",1
3296,7,Which graph database is used by the Reactome graph database?,"The adoption of this technology greatly improved query efficiency, reducing the average query time by 93%.",1
3296,8,Which graph database is used by the Reactome graph database?,"The web service built on top of the graph database provides programmatic access to Reactome data by object oriented queries, but also supports more complex queries that take advantage of the new underlying graph-based data storage.",1
3296,9,Which graph database is used by the Reactome graph database?,By adopting graph database technology we are providing a high performance pathway data resource to the community.,0
3296,10,Which graph database is used by the Reactome graph database?,The Reactome graph database use case shows the power of NoSQL database engines for complex biological data types.,0
3296,11,Which graph database is used by the Reactome graph database?,"The Neo4j graph database and its query language, Cypher, provide efficient access to the complex Reactome data model, facilitating easy traversal and knowledge discovery.",1
3296,12,Which graph database is used by the Reactome graph database?,"The Neo4j graph database and its query language, Cypher, provide efficient access to the complex Reactome data model, facilitating easy traversal and knowledge discovery.",1
688,0,Is Ctf4 involved in sister chromatid cohesion establishment?,"In addition to Eco1, several other factors contribute to cohesion establishment, including Ctf4, Ctf18, Tof1, Csm3, Chl1 and Mrc1, but little is known about their roles.",0
688,1,Is Ctf4 involved in sister chromatid cohesion establishment?,"Here, we show that each of these factors facilitates cohesin acetylation.",0
688,2,Is Ctf4 involved in sister chromatid cohesion establishment?,"Moreover, the absence of Ctf4 and Chl1, but not of the other factors, causes a synthetic growth defect in cells lacking Eco1.",0
688,3,Is Ctf4 involved in sister chromatid cohesion establishment?,"Distinct from acetylation defects, sister chromatid cohesion in ctf4Δ and chl1Δ cells is not improved by removing Wapl",0
688,4,Is Ctf4 involved in sister chromatid cohesion establishment?,"Thus, Ctf4 and Chl1 delineate an additional acetylation-independent pathway that might hold important clues as to the mechanism of sister chromatid cohesion establishment",0
688,5,Is Ctf4 involved in sister chromatid cohesion establishment?,"Genetic analyses revealed that Rmi1 promoted sister chromatid cohesion in a process that was distinct from both the cohesion establishment pathway involving Ctf4, Csm3, and Chl1",0
688,6,Is Ctf4 involved in sister chromatid cohesion establishment?,Influence of the human cohesion establishment factor Ctf4/AND-1,0
688,7,Is Ctf4 involved in sister chromatid cohesion establishment?," Here, we used Xenopus egg extracts to show that AND-1 and Tim1-Tipin, homologues of Saccharomyces cerevisiae Ctf4 and Tof1-Csm3, respectively, are associated with the replisome and are required for proper establishment of the cohesion observed in the M-phase extracts",1
688,8,Is Ctf4 involved in sister chromatid cohesion establishment?,"These data defined two cohesion pathways, one containing CSM3, TOF1, CTF4, and CHL1, and the second containing MRC1, CTF18, CTF8, and DCC1",0
688,9,Is Ctf4 involved in sister chromatid cohesion establishment?,Our results suggest that Chl1 and Ctf4 are directly involved in homologous recombination repair rather than acting indirectly via the establishment of sister chromatid cohesion,0
688,10,Is Ctf4 involved in sister chromatid cohesion establishment?,"Here we show that three proteins required for sister chromatid cohesion, Eco1, Ctf4, and Ctf18, are found at, and Ctf4 travels along chromosomes with, replication forks",0
688,11,Is Ctf4 involved in sister chromatid cohesion establishment?,"WSS1 was also found to interact genetically with SGS1, TOP3, SRS2 and CTF4, which are involved in recombination, repair of replication forks and the establishment of sister chromatid cohesion",0
688,12,Is Ctf4 involved in sister chromatid cohesion establishment?,"The catalytic subunit of budding yeast Polalpha (Pol1p) has been shown to associate in vitro with the Spt16p-Pob3p complex, a component of the nucleosome reorganization system required for both replication and transcription, and with a sister chromatid cohesion factor, Ctf4p",0
688,13,Is Ctf4 involved in sister chromatid cohesion establishment?,"Constituents of the replication fork, such as the DNA polymerase alpha-binding protein Ctf4, contribute to cohesion in ways that are poorly understood",0
688,14,Is Ctf4 involved in sister chromatid cohesion establishment?,"Genetic analyses revealed that Rmi1 promoted sister chromatid cohesion in a process that was distinct from both the cohesion establishment pathway involving Ctf4, Csm3, and Chl1 and the pathway involving the acetylation of Smc3.",0
688,15,Is Ctf4 involved in sister chromatid cohesion establishment?,Our results suggest that Chl1 and Ctf4 are directly involved in homologous recombination repair rather than acting indirectly via the establishment of sister chromatid cohesion.,0
688,16,Is Ctf4 involved in sister chromatid cohesion establishment?,Ctf4/AND-1 is a highly conserved gene product required for both DNA replication and the establishment of sister chromatid cohesion.,1
688,17,Is Ctf4 involved in sister chromatid cohesion establishment?,"Here we show that three proteins required for sister chromatid cohesion, Eco1, Ctf4, and Ctf18, are found at, and Ctf4 travels along chromosomes with, replication forks.",0
688,18,Is Ctf4 involved in sister chromatid cohesion establishment?,"Sister-chromatid cohesion mediated by the alternative RF-CCtf18/Dcc1/Ctf8, the helicase Chl1 and the polymerase-alpha-associated protein Ctf4 is essential for chromatid disjunction during meiosis II.",1
688,19,Is Ctf4 involved in sister chromatid cohesion establishment?,Saccharomyces cerevisiae CTF18 and CTF4 are required for sister chromatid cohesion.,1
688,20,Is Ctf4 involved in sister chromatid cohesion establishment?,We find that absence of either CTF4 or CTF18 causes sister chromatid cohesion failure and leads to a preanaphase accumulation of cells that depends on the spindle assembly checkpoint.,0
688,21,Is Ctf4 involved in sister chromatid cohesion establishment?,"We show here that CTF8, CTF4 and a helicase encoded by CHL1 are required for efficient sister chromatid cohesion in unperturbed mitotic cells, and provide evidence that Chl1 functions during S-phase.",0
688,22,Is Ctf4 involved in sister chromatid cohesion establishment?,"In budding yeast, a specialized replication factor C called RF-C(Ctf18/Dcc1/Ctf8) and the DNA-polymerase-alpha-associated protein Ctf4 are required to maintain sister-chromatid cohesion in cells arrested for long periods in mitosis.",0
688,23,Is Ctf4 involved in sister chromatid cohesion establishment?,"The physical and genetic interactions between CTF4, CTF18, and core components of replication fork complexes observed in this study and others suggest that both gene products act in association with the replication fork to facilitate sister chromatid cohesion.",0
688,24,Is Ctf4 involved in sister chromatid cohesion establishment?,Our results suggest that Chl1 and Ctf4 are directly involved in homologous recombination repair rather than acting indirectly via the establishment of sister chromatid cohesion.,0
688,25,Is Ctf4 involved in sister chromatid cohesion establishment?,"Thus, Ctf4 and Chl1 delineate an additional acetylation-independent pathway that might hold important clues as to the mechanism of sister chromatid cohesion establishment.",0
688,26,Is Ctf4 involved in sister chromatid cohesion establishment?,"Thus, Ctf4 and Chl1 delineate an additional acetylation-independent pathway that might hold important clues as to the mechanism of sister chromatid cohesion establishment.",0
688,27,Is Ctf4 involved in sister chromatid cohesion establishment?,Ctf4/AND-1 is a highly conserved gene product required for both DNA replication and the establishment of sister chromatid cohesion,1
688,28,Is Ctf4 involved in sister chromatid cohesion establishment?,"Genetic analyses revealed that Rmi1 promoted sister chromatid cohesion in a process that was distinct from both the cohesion establishment pathway involving Ctf4, Csm3, and Chl1 and the pathway involving the acetylation of Smc3",0
688,29,Is Ctf4 involved in sister chromatid cohesion establishment?,Establishment of sister chromatid cohesion at the S. cerevisiae replication fork.,0
2413,0,Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017),Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON),1
2413,1,Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017),Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.,1
2413,2,Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017),Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.,1
176,0,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,"Hirschsprung's disease (HSCR), also known as aganglionic megacolon, derives from a congenital malformation of the enteric nervous system (ENS).",0
176,1,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,This severe congenital condition is caused by the absence of colonic neural ganglia and thus lack of intrinsic innervation of the colon due in turn to improper colonization of the developing intestines by ENS progenitor cells.,1
176,2,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerve plexuses of the lower colon.,0
176,3,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,"Hirschsprung disease (HSCR, aganglionic megacolon) is a common congenital malformation leading to bowel obstruction, with an incidence of 1/5,000 live births.",0
176,4,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,It is characterized by the absence of intrinsic ganglion cells in the myenteric and submucosal plexuses along variable lengths of the gastrointestinal tract.,1
176,5,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder associated with the absence of intrinsic ganglion cells in the distal gastrointestinal tract.,1
176,6,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerve plexuses of the lower colon.,0
176,7,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerve plexuses of the lower colon.,0
176,8,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung's disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerves forming the plexus of the lower intestine.,0
176,9,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is an inherited disorder characterised by absence of intrinsic ganglion cells in the distal gastrointestinal tract.,0
176,10,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,"Hirschsprung disease (HSCR) is a frequent congenital disorder (1 in 5,000 newborns) of unknown origin characterized by the absence of parasympathetic intrinsic ganglion cells of the hindgut.",0
176,11,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a neurocristopathy characterized by the absence of parasympathetic intrinsic ganglion cells in the submucosal and myenteric plexuses along a variable portion of the intestinal tract.,1
176,12,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,BACKGROUND: Hirschsprungs Disease (HD) is a developmental disorder of enteric nervous system characterised by the absence of ganglion cells in submucosal (Meissners) and myenteric (Aurbachs) plexuses of distal bowel.,0
176,13,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung's disease is an inherited disorder characterized by the absence of ganglion cells in the distal bowel.,0
176,14,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disease characterized by the absence of ganglion cells in various length of distal digestive tract,0
176,15,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder associated with the absence of intrinsic ganglion cells in the distal gastrointestinal tract,0
176,16,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,"Hirschsprung's disease (HSCR) is a congenital intestinal disease, characterized by the absence of ganglion cells in the distal portion of the intestinal tract",0
176,17,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder characterized by the absence of intramural ganglion cells along with variable lengths of the gastrointestinal tract,0
176,18,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerve plexuses of the lower colon,0
176,19,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerve plexuses of the lower colon,0
176,20,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung's disease (HSCR) is a congenital disorder characterized by an absence of intrinsic ganglion cells in the nerves forming the plexus of the lower intestine,0
176,21,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,"Hirschsprung disease (HSCR) is a frequent congenital disorder (1 in 5,000 newborns) of unknown origin characterized by the absence of parasympathetic intrinsic ganglion cells of the hindgut",0
176,22,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a neurocristopathy characterized by the absence of parasympathetic intrinsic ganglion cells in the submucosal and myenteric plexuses along a variable portion of the intestinal tract,1
176,23,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is an inherited disorder characterised by absence of intrinsic ganglion cells in the distal gastrointestinal tract,0
176,24,Which disease is characterized by congenital absence of intrinsic ganglion cells of the gastrointestinal tract?,Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of ganglion cells in the nerve plexuses of the lower digestive tract,0
3444,0,Does ProSavin use an adenoviral vector?,"Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease.",1
3444,1,Does ProSavin use an adenoviral vector?,"ProSavin, a lentiviral vector based gene therapy that delivers local and continuous dopamine, was previously shown to be well tolerated in a Phase I/II first-in-human study, with significant improvements in motor behavior from baseline at 1 year.",1
2603,0,"What is the ""protein inference problem""?"," the protein inference problem still hampers the automatic assignment of peptide sequences to proteins, consequently impeding the quantification of sequence variants.",1
2603,1,"What is the ""protein inference problem""?",the protein inference problem can be regarded as a special protein quantification problem in the sense that truly present proteins are those proteins whose abundance values are not zero.,1
2603,2,"What is the ""protein inference problem""?",Protein inference is an important issue in proteomics research.,1
2603,3,"What is the ""protein inference problem""?",Its main objective is to select a proper subset of candidate proteins that best explain the observed peptides.,0
2603,4,"What is the ""protein inference problem""?","Assembling peptides identified from tandem mass spectra into a list of proteins, referred to as protein inference, is an important issue in shotgun proteomics.",1
2603,5,"What is the ""protein inference problem""?","A major challenge in shotgun proteomics has been the assignment of identified peptides to the proteins from which they originate, referred to as the protein inference problem.",1
1919,0,Where is the proteasome located?,Cellular regulation by UPS- mediated protein degradation is a highly specific and selective process that depends on time (e.g.,0
1919,1,Where is the proteasome located?,"cell cycle) and location (nucleus, mitochondria or endoplasmic reticulum).",1
1919,2,Where is the proteasome located?,"In eukaryotic cells, regulated protein degradation of intracellular proteins is mediated largely by the ubiquitin proteasome system (UPS).",0
1919,3,Where is the proteasome located?,"We followed two key parameters of this process: the distribution of proteasomes in nuclear and cytosolic compartments, and the formation of cytoplasmic aggregate-like structures called proteasome storage granules (PSGs).",1
1919,4,Where is the proteasome located?,"Subsequently, cellular distribution of the PAI-2·proteasome complexes was established by immunogold staining and electron microscopy analyses.",0
1919,5,Where is the proteasome located?,"As judged by confocal microscopy, both proteins appeared in a diffuse cytosolic pattern, but they also could be found in a dense perinuclear and nuclear location.",1
1919,6,Where is the proteasome located?, Frequently ubiquitinated proteins are targeted to the proteasome for degradation in the cytosol.,0
1919,7,Where is the proteasome located?," More recently, proteasome-mediated degradation of cell cycle regulatory proteins, production and loading of antigenic peptides onto HLA molecules, and transient homing of diverse virion proteins required for entry and/or egress have been shown to be coordinated at the centrosome.",1
1919,8,Where is the proteasome located?,We conclude that N-terminal sequences of Wld(S) protein influence the intranuclear location of both ubiquitin proteasome and NAD(+) synthesis machinery and that an evolutionary recent sequence mediates binding of mammalian Ube4b to VCP.,0
1919,9,Where is the proteasome located?,"Two new forms of proteasomes, designated as the endoplasmic reticulum (ER) membrane-associated proteasome (ERa proteasome) and ER membrane-bound proteasome (ERb proteasome), were purified to homogeneity from 0.0125 and 2.5% sodium cholate extracts, respectively, of a rat liver microsomal fraction.",0
1919,10,Where is the proteasome located?,"The proteasome is a large multicatalytic, proteinase complex located in the cytosol and the nucleus of eukaryotic cells.",0
1919,11,Where is the proteasome located?,Subcellular distribution of proteasomes implicates a major location of protein degradation in the nuclear envelope-ER network in yeast.,0
1919,12,Where is the proteasome located?,"JAB1, which is thought to bind p27KIP1 and transport it from the nucleus to the cytoplasm for proteasome/ubiquitin-mediated degradation, was found to be localized both in the cytoplasm and the nucleus in undifferentiated and differentiating tumors whereas located predominantly in the nucleus of differentiated tumor cells.",1
1919,13,Where is the proteasome located?,"20S proteasomes are present in all areas where ATPase subunits are detected, consistent with the presence of intact 26S proteasomes.",0
1919,14,Where is the proteasome located?,Inhibition of proteasomes located in axons resulted in an accumulation of ubiquitinated proteins in these axons.,0
1919,15,Where is the proteasome located?,All these observations indicate that the mouse sperm proteasome participates in the binding to the zona pellucida and the acrosome reaction and that there is a pool of proteasomes located on the sperm head..,0
1919,16,Where is the proteasome located?,"Thus, newly synthesized apoB is localized throughout the entire ER and degraded homogeneously, most likely by neighboring proteasomes located on the cytosolic side of the ER membrane.",0
1919,17,Where is the proteasome located?,"While misfolded and short-lived proteins are degraded in proteasomes located in the nucleus and cytoplasm, the degradation of organelles and long-lived proteins in the lysosome occurs by the process of autophagy.",0
1919,18,Where is the proteasome located?,The GFP-tagged proteasomes were located within both the cytoplasm and the nucleus.,0
1919,19,Where is the proteasome located?,Proteasomes are large multicatalytic proteinase complexes located in the cytosol and the nucleus of eukaryotic cells.,0
1919,20,Where is the proteasome located?,"Immunohistochemically, proteasomes (26S) were located in the cytoplasm in normal human muscle, but the staining intensity was weak.",0
1919,21,Where is the proteasome located?,"In DMRV, proteasomes often were located within or on the rim of rimmed vacuoles, and in the cytoplasm of atrophic fibers.",0
675,0,Which multiple kinase inhibitors are used in cancer therapy?,"These inhibitors generally hinder the phosphorylation of several protein kinases of membrane receptors, such as vascular endothelial growth factor receptors, platelet-derived growth factor receptors, the human epidermal growth factor receptor family, and cytoplasmic receptors such as c-Kit, Raf kinase, and FLT3.",1
675,1,Which multiple kinase inhibitors are used in cancer therapy?,"These inhibitors include ZD6474, SU11248, AEE 788, sorafenib, vatalanib, and AG-013736.",1
3948,0,What is the mechanisms of action of pexidartinib?,"A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors.",0
3948,1,What is the mechanisms of action of pexidartinib?,"Background Pexidartinib, a novel, orally administered small-molecule tyrosine kinase inhibitor, has strong selectivity against colony-stimulating factor 1 receptor.",1
3948,2,What is the mechanisms of action of pexidartinib?,The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice.,0
3948,3,What is the mechanisms of action of pexidartinib?,"Colony-stimulating factor 1 (CSF1) controls macrophage differentiation, and here we sought to determine the effect of a CSF1 receptor inhibitor, PLX3397, on adipose tissue macrophage levels and understand the impact on glucose homeostasis in mice.",0
3948,4,What is the mechanisms of action of pexidartinib?,"To address the role of these cells in disease pathogenesis, we depleted microglia from R6/2 mice, a rapidly progressing model of Huntington's disease marked by behavioural impairment, mutant huntingtin (mHTT) accumulation, and early death, through colony-stimulating factor 1 receptor inhibition (CSF1Ri) with pexidartinib (PLX3397) for the duration of disease.",0
3948,5,What is the mechanisms of action of pexidartinib?,Pexidartinib is a CSF1R antagonist that is prescribed for the treatment of tenosynovial giant cell tumors.,0
3948,6,What is the mechanisms of action of pexidartinib?,"Methods: Female MMTV-PyMT mice were treated with pexidartinib, a colony-stimulating factor 1 receptor (CSF1R) inhibitor, to reduce TAM density.",0
3948,7,What is the mechanisms of action of pexidartinib?,"ODS: This was an investigator-initiated, phase I, dose escalation study of the MEK inhibitor binimetinib combined with pexidartinib, a potent inhibitor of CSF1R, KIT, and FLT3, in patients with advanced or metastatic GIST who progressed on imatinib.",0
3948,8,What is the mechanisms of action of pexidartinib?,The,0
3948,9,What is the mechanisms of action of pexidartinib?,We evaluated the recently FDA-approved CSF1R inhibitor Pexidartinib (PLX3397) in OSA cell lines in vitro and in vivo in cell line and patient-derived xenografts.,0
3948,10,What is the mechanisms of action of pexidartinib?,"Pexidartinib (TURALIO™) is an orally administered small molecule tyrosine kinase inhibitor with selective activity against the colony-stimulating factor 1 (CSF1) receptor, KIT proto-oncogene receptor tyrosine kinase (KIT) and FMS-like tyrosine kinase 3 harboring an internal tandem duplication mutation (FLT3-ITD).",1
3948,11,What is the mechanisms of action of pexidartinib?,PURPOSE: Pexidartinib (PLX3397) is a colony-stimulating factor-1 receptor (CSF-1R) inhibitor under clinical evaluation for potential CNS tumor treatment.,1
3948,12,What is the mechanisms of action of pexidartinib?,amics of pexidartinib.,0
3948,13,What is the mechanisms of action of pexidartinib?,Special attention is given to various reported clinical trials of pexidartinib.METHODS: A comprehensive literature search was conducted in the relevant databases to identify studies published in this field during recent years Conclusion: Pexidartinib acts by inhibiting the colony-stimulating factor (CSF1)/CSF1 receptor pathway which leads to inhibition of the cell lines proliferation and promotes the autophosphorylation process,0
3948,14,What is the mechanisms of action of pexidartinib?, tumors.,0
3948,15,What is the mechanisms of action of pexidartinib?,"Pexidartinib, an oral inhibitor of tyrosine kinases including colony stimulating factor 1 receptor (CSF-1R), KIT, and FLT3, is FDA approved in adults with tenosynovial giant ce",0
3948,16,What is the mechanisms of action of pexidartinib?,PURPOSE: Pexidartinib (PLX3397) is a colony-stimulating factor-1 receptor (CSF-1R) inhibitor under clinical evaluation for potential CNS tumor t,1
3948,17,What is the mechanisms of action of pexidartinib?,"Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.",0
3948,18,What is the mechanisms of action of pexidartinib?,"MD simulation indicated (-)-kusunokinin and pexidartinib (P31, a specific CSF1R binding compound) shared some extents of functional similarity in which (-)-kusunokinin bound CSF1R at the juxtamembrane (JM) region with aromatic amino acids similar to pexidartinib using π-π interaction, as well as hydrogen bond.",0
3948,19,What is the mechanisms of action of pexidartinib?,Surgery is standard with no approved systemic therapy.,0
3948,20,What is the mechanisms of action of pexidartinib?,"We aimed to evaluate pexidartinib, a CSF1 receptor inhibitor, in patients with TGCT to provide them with a viable systemic treatment option, especially in cases that are not amenable to surgical resection.",0
3948,21,What is the mechanisms of action of pexidartinib?,"Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.",0
3948,22,What is the mechanisms of action of pexidartinib?,"Purpose: To evaluate the safety, recommended phase II dose (RP2D) and efficacy of pexidartinib, a colony stimulating factor receptor 1 (CSF-1R) inhibitor, in combination with weekly paclitaxel in patients with advanced solid tumors.",0
3948,23,What is the mechanisms of action of pexidartinib?,"Pexidartinib (PLX3397) is a small molecule tyrosine kinase and colony-stimulating factor-1 inhibitor with FDA breakthrough therapy designation for tenosynovial giant-cell tumor, and currently under study in several other tumor types, including breast cancer, non-Hodgkin's lymphoma, and glioblastoma.",1
2321,0,What is the genetic basis of Ohdo syndrome?,Mutations in MED12 cause X-linked Ohdo syndrome,1
2321,1,What is the genetic basis of Ohdo syndrome?,"In the two families, MED12 missense mutations (c.3443G>A [p.Arg1148His] or c.3493T>C [p.Ser1165Pro]) segregating with the phenotype were identified.",1
2321,2,What is the genetic basis of Ohdo syndrome?,"Upon subsequent analysis of an additional cohort of nine simplex male individuals with Ohdo syndrome, one additional de novo missense change (c.5185C>A [p.His1729Asn]) in MED12 was detected.",0
2321,3,What is the genetic basis of Ohdo syndrome?,The occurrence of three different hemizygous missense mutations in three unrelated families affected by Ohdo syndrome MKB type shows that mutations in MED12 are the underlying cause of this X-linked form of Ohdo syndrome.,1
2321,4,What is the genetic basis of Ohdo syndrome?,"FG syndrome, Lujan syndrome, and Ohdo syndrome, the Maat-Kievit-Brunner type, have been described as distinct syndromes with overlapping non-specific features and different missense mutations of the MED12 gene have been reported in all of them.",1
2321,5,What is the genetic basis of Ohdo syndrome?,Parallel sequencing of all X-chromosome exons identified a frameshift mutation (c.5898dupC) of MED12.,0
2321,6,What is the genetic basis of Ohdo syndrome?,"The severe degree of ID in male patients, as well as variable cognitive impairment in heterozygous females suggests that the duplication observed in the present family may have a more severe effect on MED12 function than missense mutations.",0
2321,7,What is the genetic basis of Ohdo syndrome?,"In a cognitively impaired male from this family, who also presented with tall stature and dysmorphism and did not have the MED12 mutation, a 600-kb duplication at 17p13.3 including the YWHAE gene, was found in a mosaic state.",0
2321,8,What is the genetic basis of Ohdo syndrome?," To date, these conditions include Opitz-Kaveggia (FG) syndrome, Lujan syndrome, Ohdo syndrome (Maat-Kievit-Brunner type, or OSMKB), and one large family with profound X-linked intellectual disability due to a novel c.5898insC frameshift mutation that unlike the other three syndromes, resulted in affected female carriers and truncation of the MED12 protein.",0
2321,9,What is the genetic basis of Ohdo syndrome?,"This case lends credence to the evolving theory that the subtypes of Ohdo, and perhaps other MED12 disorders, reflect a spectrum of characteristics, rather than distinct syndromes.",0
2321,10,What is the genetic basis of Ohdo syndrome?,"MED12 [MIM *300188] (mediator complex subunit 12) mutations have been linked to numerous XLID syndromes, including Lujan, FG, and Ohdo, and MED12 is included in many XLID panels.",0
2321,11,What is the genetic basis of Ohdo syndrome?,"Finally, direct sequencing of MED12, the gene mutated in Opitz-Kaveggia syndrome, Lujan-Fryns syndrome and X-linked Ohdo syndrome identified in the two sibs the missense mutation c.3443G>A (p.Arg1148His) inherited from the mother.",0
2321,12,What is the genetic basis of Ohdo syndrome?,Mutations in MED12 cause X-linked Ohdo syndrome.,1
2321,13,What is the genetic basis of Ohdo syndrome?,Beyond Ohdo syndrome: A familial missense mutation broadens the MED12 spectrum.,0
534,0,List inflammatory caspase proteins?," In addition to identifying caspases-4 and -5 as potential targets for limiting intestinal inflammation, this study has identified epithelial-expressed caspases-4 and -5 as biomarkers with diagnostic and therapeutic potential in CRC.",0
534,1,List inflammatory caspase proteins?,"However, the involvement of two related inflammatory caspase members, caspases-4 and -5, during intestinal homeostasis and disease has not yet been established.",0
534,2,List inflammatory caspase proteins?,This study demonstrates that caspases-4 and -5 are involved in IBD-associated intestinal inflammation.,0
534,3,List inflammatory caspase proteins?,"Altered activity of caspases, particularly caspase-1, has been implicated in the development of intestinal diseases, such as inflammatory bowel disease (IBD) and colorectal cancer (CRC)",0
534,4,List inflammatory caspase proteins?,"In contrast, engagement of various PRR in the recently identified inflammasome complexes lead to activation of a cysteine protease, caspase-1.",0
534,5,List inflammatory caspase proteins?,ctivation of inflammatory caspase proteases.,1
534,6,List inflammatory caspase proteins?,"One such caspase, CASPASE-1 (CASP1),",1
534,7,List inflammatory caspase proteins?,Inflammasomes are cytosolic multiprotein complexes assembled by intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and they initiate innate immune responses to invading pathogens and danger signals by activating caspase-1 (ref.,0
534,8,List inflammatory caspase proteins?,1).,0
534,9,List inflammatory caspase proteins?,e activation of inflammasome by different stimuli triggers the proteolytic cleavage of pro-caspase 1 into active caspase 1,0
534,10,List inflammatory caspase proteins?,"Formation of the inflammasome can lead to the activation of inflammatory caspases, such as Caspase-1, which then activate pro-inflammatory cytokines by proteolytic cleavage.",0
534,11,List inflammatory caspase proteins?,inflammatory caspase-1,1
534,12,List inflammatory caspase proteins?,"Human caspase-5 is classified as an inflammatory caspase, although its substrate has not been identified yet.",0
534,13,List inflammatory caspase proteins?,e inflammatory Caspase-1,1
534,14,List inflammatory caspase proteins?,the inflammatory caspase-1,1
534,15,List inflammatory caspase proteins?,"Although it is conventionally regarded as an inflammatory caspase, recent studies have shown that caspase-4 plays a role in induction of apoptosis by endoplasmic reticulum (ER) stress.",0
3501,0,Do MAIT cells have a role in multiple myeloma?,"hus, MAIT cells are reduced in MM patients, which may contribute to disease in these individuals, and moreover, MAIT cells may represent new immunotherapeutic targets for treatment of MM and other malignancies.",1
3501,1,Do MAIT cells have a role in multiple myeloma?,Here we have analysed the frequency and function of MAIT cells in multiple myeloma (MM) patients.,1
3501,2,Do MAIT cells have a role in multiple myeloma?,"We show that MAIT cell frequency in blood is reduced compared to healthy adult donors, but comparable to elderly healthy control donors",0
3501,3,Do MAIT cells have a role in multiple myeloma?,"Newly diagnosed MM patient MAIT cells had reduced IFNγ production and CD27 expression, suggesting an exhausted phenotype, although IFNγ-producing capacity is restored in relapsed/refractory patient samples.",0
3501,4,Do MAIT cells have a role in multiple myeloma?,We describe recent observations with regard to functional exhaustion of iNKT and MAIT cells in MM pathology and discuss the potential application of checkpoint inhibition as an attractive target for prolonged activation of these immunomodulatory T cells in the treatment of MM.,1
3501,5,Do MAIT cells have a role in multiple myeloma?,"Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.",1
3501,6,Do MAIT cells have a role in multiple myeloma?,"Thus, MAIT cells are reduced in MM patients, which may contribute to disease in these individuals, and moreover, MAIT cells may represent new immunotherapeutic targets for treatment of MM and other malignancies.",1
3279,0,Which is the primary interacting protein of BLK?,"n this study, we find that expression of Bik/Blk/Nbk is increased in human airway epithelial cells (AECs [HAECs]) in response to IFNgamma.",0
3279,1,Which is the primary interacting protein of BLK?,"Gene-gene interaction of ATG5, ATG7, BLK and BANK1 in systemic lupus erythematosus.",0
3279,2,Which is the primary interacting protein of BLK?,"Autophagy-related gene 5 (ATG5), ATG7, B-lymphoid tyrosine kinase (BLK) and B-cell scaffold protein with ankyrin repeats 1 (BANK1) are involved in B-cell signaling;",1
3279,3,Which is the primary interacting protein of BLK?,The B cell adaptor protein with ankyrin repeats (BANK1) and the B lymphoid tyrosine kinase (BLK) have been genetically associated with autoimmunity.,1
3279,4,Which is the primary interacting protein of BLK?,The proteins of these genes interact physically and work in concert during B-cell signaling.,0
3279,5,Which is the primary interacting protein of BLK?,Epistatic interaction between BANK1 and BLK in rheumatoid arthritis,0
3279,6,Which is the primary interacting protein of BLK?,"ANK1 and BLK belong to the pleiotropic autoimmune genes; recently, epistasis between BANK1 and BLK was detected in systemic lupus erythematosus.",0
3279,7,Which is the primary interacting protein of BLK?,A,0
3279,8,Which is the primary interacting protein of BLK?,Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK.,1
3279,9,Which is the primary interacting protein of BLK?,The genes BANK1 and BLK were recently described as associated with SLE,1
3279,10,Which is the primary interacting protein of BLK?,"a genetic interaction between BANK1 and BLK, and demonstrates that these molecules interact physically.",1
3133,0,Which malignancies is Keytruda approved for before 2017?,"FDA previously approved Keytruda for treatment of several types of malignancies, such as metastatic melanoma, metastatic non-small-cell lung cancer, recurrent or metastatic head and neck cancer, refractory Hodgkin lymphoma, and urothelial carcinoma, all of which carry positive programmed death-1/programmed death-ligand 1 biomarkers.",1
680,0,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?," (STAT3) is critical for cancer progression by regulating tumor cell survival, proliferation, and angiogenesis.",0
680,1,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"Herein, we investigated the regulation of STAT3 activation and the therapeutic effects of Icaritin, a prenyl flavonoid derivative from Epimedium Genus, in renal cell carcinoma (RCC).",0
680,2,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?," Overall, these results suggest that Icaritin strongly inhibits STAT3 activation and is a potentially effective therapeutic option for the treatment of renal cell carcinoma",0
680,3,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"we have reviewed important signaling pathways that are closely related to radiosensitization, such as cell cycle arrest, tumor angiogenesis, JAK/STAT3 signaling pathway and Mismatch repair",0
680,4,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"Interleukin-27 signaling is mediated by the JAK-STAT pathway via activation of STAT1 and STAT3, which have tumor suppressive and oncogenic activities, respectively.",0
680,5,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,Epithelial-mesenchymal transition (EMT) and angiogenesis are key processes in carcinogenesis.,0
680,6,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,The inhibition of STAT3 activation had no effect on the development of the epithelial phenotype.,0
680,7,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,STAT3 plays a vital role in inducing and maintaining a pro-carcinogenic inflammatory microenvironment and is reported to be a critical mediator of the oncogenic effects of EGFR mutations.,0
680,8,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,STAT3 activation is mediated through JAK family kinases,0
680,9,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?," EESB treatment could significantly suppress the activation of several CRC-related pathways, including STAT3, Erk, and p38 signalings in tumor tissues, and alter the expression of multiple critical target genes such as Bcl-2, Bax, Cyclin D1, CDK4, and p21.",0
680,10,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,These molecular effects lead to the induction of cancer cell apoptosis and inhibition of cell proliferation.,0
680,11,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,Our findings demonstrate that SB possesses a broad range of antitumor activities because of its ability to affect multiple intracellular targets,0
680,12,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,Western immunoblotting analyses of mouse lung tissues indicated significantly lower level of pSTAT3 and Mcl-1 in the carcinogen plus DMAPT group relative to the group treated with the carcinogen only.,0
680,13,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"Given the evidence that STAT3 is activated in more than half of lung cancers and it regulates genes involved in cell proliferation, survival and angiogenesis, DMAPT is a promising agent for lung cancer chemoprevention in subjects who are at high risk of developing this devastating disease.",0
680,14,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"(STAT3) is a latent cytoplasmic transcription factor, originally discovered as a transducer of signal from cell surface receptors to the nucleus.",1
680,15,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"It is activated by tyrosine phosphorylation at position 705 leading to its dimerization, nuclear translocation, DNA binding, and activation of gene transcription.",1
680,16,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"Under normal physiological conditions, STAT3 activation is tightly regulated.",1
680,17,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"However, compelling evidence suggests that STAT3 is constitutively activated in many cancers and plays a pivotal role in tumor growth and metastasis.",1
680,18,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"It regulates cellular proliferation, invasion, migration, and angiogenesis that are critical for cancer metastasis",1
680,19,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"STAT3) signaling pathway plays important roles in oncogenesis, angiogenesis, immunity, and tumor cell invasion.",0
680,20,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?,"In the present study, we investigated the association of interleukin",0
680,21,Is signal transducer and activator of transcription-3 (STAT3) critical for tumor angiogenesis progression?," Phosphorylated STAT3 (pSTAT3) regulates many genes that are necessarily expressed in cancer initiation, development, and progression, being involved in proliferation, anti-apoptosis, invasion, angiogenesis, and immune surveillance evasion",0
1600,0,Which are the musculoskeletal manifestations of Marfan syndrome?,"Musculoskeletal manifestations include scoliosis, dural ectasia, protrusio acetabuli, and ligamentous laxity.",1
1600,1,Which are the musculoskeletal manifestations of Marfan syndrome?,"Scoliosis, pectus excavatum and carinatum, arachnodactyly, and acetabular protrusion are common musculoskeletal manifestations.",1
1600,2,Which are the musculoskeletal manifestations of Marfan syndrome?,Two cases are described in which protrusio acetabuli was a major problem.,0
1600,3,Which are the musculoskeletal manifestations of Marfan syndrome?,Otto pelvis should be considered as one of the musculoskeletal manifestations of Marfan's syndrome.,1
1600,4,Which are the musculoskeletal manifestations of Marfan syndrome?,"The following musculoskeletal abnormalities were found: pectus in 3 patients (11%), pectus and scoliosis in 19 (73%), dolichostenomelia in 11 (42%) and arachnodactyly in 21 (80%).",1
1600,5,Which are the musculoskeletal manifestations of Marfan syndrome?,Musculoskeletal clinicians should be aware of the diagnostic features of Marfan syndrome.,1
1600,6,Which are the musculoskeletal manifestations of Marfan syndrome?,"Patients with three to four physically evident features, or two highly specific features (e.g., thumb and wrist signs, craniofacial features, dural ectasia, or protrusio), should be carefully reexamined and possibly referred for an echocardiogram or a genetics consultation.",0
3768,0,Is tocilizumab a tumor necrosis factor inhibitor?,"For the first-line bDMARD/tsDMARD, either tumor necrosis factor inhibitors (TNFi), non-TNFi (abatacept, tocilizumab, rituximab), or tsDMARDs, may be considered.",1
1554,0,How does thyroid hormone affect insulin resistance in the heart?,"In diabetic vs. nondiabetic patients T(1)AM concentration was significantly increased (0.232 ± 0.014 vs. 0.203 ± 0.006 pmol/ml, P = 0.044),",1
1554,1,How does thyroid hormone affect insulin resistance in the heart?,Our results are consistent with the hypothesis that circulating T(1)AM is produced from thyroid hormones and encourage further investigations on the potential role of T(1)AM in insulin resistance,1
1554,2,How does thyroid hormone affect insulin resistance in the heart?,"exogenous T3 lowered blood glucose in db/db mice, a model of type 2 diabetes.",1
1554,3,How does thyroid hormone affect insulin resistance in the heart?,"T3 potentiated insulin signaling, improved insulin sensitivity, and increased insulin synthesis, which may contribute to its anti-diabetic effects.",1
1554,4,How does thyroid hormone affect insulin resistance in the heart?,TRalpha P398H mutation is associated with visceral adiposity and insulin resistance,1
1517,0,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Here we introduce Chromatin Isolation by RNA Purification (ChIRP), where tiling oligonucleotides retrieve specific lncRNAs with bound protein and DNA sequences, which are enumerated by deep sequencing.",1
1517,1,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"ChIRP-seq of three lncRNAs reveal that RNA occupancy sites in the genome are focal, sequence-specific, and numerous.",0
1517,2,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Drosophila roX2 RNA occupies male X-linked gene bodies with increasing tendency toward the 3' end, peaking at CES sites.",0
1517,3,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,Human telomerase RNA TERC occupies telomeres and Wnt pathway genes.,0
1517,4,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,HOTAIR lncRNA preferentially occupies a GA-rich DNA motif to nucleate broad domains of Polycomb occupancy and histone H3 lysine 27 trimethylation.,0
1517,5,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"HOTAIR occupancy occurs independently of EZH2, suggesting the order of RNA guidance of Polycomb occupancy.",0
1517,6,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,ChIRP-seq is generally applicable to illuminate the intersection of RNA and chromatin with newfound precision genome wide.,0
1517,7,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,ChIRP-seq is generally applicable to illuminate the intersection of RNA and chromatin with newfound precision genome wide.,0
1517,8,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"ChIRP-seq of three lncRNAs reveal that RNA occupancy sites in the genome are focal, sequence-specific, and numerous.",0
1517,9,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Here we introduce Chromatin Isolation by RNA Purification (ChIRP), where tiling oligonucleotides retrieve specific lncRNAs with bound protein and DNA sequences, which are enumerated by deep sequencing.",1
1517,10,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Here we introduce Chromatin Isolation by RNA Purification (ChIRP), where tiling oligonucleotides retrieve specific lncRNAs with bound protein and DNA sequences, which are enumerated by deep sequencing.",1
1517,11,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,ChIRP-seq is generally applicable to illuminate the intersection of RNA and chromatin with newfound precision genome wide.,0
1517,12,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Here we introduce Chromatin Isolation by RNA Purification (ChIRP), where tiling oligonucleotides retrieve specific lncRNAs with bound protein and DNA sequences, which are enumerated by deep sequencing.",1
1517,13,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"ChIRP-seq of three lncRNAs reveal that RNA occupancy sites in the genome are focal, sequence-specific, and numerous.",0
1517,14,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"HOTAIR occupancy occurs independently of EZH2, suggesting the order of RNA guidance of Polycomb occupancy.",0
1517,15,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,ChIRP-seq is generally applicable to illuminate the intersection of RNA and chromatin with newfound precision genome wide.,0
1517,16,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Here we introduce Chromatin Isolation by RNA Purification (ChIRP), where tiling oligonucleotides retrieve specific lncRNAs with bound protein and DNA sequences, which are enumerated by deep sequencing.",1
1517,17,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"ChIRP-seq of three lncRNAs reveal that RNA occupancy sites in the genome are focal, sequence-specific, and numerous.",0
1517,18,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Long noncoding RNAs (lncRNAs) are key regulators of chromatin state, yet the nature and sites of RNA-chromatin interaction are mostly unknown.",0
1517,19,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Here we introduce Chromatin Isolation by RNA Purification (ChIRP), where tiling oligonucleotides retrieve specific lncRNAs with bound protein and DNA sequences, which are enumerated by deep sequencing.",0
1517,20,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,ChIRP-seq is generally applicable to illuminate the intersection of RNA and chromatin with newfound precision genome wide.,0
1517,21,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"Here we introduce Chromatin Isolation by RNA Purification (ChIRP), where tiling oligonucleotides retrieve specific lncRNAs with bound protein and DNA sequences, which are enumerated by deep sequencing.",0
1517,22,What is ChiRP-seq (Chromatin Isolation by RNA Purification sequencing)?,"ChIRP-seq of three lncRNAs reveal that RNA occupancy sites in the genome are focal, sequence-specific, and numerous.",0
3635,0,Can LB-100 downregulate miR-33?,PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.,1
3635,1,Can LB-100 downregulate miR-33?,"LB100 profoundly upregulates miR-181b-1, which we show directly binds to the 3' untranslated region of Bcl-2 mRNA leading to its translational inhibition.",1
3635,2,Can LB-100 downregulate miR-33?,"MiR-181b-1 ectopic overexpression further diminishes Bcl-2 expression leading to suppression of sAML cell growth, and enhancement of DNR cytotoxicity.",1
778,0,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,XDG activity is attributable to MUG,0
778,1,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,xanthine DNA glycosylase (XDG) activity in E. coli,0
778,2,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,The wild type MUG possesses more robust activity against xanthine than uracil and is active against all xanthine-containing DNA,0
778,3,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,The gene for the mismatch-specific uracil DNA glycosylase (MUG) was identified in the Escherichia coli genome as a sequence homolog of the human thymine DNA glycosylase with activity against mismatched uracil base pairs.,0
778,4,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,The bacterial mismatch-specific uracil-DNA glycosylase (MUG) and eukaryotic thymine-DNA glycosylase (TDG) enzymes form a homologous family of DNA glycosylases that initiate base-excision repair of G:U/T mismatches.,1
778,5,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,the principal role of Mug in E. coli may be to help repair damage to DNA caused by exogenous chemical agents such as chloroacetaldehyde,0
778,6,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,excise epsilonC.,0
778,7,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"The latter activity is missing in extracts from mug cells, suggesting that Mug may be the only enzyme in E. coli that can remove this mutagenic adduct.",1
778,8,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,Base-excision of a self-complementary oligonucleotide with central G:T mismatches by the G:T/U-specific mismatch DNA glycosylase (MUG),0
778,9,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,Mug does not repair U.G or T.G mismatches in vivo.,0
778,10,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"remove 3,N(4)-ethenocytosine (epsilonC) from epsilonC.G mismatches",0
778,11,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,The human thymine-DNA glycosylase has a sequence homolog in Escherichia coli that is described to excise uracils from U.G mismatches,0
778,12,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"The structure of this complex explains the preference for G:U over G:T mispairs, and reveals an essentially non-specific pyrimidine-binding pocket that allows MUG/TDG enzymes to excise the alkylated base, 3, N(4)-ethenocytosine.",0
778,13,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"One member of the uracil-DNA glycosylase family of repair enzymes, Escherichia coli mismatch-specific uracil-DNA glycosylase (Mug), is reported to distinguish U:G mispairs from U:A base pairs based upon specific contacts with the mispaired guanine after flipping the target uracil out of the duplex.",0
778,14,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,T transition in the ung mug double mutant as compared to the single ung mutant suggest that MUG may be a back-up repair enzyme to the classic uracil-DNA glycosylase.,0
778,15,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"The human thymine-DNA glycosylase has a sequence homolog in Escherichia coli that is described to excise uracils from U.G mismatches (Gallinari, P., and Jiricny, J.",0
778,16,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"(1996) Nature 383, 735-738) and is named mismatched uracil glycosylase (Mug).",0
778,17,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"Because uracil-DNA glycosylase (Ung) and Vsr are known to repair U.G and T.G mismatches, respectively, we conclude that Mug does not repair U.G or T.G mismatches in vivo.",1
778,18,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,Mismatch uracil DNA glycosylase (Mug) from Escherichia coli is an initiating enzyme in the base-excision repair pathway.,0
778,19,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"Role of mismatch-specific uracil-DNA glycosylase in repair of 3,N4-ethenocytosine in vivo.",0
778,20,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"Thus, the principal role of Mug in E. coli may be to help repair damage to DNA caused by exogenous chemical agents such as chloroacetaldehyde.",1
778,21,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"The role of the Escherichia coli mug protein in the removal of uracil and 3,N(4)-ethenocytosine from DNA.",0
778,22,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,The bacterial mismatch-specific uracil-DNA glycosylase (MUG) and eukaryotic thymine-DNA glycosylase (TDG) enzymes form a homologous family of DNA glycosylases that initiate base-excision repair of G:U/T mismatches,1
778,23,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,The gene for the mismatch-specific uracil DNA glycosylase (MUG) was identified in the Escherichia coli genome as a sequence homolog of the human thymine DNA glycosylase with activity against mismatched uracil base pairs,0
778,24,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"One member of the uracil-DNA glycosylase family of repair enzymes, Escherichia coli mismatch-specific uracil-DNA glycosylase (Mug), is reported to distinguish U:G mispairs from U:A base pairs based upon specific contacts with the mispaired guanine after flipping the target uracil out of the duplex",0
778,25,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,Mismatch uracil DNA glycosylase (Mug) from Escherichia coli is an initiating enzyme in the base-excision repair pathway,0
778,26,What is the role of mismatched uracil glycosylase (Mug) in DNA repair?,"Because uracil-DNA glycosylase (Ung) and Vsr are known to repair U.G and T.G mismatches, respectively, we conclude that Mug does not repair U.G or T.G mismatches in vivo",0
3779,0,What is the function of emergency granulopoiesis?,"During 'emergency' situations such as infections, host defense requires rapid mobilization of bone marrow granulocyte progenitors",1
3779,1,What is the function of emergency granulopoiesis?,"These data suggest a critical function for C/EBPbeta in emergency granulopoiesis, which demands both differentiation and proliferation of granulocyte precursors.",0
3779,2,What is the function of emergency granulopoiesis?,Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance,0
3779,3,What is the function of emergency granulopoiesis?,Our findings identify granulopoiesis-mediated augmentation of alloimmunity as a novel link between innate and adaptive immune responses after organ transplantation.,0
3779,4,What is the function of emergency granulopoiesis?,"Granulopoiesis is tightly regulated to meet host demands during both ""steady-state"" and ""emergency"" situations, such as infections",1
3779,5,What is the function of emergency granulopoiesis?,"After the induction of candidemia, rapid mobilization of mature granulocytes and an increase in early granulocyte precursors accompanied by cell cycle acceleration was followed by a gradual increase in granulocytes originating from the immature populations",0
3779,6,What is the function of emergency granulopoiesis?,Emergency granulopoiesis is a component of the innate immune response that is induced in response to infectious or inflammatory challenge.,1
3779,7,What is the function of emergency granulopoiesis?,Failed emergency granulopoiesis in Fancc(-/-) mice was associated with excess apoptosis of HSCs and progenitor cells in the bone marrow and impaired HSC function.,0
3779,8,What is the function of emergency granulopoiesis?,"Systemic bacterial infection induces a hematopoietic response program termed ""emergency granulopoiesis"" that is characterized by increased de novo bone marrow (BM) neutrophil production",0
3779,9,What is the function of emergency granulopoiesis?,"Our studies demonstrate a previously undescribed role for HoxA10 in terminating emergency granulopoiesis, suggesting an important contribution by Hox proteins to the innate immune response.",0
3779,10,What is the function of emergency granulopoiesis?,"However, if microbial infection cannot be controlled locally, and consequently develops into a life-threatening condition, neutrophils are used up in large quantities and the haematopoietic system has to rapidly adapt to the increased demand by switching from steady-state to emergency granulopoiesis.",0
3779,11,What is the function of emergency granulopoiesis?,"This involves the markedly increased de novo production of neutrophils, which results from enhanced myeloid precursor cell proliferation in the bone marrow",0
3779,12,What is the function of emergency granulopoiesis?,Emergency granulopoiesis refers to the increased production of neutrophils in bone marrow and their release into circulation induced by severe infection.,1
3779,13,What is the function of emergency granulopoiesis?,Emergency granulopoiesis is a very important strategy to supply efficient neutrophil number in response to infection.,0
3779,14,What is the function of emergency granulopoiesis?,"We previously showed that C/EBPβ, which is a transcription factor required for emergency granulopoiesis, plays a pivotal role at the level of hematopoietic stem/progenitor cells under stress conditions.",0
3779,15,What is the function of emergency granulopoiesis?,"In fact, emergency granulopoiesis (EG), a process regulating neutrophil homeostasis in inflammatory conditions and infections, may occur improperly in leukemic conditions, leading to reduced neutrophil counts.",0
3779,16,What is the function of emergency granulopoiesis?,"Interferon consensus sequence-binding protein (Icsbp) is required for terminating emergency granulopoiesis, an episodic event responsible for granulocyte production in response to infections and a key component of the innate immune response",0
3779,17,What is the function of emergency granulopoiesis?,"Granulocyte colony-stimulating factor (G-CSF) mediates ""emergency"" granulopoiesis during infection, a process that is mimicked by clinical G-CSF use, yet we understand little about the intracellular signaling cascades that control demand-driven neutrophil production.",0
3779,18,What is the function of emergency granulopoiesis?,"In addition, embryos, where pax9 was functionally disrupted by injecting morpholinos, failed to increase the number of neutrophils in response to pathogenic bacteria, suggesting that Pax9 is not only essential for developmental granulopoiesis but also emergency granulopoiesis.",0
3779,19,What is the function of emergency granulopoiesis?,Emergency granulopoiesis is a hematopoietic program of stem cell-driven neutrophil production used to counteract immune cell exhaustion following infection.,0
3779,20,What is the function of emergency granulopoiesis?,Infections and inflammation trigger neutrophilias that are supported by a hematopoietic program of accelerated granulopoiesis known as emergency granulopoiesis,0
3779,21,What is the function of emergency granulopoiesis?,Emergency granulopoiesis is the enhanced production of neutrophils by hematopoietic stem and progenitor cells (HSPCs) upon infection and is widely considered a homoeostatic mechanism for replacing exhausted leukocytes.,1
3779,22,What is the function of emergency granulopoiesis?,We show that stem cell-driven neutrophil production occurs in response to Shigella infection and requires macrophage-independent signaling by granulocyte colony-stimulating factor (Gcsf).,0
3779,23,What is the function of emergency granulopoiesis?,Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance.,0
4187,0,Why mothers with a CYP2D6 ultrarapid metabolizer phenotype may expose their infants to risk of adverse events when taking codeine while breastfeeding?,"Mothers with a CYP2D6 ultrarapid metabolizer phenotype may expose their infants to risk of adverse events when taking codeine while breastfeeding, by producing more of the active metabolite, morphine.",1
2044,0,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL) is a rare disorder of unknown etiology characterized by diffuse or localized dilation and eventual rupture of the enteric lymphatic vessels in mucosa, submucosa, and/or subserosa.",1
2044,1,How is primary intestinal lymphangiectasia (PIL) caused?,"Lymph, rich in all kinds of proteins and lymphocytes, leaks into the gastrointestinal tract via the affected lymphatic vessels causing hypoproteinemia and lymphopenia.",1
2044,2,How is primary intestinal lymphangiectasia (PIL) caused?,"PIL, effusions, and lymphedema can be the features of multisegmental generalized lymphatic dysplasia.",0
2044,3,How is primary intestinal lymphangiectasia (PIL) caused?,A number of disorders have been described to cause protein losing enteropathy (PLE) in children.,0
2044,4,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE.,0
2044,5,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia is a rare cause of protein-losing enteropathy and usually presents with intermittent diarrhea or malnutrition.,0
2044,6,How is primary intestinal lymphangiectasia (PIL) caused?,Diagnosis depends largely on its pathologic condition demonstrating greatly dilated lymphatics mainly in the lamina propria of the mucosa.,0
2044,7,How is primary intestinal lymphangiectasia (PIL) caused?,The histopathologic condition of the resected small intestine showed lymphatic dilation limited mainly to the subserosa and mesentery but was not prominent in the mucosa.,0
2044,8,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) is a rare disorder characterized by dilated intestinal lymphatics and the development of protein-losing enteropathy.,1
2044,9,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL), also known as Waldmann's disease, is an exudative enteropathy resulting from morphologic abnormalities in the intestinal lymphatics.",0
2044,10,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL), so-called Waldmann's disease, is an uncommon condition, characterized by dilated intestinal submucosal and subserosal lymphatics of the gastrointestinal tract.",0
2044,11,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL) is a rare disorder characterized by dilated intestinal lacteals resulting in lymph leakage into the small bowel lumen and responsible for protein-losing enteropathy leading to lymphopenia, hypoalbuminemia and hypogammaglobulinemia.",1
2044,12,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL), also known as Waldmann's disease, is a rare disorder characterized by dilated intestinal lacteals resulting in lymph leakage into the small bowel lumen and responsible for protein-losing enteropathy leading to lymphopenia, hypoalbuminemia and hypogammaglobulinemia.",0
2044,13,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL) is a protein-losing, exsudative gastroenteropathy causing lymphatic obstruction.",0
2044,14,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) is a protein-losing enteropathy characterized by tortuous and dilated lymph channels of the small bowel.,0
2044,15,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL) is a rare disease of intestinal lymphatics presenting with hypoproteinemia, bilateral lower limb edema, ascites, and protein losing enteropathy.",0
2044,16,How is primary intestinal lymphangiectasia (PIL) caused?,"Exudative enteropathy secondary to primary intestinal lymphangiectasia (PIL) is characterized by lymphopenia, hypogammaglobulinemia and hypoalbuminemia resulting from leakage of lymph fluid into the intestinal tract",0
2044,17,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) is a rare protein-losing enteropathy with lymphatic leakage into the small intestine,0
2044,18,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) is a protein-losing enteropathy characterized by tortuous and dilated lymph channels of the small bowel,0
2044,19,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL) is a rare disease of intestinal lymphatics presenting with hypoproteinemia, bilateral lower limb edema, ascites, and protein losing enteropathy",0
2044,20,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL), so-called Waldmanns disease, is an uncommon condition, characterized by dilated intestinal submucosal and subserosal lymphatics of the gastrointestinal tract",0
2044,21,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (Waldmanns disease) is a rare disease characterized by dilated lymphatics in the small bowel leading to an exudative enteropathy with lymphopenia, hypoalbuminemia and hypogammaglobulinemia.We report the case of a 23 year-old male who presented with chronic anemia and in whom primary intestinal lymphangiectasia was diagnosed",0
2044,22,How is primary intestinal lymphangiectasia (PIL) caused?,"We report a series of 4 children from Chennai, India presenting with anasarca, recurrent diarrhea, hypoproteinemia and confirmatory features of PIL on endoscopy and histopathology.",0
2044,23,How is primary intestinal lymphangiectasia (PIL) caused?,"Primary intestinal lymphangiectasia (PIL) is a protein-losing, exsudative gastroenteropathy causing lymphatic obstruction.",0
2044,24,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) is a rare protein-losing enteropathy characterized by a congenital malformation of the lymphatic vessels of the small intestine causing insufficient drainage and leakage of lymph fluid.,1
2044,25,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) is a rare protein-losing enteropathy with lymphatic leakage into the small intestine.,0
2044,26,How is primary intestinal lymphangiectasia (PIL) caused?,Primary intestinal lymphangiectasia (PIL) or Waldmann's disease is a rare protein-losing gastroenteropathy of unknown etiology.,0
3183,0,Are protamines ubiquitously expressed?,Protamines are nuclear proteins which are specifically expressed in haploid male germ cells.,1
3203,0,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"Salivary cortisone, as a biomarker for psychosocial stress, is associated with state anxiety and heart rate.",1
3203,1,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,ortisol as a stress biomarker,0
3203,2,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"The salivary cortisol level reflects psychological stress, and it is a good index to assess chronic stress.",0
3203,3,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"SUMMARY
Salivary cortisol and cortisone can be used to assess cortisol excess, deficiency and hydrocortisone replacement, with salivary cortisone having the advantage of detection when serum cortisol levels are low and there is no interference from oral hydrocortisone.",0
3203,4,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"Salivary cortisone is a superior marker of serum cortisol compared with salivary cortisol, specifically when serum cortisol is low and during hydrocortisone therapy when contamination of saliva may result in misleading salivary cortisol concentrations.",0
3203,5,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,Salivary cortisol is frequently used as a biomarker of psychological stress.,1
3203,6,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"The present paper addresses several psychological and biological variables, which may account for such dissociations, and aims to help researchers to rate the validity and psychobiological significance of salivary cortisol as an HPAA biomarker of stress in their experiments.",0
3203,7,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"However, psychobiological mechanisms, which trigger the hypothalamus-pituitary-adrenal axis (HPAA) can only indirectly be assessed by salivary cortisol measures.",0
3203,8,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,Salivary cortisol as a biomarker in stress research.,1
3203,9,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"As a biomarker for depression, salivary cortisol VAR demonstrated an optimal cutoff point at 77.8% (AUC=0.94; 95% CI, 0.85-0.98), which is associated with a sensitivity of 82.1% and a specificity of 96.0%.",0
3203,10,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"Salivary cortisol is considered to be a safe and noninvasive measure of hypothalamic-pituitary-adrenal axis functioning, and is a commonly measured biomarker of the human stress response in pediatric research.",0
3203,11,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"BACKGROUND
The aim of this study was to evaluate salivary alpha-amylase (sAA), considered a non-invasive biomarker for sympathetic nervous system (SNS) activity, and salivary cortisol as possible pain-induced stress biomarker, in horses with acute abdominal disease.",0
3203,12,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,Salivary cortisol is commonly used as a clinical biomarker of endocrine status and also as a marker of psychosocial stress.,0
3203,13,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"CONCLUSION
Salivary cortisol concentration is positively correlated with occupational stress and increases with the increasing degree of occupational stress, and can be used as an objective biomarker for the identification and evaluation of occupational stress.",0
3203,14,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"PURPOSE
Cortisol is frequently assayed as a stress-responsive biomarker which changes over the course of minutes to meet the demands of a person's social context.",0
3203,15,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"METHODS
In 323 children (5-10 years old) participating in the Belgian ChiBS study, salivary cortisol samples, a biomarker for stress, was sampled when waking up, 30 and 60 min after wake up and in the evening on two consecutive weekdays.",0
3203,16,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,Cortisol is a classical biomarker for the stress levels of human beings.,1
3203,17,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,"Finally, salivary cortisol has been used extensively as a biomarker of stress in a research setting, especially in studies examining psychological stress with repeated measurements.",0
3203,18,Salivary Cortisol is a biomarker for what disease/syndrome/condition?,Salivary cortisol as a biomarker in stress research.Salivary cortisol is frequently used as a biomarker of psychological stress.,1
4028,0,"What does ""28"" stand for in the Disease Activity Score DAS28?"," In order to further dissect this issue, we numerically and graphically modeled 28-joint disease activity scale (DAS28), simplified disease activity index (SDAI), and clinical disease activity index (CDAI) by three-dimensional (3D) plotting.",1
4028,1,"What does ""28"" stand for in the Disease Activity Score DAS28?","The 28-joint DAS (DAS28), clinical disease activity index (CDAI) and simplified disease activity index (SDAI) are indices frequently used to assess disease activity in RA patients.",1
4028,2,"What does ""28"" stand for in the Disease Activity Score DAS28?",the disease activity score with 28 joint counts with erythrocyte sedimentation rate (DAS28) remission,0
4028,3,"What does ""28"" stand for in the Disease Activity Score DAS28?",Disease activity score in 28 joints (DAS28),0
4028,4,"What does ""28"" stand for in the Disease Activity Score DAS28?","DAS were transformed to DAS28 using an existing formula quoted in the literature, and the newly developed formulas.",0
4028,5,"What does ""28"" stand for in the Disease Activity Score DAS28?",Bland and Altman plots were used to compare the transformed DAS with the recorded DAS28 to ascertain levels of agreement.,0
4028,6,"What does ""28"" stand for in the Disease Activity Score DAS28?",The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis,0
4028,7,"What does ""28"" stand for in the Disease Activity Score DAS28?","To determine the contribution of fibromyalgia (FM) to the subjective components of the Disease Activity Score 28-joints (DAS28) in patients with rheumatoid arthritis (RA), and to analyse the discriminatory performance of the derived DAS28 patient-reported components (DAS28-P) to identify patients with fibromyalgic RA.",0
4028,8,"What does ""28"" stand for in the Disease Activity Score DAS28?","Analysis of disease activity scores (DAS28 [disease activity score based on the 28-joint count]) over time showed that, after the initial rapid improvement during the first 6 to 22 weeks of therapy, a further decrease in disease activity of 0.2 units in the DAS28 score per year was observed.",0
4028,9,"What does ""28"" stand for in the Disease Activity Score DAS28?",ceiver operating characteristic (ROC) curves analysis allowed to obtain optimal cut-off predictors of a 28-joint disease activity score (DAS28) < or =2.85.,0
4028,10,"What does ""28"" stand for in the Disease Activity Score DAS28?",T,0
4028,11,"What does ""28"" stand for in the Disease Activity Score DAS28?","We hypothesize that augmented pain processing, fibromyalgic features, poorer mental health, and patient-reported 28-joint disease activity score (DAS28) components are associated in RA.",0
4028,12,"What does ""28"" stand for in the Disease Activity Score DAS28?","ter 7 years, apart from routine clinical follow-up, treating rheumatologists were asked to complete a questionnaire designed specifically for the present study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints [DAS28]) and the reasons for infliximab discontinuation.RE",0
4028,13,"What does ""28"" stand for in the Disease Activity Score DAS28?","diographs of hands and feet, pain, and the modified 28 joint disease activity score (DAS28) were also assessed.RE",0
4028,14,"What does ""28"" stand for in the Disease Activity Score DAS28?",BACKGROUND: Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).,0
4028,15,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVE: Antirheumatic treatment is frequently not appropriately modified, according to American College of Rheumatology guidelines, in patients with active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints (DAS28) score greater tha",0
4028,16,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: The Disease Activity Score based on 28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arthr,0
4028,17,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: The Disease Activity Score based on 28 joints (DAS28) has been widely used in clinical practice and research studies of rheumatoid arthr,0
4028,18,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVE: The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a composite score comprising clinical, biochemical, and patient self-report mea",0
4028,19,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVE: To determine whether using a reweighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints (DAS28) (based on swollen joint count and C-reactive protein level), produces more clinically relevant treatment outcome trajectories compared to the standard 4-component",0
4028,20,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVE: Ankle joints are frequently neglected in activity scoring systems, including the Disease Activity Score in 28 join",0
4028,21,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: The Disease Activity Score in 28 joints (DAS28) is a key measure in clinical practice and clinic,1
4028,22,"What does ""28"" stand for in the Disease Activity Score DAS28?", most widely used one is the Disease Activity Score involving 28 joint counts (DAS28) for which cut-offs were proposed to help physicians classify patients.,0
4028,23,"What does ""28"" stand for in the Disease Activity Score DAS28?",How,0
4028,24,"What does ""28"" stand for in the Disease Activity Score DAS28?",BACKGROUND: Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth,0
4028,25,"What does ""28"" stand for in the Disease Activity Score DAS28?","METHODS: Functional disability [Health Assessment Questionnaire (HAQ)], disease activity [28-joint Disease Activity Score (DAS28)], and radiographic joint damage [Sharp/van der Heijde score (SHS)] were measured in 4 consecutive randomized controlled trials with increasingly intensive (tight control) treatment strategies.",0
4028,26,"What does ""28"" stand for in the Disease Activity Score DAS28?","INTRODUCTION: The aim of this study was to determine a low disease activity threshold--a 28-joint disease activity score (DAS28) value--for the decision to maintain unchanged disease-modifying antirheumatic drug (DMARD) treatment in rheumatoid arthritis patients, based on expert opinion.",0
4028,27,"What does ""28"" stand for in the Disease Activity Score DAS28?","Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.",0
4028,28,"What does ""28"" stand for in the Disease Activity Score DAS28?","We assessed achievement of remission as defined by Boolean criteria, Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and 28-joint Disease Activity Score using C-reactive protein (DAS28[CRP]) and determined the components that limit patients in SDAI, CDAI, or DAS28(CRP) remission from achieving Boolean remission.",0
4028,29,"What does ""28"" stand for in the Disease Activity Score DAS28?","METHODS: Simplified Disease Activity Index (SDAI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints (DAS28) were calculated using data from tocilizumab trials in patients with RA in whom disease had remained active despite treatment with disease-modifying antirheumatic drugs.",0
4028,30,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: We used the 28-joint Disease Activity Score (DAS28) and the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI) articular domain to assess the effect of rituximab (RTX) and abatacept (ABA) on articular involvement in primary Sjögren syndrome (pSS).,0
4028,31,"What does ""28"" stand for in the Disease Activity Score DAS28?","METHOD: The clinical data of 189 consecutive RA patients, including RAPID3 questionnaire, Disease Activity Score based on 28-joint count (DAS28), clinical disease activity index (CDAI) and simplified disease activity index (SDAI), and ultrasonography of hand and wrist joints were collected.",0
4028,32,"What does ""28"" stand for in the Disease Activity Score DAS28?","Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism definitions, because of its association with significant residual disease activity, partly due to high weighting of acute-phase reactants (APR).",0
4028,33,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVE: To examine the influence of components of the Disease Activity Score 28 (DAS28) [tender joint count (TJC), swollen joint count (SJC), patient's general health (GH), and erythrocyte sedimentation rate (ESR)] on the total DAS28 score, and overlapping of the 4 individual components in rheumatoid arthritis (RA) patients with low, moderate, or high disease activity.",0
4028,34,"What does ""28"" stand for in the Disease Activity Score DAS28?","This study investigates if, and to what extent, non-adherence to treatment would lead to a higher 28-joint count disease activity score (DAS28) in the first year after diagnosis.",0
4028,35,"What does ""28"" stand for in the Disease Activity Score DAS28?","Radiographs of hands and feet, pain, and the modified 28 joint disease activity score (DAS28) were also assessed.",0
4028,36,"What does ""28"" stand for in the Disease Activity Score DAS28?","Tender-/swollen-joint count, Health Assessment Questionnaire Disability Index (HAQ-DI), Disease Activity Score 28-ESR (DAS28-ESR), DAS28-CRP, Simplified Disease Activity Index (SDAI) and DAS28-monocyte chemotactic protein-1 (DAS28-MCP-1) scores were obtained every 3 months.",0
4028,37,"What does ""28"" stand for in the Disease Activity Score DAS28?",METHOD: All patients were naïve to biological disease-modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein (DAS)28-CRP).,0
4028,38,"What does ""28"" stand for in the Disease Activity Score DAS28?","We compared RA disease activity using 28-joint Disease Activity Score (DAS28) and its components, and EULAR response, between patients with and without AITD, using logistic regression.",0
4028,39,"What does ""28"" stand for in the Disease Activity Score DAS28?",BACKGROUND: Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art,0
4028,40,"What does ""28"" stand for in the Disease Activity Score DAS28?","BACKGROUND: The 28-joint Disease Activity Score (DAS28) combines scores on a 28-tender and swollen joint count (TJC28 and SJC28), a patient-reported measure for general health (GH), and an inflammatory marker (either the erythrocyte sedimentation rate [ESR] or the C-reactive protein [CRP]) into a composite measure of disease activity in rheumatoid art",0
4028,41,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: The Disease Activity Score in 28 joints (DAS28) is a key measure in clinical practice and clini,1
4028,42,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: The Disease Activity Score including 28 joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis (RA,1
4028,43,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: The Disease Activity Score based on 28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth,0
4028,44,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVES: To evaluate the application of Disease Activity Score 28 (DAS28) to assess joint involvement in Systemic Lupus Erythematosus (SLE).METHODS: Sixty-nine SLE patients, complaining of joint symptoms, and 44 rheumatoid arthritis (RA) pa",0
4028,45,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVE: To examine the influence of components of the Disease Activity Score 28 (DAS28) [tender joint count (TJC), swollen joint count (SJC), patient's general health (GH), and erythrocyte sedimentation rate (ESR)] on the total DAS28 score, and overlapping of the 4 individual components in rheumatoid arthritis (RA) patients with low, moderate, or high disease activity.METHODS: The effect of each component was studied in the FIN-RACo trial patients at 6 months and in a ""theoretical model,"" where each component of the DAS28 ranged as follows: TJC and SJC from 0 to 28, GH from 0 to 100, and ESR from 1 to 100, while the other 3 compo",0
4028,46,"What does ""28"" stand for in the Disease Activity Score DAS28?",OBJECTIVE: To assess the factorial structure of the Disease Activity Score including a 28-joint count (DAS28) if applied in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).METHODS: DAS28 values from 85 consecutive PsA outpatients and 2 RA patient cohorts comprising 85 patients,0
4028,47,"What does ""28"" stand for in the Disease Activity Score DAS28?","Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",0
4028,48,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVES: Disease Activity Score in 28 joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis disease activity; however, values for remission and low disease activity (LDA) for DAS28-CRP have not bee",0
4028,49,"What does ""28"" stand for in the Disease Activity Score DAS28?","OBJECTIVE: To optimize use of the Disease Activity Score in 28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the ""squeeze test"" of forefeet.METHODS: The squeeze test is used to examine bilateral compression pain (BCP) across the metatarsophal",0
24,0,Is Alu hypomethylation associated with breast cancer?,Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer,1
24,1,Is Alu hypomethylation associated with breast cancer?,"In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status",1
24,2,Is Alu hypomethylation associated with breast cancer?,"In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients.",1
24,3,Is Alu hypomethylation associated with breast cancer?,Alu hypomethylation is probably a late event during breast cancer progression,1
24,4,Is Alu hypomethylation associated with breast cancer?,prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.,1
24,5,Is Alu hypomethylation associated with breast cancer?,"DNA methylation for three repetitive elements (LINE1, Sat2 and Alu) were analyzed in invasive ductal carcinoma of the breast, paired adjacent normal tissue and WBC from 40 breast cancer patients",0
24,6,Is Alu hypomethylation associated with breast cancer?,DNA methylation for the three repetitive elements was lower in tumor compared to adjacent tissue and WBC DNA.,0
1323,0,Do ephrins play a role in brain cancer?,migrating glioblastoma cells overexpress EphB2 in vitro and in vivo; glioma migration and invasion are promoted by activation of EphB2 or inhibited by blocking EphB2.,0
1323,1,Do ephrins play a role in brain cancer?,Dysregulation of EphB2 expression or function may underlie glioma invasion,0
1323,2,Do ephrins play a role in brain cancer?,gene expression of Eph receptors and ephrins in benign human tissues and cancers,1
1323,3,Do ephrins play a role in brain cancer?,EphA1/EphA8 was down-regulated in glioblastomas,0
1323,4,Do ephrins play a role in brain cancer?,"EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.",0
1323,5,Do ephrins play a role in brain cancer?,"high-level expressions of favorable NB genes, such as EPHB6, can in fact suppress malignant phenotype of unfavorable NB",0
1323,6,Do ephrins play a role in brain cancer?,"phrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells",0
1323,7,Do ephrins play a role in brain cancer?,crosstalk between Eph and integrin signalling pathways at the membrane protrusions and in the migration of brain cancer cells,1
1323,8,Do ephrins play a role in brain cancer?,phB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion,0
1323,9,Do ephrins play a role in brain cancer?,"deregulation of Eph/ephrin expression in medulloblastoma enhances the invasive phenotype, suggesting a potential role in local tumor cell invasion and the formation of metastases",1
1323,10,Do ephrins play a role in brain cancer?,phrinA1 is released in three forms from cancer cells,0
1323,11,Do ephrins play a role in brain cancer?,"phrinA1 is a glycosylphosphatidylinositol (GPI)-linked ligand for the EphA2 receptor, which is overexpressed in glioblastoma (GBM), among other cancers",0
1323,12,Do ephrins play a role in brain cancer?,EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients,0
1323,13,Do ephrins play a role in brain cancer?,"EphrinB2 and EphB4 expressions increase according to the histopathological grade and KPS score of glioma, and their expression levels are related to the progression-free survival of glioblastoma patients",1
1323,14,Do ephrins play a role in brain cancer?,p-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma,1
1323,15,Do ephrins play a role in brain cancer?,gliomas display over-expression of the receptor tyrosine kinase EphA2.,0
1323,16,Do ephrins play a role in brain cancer?,phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion,0
1323,17,Do ephrins play a role in brain cancer?,high expression of ephrin-B2 is a strong predictor of short-term survival and that ephrin-B2 plays a critical role in glioma invasion rendering this signaling pathway as a potential therapeutic target,0
1323,18,Do ephrins play a role in brain cancer?,phrinA5 acts as a tumor suppressor in glioma,0
1323,19,Do ephrins play a role in brain cancer?,expression of ephrinA5 was dramatically downregulated in primary gliomas compared with normal tissues,0
1323,20,Do ephrins play a role in brain cancer?,EphA2 receptor and ephrinA1 ligand in solid tumors,0
1323,21,Do ephrins play a role in brain cancer?,"investigating the ephrinA1/EphA2 system in the pathobiology of glioblastoma multiforme (GBM), we uncovered that ephrinA1 is released from GBM and breast adenocarcinoma cells as a soluble",0
1323,22,Do ephrins play a role in brain cancer?,ccumulating evidence indicates that Eph and ephrins are frequently overexpressed in different tumor types including GBM,0
1323,23,Do ephrins play a role in brain cancer?,"EphA2 receptor tyrosine kinase is overexpressed in glioblastoma multiforme (GBM) and represents a novel, attractive therapeutic target for the treatment of brain tumor",0
1323,24,Do ephrins play a role in brain cancer?,phrin-A1 is a negative regulator in glioma,0
1323,25,Do ephrins play a role in brain cancer?, ephrin-A1 serves as a critical negative regulator in the tumorigenesis of gliomas,0
1323,26,Do ephrins play a role in brain cancer?,overexpression of EphB2 in glioma cells increases cell invasion,0
1323,27,Do ephrins play a role in brain cancer?,phA2 as a novel molecular marker and target in glioblastoma multiforme,0
1323,28,Do ephrins play a role in brain cancer?,"EphA2 is both specifically overexpressed in GBM and expressed differentially with respect to its ligand, ephrinA1",0
1323,29,Do ephrins play a role in brain cancer?,EphB4 and EphrinB2 protein expression in astrocytomas,0
1323,30,Do ephrins play a role in brain cancer?,Expressions of EphB4 and EphrinB2 proteins may be related to differentiation degree of tumor cells,0
3784,0,What is CRAO in the context of the eye?,central retinal artery occlusion (CRAO),1
3784,1,What is CRAO in the context of the eye?, central retinal artery occlusion (CRAO,0
3784,2,What is CRAO in the context of the eye?, Central retinal artery occlusion (CRAO),0
3784,3,What is CRAO in the context of the eye?,Vision loss following prone surgery is most commonly attributed to direct pressure on the eye but can also be caused by central retinal artery occlusion (CRAO) in the absence of pressure on the eye.,0
3784,4,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is a rare but blinding disorder.,0
3784,5,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) causes ischemic stroke of the eye.,0
3784,6,What is CRAO in the context of the eye?,"In addition, measurements were made in six patients with rhegmatogenous retinal detachment (RRD) and three patients with central retinal artery occlusion (CRAO) for comparison.",0
3784,7,What is CRAO in the context of the eye?, crisis.,0
3784,8,What is CRAO in the context of the eye?,"In the eye, central retinal artery occlusion (CRAO) is a rare complication in SCD, with only 1 previous report of bilateral, concurrent",0
3784,9,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is considered to be an acute stroke of the eye that results in profound visual loss.,0
3784,10,What is CRAO in the context of the eye?,"n blinding ocular manifestations include central retinal artery occlusion (CRAO), central retinal vein occlusion (CRVO), severe vaso-occlusive retinopathy, and optic nerve involvement.",0
3784,11,What is CRAO in the context of the eye?,Antiphos,0
3784,12,What is CRAO in the context of the eye?,"Acute retinal arterial ischemia, including vascular transient monocular vision loss (TMVL) and branch (BRAO) and central retinal arterial occlusions (CRAO), are ocular and systemic emergencies requiring immediate diagnosis and treatment.",0
3784,13,What is CRAO in the context of the eye?,Guide,0
3784,14,What is CRAO in the context of the eye?,ision loss following prone surgery is most commonly attributed to direct pressure on the eye but can also be caused by central retinal artery occlusion (CRAO) in the absence of pressure on the eye.,0
3784,15,What is CRAO in the context of the eye?,C,0
3784,16,What is CRAO in the context of the eye?,ucial information required in the management of central retinal artery occlusion (CRAO) is the length of time the retina can survive following that.,0
3784,17,What is CRAO in the context of the eye?,An,0
3784,18,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is an ophthalmological emergency situation.,1
3784,19,What is CRAO in the context of the eye?,ive crisis.,0
3784,20,What is CRAO in the context of the eye?,"In the eye, central retinal artery occlusion (CRAO) is a rare complication in SCD, with only 1 previous report of bilateral, conc",0
3784,21,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is a devastating ocular emergency characterized by acute painless visual loss in the ipsilateral eye.,0
3784,22,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is an ophthalmological emergency situation.,1
3784,23,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is an ophthalmic emergency and the ocular analogue of cerebral stroke.,0
3784,24,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is considered to be an acute stroke of the eye that results in profound visual loss.,0
3784,25,What is CRAO in the context of the eye?,"BACKGROUND: Central retinal artery occlusion (CRAO) is an ophthalmological emergency, the retinal analog",1
3784,26,What is CRAO in the context of the eye?,OPINION STATEMENT: Central retinal artery occlusion (CRAO) is an ocular emergency and is the ocular analogue,0
3784,27,What is CRAO in the context of the eye?,"BACKGROUND AND PURPOSE: Central retinal artery occlusion (CRAO) is a sudden, frequently irreversible, monocular vision loss, analogous to a",0
3784,28,What is CRAO in the context of the eye?,"Central retinal-artery obstruction (CRAO) is a devastating complication after retrobulbar anesthesia, a procedure which was previously recommended routinely to immobilize the eye and reduce discomfort during laser surgery.",0
3784,29,What is CRAO in the context of the eye?,"Central retinal artery occlusion (CRAO) is a rare complication of ICAD, secondary either to haemodynamic compromise, with ocular hypoperfusion and reverse flow within the ophthalmic artery, or to thromboembolic events, in rarer cases.",0
3784,30,What is CRAO in the context of the eye?,"Central retinal artery occlusion (CRAO) is an uncommon eye disorder, but one that typically produces severe and irreversible vision loss in the affected eye.",0
3784,31,What is CRAO in the context of the eye?,"Central retinal artery occlusion (CRAO) is a medical emergency that, if not treated, may result in irreversible loss of vision.",0
3784,32,What is CRAO in the context of the eye?,BACKGROUND: Central retinal artery occlusion (CRAO) is an ocular emergency and most of the cases present with painless sudden persistent loss of vision in the range of counting fingers to percepti,0
3784,33,What is CRAO in the context of the eye?,Central retinal artery occlusion (CRAO) is a neuro-ophthalmological emergency.,1
2085,0,Is Musclin a secretory peptide?,"Musclin is a novel skeletal muscle-derived secretory factor,",1
2085,1,Is Musclin a secretory peptide?,"Musclin has been described as a muscle-derived secretory peptide, responsive to insulin in vivo, and inducing insulin resistance in vitro.",1
2085,2,Is Musclin a secretory peptide?,Musclin is a type of muscle-secreted cytokine and its increased gene expression induces insulin resistance in type 2 diabetes.,0
2085,3,Is Musclin a secretory peptide?,Musclin is a novel skeletal muscle-derived factor found in the signal sequence trap of mouse skeletal muscle cDNAs.,1
2085,4,Is Musclin a secretory peptide?,Musclin is a novel skeletal muscle-derived secretory factor found in the signal sequence trap of mouse skeletal muscle cDNAs.,1
2085,5,Is Musclin a secretory peptide?,Musclin is a novel skeletal muscle-derived secretory factor that was isolated by our group.,1
3409,0,Which tissues express the ACE2 protein?,in keeping with the variability of ACE2 expression we have observed previously,1
3409,1,Which tissues express the ACE2 protein?,ACE2 has been identified in various tissues and is supposed to be a modulator of cardiovascular function.,1
3409,2,Which tissues express the ACE2 protein?,"Decreases in ACE2 expression and activity have been reported in models of hypertension, heart failure, atherosclerosis, diabetic nephropathy and others.",1
3409,3,Which tissues express the ACE2 protein?,"ACE2 is expressed at high level in the primary target cells of SARS-CoV, namely pneumocytes and surface enterocytes of the small intestine.",1
3409,4,Which tissues express the ACE2 protein?,"endothelial cells, which express ACE2 to a high level,",0
3409,5,Which tissues express the ACE2 protein?,"Abundant ACE2 immunostaining was found in lung, kidney, heart, and islets of pancreas, but not in hepatocytes",1
668,0,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,The calcium channel blocker verapamil is the drug of choice for CH prevention.,1
668,1,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Other drugs that may be used for this purpose include lithium carbonate, topiramate, valproic acid, gabapentin, and baclofen.",1
668,2,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Recently, the therapeutic options for refractory CH patients have expanded with the emergence of both peripheral (mostly occipital nerve) and central (hypothalamic) neurostimulation.",1
668,3,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"With the emergence of these novel treatments, the role of ablative surgery in CH has declined.",0
668,4,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,The mainstay of prophylactic therapy is verapamil.,1
668,5,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Yet, other medications, including lithium, divalproex sodium, topiramate, methysergide, gabapentin, and even indomethacin, may be useful when the headache fails to respond to verapamil.",0
668,6,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"For medically refractory patients, surgical interventions, occipital nerve stimulation, and deep brain stimulation remain an option.",0
668,7,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,The objective of this open single-centre study was to evaluate the efficacy and tolerability of botulinum toxin type-A (BTX-A) as add-on in the prophylactic treatment of cluster headache (CH).,1
668,8,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,These findings provide evidence that BTX-A may be beneficial as an add-on prophylactic therapy for a limited number of patients with chronic CH.,0
668,9,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"There are a variety of different medications for abortive and prophylactic therapy, accompanied by a variable amount of evidence-based medicine.",0
668,10,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Most procedures are directed against the sensory trigeminal nerve and associated ganglia, eg, anesthetizing the sphenopalatine ganglion.",0
668,11,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,The mainstay of prophylactic therapy is verapamil.,0
668,12,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Lithium, divalproex sodium, or topiramate may also be useful.",0
668,13,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Based on our clinical experience, we recommended the combination of nasal sumatriptan for acute attacks and verapamil 240 mg/day for prophylaxis.",0
668,14,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,Topiramate also appears to be well tolerated and useful in the adjunctive treatment of cluster headache.,0
668,15,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"The cornerstone of maintenance prophylaxis is verapamil, yet methysergide, lithium, and divalproex sodium may also be employed.",0
668,16,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"In some patients, melatonin or topiramate may be useful adjunctive therapies.",0
668,17,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Prophylactic therapy in most cases consisted of verapamil, also with a good response.",0
668,18,What pharmacological and non-pharmacological interventions can be considered as prophylactic therapies in Cluster Headache patients?,"Patients with chronic cluster headache may achieve good results from long-term treatment with other therapies, including lithium carbonate, verapamil, and ketoprofen.",0
1541,0,What is GDF10?,"We have identified a new member of the transforming growth factor-beta (TGF-beta) superfamily, growth/differentiation factor-10 (GDF-10), which is highly related to bone morphogenetic protein-3 (BMP-3).",1
1541,1,What is GDF10?,"The nucleotide sequence of GDF-10 encodes a predicted protein of 476 amino acids with a molecular weight of approximately 52,000.",0
1541,2,What is GDF10?,"The GDF-10 polypeptide contains a potential signal sequence for secretion, a putative RXXR proteolytic processing site, and a carboxy-terminal domain with considerable homology to other known members of the TGF-beta superfamily.",1
1541,3,What is GDF10?,In the mature carboxy-terminal domain GDF-10 is more homologous to BMP-3 (83% amino acid sequence identity) than to any other previously identified TGF-beta family member.,0
1541,4,What is GDF10?,GDF-10 also shows significant homology to BMP-3 (approximately 30% amino acid sequence identity) in the pro- region of the molecule.,0
1541,5,What is GDF10?,"Based on these sequence comparisons, GDF-10 and BMP-3 define a new subgroup within the larger TGF-beta superfamily.",0
1541,6,What is GDF10?,"By Northern analysis, GDF-10 mRNA was detected primarily in murine uterus, adipose tissue, and brain and to a lesser extent in liver and spleen.",0
1541,7,What is GDF10?,"In addition, GDF-10 mRNA was present in both neonatal and adult bone samples, with higher levels being detected in calvaria than in long bone.",1
1541,8,What is GDF10?,"These results suggest that GDF10 may play multiple roles in regulating cell differentiation events, including those involved in skeletal morphogenesis.",0
1541,9,What is GDF10?,Gdf10 was mapped to the proximal region of mouse chromosome 14 close to a region known to contain a spontaneous recessive mutation that is associated with a craniofacial defect.,1
1541,10,What is GDF10?,"Growth differentiation factor 10 (Gdf10), also known as Bmp3b, is a member of the transforming growth factor (TGF)-ß superfamily",0
1541,11,What is GDF10?,"Thus, we show for the first time, that Gdf10, expressed in Bergmann glial cells, is affected by the loss of Shh as early as E18.5, suggesting a regulation of glial development by Shh.",0
1541,12,What is GDF10?,"These results suggest that GDF10 may play multiple roles in regulating cell differentiation events, including those involved in skeletal morphogenesis.",0
1541,13,What is GDF10?,Gdf10 was mapped to the proximal region of mouse chromosome 14 close to a region known to contain a spontaneous recessive mutation that is associated with a craniofacial defect.,1
49,0,Are ultraconserved elements often transcribed?,"Starting from a genome-wide expression profiling, we demonstrate for the first time a functional link between oxygen deprivation and the modulation of long noncoding transcripts from ultraconserved regions, termed transcribed-ultraconserved regions (T-UCRs)",0
49,1,Are ultraconserved elements often transcribed?,Our data gives a first glimpse of a novel functional hypoxic network comprising protein-coding transcripts and noncoding RNAs (ncRNAs) from the T-UCRs category,0
49,2,Are ultraconserved elements often transcribed?,"Highly conserved elements discovered in vertebrates are present in non-syntenic loci of tunicates, act as enhancers and can be transcribed during development",0
49,3,Are ultraconserved elements often transcribed?,"The majority of these regions map onto ultraconserved elements and we demonstrate that they can act as functional enhancers within the organism of origin, as well as in cross-transgenesis experiments, and that they are transcribed in extant species of Olfactores.",0
49,4,Are ultraconserved elements often transcribed?,We refer to the elements as 'Olfactores conserved non-coding elements',0
49,5,Are ultraconserved elements often transcribed?,We used a custom microarray to assess the levels of UCE transcription during mouse development and integrated these data with published microarray and next-generation sequencing datasets as well as with newly produced PCR validation experiments.,0
49,6,Are ultraconserved elements often transcribed?,We show that a large fraction of non-exonic UCEs is transcribed across all developmental stages examined from only one DNA strand.,1
49,7,Are ultraconserved elements often transcribed?,"Although the nature of these transcripts remains a mistery, our meta-analysis of RNA-Seq datasets indicates that they are unlikely to be short RNAs and that some of them might encode nuclear transcripts",0
49,8,Are ultraconserved elements often transcribed?,Our data shows that the concurrent presence of enhancer and transcript function in non-exonic UCE elements is more widespread than previously shown.,0
49,9,Are ultraconserved elements often transcribed?,"Moreover through our own experiments as well as the use of next-generation sequencing datasets, we were able to show that the RNAs encoded by non-exonic UCEs are likely to be long RNAs transcribed from only one DNA strand",1
49,10,Are ultraconserved elements often transcribed?,Short ultraconserved promoter regions delineate a class of preferentially expressed alternatively spliced transcripts,0
49,11,Are ultraconserved elements often transcribed?,"The importance of other classes of non-coding RNAs, such as long intergenic ncRNAs (lincRNAs) and transcribed ultraconserved regions (T-UCRs) as altered elements in neoplasia, is also gaining recognition.",0
49,12,Are ultraconserved elements often transcribed?,"Other ncRNAs, such as PIWI-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), transcribed ultraconserved regions (T-UCRs) and large intergenic non-coding RNAs (lincRNAs) are emerging as key elements of cellular homeostasis.",0
49,13,Are ultraconserved elements often transcribed?,"The majority of these regions map onto ultraconserved elements and we demonstrate that they can act as functional enhancers within the organism of origin, as well as in cross-transgenesis experiments, and that they are transcribed in extant species of Olfactores.",0
49,14,Are ultraconserved elements often transcribed?,"Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed.",0
49,15,Are ultraconserved elements often transcribed?,"Highly conserved elements discovered in vertebrates are present in non-syntenic loci of tunicates, act as enhancers and can be transcribed during development.",0
49,16,Are ultraconserved elements often transcribed?,The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator.,0
49,17,Are ultraconserved elements often transcribed?,"In this report, we show that the Dlx-5/6 ultraconserved region is transcribed to generate an alternatively spliced form of Evf-1, the ncRNA Evf-2.",0
49,18,Are ultraconserved elements often transcribed?,These studies identify a critical role for TUC338 in regulation of transformed cell growth and of transcribed ultraconserved ncRNA as a unique class of genes involved in the pathobiology of HCC.,0
49,19,Are ultraconserved elements often transcribed?,Transcribed ultraconserved region (T-UCR) transcripts are a novel class of lncRNAs transcribed from ultraconserved regions (UCRs),1
49,20,Are ultraconserved elements often transcribed?,"The majority of these regions map onto ultraconserved elements and we demonstrate that they can act as functional enhancers within the organism of origin, as well as in cross-transgenesis experiments, and that they are transcribed in extant species of Olfactores",0
49,21,Are ultraconserved elements often transcribed?,"Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed",0
49,22,Are ultraconserved elements often transcribed?,"Other ncRNAs, such as PIWI-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), transcribed ultraconserved regions (T-UCRs) and large intergenic non-coding RNAs (lincRNAs) are emerging as key elements of cellular homeostasis",0
49,23,Are ultraconserved elements often transcribed?,Transcribed ultraconserved region in human cancers.,0
49,24,Are ultraconserved elements often transcribed?,We show that a large fraction of non-exonic UCEs is transcribed across all developmental stages examined from only one DNA strand,1
49,25,Are ultraconserved elements often transcribed?,"Although uc.338 is partially located within the poly(rC) binding protein 2 (PCBP2) gene, the transcribed ncRNA encoding uc.338 is expressed independently of PCBP2 and was cloned as a 590-bp RNA gene, termed TUC338",0
49,26,Are ultraconserved elements often transcribed?,"Moreover through our own experiments as well as the use of next-generation sequencing datasets, we were able to show that the RNAs encoded by non-exonic UCEs are likely to be long RNAs transcribed from only one DNA strand.",1
1606,0,What are the reported adverse effects of gabapentin used in children?,he purpose of our study was to review our experience with using gabapentin to treat insomnia in children.,0
1606,1,What are the reported adverse effects of gabapentin used in children?,"We identified 23 children,",0
1606,2,What are the reported adverse effects of gabapentin used in children?,Adverse effects were noted in 6 children.,0
1606,3,What are the reported adverse effects of gabapentin used in children?,To determine the effectiveness of gabapentin as an add-on therapy in children presenting with overactive bladder (OAB),0
1606,4,What are the reported adverse effects of gabapentin used in children?,Data were analyzed in 30 patients as treatment was terminated in 1 due to adverse effects.,0
1606,5,What are the reported adverse effects of gabapentin used in children?,Gabapentin gives moderate results in children with OAB refractory to conventional anticholinergics.,0
1606,6,What are the reported adverse effects of gabapentin used in children?,"In general, the drug is well tolerated with fewer adverse effects.",0
1606,7,What are the reported adverse effects of gabapentin used in children?,To describe a child who developed a skin reaction during gabapentin therapy and discuss how we evaluated the probability of an adverse drug reaction,0
1606,8,What are the reported adverse effects of gabapentin used in children?,"In contrast to other antiepileptic drugs, skin reactions to gabapentin are considered uncommon.",0
1606,9,What are the reported adverse effects of gabapentin used in children?,"In adults, reported prevalence of rash possibly related to gabapentin range from 1% to 10%.",1
1606,10,What are the reported adverse effects of gabapentin used in children?,A postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash in 0.4% of 3000 patients.,1
1606,11,What are the reported adverse effects of gabapentin used in children?,The product monograph does not mention rash in children.,0
1606,12,What are the reported adverse effects of gabapentin used in children?,"This case, and limited literature data, suggest that gabapentin may cause rash that is severe enough to necessitate discontinuation in a small percentage of children.",1
1606,13,What are the reported adverse effects of gabapentin used in children?,Further research is needed to determine the actual incidence and severity of gabapentin-related rash in this population.,1
1606,14,What are the reported adverse effects of gabapentin used in children?,Five patients treated in the Children's Hospital Pain Control Service for intractable neuropathic pain were included in gabapentin treatment,0
1606,15,What are the reported adverse effects of gabapentin used in children?,"We noticed a rapid improvement, in 1 week, of our patients' VAS scores (from 9 or 10 to 4 or 3) with minimal adverse effects",0
1606,16,What are the reported adverse effects of gabapentin used in children?,The charts of all children given gabapentin for seizures were reviewed.,0
1606,17,What are the reported adverse effects of gabapentin used in children?,"Only 8 children (7%) reported adverse effects, and the drug was discontinued in two.",0
1606,18,What are the reported adverse effects of gabapentin used in children?,"A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England.",0
1606,19,What are the reported adverse effects of gabapentin used in children?,"The cohort comprised 3,100 patients, of whom 136 (4%) were children.",0
1606,20,What are the reported adverse effects of gabapentin used in children?,"The most frequently reported adverse events reported during the first month of treatment, drowsiness/sedation, dizziness, and malaise/lassitude, also were the commonest reasons for discontinuing GBP and reported as suspected adverse drug reactions (ADRs)",0
1606,21,What are the reported adverse effects of gabapentin used in children?,Neurologic-related events were the most frequently reported adverse events.,0
1606,22,What are the reported adverse effects of gabapentin used in children?,They also were the commonest reasons for discontinuing treatment and reported as suspected ADRs.,0
1606,23,What are the reported adverse effects of gabapentin used in children?,"We reviewed the reports in the literature on the safety, adverse effects and tolerance of GBP as treatment, used as monotherapy or associated with other drugs, in epilepsies in patients of all age groups, including children, adults and the elderly",0
1606,24,What are the reported adverse effects of gabapentin used in children?,GBP is a well tolerated drug when used for monotherapy or associated with other antiepileptic drugs.,0
1606,25,What are the reported adverse effects of gabapentin used in children?,"The commonest adverse effects seen were somnolence, fainting, ataxia, nystagmus, tremor and headache.",0
1606,26,What are the reported adverse effects of gabapentin used in children?,"However, their incidence was low and intensity mild.",0
1606,27,What are the reported adverse effects of gabapentin used in children?,"There was no clear relationship between the dose given and appearance of side effects, except for fainting and somnolence.",0
1606,28,What are the reported adverse effects of gabapentin used in children?,GBP is a drug which is free of unwanted side effects.,0
1606,29,What are the reported adverse effects of gabapentin used in children?,"Its safety and tolerability profile is excellent for treatment of simple and complex partial crises, with or without generalization in epileptic patients of all ages.",0
1606,30,What are the reported adverse effects of gabapentin used in children?,Two studies were conducted to determine the single-dose pharmacokinetics of gabapentin in healthy subjects age 1 month to 12 years and to guide dose selection in safety and efficacy trials in pediatric patients,0
1606,31,What are the reported adverse effects of gabapentin used in children?,Single doses of gabapentin were well tolerated by healthy pediatric subjects.,0
1606,32,What are the reported adverse effects of gabapentin used in children?,"The efficacy and safety of gabapentin as add-on therapy for refractory partial seizures in 237 children, aged 3 to 12 years were evaluated over a 6-month period.",0
1606,33,What are the reported adverse effects of gabapentin used in children?,Thirteen patients (5%) withdrew during the 6-month period because of adverse events.,0
1606,34,What are the reported adverse effects of gabapentin used in children?,"Male or female patients, at least 12 years old, with a recent history of partial seizures with or without secondary generalization, were randomized to receive gabapentin",0
1606,35,What are the reported adverse effects of gabapentin used in children?,"Of the four most common adverse events (somnolence, dizziness, ataxia, fatigue), only one, dizziness, occurred more often in the nontitrated (Rapid initiation) group than in the titrated (Slow initiation) group.",0
1606,36,What are the reported adverse effects of gabapentin used in children?,"Twenty-six children with intellectual disability and six normal children, all suffering from refractory partial seizures, received open-label gabapentin (range = 10-50 mg kg(-1) day(-1); mean = 26.7 mg kg(-1) day(-1) as an add-on medication to their antiepileptic drug regimen",0
1606,37,What are the reported adverse effects of gabapentin used in children?,"In the present patient population, patients younger than 10 years of age, all of whom had intellectual disability, were more likely to have side-effects than those older than 10 years of age.",0
1606,38,What are the reported adverse effects of gabapentin used in children?,"Observed adverse effects, which were generally mild, occurred in patients with baseline intellectual disability, attention deficit disorder and behavioural problems.",0
1606,39,What are the reported adverse effects of gabapentin used in children?,Behavioural adverse effects warranted discontinuation of the medication in only three patients.,0
1606,40,What are the reported adverse effects of gabapentin used in children?,The severity of intellectual disability (mild versus moderate or severe) did not affect the extent of the response or the occurrence of side-effects.,0
1606,41,What are the reported adverse effects of gabapentin used in children?,"However, children with intellectual disability who also are less than 10 years of age with baseline attention deficit appear to be at a higher risk of behavioural side-effects.",0
1606,42,What are the reported adverse effects of gabapentin used in children?,Efficacy and safety of gabapentin monotherapy were evaluated in 33 children with newly diagnosed absence epilepsy,0
1606,43,What are the reported adverse effects of gabapentin used in children?,Somnolence and dizziness were the only adverse events reported by at least two patients during gabapentin treatment.,0
1606,44,What are the reported adverse effects of gabapentin used in children?,No clinically important changes in laboratory assessments or other safety parameters were observed.,0
1606,45,What are the reported adverse effects of gabapentin used in children?,Thirty-two children with refractory partial epilepsy received open-label gabapentin as an additional medication to their antiepileptic drug regimen,0
1606,46,What are the reported adverse effects of gabapentin used in children?,The major reported side effects were behavioral.,0
1606,47,What are the reported adverse effects of gabapentin used in children?,"These consisted of hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit.",0
1606,48,What are the reported adverse effects of gabapentin used in children?,We report 2 children who received GBP for intractable seizures and who developed intolerable aggressive behavior requiring dose reduction or drug discontinuation.,0
1606,49,What are the reported adverse effects of gabapentin used in children?,"Behavioral changes should be recognized as a possible side effect of GBP, especially in mentally retarded children.",0
1606,50,What are the reported adverse effects of gabapentin used in children?,We report 7 children who received gabapentin (GBP) as adjunctive medic ation and subsequently developed behavioral side effects.,0
1606,51,What are the reported adverse effects of gabapentin used in children?,These behavioral changes consisted of intensification of baseline behaviors as well as new behavioral problems.,0
1606,52,What are the reported adverse effects of gabapentin used in children?,"Behaviors that parents considered most troublesome were tantrums, aggression directed toward others, hyperactivity, and defiance.",0
1606,53,What are the reported adverse effects of gabapentin used in children?,All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP.,0
1606,54,What are the reported adverse effects of gabapentin used in children?,All children had baseline attention deficit hyperactivity disorder and developmental delays.,0
1606,55,What are the reported adverse effects of gabapentin used in children?,"We described 3 learning disabled children, 1 aged 7 and 2 aged 10 years, with intractable partial seizures who developed severe behavioral problems while receiving modest doses of GBP.",0
1606,56,What are the reported adverse effects of gabapentin used in children?,The children became hyperactive and had explosive outburst consisting of aggressive and oppositional behavior.,0
1606,57,What are the reported adverse effects of gabapentin used in children?,The behavioral problems were sufficiently severe to require discontinuation of GBP despite moderately improved seizure control.,1
2177,0,What happens upon disruption of a TAD boundary?,Disruption of a TAD boundary causes ectopic chromosomal contacts and long-range transcriptional misregulation.,1
2177,1,What happens upon disruption of a TAD boundary?,Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions,1
2177,2,What happens upon disruption of a TAD boundary?,"Both in mouse limb tissue and patient-derived fibroblasts, disease-relevant structural changes cause ectopic interactions between promoters and non-coding DNA, and a cluster of limb enhancers normally associated with Epha4 is misplaced relative to TAD boundaries and drives ectopic limb expression of another gene in the locus.",1
2177,3,What happens upon disruption of a TAD boundary?,This rewiring occurred only if the variant disrupted a CTCF-associated boundary domain.,1
2177,4,What happens upon disruption of a TAD boundary?,Disruption of a TAD boundary causes ectopic chromosomal contacts and long-range transcriptional misregulation.,1
1060,0,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,"Comparative kinetic analysis of AzgA and Fcy21p, prototypes of the two major fungal hypoxanthine-adenine-guanine transporter families",1
1060,1,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,We carried out a comparative kinetic analysis of two prototypes of these transporter families.,0
1060,2,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,"The first was Fcy21p, a herein characterized protein of Candida albicans, and the second was AzgA, a transporter of Aspergillus nidulans",0
1060,3,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,The azgA gene of Aspergillus nidulans encodes a hypoxanthine-adenine-guanine transporter,1
1060,4,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,"In Aspergillus nidulans, loss-of-function mutations in the uapA and azgA genes, encoding the major uric acid-xanthine and hypoxanthine-adenine-guanine permeases, respectively, result in impaired utilization of these purines as sole nitrogen sources",0
1060,5,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,"Comparative kinetic analysis of AzgA and Fcy21p, prototypes of the two major fungal hypoxanthine-adenine-guanine transporter families.",1
1060,6,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,The azgA gene of Aspergillus nidulans encodes a hypoxanthine-adenine-guanine transporter.,1
1060,7,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,"In Aspergillus nidulans, loss-of-function mutations in the uapA and azgA genes, encoding the major uric acid-xanthine and hypoxanthine-adenine-guanine permeases, respectively, result in impaired utilization of these purines as sole nitrogen sources.",0
1060,8,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,"Modelling, substrate docking and mutational analysis identify residues essential for function and specificity of the major fungal purine transporter AzgA.",1
1060,9,List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.,"In Arabidopsis two proteins, AtAzg1 and AtAzg2, show substantial amino acid sequence similarity to the adenine-guanine-hypoxanthine transporter AzgA of Aspergillus nidulans",0
138,0,Which are the plant DNA (cytosine-5) methyltransferase families?,The topologies of the trees were overall congruent: four monophyletic groups corresponding to the four plant C5-MTase families were clearly distinguished.,1
138,1,Which are the plant DNA (cytosine-5) methyltransferase families?,"In addition, sequence analyses of the plant C5-MTase target recognition domain sequences were performed and phylogenetic trees were reconstructed showing that there is good conservation among but not within the plant C5-MTase families.",0
138,2,Which are the plant DNA (cytosine-5) methyltransferase families?,"To determine the inheritance of DNA methyltransferase genes and their expression patterns we examined three major DNA methyltransferase families (MET1, CMT3 and DRM) from tobacco and the progenitor species.",0
138,3,Which are the plant DNA (cytosine-5) methyltransferase families?,"The comparative investigation of transcription levels of different genes of cytosine DNA methyltransferase family MET (MET1, MET2a, MET2b, MET3) and their methylation patterns shows that there may exist some mechanisms defending the most actively transcribed gene MET1 of this family from methylation mediated silencing.",0
138,4,Which are the plant DNA (cytosine-5) methyltransferase families?,In contrast to DRM2 gene we could not find any adenine methylated GATC sites in the MET1 gene.,0
138,5,Which are the plant DNA (cytosine-5) methyltransferase families?,"Using the 1kb 3' terminal DNA fragment of the mouse methyltransferase cDNA as a probe and low stringent hybridisation conditions, a new potential methyltransferase (MTase) gene family was isolated from an Arabidopsis thaliana genomic DNA library.",0
138,6,Which are the plant DNA (cytosine-5) methyltransferase families?,The Dnmt3 family of de novo DNA methyltransferases has recently been characterized in animals.,1
138,7,Which are the plant DNA (cytosine-5) methyltransferase families?,"Here we describe DNA methyltransferase genes from both Arabidopsis and maize that show a high level of sequence similarity to Dnmt3, suggesting that they encode plant de novo methyltransferases.",0
138,8,Which are the plant DNA (cytosine-5) methyltransferase families?,"Relative to all known eukaryotic methyltransferases, these plant proteins contain a novel arrangement of the motifs required for DNA methyltransferase catalytic activity.",0
138,9,Which are the plant DNA (cytosine-5) methyltransferase families?,These results provide the first direct demonstration that DNA-METases of a higher eukaryote are encoded by a gene family.,0
138,10,Which are the plant DNA (cytosine-5) methyltransferase families?,Here we show that Arabidopsis DNA methyltransferase2 (AtDNMT2) is localized in nucleus and associates with histone deacetylation.,0
138,11,Which are the plant DNA (cytosine-5) methyltransferase families?,"To explore possible relationships between DNA methylation level and accumulation of DNA-(cytosine-5) methyltransferase (DNMT) transcripts, the full-length coding sequences corresponding to three different DNMT families in oil palm, namely the MET, CMT, and DRM classes, have been isolated and characterized.",1
138,12,Which are the plant DNA (cytosine-5) methyltransferase families?,In Arabidopsis a SWI2/SNF2 chromatin remodeling factor-related protein DDM1 and a cytosine methyltransferase MET1 are required for maintenance of genomic cytosine methylation.,0
138,13,Which are the plant DNA (cytosine-5) methyltransferase families?,"Relative to all known eukaryotic methyltransferases, these plant proteins contain a novel arrangement of the motifs required for DNA methyltransferase catalytic activity.",0
138,14,Which are the plant DNA (cytosine-5) methyltransferase families?,"In the present study, the isolation and characterization of two distinct cDNAs that code for carrot DNA (cytosine-5)-methyltransferase (DNA-METase) are reported.",1
138,15,Which are the plant DNA (cytosine-5) methyltransferase families?,The Arabidopsis methylase has eight of the ten conserved sequence motifs found in prokaryote cytosine-5 methyltransferases and shows 50% homology to the murine enzyme in the methyltransferase domain.,1
138,16,Which are the plant DNA (cytosine-5) methyltransferase families?,As deduced form the DNA sequence this protein contains all conserved sequence motifs specific for the 5m cytosine MTases.,0
997,0,Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences,"The problem of finding an optimal structural alignment for a pair of superimposed proteins is often amenable to the Smith-Waterman dynamic programming algorithm, which runs in time proportional to the product of lengths of the sequences being aligned.",1
997,1,Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences,"While this result is not an asymptotic improvement over the original Smith-Waterman algorithm, its complexity is characterized in terms of some sparse features of the matrix and it yields the fastest software implementation to date for such searches.",1
997,2,Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences,"If we use N, M and C to represent the size of an amino acid sequence, the size of a structure template, and the maximum cut size of long-range interactions, respectively, the algorithm finds an optimal structure-sequence alignment in O(21C NM) time, a polynomial function of N and M when C = O(log(N + M)).",1
997,3,Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences,"When running on structure-sequence alignment problems without long-range intersections, i.e.",0
997,4,Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences,"C = 0, the algorithm achieves the same asymptotic computational complexity of the Smith-Waterman sequence-sequence alignment algorithm.",1
997,5,Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences,The algorithm is based on fractional programming and its running time is O(n2log n).,0
997,6,Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences,"In practice, normalized local alignment is only 3-5 times slower than the standard Smith-Waterman algorithm.",1
2868,0,Is pazopanib an effective treatment of glioblastoma?,"RESULTS: The six-month progression-free survival (PFS) rates in phase II (n = 41) were 0% and 15% in the PTEN/EGFRvIII-positive and PTEN/EGFRvIII-negative cohorts, respectively, leading to early termination.",1
2868,1,Is pazopanib an effective treatment of glioblastoma?,Single-agent pazopanib did not prolong PFS in this patient population but showed in situ biological activity as demonstrated by radiographic responses.,1
3035,0,Is Lasmiditan effective for migraine?,"Amongst the ditans, lasmiditan: (i) fails to constrict human coronary arteries; and (ii) is effective for the acute treatment of migraine in preliminary Phase III clinical trials.",1
3035,1,Is Lasmiditan effective for migraine?,"Although ongoing phase III clinical trials are needed to confirm its efficacy and safety, lasmiditan might offer an alternative to treat acute migraine with no associated cardiovascular risk.",0
3035,2,Is Lasmiditan effective for migraine?,"Lasmiditan is considered to be the first member of a new drug category, the neurally acting anti-migraine agent (NAAMA)",0
3035,3,Is Lasmiditan effective for migraine?,Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice.,1
3035,4,Is Lasmiditan effective for migraine?,"Lasmiditan, a highly selective 5-HT1F agonist, has completed two Phase III randomized, double blind, placebo-controlled clinical trials, with a third - a long-term, open-label safety study - still underway.",0
3035,5,Is Lasmiditan effective for migraine?,Research to date suggests lasmiditan lacks vasoconstrictive properties and may be a safe and effective treatment option in patients refractory to current acute migraine medications or who have cardiovascular risk factors.,0
3035,6,Is Lasmiditan effective for migraine?,Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.,1
3035,7,Is Lasmiditan effective for migraine?,"Compared with placebo, more patients dosed with lasmiditan 200 mg were free of headache pain at 2 hours after dosing (32.2% vs 15.3%; odds ratio [OR] 2.6, 95% confidence interval [CI] 2.0-3.6, p< 0.001), similar to those dosed with lasmiditan 100 mg (28.2%; OR 2.2, 95% CI 1.6-3.0, p< 0.001).",0
3035,8,Is Lasmiditan effective for migraine?,"Furthermore, compared with those dosed with placebo, more patients dosed with lasmiditan 200 mg (40.7% vs 29.5%; OR 1.6, 95% CI 1.3-2.1, p< 0.001) and lasmiditan 100 mg (40.9%; OR 1.7, 95% CI, 1.3-2.2, p< 0.001) were free of their MBS at 2 hours after dosing.",0
3035,9,Is Lasmiditan effective for migraine?,CONCLUSIONS: Lasmiditan dosed at 200 and 100 mg was efficacious and well tolerated in the treatment of acute migraine among patients with a high level of cardiovascular risk factors,0
3035,10,Is Lasmiditan effective for migraine?,"CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for adult patients with migraine, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a migraine attack.",0
3035,11,Is Lasmiditan effective for migraine?,"For the understanding of migraine pathophysiology, it is very important to note that a selective 5-HT(1F) receptor agonist like lasmiditan is effective in the acute treatment of migraine.",0
3035,12,Is Lasmiditan effective for migraine?,"While lasmiditan most likely is effective in the treatment of migraine attacks it had, unfortunately, a high incidence of CNS related AEs in the oral RCT.",1
3035,13,Is Lasmiditan effective for migraine?,"Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial.At intravenous doses of 20 mg and higher, lasmiditan proved effective in the acute treatment of migraine.",0
3035,14,Is Lasmiditan effective for migraine?,Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice.,1
3035,15,Is Lasmiditan effective for migraine?,"BACKGROUND
Lasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study.",0
3035,16,Is Lasmiditan effective for migraine?,"INTERPRETATION
Oral lasmiditan seems to be safe and effective in the acute treatment of migraine.",0
3035,17,Is Lasmiditan effective for migraine?,"The 5-HT1F receptor agonist lasmiditan, a drug acting through non-vasoconstrictive mechanisms, represents a promising safe, effective and tolerated acute migraine therapy also for patients at cardiovascular risk.",0
3035,18,Is Lasmiditan effective for migraine?,"For the understanding of migraine pathophysiology, it is very important to note that a selective 5-HT(1F) receptor agonist like lasmiditan is effective in the acute treatment of migraine.",0
3035,19,Is Lasmiditan effective for migraine?,The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials.,0
3035,20,Is Lasmiditan effective for migraine?,"Within the past few years, new and promising drugs such as more specific 5-HT 1F receptor agonists (that is, lasmiditan) and monoclonal calcitonin gene-related peptide (CGRP) receptor antibodies entered advanced development phases while non-invasive neuromodulatory approaches were suggested to be potentially effective as non-pharmaceutical interventions for migraine.",0
3035,21,Is Lasmiditan effective for migraine?,"CLASSIFICATION OF EVIDENCE
This study provides Class I evidence that for adult patients with migraine, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a migraine attack.",0
3035,22,Is Lasmiditan effective for migraine?,"BACKGROUND Lasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study.",0
3035,23,Is Lasmiditan effective for migraine?,INTERPRETATION Oral lasmiditan seems to be safe and effective in the acute treatment of migraine.,0
3035,24,Is Lasmiditan effective for migraine?,Research to date suggests lasmiditan lacks vasoconstrictive properties and may be a safe and effective treatment option in patients refractory to current acute migraine medications or who have cardiovascular risk factors.,0
3035,25,Is Lasmiditan effective for migraine?,"The non-vascular, neural mechanism of action of lasmiditan may offer an alternative means to treat migraine especially in patients who have contra-indications for agents with vasoconstrictor activity.",0
3035,26,Is Lasmiditan effective for migraine?,"Compared with placebo, more patients dosed with lasmiditan 200 mg were free of headache pain at 2 hours after dosing (32.2% vs 15.3%; odds ratio [OR] 2.6, 95% confidence interval [CI] 2.0-3.6, <br><b>CONCLUSIONS</b>: Lasmiditan dosed at 200 and 100 mg was efficacious and well tolerated in the treatment of acute migraine among patients with a high level of cardiovascular risk factors.<br><b>CLINICALTRIALSGOV IDENTIFIER</b>: NCT02439320.<br><b>CLASSIFICATION OF EVIDENCE</b>: This study provides Class I evidence that for adult patients with migraine, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a migraine attack.<br>",0
3035,27,Is Lasmiditan effective for migraine?,"The most common adverse events were CNS related and included dizziness, fatigue, vertigo, paraesthesia, and somnolence.<br><b>INTERPRETATION</b>: Oral lasmiditan seems to be safe and effective in the acute treatment of migraine.",0
3035,28,Is Lasmiditan effective for migraine?,"Dizziness, paresthesia and sensations of heaviness (usually limb) were more common on lasmiditan.<br><b>CONCLUSIONS</b>: At intravenous doses of 20 mg and higher, lasmiditan proved effective in the acute treatment of migraine.",0
3035,29,Is Lasmiditan effective for migraine?,"<b>BACKGROUND</b>: Lasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study.",0
3035,30,Is Lasmiditan effective for migraine?,"For the understanding of migraine pathophysiology, it is very important to note that a selective 5-HT(1F) receptor agonist like lasmiditan is effective in the acute treatment of migraine.",0
3035,31,Is Lasmiditan effective for migraine?,"This study provides Class I evidence that for adult patients with migraine, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a migraine attack.",0
3035,32,Is Lasmiditan effective for migraine?,"While lasmiditan most likely is effective in the treatment of migraine attacks it had, unfortunately, a high incidence of CNS related AEs in the oral RCT.",0
2414,0,Which disease risk can be estimated with the Stop-Bang questionnaire?,"STUDY OBJECTIVE: The aim of this study is to evaluate whether adding the item of ""apple body type"" to the STOP-BANG questionnaire enhances diagnostic performance of the questionnaire for detecting obstructive sleep apnea (OSA).",0
2414,1,Which disease risk can be estimated with the Stop-Bang questionnaire?,"CONCLUSION: In the sleep center setting, adding the body type item to the STOP-BANG questionnaire improves not only clinical prediction for PSG confirmed OSA but also predicts moderate to severe of OSA.",0
2414,2,Which disease risk can be estimated with the Stop-Bang questionnaire?," High and low probability of OSA were defined as a STOP-Bang score of ≥5 (h-OSA) and of<5 (l-OSA), respectively.",0
2414,3,Which disease risk can be estimated with the Stop-Bang questionnaire?,The STOP-BANG questionnaire improves the detection of epilepsy patients at risk for obstructive sleep apnea.,1
2414,4,Which disease risk can be estimated with the Stop-Bang questionnaire?,"We performed a quality improvement project, evaluating for improvements in the screening of OSA in epilepsy patients using the STOP-BANG questionnaire.",0
2414,5,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: A bivariate meta-analysis.",0
2414,6,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Although screening tools such as the Berlin questionnaire (BQ), STOP-BANG questionnaire (SBQ), STOP questionnaire (STOP), and Epworth sleepiness scale (ESS) are widely used for OSA, the findings regarding their diagnostic accuracy are controversial.",0
2414,7,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Compared with the BQ, STOP, and ESS, the SBQ is a more accurate tool for detecting mild, moderate, and severe OSA.",0
2414,8,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Sleep specialists should use the SBQ to conduct patient interviews for the early diagnosis of OSA in clinical settings, particularly in resource-poor countries and sleep clinics where PSG is unavailable.",0
2414,9,Which disease risk can be estimated with the Stop-Bang questionnaire?,Modified Mallampati Score Improves Specificity of STOP-BANG Questionnaire for Obstructive Sleep Apnea.,0
2414,10,Which disease risk can be estimated with the Stop-Bang questionnaire?,"BACKGROUND: An accurate, clinical screening tool for obstructive sleep apnea (OSA) that identifies patients for further diagnostic testing would assist in the diagnosis of this comorbidity.",0
2414,11,Which disease risk can be estimated with the Stop-Bang questionnaire?,"One example, the STOP-BANG questionnaire (SBQ), has been validated as a screening tool with high sensitivity.",0
2414,12,Which disease risk can be estimated with the Stop-Bang questionnaire?,"The validated Berlin, STOP-BANG, and Epworth Sleepiness Scale questionnaires were administered to all eligible subjects to assess SA risk and daytime somnolence, and their demographic and clinical information, health-related quality of life, and symptoms of depression were collected using the questionnaires.",0
2414,13,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Ninety-nine (49.5%) subjects were identified as high risk for SA using the Berlin questionnaire, whereas 26 (13%), 137 (68.5%), and 37 (18.5%) subjects were classified as low, intermediate, and high risk for SA, respectively, using the STOP-BANG questionnaire.",0
2414,14,Which disease risk can be estimated with the Stop-Bang questionnaire?,"CONCLUSIONS: The SACS and the STOP-Bang questionnaires (BMI threshold of 25 kg/m2) were found to provide the best positive and negative LRs, respectively, for the prediction of OSA.",0
2414,15,Which disease risk can be estimated with the Stop-Bang questionnaire?,The aims of this study were to (1) explore the incidence of right-sided heart dysfunction (RHD) and STOP-Bang questionnaire responses consistent with obstructive sleep apnea (OSA) and (2) assess the relationship between patients with STOP-Bang questionnaire responses consistent with OSA and echocardiographic findings suggestive of RHD.,0
2414,16,Which disease risk can be estimated with the Stop-Bang questionnaire?,"This study aims: (1) to identify patients with multiple sclerosis (MS) who are at high risk for obstructive sleep apnea (OSA) by utilizing the STOP-BANG questionnaire and (2) to evaluate the relationship between OSA risk as determined by the STOP-BANG questionnaire and self-reported sleepiness and fatigue using the Epworth Sleepiness Scale (ESS) and the Fatigue Severity Scale (FSS), respectively.",0
2414,17,Which disease risk can be estimated with the Stop-Bang questionnaire?,Validation of the STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea among Different Populations: A Systematic Review and Meta-Analysis.,0
2414,18,Which disease risk can be estimated with the Stop-Bang questionnaire?,Validation of a Portuguese version of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea: Analysis in a sleep clinic.,0
2414,19,Which disease risk can be estimated with the Stop-Bang questionnaire?,This meta-analysis confirms the high performance of the STOP-Bang questionnaire in the sleep clinic and surgical population for screening of OSA.,0
2414,20,Which disease risk can be estimated with the Stop-Bang questionnaire?,"<b>PURPOSE OF REVIEW</b>: The present review aims to provide an update on the various practical applications of the STOP-Bang questionnaire in anesthesia, surgery, and perioperative medicine.<br><b>RECENT FINDINGS</b>: The STOP-Bang questionnaire was originally validated as a screening tool to identify surgical patients who are at high-risk of obstructive sleep apnea (OSA).",0
2414,21,Which disease risk can be estimated with the Stop-Bang questionnaire?,Patients with a STOP-Bang score of 0--2 can be classified as low-risk for moderate-to-severe OSA.,0
2414,22,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Further, patients with a STOP-Bang score at least 3 can be classified as high risk for moderate-to-severe OSA if the serum HCO3 at least 28 mmol/l.",0
2414,23,Which disease risk can be estimated with the Stop-Bang questionnaire?,STOP-Bang can be used as a novel tool for perioperative risk stratification because it easily identifies patients who are at increased risk of perioperative complications.<br><b>SUMMARY</b>: STOP-Bang at least 3 was recommended previously to identify the suspected or undiagnosed OSA.,0
2414,24,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Because of its practical application, STOP-Bang is a useful screening tool for patients with suspected or undiagnosed OSA.<br>",0
2414,25,Which disease risk can be estimated with the Stop-Bang questionnaire?,The STOP-BANG questionnaire has been used to identify surgical patients at risk for undiagnosed obstructive sleep apnea (OSA) by classifying patients as low risk (LR) if STOP-BANG score < 3 or high risk (HR) if STOP-BANG score ≥ 3.,1
2414,26,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Among the questionnaires that are commonly used for obstructive sleep apnoea screening, it remains unclear whether the STOP-BANG or Berlin Obstructive Sleep Apnoea Syndrome questionnaire is more effective in terms of ease of use, usage period and diagnosis of surgical patients with obstructive sleep apnoea risk.",0
2414,27,Which disease risk can be estimated with the Stop-Bang questionnaire?,Evaluation of the Arabic version of STOP-Bang questionnaire as a screening tool for obstructive sleep apnea.,0
2414,28,Which disease risk can be estimated with the Stop-Bang questionnaire?,The STOP-BANG questionnaire offers clinicians an efficient and objective tool for improving detection of OSA risk in MS patients.,0
2414,29,Which disease risk can be estimated with the Stop-Bang questionnaire?,Alternative scoring models of STOP-bang questionnaire improve specificity to detect undiagnosed obstructive sleep apnea.,1
2414,30,Which disease risk can be estimated with the Stop-Bang questionnaire?,"The Arabic version of STOP-Bang questionnaire is an easy-to-use tool that can be implemented as a reliable, quick screening tool for OSA in patients referred to sleep clinic.",0
2414,31,Which disease risk can be estimated with the Stop-Bang questionnaire?,"This study aims: (1) to identify patients with multiple sclerosis (MS) who are at high risk for obstructive sleep apnea (OSA) by utilizing the STOP-BANG questionnaire and (2) to evaluate the relationship between OSA risk as determined by the STOP-BANG questionnaire and self-reported sleepiness and fatigue using the Epworth Sleepiness Scale (ESS) and the Fatigue Severity Scale (FSS), respectively.",0
2414,32,Which disease risk can be estimated with the Stop-Bang questionnaire?,This study aimed to compare the efficiency of the STOP-BANG and Berlin Obstructive Sleep Apnoea Syndrome questionnaires for evaluating potential respiratory complications during the perioperative period.,0
2414,33,Which disease risk can be estimated with the Stop-Bang questionnaire?,OBJECTIVE The STOP-Bang questionnaire was developed as a quick and simple screening tool for obstructive sleep apnea (OSA) in preoperative clinics.,0
2414,34,Which disease risk can be estimated with the Stop-Bang questionnaire?,This study aimed to evaluate and validate the Arabic version of Stop-Bang questionnaire as a screening tool for patients with OSA symptoms referred to a sleep clinic.,0
2414,35,Which disease risk can be estimated with the Stop-Bang questionnaire?,RESULTS Eighty-three out of 200 patients had a high risk of OSA based on the STOP-Bang questionnaire.,0
2414,36,Which disease risk can be estimated with the Stop-Bang questionnaire?,"CONCLUSION The Arabic version of STOP-Bang questionnaire is an easy-to-use tool that can be implemented as a reliable, quick screening tool for OSA in patients referred to sleep clinic.",0
2414,37,Which disease risk can be estimated with the Stop-Bang questionnaire?,RECENT FINDINGS The STOP-Bang questionnaire was originally validated as a screening tool to identify surgical patients who are at high-risk of obstructive sleep apnea (OSA).,1
2414,38,Which disease risk can be estimated with the Stop-Bang questionnaire?,We aimed to evaluate the validity of the STOP-Bang questionnaire to predict moderate-to-severe and severe OSA in the general population.,0
2414,39,Which disease risk can be estimated with the Stop-Bang questionnaire?,STUDY OBJECTIVE To determine if a high score (≥ 3) on the STOP-Bang screening questionnaire for obstructive sleep apnea (OSA) predicts whether obese patients are at high risk for OSA and increased risk of difficult airway.,0
2414,40,Which disease risk can be estimated with the Stop-Bang questionnaire?,CONCLUSION The STOP-Bang questionnaire can be used as a screening tool in the general population in view of its moderate sensitivity and high negative predictive value for subjects with moderate-to-severe and severe OSA.,0
2414,41,Which disease risk can be estimated with the Stop-Bang questionnaire?,"Subjects completed a questionnaire evaluating the presence and severity of AR and the STOP-BANG questionnaire (snoring, tiredness during daytime, observed apnea, high blood pressure, body mass index, age, neck circumference, gender), a validated screening method to identify obstructive sleep apnea syndrome risk.",0
2414,42,Which disease risk can be estimated with the Stop-Bang questionnaire?,The STOP-BANG questionnaire has been used to identify surgical patients at risk for undiagnosed obstructive sleep apnea (OSA) by classifying patients as low risk (LR) if STOP-BANG score < 3 or high risk (HR) if STOP-BANG score ≥ 3.,1
2414,43,Which disease risk can be estimated with the Stop-Bang questionnaire?,The STOP-BANG questionnaire offers clinicians an efficient and objective tool for improving detection of OSA risk in MS patients.,0
2414,44,Which disease risk can be estimated with the Stop-Bang questionnaire?,"PURPOSE This study aims: (1) to identify patients with multiple sclerosis (MS) who are at high risk for obstructive sleep apnea (OSA) by utilizing the STOP-BANG questionnaire and (2) to evaluate the relationship between OSA risk as determined by the STOP-BANG questionnaire and self-reported sleepiness and fatigue using the Epworth Sleepiness Scale (ESS) and the Fatigue Severity Scale (FSS), respectively.",0
2414,45,Which disease risk can be estimated with the Stop-Bang questionnaire?,CONCLUSIONS Over 40% of MS patients were identified as high risk for OSA based on the STOP-BANG questionnaire.,0
2414,46,Which disease risk can be estimated with the Stop-Bang questionnaire?,"The high-risk group patients identified by STOP-BANG had significantly higher respiratory disturbance index and lower minimum oxygen saturation than the low-risk group patients.<br><b>CONCLUSION</b>: Among the four questionnaires studied, STOP-BANG, with only eight questions and the highest sensitivity, is the best questionnaire of the four for OSA screening.",0
2414,47,Which disease risk can be estimated with the Stop-Bang questionnaire?,"<b>BACKGROUND</b>: The present study validates and evaluates the sensitivity and specificity of four internationally popular questionnaires, translated into Chinese, for assessing suspected obstructive sleep apnea (OSA) patients, namely, the Berlin questionnaire, the ASA checklist, the STOP questionnaire and the STOP-BANG questionnaire.",0
2414,48,Which disease risk can be estimated with the Stop-Bang questionnaire?,"We hypothesized that the STOP-Bang questionnaire, a screening tool for obstructive sleep apnea (OSA), can predict difficult intubation.<br><b>PATIENTS AND METHODS</b>: In this prospective cohort study, 200 adult surgical patients undergoing surgery under general anesthesia were studied to evaluate the usefulness of the STOP-Bang questionnaire for predicting difficult intubation.",0
3304,0,Which algorithm has been developed for detecting expansions of tandem repeats?,"Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data.",1
3304,1,Which algorithm has been developed for detecting expansions of tandem repeats?,A solution to this problem is an important step toward integrating WGS into precision medicine.,1
3304,2,Which algorithm has been developed for detecting expansions of tandem repeats?,"We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length.",1
3304,3,Which algorithm has been developed for detecting expansions of tandem repeats?,We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR).,0
3304,4,Which algorithm has been developed for detecting expansions of tandem repeats?,"Compared against this truth data, ExpansionHunter correctly classified all (212/212, 95% CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions (4).",0
3304,5,Which algorithm has been developed for detecting expansions of tandem repeats?,"Additionally, 99.9% (2786/2789, 95% CI [0.997, 1.00]) of the wild-type samples were correctly classified as wild type by this method with the remaining three samples identified as possible expansions.",0
3304,6,Which algorithm has been developed for detecting expansions of tandem repeats?,"We further applied our algorithm to a set of 152 samples in which every sample had one of eight different pathogenic repeat expansions, including those associated with fragile X syndrome, Friedreich's ataxia, and Huntington's disease, and correctly flagged all but one of the known repeat expansions.",0
3304,7,Which algorithm has been developed for detecting expansions of tandem repeats?,"Thus, ExpansionHunter can be used to accurately detect known pathogenic repeat expansions and provides researchers with a tool that can be used to identify new pathogenic repeat expansions.",1
3304,8,Which algorithm has been developed for detecting expansions of tandem repeats?,"We developed a software tool called ExpansionHunter that , using PCR-free WGS short-read data , can genotype repeats at the locus of interest , even if the expanded repeat is larger than the read length",1
258,0,Which are the major types of the motor speech disorder dysarthria?,"Dysarthria is a motor speech disorder which can be classified according to the underlying neuropathology and is associated with disturbances of respiration, laryngeal function, airflow direction, and articulation resulting in difficulties of speech quality and intelligibility.",1
258,1,Which are the major types of the motor speech disorder dysarthria?,"There are six major types of dysarthria: flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria and hypokinetic dysarthria, which are related to a disorder of the extrapyramidal system.",1
258,2,Which are the major types of the motor speech disorder dysarthria?,"The sixth is generally termed a mixed dysarthria and is associated with damage in more than one area, resulting in speech characteristics of at least two groups.",0
258,3,Which are the major types of the motor speech disorder dysarthria?,address voice problems of stroke patients with mixed dysarthria,0
258,4,Which are the major types of the motor speech disorder dysarthria?,"Characterizing intonation deficit in motor speech disorders: an autosegmental-metrical analysis of spontaneous speech in hypokinetic dysarthria, ataxic dysarthria",0
258,5,Which are the major types of the motor speech disorder dysarthria?,ataxic dysarthria (AT),0
258,6,Which are the major types of the motor speech disorder dysarthria?,Acoustic analysis provides objective quantitative measures of speech that enable a comprehensive and accurate understanding of motor disorders and complement the traditional measures.,0
258,7,Which are the major types of the motor speech disorder dysarthria?,"This paper aims to distinguish between normal and pathological speech, more specifically between apraxia of speech and spastic dysarthria",0
258,8,Which are the major types of the motor speech disorder dysarthria?,Long-term phonatory instability in ataxic dysarthria.,0
258,9,Which are the major types of the motor speech disorder dysarthria?,The objective of this study is to evaluate phonation in ataxic dysarthria and a control group of normal speakers,0
258,10,Which are the major types of the motor speech disorder dysarthria?,Dysprosody is a common feature in speakers with hypokinetic dysarthria.,0
258,11,Which are the major types of the motor speech disorder dysarthria?,"The prosodic profile of Cantonese speakers with hypokinetic dysarthria is similar to those of other languages (for example, English).",0
258,12,Which are the major types of the motor speech disorder dysarthria?,"Classification of dysarthria types comprises flaccid, spastic, ataxic, hypo- and hyperkinetic and mixed dysarthria.",0
258,13,Which are the major types of the motor speech disorder dysarthria?,"Dysarthria affects linguistic domains such as respiration, phonation, articulation, resonance and prosody due to upper motor neuron, lower motor neuron, cerebellar or extrapyramidal tract lesions.",0
258,14,Which are the major types of the motor speech disorder dysarthria?,"The dysarthria types were spastic (15 subjects), flaccid (10), mixed (12), hypokinetic (12), hyperkinetic (9) and ataxic (8).",0
258,15,Which are the major types of the motor speech disorder dysarthria?,"Dysarthria is a motor speech disorder which can be classified according to the underlying neuropathology and is associated with disturbances of respiration, laryngeal function, airflow direction, and articulation resulting in difficulties of speech quality and intelligibility.",0
258,16,Which are the major types of the motor speech disorder dysarthria?,"There are six major types of dysarthria: flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria and hypokinetic dysarthria, which are related to a disorder of the extrapyramidal system.",1
258,17,Which are the major types of the motor speech disorder dysarthria?,"There are six major types of dysarthria: flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria and hypokinetic dysarthria, which are related to a disorder of the extrapyramidal system.",1
258,18,Which are the major types of the motor speech disorder dysarthria?,"Motor neuron disease encompasses a group of terminal, demyelinating diseases affecting upper- and lower-motor neurons and producing muscular weakness resulting in a flaccid, spastic, or spastic-flaccid dysarthria of speech.",0
258,19,Which are the major types of the motor speech disorder dysarthria?,"Dysarthria is a frequently occurring motor speech disorder which can be caused by neurological trauma, cerebral palsy, or degenerative neurological diseases.",0
258,20,Which are the major types of the motor speech disorder dysarthria?,Dysarthria is a motor disorder of speech characterized by abnormalities of the articulation and intelligibility of speech.,0
258,21,Which are the major types of the motor speech disorder dysarthria?,"There are six major types of dysarthria: flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria and hypokinetic dysarthria, which are related to a disorder of the extrapyramidal system",1
3683,0,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Cranial radiotherapy improves survival of the most common childhood cancers, including brain tumors and leukemia.",0
3683,1,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Unfortunately, long-term survivors are faced with consequences of secondary neoplasia, including radiation-induced meningiomas (RIMs).",0
3683,2,Is there an increased risk for meningiomas in childhood leukemia survivors?,Combined chemotherapy and prophylactic cranial irradiation has improved the prognosis of children with acute leukemia.,1
3683,3,Is there an increased risk for meningiomas in childhood leukemia survivors?,However cranial irradiation carries a latent risk of the induction of secondary intracranial tumors.,0
3683,4,Is there an increased risk for meningiomas in childhood leukemia survivors?,We encountered a patient who developed multiple intracranial radiation-induced meningiomas (RIMs) 25 years after prophylactic cranial irradiation for the treatment of acute leukemia in childhood.,0
3683,5,Is there an increased risk for meningiomas in childhood leukemia survivors?,Focal cranial hyperostosis from meningioma: a complication from previous radiation treatment for childhood T-cell acute lymphoblastic leukemia.,0
3683,6,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Presented is a case of a 20 year man with a history of T-cell lymphoblastic leukemia diagnosed at age 22 months, treated with chemotherapy and cranial irradiation.",0
3683,7,Is there an increased risk for meningiomas in childhood leukemia survivors?,He had developed increasing prominence of the top of his head over several months.,0
3683,8,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Plain radiograph showed frontal calvarium thickening with focal ""hair-on-end"" periosteal reaction.",0
3683,9,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Magnetic resonance imaging revealed an enhancing dural-based mass with transcalvarial extension, confirmed after resection to be meningioma (World Health Organization Grade I).",0
3683,10,Is there an increased risk for meningiomas in childhood leukemia survivors?,"RESULTS: Acute myeloid leukemia (AML; n = 186), myelodysplastic syndrome (MDS; n = 69), and nonmeningioma brain tumor (n = 116) were the most common types of SMNs and had the poorest outcome (5-year survival rate, 18.1% ± 2.9%, 31.1% ± 6.2%, and 18.3% ± 3.8%, respectively).",0
3683,11,Is there an increased risk for meningiomas in childhood leukemia survivors?,Radiation-induced World Health Organization grade II meningiomas in young patients following prophylactic cranial irradiation for acute lymphoblastic leukemia in childhood.,1
3683,12,Is there an increased risk for meningiomas in childhood leukemia survivors?,Three case reports.,0
3683,13,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Current chemotherapeutic regimens have been used to successfully treat many children with acute lymphoblastic leukemia (ALL), but have resulted in an increased risk of late central nervous system tumors, most commonly meningioma, particularly in patients who have received cranial irradiation.",0
3683,14,Is there an increased risk for meningiomas in childhood leukemia survivors?,"RESULTS: Fifty-nine MRI abnormalities (32 cavernomas, nine focal areas of gliosis, seven dystrophic mineralizations, five cerebral atrophies, four pituitary atrophies, one diffuse radiation leukoencephalopathy, and one meningioma) were found in 43 patients.",0
3683,15,Is there an increased risk for meningiomas in childhood leukemia survivors?,Intraventricular meningioma after cranial irradiation for childhood leukemia.,1
3683,16,Is there an increased risk for meningiomas in childhood leukemia survivors?,Radiation-induced meningiomas may also have predilection to recur.,0
3683,17,Is there an increased risk for meningiomas in childhood leukemia survivors?,The authors describe a case of an intraventricular meningioma occurring 23 years after cranial irradiation for childhood acute lymphoblastic leukemia.,0
3683,18,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Cumulative incidence at 30 years after the childhood cancer diagnosis was 20.5% (95% confidence interval [CI] = 19.1% to 21.8%) for all subsequent neoplasms, 7.9% (95% CI = 7.2% to 8.5%) for second malignant neoplasms (excluding nonmelanoma skin cancer), 9.1% (95% CI = 8.1% to 10.1%) for nonmelanoma skin cancer, and 3.1% (95% CI = 2.5% to 3.8%) for meningioma.",0
3683,19,Is there an increased risk for meningiomas in childhood leukemia survivors?,Radiation-induced meningiomas: a shadow in the success story of childhood leukemia.,0
3683,20,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Although the cohort is small, it seems probable that the increasing incidence of meningioma will shadow the future of cranially irradiated leukemia survivors.",0
3683,21,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Age at the time of irradiation, gender, or cumulative doses of chemotherapeutic agents showed no significant association with the development of meningiomas.",0
3683,22,Is there an increased risk for meningiomas in childhood leukemia survivors?,Meningioma Screening With MRI in Childhood Leukemia Survivors Treated With Cranial Radiation.,1
3683,23,Is there an increased risk for meningiomas in childhood leukemia survivors?,High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.,0
3683,24,Is there an increased risk for meningiomas in childhood leukemia survivors?,Radiation-induced World Health Organization grade II meningiomas in young patients following prophylactic cranial irradiation for acute lymphoblastic leukemia in childhood.,1
3683,25,Is there an increased risk for meningiomas in childhood leukemia survivors?,Radiation-induced meningioma following prophylactic radiotherapy for acute lymphoblastic leukemia in childhood.,0
3683,26,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Current chemotherapeutic regimens have been used to successfully treat many children with acute lymphoblastic leukemia ( ALL) , but have resulted in an increased risk of late central nervous system tumors , most commonly meningioma , particularly in patients who have received cranial irradiation",0
3683,27,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Survivors of childhood ALL treated with high-dose cranial irradiation are at risk both for early radiation injury in radiosensitive organs , such as the lens and pituitary gland , and for the later development of a radiation-induced meningioma",0
3683,28,Is there an increased risk for meningiomas in childhood leukemia survivors?,Radiation-induced meningiomas: a shadow in the success story of childhood leukemia,0
3683,29,Is there an increased risk for meningiomas in childhood leukemia survivors?,"We treated 3 young patients with World Health Organization grade II meningiomas who had previously received cranial irradiation for the treatment of childhood ALL: a cerebellopontine angle tumor in a 19-year-old woman , a petroclival tumor in a 28-year-old man , and a frontal parasagittal tumor in a 19-year-old woman",0
3683,30,Is there an increased risk for meningiomas in childhood leukemia survivors?,"We treated 3 young patients with World Health Organization grade II meningiomas who had previously received cranial irradiation for the treatment of childhood ALL: a cerebellopontine angle tumor in a 19-year-old woman, a petroclival tumor in a 28-year-old man, and a frontal parasagittal tumor in a 19-year-old woman.",0
3683,31,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Current chemotherapeutic regimens have been used to successfully treat many children with acute lymphoblastic leukemia (ALL), but have resulted in an increased risk of late central nervous system tumors, most commonly meningioma, particularly in patients who have received cranial irradiation.",0
3683,32,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Current chemotherapeutic regimens have been used to successfully treat many children with acute lymphoblastic leukemia (ALL), but have resulted in an increased risk of late central nervous system tumors, most commonly meningioma, particularly in patients who have received cranial irradiation.",0
3683,33,Is there an increased risk for meningiomas in childhood leukemia survivors?,"Long-term survivors who received radiotherapy for ALL in childhood are at risk for late complications, including radiation-induced meningioma.",0
703,0,Is there an association between FGFR3 mutation and plagiocephaly?,"Series of neurosurgical interventions were carried out, principally for acrocephaly and posterior plagiocephaly.",0
703,1,Is there an association between FGFR3 mutation and plagiocephaly?,"The most common achondroplasia mutation, a p.Gly380Arg in the fibroblast growth factor receptor 3 (FGFR3) gene, was detected.",0
703,2,Is there an association between FGFR3 mutation and plagiocephaly?," The most common mutation for achondroplasia (FGFR3 Gly380Arg, resulting in 1138G>A) was identified.",0
703,3,Is there an association between FGFR3 mutation and plagiocephaly?,"Imaging studies disclosed complex craniosynostosis and neurosurgical intervention was carried out, particularly for posterior plagiocephaly.",0
703,4,Is there an association between FGFR3 mutation and plagiocephaly?,FGFR mutations and plagiocephaly.,0
703,5,Is there an association between FGFR3 mutation and plagiocephaly?,"FGFR genes have important effects on bone development, and mutations in 4 ""hot spot"" exons of FGFR1-3 are found in many patients with craniosynostosis and some with synostotic plagiocephaly.",1
703,6,Is there an association between FGFR3 mutation and plagiocephaly?,Mutation analyses in the FGFR3 gene revealed nucleotide alterations located in the mutational hot spot at amino acid residue 250 (g.C749).,0
703,7,Is there an association between FGFR3 mutation and plagiocephaly?,"RESULTS: In our cohort of 159 patients with various craniosynostosis syndromes, mutations were found in 100% of patients with Apert syndrome, 83.3% with Pfeiffer syndrome, 72.7% with Crouzon syndrome, 50.0% with Saethre-Chotzen syndrome, 27.7% with plagiocephaly, 31.8% with brachicephaly, 20% of complex cases, and 6.9% of mixed cases.",0
703,8,Is there an association between FGFR3 mutation and plagiocephaly?,The genetic alterations that could cause unilateral coronal synostosis are more elusive.,0
703,9,Is there an association between FGFR3 mutation and plagiocephaly?,"Mutations were found in eight of 47 patients: two patients with different single-amino-acid changes in FGFR2, three patients with FGFR3 Pro250Arg, and three patients with TWIST mutations.",1
703,10,Is there an association between FGFR3 mutation and plagiocephaly?,"Other abnormalities in the craniofacial region and extremities were clues to a particular mutation in FGFR2, FGFR3, TWIST, or the X-linked mutation.",0
703,11,Is there an association between FGFR3 mutation and plagiocephaly?,"To determine whether the autosomal dominant fibroblast growth factor receptor 3 (FGFR3) Pro250Arg mutation causes anterior plagiocephaly, patients with either apparently sporadic unicoronal synostosis (N = 37) or other forms of anterior plagiocephaly (N = 10) were studied for this mutation.",0
703,12,Is there an association between FGFR3 mutation and plagiocephaly?,The occurrence of the FGFR3 mutation among patients with unicoronal synostosis provides evidence for a genetic basis of certain forms of plagiocephaly.,0
703,13,Is there an association between FGFR3 mutation and plagiocephaly?,None of the 6 patients with nonsynostotic plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 mutation.,1
703,14,Is there an association between FGFR3 mutation and plagiocephaly?,"Between January and December of 1996, patients with a diagnosis of plagiocephaly at the Children's Hospital of Philadelphia were evaluated for the FGFR3 mutation.",0
703,15,Is there an association between FGFR3 mutation and plagiocephaly?,"Between January and December of 1996, patients with a diagnosis of plagiocephaly at the Children&apos;s Hospital of Philadelphia were evaluated for the FGFR3 mutation",0
703,16,Is there an association between FGFR3 mutation and plagiocephaly?,"FGFR genes have important effects on bone development, and mutations in 4 &quot;hot spot&quot; exons of FGFR1-3 are found in many patients with craniosynostosis and some with synostotic plagiocephaly",1
703,17,Is there an association between FGFR3 mutation and plagiocephaly?,"To determine whether the autosomal dominant fibroblast growth factor receptor 3 (FGFR3) Pro250Arg mutation causes anterior plagiocephaly, patients with either apparently sporadic unicoronal synostosis (N = 37) or other forms of anterior plagiocephaly (N = 10) were studied for this mutation",0
703,18,Is there an association between FGFR3 mutation and plagiocephaly?,None of the 6 patients with nonsynostotic plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 mutation,1
703,19,Is there an association between FGFR3 mutation and plagiocephaly?,The occurrence of the FGFR3 mutation among patients with unicoronal synostosis provides evidence for a genetic basis of certain forms of plagiocephaly,0
703,20,Is there an association between FGFR3 mutation and plagiocephaly?,FGFR mutations and plagiocephaly,0
703,21,Is there an association between FGFR3 mutation and plagiocephaly?,"Between January and December of 1996, patients with a diagnosis of plagiocephaly at the Children's Hospital of Philadelphia were evaluated for the FGFR3 mutation.",0
703,22,Is there an association between FGFR3 mutation and plagiocephaly?,None of the 6 patients with nonsynostotic plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 mutation.,0
703,23,Is there an association between FGFR3 mutation and plagiocephaly?,The occurrence of the FGFR3 mutation among patients with unicoronal synostosis provides evidence for a genetic basis of certain forms of plagiocephaly.,0
703,24,Is there an association between FGFR3 mutation and plagiocephaly?," To determine whether the autosomal dominant fibroblast growth factor receptor 3 (FGFR3) Pro250Arg mutation causes anterior plagiocephaly, patients with either apparently sporadic unicoronal synostosis (N = 37) or other forms of anterior plagiocephaly (N = 10) were studied for this mutation.",0
703,25,Is there an association between FGFR3 mutation and plagiocephaly?,"Of 37 patients with unicoronal synostosis, 4 tested positive for the Pro250Arg mutation in FGFR3, and 33 were negative for this mutation.",0
703,26,Is there an association between FGFR3 mutation and plagiocephaly?,"To determine whether the autosomal dominant fibroblast growth factor receptor 3 (FGFR3) Pro250Arg mutation causes anterior plagiocephaly, patients with either apparently sporadic unicoronal synostosis (N = 37) or other forms of anterior plagiocephaly (N = 10) were studied for this mutation.",0
703,27,Is there an association between FGFR3 mutation and plagiocephaly?,In a girl with seemingly isolated plagiocephaly we identified a P250L (749C-->T) mutation in FGFR3.,0
703,28,Is there an association between FGFR3 mutation and plagiocephaly?,FGFR mutations and plagiocephaly.,0
703,29,Is there an association between FGFR3 mutation and plagiocephaly?,None of the 6 patients with nonsynostotic plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 mutation.,0
703,30,Is there an association between FGFR3 mutation and plagiocephaly?,The occurrence of the FGFR3 mutation among patients with unicoronal synostosis provides evidence for a genetic basis of certain forms of plagiocephaly.,0
22,0,Are transcription and splicing connected?,", as splicing is often cotranscriptional, a complex picture emerges in which splicing regulation not only depends on the balance of splicing factor binding to their pre-mRNA target sites but also on transcription-associated features such as protein recruitment to the transcribing machinery and elongation kinetics.",1
22,1,Are transcription and splicing connected?,recent evidence shows that chromatin structure is another layer of regulation that may act through various mechanisms,0
22,2,Are transcription and splicing connected?,"hese span from regulation of RNA polymerase II elongation, which ultimately determines splicing decisions, to splicing factor recruitment by specific histone marks.",0
22,3,Are transcription and splicing connected?,Chromatin may not only be involved in alternative splicing regulation but in constitutive exon recognition as well,0
22,4,Are transcription and splicing connected?,"Moreover, splicing was found to be necessary for the proper 'writing' of particular chromatin signatures, giving further mechanistic support to functional interconnections between splicing, transcription and chromatin structure.",1
22,5,Are transcription and splicing connected?,These links between chromatin configuration and splicing raise the intriguing possibility of the existence of a memory for splicing patterns to be inherited through epigenetic modifications.,1
22,6,Are transcription and splicing connected?,"Spliceosome assembly occurs co-transcriptionally, raising the possibility that DNA structure may directly influence alternative splicing.",0
22,7,Are transcription and splicing connected?,"upporting such an association, recent reports have identified distinct histone methylation patterns, elevated nucleosome occupancy and enriched DNA methylation at exons relative to introns",0
22,8,Are transcription and splicing connected?,"Moreover, the rate of transcription elongation has been linked to alternative splicing.",0
22,9,Are transcription and splicing connected?,"ere we provide the first evidence that a DNA-binding protein, CCCTC-binding factor (CTCF), can promote inclusion of weak upstream exons by mediating local RNA polymerase II pausing both in a mammalian model system for alternative splicing, CD45, and genome-wide",0
22,10,Are transcription and splicing connected?,"We recently showed that cotranscriptional splicing occurs efficiently in Drosophila,",0
22,11,Are transcription and splicing connected?,In recent years it became apparent that splicing is predominantly cotranscriptional,0
22,12,Are transcription and splicing connected?,"To determine the prevalence of cotranscriptional splicing in Drosophila, we sequenced nascent RNA transcripts from Drosophila S2 cells as well as from Drosophila heads.",0
22,13,Are transcription and splicing connected?,Eighty-seven percent of the introns assayed manifest >50% cotranscriptional splicing.,0
22,14,Are transcription and splicing connected?,"The remaining 13% are cotranscriptionally spliced poorly or slowly, with ∼3% being almost completely retained in nascent pre-mRNA.",0
22,15,Are transcription and splicing connected?,"We estimate that > or =90% of endogenous yeast splicing is posttranscriptional, consistent with an analysis of posttranscriptional snRNP-associated pre-mRNA.",0
22,16,Are transcription and splicing connected?,"Notably, the topoisomerase I inhibitor camptothecin, which stalls elongating Pol II, increased cotranscriptional splicing factor accumulation and splicing in parallel.",0
22,17,Are transcription and splicing connected?,"This provides direct evidence for a kinetic link between transcription, splicing factor recruitment and splicing catalysis.",0
22,18,Are transcription and splicing connected?,"Recent evidence indicates that transcriptional elongation and splicing can be influenced reciprocally: Elongation rates control alternative splicing and splicing factors can, in turn, modulate pol II elongation.",1
22,19,Are transcription and splicing connected?,"The presence of transcription factors in the spliceosome and the existence of proteins, such as the coactivator PGC-1, with dual activities in splicing and transcription can explain the links between both processes and add a new level of complexity to the regulation of gene expression in eukaryotes.",1
1958,0,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Among three isoforms, the apoE4 isoform is associated with increased frequency of atherosclerosis and Alzheimer's disease (AD).",1
1958,1,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,Homozygosity for ApoE epsilon4 is associated with atherosclerosis and Alzheimer's disease whereas ApoE epsilon2 and epsilon3 tend to be protective.,0
1958,2,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Importantly, lipoproteins containing the apoE3 isoform had higher TGF-beta levels and bioactivity than those containing apoE4, a major genetic risk factor for atherosclerosis and Alzheimer's disease.",0
1958,3,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,ApoE4 is positively associated with atherosclerosis and late-onset and sporadic Alzheimer's disease (AD).,1
1958,4,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Isoform (allele)-specific effects include the association of apoE2 with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis and the association of apoE4 with increased risk for both atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth; isoform-specific differences in cellular signaling events may also exist.",0
1958,5,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Although APOE-epsilon3 is considered a longevity gene, APOE-epsilon4 is a dual risk factor to atherosclerosis and Alzheimer disease.",0
1958,6,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"The apolipoprotein E (apoE) type epsilon 4 isoform specifies increased cerebral and cerebrovascular accumulation of amyloid-beta protein (A beta) and contributes to the genetic susceptibility underlying a large proportion (approximately 60%) of typical, sporadic Alzheimer disease.",0
1958,7,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,The structural preference of apoE4 to remain functional in solution may explain the enhanced opportunity of apoE4 isoform to display its pathophysiologic functions in atherosclerosis and Alzheimer disease.,0
1958,8,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"The apolipoprotein E (APOE) E4 allele is associated with Alzheimer's disease, cardiovascular disease, and decreased longevity.",0
1958,9,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,The apolipoprotein E type 4 allele is a susceptibility gene for late-onset Alzheimer's disease.,0
1958,10,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"The apolipoprotein E (ApoE) ε4 allele is the strongest risk factor of sporadic Alzheimers disease (AD), however, the fluid concentrations of ApoE and its different isoforms (ApoE2, ApoE3 and ApoE4) in AD patients and among APOE genotypes (APOE ε2, ε3, ε4) remain controversial",0
1958,11,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Among three isoforms, the apoE4 isoform is associated with increased frequency of atherosclerosis and Alzheimers disease (AD)",1
1958,12,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,Homozygosity for ApoE epsilon4 is associated with atherosclerosis and Alzheimers disease whereas ApoE epsilon2 and epsilon3 tend to be protective,0
1958,13,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,Homozygosity for ApoE epsilon4 is associated with atherosclerosis and Alzheimer's disease whereas ApoE epsilon2 and epsilon3 tend to be protective.,0
1958,14,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Although APOE-epsilon3 is considered a longevity gene, APOE-epsilon4 is a dual risk factor to atherosclerosis and Alzheimer disease.",0
1958,15,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,The apoE4 allele is a major risk factor for late-onset familial and sporadic Alzheimer's disease (AD) and is associated with a poor outcome after brain injury.,0
1958,16,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Among three isoforms, the apoE4 isoform is associated with increased frequency of atherosclerosis and Alzheimer's disease (AD).",1
1958,17,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,Homozygosity for ApoE epsilon4 is associated with atherosclerosis and Alzheimer's disease whereas ApoE epsilon2 and epsilon3 tend to be protective.,0
1958,18,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Importantly, lipoproteins containing the apoE3 isoform had higher TGF-beta levels and bioactivity than those containing apoE4, a major genetic risk factor for atherosclerosis and Alzheimer's disease.",0
1958,19,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Isoform (allele)-specific effects include the association of apoE2 with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis and the association of apoE4 with increased risk for both atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth; isoform-specific differences in cellular signaling events may also exist.",0
1958,20,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"The decreased antioxidant activity of E4 could contribute to its association with Alzheimer's disease, cardiovascular disease and decreased longevity.",0
1958,21,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,The isoform apoE4 is associated with an increased risk of Alzheimer's disease and it has been postulated that high intracellular cholesterol levels promote the amyloidogenic processing of amyloid precursor protein.,1
1958,22,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Among three ɛ2, ɛ3, ɛ4 alleles, ɛ4 allele is associated with the increase in cholesterol level, risk of atherosclerosis and Alzheimer disease, while ɛ2 allele is associated with the decrease in cholesterol level and risk of atherosclerosis.",0
1958,23,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,"Although APOE-epsilon3 is considered a longevity gene, APOE-epsilon4 is a dual risk factor to atherosclerosis and Alzheimer disease.",0
1958,24,Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?,The structural preference of apoE4 to remain functional in solution may explain the enhanced opportunity of apoE4 isoform to display its pathophysiologic functions in atherosclerosis and Alzheimer disease..,0
2234,0,In which fields of DNA sequencing are Bloom filters applied?,"A novel algorithm, fast and accurate classification of sequences (FACSs), is introduced that can accurately and rapidly classify sequences as belonging or not belonging to a reference sequence.",1
2234,1,In which fields of DNA sequencing are Bloom filters applied?,Classification of DNA sequences using Bloom filters,0
2234,2,In which fields of DNA sequencing are Bloom filters applied?,"Lighter is a fast, memory-efficient tool for correcting sequencing errors.",0
2234,3,In which fields of DNA sequencing are Bloom filters applied?,Lighter avoids counting k-mers.,0
2234,4,In which fields of DNA sequencing are Bloom filters applied?,"Instead, it uses a pair of Bloom filters, one holding a sample of the input k-mers and the other holding k-mers likely to be correct.",1
2234,5,In which fields of DNA sequencing are Bloom filters applied?,Fast lossless compression via cascading Bloom filters,0
2234,6,In which fields of DNA sequencing are Bloom filters applied?,"In contrast to reference-based methods that first align reads to the genome, we hash all reads into Bloom filters to encode, and decode by querying the same Bloom filters using read-length subsequences of the reference genome.",0
2234,7,In which fields of DNA sequencing are Bloom filters applied?,Further compression is achieved by using a cascade of such filters,0
2234,8,In which fields of DNA sequencing are Bloom filters applied?,Using cascading Bloom filters to improve the memory usage for de Brujin graphs,0
2234,9,In which fields of DNA sequencing are Bloom filters applied?,"In this work, we show how to reduce the memory required by the data structure of Chikhi and Rizk (WABI'12) that represents de Brujin graphs using Bloom filters.",0
2234,10,In which fields of DNA sequencing are Bloom filters applied?,We introduce a novel hash-based method for constructing the string graph.,0
2234,11,In which fields of DNA sequencing are Bloom filters applied?,"We use incremental hashing, and specifically a modification of the Karp-Rabin fingerprint, and Bloom filters",0
2234,12,In which fields of DNA sequencing are Bloom filters applied?,"Further, we note that Bloom filters would be suitable to implicitly store spaced seeds and be tolerant to sequencing errors.",1
2234,13,In which fields of DNA sequencing are Bloom filters applied?," It uses a pair of cache oblivious Bloom filters, one holding a uniform sample of [Formula: see text]-spaced sequenced [Formula: see text]-mers and the other holding [Formula: see text]-mers classified as likely correct, using a simple statistical test.",1
2234,14,In which fields of DNA sequencing are Bloom filters applied?,Improving Bloom Filter Performance on Sequence Data Using k-mer Bloom Filters,0
2234,15,In which fields of DNA sequencing are Bloom filters applied?,"BFs reduce the memory footprint required to store millions of k-mers while allowing for fast set containment queries, at the cost of a low false positive rate (FPR).",1
2234,16,In which fields of DNA sequencing are Bloom filters applied?,"We consider several variants of such k-mer Bloom filters (kBFs), derive theoretical upper bounds for their FPR, and discuss their range of applications and limitations.",0
2234,17,In which fields of DNA sequencing are Bloom filters applied?,Fast lossless compression via cascading Bloom filters.,0
2234,18,In which fields of DNA sequencing are Bloom filters applied?,Fast lossless compression via cascading Bloom filters.,0
3602,0,Has istadefylline been considered as a treatment for Parkinson's disease?,Istradefylline (ISD) is a new drug developed for the treatment of Parkinson's disease (PD).,1
3602,1,Has istadefylline been considered as a treatment for Parkinson's disease?,It is an adenosine receptor A2A antagonists that will represent an important option for patients with advanced PD where it has been demonstrated efficacy in decreasing daily OFF time and is well tolerated.,1
3602,2,Has istadefylline been considered as a treatment for Parkinson's disease?,The objective of this review is to summarize evidences emerged from clinical studies that have demonstrated the efficacy of ISD in advanced parkinsonian patients.,1
3602,3,Has istadefylline been considered as a treatment for Parkinson's disease?, ISD might represent an alternative option for patients with advanced PD.,1
2046,0,Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?,"For this 2016 release, we expanded the JASPAR CORE collection with 494 new TF binding profiles (315 in vertebrates, 11 in nematodes, 3 in insects, 1 in fungi and 164 in plants) and updated 59 profiles (58 in vertebrates and 1 in fungi).",1
2046,1,Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?,The introduced profiles represent an 83% expansion and 10% update when compared to the previous release.,1
2046,2,Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?,We updated the structural annotation of the TF DNA binding domains (DBDs) following a published hierarchical structural classification.,0
2046,3,Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?,"In addition, we introduced 130 transcription factor flexible models trained on ChIP-seq data for vertebrates, which capture dinucleotide dependencies within TF binding sites.",1
2046,4,Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?,This new JASPAR release is accompanied by a new web tool to infer JASPAR TF binding profiles recognized by a given TF protein sequence.,1
2046,5,Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?,"Moreover, we provide the users with a Ruby module complementing the JASPAR API to ease programmatic access and use of the JASPAR collection of profiles.",1
2046,6,Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?,"Finally, we provide the JASPAR2016 R/Bioconductor data package with the data of this release",0
686,0,Which enzyme is inhibited by a drug fostamatinib?,It outlines preclinical and early clinical experiences with the Syk inhibitor fostamatinib disodium (R788) and discusses various options for further clinical development of this compound.,0
686,1,Which enzyme is inhibited by a drug fostamatinib?,"To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biologic therapies.",1
686,2,Which enzyme is inhibited by a drug fostamatinib?,"The mTOR inhibitors temsirolimus and everolimus have demonstrated antitumor activity in all types of lymphoma, the Syk inhibitor fostamatinib has activity in diffuse large B-cell lymphoma and chronic lymphocytic leukemia, and the PKC-β inhibitor enzastaurin is being used as consolidation therapy after remission in diffuse large B-cell lymphoma.",0
686,3,Which enzyme is inhibited by a drug fostamatinib?,"Fostamatinib, a Syk-kinase inhibitor, does not affect methotrexate pharmacokinetics in patients with rheumatoid arthritis.",0
686,4,Which enzyme is inhibited by a drug fostamatinib?,"The objective of this phase 2 study was to evaluate the efficacy and safety of R788, an oral inhibitor of Syk, in patients with active rheumatoid arthritis despite methotrexate therapy.",0
686,5,Which enzyme is inhibited by a drug fostamatinib?,The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.,0
686,6,Which enzyme is inhibited by a drug fostamatinib?,We have now investigated whether inhibition of BCR signaling with the selective Syk inhibitor fostamatinib disodium (R788) will affect the growth of the leukemias that develop in the Eμ-TCL1 transgenic mouse model of CLL.,0
686,7,Which enzyme is inhibited by a drug fostamatinib?,"We show that conditional ablation of the syk gene in dendritic cells (DCs) abrogates FcgammaR-mediated cross priming of diabetogenic T cells in RIP-mOVA mice, a situation phenocopied in wild-type RIP-mOVA mice treated with the selective Syk inhibitor R788.",0
686,8,Which enzyme is inhibited by a drug fostamatinib?,"We investigated the ability of a small drug Syk inhibitor, R788, to protect mice against mesenteric ischemia-reperfusion (I/R)-induced local (intestine) and remote lung injury.",0
686,9,Which enzyme is inhibited by a drug fostamatinib?,The spleen tyrosine kinase (Syk) inhibitor R406 is orally administered as the prodrug R788.,0
686,10,Which enzyme is inhibited by a drug fostamatinib?,Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.,0
686,11,Which enzyme is inhibited by a drug fostamatinib?,"These data prompted a phase 1/2 clinical trial of fostamatinib disodium, the first clinically available oral Syk inhibitor, in patients with recurrent B-cell non-Hodgkin lymphoma (B-NHL).",0
686,12,Which enzyme is inhibited by a drug fostamatinib?,"We examined the effect of R788 (fostamatinib disodium), an oral prodrug of the selective Syk inhibitor R406, in nephrotoxic nephritis in Wistar-Kyoto rats.",0
686,13,Which enzyme is inhibited by a drug fostamatinib?,"Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.",0
686,14,Which enzyme is inhibited by a drug fostamatinib?,"Rigel Pharmaceuticals Inc is developing fostamatinib, a prodrug of the spleen tyrosine kinase (Syk) inhibitor R-406, for the potential treatment of autoimmune diseases such as rheumatoid arthritis (RA), idiopathic thrombocytopenic purpura (ITP) and B-cell lymphomas.",0
686,15,Which enzyme is inhibited by a drug fostamatinib?,"In developmental toxicity studies with the Syk kinase inhibitor R788, a spectrum of findings, including renal agenesis, were observed.",0
686,16,Which enzyme is inhibited by a drug fostamatinib?,"R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro and in vivo models, suggesting potential activity in the treatment of rheumatoid arthritis (RA).",1
686,17,Which enzyme is inhibited by a drug fostamatinib?,"In collagen-induced arthritis, R788/R406, a novel and potent small molecule Syk inhibitor suppressed clinical arthritis, bone erosions, pannus formation, and synovitis.",0
686,18,Which enzyme is inhibited by a drug fostamatinib?,Fostamatinib (R788) inhibits spleen tyrosine kinase (Syk) and has been in clinical trials involving both MTX inadequate responders (MTX-IRs) and biologic inadequate responders.,0
686,19,Which enzyme is inhibited by a drug fostamatinib?,"The compounds that are currently investigated in patients with CLL include ibrutinib -inhibitor of Btk, fostamatinib-inhibitor of Syk and idelalisib (GS-1101) -a specific isoform of the PI3K (PI3K) inhibitor.",0
686,20,Which enzyme is inhibited by a drug fostamatinib?,TK inhibitors including spleen TK (fostamatinib) and Janus kinases (tofacitinib) inhibitors are two novel oral therapies that have demonstrated short-term good clinical responses in active rheumatoid arthritis patients with and inadequate responses to methotrexate or other traditional (non-biologic) disease-modifying antirheumatic drugs (DMARDs).,0
686,21,Which enzyme is inhibited by a drug fostamatinib?,Progress is also being made with orally active Syk inhibitors.,0
686,22,Which enzyme is inhibited by a drug fostamatinib?,"One such inhibitor (fostamatinib) is currently in large-scale phase 3 trials, and there are others in clinical development.",0
686,23,Which enzyme is inhibited by a drug fostamatinib?,"We have shown that R406, the active metabolite of the Syk inhibitor fostamatinib, induces apoptosis and cell cycle arrest while decreasing downstream phosphatidylinositol-3'-kinase (PI3K)/Akt signaling in EBV+ B cell lymphoma PTLD lines in vitro.",0
686,24,Which enzyme is inhibited by a drug fostamatinib?,"Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial.",0
686,25,Which enzyme is inhibited by a drug fostamatinib?,"Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies.",0
686,26,Which enzyme is inhibited by a drug fostamatinib?,"Fostamatinib (R788) is an orally dosed prodrug designed to deliver the active metabolite R940406 (R406), a spleen tyrosine kinase (SYK) inhibitor, for the treatment of rheumatoid arthritis.",1
686,27,Which enzyme is inhibited by a drug fostamatinib?,"Fostamatinib demonstrates rapid and extensive conversion to R406, an inhibitor of SYK.",0
686,28,Which enzyme is inhibited by a drug fostamatinib?,"Fostamatinib, a Syk inhibitor that successfully completed phase II clinical trials, also exhibits some undesirable side effects.",0
686,29,Which enzyme is inhibited by a drug fostamatinib?,Fostamatinib (R788) is a prodrug rapidly converted to its active metabolite on oral administration.,1
686,30,Which enzyme is inhibited by a drug fostamatinib?,"This (known as R406) is a potent inhibitor of spleen tyrosine kinase, required for the expression of a number of proinflammatory cytokines.",1
686,31,Which enzyme is inhibited by a drug fostamatinib?,"The Syk inhibitor, fostamatinib, proved superior to placebo in Phase II trials and is currently under Phase III investigation.",0
686,32,Which enzyme is inhibited by a drug fostamatinib?,T,0
686,33,Which enzyme is inhibited by a drug fostamatinib?,"More recently, several KIs have been developed to target the proximal B-cell receptor (BCR) signaling pathway including spleen tyrosine kinase inhibitor (Fostamatinib) and Bruton's tyrosine kinase inhibitors (Ibrutinib, AVL-263).",0
686,34,Which enzyme is inhibited by a drug fostamatinib?,"Because inhibitors of SYK activity, such as fostamatinib, are in advanced clinical trials for rheumatoid arthritis and other autoimmune diseases, understanding the role of SYK in signalling via TLR4 is of immediate importance.",0
686,35,Which enzyme is inhibited by a drug fostamatinib?,"The search terms used were Bruton's tyrosine kinase (Btk) inhibitors, PCI-32765, GDC-0834, LFM-A13, AVL-101, AVL-292, spleen tyrosine kinase (Syk) inhibitors, R343, R406, R112, R788, fostamatinib, BAY-61-3606, C-61, piceatannol, Lyn, imatinib, nilotinib, bafetinib, dasatinib, GDC-0834, PP2, SU6656 in conjunction with lymphoid malignancy, NHL, CLL, autoimmune disease, allergic disease, asthma, and rheumatoid arthritis.",0
686,36,Which enzyme is inhibited by a drug fostamatinib?,Inhibition of Syk activity by R788 in platelets prevents remote lung tissue damage after mesenteric ischemia-reperfusion injury.,0
686,37,Which enzyme is inhibited by a drug fostamatinib?,"Recently, Syk inhibitor fostamatinib has exerted potent therapeutic efficacy against autoimmune and allergic diseases such as rheumatoid arthritis (RA), bronchial asthma and thrombocytopenic purpura (ITP).",0
686,38,Which enzyme is inhibited by a drug fostamatinib?,"In chronic lymphocytic leukemia (CLL), Syk becomes activated by external signals from the tissue microenvironment, and was targeted in a first clinical trial with R788 (fostamatinib), a relatively nonspecific Syk inhibitor.",0
686,39,Which enzyme is inhibited by a drug fostamatinib?,"In vivo expansion of luciferase(+) donor Tcs in mice developing GvHD was reduced by treatment with the Syk inhibitor Fostamatinib, which led to increased survival and reduced histologically confirmed GvHD severity.",0
686,40,Which enzyme is inhibited by a drug fostamatinib?,Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion.,0
686,41,Which enzyme is inhibited by a drug fostamatinib?,"No oral biologic agents are available at this time but promising data is emerging for two drugs, tofacitinib and fostamatinib, inhibitors of JAK and Syk kinases, respectively.",0
686,42,Which enzyme is inhibited by a drug fostamatinib?,Fostamatinib (R-788) is an orally bioavailable small molecule.,0
686,43,Which enzyme is inhibited by a drug fostamatinib?,"It is the prodrug of R406, which is a potent Syk inhibitor.",0
686,44,Which enzyme is inhibited by a drug fostamatinib?,The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.,0
686,45,Which enzyme is inhibited by a drug fostamatinib?,Low-density lipoprotein receptor-deficient mice consuming a high-cholesterol diet supplemented with 2 doses of the orally available SYK inhibitor fostamatinib for 16 weeks showed a dose-dependent reduction in atherosclerotic lesion size by up to 59±6% compared with the respective controls.,0
2915,0,"Where, in what US state, was there a measles outbreak in an Amish community","Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio,",1
2915,1,"Where, in what US state, was there a measles outbreak in an Amish community","Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",1
2915,2,"Where, in what US state, was there a measles outbreak in an Amish community","CONCLUSIONS
The key epidemiologic features of a measles outbreak in the Amish community in Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who sought vaccination.",0
2915,3,"Where, in what US state, was there a measles outbreak in an Amish community","Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio pushing the annual cases to the highest national number reported in the last 20 years.",1
2915,4,"Where, in what US state, was there a measles outbreak in an Amish community","Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio, resulting in 368 cases reported.",1
2915,5,"Where, in what US state, was there a measles outbreak in an Amish community","CONCLUSIONS The key epidemiologic features of a measles outbreak in the Amish community in Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who sought vaccination.",1
2915,6,"Where, in what US state, was there a measles outbreak in an Amish community","Modeling Measles Transmission in the North American Amish and Options for Outbreak Response.Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio pushing the annual cases to the highest national number reported in the last 20 years.",0
3986,0,What is a HapMap,"We describe the Phase II HapMap, which characterizes over 3.1 million human single nucleotide polymorphisms (SNPs) genotyped in 270 individuals from four geographically diverse populations and includes 25-35% of common SNP variation in the populations surveyed",1
3986,1,What is a HapMap,The International Haplotype Map Project (HapMap) has provided an essential database for studies of human population genetics and genome-wide association.,0
3986,2,What is a HapMap,Phases I and II of the HapMap project generated genotype data across ∼3 million SNP loci in 270 individuals representing four populations.,0
3986,3,What is a HapMap," A haplotype map (HapMap), aimed at describing these variation patterns across the entire genome, has been recently developed by the International HapMap Consortium.",1
3986,4,What is a HapMap, We discuss in the same context the haplotype map project (HapMap) as a tool to facilitate the study of possible associations of genome changes and common diseases.,0
3986,5,What is a HapMap,"The ""HapMap"" project is now underway to characterize patterns of LD in the human genome.",1
3986,6,What is a HapMap,One of the goals of the International HapMap Project is the identification of common haplotypes in genes.,0
3986,7,What is a HapMap,One of the particular important projects is The International HapMap Project which provides the catalogue of human genetic variation for disease association studies.,0
3986,8,What is a HapMap,"A key goal of the HapMap Project is to enable identification of tag single nucleotide polymorphisms (SNPs) that capture a substantial portion of common human genetic variability while requiring only a small fraction of SNPs to be genotyped [International HapMap Consortium, 2005: Nature 437:1299-1320].",0
3986,9,What is a HapMap,The International HapMap Consortium undertook an effort to catalog all common variation across the genome (variants with a minor allele frequency (MAF) of at least 5% in one or more ethnic groups).,0
3986,10,What is a HapMap,"al genome collaborations, such as HapMap and the Welcome Trust Case-Control Consortium single nucleotide polymorphism (SNP) mapping project have identified common genetic variations in diseases of major public health importance.",0
3986,11,What is a HapMap,Such genetic s,0
3986,12,What is a HapMap,"To facilitate evaluation of existing evidence of association and further work, we supplemented the extensive genotype data, available through the International HapMap Project (HapMap), about DTNBP1 by specifically typing all associated single-nucleotide polymorphisms reported in each of the studies of the Centre d'Etude du Polymorphisme Humain (CEPH)-derived HapMap sample (CEU).",0
3986,13,What is a HapMap,"In this chapter, we will demonstrate how to use the HapMap resource and the Haploview program to process and analyze genetic data from HapMap, to evaluate LD relations between SNPs, and to select tagging SNPs to be examined in disease association studies.",0
3986,14,What is a HapMap,"With the availability of the HapMap--a resource which describes common patterns of linkage disequilibrium (LD) in four different human population samples, we now have a powerful tool to help dissect the role of genetic variation in the biology of the genome.",0
3986,15,What is a HapMap,"Although our SNP selection was based on HapMap data, which is a subset of all common SNPs, these panels effectively capture the majority of all common variation and provide high power to detect risk alleles that are not represented in the HapMap data.",0
3986,16,What is a HapMap,"Our results demonstrate that the HapMap CEU samples provide an adequate basis for tag SNP selection in Finnish individuals, without the need to create a map specifically for the Finnish population, and suggest that the four-population HapMap data will provide useful information for tag SNP selection beyond the specific populations from which they were sampled.",0
3986,17,What is a HapMap,"RESULTS: For each SNP, the SCAN database provides: (i) summary information from eQTL mapping of HapMap SNPs to gene expression (evaluated by the Affymetrix exon array) in the full set of HapMap CEU (Caucasians from UT, USA) and YRI (Yoruba people from Ibadan, Nigeria) samples; (ii) LD information, in the case of a HapMap SNP, including what genes have variation in strong LD (pairwise or multilocus LD) with the variant and how well the SNP is covered by different high-throughput platforms; (iii) summary information available from public databases (e.g.",0
3986,18,What is a HapMap,"The HapMap project is one of the largest public resources of human single-nucleotide polymorphisms (SNPs), characterizing over 3 million SNPs genotyped in over 1000 individuals.",1
3986,19,What is a HapMap,"Then, we study how well the HapMap SNPs capture the untyped SNPs in the region.",0
3986,20,What is a HapMap,HapMap provides linkage disequilibrium (LD) information on a sample of 3.7 million SNPs that can be used for tag SNP selection in whole-genome association studies.,1
3986,21,What is a HapMap,"INTRODUCTIONThe primary goal of the International Haplotype Map Project has been to develop a haplotype map of the human genome that describes the common patterns of genetic variation, in order to accelerate the search for the genetic causes of human disease.",0
3986,22,What is a HapMap,"BACKGROUND: The HapMap project is a publicly available catalogue of common genetic variants that occur in humans, currently including several million SNPs across 1115 individuals spanning 11 different",0
3986,23,What is a HapMap,The goal of the International HapMap Project is to determine the common patterns of DNA sequence variation in the human genome and to make this information freely available in the public domain.,0
1537,0,What is the mechanism of action of eprotirome?,Eprotirome and Sobetirome are 2 thyromimetics that have selective TRβ1 activity.,1
1537,1,What is the mechanism of action of eprotirome?,"Recently, the development of the most promising agent in this class, eprotirome, was halted over toxicology concerns following long-term canine studies.",0
1537,2,What is the mechanism of action of eprotirome?,"Consequently, the future of contemporary TRβ agonists is unclear.",0
1537,3,What is the mechanism of action of eprotirome?,We designed novel thyromimetics with high receptor (TRβ) and organ (liver) selectivity based on the structure of eprotirome (3) and molecular modeling.,1
1537,4,What is the mechanism of action of eprotirome?,"In humans, eprotirome exerts favorable lipid-modulating effects while lacking thyroid hormone-related side-effects and maintaining normal hypothalamic-pituitary-thyroid feedback.",0
1537,5,What is the mechanism of action of eprotirome?,"This review details recent advances in the development of TRβ subtype- and liver-selective STRM analogs, and presents the results of preliminary clinical trials with one of these compounds, eprotirome (KB-2115; Karo Bio AB).",1
1537,6,What is the mechanism of action of eprotirome?,Examples of synthetic analogues are GC-1 (or sobetirome) and KB2115 (or eprotirome) which show ipolipidaemic and antiaterogenic capacities.,0
1537,7,What is the mechanism of action of eprotirome?,"METHODS: The history of thyromimetics in atherosclerosis and dyslipidaemia is reviewed as the background to the recent publication of the first human data on a new selective thyromimetic, KB-2115 (eprotirome).",0
1537,8,What is the mechanism of action of eprotirome?, Eprotirome and Sobetirome are 2 thyromimetics that have selective TRβ1 activity.,1
1537,9,What is the mechanism of action of eprotirome?,Eprotirome and Sobetirome are 2 thyromimetics that have selective TRβ1 activity,1
1537,10,What is the mechanism of action of eprotirome?,We also examined the effects of the TRβ agonist eprotirome on hepatic gene regulation,0
3855,0,Does IL18 signaling have a role in thymus?,IL18 signaling promotes homing of mature Tregs into the thymus.,1
3855,1,Does IL18 signaling have a role in thymus?,"Collectively, this study provides a detailed characterization of the mature Treg subsets in the mouse thymus and identifies a key role of IL18 signaling in controlling the CCR6-CCL20-dependent migration of Tregs into the thymus.",1
3855,2,Does IL18 signaling have a role in thymus?,"er, we show that IL18R+ Tregs are endowed with higher capacity to populate the thymus than their IL18R- or IL18R-/- counterparts, highlighting the key role of IL18R in this process",1
3855,3,Does IL18 signaling have a role in thymus?,IL18 signaling promotes homing of mature Tregs into the thymus,1
3855,4,Does IL18 signaling have a role in thymus?,"inally, we demonstrate that IL18 signaling is critical for the induction of the key thymus-homing chemokine receptor - CCR6 on Tregs.",1
3855,5,Does IL18 signaling have a role in thymus?,"Moreover, we show that IL18R+ Tregs are endowed with higher capacity to populate the thymus than their IL18R- or IL18R-/- counterparts, highlighting the key role of IL18R in this process.",0
55,0,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"The cause of familial isolated pituitary adenomas (FIPA) remains unknown in a high percentage of cases, but the AIP gene plays an important role in the etiology.",0
55,1,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Familial isolated pituitary adenoma caused by a Aip gene mutation not described before in a family context.,0
55,2,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,We report a Spanish family with FIPA in whom a mutation in the AIP gene previously unreported in a familiar context was identified.,0
55,3,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"FIPA, an autosomal-dominant disease with variable penetrance, is explained in 20% of patients by germline mutations in the tumor suppressor aryl hydrocarbon receptor interacting protein(AIP), while no gene abnormality has been identified to date in the majority of the FIPA families.",0
55,4,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Understanding the tumorigenic process in AIP-positive and AIP-negative FIPA patients could result in better diagnostic and treatment options for both familial and sporadic cases.,0
55,5,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,The aryl hydrocarbon receptor interacting protein (AIP) gene has a major role in the pathogenesis of familial isolated pituitary adenoma.,1
55,6,Mutation of which gene is implicated in the familial isolated pituitary adenoma?," The discovery of heterozygous, loss-of-function germline mutations in the gene encoding the aryl hydrocarbon receptor interacting protein (AIP) in 2006 has subsequently enabled the identification of a mutation in this gene in 20% of FIPA families and 20% of childhood-onset simplex soma- totroph adenomas.",0
55,7,Mutation of which gene is implicated in the familial isolated pituitary adenoma?, This review aims to summarize currently available clinical data on AIP mutation-positive and negative FIPA patients.,0
55,8,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,[Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].,0
55,9,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Many heterozygous mutations have been discovered in AIP in about 20% of FIPA families.,0
55,10,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Germline mutations of aryl-hydrocarbon-receptor interacting protein (AIP) are associated with pituitary adenoma predisposition.,0
55,11,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"They occur in 20 % of familial isolated pituitary adenoma (FIPA) and in about 3-5 % of sporadic pituitary adenomas, especially in early onset somatotropinomas and prolactinomas.",0
55,12,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"We report a FIPA family harbouring an AIP R16H change, supporting the hypothesis that the latter represents a variant of unknown significance.",0
55,13,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Germline mutations in the aryl-hydrocarbon interacting protein gene are identified in around 25% of familial isolated pituitary adenoma kindreds.,0
55,14,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.,0
55,15,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,About 20 % of the families with FIPA harbor inactivating mutation in aryl hydrocarbon receptor-interacting protein gene (AIP) associated with loss of heterozygosity of the same genetic locus (11q13) in the tumor.,1
55,16,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Rarely different types of extra-pituitary tumors have been described in the setting of AIP mutation-positive FIPA.,0
55,17,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Mutations in AIP account only for 15-25% of FIPA families.,0
55,18,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"In 20-40% of families with this syndrome, mutations have been identified in the aryl hydrocarbon receptor interacting protein gene while in the rest of the families the causative gene or genes have not been identified.",0
55,19,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"Germline mutations in the aryl hydrocarbon receptor-interacting protein gene (AIP) predispose to young-onset pituitary tumours, most often to GH- or prolactin-secreting adenomas, and most of these patients belong to familial isolated pituitary adenoma families.",0
55,20,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"We also briefly describe the genetic basis of three other inherited states predisposing individuals to endocrine tumors, namely Carney's syndrome, hyperparathyroidism type 2 (HRPT2) and familial isolated pituitary adenoma (FIPA), which are related to inactivating mutations in the PRKAR1-alpha, HRPT2 and AIP genes, respectively.",0
55,21,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.,1
55,22,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.",0
55,23,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"In 20% of FIPA families, heterozygous mutations have been described in the aryl hydrocarbon receptor interacting (AIP) gene, whereas in other families the causative gene(s) are unknown.",0
55,24,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.",0
55,25,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.,0
55,26,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Germline mutations in the aryl-hydrocarbon interacting protein gene are identified in around 25% of familial isolated pituitary adenoma kindreds.,0
55,27,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Mutations of the aryl hydrocarbon receptor interacting protein (AIP) gene are associated with pituitary adenomas that usually occur as familial isolated pituitary adenomas (FIPA).,0
55,28,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.,0
55,29,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.,0
55,30,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"Although the cause of familial isolated pituitary adenoma (FIPA) remains unknown in many cases, germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene were identified in approximately 20 % of families with FIPA",1
55,31,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"The cause of familial isolated pituitary adenomas (FIPA) remains unknown in a high percentage of cases, but the AIP gene plays an important role in the etiology",0
55,32,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"FIPA, an autosomal-dominant disease with variable penetrance, is explained in 20% of patients by germline mutations in the tumor suppressor aryl hydrocarbon receptor interacting protein(AIP), while no gene abnormality has been identified to date in the majority of the FIPA families",0
55,33,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,Germline mutations in the aryl-hydrocarbon interacting protein gene are identified in around 25% of familial isolated pituitary adenoma kindreds,0
55,34,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders,1
55,35,Mutation of which gene is implicated in the familial isolated pituitary adenoma?,"To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly",0
356,0,Is the yeast Μac1 transcription factor induced upon copper deficiency?,Low-affinity copper transporter CTR2 is regulated by copper-sensing transcription factor Mac1p in Saccharomyces cerevisiae.,1
356,1,Is the yeast Μac1 transcription factor induced upon copper deficiency?,The copper-depletion induced CTR2 transcription can be abrogated by genetic deletion of copper-sensing transcription factor Mac1p,0
356,2,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"Taken together, our results suggest that Mac1p can activate the expression of vacuolar copper transporter Ctr2p in response to copper deficiency, resulting in yeast resistance to copper starvation.",0
356,3,Is the yeast Μac1 transcription factor induced upon copper deficiency?,The ablation of either MAC1 or AFT1 also abrogated CTR2 expression induced by copper depletion,0
356,4,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"Our further study revealed that exogenous Aft1p upregulates CTR2 transcription only in the presence of Mac1p, whereas exogenous Mac1p upregulates CTR2 transcription only in the presence of Aft1p.",0
356,5,Is the yeast Μac1 transcription factor induced upon copper deficiency?,We previously reported that CTR2 can be upregulated by copper deficiency via copper-sensing transcription factor Mac1p.,0
356,6,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"In Saccharomyces cerevisiae, transcriptional responses to copper deficiency are mediated by the copper-responsive transcription factor Mac1",1
356,7,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"Although Mac1 activates the transcription of genes involved in high affinity copper uptake during periods of deficiency, little is known about the mechanisms by which Mac1 senses or responds to reduced copper availability.",1
356,8,Is the yeast Μac1 transcription factor induced upon copper deficiency?,The catalytic activity of Sod1 is essential for Mac1 activation and promotes a regulated increase in binding of Mac1 to copper response elements in the promoter regions of genomic Mac1 target genes.,0
356,9,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"In Saccharomyces cerevisiae, copper ions regulate gene expression through the two transcriptional activators, Ace1 and Mac1.",0
356,10,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"Ace1 mediates copper-induced gene expression in cells exposed to stressful levels of copper salts, whereas Mac1 activates a subset of genes under copper-deficient conditions.",1
356,11,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"Taken together, our results suggest that Mac1p can activate the expression of vacuolar copper transporter Ctr2p in response to copper deficiency, resulting in yeast resistance to copper starvation.",0
356,12,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"In Saccharomyces cerevisiae, transcriptional responses to copper deficiency are mediated by the copper-responsive transcription factor Mac1.",1
356,13,Is the yeast Μac1 transcription factor induced upon copper deficiency?,We previously reported that CTR2 can be upregulated by copper deficiency via copper-sensing transcription factor Mac1p.,0
356,14,Is the yeast Μac1 transcription factor induced upon copper deficiency?,The yeast Mac1 protein is a copper-sensing transcription factor that is essential for both the activation and inactivation of genes required for high affinity copper ion transport.,0
356,15,Is the yeast Μac1 transcription factor induced upon copper deficiency?,The copper-depletion induced CTR2 transcription can be abrogated by genetic deletion of copper-sensing transcription factor Mac1p.,0
356,16,Is the yeast Μac1 transcription factor induced upon copper deficiency?,Copper-mediated repression of the activation domain in the yeast Mac1p transcription factor.,0
356,17,Is the yeast Μac1 transcription factor induced upon copper deficiency?,We previously reported that CTR2 can be upregulated by copper deficiency via copper-sensing transcription factor Mac1p.,0
356,18,Is the yeast Μac1 transcription factor induced upon copper deficiency?,"In this study, we found that copper depletion can upregulate yeast CTR2 gene transcription while copper overload downregulate it.",0
356,19,Is the yeast Μac1 transcription factor induced upon copper deficiency?,The copper-depletion induced CTR2 transcription can be abrogated by genetic deletion of copper-sensing transcription factor Mac1p.,0
3050,0,What happens to retrotransposons during ageing?,Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.,1
3050,1,What happens to retrotransposons during ageing?,"These include the loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation of retrotransposons.",1
3050,2,What happens to retrotransposons during ageing?,"Retrotransposons are activated as organisms age, based on work from several model systems.",1
143,0,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?," It is possible to conclude that there is a high prevalence of myocardial fibrosis in hypertrophic cardiomyopathy patients with high-risk or recovered from cardiac sudden death, like those with clinical indication to implantable cardioverter -defibrillator.",0
143,1,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,AF in HCM is related with myocardial fibrosis detected by DE-CMR and dilatation of the LA.,1
143,2,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,"Over the follow-up period, the annualized adverse cardiovascular event rate in patients with DE exceeded that in patients without DE but did not achieve statistical significance (5.5% versus 3.3%; P=0.5).",1
143,3,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,Late gadolinium enhancement by CMR has prognostic value in predicting adverse cardiovascular events among HCM patients.,1
143,4,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,"There are significant relationships between LGE and cardiovascular mortality, heart failure death, and all-cause mortality in HCM.",1
143,5,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,"Additionally, LGE and SCD/aborted SCD displayed a trend toward significance.",0
143,6,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,"The hyperenhanced apical myocardium had a lower percentage of systolic myocardial thickening, and was associated with serious symptoms (e.g.",0
143,7,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,syncope) and ventricular arrhythmias.,0
143,8,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,A semi-quantitative index of DCE is a significant multivariable predictor of both clinical VT/VF and of risk for SCD and may contribute to risk assessment in borderline or controversial cases.,0
143,9,Which is the prognostic meaning of delayed enhancement documented in patients hypertrophic cardiomyopathy?,"Myocardial scar imaged by CE-CMR is common in patients with HCM, and is predictive of VT.",1
529,0,Is TALEN being used on stem cells?,Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.,1
529,1,Is TALEN being used on stem cells?,"Genetic correction of patient-derived induced pluripotent stem cells (iPSCs) by TALENs or CRISPR-Cas9 holds promise for DMD gene therapy; however, the safety of such nuclease treatment must be determined.",0
529,2,Is TALEN being used on stem cells?,"We generated helper-dependent, capsid-modified adenovirus (HD-Ad5/35) vectors for zinc-finger nuclease (ZFN)- or transcription activator-like effector nuclease (TALEN)-mediated genome editing in human CD34+ hematopoietic stem cells (HSCs) from mobilized adult donors.",1
529,3,Is TALEN being used on stem cells?,We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic stem cells (mESCs) to produce mice with targeted gene disruptions and insertions in two Y-linked genes--Sry and Uty.,0
529,4,Is TALEN being used on stem cells?,Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells.,0
529,5,Is TALEN being used on stem cells?,A TALEN genome-editing system for generating human stem cell-based disease models.,1
529,6,Is TALEN being used on stem cells?,Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.,0
529,7,Is TALEN being used on stem cells?,"Using CRISPR-Cas9 and TALEN targeted human pluripotent stem cell clones, we performed whole-genome sequencing at high coverage in order to assess the degree of mutagenesis across the entire genome.",0
529,8,Is TALEN being used on stem cells?,A modified TALEN-based system for robust generation of knock-out human pluripotent stem cell lines and disease models.,0
529,9,Is TALEN being used on stem cells?,"In this study, we utilized a cell-penetrating peptide-based system for ZFN and TALEN delivery.",0
529,10,Is TALEN being used on stem cells?,At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location.,0
529,11,Is TALEN being used on stem cells?,"We report here the use of TALENs to rapidly and efficiently generate mutant alleles of 15 genes in cultured somatic cells or human pluripotent stem cells, the latter for which we differentiated both the targeted lines and isogenic control lines into various metabolic cell types.",0
529,12,Is TALEN being used on stem cells?,Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) have been successfully used to knock out endogenous genes in stem cell research.,0
529,13,Is TALEN being used on stem cells?,Here we report different methods to efficiently perform TALEN-mediated gene integration and inactivation in different mammalian cell systems including induced pluripotent stem cells and delineate experimental examples associated with these approaches,0
529,14,Is TALEN being used on stem cells?,"Together, our results demonstrate that TALE-based transcriptional repressor and TALENs are two promising approaches for loss-of-function studies of microRNA clusters in somatic cells and pluripotent stem cells",0
529,15,Is TALEN being used on stem cells?,"We report here the use of TALENs to rapidly and efficiently generate mutant alleles of 15 genes in cultured somatic cells or human pluripotent stem cells, the latter for which we differentiated both the targeted lines and isogenic control lines into various metabolic cell types",0
529,16,Is TALEN being used on stem cells?,TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.,1
529,17,Is TALEN being used on stem cells?,Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells.,0
529,18,Is TALEN being used on stem cells?,We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic stem cells (mESCs) to produce mice with targeted gene disruptions and insertions in two Y-linked genes--Sry and Uty.,0
529,19,Is TALEN being used on stem cells?,"Using CRISPR-Cas9 and TALEN targeted human pluripotent stem cell clones, we performed whole-genome sequencing at high coverage in order to assess the degree of mutagenesis across the entire genome.",0
529,20,Is TALEN being used on stem cells?,A 5% modification rate was observed in human induced pluripotent stem cells (hiPSCs) treated with TAT-TALEN as measured by the Surveyor assay.,0
529,21,Is TALEN being used on stem cells?,TAT-TALEN protein-mediated gene disruption was applicable in hiPSCs and represents a promising technique for gene knockout in stem cells.,1
529,22,Is TALEN being used on stem cells?,Here we engineered transcription activator-like effector nucleases (TALENs) for five distinct genomic loci.,0
529,23,Is TALEN being used on stem cells?,At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location.,0
529,24,Is TALEN being used on stem cells?,Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs.,0
529,25,Is TALEN being used on stem cells?,At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location.,0
529,26,Is TALEN being used on stem cells?,Our data suggest that TALENs employing the specific architectures described here mediate site-specific genome modification in human pluripotent cells with similar efficiency and precision as do zinc-finger nucleases (ZFNs).,0
4132,0,List proteins that are contained in atherosclerotic plaques?,d extracellular matrix (ECM) proteins in the arterial wall,1
4132,1,List proteins that are contained in atherosclerotic plaques?,apolipoprotein A-I (apoA-I),1
4132,2,List proteins that are contained in atherosclerotic plaques?,"Among the proteins with increased abundance were prominent extracellular matrix proteins such as biglycan and lumican, whereas cytoskeletal markers for contractile smooth muscle cells (SMCs) were decreased.",1
4132,3,List proteins that are contained in atherosclerotic plaques?,", a biomarker panel of FBLN1C, APOE and CDH13 was identifie",1
2480,0,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."," Metabolic syndrome (MetS) is a collection of clinical conditions, including central obesity, hypertension, glucose intolerance and dyslipidemia.",0
2480,1,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Metabolic syndrome (MetS) is generally defined as a cluster of metabolically related cardiovascular risk factors which are often associated with the condition of insulin resistance, elevated blood pressure, and abdominal obesity",1
2480,2,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Metabolic syndrome, defined as a cluster of obesity, hypertension, dyslipidemia, and insulin resistance/glucose intolerance, has been identified as a major risk factor for coronary heart disease in women.",1
2480,3,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Metabolic syndrome is a cluster of conditions that synergistically increase the risk of cardiovascular disease, type 2 diabetes, and premature mortality.",0
2480,4,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","The components are abdominal obesity, impaired glucose metabolism, dyslipidemia, and hypertension.",0
2480,5,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","MetS is recognized clinically by numerous constitutive traits, including abdominal obesity, hypertension, dyslipidemia (elevated triglycerides, low high-density lipoprotein cholesterol), and hyperglycemia.",0
2480,6,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Abdominal obesity is frequently associated with a collection of metabolic disorders that include elevated blood pressure, characteristic lipid abnormalities (low high-density lipoprotein cholesterol and high triglycerides) and increased fasting glucose, with an underlying situation of insulin resistance, which has been defined as metabolic syndrome",1
2480,7,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","The presence of 3 or more of the following 5 components (abdominal obesity, hypertriglyceridemia, low level of high density lipoprotein cholesterol, hypertension and high fasting blood glucose) allows to diagnose metabolic syndrome.",0
2480,8,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","The metabolic syndrome has 5 criteria: central obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) levels, fasting hyperglycemia, and hypertension.",0
2480,9,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Metabolic syndrome is a constellation of interrelated risk factors of metabolic origin including abdominal obesity, atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose level, and prothrombotic and proinflammatory states that promote atherosclerotic CVD and increase the risk of type 2 diabetes mellitus.",0
2480,10,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","The waist circumference cut points for diagnosing metabolic syndrome (as defined using the new harmonised guidelines), insulin resistance, dysglycaemia, hypertension and dyslipidaemia were obtained using receiver operator characteristic curve analysis.",0
2480,11,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","The metabolic syndrome is a complex association of several risk factors including insulin resistance, dyslipidemia, and essential hypertension.",1
2480,12,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."," insulin resistance syndrome (often referred to as syndrome X or the metabolic syndrome) ie, a clustering of metabolic, atheromatous risk factors, including hypertriglyceridaemia, hyperinsulinaemia, hyper-tension, hypercholesterinaemia and obesity.",0
2480,13,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.",The metabolic syndrome is a clustering of risk factors which predispose an individual to cardiovascular morbidity and mortality.,1
2480,14,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","There is general consensus regarding the main components of the syndrome (glucose intolerance, obesity, raised blood pressure and dyslipidaemia [elevated triglycerides, low levels of high-density lipoprotein cholesterol])",0
2480,15,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Metabolic syndrome (MS) refers to the clustering of cardiometabolic risk factors - including abdominal obesity, hyperglycaemia, dyslipidaemia and elevated blood pressure",0
2480,16,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","The metabolic syndrome is a constellation of risk factors including glucose dysregulation, central obesity, dyslipidemia, and hypertension.",0
2480,17,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Insulin resistance syndrome (IRS), also termed syndrome X, is a distinctive constellation of risk factors for the development of type 2 diabetes mellitus and cardiovascular disease.",0
2480,18,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","The syndrome's hallmarks are glucose intolerance, hyperinsulinemia, a characteristic dyslipidemia (high triglycerides; low high-density lipoprotein cholesterol, and small, dense low-density lipoprotein cholesterol), obesity, upper-body fat distribution, hypertension, and increased prothrombotic and antifibrinolytic factors",0
2480,19,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","""The metabolic syndrome"" is the name for a clustering of risk factors for cardiovascular disease and type 2 diabetes that are of metabolic origin.",0
2480,20,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","These risk factors consist of atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose, a prothrombotic state, and a proinflammatory state.",0
2480,21,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","Metabolic Syndrome X is a clinical entity which comprises the following factors: diabetes mellitus, arterial hypertension, high levels of triglyceride and/or low levels of HDL cholesterol, central obesity and microalbuminuria",0
2480,22,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","metabolic syndrome, produced by genetic, hormonal and lifestyle factors such as obesity, physical inactivity and certain nutrient excesses.",0
2480,23,"According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.","This disease is characterized by the clustering of insulin resistance and hyperinsulinemia, and is often associated with dyslipidemia (atherogenic plasma lipid profile), essential hypertension, abdominal (visceral) obesity, glucose intolerance or noninsulin-dependent diabetes mellitus and an increased risk of cardiovascular events",0
2239,0,Which markers are screened with the triple test for the detection of syndromes in fetus?,Our study aimed at calculation and validation of the triple marker medians used in screening Egyptian females as well as to recommend programme conventions to unify screening in this country.,0
2239,1,Which markers are screened with the triple test for the detection of syndromes in fetus?,"Chorionic gonadotropin (CG), α-fetoprotein (AFP) and unconjugated oestriol (uE3) were measured on Siemens Immulite analyzer.",0
2239,2,Which markers are screened with the triple test for the detection of syndromes in fetus?,Triple test screening for Down syndrome: an Egyptian-tailored study.,1
2239,3,Which markers are screened with the triple test for the detection of syndromes in fetus?,"The purpose of this article was to evaluate the reliability of maternal serum triple marker screening of alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol for the prenatal diagnosis of fetal chromosomal abnormalities in Turkish pregnant women.",1
2239,4,Which markers are screened with the triple test for the detection of syndromes in fetus?,Second trimester triple test is an effective screening tool for detecting fetal Down syndrome in Turkish women.,0
2239,5,Which markers are screened with the triple test for the detection of syndromes in fetus?,"The aim of this prospective study was to compare triple test screening (alpha-fetoprotein, beta-chorionic gonadotrophin and unconjugated oestriol) with amniocentesis in the detection of fetuses with Down's syndrome in women of 35 years of age or more.",1
2239,6,Which markers are screened with the triple test for the detection of syndromes in fetus?,"The aim of this prospective study was to compare triple test screening (alpha-fetoprotein, beta-chorionic gonadotrophin and unconjugated oestriol) with amniocentesis in the detection of fetuses with Down's syndrome in women of 35 years of age or more.",1
2239,7,Which markers are screened with the triple test for the detection of syndromes in fetus?,"None of the other five markers added more than 2% detection for the same false-positive rate.The performance of screening using maternal age and serum-free beta-hCG and PAPP-A at 10 weeks of pregnancy was better than the double test (alpha-fetoprotein and hCG with maternal age) and similar to the triple test (alpha-fetoprotein, unconjugated oestriol and hCG with maternal age) at 15-22 weeks.",0
2239,8,Which markers are screened with the triple test for the detection of syndromes in fetus?,To make recommendations to physicians providing prenatal care on (1) whether prenatal screening for and diagnosis of Down syndrome (DS) is advisable and (2) alternative screening and diagnosis manoeuvres.,0
2239,9,Which markers are screened with the triple test for the detection of syndromes in fetus?,"""Triple-marker"" screening of maternal serum levels of alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol; fetal ultrasonographic examination; amniocentesis; and chorionic villus sampling (CVS).Accuracy of detection of DS in fetuses, and risks to the mother, including psychologic distress, and to the fetus from the screening and diagnostic interventions.A MEDLINE search for relevant a",0
2239,10,Which markers are screened with the triple test for the detection of syndromes in fetus?,"A decision analytic model was designed for women at increased risk for a DS fetus due to either advanced maternal age (AMA) or a positive expanded maternal serum alpha fetoprotein (MSAFP) screening test, also known as a triple screen (+triple) test.",0
2239,11,Which markers are screened with the triple test for the detection of syndromes in fetus?,"These tests have a limited detection rate for Down syndrome: approximately 40% for hCG or free beta-subunit alone, approximately 60% for the triple screen test, and approximately 70% for the quadruple marker test, all at 5%, or a relatively high, false-positive rate.",0
2239,12,Which markers are screened with the triple test for the detection of syndromes in fetus?,"Serum human chorionic gonadotropin (hCG) and hCG free beta-subunit tests are used in combination with unconjugated estriol and alpha-fetoprotein in the triple screen test, and with the addition of inhibin-A in the quadruple marker test for detecting Down syndrome in the second trimester of pregnancy.",1
2239,13,Which markers are screened with the triple test for the detection of syndromes in fetus?,"Initial and revised screen-positive rates and detection rates were reviewed for women undergoing triple-marker testing (maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol).",0
1105,0,Are thyroid hormone receptor alpha1 mutations  implicated in thyroid hormone resistance syndrome?,Mutations in human TRα1 mediate RTH with features of hypothyroidism in particular tissues (e.g.,1
1105,1,Are thyroid hormone receptor alpha1 mutations  implicated in thyroid hormone resistance syndrome?,"skeleton, gastrointestinal tract), but are not associated with a markedly dysregulated pituitary-thyroid axis.",1
1105,2,Are thyroid hormone receptor alpha1 mutations  implicated in thyroid hormone resistance syndrome?,Clinical phenotype of a new type of thyroid hormone resistance caused by a mutation of the TRα1 receptor,1
3263,0,Are astrocytes part of the blood brain barrier?,"The blood-brain barrier (BBB) is a tight boundary formed between endothelial cells and astrocytes, which separates and protects brain from most pathogens as well as neural toxins in circulation.",1
3263,1,Are astrocytes part of the blood brain barrier?,"The blood-brain barrier (BBB) consists of endothelial cells, astrocytes, and pericytes embedded in basal lamina (BL).",1
53,0,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,We found that ICLs activate a branched pathway downstream of the ATR kinase: one branch depending on CHK1 activity and the other on the FANCs-RMN complex.,0
53,1,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,"The transient slow-down of DNA synthesis was abolished in cells lacking ATR, whereas CHK1-siRNA-treated cells, NBS1 or FA cells showed partial S-phase arrest",0
53,2,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,Arrest of S-phase progression is impaired in Fanconi anemia cells,0
53,3,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,"Fanconi anemia (FA) is an inherited cancer-susceptibility disorder, characterized by genomic instability, hypersensitivity to DNA cross-linking agents, and a prolonged G2 phase of the cell cycle",1
53,4,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,"We observed a marked dose-dependent accumulation of FA cells in the G2 compartment after treatment with 4,5',8-trimethylpsoralen (Me(3)Pso) in combination with 365 nm irradiation",0
53,5,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,"Taken together, the above data suggest that, in response to damage induced by DNA cross-linking agents, the S-phase checkpoint is inefficient in FA cells.",1
53,6,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,"This would lead to accumulation of secondary lesions, such as single- and double-strand breaks and gaps.",1
53,7,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,The prolonged time in G2 phase seen in FA cells therefore exists in order to allow the cells to remove lesions which accumulated during the preceding abnormal S phase,1
53,8,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,"Fanconi anemia (FA) is a genetic disorder defined by cellular hypersensitivity to DNA cross-linking agents, such as mitomycin C (MMC).",0
53,9,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,"MMC causes increased FA cell death, chromosome breakage, and accumulation in the G2 phase of the cell cycle",0
53,10,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function,0
53,11,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,Cells from individuals with Fanconi anemia (FA) arrest excessively in the G2/M cell cycle compartment after exposure to low doses of DNA cross-linking agents,0
53,12,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,Based on these studies we conclude that the aberrant G2/M arrest that typifies the response of FA(C) cells to low doses of cross-linking agents does not represent an abnormal cell cycle response but instead represents a normal cellular response to the excessive DNA damage that results in FA(C) cells following exposure to low doses of cross-linking agents,1
53,13,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,Arrest of S-phase progression is impaired in Fanconi anemia cells.,0
53,14,In which phase of the cell cycle arrest is impaired in Fanconi anemia?,The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase.,0
647,0,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?," GJB1 is currently considered to be associated with X-linked DI-CMT, and MPZ, INF2, DNM2, YARS, GNB4, NEFL, and MFN2 are associated with autosomal DI-CMT.",1
647,1,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Moreover, GDAP1, KARS, and PLEKHG5 are associated with RI-CMT.",0
647,2,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Identification of these genes is not only important for patients and families but also provides new information about pathogenesis,1
647,3,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel mutation in LRSAM1 causes axonal Charcot-Marie-Tooth disease with dominant inheritance,0
647,4,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Charcot-Marie-Tooth disease (CMT) refers to a heterogeneous group of genetic motor and sensory neuropathies.,0
647,5,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"According to the primary site of damage, a distinction is made between demyelinating and axonal forms (CMT1 and 2, respectively, when inherited as an autosomal dominant trait).",0
647,6,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Leucine-rich repeat and sterile alpha motif-containing protein 1 (LRSAM1) is a ubiquitin-protein ligase with a role in sorting internalised cell-surface receptor proteins.,0
647,7,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"So far, mutations in the LRSAM1 gene have been shown to cause axonal CMT in three different families and can confer either dominant or recessive transmission of the disease",0
647,8,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,We have identified a novel mutation in LRSAM1 in a small family with dominant axonal CMT,0
647,9,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease,1
647,10,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K).,0
647,11,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Most of these mutations present a recessive inheritance, but few autosomal dominant GDAP1 mutations have also been reported",0
647,12,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?, Our findings highlight the relevance of dominantly transmitted p.R120W GDAP1 gene mutations which can cause an axonal CMT with a wide clinical profile,0
647,13,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease,0
647,14,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,There have been very few reports of GDAP1 mutations in autosomal dominant (AD) CMT,0
647,15,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Here, we report an AD CMT family with a novel Q218E mutation in the GDAP1 gene",0
647,16,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,CMT type 1 (CMT1; MIM 118200) is a group of autosomal dominant-inherited demyelinating neuropathies with a disease onset at or after childhood.,0
647,17,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Five different subtypes have been identified based on different causative genes.,0
647,18,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Among them, CMT1A (MIM #118220) is most common and is usually associated with a duplication of a 1.5-Mb region on chromosome 17p11.2, which includes peripheral myelin protein 22 gene (PMP22; MIM *601097)",0
647,19,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the NF-L gene (NEFL) cause autosomal dominant neuropathies that are classified either as axonal Charcot-Marie-Tooth (CMT) type 2E (CMT2E) or demyelinating CMT type 1F (CMT1F),0
647,20,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Recently, mutations affecting different domains of dynamin-2 (DNM2) were associated alternatively with autosomal dominant centronuclear myopathy or dominant intermediate (demyelinating and axonal) Charcot-Marie-Tooth disease (CMT) type B",0
647,21,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Four genes (PMP22, MPZ, LITAF, and EGR2) have been described in the last 15 yr associated with AD CMTI and a further gene (NEFL), originally described as causing AD CMT2 can also cause AD CMT1 (by neurophysiological criteria)",0
647,22,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease,0
647,23,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"We refined the locus associated with DI-CMTB on chromosome 19p12-13.2 to 4.2 Mb in three unrelated families with CMT originating from Australia, Belgium and North America.",0
647,24,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"After screening candidate genes, we identified unique mutations in dynamin 2 (DNM2) in all families",0
647,25,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Here, we report a large family showing characteristic phenotypes of Charcot-Marie-Tooth type 1A along with deafness in an autosomal dominant fashion.",0
647,26,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,We detected a sequence variation (c.68C>G) co-segregating with the disease phenotype and leading to a T23R missense mutation in PMP22,0
647,27,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,The authors recently mapped an autosomal dominant demyelinating form of CMT type 1 (CMT1C) to chromosome 16p13.1-p12.3,0
647,28,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"The authors identified missense mutations (G112S, T115N, W116G) in the LITAFgene (lipopolysaccharide-induced tumor necrosis factor-alpha factor) in three CMT1C pedigrees",0
647,29,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,We identified a novel neurofilament-light missense mutation (C64T) that causes the disease in a large Slovenian CMT2 family.,0
647,30,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,This novel mutation shows complete co-segregation with the dominantly inherited CMT2 phenotype in our family,0
647,31,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease.,1
647,32,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Ganglioside-induced differentiation associated-protein 1 (GDAP1) mutations are commonly associated with autosomal recessive Charcot-Marie-Tooth (ARCMT) neuropathy; however, in rare instances, they also lead to autosomal dominant Charcot-Marie-Tooth (ADCMT).",0
647,33,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease.,0
647,34,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"In this study, we aimed to elucidate the disease mechanisms in dominant intermediate Charcot-Marie-Tooth neuropathy type B and to find explanations for the tissue-specific defects that are associated with different DNM2 mutations in dominant intermediate Charcot-Marie-Tooth neuropathy type B versus autosomal dominant centronuclear myopathy.",0
647,35,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Mutations in dynamin 2 (DNM2) lead to dominant intermediate Charcot-Marie-Tooth neuropathy type B, while a different set of DNM2 mutations cause autosomal dominant centronuclear myopathy.",0
647,36,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease,0
647,37,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Recently, mutations affecting different domains of dynamin-2 (DNM2) were associated alternatively with autosomal dominant centronuclear myopathy or dominant intermediate (demyelinating and axonal) Charcot-Marie-Tooth disease (CMT) type B.",0
647,38,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the Dynamin 2 gene (DNM2) cause autosomal dominant centronuclear myopathy or autosomal dominant (AD) Charcot-Marie-Tooth (CMT) disease,0
647,39,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the ganglioside-induced differentiation-associated protein 1 gene cause either autosomal recessive demyelinating Charcot-Marie-Tooth disease type 4A or autosomal recessive axonal Charcot-Marie-Tooth disease with vocal cord paresis,0
647,40,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel mutation in the GDAP1 gene is associated with autosomal recessive Charcot-Marie-Tooth disease in an Amish family,0
647,41,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene,0
647,42,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Autosomal dominant Charcot-Marie-Tooth type-1A neuropathy (CMT1A) is a demyelinating peripheral nerve disorder that is commonly associated with a submicroscopic tandem DNA duplication of a 1.5-Mb region of 17p11.2p12 that contains the peripheral myelin gene PMP22.,0
647,43,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"OBJECTIVE: Ganglioside-induced differentiation associated-protein 1 (GDAP1) mutations are commonly associated with autosomal recessive Charcot-Marie-Tooth (ARCMT) neuropathy; however, in rare instances, they also lead to autosomal dominant Charcot-Marie-Tooth (ADCMT).",0
647,44,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K).,0
647,45,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the NEFL gene were recently reported as a cause for autosomal dominant Charcot-Marie-Tooth type 2E (CMT2E) linked to chromosome 8p21.,0
647,46,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.,0
647,47,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"Ganglioside-induced differentiation associated-protein 1 (GDAP1) mutations are commonly associated with autosomal recessive Charcot-Marie-Tooth (ARCMT) neuropathy; however, in rare instances, they also lead to autosomal dominant Charcot-Marie-Tooth (ADCMT).",0
647,48,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"In this study, we aimed to elucidate the disease mechanisms in dominant intermediate Charcot-Marie-Tooth neuropathy type B and to find explanations for the tissue-specific defects that are associated with different DNM2 mutations in dominant intermediate Charcot-Marie-Tooth neuropathy type B versus autosomal dominant centronuclear myopathy.",0
647,49,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"We used tissue derived from Dnm2-deficient mice to establish an appropriate peripheral nerve model and found that dominant intermediate Charcot-Marie-Tooth neuropathy type B-associated dynamin 2 mutants, but not autosomal dominant centronuclear myopathy mutants, impaired myelination.",0
647,50,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?," Mutations in dynamin 2 (DNM2) lead to dominant intermediate Charcot-Marie-Tooth neuropathy type B, while a different set of DNM2 mutations cause autosomal dominant centronuclear myopathy.",0
647,51,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"In this study, we aimed to elucidate the disease mechanisms in dominant intermediate Charcot-Marie-Tooth neuropathy type B and to find explanations for the tissue-specific defects that are associated with different DNM2 mutations in dominant intermediate Charcot-Marie-Tooth neuropathy type B versus autosomal dominant centronuclear myopathy.",0
647,52,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"We conclude that dynamin 2 mutations should be screened in the autosomal dominant Charcot-Marie-Tooth neuropathy families with intermediate or axonal NCV, and in patients with a classical mild to moderately severe Charcot-Marie-Tooth phenotype, especially when Charcot-Marie-Tooth is associated with neutropaenia or cataracts.",0
647,53,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,.,0
647,54,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease.,0
647,55,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"We conclude that dynamin 2 mutations should be screened in the autosomal dominant Charcot-Marie-Tooth neuropathy families with intermediate or axonal NCV, and in patients with a classical mild to moderately severe Charcot-Marie-Tooth phenotype, especially when Charcot-Marie-Tooth is associated with neutropaenia or cataracts.",0
647,56,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"In this study, we aimed to elucidate the disease mechanisms in dominant intermediate Charcot-Marie-Tooth neuropathy type B and to find explanations for the tissue-specific defects that are associated with different DNM2 mutations in dominant intermediate Charcot-Marie-Tooth neuropathy type B versus autosomal dominant centronuclear myopathy.",0
647,57,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease.,0
647,58,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K).,0
647,59,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,"A wide range of phenotypes have been reported in autosomal recessive (AR) Charcot-Marie-Tooth disease (CMT) patients carrying mutations in the ganglioside-induced differentiation-associated protein 1 (GDAP1) gene, such as axonal, demyelinating, and intermediate forms of AR CMT.",0
647,60,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A severe recessive and a mild dominant form of Charcot-Marie-Tooth disease associated with a newly identified Glu222Lys GDAP1 gene mutation.,1
647,61,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease.,0
647,62,Which genes are associated with autosomal dominant Charcot-Marie-Tooth?,A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease.,0
224,0,How many genes does the human hoxD cluster contain?,Both children are heterozygous for a deletion that eliminates at least eight (HOXD3-HOXD13) of the nine genes in the HOXD cluster,1
3997,0,What are the 4 types of holoprosencephaly?,Holoprosencephaly is a rare congenital disorder which results from failure of cleavage or incomplete differentiation of the forebrain structures at various levels or to various degrees.,1
3997,1,What are the 4 types of holoprosencephaly?,"Depending on the degree of involvement, it is classified into 4 types: Alobar, Semilobar, Lobar and Middle interhemispheric fusion variant.",1
3997,2,What are the 4 types of holoprosencephaly?,"Neuroradiologic studies have provided detailed characteristics of four major types of holoprosencephaly: alobar, semilobar, lobar, and middle interhemispheric variant.",1
3997,3,What are the 4 types of holoprosencephaly?,"Holoprosencephaly is addressed under the following headings: alobar, semilobar, and lobar holoprosencephaly; arrhinencephaly; agenesis of the corpus callosum; pituitary abnormalities; hindbrain abnormalities; syntelencephaly; aprosencephaly/atelencephaly; neural tube defects; facial anomalies; median cleft lip; minor facial anomalies; single maxillary central incisor; holoprosencephaly-like phenotype; epidemiology; genetic causes of holoprosencephaly; teratogenic causes of holoprosencephaly; SHH mutations; ZIC2 mutations; SIX3 mutations; TGIF mutations; PTCH mutations; GLI2 mutations; FAST1 mutations; TDGF1 mutations; and DHCR7 mutations.",1
3997,4,What are the 4 types of holoprosencephaly?,"The classifications of alobar, semilobar, and lobar types A and B holoprosencephaly are each represented, with an additional case of semilobar holoprosencephaly complicated by a subdural effusion.",1
2711,0,Which human chromosome is the product of fusion?,The evolution of African great ape subtelomeric heterochromatin and the fusion of human chromosome 2.,1
2711,1,Which human chromosome is the product of fusion?,"We propose a model where an ancestral human-chimpanzee pericentric inversion and the ancestral chromosome 2 fusion both predisposed and protected the chimpanzee and human genomes, respectively, to the formation of subtelomeric heterochromatin.",1
2711,2,Which human chromosome is the product of fusion?,It is known that human chromosome 2 originated from the fusion of two ancestral primate chromosomes.,1
2711,3,Which human chromosome is the product of fusion?,Origin of human chromosome 2: an ancestral telomere-telomere fusion.,1
2711,4,Which human chromosome is the product of fusion?,We conclude that the locus cloned in cosmids c8.1 and c29B is the relic of an ancient telomere-telomere fusion and marks the point at which two ancestral ape chromosomes fused to give rise to human chromosome 2.,0
2711,5,Which human chromosome is the product of fusion?,Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres.,0
2711,6,Which human chromosome is the product of fusion?,"We investigate the most recent product of a chromosome fusion event fixed in the human lineage, human chromosome 2, whose stability was acquired by the suppression of one centromere, resulting in a unique difference in chromosome number between humans (46 chromosomes) and our most closely related ape relatives (48 chromosomes).",0
2711,7,Which human chromosome is the product of fusion?,Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes.,0
2711,8,Which human chromosome is the product of fusion?,"By doing so, one is able to provide evidence for the presence of both active and degenerate centromeric satellite profiles on chromosome 2 in these archaic genomes, supporting the hypothesis that the chromosomal fusion event took place prior to our last common ancestor with Denisovan and Neandertal hominins and presenting a genomic reference for predicting karyotype in ancient genomic datasets.<br>",0
2711,9,Which human chromosome is the product of fusion?,Centromere Destiny in Dicentric Chromosomes: New Insights from the Evolution of Human Chromosome 2 Ancestral Centromeric Region.,1
2711,10,Which human chromosome is the product of fusion?,"Human chromosome 2 arose as a result of a telomeric fusion between acrocentric chromosomes, whereas chromosomes 4 and 19 in Gorilla gorilla are the products of a reciprocal translocation between ancestral chromosomes, syntenic to human chromosomes 5 and 17, respectively.",0
2711,11,Which human chromosome is the product of fusion?,Our results suggest two possible centromere inactivation models to explain the evolutionarily stabilization of human chromosome 2 over the last 5-6 million years.,0
587,0,List variants of the MC1R gene.,"All of the investigated variants showed positive associations with NMSC, with consistent significant results obtained for V60L, D84E, V92M, R151C, R160W, R163Q and D294H: SOR (95%CI) ranged from 1.42 (1.19-1.70) for V60L to 2.66 (1.06-6.65) for D84E variant.",1
587,1,List variants of the MC1R gene.,The melanocortin 1 receptor (MC1R) gene encodes for a seven-pass transmembrane receptor primarily expressed on melanocytes and melanoma cells.,1
587,2,List variants of the MC1R gene.,for V60L to 2.74 (1.53-4.89) for D84E.,1
587,3,List variants of the MC1R gene.," We aim to examine the influence of the MC1R variants (RHC: D84E, R151C, R160W; NRHC: V60L, R163Q and the synonymous polymorphism T314T) on the MM risk in a population from the Canary Islands.",1
4219,0,Can thiotepa be recommended for treatment of osteosarcoma?,CONCLUSION: Adjuvant HDTp failed to significantly improve OS and PFS in resectable relapsed osteosarcomas.,1
4219,1,Can thiotepa be recommended for treatment of osteosarcoma?,"Despite a trend of prolonged survival and an acceptable toxicity, thiotepa cannot be recommended.KEY MESSAGE: HDTp and autologous transplantation added to SCT did not improve OS and PFS in patients with resectable relapsed osteosarcomas.",1
4219,2,Can thiotepa be recommended for treatment of osteosarcoma?,"Despite a trend of prolonged survival, thiotepa cannot be recommended.",1
4219,3,Can thiotepa be recommended for treatment of osteosarcoma?,Conclusion.,0
4219,4,Can thiotepa be recommended for treatment of osteosarcoma?,The use of HD thiotepa and ASCT is feasible in patients with relapsed osteosarcoma.,1
4219,5,Can thiotepa be recommended for treatment of osteosarcoma?,A randomized study for recurrent osteosarcoma between standard salvage chemotherapy and high dose thiotepa with stem cell rescue is ongoing.,1
3704,0,Does radiotherapy for prostate cancer increase bladder cancer risk?,External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.,0
3704,1,Does radiotherapy for prostate cancer increase bladder cancer risk?,"On multivariable competing risk regression analyses, treatment with EBRT was independently associated with the risk of developing a second primary BCa (hazard ratio: 1.35, CI: 1.18-1.55; p<0.001), but not RCa (p=0.4).",0
3704,2,Does radiotherapy for prostate cancer increase bladder cancer risk?,CONCLUSIONS: Patients treated with EBRT are at increased risk of developing a second primary BCa compared with those treated with RP.,0
3704,3,Does radiotherapy for prostate cancer increase bladder cancer risk?,"However, no differences were found considering RCa incidence in patients treated with RP or EBRT within the first 5 yr after primary therapy.",0
3704,4,Does radiotherapy for prostate cancer increase bladder cancer risk?,We found that those treated with external beam radiotherapy are at an increased risk of developing a second primary bladder cancer tumor.,0
3704,5,Does radiotherapy for prostate cancer increase bladder cancer risk?,"All radiation modalities were found to have an increased RR of developing BlCa after 10 years, with brachytherapy having a significantly higher RR than external beam radiation (EBRT) or combined EBRT and brachytherapy in Caucasian men and a significantly higher RR than EBRT in men of other/unknown ethnicity.",0
3704,6,Does radiotherapy for prostate cancer increase bladder cancer risk?,"CONCLUSIONS: The increased risk of BlCa after prostate radiation occurs predominantly after 10 years, regardless of ethnicity.",0
3704,7,Does radiotherapy for prostate cancer increase bladder cancer risk?,The RR of developing BlCa after 10 years is significantly higher following brachytherapy than after EBRT or EBRT and brachytherapy.,0
3704,8,Does radiotherapy for prostate cancer increase bladder cancer risk?,"Based on the data in the literature, there is a consistently increased risk of bladder cancer (HR: 1.67, 95% CI 1.55-1.80), rectal cancer (HR: 1.79, 95% CI 1.34-2.38), and colorectal cancer (HR: 1.79, 95% CI 1.34-23.8) following percutaneous radiation therapy.",0
3704,9,Does radiotherapy for prostate cancer increase bladder cancer risk?,"Following brachytherapy only an increased for the development of bladder cancer (HR: 2.14, 95% CI 1.03-3.94) has been observed.",0
3704,10,Does radiotherapy for prostate cancer increase bladder cancer risk?,"When comparing with a matched general French population, the standard incidence ratio (SIR) for bladder cancer was 1.02 (95% CI: 0.46-1.93).",0
3704,11,Does radiotherapy for prostate cancer increase bladder cancer risk?,"LDR resulted in lower bladder cancer risks than HDR, and lower or similar risks of rectal cancer.",0
3704,12,Does radiotherapy for prostate cancer increase bladder cancer risk?,"Compared to external beam techniques, second rectal and bladder cancer risks were lowest for brachytherapy.",0
3704,13,Does radiotherapy for prostate cancer increase bladder cancer risk?,"OBJECTIVE: Although it is well known that radiotherapy for prostate cancer increases comorbid rate of secondary bladder cancer, the effect of aging and smoking with radiotherapy on incidence rate of secondary bladder cancer remains unknown.",0
3704,14,Does radiotherapy for prostate cancer increase bladder cancer risk?,"RESULTS: During the median follow-up period of 4.3 and 3.1 years, secondary bladder cancer occurred in 11 (3.4%) and 5 (1.1%) of patients with prostate cancer treated with external beam radiotherapy and radical prostatectomy, respectively.",0
3704,15,Does radiotherapy for prostate cancer increase bladder cancer risk?,"CONCLUSIONS

Men who receive radiotherapy for localized prostate cancer have an increased risk of bladder cancer compared to patients undergoing radical prostatectomy and compared to the general population.",0
3704,16,Does radiotherapy for prostate cancer increase bladder cancer risk?,Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.,0
3704,17,Does radiotherapy for prostate cancer increase bladder cancer risk?,"RESULTS

The relative risk of bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively.",0
3704,18,Does radiotherapy for prostate cancer increase bladder cancer risk?,"Compared to the general United States population the standardized incidence ratio for bladder cancer developing after radical prostatectomy, external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy was 0.99, 1.42, 1.10 and 1.39, respectively.",0
3704,19,Does radiotherapy for prostate cancer increase bladder cancer risk?,"OBJECTIVE

Although it is well known that radiotherapy for prostate cancer increases comorbid rate of secondary bladder cancer, the effect of aging and smoking with radiotherapy on incidence rate of secondary bladder cancer remains unknown.",0
3704,20,Does radiotherapy for prostate cancer increase bladder cancer risk?,"OBJECTIVE
Although it is well known that radiotherapy for prostate cancer increases comorbid rate of secondary bladder cancer, the effect of aging and smoking with radiotherapy on incidence rate of secondary bladder cancer remains unknown.",0
3704,21,Does radiotherapy for prostate cancer increase bladder cancer risk?,"CONCLUSIONS
Men who receive radiotherapy for localized prostate cancer have an increased risk of bladder cancer compared to patients undergoing radical prostatectomy and compared to the general population.",0
3704,22,Does radiotherapy for prostate cancer increase bladder cancer risk?,"PURPOSE
Pre-prostate specific antigen era series demonstrated an increased risk of bladder cancer and rectal cancer in men who received radiotherapy for prostate cancer.",0
3704,23,Does radiotherapy for prostate cancer increase bladder cancer risk?,"RESULTS
The relative risk of bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively.",0
3704,24,Does radiotherapy for prostate cancer increase bladder cancer risk?,"CONCLUSIONS: Taken together, these findings suggest that smoking history might be one of criteria to choose radical prostatectomy than external beam radiotherapy for prostate cancer, and that age would not be a criterion for therapeutic selection in terms of secondary bladder cancer.",0
3704,25,Does radiotherapy for prostate cancer increase bladder cancer risk?,PURPOSE: Pre-prostate specific antigen era series demonstrated an increased risk of bladder cancer and rectal cancer in men who received radiotherapy for prostate cancer.,0
3704,26,Does radiotherapy for prostate cancer increase bladder cancer risk?,"RESULTS: The relative risk of bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively.",0
3704,27,Does radiotherapy for prostate cancer increase bladder cancer risk?,"Compared to the general United States population the standardized incidence ratio for bladder cancer developing after radical prostatectomy, external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy was 0.99, 1.42, 1.10 and 1.39, respectively.",0
3704,28,Does radiotherapy for prostate cancer increase bladder cancer risk?,Pre-prostate specific antigen era series demonstrated an increased risk of bladder cancer and rectal cancer in men who received radiotherapy for prostate cancer.,1
3704,29,Does radiotherapy for prostate cancer increase bladder cancer risk?,Men who receive radiotherapy for localized prostate cancer have an increased risk of bladder cancer compared to patients undergoing radical prostatectomy and compared to the general population.,1
3704,30,Does radiotherapy for prostate cancer increase bladder cancer risk?,"The relative risk of bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively.",0
3704,31,Does radiotherapy for prostate cancer increase bladder cancer risk?,Radiotherapy for prostate cancer is associated with an increased incidence of secondary bladder cancer (BC).,1
3704,32,Does radiotherapy for prostate cancer increase bladder cancer risk?,Radiation therapy for prostate cancer is associated with an increased risk of bladder cancer.,1
3704,33,Does radiotherapy for prostate cancer increase bladder cancer risk?,"Radiotherapy for prostate cancer was associated with higher risks of developing second malignancies of the bladder, colon, and rectum compared with patients unexposed to radiotherapy, but the reported absolute rates were low.",1
2232,0,Is there any role of TBR1 in autism?,TBR1 regulates autism risk genes in the developing neocortex,0
2232,1,Is there any role of TBR1 in autism?,"Exome sequencing studies have identified multiple genes harboring de novo loss-of-function (LoF) variants in individuals with autism spectrum disorders (ASD), including TBR1, a master regulator of cortical development.",1
2232,2,Is there any role of TBR1 in autism?,We performed ChIP-seq for TBR1 during mouse cortical neurogenesis and show that TBR1-bound regions are enriched adjacent to ASD genes.,0
2232,3,Is there any role of TBR1 in autism?,"ASD genes were also enriched among genes that are differentially expressed in Tbr1 knockouts, which together with the ChIP-seq data, suggests direct transcriptional regulation.",0
2232,4,Is there any role of TBR1 in autism?,"Of the nine ASD genes examined, seven were misexpressed in the cortices of Tbr1 knockout mice, including six with increased expression in the deep cortical layers.",0
2232,5,Is there any role of TBR1 in autism?,ASD genes with adjacent cortical TBR1 ChIP-seq peaks also showed unusually low levels of LoF mutations in a reference human population and among Icelanders.,0
2232,6,Is there any role of TBR1 in autism?,We then leveraged TBR1 binding to identify an appealing subset of candidate ASD genes.,0
2232,7,Is there any role of TBR1 in autism?,"Our findings highlight a TBR1-regulated network of ASD genes in the developing neocortex that are relatively intolerant to LoF mutations, indicating that these genes may play critical roles in normal cortical development.",0
2232,8,Is there any role of TBR1 in autism?,T-Brain-1--A Potential Master Regulator in Autism Spectrum Disorders.,0
2232,9,Is there any role of TBR1 in autism?,"T-Brain-1 (TBR1), a causative gene in autism spectrum disorders (ASDs), encodes a brain-specific T-box transcription factor.",0
2232,10,Is there any role of TBR1 in autism?,It is therefore possible that TBR1 controls the expression of other autism risk factors.,0
2232,11,Is there any role of TBR1 in autism?,The downstream genes of TBR1 have been identified using microarray and promoter analyses.,0
2232,12,Is there any role of TBR1 in autism?,"In this study, we annotated individual genes downstream of TBR1 and investigated any associations with ASDs through extensive literature searches.",0
2232,13,Is there any role of TBR1 in autism?,"Of 124 TBR1 target genes, 23 were reported to be associated with ASDs.",0
2232,14,Is there any role of TBR1 in autism?,"Among these 24 genes, four transcription factors Auts2, Nfia, Nr4a2, and Sox5 were found, suggesting that TBR1 controls a transcriptional cascade relevant to autism pathogenesis.",0
2232,15,Is there any role of TBR1 in autism?,"A further five of the 24 genes (Cd44, Cdh8, Cntn6, Gpc6, and Ntng1) encode membrane proteins that regulate cell adhesion and axonal outgrowth.",0
2232,16,Is there any role of TBR1 in autism?,These genes likely contribute to the role of TBR1 in regulation of neuronal migration and axonal extension.,0
2232,17,Is there any role of TBR1 in autism?,"Besides, decreases in Grin2b expression and increases in Gad1 expression imply that neuronal activity may be aberrant in Tbr1 deficient mice.",0
2232,18,Is there any role of TBR1 in autism?,These analyses provide direction for future experiments to reveal the pathogenic mechanism of autism.,0
2232,19,Is there any role of TBR1 in autism?,The activity-regulated gene expression of transcription factors is required for neural plasticity and function in response to neuronal stimulation.,0
2232,20,Is there any role of TBR1 in autism?,"T-brain-1 (TBR1), a critical neuron-specific transcription factor for forebrain development, has been recognized as a high-confidence risk gene for autism spectrum disorders.",0
2232,21,Is there any role of TBR1 in autism?,Disruptive mutations in the TBR1 gene have been repeatedly identified in patients with autism spectrum disorders (ASDs).,0
2232,22,Is there any role of TBR1 in autism?,Next-generation sequencing recently revealed that recurrent disruptive mutations in a few genes may account for 1% of sporadic autism cases.,0
2232,23,Is there any role of TBR1 in autism?,Coupling these novel genetic data to empirical assays of protein function can illuminate crucial molecular networks.,0
2232,24,Is there any role of TBR1 in autism?,"Here we demonstrate the power of the approach, performing the first functional analyses of TBR1 variants identified in sporadic autism.",0
2232,25,Is there any role of TBR1 in autism?,T-brain-1 (TBR1) is a brain-specific T-box transcription factor.,1
2232,26,Is there any role of TBR1 in autism?,"In 1995, Tbr1 was first identified from a subtractive hybridization that compared mouse embryonic and adult telencephalons.",1
2232,27,Is there any role of TBR1 in autism?,"Previous studies of Tbr1 (-∕-) mice have indicated critical roles for TBR1 in the development of the cerebral cortex, amygdala, and olfactory bulb.",1
2232,28,Is there any role of TBR1 in autism?,Neuronal migration and axonal projection are two important developmental features controlled by TBR1.,1
2232,29,Is there any role of TBR1 in autism?,"Recently, recurrent de novo disruptive mutations in the TBR1 gene have been found in patients with autism spectrum disorders (ASDs).",0
2232,30,Is there any role of TBR1 in autism?,Human genetic studies have identified TBR1 as a high-confidence risk factor for ASDs.,0
2232,31,Is there any role of TBR1 in autism?,TBR1 regulates autism risk genes in the developing neocortex.,0
2232,32,Is there any role of TBR1 in autism?,De novo TBR1 mutations in sporadic autism disrupt protein functions.,0
2232,33,Is there any role of TBR1 in autism?,"In humans, PAX6, EOMES, and TBR1 have been linked to intellectual disability and autism.",0
2232,34,Is there any role of TBR1 in autism?,It is therefore possible that TBR1 controls the expression of other autism risk factors.,0
2232,35,Is there any role of TBR1 in autism?,"Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain.",0
2232,36,Is there any role of TBR1 in autism?,"T-Brain-1 (TBR1), a causative gene in autism spectrum disorders (ASDs), encodes a brain-specific T-box transcription factor.",0
2232,37,Is there any role of TBR1 in autism?,"Recently, recurrent de novo disruptive mutations in the TBR1 gene have been found in patients with autism spectrum disorders (ASDs).",0
2232,38,Is there any role of TBR1 in autism?,"Here we demonstrate the power of the approach, performing the first functional analyses of TBR1 variants identified in sporadic autism.",0
2232,39,Is there any role of TBR1 in autism?,"Among these 24 genes, four transcription factors Auts2, Nfia, Nr4a2, and Sox5 were found, suggesting that TBR1 controls a transcriptional cascade relevant to autism pathogenesis.",0
2232,40,Is there any role of TBR1 in autism?,Disruptive mutations in the TBR1 gene have been repeatedly identified in patients with autism spectrum disorders (ASDs).,0
2232,41,Is there any role of TBR1 in autism?,"T-Brain-1 (TBR1), a causative gene in autism spectrum disorders (ASDs), encodes a brain-specific T-box transcription factor",0
2232,42,Is there any role of TBR1 in autism?,"Among these 24 genes, four transcription factors Auts2, Nfia, Nr4a2, and Sox5 were found, suggesting that TBR1 controls a transcriptional cascade relevant to autism pathogenesis",0
2232,43,Is there any role of TBR1 in autism?,Disruptive mutations in the TBR1 gene have been repeatedly identified in patients with autism spectrum disorders (ASDs),0
2232,44,Is there any role of TBR1 in autism?,"Among these 24 genes, four transcription factors Auts2, Nfia, Nr4a2, and Sox5 were found, suggesting that TBR1 controls a transcriptional cascade relevant to autism pathogenesis.",0
2232,45,Is there any role of TBR1 in autism?,It is therefore possible that TBR1 controls the expression of other autism risk factors.,0
2232,46,Is there any role of TBR1 in autism?,TBR1 regulates autism risk genes in the developing neocortex.,0
2232,47,Is there any role of TBR1 in autism?,De novo TBR1 mutations in sporadic autism disrupt protein functions.,0
2232,48,Is there any role of TBR1 in autism?,"Our findings highlight a TBR1-regulated network of ASD genes in the developing neocortex that are relatively intolerant to LoF mutations, indicating that these genes may play critical roles in normal cortical development.",0
1897,0,Which is the genome browser database for DNA shape annotations?,GBshape: a genome browser database for DNA shape annotations,0
1897,1,Which is the genome browser database for DNA shape annotations?,"Our Genome Browser for DNA shape annotations (GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/) provides minor groove width, propeller twist, roll, helix twist and hydroxyl radical cleavage predictions for the entire genomes of 94 organisms.",1
1897,2,Which is the genome browser database for DNA shape annotations?,Additional genomes can easily be added using the GBshape framework.,0
1897,3,Which is the genome browser database for DNA shape annotations?,"GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.",1
1897,4,Which is the genome browser database for DNA shape annotations?,"As biological applications, we illustrate the periodicity of DNA shape features that are present in nucleosome-occupied sequences from human, fly and worm, and we demonstrate structural similarities between transcription start sites in the genomes of four Drosophila species",0
1897,5,Which is the genome browser database for DNA shape annotations?,GBshape: a genome browser database for DNA shape annotations.,0
1897,6,Which is the genome browser database for DNA shape annotations?,"GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.",1
1897,7,Which is the genome browser database for DNA shape annotations?,"Our Genome Browser for DNA shape annotations (GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/) provides minor groove width, propeller twist, roll, helix twist and hydroxyl radical cleavage predictions for the entire genomes of 94 organisms.",0
1897,8,Which is the genome browser database for DNA shape annotations?,"GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.",1
1897,9,Which is the genome browser database for DNA shape annotations?,"GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.",1
1897,10,Which is the genome browser database for DNA shape annotations?,GBshape: a genome browser database for DNA shape annotations.,0
1897,11,Which is the genome browser database for DNA shape annotations?,"Our Genome Browser for DNA shape annotations (GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/) provides minor groove width, propeller twist, roll, helix twist and hydroxyl radical cleavage predictions for the entire genomes of 94 organisms.",0
2175,0,List viral vectors used in gene therapy.,"Not only can some genetically engineered adenoviral vectors achieve remarkably efficient and specific gene delivery to target cells, but they also may act as anticancer agents by selectively replicating within cancer cells",1
2175,1,List viral vectors used in gene therapy.," Using these criteria, we then evaluate approaches made to model PD using viral vectors to date, including both adeno-associated viruses and lentiviruses",1
2175,2,List viral vectors used in gene therapy.,"Recombinant AAV (rAAV) vectors are a suitable vector for gene therapy studies because of desired characteristics such as low immunogenicity, transfection of non-dividing and dividing cells, and long-term expression of the transgene.",1
2175,3,List viral vectors used in gene therapy.,"Over the last five years, the number of clinical trials involving AAV (adeno-associated virus) and lentiviral vectors continue to increase by about 150 trials each year.",1
2175,4,List viral vectors used in gene therapy.,"For continued success, AAV and lentiviral expression cassettes need to be designed to meet each disease's specific needs.",0
2175,5,List viral vectors used in gene therapy.,describes commonly used gene therapeutics (herpes simplex viral vector (HSV) and adeno-associated viral vector (AAV)),1
2175,6,List viral vectors used in gene therapy.,This study examined the efficacy of gene therapy of lung adenocarcinoma using specifically controlled type I herpes simplex virus recombinant vector expressing Gibbon ape leukemia virus membrane fusion glycoprotein gene (GALV.fus),0
3523,0,Is SATB1 positioned close to AT-rich sequences?," Tryptic cleavage and peptide sequence analysis demonstrated that the 98-kD protein is identical to a recently cloned protein, special A-T-rich binding protein 1 (SATB1)",0
3523,1,Is SATB1 positioned close to AT-rich sequences?,"Special AT-rich sequence-binding protein 1 (SATB1), a DNA-binding protein expressed predominantly in thymocytes, recognizes an ATC sequence context that consists of a cluster of sequence stretches with well-mixed A's, T's, and C's without G's on one strand.",1
3523,2,Is SATB1 positioned close to AT-rich sequences?," We have purified and identified one of the core factors as the matrix attachment region (MAR) binding protein, SATB1, which is known to bind to AT-rich sequences with a high propensity to unwind",1
3523,3,Is SATB1 positioned close to AT-rich sequences?,"SATB1 (special AT-rich sequence-binding protein-1) provides a key link between DNA loop organization, chromatin modification/remodeling, and association of transcription factors at matrix attachment regions (MARs).",1
3523,4,Is SATB1 positioned close to AT-rich sequences?,Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression.,0
3523,5,Is SATB1 positioned close to AT-rich sequences?,pecial AT rich sequence binding protein 1 (SATB1) plays a crucial role in the biology of various types of human cancer.,0
3523,6,Is SATB1 positioned close to AT-rich sequences?,Loss of special AT-rich sequence-binding protein 1 (SATB1),1
3523,7,Is SATB1 positioned close to AT-rich sequences?,"Special AT-rich sequence-binding protein 1 (SATB1) is a cell type-specific matrix attachment region binding protein, functioning as a global genome organizer.",1
3523,8,Is SATB1 positioned close to AT-rich sequences?,SATB1 (special AT-rich binding protein 1) is a global chromatin organizer regulating the expression of a large number of genes,0
3523,9,Is SATB1 positioned close to AT-rich sequences?,Special AT-rich Sequence-binding Protein 1 (SATB1) Functions as an Accessory Factor in Base Excision Repair.,0
3523,10,Is SATB1 positioned close to AT-rich sequences?,Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene,0
3523,11,Is SATB1 positioned close to AT-rich sequences?,"The Special AT-rich Sequence Binding Protein 1 (SATB1) exerts multiple functions, by influencing the structural organization of chromatin and interacting with several co-activators and co-repressors of transcription.",0
3523,12,Is SATB1 positioned close to AT-rich sequences?,The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors.,0
2878,0,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,TAM-family RTKs AXL and Mer (MerTK).,1
2878,1,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"Deregulation of the TAM (TYRO3, AXL, and MERTK",0
2878,2,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,TAM family members AXL or TYRO3,0
2878,3,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,receptors of the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases (RTKs),1
2878,4,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"Tyro-3, Axl, and Mer constitute the TAM family of receptor tyrosine kinases (RTKs) characterized by a conserved sequence within the kinase domain and adhesion molecule-like extracellular domains.",1
2878,5,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"The TYRO3, AXL (also known as UFO) and MERTK (TAM) family of receptor tyrosine kinases (RTKs) are aberrantly expressed in multiple haematological and epithelial malignancies.",1
2878,6,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"Gas6 was cloned and characterized in 1993 and found to be similar to the plasma anticoagulant protein S. Soon after it was recognized as a growth factor-like molecule, as it interacted with receptor tyrosine kinases (RTKs) of the TAM family; Tyro3, Axl, and MerTK.",0
2878,7,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"The TAM subfamily of Receptor Tyrosine Kinases (RTKs) contains three human proteins of therapeutical interest, Axl, Mer, and Tyro3.",1
2878,8,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"Increasing evidence shows that the TAM (TYRO3, AXL and MERTK) family of RTKs (receptor tyrosine kinases), which is expressed in macrophages, alleviates inflammatory responses through a negative feedback loop.",0
2878,9,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"Among the TAM family of RTKs, AXL (AXL receptor tyrosine kinase) only induces autophagy in macrophages after interaction with its ligand, GAS6 (growth arrest specific 6).",0
2878,10,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"A series of recent studies now consolidates the view that phosphatidylserine (PtdSer), a common phospholipid constituent of membrane bilayers, is similarly repurposed for use as a signal between cells and that the ligands and receptors of the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases (RTKs) are prominent transducers of this signal.",0
2878,11,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.The TYRO3, AXL (also known as UFO) and MERTK (TAM) family of receptor tyrosine kinases (RTKs) are aberrantly expressed in multiple haematological and epithelial malignancies.",0
2878,12,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"The TAM family of RTKs, consisting of Tyro3, Axl, and MerTK, is prominently expressed during the development and function of the central nervous system (CNS).",0
2878,13,What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?,"The TAM family of RTKs, consisting of Tyro3, Axl, and MerTK, is prominently expressed during the development and function of the central nervous system (CNS).",0
1563,0,Are cyclophilins ubiquitously expressed?,Cyclophilin from Leishmania donovani (LdCyp) is a ubiquitous peptidyl-prolyl cis-trans isomerase,0
1563,1,Are cyclophilins ubiquitously expressed?,Cyclophilins (CYPs) and FK506-binding proteins (FKBPs) are ubiquitous proteins belonging to the peptidyl-prolyl cis/trans isomerase (PPIase) family.,1
1563,2,Are cyclophilins ubiquitously expressed?," However, their wide distribution and ubiquitous nature signifies their fundamental importance in plant survival.",0
1563,3,Are cyclophilins ubiquitously expressed?,"Cyclophilins (Cyps) are ubiquitous proteins that effect the cis-trans isomerization of Pro amide bonds, and are thus crucial to protein folding.",1
1563,4,Are cyclophilins ubiquitously expressed?,"FK506 binding proteins (FKBPs) and cyclophilins (CYPs) are abundant and ubiquitous proteins belonging to the peptidyl-prolyl cis/trans isomerase (PPIase) superfamily, which regulate much of metabolism through a chaperone or an isomerization of proline residues during protein folding.",1
1563,5,Are cyclophilins ubiquitously expressed?,Cyclophilin is a ubiquitous peptidyl prolyl cis/trans isomerase that plays critical roles in many biological processes.,0
1563,6,Are cyclophilins ubiquitously expressed?,"The receptor for cyclosporin is the protein cyclophilin, which is a ubiquitous peptidylprolyl isomerase.",0
1563,7,Are cyclophilins ubiquitously expressed?,"Cyps (cyclophilins) are ubiquitous proteins of the immunophilin superfamily with proposed functions in protein folding, protein degradation, stress response and signal transduction.",1
1563,8,Are cyclophilins ubiquitously expressed?,Cyclophilins are folding helper enzymes belonging to the class of peptidyl-prolyl cis-trans isomerases (PPIases; EC 5.2.1.8) that catalyze the cis-trans isomerization of peptidyl-prolyl bonds in proteins.,0
1563,9,Are cyclophilins ubiquitously expressed?,"They are ubiquitous proteins present in almost all living organisms analyzed to date, with extremely rare exceptions.",0
1563,10,Are cyclophilins ubiquitously expressed?,Immunophilins are ubiquitous enzymes responsible for proline isomerisation during protein synthesis and for the chaperoning of several membrane proteins.,0
1563,11,Are cyclophilins ubiquitously expressed?,Cyclophilins (CyPs) are a large class of highly conserved ubiquitous peptidyl-prolyl cis-trans isomerases.,1
1563,12,Are cyclophilins ubiquitously expressed?,"Cyclophilins belong to the family of peptidyl-prolyl cis/trans isomerases (PPIases), which are ubiquitous and highly conserved enzymes capable of cis/trans isomerizing Xaa-Pro peptide bonds.",0
1563,13,Are cyclophilins ubiquitously expressed?,"Originally identified as the cellular targets of immunosuppressant drugs, the immunophilins encompass two ubiquitous protein families: the FK-506 binding proteins or FKBPs, and the cyclosporin-binding proteins or cyclophilins.",0
2507,0,CURB65 score is used for stratification of which disease?,Severity assessment tools (e.g.,0
2507,1,CURB65 score is used for stratification of which disease?,CURB65) that are used to guide early management decisions in CAP have not been widely validated in low-income settings and locally adapted tools are required.,0
2507,2,CURB65 score is used for stratification of which disease?,"Scores for the pneumonia severity index (PSI); CURB65 (confusion, urea, respiration, blood pressure; age>65 years); Infectious Disease Society of America (IDSA) and American Thoracic Society (ATS) guidelines for severe CAP; Acute Physiology, Chronic Health Evaluation (APACHE) II; Sequential Organ Failure Assessment (SOFA); and quick SOFA (qSOFA) were calculated.",1
2507,3,CURB65 score is used for stratification of which disease?,Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.,0
2507,4,CURB65 score is used for stratification of which disease?,"AIM: (i) evaluate the performance of MR-pro-ADM in reflecting the outcome and risk for CAP patients in the emergency department, and (ii) compare the prognostic performance of MR-pro-ADM with that of clinical scores PSI and CURB65.",0
2507,5,CURB65 score is used for stratification of which disease?,CONCLUSIONS: The present study confirms that assessment of MR-pro-ADM levels in CAP patients in addition to CURB scores increases the prognostic accuracy of CURB alone and may help rule out discrepancies arising from flawed clinical severity classification.,0
2507,6,CURB65 score is used for stratification of which disease?,The cytokine response during pneumonia is different in bacterial vs viral infections; some of these cytokines correlate with clinical severity scales such as CURB65 or SOFA.,1
2507,7,CURB65 score is used for stratification of which disease?,The CURB65 score was developed to predict mortality risk in community acquired pneumonia.,0
2507,8,CURB65 score is used for stratification of which disease?,The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia.,1
2507,9,CURB65 score is used for stratification of which disease?,CURB65 should not be supplanted by SIRS or SEWS for initial prognostic assessment in CAP.,1
2507,10,CURB65 score is used for stratification of which disease?,The CURB65 score was developed to predict mortality risk in community acquired pneumonia.,0
2507,11,CURB65 score is used for stratification of which disease?,We aimed to derive a practical algorithm combining the CURB65 score with ProADM-levels in patients with community-acquired pneumonia (CAP) and non-CAP-LRTI.,0
2507,12,CURB65 score is used for stratification of which disease?,RESULTS CURB65 and ProADM predicted both adverse events and mortality similarly well in CAP and non-CAP-LRTI.,0
2507,13,CURB65 score is used for stratification of which disease?,The combined CURB65-A risk score provided better prediction of death and adverse events than the CURB65 score in the entire cohort and in CAP and non-CAP-LRTI patients.,0
2507,14,CURB65 score is used for stratification of which disease?,CONCLUSION Presepsin is a valuable biomarker in predicting severity and outcome in CAP patients in the ED and Presepsin in combination with CURB65 score significantly enhanced the predictive accuracy.,0
2507,15,CURB65 score is used for stratification of which disease?,BACKGROUND An intervention trial found a trend for shorter length of stay (LOS) in patients with community-acquired pneumonia (CAP) when the CURB65 score was combined with the prognostic biomarker proadrenomedullin (ProADM) (CURB65-A).,1
2507,16,CURB65 score is used for stratification of which disease?,A composite score (CURB65-A) was created combining CURB65 classes with ProADM cut-offs to further risk-stratify patients.<br><b>RESULTS</b>: CURB65 and ProADM predicted both adverse events and mortality similarly well in CAP and non-CAP-LRTI.,0
1961,0,Which annotated database of A-to-I RNA editing is available?,RADAR: a rigorously annotated database of A-to-I RNA editing,1
1961,1,Which annotated database of A-to-I RNA editing is available?,We present RADAR--a rigorously annotated database of A-to-I RNA editing,0
1961,2,Which annotated database of A-to-I RNA editing is available?,The identification of A-to-I RNA editing sites has been dramatically accelerated in the past few years by high-throughput RNA sequencing studies.,1
1961,3,Which annotated database of A-to-I RNA editing is available?,"RADAR includes a comprehensive collection of A-to-I RNA editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies (Drosophila melanogaster), together with extensive manually curated annotations for each editing site.",1
1961,4,Which annotated database of A-to-I RNA editing is available?,"RADAR also includes an expandable listing of tissue-specific editing levels for each editing site, which will facilitate the assignment of biological functions to specific editing sites",1
1961,5,Which annotated database of A-to-I RNA editing is available?,We present RADAR--a rigorously annotated database of A-to-I RNA editing (available at http://RNAedit.com).,0
1961,6,Which annotated database of A-to-I RNA editing is available?,RADAR: a rigorously annotated database of A-to-I RNA editing.,0
1961,7,Which annotated database of A-to-I RNA editing is available?,We present RADAR--a rigorously annotated database of A-to-I RNA editing (available at http://RNAedit.com).,0
1961,8,Which annotated database of A-to-I RNA editing is available?,"RADAR includes a comprehensive collection of A-to-I RNA editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies (Drosophila melanogaster), together with extensive manually curated annotations for each editing site.",1
1961,9,Which annotated database of A-to-I RNA editing is available?,RADAR: a rigorously annotated database of A-to-I RNA editing.,0
310,0,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature',",0
310,1,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""",the concept of a genomic signature was introduced with the observation of species-type specific Dinucleotide Relative Abundance Profiles (DRAPs),1
310,2,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The dinucleotide relative abundance profile can be regarded as a genomic signature because, despite diversity between species, it varies little between 50 kilobase or longer windows on a given genome.",0
310,3,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The profile is computed from the base step ""odds ratios"" that compare dinucleotide frequencies to those expected under the assumption of stochastic equilibrium (thorough shuffling).",0
310,4,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""",The genome signatures (dinucleotide relative abundance values),0
310,5,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""",the set of dinucleotide biases constitutes a 'genomic signature' that can discriminate sequences from different organisms.,0
310,6,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","the set of dinucleotide odds ratio (relative abundance) values constitute a signature of each DNA genome, which can discriminate between sequences from different organisms.",0
310,7,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""",Genomic homogeneity is investigated for a broad base of DNA sequences in terms of dinucleotide relative abundance distances (abbreviated delta-distances),0
310,8,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","delta-distances between different genomic sequences in the same species are low, only about 2 or 3 times the distance found in random DNA, and are generally smaller than the between-species delta-distances",1
310,9,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""",the set of dinucleotide odds ratios or 'general design' is a remarkably stable property of the DNA of an organism,1
310,10,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids.",0
310,11,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The dinucleotide relative abundance profile can be regarded as a genomic signature because, despite diversity between species, it varies little between 50 kilobase or longer windows on a given genome.",0
310,12,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""",The correlation between the genomic signature and DNA-DNA hybridisation values was high and taxa that showed less than 30% DNA-DNA binding will in general not have dinucleotide relative abundance dissimilarity (delta*) values below 40.,0
310,13,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","Previously, the concept of a genomic signature was introduced with the observation of species-type specific Dinucleotide Relative Abundance Profiles (DRAPs); dinucleotides were identified as the subsequences with the greatest bias in representation in a majority of genomes.",1
310,14,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","Comparisons within and between species sample sequences are based on the profile of dinucleotide relative abundance values (The profile is rho*XY = f*XY/f*Xf*Y for all XY, where f*X denotes the frequency of the nucleotide X and f*XY denotes the frequency of the dinucleotide XY, both computed from the sequence concatenated with its inverted complement).",0
310,15,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or genomic signature, between bacterial chromosomes and plasmids.",0
310,16,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","Comparisons within and between species sample sequences are based on the profile of dinucleotide relative abundance values (The profile is rho*XY = f*XY/f*Xf*Y for all XY, where f*X denotes the frequency of the nucleotide X and f*XY denotes the frequency of the dinucleotide XY, both computed from the sequence concatenated with its inverted complement).",0
310,17,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""",We demonstrate that the Mahalanobis distance is better than the delta-distance at measuring genomic signature differences between plasmids and chromosomes of potential hosts.,0
310,18,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids.",0
310,19,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids",0
310,20,"Which is the most common measure of differences between dinucleotide relative abundance ""genomic signatures""","Previously, the concept of a genomic signature was introduced with the observation of species-type specific Dinucleotide Relative Abundance Profiles (DRAPs); dinucleotides were identified as the subsequences with the greatest bias in representation in a majority of genomes",1
3257,0,List symptoms of the One-and-a-half syndrome.,"She experienced diplopia on right horizontal gaze due to a left internuclear ophthalmoplegia (INO) with an associated left conjugate horizontal gaze palsy, collectively described as a left one-and-a-half syndrome.",0
3257,1,List symptoms of the One-and-a-half syndrome.,"We report a case of 43-year-old male, presented with sudden onset binocular diplopia on lateral gazes.",0
3257,2,List symptoms of the One-and-a-half syndrome.,Ocular examination showed features of ipsilateral one-and-a-half syndrome.,0
3257,3,List symptoms of the One-and-a-half syndrome.,"One-and-a-half syndrome is a syndrome characterized by horizontal movement disorders of the eyeballs, which was first reported and named by Fisher in 1967.",0
3257,4,List symptoms of the One-and-a-half syndrome.,"BACKGROUND AND PURPOSE: Unilateral gaze palsy associated with internuclear ophthalmoplegia (INO), i.e., one-and-a-half syndrome, is well known.",0
3257,5,List symptoms of the One-and-a-half syndrome.,We describe a rare case in which both wall-eyed bilateral internuclear ophthalmoplegia syndrome and vertical one-and-a-half syndrome were observed in a 68-year-old man with acute ischemic stroke.,0
3257,6,List symptoms of the One-and-a-half syndrome.,"""Eight-and-a-half"" syndrome is ""one-and-a-half"" syndrome (conjugated horizontal gaze palsy and internuclear ophthalmoplegia) plus ipsilateral fascicular cranial nerve seventh palsy.",1
3257,7,List symptoms of the One-and-a-half syndrome.,"On examination, she had left fascicular type of third nerve palsy, vertical one and half syndrome (VOHS), left internuclear ophthalmoplegia and skew deviation with ipsilesional hypertropia.",0
3257,8,List symptoms of the One-and-a-half syndrome.,"""Eight-and-a-half"" syndrome is ""one-and-a-half"" syndrome (conjugated horizontal gaze palsy and internuclear ophthalmoplegia) plus ipsilateral fascicular cranial nerve seventh palsy.",1
3257,9,List symptoms of the One-and-a-half syndrome.,We report a unique neuroophthalmological syndrome consisting of vertical one-and-a-half syndrome-resulting from a combination of supranuclear conjugate upgaze palsy associated with left infranuclear (fascicular) third nerve involvement (Weber syndrome)-with concomitant contralesional pseudo-abducens palsy.,0
3257,10,List symptoms of the One-and-a-half syndrome.,One-and-a-half syndrome is a clinical disorder featuring extraocular movements characterized by horizontal conjugate gaze palsy with internuclear ophthalmoplegia.,0
3257,11,List symptoms of the One-and-a-half syndrome.,The one-and-a-half syndrome is characterised by a lateral gaze palsy in one direction and internuclear ophthalmoplegia in the other.,0
3257,12,List symptoms of the One-and-a-half syndrome.,RATIONALE One-and-a-half syndrome (OAAH) is characterized as the combination of ipsilateral horizontal gaze palsy and internuclear ophthalmoplegia.,0
3257,13,List symptoms of the One-and-a-half syndrome.,"RATIONALE

One-and-a-half syndrome (OAAH) is characterized as the combination of ipsilateral horizontal gaze palsy and internuclear ophthalmoplegia.",0
3257,14,List symptoms of the One-and-a-half syndrome.,One-and-a-half syndrome is characterized by combination of the clinical features of unilateral horizontal gaze palsy and internuclear ophthalmoplegia.,1
3257,15,List symptoms of the One-and-a-half syndrome.,The one-and-a-half syndrome is characterised by a lateral gaze palsy in one direction and internuclear ophthalmoplegia in the other .,0
3257,16,List symptoms of the One-and-a-half syndrome.,One-and-a-half syndrome is a clinical disorder featuring extraocular movements characterized by horizontal conjugate gaze palsy with internuclear ophthalmoplegia .,0
3257,17,List symptoms of the One-and-a-half syndrome.,One-and-a-half syndrome is characterized by combination of the clinical features of unilateral horizontal gaze palsy and internuclear ophthalmoplegia .,1
3257,18,List symptoms of the One-and-a-half syndrome.,"A 52-year-old patient developed an eye movement disorder first resembling a left internuclear ophthalmoplegia and subsequently a "" one-and-a-half syndrome "" as the presenting symptoms of ocular myasthenia gravis .",0
3257,19,List symptoms of the One-and-a-half syndrome.,The one-and-a-half syndrome is characterised by a lateral gaze palsy in one direction and internuclear ophthalmoplegia in the other.,0
3257,20,List symptoms of the One-and-a-half syndrome.,"RATIONALE
One-and-a-half syndrome (OAAH) is characterized as the combination of ipsilateral horizontal gaze palsy and internuclear ophthalmoplegia.",0
3257,21,List symptoms of the One-and-a-half syndrome.,One-and-a-half syndrome (OAAH) is characterized as the combination of ipsilateral horizontal gaze palsy and internuclear ophthalmoplegia.,1
1063,0,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"This was the first study to systematically investigate sodium channel variants in Chinese patients with ARVD; a new SCN5A mutation, I137M, was found.",0
1063,1,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"We describe a family showing the association between Brugada syndrome and epilepsy in which a known mutation in the SCN5A gene (p.W1095X, c.3284G>A) was identified.",1
1063,2,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"Direct sequencing and multiplex ligation-dependent probe amplification (MLPA) of the SCN5A gene for identification of mutations and larger rearrangements were performed, respectively.",0
1063,3,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"Eight patients (10.5%) had point mutations (R27H, E901K, G1743R (detected in three families), V728I, N1443S and E1152X).",0
1063,4,Which mutations of SCN5A gene are implicated in Brugada syndrome?,Brugada syndrome (BrS) is a life-threatening arrhythmia disorder associated with autosomal-dominant mutations in the SCN5A gene.,0
1063,5,Which mutations of SCN5A gene are implicated in Brugada syndrome?,We aimed to characterize the diagnostic challenges and clinical manifestations of a novel SCN5A mutation associated with BrS.,0
1063,6,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"RESULTS: From a novel SCN5A mutation (c.664C>T; p.Arg222X) identified in a proband with the characteristic electrocardiographic pattern and the history of sudden collapse, 122 family members were studied including 40 carriers of the mutation.",1
1063,7,Which mutations of SCN5A gene are implicated in Brugada syndrome?,We analyzed the sequence of this gene in 25 Spanish patients with Brugada syndrome.,0
1063,8,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"In 4 (16%), we found mutations that had not previously been described: three were amino acid changes (i.e.",0
1063,9,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"Ala2>Thr, Ala735>Thr and Val1340>Ile) and one was an intron mutation that affected messenger RNA processing (i.e.",1
1063,10,Which mutations of SCN5A gene are implicated in Brugada syndrome?,IVS18-1G>A).,0
1063,11,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"The 4 most frequent BrS1-associated mutations were E1784K (14x), F861WfsX90 (11x), D356N (8x), and G1408R (7x).",1
1063,12,Which mutations of SCN5A gene are implicated in Brugada syndrome?,One missense mutation (G400A) in SCN5A was detected in a conserved region among the cohort of 19 patients.,0
1063,13,Which mutations of SCN5A gene are implicated in Brugada syndrome?,A H558R polymorphism was detected on the same allele.,0
1063,14,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"Thus, we studied the functional restoration of nonsense-mutated SCN5A.",0
1063,15,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"RESULTS: HEK293 cells were transfected with SCN5A cDNA or its mutant carrying W822X, a nonsense mutation associated with Brugada syndrome and sudden cardiac death.",0
1063,16,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"Among the cohort of 19 patients, one missense mutation (G400A) in SCN5A was detected in a conserved region.",0
1063,17,Which mutations of SCN5A gene are implicated in Brugada syndrome?,An H558R polymorphism was detected on the same allele.,0
1063,18,Which mutations of SCN5A gene are implicated in Brugada syndrome?,Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.,0
1063,19,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"A novel nonsense SCN5A mutation (Q55X) was identified in the proband, his mother, and his asymptomatic brother.",0
1063,20,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617",0
1063,21,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"An intronic mutation (c.4810+3_4810+6dupGGGT) in the SCN5A gene, located outside the consensus splice site, was detected in this study in a family with a highly variable clinical phenotype of Brugada syndrome and/or conduction disease and in a patient with Brugada syndrome.",1
1063,22,Which mutations of SCN5A gene are implicated in Brugada syndrome?,We genetically screened 30 asymptomatic probands (29 men and 1 woman; mean age 47.1 years) exhibiting a spontaneous Brugada-type ECG.,0
1063,23,Which mutations of SCN5A gene are implicated in Brugada syndrome?,Family members of patients with Brugada syndrome were excluded from the study.,0
1063,24,Which mutations of SCN5A gene are implicated in Brugada syndrome?,Genetic screening failed to identify SCN5A mutations in most cases but demonstrated a novel double missense mutation (K1527R and A1569P) located on the same allele in another asymptomatic subject (case 2).,0
1063,25,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"We screened patients with SUNDS for mutations in SCN5A, the gene known to cause Brugada syndrome, as well as genes encoding ion channels associated with the long-QT syndrome.",0
1063,26,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"One mutation, R367H, lies in the first P segment of the pore-lining region between the DIS5 and DIS6 transmembrane segments of SCN5A.",0
1063,27,Which mutations of SCN5A gene are implicated in Brugada syndrome?,"A second mutation, A735V, lies in the first transmembrane segment of domain II (DIIS1) close to the first extracellular loop between DIIS1 and DIIS2, whereas the third mutation, R1192Q, lies in domain III.",0
1063,28,Which mutations of SCN5A gene are implicated in Brugada syndrome?,The substitution (D1790G) causes LQTS and the insertion (D1795) induces both LQTS and Brugada syndromes in carrier patients.,0
750,0,What is the usefulness of ultraconserved elements in phylogeny?,Target capture and massively parallel sequencing of ultraconserved elements for comparative studies at shallow evolutionary time scales,0
750,1,What is the usefulness of ultraconserved elements in phylogeny?,"Here, we evaluate the efficacy of genomic markers targeting ultraconserved DNA elements (UCEs) for analyses at shallow evolutionary timescales",1
750,2,What is the usefulness of ultraconserved elements in phylogeny?,"Because orthologous UCEs can be obtained from a wide array of taxa, are polymorphic at shallow evolutionary timescales, and can be generated rapidly at low cost, they are an effective genetic marker for studies investigating evolutionary patterns and processes at shallow timescales",1
750,3,What is the usefulness of ultraconserved elements in phylogeny?,A Phylogenomic Perspective on the Radiation of Ray-Finned Fishes Based upon Targeted Sequencing of Ultraconserved Elements (UCEs),0
750,4,What is the usefulness of ultraconserved elements in phylogeny?,"Here, we provide a genomic perspective on longstanding questions regarding the diversification of major groups of ray-finned fishes through targeted enrichment of ultraconserved nuclear DNA elements (UCEs) and their flanking sequence.",0
750,5,What is the usefulness of ultraconserved elements in phylogeny?,Our workflow efficiently and economically generates data sets that are orders of magnitude larger than those produced by traditional approaches and is well-suited to working with museum specimens.,0
750,6,What is the usefulness of ultraconserved elements in phylogeny?,Analysis of the UCE data set recovers a well-supported phylogeny at both shallow and deep time-scales that supports a monophyletic relationship between Amia and Lepisosteus (Holostei) and reveals elopomorphs and then osteoglossomorphs to be the earliest diverging teleost lineages.,0
750,7,What is the usefulness of ultraconserved elements in phylogeny?,Our approach additionally reveals that sequence capture of UCE regions and their flanking sequence offers enormous potential for resolving phylogenetic relationships within ray-finned fishes,0
750,8,What is the usefulness of ultraconserved elements in phylogeny?,We applied a new phylogenomic approach to resolve relationships in Neoaves using target enrichment (sequence capture) and high-throughput sequencing of ultraconserved elements (UCEs) in avian genomes.,0
750,9,What is the usefulness of ultraconserved elements in phylogeny?,We collected sequence data from UCE loci for 32 members of Neoaves and one outgroup (chicken) and analyzed data sets that differed in their amount of missing data,0
750,10,What is the usefulness of ultraconserved elements in phylogeny?,More than 1000 ultraconserved elements provide evidence that turtles are the sister group of archosaurs,0
750,11,What is the usefulness of ultraconserved elements in phylogeny?,A recent analysis of shared microRNA families found that turtles are more closely related to lepidosaurs.,0
750,12,What is the usefulness of ultraconserved elements in phylogeny?,"To test this hypothesis with data from many single-copy nuclear loci dispersed throughout the genome, we used sequence capture, high-throughput sequencing and published genomes to obtain sequences from 1145 ultraconserved elements (UCEs) and their variable flanking DNA.",0
750,13,What is the usefulness of ultraconserved elements in phylogeny?,"The resulting phylogeny provides overwhelming support for the hypothesis that turtles evolved from a common ancestor of birds and crocodilians, rejecting the hypothesized relationship between turtles and lepidosaurs",0
750,14,What is the usefulness of ultraconserved elements in phylogeny?,Ultraconserved elements anchor thousands of genetic markers spanning multiple evolutionary timescales,0
750,15,What is the usefulness of ultraconserved elements in phylogeny?,"We introduce a new class of molecular marker, anchored by ultraconserved genomic elements (UCEs), that universally enable target enrichment and sequencing of thousands of orthologous loci across species separated by hundreds of millions of years of evolution.",0
750,16,What is the usefulness of ultraconserved elements in phylogeny?,Our analyses here focus on use of UCE markers in Amniota because UCEs and phylogenetic relationships are well-known in some amniotes.,0
750,17,What is the usefulness of ultraconserved elements in phylogeny?,We perform an in silico experiment to demonstrate that sequence flanking 2030 UCEs contains information sufficient to enable unambiguous recovery of the established primate phylogeny.,0
750,18,What is the usefulness of ultraconserved elements in phylogeny?,"We extend this experiment by performing an in vitro enrichment of 2386 UCE-anchored loci from nine, non-model avian species.",0
750,19,What is the usefulness of ultraconserved elements in phylogeny?,We then use alignments of 854 of these loci to unambiguously recover the established evolutionary relationships within and among three ancient bird lineages.,0
750,20,What is the usefulness of ultraconserved elements in phylogeny?,"Because many organismal lineages have UCEs, this type of genetic marker and the analytical framework we outline can be applied across the tree of life, potentially reshaping our understanding of phylogeny at many taxonomic levels",0
750,21,What is the usefulness of ultraconserved elements in phylogeny?,Ultraconserved elements are novel phylogenomic markers that resolve placental mammal phylogeny when combined with species-tree analysis,1
750,22,What is the usefulness of ultraconserved elements in phylogeny?,we outline a phylogenomic approach using a novel class of phylogenetic markers derived from ultraconserved elements and flanking DNA.,0
750,23,What is the usefulness of ultraconserved elements in phylogeny?,"Using species-tree analysis that accounts for discord among hundreds of independent loci, we show that this class of marker is useful for recovering deep-level phylogeny in placental mammals",0
750,24,What is the usefulness of ultraconserved elements in phylogeny?,One of the most remarkable findings of our study is that ultraconserved elements and their flanking DNA are a rich source of phylogenetic information with strong potential for application across Amniotes,1
750,25,What is the usefulness of ultraconserved elements in phylogeny?,Ultraconserved elements are novel phylogenomic markers that resolve placental mammal phylogeny when combined with species-tree analysis.,1
750,26,What is the usefulness of ultraconserved elements in phylogeny?,Ultraconserved elements anchor thousands of genetic markers spanning multiple evolutionary timescales.,0
750,27,What is the usefulness of ultraconserved elements in phylogeny?,Target capture and massively parallel sequencing of ultraconserved elements for comparative studies at shallow evolutionary time scales.,0
750,28,What is the usefulness of ultraconserved elements in phylogeny?,"Here, we outline a phylogenomic approach using a novel class of phylogenetic markers derived from ultraconserved elements and flanking DNA.",0
750,29,What is the usefulness of ultraconserved elements in phylogeny?,We applied a new phylogenomic approach to resolve relationships in Neoaves using target enrichment (sequence capture) and high-throughput sequencing of ultraconserved elements (UCEs) in avian genomes.,0
750,30,What is the usefulness of ultraconserved elements in phylogeny?,We perform an in silico experiment to demonstrate that sequence flanking 2030 UCEs contains information sufficient to enable unambiguous recovery of the established primate phylogeny.,0
750,31,What is the usefulness of ultraconserved elements in phylogeny?,"Because many organismal lineages have UCEs, this type of genetic marker and the analytical framework we outline can be applied across the tree of life, potentially reshaping our understanding of phylogeny at many taxonomic levels.",0
750,32,What is the usefulness of ultraconserved elements in phylogeny?,"Here, we outline a phylogenomic approach using a novel class of phylogenetic markers derived from ultraconserved elements and flanking DNA",0
2499,0,What is Chronic Wasting Disease (CWD) in deer?,"In nature, cervids are infected with chronic wasting disease (CWD) prions by oral and nasal mucosal exposure, and studies of early CWD pathogenesis have implicated pharyngeal lymphoid tissue as the earliest sites of prion accumulation.",0
2499,1,What is Chronic Wasting Disease (CWD) in deer?,"Of the known animal prion diseases, only bovine spongiform encephalopathy prions have been shown to be transmissible from animals to humans under non-experimental conditions.",0
2499,2,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD) is a prion disease that affects cervids (e.g., deer and elk) in North America and isolated populations in Korea and Europe.",0
2499,3,What is Chronic Wasting Disease (CWD) in deer?,"Prion diseases, such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids (i.e., deer, elk, moose, and reindeer), and sheep scrapie, are caused by the misfolding of the cellular prion protein (PrPC) into a disease-causing conformer (PrPSc)",0
2499,4,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD), a prion disease of North American deer, elk and moose, affects both free-ranging and captive cervids.",0
2499,5,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD) is an evolving prion disease of cervids (deer, elk and moose) that has been recognized in North America and Korea.",0
2499,6,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD) is a fatal transmissible spongiform encephalopathy affecting white-tailed deer (Odocoileus virginianus), mule deer (Odocoileus hemionus), Rocky Mountain elk (Cervus elaphus nelsoni), and moose (Alces alces shirasi) in North America.",1
2499,7,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD) is an invariably fatal transmissible spongiform encephalopathy of white-tailed deer, mule deer, elk, and moose.",0
2499,8,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD), a prion disease affecting North American cervids, has been discovered in at least 12 states and provinces throughout the continent.",0
2499,9,What is Chronic Wasting Disease (CWD) in deer?,"The etiology of chronic wasting disease (CWD), a relatively new and burgeoning prion epidemic in deer, elk, and moose (members of the cervid family), is more enigmatic.",1
2499,10,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) is an emerging and uniformly fatal prion disease affecting free-ranging deer and elk and is now recognized in 22 U.S.,0
2499,11,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) is a fatal neurodegenerative disease affecting free-ranging and captive cervids that now occurs in 24 U.S.,0
2499,12,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD) is a contagious, fatal prion disease affecting cervids in a growing number of regions across North America.",0
2499,13,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy affecting North American cervids.,1
2499,14,What is Chronic Wasting Disease (CWD) in deer?,Prion diseases are neurodegenerative fatal disorders that affect human and non-human mammals.,0
2499,15,What is Chronic Wasting Disease (CWD) in deer?,"Chronic Wasting Disease (CWD) is a prion disease of cervids regarded as a public health problem in North America, and polymorphisms at specific codons in the PRNP gene are associated with this disease",0
2499,16,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) is a prion disease of cervids that causes neurodegeneration and death.,0
2499,17,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) has emerged as an important disease of wildlife in North America.,0
2499,18,What is Chronic Wasting Disease (CWD) in deer?,"The disease is a unique member of the transmissible spongiform encephalopathies (TSEs) or prion diseases, which naturally affect only a few species.",0
2499,19,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD) is a fatal, emerging disease of cervids associated with transmissible protease-resistant prion proteins.",0
2499,20,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD), a contagious prion disease of the deer family, has the potential to severely harm deer populations and disrupt ecosystems where deer occur in abundance.",0
2499,21,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) in cervids is one of the transmissible spongiform encephalopathies,1
2499,22,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) is a fatal contagious prion disease in cervids that is enzootic in some areas in North America.,0
2499,23,What is Chronic Wasting Disease (CWD) in deer?,"Scrapie amyloid-immunoreactive plaques are present in brain tissues of captive mule deer with chronic wasting disease (CWD), a progressive neurological disorder characterized neuropathologically by widespread spongiform change of the neuropil, intracytoplasmic vacuolation in neuronal perikarya and astrocytic hypertrophy and hyperplasia.",0
2499,24,What is Chronic Wasting Disease (CWD) in deer?,"Chronic wasting disease (CWD) is a unique transmissible spongiform encephalopathy (TSE) of mule deer (Odocoileus hemionus), white-tailed deer (O. virginianus), and Rocky Mountain elk (Cervus elaphus nelsoni).",1
2499,25,What is Chronic Wasting Disease (CWD) in deer?,Chronic wasting disease (CWD) has recently emerged in North America as an important prion disease of captive and free-ranging cervids (species in the deer family).,0
2499,26,What is Chronic Wasting Disease (CWD) in deer?,CWD is the only recognized transmissible spongiform encephalopathy (TSE) affecting free-ranging species.,0
508,0,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"During the subacute phase, the irreversible damage expands into the penumbra: multiple electrical and biological signals are triggered by periinfarct, spreading depression-like depolarizations leading to hypoxia and stepwise increase in lactate.",0
508,1,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,Experimental and clinical studies indicate that waves of cortical spreading depolarization (CSD) appearing in the ischemic penumbra contribute to secondary lesion growth.,1
508,2,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"Analysis of MCA occlusions (MCAOs) revealed a first CSD wave starting off during ischemic decline at the emerging core region, propagating concentrically over large portions of left cortex.",0
508,3,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,Subsequent recurrent waves of CSD did not propagate concentrically but preferentially circled around the ischemic core.,0
508,4,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"In the vicinity of the core region, CSDs were coupled to waves of predominantly vasoconstrictive CBF(LSF) responses, resulting in further decline of CBF in the entire inner penumbra and in expansion of the ischemic core.",1
508,5,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"We conclude that CSDs and corresponding CBF responses follow a defined spatiotemporal order, and contribute to early evolution of ischemic territories.",0
508,6,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,Astrocytes in the metabolically compromised ischemic penumbra-like area showed a long lasting swelling response to spontaneous spreading depolarizations despite rapid dendritic recovery in a photothrombotic occlusion model of focal stroke.,0
508,7,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,Spontaneous spreading depolarizations (SDs) occur in the penumbra surrounding ischemic core.,1
508,8,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"These SDs, often referred to as peri-infarct depolarizations, cause vasoconstriction and recruitment of the penumbra into the ischemic core in the critical first hours after focal ischemic stroke; however, the real-time spatiotemporal dynamics of SD-induced injury to synaptic circuitry in the penumbra remain unknown.",1
508,9,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"We propose that metabolic stress resulting from recurring SDs facilitates acute injury at the level of dendrites and dendritic spines in metabolically compromised tissue, expediting penumbral recruitment into the ischemic core.",0
508,10,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"Although the mechanism remains unknown, SDs show delayed electrophysiological recovery within the ischemic penumbra.",0
508,11,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,Spreading depression-like peri-infarct depolarizations not only characterize but also worsen penumbra conditions in cortical border zones of experimental focal ischemia.,0
508,12,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"We conclude that in focal ischemia, transient peri-infarct depolarizations emerge not only in cortical but also in striatal gray matter, thereby demonstrating the existence of subcortical zones of ischemic penumbra.",0
508,13,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"Spreading depression (SD) has been demonstrated following focal ischemia, and the additional workload imposed by SD on a tissue already compromised by a marked reduction in blood flow may contribute to the evolution of irreversible damage in the ischemic penumbra.",1
508,14,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"While the changes in the glucose-related metabolites persisted during recovery even in anterior portions of the cortex in both groups in the aftermath of the SD, the magnitude of the changes was greater in the penumbra than in the normal cortex.",0
508,15,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"SD appears to impose an equivalent increase in energy demands in control and ischemic brain, but the ability of the penumbra to recover from the insult is compromised.",0
508,16,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"Thus, increasing the energy imbalance in the penumbra after multiple SDs may hasten the deterioration of the energy status of the tissue and eventually contribute to terminal depolarization and cell death, particularly in the penumbra.",0
508,17,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"It is suggested that the limited survival of the penumbra is due to periinfarct depolarizations, which result in repeated episodes of tissue hypoxia, because the increased metabolic workload is not coupled to an adequate increase of collateral blood supply.",0
508,18,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,Transient decreases of the apparent diffusion coefficient (ADC) of water as measured by fast diffusion-weighted imaging (DWI) in the ischemic border zone are thought to reflect cellular swelling associated with spreading depression.,0
508,19,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,Severely delayed recovery time after spreading depression is thought to represent the ischemic penumbra.,0
508,20,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"One current but controversial hypothesis is that this penumbra tissue often eventually dies because of the metabolic stress imposed by multiple cortical spreading depression (CSD) waves, that is, by ischemic depolarizations.",0
508,21,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"After simulated infarction, the model displays the linear relation between final infarct size and the number of CSD waves traversing the penumbra that has been reported experimentally, although damage with each individual wave progresses nonlinearly with time.",0
508,22,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,These findings support the hypothesis that CSD waves play an important causal role in the death of ischemic penumbra tissue.,0
508,23,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"MCAO also triggers periodic periinfarction depolarizing waves (PIDs) in the ischemic penumbra, the territory of salvage.",0
508,24,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"Here, the effects of SD at reduced flow conditions as encountered in the ischemic penumbra are examined.",0
508,25,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,The experiments illustrate how peri-infarct depolarizations may detrimentally affect the penumbra.,0
508,26,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,"In the second series of experiments, periinfarct depolarizations (PIDs) were recorded with an extracellular DC electrode at two locations in the ischemic penumbra for the initial 3 h following MCAO.",0
508,27,Does cortical spreading depression appear in ischemic penumbra following ischemic stroke?,In vivo two-photon microscopy of green fluorescent protein-expressing neurons in this penumbra-like area at risk revealed that SDs were temporally correlated with rapid (<6 s) dendritic beading.,0
3284,0,Do de novo truncating mutations in WASF1 cause cancer?,De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.,1
3284,1,Do de novo truncating mutations in WASF1 cause cancer?,"Here, using exome sequencing and whole-genome sequencing, we identified three de novo truncating mutations in WAS protein family member 1 (WASF1) in five unrelated individuals with moderate to profound intellectual disability with autistic features and seizures.",1
3284,2,Do de novo truncating mutations in WASF1 cause cancer?,"WASF1, also known as WAVE1, is part of the WAVE complex and acts as a mediator between Rac-GTPase and actin to induce actin polymerization.",1
3284,3,Do de novo truncating mutations in WASF1 cause cancer?,"The three mutations connected by Matchmaker Exchange were c.1516C>T (p.Arg506Ter), which occurs in three unrelated individuals, c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG (p.Ile494MetfsTer23).",0
3284,4,Do de novo truncating mutations in WASF1 cause cancer?,All three variants are predicted to partially or fully disrupt the C-terminal actin-binding WCA domain.,0
3284,5,Do de novo truncating mutations in WASF1 cause cancer?,Functional studies using fibroblast cells from two affected individuals with the c.1516C>T mutation showed a truncated WASF1 and a defect in actin remodeling.,1
3284,6,Do de novo truncating mutations in WASF1 cause cancer?,This study provides evidence that de novo heterozygous mutations in WASF1 cause a rare form of intellectual disability.,1
148,0,Which is the cellular localization of the protein Opa1?," The subcellular distribution of mOPA1 overexpressed in COS-7 cells largely overlapped that of endogenous cytochrome c, a well known mitochondrial marker,",0
148,1,Which is the cellular localization of the protein Opa1?,elease of high MW Opa-1 isoforms from the mitochondria to the cytosol,0
148,2,Which is the cellular localization of the protein Opa1?, mitochondrial fusion (opa-1),0
148,3,Which is the cellular localization of the protein Opa1?,"mitochondrial fusion genes Mfn1 (mitofusin 1), Mfn2 (mitofusin 2), Opa1 (optic atrophy 1)",0
148,4,Which is the cellular localization of the protein Opa1?,Biochemical examinations indicate that both of the OPA1 isoforms are present in the intermembrane space.,0
148,5,Which is the cellular localization of the protein Opa1?,"Submitochondrial fractionation by sucrose density-gradient centrifugation shows that the 88-kDa protein predominantly associates with the mitochondrial outer membrane, on the contrary, the 93-kDa protein associates with the inner membrane.",0
148,6,Which is the cellular localization of the protein Opa1?,"We describe here a nuclear gene, OPA1, that maps within the candidate region and encodes a dynamin-related protein localized to mitochondria.",0
148,7,Which is the cellular localization of the protein Opa1?,"The dynamin-related protein Opa1 is localized to the mitochondrial intermembrane space, where it facilitates fusion between mitochondria.",1
148,8,Which is the cellular localization of the protein Opa1?,Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage.,0
148,9,Which is the cellular localization of the protein Opa1?,Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria.,0
148,10,Which is the cellular localization of the protein Opa1?,The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.,1
148,11,Which is the cellular localization of the protein Opa1?,"In addition to the capacity of these proteins to promote fusion, mitofusin 2 or OPA1 regulate mitochondrial metabolism and loss-of-function reduces oxygen consumption and the capacity to oxidize substrates.",0
148,12,Which is the cellular localization of the protein Opa1?,"Here, we identified two isoforms of OPA1 proteins in HeLa cells and examined their submitochondrial localization and complex formations.",0
148,13,Which is the cellular localization of the protein Opa1?,"Our experiments restrict the function of prohibitins to mitochondria and identify the processing of the dynamin-like GTPase OPA1, an essential component of the mitochondrial fusion machinery, as the central cellular process controlled by prohibitins.",0
148,14,Which is the cellular localization of the protein Opa1?,LRRK2 partially co-localizes with endosomal dynamin-1 or with mitofusins and OPA1 at mitochondrial membranes.,0
148,15,Which is the cellular localization of the protein Opa1?,"While initial fusion of mitochondria by 15d-PGJ2 required the presence of both outer (Mfn1 and Mfn2) and inner (OPA1) mitochondrial membrane fusion proteins, later mitochondrial changes involved increased degradation of the fusion protein OPA1 and ubiquitination of newly synthesized OPA1 along with decreased expression of Mfn1 and Mfn2, which likely contributed to the loss of tubular rigidity, disorganization of cristae, and formation of large swollen degenerated dysfunctional mitochondria.",0
148,16,Which is the cellular localization of the protein Opa1?,Assay and properties of the mitochondrial dynamin related protein Opa1.,0
148,17,Which is the cellular localization of the protein Opa1?,Mitochondrial remodeling following fission inhibition by 15d-PGJ2 involves molecular changes in mitochondrial fusion protein OPA1.,0
148,18,Which is the cellular localization of the protein Opa1?,We have previously described that silencing of the mitochondrial protein OPA1 enhances mitochondrial Ca(2+) signaling and aldosterone production in H295R adrenocortical cells.,0
148,19,Which is the cellular localization of the protein Opa1?,"Our results define, for the first time, a function of the middle domain of the Opa1 protein and demonstrate that mitochondrial retention of Opa1 protein is essential for normal embryogenesis.",0
148,20,Which is the cellular localization of the protein Opa1?,"Here, we identified two isoforms of OPA1 proteins in HeLa cells and examined their submitochondrial localization and complex formations",0
148,21,Which is the cellular localization of the protein Opa1?,Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria,0
148,22,Which is the cellular localization of the protein Opa1?,"The dynamin-related protein Opa1 is localized to the mitochondrial intermembrane space, where it facilitates fusion between mitochondria.",1
148,23,Which is the cellular localization of the protein Opa1?,"Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence.",0
148,24,Which is the cellular localization of the protein Opa1?,"The dynamin-related GTPase protein OPA1, localized in the intermembrane space and tethered to the inner membrane of mitochondria, participates in the fusion of these organelles.",0
148,25,Which is the cellular localization of the protein Opa1?,"Lack of mitochondrial retention of Opa1 is sufficient to cause the cellular Opa1 loss-of-function phenotype as the mitochondria are fragmented, indicating an inability to fuse.",0
148,26,Which is the cellular localization of the protein Opa1?,"Opa1, also known as Mgm1 in yeast, is a mitochondrial member of the dynamin family.",0
148,27,Which is the cellular localization of the protein Opa1?,"Unlike other dynamin family members, Opa1 has an N-terminal mitochondrial targeting sequence, suggesting that this protein is imported into mitochondria.",0
148,28,Which is the cellular localization of the protein Opa1?,"Here, we describe biochemical techniques, such as mitochondrial isolation, digitonin extraction, a protease protection assay, and carbonate extraction, that were used to determine that mammalian Opa1 resides in the intermembrane space where it is tightly bound to the inner membrane.",0
148,29,Which is the cellular localization of the protein Opa1?,"The dynamin-related protein Opa1 is localized to the mitochondrial intermembrane space,",1
148,30,Which is the cellular localization of the protein Opa1?,"The dynamin-related GTPase protein OPA1, localized in the intermembrane space and tethered to the inner membrane of mitochondria, participates in the fusion of these organelles.",0
148,31,Which is the cellular localization of the protein Opa1?,we identified two isoforms of OPA1 proteins in HeLa cells and examined their submitochondrial localization and complex formations.,0
148,32,Which is the cellular localization of the protein Opa1?,"PKA phosphorylates perilipin, a protein localized on the surface of lipid droplets that serves as a gatekeeper to regulate access of lipases converting stored triglycerides to free fatty acids and glycerol in a phosphorylation-dependent manner.",0
148,33,Which is the cellular localization of the protein Opa1?,"Here, we report a new function for optic atrophy 1 (OPA1), a protein known to regulate mitochondrial dynamics, as a dual-specificity A-kinase anchoring protein associated with lipid droplets.",0
148,34,Which is the cellular localization of the protein Opa1?,"We find that Mgm1/OPA1 is localized to the mitochondrial intermembrane space,",1
1697,0,Which mitochondrial genes are regulated by thyroid hormone?,We used a polymerase chain reaction (PCR)-based mRNA differential display (DD) analysis to obtain a profile of thyroid hormone-responsive genes in osteoblast-like cells,0
1697,1,Which mitochondrial genes are regulated by thyroid hormone?,"At the 2-hour time point, 1 true-positive novel clone was identified and shown to be the mitochondrial gene, subunit 6 of ATP synthase (ATPase-6).",1
1697,2,Which mitochondrial genes are regulated by thyroid hormone?,"We studied the coordination of the two genomes by measuring transcript levels for nuclear (IV, Va, and VIc) and mitochondrial (II and III) subunits of cytochrome-c oxidase after altering the mitochondrial content of rat muscle and liver by altering the thyroid state of the animals.",1
1697,3,Which mitochondrial genes are regulated by thyroid hormone?,Tissue levels of these mRNAs were generally decreased in hypothyroid animals and were up-regulated again after thyroid hormone (T3) treatment.,1
1697,4,Which mitochondrial genes are regulated by thyroid hormone?,"Following this procedure, we now report the identification of the mitochondrial NADH dehydrogenase subunit 3 (ND3) gene as target of thyroid hormone.",1
1697,5,Which mitochondrial genes are regulated by thyroid hormone?,Sequencing and electrophoretic mobility shift assays confirmed the presence of a thyroid hormone receptor (TR)/c-erbA specific binding site in the mitochondrial ND3 gene.,1
1241,0,Is poly (ADP- ribosylation) involved in transcriptional control?,"Histone phosphorylation, ubiquitylation, SUMOylation and poly-ADP-ribosylation, as well as ATP-dependent nucleosome remodeling complexes, play equally pivotal roles in the maintenance of transcriptional fidelity",1
1241,1,Is poly (ADP- ribosylation) involved in transcriptional control?,"oly(ADP-ribose) polymerase-1 (PARP-1; EC 2.4.2.30) is an abundant nuclear protein that is involved in DNA repair, cell cycle control, programmed cell death and transcriptional regulation.",0
1241,2,Is poly (ADP- ribosylation) involved in transcriptional control?,Many lines of evidence suggest that poly(ADP-ribose) polymerase-1 (Parp-1) is involved in transcriptional regulation of various genes as a coactivator or a corepressor by modulating chromatin structure,1
1241,3,Is poly (ADP- ribosylation) involved in transcriptional control?,These results suggest that Parp-1 is required to maintain transcriptional regulation of a wide variety of genes on a genome-wide scale,0
1241,4,Is poly (ADP- ribosylation) involved in transcriptional control?,PARP-1 was identified as a part of the mH2A1.1 nucleosome complex and was found to be associated with the Hsp70.1 promoter,1
1241,5,Is poly (ADP- ribosylation) involved in transcriptional control?,"Upon heat shock, the Hsp70.1 promoter-bound PARP-1 is released to activate transcription through ADP-ribosylation of other Hsp70.1 promoter-bound proteins",0
1241,6,Is poly (ADP- ribosylation) involved in transcriptional control?,Cycloheximide-induced cells were treated with two chemical inhibitors of poly(ADP-ribose) polymerase.,1
1241,7,Is poly (ADP- ribosylation) involved in transcriptional control?,"3-Aminobenzamide inhibited 75% of PAP gene induction and 4-hydroxyquinazolone, the highly specific inhibitor of the enzyme, blocked almost completely PAP expression, suggesting that ADP-ribosylation was indeed required for the upregulation of PAP gene expression by cycloheximide",0
1241,8,Is poly (ADP- ribosylation) involved in transcriptional control?, inhibitors of poly(ADP-ribose) polymerase suppressed UV-induced HIV-1 gene expression but not tat-mediated expression,1
1241,9,Is poly (ADP- ribosylation) involved in transcriptional control?,oly(ADP-ribose) polymerase inhibitors suppress UV-induced human immunodeficiency virus type 1 gene expression,0
1608,0,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine and carboplatin demonstrate moderate toxicity with similar efficacy in both platinum-sensitive and platinum-resistant epithelial ovarian cancer, suggesting reversal of platinum resistance by gemcitabine",0
1608,1,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients,0
1608,2,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients,0
1608,3,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",GEMOX showed encouraging activity and manageable toxicity.,0
1608,4,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Under circumstances requiring a rapid disease control, this combination regimen may offer a particularly viable option, particularly in heavily pretreated patients",0
1608,5,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Salvage therapy of gemcitabine plus endostar significantly improves progression-free survival (PFS) with platinum-resistant recurrent epithelial ovarian cancer,0
1608,6,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine plus endostar significantly improved the prognosis in patients with platinum-resistant recurrent ovarian cancer, especially in those with malignant effusion",0
1608,7,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Though the endostar cohort also improved median OS by 2.1 months, there was no statistically significant difference compared with gemcitabine alone cohort in this case",1
1608,8,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer",0
1608,9,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","The regimen of gemcitabine combined with ifosfamide and anthracycline is feasible, tolerable and effective in patients with recurrent platinum resistant/refractory epithelial ovarian cancer",1
1608,10,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.", the combination of gemcitabine and carboplatin is now approved for patients with platinum-sensitive recurrent ovarian cancer,0
1608,11,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer,0
1608,12,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Pertuzumab may add activity to gemcitabine for the treatment of platinum-resistant ovarian cancer,0
1608,13,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","The combination of gemcitabine and PLD is an effective and tolerable treatment option, with 74.3 % disease control rate for patients with platinum resistant/refractory ovarian cancer",0
1608,14,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Both gemcitabine and pegylated liposomal doxorubicin (PLD) are antineoplastic drugs with clinical activity in patients with platinum-resistant ovarian cancer,0
1608,15,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",A biweekly schedule of gemcitabine combined with PLD is an active and safe chemotherapy regimen with acceptable and easily manageable toxicities in women with recurrent platinum-resistant ovarian cancer,1
1608,16,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",the combination of carboplatin and gemcitabine resulted in significantly higher response rates and improved progression-free survival when compared with carboplatin alone,0
1608,17,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Gemcitabine is a novel agent that has shown consistent activity as a single agent in the treatment of platinum-resistant ovarian cancer and a favorable toxicity profile,1
1608,18,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Because of its clinical and preclinical synergism with platinum analogs, gemcitabine has been combined with carboplatin as a convincing approach in the treatment of platinum-sensitive recurrent ovarian cancer patients",1
1608,19,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Gemcitabine is a new antimetabolite selected for clinical trials based on its activity in preclinical studies.,0
1608,20,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","With response rates ranging from 11% to 22% in monotherapy in resistant or platinum refractory diseases, gemcitabine has quickly been shown to be an active agent in the treatment of patients with refractory recurrent ovarian cancer",0
1608,21,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.", Gemcitabine and prolonged oral etoposide have shown reproducible single-agent activity in patients with platinum/paclitaxel-resistant ovarian cancer,0
1608,22,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases",0
1608,23,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","[Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer].",0
1608,24,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine and carboplatin demonstrate moderate toxicity with similar efficacy in both platinum-sensitive and platinum-resistant epithelial ovarian cancer, suggesting reversal of platinum resistance by gemcitabine.",0
1608,25,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients.,0
1608,26,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancer.,0
1608,27,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases.",0
1608,28,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Salvage therapy of gemcitabine plus endostar significantly improves progression-free survival (PFS) with platinum-resistant recurrent epithelial ovarian cancer.,0
1608,29,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","The regimen of gemcitabine combined with ifosfamide and anthracycline is feasible, tolerable and effective in patients with recurrent platinum resistant/refractory epithelial ovarian cancer.",0
1608,30,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",To evaluate the efficacy and toxicities of gemcitabine combined with ifosfamide and anthracycline chemotherapy for recurrent platinum resistant ovarian epithelial cancer.,0
1608,31,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer.,0
1608,32,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","CONCLUSION: The regimen of gemcitabine combined with ifosfamide and anthracycline is feasible, tolerable and effective in patients with recurrent platinum resistant/refractory epithelial ovarian cancer.",0
1608,33,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases.",0
1608,34,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","The regimen of gemcitabine combined with ifosfamide and anthracycline is feasible, tolerable and effective in patients with recurrent platinum resistant/refractory epithelial ovarian cancer.",0
1608,35,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.",Gemcitabine combined with oxaliplatin (GEMOX) as salvage treatment in elderly patients with advanced ovarian cancer refractory or resistant to platinum: a single institution experience.,0
1608,36,"Elaborate on the potential efficacy of gemcitabine for the treatment of recurrent, platinum-resistant epithelial ovarian cancer.","Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases.",0
4100,0,Are synonymous sites in primates and rodents functionally constrained?,"To resolve this contradiction between expectations and observations, we used processed pseudogenes as a model for strict neutral evolution, and estimated selective constraint on synonymous sites using the rate of substitution at pseudosynonymous and pseudononsynonymous sites in pseudogenes as the neutral expectation.",1
4100,1,Are synonymous sites in primates and rodents functionally constrained?,"After controlling for the effects of GC content, our results were similar to those from previous studies, i.e., synonymous sites in primates exhibited evidence for higher selective constraint that those in rodents.",1
4100,2,Are synonymous sites in primates and rodents functionally constrained?,"Specifically, our results indicated that in primates up to 24% of synonymous sites could be under purifying selection, while in rodents synonymous sites evolved neutrally.",1
1914,0,"What is ""Epitranscriptome analysis""?",The simultaneous detection of all the post-transcriptional modifications (PTMs) that decorate cellular RNA can provide comprehensive information on the effects of changing environmental conditions on the entire epitranscriptome.,0
1914,1,"What is ""Epitranscriptome analysis""?",The advent of high-throughput sequencing technologies coupled with new detection methods of RNA modifications has enabled investigation of a new layer of gene regulation - the epitranscriptome.,1
1914,2,"What is ""Epitranscriptome analysis""?"," Other mRNA modifications, including N1-methyladenosine (m1A), 5-methylcytosine (m5C) and pseudouridine, together with m6A form the epitranscriptome and collectively code a new layer of information that controls protein synthesis.",0
1914,3,"What is ""Epitranscriptome analysis""?"," the utility of mass spectrometry approaches for discovery-based analyses of RNA modifications, such as are required for studies of the epitranscriptome.",1
1914,4,"What is ""Epitranscriptome analysis""?","Despite the intriguing advancements, little is known so far about the dynamic landscape of RNA methylome across different cell types and how the epitranscriptome is regulated at the system level by enzymes, i.e., RNA methyltransferases and demethylases.",1
1914,5,"What is ""Epitranscriptome analysis""?","Modified nucleotides in messenger RNA (mRNA) have been discovered over 40 years ago, but until recently little was known about which transcripts contain them and what their function is.",1
1914,6,"What is ""Epitranscriptome analysis""?",High-throughput sequencing approaches revealed a dynamic landscape of the 'Epitranscriptome' for many mRNA modifications in various organisms from yeast to humans.,1
1451,0,What is the main biological function of the CRISPR-CAS9 genome editing system?,Mutagenesis and homologous recombination in Drosophila cell lines using CRISPR/Cas9.,0
1451,1,What is the main biological function of the CRISPR-CAS9 genome editing system?,We have applied the CRISPR/Cas9 system to Drosophila S2 cells to generate targeted genetic mutations in more than 85% of alleles.,0
1451,2,What is the main biological function of the CRISPR-CAS9 genome editing system?,"By targeting a constitutive exon of the AGO1 gene, we demonstrate homozygous mutation in up to 82% of cells, thereby allowing the study of genetic knockouts in a Drosophila cell line for the first time.",0
1451,3,What is the main biological function of the CRISPR-CAS9 genome editing system?,"We have shown that homologous gene targeting is possible at 1-4% efficiency using this system, allowing for the construction of defined insertions and deletions.",0
1451,4,What is the main biological function of the CRISPR-CAS9 genome editing system?,"This technology enables controlled genetic manipulation in Drosophila cell lines, and its simplicity offers the opportunity to study cellular phenotypes genome-wide.",0
1451,5,What is the main biological function of the CRISPR-CAS9 genome editing system?,The prokaryotic CRISPR/Cas9 type II genome editing system has recently been applied in cell lines and vertebrates.,0
1451,6,What is the main biological function of the CRISPR-CAS9 genome editing system?,"We now demonstrate that CRISPR/Cas9 mutagenesis in zebrafish is highly efficient, reaching up to 86.0%, and is heritable.",0
1451,7,What is the main biological function of the CRISPR-CAS9 genome editing system?,The efficiency of the CRISPR/Cas9 system further facilitated the targeted knock-in of a protein tag provided by a donor oligonucleotide with knock-in efficiencies of 3.5-15.6%.,0
1451,8,What is the main biological function of the CRISPR-CAS9 genome editing system?,The ease and efficiency of the CRISPR/Cas9 system with limited off-target effects make it a powerful genome engineering tool for in vivo studies.,1
1451,9,What is the main biological function of the CRISPR-CAS9 genome editing system?,Cas9/CRISPR has been reported to efficiently induce targeted gene disruption and homologous recombination in both prokaryotic and eukaryotic cells.,1
1451,10,What is the main biological function of the CRISPR-CAS9 genome editing system?,Sequence-specific nucleases like TALENs and the CRISPR/Cas9 system have greatly expanded the genome editing possibilities in model organisms such as zebrafish.,0
1451,11,What is the main biological function of the CRISPR-CAS9 genome editing system?,"Both systems have recently been used to create knock-out alleles with great efficiency, and TALENs have also been successfully employed in knock-in of DNA cassettes at defined loci via homologous recombination (HR).",1
1451,12,What is the main biological function of the CRISPR-CAS9 genome editing system?,Here we report CRISPR/Cas9-mediated knock-in of DNA cassettes into the zebrafish genome at a very high rate by homology-independent double-strand break (DSB) repair pathways.,0
1451,13,What is the main biological function of the CRISPR-CAS9 genome editing system?,The type II CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeats/CRISPR-associated) has recently emerged as an efficient and simple tool for site-specific engineering of eukaryotic genomes.,1
1451,14,What is the main biological function of the CRISPR-CAS9 genome editing system?,The CRISPR/Cas9 system has attracted significant attention for its potential to transform genome engineering.,0
1451,15,What is the main biological function of the CRISPR-CAS9 genome editing system?,"We and others have recently shown that the RNA-guided Cas9 nuclease can be employed to engineer the Drosophila genome, and that these modifications are efficiently transmitted through the germline.",1
1451,16,What is the main biological function of the CRISPR-CAS9 genome editing system?,Here we highlight the variety of genome modifications facilitated by the CRISPR/Cas9 system along with key considerations for starting your own CRISPR genome engineering project.,0
1451,17,What is the main biological function of the CRISPR-CAS9 genome editing system?,"Here, we present a simple and highly efficient method for generating and detecting mutations of any gene in Drosophila melanogaster through the use of the CRISPR/Cas9 system (clustered regularly interspaced palindromic repeats/CRISPR-associated).",0
1451,18,What is the main biological function of the CRISPR-CAS9 genome editing system?,Recently the type II prokaryotic clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) system has been adapted to serve as a targeted genome mutagenesis tool.,0
1451,19,What is the main biological function of the CRISPR-CAS9 genome editing system?,This CRISPR/Cas9 system represents a highly effective and scalable gene knockout method in zebrafish and has the potential for applications in other model organisms.,0
1451,20,What is the main biological function of the CRISPR-CAS9 genome editing system?,The CRISPR/Cas system has been adapted as an efficient gene-targeting technology with the potential for multiplexed genome editing.,0
657,0,List all reported treatment options for anxiety in autism spectrum disorder.,"A parent report of comorbid diagnosis of attention-deficit/hyperactivity disorder, bipolar disorder, obsessive-compulsive disorder, depression, or anxiety was associated with a high rate of use, with 80% receiving ≥ 1 psychotropic medication",0
657,1,List all reported treatment options for anxiety in autism spectrum disorder.,"Mindfulness-based therapy (MBT) has been found effective in reducing anxiety and depression symptoms, however research in autism is limited.",0
657,2,List all reported treatment options for anxiety in autism spectrum disorder.,"Therefore, we examined the effects of a modified MBT protocol (MBT-AS) in high-functioning adults with ASD.",0
657,3,List all reported treatment options for anxiety in autism spectrum disorder.,the present study is the first controlled trial to demonstrate that adults with ASD can benefit from MBT-AS.,1
657,4,List all reported treatment options for anxiety in autism spectrum disorder.,"This pilot, randomized controlled trial evaluated the feasibility and preliminary outcomes of the Multimodal Anxiety and Social Skills Intervention (MASSI) program in a sample of 30 adolescents with ASD and anxiety symptoms of moderate or greater severity.",0
657,5,List all reported treatment options for anxiety in autism spectrum disorder.,These findings suggest MASSI is a feasible treatment program and further evaluation is warranted.,0
657,6,List all reported treatment options for anxiety in autism spectrum disorder.,The purpose of this pilot study was to evaluate whether a modified version of the Coping Cat program could be effective in reducing anxiety in children with autism spectrum disorder (ASD).,0
657,7,List all reported treatment options for anxiety in autism spectrum disorder.,the Coping Cat program (cognitive-behavioral therapy; CBT),1
657,8,List all reported treatment options for anxiety in autism spectrum disorder.,Results provide preliminary evidence that a modified version of the Coping Cat program may be a feasible and effective program for reducing clinically significant levels of anxiety in children with high-functioning ASD.,0
657,9,List all reported treatment options for anxiety in autism spectrum disorder.,"The intent of this article is to explore the efficacy of both the literal and concrete externalization aspects within narrative therapy, and the implementation of interactive metaphors as a combined psychotherapeutic approach for decreasing anxiety with people who present with high-functioning autism.",1
657,10,List all reported treatment options for anxiety in autism spectrum disorder.,This paper reports a case series of children and adolescents with ASD and an anxiety disorder who were treated with a standard cognitive behaviour therapy (CBT) rationale adapted to take account of the neuropsychological features of ASD.,0
657,11,List all reported treatment options for anxiety in autism spectrum disorder.,children with moderate autistic symptomology (per SRS-P) were significantly more likely to improve from family CBT (FCBT) than individual CBT (ICBT; OR = 8.67),0
657,12,List all reported treatment options for anxiety in autism spectrum disorder.,"Though both treatments reduced anxiety, FCBT outperformed ICBT for children with moderate ASD symptoms, a benefit potentially linked to more at-home exposures and greater child involvement in FCBT.",0
657,13,List all reported treatment options for anxiety in autism spectrum disorder.,A structural model-building approach was used to test the extent to which family and peer variables directly or indirectly affected ASD via child anxiety/depression.,1
657,14,List all reported treatment options for anxiety in autism spectrum disorder.,"The key findings were that anxiety/depression and ASD symptomatology were significantly related, and family conflict was more predictive of ASD symptomatology than positive family/peer influences.",0
657,15,List all reported treatment options for anxiety in autism spectrum disorder.,"The results point to the utility of expanding interventions to include conflict management for couples, even when conflict and family distress is low.",1
657,16,List all reported treatment options for anxiety in autism spectrum disorder.,"A family-based, cognitive behavioural treatment for anxiety in 47 children with comorbid anxiety disorders and High Functioning Autism Spectrum Disorder (HFA) was evaluated.",0
657,17,List all reported treatment options for anxiety in autism spectrum disorder.,"Following treatment, 71.4% of the treated participants no longer fulfilled diagnostic criteria for an anxiety disorder.",0
657,18,List all reported treatment options for anxiety in autism spectrum disorder.,"Comparisons between the two conditions indicated significant reductions in anxiety symptoms as measured by self-report, parent report and teacher report",0
2924,0,What is the 3D tomography imaging technique for diagnosis of  eye disease?,To compare the effect of elevated intraocular pressure (IOP) on retinal capillary filling in elderly vs adult rats using optical coherence tomography angiography,0
2924,1,What is the 3D tomography imaging technique for diagnosis of  eye disease?,OCT data were captured using an optical microangiography (OMAG) scanning protocol and then post-processed to obtain both structural and vascular images.,0
2924,2,What is the 3D tomography imaging technique for diagnosis of  eye disease?, Optical coherence tomography is used routinely in management of diabetic eye disease,1
2924,3,What is the 3D tomography imaging technique for diagnosis of  eye disease?,The study aims to evaluate the use of optical coherence tomography combined with a fundus camera compared with a fundus camera only,1
2924,4,What is the 3D tomography imaging technique for diagnosis of  eye disease?,To evaluate the ability of new Swept source (SS) optical coherence tomography (OCT) technology to detect changes in retinal and choroidal thickness in patients with Parkinson's disease,1
2924,5,What is the 3D tomography imaging technique for diagnosis of  eye disease?,Retinal and Choroidal Changes in Patients with Parkinson's Disease Detected by Swept-Source Optical Coherence Tomography.,0
2924,6,What is the 3D tomography imaging technique for diagnosis of  eye disease?,"New SS technology for OCT devices detects retinal thinning in PD patients, providing increased depth analysis of the choroid in these patients",0
2924,7,What is the 3D tomography imaging technique for diagnosis of  eye disease?,Diagnostic Function of 3D Optical Coherence Tomography Images in Diagnosis of Vogt-Koyanagi-Harada Disease at Acute Uveitis Stage.,0
2924,8,What is the 3D tomography imaging technique for diagnosis of  eye disease?,"This study analyzed the macular 3D-OCT images of Vogt-Koyanagi-Harada disease (VKH) in uveitis, explored the characteristics of 3D-OCT images of the macular region of VKH, and assessed which characteristics contribute most to VKH diagnosis.",0
2924,9,What is the 3D tomography imaging technique for diagnosis of  eye disease?,"The 3D-OCT examination of 25 cases of VKH was performed on the macular area, and the image characteristics were analyzed.",0
2924,10,What is the 3D tomography imaging technique for diagnosis of  eye disease?,"The implications of new image analysis approaches include improved reproducibility of measurements garnered from 3D-OCT, which may then help improve disease discrimination and progression detection.",0
2924,11,What is the 3D tomography imaging technique for diagnosis of  eye disease?,"3D spectral domain optical coherence tomography (SD-OCT), an optical imaging technique, has been commonly used to discriminate glaucomatous from healthy subjects.",1
2924,12,What is the 3D tomography imaging technique for diagnosis of  eye disease?,"3D spectral domain optical coherence tomography (SD-OCT), an optical imaging technique, has been commonly used to discriminate glaucomatous from healthy subjects.",1
2924,13,What is the 3D tomography imaging technique for diagnosis of  eye disease?,"In this paper, we present a new framework for detection of glaucoma progression using 3D SD-OCT images.",0
776,0,What is the inheritance pattern of Li–Fraumeni syndrome?,"It therefore appears that the LFS phenotype has been conferred by an aberrant gene, showing a dominant pattern of inheritance, which may be acting to compromise normal p53 function rather than by a mutation in p53 itself.",0
776,1,What is the inheritance pattern of Li–Fraumeni syndrome?,"In addition, there seem to be predispositions to a wider range of different, but well-defined neoplasms: e.g., adenocarcinomatosis of the colon and the endometrium, or the Li-Fraumeni/SBLA syndrome.",0
776,2,What is the inheritance pattern of Li–Fraumeni syndrome?,"The latter shows a spectrum of sarcoma, brain tumours, breast cancer, leukaemias, lung and adenocortical cancer.",0
776,3,What is the inheritance pattern of Li–Fraumeni syndrome?,"The genes leading to these types of dominantly inherited predispositions appear to be the tentatively so-called tumour suppressor genes, for which the Rb gene serves as a model",0
776,4,What is the inheritance pattern of Li–Fraumeni syndrome?,he Li-Fraumeni syndrome is a rare autosomal-dominant disease whose hallmark is a predisposition to a wide range of cancers among members of a family.,1
776,5,What is the inheritance pattern of Li–Fraumeni syndrome?,Li-Fraumeni Syndrome (LFS) is characterized by early-onset carcinogenesis involving multiple tumor types and shows autosomal dominant inheritance.,1
776,6,What is the inheritance pattern of Li–Fraumeni syndrome?,"BACKGROUND: Li-Fraumeni-Syndrome (LFS) is an autosomal-dominant, inherited tumour predisposition syndrome associated with heterozygous germline mutations in the TP53 gene.",1
776,7,What is the inheritance pattern of Li–Fraumeni syndrome?,"Li-Fraumeni syndrome (LFS) is a highly penetrant, autosomal dominant, human familial cancer predisposition",1
776,8,What is the inheritance pattern of Li–Fraumeni syndrome?,The Li-Fraumeni syndrome is a rare autosomal-dominant disease whose hallmark is a predisposition to a wide range of cancers among members of a family,1
2910,0,What is GeneWeaver used for?,GeneWeaver: a web-based system for integrative functional genomics.,0
2910,1,What is GeneWeaver used for?,"The freely available GeneWeaver (http://www.GeneWeaver.org) powered by the Ontological Discovery Environment is a curated repository of genomic experimental results with an accompanying tool set for dynamic integration of these data sets, enabling users to interactively address questions about sets of biological functions and their relations to sets of genes.",1
2910,2,What is GeneWeaver used for?,The GeneWeaver.org system provides a platform for cross-species integration and interrogation of heterogeneous curated and experimentally derived functional genomics data.,1
2910,3,What is GeneWeaver used for?,"GeneWeaver enables researchers to store, share, analyze, and compare results of their own genome-wide functional genomics experiments in an environment containing rich companion data obtained from major curated repositories, including the Mouse Genome Database and other model organism databases, along with derived data from highly specialized resources, publications, and user submissions.",1
2910,4,What is GeneWeaver used for?,"The GeneWeaver data and analytics website (www.geneweaver.org) is a publically available resource for storing, curating and analyzing sets of genes from heterogeneous data sources.",1
2910,5,What is GeneWeaver used for?,"GeneWeaver empowers users with the ability to construct data driven descriptions of shared and unique biological processes, diseases and traits within and across species.",0
2910,6,What is GeneWeaver used for?,"Our interactive web-based software system, Gene Weaver (http://www.geneweaver.org), couples curated results from genomic studies to graph-theoretical tools for combinatorial analysis",0
2910,7,What is GeneWeaver used for?,GeneWeaver is an online database and suite of tools at www.geneweaver.org that allows for fast aggregation and analysis of gene set-centric data.,0
2910,8,What is GeneWeaver used for?,"Here we use GeneWeaver to find genes common to multiple gene sets, prioritize candidate genes from a quantitative trait locus, and characterize a set of differentially expressed genes.",0
2910,9,What is GeneWeaver used for?,These can be entered directly into GeneWeaver or transferred from widely used resources such as GeneNetwork.org.,0
2910,10,What is GeneWeaver used for?,"GeneWeaver contains curated experimental data together with resource-level data such as GO annotations, MP annotations, and KEGG pathways, along with persistent stores of user entered data sets.",0
2910,11,What is GeneWeaver used for?,"By enumerating the common and distinct biological molecules associated with all subsets of curated or user submitted groups of gene sets and gene networks, GeneWeaver empowers users with the ability to construct data driven descriptions of shared and unique biological processes, diseases and traits within and across species.",0
2910,12,What is GeneWeaver used for?,"The GeneWeaver bipartite data model provides an efficient means to evaluate shared molecular components from sets derived across diverse species, disease states and biological processes.",0
2910,13,What is GeneWeaver used for?,Interrogating common relationships among biological networks and conventional GeneWeaver gene lists will increase functional specificity and reliability of the shared biological components.,0
2910,14,What is GeneWeaver used for?,"Our interactive web-based software system, Gene Weaver (http://www.geneweaver.org), couples curated results from genomic studies to graph-theoretical tools for combinatorial analysis.",0
2910,15,What is GeneWeaver used for?,"A robust implementation has been incorporated into GeneWeaver, an online tool for integrating and analyzing functional genomics experiments, available at http://geneweaver.org.",0
2910,16,What is GeneWeaver used for?,The GeneWeaver web-based software system brings together a large data archive from diverse functional genomics data with a suite of combinatorial tools in an interactive environment.,0
2910,17,What is GeneWeaver used for?,"Data from multiple such publications and public data resources have been incorporated in the GeneWeaver database with >60,000 gene sets including 285 alcohol withdrawal and preference-related gene sets.",0
2910,18,What is GeneWeaver used for?,"Data from multiple such publications and public data resources have been incorporated in the GeneWeaver database with &amp;gt;60,000 gene sets including 285 alcohol withdrawal and preference-related gene sets.",0
2910,19,What is GeneWeaver used for?,These can be entered directly into GeneWeaver or transferred from widely used resources such as GeneNetwork.org.,0
2910,20,What is GeneWeaver used for?,"A robust implementation has been incorporated into GeneWeaver, an online tool for integrating and analyzing functional genomics experiments, available at http://geneweaver.org.",0
2910,21,What is GeneWeaver used for?,"The freely available GeneWeaver (http://www.GeneWeaver.org) powered by the Ontological Discovery Environment is a curated repository of genomic experimental results with an accompanying tool set for dynamic integration of these data sets, enabling users to interactively address questions about sets of biological functions and their relations to sets of genes.",1
2910,22,What is GeneWeaver used for?,GeneWeaver.org is a web-based software system that employs many of these techniques and has been used in the study of complex behavior and addiction.,0
2910,23,What is GeneWeaver used for?,"GeneWeaver: data driven alignment of cross-species genomics in biology and disease.The GeneWeaver data and analytics website (www.geneweaver.org) is a publically available resource for storing, curating and analyzing sets of genes from heterogeneous data sources.",0
2910,24,What is GeneWeaver used for?,"GeneWeaver contains curated experimental data together with resource-level data such as GO annotations, MP annotations, and KEGG pathways, along with persistent stores of user entered data sets.",0
2910,25,What is GeneWeaver used for?,"Since the previous review in the 2012 Nucleic Acids Research Database issue, GeneWeaver's underlying analytics platform has been enhanced, its number and variety of publically available gene set data sources has been increased, and its advanced search mechanisms have been expanded.",0
2910,26,What is GeneWeaver used for?,"A search of over 60,000 gene sets in GeneWeaver's database revealed alcohol-related experimental results including genes identified in mouse genetic mapping studies, alcohol selected Drosophila lines, Rattus differential expression, and human alcoholic brains.",0
2910,27,What is GeneWeaver used for?,"A robust implementation has been incorporated into GeneWeaver, an online tool for integrating and analyzing functional genomics experiments, available at http://geneweaver.org.",0
2910,28,What is GeneWeaver used for?,Integrative Functional Genomics for Systems Genetics in GeneWeaver.org.,0
1490,0,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,PolC co-evolves with RNA degradation enzymes that are present only in the A+T-rich Firmicutes clade,0
1490,1,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,"Bacterial genomes displaying a strong bias between the leading and the lagging strand of DNA replication encode two DNA polymerases III, DnaE and PolC, rather than a single one.",0
1490,2,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,"SGD, PAS, and polC are all features associated with a group of low-GC, gram-positive bacteria (Firmicutes)",0
1490,3,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,PAS is a characteristic of organisms with a heterodimeric DNA polymerase III alpha-subunit constituted by polC and dnaE,1
1490,4,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,"Bacterial DNA polymerase III, the primary complex of DNA replication, consists of PolC and DnaE.",1
1490,5,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,"PolC is conserved in Gram-positive bacteria, especially in the Firmicutes with low GC content, whereas DnaE is widely conserved in most Gram-negative and Gram-positive bacteria.",1
1490,6,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,PolC-PolE DNA polymerases,0
1490,7,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,"We conclude that PAS is a characteristic of organisms with a heterodimeric DNA polymerase III alpha-subunit constituted by polC and dnaE, which may play a direct role in the maintenance of SGD.",1
1490,8,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,"Furthermore, SGD, PAS, and polC are all features associated with a group of low-GC, gram-positive bacteria (Firmicutes)",0
1490,9,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,"In contrast, PolC co-evolves with RNA degradation enzymes that are present only in the A+T-rich Firmicutes clade, suggesting at least two origins for the degradosome.",0
1490,10,Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?,A method for the construction of in frame substitutions in operons: deletion of the essential Escherichia coli holB gene coding for a subunit of the DNA polymerase III holoenzyme.,1
2569,0,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases.",1
2569,1,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to discover variants associated to specific Mendelian disorders.",1
2569,2,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Overall, Genomiser is able to identify causal regulatory variants as the top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",1
2569,3,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases.",1
2569,4,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Overall, Genomiser is able to identify causal regulatory variants as the top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",1
2569,5,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to discover variants associated to specific Mendelian disorders.",0
2569,6,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to discover variants associated to specific Mendelian disorders.",0
2569,7,Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?,"Overall, Genomiser is able to identify causal regulatory variants as the top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",0
16,0,Which are the Yamanaka factors?,"Yamanaka factors (OCT4, SOX2, MYC, and KLF4",1
16,1,Which are the Yamanaka factors?,"Yamanaka factors' (Oct4, Sox2, Klf4 and c-Myc)",1
16,2,Which are the Yamanaka factors?,"Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc)",1
16,3,Which are the Yamanaka factors?,"Yamanaka factors (c-myc, KLF4, Oct3/4 and SOX2)",0
16,4,Which are the Yamanaka factors?,"Yamanaka factors (i.e., Oct4, Sox2, Klf4, and c-Myc)",1
16,5,Which are the Yamanaka factors?,"Yamanaka factors (Oct3/4, Sox2, Klf4, and c-Myc)",0
16,6,Which are the Yamanaka factors?,"Yamanaka factors (OCT4, SOX2, KLF4, cMYC - OSKM",0
16,7,Which are the Yamanaka factors?,"Oct4, Sox2, Klf4 and cMyc (4TF, Yamanaka factors)",0
16,8,Which are the Yamanaka factors?,"Yamanaka factors (Pou5f1, Myc, Klf4, and Sox2)",0
16,9,Which are the Yamanaka factors?,"c-Myc, Klf4, Oct3/4, and Sox2 (the so-called ""Yamanaka factors"")",0
16,10,Which are the Yamanaka factors?,"Yamanaka factors, Oct3/4, Sox2, Klf4, and c-Myc",0
16,11,Which are the Yamanaka factors?,"Yamanaka factors, namely Sox2, Oct3/4 (Pou5f1), Klf4, and c-Myc",0
16,12,Which are the Yamanaka factors?,"Oct4, Sox2, Klf4 and c-Myc, also known as the Yamanaka factors.",0
16,13,Which are the Yamanaka factors?,"Yamanaka factors (SOX2, OCT3/4, and KLF4, with or without c-MYC)",0
16,14,Which are the Yamanaka factors?,"Yamanaka factors Oct4, Sox2, Klf4, and c-Myc",1
16,15,Which are the Yamanaka factors?,"amanaka factors (Oct3/4, Sox2, Klf4, c-Myc)",0
16,16,Which are the Yamanaka factors?,"Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc) are highly expressed in embryonic stem (ES) cells, and their over-expression can induce pluripotency in both mouse and human somatic cells, indicating that these factors regulate the developmental signaling network necessary for ES cell pluripotency.",0
16,17,Which are the Yamanaka factors?,"These protein sets have been called the Yamanaka factors, namely Sox2, Oct3/4 (Pou5f1), Klf4, and c-Myc, and the Thomson factors, namely Sox2, Oct3, Lin28, and Nanog",0
16,18,Which are the Yamanaka factors?,"Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc) are highly expressed in embryonic stem (ES) cells, and their over-expression can induce pluripotency in both mouse and human somatic cells, indicating that these factors regulate the developmental signaling network necessary for ES cell pluripotency",0
16,19,Which are the Yamanaka factors?,"Transcription factors, Oct4, Sox2, Klf4 and cMyc (4TF, Yamanaka factors) are used as basal conditions to generate iPS cells",0
16,20,Which are the Yamanaka factors?,"Generation of induced pluripotent stem (iPS) cells from somatic cells has been successfully achieved by ectopic expression of four transcription factors, Oct4, Sox2, Klf4 and c-Myc, also known as the Yamanaka factors",0
854,0,What is the role of photodynamic therapy for meningioma treatment?,CONCLUSIONS: Efficacy of 5-ALA PDT could be increased by adjunction of ciprofloxacin in conventional clinical dosing and by prolongation of ALA incubation time.,1
854,1,What is the role of photodynamic therapy for meningioma treatment?,CONCLUSION: Gefitinib can inhibit ABCG2-mediated PpIX efflux from malignant brain tumor cells to increase the intracellular PpIX and thereby enhance the PDT effect.,0
854,2,What is the role of photodynamic therapy for meningioma treatment?,CONCLUSION: ALA-PDT was more effective in killing U-105MG glioma cells than CH-157MN meningioma cells.,0
854,3,What is the role of photodynamic therapy for meningioma treatment?,"These data indicate unique features of AlPc which suggests its application as a potent, non-toxic photosensitizer in the photodynamic therapy of human meningiomas.",0
854,4,What is the role of photodynamic therapy for meningioma treatment?,Photodynamic therapy is being investigated as an adjuvant treatment for intracranial neoplasms.,1
854,5,What is the role of photodynamic therapy for meningioma treatment?,It was found that PDT using haematoporphyrin derivative as a photosensitizing drug showed dose-dependent activity against a variety of histological subtypes of meningioma.,0
854,6,What is the role of photodynamic therapy for meningioma treatment?,Photodynamic therapy is a promising treatment for human brain tumors because of the selective retention of certain compounds by tumor cells.,0
854,7,What is the role of photodynamic therapy for meningioma treatment?,Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity.,1
854,8,What is the role of photodynamic therapy for meningioma treatment?,We conclude that differences in intracellular PpIX concentrations between HBL-52 and BEN-MEN-1 benign meningioma cells were mainly due to differences in FECH activity and that these differences correspond to their susceptibility to 5-ALA-induced PDT.,0
854,9,What is the role of photodynamic therapy for meningioma treatment?,Photodynamic therapy (PDT) has been employed in the management of recurrent cerebral gliomas but its activity against meningiomas has not been specifically studied.,0
854,10,What is the role of photodynamic therapy for meningioma treatment?,Enhancing the effect of 5-aminolevulinic acid based photodynamic therapy in human meningioma cells.,1
854,11,What is the role of photodynamic therapy for meningioma treatment?,An in vitro study of the effect of photodynamic therapy on human meningiomas.,1
854,12,What is the role of photodynamic therapy for meningioma treatment?,Photodynamic therapy (PDT) has been employed in the management of recurrent cerebral gliomas but its activity against meningiomas has not been specifically studied.,0
3731,0,When was vivotif first licenced in Europe?,Vivotif® is an oral live attenuated vaccine which contains a mutated strain of Salmonella (Ty21a) and reproduces the natural infection.,1
3731,1,When was vivotif first licenced in Europe?,"The vaccine was first licensed in Europe in 1983 and in the US in 1989, and over the years it has proved efficacious and safe.",1
3640,0,How are SAHFS created?,"These include measurement of senescence-associated β-galactosidase activity (SA-β-gal), senescence-associated heterochromatin foci (SAHFs), proliferative arrest, morphological changes, and expression and activity of proteins involved in the senescence process, such as p53 and Rb pathway proteins and secretory proteins",0
3640,1,How are SAHFS created?,Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence.,0
3640,2,How are SAHFS created?,"Senescent cells have a distinct gene expression profile, which is often accompanied by the spatial redistribution of heterochromatin into senescence-associated heterochromatic foci (SAHFs)",1
3640,3,How are SAHFS created?," Genome-wide mapping reveals that LMNB1 is depleted during senescence, preferentially from the central regions of lamina-associated domains (LADs), which are enriched for Lys9 trimethylation on histone H3 (H3K9me3).",0
3640,4,How are SAHFS created?,"LMNB1 knockdown facilitates the spatial relocalization of perinuclear H3K9me3-positive heterochromatin, thus promoting SAHF formation, which could be inhibited by ectopic LMNB1 expression.",0
3640,5,How are SAHFS created?,nuclear rearrangement of repressive histone marks H3K9me3 and H3K27me3 into nonoverlapping structural layers characterizes senescence-associated heterochromatic foci (SAHF) formation in human fibroblasts.,1
3640,6,How are SAHFS created?,Alterations of chromatin structure are believed to contribute to the irreversible nature of the senescent state.,0
3640,7,How are SAHFS created?,"Senescent cells form characteristic heterochromatin structure called senescence-associated heterochromatic foci (SAHFs), which may repress the expression of proliferation-promoting genes, such as E2F target genes.",1
3640,8,How are SAHFS created?,"urprisingly, we show that the High-Mobility Group A (HMGA) proteins, which can promote tumorigenesis, accumulate on the chromatin of senescent fibroblasts and are essential structural components of SAHFs.",0
3640,9,How are SAHFS created?,"Remarkably, SAHF-positive senescent cells lose linker histone H1 and exhibit increased levels of chromatin-bound high mobility group A2 (HMGA2).",0
3640,10,How are SAHFS created?,Cellular senescence is a tumor-suppressing mechanism that is accompanied by characteristic chromatin condensation called senescence-associated heterochromatic foci (SAHFs).,1
3640,11,How are SAHFS created?,It is almost ten years since senescence associated heterochromatic foci (SAHFs) were first described in human diploid fibroblasts (HDFs).,1
3640,12,How are SAHFS created?,"Thus the layered HOCS of SAHFs is likely achieved mainly through the spatial rearrangement of pre-existing heterochromatin, rather than spreading of heterochromatin.",0
3640,13,How are SAHFS created?,"Evidence for the co-association of similar types of chromatin is emerging and SAHFs may provide a unique model system to study the correlation between HOCS and chromatin types, which are readily visible and regulable.",0
2757,0,List intramembrane rhomboid peptidases,rhomboid protease PARL,1
2757,1,List intramembrane rhomboid peptidases,The newly identified Pcp1 protein belongs to the rhomboid-GlpG superfamily of putative intramembrane peptidases.,1
2757,2,List intramembrane rhomboid peptidases,"We subjected Haemophilus influenzae, (hiGlpG), Escherichia coli GlpG (ecGlpG) and Bacillus subtilis (YqgP)",1
2757,3,List intramembrane rhomboid peptidases,Crystal structures of H. influenzae (hiGlpG) and E. coli GlpG (ecGlpG) rhomboids have revealed a structure with six transmembrane helices and a Ser-His catalytic dyad buried within the membrane.,1
1705,0,What is the mode of inheritance of Acromicric dysplasia?,"AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).",1
1705,1,What is the mode of inheritance of Acromicric dysplasia?,"Finally, WMS is transmitted either by an autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance.",1
1705,2,What is the mode of inheritance of Acromicric dysplasia?,The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant mode of inheritance.,1
2025,0,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum (NLD) is a chronic condition, which is characterized by single or multiple lesions on the legs, and occurs in 0.3% of patients with diabetes.",0
2025,1,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica (NL) is a rare chronic granulomatous dermatitis that usually appears in the lower extremities.,0
2025,2,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"It affects about 0.3-1.2% of diabetic patients, the majority of whom have type 1 diabetes.",0
2025,3,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"A 32-year-old woman with type 2 diabetes mellitus suffering from morbid obesity with BMI 45,14 kg/m(2) was operated on.",0
2025,4,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Not only the type 2DM but also one of its complication known as necrobiosis lipoidica diabeticorum remitted postoperatively.,0
2025,5,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica is a granulomatous skin disease of unknown etiology, associated mainly with diabetes mellitus.",1
2025,6,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum is a rare disease of unclear etiology, that occurs in about 1% of diabetic patients.",0
2025,7,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum (NLD) is a rare, granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus.",1
2025,8,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum (NLD) is a rare skin condition associated with diabetes, which characteristically occurs in the pretibial region of the lower limbs (Boulton et al., 1988).",0
2025,9,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"More than half of the patients with necrobiosis lipoidica diabeticorum have diabetes mellitus, but less than one per cent of diabetes mellitus patients have necrobiosis lipoidica diabeticorum.",0
2025,10,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,We describe the unusual case of a woman with diabetes and a history of generalized granuloma annulare who noted leg ulcers that clinically represented ulcerated necrobiosis lipoidica diabeticorum and had histologic features of necrobiosis lipoidica diabeticorum and granuloma annulare.,0
2025,11,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum (NLD) is a rare, granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus",1
2025,12,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum (NLD) is a rare skin condition associated with diabetes, which characteristically occurs in the pretibial region of the lower limbs (Boulton et al., 1988)",0
2025,13,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica is a rare inflammatory granulomatous skin disease of unknown etiology which is associated with diabetes mellitus in about 60 % of the patients,0
2025,14,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica is a granulomatous skin disease of unknown etiology, associated mainly with diabetes mellitus",1
2025,15,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica is an inflammatory granulomatous skin disease of unknown etiology which is associated with diabetes mellitus in about 60% of the patients,0
2025,16,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica dibeticum (NLD) is a granulomatous skin disease mostly associated with diabetes mellitus,0
2025,17,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica (NL) is a rare chronic granulomatous disease that has historically been associated with diabetes mellitus,0
2025,18,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica diabeticorum is an unusual dermatologic condition with a characteristic clinical appearance and a clear association with diabetes mellitus.,0
2025,19,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"However, it has not been associated previously with necrobiosis lipoidica diabeticorum (NBL), a rare skin manifestation of diabetes mellitus.",0
2025,20,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum (NLD) is a rare, granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus.",1
2025,21,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum (NLD) is a rare degenerative connective tissue disorder associated with diabetes mellitus, which usually presents with red papules or plaques with raised edges and occasional ulceration.",0
2025,22,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"We describe two children with diabetes who both developed granuloma annulare and later, necrobiosis lipoidica diabeticorum.",0
2025,23,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Granuloma annulare occurs earlier than necrobiosis lipoidica diabeticorum and the association with diabetes mellitus is much weaker.,0
2025,24,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Diabetes mellitus is associated with a range of dermatologic presentations, including granuloma annulare and necrobiosis lipoidica diabeticorum.",0
2025,25,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,In this report a patient with diabetes mellitus and generalized necrobiosis lipoidica diabeticorum with localization in surgical scars is described.,0
2025,26,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica is an idiopathic dermatological condition that is strongly associated with diabetes mellitus.,0
2025,27,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Necrobiosis lipoidica diabeticorum is an unusual dermatologic condition with a characteristic clinical appearance and a clear association with diabetes mellitus.,0
2025,28,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Necrobiosis lipoidica diabeticorum is a rare skin disorder, usually considered a marker for diabetes mellitus.",0
2025,29,Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,Recurrent necrobiosis lipoidica diabeticorum associated with venous insufficiency in an adolescent with poorly controlled type 2 diabetes mellitus.,0
2550,0,When is 16S rRNA Gene Sequencing used?,The different pipelines that may be used in 16S rRNA gene profiling of bacterial communities are known to have a significant impact on alpha and beta diversity measures and this may prevent direct comparison of results obtained in studies using different bioinformatic approaches to analyse raw sequences.,1
2550,1,When is 16S rRNA Gene Sequencing used?," Metataxonomics tools analyze high-throughput sequencing data, primarily from 16S rRNA gene sequencing and DNAseq, to identify microorganisms and viruses within a complex mixture.",1
2550,2,When is 16S rRNA Gene Sequencing used?,"Two biological methods were used, Ribosomal Intergenic Spacer Analysis (RISA), and 16S rRNA gene sequencing with Illumina Miseq, to evaluate the discriminating power of soil bacterial communities.",1
2550,3,When is 16S rRNA Gene Sequencing used?,"The aim of this study was to assess the integration of different approaches, genotypic (16S rRNA gene sequencing), proteomic (MALDI-TOF MS) and metabolomic (1H-NMR), for the taxonomic and metabolic characterization of Lactobacillus species.",1
2213,0,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis,1
2213,1,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,Six of twenty successfully genotyped polymorphisms were nominally associated with EULAR treatment response.,0
2213,2,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,Three of these were in weak to moderate linkage disequilibrium with polymorphisms previously reported associated with anti-TNF treatment response.,1
2213,3,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,"TLR5(rs5744174) variant allele carriers (odds ratio(OR) = 1.7(1.1-2.5),p = 0.010,q = 0.46) and TLR1(rs4833095) homozygous variant carriers (OR = 2.8(1.1-7.4),p = 0.037,q = 0.46) had higher odds for a positive treatment response.",0
2213,4,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,"NLRP3(rs10754558) variant allele carriers (odds ratio(OR) = 0.6(0.4-1.0),p = 0.045,q = 0.46) were more likely to have a negative treatment response.",0
2213,5,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,"The association in TLR5(rs5744174) remained significant after correction for multiple comparisons among patients negative for RF (OR = 6.2(2.4-16.3),p = 0.0002,q = 0.024).",0
2213,6,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis,1
2213,7,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,"We aimed to validate this genetic association in a patient cohort from the Spanish population, and also to identify new genes functionally related to FCGR2A that are also associated with anti-TNF response.",1
2213,8,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,A total of 348 RA patients treated with an anti-TNF therapy were included and genotyped for FCGR2A polymorphism rs1081274.,0
2213,9,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?," Using gene expression profiles from macrophages obtained from synovial fluid of RA patients, we searched for genes highly correlated with FCGR2A expression.",0
2213,10,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,We found a significant association between FCGR2A and the response to adalimumab (P=0.022).,0
2213,11,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,"Analyzing the subset of anti-CCP positive RA patients (78%), we also found a significant association between FCGR2A and the response to infliximab (P=0.035).",0
2213,12,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,DHX32 and RGS12 were the most consistently correlated genes with FCGR2A expression in RA synovial fluid macrophages (P<0.001).,1
2213,13,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,"We found a significant association between the genetic variation at DHX32 (rs12356233, corrected P=0.019) and a nominally significant association between RGS12 and the response to adalimumab (rs4690093, uncorrected P=0.040).",0
2213,14,Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?,"In the anti-CCP positive group of patients, we also found a nominally significant association between RGS12 and the response to infliximab (rs2857859, uncorrected P=0.042).",0
788,0,What is the presumed key event in Fanconi anemia pathogenesis?,"A key event in FA pathway activation is the monoubiquitylation of the FA complementation group I (FANCI)-FANCD2 (ID) complex by FA complementation group L (FANCL), an E3 ubiquitin ligase",0
788,1,What is the presumed key event in Fanconi anemia pathogenesis?,Monoubiquitination of the Fanconi anaemia protein FANCD2 is a key event leading to repair of interstrand cross-links,1
788,2,What is the presumed key event in Fanconi anemia pathogenesis?,"Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA",0
788,3,What is the presumed key event in Fanconi anemia pathogenesis?,"Fanconi anemia (FA) is characterized by congenital abnormalities, bone marrow failure, chromosome fragility, and cancer susceptibility.",0
788,4,What is the presumed key event in Fanconi anemia pathogenesis?,"Eight FA-associated genes have been identified so far, the products of which function in the FA/BRCA pathway.",0
788,5,What is the presumed key event in Fanconi anemia pathogenesis?,"A key event in the pathway is the monoubiquitination of the FANCD2 protein, which depends on a multiprotein FA core complex",1
788,6,What is the presumed key event in Fanconi anemia pathogenesis?," Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA.",0
788,7,What is the presumed key event in Fanconi anemia pathogenesis?,"This event also causes phosphorylation of the Fanconi anemia (FA) protein FANCI, triggering its monoubiquitination of the key DNA repair factor FANCD2 by the FA core E3 ligase complex, thereby promoting this central pathway of DNA repair which permits replication to be restarted.",1
788,8,What is the presumed key event in Fanconi anemia pathogenesis?,"Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA.",0
788,9,What is the presumed key event in Fanconi anemia pathogenesis?,"A key event in the pathway is the monoubiquitination of the FANCD2 protein, which depends on a multiprotein FA core complex.",1
788,10,What is the presumed key event in Fanconi anemia pathogenesis?,"The key event of the FA pathway is dependent on an eight-protein core complex (CC), required for the monoubiquitination of each member of the FANCD2-FANCI complex.",0
788,11,What is the presumed key event in Fanconi anemia pathogenesis?,"FA proteins (FancA/C/E/F/G/L) form a multiprotein complex, which is responsible for DNA damage-induced FancD2 monoubiquitination, a key event for cellular resistance to DNA damage.",0
788,12,What is the presumed key event in Fanconi anemia pathogenesis?,"A key event in FA pathway activation is the monoubiquitylation of the FA complementation group I (FANCI)-FANCD2 (ID) complex by FA complementation group L (FANCL), an E3 ubiquitin ligase.",0
788,13,What is the presumed key event in Fanconi anemia pathogenesis?,"A key event in the pathway is the monoubiquitination of the FANCD2 protein, which depends on a multiprotein FA core complex",1
788,14,What is the presumed key event in Fanconi anemia pathogenesis?,"This event also causes phosphorylation of the Fanconi anemia (FA) protein FANCI, triggering its monoubiquitination of the key DNA repair factor FANCD2 by the FA core E3 ligase complex, thereby promoting this central pathway of DNA repair which permits replication to be restarted",0
1730,0,What is the mechanism of action of geldanamycin?,Geldanamycin (HSP90 inhibitor),0
1730,1,What is the mechanism of action of geldanamycin?,Geldanamycin is an antibiotic originally discovered based on its ability to bind heat-shock protein 90.,1
1730,2,What is the mechanism of action of geldanamycin?,This interaction can lead to the disruption of heat-shock protein 90-containing multimolecular complexes.,1
1730,3,What is the mechanism of action of geldanamycin?,"It can also induce the inhibition or even degradation of partner proteins dissociated from the 90 kDa chaperone and, eventually, can cause apoptosis, for instance, in PC12 cells.",1
1730,4,What is the mechanism of action of geldanamycin?,"An Hsp90 ATPase inhibitor, geldanamycin, inhibits luciferase reactivation demonstrating the importance of the ATP-dependent chaperone activity of E. coli Hsp90 during client protein remodeling.",0
1730,5,What is the mechanism of action of geldanamycin?,"Unique proteome patterns were observed in HeLa cells treated with the HSP90 inhibitor geldanamycin, and were similar to the patterns induced by radicicol, a structurally different HSP90 inhibitor.",0
1730,6,What is the mechanism of action of geldanamycin?,the Hsp90 inhibitor geldanamycin,0
1730,7,What is the mechanism of action of geldanamycin?,"The molecular chaperone heat-shock protein (Hsp) 90 is an important anticancer drug target because it maintains the conformation, stability, and function of many important oncogenic client proteins, including those involved with signal transduction, cell proliferation, survival, differentiation, motility angiogenesis, and metastasis.",1
1730,8,What is the mechanism of action of geldanamycin?,"Using the standard inhibitors of the adenosine triphosphatase (ATPase) activity of Hsp90, geldanamycin (GA) and 17-allylamino-17- demethoxygeldanamycin (17AAG), novel solid-phase immunoassays have been validated using a time-resolved fluorescence (TRF) end point.",0
1730,9,What is the mechanism of action of geldanamycin?,Their utility for confirming the mechanism of action of Hsp90 inhibition in secondary cell-based assays has been shown and applied to the novel Hsp90 inhibitor CCT018159.,1
1730,10,What is the mechanism of action of geldanamycin?,"A recent crystal structure of the NH2-terminal domain of yeast Hsp90 established the presence of a conserved nucleotide binding site that is identical with the binding site of geldanamycin, a specific inhibitor of Hsp90.",0
1730,11,What is the mechanism of action of geldanamycin?,The functional significance of nucleotide binding by Hsp90 has remained unclear.,0
1730,12,What is the mechanism of action of geldanamycin?,Here we present evidence for a slow but clearly detectable ATPase activity in purified Hsp90.,0
3595,0,Can LB-100 sensitize ovarian carcinoma to cisplatin?,The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.,1
3595,1,Can LB-100 sensitize ovarian carcinoma to cisplatin?,LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death.,1
3595,2,Can LB-100 sensitize ovarian carcinoma to cisplatin?,Our results suggest that LB100 sensitizes ovarian cancer cells to cisplatin in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation.,1
1074,0,Which ones are the ESKAPE organisms?,"The aim of this study was to test in the clinic whether antimicrobial diversity affects resistance of Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE) pathogens in ventilator-associated pneumonia (VAP).",0
1074,1,Which ones are the ESKAPE organisms?,"Despite important geographical variations, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (ESKAPE) pathogens constitute more than 80% of ventilator-associated pneumonia (VAP) episodes.",0
1074,2,Which ones are the ESKAPE organisms?,"Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",1
1074,3,Which ones are the ESKAPE organisms?,- is of particular concern because they are responsible for many serious infections in hospitals.,0
1074,4,Which ones are the ESKAPE organisms?,"Patients recovering from traumatic injuries or surgery often require weeks to months of hospitalization, increasing the risk for wound and surgical site infections caused by ESKAPE pathogens, which include A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species).",0
1074,5,Which ones are the ESKAPE organisms?,"'ESKAPE' (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.)",1
1074,6,Which ones are the ESKAPE organisms?,pathogens play a major role in the rapidly changing scenario of antimicrobial resistance in the 21st century.,0
1074,7,Which ones are the ESKAPE organisms?,"Although bacteremias caused by the 6 ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) have recently been highlighted as a serious complication in solid organ transplant (SOT), more information is urgently needed.",1
1074,8,Which ones are the ESKAPE organisms?,"Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",1
1074,9,Which ones are the ESKAPE organisms?,"Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",1
1074,10,Which ones are the ESKAPE organisms?,- is of particular concern because they are responsible for many serious infections in hospitals.,0
1573,0,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"The clinical entity was a unique combination of levodopa-resistant parkinsonism, tremor, myoclonus, hallucinations, REM sleep behavior disorder and fronto-subcortical dementia.",1
1573,1,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"Based on the presence or the absence of supranuclear gaze palsy, two subgroups of patients were distinguished.",1
1573,2,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"One-half of the patients with this tauopathy have dopa-resistant parkinsonism, tremor, subcortical dementia and abnormal eye movements suggestive of progressive supranuclear palsy (PSP).",1
1573,3,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"They also have hallucinations, dysautonomia, which are not characteristic of PSP.",0
1573,4,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"Furthermore, the oculomotor abnormalities and the tremor, which is jerky, differ from what is observed in classical PSP patients.",0
1573,5,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"In conclusion, Gd-PSP patients have cortical myoclonus and cortical oculomotor impairments, but only minor signs of brainstem oculomotor dysfunction, suggesting that cortical dysfunction predominates over brainstem impairments.",0
1573,6,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.",0
1573,7,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"STUDY OBJECTIVE: To describe sleep characteristics and rapid eye movement (REM) sleep behavior disorder in patients with Guadeloupean atypical parkinsonism (Gd-PSP), a tauopathy resembling progressive supranuclear palsy that mainly affects the midbrain.",0
1573,8,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"RESULTS: REM sleep behavior disorder was found in 78% patients with Gd-PSP (43% of patients reported having this disorder several years before the onset of parkinsonism), 44% of patients with idiopathic Parkinson disease, 33% of patients with progressive supranuclear palsy, and no controls.",1
1573,9,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"CONCLUSION: Although Gd-PSP is a tauopathy, most patients experience REM sleep behavior disorder.",0
1573,10,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Only one-third of the patients that develop parkinsonian symptoms were reported to present the classical features of idiopathic Parkinson disease and one-third a syndrome resembling progressive supranuclear palsy (PSP).,0
1573,11,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"Patients with a PSP-like syndrome developed levodopa-resistant parkinsonism, associated with early postural instability and supranuclear oculomotor dysfunction.",0
1573,12,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"They differed, however, from classical PSP patients by the frequency of tremor (>50%), dysautonomia (50%) and the occurrence of hallucinations (59%).",0
1573,13,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"PDC patients had levodopa-resistant parkinsonism associated with frontosubcortical dementia, 52% of these patients had hallucinations, but, importantly, none had oculomotor dysfunction.",0
1573,14,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"Cerebral atrophy was seen in the majority of the PSP-like and PDC patients, with enlargement of the third ventricle and marked T2-hypointensity in the basal ganglia, particularly the substantia nigra.",0
1573,15,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Consumption of soursop was significantly greater in both PSP-like and PDC patients than in controls and Parkinson's disease patients.,0
1573,16,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"In conclusion, atypical Guadeloupean parkinsonism comprises two forms of parkinsonism and dementia that differ clinically by the presence of oculomotor signs, but have similar cognitive profiles and neuroimaging features, suggesting that they may constitute a single disease entity, and both were similarly exposed to annonaceous neurotoxins, notably annonacin.",0
1573,17,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.,0
1573,18,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"Postural instability with early falls, prominent frontal lobe dysfunction and pseudo-bulbar palsy were common and three-quarters of the patients were L-dopa unresponsive.",0
1573,19,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,One-third of all patients seen had probable progressive supranuclear palsy (PSP).,0
1573,20,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Guadeloupean parkinsonism may prove to be a tauopathy identical or closely related to PSP.,0
1573,21,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.,0
1573,22,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.," Now on Guadeloupe in the Carribbean French West Indies, Caparros-Lefebvre is identifying many patients with similar clinical and histological features.",0
1573,23,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,": On Guadeloupe, atypical parkinsonism is abnormally frequent, and represents 75% of progressive parkinsonism while Parkinson's disease (PD) accounts for only 25%, which is an inversed percentage in comparison with Europe.",0
1573,24,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"On the French West Indian island of Guadeloupe, atypical parkinsonian patients represent two-thirds of all cases of parkinsonism, which is exceptionally frequent compared to epidemiological data from European countries where atypical parkinsonism accounts for only approximately 5% of all cases.",0
1573,25,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis.,0
1573,26,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"In Guadeloupe, there is an abnormally high frequency of atypical parkinsonism.",0
1573,27,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?,0
1573,28,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Atypical parkinsonism is extremely frequent in Guadeloupe and may have an environmental cause.,0
1573,29,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin.,0
1573,30,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"The development of atypical parkinsonism in Guadeloupe and probably elsewhere, could result from synergistic toxicity, but acetogenins are probably the most potent neurotoxin, acting as mitochondrial complex I inhibitor.",0
1573,31,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses.",1
1573,32,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"Two hundred and twenty consecutive patients with Parkinson's syndrome seen by the neurology service at Pointe à Pitre, Guadeloupe University Hospital were studied.",0
1573,33,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,We characterize the clinical features of Parkinson&apos;s syndrome on Guadeloupe and describe possible environmental causes.,0
1573,34,Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.,"The subjects were 265 patients with Parkinson&apos;s syndrome living on Guadeloupe,",0
2446,0,Which stapled peptide has been designed to target Ctf4?,"The Ctf4/AND-1 protein hub, which links DNA replication, repair, and chromosome segregation, represents a novel target for the synthetic lethality approach.",0
2446,1,Which stapled peptide has been designed to target Ctf4?,"Herein, we report the design, optimization, and validation of double-click stapled peptides encoding the Ctf4-interacting peptide (CIP) of the replicative helicase subunit Sld5.",1
2446,2,Which stapled peptide has been designed to target Ctf4?,"By screening stapling positions in the Sld5 CIP, we identified an unorthodox i,i+6 stapled peptide with improved, submicromolar binding to Ctf4.",0
2446,3,Which stapled peptide has been designed to target Ctf4?,The mode of interaction with Ctf4 was confirmed by a crystal structure of the stapled Sld5 peptide bound to Ctf4.,1
2446,4,Which stapled peptide has been designed to target Ctf4?,The stapled Sld5 peptide was able to displace the Ctf4 partner DNA polymerase α from the replisome in yeast extracts.,1
2446,5,Which stapled peptide has been designed to target Ctf4?,Our study provides proof-of-principle evidence for the development of small-molecule inhibitors of the human CTF4 orthologue AND-1.,0
2446,6,Which stapled peptide has been designed to target Ctf4?,"Herein, we report the design, optimization, and validation of double-click stapled peptides encoding the Ctf4-interacting peptide (CIP) of the replicative helicase subunit Sld5.",0
2446,7,Which stapled peptide has been designed to target Ctf4?,The stapled Sld5 peptide was able to displace the Ctf4 partner DNA polymerase α from the replisome in yeast extracts.,1
2446,8,Which stapled peptide has been designed to target Ctf4?,"By screening stapling positions in the Sld5 CIP, we identified an unorthodox i,i+6 stapled peptide with improved, submicromolar binding to Ctf4.",0
2446,9,Which stapled peptide has been designed to target Ctf4?,The stapled Sld5 peptide was able to displace the Ctf4 partner DNA polymerase α from the replisome in yeast extracts.,1
3117,0,Are there tools for visualizing and processing long-read sequencing data?,NanoPack: visualizing and processing long-read sequencing data.,1
3117,1,Are there tools for visualizing and processing long-read sequencing data?,"Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.Availability and implementation: The NanoPack tools are written in Python3 and released under the GNU GPL3.0 License.",1
3117,2,Are there tools for visualizing and processing long-read sequencing data?,"The source code can be found at https://github.com/wdecoster/nanopack, together with links to separate scripts and their documentation.",0
3117,3,Are there tools for visualizing and processing long-read sequencing data?,"The scripts are compatible with Linux, Mac OS and the MS Windows 10 subsystem for Linux and are available as a graphical user interface, a web service at http://nanoplot.bioinf.be and command line tools.",1
3117,4,Are there tools for visualizing and processing long-read sequencing data?,"Summary
Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.",0
3117,5,Are there tools for visualizing and processing long-read sequencing data?,NanoPack: visualizing and processing long-read sequencing data.Supplementary data are available at Bioinformatics online.,1
3117,6,Are there tools for visualizing and processing long-read sequencing data?,"<b>Summary</b>: Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.<br><b>Availability and implementation</b>: The NanoPack tools are written in Python3 and released under the GNU GPL3.0 License.",0
3117,7,Are there tools for visualizing and processing long-read sequencing data?,"Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.",1
3969,0,Which epigenetic marks are deposited by PRC1?," In Arabidopsis thaliana, LHP1 co-localizes with H3K27me3 epigenetic marks throughout the genome and interacts with PRC1 and PRC2 members as well as with a long noncoding RNA.",0
3969,1,Which epigenetic marks are deposited by PRC1?,When cells enter senescence the binding to RD of both PRC1 and PRC2 complexes is lost leading to a decreased level of histone H3K27 trimethylation (H3K27me3).,1
3969,2,Which epigenetic marks are deposited by PRC1?,"PRC2 induces histone H3 lysine 27 (H3K27) trimethylation (H3K27me3), which is subsequently read by PRC1 that further catalyzes H2A monoubiquitination (H2Aub1), creating a transcriptional silent chromatin conformation.",1
3969,3,Which epigenetic marks are deposited by PRC1?,"Histone H2A monoubiquitination (H2Aub1), catalyzed by Polycomb-Repressive Complex1 (PRC1), is a key epigenetic mark in Polycomb silencing.",1
3969,4,Which epigenetic marks are deposited by PRC1?,"For a long time, the PcG mechanism has been proposed to follow a hierarchical recruitment of PcG repressive complexes (PRCs) to target genes in which the binding of PRC2 and the incorporation of H3 lysine 27 trimethyl marks led to recruitment of PRC1, which in turn mediated H2A monoubiquitination.",1
3969,5,Which epigenetic marks are deposited by PRC1?,"Histone H2A monoubiquitination (H2Aub1), catalyzed by Polycomb-Repressive Complex1 (PRC1), is a key epigenetic mark in Polycomb silencing.",1
3969,6,Which epigenetic marks are deposited by PRC1?,Ho,0
3969,7,Which epigenetic marks are deposited by PRC1?,"Intriguingly, many promoters were co-regulated by all three histone marks, becoming hypermethylated with loss of H3K4me3 or H3K27me3 and hypomethylated with depletion of H2AK119ub, and many of these co-regulated loci were among those commonly targeted for aberrant hypermethylation in cancer.",0
1879,0,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"A unique member of this family, Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox), respectively, the latter of which is functional in vascular smooth muscle cells (VSMC).",0
1879,1,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1.,0
1879,2,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Superoxide production by Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1 (Nox activator 1) and is markedly enhanced upon cell stimulation with phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC).",0
1879,3,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Noxa1, an interaction that participates in Nox1 activation.",0
1879,4,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production.",0
1879,5,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Furthermore, Ser154 in Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1.",0
1879,6,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1;,0
1879,7,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1 activity in different manners.,0
1879,8,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"The activity of other Nox enzymes such as gp91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47(phox) or Noxo1) andanactivatorprotein (p67(phox) or Noxa1); for the p47(phox)-dependent activation of these oxidases, treatment of cells with stimulants such as phorbol 12-myristate 13-acetate is also indispensable.",0
1879,9,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Studies of cytosolic co-factors showed that the C-terminal cytoplasmic domain of NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1.,0
1879,10,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Additionally, NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1.",1
1879,11,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1.",0
1879,12,Which NADPH oxidase family member requires interaction with NOXO1 for function?,NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation.,0
1879,13,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Activation of the superoxide-producing NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.,1
1879,14,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and NOXA1 (NOX activating protein 1), as well as the flavocytochrome component p22(phox) for maximal activity.",0
1879,15,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Activation of Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67phox, designated Noxo1 and Noxa1, respectively.",0
1879,16,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Molecular interaction of NADPH oxidase 1 with betaPix and Nox Organizer 1.,1
1879,17,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Reactive oxygen species (ROS) production by NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1",0
1879,18,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and NOXA1 (NOX activating protein 1), as well as the flavocytochrome component p22(phox) for maximal activity",0
1879,19,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Activation of the superoxide-producing NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1,1
1879,20,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",0
1879,21,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1 activator 1, and Rac1",1
1879,22,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"UNLABELLED: Superoxide production by Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1 (Nox activator 1) and is markedly enhanced upon cell stimulation with phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC).",0
1879,23,Which NADPH oxidase family member requires interaction with NOXO1 for function?,The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.,0
1879,24,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Studies of cytosolic co-factors showed that the C-terminal cytoplasmic domain of NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1.,0
1879,25,Which NADPH oxidase family member requires interaction with NOXO1 for function?,Nox activator 1 (NoxA1) is a homologue of p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1.,0
1879,26,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1, as well as the binding of Rac1 GTPase, for its activity.",0
1879,27,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1 GTPase, for its activity.",0
1879,28,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Reactive oxygen species (ROS) production by NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1.",0
1879,29,Which NADPH oxidase family member requires interaction with NOXO1 for function?,"Superoxide production by Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1 (Nox activator 1) and is markedly enhanced upon cell stimulation with phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC).",0
847,0,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,These mutations were frequent in plasmid-borne lacS expressed at a high level but not in single-copy lacS in the chromosome or at lower levels of expression in a plasmid.,0
847,1,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"The results suggest that important DNA repair or replication fidelity functions are impaired or overwhelmed in pJlacS, with results analogous to those of the ""transcription-associated mutagenesis"" seen in bacteria and eukaryotes.",0
847,2,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,the rate of point mutation in a gene increases with the expression level of the gene.,1
847,3,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"Transcription induces mutagenesis on both DNA strands, indicating simultaneous actions of several TAM mechanisms.",0
847,4,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"High-levels of transcription through a gene stimulate spontaneous mutation rate, a phenomenon termed transcription-associated mutation (TAM).",1
847,5,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"High levels of transcription in Saccharomyces cerevisiae are associated with increased genetic instability, which has been linked to DNA damage.",0
847,6,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"Here, we describe a pGAL-CAN1 forward mutation assay for studying transcription-associated mutagenesis (TAM) in yeast.",0
847,7,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,The acquisition of mutations was directly correlated to the level of transcription,0
847,8,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,Our results demonstrate that the level of Leu(+) reversions increased significantly in parallel with the induced increase in transcription levels.,0
847,9,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,Transcription-associated mutagenesis in yeast is directly proportional to the level of gene expression,1
847,10,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"spontaneous mutation rate is directly proportional to the transcription level, suggesting that movement of RNA polymerase through the target initiates a mutagenic process(es)",1
847,11,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"High transcription is associated with genetic instability, notably increased spontaneous mutation rates, which is a phenomenon termed Transcription-Associated-Mutagenesis (TAM).",0
847,12,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"Using this system, we also investigated two hypotheses that have been proposed to explain transcription-associated mutagenesis (TAM): (1) transcription impairs replication fork progression in a directional manner and (2) DNA lesions accumulate under high-transcription conditions.",0
847,13,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,Transcription-associated mutagenesis in yeast is directly proportional to the level of gene expression and influenced by the direction of DNA replication.,1
847,14,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"High levels of transcription in Saccharomyces cerevisiae are associated with increased genetic instability, which has been linked to DNA damage.",0
847,15,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"Using this system, we also investigated two hypotheses that have been proposed to explain transcription-associated mutagenesis (TAM): (1) transcription impairs replication fork progression in a directional manner and (2) DNA lesions accumulate under high-transcription conditions.",0
847,16,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"Using comparative genomics of related species as well as mutation accumulation lines, we show in yeast that the rate of point mutation in a gene increases with the expression level of the gene",0
847,17,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"High transcription is associated with genetic instability, notably increased spontaneous mutation rates, which is a phenomenon termed Transcription-Associated-Mutagenesis (TAM)",0
847,18,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"Using this system, we also investigated two hypotheses that have been proposed to explain transcription-associated mutagenesis (TAM): (1) transcription impairs replication fork progression in a directional manner and (2) DNA lesions accumulate under high-transcription conditions",0
847,19,Is transcription-associated mutagenesis (TAM) related to gene expression levels?,"High-levels of transcription through a gene stimulate spontaneous mutation rate, a phenomenon termed transcription-associated mutation (TAM)",0
3728,0,Which cells mature in the human thymus?,Late stages of T cell maturation in the thymus involve NF-κB and tonic type I interferon signaling.,1
3728,1,Which cells mature in the human thymus?,NF-κB and tonic interferon signals are involved in the final maturation of thymocytes into naive T cells.,1
3728,2,Which cells mature in the human thymus?,The inhibition of dopamine synthesis in fetuses changes the pattern of T-lymphocyte maturation in the thymus of adult rats.,0
3728,3,Which cells mature in the human thymus?, Pharmacological inhibition of catecholamine synthesis in the crucial period of thymus development leads to long-term changes in the T-system immunity due to increased production of natural regulatory T-lymphocytes.,0
3728,4,Which cells mature in the human thymus?,Role of the MHC restriction during maturation of antigen-specific human T cells in the thymus.,1
3728,5,Which cells mature in the human thymus?,This first ex vivo analysis of human antigen-specific thymocytes at different stages of human T-cell development should open new perspectives in the understanding of the human thymic selection process.,0
3728,6,Which cells mature in the human thymus?,CD44 promotes progenitor homing into the thymus and T cell maturation.,0
3728,7,Which cells mature in the human thymus?,Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP.,1
3728,8,Which cells mature in the human thymus?,Effects of nicotine exposure on T cell development in fetal thymus organ culture: arrest of T cell maturation.,0
3728,9,Which cells mature in the human thymus?,"Furthermore, d-tubocurarine alone blocked the development of both immature and mature murine thymocytes, suggesting the presence of an endogenous ligand that may engage nicotinic acetylcholine receptors on developing thymocytes and influence the course of normal thymic ontogeny.",0
3728,10,Which cells mature in the human thymus?,"However, both DP T cell subsets have an intrathymic origin since they appear in the recent thymic emigrant population after injection of FITC intrathymically.",0
3728,11,Which cells mature in the human thymus?,T-cell maturation in the human thymus and tonsil,1
3728,12,Which cells mature in the human thymus?,Expression of the HPV16E7 oncoprotein by thymic epithelium is accompanied by disrupted T cell maturation and a failure of the thymus to involute with age.,0
3728,13,Which cells mature in the human thymus?,Thymocytes with reduced levels of expression of CD4 and/or CD8 were more abundant in transgenic (tg) mice and became increasingly more so with age.,0
3754,0,"Glucoraphanin from broccoli can help reduce obesity , yes or no?",Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.,1
3754,1,"Glucoraphanin from broccoli can help reduce obesity , yes or no?","A recent study demonstrated that glucoraphanin, a precursor of the Nrf2 activator sulforaphane, ameliorates obesity by enhancing energy expenditure and browning of white adipose tissue, and attenuates obesity-related inflammation and insulin resistance by polarizing M2 macrophages and reducing metabolic endotoxemia.",1
3754,2,"Glucoraphanin from broccoli can help reduce obesity , yes or no?","Thus, this review focuses on the efficiency and safety of glucoraphanin in alleviating obesity, insulin resistance, and NAFLD.",0
3754,3,"Glucoraphanin from broccoli can help reduce obesity , yes or no?",Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance,1
3754,4,"Glucoraphanin from broccoli can help reduce obesity , yes or no?","tudy demonstrated that glucoraphanin, a precursor of the Nrf2 activator sulforaphane, ameliorates obesity by enhancing energy expenditure and browning of white adipose tissue, and attenuates obesity-related inflammation and insulin resistance by polarizing M2 macrophages and reducing metabolic endotoxemia.",1
3754,5,"Glucoraphanin from broccoli can help reduce obesity , yes or no?","Thus, this",0
3754,6,"Glucoraphanin from broccoli can help reduce obesity , yes or no?","iew focuses on the efficiency and safety of glucoraphanin in alleviating obesity, insulin resistance, and NAFLD.",1
3754,7,"Glucoraphanin from broccoli can help reduce obesity , yes or no?",Abbreviations:,0
4182,0,Describe MSstatsTMT,MSstatsTMT: Statistical Detection of Differentially Abundant Proteins in Experiments with Isobaric Labeling and Multiple Mixtures.,1
4182,1,Describe MSstatsTMT,This manuscript proposes a general statistical approach for relative protein quantification in MS- based experiments with TMT labeling.,1
4182,2,Describe MSstatsTMT,"It is applicable to experiments with multiple conditions, multiple biological replicate runs and multiple technical replicate runs, and unbalanced designs.",1
4182,3,Describe MSstatsTMT,It is based on a flexible family of linear mixed-effects models that handle complex patterns of technical artifacts and missing values.,0
4182,4,Describe MSstatsTMT,"The approach is implemented in MSstatsTMT, a freely available open-source R/Bioconductor package compatible with data processing tools such as Proteome Discoverer, MaxQuant, OpenMS, and SpectroMine.",1
4182,5,Describe MSstatsTMT,"Evaluation on a controlled mixture, simulated datasets, and three biological investigations with diverse designs demonstrated that MSstatsTMT balanced the sensitivity and the specificity of detecting differentially abundant proteins, in large-scale experiments with multiple biological mixtures.",1
2531,0,List symptoms of Heerfordt syndrome.,Case 3 showed Heerfordt syndrome with facial nerve paralysis.,0
2531,1,List symptoms of Heerfordt syndrome.,"Heerfordt's syndrome is defined as a combination of facial palsy, parotid swelling, uveitis and fever in sarcoidosis cases.",0
2531,2,List symptoms of Heerfordt syndrome.,"Heerfordt-Waldenström syndrome, a rare presentation of sarcoidosis, is characterized by the presence of parotid gland enlargement, facial palsy, anterior uveitis, and fever.",1
2531,3,List symptoms of Heerfordt syndrome.,"The patient was given a diagnosis of Heerfordt-Waldenström syndrome, or uveoparotid fever.",0
2531,4,List symptoms of Heerfordt syndrome.,"Physical examination revealed right facial paralysis, parotid gland swelling, high fever and poor general condition.",0
2531,5,List symptoms of Heerfordt syndrome.,Ophthalmoscopy revealed anterior and posterior uveitis including macular edema and chorioretinal infiltrates.,0
2531,6,List symptoms of Heerfordt syndrome.,Angiography revealed a dense pattern of hyperfluorescent lesions and these observations resulted in the diagnosis of Heerfordt syndrome.,0
2531,7,List symptoms of Heerfordt syndrome.,"BACKGROUND: Heerfordt syndrome is rare and is characterized by fever, uveitis, parotid gland enlargement, and facial nerve palsy.",1
2531,8,List symptoms of Heerfordt syndrome.,"Heerfordt's syndrome with uveitis, enlargement of the parotid glands and optional paralysis of the Nn.",0
2531,9,List symptoms of Heerfordt syndrome.,facialis is a form of sarcoidosis.,0
2531,10,List symptoms of Heerfordt syndrome.,"The Heerfordt syndrome is characterized by fever, uveitis, swelling of parotid gland and facial nerve palsy, and 53 cases have been reported in Japan until 2000.",0
2531,11,List symptoms of Heerfordt syndrome.,"The Heerfordt syndrome is characterized by fever, uveitis, swelling of parotid gland and facial nerve palsy, and 53 cases have been reported in Japan until 2000.",0
2531,12,List symptoms of Heerfordt syndrome.,"Heerfordt syndrome is an unusual manifestation of systemic sarcoidosis and is characterized by parotitis, uveitis, and facial nerve paralysis.",0
2531,13,List symptoms of Heerfordt syndrome.,Heerfordt syndrome is a rare manifestation of neurosarcoidosis and has to be included in the differential diagnosis of facial nerve palsy.,0
2531,14,List symptoms of Heerfordt syndrome.,"Heerfordt syndrome is rare and is characterized by fever, uveitis, parotid gland enlargement, and facial nerve palsy.",1
2531,15,List symptoms of Heerfordt syndrome.,Heerfordt syndrome with unilateral facial nerve palsy: a rare presentation of sarcoidosis.,0
2531,16,List symptoms of Heerfordt syndrome.,"<b>BACKGROUND</b>: Heerfordt syndrome is rare and is characterized by fever, uveitis, parotid gland enlargement, and facial nerve palsy.",0
2531,17,List symptoms of Heerfordt syndrome.,"We hereby present a case of Heerfordt syndrome with unilateral facial nerve palsy as a presentation of sarcoidosis.<br><b>HISTORY AND SIGNS</b>: A 29-year-old male patient from Sri Lanka presented with eye redness OU, blurred vision OD, fever, headache, night sweat, fatigue, and weight loss (5 kg over 1 month).",0
2531,18,List symptoms of Heerfordt syndrome.,"One year after onset of treatment, no recurrence was noted.<br><b>CONCLUSIONS</b>: Heerfordt syndrome is a rare manifestation of neurosarcoidosis and has to be included in the differential diagnosis of facial nerve palsy.<br>",0
2531,19,List symptoms of Heerfordt syndrome.,"Heerfordt's syndrome (HS) consists in its complete form of uveitis, parotid or salivary gland enlargement and cranial nerve palsy.",0
2531,20,List symptoms of Heerfordt syndrome.,"However, the otolaryngologist may encounter Heerfordt's syndrome as this syndrome presents with facial nerve palsy and swelling of the parotid gland.",0
2531,21,List symptoms of Heerfordt syndrome.,"Heerfordt's syndrome is a rare manifestation of sarcoidosis characterized by the presence of facial nerve palsy, parotid gland enlargement, anterior uveitis, and low grade fever.",1
2531,22,List symptoms of Heerfordt syndrome.,"As a subtype of the clinical presentations associated with sarcoidosis, the combination of uveitis, parotid gland swelling, and facial nerve palsy is known as Heerfordt's syndrome.",0
2531,23,List symptoms of Heerfordt syndrome.,Heerfordt's syndrome as a cause of facial palsy is very rare.,0
2531,24,List symptoms of Heerfordt syndrome.,"Heerfordt's syndrome is a rare manifestation of sarcoidosis and is defined as a combination of facial palsy, parotid swelling, and uveitis, associated with a low-grade fever.",0
2531,25,List symptoms of Heerfordt syndrome.,Heerfordt's Syndrome Presenting with Recurrent Facial Nerve Palsy:,0
2531,26,List symptoms of Heerfordt syndrome.,"BACKGROUND Heerfordt syndrome is rare and is characterized by fever, uveitis, parotid gland enlargement, and facial nerve palsy.",1
2531,27,List symptoms of Heerfordt syndrome.,We hereby present a case of Heerfordt syndrome with unilateral facial nerve palsy as a presentation of sarcoidosis.,0
439,0,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"α-Synuclein is the major protein associated with Lewy body dementia, Parkinson's disease and multiple system atrophy.",0
439,1,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"With the aim to develop antibodies showing high specificity and sensitivity for disease-associated α-synuclein, synthetic peptides containing different amino acid sequences were used for immunization of mice.",0
439,2,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,Parkinson's disease and dementia with Lewy bodies are very frequent neurological disorders of the elderly.,0
439,3,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"Mutations in the alpha-synuclein (alphaSYN) gene cause Parkinson's disease, often associated with dementia.",0
439,4,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"Neuropathologically these diseases are characterized by the presence of Lewy bodies and Lewy neurites, intraneuronal inclusions mostly composed of alphaSYN protein fibrils.",1
439,5,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).,0
439,6,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,We immunohistochemically investigated the degeneration processes of the nigro-striatal and nigro-amygdaloid pathways and the relationship between the loss of dopaminergic neurons and Lewy bodies (LB) formation in the substantia nigra using 15 autopsied cases of dementia with Lewy bodies (DLB).,0
439,7,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.",0
439,8,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"The major protein constituent of Lewy bodies (LBs), the pathological hallmark of Parkinson disease and dementia with Lewy bodies, is considered to be alpha-synuclein,",1
439,9,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"Recently, alpha-synuclein (alphaS) has been found to be a central constituent of LB.",0
439,10,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"By having the antibody AFshp raised specifically to alpha-synuclein to label Parkinson disease-specific Lewy bodies and Lewy neurites as well as synaptic boutons containing the unaltered protein, an initial attempt is made to map the overall distribution pattern and describe the staining behavior of the immunoreactive punctae in select regions of the prosencephalon.",0
439,11,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"Notably, carboxy-terminal alpha-syn epitopes were immunodominant in GCIs, but the entire panel of antibodies immunostained cortical Lewy bodies (LBs) in dementia with LBs brain with similar intensity.",0
439,12,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"Discrete immunostaining was demonstrated in NFTs and neuropil threads with various antibodies against phosphorylated tau, and in LBs with antibody against alpha-synuclein.",0
439,13,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,The identification of the alpha-synuclein gene on chromosome 4q as a locus for familial Lewy-body parkinsonism and of alpha-synuclein as a component of Lewy bodies has heralded a new era in the study of Parkinson's disease.,1
439,14,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease,0
439,15,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,recent advances in immunostaining of alpha-synuclein have suggested the possible importance of cortical Lewy bodies (CLBs) in the brains of demented patients with PD.,0
439,16,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,CLBs positive for alpha-synuclein are highly sensitive (91%) and specific (90%) neuropathologic markers of dementia in PD,0
439,17,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,CLBs detected by alpha-synuclein antibodies in patients with PD are a more sensitive and specific correlate of dementia,0
439,18,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,alpha-Synuclein immunoreactivity in dementia with Lewy bodies,0
439,19,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.,1
439,20,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles.,0
439,21,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as alpha-synuclein) is a presynaptic terminal molecule that abnormally accumulates in the plaques of Alzheimer's disease (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffuse Lewy body disease, and Parkinson's disease.",1
439,22,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"To better understand the distribution of NACP/alpha-synuclein and its fragments in the LB-bearing neurons and neurites, as well as to clarify the patterns of NACP/alpha-synuclein compartmentalization, we studied NACP/alpha-synuclein immunoreactivity using antibodies against the C-terminal, N-terminal, and NAC regions after Proteinase K and formic acid treatment in the cortex of patients with LBs.",0
439,23,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,Ultrastructural analysis revealed that NACP/alpha-synuclein immunoreactivity was diffusely distributed within the amorphous electrodense material in the LBs and as small clusters in the filaments of LBs and neurites.,0
439,24,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,These results support the view that aggregated NACP/alpha-synuclein might play an important role in the pathogenesis of disorders associated with LBs.,0
439,25,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity,0
439,26,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"PD brain demonstrated alpha-synuclein immunoreactivity in nigral Lewy bodies, pale bodies and abnormal neurites.",0
439,27,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,DLB cases demonstrated these findings as well as alpha-synuclein immunoreactivity in cortical Lewy bodies and CA2-3 neurites.,0
439,28,Against which protein is the antibody used for immonostaining of Lewy bodies raised?,"These results suggest that, even in sporadic cases, there is an early and direct role for alpha-synuclein in the pathogenesis of PD and the neuropathologically related disorder DLB.",0
2021,0,Is siltuximab effective for Castleman disease?,Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease.,0
2021,1,Is siltuximab effective for Castleman disease?,"The recent approvals in North America, Europe and Brazil of siltuximab, a monoclonal antibody against IL-6, for iMCD now provide a safe and effective therapy that targets a key aspect of pathogenesis.",0
2021,2,Is siltuximab effective for Castleman disease?,"In the first ever randomized, placebo-controlled trial in iMCD, siltuximab significantly reduced disease burden and symptoms in a large portion (34%) of patients.",0
2021,3,Is siltuximab effective for Castleman disease?,"Despite recent significant advances in our understanding of this disease and the increasing therapeutic experience with rituximab, tocilizumab and siltuximab, there are still difficult questions concerning its aetiology, prognosis and optimal treatment.",0
2021,4,Is siltuximab effective for Castleman disease?,Emerging treatments in Castleman disease - a critical appraisal of siltuximab.,0
2021,5,Is siltuximab effective for Castleman disease?," Siltuximab, a chimeric monoclonal antibody to IL-6, has thus emerged as a promising treatment option in a disease lacking efficacious therapy.",0
2021,6,Is siltuximab effective for Castleman disease?,"Here, we review the findings of recent studies evaluating single-agent siltuximab treatment in CD, including the first-ever randomized clinical trial in this disease.",0
2021,7,Is siltuximab effective for Castleman disease?,"Although much more work is needed to establish a standardized treatment approach, siltuximab appears to be a safe and effective treatment for patients with newly diagnosed and previously treated CD.",0
2021,8,Is siltuximab effective for Castleman disease?,FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease.,0
2021,9,Is siltuximab effective for Castleman disease?,"On April 22, 2014, the FDA granted full approval to siltuximab (SYLVANT for injection; Janssen Biotech, Inc.), a chimeric human-mouse monoclonal antibody to IL6, for the treatment of patients with multicentric Castleman disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.",1
2021,10,Is siltuximab effective for Castleman disease?,"Currently, there are more effective therapeutic alternatives in multicentric Castleman disease: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-IL-6 (siltuximab) or against its receptor (tocilizumab).",0
2021,11,Is siltuximab effective for Castleman disease?,"Currently, there are more effective therapeutic alternatives in multicentric Castleman disease: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-IL-6 (siltuximab) or against its receptor (tocilizumab).",0
2021,12,Is siltuximab effective for Castleman disease?,Siltuximab for multicentric Castleman disease.,0
2021,13,Is siltuximab effective for Castleman disease?,Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease.,0
2021,14,Is siltuximab effective for Castleman disease?,Siltuximab (IL6 antibody) is approved for the treatment of multicentric Castleman disease (MCD).,1
2021,15,Is siltuximab effective for Castleman disease?,"A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease.",0
2021,16,Is siltuximab effective for Castleman disease?,"A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease.",0
2021,17,Is siltuximab effective for Castleman disease?,"Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease.",0
2021,18,Is siltuximab effective for Castleman disease?,Siltuximab (Sylvant).,0
2021,19,Is siltuximab effective for Castleman disease?,Castleman's disease: good symptomatic efficacy in some patients.,0
2021,20,Is siltuximab effective for Castleman disease?,Siltuximab: a new option for the management of Castleman's disease.,0
2021,21,Is siltuximab effective for Castleman disease?,"Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease.",0
2021,22,Is siltuximab effective for Castleman disease?,"PURPOSE: To evaluate the safety and pharmacokinetics of siltuximab, an anti-interleukin-6 chimeric monoclonal antibody (mAb) in patients with B-cell non-Hodgkin lymphoma (NHL), multiple myeloma, or Castleman disease.EXPERIMENTAL DESIGN: In an open-label, dose-finding, 7 cohort, phase I study, patients with NHL, multiple myeloma, or symptomatic Castleman disease received siltuximab 3, 6, 9, or 12 mg/kg weekly, every 2 weeks, or every 3 weeks.",0
2021,23,Is siltuximab effective for Castleman disease?,Dose selection of siltuximab for multicentric Castleman's disease.,0
2021,24,Is siltuximab effective for Castleman disease?,"Here, modeling and simulation of the pharmacokinetic (PK)/pharmacodynamic (PD) relationship between siltuximab and CRP were used to support dose selection for multicentric Castleman's disease (CD).METHODS: PK/PD modeling was applied to explore the relationship between siltuximab PK and CRP suppression following intravenous siltuximab infusion in 47 patients with B cell non-Hodgkin's lymphoma (n = 17), multiple myeloma (n = 13), or CD (n = 17).",0
2021,25,Is siltuximab effective for Castleman disease?,"Currently, there are more effective therapeutic alternatives in multicentric Castleman disease: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-IL-6 (siltuximab) or against its receptor (tocilizumab)",0
2021,26,Is siltuximab effective for Castleman disease?,"Three (6%) of 53 patients had serious adverse events judged reasonably related to siltuximab (lower respiratory tract infection, anaphylactic reaction, sepsis).Siltuximab plus best supportive care was superior to best supportive care alone for patients with symptomatic multicentric Castlemans disease and well tolerated with prolonged exposure",0
2021,27,Is siltuximab effective for Castleman disease?,"Siltuximab, an anti-IL-6 monoclonal antibody, has demonstrated durable tumor and symptomatic responses in a multinational, randomized, placebo-controlled study of MCD.This preplanned safety analysis was conducted to evaluate the long-term safety of siltuximab treatment among 19 patients with MCD who had stable disease or better and were enrolled in a phase-1 study and subsequent ongoing, open-label, phase-2 extension study",0
2021,28,Is siltuximab effective for Castleman disease?,"Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease",0
2021,29,Is siltuximab effective for Castleman disease?,Siltuximab (IL6 antibody) is approved for the treatment of multicentric Castleman disease (MCD),1
2021,30,Is siltuximab effective for Castleman disease?,Siltuximab for multicentric Castleman disease,0
2021,31,Is siltuximab effective for Castleman disease?,FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease,0
2021,32,Is siltuximab effective for Castleman disease?,"On April 22, 2014, the FDA granted full approval to siltuximab (SYLVANT for injection; Janssen Biotech, Inc.), a chimeric human-mouse monoclonal antibody to IL6, for the treatment of patients with multicentric Castleman disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative",1
2021,33,Is siltuximab effective for Castleman disease?,"Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.",0
2021,34,Is siltuximab effective for Castleman disease?,"EXPERIMENTAL DESIGN: In an open-label, dose-finding, 7 cohort, phase I study, patients with NHL, multiple myeloma, or symptomatic Castleman disease received siltuximab 3, 6, 9, or 12 mg/kg weekly, every 2 weeks, or every 3 weeks.",0
2021,35,Is siltuximab effective for Castleman disease?,"Currently, there are more effective therapeutic alternatives in multicentric Castleman disease: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-IL-6 (siltuximab) or against its receptor (tocilizumab).",0
2021,36,Is siltuximab effective for Castleman disease?,"To evaluate the safety and pharmacokinetics of siltuximab, an anti-interleukin-6 chimeric monoclonal antibody (mAb) in patients with B-cell non-Hodgkin lymphoma (NHL), multiple myeloma, or Castleman disease.In an open-label, dose-finding, 7 cohort, phase I study, patients with NHL, multiple myeloma, or symptomatic Castleman disease received siltuximab 3, 6, 9, or 12 mg/kg weekly, every 2 weeks, or every 3 weeks.",0
2021,37,Is siltuximab effective for Castleman disease?,"On April 22, 2014, the FDA granted full approval to siltuximab (SYLVANT for injection; Janssen Biotech, Inc.), a chimeric human-mouse monoclonal antibody to IL6, for the treatment of patients with multicentric Castleman disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.",1
2021,38,Is siltuximab effective for Castleman disease?,"Clinical benefit response (CBR; composite of hemoglobin, fatigue, anorexia, fever/night sweats, weight, largest lymph node size) was also evaluated in Castleman disease.Sixty-seven patients received a median of 16 siltuximab doses for a median of 8.5 (maximum 60.5) months; 29 were treated 1 year or longer.",0
2021,39,Is siltuximab effective for Castleman disease?,"The recent approvals in North America, Europe and Brazil of siltuximab, a monoclonal antibody against IL-6, for iMCD now provide a safe and effective therapy that targets a key aspect of pathogenesis.",0
2021,40,Is siltuximab effective for Castleman disease?,"Although much more work is needed to establish a standardized treatment approach, siltuximab appears to be a safe and effective treatment for patients with newly diagnosed and previously treated CD.",0
2021,41,Is siltuximab effective for Castleman disease?,"No dose-limiting toxicity was reported, and only three patients had grade 3 or higher adverse events after a median exposure of 331 days (range, 1 to 1,148 days).These interim results strongly suggest that siltuximab is an effective treatment with favorable safety for the management of CD.",0
2021,42,Is siltuximab effective for Castleman disease?,"Siltuximab is a new anti-IL-6, chimeric monoclonal antibody with potential therapeutic benefit in patients with CD.METHODS: We report interim results from an open-label, dose-finding, seven-cohort, phase I study in which patients with symptomatic, multicentric or unresectable, unicentric CD received siltuximab at 1-, 2-, or 3-week intervals.",0
2021,43,Is siltuximab effective for Castleman disease?,Siltuximab for multicentric Castleman disease.,0
2021,44,Is siltuximab effective for Castleman disease?,Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease.,0
2021,45,Is siltuximab effective for Castleman disease?,Emerging treatments in Castleman disease - a critical appraisal of siltuximab.,0
2021,46,Is siltuximab effective for Castleman disease?,Siltuximab (Sylvant).,0
2021,47,Is siltuximab effective for Castleman disease?,Castleman's disease: good symptomatic efficacy in some patients.,0
2021,48,Is siltuximab effective for Castleman disease?,Siltuximab: a new option for the management of Castleman's disease.,0
2021,49,Is siltuximab effective for Castleman disease?,"Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.",0
2021,50,Is siltuximab effective for Castleman disease?,Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease.,0
1598,0,What type of DNA repair pathways is initiated by AlkA glycosylase?,The Escherichia coli 3-methyladenine DNA glycosylase II protein (AlkA) recognizes a broad range of oxidized and alkylated base lesions and catalyzes the hydrolysis of the N-glycosidic bond to initiate the base excision repair pathway.,1
1598,1,What type of DNA repair pathways is initiated by AlkA glycosylase?,"Schizosaccharomyces pombe has two paralogues of 3-methyladenine DNA glycosylase, Mag1p and Mag2p, which share homology with Escherichia coli AlkA.",0
1598,2,What type of DNA repair pathways is initiated by AlkA glycosylase?,To clarify the function of these redundant enzymes in base excision repair (BER) of alkylation damage,0
1598,3,What type of DNA repair pathways is initiated by AlkA glycosylase?,"Escherichia coli alkA tagA double mutants, which are deficient in the repair of alkylated bases.",0
1598,4,What type of DNA repair pathways is initiated by AlkA glycosylase?,"AlkA, a monofunctional DNA glycosylase that acts on alkylated bases, is structurally homologous to endo III.",0
1598,5,What type of DNA repair pathways is initiated by AlkA glycosylase?,We have now identified a shared active site motif amongst these three proteins.,0
1598,6,What type of DNA repair pathways is initiated by AlkA glycosylase?,"Using this motif as a protein database searching tool, we find that it is present in a number of other base-excision DNA repair proteins that process diverse lesions.",0
1598,7,What type of DNA repair pathways is initiated by AlkA glycosylase?,"Alkylation damage is removed by the action of DNA glycosylases, which initiate the base excision repair pathway",0
1598,8,What type of DNA repair pathways is initiated by AlkA glycosylase?,Enzymatic repair of 5-formyluracil.,0
1598,9,What type of DNA repair pathways is initiated by AlkA glycosylase?,I. Excision of 5-formyluracil site-specifically incorporated into oligonucleotide substrates by alka protein (Escherichia coli 3-methyladenine DNA glycosylase II).,0
1598,10,What type of DNA repair pathways is initiated by AlkA glycosylase?,"These results suggest that fU present in DNA can be restored by two independent repair pathways, i.e.",0
1598,11,What type of DNA repair pathways is initiated by AlkA glycosylase?,the base excision repair pathway initiated by AlkA and the methyl-directed mismatch repair pathway initiated by MutS.,0
1598,12,What type of DNA repair pathways is initiated by AlkA glycosylase?,3-Methyladenine DNA glycosylase II (AlkA) is a DNA-repair enzyme that removes alkylated bases in DNA via the base-excision repair (BER) pathway.,1
1598,13,What type of DNA repair pathways is initiated by AlkA glycosylase?,Mismatch formation between 5-formyluracil and guanine during dna replication and its recognition by two proteins involved in base excision repair (AlkA) and mismatch repair (MutS).,0
1598,14,What type of DNA repair pathways is initiated by AlkA glycosylase?,"These results suggest that fU present in DNA can be restored by two independent repair pathways, i.e.",0
1598,15,What type of DNA repair pathways is initiated by AlkA glycosylase?,the base excision repair pathway initiated by AlkA and the methyl-directed mismatch repair pathway initiated by MutS.,0
1598,16,What type of DNA repair pathways is initiated by AlkA glycosylase?,Base excision repair is initiated by DNA glycosylases removing inappropriate bases from DNA.,0
1598,17,What type of DNA repair pathways is initiated by AlkA glycosylase?,The Escherichia coli AlkA protein is a base excision repair glycosylase that removes a variety of alkylated bases from DNA.,1
1598,18,What type of DNA repair pathways is initiated by AlkA glycosylase?,Human alkyladenine glycosylase (AAG) and Escherichia coli 3-methyladenine glycosylase (AlkA) are base excision repair glycosylases that recognize and excise a variety of alkylated bases from DNA.,0
1598,19,What type of DNA repair pathways is initiated by AlkA glycosylase?,the base excision repair pathway initiated by AlkA and the methyl-directed mismatch repair pathway initiated by MutS,0
1598,20,What type of DNA repair pathways is initiated by AlkA glycosylase?,The Escherichia coli 3-methyladenine DNA glycosylase II protein (AlkA) recognizes a broad range of oxidized and alkylated base lesions and catalyzes the hydrolysis of the N-glycosidic bond to initiate the base excision repair pathway,1
1598,21,What type of DNA repair pathways is initiated by AlkA glycosylase?,"Alkylation damage is removed by the action of DNA glycosylases, which initiate the base excision repair pathway and protect the sequence information of the genome [3-5]",1
1598,22,What type of DNA repair pathways is initiated by AlkA glycosylase?,"The alkylbase DNA glycosylase, AlkA, initiates repair by removal of the damaged base, whereas endonuclease V, Endo V, hydrolyses the second phosphodiester bond 3' to the lesion",0
1598,23,What type of DNA repair pathways is initiated by AlkA glycosylase?,Base excision repair is initiated by DNA glycosylases removing inappropriate bases from DNA,0
1906,0,"What kind of analyses are performed with the software tool ""unipept""",Unipept is an open source web application that is designed for metaproteomics analysis with a focus on interactive datavisualization.,1
1906,1,"What kind of analyses are performed with the software tool ""unipept""","The Unique Peptide Finder (http://unipept.ugent.be/peptidefinder) is an interactive web application to quickly hunt for tryptic peptides that are unique to a particular species, genus, or any other taxon.",1
1906,2,"What kind of analyses are performed with the software tool ""unipept""","Computations are extremely fast since they are underpinned by the Unipept database, the lowest common ancestor algorithm implemented in Unipept and modern web technologies that facilitate in-browser data storage and parallel processing.",1
1906,3,"What kind of analyses are performed with the software tool ""unipept""",Unipept (http://unipept.ugent.be) is a web application that offers a user-friendly way to explore the biodiversity of complex metaproteome samples by providing interactive visualizations.,1
1906,4,"What kind of analyses are performed with the software tool ""unipept""",Outputted results are compatible with tools for taxonomic and functional characterization (e.g.,0
1906,5,"What kind of analyses are performed with the software tool ""unipept""","Unipept, MEGAN5)",0
1906,6,"What kind of analyses are performed with the software tool ""unipept""",The Unipept web application (http://unipept.ugent.be) supports biodiversity analysis of large and complex metaproteome samples using tryptic peptide information obtained from shotgun MS/MS experiments.,1
1495,0,List the neurotransmitters that are metabolized by MAOA., MAOA metabolizes monoamine neurotransmitters.,0
1495,1,List the neurotransmitters that are metabolized by MAOA.,"Monoamine oxidase A (MAOA) modulates metabolism of serotonin and dopamine metabolism, neurotransmitters involved in regulation of appetite and food intake.",1
1495,2,List the neurotransmitters that are metabolized by MAOA.,"Tumors from patients with high-grade aggressive prostate cancer (PCa) exhibit increased expression of monoamine oxidase A (MAOA), a mitochondrial enzyme that degrades monoamine neurotransmitters and dietary amines.",0
1495,3,List the neurotransmitters that are metabolized by MAOA.,"Monoamine oxidase A (MAOA) catalyzes monoamine neurotransmitters including dopamine, 5-hydroxytryptamine (5-HT, serotonin), and norepinephrine.",0
1495,4,List the neurotransmitters that are metabolized by MAOA.,"These traits are controlled by neurotransmitters like dopamine, serotonin and norepinephrine.",0
1495,5,List the neurotransmitters that are metabolized by MAOA.,"Monoamine oxidase A (MAOA), a mitochondrial enzyme involved in the degradation of amines, has been reported to be associated with aggression, impulsivity, depression, and mood changes.",0
1495,6,List the neurotransmitters that are metabolized by MAOA.,Monoamine Oxidase A (MAOA) is a critical enzyme in the catabolism of monoaminergic neurotransmitters.,1
1495,7,List the neurotransmitters that are metabolized by MAOA.,"Monoamine oxidases (MAO-A and MAO-B) have a key role in the degradation of amine neurotransmitters, such as dopamine, norepinephrine and serotonin.",1
1495,8,List the neurotransmitters that are metabolized by MAOA.,"Inhibitors of monoamine oxidase A (MAOA), a mitochondrial enzyme that degrades neurotransmitters including serotonin and norepinephrine, are commonly used to treat neurological conditions including depression.",1
1495,9,List the neurotransmitters that are metabolized by MAOA., Monoamine oxidase A (MAOA) is one of the major enzymes responsible for the degradation of neurotransmitters.,0
1495,10,List the neurotransmitters that are metabolized by MAOA.,Monoamine oxidase membrane enzymes are responsible for the catalytic breakdown of extra- and intracellular neurotransmitters,0
1495,11,List the neurotransmitters that are metabolized by MAOA., Monoamine oxidase-A (MAO-A) is a key mitochondrial enzyme that metabolizes biogenic amine neurotransmitters such as dopamine and serotonin,0
1495,12,List the neurotransmitters that are metabolized by MAOA.,"The monoamine oxidase-A (MAOA) gene plays a vital role in the metabolism of neurotransmitters, e.g, serotonin, norepinephrine, and dopamine.",1
85,0,Which transcription factor is considered as a master regulator of lysosomal genes?,"In this paper, we identify a novel role for Rags in controlling activation of transcription factor EB (TFEB), a master regulator of autophagic and lysosomal gene expression",0
85,1,Which transcription factor is considered as a master regulator of lysosomal genes?,"Interaction of TFEB with active Rag heterodimers promoted recruitment of TFEB to lysosomes, leading to mTORC1-dependent phosphorylation and inhibition of TFEB",0
85,2,Which transcription factor is considered as a master regulator of lysosomal genes?,"Depletion or inactivation of Rags prevented recruitment of TFEB to lysosomes, whereas expression of active Rags induced association of TFEB with lysosomal membranes",0
85,3,Which transcription factor is considered as a master regulator of lysosomal genes?,"The identification of a master regulator, transcription factor EB (TFEB), that regulates lysosomal biogenesis and autophagy has revealed how the lysosome adapts to environmental cues, such as starvation, and targeting TFEB may provide a novel therapeutic strategy for modulating lysosomal function in human disease",1
85,4,Which transcription factor is considered as a master regulator of lysosomal genes?,TFEB regulates lysosomal proteostasis,0
85,5,Which transcription factor is considered as a master regulator of lysosomal genes?,"Here, we investigate the role of the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and function, in modulating lysosomal proteostasis in LSDs",1
85,6,Which transcription factor is considered as a master regulator of lysosomal genes?,our findings identify TFEB as a specific regulator of lysosomal proteostasis,0
85,7,Which transcription factor is considered as a master regulator of lysosomal genes?,"the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, is induced by starvation through an autoregulatory feedback loop and exerts a global transcriptional control on lipid catabolism",1
85,8,Which transcription factor is considered as a master regulator of lysosomal genes?,A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.,0
85,9,Which transcription factor is considered as a master regulator of lysosomal genes?,"the Transcription Factor EB (TFEB), a master regulator of lysosomal biogenesis, colocalizes with master growth regulator mTOR complex 1 (mTORC1) on the lysosomal membrane",0
85,10,Which transcription factor is considered as a master regulator of lysosomal genes?,the lysosome senses its content and regulates its own biogenesis by a lysosome-to-nucleus signalling mechanism that involves TFEB and mTOR,0
85,11,Which transcription factor is considered as a master regulator of lysosomal genes?,"These data uncover a regulatory network linking an oncogenic transcription factor that is a master regulator of lysosomal biogenesis, TFEB, to mTORC1 and endocytosis.",0
85,12,Which transcription factor is considered as a master regulator of lysosomal genes?,"We showed that the mouse GRN gene has two possible coordinated lysosomal expression and regulation (CLEAR) sequences that bind to transcription factor EB (TFEB), a master regulator of lysosomal genes.",0
85,13,Which transcription factor is considered as a master regulator of lysosomal genes?,"In this paper, we identify a novel role for Rags in controlling activation of transcription factor EB (TFEB), a master regulator of autophagic and lysosomal gene expression.",0
85,14,Which transcription factor is considered as a master regulator of lysosomal genes?,"In particular, active RRAGs interact with the transcription factor EB (TFEB), the master regulator of a gene network that promotes lysosomal biogenesis and autophagy.",0
85,15,Which transcription factor is considered as a master regulator of lysosomal genes?,"Here, we show that the Transcription Factor EB (TFEB), a master regulator of lysosomal biogenesis, colocalizes with master growth regulator mTOR complex 1 (mTORC1) on the lysosomal membrane.",0
85,16,Which transcription factor is considered as a master regulator of lysosomal genes?,"Here, we investigate the role of the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and function, in modulating lysosomal proteostasis in LSDs.",1
85,17,Which transcription factor is considered as a master regulator of lysosomal genes?,"Here we show that the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, is induced by starvation through an autoregulatory feedback loop and exerts a global transcriptional control on lipid catabolism via Ppargc1α and Ppar1α.",0
85,18,Which transcription factor is considered as a master regulator of lysosomal genes?,"Transcription factor EB, a master regulator of lysosomal biogenesis, also negatively regulated HIF-1 activity.",0
85,19,Which transcription factor is considered as a master regulator of lysosomal genes?,"These data uncover a regulatory network linking an oncogenic transcription factor that is a master regulator of lysosomal biogenesis, TFEB, to mTORC1 and endocytosis.",0
85,20,Which transcription factor is considered as a master regulator of lysosomal genes?,"We found that ceria nanoparticles promote activation of the transcription factor EB, a master regulator of lysosomal function and autophagy, and induce upregulation of genes of the lysosome-autophagy system.",0
85,21,Which transcription factor is considered as a master regulator of lysosomal genes?,"The transcription factor EB (TFEB), a master gene for lysosomal biogenesis, coordinated this program by driving expression of autophagy and lysosomal genes.",0
85,22,Which transcription factor is considered as a master regulator of lysosomal genes?,"In particular, active RRAGs interact with the transcription factor EB (TFEB), the master regulator of a gene network that promotes lysosomal biogenesis and autophagy.",0
85,23,Which transcription factor is considered as a master regulator of lysosomal genes?,"We showed that the mouse GRN gene has two possible coordinated lysosomal expression and regulation (CLEAR) sequences that bind to transcription factor EB (TFEB), a master regulator of lysosomal genes.",0
85,24,Which transcription factor is considered as a master regulator of lysosomal genes?,"In this paper, we identify a novel role for Rags in controlling activation of transcription factor EB (TFEB), a master regulator of autophagic and lysosomal gene expression.",0
85,25,Which transcription factor is considered as a master regulator of lysosomal genes?,"We recently discovered the CLEAR (Coordinated Lysosomal Expression and Regulation) gene network and its master gene transcription factor EB (TFEB), which regulates lysosomal biogenesis and function.",0
85,26,Which transcription factor is considered as a master regulator of lysosomal genes?,Transcription factor EB (TFEB) is the only known transcription factor that is a master regulator of lysosomal biogenesis although its role in macrophages has not been studied.,0
85,27,Which transcription factor is considered as a master regulator of lysosomal genes?,"In contrast to its classical function as the waste management machinery, lysosomes are now considered to be an integral part of various cellular signaling processes.",0
85,28,Which transcription factor is considered as a master regulator of lysosomal genes?,"The diverse functionality of this single organelle requires a very complex and coordinated regulation of its activity with transcription factor EB (TFEB), a master regulator of lysosomal biogenesis, at its core.",0
85,29,Which transcription factor is considered as a master regulator of lysosomal genes?,"Here, we show that the Transcription Factor EB (TFEB), a master regulator of lysosomal biogenesis, colocalizes with master growth regulator mTOR complex 1 (mTORC1) on the lysosomal membrane.",0
85,30,Which transcription factor is considered as a master regulator of lysosomal genes?,"We showed that the mouse GRN gene has two possible coordinated lysosomal expression and regulation (CLEAR) sequences that bind to transcription factor EB (TFEB), a master regulator of lysosomal genes.",0
85,31,Which transcription factor is considered as a master regulator of lysosomal genes?,"In this paper, we identify a novel role for Rags in controlling activation of transcription factor EB (TFEB), a master regulator of autophagic and lysosomal gene expression.",0
85,32,Which transcription factor is considered as a master regulator of lysosomal genes?,"We observed that the MiT family of transcription factors, which includes the melanoma oncogene MITF (micropthalmia-associated transcription factor) and the lysosomal master regulator TFEB, had the highest phylogenetic conservation of three consecutive putative GSK3 phosphorylation sites in animal proteomes.",0
85,33,Which transcription factor is considered as a master regulator of lysosomal genes?,"Transcription factor EB, a master regulator of lysosomal biogenesis, also negatively regulated HIF-1 activity.",0
85,34,Which transcription factor is considered as a master regulator of lysosomal genes?,"Here, we investigate the role of the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and function, in modulating lysosomal proteostasis in LSDs.",1
85,35,Which transcription factor is considered as a master regulator of lysosomal genes?,Transcription factor EB (TFEB) is the only known transcription factor that is a master regulator of lysosomal biogenesis although its role in macrophages has not been studied.,0
85,36,Which transcription factor is considered as a master regulator of lysosomal genes?,"These data uncover a regulatory network linking an oncogenic transcription factor that is a master regulator of lysosomal biogenesis, TFEB, to mTORC1 and endocytosis.",0
85,37,Which transcription factor is considered as a master regulator of lysosomal genes?,"In particular, active RRAGs interact with the transcription factor EB (TFEB), the master regulator of a gene network that promotes lysosomal biogenesis and autophagy.",0
4190,0,Do honey contain diastases/amylases?,A new rapid method for the determination of honey diastase activity using direct potentiometric principles has been proposed.,1
4190,1,Do honey contain diastases/amylases?,The major alpha-amylase in honey was characterized.,1
4190,2,Do honey contain diastases/amylases?,Separation of honey amylase,1
2443,0,What is GenomeVIP?,"Here, we introduce the Genome Variant Investigation Platform (GenomeVIP), an open-source framework for performing genomics variant discovery and annotation using cloud- or local high-performance computing infrastructure.",1
2443,1,What is GenomeVIP?,"GenomeVIP orchestrates the analysis of whole-genome and exome sequence data using a set of robust and popular task-specific tools, including VarScan, GATK, Pindel, BreakDancer, Strelka, and Genome STRiP, through a web interface.",1
2443,2,What is GenomeVIP?,"Here, we introduce the Genome Variant Investigation Platform (GenomeVIP), an open-source framework for performing genomics variant discovery and annotation using cloud- or local high-performance computing infrastructure.",1
2443,3,What is GenomeVIP?,GenomeVIP orchestrates the analysis of whole-genome and exome sequence data using a set of robust and popular task-specific tools,1
2443,4,What is GenomeVIP?,"Here, we demonstrate GenomeVIP's ability to provide high-confidence annotated somatic, germline, and de novo variants of potential biological significance using publicly available data sets.",0
2443,5,What is GenomeVIP?,"GenomeVIP has been used for genomic analysis in large-data projects such as the TCGA PanCanAtlas and in other projects, such as the ICGC Pilots, CPTAC, ICGC-TCGA DREAM Challenges, and the 1000 Genomes SV Project.",0
2443,6,What is GenomeVIP?,"GenomeVIP orchestrates the analysis of whole-genome and exome sequence data using a set of robust and popular task-specific tools, including VarScan, GATK, Pindel, BreakDancer, Strelka, and Genome STRiP, through a web interface.",1
2443,7,What is GenomeVIP?,GenomeVIP: a cloud platform for genomic variant discovery and interpretation.,0
2443,8,What is GenomeVIP?,GenomeVIP: a cloud platform for genomic variant discovery and interpretation.,0
2443,9,What is GenomeVIP?,"Here, we demonstrate GenomeVIP's ability to provide high-confidence annotated somatic, germline, and de novo variants of potential biological significance using publicly available data sets..",0
2443,10,What is GenomeVIP?,"Here, we demonstrate GenomeVIP's ability to provide high-confidence annotated somatic, germline, and de novo variants of potential biological significance using publicly available data sets.<br>",0
3933,0,What are the end products of the shikimate pathway?,The shikimate pathway is indispensable for the biosynthesis of natural products with aromatic moieties.,1
3933,1,What are the end products of the shikimate pathway?,"In plants, the shikimate pathway generally occurs in plastids and leads to the biosynthesis of aromatic amino acids.",1
3933,2,What are the end products of the shikimate pathway?,the shikimate pathway responsible for the generation of aromatic amino acids,1
3933,3,What are the end products of the shikimate pathway?,Microorganisms are able to synthesize aromatic amino acids through the shikimate pathway.,1
3933,4,What are the end products of the shikimate pathway?,aromatic amino acid synthesis via the shikimate pathway,1
3897,0,Can Freund's complete adjuvant induce arthritis?,complete Freund's adjuvant (CFA) induced RA,1
3897,1,Can Freund's complete adjuvant induce arthritis?,"The RA model was established using Freund's complete adjuvant,",1
3897,2,Can Freund's complete adjuvant induce arthritis?," Rheumatoid arthritis (RA) was induced by Freund's Complete Adjuvant (FCA; 1 mg/0.1 ml paraffin oil), injected subcutaneously on days 0, 30 and 40",1
3897,3,Can Freund's complete adjuvant induce arthritis?,The rats were made arthritic using a subcutaneous injection with 0.1 ml complete Freund's adjuvant (CFA) into the footpad of the left hind paw.,1
2217,0,List clinical features of EEM syndrome.,"Hypotrichosis with juvenile macular dystrophy (HJMD) and ectodermal dysplasia, ectrodactyly and macular dystrophy (EEM) are both caused by mutations in the CDH3 gene.",0
2217,1,List clinical features of EEM syndrome.,"Loss-of-function mutations in CDH3, which encodes P-cadherin, result in two allelic autosomal recessive disorders: hypotrichosis with juvenile macular dystrophy (HJMD) and ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM) syndromes.",0
2217,2,List clinical features of EEM syndrome.,"Recently, mutations in the P-cadherin gene (CDH3) have been shown to cause two inherited diseases in humans: hypotrichosis with juvenile macular dystrophy (HJMD) and ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome).",0
2217,3,List clinical features of EEM syndrome.,"EEM syndrome is a rare condition characterised by ectodermal dysplasia, ectrodactyly and macular dystrophy.",1
2217,4,List clinical features of EEM syndrome.,"BACKGROUND: EEM syndrome is the rare association of ectodermal dysplasia, ectrodactyly, and macular dystrophy.",1
2217,5,List clinical features of EEM syndrome.,"Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome).",0
2217,6,List clinical features of EEM syndrome.,"Ectodermal dysplasia, ectrodactyly and macular dystrophy (EEM syndrome) in siblings.",1
2217,7,List clinical features of EEM syndrome.,"Association of ectodermal dysplasia, ectrodactyly, and macular dystrophy: the EEM syndrome.",0
2217,8,List clinical features of EEM syndrome.,"Association of ectodermal dysplasia, ectrodactyly and macular dystrophy: EEM syndrome (case report).",0
2217,9,List clinical features of EEM syndrome.,"EEM syndrome is the rare association of ectodermal dysplasia, ectrodactyly, and macular dystrophy.",1
2217,10,List clinical features of EEM syndrome.,"We report a brother and sister with ectodermal dysplasia, ectrodactyly, and macular dystrophy (the EEM syndrome).",0
2217,11,List clinical features of EEM syndrome.,"Ectodermal dysplasia, ectrodactyly and macular dystrophy (EEM syndrome) in siblings.",1
2217,12,List clinical features of EEM syndrome.,"Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome).",0
1561,0,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.",0
1561,1,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems.,0
1561,2,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed of catalytic and regulatory subunits.",0
1561,3,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,The serine/threonine-specific phosphatase functions within a signal transduction pathway that regulates gene expression and biological responses in many developmentally important cell types.,0
1561,4,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,Calcineurin signaling was first defined in T lymphocytes as a regulator of nuclear factor of activated T cells (NFAT) transcription factor nuclear translocation and activation.,0
1561,5,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,NFAT (nuclear factor of activated T cell) proteins are expressed in most immune system cells and regulate the transcription of cytokine genes critical for the immune response.,0
1561,6,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).,1
1561,7,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.,1
1561,8,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Calcium activated gene transcription through Nuclear Factor of Activated T-cells, (NFAT) proteins, is emerging as a ubiquitous mechanism for the control of important physiological processes.",0
1561,9,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Of the five mammalian NFAT isoforms, transcriptional activities of NFATs 1-4 are stimulated by a calcium driven association between the ubiquitous phosphatase calcineurin and the calcium-sensing protein calmodulin.",0
1561,10,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,Transcription factors of the NFAT (nuclear factor of activated T cells) family are expressed in most immune system cells and in a range of other cell types.,0
1561,11,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Signaling through NFAT is implicated in the regulation of transcription for the immune response and other processes, including differentiation and apoptosis.",0
1561,12,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"NFAT normally resides in the cytoplasm, and a key aspect of the NFAT activation pathway is the regulation of its nuclear import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",1
1561,13,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,The nuclear factor of activated T cells (NFAT) group of transcription factors is retained in the cytoplasm of quiescent cells.,0
1561,14,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,NFAT activation is mediated in part by induced nuclear import.,0
1561,15,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,This process requires calcium-dependent dephosphorylation of NFAT caused by the phosphatase calcineurin.,0
1561,16,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,The calcium-regulated protein phosphatase calcineurin (PP2B) functions as a regulator of gene expression in diverse tissues through the dephosphorylation and activation of a family of transcription factors known as nuclear factor of activated T cells (NFAT).,0
1561,17,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Calcineurin, a Ca(2+)/calmodulin-stimulated protein phosphatase, plays a key role in T-cell activation by regulating the activity of NFAT (nuclear factor of activated T cells), a family of transcription factors required for the synthesis of several cytokine genes.",0
1561,18,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"The calcium/calmodulin-dependent phosphatase calcineurin, which signals to nuclear factor of activated T cells (NFAT) transcription factors, serves as a transducer of calcium signals and is sufficient and necessary for pathologic cardiac hypertrophy and remodeling.",0
1561,19,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Upon activation, Cn directly binds to, and dephosphorylates nuclear factor of activated T cells (NFAT) transcription factors within the cytoplasm allowing them to translocate to the nucleus and participate in the regulation of gene expression.",0
1561,20,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,The functions of NFAT proteins are directly controlled by the calcium- and calmodulin-dependent phosphatase calcineurin.,1
1561,21,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,"Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin",0
1561,22,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN),1
1561,23,Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?,The functions of NFAT proteins are directly controlled by the calcium- and calmodulin-dependent phosphatase calcineurin,0
